Citrus Sinensis ID: 003232
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 837 | 2.2.26 [Sep-21-2011] | |||||||
| Q559T8 | 2102 | Probable serine/threonine | yes | no | 0.286 | 0.114 | 0.528 | 1e-76 | |
| Q6AX33 | 1482 | Microtubule-associated se | N/A | no | 0.311 | 0.176 | 0.434 | 7e-62 | |
| Q60592 | 1734 | Microtubule-associated se | yes | no | 0.293 | 0.141 | 0.454 | 2e-61 | |
| Q6P0Q8 | 1798 | Microtubule-associated se | yes | no | 0.293 | 0.136 | 0.454 | 3e-61 | |
| Q3U214 | 1321 | Microtubule-associated se | no | no | 0.274 | 0.174 | 0.459 | 7e-60 | |
| Q811L6 | 2618 | Microtubule-associated se | no | no | 0.293 | 0.093 | 0.443 | 7e-59 | |
| O60307 | 1309 | Microtubule-associated se | no | no | 0.273 | 0.174 | 0.453 | 8e-59 | |
| Q9Y2H9 | 1570 | Microtubule-associated se | no | no | 0.265 | 0.141 | 0.466 | 1e-58 | |
| O15021 | 2626 | Microtubule-associated se | no | no | 0.264 | 0.084 | 0.455 | 2e-58 | |
| Q9R1L5 | 1570 | Microtubule-associated se | no | no | 0.264 | 0.140 | 0.468 | 2e-58 |
| >sp|Q559T8|Y0701_DICDI Probable serine/threonine-protein kinase DDB_G0272282 OS=Dictyostelium discoideum GN=DDB_G0272282 PE=3 SV=1 | Back alignment and function desciption |
|---|
Score = 288 bits (737), Expect = 1e-76, Method: Compositional matrix adjust.
Identities = 146/276 (52%), Positives = 180/276 (65%), Gaps = 36/276 (13%)
Query: 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR 647
I DFEIIKPISRGAFGRV+LA+K+ TGDL+AIKVLKK D IRKN V ++ ER+IL V+
Sbjct: 1524 IADFEIIKPISRGAFGRVYLAQKKKTGDLYAIKVLKKLDTIRKNMVNHVIVERNILAMVQ 1583
Query: 648 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS 707
N FVV+ FY+F + LYLVMEYL GGD SLLR LGC +E +A+ YIAE VL LEYLH
Sbjct: 1584 NEFVVKLFYAFQSTDKLYLVMEYLIGGDCASLLRALGCFEEHMAKHYIAETVLCLEYLHK 1643
Query: 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS------------------------ 743
+VHRDLKPDN+LI GHIKLTDFGLSK+G+I+
Sbjct: 1644 SAIVHRDLKPDNMLIDGLGHIKLTDFGLSKIGIIDDKKMEDSGNTNTNTHFNFSTSPTNT 1703
Query: 744 --TDDLS---GPAVSGTTLLGDEEPQLTASEHQQERRKK-------RSAVGTPDYLAPEI 791
DD S P +G T L + + + Q++ K + VGTPDYL+PEI
Sbjct: 1704 SMMDDSSTTGNPNGNGNTSLNSSQTNILSPYPQRKNTLKTPLKKPVKKVVGTPDYLSPEI 1763
Query: 792 LLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQV 827
LLGTGHG T DWW++GIIL+E + G PPFN + P++
Sbjct: 1764 LLGTGHGQTVDWWALGIILYEFLTGSPPFNDDTPEL 1799
|
Dictyostelium discoideum (taxid: 44689) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q6AX33|MAST3_XENLA Microtubule-associated serine/threonine-protein kinase 3 OS=Xenopus laevis GN=mast3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 239 bits (610), Expect = 7e-62, Method: Compositional matrix adjust.
Identities = 123/283 (43%), Positives = 167/283 (59%), Gaps = 22/283 (7%)
Query: 544 LCELVTDDKVDITSTVIEEDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFG 603
L E+V D D S++ + D + P PS+ + DFE IK IS GA+G
Sbjct: 358 LEEIVQLDHYDTESSLQLDQEDYHDPYI------PSTPSRKKPCESDFETIKLISNGAYG 411
Query: 604 RVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCREN 663
V+L + + T FA+K + K ++I +N + + ERDIL NPFVV F SF R +
Sbjct: 412 AVYLVRHKETRQRFAMKKINKQNLILRNQIHQVFVERDILTFAENPFVVSMFCSFETRRH 471
Query: 664 LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA 723
L +VMEY+ GGD +LL+N+G L D++R+Y AE VLALEYLH+ +VHRDLKPDNLLI
Sbjct: 472 LCMVMEYVEGGDCATLLKNMGPLPVDMSRMYFAETVLALEYLHNYGIVHRDLKPDNLLIT 531
Query: 724 HDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGT 783
GHIKLTDFGLSKVGL+N T +L + E + GT
Sbjct: 532 SLGHIKLTDFGLSKVGLMNMTTNLYEGHI----------------EKDTREFLDKQVCGT 575
Query: 784 PDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826
P+Y+APE++L G+G DWW++GIIL+E +VG PF + P+
Sbjct: 576 PEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE 618
|
Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q60592|MAST2_MOUSE Microtubule-associated serine/threonine-protein kinase 2 OS=Mus musculus GN=Mast2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 238 bits (607), Expect = 2e-61, Method: Compositional matrix adjust.
Identities = 120/264 (45%), Positives = 161/264 (60%), Gaps = 18/264 (6%)
Query: 563 DAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVL 622
D P DD V S PS+ S +DFE IK IS GA+G VFL + ++T FA+K +
Sbjct: 427 DTPETDDSVEGRGVS--QPSQKTPSEEDFETIKLISNGAYGAVFLVRHKSTRQRFAMKKI 484
Query: 623 KKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN 682
K ++I +N ++ ERDIL NPFVV F SF + +L +VMEY+ GGD +LL+N
Sbjct: 485 NKQNLILRNQIQQAFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKN 544
Query: 683 LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742
+G L D+ R+Y AE VLALEYLH+ +VHRDLKPDNLLI GHIKLTDFGLSK+GL++
Sbjct: 545 IGALPVDMVRLYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 604
Query: 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTAD 802
T +L + E + GTP+Y+APE++L G+G D
Sbjct: 605 LTTNLYEGHI----------------EKDAREFLDKQVCGTPEYIAPEVILRQGYGKPVD 648
Query: 803 WWSVGIILFELIVGIPPFNAEHPQ 826
WW++GIIL+E +VG PF + P+
Sbjct: 649 WWAMGIILYEFLVGCVPFFGDTPE 672
|
Appears to link the dystrophin/utrophin network with microtubule filaments via the syntrophins. Phosphorylation of DMD or UTRN may modulate their affinities for associated proteins. Functions in a multi-protein complex in spermatid maturation. Regulates lipopolysaccharide-induced IL-12 synthesis in macrophages by forming a complex with TRAF6, resulting in the inhibition of TRAF6 NF-kappa-B activation. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6P0Q8|MAST2_HUMAN Microtubule-associated serine/threonine-protein kinase 2 OS=Homo sapiens GN=MAST2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 237 bits (604), Expect = 3e-61, Method: Compositional matrix adjust.
Identities = 120/264 (45%), Positives = 161/264 (60%), Gaps = 18/264 (6%)
Query: 563 DAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVL 622
D P DD + S PSK S +DFE IK IS GA+G VFL + ++T FA+K +
Sbjct: 486 DTPETDDSIEGHGAS--LPSKKTPSEEDFETIKLISNGAYGAVFLVRHKSTRQRFAMKKI 543
Query: 623 KKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN 682
K ++I +N ++ ERDIL NPFVV F SF + +L +VMEY+ GGD +LL+N
Sbjct: 544 NKQNLILRNQIQQAFVERDILTFAENPFVVSMFCSFDTKRHLCMVMEYVEGGDCATLLKN 603
Query: 683 LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742
+G L D+ R+Y AE VLALEYLH+ +VHRDLKPDNLLI GHIKLTDFGLSK+GL++
Sbjct: 604 IGALPVDMVRLYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 663
Query: 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTAD 802
T +L + E + GTP+Y+APE++L G+G D
Sbjct: 664 LTTNLYEGHI----------------EKDAREFLDKQVCGTPEYIAPEVILRQGYGKPVD 707
Query: 803 WWSVGIILFELIVGIPPFNAEHPQ 826
WW++GIIL+E +VG PF + P+
Sbjct: 708 WWAMGIILYEFLVGCVPFFGDTPE 731
|
Appears to link the dystrophin/utrophin network with microtubule filaments via the syntrophins. Phosphorylation of DMD or UTRN may modulate their affinities for associated proteins. Functions in a multi-protein complex in spermatid maturation. Regulates lipopolysaccharide-induced IL-12 synthesis in macrophages by forming a complex with TRAF6, resulting in the inhibition of TRAF6 NF-kappa-B activation. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3U214|MAST3_MOUSE Microtubule-associated serine/threonine-protein kinase 3 OS=Mus musculus GN=Mast3 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 232 bits (592), Expect = 7e-60, Method: Compositional matrix adjust.
Identities = 113/246 (45%), Positives = 153/246 (62%), Gaps = 16/246 (6%)
Query: 581 PSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAER 640
PS+ + DFE IK IS GA+G V+L + R T FAIK + K ++I +N ++ + ER
Sbjct: 379 PSRRKPCESDFETIKLISNGAYGAVYLVRHRDTRQRFAIKKINKQNLILRNQIQQVFVER 438
Query: 641 DILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVL 700
DIL NPFVV F SF R +L +VMEY+ GGD +LL+N+G L D+AR+Y AE VL
Sbjct: 439 DILTFAENPFVVGMFCSFETRRHLCMVMEYVEGGDCATLLKNMGPLPVDMARMYFAETVL 498
Query: 701 ALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGD 760
ALEYLH+ +VHRDLKPDNLLI GHIKLTDFGLSK+GL++ +L +
Sbjct: 499 ALEYLHNYGIVHRDLKPDNLLITSLGHIKLTDFGLSKIGLMSMATNLYEGHI-------- 550
Query: 761 EEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820
E + GTP+Y+APE++ G+G DWW++G+IL+E +VG PF
Sbjct: 551 --------EKDAREFVDKQVCGTPEYIAPEVIFRQGYGKPVDWWAMGVILYEFLVGCVPF 602
Query: 821 NAEHPQ 826
+ P+
Sbjct: 603 FGDTPE 608
|
Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q811L6|MAST4_MOUSE Microtubule-associated serine/threonine-protein kinase 4 OS=Mus musculus GN=Mast4 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 229 bits (584), Expect = 7e-59, Method: Compositional matrix adjust.
Identities = 117/264 (44%), Positives = 160/264 (60%), Gaps = 18/264 (6%)
Query: 563 DAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVL 622
+ P D+ V S TS K R S DFE IK IS GA+G V+ + + + FA+K +
Sbjct: 542 ETPEMDESVSSSNTSLRLRRKPRES--DFETIKLISNGAYGAVYFVRHKESRQRFAMKKI 599
Query: 623 KKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN 682
K ++I +N ++ ERDIL NPFVV + SF R +L +VMEY+ GGD +L++N
Sbjct: 600 NKQNLILRNQIQQAFVERDILTFAENPFVVSMYCSFETRRHLCMVMEYVEGGDCATLMKN 659
Query: 683 LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742
+G L D+AR+Y AE VLALEYLH+ +VHRDLKPDNLL+ GHIKLTDFGLSKVGL++
Sbjct: 660 MGPLPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLVTSMGHIKLTDFGLSKVGLMS 719
Query: 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTAD 802
T +L + E + GTP+Y+APE++L G+G D
Sbjct: 720 MTTNLYEGHI----------------EKDAREFLDKQVCGTPEYIAPEVILRQGYGKPVD 763
Query: 803 WWSVGIILFELIVGIPPFNAEHPQ 826
WW++GIIL+E +VG PF + P+
Sbjct: 764 WWAMGIILYEFLVGCVPFFGDTPE 787
|
Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O60307|MAST3_HUMAN Microtubule-associated serine/threonine-protein kinase 3 OS=Homo sapiens GN=MAST3 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 229 bits (583), Expect = 8e-59, Method: Compositional matrix adjust.
Identities = 111/245 (45%), Positives = 152/245 (62%), Gaps = 16/245 (6%)
Query: 582 SKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERD 641
S+ + DFE IK IS GA+G V+L + R T FAIK + K ++I +N ++ + ERD
Sbjct: 358 SRRKPCESDFETIKLISNGAYGAVYLVRHRDTRQRFAIKKINKQNLILRNQIQQVFVERD 417
Query: 642 ILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLA 701
IL NPFVV F SF R +L +VMEY+ GGD +LL+N+G L D+AR+Y AE VLA
Sbjct: 418 ILTFAENPFVVSMFCSFETRRHLCMVMEYVEGGDCATLLKNMGPLPVDMARLYFAETVLA 477
Query: 702 LEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDE 761
LEYLH+ +VHRDLKPDNLLI GHIKLTDFGLSK+GL++ +L +
Sbjct: 478 LEYLHNYGIVHRDLKPDNLLITSLGHIKLTDFGLSKIGLMSMATNLYEGHI--------- 528
Query: 762 EPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFN 821
E + GTP+Y+APE++ G+G DWW++G++L+E +VG PF
Sbjct: 529 -------EKDAREFIDKQVCGTPEYIAPEVIFRQGYGKPVDWWAMGVVLYEFLVGCVPFF 581
Query: 822 AEHPQ 826
+ P+
Sbjct: 582 GDTPE 586
|
Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9Y2H9|MAST1_HUMAN Microtubule-associated serine/threonine-protein kinase 1 OS=Homo sapiens GN=MAST1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 228 bits (582), Expect = 1e-58, Method: Compositional matrix adjust.
Identities = 111/238 (46%), Positives = 151/238 (63%), Gaps = 16/238 (6%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+DF+ IK IS GA+G V+L + R T FA+K + K ++I +N ++ ERDIL N
Sbjct: 372 NDFDTIKLISNGAYGAVYLVRHRDTRQRFAMKKINKQNLILRNQIQQAFVERDILTFAEN 431
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
PFVV F SF R +L +VMEY+ GGD +LL+N+G L ++AR+Y AE VLALEYLH+
Sbjct: 432 PFVVGMFCSFETRRHLCMVMEYVEGGDCATLLKNIGALPVEMARMYFAETVLALEYLHNY 491
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTAS 768
+VHRDLKPDNLLI GHIKLTDFGLSK+GL++ T +L +
Sbjct: 492 GIVHRDLKPDNLLITSMGHIKLTDFGLSKMGLMSLTTNLYEGHI---------------- 535
Query: 769 EHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826
E + GTP+Y+APE++L G+G DWW++GIIL+E +VG PF + P+
Sbjct: 536 EKDAREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE 593
|
Appears to link the dystrophin/utrophin network with microtubule filaments via the syntrophins. Phosphorylation of DMD or UTRN may modulate their affinities for associated proteins. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O15021|MAST4_HUMAN Microtubule-associated serine/threonine-protein kinase 4 OS=Homo sapiens GN=MAST4 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 228 bits (581), Expect = 2e-58, Method: Compositional matrix adjust.
Identities = 108/237 (45%), Positives = 149/237 (62%), Gaps = 16/237 (6%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
DFE IK IS GA+G V+ + + + FA+K + K ++I +N ++ ERDIL NP
Sbjct: 572 DFETIKLISNGAYGAVYFVRHKESRQRFAMKKINKQNLILRNQIQQAFVERDILTFAENP 631
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLR 709
FVV + SF R +L +VMEY+ GGD +L++N+G L D+AR+Y AE VLALEYLH+
Sbjct: 632 FVVSMYCSFETRRHLCMVMEYVEGGDCATLMKNMGPLPVDMARMYFAETVLALEYLHNYG 691
Query: 710 VVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASE 769
+VHRDLKPDNLL+ GHIKLTDFGLSKVGL++ T +L + E
Sbjct: 692 IVHRDLKPDNLLVTSMGHIKLTDFGLSKVGLMSMTTNLYEGHI----------------E 735
Query: 770 HQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826
+ GTP+Y+APE++L G+G DWW++GIIL+E +VG PF + P+
Sbjct: 736 KDAREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE 792
|
Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9R1L5|MAST1_MOUSE Microtubule-associated serine/threonine-protein kinase 1 OS=Mus musculus GN=Mast1 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 228 bits (580), Expect = 2e-58, Method: Compositional matrix adjust.
Identities = 111/237 (46%), Positives = 150/237 (63%), Gaps = 16/237 (6%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
DF+ IK IS GA+G V+L + R T FA+K + K ++I +N ++ ERDIL NP
Sbjct: 375 DFDTIKLISNGAYGAVYLVRHRDTRQRFAMKKINKQNLILRNQIQQAFVERDILTFAENP 434
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLR 709
FVV F SF R +L +VMEY+ GGD +LL+N+G L ++AR+Y AE VLALEYLH+
Sbjct: 435 FVVGMFCSFETRRHLCMVMEYVEGGDCATLLKNIGALPVEMARMYFAETVLALEYLHNYG 494
Query: 710 VVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASE 769
+VHRDLKPDNLLI GHIKLTDFGLSK+GL++ T +L + E
Sbjct: 495 IVHRDLKPDNLLITSMGHIKLTDFGLSKMGLMSLTTNLYEGHI----------------E 538
Query: 770 HQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826
+ GTP+Y+APE++L G+G DWW++GIIL+E +VG PF + P+
Sbjct: 539 KDAREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE 595
|
Appears to link the dystrophin/utrophin network with microtubule filaments via the syntrophins. Phosphorylation of DMD or UTRN may modulate their affinities for associated proteins. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 837 | ||||||
| 255585466 | 1289 | kinase, putative [Ricinus communis] gi|2 | 0.964 | 0.626 | 0.855 | 0.0 | |
| 224133272 | 1319 | predicted protein [Populus trichocarpa] | 0.961 | 0.610 | 0.818 | 0.0 | |
| 359491046 | 1304 | PREDICTED: uncharacterized protein LOC10 | 0.960 | 0.616 | 0.832 | 0.0 | |
| 224121136 | 1322 | predicted protein [Populus trichocarpa] | 0.955 | 0.605 | 0.817 | 0.0 | |
| 356529485 | 1395 | PREDICTED: uncharacterized protein LOC10 | 0.961 | 0.577 | 0.803 | 0.0 | |
| 356520647 | 1296 | PREDICTED: uncharacterized protein LOC10 | 0.960 | 0.620 | 0.798 | 0.0 | |
| 9294489 | 1398 | IRE homolog; protein kinase-like protein | 0.952 | 0.570 | 0.750 | 0.0 | |
| 30684702 | 1296 | protein kinase family protein [Arabidops | 0.952 | 0.614 | 0.750 | 0.0 | |
| 26449548 | 1296 | putative protein kinase [Arabidopsis tha | 0.952 | 0.614 | 0.750 | 0.0 | |
| 6729348 | 1023 | IRE homolog 1 [Arabidopsis thaliana] | 0.952 | 0.779 | 0.750 | 0.0 |
| >gi|255585466|ref|XP_002533426.1| kinase, putative [Ricinus communis] gi|223526726|gb|EEF28957.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1392 bits (3604), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 694/811 (85%), Positives = 741/811 (91%), Gaps = 4/811 (0%)
Query: 18 EEILVVIRTKFDKAKEEVNSDLAVFAGDLVGILEKNAESHPEWQETIEDLLVLARSCAMT 77
EEILVVIR KFDKAKEEVNSDLA+FA DLVG+LEKNAESHPEWQETIEDLLVLARSCAM+
Sbjct: 307 EEILVVIRAKFDKAKEEVNSDLAIFAADLVGVLEKNAESHPEWQETIEDLLVLARSCAMS 366
Query: 78 SPGEFWLQCEGIVQELDDRRQELPPGTLKQLYTRMLFILTRCTRLLQFHKESALAEDEHM 137
SP EFWLQCE IVQELDDRRQELPPG LKQL+TRMLFILTRCTRLLQFHKES LAEDE++
Sbjct: 367 SPSEFWLQCESIVQELDDRRQELPPGMLKQLHTRMLFILTRCTRLLQFHKESGLAEDENV 426
Query: 138 FQFRQSRVLHSADKRIPQGTLRDGKGSTIAKASKAASSRKSYSQEQHGLDWKRDHAVKQG 197
FQ RQSR+LHSA+KRIP +RDGK S+ AKASKAAS++KSYSQEQHGLDWKRD + G
Sbjct: 427 FQLRQSRLLHSAEKRIPPSIVRDGKSSSAAKASKAASAKKSYSQEQHGLDWKRDQVAQLG 486
Query: 198 NILSPPGDDNAKSLESSAARDRMSSWKKLPSPVGKIMKESPTSKEQNDGKVEPLKSSNIR 257
+ L P DD +K+++S + RM+SWK+LPSP GK +KE SKE ND K+EPLK N R
Sbjct: 487 SSL-PTADDASKNMDSPGSGARMASWKRLPSPAGKSVKEVAPSKENNDCKIEPLKILNNR 545
Query: 258 RGLSEIDLTA-KPSEFPPAAETLEHSSKHQHKVSWGYWGDQQNISDDSSSIICRICEEEV 316
+G+S+ DLTA K SE P A ++ EHS KHQHK+SWGYWGDQQN+SDD+S IICRICEEEV
Sbjct: 546 KGVSDADLTATKLSELPVAKDSHEHSMKHQHKISWGYWGDQQNVSDDTS-IICRICEEEV 604
Query: 317 PTSHVEDHSKICAIADRCDQKGLSVNERLLRISETLEKMMESSVQKDIHNVVVGSPDVAK 376
PT HVEDHS+ICAIADR DQKGLSVNERL RISETL+KM+ES QKD VGSPDVAK
Sbjct: 605 PTLHVEDHSRICAIADRSDQKGLSVNERLARISETLDKMIESIAQKDTQ-PAVGSPDVAK 663
Query: 377 VSNSSVTEESDVLSPKFSDWSRRGSEDMLDYVPEADNSVFMDDLKGLPSMACKTRFGPKS 436
VSNSSVTEESDVLSPK SDWSRRGSEDMLD PEADNSVFMDDLKGLPSM+CKTRFGPKS
Sbjct: 664 VSNSSVTEESDVLSPKLSDWSRRGSEDMLDCFPEADNSVFMDDLKGLPSMSCKTRFGPKS 723
Query: 437 DQGMTTSSAGSMTPRSPLLTPRTSQIDLLLAGKGALSEHDDFPQMNELADIARCVATTPL 496
DQGM TSSAGSMTPRSPLLTPRTS IDLLL GKGA SEHDD PQM ELADIARCV TTPL
Sbjct: 724 DQGMATSSAGSMTPRSPLLTPRTSPIDLLLTGKGAFSEHDDLPQMTELADIARCVVTTPL 783
Query: 497 DDDSSIPYLLSFLEDLRVVIDRRKFDALTVETFGARIEKLIREKYLQLCELVTDDKVDIT 556
DDD SIPYLLS LEDLRVVIDRRKFDALTVETFG RIEKLIREKYLQLCELV D++VDIT
Sbjct: 784 DDDRSIPYLLSCLEDLRVVIDRRKFDALTVETFGTRIEKLIREKYLQLCELVEDERVDIT 843
Query: 557 STVIEEDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDL 616
ST+I+EDAPLEDDVVRSLRTSPIH SKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDL
Sbjct: 844 STIIDEDAPLEDDVVRSLRTSPIHSSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDL 903
Query: 617 FAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 676
FAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL
Sbjct: 904 FAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 963
Query: 677 YSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS 736
YSLLRNLGCLDE+VARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS
Sbjct: 964 YSLLRNLGCLDEEVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS 1023
Query: 737 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG 796
KVGLINSTDDLSGPAVSGT++L D+EPQL+ASEHQ+ERRKKRSAVGTPDYLAPEILLGTG
Sbjct: 1024 KVGLINSTDDLSGPAVSGTSMLEDDEPQLSASEHQRERRKKRSAVGTPDYLAPEILLGTG 1083
Query: 797 HGTTADWWSVGIILFELIVGIPPFNAEHPQV 827
HGTTADWWSVG+ILFELIVGIPPFNAEHPQ+
Sbjct: 1084 HGTTADWWSVGVILFELIVGIPPFNAEHPQI 1114
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224133272|ref|XP_002321526.1| predicted protein [Populus trichocarpa] gi|222868522|gb|EEF05653.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1350 bits (3493), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 673/822 (81%), Positives = 720/822 (87%), Gaps = 17/822 (2%)
Query: 18 EEILVVIRTKFDKAKEEVNSDLAVFAGDLVGILEKNAESHPEWQETIEDLLVLARSCAMT 77
EEILVVIR KFDKAKEEVNSDLAVFA DLVGILEKNA+SHPEWQETIEDLLVLARSCAMT
Sbjct: 328 EEILVVIRAKFDKAKEEVNSDLAVFAADLVGILEKNADSHPEWQETIEDLLVLARSCAMT 387
Query: 78 SPGEFWLQCEGIVQELDDRRQELPPGTLKQLYTRMLFILTRCTRLLQFHKESALAEDEHM 137
SPGEFWLQCEGIVQ+LDDRRQELPPG LKQL+TRMLFILTRCTRLLQFHKES LAEDE++
Sbjct: 388 SPGEFWLQCEGIVQDLDDRRQELPPGILKQLHTRMLFILTRCTRLLQFHKESGLAEDENI 447
Query: 138 FQFRQSRVLHSADKRIPQGTLRDGK-----------GSTIAKASKAASSRKSYSQEQHGL 186
FQ Q R+L SADK IP G RDGK + ++ KAAS RKSYSQEQ
Sbjct: 448 FQLHQLRLLQSADKHIPPGVGRDGKISSAPKKAASAKKSYSQEQKAASVRKSYSQEQCA- 506
Query: 187 DWKRDHAVKQGNILSPPGDDNAKSLESSAARDRMSSWKKLPSPVGKIMKESPTSKEQNDG 246
W R+ V G LSP D+ KS ES R+R+SSWK LPSP KI KE + QND
Sbjct: 507 -WGREQDVLPGKFLSP-ADNTPKSDESPTGRNRISSWKPLPSPPVKITKEVVPPRGQNDD 564
Query: 247 KVEPLKSSNIRRGLSEIDLTA-KPSEFPPAAETLEHSSKHQHKVSWGYWGDQQNISDDSS 305
K EPLK+SN R+G S++ L A K SE P + EHS+KHQHK+SWG WGDQQNI+D+SS
Sbjct: 565 KNEPLKTSNDRKGASDVLLAAAKASELPLVKDLHEHSTKHQHKISWGNWGDQQNIADESS 624
Query: 306 SIICRICEEEVPTSHVEDHSKICAIADRCDQKGLSVNERLLRISETLEKMMESSVQKDIH 365
IICRICEEEVPT +VEDHS+ICAI DRCDQ LSVNERL+RISETLEKM+ES QKDI
Sbjct: 625 -IICRICEEEVPTLYVEDHSRICAITDRCDQMCLSVNERLIRISETLEKMIESFAQKDIQ 683
Query: 366 NVVVGSPDVAKVSNSSVTEESDVLSPKFSDWSRRGSEDMLDYVPEADNSVFMDDLKGLPS 425
+ V GSPD+AKVSNSSVTEESDVLSPK SDWSRRGSEDMLD+ PEADNS+FMDD+KGLPS
Sbjct: 684 HAV-GSPDIAKVSNSSVTEESDVLSPKLSDWSRRGSEDMLDFFPEADNSIFMDDMKGLPS 742
Query: 426 MACKTRFGPKSDQGMTTSSAGSMTPRSPLLTPRTSQIDLLLAGKGALSEHDDFPQMNELA 485
M+CKTRFGPKSDQGM TSSAGSMTPRSPLLTPR SQIDLLLAGK A SEHDD PQ+NELA
Sbjct: 743 MSCKTRFGPKSDQGMATSSAGSMTPRSPLLTPRNSQIDLLLAGKSAFSEHDDLPQLNELA 802
Query: 486 DIARCVATTPLDDDSSIPYLLSFLEDLRVVIDRRKFDALTVETFGARIEKLIREKYLQLC 545
DIARCVAT PL+DD +I YLL+ LEDLRVVIDRRKFDAL VETFG RIEKLIREKYLQLC
Sbjct: 803 DIARCVATMPLEDDRAISYLLTCLEDLRVVIDRRKFDALMVETFGTRIEKLIREKYLQLC 862
Query: 546 ELVTDDKVDITSTVIEEDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRV 605
ELV D+KVDIT+TVI+EDAPLEDDVVRSLRTSP HPSKDRTSIDDF IIKPISRGAFGRV
Sbjct: 863 ELVGDEKVDITNTVIDEDAPLEDDVVRSLRTSPTHPSKDRTSIDDFVIIKPISRGAFGRV 922
Query: 606 FLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 665
FLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY
Sbjct: 923 FLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 982
Query: 666 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD 725
LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL VVHRDLKPDNLLIAHD
Sbjct: 983 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLHVVHRDLKPDNLLIAHD 1042
Query: 726 GHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPD 785
GHIKLTDFGLSKVGLINSTDDLSGPAVSGT++L D+EPQL+ SEHQ+ERRKKRSAVGTPD
Sbjct: 1043 GHIKLTDFGLSKVGLINSTDDLSGPAVSGTSMLVDDEPQLSTSEHQRERRKKRSAVGTPD 1102
Query: 786 YLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQV 827
YLAPEILLGTGHGTTADWWSVG+ILFELI+GIPPFNAEHPQ
Sbjct: 1103 YLAPEILLGTGHGTTADWWSVGVILFELIIGIPPFNAEHPQT 1144
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359491046|ref|XP_003634211.1| PREDICTED: uncharacterized protein LOC100259538 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1346 bits (3484), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 679/816 (83%), Positives = 723/816 (88%), Gaps = 12/816 (1%)
Query: 18 EEILVVIRTKFDKAKEEVNSDLAVFAGDLVGILEKNAESHPEWQETIEDLLVLARSCAMT 77
EE+L VIR KFDKAKEEVNSDLA+FA DLVGILEKNAESHPEWQETIEDLLVLAR CA+T
Sbjct: 321 EEVLAVIRVKFDKAKEEVNSDLAIFAADLVGILEKNAESHPEWQETIEDLLVLARRCAVT 380
Query: 78 SPGEFWLQCEGIVQELDDRRQELPPGTLKQLYTRMLFILTRCTRLLQFHKESALAEDEHM 137
S G+FWLQCEGIVQELDDRRQELP G LKQL+TRMLFILTRCTRLLQFHKES LAEDEH+
Sbjct: 381 SSGQFWLQCEGIVQELDDRRQELPMGMLKQLHTRMLFILTRCTRLLQFHKESGLAEDEHV 440
Query: 138 FQFRQSRVLHSADKRIPQGTLRDGKGSTIAKASKAASSRKSYSQEQHGLDWKRDHAVKQG 197
Q RQSR+LHSADKR+P G RDGK S+ A + A++RKSYSQEQHGLDWK DHA++ G
Sbjct: 441 LQLRQSRILHSADKRVPSGVGRDGK-SSSAAKASRAATRKSYSQEQHGLDWKSDHAIQPG 499
Query: 198 NILSPPGDDNAKSLESSAARDRMSSWKKLPSPVGKIMKESPTSKEQNDGKVEPLKSSNIR 257
N LSP + K+L+S RDRM+SWKKLPSP GK +KES KEQ D KVE K N
Sbjct: 500 NFLSPTSE-TTKTLDSPVGRDRMASWKKLPSPAGKTVKESVPMKEQTDIKVESSKMLN-N 557
Query: 258 RGLSEIDLT-AKPSEFPPAAETLEHSS---KHQHKVSWGYWGDQQNISDDSSSIICRICE 313
+ + ++DLT AKP + PPA + HSS KHQHK SWGYWGDQ NIS+DSS IICRICE
Sbjct: 558 QAIPDVDLTTAKPPDIPPAKDFHGHSSISSKHQHKASWGYWGDQPNISEDSS-IICRICE 616
Query: 314 EEVPTSHVEDHSKICAIADRCDQKGLSVNERLLRISETLEKMMESSVQKDIHNVVVGSPD 373
EEVPTSHVEDHS+ICAIADRCDQKG+SVNERL+RI+ETLEKMMES QKD +V GSPD
Sbjct: 617 EEVPTSHVEDHSRICAIADRCDQKGISVNERLIRIAETLEKMMESLSQKDFQHV--GSPD 674
Query: 374 V-AKVSNSSVTEESDVLSPKFSDWSRRGSEDMLDYVPEADNSVFMDDLKGLPSMACKTRF 432
V AKVSNSSVTEESDVLSPK SD SRRGSEDMLD PEADN VF+DDLKG PSM+CKTRF
Sbjct: 675 VVAKVSNSSVTEESDVLSPKLSDCSRRGSEDMLDCFPEADNYVFVDDLKGFPSMSCKTRF 734
Query: 433 GPKSDQGMTTSSAGSMTPRSPLLTPRTSQIDLLLAGKGALSEHDDFPQMNELADIARCVA 492
GPKSDQGMTTSSAGSMTPRSPLLTPRTSQIDLLLAGKGA SEHDD PQMNELADI+RC A
Sbjct: 735 GPKSDQGMTTSSAGSMTPRSPLLTPRTSQIDLLLAGKGAYSEHDDLPQMNELADISRCAA 794
Query: 493 TTPLDDDSSIPYLLSFLEDLRVVIDRRKFDALTVETFGARIEKLIREKYLQLCELVTDDK 552
L DD S+ LL LEDLRVVIDRRK DALTVETFG RIEKLIREKYLQLCELV D+K
Sbjct: 795 NASLHDDHSMSILLGCLEDLRVVIDRRKLDALTVETFGTRIEKLIREKYLQLCELVDDEK 854
Query: 553 VDITSTVIEEDAPLEDDVVRSLRTSPIHP-SKDRTSIDDFEIIKPISRGAFGRVFLAKKR 611
VDITSTVI+EDAPLEDDVVRSLRTSPIH SKDRTSIDDFEIIKPISRGAFGRVFLAKKR
Sbjct: 855 VDITSTVIDEDAPLEDDVVRSLRTSPIHSTSKDRTSIDDFEIIKPISRGAFGRVFLAKKR 914
Query: 612 TTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYL 671
TTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYL
Sbjct: 915 TTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYL 974
Query: 672 NGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLT 731
NGGDLYSLLR+LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLT
Sbjct: 975 NGGDLYSLLRSLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLT 1034
Query: 732 DFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEI 791
DFGLSKVGLINSTDDLSGPAVSGT+LL +EPQL+ SE +ERRKKRSAVGTPDYLAPEI
Sbjct: 1035 DFGLSKVGLINSTDDLSGPAVSGTSLLEQDEPQLSTSEQHRERRKKRSAVGTPDYLAPEI 1094
Query: 792 LLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQV 827
LLGTGHGTTADWWSVG+ILFELIVGIPPFNAEHPQ+
Sbjct: 1095 LLGTGHGTTADWWSVGVILFELIVGIPPFNAEHPQM 1130
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224121136|ref|XP_002318507.1| predicted protein [Populus trichocarpa] gi|222859180|gb|EEE96727.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1344 bits (3479), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 677/828 (81%), Positives = 720/828 (86%), Gaps = 28/828 (3%)
Query: 18 EEILVVIRTKFDKAKEEVNSDLAVFAGDLVGILEKNAESHPEWQETIEDLLVLARSCAMT 77
EEILVVIR KFDKAKEEVNSDLA+FA DLVGILEKNA+SHPEWQETIEDLLVLARSCAMT
Sbjct: 330 EEILVVIRAKFDKAKEEVNSDLAIFAADLVGILEKNADSHPEWQETIEDLLVLARSCAMT 389
Query: 78 SPGEFWLQCEGIVQELDDRRQELPPGTLKQLYTRMLFILTRCTRLLQFHKESALAEDEHM 137
SPGEFWLQCE IVQELDDRRQELPPG LKQL+TRMLFILTRCTRLLQFHKE L E+E++
Sbjct: 390 SPGEFWLQCEVIVQELDDRRQELPPGILKQLHTRMLFILTRCTRLLQFHKERVLDENENV 449
Query: 138 FQFRQSRVLHSADKRIPQGTLRDGKGSTIAKASKAASSRKSYSQE-----------QHGL 186
F RQSR+LH DKRIP RDGK S+ AK KAAS RKSYSQE Q
Sbjct: 450 FGLRQSRLLHPVDKRIPSFVGRDGKVSSAAK--KAASGRKSYSQEHKAALVRKSYSQEQR 507
Query: 187 DWKRDHAVKQGNILSPPGD-----DNA-KSLESSAARDRMSSWKKLPSPVGKIMKESPTS 240
DW R+ + G + PG DNA KS ES RDR+SSWK LPSP GK KE
Sbjct: 508 DWSREQDILPGKL---PGKLLSLADNALKSDESPTGRDRISSWKPLPSPPGKSTKEVVPV 564
Query: 241 KEQNDGKVEPLKSSNIRRGLSEIDLTA-KPSEFPPAAETLEHSSKHQHKVSWGYWGDQQN 299
+EQND K+EPLK+SN RRG S++ L A K S+ P + E+S+KHQ K+SWG WGDQQN
Sbjct: 565 EEQNDSKIEPLKTSNDRRGASDVHLAAAKVSDLPMVKDVHENSTKHQPKISWGNWGDQQN 624
Query: 300 ISDDSSSIICRICEEEVPTSHVEDHSKICAIADRCDQKGLSVNERLLRISETLEKMMESS 359
I+D+SS IICRICEEEVPT HVEDH +ICAIADRCDQKGLSVNERL+RISETLEKM+
Sbjct: 625 IADESS-IICRICEEEVPTLHVEDHLRICAIADRCDQKGLSVNERLIRISETLEKMI--- 680
Query: 360 VQKDIHNVVVGSPDVAKVSNSSVTEESDVLSPKFSDWSRRGSEDMLDYVPEADNSVFMDD 419
VQKDIH+ V GSPDVAK+SNSSVTEESDVLSPK SDWS RGSEDMLD PEADN+VFMDD
Sbjct: 681 VQKDIHHAV-GSPDVAKISNSSVTEESDVLSPKLSDWSHRGSEDMLDCFPEADNAVFMDD 739
Query: 420 LKGLPSMACKTRFGPKSDQGMTTSSAGSMTPRSPLLTPRTSQIDLLLAGKGALSEHDDFP 479
LKGLPSM+CKTRFGPKSDQGM TSSAGSMTPRSPLLTP+TS IDLLLAGK A SEHDD P
Sbjct: 740 LKGLPSMSCKTRFGPKSDQGMATSSAGSMTPRSPLLTPKTSHIDLLLAGKSAFSEHDDLP 799
Query: 480 QMNELADIARCVATTPLDDDSSIPYLLSFLEDLRVVIDRRKFDALTVETFGARIEKLIRE 539
Q+NELADIARCVATTPL+DD S PYLL+ L DLRVVI+RRKFDALTVETFG RIEKLIRE
Sbjct: 800 QLNELADIARCVATTPLEDDRSTPYLLTCLGDLRVVIERRKFDALTVETFGTRIEKLIRE 859
Query: 540 KYLQLCELVTDDKVDITSTVIEEDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISR 599
KYLQLCELV D+KVDI STVI ED PLEDDVVRSLRTSPIH SKDRTSIDDFEIIKPISR
Sbjct: 860 KYLQLCELVEDEKVDIASTVIHEDTPLEDDVVRSLRTSPIHSSKDRTSIDDFEIIKPISR 919
Query: 600 GAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFT 659
GAFGRVFLAKKR TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFT
Sbjct: 920 GAFGRVFLAKKRATGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFT 979
Query: 660 CRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDN 719
CRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDN
Sbjct: 980 CRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDN 1039
Query: 720 LLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRS 779
LLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGT++L D+EPQL+ SEHQ+ERRKKRS
Sbjct: 1040 LLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTSMLVDDEPQLSTSEHQRERRKKRS 1099
Query: 780 AVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQV 827
AVGTPDYLAPEILLGTGHGTTADWWSVG+ILFELIVGIPPFNAEHPQ
Sbjct: 1100 AVGTPDYLAPEILLGTGHGTTADWWSVGVILFELIVGIPPFNAEHPQT 1147
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356529485|ref|XP_003533321.1| PREDICTED: uncharacterized protein LOC100776995 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1323 bits (3425), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 652/811 (80%), Positives = 716/811 (88%), Gaps = 6/811 (0%)
Query: 18 EEILVVIRTKFDKAKEEVNSDLAVFAGDLVGILEKNAESHPEWQETIEDLLVLARSCAMT 77
EEILVVIR KFDKAKE+VNSDLA+FA DLVGILEKNA++HP+WQETIEDLLVLARSCAMT
Sbjct: 322 EEILVVIRAKFDKAKEDVNSDLAIFAADLVGILEKNADTHPDWQETIEDLLVLARSCAMT 381
Query: 78 SPGEFWLQCEGIVQELDDRRQELPPGTLKQLYTRMLFILTRCTRLLQFHKESALAEDEHM 137
S GEFWLQCE IVQELDDRRQE PPG LKQL+TRMLFILTRCTRLLQFHKES LAEDE +
Sbjct: 382 SSGEFWLQCESIVQELDDRRQEHPPGMLKQLHTRMLFILTRCTRLLQFHKESGLAEDEPV 441
Query: 138 FQFRQSRVLHSADKRIPQGTLRDGKGSTIAKASKAASSRKSYSQEQHGLDWKRDHAVKQG 197
F RQSRVLHSA K IP RD K S+ AKA K SS+K++SQEQ + WK+D ++
Sbjct: 442 FNLRQSRVLHSAGKFIPPSVGRDTKSSSAAKALKP-SSKKAFSQEQSMMGWKKD-VMQPE 499
Query: 198 NILSPPGDDNAKSLESSAARDRMSSWKKLPSPVGKIMKESPTSKEQNDGKVEPLKSSNIR 257
N+ P DDNAK +SS+ R+RM+SWKK PSP G+ KE+ K+QN G+VE K+SN +
Sbjct: 500 NLSIPADDDNAKLFDSSSGRNRMASWKKFPSPTGRSPKEAVQLKDQNYGRVESSKASNNK 559
Query: 258 RGLSEIDL-TAKPSEFPPAAETLEHSSKHQHKVSWGYWGDQQNISDDSSSIICRICEEEV 316
R S++DL TAKPSE P ++L+H+SKHQHKVSWGYWGDQQN + + +SIICRICEE+V
Sbjct: 560 RFTSDVDLSTAKPSELLPVKDSLDHASKHQHKVSWGYWGDQQNNNSEENSIICRICEEDV 619
Query: 317 PTSHVEDHSKICAIADRCDQKGLSVNERLLRISETLEKMMESSVQKDIHNVVVGSPDVAK 376
PTSHVEDHS+ICA+ADRCDQKGLSVNERL+RIS+TLEKMMES QKD +V GSPDVAK
Sbjct: 620 PTSHVEDHSRICAVADRCDQKGLSVNERLVRISDTLEKMMESCTQKDTQQMV-GSPDVAK 678
Query: 377 VSNSSVTEESDVLSPKFSDWSRRGSEDMLDYVPEADNSVFMDDLKGLPSMACKTRFGPKS 436
VSNSS+TEESDV SPK SDWSRRGSEDMLD PEADNSVFMDDLKGLP M+CKTRFGPKS
Sbjct: 679 VSNSSMTEESDVPSPKLSDWSRRGSEDMLDCFPEADNSVFMDDLKGLPLMSCKTRFGPKS 738
Query: 437 DQGMTTSSAGSMTPRSPLLTPRTSQIDLLLAGKGALSEHDDFPQMNELADIARCVATTPL 496
DQGMTTSSAGSMTPRSPL+TPRTSQIDLLLAGKGA SEHDD PQMNELADIARCVA PL
Sbjct: 739 DQGMTTSSAGSMTPRSPLMTPRTSQIDLLLAGKGAYSEHDDLPQMNELADIARCVANAPL 798
Query: 497 DDDSSIPYLLSFLEDLRVVIDRRKFDALTVETFGARIEKLIREKYLQLCELVTDDKVDIT 556
DDD + YLLS L+DLRVV+DRRKFDALTVETFG RIEKLIREKYLQL E+V +K+D
Sbjct: 799 DDDRTTSYLLSCLDDLRVVVDRRKFDALTVETFGTRIEKLIREKYLQLTEMVDVEKIDTE 858
Query: 557 STVIEEDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDL 616
STV +D LEDDVVRSLRTSPIH S+DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDL
Sbjct: 859 STV--DDDILEDDVVRSLRTSPIHSSRDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDL 916
Query: 617 FAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 676
FAIKVLKKADMIRKNAVESILAERDILI+VRNPFVVRFFYSFTCRENLYLVMEYLNGGDL
Sbjct: 917 FAIKVLKKADMIRKNAVESILAERDILITVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 976
Query: 677 YSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS 736
YSLLRNLGCLDE+VARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS
Sbjct: 977 YSLLRNLGCLDEEVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS 1036
Query: 737 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG 796
KVGLINSTDDLSGPAV+GT+LL ++E + S Q+ERR+KRSAVGTPDYLAPEILLGTG
Sbjct: 1037 KVGLINSTDDLSGPAVNGTSLLEEDETDVFTSADQRERREKRSAVGTPDYLAPEILLGTG 1096
Query: 797 HGTTADWWSVGIILFELIVGIPPFNAEHPQV 827
HG TADWWSVG+ILFEL+VGIPPFNAEHPQ+
Sbjct: 1097 HGFTADWWSVGVILFELLVGIPPFNAEHPQI 1127
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356520647|ref|XP_003528972.1| PREDICTED: uncharacterized protein LOC100816852 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1297 bits (3356), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 647/810 (79%), Positives = 709/810 (87%), Gaps = 6/810 (0%)
Query: 18 EEILVVIRTKFDKAKEEVNSDLAVFAGDLVGILEKNAESHPEWQETIEDLLVLARSCAMT 77
EEILVVIR KFDKAKE+VNSDLA+FA DLVGILEKNA++HPEWQETIEDLLVLARSCAMT
Sbjct: 319 EEILVVIRAKFDKAKEDVNSDLAIFAADLVGILEKNADTHPEWQETIEDLLVLARSCAMT 378
Query: 78 SPGEFWLQCEGIVQELDDRRQELPPGTLKQLYTRMLFILTRCTRLLQFHKESALAEDEHM 137
S GEFWLQCE IVQELDDRRQE PPG LKQL+TRMLFILTRCTRLLQFHKES LAEDE +
Sbjct: 379 SSGEFWLQCESIVQELDDRRQEHPPGMLKQLHTRMLFILTRCTRLLQFHKESGLAEDEPV 438
Query: 138 FQFRQSRVLHSADKRIPQGTLRDGKGSTIAKASKAASSRKSYSQEQHGLDWKRDHAVKQG 197
F RQSRVLHSA K IP RD K S+ K K SS+K++SQEQ + WK+D ++
Sbjct: 439 FNLRQSRVLHSAGKCIPPSVGRDTKSSSATKVLKP-SSKKAFSQEQSMMGWKKD-VMQPE 496
Query: 198 NILSPPGDDNAKSLESSAARDRMSSWKKLPSPVGKIMKESPTSKEQNDGKVEPLKSSNIR 257
N+ P DDNAK SS+ R+RM+SWKK PSP G+ KE+ K+QN G++E K+SN +
Sbjct: 497 NLSIPADDDNAKHFNSSSGRNRMASWKKFPSPTGRSPKEAVQLKDQNYGRIESSKASNNK 556
Query: 258 RGLSEIDLTAKPSEFPPAAETLEHSSKHQHKVSWGYWGDQQNISDDSSSIICRICEEEVP 317
R S++D TAKPSE P ++L+H+SKHQHKVSWG+WGDQQN + + +SIICRICEE+VP
Sbjct: 557 RFSSDVD-TAKPSELHPVKDSLDHASKHQHKVSWGHWGDQQNNNSEENSIICRICEEDVP 615
Query: 318 TSHVEDHSKICAIADRCDQKGLSVNERLLRISETLEKMMESSVQKDIHNVVVGSPDVAKV 377
TSHVEDHS+ICA+ADRCDQKGLSVNERL RI+ETLEKMMES QKD +V GSPDVAKV
Sbjct: 616 TSHVEDHSRICALADRCDQKGLSVNERLGRIAETLEKMMESCTQKDTQQMV-GSPDVAKV 674
Query: 378 SNSSVTEESDVLSPKFSDWSRRGSEDMLDYVPEADNSVFMDDLKGLPSMACKTRFGPKSD 437
SNSS+TEESDV SPK SDWSRRGSEDMLD PEADNSVFMDDLKGLP M+CKTRFGPKSD
Sbjct: 675 SNSSMTEESDVPSPKLSDWSRRGSEDMLDCFPEADNSVFMDDLKGLPLMSCKTRFGPKSD 734
Query: 438 QGMTTSSAGSMTPRSPLLTPRTSQIDLLLAGKGALSEHDDFPQMNELADIARCVATTPLD 497
QGMTTSSAGSMTPRSPL+TPRTSQIDLLLAGKGA SEHDD PQMNELADIARCVA PLD
Sbjct: 735 QGMTTSSAGSMTPRSPLMTPRTSQIDLLLAGKGAYSEHDDLPQMNELADIARCVANAPLD 794
Query: 498 DDSSIPYLLSFLEDLRVVIDRRKFDALTVETFGARIEKLIREKYLQLCELVTDDKVDITS 557
DD + YLLS L+DLRVV+DRRKFDALTVETFG RIEKLIREKYLQL E+V +K+D S
Sbjct: 795 DDRTTSYLLSCLDDLRVVVDRRKFDALTVETFGTRIEKLIREKYLQLTEMVDVEKIDTES 854
Query: 558 TVIEEDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF 617
TV ++ EDDVVRSLRTSPIH S+DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF
Sbjct: 855 TVDDDLL--EDDVVRSLRTSPIHSSRDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF 912
Query: 618 AIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY 677
AIKVLKKADMIRKNAVESILAERDILI+VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY
Sbjct: 913 AIKVLKKADMIRKNAVESILAERDILITVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY 972
Query: 678 SLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 737
SLLRNLGCLDE+VARVYIAEVVLALEYLHSL VVHRDLKPDNLLIAHDGHIKLTDFGLSK
Sbjct: 973 SLLRNLGCLDEEVARVYIAEVVLALEYLHSLHVVHRDLKPDNLLIAHDGHIKLTDFGLSK 1032
Query: 738 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH 797
VGLINSTDDLSGPAV+GT+LL ++E + SE Q+ERRKKRSAVGTPDYLAPEILLGTGH
Sbjct: 1033 VGLINSTDDLSGPAVNGTSLLEEDETDVFTSEDQRERRKKRSAVGTPDYLAPEILLGTGH 1092
Query: 798 GTTADWWSVGIILFELIVGIPPFNAEHPQV 827
G TADWWSVG+ILFEL+VGIPPFNAEHPQ
Sbjct: 1093 GFTADWWSVGVILFELLVGIPPFNAEHPQT 1122
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|9294489|dbj|BAB02708.1| IRE homolog; protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1228 bits (3178), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 607/809 (75%), Positives = 681/809 (84%), Gaps = 12/809 (1%)
Query: 18 EEILVVIRTKFDKAKEEVNSDLAVFAGDLVGILEKNAESHPEWQETIEDLLVLARSCAMT 77
EE+L +IR KF+KAKEEVNSDLAVFA DLVG+LEKNAESHPEW+ET EDLL+LARSCAMT
Sbjct: 424 EEVLNLIRAKFEKAKEEVNSDLAVFAADLVGVLEKNAESHPEWEETFEDLLILARSCAMT 483
Query: 78 SPGEFWLQCEGIVQELDDRRQELPPGTLKQLYTRMLFILTRCTRLLQFHKESALAEDEHM 137
+PG+FWLQCEGIVQ+LDDRRQELPPG LKQL+TRMLFILTRCTRLLQFHKES E+E +
Sbjct: 484 TPGDFWLQCEGIVQDLDDRRQELPPGVLKQLHTRMLFILTRCTRLLQFHKES-WGEEEQV 542
Query: 138 FQFRQSRVLHSADKRIPQGTLRDGKGSTIAKASKAASSRKSYSQEQHGLDWKRDHAVKQG 197
Q RQSRVLHS +K P G R A+K S++K+YSQEQHGLDWK D V+
Sbjct: 543 VQLRQSRVLHSIEKIPPSGAGRS------YSAAKVPSTKKAYSQEQHGLDWKEDAVVRSV 596
Query: 198 NILSPPGDDNAKSLESSAARDRMSSWKKLPSPVGKIMKESPTSKEQNDGKVEPLKSSNIR 257
L+PP + K ES A DRMSSWKKLPSP K +KE+P S+EQND KVEP R
Sbjct: 597 PPLAPPENYAIKESESPANIDRMSSWKKLPSPALKTVKEAPASEEQNDSKVEPPNIVGSR 656
Query: 258 RGLSEIDLTAKPSEFPPAAETLEHSSKHQHKVSWGYWGDQQNISDDSSSIICRICEEEVP 317
+G D FPPA ++ EHSSKH+H +SWGYWG+Q IS++SS I+CRICEEEVP
Sbjct: 657 QGRD--DAAVAILNFPPAKDSHEHSSKHRHNISWGYWGEQPLISEESS-IMCRICEEEVP 713
Query: 318 TSHVEDHSKICAIADRCDQKGLSVNERLLRISETLEKMMESSVQKDIHNVVVGSPDVAKV 377
T+HVEDHS++C +AD+ DQKGLSV+ERL+ ++ TL+K+ E+ KD SPD KV
Sbjct: 714 TTHVEDHSRVCTLADKYDQKGLSVDERLMAVAGTLDKIAETFRHKD-SLAAAESPDGMKV 772
Query: 378 SNSSVTEESDVLSPKFSDWSRRGSEDMLDYVPEADNSVFMDDLKGLPSMACKTRFGPKSD 437
SNS +TEESDVLSP+ SDWSR+GSEDMLD PEADNS+FMDDL+GLP M+C+TRFGPKSD
Sbjct: 773 SNSHLTEESDVLSPRLSDWSRKGSEDMLDCFPEADNSIFMDDLRGLPLMSCRTRFGPKSD 832
Query: 438 QGMTTSSAGSMTPRSPLLTPRTSQIDLLLAGKGALSEHDDFPQMNELADIARCVATTPLD 497
QGMTTSSA SMTPRSP+ TPR I+ +L GKG + DD PQM+ELADIA+C A
Sbjct: 833 QGMTTSSASSMTPRSPIPTPRPDPIEQILGGKGTFHDQDDIPQMSELADIAKCAADAIPG 892
Query: 498 DDSSIPYLLSFLEDLRVVIDRRKFDALTVETFGARIEKLIREKYLQLCELVTDDKVDITS 557
DD SIP+LLS LEDLRVVIDRRKFDALTVETFG RIEKLIREKY+ +CEL+ D+KVD+ S
Sbjct: 893 DDQSIPFLLSCLEDLRVVIDRRKFDALTVETFGTRIEKLIREKYVHMCELMDDEKVDLLS 952
Query: 558 TVIEEDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF 617
TVI+EDAPLEDDVVRSLRTSP+HP +DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF
Sbjct: 953 TVIDEDAPLEDDVVRSLRTSPVHP-RDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF 1011
Query: 618 AIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY 677
AIKVLKKADMIRKNAVESILAERDILI+VRNPFVVRFFYSFTCR+NLYLVMEYLNGGDLY
Sbjct: 1012 AIKVLKKADMIRKNAVESILAERDILINVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLY 1071
Query: 678 SLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 737
SLLRNLGCL+ED+ RVYIAEVVLALEYLHS VVHRDLKPDNLLIAHDGHIKLTDFGLSK
Sbjct: 1072 SLLRNLGCLEEDIVRVYIAEVVLALEYLHSEGVVHRDLKPDNLLIAHDGHIKLTDFGLSK 1131
Query: 738 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH 797
VGLINSTDDL+GPAVSGT+LL +EE +L ASE Q ERRKKRSAVGTPDYLAPEILLGTGH
Sbjct: 1132 VGLINSTDDLAGPAVSGTSLLDEEESRLAASEEQLERRKKRSAVGTPDYLAPEILLGTGH 1191
Query: 798 GTTADWWSVGIILFELIVGIPPFNAEHPQ 826
G TADWWSVGIILFELIVGIPPFNAEHPQ
Sbjct: 1192 GATADWWSVGIILFELIVGIPPFNAEHPQ 1220
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|30684702|ref|NP_188412.2| protein kinase family protein [Arabidopsis thaliana] gi|332642494|gb|AEE76015.1| protein kinase family protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1228 bits (3177), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 607/809 (75%), Positives = 681/809 (84%), Gaps = 12/809 (1%)
Query: 18 EEILVVIRTKFDKAKEEVNSDLAVFAGDLVGILEKNAESHPEWQETIEDLLVLARSCAMT 77
EE+L +IR KF+KAKEEVNSDLAVFA DLVG+LEKNAESHPEW+ET EDLL+LARSCAMT
Sbjct: 321 EEVLNLIRAKFEKAKEEVNSDLAVFAADLVGVLEKNAESHPEWEETFEDLLILARSCAMT 380
Query: 78 SPGEFWLQCEGIVQELDDRRQELPPGTLKQLYTRMLFILTRCTRLLQFHKESALAEDEHM 137
+PG+FWLQCEGIVQ+LDDRRQELPPG LKQL+TRMLFILTRCTRLLQFHKES E+E +
Sbjct: 381 TPGDFWLQCEGIVQDLDDRRQELPPGVLKQLHTRMLFILTRCTRLLQFHKES-WGEEEQV 439
Query: 138 FQFRQSRVLHSADKRIPQGTLRDGKGSTIAKASKAASSRKSYSQEQHGLDWKRDHAVKQG 197
Q RQSRVLHS +K P G R A+K S++K+YSQEQHGLDWK D V+
Sbjct: 440 VQLRQSRVLHSIEKIPPSGAGRS------YSAAKVPSTKKAYSQEQHGLDWKEDAVVRSV 493
Query: 198 NILSPPGDDNAKSLESSAARDRMSSWKKLPSPVGKIMKESPTSKEQNDGKVEPLKSSNIR 257
L+PP + K ES A DRMSSWKKLPSP K +KE+P S+EQND KVEP R
Sbjct: 494 PPLAPPENYAIKESESPANIDRMSSWKKLPSPALKTVKEAPASEEQNDSKVEPPNIVGSR 553
Query: 258 RGLSEIDLTAKPSEFPPAAETLEHSSKHQHKVSWGYWGDQQNISDDSSSIICRICEEEVP 317
+G D FPPA ++ EHSSKH+H +SWGYWG+Q IS++SS I+CRICEEEVP
Sbjct: 554 QGRD--DAAVAILNFPPAKDSHEHSSKHRHNISWGYWGEQPLISEESS-IMCRICEEEVP 610
Query: 318 TSHVEDHSKICAIADRCDQKGLSVNERLLRISETLEKMMESSVQKDIHNVVVGSPDVAKV 377
T+HVEDHS++C +AD+ DQKGLSV+ERL+ ++ TL+K+ E+ KD SPD KV
Sbjct: 611 TTHVEDHSRVCTLADKYDQKGLSVDERLMAVAGTLDKIAETFRHKD-SLAAAESPDGMKV 669
Query: 378 SNSSVTEESDVLSPKFSDWSRRGSEDMLDYVPEADNSVFMDDLKGLPSMACKTRFGPKSD 437
SNS +TEESDVLSP+ SDWSR+GSEDMLD PEADNS+FMDDL+GLP M+C+TRFGPKSD
Sbjct: 670 SNSHLTEESDVLSPRLSDWSRKGSEDMLDCFPEADNSIFMDDLRGLPLMSCRTRFGPKSD 729
Query: 438 QGMTTSSAGSMTPRSPLLTPRTSQIDLLLAGKGALSEHDDFPQMNELADIARCVATTPLD 497
QGMTTSSA SMTPRSP+ TPR I+ +L GKG + DD PQM+ELADIA+C A
Sbjct: 730 QGMTTSSASSMTPRSPIPTPRPDPIEQILGGKGTFHDQDDIPQMSELADIAKCAADAIPG 789
Query: 498 DDSSIPYLLSFLEDLRVVIDRRKFDALTVETFGARIEKLIREKYLQLCELVTDDKVDITS 557
DD SIP+LLS LEDLRVVIDRRKFDALTVETFG RIEKLIREKY+ +CEL+ D+KVD+ S
Sbjct: 790 DDQSIPFLLSCLEDLRVVIDRRKFDALTVETFGTRIEKLIREKYVHMCELMDDEKVDLLS 849
Query: 558 TVIEEDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF 617
TVI+EDAPLEDDVVRSLRTSP+HP +DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF
Sbjct: 850 TVIDEDAPLEDDVVRSLRTSPVHP-RDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF 908
Query: 618 AIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY 677
AIKVLKKADMIRKNAVESILAERDILI+VRNPFVVRFFYSFTCR+NLYLVMEYLNGGDLY
Sbjct: 909 AIKVLKKADMIRKNAVESILAERDILINVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLY 968
Query: 678 SLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 737
SLLRNLGCL+ED+ RVYIAEVVLALEYLHS VVHRDLKPDNLLIAHDGHIKLTDFGLSK
Sbjct: 969 SLLRNLGCLEEDIVRVYIAEVVLALEYLHSEGVVHRDLKPDNLLIAHDGHIKLTDFGLSK 1028
Query: 738 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH 797
VGLINSTDDL+GPAVSGT+LL +EE +L ASE Q ERRKKRSAVGTPDYLAPEILLGTGH
Sbjct: 1029 VGLINSTDDLAGPAVSGTSLLDEEESRLAASEEQLERRKKRSAVGTPDYLAPEILLGTGH 1088
Query: 798 GTTADWWSVGIILFELIVGIPPFNAEHPQ 826
G TADWWSVGIILFELIVGIPPFNAEHPQ
Sbjct: 1089 GATADWWSVGIILFELIVGIPPFNAEHPQ 1117
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|26449548|dbj|BAC41900.1| putative protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1227 bits (3175), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 607/809 (75%), Positives = 681/809 (84%), Gaps = 12/809 (1%)
Query: 18 EEILVVIRTKFDKAKEEVNSDLAVFAGDLVGILEKNAESHPEWQETIEDLLVLARSCAMT 77
EE+L +IR KF+KAKEEVNSDLAVFA DLVG+LEKNAESHPEW+ET EDLL+LARSCAMT
Sbjct: 321 EEVLNLIRAKFEKAKEEVNSDLAVFAADLVGVLEKNAESHPEWEETFEDLLILARSCAMT 380
Query: 78 SPGEFWLQCEGIVQELDDRRQELPPGTLKQLYTRMLFILTRCTRLLQFHKESALAEDEHM 137
+PG+FWLQCEGIVQ+LDDRRQELPPG LKQL+TRMLFILTRCTRLLQFHKES E+E +
Sbjct: 381 TPGDFWLQCEGIVQDLDDRRQELPPGVLKQLHTRMLFILTRCTRLLQFHKES-WGEEEQV 439
Query: 138 FQFRQSRVLHSADKRIPQGTLRDGKGSTIAKASKAASSRKSYSQEQHGLDWKRDHAVKQG 197
Q RQSRVLHS +K P G R A+K S++K+YSQEQHGLDWK D V+
Sbjct: 440 VQLRQSRVLHSIEKIPPSGAGRS------YSAAKVPSTKKAYSQEQHGLDWKEDAVVRSV 493
Query: 198 NILSPPGDDNAKSLESSAARDRMSSWKKLPSPVGKIMKESPTSKEQNDGKVEPLKSSNIR 257
L+PP + K ES A DRMSSWKKLPSP K +KE+P S+EQND KVEP R
Sbjct: 494 PPLAPPENYAIKESESPANIDRMSSWKKLPSPALKTVKEAPASEEQNDSKVEPPNIVGSR 553
Query: 258 RGLSEIDLTAKPSEFPPAAETLEHSSKHQHKVSWGYWGDQQNISDDSSSIICRICEEEVP 317
+G D FPPA ++ EHSSKH+H +SWGYWG+Q IS++SS I+CRICEEEVP
Sbjct: 554 QGRD--DAAVAILNFPPAKDSHEHSSKHRHNISWGYWGEQPLISEESS-IMCRICEEEVP 610
Query: 318 TSHVEDHSKICAIADRCDQKGLSVNERLLRISETLEKMMESSVQKDIHNVVVGSPDVAKV 377
T+HVEDHS++C +AD+ DQKGLSV+ERL+ ++ TL+K+ E+ KD SPD KV
Sbjct: 611 TTHVEDHSRVCTLADKYDQKGLSVDERLMAVAGTLDKIAETFRHKD-SLAAAESPDGMKV 669
Query: 378 SNSSVTEESDVLSPKFSDWSRRGSEDMLDYVPEADNSVFMDDLKGLPSMACKTRFGPKSD 437
SNS +TEESDVLSP+ SDWSR+GSEDMLD PEADNS+FMDDL+GLP M+C+TRFGPKSD
Sbjct: 670 SNSHLTEESDVLSPRLSDWSRKGSEDMLDCFPEADNSIFMDDLRGLPLMSCRTRFGPKSD 729
Query: 438 QGMTTSSAGSMTPRSPLLTPRTSQIDLLLAGKGALSEHDDFPQMNELADIARCVATTPLD 497
QGMTTSSA SMTPRSP+ TPR I+ +L GKG + DD PQM+ELADIA+C A
Sbjct: 730 QGMTTSSASSMTPRSPIPTPRPDPIEQILGGKGTFHDQDDIPQMSELADIAKCAADAIPG 789
Query: 498 DDSSIPYLLSFLEDLRVVIDRRKFDALTVETFGARIEKLIREKYLQLCELVTDDKVDITS 557
DD SIP+LLS LEDLRVVIDRRKFDALTVETFG RIEKLIREKY+ +CEL+ D+KVD+ S
Sbjct: 790 DDQSIPFLLSCLEDLRVVIDRRKFDALTVETFGTRIEKLIREKYVHMCELMDDEKVDLLS 849
Query: 558 TVIEEDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF 617
TVI+EDAPLEDDVVRSLRTSP+HP +DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF
Sbjct: 850 TVIDEDAPLEDDVVRSLRTSPVHP-RDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF 908
Query: 618 AIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY 677
AIKVLKKADMIRKNAVESILAERDILI+VRNPFVVRFFYSFTCR+NLYLVMEYLNGGDLY
Sbjct: 909 AIKVLKKADMIRKNAVESILAERDILINVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLY 968
Query: 678 SLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 737
SLLRNLGCL+ED+ RVYIAEVVLALEYLHS VVHRDLKPDNLLIAHDGHIKLTDFGLSK
Sbjct: 969 SLLRNLGCLEEDIVRVYIAEVVLALEYLHSEGVVHRDLKPDNLLIAHDGHIKLTDFGLSK 1028
Query: 738 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH 797
VGLINSTDDL+GPAVSGT+LL +EE +L ASE Q ERRKKRSAVGTPDYLAPEILLGTGH
Sbjct: 1029 VGLINSTDDLAGPAVSGTSLLDEEESRLAASEEQLERRKKRSAVGTPDYLAPEILLGTGH 1088
Query: 798 GTTADWWSVGIILFELIVGIPPFNAEHPQ 826
G TADWWSVGIILFELIVGIPPFNAEHPQ
Sbjct: 1089 GATADWWSVGIILFELIVGIPPFNAEHPQ 1117
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|6729348|dbj|BAA89784.1| IRE homolog 1 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1226 bits (3173), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 607/809 (75%), Positives = 681/809 (84%), Gaps = 12/809 (1%)
Query: 18 EEILVVIRTKFDKAKEEVNSDLAVFAGDLVGILEKNAESHPEWQETIEDLLVLARSCAMT 77
EE+L +IR KF+KAKEEVNSDLAVFA DLVG+LEKNAESHPEW+ET EDLL+LARSCAMT
Sbjct: 48 EEVLNLIRAKFEKAKEEVNSDLAVFAADLVGVLEKNAESHPEWEETFEDLLILARSCAMT 107
Query: 78 SPGEFWLQCEGIVQELDDRRQELPPGTLKQLYTRMLFILTRCTRLLQFHKESALAEDEHM 137
+PG+FWLQCEGIVQ+LDDRRQELPPG LKQL+TRMLFILTRCTRLLQFHKES E+E +
Sbjct: 108 TPGDFWLQCEGIVQDLDDRRQELPPGVLKQLHTRMLFILTRCTRLLQFHKES-WGEEEQV 166
Query: 138 FQFRQSRVLHSADKRIPQGTLRDGKGSTIAKASKAASSRKSYSQEQHGLDWKRDHAVKQG 197
Q RQSRVLHS +K P G R A+K S++K+YSQEQHGLDWK D V+
Sbjct: 167 VQLRQSRVLHSIEKIPPSGAGRS------YSAAKVPSTKKAYSQEQHGLDWKEDAVVRSV 220
Query: 198 NILSPPGDDNAKSLESSAARDRMSSWKKLPSPVGKIMKESPTSKEQNDGKVEPLKSSNIR 257
L+PP + K ES A DRMSSWKKLPSP K +KE+P S+EQND KVEP R
Sbjct: 221 PPLAPPENYAIKESESPANIDRMSSWKKLPSPALKTVKEAPASEEQNDSKVEPPNIVGSR 280
Query: 258 RGLSEIDLTAKPSEFPPAAETLEHSSKHQHKVSWGYWGDQQNISDDSSSIICRICEEEVP 317
+G D FPPA ++ EHSSKH+H +SWGYWG+Q IS++SS I+CRICEEEVP
Sbjct: 281 QGRD--DAAVAILNFPPAKDSHEHSSKHRHNISWGYWGEQPLISEESS-IMCRICEEEVP 337
Query: 318 TSHVEDHSKICAIADRCDQKGLSVNERLLRISETLEKMMESSVQKDIHNVVVGSPDVAKV 377
T+HVEDHS++C +AD+ DQKGLSV+ERL+ ++ TL+K+ E+ KD SPD KV
Sbjct: 338 TTHVEDHSRVCTLADKYDQKGLSVDERLMAVAGTLDKIAETFRHKD-SLAAAESPDGMKV 396
Query: 378 SNSSVTEESDVLSPKFSDWSRRGSEDMLDYVPEADNSVFMDDLKGLPSMACKTRFGPKSD 437
SNS +TEESDVLSP+ SDWSR+GSEDMLD PEADNS+FMDDL+GLP M+C+TRFGPKSD
Sbjct: 397 SNSHLTEESDVLSPRLSDWSRKGSEDMLDCFPEADNSIFMDDLRGLPLMSCRTRFGPKSD 456
Query: 438 QGMTTSSAGSMTPRSPLLTPRTSQIDLLLAGKGALSEHDDFPQMNELADIARCVATTPLD 497
QGMTTSSA SMTPRSP+ TPR I+ +L GKG + DD PQM+ELADIA+C A
Sbjct: 457 QGMTTSSASSMTPRSPIPTPRPDPIEQILGGKGTFHDQDDIPQMSELADIAKCAADAIPG 516
Query: 498 DDSSIPYLLSFLEDLRVVIDRRKFDALTVETFGARIEKLIREKYLQLCELVTDDKVDITS 557
DD SIP+LLS LEDLRVVIDRRKFDALTVETFG RIEKLIREKY+ +CEL+ D+KVD+ S
Sbjct: 517 DDQSIPFLLSCLEDLRVVIDRRKFDALTVETFGTRIEKLIREKYVHMCELMDDEKVDLLS 576
Query: 558 TVIEEDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF 617
TVI+EDAPLEDDVVRSLRTSP+HP +DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF
Sbjct: 577 TVIDEDAPLEDDVVRSLRTSPVHP-RDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF 635
Query: 618 AIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY 677
AIKVLKKADMIRKNAVESILAERDILI+VRNPFVVRFFYSFTCR+NLYLVMEYLNGGDLY
Sbjct: 636 AIKVLKKADMIRKNAVESILAERDILINVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLY 695
Query: 678 SLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 737
SLLRNLGCL+ED+ RVYIAEVVLALEYLHS VVHRDLKPDNLLIAHDGHIKLTDFGLSK
Sbjct: 696 SLLRNLGCLEEDIVRVYIAEVVLALEYLHSEGVVHRDLKPDNLLIAHDGHIKLTDFGLSK 755
Query: 738 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH 797
VGLINSTDDL+GPAVSGT+LL +EE +L ASE Q ERRKKRSAVGTPDYLAPEILLGTGH
Sbjct: 756 VGLINSTDDLAGPAVSGTSLLDEEESRLAASEEQLERRKKRSAVGTPDYLAPEILLGTGH 815
Query: 798 GTTADWWSVGIILFELIVGIPPFNAEHPQ 826
G TADWWSVGIILFELIVGIPPFNAEHPQ
Sbjct: 816 GATADWWSVGIILFELIVGIPPFNAEHPQ 844
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 837 | ||||||
| TAIR|locus:2088515 | 1296 | AT3G17850 [Arabidopsis thalian | 0.952 | 0.614 | 0.731 | 4.39999999999e-313 | |
| TAIR|locus:2198012 | 1235 | AT1G48490 [Arabidopsis thalian | 0.948 | 0.642 | 0.674 | 1.5e-282 | |
| TAIR|locus:2167953 | 1168 | IRE "INCOMPLETE ROOT HAIR ELON | 0.592 | 0.424 | 0.629 | 5.4e-206 | |
| TAIR|locus:2028285 | 1067 | AT1G45160 [Arabidopsis thalian | 0.586 | 0.460 | 0.539 | 4.4e-154 | |
| DICTYBASE|DDB_G0272282 | 2102 | DDB_G0272282 "MAST family prot | 0.198 | 0.078 | 0.648 | 1.1e-66 | |
| MGI|MGI:1914371 | 865 | Mastl "microtubule associated | 0.197 | 0.190 | 0.570 | 7.1e-58 | |
| UNIPROTKB|B1WAR9 | 890 | mastl "Serine/threonine-protei | 0.199 | 0.187 | 0.552 | 8.5e-58 | |
| UNIPROTKB|F1S920 | 729 | MAST3 "Uncharacterized protein | 0.275 | 0.316 | 0.457 | 8.7e-58 | |
| TAIR|locus:2204574 | 562 | AT1G30640 [Arabidopsis thalian | 0.323 | 0.482 | 0.420 | 1.7e-57 | |
| UNIPROTKB|Q96GX5 | 879 | MASTL "Serine/threonine-protei | 0.197 | 0.187 | 0.564 | 7.7e-57 |
| TAIR|locus:2088515 AT3G17850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 3003 (1062.2 bits), Expect = 4.4e-313, P = 4.4e-313
Identities = 592/809 (73%), Positives = 659/809 (81%)
Query: 18 EEILVVIRTKFDKAKEEVNSDLAVFAGDLVGILEKNAESHPEWQETIEDLLVLARSCAMT 77
EE+L +IR KF+KAKEEVNSDLAVFA DLVG+LEKNAESHPEW+ET EDLL+LARSCAMT
Sbjct: 321 EEVLNLIRAKFEKAKEEVNSDLAVFAADLVGVLEKNAESHPEWEETFEDLLILARSCAMT 380
Query: 78 SPGEFWLQCEGIVQELDDRRQELPPGTLKQLYTRMLFILTRCTRLLQFHKESALAEDEHM 137
+PG+FWLQCEGIVQ+LDDRRQELPPG LKQL+TRMLFILTRCTRLLQFHKES E+E +
Sbjct: 381 TPGDFWLQCEGIVQDLDDRRQELPPGVLKQLHTRMLFILTRCTRLLQFHKES-WGEEEQV 439
Query: 138 FQFRQSRVLHSADKRIPQGTLRDGXXXXXXXXXXXXXXXXXXXQEQHGLDWKRDHAVKQG 197
Q RQSRVLHS +K P G R QEQHGLDWK D V+
Sbjct: 440 VQLRQSRVLHSIEKIPPSGAGRS------YSAAKVPSTKKAYSQEQHGLDWKEDAVVRSV 493
Query: 198 NILSPPGDDNAKSLESSAARDRMSSWKKLPSPVGKIMKESPTSKEQNDGKVEPLKSSNIR 257
L+PP + K ES A DRMSSWKKLPSP K +KE+P S+EQND KVEP R
Sbjct: 494 PPLAPPENYAIKESESPANIDRMSSWKKLPSPALKTVKEAPASEEQNDSKVEPPNIVGSR 553
Query: 258 RGLSEIDLTAKPSEFPPAAETLEHSSKHQHKVSWGYWGDQQNXXXXXXXXXXXXXEEEVP 317
+G D FPPA ++ EHSSKH+H +SWGYWG+Q EEEVP
Sbjct: 554 QGRD--DAAVAILNFPPAKDSHEHSSKHRHNISWGYWGEQP-LISEESSIMCRICEEEVP 610
Query: 318 TSHVEDHSKICAIADRCDQKGLSVNERLLRISETLEKMMESSVQKDIHNVVVGSPDVAKV 377
T+HVEDHS++C +AD+ DQKGLSV+ERL+ ++ TL+K+ E+ KD SPD KV
Sbjct: 611 TTHVEDHSRVCTLADKYDQKGLSVDERLMAVAGTLDKIAETFRHKD-SLAAAESPDGMKV 669
Query: 378 SNSSVTEESDVLSPKFSDWSRRGSEDMLDYVPEADNSVFMDDLKGLPSMACKTRFGPKSD 437
SNS +TEESDVLSP+ SDWSR+GSEDMLD PEADNS+FMDDL+GLP M+C+TRFGPKSD
Sbjct: 670 SNSHLTEESDVLSPRLSDWSRKGSEDMLDCFPEADNSIFMDDLRGLPLMSCRTRFGPKSD 729
Query: 438 QGMTTSSAGSMTPRSPLLTPRTSQIDLLLAGKGALSEHDDFPQMNELADIARCVATTPLD 497
QGMTTSSA SMTPRSP+ TPR I+ +L GKG + DD PQM+ELADIA+C A
Sbjct: 730 QGMTTSSASSMTPRSPIPTPRPDPIEQILGGKGTFHDQDDIPQMSELADIAKCAADAIPG 789
Query: 498 DDSSIPYLLSFLEDLRVVIDRRKFDALTVETFGARIEKLIREKYLQLCELVTDDKVDITS 557
DD SIP+LLS LEDLRVVIDRRKFDALTVETFG RIEKLIREKY+ +CEL+ D+KVD+ S
Sbjct: 790 DDQSIPFLLSCLEDLRVVIDRRKFDALTVETFGTRIEKLIREKYVHMCELMDDEKVDLLS 849
Query: 558 TVIEEDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF 617
TVI+EDAPLEDDVVRSLRTSP+HP +DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF
Sbjct: 850 TVIDEDAPLEDDVVRSLRTSPVHP-RDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF 908
Query: 618 AIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY 677
AIKVLKKADMIRKNAVESILAERDILI+VRNPFVVRFFYSFTCR+NLYLVMEYLNGGDLY
Sbjct: 909 AIKVLKKADMIRKNAVESILAERDILINVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLY 968
Query: 678 SLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 737
SLLRNLGCL+ED+ RVYIAEVVLALEYLHS VVHRDLKPDNLLIAHDGHIKLTDFGLSK
Sbjct: 969 SLLRNLGCLEEDIVRVYIAEVVLALEYLHSEGVVHRDLKPDNLLIAHDGHIKLTDFGLSK 1028
Query: 738 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH 797
VGLINSTDDL+GPAVSGT+LL +EE +L ASE Q ERRKKRSAVGTPDYLAPEILLGTGH
Sbjct: 1029 VGLINSTDDLAGPAVSGTSLLDEEESRLAASEEQLERRKKRSAVGTPDYLAPEILLGTGH 1088
Query: 798 GTTADWWSVGIILFELIVGIPPFNAEHPQ 826
G TADWWSVGIILFELIVGIPPFNAEHPQ
Sbjct: 1089 GATADWWSVGIILFELIVGIPPFNAEHPQ 1117
|
|
| TAIR|locus:2198012 AT1G48490 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2715 (960.8 bits), Expect = 1.5e-282, P = 1.5e-282
Identities = 546/809 (67%), Positives = 625/809 (77%)
Query: 18 EEILVVIRTKFDKAKEEVNSDLAVFAGDLVGILEKNAESHPEWQETIEDLLVLARSCAMT 77
E+IL +IRTKFDKAKEEVNSDL F GDL+ I +KN ESHPE TIEDLLVLA++CA T
Sbjct: 264 EDILNLIRTKFDKAKEEVNSDLFAFGGDLLDIYDKNKESHPELLVTIEDLLVLAKTCAKT 323
Query: 78 SPGEFWLQCEGIVQELDDRRQELPPGTLKQLYTRMLFILTRCTRLLQFHKESALAEDEHM 137
+ EFWLQCEGIVQ+LDDRRQELPPG LKQL+TRMLFILTRCTRLLQFHKES ++E
Sbjct: 324 TSKEFWLQCEGIVQDLDDRRQELPPGVLKQLHTRMLFILTRCTRLLQFHKES-WGQEEDA 382
Query: 138 FQFRQSRVLHSADKRIPQGTLRDGXXXXXXXXXXXXXXXXXXXQEQHGLDWKRDHAVKQG 197
Q RQS VLHSADKR P G +RDG QEQ GL+W V+
Sbjct: 383 VQLRQSGVLHSADKRDPTGEVRDGKGSSTANALKVPSTKKAYSQEQRGLNWIEGFFVRPA 442
Query: 198 NILSPPGDDNAKSLESSAARDRMSSWKKLPSPVGKIMKESPTSKEQNDGKVEPLKSSNIR 257
LS P ++ +K ES A D+MSSWK+LPSP K ++E+ SKEQND KVEP +
Sbjct: 443 P-LSSPYNETSKDSESPANIDKMSSWKRLPSPASKGVQEAAVSKEQNDRKVEPPQVVKKL 501
Query: 258 RGLSEIDLTAKPSEFPPAAETLEHSSKHQHKVSWGYWGDQQNXXXXXXXXXXXXXEEEVP 317
+S+ AK E A + EH SK++H +SWGYWG Q+ EEE+P
Sbjct: 502 VAISDDMAVAKLPEVSSAKASQEHMSKNRHNISWGYWG-HQSCISEESSIICRICEEEIP 560
Query: 318 TSHVEDHSKICAIADRCDQKGLSVNERLLRISETLEKMMESSVQKDIHNVVVGSPDVAKV 377
T+HVEDHS+ICA+AD+ DQKG+ V+ERL+ ++ TLEK+ ++ +QKD V SP+ K+
Sbjct: 561 TTHVEDHSRICALADKYDQKGVGVDERLMAVAVTLEKITDNVIQKD-SLAAVESPEGMKI 619
Query: 378 SNSSVTEESDVLSPKFSDWSRRGSEDMLDYVPEADNSVFMDDLKGLPSMACKTRFGPKSD 437
SN+S+TEE DVLSPK SDWSRRGSEDMLD PE DNSVFMDD+ LPSM+C+TRFGPKSD
Sbjct: 620 SNASLTEELDVLSPKLSDWSRRGSEDMLDCFPETDNSVFMDDMGCLPSMSCRTRFGPKSD 679
Query: 438 QGMTTSSAGSMTPRSPLLTPRTSQIDLLLAGKGALSEHDDFPQMNELADIARCVATTPLD 497
QGM TSSAGSMTPRSP+ TPR I+LLL GKG + DDFPQM+ELADIARC A
Sbjct: 680 QGMATSSAGSMTPRSPIPTPRPDPIELLLEGKGTFHDQDDFPQMSELADIARCAANAIPV 739
Query: 498 DDSSIPYLLSFLEDLRVVIDRRKFDALTVETFGARIEKLIREKYLQLCELVTDDKVDITS 557
DD SI LLS LEDLRVVIDRRKFDAL VETFG RIEKLI+EKYLQLCEL+ D+K
Sbjct: 740 DDQSIQLLLSCLEDLRVVIDRRKFDALIVETFGTRIEKLIQEKYLQLCELMDDEK----G 795
Query: 558 TVIEEDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF 617
T+I+EDAPLEDDVVRSLRTSP+H +DR SIDDFE++K ISRGAFG V LA+K TTGDLF
Sbjct: 796 TIIDEDAPLEDDVVRSLRTSPVH-LRDRISIDDFEVMKSISRGAFGHVILARKNTTGDLF 854
Query: 618 AIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY 677
AIKVL+KADMIRKNAVESILAERDILI+ RNPFVVRFFYSFTC ENLYLVMEYLNGGD Y
Sbjct: 855 AIKVLRKADMIRKNAVESILAERDILINARNPFVVRFFYSFTCSENLYLVMEYLNGGDFY 914
Query: 678 SLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 737
S+LR +GCLDE ARVYIAEVVLALEYLHS VVHRDLKPDNLLIAHDGH+KLTDFGLSK
Sbjct: 915 SMLRKIGCLDEANARVYIAEVVLALEYLHSEGVVHRDLKPDNLLIAHDGHVKLTDFGLSK 974
Query: 738 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH 797
VGLIN+TDDLSGP S T+LL +E+P+L +H KRSAVGTPDYLAPEILLGTGH
Sbjct: 975 VGLINNTDDLSGPVSSATSLLVEEKPKLPTLDH------KRSAVGTPDYLAPEILLGTGH 1028
Query: 798 GTTADWWSVGIILFELIVGIPPFNAEHPQ 826
G TADWWSVGIIL+E +VGIPPFNA+HPQ
Sbjct: 1029 GATADWWSVGIILYEFLVGIPPFNADHPQ 1057
|
|
| TAIR|locus:2167953 IRE "INCOMPLETE ROOT HAIR ELONGATION" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1590 (564.8 bits), Expect = 5.4e-206, Sum P(2) = 5.4e-206
Identities = 325/516 (62%), Positives = 399/516 (77%)
Query: 313 EEEVPTSHVEDHSKICAIADRCDQKGLSVNERLLRISETLEKMMESSVQKDIHNVVVGS- 371
E E+P HVE+HS+IC IADRCD KG++VN RL R++E+LEK++ES K +V +
Sbjct: 492 EVEIPVVHVEEHSRICTIADRCDLKGINVNLRLERVAESLEKILESWTPKS--SVTPRAV 549
Query: 372 PDVAKVSNSSVTEESDVLSPKFSDWSRRGSEDMLDYVPEADNSVFMDDLKGLPSMACKTR 431
D A++SNSS E+ D +S + SD DMLD VP + N+ +D+L L M+
Sbjct: 550 ADSARLSNSSRQEDLDEISQRCSD-------DMLDCVPRSQNTFSLDELNILNEMSMTN- 601
Query: 432 FGPKSDQGMTTSSAGSMTPRSPLLTPRTSQIDLLLAGKGALSEHDDFPQMNELADIARCV 491
G SSAGS+TP SP TPR SQ+DLLL+G+ +SE +++ Q+N+L DIAR V
Sbjct: 602 -------GTKDSSAGSLTPPSPA-TPRNSQVDLLLSGRKTISELENYQQINKLLDIARSV 653
Query: 492 ATTPLDDDSSIPYLLSFLEDLRVVIDRRKFDALTVETFGARIEKLIREKYLQLCELVTDD 551
A + SS+ +++ L++L+ VI RK DAL VETFG RIEKL++EKY++LC L+ D+
Sbjct: 654 ANVNVCGYSSLDFMIEQLDELKYVIQDRKADALVVETFGRRIEKLLQEKYIELCGLIDDE 713
Query: 552 KVDITSTVIEEDAPLEDDVVRSLRTSPIHP-SKDRTSIDDFEIIKPISRGAFGRVFLAKK 610
KVD ++ + +E++ ++D VRSLR SP++P +KDRTSI+DFEIIKPISRGAFGRVFLAKK
Sbjct: 714 KVDSSNAMPDEESSADEDTVRSLRASPLNPRAKDRTSIEDFEIIKPISRGAFGRVFLAKK 773
Query: 611 RTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEY 670
R TGDLFAIKVLKKADMIRKNAVESILAER+ILISVRNPFVVRFFYSFTCRENLYLVMEY
Sbjct: 774 RATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEY 833
Query: 671 LNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKL 730
LNGGDL+SLLRNLGCLDED+AR+YIAEVVLALEYLHS+ ++HRDLKPDNLLI DGHIKL
Sbjct: 834 LNGGDLFSLLRNLGCLDEDMARIYIAEVVLALEYLHSVNIIHRDLKPDNLLINQDGHIKL 893
Query: 731 TDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPE 790
TDFGLSKVGLINSTDDLSG + G + E+ ++ RKK + VGTPDYLAPE
Sbjct: 894 TDFGLSKVGLINSTDDLSGESSLGNSGFFAEDGSKAQHSQGKDSRKKHAVVGTPDYLAPE 953
Query: 791 ILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826
ILLG GHG TADWWSVG+ILFE++VGIPPFNAE PQ
Sbjct: 954 ILLGMGHGKTADWWSVGVILFEVLVGIPPFNAETPQ 989
|
|
| TAIR|locus:2028285 AT1G45160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1306 (464.8 bits), Expect = 4.4e-154, Sum P(2) = 4.4e-154
Identities = 280/519 (53%), Positives = 359/519 (69%)
Query: 313 EEEVPTSHVEDHSKICAIADRCDQKGLSVNERLLRISETLEKMMESSVQKDIHNVV-VGS 371
EEEVP H+E HS ICA AD+C+ + V+ERLL++ E LE++++S + +++ G
Sbjct: 406 EEEVPLFHLEPHSYICAYADKCEINCVDVDERLLKLEEILEQIIDS---RSLNSFTQAGG 462
Query: 372 PDVAKVSNSSVTEESDVLSPKFSDWSRRGSEDMLDYVPEADNSVFMDDLKGLPSMACKTR 431
+ + + S V E SPK ++W +G E M + + E D + F+D+ P + K+
Sbjct: 463 LENSVLRKSGVASEG--CSPKINEWRNKGLEGMFEDLHEMDTA-FIDESYTYP-IHLKSH 518
Query: 432 FGPKSDQGMTTSSAGSMTPRSPLLTPRTSQIDLLLAGKGALSEHDDFPQMNELADIARCV 491
G K T+SS GS+T S TPRTS D + E +D M +L+DIARC
Sbjct: 519 VGAKFCHHATSSSTGSITSVSSTNTPRTSHFDSYWLERHC-PEQEDLRLMMDLSDIARCG 577
Query: 492 ATTPLDDDSSIPYLLSFLEDLRVVIDRRKFDALTVETFGARIEKLIREKYLQLCELVTDD 551
A+T + S Y+++ ++D++ V+ + K AL ++TFG RIEKL+ EKYL EL T D
Sbjct: 578 ASTDFSKEGSCDYIMACMQDIQAVLKQGKLKALVIDTFGGRIEKLLCEKYLHAREL-TAD 636
Query: 552 KVDITSTVIEEDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKR 611
K + + I+E +DV+ +P KDR SIDDFEIIKPISRGAFG+VFLA+KR
Sbjct: 637 KSSVGN--IKES----EDVLEHASATPQLLLKDRISIDDFEIIKPISRGAFGKVFLARKR 690
Query: 612 TTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYL 671
TTGD FAIKVLKK DMIRKN +E IL ER+ILI+VR PF+VRFFYSFTCR+NLYLVMEYL
Sbjct: 691 TTGDFFAIKVLKKLDMIRKNDIERILQERNILITVRYPFLVRFFYSFTCRDNLYLVMEYL 750
Query: 672 NGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLT 731
NGGDLYSLL+ +GCLDE++AR+YIAE+VLALEYLHSL++VHRDLKPDNLLIA++GHIKLT
Sbjct: 751 NGGDLYSLLQKVGCLDEEIARIYIAELVLALEYLHSLKIVHRDLKPDNLLIAYNGHIKLT 810
Query: 732 DFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEH----QQERRKKRSAVGTPDYL 787
DFGLSK+GLIN+T DLSG D P+ T S H Q+E R + SAVGTPDYL
Sbjct: 811 DFGLSKIGLINNTIDLSGHE-------SDVSPR-TNSHHFQKNQEEERIRHSAVGTPDYL 862
Query: 788 APEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826
APEILLGT HG ADWWS GI+LFEL+ GIPPF A P+
Sbjct: 863 APEILLGTEHGYAADWWSAGIVLFELLTGIPPFTASRPE 901
|
|
| DICTYBASE|DDB_G0272282 DDB_G0272282 "MAST family protein kinase DDB_G0272282" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 539 (194.8 bits), Expect = 1.1e-66, Sum P(5) = 1.1e-66
Identities = 109/168 (64%), Positives = 130/168 (77%)
Query: 577 SPIHPSKDRTSID--DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVE 634
S + S + TSI DFEIIKPISRGAFGRV+LA+K+ TGDL+AIKVLKK D IRKN V
Sbjct: 1511 SSLTTSSNTTSISIADFEIIKPISRGAFGRVYLAQKKKTGDLYAIKVLKKLDTIRKNMVN 1570
Query: 635 SILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVY 694
++ ER+IL V+N FVV+ FY+F + LYLVMEYL GGD SLLR LGC +E +A+ Y
Sbjct: 1571 HVIVERNILAMVQNEFVVKLFYAFQSTDKLYLVMEYLIGGDCASLLRALGCFEEHMAKHY 1630
Query: 695 IAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742
IAE VL LEYLH +VHRDLKPDN+LI GHIKLTDFGLSK+G+I+
Sbjct: 1631 IAETVLCLEYLHKSAIVHRDLKPDNMLIDGLGHIKLTDFGLSKIGIID 1678
|
|
| MGI|MGI:1914371 Mastl "microtubule associated serine/threonine kinase-like" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 479 (173.7 bits), Expect = 7.1e-58, Sum P(2) = 7.1e-58
Identities = 97/170 (57%), Positives = 126/170 (74%)
Query: 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV 646
SI++F I+KPISRGAFG+V+L +K G L+A+KV+KKADMI KN + AERD L
Sbjct: 30 SIEEFTIVKPISRGAFGKVYLGQKG--GKLYAVKVVKKADMINKNMTHQVQAERDALALS 87
Query: 647 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLH 706
++PFVV +YS N+YL+MEYL GGD+ SLL G DE++A YI+EV LAL+YLH
Sbjct: 88 KSPFVVHLYYSLQSASNIYLIMEYLIGGDVKSLLHIYGYFDEEMAIKYISEVALALDYLH 147
Query: 707 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL---INSTDDLSGPAVS 753
++HRDLKPDN+LI+++GHIKLTDFGLSKV L IN D L+ P++S
Sbjct: 148 RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRDINMMDILTTPSMS 197
|
|
| UNIPROTKB|B1WAR9 mastl "Serine/threonine-protein kinase greatwall" [Xenopus (Silurana) tropicalis (taxid:8364)] | Back alignment and assigned GO terms |
|---|
Score = 489 (177.2 bits), Expect = 8.5e-58, Sum P(2) = 8.5e-58
Identities = 94/170 (55%), Positives = 129/170 (75%)
Query: 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV 646
SI++F I+KPISRGAFG+V+LA+++ LFA+KV+KKADMI KN V+ + AERD L
Sbjct: 29 SIEEFSIVKPISRGAFGKVYLARRKNNNKLFAVKVVKKADMINKNMVQQVQAERDALALS 88
Query: 647 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLH 706
++PF+V +YS N+YL+MEYL GGD+ SLL G DE++A YI+EV LAL+YLH
Sbjct: 89 KSPFIVHLYYSLQSANNIYLIMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLH 148
Query: 707 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL---INSTDDLSGPAVS 753
++HRDLKPDN+LI+++GHIKLTDFGLSKV L ++ D L+ P+++
Sbjct: 149 RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLKRELSMMDILTTPSMA 198
|
|
| UNIPROTKB|F1S920 MAST3 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 556 (200.8 bits), Expect = 8.7e-58, Sum P(2) = 8.7e-58
Identities = 114/249 (45%), Positives = 156/249 (62%)
Query: 579 IHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILA 638
+ PS+ + DFE IK IS GA+G V+L + R T FAIK + K ++I +N ++ +
Sbjct: 365 VGPSRRKPCESDFETIKLISNGAYGAVYLVRHRDTRQRFAIKKINKQNLILRNQIQQVFV 424
Query: 639 ERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEV 698
ERDIL NPFVV F SF R +L +VMEY+ GGD +LL+N+G L D+AR+Y AE
Sbjct: 425 ERDILTFAENPFVVSMFCSFETRRHLCMVMEYVEGGDCATLLKNMGPLPVDMARMYFAET 484
Query: 699 VLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL-SGPAVSGTTL 757
VLALEYLH+ +VHRDLKPDNLLI GHIKLTDFGLSK+GL++ +L G T
Sbjct: 485 VLALEYLHNYGIVHRDLKPDNLLITSLGHIKLTDFGLSKIGLMSMATNLYEGHIEKDTRE 544
Query: 758 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGI 817
D++ GTP+Y+APE++ G+G DWW++G++L+E +VG
Sbjct: 545 FVDKQ-----------------VCGTPEYIAPEVIFRQGYGKPVDWWAMGVVLYEFLVGC 587
Query: 818 PPFNAEHPQ 826
PF + P+
Sbjct: 588 VPFFGDTPE 596
|
|
| TAIR|locus:2204574 AT1G30640 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 591 (213.1 bits), Expect = 1.7e-57, P = 1.7e-57
Identities = 122/290 (42%), Positives = 178/290 (61%)
Query: 555 ITSTVIEEDAPLED--DVVRSLRTSPIHP---SKDRTSIDDFEIIKPISRGAFGRVFLAK 609
+ + + D +ED D++++ + + + +DDFE++ I RGAFG V + K
Sbjct: 79 LEQNLADADVTVEDKMDILKNFEKKEMEYMRLQRQKMGVDDFELLSIIGRGAFGEVRICK 138
Query: 610 KRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669
+++TG ++A+K LKK++M+R+ VE + AER++L V +PF+V+ YSF E+LYL+ME
Sbjct: 139 EKSTGSVYAMKKLKKSEMLRRGQVEHVKAERNVLAEVDSPFIVKLCYSFQDDEHLYLIME 198
Query: 670 YLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIK 729
YL GGD+ +LL L ED R Y+A+ +LA+E +H VHRD+KPDNLLI +GHIK
Sbjct: 199 YLPGGDMMTLLMRKDTLREDETRFYVAQTILAIESIHKHNYVHRDIKPDNLLITRNGHIK 258
Query: 730 LTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEE---------PQLTASE---HQQERRKK 777
L+DFGLSK + D V +T E P+ T E H Q+ R+
Sbjct: 259 LSDFGLSKSLESKNFPDFKAELVDRSTKPAAEHDRLSKPPSAPRRTQQEQLLHWQQNRRT 318
Query: 778 R--SAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825
S VGTPDY+APE+LL G+G DWWS+G I+FE++VG PPF +E P
Sbjct: 319 LAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMFEMLVGFPPFYSEEP 368
|
|
| UNIPROTKB|Q96GX5 MASTL "Serine/threonine-protein kinase greatwall" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 476 (172.6 bits), Expect = 7.7e-57, Sum P(2) = 7.7e-57
Identities = 96/170 (56%), Positives = 126/170 (74%)
Query: 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV 646
SI++F I+KPISRGAFG+V+L +K G L+A+KV+KKADMI KN + AERD L
Sbjct: 31 SIEEFSIVKPISRGAFGKVYLGQKG--GKLYAVKVVKKADMINKNMTHQVQAERDALALS 88
Query: 647 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLH 706
++PF+V +YS N+YLVMEYL GGD+ SLL G DE++A YI+EV LAL+YLH
Sbjct: 89 KSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLH 148
Query: 707 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL---INSTDDLSGPAVS 753
++HRDLKPDN+LI+++GHIKLTDFGLSKV L IN D L+ P+++
Sbjct: 149 RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRDINMMDILTTPSMA 198
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 2.7.1 | LOW CONFIDENCE prediction! |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 837 | |||
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-120 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-98 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-95 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-88 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-88 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-85 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-85 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-80 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-79 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-76 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-72 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-72 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-71 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-68 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-68 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-65 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-65 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-65 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-64 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-63 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-63 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-62 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-61 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-61 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-59 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 7e-59 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 8e-59 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-58 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-56 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-56 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 5e-56 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-56 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-55 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-55 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-54 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-53 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-52 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-52 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-52 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-52 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-51 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-51 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-51 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 8e-51 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-50 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-50 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-49 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-49 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-49 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-49 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-48 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-48 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-47 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-47 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-47 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 9e-47 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-46 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-46 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-46 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 8e-46 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-45 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-45 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 8e-45 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-44 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-44 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-43 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-42 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-41 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-41 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-41 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 9e-40 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-39 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-39 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-39 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 9e-39 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-38 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-36 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-36 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-36 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-35 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 8e-35 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-34 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-34 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-34 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-34 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 9e-34 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-33 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-33 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-33 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-33 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-33 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-33 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-32 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-32 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-32 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 9e-32 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-31 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-31 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-31 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 7e-31 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 9e-31 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-30 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-30 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-30 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-30 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-30 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-29 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-29 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-29 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-29 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-29 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-28 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-28 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-28 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-28 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-28 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-28 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-28 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-28 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-28 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-28 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 8e-28 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-27 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-27 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-27 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-27 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-27 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-27 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-27 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-26 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-26 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-26 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-26 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-26 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-26 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-26 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-25 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-25 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-25 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-25 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-25 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-25 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-24 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-24 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-24 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-24 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-24 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 9e-24 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-23 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-22 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-22 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-22 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-21 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-21 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-21 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-21 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-21 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-21 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-20 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-20 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-20 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-20 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-20 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-20 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-20 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-20 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 8e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-19 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-19 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-19 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-19 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-19 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-19 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-19 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-19 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-19 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-19 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-18 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-18 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-18 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-18 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-18 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-18 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-18 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-18 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-17 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-17 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 9e-17 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 9e-17 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-16 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-16 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-16 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-16 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-16 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-15 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-15 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-15 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-15 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-15 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-15 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-15 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-15 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-15 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 8e-15 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 9e-15 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-14 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-14 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-14 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-14 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-14 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-14 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-14 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-14 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-14 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 7e-14 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-14 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 9e-14 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-13 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-13 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-13 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-13 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-13 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 5e-13 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-13 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 7e-13 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-12 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-12 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-12 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-12 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-12 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-12 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-11 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-11 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-11 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-11 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-11 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-11 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-11 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-10 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-10 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-10 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-10 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 6e-10 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 7e-10 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-09 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-09 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-09 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-09 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-09 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-09 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 6e-09 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-09 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-09 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 9e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-08 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 7e-08 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 8e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 8e-08 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-07 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-07 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-07 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 3e-07 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-07 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-07 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-07 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-06 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-06 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-06 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-06 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 3e-06 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 3e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 8e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-05 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 5e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-05 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 8e-05 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 9e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 1e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-04 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 3e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-04 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-04 | |
| cd05119 | 187 | cd05119, RIO, RIO kinase family, catalytic domain | 4e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 6e-04 | |
| cd05145 | 190 | cd05145, RIO1_like, RIO kinase family; RIO1, RIO3 | 8e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 8e-04 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 8e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.001 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 0.002 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.003 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 363 bits (934), Expect = e-120
Identities = 134/230 (58%), Positives = 171/230 (74%), Gaps = 23/230 (10%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFY 656
IS+GA+GRVFLAKK++TGD++AIKV+KKADMIRKN V+ +L ERDIL ++P+VV+ +Y
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 657 SFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLK 716
SF ++NLYLVMEYL GGDL SLL N+G LDEDVAR+YIAE+VLALEYLHS ++HRDLK
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120
Query: 717 PDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRK 776
PDN+LI +GH+KLTDFGLSKVGL+ +L+ +
Sbjct: 121 PDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK-----------------------E 157
Query: 777 KRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826
+ VGTPDY+APE++LG GH T DWWS+G IL+E +VGIPPF+ E P+
Sbjct: 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE 207
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 309 bits (793), Expect = 4e-98
Identities = 117/238 (49%), Positives = 161/238 (67%), Gaps = 2/238 (0%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
DDFE+IK I RGAFG V+L + + TG ++A+KVL+K+DMI++N + + AERDIL +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
P++V+ +YSF E+LYLVMEY+ GGDL +LL E+ AR YIAE+VLAL+ +H L
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL 120
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTAS 768
+HRD+KPDN+LI DGHIKL DFGL K +N D LL + +
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLCKK--MNKAKDREYYLNDSHNLLFRDNVLVRRR 178
Query: 769 EHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826
+H+Q R + S VGTPDY+APE+L GT +G DWWS+G+IL+E++ G PPF ++ Q
Sbjct: 179 DHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 297 bits (762), Expect = 6e-95
Identities = 103/227 (45%), Positives = 143/227 (62%), Gaps = 31/227 (13%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFY 656
+ +G+FG+V L +K+ TG L+A+KVLKK +I++ VE L ER+IL + +PF+V+ Y
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 657 SFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLK 716
+F E LYLV+EY GG+L+S L G E+ AR Y AE+VLALEYLHSL +++RDLK
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 717 PDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRK 776
P+N+L+ DGHIKLTDFGL+K E +
Sbjct: 121 PENILLDADGHIKLTDFGLAKELS-------------------------------SEGSR 149
Query: 777 KRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823
+ GTP+YLAPE+LLG G+G DWWS+G++L+E++ G PPF AE
Sbjct: 150 TNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAE 196
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 279 bits (716), Expect = 4e-88
Identities = 119/234 (50%), Positives = 152/234 (64%), Gaps = 36/234 (15%)
Query: 594 IKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVV 652
+KPIS+GAFG V+LAKKR+TGD FAIKVLKK+DMI KN V ++ AER I++ +P+V
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 653 RFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVH 712
+ +YSF ++ LYLVMEYLNGGD SL++ LG L ED A+ YIAEVVL +E LH ++H
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIH 120
Query: 713 RDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQ 772
RD+KP+NLLI GH+KLTDFGLS+ GL N
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFGLSRNGLEN------------------------------ 150
Query: 773 ERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826
+ VGTPDYLAPE +LG G +DWWS+G ++FE + G PPF+AE P
Sbjct: 151 -----KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD 199
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 280 bits (718), Expect = 6e-88
Identities = 107/237 (45%), Positives = 148/237 (62%), Gaps = 34/237 (14%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
DDFE IK + G+FGRV L + + +G +A+K+L KA +++ VE +L E+ IL S+R+
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
PF+V + SF NLYLVMEY+ GG+L+S LR G E VAR Y A+VVLALEYLHSL
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL 120
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTAS 768
+V+RDLKP+NLL+ DG+IK+TDFG +K V G T
Sbjct: 121 DIVYRDLKPENLLLDSDGYIKITDFGFAKR-------------VKGRTY----------- 156
Query: 769 EHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825
+ GTP+YLAPEI+L G+G DWW++GI+++E++ G PPF ++P
Sbjct: 157 ----------TLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP 203
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 276 bits (708), Expect = 2e-85
Identities = 108/246 (43%), Positives = 153/246 (62%), Gaps = 9/246 (3%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
DDFE IK I RGAFG V L +K+ TG ++A+K L+K++M+ K V + AERDIL N
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
P+VV+ +YSF LYL+MEYL GGD+ +LL E+ R YIAE +LA++ +H L
Sbjct: 61 PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL 120
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL---INSTDDLSGPAVSGTTLLGDEEPQL 765
+HRD+KPDNLL+ GHIKL+DFGL GL + + L +
Sbjct: 121 GYIHRDIKPDNLLLDAKGHIKLSDFGLCT-GLKKSHRTEFYRILSHALPSNFLDFISKPM 179
Query: 766 TASEHQQERRKKR-----SAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820
++ + ++ R S VGTPDY+APE+ L TG+ DWWS+G+I++E++VG PPF
Sbjct: 180 SSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPF 239
Query: 821 NAEHPQ 826
+++PQ
Sbjct: 240 CSDNPQ 245
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 271 bits (695), Expect = 4e-85
Identities = 101/244 (41%), Positives = 144/244 (59%), Gaps = 35/244 (14%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
+EI++ + G+FG+V+LA+ + TG L AIKV+KK + + E IL E IL +++P
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKD--RERILREIKILKKLKHPN 58
Query: 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRV 710
+VR + F + LYLVMEY GGDL+ LL+ G L ED AR Y+ +++ ALEYLHS +
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118
Query: 711 VHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEH 770
VHRDLKP+N+L+ DGH+KL DFGL++
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLAR--------------------------------Q 146
Query: 771 QQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQVSTL 830
K + VGTP+Y+APE+LLG G+G D WS+G+IL+EL+ G PPF + Q+ L
Sbjct: 147 LDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDD-QLLEL 205
Query: 831 LRKC 834
+K
Sbjct: 206 FKKI 209
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 260 bits (667), Expect = 2e-80
Identities = 112/242 (46%), Positives = 154/242 (63%), Gaps = 24/242 (9%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+DFE IK IS GA+G V+L + + T FA+K + K ++I +N ++ + ERDIL N
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
PFVV F SF + +L +VMEY+ GGD +LL+N+G L D+AR+Y AE VLALEYLH+
Sbjct: 61 PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY 120
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTAS 768
+VHRDLKPDNLLI GHIKLTDFGLSK+GL++ T +L
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL--------------------Y 160
Query: 769 EHQQERRKK----RSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824
E E+ + + GTP+Y+APE++L G+G DWW++GIIL+E +VG PF +
Sbjct: 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT 220
Query: 825 PQ 826
P+
Sbjct: 221 PE 222
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 255 bits (655), Expect = 6e-79
Identities = 89/235 (37%), Positives = 142/235 (60%), Gaps = 12/235 (5%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-R 647
DDF+ K I G+F V LAK++ T +AIK+L K +I++ V+ + E+++L +
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 648 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS 707
+P +++ +Y+F ENLY V+EY G+L +R G LDE R Y AE++LALEYLHS
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS 120
Query: 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTA 767
++HRDLKP+N+L+ D HIK+TDFG +KV L + + +
Sbjct: 121 KGIIHRDLKPENILLDKDMHIKITDFGTAKV--------LDPNSSPESN---KGDATNID 169
Query: 768 SEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNA 822
S+ ++ RR+ S VGT +Y++PE+L G ++D W++G I+++++ G PPF
Sbjct: 170 SQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRG 224
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 252 bits (646), Expect = 2e-76
Identities = 113/249 (45%), Positives = 154/249 (61%), Gaps = 16/249 (6%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
F IK I GAFG V L +K T L+A+K L+KAD++ +N + AERDIL N +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRV 710
VV+ +YSF ++NLY VM+Y+ GGD+ SLL LG +ED+AR YIAE+ A+E +H +
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGF 122
Query: 711 VHRDLKPDNLLIAHDGHIKLTDFGL---------SKVGLINSTDDLSGPAVSGTTLLGDE 761
+HRD+KPDN+LI DGHIKLTDFGL SK D ++ + +
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK--YYQKGDHHRQDSMEPSEEWSEI 180
Query: 762 EP-QLTASE----HQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVG 816
+ +L E Q +R S VGTP+Y+APE+LL TG+ DWWSVG+IL+E++VG
Sbjct: 181 DRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 240
Query: 817 IPPFNAEHP 825
PPF A+ P
Sbjct: 241 QPPFLADTP 249
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 241 bits (616), Expect = 1e-72
Identities = 101/237 (42%), Positives = 143/237 (60%), Gaps = 34/237 (14%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
DF+I+ + +G +G+VFLAKK+ TG++ A+K +KK+ + + N V +L ERDIL + ++
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLR 709
++V+ Y+F E LYL MEY+ GGD +LL NLG L ED AR Y+AE+ A++ LH L
Sbjct: 62 WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG 121
Query: 710 VVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASE 769
+HRDLKP+N LI GHIKLTDFGLSK G++
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSK-GIVT--------------------------- 153
Query: 770 HQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826
S VG+PDY+APE+L G G+ T D+WS+G +L+E + G PPF+ P
Sbjct: 154 ------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN 204
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 239 bits (611), Expect = 4e-72
Identities = 103/236 (43%), Positives = 147/236 (62%), Gaps = 8/236 (3%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
F+ IK + +G GRVFL + + TG LFA+KVL K +MI++N V+ +L E++IL ++ +
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL--RNLGCLDEDVARVYIAEVVLALEYLH 706
PF+ + SF L LVM+Y GG+L+ LL + CL E+VAR Y AEV+LALEYLH
Sbjct: 61 PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH 120
Query: 707 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS--GTTLLGDEEPQ 764
L +V+RDLKP+N+L+ GHI L+DF LSK + A+ + P
Sbjct: 121 LLGIVYRDLKPENILLHESGHIMLSDFDLSK--QSDVEPPPVSKALRKGSRRSSVNSIPS 178
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820
T SE R S VGT +Y+APE++ G GHG+ DWW++GI+L+E++ G PF
Sbjct: 179 ETFSEEPSFR--SNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPF 232
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 235 bits (602), Expect = 1e-71
Identities = 87/236 (36%), Positives = 134/236 (56%), Gaps = 33/236 (13%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
+E+++ + G+FG V+ AK + TG + A+K+LKK + ++ E IL + +P
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRS-EKSKKDQTARREIRILRRLSHPN 59
Query: 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRV 710
+VR +F +++LYLVMEY GGDL+ L G L ED A+ +++ LEYLHS +
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 711 VHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEH 770
+HRDLKP+N+L+ +G +K+ DFGL+K L +S+
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSS-------------------------- 153
Query: 771 QQERRKKRSAVGTPDYLAPEILL-GTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825
+ VGTP Y+APE+LL G G+G D WS+G+IL+EL+ G PPF+ E+
Sbjct: 154 -----SLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENI 204
|
Length = 260 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 226 bits (579), Expect = 3e-68
Identities = 85/227 (37%), Positives = 133/227 (58%), Gaps = 32/227 (14%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFY 656
+ G FGRV L K ++ FA+K +KK ++ E I +E++IL +PF+V+ +
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 657 SFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLK 716
+F ++ +Y++MEY GG+L+++LR+ G DE AR YIA VVLA EYLH+ +++RDLK
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 717 PDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRK 776
P+NLL+ +G++KL DFG +K L +K
Sbjct: 121 PENLLLDSNGYVKLVDFGFAKK-------------------LKS-------------GQK 148
Query: 777 KRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823
+ GTP+Y+APEI+L G+ + D+WS+GI+L+EL+ G PPF +
Sbjct: 149 TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGED 195
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 230 bits (589), Expect = 3e-68
Identities = 107/255 (41%), Positives = 152/255 (59%), Gaps = 18/255 (7%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+DF +K I +GAFG V L +K+ TG ++A+K L K++M +K+ + + AERD+L +
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
P+VV +YSF + LYL+ME+L GGDL ++L EDV R Y+AE VLA+E +H L
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL 120
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD----------DLSGPAVSGTTLL 758
+HRD+KPDN+LI GHIKL+DFGLS G D + + +
Sbjct: 121 GFIHRDIKPDNILIDRGGHIKLSDFGLS-TGFHKQHDSAYYQKLLQGKSNKNRIDNRNSV 179
Query: 759 GDEEPQLTASEHQQ---ERRKKR----SAVGTPDYLAPEILLGTGHGTTADWWSVGIILF 811
+ LT S Q ++ +R S VGTPDY+APEI L G+G DWWS+G I+F
Sbjct: 180 AVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMF 239
Query: 812 ELIVGIPPFNAEHPQ 826
E ++G PPF +E+
Sbjct: 240 ECLIGWPPFCSENSH 254
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 220 bits (563), Expect = 1e-65
Identities = 90/237 (37%), Positives = 135/237 (56%), Gaps = 34/237 (14%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
DD E IK + G FGRV L + R + +A+KV+ ++IR + + E+ +L V +
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
PF++R F++ + LY++MEY+ GG+L+S LRN G Y +E+V ALEYLHS
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTAS 768
+V+RDLKP+N+L+ +GHIKLTDFG +K L + T L
Sbjct: 121 EIVYRDLKPENILLDKEGHIKLTDFGFAK-KLRDRTWTL--------------------- 158
Query: 769 EHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825
GTP+YLAPE++ GH DWW++GI+++E++VG PPF ++P
Sbjct: 159 ------------CGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP 203
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 222 bits (567), Expect = 2e-65
Identities = 108/242 (44%), Positives = 154/242 (63%), Gaps = 4/242 (1%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
DDFE +K I RGAFG V L +K+ TG ++A+K+L+KADM+ K V I AERDIL+
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
+VV+ FYSF + NLYL+ME+L GGD+ +LL L E+ + YIAE VLA++ +H L
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDF----GLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
+HRD+KPDNLL+ GH+KL+DF GL K +L+ S + +
Sbjct: 121 GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKR 180
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824
+ + R+ S VGTPDY+APE+ + TG+ DWWS+G+I++E+++G PPF +E
Sbjct: 181 KAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240
Query: 825 PQ 826
PQ
Sbjct: 241 PQ 242
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 222 bits (567), Expect = 3e-65
Identities = 115/253 (45%), Positives = 155/253 (61%), Gaps = 20/253 (7%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
F IK + GAFG V LA+K T L+A+K L+K D++ +N V + AERDIL N +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRV 710
VVR +YSF ++NLY VM+Y+ GGD+ SLL +G ED+AR YIAE+ A+E +H +
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF 122
Query: 711 VHRDLKPDNLLIAHDGHIKLTDFGL---------SKVGLINSTDDLSGPAVSGTTLLGDE 761
+HRD+KPDN+LI DGHIKLTDFGL SK S D + ++ + GD
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK--YYQSGDHVRQDSMDFSNEWGDP 180
Query: 762 E---------PQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFE 812
P + Q +R S VGTP+Y+APE+LL TG+ DWWSVG+IL+E
Sbjct: 181 ANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 240
Query: 813 LIVGIPPFNAEHP 825
++VG PPF A+ P
Sbjct: 241 MLVGQPPFLAQTP 253
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 218 bits (557), Expect = 5e-64
Identities = 108/242 (44%), Positives = 155/242 (64%), Gaps = 4/242 (1%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+DFE +K I RGAFG V L +K+ TG ++A+K+L+KADM+ K V I AERDIL+ +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
+VV+ FYSF + NLYL+ME+L GGD+ +LL L E+ + YIAE VLA++ +H L
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDF----GLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
+HRD+KPDNLL+ GH+KL+DF GL K +L+ S T +
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824
+ + R+ S VGTPDY+APE+ + TG+ DWWS+G+I++E+++G PPF +E
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240
Query: 825 PQ 826
PQ
Sbjct: 241 PQ 242
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 212 bits (543), Expect = 3e-63
Identities = 83/233 (35%), Positives = 128/233 (54%), Gaps = 34/233 (14%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
FE+++ I +GAFG+V + +KR T +FA+K + K + K +V ++L ER IL + +PF
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 651 VVRFFYSFTCRENLYLVMEYLNGGDL-YSLLRNLGCLDEDVARVYIAEVVLALEYLHSLR 709
+V +YSF EN+YLV++ L GGDL Y L + E+ + +I E+VLALEYLHS
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKG 120
Query: 710 VVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASE 769
++HRD+KPDN+L+ GH+ +TDF ++ ++T
Sbjct: 121 IIHRDIKPDNILLDEQGHVHITDFNIAT--------------------------KVTPDT 154
Query: 770 HQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNA 822
GTP Y+APE+L G+ DWWS+G+ +E + G P+
Sbjct: 155 LTTST------SGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRG 201
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 224 bits (572), Expect = 5e-63
Identities = 95/168 (56%), Positives = 125/168 (74%), Gaps = 3/168 (1%)
Query: 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV 646
SI++F I+KPISRGAFG+V+L +K+ L+A+KV+KKADMI KN V + AERD L
Sbjct: 2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS 61
Query: 647 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLH 706
++PF+V +YS N+YLVMEYL GGD+ SLL G DE++A YI+EV LAL+YLH
Sbjct: 62 KSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLH 121
Query: 707 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL---INSTDDLSGPA 751
++HRDLKPDN+LI+++GHIKLTDFGLSKV L +N D L+ P+
Sbjct: 122 RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTTPS 169
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 212 bits (542), Expect = 3e-62
Identities = 81/230 (35%), Positives = 129/230 (56%), Gaps = 32/230 (13%)
Query: 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN-PFVVR 653
K + +G+FG+V LA+ + T +L+A+KVLKK +++ + VE + E+ +L PF+ +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 654 FFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHR 713
F ++ L+ VMEY+NGGDL ++ G DE AR Y AE+VL L++LH +++R
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120
Query: 714 DLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQE 773
DLK DN+L+ +GHIK+ DFG+ K G++
Sbjct: 121 DLKLDNVLLDSEGHIKIADFGMCKEGILG------------------------------- 149
Query: 774 RRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823
+ GTPDY+APEIL +G DWW++G++L+E++ G PF +
Sbjct: 150 GVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 210 bits (536), Expect = 2e-61
Identities = 88/236 (37%), Positives = 138/236 (58%), Gaps = 34/236 (14%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
DFE+ + + G+FGRV +AK + TG+ +AIK LKK ++++ V+ + E+ IL+ + +P
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLR 709
F+V SF +Y ++E++ GG+L++ LR G DVA+ Y AE+VLA EYLHS
Sbjct: 79 FIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD 138
Query: 710 VVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASE 769
+++RDLKP+NLL+ + GH+K+TDFG +K
Sbjct: 139 IIYRDLKPENLLLDNKGHVKVTDFGFAK-------------------------------- 166
Query: 770 HQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825
+ + + GTP+YLAPE++ GHG DWW++G++L+E I G PPF + P
Sbjct: 167 --KVPDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP 220
|
Length = 329 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 212 bits (540), Expect = 2e-61
Identities = 114/257 (44%), Positives = 152/257 (59%), Gaps = 18/257 (7%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
F IK + GAFG V LA K T L+A+K L+K D++ +N V + AERDIL N +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRV 710
VV+ +YSF ++NLY VM+Y+ GGD+ SLL + E +AR YIAE+ LA+E +H +
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF 122
Query: 711 VHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI---NSTDDLSGPAVSGTTL---------- 757
+HRD+KPDN+LI DGHIKLTDFGL G NS G + ++
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLC-TGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVS 181
Query: 758 ---LGDEEPQLTASEHQQERR-KKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 813
GD L +Q +R S VGTP+Y+APE+LL G+ DWWSVG+ILFE+
Sbjct: 182 NCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM 241
Query: 814 IVGIPPFNAEHPQVSTL 830
+VG PPF A P + L
Sbjct: 242 LVGQPPFLAPTPTETQL 258
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 203 bits (519), Expect = 4e-59
Identities = 90/227 (39%), Positives = 135/227 (59%), Gaps = 32/227 (14%)
Query: 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILI-SVRNPFVVR 653
K I +G+FG+V LAK + G +A+KVL+K +++K + I+AER++L+ +V++PF+V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 654 FFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHR 713
YSF + LY V++Y+NGG+L+ L+ E AR Y AE+ AL YLHSL +++R
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120
Query: 714 DLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQE 773
DLKP+N+L+ GH+ LTDFGL K G+ S TT
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGI----------EHSKTT----------------- 153
Query: 774 RRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820
+ GTP+YLAPE+L + T DWW +G +L+E++ G+PPF
Sbjct: 154 ----STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 204 bits (521), Expect = 7e-59
Identities = 93/243 (38%), Positives = 139/243 (57%), Gaps = 35/243 (14%)
Query: 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILI 644
R +DF++IK I RGAFG V L + +++ ++A+K+L K +MI+++ ERDI+
Sbjct: 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMA 98
Query: 645 SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEY 704
+ ++V+ Y+F + LY+VMEY+ GGDL +L+ N + E AR Y AEVVLAL+
Sbjct: 99 HANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD-IPEKWARFYTAEVVLALDA 157
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
+HS+ +HRD+KPDN+L+ GH+KL DF GT + D
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSGHLKLADF--------------------GTCMKMDANGM 197
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLGTGH----GTTADWWSVGIILFELIVGIPPF 820
+ +AVGTPDY++PE+L G G DWWSVG+ L+E++VG PF
Sbjct: 198 VRCD----------TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
Query: 821 NAE 823
A+
Sbjct: 248 YAD 250
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 200 bits (512), Expect = 8e-59
Identities = 77/245 (31%), Positives = 127/245 (51%), Gaps = 32/245 (13%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
++ + + RG+FG V+LA + TG+L A+K ++ + + E++ E IL S+++P
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEEL-EALEREIRILSSLQHP 59
Query: 650 FVVRFFYSFTCRE--NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS 707
+VR++ S E L + +EY++GG L SLL+ G L E V R Y +++ L YLHS
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTA 767
+VHRD+K N+L+ DG +KL DFG +K + + G
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKR--LGDIETGEG------------------ 159
Query: 768 SEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQV 827
S GTP ++APE++ G +G AD WS+G + E+ G PP++ +
Sbjct: 160 ---------TGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM 210
Query: 828 STLLR 832
+ L +
Sbjct: 211 AALYK 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 200 bits (511), Expect = 2e-58
Identities = 91/246 (36%), Positives = 139/246 (56%), Gaps = 37/246 (15%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRT---TGDLFAIKVLKKADMIRK-NAVESILAERDILIS 645
+FE+++ + GA+G+VFL +K G L+A+KVLKKA +++K E ER +L +
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 646 VR-NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEY 704
VR PF+V Y+F L+L+++Y+NGG+L++ L E RVYIAE+VLAL++
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDH 120
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
LH L +++RD+K +N+L+ +GH+ LTDFGLSK L +
Sbjct: 121 LHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE------------------- 161
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLG--TGHGTTADWWSVGIILFELIVGIPPFNA 822
+ S GT +Y+APE++ G GH DWWS+G++ FEL+ G PF
Sbjct: 162 -----------RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV 210
Query: 823 EHPQVS 828
+ Q S
Sbjct: 211 DGEQNS 216
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 195 bits (498), Expect = 3e-56
Identities = 90/237 (37%), Positives = 138/237 (58%), Gaps = 33/237 (13%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFY 656
I +G+FG+V +KR T ++A+K ++KA ++ ++ V LAER +L V PF+V +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 657 SFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLK 716
SF E LYLV+ ++NGG+L+ L+ G D AR Y AE++ ALE LH V++RDLK
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 717 PDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRK 776
P+N+L+ + GHI L DFGL K+ + + K
Sbjct: 121 PENILLDYQGHIALCDFGLCKLNMKDDD-------------------------------K 149
Query: 777 KRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQVSTLLRK 833
+ GTP+YLAPE+LLG G+ DWW++G++L+E++ G+PPF E+ V+ + RK
Sbjct: 150 TNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN--VNEMYRK 204
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 195 bits (498), Expect = 3e-56
Identities = 93/236 (39%), Positives = 140/236 (59%), Gaps = 37/236 (15%)
Query: 594 IKPISRGAFGRVFLAKKRT---TGDLFAIKVLKKADMIRKNAVES--ILAERDILISVRN 648
+K + +G +G+VF +K T TG +FA+KVLKKA ++R N ++ AER+IL +V++
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVR-NQKDTAHTKAERNILEAVKH 59
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
PF+V Y+F LYL++EYL+GG+L+ L G ED A Y++E+ LALE+LH
Sbjct: 60 PFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ 119
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTAS 768
+++RDLKP+N+L+ GH+KLTDFGL K
Sbjct: 120 GIIYRDLKPENILLDAQGHVKLTDFGLCK------------------------------- 148
Query: 769 EHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824
E E + GT +Y+APEIL+ +GHG DWWS+G ++++++ G PPF AE+
Sbjct: 149 ESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN 204
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 195 bits (497), Expect = 5e-56
Identities = 93/245 (37%), Positives = 136/245 (55%), Gaps = 45/245 (18%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
DF++ + RG FG V + +++ TGD++A+KV+KK+ ++ + V ERDIL +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL-RNLGCLDEDVARVYIAEVVLALEYLHS 707
P++ + Y+F ++NLYLVMEY GGDL SLL R DED+A+ Y+AE+VLA+ +H
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120
Query: 708 LRVVHRDLKPDNLLIAHDGHIKLTDFG----LSKVGLINSTDDLSGPAVSGTTLLGDEEP 763
+ VHRD+KP+N+LI GHIKL DFG L+ ++NS
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSK------------------- 161
Query: 764 QLTASEHQQERRKKRSAVGTPDYLAPEILL------GTGHGTTADWWSVGIILFELIVGI 817
VGTPDY+APE+L +G DWWS+G+I +E+I G
Sbjct: 162 ---------------LPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
Query: 818 PPFNA 822
PF+
Sbjct: 207 SPFHE 211
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 195 bits (497), Expect = 5e-56
Identities = 99/241 (41%), Positives = 137/241 (56%), Gaps = 36/241 (14%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
DDFEI+K I RGAFG V + K + TG ++A+K+L K +M+++ ERD+L++
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHS 707
++ Y+F NLYLVM+Y GGDL +LL L ED+AR Y+AE+VLA++ +H
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120
Query: 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTA 767
L VHRD+KPDN+L+ +GHI+L DFG S LL D Q
Sbjct: 121 LGYVHRDIKPDNVLLDKNGHIRLADFG------------------SCLRLLADGTVQSNV 162
Query: 768 SEHQQERRKKRSAVGTPDYLAPEILL----GTGH-GTTADWWSVGIILFELIVGIPPFNA 822
AVGTPDY++PEIL G G G DWWS+G+ ++E++ G PF A
Sbjct: 163 ------------AVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210
Query: 823 E 823
E
Sbjct: 211 E 211
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 193 bits (492), Expect = 2e-55
Identities = 92/227 (40%), Positives = 139/227 (61%), Gaps = 32/227 (14%)
Query: 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILI-SVRNPFVVR 653
K I +G+FG+V LAK+++ G +A+KVL+K +++K I+AER++L+ ++++PF+V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 654 FFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHR 713
YSF E LY V++Y+NGG+L+ L+ C E AR Y AEV A+ YLHSL +++R
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 714 DLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQE 773
DLKP+N+L+ GH+ LTDFGL K G+ EP+ T S
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGV---------------------EPEETTS----- 154
Query: 774 RRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820
+ GTP+YLAPE+L + T DWW +G +L+E++ G+PPF
Sbjct: 155 -----TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 188 bits (480), Expect = 6e-55
Identities = 87/241 (36%), Positives = 127/241 (52%), Gaps = 47/241 (19%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFY 656
+ G FG V+LA+ + TG AIK++KK D + +E +L E +IL + +P +V+ +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKED--SSSLLEELLREIEILKKLNHPNIVKLYG 58
Query: 657 SFTCRENLYLVMEYLNGGDLYSLL-RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDL 715
F +LYLVMEY GG L LL N G L ED + +++ LEYLHS ++HRDL
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 716 KPDNLLIAHD-GHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQER 774
KP+N+L+ D G +KL DFGLSK ++
Sbjct: 119 KPENILLDSDNGKVKLADFGLSK-------------------------------LLTSDK 147
Query: 775 RKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVGIPPFNAEHPQVSTLLRK 833
++ VGTP Y+APE+LLG G+ +D WS+G+IL+EL P++ L+RK
Sbjct: 148 SLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------PELKDLIRK 196
Query: 834 C 834
Sbjct: 197 M 197
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 3e-54
Identities = 80/237 (33%), Positives = 124/237 (52%), Gaps = 36/237 (15%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
FEI++ I +G FG V+ A+ + TG AIKV+K +K E I+ E IL ++P
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKK---EKIINEIQILKKCKHP 57
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSL 708
+V+++ S+ ++ L++VME+ +GG L LL++ L E E++ LEYLHS
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTAS 768
++HRD+K N+L+ DG +KL DFGLS QL+ +
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSA--------------------------QLSDT 151
Query: 769 EHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825
+ + VGTP ++APE++ G + AD WS+GI EL G PP++ P
Sbjct: 152 KARNTM------VGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP 202
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 186 bits (475), Expect = 5e-53
Identities = 94/247 (38%), Positives = 147/247 (59%), Gaps = 36/247 (14%)
Query: 594 IKPISRGAFGRVFLAKKRT---TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
+K + +G+FG+VFL +K T G L+A+KVLKKA + ++ V + + ERDIL V +PF
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKM-ERDILAEVNHPF 59
Query: 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRV 710
+V+ Y+F LYL++++L GGDL++ L E+ + Y+AE+ LAL++LHSL +
Sbjct: 60 IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGI 119
Query: 711 VHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEH 770
++RDLKP+N+L+ +GHIKLTDFGLSK E
Sbjct: 120 IYRDLKPENILLDEEGHIKLTDFGLSK-------------------------------ES 148
Query: 771 QQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQVS-T 829
+K S GT +Y+APE++ GH +ADWWS G+++FE++ G PF + + + T
Sbjct: 149 IDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMT 208
Query: 830 LLRKCQL 836
++ K +L
Sbjct: 209 MILKAKL 215
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 185 bits (472), Expect = 2e-52
Identities = 82/235 (34%), Positives = 134/235 (57%), Gaps = 32/235 (13%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDIL-ISVRN 648
DF + + +G+FG+V LA+++ T +L+AIK+LKK +I+ + VE + E+ +L + +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
PF+ + F + LY VMEY+NGGDL ++ +G E A Y AE+ + L +LHS
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTAS 768
+++RDLK DN+++ +GHIK+ DFG+ K
Sbjct: 121 GIIYRDLKLDNVMLDAEGHIKIADFGMCK------------------------------- 149
Query: 769 EHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823
E+ + R+ GTPDY+APEI+ +G + DWW+ G++L+E++ G PPF+ E
Sbjct: 150 ENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE 204
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 183 bits (467), Expect = 2e-52
Identities = 77/241 (31%), Positives = 130/241 (53%), Gaps = 36/241 (14%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
+EIIK I +G+FG+V+L ++++ G L+ +K + ++M K ++ L E IL + +P
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDA-LNEVKILKKLNHP 59
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC----LDEDVARVYIAEVVLALEYL 705
+++++ SF + L +VMEY +GGDL ++ E+ + ++ LAL+YL
Sbjct: 60 NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119
Query: 706 HSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQL 765
HS +++HRD+KP N+ + +G +KL DFG+SKV ++ST DL T+
Sbjct: 120 HSRKILHRDIKPQNIFLTSNGLVKLGDFGISKV--LSSTVDL------AKTV-------- 163
Query: 766 TASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825
VGTP YL+PE+ + +D WS+G +L+EL PF E+
Sbjct: 164 ---------------VGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL 208
Query: 826 Q 826
Sbjct: 209 L 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 185 bits (471), Expect = 3e-52
Identities = 93/245 (37%), Positives = 135/245 (55%), Gaps = 37/245 (15%)
Query: 583 KDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDL--FAIKVLKKADMIRKNAVESILAER 640
K++ +DF I+ + G+FGRV LA + D AIK +K+ +I++ V+ + +ER
Sbjct: 24 KNKMKYEDFNFIRTLGTGSFGRVILATYKN-EDFPPVAIKRFEKSKIIKQKQVDHVFSER 82
Query: 641 DILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVL 700
IL + +PF V + SF LYLV+E++ GG+ ++ LR DV Y A++VL
Sbjct: 83 KILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVL 142
Query: 701 ALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGD 760
EYL SL +V+RDLKP+NLL+ DG IK+TDFG +KV
Sbjct: 143 IFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV---------------------- 180
Query: 761 EEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820
+ + GTP+Y+APEILL GHG ADWW++GI ++E++VG PPF
Sbjct: 181 ------------VDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPF 228
Query: 821 NAEHP 825
A P
Sbjct: 229 YANEP 233
|
Length = 340 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 184 bits (469), Expect = 4e-52
Identities = 90/238 (37%), Positives = 132/238 (55%), Gaps = 32/238 (13%)
Query: 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRF 654
K + +G FG+V L +++ TG +A+K+LKK +I K+ V L E +L + R+PF+
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 655 FYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRD 714
YSF + L VMEY NGG+L+ L ED AR Y AE+V AL YLHS VV+RD
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120
Query: 715 LKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQER 774
LK +NL++ DGHIK+TDFGL K G+ +
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGISDG------------------------------- 149
Query: 775 RKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF-NAEHPQVSTLL 831
++ GTP+YLAPE+L +G DWW +G++++E++ G PF N +H ++ L+
Sbjct: 150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 207
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 183 bits (465), Expect = 1e-51
Identities = 87/230 (37%), Positives = 133/230 (57%), Gaps = 32/230 (13%)
Query: 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILI-SVRNPFVVR 653
K + +G+FG+V LA+ + T + FAIK LKK ++ + VE + ER +L + +PF+
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 654 FFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHR 713
F +F +E+L+ VMEYLNGGDL +++ G DE AR Y AE++ L++LH +++R
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYR 120
Query: 714 DLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQE 773
DLK DN+L+ DGHIK+ DFG+ K + G+
Sbjct: 121 DLKLDNVLLDKDGHIKIADFGMCK-----------------ENMNGE------------- 150
Query: 774 RRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823
K + GTPDY+APEIL G + + DWWS G++L+E+++G PF+ E
Sbjct: 151 -GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 183 bits (466), Expect = 1e-51
Identities = 98/257 (38%), Positives = 149/257 (57%), Gaps = 41/257 (15%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRT---TGDLFAIKVLKKADMIRK-NAVESILAERDILIS 645
+FE++K + GA+G+VFL +K T TG L+A+KVL+KA +++K VE ER++L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 646 VR-NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEY 704
VR +PF+V Y+F L+L+++Y++GG++++ L ED R Y E++LALE+
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
LH L +V+RD+K +N+L+ +GH+ LTDFGLSK L
Sbjct: 121 LHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL------------------------ 156
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAE 823
+E+ + S GT +Y+APEI+ G GHG DWWS+GI++FEL+ G PF E
Sbjct: 157 ------SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE 210
Query: 824 -----HPQVSTLLRKCQ 835
+VS + KC
Sbjct: 211 GERNTQSEVSRRILKCD 227
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 181 bits (460), Expect = 7e-51
Identities = 87/233 (37%), Positives = 127/233 (54%), Gaps = 35/233 (15%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILI---SVR 647
F + + RG FG+V LA+ + TG+L+AIK LKK D+I ++ VES++ E+ I S R
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 648 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS 707
+PF+V F F +++ VMEY GGDL + E A Y A VVL L+YLH
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHE 119
Query: 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTA 767
++V+RDLK DNLL+ +G +K+ DFGL K G+ G +T
Sbjct: 120 NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM--------GFGDRTSTF---------- 161
Query: 768 SEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820
GTP++LAPE+L T + DWW +G++++E++VG PF
Sbjct: 162 -------------CGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPF 201
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 8e-51
Identities = 89/230 (38%), Positives = 134/230 (58%), Gaps = 32/230 (13%)
Query: 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDIL-ISVRNPFVVR 653
K + +G+FG+VFLA+ + T FAIK LKK ++ + VE + E+ +L ++ +PF+
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 654 FFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHR 713
+ +F +ENL+ VMEYLNGGDL +++ D A Y AE++ L++LHS +V+R
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYR 120
Query: 714 DLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQE 773
DLK DN+L+ DGHIK+ DFG+ K +LGD
Sbjct: 121 DLKLDNILLDTDGHIKIADFGMCK-----------------ENMLGDA------------ 151
Query: 774 RRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823
K + GTPDY+APEILLG + T+ DWWS G++L+E+++G PF+
Sbjct: 152 --KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGH 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 2e-50
Identities = 89/227 (39%), Positives = 136/227 (59%), Gaps = 32/227 (14%)
Query: 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILI-SVRNPFVVR 653
K I +G+FG+V LAK++ G +A+KVL+K ++ + + I+AER++L+ +V++PF+V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 654 FFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHR 713
YSF E LY V++++NGG+L+ L+ E AR Y AE+ AL YLHS+ +V+R
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120
Query: 714 DLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQE 773
DLKP+N+L+ GH+ LTDFGL K G+ A S TT
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGI----------AQSDTT----------------- 153
Query: 774 RRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820
+ GTP+YLAPE++ + T DWW +G +L+E++ G+PPF
Sbjct: 154 ----TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 179 bits (455), Expect = 3e-50
Identities = 86/231 (37%), Positives = 137/231 (59%), Gaps = 32/231 (13%)
Query: 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDIL-ISVRNPFVVR 653
K + +G+FG+V LA+ + T +++AIKVLKK +++ + V+ + E+ IL ++ ++PF+
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 654 FFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHR 713
F ++ L+ VMEY+NGGDL ++ DE +R Y AEV LAL +LH V++R
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120
Query: 714 DLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQE 773
DLK DN+L+ +GH KL DFG+ K G++N V+ TT
Sbjct: 121 DLKLDNILLDAEGHCKLADFGMCKEGILNG--------VTTTTF---------------- 156
Query: 774 RRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824
GTPDY+APEIL +G + DWW++G++++E++ G PPF A++
Sbjct: 157 -------CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 179 bits (455), Expect = 1e-49
Identities = 96/247 (38%), Positives = 143/247 (57%), Gaps = 43/247 (17%)
Query: 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILI 644
R +D+E++K I RGAFG V L + ++T ++A+K+L K +MI+++ ERDI+
Sbjct: 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 98
Query: 645 SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEY 704
+P+VV+ FY+F LY+VMEY+ GGDL +L+ N + E AR Y AEVVLAL+
Sbjct: 99 FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDA 157
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFG----LSKVGLINSTDDLSGPAVSGTTLLGD 760
+HS+ +HRD+KPDN+L+ GH+KL DFG ++K G++
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCD---------------- 201
Query: 761 EEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG----HGTTADWWSVGIILFELIVG 816
+AVGTPDY++PE+L G +G DWWSVG+ L+E++VG
Sbjct: 202 ------------------TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
Query: 817 IPPFNAE 823
PF A+
Sbjct: 244 DTPFYAD 250
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 177 bits (450), Expect = 1e-49
Identities = 88/227 (38%), Positives = 134/227 (59%), Gaps = 32/227 (14%)
Query: 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILI-SVRNPFVVR 653
K I +G+FG+V LA+ + +A+KVL+K +++K + I++ER++L+ +V++PF+V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 654 FFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHR 713
+SF + LY V++Y+NGG+L+ L+ C E AR Y AE+ AL YLHSL +V+R
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 714 DLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQE 773
DLKP+N+L+ GHI LTDFGL K + E T S
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLCKENI---------------------EHNGTTS----- 154
Query: 774 RRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820
+ GTP+YLAPE+L + T DWW +G +L+E++ G+PPF
Sbjct: 155 -----TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 177 bits (450), Expect = 2e-49
Identities = 91/234 (38%), Positives = 134/234 (57%), Gaps = 35/234 (14%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV---RNPFVVR 653
I +G FG+V+ +K+ T ++A+KVL K +++ K V + ER+IL+ +PF+V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 654 FFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHR 713
+SF +LYLV +Y++GG+L+ L+ G ED A+ YIAE+VLALE+LH +V+R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 714 DLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQE 773
DLKP+N+L+ GHI L DFGLSK L TD+ + GTT
Sbjct: 121 DLKPENILLDATGHIALCDFGLSKANL---TDNKTTNTFCGTT----------------- 160
Query: 774 RRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826
+YLAPE+LL G+ D+WS+G+++FE+ G PF AE Q
Sbjct: 161 -----------EYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ 203
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 176 bits (448), Expect = 3e-49
Identities = 85/228 (37%), Positives = 131/228 (57%), Gaps = 32/228 (14%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN-PFVVRFF 655
+ +G+FG+V LA+ + +G L+A+KVLKK +++ + VE + E+ IL RN PF+ + +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 656 YSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDL 715
F + L+ VME++NGGDL ++ DE AR Y AE+ AL +LH +++RDL
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDL 122
Query: 716 KPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERR 775
K DN+L+ H+GH KL DFG+ K G+ N T+
Sbjct: 123 KLDNVLLDHEGHCKLADFGMCKEGIFNGK--------------------TTS-------- 154
Query: 776 KKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823
+ GTPDY+APEIL +G + DWW++G++L+E++ G PF AE
Sbjct: 155 ---TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 172 bits (437), Expect = 2e-48
Identities = 74/231 (32%), Positives = 121/231 (52%), Gaps = 32/231 (13%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
++++ I RGAFG V+ TGD AIK + I++ A++SI+ E D+L ++++P
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEK-IKEEALKSIMQEIDLLKNLKHP 59
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLR 709
+V++ S ++LY+++EY G L +++ G E + VY+ +V+ L YLH
Sbjct: 60 NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119
Query: 710 VVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASE 769
V+HRD+K N+L DG +KL DFG++ T L D
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVA-------------------TKLNDVSKDDA--- 157
Query: 770 HQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820
S VGTP ++APE++ +G T +D WS+G + EL+ G PP+
Sbjct: 158 ---------SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPY 199
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 2e-48
Identities = 93/239 (38%), Positives = 142/239 (59%), Gaps = 35/239 (14%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+D++++K I RGAFG V L + +++ ++A+K+L K +MI+++ ERDI+ +
Sbjct: 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
P+VV+ F +F + LY+VMEY+ GGDL +L+ N + E A+ Y AEVVLAL+ +HS+
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLALDAIHSM 161
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTAS 768
++HRD+KPDN+L+ GH+KL DF GT + DE +
Sbjct: 162 GLIHRDVKPDNMLLDKHGHLKLADF--------------------GTCMKMDETGMVRCD 201
Query: 769 EHQQERRKKRSAVGTPDYLAPEILLGTG----HGTTADWWSVGIILFELIVGIPPFNAE 823
+AVGTPDY++PE+L G +G DWWSVG+ LFE++VG PF A+
Sbjct: 202 ----------TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD 250
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 2e-47
Identities = 87/238 (36%), Positives = 137/238 (57%), Gaps = 32/238 (13%)
Query: 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRF 654
K + +G FG+V L +++ TG +A+K+L+K +I K+ V + E +L + R+PF+
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 655 FYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRD 714
Y+F + L VMEY NGG+L+ L E+ AR Y AE+V ALEYLHS VV+RD
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120
Query: 715 LKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQER 774
+K +NL++ DGHIK+TDFGL K G+ + G T+
Sbjct: 121 IKLENLMLDKDGHIKITDFGLCKEGISD-----------GATM----------------- 152
Query: 775 RKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVG-IPPFNAEHPQVSTLL 831
++ GTP+YLAPE+L +G DWW +G++++E++ G +P +N +H ++ L+
Sbjct: 153 ---KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 207
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 171 bits (433), Expect = 3e-47
Identities = 96/241 (39%), Positives = 138/241 (57%), Gaps = 36/241 (14%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+DFEI+K I RGAFG V + K + +FA+K+L K +M+++ ERD+L++ N
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHS 707
++ Y+F NLYLVM+Y GGDL +LL L ED+AR Y+AE+V+A++ +H
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTA 767
L VHRD+KPDN+L+ +GHI+L DFG S L+ D Q +
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIRLADFG------------------SCLKLMEDGTVQSSV 162
Query: 768 SEHQQERRKKRSAVGTPDYLAPEILL----GTG-HGTTADWWSVGIILFELIVGIPPFNA 822
AVGTPDY++PEIL G G +G DWWS+G+ ++E++ G PF A
Sbjct: 163 ------------AVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA 210
Query: 823 E 823
E
Sbjct: 211 E 211
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 5e-47
Identities = 96/241 (39%), Positives = 135/241 (56%), Gaps = 36/241 (14%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
DDFEIIK I RGAFG V + K + T ++A+K+L K +M+++ ER++L++
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHS 707
++ Y+F LYLVM+Y GGDL +LL L ED+AR YIAE+VLA+ +H
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120
Query: 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTA 767
L VHRD+KPDN+L+ +GHI+L DFG + D GT
Sbjct: 121 LHYVHRDIKPDNVLLDMNGHIRLADFG----SCLKMNQD-------GTV----------- 158
Query: 768 SEHQQERRKKRSAVGTPDYLAPEILL----GTG-HGTTADWWSVGIILFELIVGIPPFNA 822
+ AVGTPDY++PEIL G G +G DWWS+G+ ++E++ G PF A
Sbjct: 159 --------QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210
Query: 823 E 823
E
Sbjct: 211 E 211
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 9e-47
Identities = 79/232 (34%), Positives = 125/232 (53%), Gaps = 38/232 (16%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
++ ++ I GA G V+ A R TG AIK ++ +RK E I+ E I+ ++P
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMR----LRKQNKELIINEILIMKDCKHPN 76
Query: 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDED-VARVYIAEVVLALEYLHSL 708
+V ++ S+ + L++VMEY++GG L ++ N ++E +A V EV+ LEYLHS
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYV-CREVLQGLEYLHSQ 135
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTAS 768
V+HRD+K DN+L++ DG +KL DFG + QLT
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFAA--------------------------QLT-- 167
Query: 769 EHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820
+E+ K+ S VGTP ++APE++ +G D WS+GI+ E+ G PP+
Sbjct: 168 ---KEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 166 bits (424), Expect = 1e-46
Identities = 71/237 (29%), Positives = 118/237 (49%), Gaps = 38/237 (16%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKAD--MIRKNAVESILAERDILISV 646
D E +K + +G+ G V+ + + TG ++A+K + RK +L E L S
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRK----QLLRELKTLRSC 56
Query: 647 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLH 706
+P+VV+ + +F + +V+EY++GG L LL+ +G + E V +++ L+YLH
Sbjct: 57 ESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLH 116
Query: 707 S-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQL 765
+ ++HRD+KP NLLI G +K+ DFG+SKV + +T D
Sbjct: 117 TKRHIIHRDIKPSNLLINSKGEVKIADFGISKV--LENTLD------------------- 155
Query: 766 TASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNA 822
+ + VGT Y++PE + G + AD WS+G+ L E +G PF
Sbjct: 156 ----------QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLP 202
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 2e-46
Identities = 86/241 (35%), Positives = 139/241 (57%), Gaps = 37/241 (15%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRT---TGDLFAIKVLKKADMIRK-NAVESILAERDILIS 645
+FE++K + GA+G+VFL +K + +G L+A+KVLKKA +++K E ER +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 646 VR-NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEY 704
+R +PF+V Y+F L+L+++Y+NGG+L++ L E ++Y E+VLALE+
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
LH L +++RD+K +N+L+ +GH+ LTDFGLSK
Sbjct: 121 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK--------------------------- 153
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLG--TGHGTTADWWSVGIILFELIVGIPPFNA 822
H+ E + S GT +Y+AP+I+ G GH DWWS+G++++EL+ G PF
Sbjct: 154 ---EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV 210
Query: 823 E 823
+
Sbjct: 211 D 211
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 168 bits (426), Expect = 3e-46
Identities = 86/238 (36%), Positives = 137/238 (57%), Gaps = 32/238 (13%)
Query: 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRF 654
K + +G FG+V L +++ +G +A+K+LKK +I K+ V L E +L + R+PF+
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 655 FYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRD 714
YSF ++ L VMEY+NGG+L+ L ED R Y AE+V AL+YLHS ++V+RD
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120
Query: 715 LKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQER 774
LK +NL++ DGHIK+TDFGL K G+ ++
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGITDAA------------------------------ 150
Query: 775 RKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVG-IPPFNAEHPQVSTLL 831
++ GTP+YLAPE+L +G DWW +G++++E++ G +P +N +H ++ L+
Sbjct: 151 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 207
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 8e-46
Identities = 91/239 (38%), Positives = 138/239 (57%), Gaps = 33/239 (13%)
Query: 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRF 654
K + +G FG+V L K++ TG +A+K+LKK ++ K+ V L E +L + R+PF+
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 655 FYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLR-VVHR 713
YSF + L VMEY NGG+L+ L ED AR Y AE+V AL+YLHS + VV+R
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120
Query: 714 DLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQE 773
DLK +NL++ DGHIK+TDFGL K G+ + G T+
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLCKEGIKD-----------GATM---------------- 153
Query: 774 RRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVG-IPPFNAEHPQVSTLL 831
++ GTP+YLAPE+L +G DWW +G++++E++ G +P +N +H ++ L+
Sbjct: 154 ----KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 208
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 4e-45
Identities = 82/240 (34%), Positives = 127/240 (52%), Gaps = 38/240 (15%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKV--LKKADMIRKNAVESILAERDILISV 646
+ F +++ I +G+FG V+ A + T + AIKV L++A+ + +E I E L
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAE----DEIEDIQQEIQFLSQC 56
Query: 647 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLH 706
R+P++ +++ SF L+++MEY GG LL+ G LDE + EV+L LEYLH
Sbjct: 57 RSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLK-PGKLDETYIAFILREVLLGLEYLH 115
Query: 707 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLT 766
+HRD+K N+L++ +G +KL DFG VSG QLT
Sbjct: 116 EEGKIHRDIKAANILLSEEGDVKLADFG-----------------VSG---------QLT 149
Query: 767 ASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826
++ K+ + VGTP ++APE++ +G+ AD WS+GI EL G PP + HP
Sbjct: 150 ST-----MSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 164 bits (416), Expect = 5e-45
Identities = 82/235 (34%), Positives = 134/235 (57%), Gaps = 32/235 (13%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDIL-ISVRN 648
DF + + +G+FG+V LA+++ T +L+AIK+LKK +I+ + VE + E+ +L +S +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
PF+ + F + LY VMEY+NGGDL ++ +G E A Y AE+ + L +LHS
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTAS 768
+++RDLK DN+++ +GHIK+ DFG+ K + + G T
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD-----------GVT------------ 157
Query: 769 EHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823
++ GTPDY+APEI+ +G + DWW+ G++L+E++ G PF E
Sbjct: 158 --------TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 164 bits (415), Expect = 8e-45
Identities = 82/235 (34%), Positives = 133/235 (56%), Gaps = 32/235 (13%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDIL-ISVRN 648
DF + + +G+FG+V LA+++ T +L+AIK+LKK +I+ + VE + E+ +L + +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
PF+ + F + LY VMEY+NGGDL ++ +G E A Y AE+ + L +LH
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTAS 768
+++RDLK DN+++ +GHIK+ DFG+ K
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCK------------------------------- 149
Query: 769 EHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823
EH + R+ GTPDY+APEI+ +G + DWW+ G++L+E++ G PPF+ E
Sbjct: 150 EHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 1e-44
Identities = 82/230 (35%), Positives = 133/230 (57%), Gaps = 32/230 (13%)
Query: 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDIL-ISVRNPFVVR 653
K + +G+FG+V LA+ + G+ FA+K LKK ++ + VE + E+ +L ++ NPF+
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 654 FFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHR 713
+ +F +E+L+ VME+LNGGDL +++ G D A Y AE+V L++LHS +++R
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120
Query: 714 DLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQE 773
DLK DN+++ DGHIK+ DFG+ K + GD
Sbjct: 121 DLKLDNVMLDRDGHIKIADFGMCK-----------------ENVFGDN------------ 151
Query: 774 RRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823
+ + GTPDY+APEIL G + + DWWS G++L+E+++G PF+ +
Sbjct: 152 --RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 4e-44
Identities = 81/227 (35%), Positives = 120/227 (52%), Gaps = 31/227 (13%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFY 656
I G FG+V+ A TG+L A+K ++ D K ++ I E +L +++P +V+++
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKT-IKEIADEMKVLELLKHPNLVKYYG 66
Query: 657 SFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLK 716
RE +Y+ MEY +GG L LL + LDE V RVY +++ L YLHS +VHRD+K
Sbjct: 67 VEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIK 126
Query: 717 PDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRK 776
P N+ + H+G IKL DFG + + TT +G E Q
Sbjct: 127 PANIFLDHNGVIKLGDFGCAVK------------LKNNTTTMG---------EEVQ---- 161
Query: 777 KRSAVGTPDYLAPEILLGT---GHGTTADWWSVGIILFELIVGIPPF 820
S GTP Y+APE++ G GHG AD WS+G ++ E+ G P+
Sbjct: 162 --SLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPW 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 4e-43
Identities = 73/234 (31%), Positives = 120/234 (51%), Gaps = 34/234 (14%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFY 656
+ +G FG V + + TG ++A K L K + ++ + L E+ IL V + F+V Y
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 657 SFTCRENLYLVMEYLNGGDLYSLLRNLGC--LDEDVARVYIAEVVLALEYLHSLRVVHRD 714
+F +++L LVM +NGGDL + N+G E A Y A+++ LE+LH R+V+RD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 715 LKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQER 774
LKP+N+L+ G+++++D GL AV +
Sbjct: 121 LKPENVLLDDHGNVRISDLGL---------------AV-----------------ELKGG 148
Query: 775 RKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQVS 828
+K + GTP Y+APE+L G + + DW+++G L+E+I G PF +V
Sbjct: 149 KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 159 bits (403), Expect = 1e-42
Identities = 90/244 (36%), Positives = 131/244 (53%), Gaps = 36/244 (14%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-N 648
+ I++ + G+FG V+LA+ R A+KVL K + VE L E IL S+
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG---CLDEDVARVYIAEVVLALEYL 705
P +V+ + F +LYLVMEY++GG L LL+ +G L E A +A+++ ALEYL
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 706 HSLRVVHRDLKPDNLLIAHDGH-IKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
HS ++HRD+KP+N+L+ DG +KL DFGL+K LL D
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAK-------------------LLPDP--- 155
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLGTGH---GTTADWWSVGIILFELIVGIPPFN 821
++VGTP Y+APE+LLG +++D WS+GI L+EL+ G+PPF
Sbjct: 156 ---GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFE 212
Query: 822 AEHP 825
E
Sbjct: 213 GEKN 216
|
Length = 384 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 1e-41
Identities = 71/238 (29%), Positives = 122/238 (51%), Gaps = 37/238 (15%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ F+I++ + G++G V+ A + TG + AIKV+ + ++ I+ E IL +
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPV-----EEDLQEIIKEISILKQCDS 57
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHS 707
P++V+++ S+ +L++VMEY G + +++ L E+ + + + LEYLHS
Sbjct: 58 PYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS 117
Query: 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTA 767
+ +HRD+K N+L+ +G KL DFG VSG QLT
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFG-----------------VSG---------QLT- 150
Query: 768 SEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825
K+ + +GTP ++APE++ G+ AD WS+GI E+ G PP++ HP
Sbjct: 151 ----DTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHP 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 1e-41
Identities = 77/238 (32%), Positives = 130/238 (54%), Gaps = 36/238 (15%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN-PFVVRFF 655
I RG++ +V L + + T ++A+KV+KK + ++ + E+ + + N PF+V
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 656 YSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDL 715
F L+ V+E+++GGDL ++ L E+ AR Y AE+ LAL +LH +++RDL
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDL 122
Query: 716 KPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERR 775
K DN+L+ +GHIKLTD+G+ K G+ P + +T
Sbjct: 123 KLDNVLLDAEGHIKLTDYGMCKEGI--------RPGDTTSTF------------------ 156
Query: 776 KKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF----NAEHPQVST 829
GTP+Y+APEIL G +G + DWW++G+++FE++ G PF +++P +T
Sbjct: 157 -----CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNT 209
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 8e-41
Identities = 83/247 (33%), Positives = 120/247 (48%), Gaps = 50/247 (20%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+D+E+I+ I G +G V+ A+ TG+L AIKV+K + E I E +L R+
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECRH 59
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGG---DLYSLLRNLGCLDEDVARVYIA----EVVLA 701
P +V +F S+ R+ L++VMEY GG D+Y + R G L E IA E +
Sbjct: 60 PNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTR--GPLSELQ----IAYVCRETLKG 113
Query: 702 LEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDE 761
L YLH +HRD+K N+L+ DG +KL DFG+S
Sbjct: 114 LAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSA------------------------ 149
Query: 762 EPQLTASEHQQERRKKRSAVGTPDYLAPEIL---LGTGHGTTADWWSVGIILFELIVGIP 818
QLTA+ K++S +GTP ++APE+ G+ D W++GI EL P
Sbjct: 150 --QLTAT-----IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQP 202
Query: 819 PFNAEHP 825
P HP
Sbjct: 203 PMFDLHP 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 9e-40
Identities = 69/244 (28%), Positives = 121/244 (49%), Gaps = 43/244 (17%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
D+E+++ I +G+FG V ++++ G + K + +M K + +++E +IL +++P
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEK-QQLVSEVNILRELKHP 59
Query: 650 FVVRFFYSFTCREN--LYLVMEYLNGGDLYSLLRNL----GCLDEDVARVYIAEVVLALE 703
+VR++ R N LY+VMEY GGDL L++ ++E+ + +++LAL
Sbjct: 60 NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119
Query: 704 YLH-----SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 758
H V+HRDLKP N+ + + ++KL DFGL+K ++
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK--ILGHDSSF----------- 166
Query: 759 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIP 818
A + VGTP Y++PE L + +D WS+G +++EL P
Sbjct: 167 --------AKTY----------VGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSP 208
Query: 819 PFNA 822
PF A
Sbjct: 209 PFTA 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 2e-39
Identities = 69/229 (30%), Positives = 113/229 (49%), Gaps = 35/229 (15%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKAD--MIRKNAVESILAERDILISVRNPFVVRF 654
+ G+FG V+ GD FA+K + AD + AV+ + E +L +++P +V++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 655 FYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRD 714
+ +NLY+ +E + GG L LL+ G E V R+Y +++L LEYLH VHRD
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRD 127
Query: 715 LKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQER 774
+K N+L+ +G +KL DFG++K E
Sbjct: 128 IKGANILVDTNGVVKLADFGMAK--------------------------------QVVEF 155
Query: 775 RKKRSAVGTPDYLAPEILLGTG-HGTTADWWSVGIILFELIVGIPPFNA 822
+S G+P ++APE++ G +G AD WS+G + E+ G PP++
Sbjct: 156 SFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQ 204
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 4e-39
Identities = 78/252 (30%), Positives = 125/252 (49%), Gaps = 36/252 (14%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNA-VESILAERDILISVR 647
DD+E+I+ I GA V+ A + AIK + D+ + V+ + E +
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRI---DLEKCQTSVDELRKEVQAMSQCN 57
Query: 648 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR---NLGCLDEDVARVYIAEVVLALEY 704
+P VV+++ SF + L+LVM YL+GG L +++ G LDE + + EV+ LEY
Sbjct: 58 HPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEY 117
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
LHS +HRD+K N+L+ DG +K+ DFG+S L + D
Sbjct: 118 LHSNGQIHRDIKAGNILLGEDGSVKIADFGVS-ASLADGGDR------------------ 158
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEIL-LGTGHGTTADWWSVGIILFELIVGIPPFNAE 823
R+ +++ VGTP ++APE++ G+ AD WS GI EL G P+ ++
Sbjct: 159 --------TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPY-SK 209
Query: 824 HPQVSTLLRKCQ 835
+P + L+ Q
Sbjct: 210 YPPMKVLMLTLQ 221
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 5e-39
Identities = 81/236 (34%), Positives = 131/236 (55%), Gaps = 34/236 (14%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFF 655
I RG++ +V L + + ++A+KV+KK + ++ + E+ + NPF+V
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 656 YSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDL 715
F L+LV+EY+NGGDL ++ L E+ AR Y AE+ +AL +LH +++RDL
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDL 122
Query: 716 KPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERR 775
K DN+L+ DGHIKLTD+G+ K GL GP + +T
Sbjct: 123 KLDNVLLDADGHIKLTDYGMCKEGL--------GPGDTTSTF------------------ 156
Query: 776 KKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFN--AEHPQVST 829
GTP+Y+APEIL G +G + DWW++G+++FE++ G PF+ ++P ++T
Sbjct: 157 -----CGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNT 207
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 9e-39
Identities = 76/239 (31%), Positives = 112/239 (46%), Gaps = 40/239 (16%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVL---KKADMIRKNAVESILAERDILISV 646
++I+ I GA G VF AK R TG+ A+K + + I A+ I A L +
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKA----LQAC 56
Query: 647 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYL 705
++P+VV+ F LVMEY+ DL +LR+ L E + Y+ ++ + Y+
Sbjct: 57 QHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYM 115
Query: 706 HSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQL 765
H+ ++HRDLKP NLLI+ DG +K+ DFGL+++ +E
Sbjct: 116 HANGIMHRDLKPANLLISADGVLKIADFGLARL------------------FSEEEPRLY 157
Query: 766 TASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVGIPPFNAE 823
+ HQ V T Y APE+L G D W+VG I EL+ G P F E
Sbjct: 158 S---HQ---------VATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGE 204
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 6e-38
Identities = 80/226 (35%), Positives = 123/226 (54%), Gaps = 32/226 (14%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN-PFVVRFF 655
I RG++ +V L + + T ++A+KV+KK + ++ + E+ + N PF+V
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 656 YSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDL 715
F L+ V+EY+NGGDL ++ L E+ AR Y AE+ LAL YLH +++RDL
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDL 122
Query: 716 KPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERR 775
K DN+L+ +GHIKLTD+G+ K GL P T S
Sbjct: 123 KLDNVLLDSEGHIKLTDYGMCKEGL---------------------RPGDTTSTF----- 156
Query: 776 KKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFN 821
GTP+Y+APEIL G +G + DWW++G+++FE++ G PF+
Sbjct: 157 -----CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 1e-36
Identities = 72/235 (30%), Positives = 121/235 (51%), Gaps = 35/235 (14%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFY 656
+ +G FG V + R TG L+A K L K + ++ E + E+ IL V + F+V Y
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 657 SFTCRENLYLVMEYLNGGDL----YSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVH 712
+F + +L LVM +NGGDL Y++ E A Y A+++ LE+LH R+++
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 713 RDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQ 772
RDLKP+N+L+ +DG+++++D GL A E +
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGL-------------------------------AVELKD 149
Query: 773 ERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQV 827
+ K + GTP ++APE+L G + + D++++G+ L+E+I PF A +V
Sbjct: 150 GQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 73/229 (31%), Positives = 114/229 (49%), Gaps = 30/229 (13%)
Query: 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLK--KADMIRKNAVESILAERDILISVRNPFVV 652
K + +GAFGRV+L TG A+K + K V ++ E +L ++++ +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 653 RFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVH 712
+++ E L + MEY+ GG + L+ G L E V R Y +++ +EYLHS +VH
Sbjct: 68 QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVH 127
Query: 713 RDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQ 772
RD+K N+L G++KL DFG SK L SGT +
Sbjct: 128 RDIKGANILRDSAGNVKLGDFGASK--------RLQTICSSGTGM--------------- 164
Query: 773 ERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFN 821
+S GTP +++PE++ G G+G AD WSVG + E++ PP+
Sbjct: 165 -----KSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWA 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 77/239 (32%), Positives = 118/239 (49%), Gaps = 34/239 (14%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
F + + +G FG V + R TG ++A K L+K + ++ L E+ IL V + F
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSL 708
VV Y++ ++ L LV+ +NGGDL + N+G DE+ A Y AE+ LE LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTAS 768
R+V+RDLKP+N+L+ GHI+++D GL AV
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGL---------------AV---------------- 150
Query: 769 EHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQV 827
E R VGT Y+APE++ + + DWW +G +++E+I G PF +V
Sbjct: 151 -EIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV 208
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 62/238 (26%), Positives = 111/238 (46%), Gaps = 38/238 (15%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
DF+++K + +G++G V+ K+ + +A+K + M +K +++ E IL SV +P
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAV-NEIRILASVNHP 59
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC----LDEDVARVYIAEVVLALEYL 705
++ + +F L +VMEY GDL + + E +++ L+ L
Sbjct: 60 NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119
Query: 706 HSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQL 765
H +++HRDLK N+L+ + +K+ D G+SKV N
Sbjct: 120 HEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMA--------------------- 158
Query: 766 TASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823
++ +GTP Y+APE+ G + +D WS+G +L+E+ PPF A
Sbjct: 159 ------------KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEAR 204
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 8e-35
Identities = 78/228 (34%), Positives = 120/228 (52%), Gaps = 37/228 (16%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN---PFVVR 653
I RG FG V+ +K TG ++A+K L K + K L ER +L V PF+V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 654 FFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHR 713
Y+F + L +++ +NGGDL+ L G E R Y AE++L LE++H+ VV+R
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYR 121
Query: 714 DLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQE 773
DLKP N+L+ GH++++D GL+ D S
Sbjct: 122 DLKPANILLDEHGHVRISDLGLAC--------DFS------------------------- 148
Query: 774 RRKKRSAVGTPDYLAPEILL-GTGHGTTADWWSVGIILFELIVGIPPF 820
++K ++VGT Y+APE+L G + ++ADW+S+G +LF+L+ G PF
Sbjct: 149 KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 78/228 (34%), Positives = 120/228 (52%), Gaps = 37/228 (16%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN---PFVVR 653
I RG FG V+ +K TG ++A+K L K + K L ER +L V PF+V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 654 FFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHR 713
Y+F + L +++ +NGGDL+ L G E R Y E++L LE++H+ VV+R
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYR 121
Query: 714 DLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQE 773
DLKP N+L+ GH++++D GL+ D S
Sbjct: 122 DLKPANILLDEHGHVRISDLGLAC--------DFS------------------------- 148
Query: 774 RRKKRSAVGTPDYLAPEILL-GTGHGTTADWWSVGIILFELIVGIPPF 820
++K ++VGT Y+APE+L GT + ++ADW+S+G +LF+L+ G PF
Sbjct: 149 KKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 77/256 (30%), Positives = 121/256 (47%), Gaps = 50/256 (19%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESI----LAERDILISV 646
+E ++ + G +G V+ A+ + TG++ A+K ++ + + E I L E +L +
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIR---LDNEE--EGIPSTALREISLLKEL 55
Query: 647 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYL 705
++P +V+ LYLV EY + DL L G L ++ + + +++ L Y
Sbjct: 56 KHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYC 114
Query: 706 HSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK---VGLINSTDDLSGPAVSGTTLLGDEE 762
HS R++HRDLKP N+LI DG +KL DFGL++ + L T +
Sbjct: 115 HSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE---------------- 158
Query: 763 PQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVGIPPFN 821
V T Y APEILLG+ H T D WSVG I E+I G P F
Sbjct: 159 ------------------VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFP 200
Query: 822 AEHPQVSTLLRKCQLL 837
+ ++ L + Q+L
Sbjct: 201 GDS-EIDQLFKIFQIL 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 6e-34
Identities = 77/239 (32%), Positives = 115/239 (48%), Gaps = 40/239 (16%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILI--SVRN 648
+E I I G +G+V+ A+ + TG+L A LKK M + I A R+I + +R+
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVA---LKKIRMENEKEGFPITAIREIKLLQKLRH 57
Query: 649 PFVVRFFYSFTCRE--NLYLVMEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYL 705
P +VR T + ++Y+V EY++ DL LL + E + Y+ +++ L+YL
Sbjct: 58 PNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYL 116
Query: 706 HSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQL 765
HS ++HRD+K N+LI +DG +KL DFGL++
Sbjct: 117 HSNGILHRDIKGSNILINNDGVLKLADFGLAR------------------PYTKRNSADY 158
Query: 766 TASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAE 823
T + V T Y PE+LLG T +G D WSVG IL EL +G P F
Sbjct: 159 T------------NRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGS 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 7e-34
Identities = 83/261 (31%), Positives = 130/261 (49%), Gaps = 43/261 (16%)
Query: 567 EDDVVRSLRT--SPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKK 624
+++++ LRT S P K T + I +GA G V+ A TG AIK +
Sbjct: 1 DEEILEKLRTIVSVGDPKKKYTRFEK------IGQGASGTVYTAIDVATGQEVAIKQMNL 54
Query: 625 ADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG 684
+K E I+ E ++ ++P +V + S+ + L++VMEYL GG L ++
Sbjct: 55 QQQPKK---ELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET- 110
Query: 685 CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744
C+DE E + ALE+LHS +V+HRD+K DN+L+ DG +KLTDFG
Sbjct: 111 CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA------- 163
Query: 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWW 804
Q+T E+ K+ + VGTP ++APE++ +G D W
Sbjct: 164 -------------------QITP-----EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 199
Query: 805 SVGIILFELIVGIPPFNAEHP 825
S+GI+ E++ G PP+ E+P
Sbjct: 200 SLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 9e-34
Identities = 71/244 (29%), Positives = 118/244 (48%), Gaps = 40/244 (16%)
Query: 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR 647
D +EII + GAFG+V+ A+ + TG A K+ + + +E + E DIL +
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKI---IQIESEEELEDFMVEIDILSECK 60
Query: 648 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLH 706
+P +V + ++ L++++E+ +GG L S++ L L E R +++ AL +LH
Sbjct: 61 HPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH 120
Query: 707 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLT 766
S +V+HRDLK N+L+ DG +KL DFG+S
Sbjct: 121 SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNK-------------------------- 154
Query: 767 ASEHQQERRKKRSAVGTPDYLAPEILL-----GTGHGTTADWWSVGIILFELIVGIPPFN 821
+K+ + +GTP ++APE++ + AD WS+GI L EL PP +
Sbjct: 155 -----STLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHH 209
Query: 822 AEHP 825
+P
Sbjct: 210 ELNP 213
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 72/248 (29%), Positives = 126/248 (50%), Gaps = 47/248 (18%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVL-------KKADMIRKNAVESILAERDILISVRNP 649
I RGA+G V+ K TG + A+K++ +D+ R+ A+ S L + P
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQP------P 62
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLR 709
+ +++ S+ L+++MEY GG + +L++ G + E V I EV++AL+Y+H +
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVG 121
Query: 710 VVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASE 769
V+HRD+K N+L+ + G++KL DFG+ A+
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGV-------------------------------AAL 150
Query: 770 HQQERRKKRSAVGTPDYLAPEILL-GTGHGTTADWWSVGIILFELIVGIPPFNAEHP-QV 827
Q K+ + VGTP ++APE++ G + T AD WS+GI ++E+ G PP++ +
Sbjct: 151 LNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA 210
Query: 828 STLLRKCQ 835
L+ K +
Sbjct: 211 MMLIPKSK 218
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 77/251 (30%), Positives = 121/251 (48%), Gaps = 46/251 (18%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKA--DMIRKNAVESILAERDILISV 646
DD E + + G G V R TG + A+K ++ + I+K IL E DIL
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQK----QILRELDILHKC 56
Query: 647 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDV-ARVYIAEVVLALEY 704
+P++V F+ +F ++ + MEY++GG L +L+ + G + E + ++ +A V+ L Y
Sbjct: 57 NSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVA-VLKGLTY 115
Query: 705 LHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEP 763
LH +++HRD+KP N+L+ G IKL DFG+S L+NS
Sbjct: 116 LHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQ-LVNS-------------------- 154
Query: 764 QLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVG---IPPF 820
++ VGT Y+APE + G + +D WS+G+ L EL G PP
Sbjct: 155 ------------LAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202
Query: 821 NAEHPQVSTLL 831
N + LL
Sbjct: 203 NDPPDGIFELL 213
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 75/253 (29%), Positives = 117/253 (46%), Gaps = 51/253 (20%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
FE+++ I G +G+V+ A+ + TG L AIK++ I ++ E I E +IL N
Sbjct: 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD----IIEDEEEEIKEEYNILRKYSN 61
Query: 649 -PFVVRFFYSF------TCRENLYLVMEYLNGG---DLYSLLRNLG-CLDEDVARVYIAE 697
P + F+ +F + L+LVME GG DL LR G L E+ + E
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 698 VVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 757
+ L YLH +V+HRD+K N+L+ + +KL DFG+S
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA-------------------- 161
Query: 758 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEIL-----LGTGHGTTADWWSVGIILFE 812
QL ++ ++ + +GTP ++APE++ + +D WS+GI E
Sbjct: 162 ------QLDSTLG-----RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIE 210
Query: 813 LIVGIPPFNAEHP 825
L G PP HP
Sbjct: 211 LADGKPPLCDMHP 223
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 3e-33
Identities = 74/239 (30%), Positives = 118/239 (49%), Gaps = 34/239 (14%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
F + + +G FG V + R TG ++A K L+K + ++ L E+ IL V + F
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSL 708
VV Y++ ++ L LV+ +NGGDL + N+G +E+ A Y AE++ LE LH
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTAS 768
V+RDLKP+N+L+ GHI+++D GL+ + P
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGLA----------VKIP------------------ 153
Query: 769 EHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQV 827
E R VGT Y+APE+L + + D+W +G +++E+I G PF +V
Sbjct: 154 ----EGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV 208
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 4e-33
Identities = 73/239 (30%), Positives = 119/239 (49%), Gaps = 34/239 (14%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
F + + +G FG V + R TG ++A K L+K + ++ L E+ IL V + F
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSL 708
VV Y++ ++ L LV+ +NGGDL + ++G +E A Y AE+ LE LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTAS 768
R+V+RDLKP+N+L+ GHI+++D GL+
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLAV------------------------------- 150
Query: 769 EHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQV 827
H E + + VGT Y+APE++ + + DWW++G +L+E+I G PF ++
Sbjct: 151 -HVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI 208
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 5e-33
Identities = 77/253 (30%), Positives = 133/253 (52%), Gaps = 39/253 (15%)
Query: 581 PSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAER 640
P R+ +D+F I G+ G V +A ++TG A+K K D+ ++ E + E
Sbjct: 14 PGDPRSYLDNF---VKIGEGSTGIVCIATDKSTGRQVAVK---KMDLRKQQRRELLFNEV 67
Query: 641 DILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVL 700
I+ ++P +V + S+ + L++VME+L GG L ++ + +E +A V +A V+
Sbjct: 68 VIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLA-VLK 126
Query: 701 ALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGD 760
AL +LH+ V+HRD+K D++L+ DG +KL+DFG
Sbjct: 127 ALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCA----------------------- 163
Query: 761 EEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820
Q++ +E +++S VGTP ++APE++ +GT D WS+GI++ E++ G PP+
Sbjct: 164 ---QVS-----KEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPY 215
Query: 821 NAEHP-QVSTLLR 832
E P Q +R
Sbjct: 216 FNEPPLQAMKRIR 228
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 3e-32
Identities = 75/250 (30%), Positives = 125/250 (50%), Gaps = 41/250 (16%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKAD---MIRKNAVESILAERDILISVR 647
+E++ + GA+G V + + TG++ AIK K+++ ++K + L E +L +R
Sbjct: 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKK----TALREVKVLRQLR 58
Query: 648 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS 707
+ +V +F + LYLV EY+ L L + G L D R YI +++ A+ Y HS
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHS 118
Query: 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTA 767
++HRD+KP+N+L++ G +KL DFG ++ L LT
Sbjct: 119 HNIIHRDIKPENILVSESGVLKLCDFGFARA--------LRARP----------ASPLT- 159
Query: 768 SEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPF--NAEH 824
V T Y APE+L+G T +G D W++G I+ EL+ G P F +++
Sbjct: 160 -----------DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI 208
Query: 825 PQVSTLLRKC 834
Q+ L++KC
Sbjct: 209 DQLY-LIQKC 217
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 75/239 (31%), Positives = 117/239 (48%), Gaps = 34/239 (14%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
F + + +G FG V + R TG ++A K L+K + ++ L E+ IL V + F
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSL 708
VV Y++ ++ L LV+ +NGGDL + N+G DE A Y AE+ LE L
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE 121
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTAS 768
R+V+RDLKP+N+L+ GHI+++D GL+ + P
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLAV-----------------------QIP----- 153
Query: 769 EHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQV 827
E R VGT Y+APE++ + + DWW +G +++E+I G PF +V
Sbjct: 154 ----EGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV 208
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 8e-32
Identities = 72/247 (29%), Positives = 128/247 (51%), Gaps = 38/247 (15%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
DFEI+ I +G+FG VF ++ ++A+K + + M R+ E+I E +L + +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAI-DEARVLAKLDSS 59
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLL---RNLGCLDEDVARVYIAEVVLALEYLH 706
+++R++ SF + L +VMEY GDL+ LL R ++ V R +I +++L L +LH
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI-QILLGLAHLH 118
Query: 707 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLT 766
S +++HRD+K NL + ++K+ D G++K+ +S T
Sbjct: 119 SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKL-------------LSDNTNFA------- 158
Query: 767 ASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826
+ VGTP YL+PE+ + +D W++G++L+E G PF+A + Q
Sbjct: 159 -----------NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN-Q 206
Query: 827 VSTLLRK 833
+ L+ K
Sbjct: 207 GA-LILK 212
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 9e-32
Identities = 75/235 (31%), Positives = 117/235 (49%), Gaps = 41/235 (17%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKK---ADMIRKNAVESILAERDILISVR 647
++ + I G +G V+ A+ + TG++ AIK +K ++ I K A L E +L +
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTA----LREIKLLKELN 56
Query: 648 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARVYIAEVVLALEYLH 706
+P +++ F + +LYLV E+++ DLY L++ L E + + Y+ +++ L + H
Sbjct: 57 HPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH 115
Query: 707 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLT 766
S ++HRDLKP+NLLI +G +KL DFGL++ P T
Sbjct: 116 SHGILHRDLKPENLLINTEGVLKLADFGLARS--------FGSPVRPYT----------- 156
Query: 767 ASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPF 820
H V T Y APE+LLG G+ T D WSVG I EL+ P F
Sbjct: 157 ---HY---------VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLF 199
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 5e-31
Identities = 71/225 (31%), Positives = 118/225 (52%), Gaps = 34/225 (15%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
+ +K I G+FG+ L K + G + IK + + M K ES E +L ++++P
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREES-RKEVAVLSNMKHPN 60
Query: 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCL-DEDVARVYIAEVVLALEYLHSL 708
+V++ SF NLY+VM+Y GGDLY + G L ED + ++ LAL+++H
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR 120
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTAS 768
+++HRD+K N+ + DG IKL DFG+++V +NST +L+
Sbjct: 121 KILHRDIKSQNIFLTKDGTIKLGDFGIARV--LNSTVELA-------------------- 158
Query: 769 EHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 813
R+ +GTP YL+PEI + +D W++G +L+E+
Sbjct: 159 ---------RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEM 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 5e-31
Identities = 73/242 (30%), Positives = 118/242 (48%), Gaps = 40/242 (16%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVES--ILAERDILISVRN 648
+E++KPI GA+G V A + TG AIK K + + +++ IL E +L +R+
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIK---KISNVFDDLIDAKRILREIKLLRHLRH 58
Query: 649 PFVVR---FFY--SFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALE 703
++ S ++Y+V E + DL+ ++++ L +D + ++ +++ L+
Sbjct: 59 ENIIGLLDILRPPSPEDFNDVYIVTELM-ETDLHKVIKSPQPLTDDHIQYFLYQILRGLK 117
Query: 704 YLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEP 763
YLHS V+HRDLKP N+L+ + +K+ DFGL++ G DE+
Sbjct: 118 YLHSANVIHRDLKPSNILVNSNCDLKICDFGLAR----------------GVDPDEDEKG 161
Query: 764 QLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIVGIPPFNA 822
LT E+ V T Y APE+LL + T A D WSVG I EL+ P F
Sbjct: 162 FLT--EY----------VVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPG 209
Query: 823 EH 824
Sbjct: 210 RD 211
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 5e-31
Identities = 71/234 (30%), Positives = 121/234 (51%), Gaps = 34/234 (14%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFY 656
+ +G FG V + + TG ++A K L K + +K+ + L E++IL V +PF+V Y
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 657 SFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARV--YIAEVVLALEYLHSLRVVHRD 714
+F + +L LVM +NGGDL + N+G ++ RV Y A++ + +LHS+ +V+RD
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120
Query: 715 LKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQER 774
+KP+N+L+ G+ +L+D GL AV +L + +R
Sbjct: 121 MKPENVLLDDQGNCRLSDLGL---------------AV-----------ELKDGKTITQR 154
Query: 775 RKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQVS 828
GT Y+APEIL + DW+++G ++E++ G PF +V+
Sbjct: 155 ------AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 7e-31
Identities = 76/235 (32%), Positives = 116/235 (49%), Gaps = 42/235 (17%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESI----LAERDILISV 646
+E K + G + V+ A+ + TG + AIK +K + RK A + I L E +L +
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGE--RKEAKDGINFTALREIKLLQEL 59
Query: 647 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARV--YIAEVVLALEY 704
++P ++ F + N+ LV E++ DL ++++ + A + Y+ + LEY
Sbjct: 60 KHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKD-KSIVLTPADIKSYMLMTLRGLEY 117
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
LHS ++HRDLKP+NLLIA DG +KL DFGL++ G +
Sbjct: 118 LHSNWILHRDLKPNNLLIASDGVLKLADFGLARS-------------------FGSPNRK 158
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVGIP 818
+T HQ V T Y APE+L G H G D WSVG I EL++ +P
Sbjct: 159 MT---HQ---------VVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 9e-31
Identities = 85/261 (32%), Positives = 133/261 (50%), Gaps = 43/261 (16%)
Query: 567 EDDVVRSLRT--SPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKK 624
+++++ LRT S P K T + I +GA G VF A TG AIK +
Sbjct: 1 DEEIMEKLRTIVSIGDPKKKYTRYEK------IGQGASGTVFTAIDVATGQEVAIK---Q 51
Query: 625 ADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG 684
++ ++ E I+ E ++ ++NP +V F SF + L++VMEYL GG L ++
Sbjct: 52 INLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET- 110
Query: 685 CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744
C+DE E + ALE+LH+ +V+HRD+K DN+L+ DG +KLTDFG
Sbjct: 111 CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCA------- 163
Query: 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWW 804
Q+T E+ K+ + VGTP ++APE++ +G D W
Sbjct: 164 -------------------QITP-----EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 199
Query: 805 SVGIILFELIVGIPPFNAEHP 825
S+GI+ E++ G PP+ E+P
Sbjct: 200 SLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 122 bits (306), Expect = 1e-30
Identities = 83/261 (31%), Positives = 130/261 (49%), Gaps = 43/261 (16%)
Query: 567 EDDVVRSLRT--SPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKK 624
+++++ LR+ S P K T + I +GA G V+ A TG AI+ +
Sbjct: 2 DEEILEKLRSIVSVGDPKKKYTRFEK------IGQGASGTVYTAMDVATGQEVAIRQMNL 55
Query: 625 ADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG 684
+K E I+ E ++ +NP +V + S+ + L++VMEYL GG L ++
Sbjct: 56 QQQPKK---ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET- 111
Query: 685 CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744
C+DE E + ALE+LHS +V+HRD+K DN+L+ DG +KLTDFG
Sbjct: 112 CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA------- 164
Query: 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWW 804
Q+T E+ K+ + VGTP ++APE++ +G D W
Sbjct: 165 -------------------QITP-----EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 805 SVGIILFELIVGIPPFNAEHP 825
S+GI+ E+I G PP+ E+P
Sbjct: 201 SLGIMAIEMIEGEPPYLNENP 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 2e-30
Identities = 71/250 (28%), Positives = 121/250 (48%), Gaps = 35/250 (14%)
Query: 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR 647
+ +F+I K I +G F V+ A G + A+K ++ +M+ A + L E D+L +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 648 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG----CLDEDVARVYIAEVVLALE 703
+P V+++ SF L +V+E + GDL ++++ + E Y ++ ALE
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 704 YLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEP 763
++HS R++HRD+KP N+ I G +KL D GL G S+
Sbjct: 121 HMHSKRIMHRDIKPANVFITATGVVKLGDLGL---GRFFSSK------------------ 159
Query: 764 QLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823
T + H S VGTP Y++PE + G+ +D WS+G +L+E+ PF +
Sbjct: 160 --TTAAH--------SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209
Query: 824 HPQVSTLLRK 833
+ +L +K
Sbjct: 210 KMNLYSLCKK 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 82/261 (31%), Positives = 130/261 (49%), Gaps = 43/261 (16%)
Query: 567 EDDVVRSLRT--SPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKK 624
+++++ LR+ S P K T + I +GA G V+ A TG AIK +
Sbjct: 1 DEEILEKLRSIVSVGDPKKKYTRFEK------IGQGASGTVYTAIDIATGQEVAIKQMNL 54
Query: 625 ADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG 684
+K E I+ E ++ +NP +V + S+ + L++VMEYL GG L ++
Sbjct: 55 QQQPKK---ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET- 110
Query: 685 CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744
C+DE E + AL++LHS +V+HRD+K DN+L+ DG +KLTDFG
Sbjct: 111 CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA------- 163
Query: 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWW 804
Q+T E+ K+ + VGTP ++APE++ +G D W
Sbjct: 164 -------------------QITP-----EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 199
Query: 805 SVGIILFELIVGIPPFNAEHP 825
S+GI+ E++ G PP+ E+P
Sbjct: 200 SLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 64/229 (27%), Positives = 96/229 (41%), Gaps = 36/229 (15%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLF----AIKVLKKADMIRKNAVESILAERDILISV 646
E+ K + GAFG V+ + G+ A+K LK+ E L E I+ +
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEE--EREEFLEEASIMKKL 58
Query: 647 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARVYIAEVVLALEYL 705
+P +VR T E LY+V EY+ GGDL LR + L ++ +EYL
Sbjct: 59 SHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYL 118
Query: 706 HSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQL 765
S VHRDL N L+ + +K++DFGLS+ I D
Sbjct: 119 ESKNFVHRDLAARNCLVTENLVVKISDFGLSR--DIYEDDYY------------------ 158
Query: 766 TASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI 814
RK+ ++APE L + +D WS G++L+E+
Sbjct: 159 ---------RKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIF 198
|
Length = 258 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (302), Expect = 5e-30
Identities = 72/238 (30%), Positives = 110/238 (46%), Gaps = 47/238 (19%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKA-----DMIRKNAVESILAERDILIS 645
+++IK + G FG V+LA+ + TG+L AIK +KK + + V+S+
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLN----- 55
Query: 646 VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL--RNLGCLDEDVARVYIAEVVLALE 703
+P +V+ F + LY V EY+ G +LY L+ R E V R I +++ L
Sbjct: 56 -EHPNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLA 113
Query: 704 YLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEP 763
++H HRDLKP+NLL++ +K+ DFGL++ I S P
Sbjct: 114 HIHKHGFFHRDLKPENLLVSGPEVVKIADFGLARE--IRS------------------RP 153
Query: 764 QLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIVGIPPF 820
T V T Y APEILL + ++ D W++G I+ EL P F
Sbjct: 154 PYTDY------------VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLF 199
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 1e-29
Identities = 77/247 (31%), Positives = 131/247 (53%), Gaps = 38/247 (15%)
Query: 579 IHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILA 638
+ P RT +D+F IK I G+ G V +A +++G L A+K K D+ ++ E +
Sbjct: 13 VDPGDPRTYLDNF--IK-IGEGSTGIVCIATVKSSGKLVAVK---KMDLRKQQRRELLFN 66
Query: 639 ERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEV 698
E I+ ++ VV + S+ + L++VME+L GG L ++ + +E +A V +A V
Sbjct: 67 EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA-V 125
Query: 699 VLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 758
+ AL LH+ V+HRD+K D++L+ HDG +KL+DFG
Sbjct: 126 LKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGF----------------------- 162
Query: 759 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIP 818
++ +E +++S VGTP ++APE++ +G D WS+GI++ E++ G P
Sbjct: 163 --------CAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEP 214
Query: 819 PFNAEHP 825
P+ E P
Sbjct: 215 PYFNEPP 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 72/235 (30%), Positives = 121/235 (51%), Gaps = 34/235 (14%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
F ++ I +G+FG V+ T ++ AIK++ + ++ +E I E +L +P+
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPY 63
Query: 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRV 710
+ R++ S+ L+++MEYL GG LL+ G L+E + E++ L+YLHS R
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERK 122
Query: 711 VHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEH 770
+HRD+K N+L++ G +KL DFG++ QLT ++
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAG--------------------------QLTDTQ- 155
Query: 771 QQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825
K+ + VGTP ++APE++ + + AD WS+GI EL G PP + HP
Sbjct: 156 ----IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHP 206
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 5e-29
Identities = 85/259 (32%), Positives = 133/259 (51%), Gaps = 51/259 (19%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
D +EII+ I +G +G+V+ + G L A+K+L D I + E I AE +IL S+ N
Sbjct: 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKIL---DPIS-DVDEEIEAEYNILQSLPN 77
Query: 649 -PFVVRFFYSFTCREN-----LYLVMEYLNGGDLYSLLRNL-GC---LDEDVARVYIAEV 698
P VV+F+ F + L+LV+E NGG + L++ L C LDE + +
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137
Query: 699 VLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 758
+L L++LH+ R++HRD+K +N+L+ +G +KL DFG+S
Sbjct: 138 LLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA--------------------- 176
Query: 759 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEIL-----LGTGHGTTADWWSVGIILFEL 813
QLT++ R ++ ++VGTP ++APE++ + D WS+GI EL
Sbjct: 177 -----QLTST-----RLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226
Query: 814 IVGIPPFNAEHPQVSTLLR 832
G PP HP V TL +
Sbjct: 227 GDGDPPLFDMHP-VKTLFK 244
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 5e-29
Identities = 75/248 (30%), Positives = 125/248 (50%), Gaps = 36/248 (14%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
+EIIK I G+FG+++LAK ++ + IK + M K E+ E +L +++P
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEK-EASKKEVILLAKMKHPN 60
Query: 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSLL-RNLGCL-DEDVARVYIAEVVLALEYLHSL 708
+V FF SF L++VMEY +GGDL + R G L ED + ++ L L+++H
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120
Query: 709 RVVHRDLKPDNLLIAHDGHI-KLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTA 767
+++HRD+K N+ ++ +G + KL DFG+++ +N + +L+
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELA------------------- 159
Query: 768 SEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQV 827
+ VGTP YL+PEI + D WS+G +L+EL PF +
Sbjct: 160 ----------YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH- 208
Query: 828 STLLRKCQ 835
+L+ CQ
Sbjct: 209 QLVLKICQ 216
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 7e-29
Identities = 58/229 (25%), Positives = 97/229 (42%), Gaps = 40/229 (17%)
Query: 592 EIIKPISRGAFGRVFLAK----KRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR 647
+ K + GAFG V+ A+K LK+ +E L E I+ +
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASE--QQIEEFLREARIMRKLD 59
Query: 648 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARV--YIAEVVLALEYL 705
+P +V+ T E L +VMEY+ GGDL LR + ++ + + ++ +EYL
Sbjct: 60 HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL 119
Query: 706 HSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQL 765
S +HRDL N L+ + +K++DFGLS+ + + G
Sbjct: 120 ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKG---------------- 163
Query: 766 TASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFEL 813
+ + ++APE L G T+ D WS G++L+E+
Sbjct: 164 -----------GKLPI---RWMAPESLK-EGKFTSKSDVWSFGVLLWEI 197
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 73/235 (31%), Positives = 120/235 (51%), Gaps = 34/235 (14%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
F ++ I +G+FG VF T + AIK++ + ++ +E I E +L +P+
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPY 63
Query: 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRV 710
V +++ S+ L+++MEYL GG LL G LDE + E++ L+YLHS +
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKK 122
Query: 711 VHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEH 770
+HRD+K N+L++ G +KL DFG++ QLT ++
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAG--------------------------QLTDTQ- 155
Query: 771 QQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825
K+ + VGTP ++APE++ + + + AD WS+GI EL G PP + HP
Sbjct: 156 ----IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP 206
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 75/235 (31%), Positives = 121/235 (51%), Gaps = 34/235 (14%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
F ++ I +G+FG VF T + AIK++ + ++ +E I E +L +P+
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPY 63
Query: 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRV 710
V +++ S+ L+++MEYL GG LLR G DE + E++ L+YLHS +
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLR-AGPFDEFQIATMLKEILKGLDYLHSEKK 122
Query: 711 VHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEH 770
+HRD+K N+L++ G +KL DFG V+G QLT ++
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFG-----------------VAG---------QLTDTQ- 155
Query: 771 QQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825
K+ + VGTP ++APE++ + + + AD WS+GI EL G PP + HP
Sbjct: 156 ----IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHP 206
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 114 bits (289), Expect = 2e-28
Identities = 65/236 (27%), Positives = 98/236 (41%), Gaps = 55/236 (23%)
Query: 592 EIIKPISRGAFGRVFLAK----KRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR 647
+ K + GAFG V+ K A+K LK+ + +E L E I+ +
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDAS--EQQIEEFLREARIMRKLD 59
Query: 648 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG---CLDE------DVARVYIAEV 698
+P VV+ T E LY+VMEY+ GGDL S LR L + +AR
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIAR------ 113
Query: 699 VLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 758
+EYL S +HRDL N L+ + +K++DFGLS+ + G
Sbjct: 114 --GMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRG--------- 162
Query: 759 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFEL 813
+ + ++APE L G T+ D WS G++L+E+
Sbjct: 163 ------------------GKLPI---RWMAPESLK-EGKFTSKSDVWSFGVLLWEI 196
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 72/247 (29%), Positives = 131/247 (53%), Gaps = 38/247 (15%)
Query: 579 IHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILA 638
+ R+ ++++ IK I G+ G V +A+++ +G A+K++ D+ ++ E +
Sbjct: 14 VDQGDPRSLLENY--IK-IGEGSTGIVCIAREKHSGRQVAVKMM---DLRKQQRRELLFN 67
Query: 639 ERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEV 698
E I+ ++ VV + S+ E L+++ME+L GG L ++ +E +A V V
Sbjct: 68 EVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATV-CESV 126
Query: 699 VLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 758
+ AL YLHS V+HRD+K D++L+ DG +KL+DFG
Sbjct: 127 LQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGF----------------------- 163
Query: 759 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIP 818
++ ++ K++S VGTP ++APE++ T +GT D WS+GI++ E++ G P
Sbjct: 164 --------CAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEP 215
Query: 819 PFNAEHP 825
P+ ++ P
Sbjct: 216 PYFSDSP 222
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 65/232 (28%), Positives = 110/232 (47%), Gaps = 33/232 (14%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLK---KADMIRKNAVESILAERDILISVRNPFVVR 653
+ GAF + A+ TG L A+K + ++ VE++ E ++ + +P ++R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 654 FFYSFTCRENLY-LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVH 712
TC ++ + L +E++ GG + LL G E V Y +++ L YLH +++H
Sbjct: 68 M-LGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIH 126
Query: 713 RDLKPDNLLIAHDGH-IKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQ 771
RD+K NLLI G +++ DFG + +G A E Q
Sbjct: 127 RDVKGANLLIDSTGQRLRIADFGAA----ARLAAKGTG-----------------AGEFQ 165
Query: 772 QERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823
+ +GT ++APE+L G +G + D WSVG ++ E+ PP+NAE
Sbjct: 166 GQ------LLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 3e-28
Identities = 79/247 (31%), Positives = 128/247 (51%), Gaps = 38/247 (15%)
Query: 579 IHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILA 638
+ P R +D F IK I G+ G V +A ++ TG A+K K D+ ++ E +
Sbjct: 15 VSPGDPREYLDSF--IK-IGEGSTGIVCIATEKHTGKQVAVK---KMDLRKQQRRELLFN 68
Query: 639 ERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEV 698
E I+ + VV + S+ + L++VME+L GG L ++ + +E +A V ++ V
Sbjct: 69 EVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLS-V 127
Query: 699 VLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 758
+ AL YLH+ V+HRD+K D++L+ DG IKL+DFG
Sbjct: 128 LRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGF----------------------- 164
Query: 759 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIP 818
++ +E K++S VGTP ++APE++ +GT D WS+GI++ E+I G P
Sbjct: 165 --------CAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEP 216
Query: 819 PFNAEHP 825
P+ E P
Sbjct: 217 PYFNEPP 223
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 3e-28
Identities = 74/252 (29%), Positives = 132/252 (52%), Gaps = 40/252 (15%)
Query: 580 HPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAE 639
H +D + +EII + GAFG+V+ AK + TG L A KV++ + +E + E
Sbjct: 3 HVRRDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYMVE 59
Query: 640 RDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG-CLDEDVARVYIAEV 698
+IL + +P++V+ +F L++++E+ GG + +++ L L E +V ++
Sbjct: 60 IEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQM 119
Query: 699 VLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 758
+ AL+YLHS++++HRDLK N+L+ DG IKL DFG+S
Sbjct: 120 LEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVS---------------------- 157
Query: 759 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-----GTGHGTTADWWSVGIILFEL 813
+++ + +++ S +GTP ++APE+++ T + AD WS+GI L E+
Sbjct: 158 ---------AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208
Query: 814 IVGIPPFNAEHP 825
PP + +P
Sbjct: 209 AQIEPPHHELNP 220
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 72/240 (30%), Positives = 110/240 (45%), Gaps = 58/240 (24%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLK--------KADMIRKNAVESILAERDI 642
+E + I GA+G V+ A+ TG A+K ++ +R+ A+ L +
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIAL---LKQ--- 54
Query: 643 LISVRNPFVVRFFYSF----TCRE-NLYLVMEYLNGGDLYSLLRNLGC----LDEDVARV 693
L S +P +VR T RE L LV E+++ DL + L C L + +
Sbjct: 55 LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSK--CPKPGLPPETIKD 111
Query: 694 YIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753
+ +++ +++LHS R+VHRDLKP N+L+ DG +K+ DFGL+++
Sbjct: 112 LMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI--------------- 156
Query: 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 813
E LT S V T Y APE+LL + + T D WSVG I EL
Sbjct: 157 -----YSFEMALT------------SVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 63/239 (26%), Positives = 102/239 (42%), Gaps = 44/239 (18%)
Query: 595 KPISRGAFGRVFLAK---KRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFV 651
K + GAFG V+ K K A+K LK+ + + L E ++ + +P V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEE--RKDFLKEARVMKKLGHPNV 58
Query: 652 VRFFYSFTCRENLYLVMEYLNGGDLYSLLRN---------LGCLDEDVARVYIAEVVLAL 702
VR T E LYLV+EY+ GGDL LR L + ++ +
Sbjct: 59 VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 703 EYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEE 762
EYL S + VHRDL N L+ D +K++DFGLS+
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSR------------------------- 153
Query: 763 PQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPF 820
+ ++ +++ + + ++APE L + +D WS G++L+E+ G P+
Sbjct: 154 -DVYDDDYYRKKTGGKLPI---RWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPY 208
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 7e-28
Identities = 63/230 (27%), Positives = 119/230 (51%), Gaps = 31/230 (13%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIK------VLKKADMIRKNAVESILAERDILISVRNPF 650
I G+FG V+L ++G+L A+K V + +++ ++++ E +L +++
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRV 710
+V++ S ++L + +EY+ GG + +LL N G +E + R ++ +++ L YLH+ +
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGI 127
Query: 711 VHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEH 770
+HRD+K N+L+ + G IK++DFG+SK NS +T P L S
Sbjct: 128 IHRDIKGANILVDNKGGIKISDFGISKKLEANSL----------STKTNGARPSLQGSVF 177
Query: 771 QQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820
++APE++ T + AD WS+G ++ E++ G PF
Sbjct: 178 ---------------WMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPF 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 8e-28
Identities = 72/244 (29%), Positives = 125/244 (51%), Gaps = 40/244 (16%)
Query: 591 FEIIKP--ISRGAFGRVFLAKKRTTGDLFAIK-------VLKKADMIRKNAVESILAERD 641
F+ +K I +G +GRV+LA TTG++ A+K + + D +K+ V+++ +E +
Sbjct: 1 FKWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIE 60
Query: 642 ILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLA 701
L + + +V++ T E L + +EY+ GG + S LR G +E + R + +V+
Sbjct: 61 TLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEG 120
Query: 702 LEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDE 761
L YLHS ++HRDLK DNLL+ DG K++DFG+SK +DD+ ++
Sbjct: 121 LAYLHSKGILHRDLKADNLLVDADGICKISDFGISK-----KSDDIYD-NDQNMSMQ--- 171
Query: 762 EPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA--DWWSVGIILFELIVGIPP 819
G+ ++APE++ G +A D WS+G ++ E+ G P
Sbjct: 172 --------------------GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
Query: 820 FNAE 823
++ E
Sbjct: 212 WSDE 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 71/238 (29%), Positives = 112/238 (47%), Gaps = 42/238 (17%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVL---KKADMIRKNAVESILAERDILIS 645
+D E I + G G V K TG + A KV+ K+ + ++ IL E I+
Sbjct: 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQ-----ILRELQIMHE 59
Query: 646 VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYL 705
R+P++V F+ +F N+ + ME+++ G L + + G + ++ VV L YL
Sbjct: 60 CRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYL 119
Query: 706 HS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
++ R++HRD+KP N+L+ G IKL DFG+S LINS D
Sbjct: 120 YNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSG-ELINSIAD------------------ 160
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNA 822
+ VGT Y++PE + G + +D WS+GI + EL +G PF
Sbjct: 161 --------------TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAF 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 70/245 (28%), Positives = 121/245 (49%), Gaps = 48/245 (19%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTG-DLFAIK-------VLKKADMIRKNAVESILAERDI 642
+ +++ + GAFG V+ +K+ G +L A+K K R ++ I++E I
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 643 LI-SVRNPFVVRFFYSFTCRENLYLVMEYLNG---GDLYSLLRNLG--CLDEDVARVYIA 696
+ +R+P +VR++ +F + LY+VM+ + G G+ ++ L+ +E + +++
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV- 120
Query: 697 EVVLALEYLH-SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGT 755
++VLAL YLH R+VHRDL P+N+++ D + +TDFGL+K
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK------------------ 162
Query: 756 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV 815
+Q K S VGT Y PEI+ +G AD W+ G IL+++
Sbjct: 163 --------------QKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT 208
Query: 816 GIPPF 820
PPF
Sbjct: 209 LQPPF 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 2e-27
Identities = 76/250 (30%), Positives = 117/250 (46%), Gaps = 37/250 (14%)
Query: 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILI 644
R +DFE+I+ I G +G V+ A+ TG+L AIKV+K + + E ++
Sbjct: 5 RNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIK---LEPGEDFAVVQQEIIMMK 61
Query: 645 SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEY 704
++ +V +F S+ R+ L++ ME+ GG L + G L E E + L Y
Sbjct: 62 DCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYY 121
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
LHS +HRD+K N+L+ +GH+KL DFG+S Q
Sbjct: 122 LHSKGKMHRDIKGANILLTDNGHVKLADFGVSA--------------------------Q 155
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILL---GTGHGTTADWWSVGIILFELIVGIPPFN 821
+TA+ K++S +GTP ++APE+ G+ D W+VGI EL PP
Sbjct: 156 ITAT-----IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMF 210
Query: 822 AEHPQVSTLL 831
HP + L
Sbjct: 211 DLHPMRALFL 220
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 69/248 (27%), Positives = 118/248 (47%), Gaps = 36/248 (14%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
+ +++ + G+FGR L + + +A+K ++ +AVE E +L +++P
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLP--KSSSAVEDSRKEAVLLAKMKHP 58
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHS 707
+V F SF +LY+VMEY +GGDL ++ ED + ++ L ++++H
Sbjct: 59 NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118
Query: 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTA 767
RV+HRD+K N+ + +G +KL DFG +++ L+ P T
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARL--------LTSPGAYACTY---------- 160
Query: 768 SEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQV 827
VGTP Y+ PEI + +D WS+G IL+EL PF A +
Sbjct: 161 -------------VGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK- 206
Query: 828 STLLRKCQ 835
+ +L+ CQ
Sbjct: 207 NLILKVCQ 214
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 70/236 (29%), Positives = 112/236 (47%), Gaps = 49/236 (20%)
Query: 590 DFEIIKPI--SRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAE--RDILIS 645
+ EI+K + G FG+V + K + T LF K++K + NA+E ++ + +D
Sbjct: 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNF---NAIEPMVHQLMKD---- 67
Query: 646 VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYL 705
NP ++ +YS T + L+M+Y+ GDL+ LL+ G L E + I ++V AL L
Sbjct: 68 --NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDL 125
Query: 706 HSLRVVHRDLKPDNLLI-AHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
H ++H D+K +N+L I L D+GL K + GT D
Sbjct: 126 HKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK--------------IIGTPSCYD---- 167
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820
GT DY +PE + G + + DWW+VG++ +EL+ G PF
Sbjct: 168 -----------------GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPF 206
|
Length = 267 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 77/240 (32%), Positives = 115/240 (47%), Gaps = 50/240 (20%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIR----KNAVESILAERDI--LI 644
++ ++ I G +G V+ A+ + TG++ A LKK IR V S A R+I L
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVA---LKK---IRLETEDEGVPST-AIREISLLK 53
Query: 645 SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC--LDEDVARVYIAEVVLAL 702
+ +P +VR LYLV E+L+ DL + + LD + + Y+ +++ +
Sbjct: 54 ELNHPNIVRLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGI 112
Query: 703 EYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK-VGLINSTDDLSGPAVSGTTLLGDE 761
Y HS RV+HRDLKP NLLI +G +KL DFGL++ G+ P
Sbjct: 113 AYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGV---------P----------- 152
Query: 762 EPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIVGIPPF 820
+ H+ V T Y APEILLG+ +T D WS+G I E++ P F
Sbjct: 153 ---VRTYTHE---------VVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLF 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 3e-27
Identities = 64/226 (28%), Positives = 111/226 (49%), Gaps = 36/226 (15%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
+E I+ + RGAFG V L +++ L IK + M + + E +L + +P
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDER-LAAQNECQVLKLLSHPN 60
Query: 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSL 708
++ ++ +F + L +VMEY GG L ++ LDED + +++LAL ++H+
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 709 RVVHRDLKPDNLLI-AHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTA 767
++HRDLK N+L+ H +K+ DFG+SK+ LS
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKI--------LS------------------- 153
Query: 768 SEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 813
+ K + VGTP Y++PE+ G + +D W++G +L+EL
Sbjct: 154 -----SKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYEL 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-26
Identities = 86/247 (34%), Positives = 130/247 (52%), Gaps = 43/247 (17%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDI--LISVRN 648
+EI++ + +GA+G V+ A R T ++ A+K K D R NA ++ R+I L + +
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALK--KIFDAFR-NATDAQRTFREIMFLQELGD 65
Query: 649 -PFVVRFFYSFTCREN--LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIA-EVVLALEY 704
P +V+ + +YLV EY+ DL++++R L EDV + YI +++ AL+Y
Sbjct: 66 HPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVIRA-NIL-EDVHKRYIMYQLLKALKY 122
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
+HS V+HRDLKP N+L+ D +KL DFGL++ ++ ++ E P
Sbjct: 123 IHSGNVIHRDLKPSNILLNSDCRVKLADFGLAR--SLSELEE------------NPENPV 168
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIVGIPPFNAE 823
LT V T Y APEILLG+ T D WSVG IL E+++G P F
Sbjct: 169 LT------------DYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLF--- 213
Query: 824 HPQVSTL 830
P STL
Sbjct: 214 -PGTSTL 219
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 74/247 (29%), Positives = 118/247 (47%), Gaps = 47/247 (19%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVL--KKADMIRKNAVESILAERDILISV 646
+ + + GA G V + + TG +FA+K + ++K IL E +I S
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQ----ILRELEINKSC 56
Query: 647 RNPFVVRFFYSFTCRE--NLYLVMEYLNGGDLYSLLRNL----GCLDEDVARVYIAEVVL 700
++P++V+++ +F ++ + MEY GG L S+ + + G + E V IAE VL
Sbjct: 57 KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVL-GKIAESVL 115
Query: 701 -ALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLG 759
L YLHS +++HRD+KP N+L+ G +KL DFG+S L+NS ++GT
Sbjct: 116 KGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSG-ELVNS--------LAGTF--- 163
Query: 760 DEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPP 819
GT Y+APE + G + T+D WS+G+ L E+ P
Sbjct: 164 ---------------------TGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202
Query: 820 FNAEHPQ 826
F E
Sbjct: 203 FPPEGEP 209
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 69/239 (28%), Positives = 117/239 (48%), Gaps = 38/239 (15%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILA--ERDILISVRN 648
+ I+ + +GAFG L ++ L V K+ ++ R + E A E IL +++
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLV---VWKEVNLTRLSEKERRDALNEIVILSLLQH 58
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYS-LLRNLGCL-DEDVARVYIAEVVLALEYLH 706
P ++ ++ F L + MEY NGG LY ++R G L +E++ Y+ ++V A+ Y+H
Sbjct: 59 PNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH 118
Query: 707 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLT 766
++HRD+K N+ + G IKL DFG+SK+ LG E
Sbjct: 119 KAGILHRDIKTLNIFLTKAGLIKLGDFGISKI-------------------LGSEYSM-- 157
Query: 767 ASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825
+ VGTP Y++PE+ G + +D W++G +L+EL+ F+A +P
Sbjct: 158 ----------AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 5e-26
Identities = 74/243 (30%), Positives = 123/243 (50%), Gaps = 40/243 (16%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ +EII + GAFG+V+ A+ + TG L A KV+ D + +E + E DIL S +
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVI---DTKSEEELEDYMVEIDILASCDH 61
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHS 707
P +V+ +F NL++++E+ GG + +++ L L E RV + + AL YLH
Sbjct: 62 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE 121
Query: 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTA 767
+++HRDLK N+L DG IKL DFG+S
Sbjct: 122 NKIIHRDLKAGNILFTLDGDIKLADFGVS------------------------------- 150
Query: 768 SEHQQERRKKRSAVGTPDYLAPEILL-----GTGHGTTADWWSVGIILFELIVGIPPFNA 822
+++ + +++ S +GTP ++APE+++ + AD WS+GI L E+ PP +
Sbjct: 151 AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHE 210
Query: 823 EHP 825
+P
Sbjct: 211 LNP 213
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 73/251 (29%), Positives = 113/251 (45%), Gaps = 61/251 (24%)
Query: 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV 646
S+D++E + I G +G V+ A+ + TG++ A+K LK + S L E +IL+ +
Sbjct: 3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITS-LREINILLKL 61
Query: 647 RNPFVVRFFYSFTCRE--------NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEV 698
++P +V T +E +Y+VMEY+ DL SL+ + + +EV
Sbjct: 62 QHPNIV------TVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETM---KQPFL---QSEV 108
Query: 699 -------VLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 751
+ + +LH ++HRDLK NLL+ + G +K+ DFGL
Sbjct: 109 KCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGL---------------- 152
Query: 752 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIIL 810
A E+ + V T Y APE+LLG +TA D WSVG I
Sbjct: 153 ---------------AREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIF 197
Query: 811 FELIVGIPPFN 821
EL+ P F
Sbjct: 198 AELLTKKPLFP 208
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 71/250 (28%), Positives = 119/250 (47%), Gaps = 35/250 (14%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
+F I K I RG F V+ A G A+K ++ D++ A + E D+L + +P
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG----CLDEDVARVYIAEVVLALEYL 705
V++++ SF L +V+E + GDL ++++ + E Y ++ ALE++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 706 HSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQL 765
HS RV+HRD+KP N+ I G +KL D GL + +S
Sbjct: 123 HSRRVMHRDIKPANVFITATGVVKLGDLGLGR--FFSSK--------------------- 159
Query: 766 TASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825
T + H S VGTP Y++PE + G+ +D WS+G +L+E+ PF +
Sbjct: 160 TTAAH--------SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM 211
Query: 826 QVSTLLRKCQ 835
+ +L +K +
Sbjct: 212 NLYSLCKKIE 221
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 9e-26
Identities = 75/261 (28%), Positives = 120/261 (45%), Gaps = 46/261 (17%)
Query: 574 LRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAV 633
LR +P H D+E+I+ + G +G V+ A+ TG+L A+K++K + +
Sbjct: 3 LRRNPQH---------DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIK---LEPGDDF 50
Query: 634 ESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARV 693
I E ++ ++ +V +F S+ RE L++ MEY GG L + G L E
Sbjct: 51 SLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAY 110
Query: 694 YIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753
E + L YLHS +HRD+K N+L+ +G +KL DFG++
Sbjct: 111 VCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAA---------------- 154
Query: 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL---GTGHGTTADWWSVGIIL 810
++TA+ K++S +GTP ++APE+ G+ D W+VGI
Sbjct: 155 ----------KITAT-----IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITA 199
Query: 811 FELIVGIPPFNAEHPQVSTLL 831
EL PP HP + L
Sbjct: 200 IELAELQPPMFDLHPMRALFL 220
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 75/252 (29%), Positives = 124/252 (49%), Gaps = 50/252 (19%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
D +EII+ I +G +G+VF + G A+K+L I E I AE +IL ++ +
Sbjct: 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID----EEIEAEYNILKALSD 73
Query: 649 -PFVVRFFYSFTCRE-----NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIA----EV 698
P VV+F+ + ++ L+LV+E NGG + L++ E + IA E
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133
Query: 699 VLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 758
++ L++LH + +HRD+K +N+L+ +G +KL DFG+S
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSA--------------------- 172
Query: 759 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEIL-----LGTGHGTTADWWSVGIILFEL 813
QLT++ ++ ++VGTP ++APE++ L + + D WS+GI EL
Sbjct: 173 -----QLTSTRL-----RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222
Query: 814 IVGIPPFNAEHP 825
G PP HP
Sbjct: 223 GDGDPPLADLHP 234
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 72/239 (30%), Positives = 117/239 (48%), Gaps = 41/239 (17%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
DDFE + + G G V R +G + A K++ I+ I+ E +L +
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE--IKPAIRNQIIRELKVLHECNS 58
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDV-ARVYIAEVVLALEYLHS 707
P++V F+ +F + + ME+++GG L +L+ G + E++ ++ IA V+ L YL
Sbjct: 59 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIA-VLRGLTYLRE 117
Query: 708 -LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLT 766
+++HRD+KP N+L+ G IKL DFG+S LI+S +
Sbjct: 118 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ-LIDSMAN-------------------- 156
Query: 767 ASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVG---IPPFNA 822
S VGT Y++PE L GT + +D WS+G+ L E+ +G IPP +A
Sbjct: 157 ------------SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA 203
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 73/242 (30%), Positives = 121/242 (50%), Gaps = 33/242 (13%)
Query: 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLK--KADMIRKNAVESILAERDILISVRNPFVV 652
K + +GAFGRV+L TG A K ++ V ++ E +L ++++ +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 653 RFFYSFTCR--ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRV 710
+++ R + L + MEY+ GG + L+ G L E V R Y +++ + YLHS +
Sbjct: 68 QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMI 127
Query: 711 VHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEH 770
VHRD+K N+L G++KL DFG SK L +SGT +
Sbjct: 128 VHRDIKGANILRDSAGNVKLGDFGASK--------RLQTICMSGTGI------------- 166
Query: 771 QQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQVSTL 830
RS GTP +++PE++ G G+G AD WS+G + E++ PP+ AE+ ++ +
Sbjct: 167 -------RSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPW-AEYEAMAAI 218
Query: 831 LR 832
+
Sbjct: 219 FK 220
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 67/233 (28%), Positives = 119/233 (51%), Gaps = 41/233 (17%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIK--VLKKADMIR-KNAVESILAERDILISVRNPFVVR 653
+ +GA+G V+ G L A+K L ++++ + E + E D+L S+++ +V+
Sbjct: 8 LGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 654 FFYSFTCREN--LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVV 711
Y TC ++ + + ME++ GG + S+L G L E V Y +++ + YLH+ VV
Sbjct: 67 --YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVV 124
Query: 712 HRDLKPDNLLIAHDGHIKLTDFGLSK----VGLINSTDDLSGPAVSGTTLLGDEEPQLTA 767
HRD+K +N+++ +G IKL DFG ++ VGL + ++
Sbjct: 125 HRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNML------------------- 165
Query: 768 SEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820
+S GTP ++APE++ +G+G +D WS+G +FE+ G PP
Sbjct: 166 ----------KSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 83/259 (32%), Positives = 127/259 (49%), Gaps = 46/259 (17%)
Query: 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIR-KNAVE-SILAERDILI 644
S+ +FE + I G +G V+ A+ T+G++ A LKK M ++ + S L E +L+
Sbjct: 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVA---LKKVRMDNERDGIPISSLREITLLL 61
Query: 645 SVRNPFVVRFFYSFTCR--ENLYLVMEYLNGGDLYSLLRNLGC-LDEDVARVYIAEVVLA 701
++R+P +V + ++++LVMEY DL SLL N+ E + + +++
Sbjct: 62 NLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRG 120
Query: 702 LEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDE 761
L+YLH ++HRDLK NLL+ G +K+ DFGL++ PA T
Sbjct: 121 LQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLART--------YGLPAKPMT------ 166
Query: 762 EPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIVGIP-- 818
P+ V T Y APE+LLG TTA D W+VG IL EL+ P
Sbjct: 167 -PK----------------VVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLL 209
Query: 819 PFNAEHPQVSTLLRKCQLL 837
P +E Q+ + QLL
Sbjct: 210 PGKSEIEQLDLI---IQLL 225
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 76/237 (32%), Positives = 118/237 (49%), Gaps = 35/237 (14%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ FE++ + GA+G V + + T ++ AIK K ++ + E+ L E +L +++
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQ 59
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLH 706
+V +F R LYLV EY+ ++ LL + G E V R YI +++ A+ + H
Sbjct: 60 ENIVELKEAFRRRGKLYLVFEYVEK-NMLELLEEMPNGVPPEKV-RSYIYQLIKAIHWCH 117
Query: 707 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLT 766
+VHRD+KP+NLLI+H+ +KL DFG ++ +LS E
Sbjct: 118 KNDIVHRDIKPENLLISHNDVLKLCDFGFAR--------NLS------------EGSNAN 157
Query: 767 ASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823
+E+ V T Y +PE+LLG +G D WSVG IL EL G P F E
Sbjct: 158 YTEY----------VATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGE 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 69/234 (29%), Positives = 112/234 (47%), Gaps = 39/234 (16%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKAD---MIRKNAVESILAERDILIS 645
+ +E + I G++G VF + R TG + AIK +++ +I+K A L E +L
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIA----LREIRMLKQ 56
Query: 646 VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYL 705
+++P +V F + L+LV EY + L L +N + E + + I + + A+ +
Sbjct: 57 LKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFC 116
Query: 706 HSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQL 765
H +HRD+KP+N+LI G IKL DFG +++ L+GP T
Sbjct: 117 HKHNCIHRDVKPENILITKQGQIKLCDFGFARI--------LTGPGDDYT---------- 158
Query: 766 TASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIP 818
V T Y APE+L+G T +G D W++G + EL+ G P
Sbjct: 159 -------------DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-24
Identities = 69/230 (30%), Positives = 114/230 (49%), Gaps = 32/230 (13%)
Query: 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLK--KADMIRKNAVESILAERDILISVRNPFVV 652
K + +GAFGRV+L TG A+K ++ V ++ E +L ++ + +V
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67
Query: 653 RFFYSF--TCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRV 710
+++ L + ME++ GG + L++ G L E+V R Y +++ + YLHS +
Sbjct: 68 QYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMI 127
Query: 711 VHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEH 770
VHRD+K N+L G++KL DFG SK L +SGT +
Sbjct: 128 VHRDIKGANILRDSVGNVKLGDFGASK--------RLQTICLSGTGM------------- 166
Query: 771 QQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820
+S GTP +++PE++ G G+G AD WSVG + E++ PP+
Sbjct: 167 -------KSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-24
Identities = 70/252 (27%), Positives = 119/252 (47%), Gaps = 35/252 (13%)
Query: 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR 647
+ +F+I K I RG F V+ A A+K ++ +M+ A + + E D+L +
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60
Query: 648 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG----CLDEDVARVYIAEVVLALE 703
+P V+++ SF L +V+E + GDL +++ + E Y ++ A+E
Sbjct: 61 HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 704 YLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEP 763
++HS RV+HRD+KP N+ I G +KL D GL G S+
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGL---GRFFSSK------------------ 159
Query: 764 QLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823
T + H S VGTP Y++PE + G+ +D WS+G +L+E+ PF +
Sbjct: 160 --TTAAH--------SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209
Query: 824 HPQVSTLLRKCQ 835
+ +L +K +
Sbjct: 210 KMNLFSLCQKIE 221
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 70/228 (30%), Positives = 113/228 (49%), Gaps = 38/228 (16%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
F+ ++ I G +G V+ A+ + TG++ A+K ++ D + + + E +L + +P
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPN 60
Query: 651 VVRFFYSFTCRENLYLVMEYLNGGDL--YSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
+V+ LYLV E+L+ DL + L + + + Y+ +++ L + HS
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKV-GLINSTDDLSGPAVSGTTLLGDEEPQLTA 767
RV+HRDLKP NLLI +G IKL DFGL++ G+ P + T
Sbjct: 120 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV---------PVRTYT------------ 158
Query: 768 SEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELI 814
H+ V T Y APEILLG + +TA D WS+G I E++
Sbjct: 159 --HE---------VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 68/234 (29%), Positives = 112/234 (47%), Gaps = 45/234 (19%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
D + + + G G V+ A T + A+KV+ I + I++E +IL +P
Sbjct: 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLD--ITVELQKQIMSELEILYKCDSP 59
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGG--DLYSLLRNLGCLDEDV-ARVYIAEVVLALEYLH 706
+++ F+ +F + + E+++GG D+Y + E V R+ +A VV L YL
Sbjct: 60 YIIGFYGAFFVENRISICTEFMDGGSLDVY------RKIPEHVLGRIAVA-VVKGLTYLW 112
Query: 707 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLT 766
SL+++HRD+KP N+L+ G +KL DFG+S L+NS
Sbjct: 113 SLKILHRDVKPSNMLVNTRGQVKLCDFGVST-QLVNSI---------------------- 149
Query: 767 ASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820
++ VGT Y+APE + G +G +D WS+GI EL +G P+
Sbjct: 150 ----------AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 9e-24
Identities = 71/242 (29%), Positives = 122/242 (50%), Gaps = 33/242 (13%)
Query: 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNA--VESILAERDILISVRNPFVV 652
K + RGAFG V+L TG A+K + ++ + V ++ E +L ++R+ +V
Sbjct: 8 KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67
Query: 653 RFFYSFTCREN--LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRV 710
+++ E L + +EY+ GG + L+ G L E+V R Y +++ + YLHS +
Sbjct: 68 QYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMI 127
Query: 711 VHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEH 770
VHRD+K N+L G++KL DFG SK + +SGT +
Sbjct: 128 VHRDIKGANILRDSAGNVKLGDFGASK--------RIQTICMSGTGI------------- 166
Query: 771 QQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQVSTL 830
+S GTP +++PE++ G G+G AD WSV + E++ PP+ AE+ ++ +
Sbjct: 167 -------KSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPW-AEYEAMAAI 218
Query: 831 LR 832
+
Sbjct: 219 FK 220
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 67/234 (28%), Positives = 113/234 (48%), Gaps = 39/234 (16%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVL---KKADMIRKNAVESILAERDILISVR 647
+E + + G++G V K + TG + AIK + M++K A+ I +L +R
Sbjct: 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREI----RMLKQLR 58
Query: 648 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS 707
+ +V F ++ LYLV E+++ L L + LDE R Y+ +++ +E+ HS
Sbjct: 59 HENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHS 118
Query: 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTA 767
++HRD+KP+N+L++ G +KL DFG ++ L+ P T
Sbjct: 119 HNIIHRDIKPENILVSQSGVVKLCDFGFART--------LAAPGEVYT------------ 158
Query: 768 SEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPF 820
V T Y APE+L+G T +G D W+VG ++ E++ G P F
Sbjct: 159 -----------DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 2e-22
Identities = 70/241 (29%), Positives = 114/241 (47%), Gaps = 54/241 (22%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIK--------------VLKKADMIRKNAVE 634
++ I+ I GA+G V A +G AIK L++ ++R +
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 635 SILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVY 694
+I+A RDIL F +++Y+VM+ L DL+ ++ + L E+ R +
Sbjct: 65 NIIAIRDILRPPGADF-----------KDVYVVMD-LMESDLHHIIHSDQPLTEEHIRYF 112
Query: 695 IAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 754
+ +++ L+Y+HS V+HRDLKP NLL+ D +++ DFG+++ GL +S
Sbjct: 113 LYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMAR-GLSSSP---------- 161
Query: 755 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFEL 813
E + +E+ V T Y APE+LL TTA D WSVG I E+
Sbjct: 162 ------TEHKYFMTEY----------VATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEM 205
Query: 814 I 814
+
Sbjct: 206 L 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 4e-22
Identities = 74/252 (29%), Positives = 116/252 (46%), Gaps = 65/252 (25%)
Query: 591 FEI------IKPISRGAFGRVFLAKKRTTGDLFAIK--------------VLKKADMIRK 630
FE+ IKPI RGA+G V AK T + AIK L++ ++R
Sbjct: 1 FEVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRH 60
Query: 631 NAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDED 689
E+++A +DI+ R F ++Y+V E L DL+ ++R+ L +D
Sbjct: 61 LDHENVIAIKDIMPPPHREAF-----------NDVYIVYE-LMDTDLHQIIRSSQTLSDD 108
Query: 690 VARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 749
+ ++ +++ L+Y+HS V+HRDLKP NLL+ + +K+ DFGL++ + D
Sbjct: 109 HCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT--SEKGDF-- 164
Query: 750 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGI 808
+E+ V T Y APE+LL + + T D WSVG
Sbjct: 165 -----------------MTEY----------VVTRWYRAPELLLNCSEYTTAIDVWSVGC 197
Query: 809 ILFELIVGIPPF 820
I EL+ P F
Sbjct: 198 IFAELLGRKPLF 209
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 5e-22
Identities = 74/240 (30%), Positives = 118/240 (49%), Gaps = 41/240 (17%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
DDFE I + G G VF + +G + A K++ I+ I+ E +L +
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNS 62
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDV-ARVYIAEVVLALEYLHS 707
P++V F+ +F + + ME+++GG L +L+ G + E + +V IA V+ L YL
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA-VIKGLTYLRE 121
Query: 708 L-RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLT 766
+++HRD+KP N+L+ G IKL DFG+S LI+S +
Sbjct: 122 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMAN-------------------- 160
Query: 767 ASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVG---IPPFNAE 823
S VGT Y++PE L GT + +D WS+G+ L E+ +G IPP +A+
Sbjct: 161 ------------SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAK 208
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 1e-21
Identities = 67/245 (27%), Positives = 114/245 (46%), Gaps = 45/245 (18%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
D+ E++ + +G +G V+ R TG A+K ++ + ++ I+ E DIL +
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAVS 58
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGD---LYSLLRNLGCLDEDVARVYIAEVVLALEYL 705
P++V F+ +F +Y+ MEY++ G LY+ + EDV R VV L++L
Sbjct: 59 PYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118
Query: 706 -HSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
++HRD+KP N+L+ +G +KL DFG VSG
Sbjct: 119 KEEHNIIHRDVKPTNVLVNGNGQVKLCDFG-----------------VSG---------N 152
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLG---TGHGT---TADWWSVGIILFELIVGIP 818
L AS ++ +G Y+APE + + T +D WS+G+ + E+ +G
Sbjct: 153 LVAS-------LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRY 205
Query: 819 PFNAE 823
P+ E
Sbjct: 206 PYPPE 210
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 2e-21
Identities = 72/250 (28%), Positives = 113/250 (45%), Gaps = 54/250 (21%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIK-------------VLKKADMIRKNAVES 635
++ + I GA+G V A + TG AIK L++ ++R+ E+
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64
Query: 636 ILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYI 695
I+ DI+ F SF ++Y+V E + DLY L++ L D + ++
Sbjct: 65 IIGILDIIRP-------PSFESF---NDVYIVQELMET-DLYKLIKTQH-LSNDHIQYFL 112
Query: 696 AEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGT 755
+++ L+Y+HS V+HRDLKP NLL+ + +K+ DFGL+++
Sbjct: 113 YQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARI----------------A 156
Query: 756 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELI 814
D LT E+ V T Y APEI+L + T A D WSVG IL E++
Sbjct: 157 DPEHDHTGFLT--EY----------VATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEML 204
Query: 815 VGIPPFNAEH 824
P F +
Sbjct: 205 SNRPLFPGKD 214
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 4e-21
Identities = 70/238 (29%), Positives = 112/238 (47%), Gaps = 43/238 (18%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLK---KADMIRKNAVESILAERDILISV 646
D+ I+ I G +G V+ + + TG + A+K ++ + + + A+ I +L +
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREI----SLLKEL 56
Query: 647 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC---LDEDVARVYIAEVVLALE 703
++P +V LYL+ E+L+ DL L +L +D ++ + Y+ +++ +
Sbjct: 57 QHPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGIL 115
Query: 704 YLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEP 763
+ HS RV+HRDLKP NLLI + G IKL DFGL++ G V T
Sbjct: 116 FCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARA---------FGIPVRVYT------- 159
Query: 764 QLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPF 820
H+ V T Y APE+LLG + T D WS+G I E+ P F
Sbjct: 160 ------HE---------VVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 5e-21
Identities = 75/251 (29%), Positives = 115/251 (45%), Gaps = 56/251 (22%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIK--------------VLKKADMIRKNAVES 635
D E +PI GAFG V+ G A+K V ++ M+ ++
Sbjct: 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDN 60
Query: 636 ILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYI 695
+L+ DIL P + F E +Y+V E + DL+ ++ + L D +V++
Sbjct: 61 VLSALDIL----QPPHIDPF------EEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFL 109
Query: 696 AEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGT 755
+++ L+YLHS ++HRD+KP NLL+ + +K+ DFGL++V
Sbjct: 110 YQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARV----------------- 152
Query: 756 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELI 814
EEP E + V T Y APEIL+G+ H T+A D WSVG I EL+
Sbjct: 153 -----EEP--------DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELL 199
Query: 815 VGIPPFNAEHP 825
F A+ P
Sbjct: 200 GRRILFQAQSP 210
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 5e-21
Identities = 72/247 (29%), Positives = 110/247 (44%), Gaps = 50/247 (20%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKA--DMIRKNAVESILAERDILISV 646
D +E ++ I G +G+V+ A+ + TG L A LKK +M + + L E +L +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVA---LKKTRLEMDEEGIPPTALREISLLQML 57
Query: 647 -RNPFVVRFFYSFTCREN-----LYLVMEYLNGGDLYSLLRNLG-----CLDEDVARVYI 695
+ ++VR E LYLV EYL+ DL + + G L + ++
Sbjct: 58 SESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFM 116
Query: 696 AEVVLALEYLHSLRVVHRDLKPDNLLIAHD-GHIKLTDFGLSKVGLINSTDDLSGPAVSG 754
+++ + + H V+HRDLKP NLL+ G +K+ D GL + S P S
Sbjct: 117 YQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA--------FSIPVKSY 168
Query: 755 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFEL 813
T H+ + T Y APE+LLG+ H +T D WSVG I E+
Sbjct: 169 T--------------HE---------IVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEM 205
Query: 814 IVGIPPF 820
P F
Sbjct: 206 SRKQPLF 212
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 5e-21
Identities = 78/266 (29%), Positives = 118/266 (44%), Gaps = 50/266 (18%)
Query: 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILI 644
+ +D F+II I G +G+V+ A+ + TG+L A LKK + + I A R+I I
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVA---LKKVRLDNEKEGFPITAIREIKI 59
Query: 645 --SVRNPFVVRFFYSFTC----------RENLYLVMEYLNGGDLYSLLRN-LGCLDEDVA 691
+ + +V T + YLV EY++ DL LL + L ED
Sbjct: 60 LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHI 118
Query: 692 RVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 751
+ ++ +++ L Y H +HRD+K N+L+ + G IKL DFGL+++
Sbjct: 119 KSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARL------------- 165
Query: 752 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTADWWSVGIIL 810
+ +E R + V T Y PE+LLG +G D WS G IL
Sbjct: 166 -----------------YNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 208
Query: 811 FELIVGIPPFNA--EHPQVSTLLRKC 834
EL P F A E Q+ + R C
Sbjct: 209 GELFTKKPIFQANQELAQLELISRLC 234
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 1e-20
Identities = 72/278 (25%), Positives = 125/278 (44%), Gaps = 59/278 (21%)
Query: 572 RSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKN 631
RSL + +D I FE+++ + G +G+V+ + TG L AIKV+ + ++
Sbjct: 1 RSLDDIDLSALRDPAGI--FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTED 54
Query: 632 AVESILAERDILISV---RNPFVVRFFYSFTCR------ENLYLVMEYLNGGDLYSLLRN 682
E I E ++L RN + ++ +F + + L+LVME+ G + L++N
Sbjct: 55 EEEEIKLEINMLKKYSHHRN--IATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKN 112
Query: 683 L--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740
L ED E++ L +LH+ +V+HRD+K N+L+ + +KL DFG+S
Sbjct: 113 TKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--- 169
Query: 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERR--KKRSAVGTPDYLAPEILL----- 793
Q +R ++ + +GTP ++APE++
Sbjct: 170 ------------------------------QLDRTVGRRNTFIGTPYWMAPEVIACDENP 199
Query: 794 GTGHGTTADWWSVGIILFELIVGIPPFNAEHPQVSTLL 831
+ +D WS+GI E+ G PP HP + L
Sbjct: 200 DATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL 237
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 1e-20
Identities = 69/247 (27%), Positives = 111/247 (44%), Gaps = 40/247 (16%)
Query: 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVES--ILAERDIL 643
+ + D+EI+ + G FG V+ A++ TG + A LKK ++ N + I A R+I
Sbjct: 5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVA---LKK--ILMHNEKDGFPITALREIK 59
Query: 644 I--SVRNPFVVRF---FYSFTCREN-----LYLVMEYLNGGDLYSLLRNLGC-LDEDVAR 692
I +++P VV + +Y+V Y++ DL LL N L E +
Sbjct: 60 ILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIK 118
Query: 693 VYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 752
Y+ +++ + YLH ++HRD+K N+LI + G +K+ DFGL++ + G
Sbjct: 119 CYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGG 178
Query: 753 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILF 811
RK + V T Y PE+LLG TTA D W +G +
Sbjct: 179 G--------------------TRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFA 218
Query: 812 ELIVGIP 818
E+ P
Sbjct: 219 EMFTRRP 225
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 63/239 (26%), Positives = 99/239 (41%), Gaps = 45/239 (18%)
Query: 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILI--S 645
+ +E + I +G FG VF A+ + T + A LKK M + I A R+I I
Sbjct: 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVA---LKKVLMENEKEGFPITALREIKILQL 67
Query: 646 VRNPFVVRFF---------YSFTCRENLYLVMEYLNGGDLYSLLRNLGC-LDEDVARVYI 695
+++ VV Y+ + + YLV E+ DL LL N + +
Sbjct: 68 LKHENVVNLIEICRTKATPYN-RYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVM 125
Query: 696 AEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGT 755
++ L Y+H +++HRD+K N+LI DG +KL DFGL++ ++
Sbjct: 126 KMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSK--------- 176
Query: 756 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFEL 813
+ + V T Y PE+LLG G D W G I+ E+
Sbjct: 177 ------------------PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEM 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 2e-20
Identities = 72/245 (29%), Positives = 111/245 (45%), Gaps = 56/245 (22%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVES-ILAERD-----I 642
D ++ + P+ GA+G+V A TG AIK L + +S I A+R +
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRP-------FQSAIHAKRTYRELRL 67
Query: 643 LISVRNPFVVRFFYSFTCRENL------YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIA 696
L + + V+ FT +L YLV L G DL ++++ L +D + +
Sbjct: 68 LKHMDHENVIGLLDVFTPASSLEDFQDVYLVTH-LMGADLNNIVK-CQKLSDDHIQFLVY 125
Query: 697 EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 756
+++ L+Y+HS ++HRDLKP N+ + D +K+ DFGL++ TDD
Sbjct: 126 QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR-----HTDD---------- 170
Query: 757 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT-TADWWSVGIILFELIV 815
++T V T Y APEI+L H T D WSVG I+ EL+
Sbjct: 171 -------EMTGY------------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 211
Query: 816 GIPPF 820
G F
Sbjct: 212 GKTLF 216
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 3e-20
Identities = 72/243 (29%), Positives = 112/243 (46%), Gaps = 46/243 (18%)
Query: 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVL--KKADMIRKNAVESILAERDI 642
S+ + E + I GA G V+ R TG L+A+KV+ D +R+ I E +I
Sbjct: 70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRR----QICREIEI 125
Query: 643 LISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLAL 702
L V +P VV+ F + +++E+++GG L DVAR +++ +
Sbjct: 126 LRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----QILSGI 181
Query: 703 EYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEE 762
YLH +VHRD+KP NLLI ++K+ DFG+S++ + T D P
Sbjct: 182 AYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRI--LAQTMD---PC----------- 225
Query: 763 PQLTASEHQQERRKKRSAVGTPDYLAPEIL---LGTG--HGTTADWWSVGIILFELIVGI 817
S+VGT Y++PE + L G G D WS+G+ + E +G
Sbjct: 226 ---------------NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
Query: 818 PPF 820
PF
Sbjct: 271 FPF 273
|
Length = 353 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 3e-20
Identities = 73/240 (30%), Positives = 118/240 (49%), Gaps = 41/240 (17%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
DDFE I + G G V + + +G + A K++ I+ I+ E +L +
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNS 62
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDV-ARVYIAEVVLALEYLHS 707
P++V F+ +F + + ME+++GG L +L+ + E++ +V IA V+ L YL
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA-VLRGLAYLRE 121
Query: 708 L-RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLT 766
+++HRD+KP N+L+ G IKL DFG+S LI+S +
Sbjct: 122 KHQIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMAN-------------------- 160
Query: 767 ASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVG---IPPFNAE 823
S VGT Y++PE L GT + +D WS+G+ L EL +G IPP +A+
Sbjct: 161 ------------SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK 208
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 6e-20
Identities = 64/223 (28%), Positives = 110/223 (49%), Gaps = 38/223 (17%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILA--ERDILISVRNPFVVRF 654
+ +G+FG V+L K + +KVLK+ + N E++ A E +L + +P +V+F
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 655 FYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAE----VVLALEYLHSLRV 710
SF R+ ++ EY G DL L L + ++ + E ++L + Y+H R+
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRI 127
Query: 711 VHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEH 770
+HRDLK N+ + ++ +K+ DFG+S++ L+ S D TT
Sbjct: 128 LHRDLKAKNIFLKNN-LLKIGDFGVSRL-LMGSCD-------LATTF------------- 165
Query: 771 QQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 813
GTP Y++PE L G+ + +D WS+G IL+E+
Sbjct: 166 ----------TGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 7e-20
Identities = 71/242 (29%), Positives = 111/242 (45%), Gaps = 65/242 (26%)
Query: 594 IKPISRGAFGRVFLAKKRTTGDLFAIKVLKKA--------------DMIRKNAVESILAE 639
++P+ GAFG V A+ + TG AIK + K +++ E+I++
Sbjct: 15 LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISL 74
Query: 640 RDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVV 699
DI IS P E++Y V E L G DL+ LL + L++ + ++ +++
Sbjct: 75 SDIFIS---P-----------LEDIYFVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQIL 118
Query: 700 LALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLG 759
L+Y+HS VVHRDLKP N+LI + +K+ DFGL+++
Sbjct: 119 RGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARI--------------------- 157
Query: 760 DEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIP 818
++PQ+T V T Y APEI+L + D WS G I E++ G P
Sbjct: 158 -QDPQMTGY------------VSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKP 204
Query: 819 PF 820
F
Sbjct: 205 LF 206
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 8e-20
Identities = 70/243 (28%), Positives = 110/243 (45%), Gaps = 49/243 (20%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR--- 647
++I+ I G F V A+ R TG +AIK +KK ++E + R+I R
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKK----HFKSLEQVNNLREIQALRRLSP 56
Query: 648 NPFVVRF----FYSFTCRENLYLVMEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLAL 702
+P ++R F T R L LV E ++ +LY L++ L E + Y+ +++ +L
Sbjct: 57 HPNILRLIEVLFDRKTGR--LALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSL 113
Query: 703 EYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEE 762
+++H + HRD+KP+N+LI D +KL DFG + I S
Sbjct: 114 DHMHRNGIFHRDIKPENILI-KDDILKLADFGSCRG--IYSK------------------ 152
Query: 763 PQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTADWWSVGIILFELIVGIPPFN 821
P T + T Y APE LL G +G D W+VG + FE++ P F
Sbjct: 153 PPYTEY------------ISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFP 200
Query: 822 AEH 824
+
Sbjct: 201 GTN 203
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 1e-19
Identities = 69/240 (28%), Positives = 99/240 (41%), Gaps = 49/240 (20%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVES---ILAERDILISVR 647
F ++ I G+FG V+ A+ T ++ AIK K K + E I+ E L +R
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIK---KMSYSGKQSNEKWQDIIKEVRFLQQLR 73
Query: 648 NPFVVRFFYSFTCRENLYLVMEYLNG--GDLYSLLRNLGCLDEDVARVYIAEVVLALEYL 705
+P + + + +LVMEY G D+ + + L E + L YL
Sbjct: 74 HPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKK--PLQEVEIAAICHGALQGLAYL 131
Query: 706 HSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQL 765
HS +HRD+K N+L+ G +KL DFG + L PA
Sbjct: 132 HSHERIHRDIKAGNILLTEPGTVKLADFG---------SASLVSPA-------------- 168
Query: 766 TASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT---TADWWSVGIILFELIVGIPP-FN 821
S VGTP ++APE++L G D WS+GI EL PP FN
Sbjct: 169 ------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 1e-19
Identities = 61/218 (27%), Positives = 94/218 (43%), Gaps = 44/218 (20%)
Query: 600 GAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFT 659
G +V L T F +K L+K+ + ER +I P +V
Sbjct: 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSR--------ERLTIIPHCVPNMVCLHKYIV 55
Query: 660 CRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDN 719
++++LV+++ GG L+S + + E+ + + AE+V+AL+ LH +V RDL P+N
Sbjct: 56 SEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNN 115
Query: 720 LLIAHDGHIKLTDFG-LSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKR 778
+L+ GHI+LT F S+V D G AV
Sbjct: 116 ILLDDRGHIQLTYFSRWSEV-----EDSCDGEAVENM----------------------- 147
Query: 779 SAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVG 816
Y APE+ + DWWS+G ILFEL+ G
Sbjct: 148 -------YCAPEVGGISEETEACDWWSLGAILFELLTG 178
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 63/235 (26%), Positives = 111/235 (47%), Gaps = 39/235 (16%)
Query: 594 IKPISRGAFGRVFLAKKRTTGDLFAIKVL--KKADMIRKNAVESILAERDILISVRNPFV 651
++ + +G++G V L + RT G + IK L + A + A E E +L +++P +
Sbjct: 5 VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQ---EAQLLSQLKHPNI 61
Query: 652 VRFFYSFTCREN-LYLVMEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSL 708
V + S+ + LY+VM + GGDLY L+ L E+ + ++ +AL+YLH
Sbjct: 62 VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTAS 768
++HRDLK N+ + IK+ D G+++V L N D S
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARV-LENQCDMAS-------------------- 160
Query: 769 EHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823
+ +GTP Y++PE+ + +D W++G ++E+ FNA+
Sbjct: 161 ----------TLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 89.8 bits (222), Expect = 2e-19
Identities = 62/233 (26%), Positives = 110/233 (47%), Gaps = 34/233 (14%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
D +E ++ + G++ V+ K + G L A+KV++ + + + + E +L +++
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE--EEGTPFTAIREASLLKGLKH 62
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
+V +E L LV EY++ + ++ G L + ++++ +++ L Y+H
Sbjct: 63 ANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR 122
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTAS 768
++HRDLKP NLLI+ G +KL DFGL++ + P T S
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLARAKSV---------------------PSHTYS 161
Query: 769 EHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPF 820
+ V T Y P++LLG T + T D W VG I E+I G+ F
Sbjct: 162 ----------NEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 64/228 (28%), Positives = 106/228 (46%), Gaps = 41/228 (17%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLK---KADMIRKNAVESILAERDILISVR 647
+E ++ I G +G VF AK R T ++ A+K ++ + + +A+ I +L ++
Sbjct: 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREIC----LLKELK 57
Query: 648 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLH 706
+ +VR + + L LV EY + DL + G +D ++ + ++ +++ L + H
Sbjct: 58 HKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH 116
Query: 707 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLT 766
S V+HRDLKP NLLI +G +KL DFGL++ I P
Sbjct: 117 SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGI--------PV--------------- 153
Query: 767 ASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFEL 813
R + V T Y P++L G + T+ D WS G I EL
Sbjct: 154 --------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 2e-19
Identities = 63/255 (24%), Positives = 114/255 (44%), Gaps = 49/255 (19%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
FE+++ + G +G+V+ + TG L AIKV+ + + E I E ++L +
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHHR 63
Query: 651 VVRFFYSFTCREN-------LYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLA 701
+ +Y ++N L+LVME+ G + L++N L E+ E++
Sbjct: 64 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 123
Query: 702 LEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDE 761
L +LH +V+HRD+K N+L+ + +KL DFG+S
Sbjct: 124 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS------------------------- 158
Query: 762 EPQLTASEHQQERRKKRSAVGTPDYLAPEILL-----GTGHGTTADWWSVGIILFELIVG 816
++ + ++ + +GTP ++APE++ + +D WS+GI E+ G
Sbjct: 159 ------AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
Query: 817 IPPFNAEHPQVSTLL 831
PP HP + L
Sbjct: 213 APPLCDMHPMRALFL 227
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 3e-19
Identities = 74/245 (30%), Positives = 113/245 (46%), Gaps = 51/245 (20%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
+E+IK + +GA+G V A+ T + + + K ++ K ILA+R ++R
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSK----KILAKR----ALRELK 53
Query: 651 VVRFFY---SFTCR-----------ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIA 696
++R F + TC LYL E L DL+ ++R+ L + + +I
Sbjct: 54 LLRHFRGHKNITCLYDMDIVFPGNFNELYLYEE-LMEADLHQIIRSGQPLTDAHFQSFIY 112
Query: 697 EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 756
+++ L+Y+HS V+HRDLKP NLL+ D +K+ DFGL++ N
Sbjct: 113 QILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP------------- 159
Query: 757 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIV 815
G+ +T V T Y APEI+L T A D WSVG IL EL+
Sbjct: 160 --GENAGFMT------------EYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLG 205
Query: 816 GIPPF 820
P F
Sbjct: 206 RKPVF 210
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 4e-19
Identities = 66/232 (28%), Positives = 110/232 (47%), Gaps = 44/232 (18%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFY 656
+ +G +G V+ A+ +T AIK + + D V+ + E + +++ +V++
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDS---RYVQPLHEEIALHSYLKHRNIVQYLG 72
Query: 657 SFTCRENLYLVMEYLNGGDLYSLLRN-LGCL--DEDVARVYIAEVVLALEYLHSLRVVHR 713
S + + ME + GG L +LLR+ G L +E Y +++ L+YLH ++VHR
Sbjct: 73 SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHR 132
Query: 714 DLKPDNLLI-AHDGHIKLTDFGLSKVGLINSTDDLSG--PAVSGTTLLGDEEPQLTASEH 770
D+K DN+L+ + G +K++DFG SK L+G P T
Sbjct: 133 DIKGDNVLVNTYSGVVKISDFGTSK--------RLAGINPCTETFT-------------- 170
Query: 771 QQERRKKRSAVGTPDYLAPEILLG--TGHGTTADWWSVGIILFELIVGIPPF 820
GT Y+APE++ G+G AD WS+G + E+ G PPF
Sbjct: 171 -----------GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF 211
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 6e-19
Identities = 67/239 (28%), Positives = 110/239 (46%), Gaps = 44/239 (18%)
Query: 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVE----SILAERDIL 643
++ ++ + + G++ V+ + + TG L A+K IR E + + E +L
Sbjct: 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKE------IRLEHEEGAPFTAIREASLL 57
Query: 644 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLAL 702
+++ +V ++ L LV EYL+ DL + + G L R+++ +++ L
Sbjct: 58 KDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGL 116
Query: 703 EYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEE 762
Y H RV+HRDLKP NLLI+ G +KL DFGL++ +
Sbjct: 117 AYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSV--------------------- 155
Query: 763 PQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPF 820
P T S + V T Y P++LLG T + T+ D W VG I +E+ G P F
Sbjct: 156 PSKTYS----------NEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 8e-19
Identities = 73/247 (29%), Positives = 113/247 (45%), Gaps = 49/247 (19%)
Query: 591 FEIIKPISRGAFGRVFLA--KKRTTGDLFAIKVLKKADMIRKNAVESILAERDI--LISV 646
+EI I RG +GRV+ A K G +AIK K D + + S A R+I L +
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFK-GDKEQYTGI-SQSACREIALLREL 59
Query: 647 RNPFVV---RFFYSFTCRENLYLVMEYLNGGDLYSLLR-----NLGCLDEDVARVYIAEV 698
++ VV F + +YL+ +Y DL+ +++ + + + + ++
Sbjct: 60 KHENVVSLVEVFLEHADKS-VYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQI 117
Query: 699 VLALEYLHSLRVVHRDLKPDNLLIAHDGH----IKLTDFGLSKVGLINSTDDLSGPAVSG 754
+ + YLHS V+HRDLKP N+L+ +G +K+ D GL++ L N+ P
Sbjct: 118 LNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR--LFNA------PLKP- 168
Query: 755 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFEL 813
L D +P V T Y APE+LLG H T A D W++G I EL
Sbjct: 169 ---LADLDP----------------VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAEL 209
Query: 814 IVGIPPF 820
+ P F
Sbjct: 210 LTLEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.0 bits (225), Expect = 1e-18
Identities = 69/252 (27%), Positives = 128/252 (50%), Gaps = 33/252 (13%)
Query: 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILIS 645
+ ++++E+IK I G FG VFL K + T + F K + + + + ++ E +++
Sbjct: 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVI-EVNVMRE 68
Query: 646 VRNPFVVRFFYSFTCREN--LYLVMEYLNGGDLYSLLRN----LGCLDEDVARVYIAEVV 699
+++ +VR+ F + N LY++ME+ + GDL ++ G ++E +++
Sbjct: 69 LKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLL 128
Query: 700 LALEYLHSL-------RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS-TDDLSGPA 751
AL Y H+L RV+HRDLKP N+ ++ G+ +G I + ++L+G
Sbjct: 129 HALAYCHNLKDGPNGERVLHRDLKPQNIFLST---------GIRHIGKITAQANNLNGRP 179
Query: 752 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL--GTGHGTTADWWSVGII 809
++ +GD S++ S VGTP Y +PE+LL + +D W++G I
Sbjct: 180 IAK---IGD----FGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCI 232
Query: 810 LFELIVGIPPFN 821
++EL G PF+
Sbjct: 233 IYELCSGKTPFH 244
|
Length = 1021 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 2e-18
Identities = 75/239 (31%), Positives = 115/239 (48%), Gaps = 41/239 (17%)
Query: 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDI--LIS 645
+D +E ++ I G +G V+ A+ R T + A LKK + +++ A R+I L
Sbjct: 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIA---LKKIRLEQEDEGVPSTAIREISLLKE 57
Query: 646 VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDED--VARVYIAEVVLALE 703
+++ +VR + LYLV EYL+ DL + + ++ + + Y+ +++ +
Sbjct: 58 MQHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116
Query: 704 YLHSLRVVHRDLKPDNLLIAHDGH-IKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEE 762
Y HS RV+HRDLKP NLLI + +KL DFGL++ I P + T
Sbjct: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI--------PVRTFT------- 161
Query: 763 PQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVGIPPF 820
H+ V T Y APEILLG+ H T D WSVG I E++ P F
Sbjct: 162 -------HE---------VVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLF 204
|
Length = 294 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 68/242 (28%), Positives = 111/242 (45%), Gaps = 45/242 (18%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDI-LISVR 647
DD E+I+ + RGA+G V + TG + A+K ++ + + +L + DI + SV
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRAT--VNSQEQKRLLMDLDISMRSVD 58
Query: 648 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL----GCLDEDVARVYIAEVVLALE 703
P+ V F+ + ++++ ME ++ L + + + ED+ +V ALE
Sbjct: 59 CPYTVTFYGALFREGDVWICMEVMDTS-LDKFYKKVYDKGLTIPEDILGKIAVSIVKALE 117
Query: 704 YLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEE 762
YLHS L V+HRD+KP N+LI +G +KL DFG+S D ++
Sbjct: 118 YLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISG----YLVDSVA-------------- 159
Query: 763 PQLTASEHQQERRKKRSAVGTPDYLAPEILLG----TGHGTTADWWSVGIILFELIVGIP 818
K G Y+APE + G+ +D WS+GI + EL G
Sbjct: 160 --------------KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRF 205
Query: 819 PF 820
P+
Sbjct: 206 PY 207
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 2e-18
Identities = 69/238 (28%), Positives = 111/238 (46%), Gaps = 46/238 (19%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVE----SILAERDILISV 646
F+ ++ + G + V+ + RTTG++ A+K I +A E + + E ++ +
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKE------IHLDAEEGTPSTAIREISLMKEL 55
Query: 647 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR---NLGCLDEDVARVYIAEVVLALE 703
++ +VR L LV EY++ DL + G LD + + + +++ +
Sbjct: 56 KHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIA 114
Query: 704 YLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEP 763
+ H RV+HRDLKP NLLI G +KL DFGL++ I P
Sbjct: 115 FCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGI---------------------P 153
Query: 764 QLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPF 820
T S + V T Y AP++LLG+ + T+ D WSVG I+ E+I G P F
Sbjct: 154 VNTFS----------NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLF 201
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 3e-18
Identities = 73/246 (29%), Positives = 115/246 (46%), Gaps = 50/246 (20%)
Query: 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVES--ILAERDI- 642
++D E + I G G+V+ + + TG + A+K +++ N E+ IL + D+
Sbjct: 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG----NKEENKRILMDLDVV 67
Query: 643 LISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLA 701
L S P++V+ + F ++++ ME L L LL+ + G + ED+ +V A
Sbjct: 68 LKSHDCPYIVKCYGYFITDSDVFICME-LMSTCLDKLLKRIQGPIPEDILGKMTVAIVKA 126
Query: 702 LEYL---HSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 758
L YL H V+HRD+KP N+L+ G++KL DFG+S L++S
Sbjct: 127 LHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGR-LVDS--------------- 168
Query: 759 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPE-ILLGTGHGT---TADWWSVGIILFELI 814
+ K RSA G Y+APE I + AD WS+GI L EL
Sbjct: 169 ---------------KAKTRSA-GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELA 212
Query: 815 VGIPPF 820
G P+
Sbjct: 213 TGQFPY 218
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 4e-18
Identities = 68/242 (28%), Positives = 109/242 (45%), Gaps = 54/242 (22%)
Query: 600 GAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFT 659
GA G V AK+ + G+ FA+KV+ M + + AE L++ FF
Sbjct: 43 GATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRA-QAEVCCLLNCD------FFSIVK 95
Query: 660 CRENLY--------------LVMEYLNGGDLYSLLRNLG----CLDEDVARVYIAEVVLA 701
C E+ LV++Y N GDL +++ E A + +V+LA
Sbjct: 96 CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLA 155
Query: 702 LEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDE 761
+ ++HS ++HRD+K N+L+ +G +KL DFG SK+ +DD+
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVG------------- 202
Query: 762 EPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFN 821
R+ GTP Y+APEI + AD +S+G++L+EL+ PF+
Sbjct: 203 ----------------RTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246
Query: 822 AE 823
E
Sbjct: 247 GE 248
|
Length = 496 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 4e-18
Identities = 71/242 (29%), Positives = 114/242 (47%), Gaps = 50/242 (20%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKK---ADMIRKNAVESILAERDILIS 645
D + +K + GA+G V A R TG AIK L + +++ K A E +L
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLKH 70
Query: 646 VRNPFVVRFFYSFTCRENL------YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVV 699
+++ V+ FT +L YLVM ++ G DL L+++ L ED + + +++
Sbjct: 71 MKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEK-LSEDRIQFLVYQML 128
Query: 700 LALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLG 759
L+Y+H+ ++HRDLKP NL + D +K+ DFGL++ + +++G V
Sbjct: 129 KGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR----QTDSEMTGYVV------- 177
Query: 760 DEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT-TADWWSVGIILFELIVGIP 818
T Y APE++L H T T D WSVG I+ E++ G P
Sbjct: 178 -----------------------TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKP 214
Query: 819 PF 820
F
Sbjct: 215 LF 216
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 5e-18
Identities = 65/245 (26%), Positives = 108/245 (44%), Gaps = 46/245 (18%)
Query: 594 IKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESI----LAERDILISVRNP 649
++ + G++ V+ R G L A+KV I E + + E +L +++
Sbjct: 10 LEKLGEGSYATVYKGISRINGQLVALKV------ISMKTEEGVPFTAIREASLLKGLKHA 63
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLR 709
+V +E L V EY++ ++++ G L R+++ +++ L Y+H
Sbjct: 64 NIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH 123
Query: 710 VVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASE 769
++HRDLKP NLLI++ G +KL DFGL++ I P T S
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLARAKSI---------------------PSQTYS- 161
Query: 770 HQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHPQVS 828
S V T Y P++LLG T + + D W G I E++ G P F P VS
Sbjct: 162 ---------SEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAF----PGVS 208
Query: 829 TLLRK 833
+ +
Sbjct: 209 DVFEQ 213
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 59/241 (24%), Positives = 99/241 (41%), Gaps = 48/241 (19%)
Query: 589 DDFEIIKPISRGAFGRVF--LAKKRTTGDLF---AIKVLKKADMIRKNAVESILAERDIL 643
+ +I+ + +G+FG V+ LAK G+ AIK + + +R+ L E ++
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI--EFLNEASVM 63
Query: 644 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYI-------- 695
VVR + + +VME + GDL S LR+ + +
Sbjct: 64 KEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRP-EAENNPGLGPPTLQKFI 122
Query: 696 ---AEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 752
AE+ + YL + + VHRDL N ++A D +K+ DFG+++ I TD
Sbjct: 123 QMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR--DIYETD------- 173
Query: 753 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFE 812
RK + ++APE L T +D WS G++L+E
Sbjct: 174 --------------------YYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWE 213
Query: 813 L 813
+
Sbjct: 214 M 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 6e-17
Identities = 69/248 (27%), Positives = 117/248 (47%), Gaps = 57/248 (22%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVES----ILAERDILI 644
+D + + I RGAFG V + +G + A+K IR E +L + D+++
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVK------RIRSTVDEKEQKRLLMDLDVVM 57
Query: 645 SVRN-PFVVRFFYSFTCRE-NLYLVMEYLNGG--DLYSLLRNL--GCLDEDV-ARVYIAE 697
+ P++V+F Y RE + ++ ME ++ Y + + + E++ ++ +A
Sbjct: 58 RSSDCPYIVKF-YGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVA- 115
Query: 698 VVLALEYL-HSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG-LINSTDDLSGPAVSGT 755
V AL YL L+++HRD+KP N+L+ +G+IKL DFG+S G L++S
Sbjct: 116 TVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGIS--GQLVDSI----------- 162
Query: 756 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL---GTGHGTTADWWSVGIILFE 812
K R A G Y+APE + G+ +D WS+GI L+E
Sbjct: 163 -------------------AKTRDA-GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYE 202
Query: 813 LIVGIPPF 820
+ G P+
Sbjct: 203 VATGKFPY 210
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 6e-17
Identities = 75/242 (30%), Positives = 111/242 (45%), Gaps = 47/242 (19%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFA----IKVLKKADMIRKNAVESILAERDILISV 646
+E + I GA+G+VF A+ G F ++V + + + + + R L +
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH-LETF 61
Query: 647 RNPFVVRFF----YSFTCREN-LYLVMEYLNGGDLYSLLRNL---GCLDEDVARVYIAEV 698
+P VVR F S T RE L LV E+++ DL + L + G E + + + ++
Sbjct: 62 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDM-MFQL 119
Query: 699 VLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 758
+ L++LHS RVVHRDLKP N+L+ G IKL DFGL+++ S L
Sbjct: 120 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI-------------YSFQMAL 166
Query: 759 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIP 818
S V T Y APE+LL + + T D WSVG I E+ P
Sbjct: 167 T-------------------SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 207
Query: 819 PF 820
F
Sbjct: 208 LF 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 9e-17
Identities = 65/240 (27%), Positives = 102/240 (42%), Gaps = 32/240 (13%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVES------------ILAERDILI 644
+ G +G+V A TG + AIK +K + I + + L E I+
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIE-ISNDVTKDRQLVGMCGIHFTTLRELKIMN 75
Query: 645 SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEY 704
+++ ++ + + + LVM+ + DL ++ L E + + +++ L
Sbjct: 76 EIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLNV 134
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
LH +HRDL P N+ I G K+ DFGL++ P S T
Sbjct: 135 LHKWYFMHRDLSPANIFINSKGICKIADFGLAR--------RYGYPPYSDT--------- 177
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAE 823
L+ E Q R + S V T Y APE+L+G + D WSVG I EL+ G P F E
Sbjct: 178 LSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237
|
Length = 335 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 9e-17
Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 36/226 (15%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFY 656
+ G + VF + + T +L A+K ++ + A + + E +L ++++ +V
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 657 SFTCRENLYLVMEYLNGGDLYSLLRNLGCL-DEDVARVYIAEVVLALEYLHSLRVVHRDL 715
L LV EYL+ DL L N G L ++++ +++ L Y H +++HRDL
Sbjct: 71 IIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDL 129
Query: 716 KPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERR 775
KP NLLI G +KL DFGL++ + P T S
Sbjct: 130 KPQNLLINEKGELKLADFGLARAKSV---------------------PTKTYS------- 161
Query: 776 KKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPF 820
+ V T Y P++LLG T + T D W VG IL+E+ G P F
Sbjct: 162 ---NEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-16
Identities = 58/174 (33%), Positives = 82/174 (47%), Gaps = 33/174 (18%)
Query: 651 VVRFFYSFTCRENLYLVMEYLNGGDL----YSLLRNLGCLDEDVARVYIAEVVLALEYLH 706
+V+ F F + L L+MEY +GGDL L+ E + ++VLAL+ +H
Sbjct: 127 IVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH 186
Query: 707 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLT 766
S +++HRDLK N+ + G IKL DFG SK +D +S S
Sbjct: 187 SRKMMHRDLKSANIFLMPTGIIKLGDFGFSK----QYSDSVSLDVAS------------- 229
Query: 767 ASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820
S GTP YLAPE+ + AD WS+G+IL+EL+ PF
Sbjct: 230 ------------SFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPF 271
|
Length = 478 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 47/153 (30%), Positives = 75/153 (49%), Gaps = 8/153 (5%)
Query: 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV 646
+ + ++ I +G FG V L R G A+K LK A ++ LAE ++ ++
Sbjct: 4 NSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKD----DSTAAQAFLAEASVMTTL 57
Query: 647 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEY 704
R+P +V+ LY+V EY+ G L LR+ G + + +V +EY
Sbjct: 58 RHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEY 117
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 737
L VHRDL N+L++ D K++DFGL+K
Sbjct: 118 LEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 1e-16
Identities = 58/225 (25%), Positives = 102/225 (45%), Gaps = 43/225 (19%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
+ +IK ++ G+ GRVF+A K D +K+ +K + L E +L +V +P
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPS 118
Query: 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSLL-RNLGCLDEDVARVYIAEVVLALEYLHSLR 709
V+R + +V+ + + DLY+ L + L D A + +++ L YLH+ R
Sbjct: 119 VIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR 177
Query: 710 VVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASE 769
++HRD+K +N+ I + + D G ++ + + L G A
Sbjct: 178 IIHRDVKTENIFINDVDQVCIGDLGAAQFP-VVAPAFL-GLA------------------ 217
Query: 770 HQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI 814
GT + APE+L + + AD WS GI+LFE++
Sbjct: 218 ------------GTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 64/245 (26%), Positives = 108/245 (44%), Gaps = 52/245 (21%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKR---TTGD--LFAIKVLKKADMIRKNAVESILAERDIL 643
D + + + GAFG+VFL + D L A+K LK + +A + E ++L
Sbjct: 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLK--ETASNDARKDFEREAELL 62
Query: 644 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN-------LGCLDEDVAR---- 692
+ ++ +V+F+ T + +V EY+ GDL LR+ L D +
Sbjct: 63 TNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLS 122
Query: 693 --VYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 749
+ IA ++ + YL S VHRDL N L+ +D +K+ DFG+S+ + +TD
Sbjct: 123 QLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRD--VYTTDYYR- 179
Query: 750 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTP-DYLAPEILLGTGHGTTADWWSVGI 808
V G T+L P ++ PE ++ T +D WS G+
Sbjct: 180 --VGGHTML-------------------------PIRWMPPESIMYRKFTTESDVWSFGV 212
Query: 809 ILFEL 813
+L+E+
Sbjct: 213 VLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 4e-16
Identities = 69/230 (30%), Positives = 107/230 (46%), Gaps = 44/230 (19%)
Query: 594 IKPISRGAFGRVFLAK----KRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
I+ + +G FG V L + + TG++ A+K L+ + + E +IL S+++
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQHD 65
Query: 650 FVVRFFYSFTC----RENLYLVMEYLNGGDLYSLL-RNLGCLDEDVARVYIAEVVLALEY 704
+V+ Y C R NL LVMEYL G L L ++ LD +Y +++ +EY
Sbjct: 66 NIVK--YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEY 123
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
L S R VHRDL N+L+ + +K+ DFGL+KV PQ
Sbjct: 124 LGSKRYVHRDLATRNILVESENRVKIGDFGLTKV-----------------------LPQ 160
Query: 765 LTASEHQQERRKKRSAVGTPDY-LAPEILLGTGHGTTADWWSVGIILFEL 813
+E K R +P + APE L + +D WS G++L+EL
Sbjct: 161 ------DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 7e-16
Identities = 63/247 (25%), Positives = 109/247 (44%), Gaps = 49/247 (19%)
Query: 594 IKPISRGAFGRVFLAKKRTTGDLFAIK------------VLKKADMIRKNAVESILAERD 641
++P+ G+ G VF A A+K L++ +IR+ ++I+ +
Sbjct: 10 LRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYE 69
Query: 642 ILIS--VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVV 699
+L V ++Y+V EY+ DL ++L G L E+ AR+++ +++
Sbjct: 70 VLGPSGSDLTEDVGSLTEL---NSVYIVQEYMET-DLANVL-EQGPLSEEHARLFMYQLL 124
Query: 700 LALEYLHSLRVVHRDLKPDNLLI-AHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 758
L+Y+HS V+HRDLKP N+ I D +K+ DFGL+++
Sbjct: 125 RGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARI-------------------- 164
Query: 759 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIVGI 817
+P + + E + T Y +P +LL + T A D W+ G I E++ G
Sbjct: 165 --VDPHYSHKGYLSE------GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
Query: 818 PPFNAEH 824
P F H
Sbjct: 217 PLFAGAH 223
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 1e-15
Identities = 30/46 (65%), Positives = 36/46 (78%)
Query: 781 VGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826
+GTPDYLAPE+LLG HG DWW++G+ LFE + GIPPFN E PQ
Sbjct: 541 LGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQ 586
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-15
Identities = 64/226 (28%), Positives = 104/226 (46%), Gaps = 36/226 (15%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFY 656
+ G + V+ + + T +L A+K ++ + A + + E +L +++ +V
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEH--EEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 657 SFTCRENLYLVMEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDL 715
++L LV EYL+ DL L + G ++ ++++ +++ L Y H +V+HRDL
Sbjct: 72 IIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDL 130
Query: 716 KPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERR 775
KP NLLI G +KL DFGL++ I P T S
Sbjct: 131 KPQNLLINERGELKLADFGLARAKSI---------------------PTKTYS------- 162
Query: 776 KKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPF 820
+ V T Y P+ILLG T + T D W VG I +E+ G P F
Sbjct: 163 ---NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 72/237 (30%), Positives = 108/237 (45%), Gaps = 52/237 (21%)
Query: 597 ISRGAFGRVFLAK-----KRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFV 651
+ GAFG+VFLA+ L A+K LK+A ++A + E ++L +++ +
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHI 69
Query: 652 VRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG----CLD--EDVA--------RVYIA- 696
VRF+ T L +V EY+ GDL LR+ G L EDVA + IA
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 697 EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 756
++ + YL SL VHRDL N L+ +K+ DFG+S+ I STD V G T
Sbjct: 130 QIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRD--IYSTDYYR---VGGRT 184
Query: 757 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 813
+L ++ PE +L T +D WS G++L+E+
Sbjct: 185 MLPIR------------------------WMPPESILYRKFTTESDIWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 65/235 (27%), Positives = 99/235 (42%), Gaps = 51/235 (21%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFY 656
I G+FG V+ A T ++ A+K + + + I+ E L +++P + +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 657 SFTCRENLYLVMEYLNGG--DLYSLLRNLGCLDEDVARVYIAEV----VLALEYLHSLRV 710
+ +LVMEY G DL + + + + V IA + + L YLHS +
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLLEVHK------KPLQEVEIAAITHGALQGLAYLHSHNM 142
Query: 711 VHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEH 770
+HRD+K N+L+ G +KL DFG + S PA
Sbjct: 143 IHRDIKAGNILLTEPGQVKLADFGSASK---------SSPA------------------- 174
Query: 771 QQERRKKRSAVGTPDYLAPEILLGTGHGT---TADWWSVGIILFELIVGIPP-FN 821
S VGTP ++APE++L G D WS+GI EL PP FN
Sbjct: 175 -------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 222
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 60/223 (26%), Positives = 97/223 (43%), Gaps = 44/223 (19%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFY 656
I RG FG VF + R A+K + + + + L E IL +P +VR
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCR--ETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 657 SFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVV-------LALEYLHSLR 709
T ++ +Y+VME + GGD + LR G R+ + E++ +EYL S
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEG------PRLKVKELIQMVENAAAGMEYLESKH 114
Query: 710 VVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASE 769
+HRDL N L+ +K++DFG+S+ +EE + AS
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMSR----------------------EEEDGVYAST 152
Query: 770 HQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFE 812
++ + + APE L + + +D WS GI+L+E
Sbjct: 153 GGMKQIPVK-------WTAPEALNYGRYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 64/235 (27%), Positives = 98/235 (41%), Gaps = 39/235 (16%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
F ++ I G+FG V+ A+ T ++ AIK + + + I+ E L +++P
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRV 710
+ + + +LVMEY G L + L E + L YLHS +
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 146
Query: 711 VHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEH 770
+HRD+K N+L+ G +KL DFG + ++ PA
Sbjct: 147 IHRDIKAGNILLTEPGQVKLADFG---------SASIASPA------------------- 178
Query: 771 QQERRKKRSAVGTPDYLAPEILLGTGHGT---TADWWSVGIILFELIVGIPP-FN 821
S VGTP ++APE++L G D WS+GI EL PP FN
Sbjct: 179 -------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 226
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 55/227 (24%), Positives = 99/227 (43%), Gaps = 37/227 (16%)
Query: 594 IKPISRGAFGRVFLAK----KRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
IK + G FG+V L + TG+ A+K L + E +IL ++ +
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNH--SGEEQHRSDFEREIEILRTLDHE 66
Query: 650 FVVRFFYSFT--CRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARVYIAEVVLALEYLH 706
+V++ +L L+MEYL G L L+ + ++ ++ +++ ++YL
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG 126
Query: 707 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLT 766
S R +HRDL N+L+ + +K++DFGL+KV D
Sbjct: 127 SQRYIHRDLAARNILVESEDLVKISDFGLAKVL---PEDK-------------------- 163
Query: 767 ASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 813
++ + S + + APE L + + +D WS G+ L+EL
Sbjct: 164 --DYYYVKEPGESPI---FWYAPECLRTSKFSSASDVWSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 4e-15
Identities = 64/242 (26%), Positives = 115/242 (47%), Gaps = 38/242 (15%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR--- 647
++II+ I +G G V+LA A LKK IR++ E+ L ++ L +
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVA---LKK---IREDLSENPLLKKRFLREAKIAA 57
Query: 648 ---NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL---GCLDEDVA---------R 692
+P +V + + + +Y M Y+ G L SLL+++ L +++A
Sbjct: 58 DLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLS 117
Query: 693 VYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 752
++ ++ +EY+HS V+HRDLKPDN+L+ G + + D+G + ++
Sbjct: 118 IFH-KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI--FKKLEEE------ 168
Query: 753 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFE 812
L D + + VGTPDY+APE LLG + D +++G+IL++
Sbjct: 169 ----DLLDIDVDERNICY-SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQ 223
Query: 813 LI 814
++
Sbjct: 224 ML 225
|
Length = 932 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 5e-15
Identities = 68/237 (28%), Positives = 111/237 (46%), Gaps = 48/237 (20%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ ++ + P+ GA+G V A TG A+K L + +A + E +L +++
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTYRELRLLKHMKH 75
Query: 649 PFVVRFFYSFTCRENL------YLVMEYLNGGDLYSLLRNLGC--LDEDVARVYIAEVVL 700
V+ FT +L YLV +L G DL ++++ C L +D + I +++
Sbjct: 76 ENVIGLLDVFTPARSLEEFNDVYLVT-HLMGADLNNIVK---CQKLTDDHVQFLIYQILR 131
Query: 701 ALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGD 760
L+Y+HS ++HRDLKP NL + D +K+ DFGL++ ++ D+++G
Sbjct: 132 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTG----------- 176
Query: 761 EEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVG 816
V T Y APEI+L H T D WSVG I+ EL+ G
Sbjct: 177 -------------------YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 6e-15
Identities = 79/272 (29%), Positives = 125/272 (45%), Gaps = 63/272 (23%)
Query: 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIK-VLKKADMIRKNAVESILAERDI 642
+R+ +++ I G+FG V+ A T + AIK VL+ D KN R++
Sbjct: 61 NRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQ--DPQYKN--------REL 110
Query: 643 LI-----SVRNPFVVRFFYSFTCREN-----LYLVMEYLNGG-----DLYSLLRNLGCLD 687
LI + F+ ++Y+ ++N L +VME++ Y+ RN L
Sbjct: 111 LIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYA--RNNHALP 168
Query: 688 EDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGH-IKLTDFGLSKVGLINSTDD 746
+ ++Y ++ AL Y+HS + HRDLKP NLLI + H +KL DFG
Sbjct: 169 LFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG------------ 216
Query: 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWS 805
S LL + + S + + Y APE++LG T + T D WS
Sbjct: 217 ------SAKNLLAGQ--------------RSVSYICSRFYRAPELMLGATNYTTHIDLWS 256
Query: 806 VGIILFELIVGIPPFNAEHPQVSTLLRKCQLL 837
+G I+ E+I+G P F+ + V L+R Q+L
Sbjct: 257 LGCIIAEMILGYPIFSGQ-SSVDQLVRIIQVL 287
|
Length = 440 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 8e-15
Identities = 63/235 (26%), Positives = 97/235 (41%), Gaps = 39/235 (16%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
F ++ I G+FG V+ A+ ++ AIK + + + I+ E L +R+P
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRV 710
+++ + +LVMEY G L + L E + L YLHS +
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136
Query: 711 VHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEH 770
+HRD+K N+L++ G +KL DFG + + PA
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASI---------MAPA------------------- 168
Query: 771 QQERRKKRSAVGTPDYLAPEILLGTGHGT---TADWWSVGIILFELIVGIPP-FN 821
VGTP ++APE++L G D WS+GI EL PP FN
Sbjct: 169 -------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 9e-15
Identities = 62/229 (27%), Positives = 105/229 (45%), Gaps = 36/229 (15%)
Query: 594 IKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVR 653
++ + G + VF + + T +L A+K ++ + A + + E +L +++ +V
Sbjct: 11 LEKLGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKDLKHANIVT 68
Query: 654 FFYSFTCRENLYLVMEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVH 712
++L LV EYL+ DL + + G + ++++ +++ L Y H +V+H
Sbjct: 69 LHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLH 127
Query: 713 RDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQ 772
RDLKP NLLI G +KL DFGL++ + P T S
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSV---------------------PTKTYS---- 162
Query: 773 ERRKKRSAVGTPDYLAPEILLGTG-HGTTADWWSVGIILFELIVGIPPF 820
+ V T Y P++LLG+ + T D W VG I FE+ G P F
Sbjct: 163 ------NEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 1e-14
Identities = 67/237 (28%), Positives = 105/237 (44%), Gaps = 58/237 (24%)
Query: 594 IKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERD--ILISVRNPFV 651
+KPI GA G V A TG AIK L + +N + A R+ ++ V + +
Sbjct: 21 LKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRP---FQNVTHAKRAYRELVLMKLVNHKNI 77
Query: 652 VRFFYSFTCRENL------YLVMEYLNGGDLYSLLRNLGC------LDEDVARVYIAEVV 699
+ FT +++L YLVME ++ NL C LD + + +++
Sbjct: 78 IGLLNVFTPQKSLEEFQDVYLVMELMDA--------NL-CQVIQMDLDHERMSYLLYQML 128
Query: 700 LALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLG 759
+++LHS ++HRDLKP N+++ D +K+ DFGL++ T + P V
Sbjct: 129 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVV------ 179
Query: 760 DEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVG 816
T Y APE++LG G+ D WSVG I+ E+I G
Sbjct: 180 -----------------------TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 58/228 (25%), Positives = 105/228 (46%), Gaps = 42/228 (18%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
D +K + G FG V K R D+ AIK++K+ M +E E +++ + +
Sbjct: 5 DLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIE----EAKVMMKLSHE 59
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIA-EVVLALEYLHSL 708
+V+ + T + +Y+V EY++ G L + LR G + + + +V + YL S
Sbjct: 60 KLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK 119
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTAS 768
+ +HRDL N L+ G +K++DFGLS+ +L DE
Sbjct: 120 QFIHRDLAARNCLVDDQGCVKVSDFGLSRY------------------VLDDE------- 154
Query: 769 EHQQERRKKRSAVGTP---DYLAPEILLGTGHGTTADWWSVGIILFEL 813
S+VG+ + PE+LL + + +D W+ G++++E+
Sbjct: 155 --------YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 2e-14
Identities = 64/233 (27%), Positives = 109/233 (46%), Gaps = 51/233 (21%)
Query: 594 IKPISRGAFGRVFLAKKRTTGDLFAIKVLKK---ADMIRKNAVESILAERDILISVRNPF 650
+K + GA+G V A + TG+ AIK L + +++ K A + +L +++
Sbjct: 20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELT----LLKHMQHEN 75
Query: 651 VVRFFYSFTCR------ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEY 704
V+ FT ++ YLVM Y+ DL ++ + L ED + + +++ L+Y
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHP--LSEDKVQYLVYQMLCGLKY 132
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
+HS ++HRDLKP NL + D +K+ DFGL++ ++ +++G V
Sbjct: 133 IHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR----HADAEMTGYVV------------ 176
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT-TADWWSVGIILFELIVG 816
T Y APE++L H T D WSVG I+ E++ G
Sbjct: 177 ------------------TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTG 211
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 58/219 (26%), Positives = 96/219 (43%), Gaps = 44/219 (20%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFY 656
I G FG V + TG A+K +K D+ ++ L E ++ + + +VR
Sbjct: 14 IGEGEFGAVL--QGEYTGQKVAVKNIK-CDV----TAQAFLEETAVMTKLHHKNLVRLL- 65
Query: 657 SFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARV--YIAEVVLALEYLHSLRVVHRD 714
LY+VME ++ G+L + LR G V ++ + +V +EYL S ++VHRD
Sbjct: 66 GVILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRD 125
Query: 715 LKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQER 774
L N+L++ DG K++DFGL++V G + L
Sbjct: 126 LAARNILVSEDGVAKVSDFGLARV----------GSMGVDNSKL---------------- 159
Query: 775 RKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 813
+ APE L + +D WS G++L+E+
Sbjct: 160 --------PVKWTAPEALKHKKFSSKSDVWSYGVLLWEV 190
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 45/163 (27%), Positives = 82/163 (50%), Gaps = 22/163 (13%)
Query: 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDIL 643
R S+ ++ + + G FG V++ T + A+K LK M + E+ L E I+
Sbjct: 4 PRESL---KLERKLGAGQFGEVWMGTWNGTTKV-AVKTLKPGTM----SPEAFLQEAQIM 55
Query: 644 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN-------LGCLDEDVARVYIA 696
+R+ +V+ + + E +Y+V EY++ G L L++ L L D+A A
Sbjct: 56 KKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQL-VDMA----A 110
Query: 697 EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHI-KLTDFGLSKV 738
++ + YL S +HRDL N+L+ + + K+ DFGL+++
Sbjct: 111 QIAEGMAYLESRNYIHRDLAARNILVG-ENLVCKIADFGLARL 152
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 62/236 (26%), Positives = 110/236 (46%), Gaps = 43/236 (18%)
Query: 579 IHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILA 638
I PS + +K + G FG V L K R D+ AIK++++ M + +E
Sbjct: 1 IDPS-------ELTFLKELGSGQFGVVHLGKWRGKIDV-AIKMIREGAMSEDDFIE---- 48
Query: 639 ERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARVYIAE 697
E +++ + +P +V+ + T + +++V EY+ G L + LR G L + ++
Sbjct: 49 EAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSD 108
Query: 698 VVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 757
V A+EYL S +HRDL N L+ D +K++DFGL++ L DD
Sbjct: 109 VCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVL----DD----------- 153
Query: 758 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 813
Q T+S+ + K + PE+ + + +D WS G++++E+
Sbjct: 154 ------QYTSSQGTKFPVK---------WAPPEVFDYSRFSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 3e-14
Identities = 62/239 (25%), Positives = 108/239 (45%), Gaps = 46/239 (19%)
Query: 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILI- 644
T + ++ +KPI GA G V A G A+K L + +N + A R++++
Sbjct: 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP---FQNQTHAKRAYRELVLL 74
Query: 645 -SVRNPFVVRFFYSFTCR------ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAE 697
V + ++ FT + +++YLVME ++ + L D + + +
Sbjct: 75 KCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMEL---DHERMSYLLYQ 131
Query: 698 VVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 757
++ +++LHS ++HRDLKP N+++ D +K+ DFGL++ T+ + P V
Sbjct: 132 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---CTNFMMTPYVV---- 184
Query: 758 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVG 816
T Y APE++LG G+ D WSVG I+ EL+ G
Sbjct: 185 -------------------------TRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 65/231 (28%), Positives = 102/231 (44%), Gaps = 46/231 (19%)
Query: 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV 646
++ + ++++ I +G FG V L R G+ A+K +K ++ LAE ++ +
Sbjct: 4 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKN-----DATAQAFLAEASVMTQL 56
Query: 647 RNPFVVRFFYSFTCREN--LYLVMEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLAL 702
R+ +V+ E LY+V EY+ G L LR+ G L D + +V A+
Sbjct: 57 RHSNLVQLL-GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 115
Query: 703 EYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEE 762
EYL + VHRDL N+L++ D K++DFGL+K +ST D V T
Sbjct: 116 EYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKE--ASSTQDTGKLPVKWT------- 166
Query: 763 PQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 813
APE L T +D WS GI+L+E+
Sbjct: 167 -------------------------APEALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 3e-14
Identities = 65/266 (24%), Positives = 111/266 (41%), Gaps = 73/266 (27%)
Query: 595 KPISRGAFGRV-----FLAKKRTTGDLFAIKVLKKADMIRKNAVE--SILAERDILISVR 647
K + G FG+V F K R A+K+LK+ ++ E +L+E ++L V
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN----ASSSELRDLLSEFNLLKQVN 61
Query: 648 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR----------------NLGCLDEDVA 691
+P V++ + + + L L++EY G L S LR N LD
Sbjct: 62 HPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDE 121
Query: 692 RVYIAEVVLA--------LEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743
R +++ ++YL +++VHRDL N+L+A +K++DFGLS+
Sbjct: 122 RALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSR------ 175
Query: 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTP-DYLAPEILLGTGHGTTAD 802
++++ KRS P ++A E L + T +D
Sbjct: 176 ------------------------DVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSD 211
Query: 803 WWSVGIILFELIV-------GIPPFN 821
WS G++L+E++ GI P
Sbjct: 212 VWSFGVLLWEIVTLGGNPYPGIAPER 237
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 4e-14
Identities = 70/243 (28%), Positives = 113/243 (46%), Gaps = 49/243 (20%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKK-----ADMIRKNAVESILAERDILIS 645
++I + I +G++G V A TG+ AIK + +D R IL E +L
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATR------ILREIKLLRL 55
Query: 646 VRNPFVV---RFFYSFTCRE--NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVL 700
+R+P +V + RE ++Y+V E L DL+ +++ L + + ++ +++
Sbjct: 56 LRHPDIVEIKHIMLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTPEHHQFFLYQLLR 114
Query: 701 ALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGD 760
AL+Y+H+ V HRDLKP N+L D +K+ DFGL++V + + A+ T
Sbjct: 115 ALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND-----TPTAIFWT----- 164
Query: 761 EEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHG--TTA-DWWSVGIILFELIVGI 817
V T Y APE L G+ T A D WS+G I E++ G
Sbjct: 165 ------------------DYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
Query: 818 PPF 820
P F
Sbjct: 206 PLF 208
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 6e-14
Identities = 63/235 (26%), Positives = 109/235 (46%), Gaps = 43/235 (18%)
Query: 594 IKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAV--ESILAERDILISVRNPFV 651
+K + G FG V L K R IKV KA I + A+ E + E +++ + +P +
Sbjct: 9 MKELGSGQFGVVHLGKWRAQ-----IKVAIKA--INEGAMSEEDFIEEAKVMMKLSHPKL 61
Query: 652 VRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARVYIAEVVLALEYLHSLRV 710
V+ + T ++ LY+V E++ G L + LR G L +D+ +V +EYL
Sbjct: 62 VQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSF 121
Query: 711 VHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEH 770
+HRDL N L++ G +K++DFG+++ L DD + T+S
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVL----DD-----------------EYTSS-- 158
Query: 771 QQERRKKRSAVGTP-DYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAE 823
S P + PE+ + + + +D WS G++++E+ G PF +
Sbjct: 159 --------SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 7e-14
Identities = 62/239 (25%), Positives = 112/239 (46%), Gaps = 46/239 (19%)
Query: 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILI- 644
T + ++ +KPI GA G V A AIK L + +N + A R++++
Sbjct: 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP---FQNQTHAKRAYRELVLM 77
Query: 645 -SVRNPFVVRFFYSFTCR------ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAE 697
V + ++ FT + +++Y+VME ++ +L +++ LD + + +
Sbjct: 78 KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQME--LDHERMSYLLYQ 134
Query: 698 VVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 757
++ +++LHS ++HRDLKP N+++ D +K+ DFGL++ +GT+
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--------------TAGTSF 180
Query: 758 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVG 816
+ V T Y APE++LG G+ D WSVG I+ E+I G
Sbjct: 181 MMTPY------------------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 7e-14
Identities = 75/250 (30%), Positives = 115/250 (46%), Gaps = 48/250 (19%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIK---VLKKADMIRKNAV-ESILAERDILISV 646
+E + I GA+G V+ A+ +G A+K V D + + V E L +R L +
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKR--LEAF 59
Query: 647 RNPFVVRFF----YSFTCRE-NLYLVMEYLNGGDLYSLLRNLGC--LDEDVARVYIAEVV 699
+P +VR S T RE + LV E+++ DL + L + L + + + + +
Sbjct: 60 DHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFL 118
Query: 700 LALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLG 759
L++LH+ +VHRDLKP+N+L+ G +KL DFGL++ I S P V TL
Sbjct: 119 RGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLAR---IYSCQMALTPVV--VTLW- 172
Query: 760 DEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPP 819
Y APE+LL + + T D WSVG I E+ P
Sbjct: 173 --------------------------YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPL 206
Query: 820 F--NAEHPQV 827
F N+E Q+
Sbjct: 207 FCGNSEADQL 216
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 9e-14
Identities = 39/146 (26%), Positives = 62/146 (42%), Gaps = 6/146 (4%)
Query: 595 KPISRGAFGRVFLAKKRTTGDL---FAIKVLKKADMIRKNAVESILAERDILISVRNPFV 651
K + G FG V A+K LK+ + + L E ++ + +P +
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHI--AAGKKEFLREASVMAQLDHPCI 58
Query: 652 VRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVV 711
VR E L LVME G L L+ + + +V + + YL S V
Sbjct: 59 VRLI-GVCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV 117
Query: 712 HRDLKPDNLLIAHDGHIKLTDFGLSK 737
HRDL N+L+ + K++DFG+S+
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSR 143
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 58/201 (28%), Positives = 90/201 (44%), Gaps = 42/201 (20%)
Query: 618 AIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR-ENLYLVMEYLNGGDL 676
AIKVLK + K+ + ++ E +I+ + NP++VR C E L LVME +GG L
Sbjct: 26 AIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIG--VCEAEALMLVMEMASGGPL 81
Query: 677 YSLLRNLGCLDEDVARVYIAE----VVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTD 732
L +++ + E V + ++YL VHRDL N+L+ + + K++D
Sbjct: 82 NKFL---SGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISD 138
Query: 733 FGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTP-DYLAPEI 791
FGLSK LG ++ A RSA P + APE
Sbjct: 139 FGLSKA-------------------LGADDSYYKA----------RSAGKWPLKWYAPEC 169
Query: 792 LLGTGHGTTADWWSVGIILFE 812
+ + +D WS GI ++E
Sbjct: 170 INFRKFSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 61/235 (25%), Positives = 99/235 (42%), Gaps = 51/235 (21%)
Query: 594 IKPISRGAFGRVFLAK----KRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
I+ + G FG+V L + TG+ A+K LK N + + E +IL ++ +
Sbjct: 9 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHE 66
Query: 650 FVVRFFYSFTCREN----LYLVMEYLNGGDLYSLL-RNLGCLDEDVARVYIAEVVLALEY 704
+V+ Y C E+ + L+ME+L G L L RN ++ Y ++ ++Y
Sbjct: 67 NIVK--YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDY 124
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV-----GLINSTDDLSGPAVSGTTLLG 759
L S + VHRDL N+L+ + +K+ DFGL+K DDL P
Sbjct: 125 LGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVF------- 177
Query: 760 DEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI 814
+ APE L+ + +D WS G+ L+EL+
Sbjct: 178 --------------------------WYAPECLIQSKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-13
Identities = 62/237 (26%), Positives = 111/237 (46%), Gaps = 46/237 (19%)
Query: 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILI- 644
T + ++ +KPI GA G V A AIK L + +N + A R++++
Sbjct: 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP---FQNQTHAKRAYRELVLM 70
Query: 645 -SVRNPFVVRFFYSFTCRENL------YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAE 697
V + ++ FT +++L YLVME ++ +L +++ LD + + +
Sbjct: 71 KCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQME--LDHERMSYLLYQ 127
Query: 698 VVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 757
++ +++LHS ++HRDLKP N+++ D +K+ DFGL++ +GT+
Sbjct: 128 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--------------TAGTSF 173
Query: 758 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI 814
+ V T Y APE++LG G+ D WSVG I+ E++
Sbjct: 174 M------------------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 54/233 (23%), Positives = 100/233 (42%), Gaps = 39/233 (16%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
+F + + + G FG V+ + + AIK+LK D++++ + E L +R+
Sbjct: 7 EFTLERKLGSGYFGEVWEGLWKNRVRV-AIKILKSDDLLKQQDFQK---EVQALKRLRHK 62
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVAR-VYIA-EVVLALEYLHS 707
++ F + E +Y++ E + G L + LR+ VA + +A +V + YL
Sbjct: 63 HLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE 122
Query: 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTA 767
+HRDL N+L+ D K+ DFGL+++ +E +
Sbjct: 123 QNSIHRDLAARNILVGEDLVCKVADFGLARL---------------------IKEDVYLS 161
Query: 768 SEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV--GIP 818
S+ + + + APE T +D WS GI+L+E+ +P
Sbjct: 162 SDKKIPYK----------WTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVP 204
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 58/221 (26%), Positives = 94/221 (42%), Gaps = 41/221 (18%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKK---ADMIRKNAVESILAERDILISVRNPFVVR 653
I +G FG V+ + ++ A+K + D+ RK L E +IL +P +V+
Sbjct: 3 IGKGNFGDVYKGVLKGNTEV-AVKTCRSTLPPDLKRK-----FLQEAEILKQYDHPNIVK 56
Query: 654 FFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARVYIAEVVLALEYLHSLRVVH 712
++ +Y+VME + GG L + LR L + +EYL S +H
Sbjct: 57 LIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIH 116
Query: 713 RDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQ 772
RDL N L+ + +K++DFG+S+ +E T S+ +
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR---------------------EEEGGIYTVSDGLK 155
Query: 773 ERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFE 812
+ K + APE L G T+ D WS GI+L+E
Sbjct: 156 QIPIK--------WTAPEA-LNYGRYTSESDVWSYGILLWE 187
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 4e-13
Identities = 62/244 (25%), Positives = 114/244 (46%), Gaps = 42/244 (17%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ +++K + G FG V++ + AIK LK+ M + E+ LAE +++ +++
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKV-AIKSLKQGSM----SPEAFLAEANLMKQLQH 60
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARV--YIAEVVLALEYLH 706
P +VR Y+ +E +Y++ EY+ G L L+ + + ++ A++ + ++
Sbjct: 61 PRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE 119
Query: 707 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLT 766
+HRDL+ N+L++ K+ DFGL++ LI E+ + T
Sbjct: 120 RKNYIHRDLRAANILVSETLCCKIADFGLAR--LI-------------------EDNEYT 158
Query: 767 ASEHQQERRKKRSAVGTPDYLAPE-ILLGTGHGTTADWWSVGIILFELIV--GIPPFNAE 823
A E + K + APE I GT +D WS GI+L E++ IP
Sbjct: 159 AREGAKFPIK---------WTAPEAINYGT-FTIKSDVWSFGILLTEIVTYGRIPYPGMT 208
Query: 824 HPQV 827
+P+V
Sbjct: 209 NPEV 212
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 5e-13
Identities = 62/249 (24%), Positives = 106/249 (42%), Gaps = 44/249 (17%)
Query: 597 ISRGAFGR--VFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILIS--VRNPFVV 652
I + V LAK + T L A+K K ++ + + L +++I+ S +++P ++
Sbjct: 6 IGKCFEDLMIVHLAKHKPTNTLVAVK---KINLDSCSKEDLKLLQQEIITSRQLQHPNIL 62
Query: 653 RFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC--LDEDVARVYIAEVVLALEYLHSLRV 710
+ SF LY+V + G LL+ L E + +V+ AL+Y+HS
Sbjct: 63 PYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGF 122
Query: 711 VHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEH 770
+HR +K ++L++ DG + L+ V +I +H
Sbjct: 123 IHRSVKASHILLSGDGKVVLSGLR-YSVSMI---------------------------KH 154
Query: 771 QQERRK----KRSAVGTPDYLAPEILLGTGHGTTA--DWWSVGIILFELIVGIPPFNAEH 824
+ +R +S+V +L+PE+L G D +SVGI EL G PF +
Sbjct: 155 GKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPF-KDM 213
Query: 825 PQVSTLLRK 833
P LL K
Sbjct: 214 PATQMLLEK 222
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 5e-13
Identities = 71/257 (27%), Positives = 111/257 (43%), Gaps = 45/257 (17%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDL----FAIKVLKKADMIRKNAVESILAERDILISV 646
E IK + GAFG V+ G+ AIKVL++ + K E IL E ++ SV
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLRE-ETSPKANKE-ILDEAYVMASV 66
Query: 647 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN----LGCLDEDVARVYIAEVVLAL 702
+P VVR + L+ + + G L +RN +G V IA+ +
Sbjct: 67 DHPHVVRL-LGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAK---GM 122
Query: 703 EYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEE 762
YL R+VHRDL N+L+ H+K+TDFGL+K LL +E
Sbjct: 123 SYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAK-------------------LLDVDE 163
Query: 763 PQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPF- 820
+ A + + ++A E +L + +D WS G+ ++EL+ G P+
Sbjct: 164 KEYHAEGGKVPIK----------WMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
Query: 821 NAEHPQVSTLLRKCQLL 837
++ LL K + L
Sbjct: 214 GIPAVEIPDLLEKGERL 230
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 7e-13
Identities = 62/236 (26%), Positives = 100/236 (42%), Gaps = 50/236 (21%)
Query: 594 IKPISRGAFGRVFLAKKRTTGD-----LFAIKVLKKADMIRKNAVESILAERDILISVRN 648
I + RG FG VFLAK + + L +K L+K +N E D+ + +
Sbjct: 10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSH 67
Query: 649 PFVVRFFYSFTCREN--LYLVMEYLNGGDLYSLLRNLGCLDEDV--------ARVYIA-E 697
VVR CRE Y+++EY + GDL LR DE + +V + +
Sbjct: 68 KNVVRLLG--LCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 698 VVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 757
+ L +++L + R VHRDL N L++ +K++ LSK
Sbjct: 126 IALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSK-------------------- 165
Query: 758 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 813
+ E K R+A+ +LAPE + T +D WS G++++E+
Sbjct: 166 ----------DVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 60/238 (25%), Positives = 104/238 (43%), Gaps = 38/238 (15%)
Query: 600 GAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFT 659
G +G V+ + A+K LK+ M VE L E ++ +++P +V+ T
Sbjct: 17 GQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 660 CRENLYLVMEYLNGGDLYSLLRNLGCLDED-VARVYIA-EVVLALEYLHSLRVVHRDLKP 717
Y++ E++ G+L LR + + V +Y+A ++ A+EYL +HRDL
Sbjct: 73 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAA 132
Query: 718 DNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKK 777
N L+ + +K+ DFGLS+ + + D + A G + P
Sbjct: 133 RNCLVGENHLVKVADFGLSR---LMTGDTYTAHA-------GAKFP-------------- 168
Query: 778 RSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNA-EHPQVSTLLRK 833
+ APE L +D W+ G++L+E+ G+ P+ + QV LL K
Sbjct: 169 ------IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 220
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 62/237 (26%), Positives = 103/237 (43%), Gaps = 48/237 (20%)
Query: 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDIL 643
DRTSI ++++ + G FG V+ T + A+K LK M + LAE I+
Sbjct: 4 DRTSI---QLLRKLGAGQFGEVWEGLWNNTTPV-AVKTLKPGTM----DPKDFLAEAQIM 55
Query: 644 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC----LDE--DVARVYIAE 697
+R+P +++ + T E +Y+V E + G L L+ L + D+A A+
Sbjct: 56 KKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMA----AQ 111
Query: 698 VVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 757
V + YL + +HRDL N+L+ + K+ DFGL++V
Sbjct: 112 VASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARV------------------- 152
Query: 758 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI 814
+ ++ A E + K + APE L +D WS GI+L E++
Sbjct: 153 IKEDI--YEAREGAKFPIK---------WTAPEAALYNRFSIKSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 53/233 (22%), Positives = 107/233 (45%), Gaps = 47/233 (20%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ +++K + G FG V++ + + A+K LK M +V++ L E +++ ++++
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKV-AVKTLKPGTM----SVQAFLEEANLMKTLQH 60
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARV-------YIAEVVLA 701
+VR + T E +Y++ EY+ G L L++ ++ +V + A++
Sbjct: 61 DKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKS-----DEGGKVLLPKLIDFSAQIAEG 115
Query: 702 LEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDE 761
+ Y+ +HRDL+ N+L++ K+ DFGL++V E
Sbjct: 116 MAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARV---------------------IE 154
Query: 762 EPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI 814
+ + TA E + K + APE + +D WS GI+L+E++
Sbjct: 155 DNEYTAREGAKFPIK---------WTAPEAINFGSFTIKSDVWSFGILLYEIV 198
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 2e-12
Identities = 65/237 (27%), Positives = 107/237 (45%), Gaps = 50/237 (21%)
Query: 595 KPISRGAFGRVFLAK-----KRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
+ + GAFG+VFLA+ L A+K LK A NA + E ++L ++++
Sbjct: 11 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHE 67
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVAR------------VYIAE 697
+V+F+ + L +V EY+ GDL LR G +A ++IA+
Sbjct: 68 HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 698 VVLA-LEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 756
+ A + YL S VHRDL N L+ + +K+ DFG+S+ + STD V G T
Sbjct: 128 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRD--VYSTDYYR---VGGHT 182
Query: 757 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 813
+L ++ PE ++ T +D WS+G++L+E+
Sbjct: 183 MLPIR------------------------WMPPESIMYRKFTTESDVWSLGVVLWEI 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 63/232 (27%), Positives = 103/232 (44%), Gaps = 46/232 (19%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ ++IK + G FG V++ + A+K LK M + ES L E I+ +R+
Sbjct: 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKV-AVKTLKPGTM----SPESFLEEAQIMKKLRH 60
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL-----RNLGCLD-EDVARVYIAEVVLAL 702
+V+ Y+ E +Y+V EY++ G L L R L + D+A A+V +
Sbjct: 61 DKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMA----AQVAAGM 115
Query: 703 EYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEE 762
Y+ + +HRDL+ N+L+ K+ DFGL++ LI E+
Sbjct: 116 AYIERMNYIHRDLRSANILVGDGLVCKIADFGLAR--LI-------------------ED 154
Query: 763 PQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI 814
+ TA ++ A + APE L +D WS GI+L EL+
Sbjct: 155 NEYTA---------RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELV 197
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 5e-12
Identities = 53/210 (25%), Positives = 84/210 (40%), Gaps = 28/210 (13%)
Query: 613 TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCREN-LYLVMEYL 671
TG AIK+L+ ++ E + + +P +V S L+ V EY+
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 672 NGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG---HI 728
G L +L G L + +V+ AL H+ +VHRDLKP N++++ G H
Sbjct: 62 PGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHA 121
Query: 729 KLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLA 788
K+ DFG+ + G D + + +GTP Y A
Sbjct: 122 KVLDFGIGTLL-------------PGV---RDADVATLTRTTE--------VLGTPTYCA 157
Query: 789 PEILLGTGHGTTADWWSVGIILFELIVGIP 818
PE L G +D ++ G+I E + G
Sbjct: 158 PEQLRGEPVTPNSDLYAWGLIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 6e-12
Identities = 63/233 (27%), Positives = 105/233 (45%), Gaps = 44/233 (18%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
++ + P+ GA+G V A A+K L + +A + E +L +++
Sbjct: 17 YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRT-YRELRLLKHMKHEN 75
Query: 651 VVRFFYSFTCRENL------YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEY 704
V+ FT ++ YLV L G DL ++++ DE V + I +++ L+Y
Sbjct: 76 VIGLLDVFTPATSIENFNEVYLVTN-LMGADLNNIVKCQKLSDEHV-QFLIYQLLRGLKY 133
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
+HS ++HRDLKP N+ + D +++ DFGL++ + D+++G
Sbjct: 134 IHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR----QADDEMTG--------------- 174
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVG 816
V T Y APEI+L H T D WSVG I+ EL+ G
Sbjct: 175 ---------------YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKG 212
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 67/267 (25%), Positives = 115/267 (43%), Gaps = 54/267 (20%)
Query: 594 IKPISRGAFGRVFLAKKRTTG----DLFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
++ + AFG+++ G L AIK LK D+ E ++ + +P
Sbjct: 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLK--DINNPQQWGEFQQEASLMAELHHP 67
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLL------RNLGCLDEDVARV---------- 693
+V T + + ++ EYLN GDL+ L ++GC ++ V
Sbjct: 68 NIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127
Query: 694 YIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 752
+IA ++ +EYL S VH+DL N+LI H+K++D GLS+ I S D V
Sbjct: 128 HIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSRE--IYSADYYR---V 182
Query: 753 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFE 812
+LL ++ PE ++ + +D WS G++L+E
Sbjct: 183 QPKSLLPIR------------------------WMPPEAIMYGKFSSDSDIWSFGVVLWE 218
Query: 813 LI-VGIPPFNA-EHPQVSTLLRKCQLL 837
+ G+ P+ + +V ++RK QLL
Sbjct: 219 IFSFGLQPYYGFSNQEVIEMVRKRQLL 245
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 2e-11
Identities = 66/284 (23%), Positives = 108/284 (38%), Gaps = 64/284 (22%)
Query: 553 VDITSTVIEEDAPLEDDVVRSLRTSPIHPSKDRTSIDD----------------FEIIKP 596
++ + +D L +D + I +D + D F I++
Sbjct: 40 SEMNPGIESDDDCLYEDKHMDIDIFDIFADEDESDADASLALCAEARAGIEKAGFSILET 99
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFY 656
+ GA G F T + IK ++ E IL ++ +P +++
Sbjct: 100 FTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKG 150
Query: 657 SFTCRENLYLVMEYLNGGDLYSLL---RNLGCLDEDVARVYIAEVVL-ALEYLHSLRVVH 712
+FT + L++ DLY L RN+ D + I VL A++YLH R++H
Sbjct: 151 TFTYNKFTCLILPRYKT-DLYCYLAAKRNIAICD----ILAIERSVLRAIQYLHENRIIH 205
Query: 713 RDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQ 772
RD+K +N+ I H G + L DFG + + + + G A
Sbjct: 206 RDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWA--------------------- 244
Query: 773 ERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVG 816
GT APE+L +G D WS GI+LFE+
Sbjct: 245 ---------GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 69/279 (24%), Positives = 116/279 (41%), Gaps = 60/279 (21%)
Query: 585 RTSIDDFEIIKPISRGAFGRV-----FLAKKRTTGDLFAIKVLKKADMIRKNAVESILAE 639
+ ++ + GAFG+V +R + AIK LK+ + + E
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQ--QEFRQE 58
Query: 640 RDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYS-LLRN-------LGCLDEDVA 691
+++ +++P +V T + ++ EYL GDL+ L+RN DE V
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118
Query: 692 R-------VYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743
++IA ++ +EYL S VHRDL N L+ +K++DFGLS+ I S
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSR--DIYS 176
Query: 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADW 803
D R + ++ ++ PE +L T +D
Sbjct: 177 AD---------------------------YYRVQSKSLLPVRWMPPEAILYGKFTTESDI 209
Query: 804 WSVGIILFELI-VGIPPF----NAEHPQVSTLLRKCQLL 837
WS G++L+E+ G+ P+ N E V ++R QLL
Sbjct: 210 WSFGVVLWEIFSYGLQPYYGFSNQE---VIEMIRSRQLL 245
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-11
Identities = 70/259 (27%), Positives = 117/259 (45%), Gaps = 47/259 (18%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRTTGDLF----AIKVLKKADMIRKNAVESILAERDILIS 645
+F+ IK + GAFG V+ G+ AIK L++A + N + IL E ++ S
Sbjct: 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 65
Query: 646 VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYI----AEVVLA 701
V NP V R + L+ + + G L +R +++ Y+ ++
Sbjct: 66 VDNPHVCRLL-GICLTSTVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKG 121
Query: 702 LEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDE 761
+ YL R+VHRDL N+L+ H+K+TDFGL+K LLG +
Sbjct: 122 MNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAK-------------------LLGAD 162
Query: 762 EPQLTASEHQQERRKKRSAVGTP-DYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPP 819
E E+ E K P ++A E +L + +D WS G+ ++EL+ G P
Sbjct: 163 E-----KEYHAEGGK------VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 211
Query: 820 FNA-EHPQVSTLLRKCQLL 837
++ ++S++L K + L
Sbjct: 212 YDGIPASEISSILEKGERL 230
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 3e-11
Identities = 68/287 (23%), Positives = 112/287 (39%), Gaps = 78/287 (27%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTG-------DLFAIKVLK-------KADMIRKNAVE 634
++ E ++ I +GAFGRVF A R G + A+K+LK +AD R+ A
Sbjct: 5 NNIEYVRDIGQGAFGRVFQA--RAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA-- 60
Query: 635 SILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-----NLGCLDED 689
++AE D +P +V+ + + L+ EY+ GDL LR L
Sbjct: 61 -LMAEFD------HPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHS 113
Query: 690 VARVYI-----------------AEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTD 732
+ +V + YL + VHRDL N L+ + +K+ D
Sbjct: 114 TSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIAD 173
Query: 733 FGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEIL 792
FGLS+ I S D E + ++ PE +
Sbjct: 174 FGLSRN--IYSADYYK----------ASENDAIPIR-----------------WMPPESI 204
Query: 793 LGTGHGTTADWWSVGIILFELI-VGIPP-FNAEHPQVSTLLRKCQLL 837
+ T +D W+ G++L+E+ G+ P + H +V +R +L
Sbjct: 205 FYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVL 251
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 57/223 (25%), Positives = 100/223 (44%), Gaps = 38/223 (17%)
Query: 595 KPISRGAFGRVF--LAKKRTTGDLFAIKVLKKADMIRKNAV-ESILAERDILISVRNPFV 651
+ G FG V + K + + A+K+LK + A+ + +L E +++ + NP++
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN--NDPALKDELLREANVMQQLDNPYI 58
Query: 652 VRFFYSFTCR-ENLYLVMEYLNGGDLYSLL-RNLGCLDEDVARVYIAEVVLALEYLHSLR 709
VR C E+ LVME G L L +N ++++ + + +V + ++YL
Sbjct: 59 VRMIG--ICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITEL-VHQVSMGMKYLEETN 115
Query: 710 VVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASE 769
VHRDL N+L+ + K++DFGLSK LG +E A
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKA-------------------LGADENYYKAKT 156
Query: 770 HQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFE 812
H + K + APE + + +D WS G++++E
Sbjct: 157 HGKWPVK---------WYAPECMNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 43/148 (29%), Positives = 68/148 (45%), Gaps = 8/148 (5%)
Query: 595 KPISRGAFGRVFLAK-KRTTGDLF--AIKVLKKADMIRKNAVESILAERDILISVRNPFV 651
K + G+FG V + + G + A+K LK + + ++ L E I+ S+ + +
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL--SDIMDDFLKEAAIMHSLDHENL 58
Query: 652 VRFFYSFTCRENLYLVMEYLNGGDLYSLLRN--LGCLDEDVARVYIAEVVLALEYLHSLR 709
+R Y L +V E G L LR LG Y ++ + YL S R
Sbjct: 59 IRL-YGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117
Query: 710 VVHRDLKPDNLLIAHDGHIKLTDFGLSK 737
+HRDL N+L+A D +K+ DFGL +
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMR 145
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 4e-11
Identities = 62/230 (26%), Positives = 102/230 (44%), Gaps = 43/230 (18%)
Query: 594 IKPISRGAFGRVFL----AKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
I+ + G FG+V L TG++ A+K LK + ++N E +IL ++ +
Sbjct: 9 IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLK-RECGQQNT-SGWKKEINILKTLYHE 66
Query: 650 FVVRFFYSFTCREN----LYLVMEYLNGGDLYSLL-RNLGCLDEDVARVYIAEVVLALEY 704
+V+ Y C E L L+MEY+ G L L ++ L + + ++ ++ + Y
Sbjct: 67 NIVK--YKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLL--LFAQQICEGMAY 122
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
LHS +HRDL N+L+ +D +K+ DFGL+K AV
Sbjct: 123 LHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAK-------------AVP----------- 158
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI 814
E+ + R S V + A E L +D WS G+ L+EL+
Sbjct: 159 -EGHEYYRVREDGDSPVF---WYAVECLKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 67/245 (27%), Positives = 109/245 (44%), Gaps = 53/245 (21%)
Query: 590 DFEIIKPISRGAFGRVFLAK---KRTTGD--LFAIKVLKKADMIRKNAVESILAERDILI 644
D + + + GAFG+VFLA+ T D L A+K LK + A + E ++L
Sbjct: 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL---AARKDFQREAELLT 62
Query: 645 SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG----CLDEDVAR-------- 692
++++ +V+F+ + L +V EY+ GDL LR G L + R
Sbjct: 63 NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 122
Query: 693 ---VYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748
++IA ++ + YL S VHRDL N L+ + +K+ DFG+S+ + STD
Sbjct: 123 SQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRD--VYSTDYYR 180
Query: 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGI 808
V G T+L ++ PE ++ T +D WS G+
Sbjct: 181 ---VGGHTMLPIR------------------------WMPPESIMYRKFTTESDVWSFGV 213
Query: 809 ILFEL 813
IL+E+
Sbjct: 214 ILWEI 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 58/245 (23%), Positives = 106/245 (43%), Gaps = 50/245 (20%)
Query: 597 ISRGAFGRVFLAKKRT-----TGDL-FAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
+ GAFG V+ +G + A+K L+K ++ L E ++ + +P
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKK--EFLKEAHLMSNFNHPN 60
Query: 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVV-LALE------ 703
+V+ E Y++ME + GGDL S LR+ + + E++ + L+
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 704 YLHSLRVVHRDLKPDNLLIAHDGH-----IKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 758
YL + +HRDL N L++ G+ +K+ DFGL++
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR--------------------- 159
Query: 759 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFE-LIVGI 817
+ S++ ++ + V ++APE LL T +D WS G++++E L +G
Sbjct: 160 -----DIYKSDYYRKEGEGLLPV---RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQ 211
Query: 818 PPFNA 822
P+ A
Sbjct: 212 QPYPA 216
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 60/252 (23%), Positives = 107/252 (42%), Gaps = 61/252 (24%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDL-----FAIKVLKKADMIRKNAVESILAERDIL 643
D + KP+ GAFG+V A+ + A+K+LK D K+ + +++E +++
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLK-DDATEKD-LSDLVSEMEMM 69
Query: 644 ISV-RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-------------------NL 683
+ ++ ++ T LY+V+EY G+L LR L
Sbjct: 70 KMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETL 129
Query: 684 GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743
D V+ Y +V +E+L S + +HRDL N+L+ D +K+ DFGL++
Sbjct: 130 TQKDL-VSFAY--QVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLAR------ 180
Query: 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTP-DYLAPEILLGTGHGTTAD 802
D+ H + +K + P ++APE L + +D
Sbjct: 181 --DI----------------------HHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSD 216
Query: 803 WWSVGIILFELI 814
WS G++L+E+
Sbjct: 217 VWSFGVLLWEIF 228
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 56/236 (23%), Positives = 105/236 (44%), Gaps = 43/236 (18%)
Query: 579 IHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILA 638
IHP + +++ I G FG V+L AIK +++ M ++ +E
Sbjct: 1 IHP-------SELTLVQEIGSGQFGLVWLGYWLEK-RKVAIKTIREGAMSEEDFIE---- 48
Query: 639 ERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARVYIAE 697
E +++ + +P +V+ + T R + LV E++ G L LR G ++ +
Sbjct: 49 EAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLD 108
Query: 698 VVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 757
V + YL S V+HRDL N L+ + +K++DFG+++ L DD
Sbjct: 109 VCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVL----DD----------- 153
Query: 758 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 813
Q T+S + K + +PE+ + + + +D WS G++++E+
Sbjct: 154 ------QYTSSTGTKFPVK---------WSSPEVFSFSKYSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 47/154 (30%), Positives = 69/154 (44%), Gaps = 9/154 (5%)
Query: 589 DDFEIIKPISRGAFGRVFLA---KKRTTGDLFAIKVLKKADMIRKNAVESILAERDILIS 645
+D + + I G FG V+ A+K K E L E I+
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVR--EKFLQEAYIMRQ 63
Query: 646 VRNPFVVRFFYSFTCREN-LYLVMEYLNGGDLYSLL-RNLGCLDEDVARVYIAEVVLALE 703
+P +V+ EN +++VME G+L S L N LD +Y ++ AL
Sbjct: 64 FDHPHIVKLIG--VITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALA 121
Query: 704 YLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 737
YL S R VHRD+ N+L++ +KL DFGLS+
Sbjct: 122 YLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSR 155
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 67/254 (26%), Positives = 116/254 (45%), Gaps = 58/254 (22%)
Query: 597 ISRGAFGRVFLAKKRTTGDL--FAIKVLKKADMIRKNAVESILAERDI--LISVRNPFVV 652
+ RG +G V+ AK++ D +A+K ++ + S+ A R+I L +++P V+
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-------SMSACREIALLRELKHPNVI 61
Query: 653 ---RFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC---------LDEDVARVYIAEVVL 700
+ F S R+ ++L+ +Y DL+ +++ L + + + +++
Sbjct: 62 SLQKVFLSHADRK-VWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 119
Query: 701 ALEYLHSLRVVHRDLKPDNLLIAHD----GHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 756
+ YLH+ V+HRDLKP N+L+ + G +K+ D G ++ L NS
Sbjct: 120 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR--LFNSP----------LK 167
Query: 757 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIV 815
L D +P V T Y APE+LLG H T A D W++G I EL+
Sbjct: 168 PLADLDP----------------VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
Query: 816 GIPPFNAEHPQVST 829
P F+ + T
Sbjct: 212 SEPIFHCRQEDIKT 225
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 7e-10
Identities = 58/229 (25%), Positives = 100/229 (43%), Gaps = 41/229 (17%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFY 656
+ +G FG VF K T D + V + + + L+E IL +P +V+
Sbjct: 3 LGKGNFGEVF---KGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIG 59
Query: 657 SFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVL----ALEYLHSLRVVH 712
T R+ +Y+VME + GGD S LR +++ + + L + YL S +H
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFLRKK---KDELKTKQLVKFALDAAAGMAYLESKNCIH 116
Query: 713 RDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQ 772
RDL N L+ + +K++DFG+S+ E+ + +S +
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR----------------------QEDDGIYSSSGLK 154
Query: 773 ERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI-VGIPPF 820
+ K + APE L + + +D WS GI+L+E +G+ P+
Sbjct: 155 QIPIK--------WTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPY 195
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 7e-10
Identities = 40/133 (30%), Positives = 65/133 (48%), Gaps = 13/133 (9%)
Query: 616 LFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 675
L A+K+L+ D KNA L E I+ +++P ++R + L ++ EY+ GD
Sbjct: 48 LVAVKMLR-EDA-NKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGD 105
Query: 676 LYSLLRNL----GCLDEDVARV------YIA-EVVLALEYLHSLRVVHRDLKPDNLLIAH 724
L L DV + ++A ++ ++YL SL VHRDL N L+
Sbjct: 106 LNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGK 165
Query: 725 DGHIKLTDFGLSK 737
+ IK+ DFG+S+
Sbjct: 166 NYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 7e-10
Identities = 67/254 (26%), Positives = 117/254 (46%), Gaps = 58/254 (22%)
Query: 597 ISRGAFGRVFLAKKRTTGDL--FAIKVLKKADMIRKNAVESILAERDI--LISVRNPFVV 652
+ RG +G V+ AK++ D +A+K ++ + S+ A R+I L +++P V+
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-------SMSACREIALLRELKHPNVI 61
Query: 653 ---RFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC---------LDEDVARVYIAEVVL 700
+ F S + R+ ++L+ +Y DL+ +++ L + + + +++
Sbjct: 62 ALQKVFLSHSDRK-VWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILD 119
Query: 701 ALEYLHSLRVVHRDLKPDNLLIAHD----GHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 756
+ YLH+ V+HRDLKP N+L+ + G +K+ D G ++ L NS
Sbjct: 120 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR--LFNSP----------LK 167
Query: 757 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIV 815
L D +P V T Y APE+LLG H T A D W++G I EL+
Sbjct: 168 PLADLDP----------------VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
Query: 816 GIPPFNAEHPQVST 829
P F+ + T
Sbjct: 212 SEPIFHCRQEDIKT 225
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 38/219 (17%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFY 656
+ +G FG V++ T + AIK LK M + E+ L E ++ +R+ +V+ Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 67
Query: 657 SFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARV--YIAEVVLALEYLHSLRVVHRD 714
+ E +Y+V EY++ G L L+ + ++ A++ + Y+ + VHRD
Sbjct: 68 AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 127
Query: 715 LKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQER 774
L+ N+L+ + K+ DFGL++ LI E+ + TA
Sbjct: 128 LRAANILVGENLVCKVADFGLAR--LI-------------------EDNEYTA------- 159
Query: 775 RKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 813
++ A + APE L +D WS GI+L EL
Sbjct: 160 --RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 59/244 (24%), Positives = 103/244 (42%), Gaps = 39/244 (15%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
+ I+ ++ G+ G VF+ K GD KV+ KA K I DIL ++ +
Sbjct: 94 YNILSSLTPGSEGEVFVCTKH--GDEQRKKVIVKAVTGGKTPGREI----DILKTISHRA 147
Query: 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVL-ALEYLHSLR 709
++ +++ + + +VM DL++ + G L + A + I +L AL YLH
Sbjct: 148 IINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQA-ITIQRRLLEALAYLHGRG 205
Query: 710 VVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASE 769
++HRD+K +N+ + + L DFG + +L A
Sbjct: 206 IIHRDVKTENIFLDEPENAVLGDFGAA--------------------------CKLDAHP 239
Query: 770 HQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQVS 828
+ GT + +PE+L + D WS G++LFE+ V + F + S
Sbjct: 240 DTP---QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSS 296
Query: 829 TLLR 832
+ LR
Sbjct: 297 SQLR 300
|
Length = 392 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 45/157 (28%), Positives = 77/157 (49%), Gaps = 8/157 (5%)
Query: 594 IKPISRGAFGRVFLAKKRTTGD----LFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
+K + GAFG V+ G+ AIKVL++ + N + IL E ++ V +P
Sbjct: 12 VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN--KEILDEAYVMAGVGSP 69
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARVYIAEVVLALEYLHSL 708
+V R + LV + + G L +R N + + ++ + YL +
Sbjct: 70 YVCRLL-GICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV 128
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745
R+VHRDL N+L+ H+K+TDFGL+++ I+ T+
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE 165
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 49/174 (28%), Positives = 73/174 (41%), Gaps = 31/174 (17%)
Query: 592 EIIKPISRGAFGRVFLAK---------------KRTTG-DLFAIKVLKK-ADMIRKNAVE 634
++ + G FG V L + L A+KVL+ A NA E
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS---DNARE 64
Query: 635 SILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVAR-- 692
L E IL + +P + R T L ++MEY+ GDL L+ +A
Sbjct: 65 DFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNS 124
Query: 693 --------VYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 737
+Y+A ++ + YL SL VHRDL N L+ + IK+ DFG+S+
Sbjct: 125 KSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 59/240 (24%), Positives = 105/240 (43%), Gaps = 46/240 (19%)
Query: 589 DDFEIIKPISRGAFGRVF--LAKKRTTGDL---FAIKVLKKADMIRKNAVESILAERDIL 643
+ +++ + +G+FG V+ A+ G+ A+K + ++ +R+ L E ++
Sbjct: 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVM 63
Query: 644 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDED-------VARVYI- 695
VVR + + +VME + GDL S LR+L E+ + I
Sbjct: 64 KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 123
Query: 696 --AEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753
AE+ + YL++ + VHRDL N ++AHD +K+ DFG+++ I TD
Sbjct: 124 MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRD--IYETD-------- 173
Query: 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 813
RK + ++APE L T++D WS G++L+E+
Sbjct: 174 -------------------YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 5e-09
Identities = 54/218 (24%), Positives = 94/218 (43%), Gaps = 50/218 (22%)
Query: 616 LFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 675
L A+K+L+ D KNA L E IL +++P ++R + L ++ EY+ GD
Sbjct: 48 LVAVKILR-PDA-NKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGD 105
Query: 676 LYSLLRNLGCLDEDV------------------ARVYIA-EVVLALEYLHSLRVVHRDLK 716
L L + D++ + +++A ++ ++YL SL VHRDL
Sbjct: 106 LNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLA 165
Query: 717 PDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRK 776
N L+ + IK+ DFG+S+ L A ++ R
Sbjct: 166 TRNCLVGENLTIKIADFGMSR--------------------------NLYAGDYY---RI 196
Query: 777 KRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI 814
+ AV ++A E +L T +D W+ G+ L+E++
Sbjct: 197 QGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 52/224 (23%), Positives = 105/224 (46%), Gaps = 42/224 (18%)
Query: 595 KPISRGAFGRVFLA--KKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVV 652
K + G FG V++A K T A+K +K M +VE+ LAE +++ ++++ +V
Sbjct: 12 KKLGAGQFGEVWMATYNKHTK---VAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLV 64
Query: 653 RFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARV--YIAEVVLALEYLHSLRV 710
+ ++ +E +Y++ E++ G L L++ + + ++ + A++ + ++
Sbjct: 65 KL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY 123
Query: 711 VHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEH 770
+HRDL+ N+L++ K+ DFGL++V E+ + TA E
Sbjct: 124 IHRDLRAANILVSASLVCKIADFGLARV---------------------IEDNEYTAREG 162
Query: 771 QQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI 814
+ K + APE + +D WS GI+L E++
Sbjct: 163 AKFPIK---------WTAPEAINFGSFTIKSDVWSFGILLMEIV 197
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 6e-09
Identities = 63/243 (25%), Positives = 101/243 (41%), Gaps = 44/243 (18%)
Query: 589 DDFEIIKPISRGAFGRVFLAK-----KRTTGDLFAIKVLK-KADMIRKNAVESILAERDI 642
++ K + GAFG+V A K A+K+LK A + A+ S L
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 643 LISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVL 700
L + N +V + T + ++ EY GDL + LR L + + +V
Sbjct: 95 LGNHEN--IVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAK 152
Query: 701 ALEYLHSLRVVHRDLKPDNLLIAHDGHI-KLTDFGLSKVGLINSTDDLSGPAVSGTTLLG 759
+ +L S +HRDL N+L+ H G I K+ DFGL++ ++N S V G L
Sbjct: 153 GMAFLASKNCIHRDLAARNVLLTH-GKIVKICDFGLAR-DIMND----SNYVVKGNARL- 205
Query: 760 DEEPQLTASEHQQERRKKRSAVGTP-DYLAPEILLGTGHGTTADWWSVGIILFELI-VGI 817
P ++APE + + +D WS GI+L+E+ +G
Sbjct: 206 ------------------------PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGS 241
Query: 818 PPF 820
P+
Sbjct: 242 NPY 244
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 6e-09
Identities = 39/134 (29%), Positives = 63/134 (47%), Gaps = 14/134 (10%)
Query: 616 LFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 675
L A+K+L+ AD + K A L E I+ ++NP ++R + L ++ EY+ GD
Sbjct: 46 LVAVKMLR-AD-VTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGD 103
Query: 676 LYSLL------------RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA 723
L L N+ + ++ ++YL SL VHRDL N L+
Sbjct: 104 LNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG 163
Query: 724 HDGHIKLTDFGLSK 737
+ IK+ DFG+S+
Sbjct: 164 NHYTIKIADFGMSR 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 61/252 (24%), Positives = 112/252 (44%), Gaps = 58/252 (23%)
Query: 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKA-DMIRKNAVES----ILAERDILISV-RN 648
KP+ G FG+V +A+ +V K A M++ +A E +++E +++ + ++
Sbjct: 24 KPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 83
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-----------NLGCLDED-------V 690
++ + T LY+++EY + G+L LR N + E+ V
Sbjct: 84 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143
Query: 691 ARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 750
+ Y +V +EYL S + +HRDL N+L+ D +K+ DFGL++ D+
Sbjct: 144 SCAY--QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR--------DI--- 190
Query: 751 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTP-DYLAPEILLGTGHGTTADWWSVGII 809
H + KK + P ++APE L + +D WS G++
Sbjct: 191 -------------------HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 231
Query: 810 LFELI-VGIPPF 820
L+E+ +G P+
Sbjct: 232 LWEIFTLGGSPY 243
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 8e-09
Identities = 58/237 (24%), Positives = 87/237 (36%), Gaps = 43/237 (18%)
Query: 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGD---LFAIKVLKKADMIRKNAVESILAERDI 642
I K I G FG V + + G AIK LK L E I
Sbjct: 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLK--AGSSDKQRLDFLTEASI 58
Query: 643 LISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAE----V 698
+ +P ++R T + ++ EY+ G L LR D + +
Sbjct: 59 MGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLREN---DGKFTVGQLVGMLRGI 115
Query: 699 VLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 758
++YL + VHRDL N+L+ + K++DFGLS+ L
Sbjct: 116 ASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRR-------------------L 156
Query: 759 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELI 814
D E T + K T APE + T+A D WS GI+++E++
Sbjct: 157 EDSEATYTT------KGGKIPIRWT----APEA-IAYRKFTSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 9e-09
Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 38/220 (17%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFY 656
+ +G FG V++ T + AIK LK M E+ L E I+ +R+ +V Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTKV-AIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPL-Y 67
Query: 657 SFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARV--YIAEVVLALEYLHSLRVVHRD 714
+ E +Y+V E++ G L L+ + ++ A++ + Y+ + +HRD
Sbjct: 68 AVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRD 127
Query: 715 LKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQER 774
L+ N+L+ + K+ DFGL++ LI E+ + TA
Sbjct: 128 LRAANILVGDNLVCKIADFGLAR--LI-------------------EDNEYTA------- 159
Query: 775 RKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI 814
++ A + APE L +D WS GI+L EL+
Sbjct: 160 --RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELV 197
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 57/251 (22%), Positives = 101/251 (40%), Gaps = 52/251 (20%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-R 647
+D + I G FG+V A+ + G + + + K+ E ++L +
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66
Query: 648 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARV-------------- 693
+P ++ + R LYL +EY G+L LR L+ D A
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 694 --YIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 751
+ A+V ++YL + +HRDL N+L+ + K+ DFGLS+
Sbjct: 127 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-------------- 172
Query: 752 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTP-DYLAPEILLGTGHGTTADWWSVGIIL 810
QE K++ P ++A E L + + T +D WS G++L
Sbjct: 173 -------------------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 213
Query: 811 FELI-VGIPPF 820
+E++ +G P+
Sbjct: 214 WEIVSLGGTPY 224
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 59/260 (22%), Positives = 111/260 (42%), Gaps = 58/260 (22%)
Query: 587 SIDDFEIIKPISRGAFGRVFLAK-------KRTTGDLFAIKVLKKADMIRKNAVESILAE 639
S D + KP+ G FG+V +A+ K A+K+LK D + + +++E
Sbjct: 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLK--DDATEKDLSDLVSE 70
Query: 640 RDILISV-RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDE----DVARV- 693
+++ + ++ ++ + T LY+++EY + G+L LR D+ARV
Sbjct: 71 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVP 130
Query: 694 -----------YIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742
+V +EYL S + +HRDL N+L+ + +K+ DFGL++
Sbjct: 131 DEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR----- 185
Query: 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTP-DYLAPEILLGTGHGTTA 801
+ + KK + P ++APE L + +
Sbjct: 186 -------------------------DVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS 220
Query: 802 DWWSVGIILFELI-VGIPPF 820
D WS G++++E+ +G P+
Sbjct: 221 DVWSFGVLMWEIFTLGGSPY 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 61/250 (24%), Positives = 99/250 (39%), Gaps = 69/250 (27%)
Query: 595 KPISRGAFGRVFLAK----KRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV---- 646
KP+ G FG+V A+ ++ D +K M++ NA + LA+ LIS
Sbjct: 18 KPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVK---MLKDNATDKDLAD---LISEMELM 71
Query: 647 ----RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR------------------NLG 684
++ ++ T LY+++EY G+L LR
Sbjct: 72 KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131
Query: 685 CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744
+ V+ Y +V +EYL S R +HRDL N+L+ D +K+ DFGL++
Sbjct: 132 SFKDLVSCAY--QVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLAR------- 182
Query: 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTP-DYLAPEILLGTGHGTTADW 803
H + KK S P ++APE L + +D
Sbjct: 183 -----------------------GVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDV 219
Query: 804 WSVGIILFEL 813
WS GI+++E+
Sbjct: 220 WSFGILMWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 7e-08
Identities = 66/297 (22%), Positives = 118/297 (39%), Gaps = 76/297 (25%)
Query: 549 TDDKVDITSTVIEEDAPLEDDVVRSLRTSPIHPSKDRTSIDD-----FEIIKPISRGAFG 603
+ D + +E P P+ ++ + DD F +I + GAFG
Sbjct: 111 GAEDSDASHLDFDEAPPDAA--------GPVPLAQAKLKHDDEFLAHFRVIDDLPAGAFG 162
Query: 604 RVFL-AKKRTTGDLFAIKVLKK------------ADMIRKNAVESILAERDILISVR--N 648
++F+ A + +T + A + + A ++ + +I E +IL R +
Sbjct: 163 KIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNH 222
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDV----------ARVYIAEV 698
+++ N Y++ + + DLYS + DE R + ++
Sbjct: 223 ENILKIEEILRSEANTYMITQKYDF-DLYSFM-----YDEAFDWKDRPLLKQTRAIMKQL 276
Query: 699 VLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 758
+ A+EY+H +++HRD+K +N+ + DG I L DFG
Sbjct: 277 LCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFG------------------------ 312
Query: 759 GDEEPQLTASEHQQERRKKRSA-VGTPDYLAPEILLGTGHGTTADWWSVGIILFELI 814
TA ++ER VGT +PEIL G G+ D WS G+IL +++
Sbjct: 313 -------TAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 8e-08
Identities = 58/232 (25%), Positives = 96/232 (41%), Gaps = 46/232 (19%)
Query: 593 IIKPISRGAFGRVFLAKKRTTGD---LFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
I K I G FG V + + G AIK LK ++ L+E I+ +P
Sbjct: 8 IEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR--RDFLSEASIMGQFDHP 65
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVV-------LAL 702
++ T + + +V EY+ G L + LR + + + ++V +
Sbjct: 66 NIIHLEGVVTKSKPVMIVTEYMENGSLDAFLR------KHDGQFTVIQLVGMLRGIASGM 119
Query: 703 EYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEE 762
+YL + VHRDL N+L+ + K++DFGLS+V DD P + TT G
Sbjct: 120 KYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV----LEDD---PEAAYTTRGGKIP 172
Query: 763 PQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI 814
+ TA E R+ + +D WS GI+++E++
Sbjct: 173 IRWTAPEAIAYRK---------------------FTSASDVWSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 8e-08
Identities = 59/247 (23%), Positives = 106/247 (42%), Gaps = 63/247 (25%)
Query: 595 KPISRGAFGRVFLA------KKRTTGDL-FAIKVLKKADMIRKNAVESILAERDILISV- 646
KP+ G FG+V +A K + + A+K+LK D K+ + +++E +++ +
Sbjct: 18 KPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKD-DATDKD-LSDLVSEMEMMKMIG 75
Query: 647 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-------------------NLGCLD 687
++ ++ + T LY+++EY + G+L LR L D
Sbjct: 76 KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135
Query: 688 EDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747
V+ Y +V +EYL S + +HRDL N+L+ D +K+ DFGL++
Sbjct: 136 L-VSCAY--QVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLAR---------- 182
Query: 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTP-DYLAPEILLGTGHGTTADWWSV 806
H + KK + P ++APE L + +D WS
Sbjct: 183 --------------------DVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 222
Query: 807 GIILFEL 813
G++L+E+
Sbjct: 223 GVLLWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 43/167 (25%), Positives = 71/167 (42%), Gaps = 23/167 (13%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKR-TTGDLFAIKVLKKA--DMIRKNAVESILAERDILIS 645
D +++ + GAFG V+ R GD ++V K + + L E I+
Sbjct: 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSK 65
Query: 646 VRNPFVVRFF-YSFTCRENLYLVMEYLNGGDLYSLLRN----------LGCLDEDVARVY 694
+ +VR SF R ++++E + GGDL S LR L D ++
Sbjct: 66 FNHQNIVRLIGVSFE-RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKD----LLF 120
Query: 695 IA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGH---IKLTDFGLSK 737
A +V +YL +HRD+ N L+ G K+ DFG+++
Sbjct: 121 CARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 61/252 (24%), Positives = 104/252 (41%), Gaps = 54/252 (21%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLF--AIKVLKKADMIRKNAVESILAERDILISV 646
+D + I G FG+V A + G AIK+LK + +N E ++L +
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLK--EFASENDHRDFAGELEVLCKL 59
Query: 647 -RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARV------------ 693
+P ++ + R LY+ +EY G+L LR L+ D A
Sbjct: 60 GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQ 119
Query: 694 ----YIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 749
+ ++V ++YL + +HRDL N+L+ + K+ DFGLS+ G
Sbjct: 120 QLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR-----------G 168
Query: 750 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGII 809
V +G R R ++A E L + + T +D WS G++
Sbjct: 169 EEVYVKKTMG--------------RLPVR-------WMAIESLNYSVYTTKSDVWSFGVL 207
Query: 810 LFELI-VGIPPF 820
L+E++ +G P+
Sbjct: 208 LWEIVSLGGTPY 219
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 57/227 (25%), Positives = 92/227 (40%), Gaps = 40/227 (17%)
Query: 595 KPISRGAFGRVFLAKKRTTGD---LFAIKVLKKADMIRKNAVESILAERDILISVRNPFV 651
K I G FG VF + G AIK LK K + L+E I+ + +
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLK-PGYTEKQRQD-FLSEASIMGQFSHHNI 68
Query: 652 VRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAE----VVLALEYLHS 707
+R T + ++ EY+ G L LR+ D + + + + ++YL
Sbjct: 69 IRLEGVVTKFKPAMIITEYMENGALDKYLRDH---DGEFSSYQLVGMLRGIAAGMKYLSD 125
Query: 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTA 767
+ VHRDL N+L+ + K++DFGLS+V L D E T
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRV------------------LEDDPEGTYTT 167
Query: 768 SEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI 814
S + R + APE + + +D WS GI+++E++
Sbjct: 168 SGGKIPIR----------WTAPEAIAYRKFTSASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-07
Identities = 21/48 (43%), Positives = 33/48 (68%)
Query: 687 DEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFG 734
D +V + + +V+ L LH + +VHRD+KP+NLL+ DG +K+ DFG
Sbjct: 307 DINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFG 354
|
Length = 507 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 5e-07
Identities = 41/162 (25%), Positives = 75/162 (46%), Gaps = 16/162 (9%)
Query: 591 FEIIKPISRGAFGRV---FLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR 647
F + + + +G FG V L + + A+K+LK AD+ + +E L E +
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLK-ADIFSSSDIEEFLREAACMKEFD 59
Query: 648 NPFVVRFF-YSFTCRENLYL-----VMEYLNGGDLYS--LLRNLG----CLDEDVARVYI 695
+P V++ S R L ++ ++ GDL++ L+ +G L ++
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 696 AEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 737
++ +EYL S +HRDL N ++ + + + DFGLSK
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 5e-07
Identities = 57/234 (24%), Positives = 97/234 (41%), Gaps = 46/234 (19%)
Query: 595 KPISRGAFGRVF--LAK---KRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
+ + +G+FG V+ +AK K AIK + +A +R+ L E ++
Sbjct: 12 RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMKEFNCH 69
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYI----------AEVV 699
VVR + + ++ME + GDL S LR+L E+ E+
Sbjct: 70 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIA 129
Query: 700 LALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLG 759
+ YL++ + VHRDL N ++A D +K+ DFG+++ I TD
Sbjct: 130 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD--IYETD-------------- 173
Query: 760 DEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 813
RK + +++PE L T +D WS G++L+E+
Sbjct: 174 -------------YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 6e-07
Identities = 56/222 (25%), Positives = 92/222 (41%), Gaps = 32/222 (14%)
Query: 597 ISRGAFGRVFLAKKRTTG---DLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVR 653
I G FG V + + G AIK LK ++ L+E I+ +P ++
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQR--RDFLSEASIMGQFDHPNIIH 69
Query: 654 FFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARVYIAEVVLALEYLHSLRVVH 712
T + ++ E++ G L S LR N G + + ++YL + VH
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVH 129
Query: 713 RDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQ 772
RDL N+L+ + K++DFGLS+ DD S P T+ LG + P
Sbjct: 130 RDLAARNILVNSNLVCKVSDFGLSRF----LEDDTSDPTY--TSSLGGKIPI-------- 175
Query: 773 ERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI 814
+ APE + + +D WS GI+++E++
Sbjct: 176 ------------RWTAPEAIAYRKFTSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 41/153 (26%), Positives = 72/153 (47%), Gaps = 14/153 (9%)
Query: 594 IKPISRGAFGRVF----LAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
+K + GAFG V+ + + T AIK+L + + N + E I+ S+ +P
Sbjct: 12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV--EFMDEALIMASMDHP 69
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR----NLGCLDEDVARVYIAEVVLALEYL 705
+VR + LV + + G L + N+G + + ++ + YL
Sbjct: 70 HLVRLL-GVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIG---SQLLLNWCVQIAKGMMYL 125
Query: 706 HSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738
R+VHRDL N+L+ H+K+TDFGL+++
Sbjct: 126 EERRLVHRDLAARNVLVKSPNHVKITDFGLARL 158
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 1e-06
Identities = 61/244 (25%), Positives = 101/244 (41%), Gaps = 54/244 (22%)
Query: 597 ISRGAFGRVFLAKKRTTGDLF--AIKVLKKADMIRKNAVESILAERDILISV-RNPFVVR 653
I G FG+V A+ + G AIK +K + K+ E ++L + +P ++
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMK--EYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 654 FFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARV----------------YIAE 697
+ R LYL +EY G+L LR L+ D A + A+
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 698 VVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 757
V ++YL + +HRDL N+L+ + K+ DFGLS+ G V
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-----------GQEVYVKKT 169
Query: 758 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI-VG 816
+G R R ++A E L + + T +D WS G++L+E++ +G
Sbjct: 170 MG--------------RLPVR-------WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG 208
Query: 817 IPPF 820
P+
Sbjct: 209 GTPY 212
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 59/250 (23%), Positives = 101/250 (40%), Gaps = 37/250 (14%)
Query: 594 IKPISRGAFGRVFLAKKRTTGDLFAIKVLKKA--DMIRKNAVESILAERDILISVRNPFV 651
+K + G FG V GD I V K D + + I + S+ + ++
Sbjct: 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYI 71
Query: 652 VRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARVYIAEVVLALEYLHSLRV 710
VR +L LV + G L +R + LD + ++ + YL R+
Sbjct: 72 VRLL-GICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRM 130
Query: 711 VHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEH 770
VHR+L N+L+ D +++ DFG++ LL ++ + SEH
Sbjct: 131 VHRNLAARNILLKSDSIVQIADFGVAD-------------------LLYPDDKKYFYSEH 171
Query: 771 QQERRKKRSAVGTP-DYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQ-V 827
+ TP ++A E +L + +D WS G+ ++E++ G P+ P V
Sbjct: 172 K-----------TPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV 220
Query: 828 STLLRKCQLL 837
LL K + L
Sbjct: 221 PDLLEKGERL 230
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 41/158 (25%), Positives = 73/158 (46%), Gaps = 16/158 (10%)
Query: 595 KPISRGAFGRVF---LAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFV 651
K + G FG V L++ + A+K +K D+ + +E L+E + +P V
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMK-LDIHTYSEIEEFLSEAACMKDFDHPNV 63
Query: 652 VRFF-YSFTCRENLYL-----VMEYLNGGDLYSLL--RNLGCLDEDVAR----VYIAEVV 699
++ F + ++ ++ GDL+S L LG L E + ++ ++
Sbjct: 64 MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIA 123
Query: 700 LALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 737
L +EYL + +HRDL N ++ D + + DFGLSK
Sbjct: 124 LGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 3e-06
Identities = 64/251 (25%), Positives = 108/251 (43%), Gaps = 37/251 (14%)
Query: 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNA-VESILAERDILIS 645
S F+I+ + G FG+V A R + A+K+++ ++A +E E+
Sbjct: 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQAD 186
Query: 646 VRNPF----VVRFFYSFTCRENLYLVM-EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVL 700
+ F + R+F + T ++ +VM +Y G L + G I + +
Sbjct: 187 PADRFPLMKIQRYFQNET--GHMCIVMPKY--GPCLLDWIMKHGPFSHRHLAQIIFQTGV 242
Query: 701 ALEYLHS-LRVVHRDLKPDNLLI-AHDGHIK-LTDFGLSKVGLINSTDDLSGPAVSGTTL 757
AL+Y H+ L ++H DLKP+N+L+ D + +T+ L DL G
Sbjct: 243 ALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCC------ 296
Query: 758 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGI 817
ER + + V T Y +PE++LG G + D WS+G I++EL G
Sbjct: 297 --------------DERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342
Query: 818 PPF----NAEH 824
+ N EH
Sbjct: 343 LLYDTHDNLEH 353
|
Length = 467 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 3e-06
Identities = 45/159 (28%), Positives = 69/159 (43%), Gaps = 32/159 (20%)
Query: 594 IKPISRGAFGRVFLAKKRTTGDLFAIKV-----LKKADMIRKNAVESILAERDI----LI 644
+K I RGA ++L GD IK + K + E I ER ++
Sbjct: 1 MKLIKRGAEAEIYL------GDFLGIKAVIKWRIPKRYRHPELD-ERIRRERTRREARIM 53
Query: 645 S------VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEV 698
S V P V EN +VMEY+ G L L+ + G + +++R E+
Sbjct: 54 SRARKAGVNVPAVYFVDP-----ENFIIVMEYIEGEPLKDLINSNGMEELELSR----EI 104
Query: 699 VLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 737
+ LHS ++H DL N+++ G I L DFGL++
Sbjct: 105 GRLVGKLHSAGIIHGDLTTSNMIL-SGGKIYLIDFGLAE 142
|
Length = 211 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 5e-06
Identities = 43/170 (25%), Positives = 72/170 (42%), Gaps = 44/170 (25%)
Query: 670 YLNGGDLYSLLRNLGCLDEDVAR-------VYIA-EVVLALEYLHSLRVVHRDLKPDNLL 721
Y+N G+L L+ + + + V++A ++ + YLH V+H+D+ N +
Sbjct: 90 YMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCV 149
Query: 722 IAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAV 781
I + +K+TD LS+ DL P LGD E R K
Sbjct: 150 IDEELQVKITDNALSR--------DLF-P--MDYHCLGDNE----------NRPVK---- 184
Query: 782 GTPDYLAPEILLGTGHGTTADWWSVGIILFELI-------VGIPPFNAEH 824
++A E L+ + + +D WS G++L+EL+ V I PF
Sbjct: 185 ----WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAA 230
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 8e-06
Identities = 55/237 (23%), Positives = 103/237 (43%), Gaps = 38/237 (16%)
Query: 605 VFLAKKRTTGDLFAIKV--LKKADMIRKNAVESILAERDILIS--VRNPFVVRFFYSFTC 660
V+LA+ TG L +++ L+ A++ ++++S R+P ++ + FT
Sbjct: 16 VYLARHTPTGTLVTVRITDLENCTEEHLKALQ-----NEVVLSHFFRHPNIMTSWTVFTT 70
Query: 661 RENLYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPD 718
L+++ ++ G SLL+ + E + + + L YLH +HR++K
Sbjct: 71 GSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKAS 130
Query: 719 NLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKR 778
++LI+ DG + L+ GLS + + + + PQ + S
Sbjct: 131 HILISGDGLVSLS--GLSHLYSLVRNGQKAKVVY--------DFPQFSTS---------- 170
Query: 779 SAVGTPDYLAPEILLG--TGHGTTADWWSVGIILFELIVGIPPFNAEHPQVSTLLRK 833
+L+PE+L G+ +D +SVGI EL G PF + + LL+K
Sbjct: 171 ----VLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQ-DMLRTQMLLQK 222
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 1e-05
Identities = 42/146 (28%), Positives = 63/146 (43%), Gaps = 38/146 (26%)
Query: 675 DLYSLL----RNLGCLD-EDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIK 729
DLY+ L R LG VAR +++ A++Y+H ++HRD+K +N+L+ I
Sbjct: 245 DLYTYLGARLRPLGLAQVTAVAR----QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDIC 300
Query: 730 LTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAP 789
L DFG + + S P G GT D AP
Sbjct: 301 LGDFGAACF----ARGSWSTPFHYGIA-------------------------GTVDTNAP 331
Query: 790 EILLGTGHGTTADWWSVGIILFELIV 815
E+L G + + D WS G+++FE V
Sbjct: 332 EVLAGDPYTPSVDIWSAGLVIFEAAV 357
|
Length = 461 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 4e-05
Identities = 34/127 (26%), Positives = 60/127 (47%), Gaps = 31/127 (24%)
Query: 694 YIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753
+ +V +E+L S VHRDL N+L+A +K+ DFGL++ +++ ++ +S
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLAR-DIMHDSNYVS----K 296
Query: 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 813
G+T L ++APE + + T +D WS GI+L+E+
Sbjct: 297 GSTFL------------------------PVKWMAPESIFDNLYTTLSDVWSYGILLWEI 332
Query: 814 --IVGIP 818
+ G P
Sbjct: 333 FSLGGTP 339
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 55/255 (21%), Positives = 107/255 (41%), Gaps = 46/255 (18%)
Query: 595 KPISRGAFGRVFLAKKRTTGDLF--AIKVLKKADMIRKNAVESILAERDILISVRNPFVV 652
K + G FG V + + A+K +K A + ++ +E L+E + +P V+
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIA-ICTRSEMEDFLSEAVCMKEFDHPNVM 63
Query: 653 RFF---YSFTCRENL---YLVMEYLNGGDLYSLL--RNLG----CLDEDVARVYIAEVVL 700
R E +++ ++ GDL+S L LG L + ++ ++
Sbjct: 64 RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIAS 123
Query: 701 ALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGD 760
+EYL S +HRDL N ++ + ++ + DFGLSK
Sbjct: 124 GMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK----------------------- 160
Query: 761 EEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPP 819
++ ++ ++ R + V ++A E L + T +D WS G+ ++E+ G P
Sbjct: 161 ---KIYNGDYYRQGRIAKMPV---KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
Query: 820 F-NAEHPQVSTLLRK 833
+ E+ ++ LR+
Sbjct: 215 YPGVENSEIYDYLRQ 229
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 5e-05
Identities = 67/258 (25%), Positives = 109/258 (42%), Gaps = 52/258 (20%)
Query: 592 EIIKPISRG--AFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
E++ I RG V LA+ + TG+ ++ + + V + E + +P
Sbjct: 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRIN-LEACTNEMVTFLQGELHVSKLFNHP 59
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLD-----EDVARVYIAEVVL-ALE 703
+V + +F L++V ++ Y ++L C ++A YI + VL AL+
Sbjct: 60 NIVPYRATFIADNELWVVTSFM----AYGSAKDLICTHFMDGMSELAIAYILQGVLKALD 115
Query: 704 YLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGL-SKVGLINSTDDLSGPAVSGTTLLGDEE 762
Y+H + VHR +K ++LI+ DG + L+ GL S + +IN
Sbjct: 116 YIHHMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMIN-------------------- 153
Query: 763 PQLTASEHQQERR-----KKRSAVGTPDYLAPEILLGT--GHGTTADWWSVGIILFELIV 815
H Q R K S P +L+PE+L G+ +D +SVGI EL
Sbjct: 154 -------HGQRLRVVHDFPKYSVKVLP-WLSPEVLQQNLQGYDAKSDIYSVGITACELAN 205
Query: 816 GIPPFNAEHPQVSTLLRK 833
G PF + P LL K
Sbjct: 206 GHVPFK-DMPATQMLLEK 222
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 8e-05
Identities = 33/128 (25%), Positives = 59/128 (46%), Gaps = 30/128 (23%)
Query: 694 YIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753
Y +V +E+L S + +HRDL N+L++ + +K+ DFGL++ D P
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR-------DIYKDP--- 228
Query: 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 813
+ +K SA ++APE + + T +D WS G++L+E+
Sbjct: 229 -------------------DYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEI 269
Query: 814 I-VGIPPF 820
+G P+
Sbjct: 270 FSLGASPY 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 8e-05
Identities = 56/238 (23%), Positives = 93/238 (39%), Gaps = 51/238 (21%)
Query: 597 ISRGAFGRVF------LAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
I +G FG V+ ++ A+K L + + + VE L E I+ +P
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIH---CAVKSLNRITDLEE--VEQFLKEGIIMKDFSHPN 57
Query: 651 VVRFFYSFTCRENLYLV-MEYLNGGDLYSLLRNLGCLDEDVARV-----YIAEVVLALEY 704
V+ E LV + Y+ GDL + +R+ + V + +V +EY
Sbjct: 58 VLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRS----ETHNPTVKDLIGFGLQVAKGMEY 113
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
L S + VHRDL N ++ +K+ DFGL++
Sbjct: 114 LASKKFVHRDLAARNCMLDESFTVKVADFGLAR--------------------------D 147
Query: 765 LTASEHQQERRKKRSAVGTP-DYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPF 820
+ E+ P ++A E L T +D WS G++L+EL+ G PP+
Sbjct: 148 IYDKEYYSVHNHT--GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 203
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 9e-05
Identities = 25/81 (30%), Positives = 34/81 (41%), Gaps = 24/81 (29%)
Query: 666 LVMEYLNGGDL--------YSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKP 717
+VMEY+ G L LLR +G V + LH +VH DL
Sbjct: 74 IVMEYIEGKPLKDVIEEGNDELLREIG---RLVGK------------LHKAGIVHGDLTT 118
Query: 718 DNLLIAHDGHIKLTDFGLSKV 738
N+++ D + L DFGL K
Sbjct: 119 SNIIV-RDDKLYLIDFGLGKY 138
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 33/159 (20%), Positives = 59/159 (37%), Gaps = 33/159 (20%)
Query: 593 IIKPISRGAFGRVFLAK--------KRTTGDLFAIKVLKKADMIRKNAVESILAERDILI 644
IK + G RV+L K ++ +++ +LA + + +
Sbjct: 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREKGADREREVAILQ------LLARKGLPV 55
Query: 645 SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVL-ALE 703
P V+ S YL+ME++ G L + + + IAE + L
Sbjct: 56 ----PKVL---ASGESDGWSYLLMEWIEGETLDEV--------SEEEKEDIAEQLAELLA 100
Query: 704 YLHSLR---VVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 739
LH L + H DL P N+L+ + + D+ + G
Sbjct: 101 KLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 32/117 (27%), Positives = 54/117 (46%), Gaps = 29/117 (24%)
Query: 697 EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 756
+V +E+L S VHRDL N+LI +K+ DFGL++ ++ ++ +S G+T
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLAR-DIMRDSNYIS----KGST 301
Query: 757 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 813
L ++APE + + T +D WS GI+L+E+
Sbjct: 302 FL------------------------PLKWMAPESIFNNLYTTLSDVWSFGILLWEI 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 2e-04
Identities = 38/131 (29%), Positives = 61/131 (46%), Gaps = 17/131 (12%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFY 656
ISRG G + K G F +K + + I S +A+ + +++P +V+
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP----SSEIAD---MGKLQHPNIVKLIG 750
Query: 657 SFTCREN--LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLH---SLRVV 711
CR YL+ EY+ G +L +LRNL + IA+ AL +LH S VV
Sbjct: 751 --LCRSEKGAYLIHEYIEGKNLSEVLRNLSWERRRKIAIGIAK---ALRFLHCRCSPAVV 805
Query: 712 HRDLKPDNLLI 722
+L P+ ++I
Sbjct: 806 VGNLSPEKIII 816
|
Length = 968 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 3e-04
Identities = 29/93 (31%), Positives = 39/93 (41%), Gaps = 14/93 (15%)
Query: 646 VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYL 705
V P + Y E +VMEY+ G DL +L L V +A+ L
Sbjct: 398 VPTPVI----YDVD-PEEKTIVMEYIGGKDLKDVLEGNPELVRKVGE-IVAK-------L 444
Query: 706 HSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738
H +VH DL N ++ D + L DFGL K
Sbjct: 445 HKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476
|
Length = 535 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 31/132 (23%), Positives = 57/132 (43%), Gaps = 30/132 (22%)
Query: 694 YIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753
Y +V +E+L S + +HRDL N+L++ + +K+ DFGL++ D P
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR-------DIYKDP--- 233
Query: 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 813
+ +K A ++APE + + +D WS G++L+E+
Sbjct: 234 -------------------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 274
Query: 814 I-VGIPPFNAEH 824
+G P+
Sbjct: 275 FSLGASPYPGVK 286
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 4e-04
Identities = 39/151 (25%), Positives = 64/151 (42%), Gaps = 13/151 (8%)
Query: 595 KPISRGAFGRVFL--AKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVV 652
I G FG+V L A + + +K L+ + + L E + +P V+
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQ--LLFLQEVQPYRELNHPNVL 58
Query: 653 RFFYSFTCREN--LYLVMEYLNGGDLYSLLRN-----LGCLDEDVARVYIAEVVLALEYL 705
+ C E+ LV+E+ GDL + LR+ +DV + EV L +L
Sbjct: 59 QCLGQ--CIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL 116
Query: 706 HSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS 736
H +H DL N + D +K+ D+GL+
Sbjct: 117 HQADFIHSDLALRNCQLTADLSVKIGDYGLA 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|240158 cd05119, RIO, RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Score = 42.1 bits (100), Expect = 4e-04
Identities = 19/73 (26%), Positives = 34/73 (46%), Gaps = 9/73 (12%)
Query: 666 LVMEYLNGGDLYS-LLRNLGCLDEDVARVY---IAEVVLALEYLHSLRVVHRDLKPDNLL 721
LVME++ G + + L+++ L ED +Y + + +VH DL N+L
Sbjct: 92 LVMEFIGGDGIPAPRLKDVR-LLEDPEELYDQILELMRKLY---REAGLVHGDLSEYNIL 147
Query: 722 IAHDGHIKLTDFG 734
+ DG + + D
Sbjct: 148 V-DDGKVYIIDVP 159
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They function as non-ribosomal factors necessary for late 18S rRNA processing. RIO1 is also required for proper cell cycle progression and chromosome maintenance. The biological substrates for RIO kinases are still unknown. Length = 187 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 6e-04
Identities = 18/90 (20%), Positives = 45/90 (50%), Gaps = 8/90 (8%)
Query: 653 RFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVH 712
R +Y F E L + + + + C ++ + + + +++ LEY+H + H
Sbjct: 98 RMYYRFILLEKLVE--------NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISH 149
Query: 713 RDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742
D+KP+N+++ + + D+G++ +I+
Sbjct: 150 GDIKPENIMVDGNNRGYIIDYGIASHFIIH 179
|
Length = 294 |
| >gnl|CDD|240168 cd05145, RIO1_like, RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 8e-04
Identities = 38/164 (23%), Positives = 67/164 (40%), Gaps = 30/164 (18%)
Query: 596 PISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAER--DILISVRNPFVVR 653
IS G V+ A+ G+ A+K+ K + + K+ + I + S NP +
Sbjct: 4 CISTGKEANVYHAR-TGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNP--RK 60
Query: 654 FFYSFTCRE--NLY-------------------LVMEYL-NGGDLYSLLRNLGCLDEDVA 691
+++ +E NL LVME++ + G L+++ +E+
Sbjct: 61 LVFAWAEKEFRNLKRLYEAGVPVPEPILLKKNVLVMEFIGDDGSPAPRLKDVPLEEEEAE 120
Query: 692 RVYIAEVVLALEYL-HSLRVVHRDLKPDNLLIAHDGHIKLTDFG 734
+Y +VV + L +VH DL N+L HDG + D
Sbjct: 121 ELY-EQVVEQMRRLYQEAGLVHGDLSEYNILY-HDGKPYIIDVS 162
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and chromosome maintenance. The biological substrates for RIO1 are unknown. The function of RIO3 is also unknown. Length = 190 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 8e-04
Identities = 42/155 (27%), Positives = 64/155 (41%), Gaps = 21/155 (13%)
Query: 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRF 654
K I G FG+V L + + +V+ K +R +A S+ + L + P+
Sbjct: 1 KEIGNGWFGKVILGEVNS--GYTPAQVVVKE--LRVSA--SVQEQMKFLEEAQ-PYRSLQ 53
Query: 655 FYSF-----TCRENL--YLVMEYLNGGDLYSLLR------NLGCLDEDVARVYIAEVVLA 701
+ C E LVME+ GDL LR + D + E+ L
Sbjct: 54 HSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTP-DPTTLQRMACEIALG 112
Query: 702 LEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS 736
L +LH +H DL N L+ D +K+ D+GLS
Sbjct: 113 LLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 8e-04
Identities = 36/167 (21%), Positives = 59/167 (35%), Gaps = 49/167 (29%)
Query: 594 IKPISRGAFGRVFLAKKRTTGDLFAIKVLKKA------------DMIRK--NAVESILAE 639
+ I +GA ++L D + + K + +R+ E+ +
Sbjct: 1 MDLIKQGAEAIIYL------TDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILA 54
Query: 640 RDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL--------YSLLRNLGCLDEDVA 691
+ V P +V N +VMEY+ G L LLR +G V
Sbjct: 55 KAREAGVPVP-IVYDVDPD----NGLIVMEYIEGELLKDALEEARPDLLREVG---RLVG 106
Query: 692 RVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738
+ LH +VH DL N++++ G I DFGL +
Sbjct: 107 K------------LHKAGIVHGDLTTSNIILS-GGRIYFIDFGLGEF 140
|
Length = 204 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 32/126 (25%), Positives = 49/126 (38%), Gaps = 38/126 (30%)
Query: 700 LALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLG 759
+ L+ L +LR +HR K N+L+ DG +KL G V P S
Sbjct: 22 VCLQCLGALRELHRQAKSGNILLTWDGLLKL--DGS--VAF-------KTPEQSR----- 65
Query: 760 DEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPP 819
P ++APE++ G + AD +S+GI L+E + P
Sbjct: 66 ----------------------PDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELP 103
Query: 820 FNAEHP 825
+N E
Sbjct: 104 YNEERE 109
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 52/238 (21%), Positives = 97/238 (40%), Gaps = 49/238 (20%)
Query: 618 AIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY 677
AIK LK D E E + +++P +V T + L ++ Y + DL+
Sbjct: 39 AIKTLK--DKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLH 96
Query: 678 SLL------RNLGCLDEDVARV----------YIAEVVLALEYLHSLRVVHRDLKPDNLL 721
L ++G D+D + ++ +E+L S VVH+DL N+L
Sbjct: 97 EFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVL 156
Query: 722 IAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAV 781
+ ++K++D GL + + + D + G +LL
Sbjct: 157 VFDKLNVKISDLGLFRE--VYAADYYK---LMGNSLLPIR-------------------- 191
Query: 782 GTPDYLAPEILLGTGHGTTADWWSVGIILFELI-VGIPPFNAEHPQ-VSTLLRKCQLL 837
+++PE ++ +D WS G++L+E+ G+ P+ Q V ++R Q+L
Sbjct: 192 ----WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVL 245
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 32/128 (25%), Positives = 58/128 (45%), Gaps = 30/128 (23%)
Query: 694 YIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753
Y +V +E+L S + +HRDL N+L++ + +K+ DFGL++ D P
Sbjct: 178 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR-------DIYKDP--- 227
Query: 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 813
+ +K A ++APE + + T +D WS G++L+E+
Sbjct: 228 -------------------DYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEI 268
Query: 814 I-VGIPPF 820
+G P+
Sbjct: 269 FSLGASPY 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 837 | |||
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.98 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.98 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.98 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.98 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.98 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.98 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.98 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.98 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.98 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.98 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.98 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.98 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.98 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.98 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.98 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.98 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.98 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.98 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.98 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.98 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.98 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.98 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.98 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.98 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.97 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.97 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.97 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.97 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.97 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.97 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.97 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.97 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.97 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.97 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.97 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.97 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.97 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.97 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.97 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.97 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.97 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.97 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.97 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.97 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.97 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.96 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.96 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.96 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.96 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.96 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.95 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.95 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.95 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.95 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.95 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.95 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.95 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.94 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.94 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.94 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.94 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.94 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.94 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.94 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.93 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.92 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.92 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.92 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.92 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.91 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.9 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.87 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.85 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.8 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.77 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.75 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.75 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.73 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.72 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.72 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.72 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.71 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.7 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.66 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.66 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.65 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.63 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.58 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.57 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.57 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.57 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.45 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.39 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.32 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.28 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.28 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.27 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.25 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.16 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.14 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.07 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.06 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.03 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.94 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.82 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.77 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.61 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.56 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.55 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.55 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.43 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.37 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.29 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.28 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.23 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.18 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.14 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.03 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.8 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.75 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.74 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 97.66 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.65 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.63 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.52 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.43 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.36 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.24 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.22 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.01 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.99 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.97 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 96.91 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.89 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.82 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.73 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.72 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.52 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.32 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.32 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.22 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.84 | |
| PLN02236 | 344 | choline kinase | 95.69 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.67 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.43 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.32 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.11 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 94.7 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 93.95 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 93.89 | |
| PTZ00384 | 383 | choline kinase; Provisional | 93.18 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 93.05 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 92.59 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 91.87 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 91.09 | |
| PTZ00296 | 442 | choline kinase; Provisional | 90.37 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 87.48 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 85.61 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 81.51 |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-53 Score=497.60 Aligned_cols=775 Identities=35% Similarity=0.432 Sum_probs=583.6
Q ss_pred hhhhhhhhhhhhhhhhhccc-----hhhhhhhHHHHhhhccccCchhhHHHHHHHHHHhhhcccCCcceeeeehhhhhhh
Q 003232 19 EILVVIRTKFDKAKEEVNSD-----LAVFAGDLVGILEKNAESHPEWQETIEDLLVLARSCAMTSPGEFWLQCEGIVQEL 93 (837)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 93 (837)
+.++.|+++|...++=+..| +++|++|.|-..|+.-+.-+|-|+.|++||..+..|..+.+|+||+-|++|+|-|
T Consensus 242 wamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~L 321 (1205)
T KOG0606|consen 242 WAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLL 321 (1205)
T ss_pred HHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeec
Confidence 88999999999999999999 9999999999999999999999999999999999999999999999999999999
Q ss_pred hhh---cccCCcchHHHHHHHHHHHHHhhHHHhhhhcccccccccccccccccccccccccCCCCcc---ccCCCcchHh
Q 003232 94 DDR---RQELPPGTLKQLYTRMLFILTRCTRLLQFHKESALAEDEHMFQFRQSRVLHSADKRIPQGT---LRDGKGSTIA 167 (837)
Q Consensus 94 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 167 (837)
|.- ||+++-+.+++.+.+|+||+|||+|.-||.+|.- ...|+...|||-- +.--|+++.. .+=-.-++.+
T Consensus 322 Dw~~llRqkaefvpql~~eddtsyfdTRs~Ryh~~~se~~-~~ees~~~~~qFs---scs~r~~kv~ss~~~l~~~~t~~ 397 (1205)
T KOG0606|consen 322 DWKSLLRQKAEFVPQLESEDDTSYFDTRSDRYHHFESEDT-GDEESSLEFRQFS---SCSPRFSKVYSSWESLAQLETAT 397 (1205)
T ss_pred ccchhhhhhccccccccccccchhhcccchheeeccccCC-ccccccccccccc---cccccccccccchhhhhcccccc
Confidence 999 9999999999999999999999999999999983 3344545677632 1112222211 1100011222
Q ss_pred hhhhhhcccccc---hhhhhcc--CccccccccCCcccCCCCCCCcccccChhhhhcccccccCCCCcccccccCCCccc
Q 003232 168 KASKAASSRKSY---SQEQHGL--DWKRDHAVKQGNILSPPGDDNAKSLESSAARDRMSSWKKLPSPVGKIMKESPTSKE 242 (837)
Q Consensus 168 ~~~~~~~~~~~~---~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (837)
.+.+ +.-++| ++--.+. +|++.- +.+..+-.+. +.+.-++. ++++.|+.++++--+.-+...+.+-
T Consensus 398 ~~~~--~~~~~~~~~~~~~~g~k~~~~~~s----p~~~kl~~st-~~ss~s~~--~~~s~~~~~~~~~s~~~~~~~~s~~ 468 (1205)
T KOG0606|consen 398 PREK--SSQSSQGEVSPSSAGQKDSWKSNS----PESSKLELST-ALSSVSPN--HPGSPSKSLTSAASTLRTALRTSSP 468 (1205)
T ss_pred cccc--ccccccccccCCccccccccccCC----hhhhhccccc-hhhhcccc--cCCCccccccchhhhhccccccCCC
Confidence 2222 222222 2211111 355432 2222222222 22222222 7999999999999999999999999
Q ss_pred cCCCccccccccccccCCcccccccCCCCCCchhhhhhccc---cccCcccccccCCCCccCCCCcceeeecccccCCCc
Q 003232 243 QNDGKVEPLKSSNIRRGLSEIDLTAKPSEFPPAAETLEHSS---KHQHKVSWGYWGDQQNISDDSSSIICRICEEEVPTS 319 (837)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (837)
++|+++.|+...--+ --.++-..+-|+.+...+-++ .--+.--|+.|++-+-+.-. .+.||||||.+.|+.
T Consensus 469 ~~ds~~~~~~~~p~~-----~~~~~~~~~~~~~~~~~~~~s~~~~d~s~~~~~~r~~~~~v~~~-d~~i~~~~e~~~p~~ 542 (1205)
T KOG0606|consen 469 SEDSKIFPLRAPPPP-----SSYASEEPESPKPKFSVSPESGQPGDDSEALDRSRLWSKCVGTS-DSGICRICEAEGPRL 542 (1205)
T ss_pred CCCccccccCCCCCc-----cccccCCCCCCCcccccCCCCCCcccchhhhccccccccccccC-Ccccccccccccccc
Confidence 999999998633222 122233333333333221111 11223449999888877665 788999999999999
Q ss_pred ccccccchhhhhccccccCCccchhHHHHHHHHHHHHHHhhhcc-ccccccCCcccccccCCcccccccCCCCccccccc
Q 003232 320 HVEDHSKICAIADRCDQKGLSVNERLLRISETLEKMMESSVQKD-IHNVVVGSPDVAKVSNSSVTEESDVLSPKFSDWSR 398 (837)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (837)
|.|.|++||.++++|+-++++++.|+.+|.+-+++...|..-+- ... -|+|.-.-.|+.+ .-|+..| +-+.|||
T Consensus 543 ~~e~~~~~~~~~~ks~~~s~e~~~~~~kv~ks~s~~alS~~i~s~~~~--~~~~l~s~lS~~~--~sS~p~S-rdsspsr 617 (1205)
T KOG0606|consen 543 HSENHSRICKHQAKSELNSIEVKSRLRKVNKSLSASALSLMINSSDTP--TGGPLCSPLSPRS--LSSNPSS-RDSSPSR 617 (1205)
T ss_pred cccCcchHHHhhhhcccCccccccchhhHHHHHHhhhcccccccccCC--cccccccccCCCC--CCCCccc-Ccccccc
Confidence 99999999999999999999999999999999999988865433 222 2455555555433 3455556 9999999
Q ss_pred cCccccccccccCCCcccccccCCCCCcccccccCCCCCCCCccCCCCCCCCCCCCCCCCcchhhhhhhccCCCCCCCCc
Q 003232 399 RGSEDMLDYVPEADNSVFMDDLKGLPSMACKTRFGPKSDQGMTTSSAGSMTPRSPLLTPRTSQIDLLLAGKGALSEHDDF 478 (837)
Q Consensus 399 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 478 (837)
++|+.|+++.|.-+..-.-+.+. +-.|+-+.-.|-++ .-..-++.++-++-||+-+++..|.||+.-+++-...-=+.
T Consensus 618 d~s~~~~~~~ppI~i~~~~~~yG-ft~~airVy~Gd~d-~ytvhh~v~sv~egsPA~~agls~~DlIthvnge~v~gl~H 695 (1205)
T KOG0606|consen 618 DSSAAMLSLRPPITIHFSGKKYG-FTLRAIRVYMGDKD-VYTVHHSVGSVEEGSPAFEAGLSAGDLITHVNGEPVHGLVH 695 (1205)
T ss_pred ccchhhcCcCCceeeeccccccC-ceeeeEEEecCCcc-cceeeeeeeeecCCCCccccCCCccceeEeccCcccchhhH
Confidence 99999999999777665555544 66777777778887 55556889999999999999999999999888877766667
Q ss_pred cchhhHHh--hhhhc-CCCCCCCCCCcchhhhhhcceeEEEecCCCccchHHhHH-HHHHHHHHHHHHHhhhhccCCCCc
Q 003232 479 PQMNELAD--IARCV-ATTPLDDDSSIPYLLSFLEDLRVVIDRRKFDALTVETFG-ARIEKLIREKYLQLCELVTDDKVD 554 (837)
Q Consensus 479 ~~~~~~~~--i~~~~-~~~P~~~~~~l~~ll~~l~dvRv~id~Rk~~slT~es~~-~ri~kl~reky~~Lcelvs~dkld 554 (837)
+|+++|.. ++++. .++|+ ++.++-+.-.-..+..-++.+|+-.++..|.++ +|+.+++++.|.+.|.+..++...
T Consensus 696 ~ev~~Lll~~gn~v~~~ttpl-enTSik~g~arr~~~k~~m~~R~kk~~~~E~~~~rr~~kLlr~~~~q~~~l~~~~~s~ 774 (1205)
T KOG0606|consen 696 TEVMELLLKSGNKVTLRTTPL-ENTSIKSGPARRDSYKAVMARRKKKALVPETFGIRRIEKLLRKISKQDCELLHTSRSF 774 (1205)
T ss_pred HHHHHHHHhcCCeeEEEeecc-ccchhhhhHHHHHHHHHHHhhcccccccccccccccHHHHHHHHHhhhhhhhcccccc
Confidence 99988655 77554 45566 445565655545555666678899999999999 889999999999999887765443
Q ss_pred ccccccCCCCCCchhhhccccCCCCCCCCCCcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHH
Q 003232 555 ITSTVIEEDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVE 634 (837)
Q Consensus 555 l~st~Iee~~~lEeE~i~sl~ss~~~P~k~g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie 634 (837)
......+..+..+.....+..|.+.....+.+.+.+-+-.|.++.++.+.-..+|-..+.|+............+
T Consensus 775 -----~ss~eS~pgdp~~sls~sP~sp~~yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~ 849 (1205)
T KOG0606|consen 775 -----LSSSESLPGDPTRSLSASPRSPTKYRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYE 849 (1205)
T ss_pred -----ccccccCCCCcccccccCCCCcccccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhcccccc
Confidence 122222233345555555666665667788999999999999999999988888877888877666555555555
Q ss_pred HHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccc
Q 003232 635 SILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRD 714 (837)
Q Consensus 635 ~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRD 714 (837)
....+..++-...+|.++.....+......+|+++|++|++|...+++.+..+.+.++.++..+..+++|||+..++|+|
T Consensus 850 s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~ 929 (1205)
T KOG0606|consen 850 SIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRD 929 (1205)
T ss_pred ccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhccc
Confidence 66666666666678999988887888889999999999999999999988889889999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEEecC-CccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhc
Q 003232 715 LKPDNLLIAHDGHIKLTDFG-LSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL 793 (837)
Q Consensus 715 IKPeNILLd~dG~IKLiDFG-LArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLl 793 (837)
++|.|+++..+|+.++.||| +...+..+......+...+++................ ..+......||+.|.+||.+.
T Consensus 930 ~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~~~t~~~laPe~~l 1008 (1205)
T KOG0606|consen 930 LKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSAD-EARRKHAVVGTPDYLAPEILL 1008 (1205)
T ss_pred ccccchhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccc-hhhccccccCCCcccCCcccc
Confidence 99999999999999999999 6666777776666555444443322222222222221 334566788999999999999
Q ss_pred CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCcC
Q 003232 794 GTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826 (837)
Q Consensus 794 g~~~s~kSDIWSLGVILyELLTGr~PF~~~dpd 826 (837)
+....+.+|+|++|+++++.++|.+||....++
T Consensus 1009 g~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq 1041 (1205)
T KOG0606|consen 1009 GRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQ 1041 (1205)
T ss_pred cccCCCcchhhhhhhhhhhhhcCCCCCCCcchh
Confidence 999999999999999999999999999988765
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=391.31 Aligned_cols=244 Identities=50% Similarity=0.833 Sum_probs=204.4
Q ss_pred CCcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCe
Q 003232 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCREN 663 (837)
Q Consensus 584 ~g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ 663 (837)
.....++|++++.||+|+||.||+|+.+.+|..+|+|++++..+.....++.+..|..+|....+|+||++|.+|++..+
T Consensus 136 ~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~ 215 (550)
T KOG0605|consen 136 TRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEY 215 (550)
T ss_pred ccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCe
Confidence 35577899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCC
Q 003232 664 LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~s 743 (837)
+||||||++||++..++.+.+.|++..++.|+.+++.||+.||..|+|||||||+|+|||..|++||+|||+|.......
T Consensus 216 LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~ 295 (550)
T KOG0605|consen 216 LYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH 295 (550)
T ss_pred eEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999995321111
Q ss_pred CCCCCC------CCccCcc----------cCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHH
Q 003232 744 TDDLSG------PAVSGTT----------LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVG 807 (837)
Q Consensus 744 tddl~~------p~~Sgtt----------Ll~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLG 807 (837)
..+... ...+... ..+..............+....+.+|||.|||||++.+.+|+..+|+||||
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG 375 (550)
T KOG0605|consen 296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG 375 (550)
T ss_pred hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence 111000 0000000 000000111112222333445678999999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCCCCcCH
Q 003232 808 IILFELIVGIPPFNAEHPQV 827 (837)
Q Consensus 808 VILyELLTGr~PF~~~dpdv 827 (837)
|||||||.|.+||.+++|+.
T Consensus 376 ~ImyEmLvGyPPF~s~tp~~ 395 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSETPQE 395 (550)
T ss_pred HHHHHHHhCCCCCCCCCHHH
Confidence 99999999999999998864
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=378.13 Aligned_cols=209 Identities=52% Similarity=0.959 Sum_probs=194.5
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEE
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 665 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ly 665 (837)
...++|++++.||+|+||.||.++.+.+++.||+|++++.............+|..+|..++||+||+++..|++..++|
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 44678999999999999999999999999999999999988777778899999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCC
Q 003232 666 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745 (837)
Q Consensus 666 LVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~std 745 (837)
+|+||+.||.|+-++.+.+.+++..++.|+.+|+.||.|||++|||||||||+|||++.+|+++|+|||+|+.....
T Consensus 102 lVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~--- 178 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD--- 178 (357)
T ss_pred EEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccC---
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999842111
Q ss_pred CCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 746 dl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
...+.+.|||+.|||||++.+.+|+..+|+||||+++|||++|.+||.+.+.
T Consensus 179 ----------------------------~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~ 230 (357)
T KOG0598|consen 179 ----------------------------GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV 230 (357)
T ss_pred ----------------------------CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH
Confidence 1223468999999999999999999999999999999999999999998763
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=371.90 Aligned_cols=208 Identities=36% Similarity=0.690 Sum_probs=188.7
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEE
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 665 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ly 665 (837)
....+|.+.+.||.|+||+||+|+++.++..||||.+.+... .....+.+..|+.+|+.++|||||.+++++...+++|
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~ 85 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIY 85 (429)
T ss_pred cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEE
Confidence 456789999999999999999999999999999999987653 5666788999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccC------CcEEEEecCCcccc
Q 003232 666 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD------GHIKLTDFGLSKVG 739 (837)
Q Consensus 666 LVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~d------G~IKLiDFGLArvg 739 (837)
+|||||+||+|.+++++.+.+++..++.++.||+.||++||+++||||||||+|||++.. -.+||+|||+|+..
T Consensus 86 lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 86 LVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 999999999999999999999999999999999999999999999999999999999764 45899999999842
Q ss_pred ccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCC
Q 003232 740 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPP 819 (837)
Q Consensus 740 ~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~P 819 (837)
. ......+.||+|.|||||++....|+.|+|+||+|+++|++++|++|
T Consensus 166 ~--------------------------------~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~P 213 (429)
T KOG0595|consen 166 Q--------------------------------PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPP 213 (429)
T ss_pred C--------------------------------chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCC
Confidence 1 11223467999999999999999999999999999999999999999
Q ss_pred CCCCCcC
Q 003232 820 FNAEHPQ 826 (837)
Q Consensus 820 F~~~dpd 826 (837)
|...++.
T Consensus 214 f~a~t~~ 220 (429)
T KOG0595|consen 214 FDAETPK 220 (429)
T ss_pred ccccCHH
Confidence 9976644
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=353.73 Aligned_cols=206 Identities=45% Similarity=0.900 Sum_probs=195.3
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEE
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 665 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ly 665 (837)
..+++|+.++.||.|+||.|.+++++.+|.+||+|++.+.......+.+...+|.++|+.+.||+++++++.|.+..++|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 56789999999999999999999999999999999999988888888899999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCC
Q 003232 666 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745 (837)
Q Consensus 666 LVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~std 745 (837)
+||||++||.|+.++++.+.+++..++.|+.||+.||+|||+++|++|||||+|||+|.+|.+||.|||+|+..
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v------ 194 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRV------ 194 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEe------
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999730
Q ss_pred CCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 746 dl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
..++.+.||||.|+|||++...+|+..+|+|||||++|||+.|.+||...++
T Consensus 195 ----------------------------~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~ 246 (355)
T KOG0616|consen 195 ----------------------------SGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP 246 (355)
T ss_pred ----------------------------cCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence 1124577999999999999999999999999999999999999999998877
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=374.08 Aligned_cols=204 Identities=35% Similarity=0.657 Sum_probs=191.6
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVm 668 (837)
..|...+.||+|||+.||.+++..+|..||+|++.+..+......+.+.+|+++.+.|+|||||+++++|.+.+++|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 45999999999999999999999999999999999888778888899999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCC
Q 003232 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (837)
Q Consensus 669 Ey~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~ 748 (837)
|+|..++|..++++.+.++|.+++.+++||+.||.|||+++|||||||..|+|++.+.++||+|||+|....
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le-------- 169 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLE-------- 169 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeec--------
Confidence 999999999999999999999999999999999999999999999999999999999999999999997411
Q ss_pred CCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003232 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823 (837)
Q Consensus 749 ~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~ 823 (837)
....++.+.||||.|+|||++...+++..+||||+||+||-||+|++||...
T Consensus 170 -----------------------~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk 221 (592)
T KOG0575|consen 170 -----------------------YDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK 221 (592)
T ss_pred -----------------------CcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc
Confidence 1124567889999999999999999999999999999999999999999764
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=351.09 Aligned_cols=203 Identities=33% Similarity=0.634 Sum_probs=185.7
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCe-E
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCREN-L 664 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~-l 664 (837)
...++.+.+..||+|+.|+||+++|+.+++.+|+|++.-. .+....+++.+|+++++.++|||||++|++|..... +
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i 153 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI 153 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence 4556788899999999999999999999999999999433 456677899999999999999999999999999984 9
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCcEEEccCCcEEEEecCCccccccCC
Q 003232 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHS-kGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~s 743 (837)
+|+||||+||||.+++...+.+++..+..++.+|++||.|||+ ++||||||||+|||++..|.+||||||.++...
T Consensus 154 sI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv--- 230 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILV--- 230 (364)
T ss_pred EeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhh---
Confidence 9999999999999999988999999999999999999999995 999999999999999999999999999987310
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~ 823 (837)
.....+.+||..|||||.+.+..|+.++||||||++++|+.+|+.||...
T Consensus 231 ------------------------------nS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~ 280 (364)
T KOG0581|consen 231 ------------------------------NSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP 280 (364)
T ss_pred ------------------------------hhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc
Confidence 01345789999999999999999999999999999999999999999886
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=357.28 Aligned_cols=209 Identities=36% Similarity=0.632 Sum_probs=183.4
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEeccccccc----HHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIR----KNAVESILAERDILISVRNPFVVRFFYSFTCRE 662 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~----~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~ 662 (837)
..+.|.+.+.||+|+||.|-+|..+.+|+.||||++++..... ......+.+|+++|++|+|||||+++++|....
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 4456999999999999999999999999999999998754332 223345679999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccC---CcEEEEecCCcccc
Q 003232 663 NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD---GHIKLTDFGLSKVG 739 (837)
Q Consensus 663 ~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~d---G~IKLiDFGLArvg 739 (837)
..||||||+.||.|.+.+-.++.+.+..-+.+++||+.||.|||++||+||||||+|||+..+ -.+||+|||+|++.
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~ 329 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS 329 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence 999999999999999999999999999999999999999999999999999999999999766 67999999999851
Q ss_pred ccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCC---CchHHHHHHHHHHHHHHcC
Q 003232 740 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH---GTTADWWSVGIILFELIVG 816 (837)
Q Consensus 740 ~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~---s~kSDIWSLGVILyELLTG 816 (837)
. ......+.||||.|.|||++.+.++ ..++|||||||++|-+|+|
T Consensus 330 g--------------------------------~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG 377 (475)
T KOG0615|consen 330 G--------------------------------EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSG 377 (475)
T ss_pred c--------------------------------cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEecc
Confidence 0 1122457899999999999987654 3478999999999999999
Q ss_pred CCCCCCCCcCH
Q 003232 817 IPPFNAEHPQV 827 (837)
Q Consensus 817 r~PF~~~dpdv 827 (837)
.+||.....+.
T Consensus 378 ~pPFS~~~~~~ 388 (475)
T KOG0615|consen 378 YPPFSEEYTDP 388 (475)
T ss_pred CCCcccccCCc
Confidence 99999876554
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=360.40 Aligned_cols=224 Identities=39% Similarity=0.748 Sum_probs=196.8
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEeEeecCCe
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCREN 663 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~gsf~d~~~ 663 (837)
....++|.+.+.||.|+|++|++|+.+.+++.||||++.+..+..+...+.+..|..+|.+| .||.|+++|..|+++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 34557899999999999999999999999999999999988888888888999999999999 89999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCC
Q 003232 664 LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~s 743 (837)
+|+|+||+++|.|.+++++.+.|++..++.|+.||+.||+|||++|||||||||+|||++.+|+++|.|||.|++.....
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999998633222
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~ 823 (837)
..+- .+.. + ........+++||..|.+||++.....++.+|||+||||+|+|+.|.+||.+.
T Consensus 229 ~~~~-~~~~----------~-------~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~ 290 (604)
T KOG0592|consen 229 KSQE-NPVD----------P-------NQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAA 290 (604)
T ss_pred cccc-CccC----------c-------ccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccc
Confidence 2110 0000 0 00011135789999999999999999999999999999999999999999886
Q ss_pred CcC
Q 003232 824 HPQ 826 (837)
Q Consensus 824 dpd 826 (837)
+.-
T Consensus 291 Ney 293 (604)
T KOG0592|consen 291 NEY 293 (604)
T ss_pred cHH
Confidence 543
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=336.37 Aligned_cols=237 Identities=44% Similarity=0.793 Sum_probs=187.2
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVm 668 (837)
++|++++.||+|+||+||+|++..+++.||+|++.............+.+|+.++..++||||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998755444555677889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCC
Q 003232 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (837)
Q Consensus 669 Ey~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~ 748 (837)
||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++...........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999998742111100000
Q ss_pred CCC----ccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 749 GPA----VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 749 ~p~----~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
... .....+.......................+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~ 240 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCC
Confidence 000 0000000000000000000001111235689999999999999999999999999999999999999998765
Q ss_pred c
Q 003232 825 P 825 (837)
Q Consensus 825 p 825 (837)
+
T Consensus 241 ~ 241 (363)
T cd05628 241 P 241 (363)
T ss_pred H
Confidence 4
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=334.74 Aligned_cols=237 Identities=44% Similarity=0.785 Sum_probs=186.6
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVm 668 (837)
++|++++.||.|+||+||+|++..+++.||||++.............+.+|+.+++.++||||+++++.+....++|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998654444555667889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCC
Q 003232 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (837)
Q Consensus 669 Ey~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~ 748 (837)
||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++...........
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999998642211110000
Q ss_pred CCCccCc-----c--cCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCC
Q 003232 749 GPAVSGT-----T--LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFN 821 (837)
Q Consensus 749 ~p~~Sgt-----t--Ll~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~ 821 (837)
....... . ........................+||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~ 240 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC 240 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCC
Confidence 0000000 0 00000000000000000111234579999999999999999999999999999999999999998
Q ss_pred CCCc
Q 003232 822 AEHP 825 (837)
Q Consensus 822 ~~dp 825 (837)
..++
T Consensus 241 ~~~~ 244 (364)
T cd05599 241 SDNP 244 (364)
T ss_pred CCCH
Confidence 7653
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=340.88 Aligned_cols=215 Identities=31% Similarity=0.557 Sum_probs=187.2
Q ss_pred CCcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEe-EeecCC
Q 003232 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFY-SFTCRE 662 (837)
Q Consensus 584 ~g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~g-sf~d~~ 662 (837)
....+.+|+|+++||.|+||+||++....+|..+|+|.+.-.. .+....+.+..|+.+|++|+|||||++++ .|..++
T Consensus 14 ~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~-md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ 92 (375)
T KOG0591|consen 14 PQKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM-MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN 92 (375)
T ss_pred CcccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhh-ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence 4556778999999999999999999999999999999998543 45556678999999999999999999998 666666
Q ss_pred e-EEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh--CC--cccccCCCCcEEEccCCcEEEEec
Q 003232 663 N-LYLVMEYLNGGDLYSLLRN----LGCLDEDVARVYIAEVVLALEYLHS--LR--VVHRDLKPDNLLIAHDGHIKLTDF 733 (837)
Q Consensus 663 ~-lyLVmEy~~GGSL~dlLk~----~g~Lsee~irkIl~QIa~ALsYLHS--kG--IIHRDIKPeNILLd~dG~IKLiDF 733 (837)
. ++||||||.+|+|.++++. ...+++..+++++.|++.||.++|+ .. |+||||||.||+++.+|.+||+||
T Consensus 93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf 172 (375)
T KOG0591|consen 93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF 172 (375)
T ss_pred hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence 5 8999999999999999853 3569999999999999999999998 44 999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHH
Q 003232 734 GLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 813 (837)
Q Consensus 734 GLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyEL 813 (837)
|++++.... ..-..+.+|||.||+||.+.+.+|+.++|||||||++|||
T Consensus 173 GL~r~l~s~-------------------------------~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEM 221 (375)
T KOG0591|consen 173 GLGRFLSSK-------------------------------TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEM 221 (375)
T ss_pred hhHhHhcch-------------------------------hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHH
Confidence 999852111 1124578999999999999999999999999999999999
Q ss_pred HcCCCCCCCCCcCHHHHHH
Q 003232 814 IVGIPPFNAEHPQVSTLLR 832 (837)
Q Consensus 814 LTGr~PF~~~dpdv~~lle 832 (837)
..=.+||.++ ++..+.+
T Consensus 222 caL~~PF~g~--n~~~L~~ 238 (375)
T KOG0591|consen 222 CALQSPFYGD--NLLSLCK 238 (375)
T ss_pred HhcCCCcccc--cHHHHHH
Confidence 9999999987 4444443
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=357.31 Aligned_cols=210 Identities=41% Similarity=0.822 Sum_probs=191.8
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcC-CCceEEEEeEeecCCe
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCREN 663 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~Lr-HPNIVkL~gsf~d~~~ 663 (837)
...+++|.++++||+|+||+|+++..+.+++.||||++++..+...+.++..+.|.+|+.... ||+++.++..|+..++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 556789999999999999999999999999999999999999999999999999999998775 9999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCC
Q 003232 664 LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~s 743 (837)
+|.||||+.||++..+. ..+.+++..++.|+..|+.||.|||++|||+||||.+|||+|.+|++||+|||+++-+...
T Consensus 444 l~fvmey~~Ggdm~~~~-~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~- 521 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHI-HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ- 521 (694)
T ss_pred EEEEEEecCCCcEEEEE-ecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCC-
Confidence 99999999999955443 3377999999999999999999999999999999999999999999999999999842211
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~ 823 (837)
+..+.+.||||.|||||++.+..|+..+|+|||||+|||||.|..||.++
T Consensus 522 ------------------------------g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd 571 (694)
T KOG0694|consen 522 ------------------------------GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGD 571 (694)
T ss_pred ------------------------------CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 12356789999999999999999999999999999999999999999987
Q ss_pred CcC
Q 003232 824 HPQ 826 (837)
Q Consensus 824 dpd 826 (837)
+.+
T Consensus 572 dEe 574 (694)
T KOG0694|consen 572 DEE 574 (694)
T ss_pred CHH
Confidence 654
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=330.26 Aligned_cols=207 Identities=43% Similarity=0.871 Sum_probs=185.6
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeE
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~l 664 (837)
...+++|++.+.||.|+||.||+|+++.+++.||+|++.............+.+|+.+++.++||||+++++++...+.+
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 93 (329)
T PTZ00263 14 SWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRV 93 (329)
T ss_pred CCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEE
Confidence 44568899999999999999999999999999999999865444445567789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCC
Q 003232 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~st 744 (837)
|+||||+.|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 94 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~---- 169 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP---- 169 (329)
T ss_pred EEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcC----
Confidence 9999999999999999888889999999999999999999999999999999999999999999999999986310
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 745 ddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||...+
T Consensus 170 ------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 219 (329)
T PTZ00263 170 ------------------------------DRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT 219 (329)
T ss_pred ------------------------------CCcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC
Confidence 00113468999999999999999999999999999999999999998755
Q ss_pred c
Q 003232 825 P 825 (837)
Q Consensus 825 p 825 (837)
+
T Consensus 220 ~ 220 (329)
T PTZ00263 220 P 220 (329)
T ss_pred H
Confidence 3
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=323.05 Aligned_cols=203 Identities=43% Similarity=0.860 Sum_probs=181.7
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVm 668 (837)
++|++.+.||.|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46999999999999999999999999999999997654333445567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCC
Q 003232 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (837)
Q Consensus 669 Ey~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~ 748 (837)
||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++...
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~-------- 152 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR-------- 152 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhcc--------
Confidence 999999999999888889999999999999999999999999999999999999999999999999986310
Q ss_pred CCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 749 ~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||...++
T Consensus 153 --------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~ 203 (291)
T cd05612 153 --------------------------DRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP 203 (291)
T ss_pred --------------------------CCcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 001234689999999999999999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=333.78 Aligned_cols=237 Identities=44% Similarity=0.781 Sum_probs=185.4
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVm 668 (837)
++|++++.||.|+||+||++.+..+++.||+|++.............+.+|+.+++.++||||++++++|....++|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46999999999999999999999999999999997654444556678899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCC
Q 003232 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (837)
Q Consensus 669 Ey~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~ 748 (837)
||++||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||+++...........
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999998631110000000
Q ss_pred ----CCCcc-----CcccCCCCCccch-------hhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHH
Q 003232 749 ----GPAVS-----GTTLLGDEEPQLT-------ASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFE 812 (837)
Q Consensus 749 ----~p~~S-----gttLl~~~~~~~~-------~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyE 812 (837)
..... ............. ..............+||+.|+|||++.+..++.++|||||||++|+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e 240 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhh
Confidence 00000 0000000000000 0000000001124579999999999999999999999999999999
Q ss_pred HHcCCCCCCCCCc
Q 003232 813 LIVGIPPFNAEHP 825 (837)
Q Consensus 813 LLTGr~PF~~~dp 825 (837)
|++|..||...++
T Consensus 241 lltG~~Pf~~~~~ 253 (377)
T cd05629 241 CLIGWPPFCSENS 253 (377)
T ss_pred hhcCCCCCCCCCH
Confidence 9999999987654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=333.74 Aligned_cols=238 Identities=45% Similarity=0.779 Sum_probs=186.0
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVm 668 (837)
.+|++++.||+|+||+||+|++..+++.||+|++.............+.+|+.+++.++||||+++++.+...+++|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36999999999999999999999999999999997654333445567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCC
Q 003232 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (837)
Q Consensus 669 Ey~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~ 748 (837)
||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++............
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999998532111100000
Q ss_pred CC-------CccCcccCCCCC--ccch---hhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcC
Q 003232 749 GP-------AVSGTTLLGDEE--PQLT---ASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVG 816 (837)
Q Consensus 749 ~p-------~~SgttLl~~~~--~~~~---~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTG 816 (837)
.. ............ +... ..............+||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G 240 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 240 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhC
Confidence 00 000000000000 0000 00000001112346899999999999999999999999999999999999
Q ss_pred CCCCCCCCcC
Q 003232 817 IPPFNAEHPQ 826 (837)
Q Consensus 817 r~PF~~~dpd 826 (837)
+.||...++.
T Consensus 241 ~~Pf~~~~~~ 250 (376)
T cd05598 241 QPPFLADTPA 250 (376)
T ss_pred CCCCCCCCHH
Confidence 9999876643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=332.77 Aligned_cols=237 Identities=46% Similarity=0.770 Sum_probs=187.0
Q ss_pred CeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEE
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmE 669 (837)
.|++++.||+|+||+||+|++..+++.||+|++.............+.+|+.+++.++||||+++++.+....++|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 58999999999999999999999999999999987554455566789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCC
Q 003232 670 YLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 749 (837)
Q Consensus 670 y~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~ 749 (837)
|++||+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.+++++|+|||+++............
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~ 161 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ 161 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccc
Confidence 99999999999888889999999999999999999999999999999999999999999999999976321111000000
Q ss_pred -------CCccCcccCCC--------CCccchh-hhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHH
Q 003232 750 -------PAVSGTTLLGD--------EEPQLTA-SEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 813 (837)
Q Consensus 750 -------p~~SgttLl~~--------~~~~~~~-~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyEL 813 (837)
.......+... ....... .............+||+.|+|||++.+..++.++|||||||++|+|
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~el 241 (381)
T cd05626 162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM 241 (381)
T ss_pred ccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHH
Confidence 00000000000 0000000 0000001112356899999999999999999999999999999999
Q ss_pred HcCCCCCCCCCcC
Q 003232 814 IVGIPPFNAEHPQ 826 (837)
Q Consensus 814 LTGr~PF~~~dpd 826 (837)
++|..||...++.
T Consensus 242 ltG~~Pf~~~~~~ 254 (381)
T cd05626 242 LVGQPPFLAPTPT 254 (381)
T ss_pred HhCCCCCcCCCHH
Confidence 9999999876654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=337.61 Aligned_cols=207 Identities=41% Similarity=0.735 Sum_probs=182.9
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccc-c-HHHHHHHHHHHHHHHhcC-CCceEEEEeEeecCC
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMI-R-KNAVESILAERDILISVR-NPFVVRFFYSFTCRE 662 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~-~-~e~ie~~~rEieILk~Lr-HPNIVkL~gsf~d~~ 662 (837)
.....|.+.+.||.|+||+|++|++..++..||+|++...... . ....+.+.+|+.+++.++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 4456799999999999999999999999999999988764221 1 133456778999999999 999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccC-CcEEEEecCCcccccc
Q 003232 663 NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD-GHIKLTDFGLSKVGLI 741 (837)
Q Consensus 663 ~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~d-G~IKLiDFGLArvg~~ 741 (837)
.+|+||||+.||+|++++.+.+++.+..++.+++||+.|++|||++||+||||||+|||++.+ +++||+|||++....
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~- 172 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP- 172 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC-
Confidence 999999999999999999998999999999999999999999999999999999999999999 999999999987421
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCC-CC-chHHHHHHHHHHHHHHcCCCC
Q 003232 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-HG-TTADWWSVGIILFELIVGIPP 819 (837)
Q Consensus 742 ~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~-~s-~kSDIWSLGVILyELLTGr~P 819 (837)
. ......+.+||+.|+|||++.+.. |+ .++||||+||+||-|++|+.|
T Consensus 173 -~-----------------------------~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~P 222 (370)
T KOG0583|consen 173 -G-----------------------------EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLP 222 (370)
T ss_pred -C-----------------------------CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCC
Confidence 0 011234679999999999999987 85 889999999999999999999
Q ss_pred CCCC
Q 003232 820 FNAE 823 (837)
Q Consensus 820 F~~~ 823 (837)
|...
T Consensus 223 F~d~ 226 (370)
T KOG0583|consen 223 FDDS 226 (370)
T ss_pred CCCc
Confidence 9873
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=332.61 Aligned_cols=237 Identities=47% Similarity=0.785 Sum_probs=186.3
Q ss_pred CeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEE
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmE 669 (837)
.|+++++||+|+||+||+|++..+++.||+|++.............+.+|+.+++.++||||+++++.+....++|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 58999999999999999999999999999999986554445566788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCC
Q 003232 670 YLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 749 (837)
Q Consensus 670 y~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~ 749 (837)
|++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.++|+|||++.............
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~ 161 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccc
Confidence 99999999999887889999999999999999999999999999999999999999999999999975321111000000
Q ss_pred CC---------ccCcc----c--CCCCCccchhhh-hHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHH
Q 003232 750 PA---------VSGTT----L--LGDEEPQLTASE-HQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 813 (837)
Q Consensus 750 p~---------~Sgtt----L--l~~~~~~~~~~~-~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyEL 813 (837)
.. ++... . .++......... ...........+||+.|+|||++.+..++.++|||||||++|+|
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~el 241 (382)
T cd05625 162 SGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 241 (382)
T ss_pred cccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHH
Confidence 00 00000 0 000000000000 00001112346799999999999999999999999999999999
Q ss_pred HcCCCCCCCCCcC
Q 003232 814 IVGIPPFNAEHPQ 826 (837)
Q Consensus 814 LTGr~PF~~~dpd 826 (837)
++|+.||...++.
T Consensus 242 ltG~~Pf~~~~~~ 254 (382)
T cd05625 242 LVGQPPFLAQTPL 254 (382)
T ss_pred HhCCCCCCCCCHH
Confidence 9999999876543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=325.99 Aligned_cols=203 Identities=49% Similarity=0.904 Sum_probs=183.2
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVm 668 (837)
++|++++.||.|+||.||+|++..+++.||+|++.............+.+|+.++..++||||+++++++....+.|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36999999999999999999999999999999998654434445677889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCC
Q 003232 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (837)
Q Consensus 669 Ey~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~ 748 (837)
||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~------- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT------- 153 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-------
Confidence 9999999999998888899999999999999999999999999999999999999999999999999863100
Q ss_pred CCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 749 ~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
......||+.|+|||++.+..++.++|||||||++|+|++|..||...++
T Consensus 154 ---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~ 203 (333)
T cd05600 154 ---------------------------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203 (333)
T ss_pred ---------------------------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH
Confidence 12345799999999999999999999999999999999999999987554
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=330.55 Aligned_cols=238 Identities=45% Similarity=0.811 Sum_probs=187.7
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVm 668 (837)
++|++++.||+|+||+||+|+++.+++.||+|++.............+.+|+.++..++||||+++++.+....++|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46999999999999999999999999999999998655444556678889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCC
Q 003232 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (837)
Q Consensus 669 Ey~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~ 748 (837)
||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.++|+|||++............
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999998632111110000
Q ss_pred C----CCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 749 G----PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 749 ~----p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
. .......+.......................+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~ 240 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCC
Confidence 0 000000000000000000000001111234689999999999999999999999999999999999999998766
Q ss_pred cC
Q 003232 825 PQ 826 (837)
Q Consensus 825 pd 826 (837)
+.
T Consensus 241 ~~ 242 (360)
T cd05627 241 PQ 242 (360)
T ss_pred HH
Confidence 53
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=337.18 Aligned_cols=204 Identities=34% Similarity=0.570 Sum_probs=178.7
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcE-EEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC-eEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDL-FAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE-NLY 665 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~-VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~-~ly 665 (837)
..++.+.+.||.|+||+||++.++ |.. ||+|++......... .+.|.+|+.+|.+++|||||++++++.... .++
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~ 116 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLC 116 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceE
Confidence 345666677999999999999986 555 999999876544444 789999999999999999999999999887 799
Q ss_pred EEEEecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC-cccccCCCCcEEEccCC-cEEEEecCCcccccc
Q 003232 666 LVMEYLNGGDLYSLLRN--LGCLDEDVARVYIAEVVLALEYLHSLR-VVHRDLKPDNLLIAHDG-HIKLTDFGLSKVGLI 741 (837)
Q Consensus 666 LVmEy~~GGSL~dlLk~--~g~Lsee~irkIl~QIa~ALsYLHSkG-IIHRDIKPeNILLd~dG-~IKLiDFGLArvg~~ 741 (837)
|||||+++|+|.+++.. ...++...+..++.||++||+|||+++ ||||||||+|||++.++ ++||+|||+++....
T Consensus 117 iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 117 IVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred EEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 99999999999999987 578999999999999999999999999 99999999999999998 999999999974111
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhc--CCCCCchHHHHHHHHHHHHHHcCCCC
Q 003232 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL--GTGHGTTADWWSVGIILFELIVGIPP 819 (837)
Q Consensus 742 ~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLl--g~~~s~kSDIWSLGVILyELLTGr~P 819 (837)
.. .......||+.|||||++. +..|+.++||||||+++|||+||+.|
T Consensus 197 ~~-------------------------------~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~P 245 (362)
T KOG0192|consen 197 SK-------------------------------TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIP 245 (362)
T ss_pred cc-------------------------------ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCC
Confidence 00 1122367999999999999 66999999999999999999999999
Q ss_pred CCCCCc
Q 003232 820 FNAEHP 825 (837)
Q Consensus 820 F~~~dp 825 (837)
|....+
T Consensus 246 f~~~~~ 251 (362)
T KOG0192|consen 246 FEDLAP 251 (362)
T ss_pred CCCCCH
Confidence 998776
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=328.29 Aligned_cols=209 Identities=44% Similarity=0.857 Sum_probs=185.0
Q ss_pred CCcccCCeEEEEEecccCceEEEEEEECCCC-cEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC
Q 003232 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTG-DLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE 662 (837)
Q Consensus 584 ~g~~lddYeIlkkLGsG~FGtVYkArdk~tG-~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~ 662 (837)
.....++|++.+.||.|+||.||+|.+..++ ..||+|++.............+.+|+.+++.++||||+++++++....
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 104 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES 104 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence 4556788999999999999999999876655 689999997654444455677889999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccC
Q 003232 663 NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (837)
Q Consensus 663 ~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~ 742 (837)
.+|+||||+.||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++...
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~-- 182 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD-- 182 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecC--
Confidence 999999999999999999888889999999999999999999999999999999999999999999999999986310
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003232 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNA 822 (837)
Q Consensus 743 stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~ 822 (837)
. ......||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 183 -~-------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~ 230 (340)
T PTZ00426 183 -T-------------------------------RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYA 230 (340)
T ss_pred -C-------------------------------CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCC
Confidence 0 01234689999999999999999999999999999999999999987
Q ss_pred CCcC
Q 003232 823 EHPQ 826 (837)
Q Consensus 823 ~dpd 826 (837)
.++.
T Consensus 231 ~~~~ 234 (340)
T PTZ00426 231 NEPL 234 (340)
T ss_pred CCHH
Confidence 6653
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=330.27 Aligned_cols=209 Identities=27% Similarity=0.502 Sum_probs=181.7
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVm 668 (837)
+.|+.+.++|+|+||.||+|+++.+|+.||||.+.... .++...+-.++|+++|++++|||+|.++++|.....+++|+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 56899999999999999999999999999999997654 34555667899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCC
Q 003232 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (837)
Q Consensus 669 Ey~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~ 748 (837)
|||+..-|.++-+....++.+.++.|+.|++.|+.|+|++++|||||||+|||++.+|.+||||||+|+.... .
T Consensus 81 E~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--p---- 154 (396)
T KOG0593|consen 81 EYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA--P---- 154 (396)
T ss_pred eecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC--C----
Confidence 9997766666555556699999999999999999999999999999999999999999999999999984211 0
Q ss_pred CCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCcCH
Q 003232 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHPQV 827 (837)
Q Consensus 749 ~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLTGr~PF~~~dpdv 827 (837)
....+.++.|.+|+|||.+.| .+|+..+||||+||++.||++|.+.|.+.++ +
T Consensus 155 -------------------------gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SD-i 208 (396)
T KOG0593|consen 155 -------------------------GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSD-I 208 (396)
T ss_pred -------------------------cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcch-H
Confidence 111235677899999999998 7899999999999999999999999877654 4
Q ss_pred HHH
Q 003232 828 STL 830 (837)
Q Consensus 828 ~~l 830 (837)
+|+
T Consensus 209 DQL 211 (396)
T KOG0593|consen 209 DQL 211 (396)
T ss_pred HHH
Confidence 444
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=322.43 Aligned_cols=200 Identities=44% Similarity=0.803 Sum_probs=177.3
Q ss_pred EEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEEecCCC
Q 003232 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGG 674 (837)
Q Consensus 595 kkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmEy~~GG 674 (837)
+.||+|+||.||+|++..+|+.||+|++.............+.+|+.+++.++||||+++++.+....++|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999999999999999998654444555667889999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCCCccC
Q 003232 675 DLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 754 (837)
Q Consensus 675 SL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~Sg 754 (837)
+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~------------ 148 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD------------ 148 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC------------
Confidence 99999988888999999999999999999999999999999999999999999999999998631000
Q ss_pred cccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 755 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 755 ttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 149 -------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~ 200 (323)
T cd05571 149 -------------------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 200 (323)
T ss_pred -------------------CCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH
Confidence 0011245799999999999999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=347.20 Aligned_cols=203 Identities=37% Similarity=0.663 Sum_probs=185.0
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLV 667 (837)
+++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+.. ..+..++.+.+|+++++.++||||+.+++.|....++|+|
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g-r~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG-RNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcC-CchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence 367999999999999999999999999999999998765 3455678899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCC
Q 003232 668 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (837)
Q Consensus 668 mEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl 747 (837)
+||+.| +|+.++...+.++++.++.++.+++.||.|||+.+|+|||+||.|||++..|++|+||||+|+....
T Consensus 80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~------ 152 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST------ 152 (808)
T ss_pred ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc------
Confidence 999976 9999999999999999999999999999999999999999999999999999999999999984100
Q ss_pred CCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003232 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823 (837)
Q Consensus 748 ~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~ 823 (837)
+ ....+...|||.|||||+..+.+|+..+|+|||||++||+++|++||...
T Consensus 153 ------~-------------------t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~ 203 (808)
T KOG0597|consen 153 ------N-------------------TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR 203 (808)
T ss_pred ------C-------------------ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH
Confidence 0 01234668999999999999999999999999999999999999999763
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=321.64 Aligned_cols=235 Identities=49% Similarity=0.875 Sum_probs=187.2
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVm 668 (837)
++|++.+.||.|+||+||+|++..+++.||+|++.............+.+|+.++..++||||+++++.+....++|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46999999999999999999999999999999998755444455677899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCC
Q 003232 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (837)
Q Consensus 669 Ey~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~ 748 (837)
||+.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++............
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 99999999999988788999999999999999999999999999999999999999999999999998742211100000
Q ss_pred CCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 749 ~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
... ........... .................||+.|+|||++.+..++.++|||||||++|+|++|+.||...++
T Consensus 161 ~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 161 LND-SHNLLFRDNVL-VRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred ccc-ccccccccccc-ccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 000 00000000000 0000000111123356799999999999999999999999999999999999999987663
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=316.13 Aligned_cols=205 Identities=40% Similarity=0.806 Sum_probs=179.6
Q ss_pred CeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCC-ceEEEEeEeecCCeEEEEE
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP-FVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHP-NIVkL~gsf~d~~~lyLVm 668 (837)
+|++++.||.|+||.||+|++..+++.||+|++...........+.+..|..++..++|+ +|+++++.+...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 589999999999999999999999999999999875444445567788999999999765 6888999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCC
Q 003232 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (837)
Q Consensus 669 Ey~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~ 748 (837)
||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~----- 155 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG----- 155 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-----
Confidence 999999999999888889999999999999999999999999999999999999999999999999876210000
Q ss_pred CCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 749 ~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.
T Consensus 156 --------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~ 206 (324)
T cd05587 156 --------------------------KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE 206 (324)
T ss_pred --------------------------CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH
Confidence 011245699999999999999999999999999999999999999986553
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=309.90 Aligned_cols=204 Identities=35% Similarity=0.631 Sum_probs=177.8
Q ss_pred CeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEE
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmE 669 (837)
.|++.+.||+|+||+||+|.+..+++.||+|.+.............+.+|+.+++.++|+||+++++.+...+.+|+|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 38899999999999999999999999999999876543333444567899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCC
Q 003232 670 YLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (837)
Q Consensus 670 y~~GGSL~dlLk~~--g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl 747 (837)
|+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~----- 155 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG----- 155 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-----
Confidence 99999999887543 35899999999999999999999999999999999999999999999999998631000
Q ss_pred CCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 748 ~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus 156 ---------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~ 206 (285)
T cd05631 156 ---------------------------ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE 206 (285)
T ss_pred ---------------------------CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCc
Confidence 001234689999999999999999999999999999999999999987554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=318.45 Aligned_cols=200 Identities=42% Similarity=0.798 Sum_probs=176.6
Q ss_pred EEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEEecCCC
Q 003232 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGG 674 (837)
Q Consensus 595 kkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmEy~~GG 674 (837)
+.||+|+||.||++++..+|..||+|++.............+.+|+.+++.++||||+++++.|.....+|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36899999999999999999999999998654444455667889999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCCCccC
Q 003232 675 DLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 754 (837)
Q Consensus 675 SL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~Sg 754 (837)
+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~----------- 149 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG----------- 149 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-----------
Confidence 999999888889999999999999999999999999999999999999999999999999876210000
Q ss_pred cccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 755 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 755 ttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 150 --------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~ 200 (323)
T cd05595 150 --------------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 200 (323)
T ss_pred --------------------CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH
Confidence 011235699999999999999999999999999999999999999976554
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=315.28 Aligned_cols=205 Identities=39% Similarity=0.786 Sum_probs=179.4
Q ss_pred CeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEeEeecCCeEEEEE
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~gsf~d~~~lyLVm 668 (837)
+|++++.||+|+||.||+|++..+++.||+|++.+...........+..|..++..+ +|++|+++++++...+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 589999999999999999999999999999999865433444556677888888776 5899999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCC
Q 003232 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (837)
Q Consensus 669 Ey~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~ 748 (837)
||+++|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~----- 155 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG----- 155 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-----
Confidence 999999999999888889999999999999999999999999999999999999999999999999986210000
Q ss_pred CCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 749 ~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.
T Consensus 156 --------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~ 206 (323)
T cd05616 156 --------------------------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 206 (323)
T ss_pred --------------------------CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH
Confidence 012245799999999999999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=315.39 Aligned_cols=197 Identities=44% Similarity=0.879 Sum_probs=175.4
Q ss_pred ecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEEecCCCCH
Q 003232 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 676 (837)
Q Consensus 597 LGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmEy~~GGSL 676 (837)
||+|+||.||+|++..+++.||+|++.............+.+|+.+++.++||||+++++.+......|+||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999999999999999999999765444455567788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCCCccCcc
Q 003232 677 YSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 756 (837)
Q Consensus 677 ~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~Sgtt 756 (837)
.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~------------- 147 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD------------- 147 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-------------
Confidence 9999888889999999999999999999999999999999999999999999999999986310000
Q ss_pred cCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 757 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 757 Ll~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||...+
T Consensus 148 ------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~ 197 (312)
T cd05585 148 ------------------DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN 197 (312)
T ss_pred ------------------CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC
Confidence 01124579999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=330.51 Aligned_cols=242 Identities=39% Similarity=0.656 Sum_probs=197.4
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeE
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~l 664 (837)
...++.|++++.||.|.-|+||+++.+.++..+|+|++.+..+.....+.+...|.+||+.++||+++.+|..|..+...
T Consensus 73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~ 152 (459)
T KOG0610|consen 73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYS 152 (459)
T ss_pred ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecccee
Confidence 34456799999999999999999999999999999999998888888889999999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccC
Q 003232 665 YLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~--g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~ 742 (837)
|+|||||+||+|..+++++ +.+++..++.|+.+++-||+|||-.|||.|||||+|||+.++|++.|+||.++......
T Consensus 153 cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 153 CLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred EEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 9999999999999998765 56999999999999999999999999999999999999999999999999998643221
Q ss_pred CCCCCC------CCCccCcc-cCCCCCccchhh------------------hhHHhhhhccCCCCCCCccChhhhcCCCC
Q 003232 743 STDDLS------GPAVSGTT-LLGDEEPQLTAS------------------EHQQERRKKRSAVGTPDYLAPEILLGTGH 797 (837)
Q Consensus 743 stddl~------~p~~Sgtt-Ll~~~~~~~~~~------------------~~~~~~~k~~s~vGTp~YmAPEVLlg~~~ 797 (837)
.+-... ....+... ......+..... -......+..+.+||-.|+|||++.|.+.
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 110000 00000000 000111110000 00112345678899999999999999999
Q ss_pred CchHHHHHHHHHHHHHHcCCCCCCCCCcC
Q 003232 798 GTTADWWSVGIILFELIVGIPPFNAEHPQ 826 (837)
Q Consensus 798 s~kSDIWSLGVILyELLTGr~PF~~~dpd 826 (837)
+.++|+|+||+++||||+|..||.+.+..
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~ 341 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNK 341 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCch
Confidence 99999999999999999999999986654
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=318.12 Aligned_cols=200 Identities=42% Similarity=0.818 Sum_probs=177.1
Q ss_pred EEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEEecCCC
Q 003232 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGG 674 (837)
Q Consensus 595 kkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmEy~~GG 674 (837)
+.||+|+||.||++++..+++.||+|++.............+.+|+.+++.++||||+++++.+.....+|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999999999999999998654444556678889999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCCCccC
Q 003232 675 DLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 754 (837)
Q Consensus 675 SL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~Sg 754 (837)
+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~----------- 149 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA----------- 149 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-----------
Confidence 999999888889999999999999999999999999999999999999999999999999986311000
Q ss_pred cccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 755 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 755 ttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 150 --------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~ 200 (328)
T cd05593 150 --------------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 200 (328)
T ss_pred --------------------cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH
Confidence 011235699999999999999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=343.89 Aligned_cols=214 Identities=35% Similarity=0.637 Sum_probs=194.4
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLV 667 (837)
..-|++.+.||.|+.|.|.+|++..+|+.+|||++.+...........+.+|+-+|+.+.||||+++|++|....++|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 45599999999999999999999999999999999876445555567889999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCC
Q 003232 668 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (837)
Q Consensus 668 mEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl 747 (837)
.||++||.|++++-..+++++.++.++++||+.|+.|+|..+|+|||+||+|+|++..++|||+|||+|.+...
T Consensus 91 lEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~------ 164 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVP------ 164 (786)
T ss_pred EEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccC------
Confidence 99999999999999999999999999999999999999999999999999999999999999999999974111
Q ss_pred CCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCC-CchHHHHHHHHHHHHHHcCCCCCCCCCcC
Q 003232 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVGIPPFNAEHPQ 826 (837)
Q Consensus 748 ~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~-s~kSDIWSLGVILyELLTGr~PF~~~dpd 826 (837)
..-..+.||+|.|.|||++.|.+| +.++||||.|||||.||+|++||+ +++
T Consensus 165 --------------------------gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd--DdN 216 (786)
T KOG0588|consen 165 --------------------------GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD--DDN 216 (786)
T ss_pred --------------------------CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC--Ccc
Confidence 112346799999999999999998 689999999999999999999998 788
Q ss_pred HHHHHHhcc
Q 003232 827 VSTLLRKCQ 835 (837)
Q Consensus 827 v~~lle~~h 835 (837)
+..++.+++
T Consensus 217 ir~LLlKV~ 225 (786)
T KOG0588|consen 217 IRVLLLKVQ 225 (786)
T ss_pred HHHHHHHHH
Confidence 888887764
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=324.56 Aligned_cols=207 Identities=44% Similarity=0.812 Sum_probs=179.1
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLV 667 (837)
.++|++.+.||.|+||.||++++..+++.||+|++.+...........+.+|+.+++.++||||+++++.+....++|+|
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV 121 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 36799999999999999999999999999999999764433344456688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCC
Q 003232 668 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (837)
Q Consensus 668 mEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl 747 (837)
|||++||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... ...
T Consensus 122 ~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~--~~~-- 196 (370)
T cd05621 122 MEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD--ETG-- 196 (370)
T ss_pred EcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecc--cCC--
Confidence 999999999999876 458999999999999999999999999999999999999999999999999986310 000
Q ss_pred CCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCC----CCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003232 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG----HGTTADWWSVGIILFELIVGIPPFNAE 823 (837)
Q Consensus 748 ~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~----~s~kSDIWSLGVILyELLTGr~PF~~~ 823 (837)
.......+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...
T Consensus 197 --------------------------~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~ 250 (370)
T cd05621 197 --------------------------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD 250 (370)
T ss_pred --------------------------ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC
Confidence 00112457999999999997643 778999999999999999999999876
Q ss_pred Cc
Q 003232 824 HP 825 (837)
Q Consensus 824 dp 825 (837)
+.
T Consensus 251 ~~ 252 (370)
T cd05621 251 SL 252 (370)
T ss_pred CH
Confidence 53
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=324.16 Aligned_cols=210 Identities=45% Similarity=0.816 Sum_probs=181.0
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeE
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~l 664 (837)
....++|++.+.||.|+||.||+|++..+++.||+|++.............+.+|+.+++.++||||+++++.+....++
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 118 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 34457899999999999999999999999999999999764433444456688999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCC
Q 003232 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~st 744 (837)
|+||||++|++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 119 ~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~- 196 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG- 196 (371)
T ss_pred EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC-
Confidence 999999999999999876 458999999999999999999999999999999999999999999999999986311000
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCC----CCchHHHHHHHHHHHHHHcCCCCC
Q 003232 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG----HGTTADWWSVGIILFELIVGIPPF 820 (837)
Q Consensus 745 ddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~----~s~kSDIWSLGVILyELLTGr~PF 820 (837)
.......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||
T Consensus 197 -----------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf 247 (371)
T cd05622 197 -----------------------------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247 (371)
T ss_pred -----------------------------cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCC
Confidence 00112457999999999997643 788999999999999999999999
Q ss_pred CCCCc
Q 003232 821 NAEHP 825 (837)
Q Consensus 821 ~~~dp 825 (837)
.+.+.
T Consensus 248 ~~~~~ 252 (371)
T cd05622 248 YADSL 252 (371)
T ss_pred CCCCH
Confidence 87654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=336.59 Aligned_cols=216 Identities=35% Similarity=0.574 Sum_probs=188.0
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecC--CeEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR--ENLY 665 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~--~~ly 665 (837)
.+.|+.+++||+|.||.||+|++..+|+.||+|.+.... .......-..+|+.||++|+||||+++.+..... ..+|
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~-~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDN-EKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeeccc-CCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 456999999999999999999999999999999998765 3455667788999999999999999999998876 6899
Q ss_pred EEEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCC
Q 003232 666 LVMEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (837)
Q Consensus 666 LVmEy~~GGSL~dlLk~~g-~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~st 744 (837)
||+|||+ -+|.-++...+ .|++.+++-|+.||+.||+|||++||+|||||.+||||+.+|.+||+|||+|++......
T Consensus 195 lVFeYMd-hDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~ 273 (560)
T KOG0600|consen 195 LVFEYMD-HDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS 273 (560)
T ss_pred EEEeccc-chhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCC
Confidence 9999995 48888877643 599999999999999999999999999999999999999999999999999986322222
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003232 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAE 823 (837)
Q Consensus 745 ddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLTGr~PF~~~ 823 (837)
. ..+..+-|..|+|||.++| ..|+..+|+||.||||.||++|++.|.+.
T Consensus 274 ~------------------------------~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~ 323 (560)
T KOG0600|consen 274 A------------------------------PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGR 323 (560)
T ss_pred c------------------------------ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCc
Confidence 1 1345678999999999998 56899999999999999999999998775
Q ss_pred CcCHHHHHHhccc
Q 003232 824 HPQVSTLLRKCQL 836 (837)
Q Consensus 824 dpdv~~lle~~hL 836 (837)
.++.|+..+++|
T Consensus 324 -tEveQl~kIfkl 335 (560)
T KOG0600|consen 324 -TEVEQLHKIFKL 335 (560)
T ss_pred -cHHHHHHHHHHH
Confidence 567788877765
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=308.26 Aligned_cols=205 Identities=30% Similarity=0.565 Sum_probs=173.8
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLV 667 (837)
.++|++.+.||.|+||+||+|++..+++.||+|++..... ......+.+|+.+++.++||||+++++++......|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 3679999999999999999999999999999999875431 12234567899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCC
Q 003232 668 MEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (837)
Q Consensus 668 mEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stdd 746 (837)
|||+. ++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--- 157 (303)
T cd07869 82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS--- 157 (303)
T ss_pred EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC---
Confidence 99995 6788777653 568999999999999999999999999999999999999999999999999986310000
Q ss_pred CCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 747 l~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..+
T Consensus 158 ----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 209 (303)
T cd07869 158 ----------------------------HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD 209 (303)
T ss_pred ----------------------------ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc
Confidence 01123468899999999876 4578999999999999999999999987654
Q ss_pred C
Q 003232 826 Q 826 (837)
Q Consensus 826 d 826 (837)
.
T Consensus 210 ~ 210 (303)
T cd07869 210 I 210 (303)
T ss_pred H
Confidence 3
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=312.79 Aligned_cols=202 Identities=42% Similarity=0.798 Sum_probs=175.0
Q ss_pred eEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHH---HhcCCCceEEEEeEeecCCeEEEE
Q 003232 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDIL---ISVRNPFVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 591 YeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieIL---k~LrHPNIVkL~gsf~d~~~lyLV 667 (837)
|++++.||.|+||.||+|.+..+++.||+|+++..........+.+.+|.+++ +.++||||+++++++....++|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 78899999999999999999999999999999865433344456677777665 466799999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCC
Q 003232 668 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (837)
Q Consensus 668 mEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl 747 (837)
|||++|++|..++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~----- 154 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF----- 154 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC-----
Confidence 999999999988865 57999999999999999999999999999999999999999999999999987621100
Q ss_pred CCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 748 ~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+
T Consensus 155 --------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~ 205 (324)
T cd05589 155 --------------------------GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD 205 (324)
T ss_pred --------------------------CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Confidence 011234579999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=303.19 Aligned_cols=205 Identities=34% Similarity=0.546 Sum_probs=177.1
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVm 668 (837)
++|++.+.||.|+||+||+|+++.+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.....+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 469999999999999999999999999999999976432 2334567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCC
Q 003232 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (837)
Q Consensus 669 Ey~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~ 748 (837)
||++++.+..+......+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---- 155 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN---- 155 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc----
Confidence 9999887776665556799999999999999999999999999999999999999999999999999863110000
Q ss_pred CCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 749 ~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
.......||+.|+|||++.+..++.++|||||||++|+|++|++||...+
T Consensus 156 --------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~ 205 (287)
T cd07848 156 --------------------------ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGES 205 (287)
T ss_pred --------------------------ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCC
Confidence 01123468999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=315.76 Aligned_cols=206 Identities=45% Similarity=0.797 Sum_probs=178.6
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVm 668 (837)
++|++.+.||+|+||+||++++..+++.||+|++.+...........+.+|..++..++|+||+++++.+...++.|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999997644334444566888999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCC
Q 003232 669 EYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (837)
Q Consensus 669 Ey~~GGSL~dlLk~-~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl 747 (837)
||+.||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~--- 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT--- 157 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc---
Confidence 99999999999976 46799999999999999999999999999999999999999999999999999863110000
Q ss_pred CCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-----CCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003232 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-----TGHGTTADWWSVGIILFELIVGIPPFNA 822 (837)
Q Consensus 748 ~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-----~~~s~kSDIWSLGVILyELLTGr~PF~~ 822 (837)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..
T Consensus 158 ---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 210 (331)
T cd05624 158 ---------------------------VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred ---------------------------eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence 01123469999999999876 4578899999999999999999999976
Q ss_pred CC
Q 003232 823 EH 824 (837)
Q Consensus 823 ~d 824 (837)
.+
T Consensus 211 ~~ 212 (331)
T cd05624 211 ES 212 (331)
T ss_pred CC
Confidence 54
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=320.97 Aligned_cols=208 Identities=43% Similarity=0.787 Sum_probs=179.3
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEE
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyL 666 (837)
..++|++.+.||.|+||.||++++..+++.||+|++.............+.+|+.+++.++||||+++++++....++|+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 45679999999999999999999999999999999976443334445567899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCC
Q 003232 667 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stdd 746 (837)
||||++||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.... ...
T Consensus 121 v~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~--~~~- 196 (370)
T cd05596 121 VMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD--ANG- 196 (370)
T ss_pred EEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeecc--CCC-
Confidence 9999999999999876 468899999999999999999999999999999999999999999999999986310 000
Q ss_pred CCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCC----CCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003232 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT----GHGTTADWWSVGIILFELIVGIPPFNA 822 (837)
Q Consensus 747 l~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~----~~s~kSDIWSLGVILyELLTGr~PF~~ 822 (837)
.......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+
T Consensus 197 ---------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~ 249 (370)
T cd05596 197 ---------------------------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249 (370)
T ss_pred ---------------------------cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCC
Confidence 0011245799999999998754 378899999999999999999999987
Q ss_pred CCc
Q 003232 823 EHP 825 (837)
Q Consensus 823 ~dp 825 (837)
.+.
T Consensus 250 ~~~ 252 (370)
T cd05596 250 DSL 252 (370)
T ss_pred CCH
Confidence 654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=313.48 Aligned_cols=206 Identities=46% Similarity=0.837 Sum_probs=177.9
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVm 668 (837)
++|++++.||+|+||+||++++..+++.||+|++.+...........+.+|+.+++.++|+||+++++.+....++|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999997644344445567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCC
Q 003232 669 EYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (837)
Q Consensus 669 Ey~~GGSL~dlLk~-~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl 747 (837)
||++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--- 157 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT--- 157 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC---
Confidence 99999999999976 45699999999999999999999999999999999999999999999999999862110000
Q ss_pred CCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-----CCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003232 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-----TGHGTTADWWSVGIILFELIVGIPPFNA 822 (837)
Q Consensus 748 ~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-----~~~s~kSDIWSLGVILyELLTGr~PF~~ 822 (837)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..
T Consensus 158 ---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 158 ---------------------------VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred ---------------------------ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 01122469999999999973 4467899999999999999999999976
Q ss_pred CC
Q 003232 823 EH 824 (837)
Q Consensus 823 ~d 824 (837)
.+
T Consensus 211 ~~ 212 (331)
T cd05597 211 ES 212 (331)
T ss_pred CC
Confidence 54
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=315.28 Aligned_cols=200 Identities=44% Similarity=0.808 Sum_probs=176.0
Q ss_pred EEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEEecCCC
Q 003232 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGG 674 (837)
Q Consensus 595 kkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmEy~~GG 674 (837)
+.||.|+||.||++++..+++.||+|++.............+.+|+.+++.++||||+++++.+.....+|+||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999999999999999998754444455667889999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCCCcc
Q 003232 675 DLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753 (837)
Q Consensus 675 SL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHS-kGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~S 753 (837)
+|..++...+.+++..++.++.||+.||.|||+ .||+||||||+|||++.++.++|+|||+++......
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~---------- 150 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG---------- 150 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC----------
Confidence 999999887889999999999999999999997 899999999999999999999999999986311000
Q ss_pred CcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 754 gttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 151 ---------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~ 201 (325)
T cd05594 151 ---------------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 201 (325)
T ss_pred ---------------------cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH
Confidence 011234699999999999999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=311.43 Aligned_cols=205 Identities=39% Similarity=0.792 Sum_probs=178.8
Q ss_pred CeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcC-CCceEEEEeEeecCCeEEEEE
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~Lr-HPNIVkL~gsf~d~~~lyLVm 668 (837)
+|++.+.||.|+||+||+|+++.+++.||+|++...........+.+..|..+++.+. |++|+++++++...+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4788999999999999999999999999999998654334455567888999988875 577888999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCC
Q 003232 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (837)
Q Consensus 669 Ey~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~ 748 (837)
||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++......
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~----- 155 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG----- 155 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC-----
Confidence 999999999999888889999999999999999999999999999999999999999999999999986210000
Q ss_pred CCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 749 ~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.++
T Consensus 156 --------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~ 206 (323)
T cd05615 156 --------------------------VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE 206 (323)
T ss_pred --------------------------ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH
Confidence 011245689999999999999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=311.92 Aligned_cols=200 Identities=43% Similarity=0.827 Sum_probs=173.2
Q ss_pred EEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHh-cCCCceEEEEeEeecCCeEEEEEEecCC
Q 003232 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILIS-VRNPFVVRFFYSFTCRENLYLVMEYLNG 673 (837)
Q Consensus 595 kkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~-LrHPNIVkL~gsf~d~~~lyLVmEy~~G 673 (837)
+.||+|+||.||+|++..+++.||+|+++..........+.+..|..++.. .+||||+++++.+.....+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999999999999999999986543334445566677777765 4899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCCCcc
Q 003232 674 GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753 (837)
Q Consensus 674 GSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~S 753 (837)
++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++......
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~---------- 150 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE---------- 150 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC----------
Confidence 9999999888889999999999999999999999999999999999999999999999999986310000
Q ss_pred CcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 754 gttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.
T Consensus 151 ---------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~ 201 (316)
T cd05592 151 ---------------------GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE 201 (316)
T ss_pred ---------------------CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH
Confidence 112245799999999999999999999999999999999999999987553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=314.38 Aligned_cols=207 Identities=43% Similarity=0.803 Sum_probs=180.4
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVm 668 (837)
++|++.+.||.|+||+||++++..+++.||+|+++............+.+|+.+++.++||||+++++.+.....+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46999999999999999999999999999999998755444556677889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCC
Q 003232 669 EYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (837)
Q Consensus 669 Ey~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl 747 (837)
||+++++|.+++... +.+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~--- 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM--- 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc---
Confidence 999999999999875 6799999999999999999999999999999999999999999999999999863110000
Q ss_pred CCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhc------CCCCCchHHHHHHHHHHHHHHcCCCCCC
Q 003232 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL------GTGHGTTADWWSVGIILFELIVGIPPFN 821 (837)
Q Consensus 748 ~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLl------g~~~s~kSDIWSLGVILyELLTGr~PF~ 821 (837)
.......||+.|+|||++. +..++.++|||||||++|+|++|..||.
T Consensus 158 ---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 210 (330)
T cd05601 158 ---------------------------VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH 210 (330)
T ss_pred ---------------------------eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCC
Confidence 0112346899999999987 4567899999999999999999999997
Q ss_pred CCCc
Q 003232 822 AEHP 825 (837)
Q Consensus 822 ~~dp 825 (837)
..+.
T Consensus 211 ~~~~ 214 (330)
T cd05601 211 EGTS 214 (330)
T ss_pred CCCH
Confidence 6543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=303.03 Aligned_cols=205 Identities=30% Similarity=0.550 Sum_probs=174.5
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEE
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyL 666 (837)
.+++|++.+.||.|+||+||+|++..++..||+|+++.... ......+.+|+.+++.++||||+++++++......|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 80 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTL 80 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 35679999999999999999999999999999999875431 1223467789999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCC
Q 003232 667 VMEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~~g-~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~std 745 (837)
||||+.+ +|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 81 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-- 157 (288)
T cd07871 81 VFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-- 157 (288)
T ss_pred EEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC--
Confidence 9999975 8999887544 47899999999999999999999999999999999999999999999999986310000
Q ss_pred CCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 746 dl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
.......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+
T Consensus 158 -----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~ 208 (288)
T cd07871 158 -----------------------------KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGST 208 (288)
T ss_pred -----------------------------ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 01123467899999999876 568999999999999999999999998765
Q ss_pred c
Q 003232 825 P 825 (837)
Q Consensus 825 p 825 (837)
.
T Consensus 209 ~ 209 (288)
T cd07871 209 V 209 (288)
T ss_pred H
Confidence 3
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=311.88 Aligned_cols=200 Identities=42% Similarity=0.814 Sum_probs=175.3
Q ss_pred EEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEeEeecCCeEEEEEEecCC
Q 003232 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLVMEYLNG 673 (837)
Q Consensus 595 kkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~gsf~d~~~lyLVmEy~~G 673 (837)
+.||.|+||.||+|++..+++.||+|++.............+..|.+++..+ +||||+++++++.....+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 3689999999999999999999999999875444455566778899998865 799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCCCcc
Q 003232 674 GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753 (837)
Q Consensus 674 GSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~S 753 (837)
++|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~---------- 150 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG---------- 150 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCC----------
Confidence 9999999888889999999999999999999999999999999999999999999999999986311000
Q ss_pred CcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 754 gttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||...++
T Consensus 151 ---------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~ 201 (321)
T cd05591 151 ---------------------VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE 201 (321)
T ss_pred ---------------------ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH
Confidence 011234689999999999999999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=312.32 Aligned_cols=206 Identities=44% Similarity=0.814 Sum_probs=177.8
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVm 668 (837)
++|++.++||+|+||.||+++++.+++.||+|++.+...........+.+|+.++..++|+||+++++.+.....+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999997644333444556888999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCC
Q 003232 669 EYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (837)
Q Consensus 669 Ey~~GGSL~dlLk~-~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl 747 (837)
||+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~---- 156 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG---- 156 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCC----
Confidence 99999999999976 4678999999999999999999999999999999999999999999999999986311000
Q ss_pred CCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhc-----CCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003232 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-----GTGHGTTADWWSVGIILFELIVGIPPFNA 822 (837)
Q Consensus 748 ~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLl-----g~~~s~kSDIWSLGVILyELLTGr~PF~~ 822 (837)
.......+||+.|+|||++. ...++.++|||||||++|+|++|+.||..
T Consensus 157 --------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~ 210 (332)
T cd05623 157 --------------------------TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (332)
T ss_pred --------------------------cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC
Confidence 00112357999999999986 34578899999999999999999999986
Q ss_pred CC
Q 003232 823 EH 824 (837)
Q Consensus 823 ~d 824 (837)
.+
T Consensus 211 ~~ 212 (332)
T cd05623 211 ES 212 (332)
T ss_pred CC
Confidence 54
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=311.76 Aligned_cols=200 Identities=41% Similarity=0.816 Sum_probs=175.0
Q ss_pred EEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEeEeecCCeEEEEEEecCC
Q 003232 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLVMEYLNG 673 (837)
Q Consensus 595 kkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~gsf~d~~~lyLVmEy~~G 673 (837)
+.||+|+||+||+|+++.+++.||+|++.+...........+..|..++..+ +||||+++++++.....+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 3689999999999999999999999999865433445566778888888876 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCCCcc
Q 003232 674 GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753 (837)
Q Consensus 674 GSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~S 753 (837)
++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++......
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~---------- 150 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG---------- 150 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC----------
Confidence 9999999888889999999999999999999999999999999999999999999999999976210000
Q ss_pred CcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 754 gttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 151 ---------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~ 201 (320)
T cd05590 151 ---------------------KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE 201 (320)
T ss_pred ---------------------CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH
Confidence 011234699999999999999999999999999999999999999987553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=305.52 Aligned_cols=205 Identities=29% Similarity=0.468 Sum_probs=173.2
Q ss_pred CeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecC-----CeE
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR-----ENL 664 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~-----~~l 664 (837)
+|++.+.||.|+||.||+|++..+++.||+|.+.... ........+.+|+.+++.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh-ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 5899999999999999999999999999999987432 1223345788999999999999999999887543 358
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCC
Q 003232 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~st 744 (837)
|+||||+ +++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.......
T Consensus 80 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 80 YVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred EEEEecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 9999999 579999998878899999999999999999999999999999999999999999999999999873111000
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC--CCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003232 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG--TGHGTTADWWSVGIILFELIVGIPPFNA 822 (837)
Q Consensus 745 ddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg--~~~s~kSDIWSLGVILyELLTGr~PF~~ 822 (837)
. ........||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+
T Consensus 159 ~----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~ 210 (338)
T cd07859 159 T----------------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 210 (338)
T ss_pred c----------------------------cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 0 001124579999999999876 6789999999999999999999999976
Q ss_pred CC
Q 003232 823 EH 824 (837)
Q Consensus 823 ~d 824 (837)
.+
T Consensus 211 ~~ 212 (338)
T cd07859 211 KN 212 (338)
T ss_pred CC
Confidence 54
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=312.34 Aligned_cols=197 Identities=37% Similarity=0.743 Sum_probs=174.3
Q ss_pred EEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEeEeecCCeEEEEEEecCC
Q 003232 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLVMEYLNG 673 (837)
Q Consensus 595 kkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~gsf~d~~~lyLVmEy~~G 673 (837)
+.||.|+||.||+|++..+++.||+|+++............+.+|..+++.+ +||||+++++++.....+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 3689999999999999999999999999875444445566788999999888 799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCCCcc
Q 003232 674 GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753 (837)
Q Consensus 674 GSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~S 753 (837)
++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++......
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~---------- 150 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG---------- 150 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCC----------
Confidence 9999999887889999999999999999999999999999999999999999999999999986210000
Q ss_pred CcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003232 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNA 822 (837)
Q Consensus 754 gttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~ 822 (837)
......+||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 151 ---------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 151 ---------------------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred ---------------------CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 011235799999999999999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=310.15 Aligned_cols=199 Identities=44% Similarity=0.879 Sum_probs=171.6
Q ss_pred EEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHH-HHHhcCCCceEEEEeEeecCCeEEEEEEecCC
Q 003232 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERD-ILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 673 (837)
Q Consensus 595 kkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEie-ILk~LrHPNIVkL~gsf~d~~~lyLVmEy~~G 673 (837)
+.||.|+||.||+|++..+++.||+|++.+...........+..|.. +++.++||||+++++.+...+..|+||||++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999999999999999997654333334455556654 57889999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCCCcc
Q 003232 674 GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753 (837)
Q Consensus 674 GSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~S 753 (837)
++|..++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~---------- 150 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE---------- 150 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC----------
Confidence 9999999887889999999999999999999999999999999999999999999999999886210000
Q ss_pred CcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 754 gttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||...+
T Consensus 151 ---------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 200 (321)
T cd05603 151 ---------------------ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200 (321)
T ss_pred ---------------------CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC
Confidence 01123468999999999999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=311.37 Aligned_cols=199 Identities=44% Similarity=0.876 Sum_probs=171.6
Q ss_pred EEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHH-HHHhcCCCceEEEEeEeecCCeEEEEEEecCC
Q 003232 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERD-ILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 673 (837)
Q Consensus 595 kkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEie-ILk~LrHPNIVkL~gsf~d~~~lyLVmEy~~G 673 (837)
+.||.|+||+||+|++..+|+.||+|++.............+..|.. +++.++||||+++++.+.....+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36899999999999999999999999997654333334455566655 45789999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCCCcc
Q 003232 674 GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753 (837)
Q Consensus 674 GSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~S 753 (837)
++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~---------- 150 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS---------- 150 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC----------
Confidence 9999999888889999999999999999999999999999999999999999999999999886310000
Q ss_pred CcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 754 gttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||...+
T Consensus 151 ---------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 200 (323)
T cd05575 151 ---------------------KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200 (323)
T ss_pred ---------------------CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC
Confidence 01123468999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=311.64 Aligned_cols=199 Identities=43% Similarity=0.850 Sum_probs=172.0
Q ss_pred EEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHH-HHhcCCCceEEEEeEeecCCeEEEEEEecCC
Q 003232 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDI-LISVRNPFVVRFFYSFTCRENLYLVMEYLNG 673 (837)
Q Consensus 595 kkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieI-Lk~LrHPNIVkL~gsf~d~~~lyLVmEy~~G 673 (837)
+.||.|+||+||+|++..+|+.||+|++.............+..|..+ ++.++||||+++++.+...+.+|+||||+.|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 368999999999999999999999999976543333444556666654 6779999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCCCcc
Q 003232 674 GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753 (837)
Q Consensus 674 GSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~S 753 (837)
++|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~---------- 150 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS---------- 150 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC----------
Confidence 9999999888889999999999999999999999999999999999999999999999999986311000
Q ss_pred CcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 754 gttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||...+
T Consensus 151 ---------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~ 200 (325)
T cd05604 151 ---------------------DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD 200 (325)
T ss_pred ---------------------CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC
Confidence 01124568999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=310.73 Aligned_cols=200 Identities=43% Similarity=0.853 Sum_probs=170.7
Q ss_pred EEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHH-HHHhcCCCceEEEEeEeecCCeEEEEEEecCC
Q 003232 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERD-ILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 673 (837)
Q Consensus 595 kkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEie-ILk~LrHPNIVkL~gsf~d~~~lyLVmEy~~G 673 (837)
+.||+|+||+||+|++..+++.||+|++.............+..|.. +++.++||||+++++.+...+.+|+||||++|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999999999999999997644322333344455544 46789999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCCCcc
Q 003232 674 GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753 (837)
Q Consensus 674 GSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~S 753 (837)
++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++......
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~---------- 150 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN---------- 150 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC----------
Confidence 9999999888889999999999999999999999999999999999999999999999999986210000
Q ss_pred CcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 754 gttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 151 ---------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 201 (325)
T cd05602 151 ---------------------GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT 201 (325)
T ss_pred ---------------------CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH
Confidence 012245799999999999999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=308.53 Aligned_cols=204 Identities=44% Similarity=0.856 Sum_probs=175.0
Q ss_pred CeEEEEEecccCceEEEEEEEC---CCCcEEEEEEecccccc-cHHHHHHHHHHHHHHHhc-CCCceEEEEeEeecCCeE
Q 003232 590 DFEIIKPISRGAFGRVFLAKKR---TTGDLFAIKVLKKADMI-RKNAVESILAERDILISV-RNPFVVRFFYSFTCRENL 664 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk---~tG~~VAVKIikk~~~~-~~e~ie~~~rEieILk~L-rHPNIVkL~gsf~d~~~l 664 (837)
+|++++.||+|+||.||++++. .+++.||+|++.+.... .....+.+..|+.+++.+ +||||+++++.+.....+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999874 47899999999764322 233456788899999999 589999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCC
Q 003232 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~st 744 (837)
|+||||+.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++......
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~- 159 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE- 159 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC-
Confidence 9999999999999999888889999999999999999999999999999999999999999999999999986311000
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003232 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAE 823 (837)
Q Consensus 745 ddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~-~~s~kSDIWSLGVILyELLTGr~PF~~~ 823 (837)
........||+.|+|||++.+. .++.++|||||||++|+|++|..||...
T Consensus 160 -----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 210 (332)
T cd05614 160 -----------------------------KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE 210 (332)
T ss_pred -----------------------------CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCC
Confidence 0011245799999999999875 4788999999999999999999999753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=309.21 Aligned_cols=197 Identities=39% Similarity=0.760 Sum_probs=174.5
Q ss_pred EEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEeEeecCCeEEEEEEecCC
Q 003232 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLVMEYLNG 673 (837)
Q Consensus 595 kkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~gsf~d~~~lyLVmEy~~G 673 (837)
+.||.|+||+||+|++..+++.||+|++.............+.+|..++..+ +||||+++++.+.....+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 3699999999999999999999999999875544455567788999999887 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCCCcc
Q 003232 674 GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753 (837)
Q Consensus 674 GSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~S 753 (837)
++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---------- 150 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG---------- 150 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC----------
Confidence 9999999887889999999999999999999999999999999999999999999999999886210000
Q ss_pred CcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003232 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNA 822 (837)
Q Consensus 754 gttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~ 822 (837)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 151 ---------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 151 ---------------------DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred ---------------------CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence 012245799999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=308.25 Aligned_cols=209 Identities=27% Similarity=0.440 Sum_probs=171.8
Q ss_pred cccCCeEEEEEecccCceEEEEEEEC-----CCCcEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEeEee
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKR-----TTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFT 659 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk-----~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~gsf~ 659 (837)
...++|++.++||.|+||.||+|.+. .++..||+|+++... .......+.+|+.+++.+ +||||+++++++.
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACT 81 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence 44578999999999999999999853 345689999987532 233456789999999999 8999999999887
Q ss_pred cC-CeEEEEEEecCCCCHHHHHHhc-------------------------------------------------------
Q 003232 660 CR-ENLYLVMEYLNGGDLYSLLRNL------------------------------------------------------- 683 (837)
Q Consensus 660 d~-~~lyLVmEy~~GGSL~dlLk~~------------------------------------------------------- 683 (837)
.. ..+|+||||+++|+|.+++...
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 64 4689999999999999998642
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCCCccCcc
Q 003232 684 -------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 756 (837)
Q Consensus 684 -------g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~Sgtt 756 (837)
..++...+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.......
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~------------ 229 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD------------ 229 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcc------------
Confidence 2367788899999999999999999999999999999999999999999999863110000
Q ss_pred cCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCc
Q 003232 757 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHP 825 (837)
Q Consensus 757 Ll~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~~~dp 825 (837)
........+++.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 230 -----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~ 282 (338)
T cd05102 230 -----------------YVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI 282 (338)
T ss_pred -----------------hhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCc
Confidence 001123346788999999999999999999999999999997 9999987543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=305.85 Aligned_cols=202 Identities=31% Similarity=0.522 Sum_probs=180.0
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLV 667 (837)
.++|++++.||.|+||.||++++..++..+|+|++.... .......+.+|+.+++.++||||+++++++.....+++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 467999999999999999999999999999999987542 234456799999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCcEEEccCCcEEEEecCCccccccCCCCC
Q 003232 668 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL-RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (837)
Q Consensus 668 mEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSk-GIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stdd 746 (837)
|||+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.++|+|||++.....
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~----- 156 (331)
T cd06649 82 MEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----- 156 (331)
T ss_pred eecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc-----
Confidence 99999999999998888899999999999999999999986 699999999999999999999999998762100
Q ss_pred CCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 747 l~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+
T Consensus 157 ----------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 206 (331)
T cd06649 157 ----------------------------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD 206 (331)
T ss_pred ----------------------------cccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 00123468999999999999999999999999999999999999997544
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=308.27 Aligned_cols=200 Identities=40% Similarity=0.795 Sum_probs=173.0
Q ss_pred EEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHh-cCCCceEEEEeEeecCCeEEEEEEecCC
Q 003232 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILIS-VRNPFVVRFFYSFTCRENLYLVMEYLNG 673 (837)
Q Consensus 595 kkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~-LrHPNIVkL~gsf~d~~~lyLVmEy~~G 673 (837)
+.||.|+||.||+|+++.+|+.||+|+++...............|..++.. ++||||+++++.+...+++|+||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 369999999999999999999999999986543223344567778888875 4899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCCCcc
Q 003232 674 GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753 (837)
Q Consensus 674 GSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~S 753 (837)
++|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.....
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----------- 149 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG----------- 149 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccC-----------
Confidence 999999988788999999999999999999999999999999999999999999999999987621000
Q ss_pred CcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 754 gttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.
T Consensus 150 --------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~ 201 (316)
T cd05620 150 --------------------DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE 201 (316)
T ss_pred --------------------CCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH
Confidence 0012245799999999999999999999999999999999999999986553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=310.29 Aligned_cols=199 Identities=44% Similarity=0.872 Sum_probs=172.7
Q ss_pred EEecccCceEEEEEEEC---CCCcEEEEEEecccccc-cHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEEe
Q 003232 595 KPISRGAFGRVFLAKKR---TTGDLFAIKVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEY 670 (837)
Q Consensus 595 kkLGsG~FGtVYkArdk---~tG~~VAVKIikk~~~~-~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmEy 670 (837)
+.||+|+||.||++++. .+++.||+|++...... .......+.+|+.+++.++||||+++++.+..+..+|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 67999999999999874 47889999999764322 223345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCC
Q 003232 671 LNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 750 (837)
Q Consensus 671 ~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p 750 (837)
+.|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.....
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-------- 153 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE-------- 153 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC--------
Confidence 999999999988888999999999999999999999999999999999999999999999999998621000
Q ss_pred CccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 751 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 751 ~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||...+
T Consensus 154 -----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~ 204 (323)
T cd05584 154 -----------------------GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN 204 (323)
T ss_pred -----------------------CCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC
Confidence 001123569999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=297.60 Aligned_cols=198 Identities=35% Similarity=0.631 Sum_probs=171.5
Q ss_pred ecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEEecCCCCH
Q 003232 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 676 (837)
Q Consensus 597 LGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmEy~~GGSL 676 (837)
||.|+||+||++.+..+++.||+|.+...........+.+..|+.+++.++||||+++++.+.....+|+||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999999999999999999765433344456778999999999999999999999999999999999999999
Q ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCCCc
Q 003232 677 YSLLRN----LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 752 (837)
Q Consensus 677 ~dlLk~----~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~ 752 (837)
.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~--------- 151 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--------- 151 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC---------
Confidence 888743 3468999999999999999999999999999999999999999999999999886310000
Q ss_pred cCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 753 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 753 SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus 152 ----------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~ 202 (280)
T cd05608 152 ----------------------SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGE 202 (280)
T ss_pred ----------------------ccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCc
Confidence 011234689999999999999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=306.39 Aligned_cols=199 Identities=41% Similarity=0.825 Sum_probs=174.9
Q ss_pred EEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEeEeecCCeEEEEEEecCC
Q 003232 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLVMEYLNG 673 (837)
Q Consensus 595 kkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~gsf~d~~~lyLVmEy~~G 673 (837)
+.||.|+||+||+|++..+++.||+|++++...........+..|..+++.+ +||||+++++++....++|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999999999999999999875444445566778899999877 799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCCCcc
Q 003232 674 GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753 (837)
Q Consensus 674 GSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~S 753 (837)
++|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---------- 150 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG---------- 150 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC----------
Confidence 9999999888889999999999999999999999999999999999999999999999999886211000
Q ss_pred CcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 754 gttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+
T Consensus 151 ---------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~ 200 (318)
T cd05570 151 ---------------------VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD 200 (318)
T ss_pred ---------------------CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC
Confidence 01123468999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=323.80 Aligned_cols=206 Identities=34% Similarity=0.673 Sum_probs=191.3
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVm 668 (837)
.+|++.+.||+|.||.|-+|+....|+.||||.++++.+.++..+-.+.+|++||+.|+||||+.+|++|.....+.|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 46999999999999999999999999999999999998888888889999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCC
Q 003232 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (837)
Q Consensus 669 Ey~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~ 748 (837)
||..+|.|++|+...+.|++.+++.+++||..|+.|+|.++++|||||.+|||+|.++++||+|||++-..
T Consensus 133 EYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly--------- 203 (668)
T KOG0611|consen 133 EYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLY--------- 203 (668)
T ss_pred EecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhh---------
Confidence 99999999999999999999999999999999999999999999999999999999999999999997531
Q ss_pred CCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCC-CchHHHHHHHHHHHHHHcCCCCCCCCCcC
Q 003232 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVGIPPFNAEHPQ 826 (837)
Q Consensus 749 ~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~-s~kSDIWSLGVILyELLTGr~PF~~~dpd 826 (837)
....-..++||+|.|.+||++.|.+| ++.+|-||||++||-|+.|.+||.+.+..
T Consensus 204 -----------------------~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk 259 (668)
T KOG0611|consen 204 -----------------------ADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK 259 (668)
T ss_pred -----------------------ccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH
Confidence 01122357899999999999999998 68899999999999999999999987643
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=309.94 Aligned_cols=196 Identities=39% Similarity=0.765 Sum_probs=172.9
Q ss_pred EEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEeEeecCCeEEEEEEecCC
Q 003232 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLVMEYLNG 673 (837)
Q Consensus 595 kkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~gsf~d~~~lyLVmEy~~G 673 (837)
+.||+|+||.||+|++..+++.||+|++.+...........+.+|..++..+ +||||+++++++.....+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 3699999999999999999999999999875444445556788899888776 899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCCCcc
Q 003232 674 GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753 (837)
Q Consensus 674 GSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~S 753 (837)
++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~---------- 150 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG---------- 150 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC----------
Confidence 9999999888889999999999999999999999999999999999999999999999999986310000
Q ss_pred CcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCC
Q 003232 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFN 821 (837)
Q Consensus 754 gttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~ 821 (837)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 151 ---------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 197 (329)
T cd05618 151 ---------------------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred ---------------------CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCc
Confidence 01123578999999999999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=297.55 Aligned_cols=204 Identities=35% Similarity=0.641 Sum_probs=177.7
Q ss_pred CeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEE
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmE 669 (837)
.|++.+.||.|+||+||++.+..+++.||+|++.............+.+|+.+++.++||||+++++.+....++|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48999999999999999999998999999999976443333344567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCC
Q 003232 670 YLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (837)
Q Consensus 670 y~~GGSL~dlLk~~--g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl 747 (837)
|+.+++|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~----- 155 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG----- 155 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC-----
Confidence 99999999888653 45899999999999999999999999999999999999999999999999988631000
Q ss_pred CCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 748 ~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
.......|++.|+|||++.+..++.++|||||||++|+|++|..||.+...
T Consensus 156 ---------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~ 206 (285)
T cd05605 156 ---------------------------ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE 206 (285)
T ss_pred ---------------------------CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCch
Confidence 001234689999999999999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=305.77 Aligned_cols=199 Identities=43% Similarity=0.818 Sum_probs=172.3
Q ss_pred EEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHh-cCCCceEEEEeEeecCCeEEEEEEecCC
Q 003232 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILIS-VRNPFVVRFFYSFTCRENLYLVMEYLNG 673 (837)
Q Consensus 595 kkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~-LrHPNIVkL~gsf~d~~~lyLVmEy~~G 673 (837)
+.||+|+||.||+|++..+++.||+|+++...............|..+++. ++||||+++++++.....+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 368999999999999999999999999986533223344566778888875 5899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCCCcc
Q 003232 674 GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753 (837)
Q Consensus 674 GSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~S 753 (837)
|+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~---------- 150 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD---------- 150 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC----------
Confidence 9999999887789999999999999999999999999999999999999999999999999986210000
Q ss_pred CcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 754 gttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+
T Consensus 151 ---------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~ 200 (316)
T cd05619 151 ---------------------AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD 200 (316)
T ss_pred ---------------------CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC
Confidence 01123568999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=323.92 Aligned_cols=220 Identities=35% Similarity=0.645 Sum_probs=178.6
Q ss_pred CCCCCCCCcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccc-----------cHHHHHHHHHHHHHHHhc
Q 003232 578 PIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMI-----------RKNAVESILAERDILISV 646 (837)
Q Consensus 578 ~~~P~k~g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~-----------~~e~ie~~~rEieILk~L 646 (837)
.+.+......+++|++++.||+|.||.|-+|++..+++.||||++.+.... ....++...+|+.+|++|
T Consensus 86 ~~~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl 165 (576)
T KOG0585|consen 86 RYDDDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKL 165 (576)
T ss_pred eecCcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhc
Confidence 344455667789999999999999999999999999999999999753211 112246899999999999
Q ss_pred CCCceEEEEeEeecC--CeEEEEEEecCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEc
Q 003232 647 RNPFVVRFFYSFTCR--ENLYLVMEYLNGGDLYSLLRNLGC-LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA 723 (837)
Q Consensus 647 rHPNIVkL~gsf~d~--~~lyLVmEy~~GGSL~dlLk~~g~-Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd 723 (837)
.|||||+++++..+. +.+|||+|||..|.+...-.. ++ +++.++++|+++++.||+|||.+|||||||||+|+|++
T Consensus 166 ~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d-~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~ 244 (576)
T KOG0585|consen 166 HHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPD-KPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLS 244 (576)
T ss_pred CCcCeeEEEEeecCcccCceEEEEEeccCCccccCCCC-cccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEc
Confidence 999999999998874 579999999998887654333 44 99999999999999999999999999999999999999
Q ss_pred cCCcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCC----CCc
Q 003232 724 HDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG----HGT 799 (837)
Q Consensus 724 ~dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~----~s~ 799 (837)
.+|++||+|||.+......... ... .. ....+|||.|+|||...+.. -+.
T Consensus 245 ~~g~VKIsDFGVs~~~~~~~~~----------------------~~d-~~---L~~tvGTPAF~APE~c~~~~~~~~~g~ 298 (576)
T KOG0585|consen 245 SDGTVKISDFGVSNEFPQGSDE----------------------GSD-DQ---LSRTVGTPAFFAPELCSGGNSFSYSGF 298 (576)
T ss_pred CCCcEEeeccceeeecccCCcc----------------------ccH-HH---HhhcCCCccccchHhhcCCCCccccch
Confidence 9999999999998642111000 000 11 11268999999999987632 256
Q ss_pred hHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 800 TADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 800 kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
+.||||+||+||.|+.|+.||.++.
T Consensus 299 a~DiWalGVTLYCllfG~~PF~~~~ 323 (576)
T KOG0585|consen 299 ALDIWALGVTLYCLLFGQLPFFDDF 323 (576)
T ss_pred hhhhhhhhhhHHHhhhccCCcccch
Confidence 7899999999999999999998643
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=318.91 Aligned_cols=203 Identities=36% Similarity=0.646 Sum_probs=173.8
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC--eEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE--NLYL 666 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~--~lyL 666 (837)
.+|...+.||.|+||+||++.+..+|...|+|.+..... ...+.+.+|+.+|++++|||||++++...... .+++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~---~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i 93 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS---PTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI 93 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccc---hhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence 458888999999999999999999999999999876521 12677899999999999999999999755544 6999
Q ss_pred EEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEcc-CCcEEEEecCCccccccCCC
Q 003232 667 VMEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH-DGHIKLTDFGLSKVGLINST 744 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~~g-~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~-dG~IKLiDFGLArvg~~~st 744 (837)
.|||+.+|||.+++.+.+ .+++..++.+.+||+.||.|||++|||||||||+|||++. ++.+||+|||+++.......
T Consensus 94 ~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred eeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 999999999999999877 7999999999999999999999999999999999999999 79999999999873111000
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003232 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNA 822 (837)
Q Consensus 745 ddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLTGr~PF~~ 822 (837)
.........||+.|||||++.+ ....+++|||||||++.||+||..||..
T Consensus 174 ----------------------------~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~ 224 (313)
T KOG0198|consen 174 ----------------------------KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE 224 (313)
T ss_pred ----------------------------cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence 0112235689999999999985 3344699999999999999999999986
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=331.12 Aligned_cols=216 Identities=31% Similarity=0.524 Sum_probs=185.7
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcC-CCceEEEEeEeecCC-e
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCRE-N 663 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~Lr-HPNIVkL~gsf~d~~-~ 663 (837)
...++|.++++||.|+||.||+|+.+.+|..||||.++..... .+ .-.-.+|+..|++++ ||||+++.+++.+.. +
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~e-e~~nLREvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WE-ECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HH-HHHHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 4457899999999999999999999999999999999875432 22 234578999999999 999999999999987 9
Q ss_pred EEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccC
Q 003232 664 LYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~ 742 (837)
+|+||||| ..+|+++++.. ..+++..++.|+.||++||+|+|.+|+.|||+||+|||+.....+||+|||+|+- ..
T Consensus 85 L~fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARe--v~ 161 (538)
T KOG0661|consen 85 LYFVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLARE--VR 161 (538)
T ss_pred EeeeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccc--cc
Confidence 99999999 57999999754 5699999999999999999999999999999999999999899999999999982 11
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCC
Q 003232 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFN 821 (837)
Q Consensus 743 stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLTGr~PF~ 821 (837)
+ ....+.++-|..|+|||+++. .-|+.+.|+||+|||++|+++=++.|.
T Consensus 162 S------------------------------kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFP 211 (538)
T KOG0661|consen 162 S------------------------------KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFP 211 (538)
T ss_pred c------------------------------CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCC
Confidence 1 112345678999999999875 568999999999999999999999998
Q ss_pred CCCcCHHHHHHhcccC
Q 003232 822 AEHPQVSTLLRKCQLL 837 (837)
Q Consensus 822 ~~dpdv~~lle~~hL~ 837 (837)
+.+ +++|+-++|.+|
T Consensus 212 G~s-E~Dqi~KIc~VL 226 (538)
T KOG0661|consen 212 GAS-EIDQIYKICEVL 226 (538)
T ss_pred CCc-HHHHHHHHHHHh
Confidence 754 566787777664
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=305.66 Aligned_cols=217 Identities=36% Similarity=0.698 Sum_probs=196.8
Q ss_pred CCcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCe
Q 003232 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCREN 663 (837)
Q Consensus 584 ~g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ 663 (837)
....+++|++.+.||.|.||.||+|+.+.++-.||+|++.+..+.......++.+|++|-..|+||||.++|++|.+...
T Consensus 17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r 96 (281)
T KOG0580|consen 17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR 96 (281)
T ss_pred cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccce
Confidence 44567899999999999999999999999999999999998877777777899999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCcccccc
Q 003232 664 LYLVMEYLNGGDLYSLLR--NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 741 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk--~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~ 741 (837)
.||++||..+|+|+..+. ....+++.....|+.|++.||.|+|.+++|||||||+|+|++..|.+||+|||.+...+
T Consensus 97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 999999999999999998 55779999999999999999999999999999999999999999999999999986311
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCC
Q 003232 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFN 821 (837)
Q Consensus 742 ~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~ 821 (837)
..+..+.|||..|.+||...+..++..+|+|++|++.||++.|.+||.
T Consensus 176 --------------------------------~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFe 223 (281)
T KOG0580|consen 176 --------------------------------SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFE 223 (281)
T ss_pred --------------------------------CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchh
Confidence 123456799999999999999999999999999999999999999999
Q ss_pred CCCcCHHHHHHhc
Q 003232 822 AEHPQVSTLLRKC 834 (837)
Q Consensus 822 ~~dpdv~~lle~~ 834 (837)
..+ ....+.++.
T Consensus 224 s~~-~~etYkrI~ 235 (281)
T KOG0580|consen 224 SQS-HSETYKRIR 235 (281)
T ss_pred hhh-hHHHHHHHH
Confidence 877 444455544
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=301.57 Aligned_cols=203 Identities=32% Similarity=0.545 Sum_probs=179.9
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLV 667 (837)
.++|++.++||.|+||.||++.+..++..+|+|++.... .......+.+|+++++.++||||++++++|...+++|+|
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 467999999999999999999999999999999987542 234456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCcEEEccCCcEEEEecCCccccccCCCCC
Q 003232 668 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL-RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (837)
Q Consensus 668 mEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSk-GIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stdd 746 (837)
|||+++++|.+++...+.+++..+..++.|++.||.|||+. +|+|+||||+|||++.++.++|+|||++.....
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~----- 156 (333)
T cd06650 82 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----- 156 (333)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh-----
Confidence 99999999999998888899999999999999999999985 799999999999999999999999998762100
Q ss_pred CCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 747 l~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
.......||..|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus 157 ----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~ 207 (333)
T cd06650 157 ----------------------------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDA 207 (333)
T ss_pred ----------------------------hccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcch
Confidence 011234689999999999999999999999999999999999999976544
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=353.66 Aligned_cols=210 Identities=44% Similarity=0.817 Sum_probs=188.1
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeE
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~l 664 (837)
+...++|.|+++||.|+||.|.+++++.+++.||+|++++-.+........|..|..+|...+.+.|+.++.+|.+.+++
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~L 150 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYL 150 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccce
Confidence 34457899999999999999999999999999999999987766666667899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCC
Q 003232 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~st 744 (837)
|+||||++||+|..++.+.+.+++..++.|+.+|+.||..||+.|+|||||||+||||+..|++||+|||.|.....+.
T Consensus 151 YlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG- 229 (1317)
T KOG0612|consen 151 YLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG- 229 (1317)
T ss_pred EEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCC-
Confidence 9999999999999999998899999999999999999999999999999999999999999999999999885211110
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhc----C-CCCCchHHHHHHHHHHHHHHcCCCC
Q 003232 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL----G-TGHGTTADWWSVGIILFELIVGIPP 819 (837)
Q Consensus 745 ddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLl----g-~~~s~kSDIWSLGVILyELLTGr~P 819 (837)
.......+|||.|++||++. + ..|+..||+||+||++|||++|..|
T Consensus 230 -----------------------------~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TP 280 (1317)
T KOG0612|consen 230 -----------------------------TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETP 280 (1317)
T ss_pred -----------------------------cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCc
Confidence 11234679999999999995 2 5689999999999999999999999
Q ss_pred CCCCC
Q 003232 820 FNAEH 824 (837)
Q Consensus 820 F~~~d 824 (837)
|++++
T Consensus 281 FYads 285 (1317)
T KOG0612|consen 281 FYADS 285 (1317)
T ss_pred chHHH
Confidence 98753
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=306.92 Aligned_cols=198 Identities=44% Similarity=0.834 Sum_probs=170.1
Q ss_pred ecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhc---CCCceEEEEeEeecCCeEEEEEEecCC
Q 003232 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV---RNPFVVRFFYSFTCRENLYLVMEYLNG 673 (837)
Q Consensus 597 LGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L---rHPNIVkL~gsf~d~~~lyLVmEy~~G 673 (837)
||+|+||+||+|++..+++.||+|++................|..++... +||||++++..+.....+|+||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 69999999999999999999999999765433344455666777777665 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCCCcc
Q 003232 674 GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753 (837)
Q Consensus 674 GSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~S 753 (837)
++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~----------- 149 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTD----------- 149 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCC-----------
Confidence 999999988888999999999999999999999999999999999999999999999999998621000
Q ss_pred CcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 754 gttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~-~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
.......+||+.|+|||++.+. .++.++|||||||++|+|++|..||...+.
T Consensus 150 --------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~ 202 (330)
T cd05586 150 --------------------NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT 202 (330)
T ss_pred --------------------CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH
Confidence 0012245799999999999764 578999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=312.67 Aligned_cols=198 Identities=27% Similarity=0.390 Sum_probs=173.6
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeE
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~l 664 (837)
+....+|++++.||.|+||.||+|++..+++.||+|.... ..+.+|+.+++.++||||++++++|......
T Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 158 (391)
T PHA03212 88 GIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFT 158 (391)
T ss_pred ccccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCee
Confidence 3445679999999999999999999999999999997542 2467899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCC
Q 003232 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~st 744 (837)
|+|||++ +++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 159 ~lv~e~~-~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~- 236 (391)
T PHA03212 159 CLILPRY-KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN- 236 (391)
T ss_pred EEEEecC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-
Confidence 9999999 57899998877789999999999999999999999999999999999999999999999999986310000
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003232 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNA 822 (837)
Q Consensus 745 ddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~ 822 (837)
........||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 237 -----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 237 -----------------------------ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred -----------------------------ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 0011245799999999999999999999999999999999999988754
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=306.31 Aligned_cols=199 Identities=44% Similarity=0.843 Sum_probs=172.6
Q ss_pred EEecccCceEEEEEEEC---CCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEEec
Q 003232 595 KPISRGAFGRVFLAKKR---TTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYL 671 (837)
Q Consensus 595 kkLGsG~FGtVYkArdk---~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmEy~ 671 (837)
+.||+|+||.||++++. .+|+.||+|++..... .......+.+|+.+++.++||||+++++.+.....+|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL-KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 57999999999999873 5789999999976432 2223456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCCC
Q 003232 672 NGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 751 (837)
Q Consensus 672 ~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~ 751 (837)
.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.....
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~--------- 151 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--------- 151 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC---------
Confidence 99999999988788999999999999999999999999999999999999999999999999998631000
Q ss_pred ccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 752 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 752 ~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 152 ----------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~ 203 (318)
T cd05582 152 ----------------------EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR 203 (318)
T ss_pred ----------------------CCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH
Confidence 0012245789999999999999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=302.41 Aligned_cols=203 Identities=31% Similarity=0.483 Sum_probs=172.8
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC---
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE--- 662 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~--- 662 (837)
...++|++.+.||.|+||.||++.+..+|+.||+|++.... ........+.+|+.+++.++||||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE 96 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc-cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence 34678999999999999999999999999999999997543 23344567889999999999999999999886543
Q ss_pred ---eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCcccc
Q 003232 663 ---NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 739 (837)
Q Consensus 663 ---~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg 739 (837)
.+|+||||+.+ +|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++..
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 97 EFQDVYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred ccceeEEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 57999999964 67666643 4888999999999999999999999999999999999999999999999998631
Q ss_pred ccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCC
Q 003232 740 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPP 819 (837)
Q Consensus 740 ~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~P 819 (837)
... .......||+.|+|||++.+..++.++|||||||++|+|++|+.|
T Consensus 174 ~~~--------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~p 221 (359)
T cd07876 174 CTN--------------------------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVI 221 (359)
T ss_pred ccC--------------------------------ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCC
Confidence 000 011234689999999999999999999999999999999999999
Q ss_pred CCCCC
Q 003232 820 FNAEH 824 (837)
Q Consensus 820 F~~~d 824 (837)
|.+.+
T Consensus 222 f~~~~ 226 (359)
T cd07876 222 FQGTD 226 (359)
T ss_pred CCCCC
Confidence 98764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=284.25 Aligned_cols=210 Identities=30% Similarity=0.520 Sum_probs=181.3
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVm 668 (837)
++|++.+.||.|+||.||+|++..+++.||+|.+.............+.+|+.+++.++||||+++++.+...+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57999999999999999999999999999999987644445556677899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCC
Q 003232 669 EYLNGGDLYSLLRN----LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (837)
Q Consensus 669 Ey~~GGSL~dlLk~----~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~st 744 (837)
||+++++|.+++.. ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~-- 159 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-- 159 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccch--
Confidence 99999999988853 345889999999999999999999999999999999999999999999999987631000
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 745 ddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
........|++.|+|||.+.+..++.++|+||||+++|+|++|..||....
T Consensus 160 -----------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~ 210 (267)
T cd08228 160 -----------------------------TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred -----------------------------hHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccc
Confidence 001123468889999999999889999999999999999999999997665
Q ss_pred cCHHH
Q 003232 825 PQVST 829 (837)
Q Consensus 825 pdv~~ 829 (837)
.+...
T Consensus 211 ~~~~~ 215 (267)
T cd08228 211 MNLFS 215 (267)
T ss_pred ccHHH
Confidence 44333
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=301.28 Aligned_cols=215 Identities=32% Similarity=0.545 Sum_probs=183.5
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVm 668 (837)
.+|..+++||+|.||.||+|++..+|+.||||.++.... .........+|+..|+.++|+||+.++++|.....+.||+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~-kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNA-KDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccc-ccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 468889999999999999999999999999999987642 2233356789999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCC
Q 003232 669 EYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (837)
Q Consensus 669 Ey~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl 747 (837)
||++ .+|...++.. ..++..+++.|+.+++.||+|||++.|+||||||.|+||+.+|.+||+|||+++.....+.
T Consensus 81 Efm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~--- 156 (318)
T KOG0659|consen 81 EFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR--- 156 (318)
T ss_pred Eecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc---
Confidence 9995 6999999764 5699999999999999999999999999999999999999999999999999985221111
Q ss_pred CCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCcC
Q 003232 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826 (837)
Q Consensus 748 ~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLTGr~PF~~~dpd 826 (837)
.....+-|..|+|||.+.| ..|+..+|+||.||++.||+-|.+-|. .+.+
T Consensus 157 ----------------------------~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fp-G~sD 207 (318)
T KOG0659|consen 157 ----------------------------IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFP-GDSD 207 (318)
T ss_pred ----------------------------ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCC-CCch
Confidence 1122367889999999987 678999999999999999998876554 4667
Q ss_pred HHHHHHhcccC
Q 003232 827 VSTLLRKCQLL 837 (837)
Q Consensus 827 v~~lle~~hL~ 837 (837)
++|+..++..|
T Consensus 208 idQL~~If~~L 218 (318)
T KOG0659|consen 208 IDQLSKIFRAL 218 (318)
T ss_pred HHHHHHHHHHc
Confidence 88887776543
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=316.26 Aligned_cols=216 Identities=42% Similarity=0.793 Sum_probs=198.7
Q ss_pred CCCCCcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeec
Q 003232 581 PSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC 660 (837)
Q Consensus 581 P~k~g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d 660 (837)
+.+....+++|..+++||+|.||.|.+++.+.+++.||+|++++.-+...+.......|-++|+..+||++..+-.+|+.
T Consensus 160 ~~~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt 239 (516)
T KOG0690|consen 160 KRKNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT 239 (516)
T ss_pred cccceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc
Confidence 34556678999999999999999999999999999999999999888888888899999999999999999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccc
Q 003232 661 RENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740 (837)
Q Consensus 661 ~~~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~ 740 (837)
..++|+||||.+||.|+-++.+...+++...+.|..+|+.||.|||+++||.||||.+|+|++.+|++||.|||+|+-+
T Consensus 240 ~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~- 318 (516)
T KOG0690|consen 240 QDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE- 318 (516)
T ss_pred CceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhc-
Confidence 9999999999999999999988888999999999999999999999999999999999999999999999999999831
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCC
Q 003232 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820 (837)
Q Consensus 741 ~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF 820 (837)
+. .+....+.||||.|+|||++....|+..+|+|.+||+||||+||+.||
T Consensus 319 ------I~------------------------~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPF 368 (516)
T KOG0690|consen 319 ------IK------------------------YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPF 368 (516)
T ss_pred ------cc------------------------ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcc
Confidence 11 122345789999999999999999999999999999999999999999
Q ss_pred CCCCcCH
Q 003232 821 NAEHPQV 827 (837)
Q Consensus 821 ~~~dpdv 827 (837)
...+.+.
T Consensus 369 yn~dh~k 375 (516)
T KOG0690|consen 369 YNKDHEK 375 (516)
T ss_pred cccchhH
Confidence 9877654
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=323.44 Aligned_cols=244 Identities=45% Similarity=0.754 Sum_probs=203.0
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEE
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 665 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ly 665 (837)
....-|..++.||-|+||.|.+++...+...||+|.+.+.+............|..||..-.++.||++|..|.++.++|
T Consensus 626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLY 705 (1034)
T KOG0608|consen 626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY 705 (1034)
T ss_pred ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceE
Confidence 33345999999999999999999999999999999999988888888889999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCC
Q 003232 666 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745 (837)
Q Consensus 666 LVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~std 745 (837)
+||+|++||++..++-+.+.+.+..++.|+.++..|+++.|..|+|||||||+|||||.+|+|||.|||+|+-.-+.+..
T Consensus 706 FVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred EEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccc
Confidence 99999999999999998899999999999999999999999999999999999999999999999999999754444433
Q ss_pred CCCCCCcc-------CcccCCCCCccchhhh----hHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHH
Q 003232 746 DLSGPAVS-------GTTLLGDEEPQLTASE----HQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI 814 (837)
Q Consensus 746 dl~~p~~S-------gttLl~~~~~~~~~~~----~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELL 814 (837)
.++....+ ......+-..-..... ....+......+||+.|+|||++...+|+..||+||.|||||||+
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML 865 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence 33321110 0000111111111111 112233356789999999999999999999999999999999999
Q ss_pred cCCCCCCCCCcCHHH
Q 003232 815 VGIPPFNAEHPQVST 829 (837)
Q Consensus 815 TGr~PF~~~dpdv~~ 829 (837)
.|++||..++|...+
T Consensus 866 ~g~~pf~~~tp~~tq 880 (1034)
T KOG0608|consen 866 VGQPPFLADTPGETQ 880 (1034)
T ss_pred hCCCCccCCCCCcce
Confidence 999999998886554
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=291.37 Aligned_cols=202 Identities=51% Similarity=0.941 Sum_probs=181.8
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVm 668 (837)
++|++.+.||.|+||.||++.+..+++.+|+|++.............+.+|+.++++++||||+++++.+.....+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46999999999999999999999999999999997655444555678899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCC
Q 003232 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (837)
Q Consensus 669 Ey~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~ 748 (837)
||+++++|.+++...+.+++..+..++.||+.||.|||+.|++|+||+|.||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~------- 153 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG------- 153 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCC-------
Confidence 9999999999998888899999999999999999999999999999999999999999999999998863100
Q ss_pred CCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 749 ~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
......|++.|+|||.+.+..++.++||||||+++|+|++|..||...+
T Consensus 154 ---------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 202 (290)
T cd05580 154 ---------------------------RTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN 202 (290)
T ss_pred ---------------------------CCCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 0123468899999999988888999999999999999999999997765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=314.30 Aligned_cols=205 Identities=29% Similarity=0.435 Sum_probs=175.9
Q ss_pred cCCeEEEEEecccCceEEEEEEECCC-CcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTT-GDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~t-G~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyL 666 (837)
...|.+.+.||.|+||.||+|....+ +..||+|.+... .......+.+|+.+++.++||||+++++.+...+++||
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l 142 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL 142 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence 34599999999999999999998877 788999977543 23344567889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccC
Q 003232 667 VMEYLNGGDLYSLLRN----LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~----~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~ 742 (837)
||||++||+|.+++.. ..++++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.....
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 9999999999988753 346899999999999999999999999999999999999999999999999998731100
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003232 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNA 822 (837)
Q Consensus 743 stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~ 822 (837)
.. .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 223 ~~-----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~ 273 (478)
T PTZ00267 223 VS-----------------------------LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG 273 (478)
T ss_pred cc-----------------------------cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence 00 0112345799999999999999999999999999999999999999976
Q ss_pred CC
Q 003232 823 EH 824 (837)
Q Consensus 823 ~d 824 (837)
.+
T Consensus 274 ~~ 275 (478)
T PTZ00267 274 PS 275 (478)
T ss_pred CC
Confidence 54
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=290.58 Aligned_cols=197 Identities=33% Similarity=0.616 Sum_probs=169.0
Q ss_pred ecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEEecCCCCH
Q 003232 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 676 (837)
Q Consensus 597 LGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmEy~~GGSL 676 (837)
||.|+||.||+++++.+|+.||+|.+.............+..|+++++.++||||+++++.+....++|+||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999999999999999999754433333344566799999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCCCccC
Q 003232 677 YSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 754 (837)
Q Consensus 677 ~dlLk~~g--~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~Sg 754 (837)
.+++...+ .+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~------------ 148 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG------------ 148 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC------------
Confidence 98886543 4888899999999999999999999999999999999999999999999988631000
Q ss_pred cccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 755 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 755 ttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
.......|++.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 149 --------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~ 199 (277)
T cd05607 149 --------------------KTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKE 199 (277)
T ss_pred --------------------ceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcc
Confidence 001234689999999999998899999999999999999999999976543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=313.84 Aligned_cols=210 Identities=39% Similarity=0.654 Sum_probs=187.7
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcC-CCceEEEEeEeecCCeE
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCRENL 664 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~Lr-HPNIVkL~gsf~d~~~l 664 (837)
.....|++.+.||.|.||.||+++.+.+|+.+|+|++.+...........+.+|+.+|+.+. ||||+.+++.|.....+
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 33456999999999999999999999999999999998766544445678999999999998 99999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccC----CcEEEEecCCccccc
Q 003232 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD----GHIKLTDFGLSKVGL 740 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~d----G~IKLiDFGLArvg~ 740 (837)
++|||++.||.|++.+... .+++..+..++.|++.++.|||+.|++||||||+|+|+... +.++++|||++....
T Consensus 112 ~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 9999999999999999776 49999999999999999999999999999999999999643 479999999997411
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCC
Q 003232 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820 (837)
Q Consensus 741 ~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF 820 (837)
. .......+||+.|+|||++...+|+..+||||+|+++|.|++|..||
T Consensus 191 ~--------------------------------~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF 238 (382)
T KOG0032|consen 191 P--------------------------------GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPF 238 (382)
T ss_pred C--------------------------------CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCC
Confidence 1 22345789999999999999999999999999999999999999999
Q ss_pred CCCCcCHH
Q 003232 821 NAEHPQVS 828 (837)
Q Consensus 821 ~~~dpdv~ 828 (837)
.+.+....
T Consensus 239 ~~~~~~~~ 246 (382)
T KOG0032|consen 239 WGETEFEI 246 (382)
T ss_pred cCCChhHH
Confidence 99886544
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=290.47 Aligned_cols=204 Identities=34% Similarity=0.647 Sum_probs=177.3
Q ss_pred CeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEE
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmE 669 (837)
.|++.+.||.|+||+||++.+..+++.||+|.+.............+.+|+.+++.++|+||+.+++.+.....+|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 37888999999999999999999999999999876543344445667889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCC
Q 003232 670 YLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (837)
Q Consensus 670 y~~GGSL~dlLk~~--g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl 747 (837)
|++|++|.+++... ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~----- 155 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG----- 155 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC-----
Confidence 99999999988543 35899999999999999999999999999999999999999999999999987631000
Q ss_pred CCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 748 ~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
.......|+..|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus 156 ---------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~ 206 (285)
T cd05630 156 ---------------------------QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKK 206 (285)
T ss_pred ---------------------------ccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCc
Confidence 001134689999999999999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=291.27 Aligned_cols=203 Identities=34% Similarity=0.533 Sum_probs=166.9
Q ss_pred CCeEEEEEecccCceEEEEEEECC-CCcEEEEEEecccccccHHHHHHHHHHHHHHHhc---CCCceEEEEeEeec----
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRT-TGDLFAIKVLKKADMIRKNAVESILAERDILISV---RNPFVVRFFYSFTC---- 660 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~-tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L---rHPNIVkL~gsf~d---- 660 (837)
++|++.+.||.|+||.||+|++.. +++.||+|++...... ......+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCC-CCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 369999999999999999999854 4688999998754321 22223455677776655 69999999998752
Q ss_pred -CCeEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCcc
Q 003232 661 -RENLYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 737 (837)
Q Consensus 661 -~~~lyLVmEy~~GGSL~dlLk~~--g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLAr 737 (837)
...+++||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 456899999996 6899988653 458999999999999999999999999999999999999999999999999986
Q ss_pred ccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCC
Q 003232 738 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGI 817 (837)
Q Consensus 738 vg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr 817 (837)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|+
T Consensus 159 ~~~~~--------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~ 206 (290)
T cd07862 159 IYSFQ--------------------------------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206 (290)
T ss_pred eccCC--------------------------------cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCC
Confidence 31100 0122446899999999999999999999999999999999999
Q ss_pred CCCCCCCc
Q 003232 818 PPFNAEHP 825 (837)
Q Consensus 818 ~PF~~~dp 825 (837)
+||.+.++
T Consensus 207 ~~f~~~~~ 214 (290)
T cd07862 207 PLFRGSSD 214 (290)
T ss_pred CCcCCCCH
Confidence 99987653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=308.98 Aligned_cols=215 Identities=32% Similarity=0.549 Sum_probs=183.5
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCc-eEEEEeEeecCC----
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF-VVRFFYSFTCRE---- 662 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPN-IVkL~gsf~d~~---- 662 (837)
...|+.+++||.|+||+||+|+.+.+|+.||+|.++-... .+.......+|+.+++.++|+| |+.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~-~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFE-EEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEecccc-ccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 4568888899999999999999999999999999976532 1223445689999999999999 999999999877
Q ss_pred --eEEEEEEecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCc
Q 003232 663 --NLYLVMEYLNGGDLYSLLRNLG----CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS 736 (837)
Q Consensus 663 --~lyLVmEy~~GGSL~dlLk~~g----~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLA 736 (837)
.+++|+||+ ..+|..++...+ .++...++.++.||+.||+|||++||+||||||+||||+..|.+||+|||+|
T Consensus 89 ~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 899999999 569999987654 4788899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCC-CCCchHHHHHHHHHHHHHHc
Q 003232 737 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIV 815 (837)
Q Consensus 737 rvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~-~~s~kSDIWSLGVILyELLT 815 (837)
+..... .+.....++|..|+|||++.|. .|+...||||+|||++||++
T Consensus 168 ra~~ip-------------------------------~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~ 216 (323)
T KOG0594|consen 168 RAFSIP-------------------------------MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFT 216 (323)
T ss_pred HHhcCC-------------------------------cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHh
Confidence 831111 0113456789999999999986 78999999999999999999
Q ss_pred CCCCCCCCCcCHHHHHHhccc
Q 003232 816 GIPPFNAEHPQVSTLLRKCQL 836 (837)
Q Consensus 816 Gr~PF~~~dpdv~~lle~~hL 836 (837)
+++.|.+.+. ..++..++.+
T Consensus 217 ~~~LFpG~se-~~ql~~If~~ 236 (323)
T KOG0594|consen 217 RRPLFPGDSE-IDQLFRIFRL 236 (323)
T ss_pred CCCCCCCCcH-HHHHHHHHHH
Confidence 9999988776 6667666654
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=281.48 Aligned_cols=201 Identities=37% Similarity=0.661 Sum_probs=177.7
Q ss_pred eEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEEe
Q 003232 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEY 670 (837)
Q Consensus 591 YeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmEy 670 (837)
|++.+.||+|+||+||++++..+++.||+|++....... .......+|+.+++.++||||+++++++......++||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEE-EEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHH-HHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccc-cccchhhhhhhccccccccccccccccccccccccccccc
Confidence 889999999999999999999999999999998765322 2223445699999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCC
Q 003232 671 LNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 750 (837)
Q Consensus 671 ~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p 750 (837)
+.+++|.+++...+.+++..+..++.||+.||.+||+.|++|+||||+||+++.++.++|+|||.+... .
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~----~------ 149 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKL----S------ 149 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEES----T------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc----c------
Confidence 999999999997788999999999999999999999999999999999999999999999999998631 0
Q ss_pred CccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhc-CCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003232 751 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-GTGHGTTADWWSVGIILFELIVGIPPFNAE 823 (837)
Q Consensus 751 ~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLl-g~~~s~kSDIWSLGVILyELLTGr~PF~~~ 823 (837)
..........++..|+|||++. +..++.++||||||+++|+|++|..||...
T Consensus 150 ---------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 150 ---------------------ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp ---------------------STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred ---------------------ccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 0011233567889999999998 888999999999999999999999999876
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=290.21 Aligned_cols=204 Identities=34% Similarity=0.619 Sum_probs=177.2
Q ss_pred CeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEE
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmE 669 (837)
.|+..+.||.|+||+||++.+..+++.||+|.+.............+.+|+.+++.++|+||+.+++.+..++..|+|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 37888999999999999999999999999999976543333444567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCC
Q 003232 670 YLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (837)
Q Consensus 670 y~~GGSL~dlLk~~--g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl 747 (837)
|+++++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~----- 155 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG----- 155 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC-----
Confidence 99999999888653 35999999999999999999999999999999999999999999999999987521000
Q ss_pred CCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 748 ~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
.......|+..|+|||++.+..++.++|+||||+++|+|++|..||....+
T Consensus 156 ---------------------------~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~ 206 (285)
T cd05632 156 ---------------------------ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE 206 (285)
T ss_pred ---------------------------CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 001234689999999999999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=325.75 Aligned_cols=206 Identities=33% Similarity=0.590 Sum_probs=183.3
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeE
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~l 664 (837)
+.....|...++||+|+.|.||.++...+++.||+|.+..... ...+-+.+|+.+|+..+|+|||.+++.|...+.+
T Consensus 269 ~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q---~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deL 345 (550)
T KOG0578|consen 269 GDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ---PKKELLLNEILVMRDLHHPNIVNFLDSYLVGDEL 345 (550)
T ss_pred CChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC---CchhhhHHHHHHHHhccchHHHHHHHHhccccee
Confidence 3444568888999999999999999999999999999976542 2335689999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCC
Q 003232 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~st 744 (837)
|+||||++||+|.+.+... .+++.++..++++++.||.|||.+||||||||.+|||++.+|.+||+|||+|......
T Consensus 346 WVVMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~-- 422 (550)
T KOG0578|consen 346 WVVMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE-- 422 (550)
T ss_pred EEEEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccc--
Confidence 9999999999999998763 4899999999999999999999999999999999999999999999999998732111
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 745 ddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
..+..+.+|||+|||||+.....|++++||||||+|++||+.|.+||-.++
T Consensus 423 -----------------------------~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~ 473 (550)
T KOG0578|consen 423 -----------------------------QSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN 473 (550)
T ss_pred -----------------------------cCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC
Confidence 113457899999999999999999999999999999999999999998755
Q ss_pred c
Q 003232 825 P 825 (837)
Q Consensus 825 p 825 (837)
|
T Consensus 474 P 474 (550)
T KOG0578|consen 474 P 474 (550)
T ss_pred h
Confidence 4
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=303.79 Aligned_cols=204 Identities=30% Similarity=0.489 Sum_probs=174.5
Q ss_pred CeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC-----eE
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE-----NL 664 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~-----~l 664 (837)
+|++.+.||.|+||+||++.+..+++.||+|.+.... ......+.+.+|+.+++.++||||+++++++.... ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 4788999999999999999999999999999986532 22334567889999999999999999999998766 79
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCC
Q 003232 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~st 744 (837)
|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.......
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~ 158 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES 158 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence 99999995 68988888778899999999999999999999999999999999999999999999999999874111000
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003232 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAE 823 (837)
Q Consensus 745 ddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~-~~s~kSDIWSLGVILyELLTGr~PF~~~ 823 (837)
.......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.
T Consensus 159 ------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 208 (372)
T cd07853 159 ------------------------------KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQ 208 (372)
T ss_pred ------------------------------ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCC
Confidence 011234678999999999874 4789999999999999999999999876
Q ss_pred Cc
Q 003232 824 HP 825 (837)
Q Consensus 824 dp 825 (837)
++
T Consensus 209 ~~ 210 (372)
T cd07853 209 SP 210 (372)
T ss_pred CH
Confidence 53
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=309.21 Aligned_cols=211 Identities=34% Similarity=0.585 Sum_probs=182.2
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEE
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 665 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ly 665 (837)
...+.|++.+.||.|..++||+|+.+.++..||||++.-.... .....+.+|+..|+.++||||++++.+|..+..+|
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~--~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LW 100 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN--NDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELW 100 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh--hhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeE
Confidence 3446799999999999999999999999999999999765432 23678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCC
Q 003232 666 LVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 666 LVmEy~~GGSL~dlLk~~--g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~s 743 (837)
+||.||.+||+.++++.. ..+.+..+..+++++++||.|||.+|.||||||+.||||+.+|.+||+|||.+.... ++
T Consensus 101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~-~~ 179 (516)
T KOG0582|consen 101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLF-DS 179 (516)
T ss_pred EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeec-cc
Confidence 999999999999999754 449999999999999999999999999999999999999999999999999875311 10
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhc--CCCCCchHHHHHHHHHHHHHHcCCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL--GTGHGTTADWWSVGIILFELIVGIPPFN 821 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLl--g~~~s~kSDIWSLGVILyELLTGr~PF~ 821 (837)
| . ....+.+..+||+.|||||++. ..+|+.|+||||||++..||.+|..||.
T Consensus 180 ----------G---------------~-R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~ 233 (516)
T KOG0582|consen 180 ----------G---------------D-RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFS 233 (516)
T ss_pred ----------C---------------c-eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcc
Confidence 0 0 0011115779999999999964 4689999999999999999999999997
Q ss_pred CCCc
Q 003232 822 AEHP 825 (837)
Q Consensus 822 ~~dp 825 (837)
.-.|
T Consensus 234 k~pP 237 (516)
T KOG0582|consen 234 KYPP 237 (516)
T ss_pred cCCh
Confidence 6443
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=281.17 Aligned_cols=208 Identities=33% Similarity=0.561 Sum_probs=179.4
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccc--cHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMI--RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~--~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyL 666 (837)
++|++.+.||.|++|.||++.+..+++.||+|.+...... .......+.+|+.+++.++||||+++++++.....+|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4699999999999999999999999999999998754321 23345678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCC
Q 003232 667 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stdd 746 (837)
||||+++++|.+++...+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||+++.......
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~-- 159 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS-- 159 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccc--
Confidence 999999999999998888899999999999999999999999999999999999999999999999999863110000
Q ss_pred CCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 747 l~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
.........|+..|+|||++.+..++.++||||||+++|+|++|+.||...+
T Consensus 160 --------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 211 (263)
T cd06625 160 --------------------------SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFE 211 (263)
T ss_pred --------------------------ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccc
Confidence 0000123457889999999999889999999999999999999999997653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=291.24 Aligned_cols=206 Identities=27% Similarity=0.426 Sum_probs=170.5
Q ss_pred cCCeEEEEEecccCceEEEEEEECC----------------CCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCce
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRT----------------TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFV 651 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~----------------tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNI 651 (837)
.++|++.++||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.++..++||||
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCCe
Confidence 3579999999999999999998632 34479999987642 23445678999999999999999
Q ss_pred EEEEeEeecCCeEEEEEEecCCCCHHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 003232 652 VRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG-------------------CLDEDVARVYIAEVVLALEYLHSLRVVH 712 (837)
Q Consensus 652 VkL~gsf~d~~~lyLVmEy~~GGSL~dlLk~~g-------------------~Lsee~irkIl~QIa~ALsYLHSkGIIH 712 (837)
+++++++......|+||||+.+++|.+++.... .++...+..++.||+.||.|||+.||+|
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH 161 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 999999999999999999999999999986431 3567788999999999999999999999
Q ss_pred ccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhh
Q 003232 713 RDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEIL 792 (837)
Q Consensus 713 RDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVL 792 (837)
|||||+|||++.++.++|+|||+++....... ........++..|+|||++
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~-----------------------------~~~~~~~~~~~~y~aPE~~ 212 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDY-----------------------------YRIQGRAVLPIRWMAWECI 212 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCce-----------------------------eEecCcCCCCccccCHHHH
Confidence 99999999999999999999999863100000 0011233567889999999
Q ss_pred cCCCCCchHHHHHHHHHHHHHHc--CCCCCCCCC
Q 003232 793 LGTGHGTTADWWSVGIILFELIV--GIPPFNAEH 824 (837)
Q Consensus 793 lg~~~s~kSDIWSLGVILyELLT--Gr~PF~~~d 824 (837)
.+..++.++||||||+++|+|++ +..||...+
T Consensus 213 ~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~ 246 (304)
T cd05096 213 LMGKFTTASDVWAFGVTLWEILMLCKEQPYGELT 246 (304)
T ss_pred hcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCC
Confidence 98899999999999999999986 667887643
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=323.20 Aligned_cols=208 Identities=34% Similarity=0.562 Sum_probs=179.9
Q ss_pred CeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcC-C-----CceEEEEeEeecCCe
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-N-----PFVVRFFYSFTCREN 663 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~Lr-H-----PNIVkL~gsf~d~~~ 663 (837)
+|.|++.||+|+||.|.+|.+..+++.||||+++.. .....+...|+.+|..++ | -|+|+++++|...+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 799999999999999999999999999999999853 456678889999999997 4 289999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccC--CcEEEEecCCcccc
Q 003232 664 LYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD--GHIKLTDFGLSKVG 739 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk~~--g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~d--G~IKLiDFGLArvg 739 (837)
+|||+|.+ ..+|+++++.+ ..++...++.++.||+.||.+||+.||||+||||+|||+..- ..+||+|||++.+.
T Consensus 263 lciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 263 LCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 99999999 67999999865 458999999999999999999999999999999999999653 37999999998631
Q ss_pred ccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCC
Q 003232 740 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPP 819 (837)
Q Consensus 740 ~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~P 819 (837)
. ..-..++.+..|+|||+++|.+|+.+.||||||||+.||++|.+.
T Consensus 342 ~----------------------------------q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PL 387 (586)
T KOG0667|consen 342 S----------------------------------QRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPL 387 (586)
T ss_pred C----------------------------------CcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccc
Confidence 0 111245678889999999999999999999999999999999777
Q ss_pred CCCCCcCHHHHHHhcccC
Q 003232 820 FNAEHPQVSTLLRKCQLL 837 (837)
Q Consensus 820 F~~~dpdv~~lle~~hL~ 837 (837)
|.++ .+.+|+..+..+|
T Consensus 388 fpG~-ne~DQl~~I~e~l 404 (586)
T KOG0667|consen 388 FPGD-NEYDQLARIIEVL 404 (586)
T ss_pred cCCC-CHHHHHHHHHHHh
Confidence 7664 4566676665543
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=299.37 Aligned_cols=202 Identities=28% Similarity=0.450 Sum_probs=172.4
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecC-----
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR----- 661 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~----- 661 (837)
..++|++++.||.|+||.||++.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc-cChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 4678999999999999999999999999999999987643 2334456788999999999999999999988643
Q ss_pred -CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccc
Q 003232 662 -ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740 (837)
Q Consensus 662 -~~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~ 740 (837)
...|+||||+++ +|.+.+.. .++...+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++...
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence 357999999964 67776653 48889999999999999999999999999999999999999999999999986310
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCC
Q 003232 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820 (837)
Q Consensus 741 ~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF 820 (837)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 171 ~~--------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf 218 (355)
T cd07874 171 TS--------------------------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 218 (355)
T ss_pred Cc--------------------------------cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 00 0112346899999999999999999999999999999999999999
Q ss_pred CCCC
Q 003232 821 NAEH 824 (837)
Q Consensus 821 ~~~d 824 (837)
.+.+
T Consensus 219 ~~~~ 222 (355)
T cd07874 219 PGRD 222 (355)
T ss_pred CCCC
Confidence 8754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=287.75 Aligned_cols=221 Identities=50% Similarity=0.903 Sum_probs=183.7
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVm 668 (837)
++|++++.||.|+||.||++.+..+++.|++|.+.............+.+|+.+++.++||||+++++.+....++|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46999999999999999999999999999999987654333445567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCC
Q 003232 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (837)
Q Consensus 669 Ey~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~ 748 (837)
||++|++|.+++...+.+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||+++.+.........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999998742211111100
Q ss_pred CCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 749 ~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
... . .............|+..|+|||.+.+..++.++||||||+++|+|++|..||.+.++
T Consensus 161 ~~~---------~-------~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~ 221 (305)
T cd05609 161 EGH---------I-------EKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP 221 (305)
T ss_pred ccc---------c-------ccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 000 0 000001112234678899999999988899999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=276.50 Aligned_cols=203 Identities=32% Similarity=0.604 Sum_probs=178.0
Q ss_pred CeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEE
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmE 669 (837)
+|.+.+.||.|++|.||+|.+..+++.|++|.+..... .......+.+|+.+++.++||||+++++.+.....+|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM-NRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC-CHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 58899999999999999999999999999999875432 24455678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCC
Q 003232 670 YLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (837)
Q Consensus 670 y~~GGSL~dlLk~~--g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl 747 (837)
|++|++|.+++... ..++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||+++......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~---- 155 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT---- 155 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc----
Confidence 99999999999764 568999999999999999999999999999999999999999999999999876311000
Q ss_pred CCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 748 ~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
.......|++.|+|||++.+..++.++|+||||+++|+|++|+.||...+
T Consensus 156 ---------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 205 (256)
T cd08529 156 ---------------------------NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN 205 (256)
T ss_pred ---------------------------chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 01123467889999999999989999999999999999999999998665
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=291.12 Aligned_cols=204 Identities=28% Similarity=0.535 Sum_probs=172.9
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLV 667 (837)
+++|.+.+.||.|+||+||+|++..+++.||+|.++.... ......+.+|+.+++.++||||+++++++......|+|
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence 4679999999999999999999999999999999875432 22234567899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCC
Q 003232 668 MEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (837)
Q Consensus 668 mEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stdd 746 (837)
|||+.+ +|.+++... ..++...++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--- 158 (309)
T cd07872 83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT--- 158 (309)
T ss_pred EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCc---
Confidence 999964 888887654 458899999999999999999999999999999999999999999999999986310000
Q ss_pred CCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 747 l~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.
T Consensus 159 ----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 210 (309)
T cd07872 159 ----------------------------KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTV 210 (309)
T ss_pred ----------------------------cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 00123457889999999875 4578999999999999999999999987653
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=284.85 Aligned_cols=206 Identities=22% Similarity=0.303 Sum_probs=173.8
Q ss_pred cCCeEEEEEecccCceEEEEEEEC---CCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKR---TTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk---~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~l 664 (837)
.++|++.+.||+|+||.||+|.+. ..+..||+|.++... .......+.+|+.+++.++||||+++++.+....+.
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 356999999999999999999875 345689999987643 233446789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCC
Q 003232 665 YLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~s 743 (837)
|+||||+++++|.+++... ..+++..++.++.||+.||+|||++|++||||||+|||++.++.++++|||.+....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~--- 158 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK--- 158 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccc---
Confidence 9999999999999998764 568999999999999999999999999999999999999999999999999765210
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNA 822 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~~ 822 (837)
... ........++..|+|||++.+..++.++|||||||++|++++ |..||..
T Consensus 159 ~~~---------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~ 211 (266)
T cd05064 159 SEA---------------------------IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWD 211 (266)
T ss_pred ccc---------------------------hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCc
Confidence 000 000112345678999999999999999999999999999875 9999976
Q ss_pred CCc
Q 003232 823 EHP 825 (837)
Q Consensus 823 ~dp 825 (837)
.++
T Consensus 212 ~~~ 214 (266)
T cd05064 212 MSG 214 (266)
T ss_pred CCH
Confidence 543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=288.01 Aligned_cols=235 Identities=42% Similarity=0.776 Sum_probs=184.3
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVm 668 (837)
++|++.+.||.|+||+||+|.+..+++.||+|.+.............+.+|+.+++.++||||+++++.+......|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36999999999999999999999899999999998765444456678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCC
Q 003232 669 EYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (837)
Q Consensus 669 Ey~~GGSL~dlLk~~--g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stdd 746 (837)
||+.|++|.+++... ..+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++..........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999999998754 568999999999999999999999999999999999999999999999999986421111000
Q ss_pred CCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 747 l~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
.. ............... ................||..|+|||++.+..++.++||||||+++|+|++|..||...+.
T Consensus 161 ~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 161 SK-ALRKGSRRSSVNSIP-SETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cc-ccccccccccccccc-hhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 00 000000000000000 000000011123356789999999999999999999999999999999999999976654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=302.15 Aligned_cols=201 Identities=31% Similarity=0.539 Sum_probs=169.8
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeE
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~l 664 (837)
...+++|+++++||.|+||+||+|++..+++.||+|++.... .......+.+|+.+++.++|+||+++++++.....+
T Consensus 70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 147 (353)
T PLN00034 70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEI 147 (353)
T ss_pred CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeE
Confidence 334567899999999999999999999999999999986532 234456789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCC
Q 003232 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~st 744 (837)
|+||||+++++|... ....+..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.....
T Consensus 148 ~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~-- 221 (353)
T PLN00034 148 QVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT-- 221 (353)
T ss_pred EEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccc--
Confidence 999999999998653 34567888899999999999999999999999999999999999999999998731100
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-----CCCCchHHHHHHHHHHHHHHcCCCC
Q 003232 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-----TGHGTTADWWSVGIILFELIVGIPP 819 (837)
Q Consensus 745 ddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-----~~~s~kSDIWSLGVILyELLTGr~P 819 (837)
........||..|+|||++.. ...+.++|||||||++|+|++|+.|
T Consensus 222 -----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~p 272 (353)
T PLN00034 222 -----------------------------MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272 (353)
T ss_pred -----------------------------cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCC
Confidence 001123478999999998743 3345689999999999999999999
Q ss_pred CCC
Q 003232 820 FNA 822 (837)
Q Consensus 820 F~~ 822 (837)
|..
T Consensus 273 f~~ 275 (353)
T PLN00034 273 FGV 275 (353)
T ss_pred CCC
Confidence 974
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=276.83 Aligned_cols=208 Identities=31% Similarity=0.546 Sum_probs=180.4
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVm 668 (837)
++|++.+.||.|+||.||+|.+..+|+.||+|.++............+.+|+.++++++|+||+++++.+...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999999899999999987644444455678899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCC
Q 003232 669 EYLNGGDLYSLLRN----LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (837)
Q Consensus 669 Ey~~GGSL~dlLk~----~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~st 744 (837)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~- 160 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC-
Confidence 99999999999864 2458999999999999999999999999999999999999999999999999876311000
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 745 ddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
.......|++.|+|||.+.+..++.++|+||||+++|+|++|..||....
T Consensus 161 ------------------------------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08224 161 ------------------------------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred ------------------------------cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC
Confidence 00123457888999999999999999999999999999999999997665
Q ss_pred cCH
Q 003232 825 PQV 827 (837)
Q Consensus 825 pdv 827 (837)
.+.
T Consensus 211 ~~~ 213 (267)
T cd08224 211 MNL 213 (267)
T ss_pred ccH
Confidence 443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=286.41 Aligned_cols=202 Identities=30% Similarity=0.488 Sum_probs=166.4
Q ss_pred CeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhc---CCCceEEEEeEeec-----C
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV---RNPFVVRFFYSFTC-----R 661 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L---rHPNIVkL~gsf~d-----~ 661 (837)
+|++.+.||.|+||+||+|+++.+++.||+|.++..... ......+.+|+.+++.+ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNE-DGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCC-CCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 489999999999999999999999999999998754211 11123445666666655 79999999998764 3
Q ss_pred CeEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCcccc
Q 003232 662 ENLYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 739 (837)
Q Consensus 662 ~~lyLVmEy~~GGSL~dlLk~~--g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg 739 (837)
..+++||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++...
T Consensus 80 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 46899999997 5898888653 34899999999999999999999999999999999999999999999999988631
Q ss_pred ccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCC
Q 003232 740 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPP 819 (837)
Q Consensus 740 ~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~P 819 (837)
... .......||+.|+|||++.+..++.++|||||||++|+|++|.+|
T Consensus 159 ~~~--------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~ 206 (288)
T cd07863 159 SCQ--------------------------------MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPL 206 (288)
T ss_pred cCc--------------------------------ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcC
Confidence 000 001234678999999999999999999999999999999999999
Q ss_pred CCCCCc
Q 003232 820 FNAEHP 825 (837)
Q Consensus 820 F~~~dp 825 (837)
|.....
T Consensus 207 f~~~~~ 212 (288)
T cd07863 207 FCGNSE 212 (288)
T ss_pred cCCCCH
Confidence 976543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=299.33 Aligned_cols=202 Identities=29% Similarity=0.456 Sum_probs=172.4
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecC-----
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR----- 661 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~----- 661 (837)
..++|++.+.||+|+||.||++.+..+++.||||++.... ........+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 4578999999999999999999999999999999987543 2234456788999999999999999999887643
Q ss_pred -CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccc
Q 003232 662 -ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740 (837)
Q Consensus 662 -~~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~ 740 (837)
..+|+||||+. ++|.+.+.. .++...+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++...
T Consensus 101 ~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 101 FQDVYIVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred cCeEEEEEeCCC-CCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 35799999996 577777753 47889999999999999999999999999999999999999999999999986310
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCC
Q 003232 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820 (837)
Q Consensus 741 ~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF 820 (837)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 178 ~~--------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf 225 (364)
T cd07875 178 TS--------------------------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 225 (364)
T ss_pred CC--------------------------------CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCC
Confidence 00 0112346899999999999999999999999999999999999999
Q ss_pred CCCC
Q 003232 821 NAEH 824 (837)
Q Consensus 821 ~~~d 824 (837)
.+.+
T Consensus 226 ~~~~ 229 (364)
T cd07875 226 PGTD 229 (364)
T ss_pred CCCC
Confidence 8755
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=281.80 Aligned_cols=209 Identities=32% Similarity=0.542 Sum_probs=180.6
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVm 668 (837)
++|++.+.||.|+||.||++++..+++.+|+|.+.............+.+|+.+++.++||||+++++.+.....++++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 57899999999999999999999999999999887654444555578899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCC
Q 003232 669 EYLNGGDLYSLLRN----LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (837)
Q Consensus 669 Ey~~GGSL~dlLk~----~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~st 744 (837)
||+++++|.+++.. ...+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC-
Confidence 99999999998863 3458999999999999999999999999999999999999999999999999876311000
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 745 ddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
.......|+..|+|||++.+..++.++|+||||+++|+|++|..||.+..
T Consensus 161 ------------------------------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08229 161 ------------------------------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred ------------------------------cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccccc
Confidence 00123468889999999999999999999999999999999999998665
Q ss_pred cCHH
Q 003232 825 PQVS 828 (837)
Q Consensus 825 pdv~ 828 (837)
.+..
T Consensus 211 ~~~~ 214 (267)
T cd08229 211 MNLY 214 (267)
T ss_pred chHH
Confidence 5433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=314.00 Aligned_cols=208 Identities=31% Similarity=0.501 Sum_probs=177.2
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC----
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE---- 662 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~---- 662 (837)
..++|++.+.||.|+||+||+|++..+++.||||++..... .......+.+|+.++..++|+||++++..+....
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 34679999999999999999999999999999999976542 3445567889999999999999999988775432
Q ss_pred ----eEEEEEEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecC
Q 003232 663 ----NLYLVMEYLNGGDLYSLLRNL----GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFG 734 (837)
Q Consensus 663 ----~lyLVmEy~~GGSL~dlLk~~----g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFG 734 (837)
.+++||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecc
Confidence 378999999999999998642 468999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHH
Q 003232 735 LSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI 814 (837)
Q Consensus 735 LArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELL 814 (837)
+++....... .......+||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 189 ls~~~~~~~~-----------------------------~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLl 239 (496)
T PTZ00283 189 FSKMYAATVS-----------------------------DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELL 239 (496)
T ss_pred cCeecccccc-----------------------------ccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence 9873111000 00123457999999999999999999999999999999999
Q ss_pred cCCCCCCCCC
Q 003232 815 VGIPPFNAEH 824 (837)
Q Consensus 815 TGr~PF~~~d 824 (837)
+|+.||.+.+
T Consensus 240 tG~~Pf~~~~ 249 (496)
T PTZ00283 240 TLKRPFDGEN 249 (496)
T ss_pred HCCCCCCCCC
Confidence 9999998654
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=279.51 Aligned_cols=207 Identities=31% Similarity=0.538 Sum_probs=176.3
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccc--cccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecC--CeE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKAD--MIRKNAVESILAERDILISVRNPFVVRFFYSFTCR--ENL 664 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~--~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~--~~l 664 (837)
++|++.+.||.|+||.||++.+..+++.||+|.+.... .......+.+.+|+.+++.++||||+++++.+.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57999999999999999999999999999999886432 12234457888999999999999999999988763 568
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCC
Q 003232 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~st 744 (837)
++||||+++++|.+++...+.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 89999999999999998877889999999999999999999999999999999999999999999999998863110000
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003232 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823 (837)
Q Consensus 745 ddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~ 823 (837)
. ........|+..|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 162 ~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 212 (265)
T cd06652 162 S----------------------------GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF 212 (265)
T ss_pred c----------------------------ccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc
Confidence 0 00112345888999999999888999999999999999999999999764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=284.97 Aligned_cols=208 Identities=25% Similarity=0.430 Sum_probs=175.8
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCC-----cEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecC
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTG-----DLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR 661 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG-----~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~ 661 (837)
.+++|++++.||.|+||.||+|.+...+ ..||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 4567999999999999999999986555 689999987542 234456789999999999999999999999998
Q ss_pred CeEEEEEEecCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccC
Q 003232 662 ENLYLVMEYLNGGDLYSLLRNL----------------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD 725 (837)
Q Consensus 662 ~~lyLVmEy~~GGSL~dlLk~~----------------g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~d 725 (837)
...|++|||+++++|.+++... ..++...+..++.||+.||.|||+.|++|+||||+||+++.+
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence 9999999999999999999754 447888999999999999999999999999999999999999
Q ss_pred CcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHH
Q 003232 726 GHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWS 805 (837)
Q Consensus 726 G~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWS 805 (837)
+.++|+|||++........ ........+++.|+|||.+.+..++.++||||
T Consensus 161 ~~~~L~dfg~~~~~~~~~~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s 211 (283)
T cd05048 161 LTVKISDFGLSRDIYSADY-----------------------------YRVQSKSLLPVRWMPPEAILYGKFTTESDIWS 211 (283)
T ss_pred CcEEECCCcceeecccccc-----------------------------ccccCCCcccccccCHHHhccCcCchhhhHHH
Confidence 9999999999863110000 01112345678899999999889999999999
Q ss_pred HHHHHHHHHc-CCCCCCCCCc
Q 003232 806 VGIILFELIV-GIPPFNAEHP 825 (837)
Q Consensus 806 LGVILyELLT-Gr~PF~~~dp 825 (837)
|||++|+|++ |..||.+.++
T Consensus 212 lG~il~el~~~g~~p~~~~~~ 232 (283)
T cd05048 212 FGVVLWEIFSYGLQPYYGFSN 232 (283)
T ss_pred HHHHHHHHHcCCCCCCCCCCH
Confidence 9999999998 9999986543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=288.98 Aligned_cols=201 Identities=31% Similarity=0.534 Sum_probs=178.1
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVm 668 (837)
++|++.+.||.|+||.||++.+..++..+|+|.+.... .......+.+|+++++.++||||+++++.+.....+|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 46999999999999999999999999999999987532 2344567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCC
Q 003232 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (837)
Q Consensus 669 Ey~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHS-kGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl 747 (837)
||++|++|.+++...+.+++..+..++.|++.||.|||+ .+++|+||||+|||++.++.++|+|||++.....
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 152 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID------ 152 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccc------
Confidence 999999999999888889999999999999999999997 6999999999999999999999999998752100
Q ss_pred CCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 748 ~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
.......|++.|+|||++.+..++.++|+||||+++|+|++|+.||...+
T Consensus 153 ---------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~ 202 (308)
T cd06615 153 ---------------------------SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD 202 (308)
T ss_pred ---------------------------cccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc
Confidence 00123468899999999988889999999999999999999999997544
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=309.38 Aligned_cols=199 Identities=25% Similarity=0.452 Sum_probs=166.8
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCC------CceEEEEeEeecC
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN------PFVVRFFYSFTCR 661 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrH------PNIVkL~gsf~d~ 661 (837)
.++|+++++||.|+||+||+|.+..+++.||||+++... ........|+.+++.++| +++++++++|...
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 367999999999999999999999999999999996432 122345567777766654 4588888888764
Q ss_pred -CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCcEEEccCC-------------
Q 003232 662 -ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDG------------- 726 (837)
Q Consensus 662 -~~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHS-kGIIHRDIKPeNILLd~dG------------- 726 (837)
.++|+|||++ |++|.+++...+.+++..++.++.||+.||.|||+ .|||||||||+|||++.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~ 282 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP 282 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence 5799999988 78999999888889999999999999999999998 6999999999999998765
Q ss_pred ---cEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHH
Q 003232 727 ---HIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADW 803 (837)
Q Consensus 727 ---~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDI 803 (837)
.+||+|||++.... ......+||+.|+|||++.+..++.++||
T Consensus 283 ~~~~vkl~DfG~~~~~~----------------------------------~~~~~~~gt~~Y~APE~~~~~~~~~~~Di 328 (467)
T PTZ00284 283 DPCRVRICDLGGCCDER----------------------------------HSRTAIVSTRHYRSPEVVLGLGWMYSTDM 328 (467)
T ss_pred CCceEEECCCCccccCc----------------------------------cccccccCCccccCcHHhhcCCCCcHHHH
Confidence 49999999875200 01224579999999999999999999999
Q ss_pred HHHHHHHHHHHcCCCCCCCCCc
Q 003232 804 WSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 804 WSLGVILyELLTGr~PF~~~dp 825 (837)
|||||++|||++|++||.+.+.
T Consensus 329 wSlGvil~elltG~~pf~~~~~ 350 (467)
T PTZ00284 329 WSMGCIIYELYTGKLLYDTHDN 350 (467)
T ss_pred HHHHHHHHHHHhCCCCCCCCCh
Confidence 9999999999999999987553
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=304.48 Aligned_cols=217 Identities=33% Similarity=0.521 Sum_probs=183.6
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecC--CeE
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR--ENL 664 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~--~~l 664 (837)
..++|+.+..|++|+||.||+|+++.+++.||+|.++... ......---++|+.+|..++|||||.+-++.... +.+
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek-ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK-EKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc-ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 4567999999999999999999999999999999998654 2233334567999999999999999998877653 469
Q ss_pred EEEEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCC
Q 003232 665 YLVMEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~g-~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~s 743 (837)
|||||||+ -+|..++.+-+ ++...+++-++.|++.||.|||.++|+||||||+|+|+...|.+||+|||+|+....
T Consensus 153 y~VMe~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs-- 229 (419)
T KOG0663|consen 153 YIVMEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGS-- 229 (419)
T ss_pred eeeHHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcC--
Confidence 99999995 58998887654 799999999999999999999999999999999999999999999999999983110
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNA 822 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLTGr~PF~~ 822 (837)
.....+..+-|..|+|||.++| ..|+...|+||+|||+.||+++++.|.+
T Consensus 230 -----------------------------p~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G 280 (419)
T KOG0663|consen 230 -----------------------------PLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPG 280 (419)
T ss_pred -----------------------------CcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCC
Confidence 0122345678999999999998 5689999999999999999999999987
Q ss_pred CCcCHHHHHHhcccC
Q 003232 823 EHPQVSTLLRKCQLL 837 (837)
Q Consensus 823 ~dpdv~~lle~~hL~ 837 (837)
.+ ++.|+..++++|
T Consensus 281 ~s-E~dQl~~If~ll 294 (419)
T KOG0663|consen 281 KS-EIDQLDKIFKLL 294 (419)
T ss_pred Cc-hHHHHHHHHHHh
Confidence 54 566677776654
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=275.23 Aligned_cols=202 Identities=37% Similarity=0.607 Sum_probs=178.2
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVm 668 (837)
++|++.+.||.|+||.||+|.+..+++.+++|++.... ....+.+.+|+.+++.++||||+++++.+.....+|++|
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 57999999999999999999999899999999997643 224578899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCC
Q 003232 669 EYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (837)
Q Consensus 669 Ey~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl 747 (837)
||+.+++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~------ 153 (262)
T cd06613 80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTA------ 153 (262)
T ss_pred eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhh------
Confidence 999999999998775 7799999999999999999999999999999999999999999999999998763100
Q ss_pred CCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCC---CCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT---GHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 748 ~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~---~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
.........|+..|+|||.+.+. .++.++|+||||+++|+|++|..||...+
T Consensus 154 -------------------------~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~ 208 (262)
T cd06613 154 -------------------------TIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH 208 (262)
T ss_pred -------------------------hhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 00112234688899999999877 78899999999999999999999998654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=280.58 Aligned_cols=203 Identities=33% Similarity=0.551 Sum_probs=175.2
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLV 667 (837)
.++|++.+.||.|+||.||+|++..+++.||+|++.... ......+.+|+.+++.++||||+++++.+.....+|+|
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv 84 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC 84 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence 457999999999999999999999999999999987532 22334678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCC
Q 003232 668 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (837)
Q Consensus 668 mEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl 747 (837)
|||+++++|.+++...+.+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~----- 159 (267)
T cd06646 85 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT----- 159 (267)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccc-----
Confidence 999999999999987788999999999999999999999999999999999999999999999999998631000
Q ss_pred CCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhc---CCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL---GTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 748 ~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLl---g~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
........|++.|+|||.+. ...++.++|+|||||++|+|++|..||....
T Consensus 160 --------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~ 213 (267)
T cd06646 160 --------------------------IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLH 213 (267)
T ss_pred --------------------------ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccc
Confidence 00112346888999999985 3447789999999999999999999996544
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=296.91 Aligned_cols=201 Identities=28% Similarity=0.467 Sum_probs=171.4
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecC-----
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR----- 661 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~----- 661 (837)
..++|++++.||.|+||+||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF-QSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchh-hhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 3467999999999999999999999999999999987643 2223445678999999999999999999887543
Q ss_pred -CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccc
Q 003232 662 -ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740 (837)
Q Consensus 662 -~~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~ 740 (837)
...|++|+++ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++...
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecC
Confidence 3579999988 7899888764 569999999999999999999999999999999999999999999999999986310
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCC
Q 003232 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPP 819 (837)
Q Consensus 741 ~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLTGr~P 819 (837)
. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus 170 ~----------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~p 215 (343)
T cd07878 170 D----------------------------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKAL 215 (343)
T ss_pred C----------------------------------CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCC
Confidence 0 0123468999999999977 5688999999999999999999999
Q ss_pred CCCCC
Q 003232 820 FNAEH 824 (837)
Q Consensus 820 F~~~d 824 (837)
|...+
T Consensus 216 f~~~~ 220 (343)
T cd07878 216 FPGND 220 (343)
T ss_pred CCCCC
Confidence 97643
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=283.43 Aligned_cols=196 Identities=31% Similarity=0.541 Sum_probs=172.2
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVm 668 (837)
++|++++.||.|+||.||+|.+..+++.||+|++.... .......+.+|+.++++++||||+++++.+...+..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 36889999999999999999999999999999987542 2334567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCC
Q 003232 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (837)
Q Consensus 669 Ey~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~ 748 (837)
||+++++|..+ ..+++..+..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++.....
T Consensus 79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~------- 147 (279)
T cd06619 79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN------- 147 (279)
T ss_pred ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc-------
Confidence 99999999754 3578889999999999999999999999999999999999999999999999862100
Q ss_pred CCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003232 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823 (837)
Q Consensus 749 ~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~ 823 (837)
.......||..|+|||++.+..++.++|+||||+++|+|++|+.||...
T Consensus 148 --------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 196 (279)
T cd06619 148 --------------------------SIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQI 196 (279)
T ss_pred --------------------------ccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhh
Confidence 0112356899999999999999999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=287.76 Aligned_cols=195 Identities=17% Similarity=0.186 Sum_probs=170.2
Q ss_pred EEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeec----CCeEEEEEEe
Q 003232 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC----RENLYLVMEY 670 (837)
Q Consensus 595 kkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d----~~~lyLVmEy 670 (837)
..||.|+++.||+|.+ +|+.||+|+++..........+.+.+|+.+|++++||||+++++++.+ ...+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5689999999999997 689999999987654445556788999999999999999999999876 3578999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCC
Q 003232 671 LNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 749 (837)
Q Consensus 671 ~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHS-kGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~ 749 (837)
+++|+|.+++...+.++......++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++....
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~-------- 175 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSS-------- 175 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcc--------
Confidence 9999999999887889999999999999999999998 5999999999999999999999999999863100
Q ss_pred CCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC--CCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 750 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG--TGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 750 p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg--~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.
T Consensus 176 --------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~ 227 (283)
T PHA02988 176 --------------------------PPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT 227 (283)
T ss_pred --------------------------ccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH
Confidence 0112467889999999976 6789999999999999999999999987653
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=280.50 Aligned_cols=205 Identities=30% Similarity=0.520 Sum_probs=175.9
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVm 668 (837)
++|++.+.||.|+||.||+|.++.+++.||+|++..... .....+.+.+|+.+++.++||||+++++.+.....+++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 469999999999999999999998999999999865431 1223346789999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCC
Q 003232 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (837)
Q Consensus 669 Ey~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~ 748 (837)
||++++.|..++.....+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~----- 154 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPG----- 154 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCc-----
Confidence 999999998888776779999999999999999999999999999999999999999999999999986311000
Q ss_pred CCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 749 ~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
.......++..|+|||++.+ ..++.++||||||+++|+|++|+.||.+.++
T Consensus 155 --------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~ 206 (286)
T cd07847 155 --------------------------DDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSD 206 (286)
T ss_pred --------------------------ccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 01123457788999999876 4578899999999999999999999987654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=307.13 Aligned_cols=198 Identities=30% Similarity=0.431 Sum_probs=164.4
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecC------
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR------ 661 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~------ 661 (837)
..+|++.+.||.|+||.||+|.+..+++.||||.+.... ....+|+.+++.++||||++++++|...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 356999999999999999999999999999999886432 1234799999999999999998876432
Q ss_pred --CeEEEEEEecCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCC-cEEEEecC
Q 003232 662 --ENLYLVMEYLNGGDLYSLLR----NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG-HIKLTDFG 734 (837)
Q Consensus 662 --~~lyLVmEy~~GGSL~dlLk----~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG-~IKLiDFG 734 (837)
..+++||||++ ++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 138 ~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 138 KNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred CceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 25789999996 47777664 345699999999999999999999999999999999999998665 79999999
Q ss_pred CccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCC-CCCchHHHHHHHHHHHHH
Q 003232 735 LSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFEL 813 (837)
Q Consensus 735 LArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~-~~s~kSDIWSLGVILyEL 813 (837)
+++.... ........||+.|+|||++.+. .++.++|||||||++|+|
T Consensus 217 la~~~~~--------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el 264 (440)
T PTZ00036 217 SAKNLLA--------------------------------GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEM 264 (440)
T ss_pred cchhccC--------------------------------CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHH
Confidence 9873110 0011235689999999998764 689999999999999999
Q ss_pred HcCCCCCCCCCc
Q 003232 814 IVGIPPFNAEHP 825 (837)
Q Consensus 814 LTGr~PF~~~dp 825 (837)
++|.+||.+.++
T Consensus 265 ltG~~pf~~~~~ 276 (440)
T PTZ00036 265 ILGYPIFSGQSS 276 (440)
T ss_pred HhCCCCCCCCCh
Confidence 999999987653
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=307.16 Aligned_cols=208 Identities=34% Similarity=0.544 Sum_probs=177.5
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC-----e
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE-----N 663 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~-----~ 663 (837)
-.|...+++|.|+||.||.|....+++.||||....+.. .-.+|+.+|+.++|||||++..+|.... +
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ 96 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVY 96 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence 358999999999999999999999999999999876432 2347999999999999999988886532 4
Q ss_pred EEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccC-CcEEEEecCCccc
Q 003232 664 LYLVMEYLNGGDLYSLLRN----LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD-GHIKLTDFGLSKV 738 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk~----~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~d-G~IKLiDFGLArv 738 (837)
..+||||++ .+|.++++. +..++.-.++.|.+||++||.|||+.||+||||||.|+|+|.+ |.+||||||+|+.
T Consensus 97 lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 97 LNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 679999995 699988874 4668888999999999999999999999999999999999975 8999999999985
Q ss_pred cccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHcCC
Q 003232 739 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGI 817 (837)
Q Consensus 739 g~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLTGr 817 (837)
... .....++..|..|+|||.+.| ..|+.+.||||.||++.||+-|.
T Consensus 176 L~~--------------------------------~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~ 223 (364)
T KOG0658|consen 176 LVK--------------------------------GEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQ 223 (364)
T ss_pred ecc--------------------------------CCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCC
Confidence 211 122345678899999999987 56899999999999999999999
Q ss_pred CCCCCCCcCHHHHHHhcccC
Q 003232 818 PPFNAEHPQVSTLLRKCQLL 837 (837)
Q Consensus 818 ~PF~~~dpdv~~lle~~hL~ 837 (837)
+.|.+ .....|+.+++++|
T Consensus 224 plFpG-~s~~dQL~eIik~l 242 (364)
T KOG0658|consen 224 PLFPG-DSSVDQLVEIIKVL 242 (364)
T ss_pred cccCC-CCHHHHHHHHHHHh
Confidence 99999 55567788888765
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=281.17 Aligned_cols=204 Identities=35% Similarity=0.580 Sum_probs=176.9
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLV 667 (837)
.++|++.+.||.|+||.||+|++..+++.||+|+++... ......+.+|+.+++.++||||+++++.+.....+|+|
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv 84 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC 84 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence 357999999999999999999999999999999987542 22335678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCC
Q 003232 668 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (837)
Q Consensus 668 mEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl 747 (837)
|||+++++|.+++...+.+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~----- 159 (267)
T cd06645 85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT----- 159 (267)
T ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc-----
Confidence 999999999999988888999999999999999999999999999999999999999999999999987631100
Q ss_pred CCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhc---CCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL---GTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 748 ~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLl---g~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
........|++.|+|||++. +..++.++|+|||||++|+|++|..||....
T Consensus 160 --------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~ 213 (267)
T cd06645 160 --------------------------IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLH 213 (267)
T ss_pred --------------------------ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCccccc
Confidence 00112346899999999984 4567889999999999999999999987544
Q ss_pred c
Q 003232 825 P 825 (837)
Q Consensus 825 p 825 (837)
+
T Consensus 214 ~ 214 (267)
T cd06645 214 P 214 (267)
T ss_pred c
Confidence 3
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=314.71 Aligned_cols=208 Identities=33% Similarity=0.596 Sum_probs=185.3
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCe-EEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCREN-LYL 666 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~-lyL 666 (837)
+++|.+++.+|.|+||.+++++++.+++.|++|.+.-....... .+...+|+.++++++|||||.+.++|..++. +||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 56799999999999999999999999999999999876544333 3478899999999999999999999999888 999
Q ss_pred EEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCC
Q 003232 667 VMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~~--g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~st 744 (837)
||+||+||+|.+.+... ..++++.+..|+.||+.|+.|||+++|+|||||+.|||++.++.++|+|||+|+.....
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~-- 159 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE-- 159 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCc--
Confidence 99999999999999754 35899999999999999999999999999999999999999999999999999851100
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 745 ddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
.....+.+|||.||.||.+.+.+|+.++|||||||++|||++=+++|.+.+
T Consensus 160 -----------------------------~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~ 210 (426)
T KOG0589|consen 160 -----------------------------DSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN 210 (426)
T ss_pred -----------------------------hhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc
Confidence 012346789999999999999999999999999999999999999999876
Q ss_pred cCH
Q 003232 825 PQV 827 (837)
Q Consensus 825 pdv 827 (837)
..-
T Consensus 211 m~~ 213 (426)
T KOG0589|consen 211 MSE 213 (426)
T ss_pred hHH
Confidence 543
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=275.26 Aligned_cols=203 Identities=31% Similarity=0.565 Sum_probs=176.7
Q ss_pred CeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEE
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmE 669 (837)
+|++.+.||.|+||.||++.+..+++.+|+|.++... .....+.+.+|+.+++.++||||+++++.+.....+|+|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 5899999999999999999999999999999986543 23345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCC
Q 003232 670 YLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (837)
Q Consensus 670 y~~GGSL~dlLk~~--g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl 747 (837)
|+++++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~----- 153 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP----- 153 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccc-----
Confidence 99999999988643 45899999999999999999999999999999999999999999999999987631000
Q ss_pred CCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 748 ~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
........|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.
T Consensus 154 --------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~ 205 (255)
T cd08219 154 --------------------------GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW 205 (255)
T ss_pred --------------------------ccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH
Confidence 0011234688899999999999999999999999999999999999986553
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=305.38 Aligned_cols=202 Identities=30% Similarity=0.442 Sum_probs=174.0
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC-eEE
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE-NLY 665 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~-~ly 665 (837)
..++|.....||+|+||.||+|... +|..||||.+....... ..+|.+|+.++.+++|||+++++|+|.+.+ +.+
T Consensus 73 AT~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~ 148 (361)
T KOG1187|consen 73 ATNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRL 148 (361)
T ss_pred HHhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEE
Confidence 3467888899999999999999984 55899999887644221 345999999999999999999999999988 599
Q ss_pred EEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccccCCCCcEEEccCCcEEEEecCCccccc
Q 003232 666 LVMEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSL---RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740 (837)
Q Consensus 666 LVmEy~~GGSL~dlLk~~g--~Lsee~irkIl~QIa~ALsYLHSk---GIIHRDIKPeNILLd~dG~IKLiDFGLArvg~ 740 (837)
||+||+.+|+|.+++.... .+++....+|+.++|+||+|||+. .||||||||+|||+|.+.++||+|||+|+.++
T Consensus 149 LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~ 228 (361)
T KOG1187|consen 149 LVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGP 228 (361)
T ss_pred EEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCC
Confidence 9999999999999997654 899999999999999999999984 39999999999999999999999999997432
Q ss_pred c-CCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCC-CCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCC
Q 003232 741 I-NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSA-VGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIP 818 (837)
Q Consensus 741 ~-~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~-vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~ 818 (837)
. ... .... .||.+|+|||++.....+.++||||||++|+||++|+.
T Consensus 229 ~~~~~--------------------------------~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~ 276 (361)
T KOG1187|consen 229 EGDTS--------------------------------VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRK 276 (361)
T ss_pred ccccc--------------------------------eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCc
Confidence 1 100 0111 79999999999998889999999999999999999998
Q ss_pred CCCCCC
Q 003232 819 PFNAEH 824 (837)
Q Consensus 819 PF~~~d 824 (837)
|.....
T Consensus 277 ~~d~~~ 282 (361)
T KOG1187|consen 277 AVDQSR 282 (361)
T ss_pred ccCCCC
Confidence 887543
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=301.85 Aligned_cols=211 Identities=27% Similarity=0.395 Sum_probs=174.7
Q ss_pred CCcccCCeEEEEEecccCceEEEEEEECCCC-----cEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEeE
Q 003232 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTG-----DLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYS 657 (837)
Q Consensus 584 ~g~~lddYeIlkkLGsG~FGtVYkArdk~tG-----~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~gs 657 (837)
+....++|++.+.||.|+||.||+|++...+ ..||+|+++... .......+.+|+.+++.+ +||||+++++.
T Consensus 33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~~ 110 (374)
T cd05106 33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLGA 110 (374)
T ss_pred ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEeeE
Confidence 4455678999999999999999999875433 579999997643 233456788999999999 89999999999
Q ss_pred eecCCeEEEEEEecCCCCHHHHHHhc------------------------------------------------------
Q 003232 658 FTCRENLYLVMEYLNGGDLYSLLRNL------------------------------------------------------ 683 (837)
Q Consensus 658 f~d~~~lyLVmEy~~GGSL~dlLk~~------------------------------------------------------ 683 (837)
+.....+|+||||+++|+|.+++...
T Consensus 111 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 111 CTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred ecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 99999999999999999999998542
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCC
Q 003232 684 ----------------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (837)
Q Consensus 684 ----------------g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl 747 (837)
..++...+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.......
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~--- 267 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN--- 267 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc---
Confidence 1367788999999999999999999999999999999999999999999999863110000
Q ss_pred CCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCc
Q 003232 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHP 825 (837)
Q Consensus 748 ~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~~~dp 825 (837)
........++..|+|||++.+..++.++|||||||++|+|++ |+.||.....
T Consensus 268 --------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~ 320 (374)
T cd05106 268 --------------------------YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV 320 (374)
T ss_pred --------------------------eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccc
Confidence 000112235678999999999999999999999999999997 9999976554
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=278.76 Aligned_cols=204 Identities=40% Similarity=0.779 Sum_probs=182.0
Q ss_pred CeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEE
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmE 669 (837)
+|++.+.||.|+||.||+|.+..++..||+|++...........+.+.+|+.++++++||||+++++.+......|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 58999999999999999999998999999999986554444567789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCC
Q 003232 670 YLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 749 (837)
Q Consensus 670 y~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~ 749 (837)
|+.|++|.+++.....+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~------ 154 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT------ 154 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc------
Confidence 99999999999887789999999999999999999999999999999999999999999999999876311000
Q ss_pred CCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 750 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 750 p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
......|+..|+|||++.+..++.++|+||||+++|+|++|..||...+.
T Consensus 155 --------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 204 (258)
T cd05578 155 --------------------------LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR 204 (258)
T ss_pred --------------------------cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCc
Confidence 11234578889999999988899999999999999999999999987764
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=278.10 Aligned_cols=202 Identities=33% Similarity=0.572 Sum_probs=171.7
Q ss_pred CeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEE
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmE 669 (837)
+|++.+.||.|++|.||+|++..++..||+|++.... ........+.+|+.+++.++||||+++++.+..+..+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLES-EEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccc-ccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 5899999999999999999999999999999987543 222234567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCC
Q 003232 670 YLNGGDLYSLLRNL---GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (837)
Q Consensus 670 y~~GGSL~dlLk~~---g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stdd 746 (837)
|+. ++|.+++... ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--- 155 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV--- 155 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc---
Confidence 997 6898887543 458999999999999999999999999999999999999999999999999986310000
Q ss_pred CCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 747 l~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~-~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
.......+++.|+|||++.+. .++.++|||||||++|+|++|++||.+.+
T Consensus 156 ----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~ 206 (285)
T cd07861 156 ----------------------------RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDS 206 (285)
T ss_pred ----------------------------ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 011233578899999998764 46889999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=286.55 Aligned_cols=205 Identities=28% Similarity=0.441 Sum_probs=171.9
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCCcE--EEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEeEeecCC
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDL--FAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRE 662 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG~~--VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~gsf~d~~ 662 (837)
...++|++.+.||.|+||.||+|.++.++.. +++|.++.. ........+.+|+.++.++ +||||+++++++....
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~ 81 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 81 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence 4567899999999999999999999877764 466666532 2344556788999999999 8999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCC
Q 003232 663 NLYLVMEYLNGGDLYSLLRNLG----------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG 726 (837)
Q Consensus 663 ~lyLVmEy~~GGSL~dlLk~~g----------------~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG 726 (837)
.+|+||||+++++|.+++...+ .+++..++.++.||+.||+|||++|++||||||+|||++.++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 161 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence 9999999999999999996532 478899999999999999999999999999999999999999
Q ss_pred cEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHH
Q 003232 727 HIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSV 806 (837)
Q Consensus 727 ~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSL 806 (837)
.++|+|||++..... ........++..|+|||++.+..++.++|||||
T Consensus 162 ~~kl~dfg~~~~~~~--------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 209 (303)
T cd05088 162 VAKIADFGLSRGQEV--------------------------------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSY 209 (303)
T ss_pred cEEeCccccCcccch--------------------------------hhhcccCCCcccccCHHHHhccCCcccccchhh
Confidence 999999998752000 000112234667999999988889999999999
Q ss_pred HHHHHHHHc-CCCCCCCCC
Q 003232 807 GIILFELIV-GIPPFNAEH 824 (837)
Q Consensus 807 GVILyELLT-Gr~PF~~~d 824 (837)
||++|+|++ |..||...+
T Consensus 210 G~il~ellt~g~~p~~~~~ 228 (303)
T cd05088 210 GVLLWEIVSLGGTPYCGMT 228 (303)
T ss_pred hhHHHHHHhcCCCCcccCC
Confidence 999999998 999997544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-32 Score=271.12 Aligned_cols=203 Identities=28% Similarity=0.543 Sum_probs=174.4
Q ss_pred CeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeec-CCeEEEEE
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC-RENLYLVM 668 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d-~~~lyLVm 668 (837)
+|++.+.||.|++|.||++.++.+++.||+|.+.... ......+.+.+|+.+++.++|||++++++.+.. ...+|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRN-ASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhh-cCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 4899999999999999999999999999999986543 223345678899999999999999999988764 44689999
Q ss_pred EecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCC
Q 003232 669 EYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (837)
Q Consensus 669 Ey~~GGSL~dlLk~~--g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stdd 746 (837)
||+++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~--- 156 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC--- 156 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC---
Confidence 999999999998753 458999999999999999999999999999999999999999999999999986311000
Q ss_pred CCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 747 l~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
.......|++.|+|||++.+..++.++||||||+++|+|++|+.||...+
T Consensus 157 ----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 206 (257)
T cd08223 157 ----------------------------DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD 206 (257)
T ss_pred ----------------------------CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 01123468889999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=297.05 Aligned_cols=200 Identities=23% Similarity=0.357 Sum_probs=172.0
Q ss_pred cCCeEEEEEecccCceEEEEEEEC--CCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKR--TTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 665 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk--~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ly 665 (837)
..+|++++.||.|+||.||++... .+++.||+|.+.... ...+|+.+++.++||||+++++.+......|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 356999999999999999999764 356789999886532 3457999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCC
Q 003232 666 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745 (837)
Q Consensus 666 LVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~std 745 (837)
+|||++. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++........
T Consensus 163 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~- 240 (392)
T PHA03207 163 MVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD- 240 (392)
T ss_pred EEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc-
Confidence 9999994 68999987778899999999999999999999999999999999999999999999999999863110000
Q ss_pred CCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 746 dl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+...
T Consensus 241 ----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~ 292 (392)
T PHA03207 241 ----------------------------TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQV 292 (392)
T ss_pred ----------------------------cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCC
Confidence 0112245799999999999999999999999999999999999999977553
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-32 Score=283.10 Aligned_cols=207 Identities=35% Similarity=0.622 Sum_probs=179.5
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeE
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~l 664 (837)
+....+|++.+.||.|+||.||++.+..+++.|++|.+..... .....+.+|+.+++.+.||||+++++.+....+.
T Consensus 16 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~ 92 (296)
T cd06654 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDEL 92 (296)
T ss_pred CCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc---chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEE
Confidence 4445689999999999999999999999999999999876432 2345688999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCC
Q 003232 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~st 744 (837)
|+||||+++++|.+++.. ..++...+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++......
T Consensus 93 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~-- 169 (296)
T cd06654 93 WVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-- 169 (296)
T ss_pred EEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccc--
Confidence 999999999999999865 46899999999999999999999999999999999999999999999999987621000
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 745 ddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
........|++.|+|||.+.+..++.++|||||||++|+|++|+.||....
T Consensus 170 -----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~ 220 (296)
T cd06654 170 -----------------------------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (296)
T ss_pred -----------------------------ccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Confidence 001123468899999999998888999999999999999999999998766
Q ss_pred cC
Q 003232 825 PQ 826 (837)
Q Consensus 825 pd 826 (837)
+.
T Consensus 221 ~~ 222 (296)
T cd06654 221 PL 222 (296)
T ss_pred HH
Confidence 53
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=280.31 Aligned_cols=208 Identities=25% Similarity=0.433 Sum_probs=173.8
Q ss_pred ccCCeEEEEEecccCceEEEEEEEC----CCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKR----TTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE 662 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk----~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~ 662 (837)
.+++|++.+.||+|+||+||+|.+. .++..+++|.+.... .......+.+|+.+++.++||||+++++.+....
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 80 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ 80 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence 3567999999999999999999863 456789999987532 2344567889999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccC
Q 003232 663 NLYLVMEYLNGGDLYSLLRNL-----------------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD 725 (837)
Q Consensus 663 ~lyLVmEy~~GGSL~dlLk~~-----------------g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~d 725 (837)
..|+||||+.+++|.+++... ..+++..+..++.||+.||.|||++|++|+||||+|||++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 999999999999999998532 237788899999999999999999999999999999999999
Q ss_pred CcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHH
Q 003232 726 GHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWS 805 (837)
Q Consensus 726 G~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWS 805 (837)
+.++|+|||+++....... ........++..|+|||++.+..++.++||||
T Consensus 161 ~~~kl~dfg~~~~~~~~~~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s 211 (283)
T cd05090 161 LHVKISDLGLSREIYSADY-----------------------------YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWS 211 (283)
T ss_pred CcEEeccccccccccCCcc-----------------------------eecccCCCccceecChHHhccCCCCchhhhHH
Confidence 9999999999873110000 00112334577899999999888999999999
Q ss_pred HHHHHHHHHc-CCCCCCCCCc
Q 003232 806 VGIILFELIV-GIPPFNAEHP 825 (837)
Q Consensus 806 LGVILyELLT-Gr~PF~~~dp 825 (837)
||+++|+|++ |..||.+..+
T Consensus 212 lG~il~el~~~g~~p~~~~~~ 232 (283)
T cd05090 212 FGVVLWEIFSFGLQPYYGFSN 232 (283)
T ss_pred HHHHHHHHHcCCCCCCCCCCH
Confidence 9999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=280.11 Aligned_cols=204 Identities=31% Similarity=0.576 Sum_probs=172.4
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLV 667 (837)
+++|++.+.||.|++|.||+|.++.+++.||+|.+..... ......+.+|+.+++.++||||+++++++....+.|+|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE--EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc--cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence 5789999999999999999999998999999999875431 11223467899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCC
Q 003232 668 MEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (837)
Q Consensus 668 mEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stdd 746 (837)
|||+.+ +|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||+++......
T Consensus 82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~--- 157 (291)
T cd07844 82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS--- 157 (291)
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCC---
Confidence 999974 999988654 468999999999999999999999999999999999999999999999999876210000
Q ss_pred CCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 747 l~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
.......++..|+|||++.+ ..++.++||||||+++|+|++|+.||.....
T Consensus 158 ----------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~ 209 (291)
T cd07844 158 ----------------------------KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD 209 (291)
T ss_pred ----------------------------ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCcc
Confidence 00112346788999999876 4578999999999999999999999976653
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=278.92 Aligned_cols=208 Identities=24% Similarity=0.374 Sum_probs=171.6
Q ss_pred ccCCeEEEEEecccCceEEEEEEECC-----CCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecC
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRT-----TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR 661 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~-----tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~ 661 (837)
..++|++.+.||.|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 45679999999999999999998752 35679999986532 223345688999999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEE
Q 003232 662 ENLYLVMEYLNGGDLYSLLRNLG----------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLT 731 (837)
Q Consensus 662 ~~lyLVmEy~~GGSL~dlLk~~g----------~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLi 731 (837)
...++||||+++++|.+++.... .++...+..++.|++.||.|||+.|++|+||||+||+++.++.++|+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEEC
Confidence 99999999999999999986532 25677888999999999999999999999999999999999999999
Q ss_pred ecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHH
Q 003232 732 DFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILF 811 (837)
Q Consensus 732 DFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILy 811 (837)
|||+++....... ........+++.|+|||++.+..++.++|||||||++|
T Consensus 162 dfg~~~~~~~~~~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 212 (277)
T cd05062 162 DFGMTRDIYETDY-----------------------------YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLW 212 (277)
T ss_pred CCCCccccCCcce-----------------------------eecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHH
Confidence 9998863110000 00011234577899999999988999999999999999
Q ss_pred HHHc-CCCCCCCCCc
Q 003232 812 ELIV-GIPPFNAEHP 825 (837)
Q Consensus 812 ELLT-Gr~PF~~~dp 825 (837)
+|++ |..||.....
T Consensus 213 el~~~~~~p~~~~~~ 227 (277)
T cd05062 213 EIATLAEQPYQGMSN 227 (277)
T ss_pred HHHcCCCCCCCCCCH
Confidence 9998 7899976543
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=286.62 Aligned_cols=205 Identities=28% Similarity=0.438 Sum_probs=171.3
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcE----EEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCe
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDL----FAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCREN 663 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~----VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ 663 (837)
..+|++.+.||+|+||.||+|.+..++.. ||+|+++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 35699999999999999999998766654 8999987532 234456788999999999999999999988764 5
Q ss_pred EEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccC
Q 003232 664 LYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~ 742 (837)
.++|+||+++|+|.+++... ..++...+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.....
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence 78999999999999999764 45889999999999999999999999999999999999999999999999998742111
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCC
Q 003232 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFN 821 (837)
Q Consensus 743 stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~ 821 (837)
... .......++..|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 163 ~~~-----------------------------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~ 213 (316)
T cd05108 163 EKE-----------------------------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213 (316)
T ss_pred Ccc-----------------------------eeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence 000 00112234678999999999999999999999999999997 999997
Q ss_pred CCC
Q 003232 822 AEH 824 (837)
Q Consensus 822 ~~d 824 (837)
+..
T Consensus 214 ~~~ 216 (316)
T cd05108 214 GIP 216 (316)
T ss_pred CCC
Confidence 654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-32 Score=271.24 Aligned_cols=204 Identities=29% Similarity=0.553 Sum_probs=178.4
Q ss_pred CeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEE
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmE 669 (837)
+|++++.||.|+||.||.+++..+++.+++|.+..... .......+.+|+.++++++|+||+++++++.....++++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL-SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc-chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 48999999999999999999999999999999875442 23445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCC
Q 003232 670 YLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (837)
Q Consensus 670 y~~GGSL~dlLk~~--g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl 747 (837)
|+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--- 156 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--- 156 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc---
Confidence 99999999999764 4589999999999999999999999999999999999999999999999999863211100
Q ss_pred CCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 748 ~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
......|++.|+|||++.+..++.++|+||||+++|+|++|..||...++
T Consensus 157 ----------------------------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~ 206 (256)
T cd08221 157 ----------------------------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP 206 (256)
T ss_pred ----------------------------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH
Confidence 11234688999999999988889999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=280.46 Aligned_cols=210 Identities=29% Similarity=0.501 Sum_probs=174.0
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLV 667 (837)
.++|++.+.||.|+||.||+|.+..++..||+|++..... ......+.+|+.+++.++|+||+++++++......|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 3679999999999999999999999999999999865431 12223567899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCC
Q 003232 668 MEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (837)
Q Consensus 668 mEy~~GGSL~dlLk~-~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stdd 746 (837)
|||+. ++|.+++.. ...+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||+++......
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--- 157 (291)
T cd07870 82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS--- 157 (291)
T ss_pred Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC---
Confidence 99995 677776654 3567888999999999999999999999999999999999999999999999886310000
Q ss_pred CCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 747 l~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~-~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
.......+++.|+|||++.+. .++.++||||||+++|+|++|..||...++
T Consensus 158 ----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~ 209 (291)
T cd07870 158 ----------------------------QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD 209 (291)
T ss_pred ----------------------------CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh
Confidence 001233568899999998764 578899999999999999999999987665
Q ss_pred CHHHHH
Q 003232 826 QVSTLL 831 (837)
Q Consensus 826 dv~~ll 831 (837)
....+.
T Consensus 210 ~~~~~~ 215 (291)
T cd07870 210 VFEQLE 215 (291)
T ss_pred HHHHHH
Confidence 544443
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-32 Score=323.33 Aligned_cols=223 Identities=26% Similarity=0.433 Sum_probs=180.0
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVm 668 (837)
++|++.++||.|+||.||+|++..+++.||+|++...........+++.+|+.+++.++||||+++++.+...+..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 67999999999999999999999999999999997654334455678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCcc
Q 003232 669 EYLNGGDLYSLLRNL-----------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 737 (837)
Q Consensus 669 Ey~~GGSL~dlLk~~-----------g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLAr 737 (837)
||++|++|.+++... ..++...+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 999999999998641 224556778899999999999999999999999999999999999999999997
Q ss_pred ccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCC
Q 003232 738 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGI 817 (837)
Q Consensus 738 vg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr 817 (837)
.................... ..........+||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 162 ~i~~~~~~~~~l~~~~~~s~-------------~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~ 228 (932)
T PRK13184 162 FKKLEEEDLLDIDVDERNIC-------------YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLS 228 (932)
T ss_pred eccccccccccccccccccc-------------ccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCC
Confidence 43111110000000000000 00001122457999999999999999999999999999999999999
Q ss_pred CCCCCCC
Q 003232 818 PPFNAEH 824 (837)
Q Consensus 818 ~PF~~~d 824 (837)
.||...+
T Consensus 229 ~PF~~~~ 235 (932)
T PRK13184 229 FPYRRKK 235 (932)
T ss_pred CCCCCcc
Confidence 9997644
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=299.13 Aligned_cols=209 Identities=26% Similarity=0.392 Sum_probs=173.0
Q ss_pred CcccCCeEEEEEecccCceEEEEEEE-----CCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEeEe
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKK-----RTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSF 658 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArd-----k~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~gsf 658 (837)
....++|++.+.||.|+||.||+|.+ ..++..||+|+++... .....+.+.+|+.+++.+ +||||+++++++
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~ 108 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLGAC 108 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence 34456799999999999999999975 3456789999997543 223346788999999999 899999999999
Q ss_pred ecCCeEEEEEEecCCCCHHHHHHhcC------------------------------------------------------
Q 003232 659 TCRENLYLVMEYLNGGDLYSLLRNLG------------------------------------------------------ 684 (837)
Q Consensus 659 ~d~~~lyLVmEy~~GGSL~dlLk~~g------------------------------------------------------ 684 (837)
......++||||++||+|.+++....
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 99999999999999999999986421
Q ss_pred ---------------------CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCC
Q 003232 685 ---------------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 685 ---------------------~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~s 743 (837)
.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++......
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 36778889999999999999999999999999999999999999999999986311000
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNA 822 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~~ 822 (837)
. ........++..|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus 269 ~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~ 319 (375)
T cd05104 269 N-----------------------------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPG 319 (375)
T ss_pred c-----------------------------ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCC
Confidence 0 000112345678999999999999999999999999999997 8999976
Q ss_pred CC
Q 003232 823 EH 824 (837)
Q Consensus 823 ~d 824 (837)
..
T Consensus 320 ~~ 321 (375)
T cd05104 320 MP 321 (375)
T ss_pred CC
Confidence 54
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=274.38 Aligned_cols=205 Identities=25% Similarity=0.448 Sum_probs=173.7
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEE
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 665 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ly 665 (837)
...++|+++++||.|+||.||+|.+ .++..||+|.+.... ...+.+.+|+.+++.++||||+++++.+......+
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY 77 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCc----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 3457799999999999999999997 456789999987532 23467889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCC
Q 003232 666 LVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 666 LVmEy~~GGSL~dlLk~~--g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~s 743 (837)
++|||+.+++|.+++... ..++...+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 999999999999998653 458888999999999999999999999999999999999999999999999986311000
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNA 822 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~~ 822 (837)
. .......++..|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus 158 ~------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~ 207 (261)
T cd05072 158 Y------------------------------TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPG 207 (261)
T ss_pred e------------------------------eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCC
Confidence 0 00112345678999999998889999999999999999998 9999976
Q ss_pred CCc
Q 003232 823 EHP 825 (837)
Q Consensus 823 ~dp 825 (837)
..+
T Consensus 208 ~~~ 210 (261)
T cd05072 208 MSN 210 (261)
T ss_pred CCH
Confidence 543
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=313.53 Aligned_cols=203 Identities=34% Similarity=0.632 Sum_probs=184.0
Q ss_pred CeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEE
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmE 669 (837)
.|..++.||.|+||.||+|.+..+++.||+|++.-.. ....++.+..|+.+|.+++++||.++|+.|..+..++++||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~--~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE--AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhh--cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 4888899999999999999999999999999998653 34556789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCC
Q 003232 670 YLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 749 (837)
Q Consensus 670 y~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~ 749 (837)
||.||++.+.++..+.+.+..+..++++++.||.|||+++.+|||||+.|||+..+|.+||+|||++....
T Consensus 92 y~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~--------- 162 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLT--------- 162 (467)
T ss_pred HhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeee---------
Confidence 99999999999987777999999999999999999999999999999999999999999999999986310
Q ss_pred CCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 750 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 750 p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
....+..+.+|||.|||||++.+..|+.++||||||++.+||.+|.+||...+|
T Consensus 163 ----------------------~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP 216 (467)
T KOG0201|consen 163 ----------------------NTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP 216 (467)
T ss_pred ----------------------chhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc
Confidence 011233688999999999999999999999999999999999999999987665
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=275.01 Aligned_cols=210 Identities=29% Similarity=0.548 Sum_probs=178.1
Q ss_pred CeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccc------cHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCe
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMI------RKNAVESILAERDILISVRNPFVVRFFYSFTCREN 663 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~------~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ 663 (837)
+|.+...||.|++|.||+|.+..+++.+|+|.+...... .....+.+.+|+.+++.++||||+++++.+.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 367788999999999999999889999999988654322 12334678899999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCC
Q 003232 664 LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~s 743 (837)
.++||||+++++|.+++...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||+++....+.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999987421110
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~ 823 (837)
... ..........|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...
T Consensus 161 ~~~-------------------------~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 215 (267)
T cd06628 161 LST-------------------------KTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC 215 (267)
T ss_pred ccC-------------------------CccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCc
Confidence 000 0001112345889999999999988999999999999999999999999764
Q ss_pred C
Q 003232 824 H 824 (837)
Q Consensus 824 d 824 (837)
+
T Consensus 216 ~ 216 (267)
T cd06628 216 T 216 (267)
T ss_pred c
Confidence 3
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=280.13 Aligned_cols=206 Identities=28% Similarity=0.453 Sum_probs=174.0
Q ss_pred cCCeEEEEEecccCceEEEEEEECC-----CCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRT-----TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE 662 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~-----tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~ 662 (837)
.++|.+.+.||.|+||.||+|.+.. ++..||+|+++... .......+.+|+++++.++||||+++++.+....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 3569999999999999999998753 35789999987643 2334568899999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcE
Q 003232 663 NLYLVMEYLNGGDLYSLLRNLG--------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHI 728 (837)
Q Consensus 663 ~lyLVmEy~~GGSL~dlLk~~g--------------~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~I 728 (837)
..|+||||+++++|.+++...+ .+++..+..++.||+.||.|||++|++|+||||+||+++.++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence 9999999999999999997542 37888999999999999999999999999999999999999999
Q ss_pred EEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHH
Q 003232 729 KLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGI 808 (837)
Q Consensus 729 KLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGV 808 (837)
+|+|||++........ ........+++.|+|||++.+..++.++|||||||
T Consensus 162 kl~d~g~~~~~~~~~~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 212 (280)
T cd05049 162 KIGDFGMSRDVYTTDY-----------------------------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGV 212 (280)
T ss_pred EECCcccceecccCcc-----------------------------eecCCCCcccceecChhhhccCCcchhhhHHHHHH
Confidence 9999998863110000 00012334678899999999999999999999999
Q ss_pred HHHHHHc-CCCCCCCCC
Q 003232 809 ILFELIV-GIPPFNAEH 824 (837)
Q Consensus 809 ILyELLT-Gr~PF~~~d 824 (837)
++|+|++ |..||...+
T Consensus 213 il~e~~~~g~~p~~~~~ 229 (280)
T cd05049 213 VLWEIFTYGKQPWYGLS 229 (280)
T ss_pred HHHHHHhcCCCCCCCCC
Confidence 9999998 999997644
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=283.44 Aligned_cols=205 Identities=29% Similarity=0.540 Sum_probs=173.4
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEE
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyL 666 (837)
.+++|++++.||.|+||.||+|++..+++.||+|.+..... ......+.+|+.+++.++||||+++++++.....+|+
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 81 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 81 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence 35789999999999999999999999999999999875431 1223456789999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCC
Q 003232 667 VMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~std 745 (837)
||||+. ++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++.......
T Consensus 82 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-- 158 (301)
T cd07873 82 VFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-- 158 (301)
T ss_pred EEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC--
Confidence 999996 5898888653 568999999999999999999999999999999999999999999999999886310000
Q ss_pred CCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 746 dl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
.......+++.|+|||++.+ ..++.++|||||||++|+|++|++||...+
T Consensus 159 -----------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~ 209 (301)
T cd07873 159 -----------------------------KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGST 209 (301)
T ss_pred -----------------------------CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 00122356889999999876 457889999999999999999999998765
Q ss_pred c
Q 003232 825 P 825 (837)
Q Consensus 825 p 825 (837)
.
T Consensus 210 ~ 210 (301)
T cd07873 210 V 210 (301)
T ss_pred H
Confidence 3
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-32 Score=276.34 Aligned_cols=208 Identities=25% Similarity=0.382 Sum_probs=173.9
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCC-----cEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeec
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTG-----DLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC 660 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG-----~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d 660 (837)
...++|++.+.||.|+||.||++.+...+ ..||+|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVST 80 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence 34567999999999999999999986443 789999986543 22334578899999999999999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEE
Q 003232 661 RENLYLVMEYLNGGDLYSLLRNL----------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKL 730 (837)
Q Consensus 661 ~~~lyLVmEy~~GGSL~dlLk~~----------g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKL 730 (837)
....|+||||+++++|.+++... ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence 99999999999999999998643 23677889999999999999999999999999999999999999999
Q ss_pred EecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHH
Q 003232 731 TDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIIL 810 (837)
Q Consensus 731 iDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVIL 810 (837)
+|||+++....... ........++..|+|||.+.+..++.++|||||||++
T Consensus 161 ~dfg~~~~~~~~~~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 211 (277)
T cd05032 161 GDFGMTRDIYETDY-----------------------------YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVL 211 (277)
T ss_pred CCcccchhhccCcc-----------------------------cccCCCCCccccccCHHHHhcCCCCcccchHHHHHHH
Confidence 99999863110000 0011233567889999999888899999999999999
Q ss_pred HHHHc-CCCCCCCCC
Q 003232 811 FELIV-GIPPFNAEH 824 (837)
Q Consensus 811 yELLT-Gr~PF~~~d 824 (837)
|++++ |..||...+
T Consensus 212 ~el~t~g~~p~~~~~ 226 (277)
T cd05032 212 WEMATLAEQPYQGLS 226 (277)
T ss_pred HHhhccCCCCCccCC
Confidence 99998 999997654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-32 Score=274.08 Aligned_cols=208 Identities=29% Similarity=0.539 Sum_probs=177.5
Q ss_pred CeEEEEEecccCceEEEEEEECCCCcEEEEEEeccccc---ccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEE
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADM---IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~---~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyL 666 (837)
+|+..+.||+|+||.||++.+..+++.||+|++..... ......+.+.+|+.+++.++||||+++++.+...+++++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 47888999999999999999999999999999875331 123346789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCC-cEEEEecCCccccccCCCC
Q 003232 667 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG-HIKLTDFGLSKVGLINSTD 745 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG-~IKLiDFGLArvg~~~std 745 (837)
||||+.|++|.+++...+.+++..+..++.||+.||.|||++|++|+||+|+||+++.++ .++|+|||++.........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 999999999999998888899999999999999999999999999999999999998776 5999999998632111000
Q ss_pred CCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 746 dl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
.........|+..|+|||++.+..++.++|+||||+++|+|++|..||....
T Consensus 161 ---------------------------~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 212 (268)
T cd06630 161 ---------------------------AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEK 212 (268)
T ss_pred ---------------------------CCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 0001123468899999999998889999999999999999999999997543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-32 Score=273.60 Aligned_cols=203 Identities=27% Similarity=0.496 Sum_probs=171.8
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLV 667 (837)
.++|++.+.||.|+||.||++.++ ++..+|+|.+..... ....+.+|+.+++.++||||+++++++......|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 77 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAM----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV 77 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCc----cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence 356999999999999999999885 456899998875432 234688899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCC
Q 003232 668 MEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (837)
Q Consensus 668 mEy~~GGSL~dlLk~-~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stdd 746 (837)
|||+++++|.+++.. .+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.++......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~--- 154 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE--- 154 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCc---
Confidence 999999999999875 3568999999999999999999999999999999999999999999999999886310000
Q ss_pred CCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCc
Q 003232 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHP 825 (837)
Q Consensus 747 l~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~~~dp 825 (837)
........++..|+|||++.+..++.++||||||+++|+|++ |+.||...+.
T Consensus 155 ---------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~ 207 (256)
T cd05114 155 ---------------------------YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN 207 (256)
T ss_pred ---------------------------eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH
Confidence 000112235668999999998889999999999999999999 9999976553
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=286.51 Aligned_cols=197 Identities=26% Similarity=0.484 Sum_probs=160.0
Q ss_pred EEecccCceEEEEEEEC--CCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeec--CCeEEEEEEe
Q 003232 595 KPISRGAFGRVFLAKKR--TTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC--RENLYLVMEY 670 (837)
Q Consensus 595 kkLGsG~FGtVYkArdk--~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d--~~~lyLVmEy 670 (837)
.+||+|+||+||+|+++ .+++.||+|.+..... ...+.+|+.+++.++||||+++++.+.. ...+|+||||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 57999999999999975 3678999999875421 2346789999999999999999998854 4578999999
Q ss_pred cCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEE----ccCCcEEEEecCCcc
Q 003232 671 LNGGDLYSLLRNL---------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI----AHDGHIKLTDFGLSK 737 (837)
Q Consensus 671 ~~GGSL~dlLk~~---------g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILL----d~dG~IKLiDFGLAr 737 (837)
+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 82 AE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred cC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 84 5888887532 248899999999999999999999999999999999999 456789999999987
Q ss_pred ccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHcC
Q 003232 738 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVG 816 (837)
Q Consensus 738 vg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLTG 816 (837)
....... .........||+.|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 161 ~~~~~~~----------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g 212 (317)
T cd07868 161 LFNSPLK----------------------------PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 212 (317)
T ss_pred ccCCCCc----------------------------cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhC
Confidence 3110000 0011224578999999999987 4589999999999999999999
Q ss_pred CCCCCCCCc
Q 003232 817 IPPFNAEHP 825 (837)
Q Consensus 817 r~PF~~~dp 825 (837)
++||.....
T Consensus 213 ~~~f~~~~~ 221 (317)
T cd07868 213 EPIFHCRQE 221 (317)
T ss_pred CCCccCCcc
Confidence 999976543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=279.28 Aligned_cols=203 Identities=33% Similarity=0.524 Sum_probs=170.6
Q ss_pred CeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEE
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmE 669 (837)
+|++.+.||.|+||.||+|+++.+|+.||+|.++... ........+.+|+.+++.++||||+++++++.....+|+|+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccc-ccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 4899999999999999999999999999999987543 122233467789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCC
Q 003232 670 YLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (837)
Q Consensus 670 y~~GGSL~dlLk~-~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~ 748 (837)
|+. ++|.+++.. .+.+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||+++......
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~----- 153 (284)
T cd07839 80 YCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV----- 153 (284)
T ss_pred cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC-----
Confidence 996 578887754 4679999999999999999999999999999999999999999999999999886210000
Q ss_pred CCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 749 ~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~-~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
.......+++.|+|||++.+. .++.++|||||||++|+|++|..||....+
T Consensus 154 --------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~ 205 (284)
T cd07839 154 --------------------------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 205 (284)
T ss_pred --------------------------CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCC
Confidence 001234578899999998774 468999999999999999999988654443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-32 Score=274.70 Aligned_cols=207 Identities=31% Similarity=0.549 Sum_probs=176.4
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccc--cccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecC--CeE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKAD--MIRKNAVESILAERDILISVRNPFVVRFFYSFTCR--ENL 664 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~--~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~--~~l 664 (837)
.+|++.+.||+|+||.||++++..+++.||+|++.... .........+.+|+.+++.++||||+++++.+... ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46999999999999999999999999999999875321 12344557889999999999999999999988764 468
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCC
Q 003232 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~st 744 (837)
+++|||+++++|.+++...+.+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||+++.......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 99999999999999998877899999999999999999999999999999999999999999999999999863110000
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003232 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823 (837)
Q Consensus 745 ddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~ 823 (837)
. ........|+..|+|||++.+..++.++|+|||||++|+|++|+.||...
T Consensus 162 ~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 212 (264)
T cd06653 162 S----------------------------GTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY 212 (264)
T ss_pred c----------------------------CccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence 0 00112345889999999999988999999999999999999999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=279.86 Aligned_cols=203 Identities=35% Similarity=0.624 Sum_probs=175.9
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVm 668 (837)
++|++++.||.|+||.||++.+..++..+|+|++... .....+.+.+|+.+++.++||||+++++.+......|+||
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 5699999999999999999999889999999998753 3445567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCC
Q 003232 669 EYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (837)
Q Consensus 669 Ey~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl 747 (837)
||+++++|.+++... ..+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~----- 156 (280)
T cd06611 82 EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST----- 156 (280)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc-----
Confidence 999999999998764 56999999999999999999999999999999999999999999999999987531000
Q ss_pred CCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhc-----CCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003232 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-----GTGHGTTADWWSVGIILFELIVGIPPFNA 822 (837)
Q Consensus 748 ~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLl-----g~~~s~kSDIWSLGVILyELLTGr~PF~~ 822 (837)
........|++.|+|||++. +..++.++|+||||+++|+|++|+.||..
T Consensus 157 --------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~ 210 (280)
T cd06611 157 --------------------------LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHE 210 (280)
T ss_pred --------------------------ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCccc
Confidence 00112346889999999985 34567899999999999999999999986
Q ss_pred CCc
Q 003232 823 EHP 825 (837)
Q Consensus 823 ~dp 825 (837)
.++
T Consensus 211 ~~~ 213 (280)
T cd06611 211 LNP 213 (280)
T ss_pred CCH
Confidence 543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-32 Score=273.08 Aligned_cols=197 Identities=43% Similarity=0.812 Sum_probs=175.1
Q ss_pred ecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEEecCCCCH
Q 003232 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 676 (837)
Q Consensus 597 LGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmEy~~GGSL 676 (837)
||.|+||.||+|++..+++.||+|++...........+.+.+|+.+++.++||||+++++.+.....+|+||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 68999999999999989999999999865544445567899999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCCCccCcc
Q 003232 677 YSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 756 (837)
Q Consensus 677 ~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~Sgtt 756 (837)
.+++.+...+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~------------- 147 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ------------- 147 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-------------
Confidence 9999887789999999999999999999999999999999999999999999999999886311000
Q ss_pred cCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 757 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 757 Ll~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
......|++.|++||.+.+..++.++|+||||+++|+|++|..||.....
T Consensus 148 -------------------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 197 (262)
T cd05572 148 -------------------KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE 197 (262)
T ss_pred -------------------ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC
Confidence 11234678899999999888899999999999999999999999987763
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=275.79 Aligned_cols=205 Identities=24% Similarity=0.427 Sum_probs=175.3
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEE
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 665 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ly 665 (837)
....+|.+.+.||.|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.++||||+++++.+.....++
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 78 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence 34467999999999999999999999999999999987542 23457889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCC
Q 003232 666 LVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 666 LVmEy~~GGSL~dlLk~~--g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~s 743 (837)
+||||+++++|.+++... ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 999999999999998653 358899999999999999999999999999999999999999999999999986311000
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNA 822 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~~ 822 (837)
. .......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+
T Consensus 159 ~------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~ 208 (263)
T cd05052 159 Y------------------------------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 208 (263)
T ss_pred e------------------------------eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 0 00112234668999999999999999999999999999998 9999976
Q ss_pred CC
Q 003232 823 EH 824 (837)
Q Consensus 823 ~d 824 (837)
.+
T Consensus 209 ~~ 210 (263)
T cd05052 209 ID 210 (263)
T ss_pred CC
Confidence 54
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-32 Score=280.89 Aligned_cols=206 Identities=35% Similarity=0.621 Sum_probs=178.5
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeE
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~l 664 (837)
+....+|++++.||.|+||.||++.+..+++.||+|.+..... ...+.+.+|+.+++.++||||+++++.+....+.
T Consensus 15 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~ 91 (297)
T cd06656 15 GDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDEL 91 (297)
T ss_pred CChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEE
Confidence 3344679999999999999999999999999999999875432 2335688999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCC
Q 003232 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~st 744 (837)
|+||||+++++|.+++.+ ..+++..+..++.|++.||.|||+.|++|+||||+|||++.++.++|+|||++.......
T Consensus 92 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~- 169 (297)
T cd06656 92 WVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 169 (297)
T ss_pred EEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc-
Confidence 999999999999999865 568899999999999999999999999999999999999999999999999876210000
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 745 ddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
.......|++.|+|||.+.+..++.++|+|||||++|+|++|..||...+
T Consensus 170 ------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~ 219 (297)
T cd06656 170 ------------------------------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (297)
T ss_pred ------------------------------cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 01123468889999999999889999999999999999999999997655
Q ss_pred c
Q 003232 825 P 825 (837)
Q Consensus 825 p 825 (837)
+
T Consensus 220 ~ 220 (297)
T cd06656 220 P 220 (297)
T ss_pred c
Confidence 4
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-32 Score=272.91 Aligned_cols=199 Identities=28% Similarity=0.436 Sum_probs=168.1
Q ss_pred EecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEEecCCCC
Q 003232 596 PISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 675 (837)
Q Consensus 596 kLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmEy~~GGS 675 (837)
.||.|+||.||+|.+..+++.||+|.+.... .......+.+|+++++.++||||+++++++......|+||||+++++
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 6899999999999999999999999886432 34445678999999999999999999999999999999999999999
Q ss_pred HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCCCccC
Q 003232 676 LYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 754 (837)
Q Consensus 676 L~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~Sg 754 (837)
|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++..... .. . .
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~-~~---~-----~ 150 (252)
T cd05084 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEED-GV---Y-----A 150 (252)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCccccc-cc---c-----c
Confidence 99999764 4589999999999999999999999999999999999999999999999998762100 00 0 0
Q ss_pred cccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCc
Q 003232 755 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHP 825 (837)
Q Consensus 755 ttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~~~dp 825 (837)
.......++..|+|||.+.+..++.++||||||+++|+|++ |..||...++
T Consensus 151 --------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~ 202 (252)
T cd05084 151 --------------------STGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN 202 (252)
T ss_pred --------------------ccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH
Confidence 00011123457999999998889999999999999999997 9999976543
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-32 Score=279.72 Aligned_cols=203 Identities=34% Similarity=0.630 Sum_probs=174.6
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLV 667 (837)
.+.|++++.||.|+||.||+|++..+++.+++|++... .......+.+|+.+++.++||||+++++.+.....+|+|
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence 35699999999999999999999999999999999753 244567788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCC
Q 003232 668 MEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (837)
Q Consensus 668 mEy~~GGSL~dlLk~-~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stdd 746 (837)
|||+++++|..++.+ ...+++..+..++.|++.+|.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~---- 163 (292)
T cd06644 88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT---- 163 (292)
T ss_pred EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc----
Confidence 999999999988754 456899999999999999999999999999999999999999999999999987521000
Q ss_pred CCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhc-----CCCCCchHHHHHHHHHHHHHHcCCCCCC
Q 003232 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-----GTGHGTTADWWSVGIILFELIVGIPPFN 821 (837)
Q Consensus 747 l~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLl-----g~~~s~kSDIWSLGVILyELLTGr~PF~ 821 (837)
........|++.|+|||++. ...++.++|||||||++|+|++|..||.
T Consensus 164 ---------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~ 216 (292)
T cd06644 164 ---------------------------LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHH 216 (292)
T ss_pred ---------------------------ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCc
Confidence 00112345788999999985 3456889999999999999999999997
Q ss_pred CCC
Q 003232 822 AEH 824 (837)
Q Consensus 822 ~~d 824 (837)
..+
T Consensus 217 ~~~ 219 (292)
T cd06644 217 ELN 219 (292)
T ss_pred ccc
Confidence 654
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-31 Score=273.03 Aligned_cols=208 Identities=32% Similarity=0.539 Sum_probs=176.8
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEeccccc--ccHHHHHHHHHHHHHHHhcCCCceEEEEeEeec--CCeE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADM--IRKNAVESILAERDILISVRNPFVVRFFYSFTC--RENL 664 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~--~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d--~~~l 664 (837)
.+|++.+.||+|+||.||+|.+..++..|++|.+..... ........+.+|+.+++.++||||+++++.+.. ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 468999999999999999999999999999999865431 223445678899999999999999999998875 3678
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCC
Q 003232 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~st 744 (837)
+++|||+++++|.+++...+.+++.....++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++........
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 99999999999999998877899999999999999999999999999999999999999999999999999863110000
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 745 ddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
. ........|+..|+|||++.+..++.++|||||||++|+|++|+.||...+
T Consensus 162 ~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~ 213 (266)
T cd06651 162 S----------------------------GTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYE 213 (266)
T ss_pred c----------------------------CCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccc
Confidence 0 000112457889999999999889999999999999999999999997653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-31 Score=272.01 Aligned_cols=209 Identities=29% Similarity=0.525 Sum_probs=177.0
Q ss_pred CeEEEEEecccCceEEEEEEECCCCcEEEEEEeccccc---ccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEE
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADM---IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~---~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyL 666 (837)
+|++.+.||.|+||+||+|.. .+++.+|+|.+..... ........+.+|+.+++.++|+||+++++++.....+|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 478889999999999999987 5788999999864321 223445678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCC
Q 003232 667 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stdd 746 (837)
||||++|++|.+++.+.+.+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++..........
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 99999999999999887889999999999999999999999999999999999999999999999999886321100000
Q ss_pred CCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 747 l~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
..........|+..|+|||++.+..++.++|+||||+++|+|++|..||...+
T Consensus 160 -------------------------~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 212 (265)
T cd06631 160 -------------------------THSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMD 212 (265)
T ss_pred -------------------------cccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCC
Confidence 00001123468999999999999889999999999999999999999997654
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-31 Score=277.68 Aligned_cols=196 Identities=38% Similarity=0.688 Sum_probs=163.6
Q ss_pred EecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHH---hcCCCceEEEEeEeecCCeEEEEEEecC
Q 003232 596 PISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILI---SVRNPFVVRFFYSFTCRENLYLVMEYLN 672 (837)
Q Consensus 596 kLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk---~LrHPNIVkL~gsf~d~~~lyLVmEy~~ 672 (837)
.||+|+||.||++.+..+++.+|+|.+...............+|..+++ ..+||||+.+++.+...+..|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999999999999999987644322222233344444433 3479999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCCCc
Q 003232 673 GGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 752 (837)
Q Consensus 673 GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~ 752 (837)
+++|.+++...+.+++..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++.... .
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~--~--------- 149 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS--K--------- 149 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecc--c---------
Confidence 99999999888889999999999999999999999999999999999999999999999999875210 0
Q ss_pred cCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhc-CCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 753 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-GTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 753 SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLl-g~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
.......|++.|+|||.+. +..++.++|||||||++|+|++|..||....
T Consensus 150 ----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 200 (279)
T cd05633 150 ----------------------KKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200 (279)
T ss_pred ----------------------cCccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCC
Confidence 0011236899999999986 4668999999999999999999999997654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-32 Score=275.39 Aligned_cols=202 Identities=36% Similarity=0.655 Sum_probs=177.4
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVm 668 (837)
++|++.+.||.|+||.||+|.+..+++.||+|++.... .......+.+|+.+++.++||||+++++.+.....+|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 36889999999999999999999999999999987543 2334456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCC
Q 003232 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (837)
Q Consensus 669 Ey~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~ 748 (837)
||+.+++|.+++... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||+++......
T Consensus 79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~----- 152 (274)
T cd06609 79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM----- 152 (274)
T ss_pred EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc-----
Confidence 999999999999764 78999999999999999999999999999999999999999999999999986311100
Q ss_pred CCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 749 ~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
.......|++.|+|||++.+..++.++||||||+++|+|++|..||...+
T Consensus 153 --------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~ 202 (274)
T cd06609 153 --------------------------SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH 202 (274)
T ss_pred --------------------------cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc
Confidence 01123468889999999999889999999999999999999999997654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-32 Score=276.33 Aligned_cols=205 Identities=27% Similarity=0.459 Sum_probs=171.3
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCc----EEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCe
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGD----LFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCREN 663 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~----~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ 663 (837)
.++|++++.||.|+||+||+|++..++. .||+|++.... .......+.+|+.+++.++||||+++++.+.. ..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~ 82 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-ST 82 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CC
Confidence 4679999999999999999999877776 48999987542 33445678899999999999999999998865 45
Q ss_pred EEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccC
Q 003232 664 LYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~ 742 (837)
.+++|||+++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.....
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence 78999999999999999763 56899999999999999999999999999999999999999999999999998742110
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCC
Q 003232 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFN 821 (837)
Q Consensus 743 stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~ 821 (837)
... .......+++.|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 163 ~~~-----------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~ 213 (279)
T cd05109 163 ETE-----------------------------YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213 (279)
T ss_pred cce-----------------------------eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 000 00112235678999999999999999999999999999998 999997
Q ss_pred CCC
Q 003232 822 AEH 824 (837)
Q Consensus 822 ~~d 824 (837)
...
T Consensus 214 ~~~ 216 (279)
T cd05109 214 GIP 216 (279)
T ss_pred CCC
Confidence 644
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-32 Score=277.07 Aligned_cols=204 Identities=30% Similarity=0.551 Sum_probs=175.4
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVm 668 (837)
++|++.+.||.|+||.||+|.+..+++.||+|++..... .....+.+.+|+++++.++||||+++++++......|+||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED-DKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccC-cchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 469999999999999999999988999999999876432 2234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCC
Q 003232 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (837)
Q Consensus 669 Ey~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~ 748 (837)
||+++++|..+......+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~----- 154 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG----- 154 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-----
Confidence 999999999887766679999999999999999999999999999999999999999999999999886311000
Q ss_pred CCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 749 ~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
.......|+..|+|||++.+ ..++.++||||||+++|+|++|++||....
T Consensus 155 --------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~ 205 (286)
T cd07846 155 --------------------------EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS 205 (286)
T ss_pred --------------------------cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCc
Confidence 01123457889999999876 346789999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=296.77 Aligned_cols=205 Identities=34% Similarity=0.522 Sum_probs=178.5
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeec-----CCe
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC-----REN 663 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d-----~~~ 663 (837)
..|..++.||.|+||.|+.+.++.+|+.||||.+.... ......++..+|+.+|+.++|+||+.+++++.. -+.
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F-~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPF-ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhh-hchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 45777899999999999999999999999999987543 445667899999999999999999999999876 346
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCC
Q 003232 664 LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~s 743 (837)
+|+|+|++ +.+|.+.++.+..+++..++.++.||++||.|+|+.|++||||||.|+|++.+..+||+|||+|+.....
T Consensus 101 vYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~- 178 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF- 178 (359)
T ss_pred eEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecccc-
Confidence 89999999 7799999999888999999999999999999999999999999999999999999999999999852211
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNA 822 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLTGr~PF~~ 822 (837)
. .....+.++-|..|+|||++.. ..|+...||||+||||.|||+|++.|.+
T Consensus 179 ~----------------------------~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG 230 (359)
T KOG0660|consen 179 F----------------------------EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPG 230 (359)
T ss_pred C----------------------------cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCC
Confidence 0 0112345678999999999864 7799999999999999999999999987
Q ss_pred CC
Q 003232 823 EH 824 (837)
Q Consensus 823 ~d 824 (837)
.+
T Consensus 231 ~d 232 (359)
T KOG0660|consen 231 KD 232 (359)
T ss_pred Cc
Confidence 54
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-31 Score=268.92 Aligned_cols=208 Identities=35% Similarity=0.611 Sum_probs=178.1
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVm 668 (837)
++|++.+.||.|+||+||+|.+..++..+++|++...... .....+.+|+.+++.++|+||+++++.+...+.+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ--TSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcc--hHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 4699999999999999999999889999999998754322 25578899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCC
Q 003232 669 EYLNGGDLYSLLRNL---GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745 (837)
Q Consensus 669 Ey~~GGSL~dlLk~~---g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~std 745 (837)
|++++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.........
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 999999999999764 45899999999999999999999999999999999999999999999999988632111100
Q ss_pred CCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 746 dl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~-~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
.........|+..|+|||++... .++.++|+||||+++|+|++|+.||...+
T Consensus 159 ---------------------------~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~ 211 (267)
T cd06610 159 ---------------------------TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYP 211 (267)
T ss_pred ---------------------------cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccC
Confidence 00112234688999999998776 78999999999999999999999997654
Q ss_pred c
Q 003232 825 P 825 (837)
Q Consensus 825 p 825 (837)
+
T Consensus 212 ~ 212 (267)
T cd06610 212 P 212 (267)
T ss_pred h
Confidence 3
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-32 Score=278.60 Aligned_cols=205 Identities=28% Similarity=0.475 Sum_probs=173.2
Q ss_pred CCeEEEEEecccCceEEEEEEEC-----CCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCe
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKR-----TTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCREN 663 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk-----~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ 663 (837)
++|.+.+.||.|+||.||++... .++..+|+|.+.... ......+.+|+.+++.++||||+++++.+.....
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 81 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 56999999999999999999853 345678999887532 3445678999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEE
Q 003232 664 LYLVMEYLNGGDLYSLLRNLG-------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKL 730 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk~~g-------------~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKL 730 (837)
+|+||||+++++|.+++...+ .+++..+..++.||+.||.|||++|++||||||+|||++.++.++|
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEe
Confidence 999999999999999997543 3899999999999999999999999999999999999999999999
Q ss_pred EecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHH
Q 003232 731 TDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIIL 810 (837)
Q Consensus 731 iDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVIL 810 (837)
+|||++........ ........+++.|+|||++.+..++.++|||||||++
T Consensus 162 ~dfg~~~~~~~~~~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il 212 (288)
T cd05093 162 GDFGMSRDVYSTDY-----------------------------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVL 212 (288)
T ss_pred ccCCccccccCCce-----------------------------eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHH
Confidence 99999863110000 0011223467789999999999999999999999999
Q ss_pred HHHHc-CCCCCCCCCc
Q 003232 811 FELIV-GIPPFNAEHP 825 (837)
Q Consensus 811 yELLT-Gr~PF~~~dp 825 (837)
|+|++ |..||....+
T Consensus 213 ~~l~t~g~~p~~~~~~ 228 (288)
T cd05093 213 WEIFTYGKQPWYQLSN 228 (288)
T ss_pred HHHHhCCCCCCCCCCH
Confidence 99998 9999976553
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=279.26 Aligned_cols=203 Identities=32% Similarity=0.538 Sum_probs=179.1
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLV 667 (837)
.++|++++.||+|+||+||++.+..+++.||+|++.... .....+.+.+|+.+++.++||||+++++.+.....+|+|
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 357999999999999999999999999999999986532 233456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCC
Q 003232 668 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (837)
Q Consensus 668 mEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHS-kGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stdd 746 (837)
|||+++++|.+++...+.++...+..++.+++.+|.|||+ .|++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~----- 156 (284)
T cd06620 82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN----- 156 (284)
T ss_pred EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhh-----
Confidence 9999999999999887889999999999999999999997 6999999999999999999999999998752100
Q ss_pred CCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 747 l~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
.......|+..|+|||++.+..++.++|||||||++|+|++|..||....+
T Consensus 157 ----------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~ 207 (284)
T cd06620 157 ----------------------------SIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNI 207 (284)
T ss_pred ----------------------------hccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccch
Confidence 001234689999999999888899999999999999999999999986554
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=275.75 Aligned_cols=197 Identities=36% Similarity=0.665 Sum_probs=171.0
Q ss_pred ecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEEecCCCCH
Q 003232 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 676 (837)
Q Consensus 597 LGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmEy~~GGSL 676 (837)
||.|+||+||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++.+...+.+|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999999999999999999764433334455678899999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCCCccC
Q 003232 677 YSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 754 (837)
Q Consensus 677 ~dlLk~~g--~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~Sg 754 (837)
.+++...+ .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++..... .
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~--~---------- 148 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG--G---------- 148 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc--C----------
Confidence 99997655 689999999999999999999999999999999999999999999999998763110 0
Q ss_pred cccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 755 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 755 ttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
.......|+..|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus 149 --------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 199 (277)
T cd05577 149 --------------------KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKE 199 (277)
T ss_pred --------------------CccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcc
Confidence 001233578889999999988899999999999999999999999976543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-32 Score=276.92 Aligned_cols=201 Identities=36% Similarity=0.623 Sum_probs=173.3
Q ss_pred eEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEEe
Q 003232 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEY 670 (837)
Q Consensus 591 YeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmEy 670 (837)
|++.+.||.|+||.||++.+..++..+++|.+.... ......+.+|+.+++.++||||+++++.+......|+||||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 788899999999999999999999999999986532 34456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCC
Q 003232 671 LNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 749 (837)
Q Consensus 671 ~~GGSL~dlLk~-~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~ 749 (837)
+++++|..++.. ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~------- 156 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT------- 156 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc-------
Confidence 999999988764 466899999999999999999999999999999999999999999999999988631000
Q ss_pred CCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhc-----CCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 750 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-----GTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 750 p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLl-----g~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
........|++.|+|||++. +..++.++|||||||++|+|++|.+||...+
T Consensus 157 ------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 212 (282)
T cd06643 157 ------------------------IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN 212 (282)
T ss_pred ------------------------ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC
Confidence 00112346888999999984 4557789999999999999999999998655
Q ss_pred c
Q 003232 825 P 825 (837)
Q Consensus 825 p 825 (837)
+
T Consensus 213 ~ 213 (282)
T cd06643 213 P 213 (282)
T ss_pred H
Confidence 3
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=276.14 Aligned_cols=207 Identities=25% Similarity=0.408 Sum_probs=172.5
Q ss_pred cCCeEEEEEecccCceEEEEEEECC-----CCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRT-----TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE 662 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~-----tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~ 662 (837)
.++|++.+.||.|+||.||+|.+.. ++..|++|.+.... .......+.+|+.+++.++|+||+++++++....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 3679999999999999999999977 67889999886532 2333457889999999999999999999999989
Q ss_pred eEEEEEEecCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCC---cEEEEe
Q 003232 663 NLYLVMEYLNGGDLYSLLRNLG-------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG---HIKLTD 732 (837)
Q Consensus 663 ~lyLVmEy~~GGSL~dlLk~~g-------~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG---~IKLiD 732 (837)
..++||||++|++|.+++...+ .+++..+..++.||+.||.|||++|++|+||||+||+++.++ .++|+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence 9999999999999999997643 488899999999999999999999999999999999998755 599999
Q ss_pred cCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHH
Q 003232 733 FGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFE 812 (837)
Q Consensus 733 FGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyE 812 (837)
||+++... ... . ........++..|+|||++.+..++.++|||||||++|+
T Consensus 163 fg~~~~~~--~~~-~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~e 213 (277)
T cd05036 163 FGMARDIY--RAS-Y--------------------------YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWE 213 (277)
T ss_pred CccccccC--Ccc-c--------------------------eecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHH
Confidence 99987310 000 0 000112233567999999999999999999999999999
Q ss_pred HHc-CCCCCCCCCc
Q 003232 813 LIV-GIPPFNAEHP 825 (837)
Q Consensus 813 LLT-Gr~PF~~~dp 825 (837)
|++ |..||...+.
T Consensus 214 l~~~g~~pf~~~~~ 227 (277)
T cd05036 214 IFSLGYMPYPGRTN 227 (277)
T ss_pred HHcCCCCCCCCCCH
Confidence 997 9999986543
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=269.41 Aligned_cols=201 Identities=33% Similarity=0.647 Sum_probs=176.9
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVm 668 (837)
++|++.+.||.|+||.||++.+..+++.+++|.+.... ....+.+|+.+++.++||||+++++.+....++|+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 57999999999999999999998889999999987542 1568899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCC
Q 003232 669 EYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (837)
Q Consensus 669 Ey~~GGSL~dlLk~-~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl 747 (837)
||+.+++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~---- 153 (256)
T cd06612 78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM---- 153 (256)
T ss_pred ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCc----
Confidence 99999999999975 4568999999999999999999999999999999999999999999999999986311000
Q ss_pred CCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 748 ~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
.......|+..|+|||++.+..++.++||||||+++|+|++|+.||...++
T Consensus 154 ---------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~ 204 (256)
T cd06612 154 ---------------------------AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHP 204 (256)
T ss_pred ---------------------------cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcch
Confidence 011234578899999999999999999999999999999999999976543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-32 Score=268.29 Aligned_cols=199 Identities=33% Similarity=0.512 Sum_probs=172.4
Q ss_pred EEecccCceEEEEEEECCC---CcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEEec
Q 003232 595 KPISRGAFGRVFLAKKRTT---GDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYL 671 (837)
Q Consensus 595 kkLGsG~FGtVYkArdk~t---G~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmEy~ 671 (837)
+.||.|+||.||+|.+... +..|++|++....... ....+.+|+.+++.++|+||+++++++.....+++||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 3689999999999999866 8899999998654322 4678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccC
Q 003232 672 NGGDLYSLLRNL---------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (837)
Q Consensus 672 ~GGSL~dlLk~~---------g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~ 742 (837)
++++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 999999999875 67999999999999999999999999999999999999999999999999998731111
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCC
Q 003232 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFN 821 (837)
Q Consensus 743 stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~ 821 (837)
.. ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||.
T Consensus 159 ~~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~ 209 (262)
T cd00192 159 DY-----------------------------YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYP 209 (262)
T ss_pred cc-----------------------------cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCC
Confidence 00 011224457889999999998889999999999999999998 699998
Q ss_pred CCC
Q 003232 822 AEH 824 (837)
Q Consensus 822 ~~d 824 (837)
..+
T Consensus 210 ~~~ 212 (262)
T cd00192 210 GLS 212 (262)
T ss_pred CCC
Confidence 764
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=311.72 Aligned_cols=208 Identities=22% Similarity=0.402 Sum_probs=178.4
Q ss_pred CCCCcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecC
Q 003232 582 SKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR 661 (837)
Q Consensus 582 ~k~g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~ 661 (837)
..|.+..++..+...||+|.||+||+|+|- -.||||+++... ...+..+.|.+|+.++++-+|.||+-|.|++...
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~-pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDD-PTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc---cceEEEEEecCC-CCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 456777788999999999999999999994 469999998876 3455889999999999999999999999999887
Q ss_pred CeEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccc
Q 003232 662 ENLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740 (837)
Q Consensus 662 ~~lyLVmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~ 740 (837)
.. .||+.+|+|.+|+.+++-. ..|.....+.|++||++|+.|||.++|||||||..|||+.+++++||+|||++.+-.
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred ce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeee
Confidence 77 9999999999999999743 458888999999999999999999999999999999999999999999999987411
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhc---CCCCCchHHHHHHHHHHHHHHcCC
Q 003232 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL---GTGHGTTADWWSVGIILFELIVGI 817 (837)
Q Consensus 741 ~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLl---g~~~s~kSDIWSLGVILyELLTGr 817 (837)
-.. .........|...|||||++. ..+|++.+||||||+++|||+||.
T Consensus 540 ~w~-----------------------------g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~ 590 (678)
T KOG0193|consen 540 RWS-----------------------------GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGE 590 (678)
T ss_pred eec-----------------------------cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCc
Confidence 000 011122345788899999996 467899999999999999999999
Q ss_pred CCCCCC
Q 003232 818 PPFNAE 823 (837)
Q Consensus 818 ~PF~~~ 823 (837)
.||...
T Consensus 591 lPysi~ 596 (678)
T KOG0193|consen 591 LPYSIQ 596 (678)
T ss_pred CCcCCC
Confidence 999843
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-31 Score=268.26 Aligned_cols=203 Identities=34% Similarity=0.618 Sum_probs=177.5
Q ss_pred CeEEEEEecccCceEEEEEEECCCCcEEEEEEeccccc--ccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEE
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADM--IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~--~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLV 667 (837)
+|+..+.||.|+||.||+|.+..++..|++|.+..... ......+.+.+|+.+++.++||||+++++.+.....+|++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 47778899999999999999988999999999865431 2244567899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCC
Q 003232 668 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (837)
Q Consensus 668 mEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl 747 (837)
|||+++++|.+++...+.+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---- 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---- 156 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc----
Confidence 9999999999999887789999999999999999999999999999999999999999999999999876311000
Q ss_pred CCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCC-CCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 748 ~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~-~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
......|++.|+|||.+.+.. ++.++|+||||+++|+|++|..||....
T Consensus 157 ----------------------------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~ 206 (258)
T cd06632 157 ----------------------------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE 206 (258)
T ss_pred ----------------------------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc
Confidence 112346888999999998776 8999999999999999999999997655
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=271.22 Aligned_cols=204 Identities=26% Similarity=0.426 Sum_probs=172.8
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEE
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyL 666 (837)
..++|++.+.||.|+||.||+|.+. .++.||+|.++.... ..+.+.+|+.++++++||||+++++++...+..|+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYI 78 (261)
T ss_pred chhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeee
Confidence 3467999999999999999999974 567899999876432 23568889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCC
Q 003232 667 VMEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~~g--~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~st 744 (837)
||||+.+++|.+++.... .++...+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||+++.......
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 999999999999997643 689999999999999999999999999999999999999999999999999874210000
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 003232 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAE 823 (837)
Q Consensus 745 ddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~~~ 823 (837)
.......++..|+|||++.+..++.++||||||+++|+|++ |+.||.+.
T Consensus 159 ------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 208 (261)
T cd05068 159 ------------------------------EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGM 208 (261)
T ss_pred ------------------------------cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCC
Confidence 00011223457999999999899999999999999999998 99999875
Q ss_pred Cc
Q 003232 824 HP 825 (837)
Q Consensus 824 dp 825 (837)
++
T Consensus 209 ~~ 210 (261)
T cd05068 209 TN 210 (261)
T ss_pred CH
Confidence 53
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=278.84 Aligned_cols=203 Identities=37% Similarity=0.648 Sum_probs=177.3
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLV 667 (837)
..+|++.+.||.|+||.||++.+..+++.|++|.+.... ....+.+.+|+.+++.++||||+++++.+.....+|+|
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 94 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK---QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV 94 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc---CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence 356999999999999999999999999999999986543 22345688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCC
Q 003232 668 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (837)
Q Consensus 668 mEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl 747 (837)
|||+++++|..++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 95 ~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~---- 169 (296)
T cd06655 95 MEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ---- 169 (296)
T ss_pred EEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccc----
Confidence 999999999998875 468999999999999999999999999999999999999999999999999876310000
Q ss_pred CCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 748 ~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
.......|++.|+|||.+.+..++.++|||||||++|+|++|+.||...++
T Consensus 170 ---------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~ 220 (296)
T cd06655 170 ---------------------------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220 (296)
T ss_pred ---------------------------ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 011234688899999999988899999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-31 Score=267.63 Aligned_cols=207 Identities=37% Similarity=0.641 Sum_probs=179.3
Q ss_pred CeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEE
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmE 669 (837)
+|++.+.||.|+||.||++.+..+++.|++|.++.... .......+.+|+.+++.++|+||+++++.+.....+++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN-DPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECccc-chHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 58999999999999999999988999999999976542 24567889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCC
Q 003232 670 YLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 749 (837)
Q Consensus 670 y~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~ 749 (837)
|+++++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~--- 156 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM--- 156 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc---
Confidence 99999999999887778999999999999999999999999999999999999999999999999986421111100
Q ss_pred CCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCC---CCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 750 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG---HGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 750 p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~---~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
........+++.|+|||++.+.. ++.++||||||+++|++++|..||...+
T Consensus 157 ------------------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~ 210 (264)
T cd06626 157 ------------------------GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD 210 (264)
T ss_pred ------------------------cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc
Confidence 00012346788999999998766 8899999999999999999999997654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=272.13 Aligned_cols=206 Identities=25% Similarity=0.359 Sum_probs=173.8
Q ss_pred cCCeEEEEEecccCceEEEEEEECCC---CcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTT---GDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~t---G~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~l 664 (837)
.++|++.+.||.|+||+||+|.+..+ ...||+|+++... .......+.+|+.+++.++||||+++++.+......
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 35799999999999999999998654 4589999987543 234456788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCC
Q 003232 665 YLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~s 743 (837)
|+||||+++++|.+++... +.++...+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++..... .
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~-~ 159 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED-S 159 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccc-c
Confidence 9999999999999998764 4689999999999999999999999999999999999999999999999999874210 0
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNA 822 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~~ 822 (837)
.. ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||..
T Consensus 160 ~~----------------------------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~ 211 (266)
T cd05033 160 EA----------------------------TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWD 211 (266)
T ss_pred cc----------------------------ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCC
Confidence 00 000112235678999999999899999999999999999997 9999965
Q ss_pred CC
Q 003232 823 EH 824 (837)
Q Consensus 823 ~d 824 (837)
..
T Consensus 212 ~~ 213 (266)
T cd05033 212 MS 213 (266)
T ss_pred CC
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=268.04 Aligned_cols=203 Identities=33% Similarity=0.601 Sum_probs=179.9
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVm 668 (837)
++|++.+.||.|++|.||+|.+..+++.|++|++..... ......+.+|+..++.++||||+++++.+.....+++||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD--EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 468999999999999999999999999999999876542 144578999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCC
Q 003232 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (837)
Q Consensus 669 Ey~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHS-kGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl 747 (837)
||+++++|.+++.....+++..+..++.||+.||.|||+ .|++|+||+|+||+++.++.++|+|||++.......
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~---- 154 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL---- 154 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC----
Confidence 999999999999887889999999999999999999999 999999999999999999999999999876311000
Q ss_pred CCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 748 ~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
.......++..|+|||.+.+..++.++|+||||+++|+|++|..||....
T Consensus 155 ---------------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 155 ---------------------------DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred ---------------------------CcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 00113457888999999999889999999999999999999999997765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.2e-32 Score=278.43 Aligned_cols=201 Identities=31% Similarity=0.593 Sum_probs=172.9
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVm 668 (837)
++|++++.||.|+||.||++++..++..||+|.++... .......+.+|+.+++.++||||+++++.+.....+|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 46899999999999999999999899999999986532 3344567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCcEEEccCCcEEEEecCCccccccCCC
Q 003232 669 EYLNGGDLYSLLRNL---GCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (837)
Q Consensus 669 Ey~~GGSL~dlLk~~---g~Lsee~irkIl~QIa~ALsYLHS-kGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~st 744 (837)
||+++++|..++... ..+++..+..++.||+.||.|||+ .||+|+||||+||+++.++.++|+|||++.....
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--- 155 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA--- 155 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC---
Confidence 999999999988763 368999999999999999999997 6999999999999999999999999998762100
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCC------CCchHHHHHHHHHHHHHHcCCC
Q 003232 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG------HGTTADWWSVGIILFELIVGIP 818 (837)
Q Consensus 745 ddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~------~s~kSDIWSLGVILyELLTGr~ 818 (837)
.......|++.|+|||++.+.. ++.++|||||||++|+|++|+.
T Consensus 156 ------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~ 205 (286)
T cd06622 156 ------------------------------SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRY 205 (286)
T ss_pred ------------------------------CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCC
Confidence 0012335788999999985543 4789999999999999999999
Q ss_pred CCCCCC
Q 003232 819 PFNAEH 824 (837)
Q Consensus 819 PF~~~d 824 (837)
||....
T Consensus 206 pf~~~~ 211 (286)
T cd06622 206 PYPPET 211 (286)
T ss_pred CCCCcc
Confidence 997644
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=280.04 Aligned_cols=197 Identities=26% Similarity=0.485 Sum_probs=159.1
Q ss_pred EEecccCceEEEEEEECC--CCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeec--CCeEEEEEEe
Q 003232 595 KPISRGAFGRVFLAKKRT--TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC--RENLYLVMEY 670 (837)
Q Consensus 595 kkLGsG~FGtVYkArdk~--tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d--~~~lyLVmEy 670 (837)
.+||.|+||+||+|+++. ++..||+|.+..... ...+.+|+.+++.++||||+++++++.. ...+|+||||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 679999999999999754 567899999875431 2356789999999999999999998854 5678999999
Q ss_pred cCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEE----ccCCcEEEEecCCcc
Q 003232 671 LNGGDLYSLLRNL---------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI----AHDGHIKLTDFGLSK 737 (837)
Q Consensus 671 ~~GGSL~dlLk~~---------g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILL----d~dG~IKLiDFGLAr 737 (837)
+. ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.++|+|||+++
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 82 AE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred eC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 85 5788776421 247889999999999999999999999999999999999 456799999999987
Q ss_pred ccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHcC
Q 003232 738 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVG 816 (837)
Q Consensus 738 vg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLTG 816 (837)
....... .........||+.|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 161 ~~~~~~~----------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg 212 (317)
T cd07867 161 LFNSPLK----------------------------PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 212 (317)
T ss_pred ccCCCcc----------------------------cccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhC
Confidence 3110000 0011224568999999999977 4578999999999999999999
Q ss_pred CCCCCCCCc
Q 003232 817 IPPFNAEHP 825 (837)
Q Consensus 817 r~PF~~~dp 825 (837)
++||.....
T Consensus 213 ~~~f~~~~~ 221 (317)
T cd07867 213 EPIFHCRQE 221 (317)
T ss_pred CCCcccccc
Confidence 999986543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-31 Score=265.46 Aligned_cols=203 Identities=33% Similarity=0.629 Sum_probs=175.0
Q ss_pred CeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeec--CCeEEEE
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC--RENLYLV 667 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d--~~~lyLV 667 (837)
+|++++.||.|+||.||++.+..++..+|+|++..... .....+.+.+|+.+++.++||||+++++.+.. ....|++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 58999999999999999999999999999999876442 34445678899999999999999999987754 4568999
Q ss_pred EEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----hCCcccccCCCCcEEEccCCcEEEEecCCccc
Q 003232 668 MEYLNGGDLYSLLRN----LGCLDEDVARVYIAEVVLALEYLH-----SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (837)
Q Consensus 668 mEy~~GGSL~dlLk~----~g~Lsee~irkIl~QIa~ALsYLH-----SkGIIHRDIKPeNILLd~dG~IKLiDFGLArv 738 (837)
|||+++++|.+++.. ...+++..+..++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999999865 356899999999999999999999 89999999999999999999999999999863
Q ss_pred cccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCC
Q 003232 739 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIP 818 (837)
Q Consensus 739 g~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~ 818 (837)
..... .......|++.|+|||++.+..++.++|+||||+++|+|++|..
T Consensus 160 ~~~~~-------------------------------~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~ 208 (265)
T cd08217 160 LGHDS-------------------------------SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSP 208 (265)
T ss_pred ccCCc-------------------------------ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCC
Confidence 11000 00123468899999999998889999999999999999999999
Q ss_pred CCCCCC
Q 003232 819 PFNAEH 824 (837)
Q Consensus 819 PF~~~d 824 (837)
||...+
T Consensus 209 p~~~~~ 214 (265)
T cd08217 209 PFTARN 214 (265)
T ss_pred cccCcC
Confidence 998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=269.90 Aligned_cols=196 Identities=61% Similarity=1.063 Sum_probs=168.8
Q ss_pred EEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHH-HhcCCCceEEEEeEeecCCeEEEEEEecCC
Q 003232 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDIL-ISVRNPFVVRFFYSFTCRENLYLVMEYLNG 673 (837)
Q Consensus 595 kkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieIL-k~LrHPNIVkL~gsf~d~~~lyLVmEy~~G 673 (837)
+.||.|+||.||+|.+..+++.||+|++.............+..|..++ ...+||||+++++.+...+.+|+||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5689999999999999999999999999765433333334455565554 455899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCCCcc
Q 003232 674 GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753 (837)
Q Consensus 674 GSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~S 753 (837)
++|.+++...+.+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------------ 149 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------------ 149 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc------------
Confidence 99999998878899999999999999999999999999999999999999999999999998763100
Q ss_pred CcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 754 gttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
.....|++.|+|||.+.+..++.++||||||+++|+|++|..||...++
T Consensus 150 -----------------------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 198 (260)
T cd05611 150 -----------------------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP 198 (260)
T ss_pred -----------------------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH
Confidence 1234578889999999988889999999999999999999999976554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-31 Score=275.69 Aligned_cols=208 Identities=26% Similarity=0.408 Sum_probs=170.7
Q ss_pred cccCCeEEEEEecccCceEEEEEEECC-----CCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeec
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRT-----TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC 660 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~-----tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d 660 (837)
...++|++.+.||.|+||.||+|.++. .+..||+|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVSK 80 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 345779999999999999999997652 34589999886543 22333467889999999999999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEE
Q 003232 661 RENLYLVMEYLNGGDLYSLLRNL----------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKL 730 (837)
Q Consensus 661 ~~~lyLVmEy~~GGSL~dlLk~~----------g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKL 730 (837)
....|+||||+++|+|.+++... ..++...+..++.||+.||.|||++||+||||||+||+++.++.++|
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEE
Confidence 99999999999999999999653 23456788899999999999999999999999999999999999999
Q ss_pred EecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHH
Q 003232 731 TDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIIL 810 (837)
Q Consensus 731 iDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVIL 810 (837)
+|||+++....... ........++..|+|||.+.+..++.++|||||||++
T Consensus 161 ~Dfg~~~~~~~~~~-----------------------------~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l 211 (288)
T cd05061 161 GDFGMTRDIYETDY-----------------------------YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVL 211 (288)
T ss_pred CcCCcccccccccc-----------------------------ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHH
Confidence 99999863110000 0001123456789999999988899999999999999
Q ss_pred HHHHc-CCCCCCCCC
Q 003232 811 FELIV-GIPPFNAEH 824 (837)
Q Consensus 811 yELLT-Gr~PF~~~d 824 (837)
|+|++ |..||.+.+
T Consensus 212 ~el~~~~~~p~~~~~ 226 (288)
T cd05061 212 WEITSLAEQPYQGLS 226 (288)
T ss_pred HHHHhCCCCCCCCCC
Confidence 99998 789997644
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=272.52 Aligned_cols=202 Identities=30% Similarity=0.570 Sum_probs=170.5
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEeEeecC------
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCR------ 661 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~gsf~d~------ 661 (837)
+.|++.+.||.|+||.||+|.+..+++.||+|++.... .....+..|+.+++.+ +||||+++++.+...
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 45889999999999999999999999999999987542 1234678899999988 799999999998753
Q ss_pred CeEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCcccc
Q 003232 662 ENLYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 739 (837)
Q Consensus 662 ~~lyLVmEy~~GGSL~dlLk~~--g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg 739 (837)
..+|+||||+.+++|.+++... ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++...
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence 4689999999999999998763 45899999999999999999999999999999999999999999999999998631
Q ss_pred ccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhc-----CCCCCchHHHHHHHHHHHHHH
Q 003232 740 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-----GTGHGTTADWWSVGIILFELI 814 (837)
Q Consensus 740 ~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLl-----g~~~s~kSDIWSLGVILyELL 814 (837)
... ........|++.|+|||++. +..++.++|||||||++|+|+
T Consensus 162 ~~~-------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~ 210 (272)
T cd06637 162 DRT-------------------------------VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMA 210 (272)
T ss_pred ccc-------------------------------cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHH
Confidence 000 00122456889999999986 345788999999999999999
Q ss_pred cCCCCCCCCCc
Q 003232 815 VGIPPFNAEHP 825 (837)
Q Consensus 815 TGr~PF~~~dp 825 (837)
+|..||....+
T Consensus 211 ~g~~p~~~~~~ 221 (272)
T cd06637 211 EGAPPLCDMHP 221 (272)
T ss_pred hCCCCccccCH
Confidence 99999975443
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=282.66 Aligned_cols=207 Identities=24% Similarity=0.396 Sum_probs=169.5
Q ss_pred EEEEeccc--CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEEe
Q 003232 593 IIKPISRG--AFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEY 670 (837)
Q Consensus 593 IlkkLGsG--~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmEy 670 (837)
++++||.| +|++||+++++.+|+.||+|.+..... .......+.+|+.+++.++||||+++++++..++..|+||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 46789999 789999999999999999999876432 234456788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCC
Q 003232 671 LNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (837)
Q Consensus 671 ~~GGSL~dlLk~~--g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~ 748 (837)
+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++++||+...... ......
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~-~~~~~~- 158 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI-NHGQRL- 158 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccc-cccccc-
Confidence 9999999998653 458999999999999999999999999999999999999999999999998654210 000000
Q ss_pred CCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC--CCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG--TGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 749 ~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg--~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
... ........++..|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus 159 -------~~~---------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 214 (327)
T cd08227 159 -------RVV---------------HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 214 (327)
T ss_pred -------ccc---------------ccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 000 000112356778999999976 468899999999999999999999997543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=272.89 Aligned_cols=205 Identities=32% Similarity=0.579 Sum_probs=176.7
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVm 668 (837)
++|++.+.||.|+||.||+|.+..+++.||+|+++... ........+.+|+.+++.++|+||+++++.+......|+||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESE-DDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhc-ccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 36999999999999999999999999999999987543 22344567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCC
Q 003232 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (837)
Q Consensus 669 Ey~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~ 748 (837)
||++++.+..+......+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~---- 155 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA---- 155 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc----
Confidence 9999877777776666799999999999999999999999999999999999999999999999999863111100
Q ss_pred CCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 749 ~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~-~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
.......++..|+|||++.+. .++.++||||||+++|+|++|.+||....
T Consensus 156 --------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~ 206 (288)
T cd07833 156 --------------------------SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDS 206 (288)
T ss_pred --------------------------ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 011234678889999999887 88999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=276.39 Aligned_cols=209 Identities=26% Similarity=0.449 Sum_probs=173.8
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCCC-----cEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEeEe
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTG-----DLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSF 658 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~tG-----~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~gsf 658 (837)
....++|++.+.||+|+||.||++.+...+ ..+|+|.+.... .......+.+|+.+++.+ +||||+++++++
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 344567999999999999999999986433 689999987642 233446788999999999 899999999999
Q ss_pred ecCCeEEEEEEecCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEE
Q 003232 659 TCRENLYLVMEYLNGGDLYSLLRNL----------------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI 722 (837)
Q Consensus 659 ~d~~~lyLVmEy~~GGSL~dlLk~~----------------g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILL 722 (837)
.....++++|||+++++|..++... +.+++..+..++.||+.||.|||+.||+|+||||+|||+
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~ 165 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV 165 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE
Confidence 9999999999999999999998642 458889999999999999999999999999999999999
Q ss_pred ccCCcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHH
Q 003232 723 AHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTAD 802 (837)
Q Consensus 723 d~dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSD 802 (837)
+.++.++|+|||+++....... ........++..|+|||++.+..++.++|
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 216 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDY-----------------------------YRKTTNGRLPVKWMAPEALFDRVYTHQSD 216 (293)
T ss_pred cCCCeEEeCccccccccccccc-----------------------------eeccCCCCCCccccCHHHhccCCcCcccc
Confidence 9999999999999873110000 00011123467799999999999999999
Q ss_pred HHHHHHHHHHHHc-CCCCCCCCC
Q 003232 803 WWSVGIILFELIV-GIPPFNAEH 824 (837)
Q Consensus 803 IWSLGVILyELLT-Gr~PF~~~d 824 (837)
||||||++|+|++ |..||....
T Consensus 217 i~slG~il~el~~~g~~p~~~~~ 239 (293)
T cd05053 217 VWSFGVLLWEIFTLGGSPYPGIP 239 (293)
T ss_pred eeehhhHHHHHhcCCCCCCCCCC
Confidence 9999999999997 999997654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-31 Score=271.34 Aligned_cols=203 Identities=35% Similarity=0.578 Sum_probs=174.1
Q ss_pred CeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEE
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmE 669 (837)
+|++.+.||.|+||.||+|.+..+|..||+|++..... .......+.+|+.+++.++||||+++++++.....+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL-EGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc-cchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 58999999999999999999999999999999976542 23345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCC
Q 003232 670 YLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (837)
Q Consensus 670 y~~GGSL~dlLk~-~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~ 748 (837)
|+ +++|.+++.. ...+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~---- 154 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP---- 154 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC----
Confidence 99 9999999865 35689999999999999999999999999999999999999999999999998863110000
Q ss_pred CCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 749 ~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~-~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
.......|+..|+|||++.+. .++.++||||||+++|+|++|.+||.+.+
T Consensus 155 --------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~ 205 (286)
T cd07832 155 --------------------------RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEN 205 (286)
T ss_pred --------------------------CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCC
Confidence 011234688899999998754 46899999999999999999988886654
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=275.38 Aligned_cols=206 Identities=28% Similarity=0.434 Sum_probs=174.2
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCC----------------cEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCce
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTG----------------DLFAIKVLKKADMIRKNAVESILAERDILISVRNPFV 651 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG----------------~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNI 651 (837)
..+|++.+.||.|+||.||+|.+...+ ..||+|.+.... .......+.+|+.+++.++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhcCCCCE
Confidence 357999999999999999999876543 568999987643 23455788999999999999999
Q ss_pred EEEEeEeecCCeEEEEEEecCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcE
Q 003232 652 VRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG-----------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNL 720 (837)
Q Consensus 652 VkL~gsf~d~~~lyLVmEy~~GGSL~dlLk~~g-----------~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNI 720 (837)
+++++++......++||||+.+++|.+++.... .+++..++.++.|++.||.|||+.|++|+||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 999999999999999999999999999997655 689999999999999999999999999999999999
Q ss_pred EEccCCcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCch
Q 003232 721 LIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT 800 (837)
Q Consensus 721 LLd~dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~k 800 (837)
+++.++.++|+|||++........ ........+++.|+|||++.+..++.+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~ 212 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDY-----------------------------YRVQGRAPLPIRWMAWESVLLGKFTTK 212 (296)
T ss_pred eecCCCceEEccccceeecccCcc-----------------------------eeecCcCCCCceecCHHHhhcCCCCcc
Confidence 999999999999998863110000 001123456788999999998889999
Q ss_pred HHHHHHHHHHHHHHc--CCCCCCCCC
Q 003232 801 ADWWSVGIILFELIV--GIPPFNAEH 824 (837)
Q Consensus 801 SDIWSLGVILyELLT--Gr~PF~~~d 824 (837)
+|||||||++|+|++ |..||...+
T Consensus 213 ~Dv~slG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05051 213 SDVWAFGVTLWEILTLCREQPYEHLT 238 (296)
T ss_pred chhhhhHHHHHHHHhcCCCCCCCCcC
Confidence 999999999999998 788887643
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-31 Score=278.11 Aligned_cols=208 Identities=25% Similarity=0.433 Sum_probs=172.1
Q ss_pred cccCCeEEEEEecccCceEEEEEEECC-------CCcEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEeE
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRT-------TGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYS 657 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~-------tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~gs 657 (837)
...++|.+.+.||+|+||.||++++.. +...+|+|++.... .......+.+|+.+++.+ +||||+++++.
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGA 92 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 334679999999999999999998753 23469999997642 233456788899999999 79999999999
Q ss_pred eecCCeEEEEEEecCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEE
Q 003232 658 FTCRENLYLVMEYLNGGDLYSLLRNLG----------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLL 721 (837)
Q Consensus 658 f~d~~~lyLVmEy~~GGSL~dlLk~~g----------------~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNIL 721 (837)
+......|+||||+.+++|.+++.... .++...+..++.||+.||.|||++|++|+||||+||+
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil 172 (307)
T cd05098 93 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 172 (307)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheE
Confidence 999999999999999999999997532 3788899999999999999999999999999999999
Q ss_pred EccCCcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchH
Q 003232 722 IAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA 801 (837)
Q Consensus 722 Ld~dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kS 801 (837)
++.++.++|+|||+++....... ........+++.|+|||++.+..++.++
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 223 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDY-----------------------------YKKTTNGRLPVKWMAPEALFDRIYTHQS 223 (307)
T ss_pred EcCCCcEEECCCcccccccccch-----------------------------hhccccCCCccceeChHHhccCCCCcHH
Confidence 99999999999998863110000 0001122345789999999998899999
Q ss_pred HHHHHHHHHHHHHc-CCCCCCCCC
Q 003232 802 DWWSVGIILFELIV-GIPPFNAEH 824 (837)
Q Consensus 802 DIWSLGVILyELLT-Gr~PF~~~d 824 (837)
|||||||++|+|++ |..||....
T Consensus 224 DvwslG~~l~el~~~g~~p~~~~~ 247 (307)
T cd05098 224 DVWSFGVLLWEIFTLGGSPYPGVP 247 (307)
T ss_pred HHHHHHHHHHHHHcCCCCCCCcCC
Confidence 99999999999998 889997644
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=285.76 Aligned_cols=202 Identities=30% Similarity=0.475 Sum_probs=172.2
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecC-----
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR----- 661 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~----- 661 (837)
..++|++.+.||.|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||++++++|...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc-cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 4577999999999999999999999999999999986543 2233445678899999999999999999988643
Q ss_pred -CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccc
Q 003232 662 -ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740 (837)
Q Consensus 662 -~~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~ 740 (837)
.+.|+||||+. ++|.+.+... ++...+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++....
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 35799999995 5888887653 8999999999999999999999999999999999999999999999999986310
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCC
Q 003232 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820 (837)
Q Consensus 741 ~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF 820 (837)
.. .......|++.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 170 ~~--------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf 217 (353)
T cd07850 170 TS--------------------------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLF 217 (353)
T ss_pred CC--------------------------------CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCC
Confidence 00 0012345788999999999999999999999999999999999999
Q ss_pred CCCC
Q 003232 821 NAEH 824 (837)
Q Consensus 821 ~~~d 824 (837)
...+
T Consensus 218 ~~~~ 221 (353)
T cd07850 218 PGTD 221 (353)
T ss_pred CCCC
Confidence 7654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=270.93 Aligned_cols=225 Identities=40% Similarity=0.747 Sum_probs=185.1
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcC-CCceEEEEeEeecCCeEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~Lr-HPNIVkL~gsf~d~~~lyLV 667 (837)
++|++.+.||.|+||.||++.+..+++.||+|++.............+.+|..+++.++ ||||+++++.+......++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46999999999999999999999999999999998755444555678889999999998 99999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCC
Q 003232 668 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (837)
Q Consensus 668 mEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl 747 (837)
|||+.+++|.+++...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 99999999999999888899999999999999999999999999999999999999999999999999874221111000
Q ss_pred CCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 748 ~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
..... .. ................|+..|+|||++.+..++.++|+||||+++|++++|..||...+
T Consensus 161 ~~~~~--~~---------~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (280)
T cd05581 161 NKGDA--TN---------IDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226 (280)
T ss_pred CCCCC--cc---------ccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 00000 00 00000011122345568899999999998889999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.6e-32 Score=288.68 Aligned_cols=210 Identities=28% Similarity=0.447 Sum_probs=172.4
Q ss_pred CCcccCCeEEEEEecccCceEEEEEEECC-----CCcEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEeE
Q 003232 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRT-----TGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYS 657 (837)
Q Consensus 584 ~g~~lddYeIlkkLGsG~FGtVYkArdk~-----tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~gs 657 (837)
|....++|++.+.||.|+||.||+|.+.. +++.||+|++.... .....+.+..|+.+++.+ +||||+++++.
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~ 79 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGA 79 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeee
Confidence 33445679999999999999999997543 45789999987542 233446788899999999 89999999998
Q ss_pred eec-CCeEEEEEEecCCCCHHHHHHhc-----------------------------------------------------
Q 003232 658 FTC-RENLYLVMEYLNGGDLYSLLRNL----------------------------------------------------- 683 (837)
Q Consensus 658 f~d-~~~lyLVmEy~~GGSL~dlLk~~----------------------------------------------------- 683 (837)
+.. ...++++|||+++++|.+++...
T Consensus 80 ~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (337)
T cd05054 80 CTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED 159 (337)
T ss_pred EecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence 765 45789999999999999998532
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCCCccCc
Q 003232 684 --------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGT 755 (837)
Q Consensus 684 --------g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~Sgt 755 (837)
..++...+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++........
T Consensus 160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~----------- 228 (337)
T cd05054 160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD----------- 228 (337)
T ss_pred hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcc-----------
Confidence 2578889999999999999999999999999999999999999999999999873111000
Q ss_pred ccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 003232 756 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEH 824 (837)
Q Consensus 756 tLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~~~d 824 (837)
........++..|+|||++.+..++.++|||||||++|+|++ |..||.+..
T Consensus 229 ------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~ 280 (337)
T cd05054 229 ------------------YVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 280 (337)
T ss_pred ------------------hhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCC
Confidence 001223456778999999999999999999999999999997 999997644
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.6e-32 Score=277.27 Aligned_cols=207 Identities=21% Similarity=0.353 Sum_probs=171.9
Q ss_pred cCCeEEEEEecccCceEEEEEEECC-----CCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRT-----TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE 662 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~-----tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~ 662 (837)
+.+|++.+.||.|+||.||+|.+.. .+..||+|+++... .......+.+|+.++..++||||+++++.+....
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~ 81 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ 81 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence 4568888999999999999998754 35789999997543 2334467889999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCC
Q 003232 663 NLYLVMEYLNGGDLYSLLRNL----------------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG 726 (837)
Q Consensus 663 ~lyLVmEy~~GGSL~dlLk~~----------------g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG 726 (837)
..++++||+.+++|.+++... ..++...+..++.|++.||.|||++||+||||||+||+++.++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC
Confidence 999999999999999998531 2478888999999999999999999999999999999999999
Q ss_pred cEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHH
Q 003232 727 HIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSV 806 (837)
Q Consensus 727 ~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSL 806 (837)
.++|+|||+++...... .........+++.|+|||++.+..++.++|||||
T Consensus 162 ~~kl~Dfg~~~~~~~~~-----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 212 (283)
T cd05091 162 NVKISDLGLFREVYAAD-----------------------------YYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSY 212 (283)
T ss_pred ceEecccccccccccch-----------------------------heeeccCccCCccccCHHHHhcCCCCcchhHHHH
Confidence 99999999886310000 0011123346788999999998889999999999
Q ss_pred HHHHHHHHc-CCCCCCCCCc
Q 003232 807 GIILFELIV-GIPPFNAEHP 825 (837)
Q Consensus 807 GVILyELLT-Gr~PF~~~dp 825 (837)
||++|||++ |..||.+...
T Consensus 213 G~~l~el~~~g~~p~~~~~~ 232 (283)
T cd05091 213 GVVLWEVFSYGLQPYCGYSN 232 (283)
T ss_pred HHHHHHHHcCCCCCCCCCCH
Confidence 999999998 8889876543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=271.07 Aligned_cols=201 Identities=34% Similarity=0.615 Sum_probs=177.5
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVm 668 (837)
++|++.+.||.|+||.||++.++.+++.+|+|.+..... ......+.+|+.+++.++||||+++++.+.....+|++|
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 368888999999999999999999999999999876532 244567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCC
Q 003232 669 EYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (837)
Q Consensus 669 Ey~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHS-kGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stdd 746 (837)
||+.+++|.+++... ..+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~------ 152 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV------ 152 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhH------
Confidence 999999999999875 779999999999999999999999 999999999999999999999999999875210
Q ss_pred CCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 747 l~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
. .......|+..|+|||.+.+..++.++||||||+++|+|++|..||...+
T Consensus 153 -------------------------~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 203 (265)
T cd06605 153 -------------------------N--SLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEN 203 (265)
T ss_pred -------------------------H--HHhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccc
Confidence 0 00111568889999999999999999999999999999999999997653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=273.48 Aligned_cols=202 Identities=34% Similarity=0.629 Sum_probs=176.2
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVm 668 (837)
..|+.++.||.|+||.||+|.+..++..||+|++.... .......+.+|+.+++.++||||+++++.+......|+||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 34888899999999999999998899999999987542 2344568899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCC
Q 003232 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (837)
Q Consensus 669 Ey~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~ 748 (837)
||++|++|.+++.. +.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~----- 155 (277)
T cd06640 82 EYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ----- 155 (277)
T ss_pred ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc-----
Confidence 99999999999875 568999999999999999999999999999999999999999999999999886310000
Q ss_pred CCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 749 ~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
.......++..|+|||++.+..++.++|+|||||++|+|++|..||...+
T Consensus 156 --------------------------~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 205 (277)
T cd06640 156 --------------------------IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH 205 (277)
T ss_pred --------------------------cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 01123457888999999998889999999999999999999999997654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.2e-33 Score=309.02 Aligned_cols=196 Identities=26% Similarity=0.468 Sum_probs=173.9
Q ss_pred CCcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCe
Q 003232 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCREN 663 (837)
Q Consensus 584 ~g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ 663 (837)
|...++....++-||+|+.|.||+|+.. ++.||||.++.. -..+++-|+.|+||||+.|.++|.....
T Consensus 119 WeiPFe~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~el----------kETdIKHLRkLkH~NII~FkGVCtqsPc 186 (904)
T KOG4721|consen 119 WEIPFEEISELEWLGSGAQGAVFLGRLH--NETVAVKKVREL----------KETDIKHLRKLKHPNIITFKGVCTQSPC 186 (904)
T ss_pred ccCCHHHhhhhhhhccCcccceeeeecc--CceehhHHHhhh----------hhhhHHHHHhccCcceeeEeeeecCCce
Confidence 3445566667788999999999999974 789999987642 2357888999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCC
Q 003232 664 LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~s 743 (837)
+|||||||..|.|+.+++....++......|..+|+.|++|||.+.|||||||.-||||..+..+||+|||-++..
T Consensus 187 yCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~---- 262 (904)
T KOG4721|consen 187 YCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKEL---- 262 (904)
T ss_pred eEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhh----
Confidence 9999999999999999999889999999999999999999999999999999999999999999999999987621
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~ 823 (837)
.....+..++||..|||||++.+.+-+.++|||||||+|||||||..||...
T Consensus 263 ----------------------------~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdV 314 (904)
T KOG4721|consen 263 ----------------------------SDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDV 314 (904)
T ss_pred ----------------------------hhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCcccc
Confidence 1112345789999999999999999999999999999999999999999753
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=270.53 Aligned_cols=204 Identities=23% Similarity=0.358 Sum_probs=168.1
Q ss_pred eEEEEEecccCceEEEEEEECCC---CcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCe----
Q 003232 591 FEIIKPISRGAFGRVFLAKKRTT---GDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCREN---- 663 (837)
Q Consensus 591 YeIlkkLGsG~FGtVYkArdk~t---G~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~---- 663 (837)
|++.+.||.|+||.||+|.+..+ +..||+|+++... ........+.+|+..++.++||||+++++.+.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDI-HTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCc-CCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 56789999999999999987653 4789999987543 234445678999999999999999999998765443
Q ss_pred --EEEEEEecCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCC
Q 003232 664 --LYLVMEYLNGGDLYSLLRNL------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGL 735 (837)
Q Consensus 664 --lyLVmEy~~GGSL~dlLk~~------g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGL 735 (837)
.+++|||+++++|..++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 79999999999999988432 3588999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc
Q 003232 736 SKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV 815 (837)
Q Consensus 736 Arvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT 815 (837)
++....... ........++..|+|||++.+..++.++|||||||++|||++
T Consensus 160 ~~~~~~~~~-----------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~ 210 (273)
T cd05035 160 SKKIYSGDY-----------------------------YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210 (273)
T ss_pred eeecccccc-----------------------------ccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHh
Confidence 873211100 000112234678999999998899999999999999999999
Q ss_pred -CCCCCCCCC
Q 003232 816 -GIPPFNAEH 824 (837)
Q Consensus 816 -Gr~PF~~~d 824 (837)
|..||....
T Consensus 211 ~g~~p~~~~~ 220 (273)
T cd05035 211 RGQTPYPGVE 220 (273)
T ss_pred CCCCCCCCCC
Confidence 899997644
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-31 Score=266.52 Aligned_cols=203 Identities=32% Similarity=0.555 Sum_probs=175.9
Q ss_pred CeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEE
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmE 669 (837)
+|++.+.||.|+||.||++.+..+++.+|+|.+..... .......+.+|+.+++.++||||+++++.+......++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc-ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 58999999999999999999999999999999876543 33445788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccC-CcEEEEecCCccccccCCCCC
Q 003232 670 YLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD-GHIKLTDFGLSKVGLINSTDD 746 (837)
Q Consensus 670 y~~GGSL~dlLk~~--g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~d-G~IKLiDFGLArvg~~~stdd 746 (837)
|+++++|.+++... ..+++..+..++.|++.+|.|||++|++|+||+|+||+++.+ +.++|+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~---- 155 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK---- 155 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC----
Confidence 99999999999763 348999999999999999999999999999999999999865 46899999998631100
Q ss_pred CCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 747 l~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
.......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+.
T Consensus 156 ----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 206 (256)
T cd08220 156 ----------------------------SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL 206 (256)
T ss_pred ----------------------------ccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch
Confidence 011234678899999999988899999999999999999999999977554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-31 Score=267.62 Aligned_cols=198 Identities=31% Similarity=0.511 Sum_probs=173.0
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEE
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyL 666 (837)
..++|++.+.||.|+||.||+|... |+.||+|.+..... ..+.+.+|+.+++.++|+||+++++.+......|+
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 77 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYI 77 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEE
Confidence 3567999999999999999999874 88999999976432 45678999999999999999999999998899999
Q ss_pred EEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCC
Q 003232 667 VMEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~~g--~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~st 744 (837)
||||+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||+++....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~--- 154 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ--- 154 (256)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccc---
Confidence 999999999999997655 689999999999999999999999999999999999999999999999999863100
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 003232 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAE 823 (837)
Q Consensus 745 ddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~~~ 823 (837)
......++..|+|||++.+..++.++||||||+++|++++ |..||...
T Consensus 155 -------------------------------~~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 203 (256)
T cd05039 155 -------------------------------GQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 203 (256)
T ss_pred -------------------------------ccccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC
Confidence 0011234567999999998889999999999999999997 99999765
Q ss_pred C
Q 003232 824 H 824 (837)
Q Consensus 824 d 824 (837)
.
T Consensus 204 ~ 204 (256)
T cd05039 204 P 204 (256)
T ss_pred C
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-31 Score=267.26 Aligned_cols=205 Identities=26% Similarity=0.413 Sum_probs=173.7
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEE
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 665 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ly 665 (837)
...++|++.+.||.|+||.||++.+. .++.+|+|.+..... ....+.+|+.+++.++||||+++++.+......+
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence 34578999999999999999999975 567899999876432 2356889999999999999999999999888999
Q ss_pred EEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCC
Q 003232 666 LVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 666 LVmEy~~GGSL~dlLk~~--g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~s 743 (837)
+||||+++++|.+++... ..++...+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~- 156 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD- 156 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccch-
Confidence 999999999999999764 35899999999999999999999999999999999999999999999999988631100
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNA 822 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~~ 822 (837)
.........++..|+|||.+.+..++.++|+||||+++|+|++ |+.||.+
T Consensus 157 -----------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 207 (261)
T cd05034 157 -----------------------------EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPG 207 (261)
T ss_pred -----------------------------hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 0000112234568999999999889999999999999999998 9999976
Q ss_pred CCc
Q 003232 823 EHP 825 (837)
Q Consensus 823 ~dp 825 (837)
.++
T Consensus 208 ~~~ 210 (261)
T cd05034 208 MTN 210 (261)
T ss_pred CCH
Confidence 543
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-31 Score=266.77 Aligned_cols=203 Identities=32% Similarity=0.589 Sum_probs=176.0
Q ss_pred CeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEE
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmE 669 (837)
+|++.+.||.|+||.||++.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++.+....+.|+|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM-SPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC-ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 48999999999999999999999999999999875432 23345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCC
Q 003232 670 YLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (837)
Q Consensus 670 y~~GGSL~dlLk~~--g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl 747 (837)
|+.+++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~----- 154 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST----- 154 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc-----
Confidence 99999999998754 25789999999999999999999999999999999999999999999999988631000
Q ss_pred CCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 748 ~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
........|++.|+|||++.+..++.++|+|||||++|+|++|..||...+
T Consensus 155 --------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~ 205 (256)
T cd08218 155 --------------------------VELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN 205 (256)
T ss_pred --------------------------hhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC
Confidence 000123457889999999999889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-31 Score=270.36 Aligned_cols=209 Identities=25% Similarity=0.398 Sum_probs=173.7
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCc---EEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGD---LFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~---~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~l 664 (837)
..+|++.+.||.|+||.||+|.++.+++ .||+|++.... .......+..|+.+++.++||||+++++.+......
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 3569999999999999999999987665 59999987542 344557899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCC
Q 003232 665 YLVMEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~-~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~s 743 (837)
++||||+++++|.+++.. .+.++...+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 999999999999999875 3568999999999999999999999999999999999999999999999999876311100
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNA 822 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~~ 822 (837)
.. +. ........++..|+|||++.+..++.++|||||||++||+++ |..||..
T Consensus 161 ~~----~~----------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~ 214 (269)
T cd05065 161 SD----PT----------------------YTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD 214 (269)
T ss_pred cc----cc----------------------cccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCC
Confidence 00 00 000011122457999999999999999999999999999886 9999976
Q ss_pred CC
Q 003232 823 EH 824 (837)
Q Consensus 823 ~d 824 (837)
.+
T Consensus 215 ~~ 216 (269)
T cd05065 215 MS 216 (269)
T ss_pred CC
Confidence 54
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-31 Score=272.03 Aligned_cols=205 Identities=33% Similarity=0.590 Sum_probs=170.9
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEeEee----
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFT---- 659 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~gsf~---- 659 (837)
....++|++.+.||.|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++.+ +||||+++++.+.
T Consensus 14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 344578999999999999999999999999999999986532 1224577899999998 6999999999874
Q ss_pred -cCCeEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecC
Q 003232 660 -CRENLYLVMEYLNGGDLYSLLRN----LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFG 734 (837)
Q Consensus 660 -d~~~lyLVmEy~~GGSL~dlLk~----~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFG 734 (837)
....+++||||++|++|.+++.. ...+++..+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg 169 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFG 169 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCC
Confidence 34579999999999999998753 2458889999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-----CCCCchHHHHHHHHH
Q 003232 735 LSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-----TGHGTTADWWSVGII 809 (837)
Q Consensus 735 LArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-----~~~s~kSDIWSLGVI 809 (837)
++...... ........|++.|+|||++.+ ..++.++|||||||+
T Consensus 170 ~~~~~~~~-------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi 218 (286)
T cd06638 170 VSAQLTST-------------------------------RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGIT 218 (286)
T ss_pred ceeecccC-------------------------------CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHH
Confidence 98631100 001123468999999999853 457889999999999
Q ss_pred HHHHHcCCCCCCCCC
Q 003232 810 LFELIVGIPPFNAEH 824 (837)
Q Consensus 810 LyELLTGr~PF~~~d 824 (837)
+|+|++|+.||....
T Consensus 219 ~~el~~g~~p~~~~~ 233 (286)
T cd06638 219 AIELGDGDPPLADLH 233 (286)
T ss_pred HHHHhcCCCCCCCCc
Confidence 999999999997654
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-31 Score=292.18 Aligned_cols=211 Identities=27% Similarity=0.378 Sum_probs=174.3
Q ss_pred CCCcccCCeEEEEEecccCceEEEEEEECCC-----CcEEEEEEecccccccHHHHHHHHHHHHHHHhcC-CCceEEEEe
Q 003232 583 KDRTSIDDFEIIKPISRGAFGRVFLAKKRTT-----GDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFY 656 (837)
Q Consensus 583 k~g~~lddYeIlkkLGsG~FGtVYkArdk~t-----G~~VAVKIikk~~~~~~e~ie~~~rEieILk~Lr-HPNIVkL~g 656 (837)
++....++|++.+.||.|+||.||+|.+... +..||+|++.... .....+.+.+|+.+++.+. ||||+++++
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~ 108 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLG 108 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence 3444567899999999999999999987533 3469999997543 2334467899999999996 999999999
Q ss_pred EeecCCeEEEEEEecCCCCHHHHHHhc-----------------------------------------------------
Q 003232 657 SFTCRENLYLVMEYLNGGDLYSLLRNL----------------------------------------------------- 683 (837)
Q Consensus 657 sf~d~~~lyLVmEy~~GGSL~dlLk~~----------------------------------------------------- 683 (837)
++.....+|+||||+++|+|.+++...
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 999999999999999999999988542
Q ss_pred -------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcE
Q 003232 684 -------------------------------------------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNL 720 (837)
Q Consensus 684 -------------------------------------------g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNI 720 (837)
..+++..+..++.||+.||.|||+.||+|+||||+||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Ni 268 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNV 268 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhE
Confidence 1367778889999999999999999999999999999
Q ss_pred EEccCCcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCch
Q 003232 721 LIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT 800 (837)
Q Consensus 721 LLd~dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~k 800 (837)
|++.++.++|+|||+++....... ........+++.|+|||++.+..++.+
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~ 319 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSN-----------------------------YVSKGSTFLPVKWMAPESIFDNLYTTL 319 (400)
T ss_pred EEeCCCEEEEEeCCcceecccccc-----------------------------ccccCCcCCCcceEChhhhcCCCCCch
Confidence 999999999999999863111000 001123457788999999999999999
Q ss_pred HHHHHHHHHHHHHHc-CCCCCCCCC
Q 003232 801 ADWWSVGIILFELIV-GIPPFNAEH 824 (837)
Q Consensus 801 SDIWSLGVILyELLT-Gr~PF~~~d 824 (837)
+|||||||++|+|++ |..||....
T Consensus 320 ~DiwSlGvil~ellt~g~~P~~~~~ 344 (400)
T cd05105 320 SDVWSYGILLWEIFSLGGTPYPGMI 344 (400)
T ss_pred hhHHHHHHHHHHHHHCCCCCCcccc
Confidence 999999999999996 999997643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=276.05 Aligned_cols=204 Identities=34% Similarity=0.553 Sum_probs=173.8
Q ss_pred CeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccc--cHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEE
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMI--RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~--~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLV 667 (837)
+|++.+.||.|+||.||+|.+..+++.||+|.+...... .......+.+|+.+++.++|+||+++++++......|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 488999999999999999999989999999999765432 123345677899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCC
Q 003232 668 MEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (837)
Q Consensus 668 mEy~~GGSL~dlLk~~g-~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stdd 746 (837)
|||+ +++|.+++.... .+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--- 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN--- 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC---
Confidence 9999 899999998765 79999999999999999999999999999999999999999999999999986311000
Q ss_pred CCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 747 l~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
.......+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||.+.++
T Consensus 157 ----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~ 208 (298)
T cd07841 157 ----------------------------RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD 208 (298)
T ss_pred ----------------------------ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc
Confidence 01122356788999999865 4578999999999999999999888876553
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=270.21 Aligned_cols=202 Identities=26% Similarity=0.478 Sum_probs=170.3
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVm 668 (837)
.+|++.+.||.|+||.||++.+. ++..+|+|++..... ....+.+|+.+++.++||||+++++++......|+||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT 78 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence 46889999999999999999985 567899999875432 1235778999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCC
Q 003232 669 EYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (837)
Q Consensus 669 Ey~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl 747 (837)
||++|++|.+++... +.+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||+++.......
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~--- 155 (256)
T cd05059 79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY--- 155 (256)
T ss_pred ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccc---
Confidence 999999999998753 4689999999999999999999999999999999999999999999999998863110000
Q ss_pred CCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCc
Q 003232 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHP 825 (837)
Q Consensus 748 ~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~~~dp 825 (837)
.......++..|+|||.+.+..++.++||||||+++|+|++ |+.||...++
T Consensus 156 ---------------------------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 207 (256)
T cd05059 156 ---------------------------TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN 207 (256)
T ss_pred ---------------------------cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH
Confidence 00011224567999999999999999999999999999998 8999976543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=267.33 Aligned_cols=206 Identities=65% Similarity=1.165 Sum_probs=176.3
Q ss_pred ecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEEecCCCCH
Q 003232 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 676 (837)
Q Consensus 597 LGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmEy~~GGSL 676 (837)
||.|+||.||++++..+++.+++|++.............+.+|+.+++.++||||+++++.+......|++|||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999989999999999776544456677899999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCCCccCcc
Q 003232 677 YSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 756 (837)
Q Consensus 677 ~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~Sgtt 756 (837)
.+++...+.+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++...........
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~--------- 151 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL--------- 151 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc---------
Confidence 99998877899999999999999999999999999999999999999999999999999874221111000
Q ss_pred cCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 757 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 757 Ll~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
...........++..|+|||.+.+..++.++|+||||+++|+|++|..||....+
T Consensus 152 --------------~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~ 206 (265)
T cd05579 152 --------------NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP 206 (265)
T ss_pred --------------ccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 0000112345678899999999988899999999999999999999999976653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-31 Score=274.99 Aligned_cols=207 Identities=22% Similarity=0.368 Sum_probs=170.6
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcE----EEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCe
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDL----FAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCREN 663 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~----VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ 663 (837)
.++|++++.||.|+||+||+|.+..++.. +++|.+... ........+..|+.+++.++||||+++++++. ...
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~ 82 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GAS 82 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCc
Confidence 35799999999999999999999877764 677776432 12334467788888999999999999999875 456
Q ss_pred EEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccC
Q 003232 664 LYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~ 742 (837)
.++++||+++|+|.+++... +.+++..+..++.||+.||.|||++|++|+||||+|||++.++.++|+|||+++.....
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 78999999999999999753 56899999999999999999999999999999999999999999999999998632110
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCC
Q 003232 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFN 821 (837)
Q Consensus 743 stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~ 821 (837)
.. ........|+..|+|||++.+..++.++||||||+++|||++ |..||.
T Consensus 163 ~~-----------------------------~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~ 213 (279)
T cd05111 163 DK-----------------------------KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYA 213 (279)
T ss_pred Cc-----------------------------ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 00 000122346778999999998899999999999999999998 999998
Q ss_pred CCCcC
Q 003232 822 AEHPQ 826 (837)
Q Consensus 822 ~~dpd 826 (837)
+..+.
T Consensus 214 ~~~~~ 218 (279)
T cd05111 214 GMRPH 218 (279)
T ss_pred CCCHH
Confidence 76543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=271.03 Aligned_cols=205 Identities=33% Similarity=0.561 Sum_probs=174.7
Q ss_pred CeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccc-------cHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMI-------RKNAVESILAERDILISVRNPFVVRFFYSFTCRE 662 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~-------~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~ 662 (837)
+|.+.+.||.|+||.||+|.+..+++.+|+|.+...... .....+.+..|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 488889999999999999999889999999988642211 1223457888999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccC
Q 003232 663 NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (837)
Q Consensus 663 ~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~ 742 (837)
..++||||+++++|.+++...+.+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999999988888999999999999999999999999999999999999999999999999988631100
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCC--CCchHHHHHHHHHHHHHHcCCCCC
Q 003232 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG--HGTTADWWSVGIILFELIVGIPPF 820 (837)
Q Consensus 743 stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~--~s~kSDIWSLGVILyELLTGr~PF 820 (837)
.. ........|+..|+|||++.+.. ++.++|+||||+++|++++|..||
T Consensus 162 ~~-----------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~ 212 (272)
T cd06629 162 YD-----------------------------NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPW 212 (272)
T ss_pred cc-----------------------------ccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCC
Confidence 00 00112345888999999987654 789999999999999999999999
Q ss_pred CCC
Q 003232 821 NAE 823 (837)
Q Consensus 821 ~~~ 823 (837)
...
T Consensus 213 ~~~ 215 (272)
T cd06629 213 SDE 215 (272)
T ss_pred cCc
Confidence 643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=271.47 Aligned_cols=207 Identities=26% Similarity=0.389 Sum_probs=173.0
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCc---EEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGD---LFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~---~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~l 664 (837)
..+|++.+.||.|+||.||+|.++.++. .+|+|.++... .......+.+|+.+++.++||||+++++++...+..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 3579999999999999999999865543 79999987543 233456789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCC
Q 003232 665 YLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~s 743 (837)
|+||||+++++|.+++... +.++...+..++.|++.||.|||+.|++|+||||+|||++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999999999764 468999999999999999999999999999999999999999999999999987311000
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNA 822 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~~ 822 (837)
.. ........++..|+|||++.+..++.++|+||||+++|++++ |..||..
T Consensus 161 ~~----------------------------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~ 212 (267)
T cd05066 161 EA----------------------------AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWE 212 (267)
T ss_pred ce----------------------------eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCccc
Confidence 00 000112234567999999998889999999999999999886 9999976
Q ss_pred CC
Q 003232 823 EH 824 (837)
Q Consensus 823 ~d 824 (837)
..
T Consensus 213 ~~ 214 (267)
T cd05066 213 MS 214 (267)
T ss_pred CC
Confidence 54
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-31 Score=272.71 Aligned_cols=204 Identities=26% Similarity=0.387 Sum_probs=168.2
Q ss_pred eEEEEEecccCceEEEEEEE----CCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecC--CeE
Q 003232 591 FEIIKPISRGAFGRVFLAKK----RTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR--ENL 664 (837)
Q Consensus 591 YeIlkkLGsG~FGtVYkArd----k~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~--~~l 664 (837)
|++++.||.|+||+||++.. ..++..||+|+++... .......+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 49999999999999988653 3567899999987642 123445788999999999999999999987653 468
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCC
Q 003232 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~st 744 (837)
|+||||+++++|.+++.. ..+++..++.++.|++.||.|||++|++|+||||+|||++.++.++|+|||+++.......
T Consensus 84 ~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 162 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 162 (283)
T ss_pred EEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence 999999999999999976 4599999999999999999999999999999999999999999999999999863110000
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 745 ddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
.........++..|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 163 ----------------------------~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~ 214 (283)
T cd05080 163 ----------------------------YYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPP 214 (283)
T ss_pred ----------------------------hhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCc
Confidence 0000112345667999999998889999999999999999999999987654
Q ss_pred c
Q 003232 825 P 825 (837)
Q Consensus 825 p 825 (837)
.
T Consensus 215 ~ 215 (283)
T cd05080 215 K 215 (283)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=288.93 Aligned_cols=191 Identities=29% Similarity=0.460 Sum_probs=165.2
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLV 667 (837)
..+|++++.||.|+||.||+|++..++..||+|+.... ....|+.+++.++||||+++++++......|+|
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 34699999999999999999999999999999986543 234689999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCC
Q 003232 668 MEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (837)
Q Consensus 668 mEy~~GGSL~dlLk~-~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stdd 746 (837)
||++. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.....
T Consensus 136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---- 210 (357)
T PHA03209 136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA---- 210 (357)
T ss_pred EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC----
Confidence 99995 688888754 466999999999999999999999999999999999999999999999999998631000
Q ss_pred CCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCC
Q 003232 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820 (837)
Q Consensus 747 l~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF 820 (837)
.......||+.|+|||++.+..++.++|||||||++|+|+++..|+
T Consensus 211 ----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 ----------------------------PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ----------------------------cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 0112346899999999999999999999999999999999855444
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-31 Score=269.75 Aligned_cols=203 Identities=26% Similarity=0.451 Sum_probs=171.4
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLV 667 (837)
.++|++.+.||.|+||+||++.+. .+..+|+|.+..... ....+.+|+.+++.++||||+++++++.....+|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence 356999999999999999999875 345699999875432 234688999999999999999999999988899999
Q ss_pred EEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCC
Q 003232 668 MEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (837)
Q Consensus 668 mEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stdd 746 (837)
|||+.+++|.+++... ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||.++.......
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-- 155 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-- 155 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce--
Confidence 9999999999998764 4689999999999999999999999999999999999999999999999998763110000
Q ss_pred CCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCc
Q 003232 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHP 825 (837)
Q Consensus 747 l~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~~~dp 825 (837)
.......++..|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 156 ----------------------------~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~ 207 (256)
T cd05113 156 ----------------------------TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN 207 (256)
T ss_pred ----------------------------eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH
Confidence 00112345678999999998889999999999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-31 Score=274.69 Aligned_cols=205 Identities=27% Similarity=0.462 Sum_probs=170.5
Q ss_pred CeEEEEEecccCceEEEEEEECC-----CCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeE
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRT-----TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~-----tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~l 664 (837)
+|++.+.||+|+||.||+|.+.. ....+++|.+.... .......+.+|+.+++.++||||+++++.+......
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 47889999999999999998753 23578999887543 233456789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcE
Q 003232 665 YLVMEYLNGGDLYSLLRNL------------------------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNL 720 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~------------------------g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNI 720 (837)
+++|||+.+++|.+++... ..++...+..++.|++.||.|||+.|++||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 9999999999999998642 2377888999999999999999999999999999999
Q ss_pred EEccCCcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCch
Q 003232 721 LIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT 800 (837)
Q Consensus 721 LLd~dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~k 800 (837)
|++.++.++|+|||+++....... ........++..|+|||++.+..++.+
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~-----------------------------~~~~~~~~~~~~y~apE~~~~~~~~~~ 209 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDS-----------------------------YVKRSKGRIPVKWMAIESLFDHIYTTQ 209 (290)
T ss_pred EEcCCCcEEeccccccccccCccc-----------------------------hhcccCCCCCccccCHHHHccCCcchH
Confidence 999999999999999863110000 001122345678999999999999999
Q ss_pred HHHHHHHHHHHHHHc-CCCCCCCCCc
Q 003232 801 ADWWSVGIILFELIV-GIPPFNAEHP 825 (837)
Q Consensus 801 SDIWSLGVILyELLT-Gr~PF~~~dp 825 (837)
+||||||+++|+|++ |..||.+..+
T Consensus 210 ~Di~slG~~l~el~t~g~~p~~~~~~ 235 (290)
T cd05045 210 SDVWSFGVLLWEIVTLGGNPYPGIAP 235 (290)
T ss_pred hHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 999999999999998 9999976554
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-31 Score=268.60 Aligned_cols=208 Identities=25% Similarity=0.372 Sum_probs=173.3
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCc---EEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGD---LFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~---~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~l 664 (837)
.++|+..+.||.|+||.||+|.+..++. .+++|.+.... .......+.+|+.+++.++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA 81 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence 3579999999999999999999876655 79999986542 233446788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCC
Q 003232 665 YLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~s 743 (837)
|+||||+++++|.+++... +.+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 9999999999999998753 568999999999999999999999999999999999999999999999999886311000
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNA 822 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~~ 822 (837)
.. .........++.|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus 162 ~~----------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~ 213 (268)
T cd05063 162 EG----------------------------TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWD 213 (268)
T ss_pred cc----------------------------ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCc
Confidence 00 000011223467999999998889999999999999999997 9999976
Q ss_pred CCc
Q 003232 823 EHP 825 (837)
Q Consensus 823 ~dp 825 (837)
.+.
T Consensus 214 ~~~ 216 (268)
T cd05063 214 MSN 216 (268)
T ss_pred CCH
Confidence 543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-31 Score=275.50 Aligned_cols=206 Identities=28% Similarity=0.445 Sum_probs=172.8
Q ss_pred cCCeEEEEEecccCceEEEEEEECC-----CCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRT-----TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE 662 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~-----tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~ 662 (837)
..+|.+.+.||.|+||.||+|.+.. ++..+++|.+.... ....+.+.+|+.+++.++||||+++++.+....
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 3569999999999999999998643 45578999886533 333457889999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCC
Q 003232 663 NLYLVMEYLNGGDLYSLLRNLG----------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG 726 (837)
Q Consensus 663 ~lyLVmEy~~GGSL~dlLk~~g----------------~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG 726 (837)
..++||||+++++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL 160 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 9999999999999999997542 378899999999999999999999999999999999999999
Q ss_pred cEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHH
Q 003232 727 HIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSV 806 (837)
Q Consensus 727 ~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSL 806 (837)
.++|+|||++........ ........|+..|+|||++.+..++.++|||||
T Consensus 161 ~~~l~dfg~a~~~~~~~~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 211 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDY-----------------------------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSF 211 (291)
T ss_pred cEEECCCCcccccCCCce-----------------------------eecCCCCCcceeecChHHhccCCCCchhhHHHH
Confidence 999999999863110000 001123456788999999999999999999999
Q ss_pred HHHHHHHHc-CCCCCCCCCc
Q 003232 807 GIILFELIV-GIPPFNAEHP 825 (837)
Q Consensus 807 GVILyELLT-Gr~PF~~~dp 825 (837)
|+++|+|++ |..||...++
T Consensus 212 G~il~el~t~g~~p~~~~~~ 231 (291)
T cd05094 212 GVILWEIFTYGKQPWFQLSN 231 (291)
T ss_pred HHHHHHHHhCCCCCCCCCCH
Confidence 999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-31 Score=276.20 Aligned_cols=203 Identities=28% Similarity=0.433 Sum_probs=169.8
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCc--EEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEeEeecCCeEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGD--LFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLY 665 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~--~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~gsf~d~~~ly 665 (837)
++|++.+.||.|+||.||+|.+..++. .+++|.++.. ......+.+.+|+.+++++ +||||+++++.+.....+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 579999999999999999999877765 4688887642 2233456788999999999 7999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEE
Q 003232 666 LVMEYLNGGDLYSLLRNLG----------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIK 729 (837)
Q Consensus 666 LVmEy~~GGSL~dlLk~~g----------------~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IK 729 (837)
+||||+++++|.+++.... .++...++.++.||+.||+|||++|++||||||+|||++.++.++
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 9999999999999996532 478889999999999999999999999999999999999999999
Q ss_pred EEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHH
Q 003232 730 LTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGII 809 (837)
Q Consensus 730 LiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVI 809 (837)
|+|||++...... ........+..|+|||++.+..++.++|||||||+
T Consensus 160 l~dfg~~~~~~~~--------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~i 207 (297)
T cd05089 160 IADFGLSRGEEVY--------------------------------VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVL 207 (297)
T ss_pred ECCcCCCccccce--------------------------------eccCCCCcCccccCchhhccCCCCchhhHHHHHHH
Confidence 9999987520000 00011123457999999999899999999999999
Q ss_pred HHHHHc-CCCCCCCCCc
Q 003232 810 LFELIV-GIPPFNAEHP 825 (837)
Q Consensus 810 LyELLT-Gr~PF~~~dp 825 (837)
+|+|++ |..||...++
T Consensus 208 l~el~t~g~~pf~~~~~ 224 (297)
T cd05089 208 LWEIVSLGGTPYCGMTC 224 (297)
T ss_pred HHHHHcCCCCCCCCCCH
Confidence 999997 9999976543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-32 Score=306.37 Aligned_cols=206 Identities=29% Similarity=0.489 Sum_probs=174.6
Q ss_pred CCcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCe
Q 003232 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCREN 663 (837)
Q Consensus 584 ~g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ 663 (837)
+......+++++.||+|.||.||.|.+. ....||+|.++...+. .+.|.+|+.+|++|+|+|||++++++..+..
T Consensus 201 wei~r~~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m~----~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~p 275 (468)
T KOG0197|consen 201 WEIPREELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSMS----PEAFLREAQIMKKLRHEKLVKLYGVCTKQEP 275 (468)
T ss_pred eeecHHHHHHHHHhcCCccceEEEEEEc-CCCcccceEEeccccC----hhHHHHHHHHHHhCcccCeEEEEEEEecCCc
Confidence 3344455888899999999999999994 3458999999875432 2467799999999999999999999999889
Q ss_pred EEEEEEecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCcccccc
Q 003232 664 LYLVMEYLNGGDLYSLLRN--LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 741 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk~--~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~ 741 (837)
+||||||++.|+|.++++. ...+...+...++.|||+|++||.++++|||||..+|||++.+..+||+|||+|+..
T Consensus 276 iyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~-- 353 (468)
T KOG0197|consen 276 IYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLI-- 353 (468)
T ss_pred eEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEccccccccc--
Confidence 9999999999999999986 456999999999999999999999999999999999999999999999999999831
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCC
Q 003232 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPF 820 (837)
Q Consensus 742 ~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF 820 (837)
..+. +. ......-...|+|||++....++.++||||||++||||+| |+.||
T Consensus 354 -~d~~-Y~--------------------------~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py 405 (468)
T KOG0197|consen 354 -GDDE-YT--------------------------ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPY 405 (468)
T ss_pred -CCCc-ee--------------------------ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCC
Confidence 1111 00 0112233567999999999999999999999999999997 99998
Q ss_pred CCCC
Q 003232 821 NAEH 824 (837)
Q Consensus 821 ~~~d 824 (837)
.+.+
T Consensus 406 ~~ms 409 (468)
T KOG0197|consen 406 PGMS 409 (468)
T ss_pred CCCC
Confidence 7643
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=269.96 Aligned_cols=202 Identities=31% Similarity=0.564 Sum_probs=171.8
Q ss_pred CeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEE
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmE 669 (837)
+|++.+.||.|++|.||+|++..+|..||+|.++.... ......+.+|+.+++.++||||+++++.+...+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 58999999999999999999999999999999876432 2233567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCC
Q 003232 670 YLNGGDLYSLLRNL---GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (837)
Q Consensus 670 y~~GGSL~dlLk~~---g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stdd 746 (837)
|+.+ +|.+++... ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~---- 153 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP---- 153 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC----
Confidence 9975 888888654 35899999999999999999999999999999999999999999999999988631000
Q ss_pred CCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 747 l~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~-~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
........++..|++||++.+. .++.++||||||+++|+|++|+.||.+.+.
T Consensus 154 ---------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~ 206 (284)
T cd07836 154 ---------------------------VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN 206 (284)
T ss_pred ---------------------------ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 0011233578899999998764 568899999999999999999999987653
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=273.69 Aligned_cols=196 Identities=37% Similarity=0.666 Sum_probs=163.5
Q ss_pred EecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHH---HHHhcCCCceEEEEeEeecCCeEEEEEEecC
Q 003232 596 PISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERD---ILISVRNPFVVRFFYSFTCRENLYLVMEYLN 672 (837)
Q Consensus 596 kLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEie---ILk~LrHPNIVkL~gsf~d~~~lyLVmEy~~ 672 (837)
.||.|+||.||++++..+++.||+|.+.............+..|.. .++...||||+++++.+.....+|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 3899999999999999999999999987643222222222334433 3445689999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCCCc
Q 003232 673 GGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 752 (837)
Q Consensus 673 GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~ 752 (837)
|++|.+++...+.+++..++.++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++.... .
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~--~--------- 149 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS--K--------- 149 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccC--c---------
Confidence 99999999888889999999999999999999999999999999999999999999999999875210 0
Q ss_pred cCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 753 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 753 SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
.......|+..|+|||++.+ ..++.++||||||+++|+|++|+.||....
T Consensus 150 ----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~ 200 (278)
T cd05606 150 ----------------------KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200 (278)
T ss_pred ----------------------cCCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCC
Confidence 00123468999999999975 468899999999999999999999997653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=269.83 Aligned_cols=199 Identities=26% Similarity=0.424 Sum_probs=166.4
Q ss_pred EecccCceEEEEEEE--CCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEEecCC
Q 003232 596 PISRGAFGRVFLAKK--RTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 673 (837)
Q Consensus 596 kLGsG~FGtVYkArd--k~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmEy~~G 673 (837)
.||+|+||.||+|.+ ..++..+|+|+++... ......+.+.+|+.+++.++||||+++++.+. ....++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 589999999999965 4567899999987543 33445678899999999999999999998875 4567999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCCCcc
Q 003232 674 GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753 (837)
Q Consensus 674 GSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~S 753 (837)
++|.+++.....+++..+..++.|++.||.|||++|++|+||||.||+++.++.++|+|||++.........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~-------- 151 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY-------- 151 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCe--------
Confidence 999999988778999999999999999999999999999999999999999999999999998631100000
Q ss_pred CcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 003232 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEH 824 (837)
Q Consensus 754 gttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~~~d 824 (837)
........++..|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 152 --------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 203 (257)
T cd05116 152 --------------------YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK 203 (257)
T ss_pred --------------------eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 000112345678999999988889999999999999999997 999997654
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-32 Score=305.59 Aligned_cols=217 Identities=32% Similarity=0.476 Sum_probs=186.5
Q ss_pred CCCCCCCCcccCCeEEEEEecccCceEEEEEEECCCCc---E-EEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEE
Q 003232 578 PIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGD---L-FAIKVLKKADMIRKNAVESILAERDILISVRNPFVVR 653 (837)
Q Consensus 578 ~~~P~k~g~~lddYeIlkkLGsG~FGtVYkArdk~tG~---~-VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVk 653 (837)
++....|....++..+.++||+|+||.||+|+.+..+. . ||+|..+............+.+|.++|++++|||||+
T Consensus 146 PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr 225 (474)
T KOG0194|consen 146 PIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVR 225 (474)
T ss_pred cccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEE
Confidence 44445677777888888999999999999999876433 3 8999988655466788899999999999999999999
Q ss_pred EEeEeecCCeEEEEEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEe
Q 003232 654 FFYSFTCRENLYLVMEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTD 732 (837)
Q Consensus 654 L~gsf~d~~~lyLVmEy~~GGSL~dlLk~~g-~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiD 732 (837)
+||+...+..+|||||+|+||+|.++++..+ .++..+...++.+.+.||+|||++++|||||-.+|+|++.++.+||+|
T Consensus 226 ~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISD 305 (474)
T KOG0194|consen 226 FYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISD 305 (474)
T ss_pred EEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCc
Confidence 9999999999999999999999999999876 499999999999999999999999999999999999999999999999
Q ss_pred cCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHH
Q 003232 733 FGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFE 812 (837)
Q Consensus 733 FGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyE 812 (837)
||+++.+...... .....-...|+|||.+....+++++|||||||++||
T Consensus 306 FGLs~~~~~~~~~-------------------------------~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~E 354 (474)
T KOG0194|consen 306 FGLSRAGSQYVMK-------------------------------KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWE 354 (474)
T ss_pred cccccCCcceeec-------------------------------cccccCcceecChhhhccCccccccchhheeeeEEe
Confidence 9998853211110 001124568999999999999999999999999999
Q ss_pred HHc-CCCCCCCCCc
Q 003232 813 LIV-GIPPFNAEHP 825 (837)
Q Consensus 813 LLT-Gr~PF~~~dp 825 (837)
+++ |..||.+...
T Consensus 355 if~~g~~Py~g~~~ 368 (474)
T KOG0194|consen 355 IFENGAEPYPGMKN 368 (474)
T ss_pred eeccCCCCCCCCCH
Confidence 998 8889987653
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=267.39 Aligned_cols=198 Identities=31% Similarity=0.551 Sum_probs=167.9
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEee-cCCeE
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFT-CRENL 664 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~-d~~~l 664 (837)
....+|++.+.||.|+||.||++... +..+|+|.++... ..+.+.+|+.+++.++|+|++++++++. .....
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 75 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCce
Confidence 34568999999999999999999864 7889999986532 2356889999999999999999998754 45679
Q ss_pred EEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccC
Q 003232 665 YLVMEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~g--~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~ 742 (837)
|+||||+++++|.+++...+ .+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~- 154 (256)
T cd05082 76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS- 154 (256)
T ss_pred EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccc-
Confidence 99999999999999987643 378899999999999999999999999999999999999999999999998762100
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCC
Q 003232 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFN 821 (837)
Q Consensus 743 stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~ 821 (837)
......++..|+|||++.+..++.++|||||||++|+|++ |+.||.
T Consensus 155 ---------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~ 201 (256)
T cd05082 155 ---------------------------------TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 201 (256)
T ss_pred ---------------------------------cCCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 0011234567999999999899999999999999999997 999997
Q ss_pred CCC
Q 003232 822 AEH 824 (837)
Q Consensus 822 ~~d 824 (837)
...
T Consensus 202 ~~~ 204 (256)
T cd05082 202 RIP 204 (256)
T ss_pred CCC
Confidence 543
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=268.96 Aligned_cols=203 Identities=33% Similarity=0.550 Sum_probs=167.0
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHH-HHhcCCCceEEEEeEeecCCeEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDI-LISVRNPFVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieI-Lk~LrHPNIVkL~gsf~d~~~lyLV 667 (837)
++|++.+.||.|+||.||++.+..+|+.||+|.++..... .....+..|..+ ++.++||||+++++.+......|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS--QEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc--HHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 4699999999999999999999999999999998764321 222345556665 5677999999999999999999999
Q ss_pred EEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCcEEEccCCcEEEEecCCccccccC
Q 003232 668 MEYLNGGDLYSLLRN----LGCLDEDVARVYIAEVVLALEYLHSL-RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (837)
Q Consensus 668 mEy~~GGSL~dlLk~----~g~Lsee~irkIl~QIa~ALsYLHSk-GIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~ 742 (837)
|||++ ++|.+++.. ...+++..+..++.||+.||.|||++ +++||||||+||+++.++.++|+|||++......
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99996 688877753 24689999999999999999999997 9999999999999999999999999998631000
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC----CCCCchHHHHHHHHHHHHHHcCCC
Q 003232 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG----TGHGTTADWWSVGIILFELIVGIP 818 (837)
Q Consensus 743 stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg----~~~s~kSDIWSLGVILyELLTGr~ 818 (837)
.......|+..|+|||++.+ ..++.++|+|||||++|+|++|..
T Consensus 158 --------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 205 (283)
T cd06617 158 --------------------------------VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRF 205 (283)
T ss_pred --------------------------------cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCC
Confidence 00112357888999999865 456889999999999999999999
Q ss_pred CCCCCCcC
Q 003232 819 PFNAEHPQ 826 (837)
Q Consensus 819 PF~~~dpd 826 (837)
||......
T Consensus 206 p~~~~~~~ 213 (283)
T cd06617 206 PYDSWKTP 213 (283)
T ss_pred CCCccccC
Confidence 99754433
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-34 Score=293.31 Aligned_cols=203 Identities=33% Similarity=0.560 Sum_probs=178.5
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVm 668 (837)
++|++-+.||+|.|+.||++.++.+|+.+|+|++...... ....+.+.+|++|-+.|+||||+++++.+......|||+
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~-~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhc-cccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 5699999999999999999999999999999999765433 335678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEcc---CCcEEEEecCCccccccCCCC
Q 003232 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGLINSTD 745 (837)
Q Consensus 669 Ey~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~---dG~IKLiDFGLArvg~~~std 745 (837)
|++.|+.|..-+-..-.+++..+..+++||+.+|.|+|.+||||||+||+|+++.. ..-+||+|||++....
T Consensus 90 e~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~----- 164 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN----- 164 (355)
T ss_pred ecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC-----
Confidence 99999999765544456889999999999999999999999999999999999954 3468999999997311
Q ss_pred CCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 746 dl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
.+..+...+|||.|||||++...+|+..+|||+.||+||-||.|.+||++.+
T Consensus 165 ---------------------------~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~ 216 (355)
T KOG0033|consen 165 ---------------------------DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 216 (355)
T ss_pred ---------------------------CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc
Confidence 1123456789999999999999999999999999999999999999999844
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-31 Score=270.37 Aligned_cols=207 Identities=35% Similarity=0.598 Sum_probs=172.4
Q ss_pred CCcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEeEeecC-
Q 003232 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCR- 661 (837)
Q Consensus 584 ~g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~gsf~d~- 661 (837)
.+...++|++.+.||.|+||.||++.+..+++.+|+|++.... .....+.+|+.+++++ +||||+++++++...
T Consensus 17 ~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~ 92 (291)
T cd06639 17 LGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD 92 (291)
T ss_pred CCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence 3445678999999999999999999999999999999986532 1234567889999988 899999999988653
Q ss_pred ----CeEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEec
Q 003232 662 ----ENLYLVMEYLNGGDLYSLLRN----LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDF 733 (837)
Q Consensus 662 ----~~lyLVmEy~~GGSL~dlLk~----~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDF 733 (837)
..+|+||||++|++|.++++. ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+||
T Consensus 93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~df 172 (291)
T cd06639 93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDF 172 (291)
T ss_pred ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeec
Confidence 368999999999999998853 356899999999999999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCC-----CCCchHHHHHHHH
Q 003232 734 GLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-----GHGTTADWWSVGI 808 (837)
Q Consensus 734 GLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~-----~~s~kSDIWSLGV 808 (837)
|++....... .......|+..|+|||++... .++.++|||||||
T Consensus 173 g~~~~~~~~~-------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGv 221 (291)
T cd06639 173 GVSAQLTSTR-------------------------------LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGI 221 (291)
T ss_pred ccchhccccc-------------------------------ccccCccCCccccChhhhcCCCCcccccCCccchHHHHH
Confidence 9876311000 011234688899999998643 3678999999999
Q ss_pred HHHHHHcCCCCCCCCCc
Q 003232 809 ILFELIVGIPPFNAEHP 825 (837)
Q Consensus 809 ILyELLTGr~PF~~~dp 825 (837)
++|+|++|+.||...++
T Consensus 222 i~~el~~g~~p~~~~~~ 238 (291)
T cd06639 222 TAIELGDGDPPLFDMHP 238 (291)
T ss_pred HHHHHhhCCCCCCCCcH
Confidence 99999999999986543
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-32 Score=301.72 Aligned_cols=206 Identities=37% Similarity=0.686 Sum_probs=185.3
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLV 667 (837)
.+.|.+.++||.|+||.||-++-+.+|+-||.|.+.+..+..........+|..+|++++.++||.+-.+|...+.+|+|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 45689999999999999999999999999999999776665666667889999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCC
Q 003232 668 MEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745 (837)
Q Consensus 668 mEy~~GGSL~dlLk~~g--~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~std 745 (837)
|..|+||+|.-++.+.+ .++++.++.|+.+|+.||++||..+||.||+||+|||+|++|+++|+|+|+|.-..
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~----- 338 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP----- 338 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecC-----
Confidence 99999999998887765 69999999999999999999999999999999999999999999999999986210
Q ss_pred CCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 746 dl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
........+||.+|||||++.+..|++..|+|||||++|||+.|+-||...-.
T Consensus 339 ---------------------------~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke 391 (591)
T KOG0986|consen 339 ---------------------------EGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE 391 (591)
T ss_pred ---------------------------CCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh
Confidence 11223455899999999999999999999999999999999999999976543
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=275.00 Aligned_cols=209 Identities=29% Similarity=0.480 Sum_probs=172.7
Q ss_pred CeEEEEEecccCceEEEEEEECC--CCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecC--CeEE
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRT--TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR--ENLY 665 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~--tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~--~~ly 665 (837)
+|++.+.||.|+||.||+|.+.. ++..||+|.+.............+.+|+.+++.++||||+++++.+... ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 48999999999999999999988 8999999999864322233345678899999999999999999999988 7899
Q ss_pred EEEEecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEcc----CCcEEEEecCCc
Q 003232 666 LVMEYLNGGDLYSLLRNL-----GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH----DGHIKLTDFGLS 736 (837)
Q Consensus 666 LVmEy~~GGSL~dlLk~~-----g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~----dG~IKLiDFGLA 736 (837)
+||||++ ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+||+++. ++.++|+|||++
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 9999996 4777766432 36899999999999999999999999999999999999999 899999999998
Q ss_pred cccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHc
Q 003232 737 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIV 815 (837)
Q Consensus 737 rvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLT 815 (837)
......... ........+++.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 160 ~~~~~~~~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~ 211 (316)
T cd07842 160 RLFNAPLKP----------------------------LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211 (316)
T ss_pred cccCCCccc----------------------------ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHh
Confidence 731111000 011223468899999999876 457899999999999999999
Q ss_pred CCCCCCCCCcCH
Q 003232 816 GIPPFNAEHPQV 827 (837)
Q Consensus 816 Gr~PF~~~dpdv 827 (837)
|++||.......
T Consensus 212 ~~~~~~~~~~~~ 223 (316)
T cd07842 212 LEPIFKGREAKI 223 (316)
T ss_pred cCCCCcCCcccc
Confidence 999998766543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=266.80 Aligned_cols=202 Identities=33% Similarity=0.594 Sum_probs=171.4
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEeEeecCC----
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRE---- 662 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~gsf~d~~---- 662 (837)
.++|++.+.||.|+||.||+|.++.+++.+++|++.... .....+.+|+.+++++ +||||+++++.+....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 367999999999999999999999899999999987643 2345788999999998 7999999999997644
Q ss_pred --eEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCc
Q 003232 663 --NLYLVMEYLNGGDLYSLLRN----LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS 736 (837)
Q Consensus 663 --~lyLVmEy~~GGSL~dlLk~----~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLA 736 (837)
.+|+||||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence 58999999999999999864 357899999999999999999999999999999999999999999999999987
Q ss_pred cccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-----CCCCchHHHHHHHHHHH
Q 003232 737 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-----TGHGTTADWWSVGIILF 811 (837)
Q Consensus 737 rvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-----~~~s~kSDIWSLGVILy 811 (837)
...... ........|+..|+|||++.. ..++.++||||||+++|
T Consensus 161 ~~~~~~-------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~ 209 (275)
T cd06608 161 AQLDST-------------------------------LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAI 209 (275)
T ss_pred eecccc-------------------------------hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHH
Confidence 631000 011123468899999999854 34678899999999999
Q ss_pred HHHcCCCCCCCCC
Q 003232 812 ELIVGIPPFNAEH 824 (837)
Q Consensus 812 ELLTGr~PF~~~d 824 (837)
+|++|..||....
T Consensus 210 ~l~~g~~p~~~~~ 222 (275)
T cd06608 210 ELADGKPPLCDMH 222 (275)
T ss_pred HHHhCCCCccccc
Confidence 9999999997543
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=270.40 Aligned_cols=202 Identities=25% Similarity=0.405 Sum_probs=173.9
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLV 667 (837)
..+|++.+.||.|+||.||+|.+.. +..+++|++.... ......+.+|+.+++.++||||+++++.+.....+|+|
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD---LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc---hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 3569999999999999999999976 8999999987643 22345688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCC
Q 003232 668 MEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745 (837)
Q Consensus 668 mEy~~GGSL~dlLk~~--g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~std 745 (837)
|||+++++|.+++... ..++...+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~-- 158 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV-- 158 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcc--
Confidence 9999999999999753 458999999999999999999999999999999999999999999999999886310000
Q ss_pred CCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 003232 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEH 824 (837)
Q Consensus 746 dl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~~~d 824 (837)
.......++..|+|||++.+..++.++||||||+++|+|++ |+.||...+
T Consensus 159 -----------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~ 209 (261)
T cd05148 159 -----------------------------YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN 209 (261)
T ss_pred -----------------------------ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC
Confidence 00112345678999999998889999999999999999998 899997655
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=268.57 Aligned_cols=202 Identities=26% Similarity=0.459 Sum_probs=169.9
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEE
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyL 666 (837)
..++|+++++||+|+||.||+|.. .+++.||+|.+..... ....+.+|+.+++.++||||+++++.+. ....|+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYI 77 (260)
T ss_pred chHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEE
Confidence 346799999999999999999986 4678899999876432 2346889999999999999999998764 567899
Q ss_pred EEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCC
Q 003232 667 VMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~~--g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~st 744 (837)
+|||+.+++|.+++... ..++...+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 78 ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 99999999999998653 4588999999999999999999999999999999999999999999999998863110000
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 003232 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAE 823 (837)
Q Consensus 745 ddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~~~ 823 (837)
.......++..|+|||++.+..++.++||||||+++|++++ |+.||.+.
T Consensus 158 ------------------------------~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 207 (260)
T cd05067 158 ------------------------------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM 207 (260)
T ss_pred ------------------------------ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 00112345678999999998889999999999999999998 99999765
Q ss_pred C
Q 003232 824 H 824 (837)
Q Consensus 824 d 824 (837)
+
T Consensus 208 ~ 208 (260)
T cd05067 208 T 208 (260)
T ss_pred C
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=269.25 Aligned_cols=203 Identities=25% Similarity=0.383 Sum_probs=166.1
Q ss_pred EEEEEecccCceEEEEEEECCCCc--EEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecC------Ce
Q 003232 592 EIIKPISRGAFGRVFLAKKRTTGD--LFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR------EN 663 (837)
Q Consensus 592 eIlkkLGsG~FGtVYkArdk~tG~--~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~------~~ 663 (837)
.+.+.||+|+||.||+|.+..++. .+|+|.++... ......+.+.+|+.+++.++||||+++++.+... ..
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 466889999999999999877765 68999987643 2345567889999999999999999999876432 25
Q ss_pred EEEEEEecCCCCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCcc
Q 003232 664 LYLVMEYLNGGDLYSLLRN------LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 737 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk~------~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLAr 737 (837)
.+++|||+.+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 7899999999999988742 1347899999999999999999999999999999999999999999999999987
Q ss_pred ccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-C
Q 003232 738 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-G 816 (837)
Q Consensus 738 vg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-G 816 (837)
....... ........+++.|+|||++.+..++.++||||||+++|+|++ |
T Consensus 161 ~~~~~~~-----------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g 211 (272)
T cd05075 161 KIYNGDY-----------------------------YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRG 211 (272)
T ss_pred ccCcccc-----------------------------eecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCC
Confidence 3110000 000112345678999999999999999999999999999999 8
Q ss_pred CCCCCCCC
Q 003232 817 IPPFNAEH 824 (837)
Q Consensus 817 r~PF~~~d 824 (837)
..||....
T Consensus 212 ~~p~~~~~ 219 (272)
T cd05075 212 QTPYPGVE 219 (272)
T ss_pred CCCCCCCC
Confidence 99997643
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=302.85 Aligned_cols=207 Identities=36% Similarity=0.634 Sum_probs=186.7
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeE
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~l 664 (837)
......|.+.+.||+|.|+.|.++++..++..||||++.+.... ......+.+|+++|+.++||||++++.+......+
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln-~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~l 130 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLN-PSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATL 130 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccC-hHHHHHHHHHHHHHHhcCCcceeeeeeeeeeccee
Confidence 34456799999999999999999999999999999999987644 34444599999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCC
Q 003232 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~st 744 (837)
|+||||+.+|.+++++.+++...+..++.++.|+..|++|||+++|+|||||.+|||++.+.++||+|||++.+....
T Consensus 131 ylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~-- 208 (596)
T KOG0586|consen 131 YLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG-- 208 (596)
T ss_pred EEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999998752211
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCC-CchHHHHHHHHHHHHHHcCCCCCCCC
Q 003232 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVGIPPFNAE 823 (837)
Q Consensus 745 ddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~-s~kSDIWSLGVILyELLTGr~PF~~~ 823 (837)
....+.+|++.|.|||++.|..| ++.+|+||+|+++|-|+.|.+||.+.
T Consensus 209 ------------------------------~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~ 258 (596)
T KOG0586|consen 209 ------------------------------LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQ 258 (596)
T ss_pred ------------------------------ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCc
Confidence 12346799999999999999887 68999999999999999999999864
Q ss_pred C
Q 003232 824 H 824 (837)
Q Consensus 824 d 824 (837)
+
T Consensus 259 ~ 259 (596)
T KOG0586|consen 259 N 259 (596)
T ss_pred c
Confidence 3
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-32 Score=299.44 Aligned_cols=207 Identities=37% Similarity=0.657 Sum_probs=182.1
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeE
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~l 664 (837)
+.+..=|.+.+.||.|.|+.|-+|++.-+|..||||++.+..+ +......+..|++.|+.++|||||++|++......+
T Consensus 14 gkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKl-D~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKl 92 (864)
T KOG4717|consen 14 GKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKL 92 (864)
T ss_pred cceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEeccccc-chhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceE
Confidence 3444559999999999999999999999999999999988764 334446789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEc-cCCcEEEEecCCccccccC
Q 003232 665 YLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA-HDGHIKLTDFGLSKVGLIN 742 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd-~dG~IKLiDFGLArvg~~~ 742 (837)
|||+|+=++|+|++|+.++ ..+.+..+++|+.||+.|+.|+|...+|||||||+||.+. .-|-+||.|||++-.
T Consensus 93 yLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNk---- 168 (864)
T KOG4717|consen 93 YLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNK---- 168 (864)
T ss_pred EEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeecccccc----
Confidence 9999999999999999765 5599999999999999999999999999999999998764 579999999998741
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCC-chHHHHHHHHHHHHHHcCCCCCC
Q 003232 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHG-TTADWWSVGIILFELIVGIPPFN 821 (837)
Q Consensus 743 stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s-~kSDIWSLGVILyELLTGr~PF~ 821 (837)
+ ..+.+..+.||+..|.|||+++|..|+ +++||||||||||-|+||.+||.
T Consensus 169 ----f------------------------~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFq 220 (864)
T KOG4717|consen 169 ----F------------------------QPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQ 220 (864)
T ss_pred ----C------------------------CCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccc
Confidence 0 123455678999999999999999996 56799999999999999999997
Q ss_pred CCC
Q 003232 822 AEH 824 (837)
Q Consensus 822 ~~d 824 (837)
..+
T Consensus 221 eAN 223 (864)
T KOG4717|consen 221 EAN 223 (864)
T ss_pred ccc
Confidence 544
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=269.19 Aligned_cols=202 Identities=34% Similarity=0.658 Sum_probs=173.6
Q ss_pred CeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcC---CCceEEEEeEeecCCeEEE
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR---NPFVVRFFYSFTCRENLYL 666 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~Lr---HPNIVkL~gsf~d~~~lyL 666 (837)
.|++.+.||.|+||.||+|.+..+++.||+|++.... .......+.+|+.+++.++ |||++++++++.....+|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 4888899999999999999999999999999987542 2334457888999999986 9999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCC
Q 003232 667 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stdd 746 (837)
||||++|++|.+++.. +.+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--- 155 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--- 155 (277)
T ss_pred EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc---
Confidence 9999999999999866 478999999999999999999999999999999999999999999999999886311100
Q ss_pred CCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 747 l~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
.......|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||.....
T Consensus 156 ----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~ 207 (277)
T cd06917 156 ----------------------------SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA 207 (277)
T ss_pred ----------------------------cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 01123468889999999865 4568899999999999999999999976543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=267.47 Aligned_cols=202 Identities=28% Similarity=0.472 Sum_probs=169.4
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEE
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyL 666 (837)
..++|++.+.||.|+||.||+|.+. .+..+|+|.+...... ...+.+|+.+++.++||||+++++.+. ....|+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l 77 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYI 77 (260)
T ss_pred chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEE
Confidence 4467999999999999999999874 6677999998764321 246889999999999999999998875 456899
Q ss_pred EEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCC
Q 003232 667 VMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~~--g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~st 744 (837)
+|||+.+++|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 99999999999998753 3589999999999999999999999999999999999999999999999999863110000
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 003232 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAE 823 (837)
Q Consensus 745 ddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~~~ 823 (837)
.......++..|+|||++.+..++.++||||||+++|+|++ |.+||...
T Consensus 158 ------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~ 207 (260)
T cd05070 158 ------------------------------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM 207 (260)
T ss_pred ------------------------------ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence 00112235667999999998889999999999999999999 99999765
Q ss_pred C
Q 003232 824 H 824 (837)
Q Consensus 824 d 824 (837)
+
T Consensus 208 ~ 208 (260)
T cd05070 208 N 208 (260)
T ss_pred C
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=270.84 Aligned_cols=206 Identities=28% Similarity=0.450 Sum_probs=173.3
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCc----EEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCe
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGD----LFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCREN 663 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~----~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ 663 (837)
..+|++.+.||+|+||.||+|.++.+|. .+|+|.+..... ......+.+|+.+++.++||||+++++.+.. ..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 82 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ 82 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence 3579999999999999999999876665 589998876532 3445678899999999999999999998876 78
Q ss_pred EEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccC
Q 003232 664 LYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~ 742 (837)
.++||||+.+++|.+++... ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||+++.....
T Consensus 83 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred eEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 99999999999999999764 46899999999999999999999999999999999999999999999999998732100
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCC
Q 003232 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFN 821 (837)
Q Consensus 743 stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~ 821 (837)
... .......++..|+|||.+.+..++.++||||||+++|++++ |+.||.
T Consensus 163 ~~~-----------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 213 (279)
T cd05057 163 EKE-----------------------------YHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213 (279)
T ss_pred ccc-----------------------------eecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCC
Confidence 000 00111224568999999988889999999999999999998 999998
Q ss_pred CCCc
Q 003232 822 AEHP 825 (837)
Q Consensus 822 ~~dp 825 (837)
...+
T Consensus 214 ~~~~ 217 (279)
T cd05057 214 GIPA 217 (279)
T ss_pred CCCH
Confidence 7653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=257.88 Aligned_cols=206 Identities=36% Similarity=0.611 Sum_probs=180.6
Q ss_pred CeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecC--CeEEEE
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR--ENLYLV 667 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~--~~lyLV 667 (837)
+|++.+.||.|++|.||+|.+..+++.|++|++..... .....+.+.+|+.++++++||||+++++.+... ..+++|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD-SEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 48889999999999999999998999999999976542 245567899999999999999999999999988 899999
Q ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCC
Q 003232 668 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (837)
Q Consensus 668 mEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl 747 (837)
|||+++++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-- 157 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG-- 157 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc--
Confidence 999999999999988778999999999999999999999999999999999999999999999999988642111100
Q ss_pred CCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 748 ~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
.......++..|+|||.+.+...+.++||||||+++|+|++|..||.....
T Consensus 158 ---------------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 208 (260)
T cd06606 158 ---------------------------EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN 208 (260)
T ss_pred ---------------------------ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 011234678899999999988899999999999999999999999987763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=275.40 Aligned_cols=209 Identities=24% Similarity=0.432 Sum_probs=172.8
Q ss_pred CcccCCeEEEEEecccCceEEEEEEEC-------CCCcEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEe
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKR-------TTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFY 656 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk-------~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~g 656 (837)
....++|.+.+.||.|+||.||+|++. ..+..||+|.+.... .......+.+|+.+++.+ +||||+++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 88 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 88 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeE
Confidence 445577999999999999999999753 234579999987532 234456789999999999 8999999999
Q ss_pred EeecCCeEEEEEEecCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcE
Q 003232 657 SFTCRENLYLVMEYLNGGDLYSLLRNL----------------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNL 720 (837)
Q Consensus 657 sf~d~~~lyLVmEy~~GGSL~dlLk~~----------------g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNI 720 (837)
.+.....+|+||||+++++|.+++... ..++...+..++.||+.||.|||++|++||||||+||
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 168 (304)
T cd05101 89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV 168 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence 999999999999999999999999753 2367788899999999999999999999999999999
Q ss_pred EEccCCcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCch
Q 003232 721 LIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT 800 (837)
Q Consensus 721 LLd~dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~k 800 (837)
+++.++.++|+|||+++....... ........+++.|+|||++.+..++.+
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~ 219 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDY-----------------------------YKKTTNGRLPVKWMAPEALFDRVYTHQ 219 (304)
T ss_pred EEcCCCcEEECCCccceecccccc-----------------------------cccccCCCCCceeeCchhhccCCCCch
Confidence 999999999999999873110000 001122346678999999999889999
Q ss_pred HHHHHHHHHHHHHHc-CCCCCCCCC
Q 003232 801 ADWWSVGIILFELIV-GIPPFNAEH 824 (837)
Q Consensus 801 SDIWSLGVILyELLT-Gr~PF~~~d 824 (837)
+||||||+++|+|++ |..||.+.+
T Consensus 220 ~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 220 SDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred hhHHHHHHHHHHHHcCCCCCcccCC
Confidence 999999999999998 888987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=266.97 Aligned_cols=200 Identities=26% Similarity=0.389 Sum_probs=167.2
Q ss_pred EEecccCceEEEEEEECCCC---cEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEEec
Q 003232 595 KPISRGAFGRVFLAKKRTTG---DLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYL 671 (837)
Q Consensus 595 kkLGsG~FGtVYkArdk~tG---~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmEy~ 671 (837)
++||.|+||.||+|.+...+ ..+|+|.+...... ...+.+.+|+.+++.+.||||+++++++. ....++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 36899999999999876555 78999999865432 44567899999999999999999999765 45689999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCCC
Q 003232 672 NGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 751 (837)
Q Consensus 672 ~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~ 751 (837)
++++|.+++...+.+++..+..++.|++.||.|||+.|++|+||||+|||++.++.++|+|||+++........
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~------ 151 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY------ 151 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcc------
Confidence 99999999988778999999999999999999999999999999999999999999999999998631110000
Q ss_pred ccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCc
Q 003232 752 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHP 825 (837)
Q Consensus 752 ~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~~~dp 825 (837)
........++..|+|||.+.+..++.++||||||+++|+|++ |..||...++
T Consensus 152 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~ 204 (257)
T cd05060 152 ----------------------YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG 204 (257)
T ss_pred ----------------------cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH
Confidence 000111234567999999999999999999999999999997 9999976543
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=273.06 Aligned_cols=204 Identities=30% Similarity=0.481 Sum_probs=171.6
Q ss_pred CCeEEEEEecccCceEEEEEEEC-----CCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCe
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKR-----TTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCREN 663 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk-----~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ 663 (837)
.+|.+.++||.|+||.||++... .++..+|+|.+.... ......+.+|+++++.++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRP 81 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCc
Confidence 56889999999999999999753 346689999887532 3445678999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcE
Q 003232 664 LYLVMEYLNGGDLYSLLRNLG---------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHI 728 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk~~g---------------~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~I 728 (837)
.|++|||+.+++|.+++...+ .+++..+..++.||+.||.|||++|++|+||||+|||++.++.+
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCE
Confidence 999999999999999987643 47889999999999999999999999999999999999999999
Q ss_pred EEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHH
Q 003232 729 KLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGI 808 (837)
Q Consensus 729 KLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGV 808 (837)
+|+|||++........ ........+++.|+|||++.+..++.++|||||||
T Consensus 162 kL~dfg~~~~~~~~~~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 212 (280)
T cd05092 162 KIGDFGMSRDIYSTDY-----------------------------YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGV 212 (280)
T ss_pred EECCCCceeEcCCCce-----------------------------eecCCCccccccccCHHHhccCCcCchhhHHHHHH
Confidence 9999999863110000 00112234567899999999999999999999999
Q ss_pred HHHHHHc-CCCCCCCCC
Q 003232 809 ILFELIV-GIPPFNAEH 824 (837)
Q Consensus 809 ILyELLT-Gr~PF~~~d 824 (837)
++|+|++ |.+||....
T Consensus 213 il~el~~~g~~p~~~~~ 229 (280)
T cd05092 213 VLWEIFTYGKQPWYQLS 229 (280)
T ss_pred HHHHHHcCCCCCCccCC
Confidence 9999998 999996543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=270.01 Aligned_cols=204 Identities=33% Similarity=0.532 Sum_probs=169.9
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLV 667 (837)
+++|++.+.||.|++|+||+|.++.+++.||+|.+..... .......+.+|+.+++.++||||+++++++....+.|+|
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence 3679999999999999999999999999999999865432 223345678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEcc-CCcEEEEecCCccccccCCC
Q 003232 668 MEYLNGGDLYSLLRNLGC--LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH-DGHIKLTDFGLSKVGLINST 744 (837)
Q Consensus 668 mEy~~GGSL~dlLk~~g~--Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~-dG~IKLiDFGLArvg~~~st 744 (837)
|||++ ++|.+++..... +++..+..++.||+.||.|||++|++|+||+|+||+++. ++.++|+|||++.......
T Consensus 80 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~- 157 (294)
T PLN00009 80 FEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV- 157 (294)
T ss_pred Eeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc-
Confidence 99995 588888765433 578888999999999999999999999999999999985 5679999999986311000
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003232 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAE 823 (837)
Q Consensus 745 ddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLTGr~PF~~~ 823 (837)
.......|++.|+|||++.+ ..++.++||||||+++|+|++|.+||...
T Consensus 158 ------------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~ 207 (294)
T PLN00009 158 ------------------------------RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGD 207 (294)
T ss_pred ------------------------------cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 00122357889999999876 45789999999999999999999999765
Q ss_pred C
Q 003232 824 H 824 (837)
Q Consensus 824 d 824 (837)
+
T Consensus 208 ~ 208 (294)
T PLN00009 208 S 208 (294)
T ss_pred C
Confidence 4
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-33 Score=300.18 Aligned_cols=213 Identities=39% Similarity=0.797 Sum_probs=193.2
Q ss_pred CCcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEeEeecCC
Q 003232 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRE 662 (837)
Q Consensus 584 ~g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~gsf~d~~ 662 (837)
......+|..+.+||+|+||.|-++..+.+.+.||||+++++-+.+.+..+-.+.|-++|... +-|++++++..|+.-+
T Consensus 344 d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD 423 (683)
T KOG0696|consen 344 DRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD 423 (683)
T ss_pred cceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh
Confidence 445567899999999999999999999999999999999998888888888888899999876 5679999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccC
Q 003232 663 NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (837)
Q Consensus 663 ~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~ 742 (837)
.+|+||||+.||+|.-.++..+.+.+..+..|+.+|+-||-+||++|||.||||.+|||++.+|++||+|||+++-...
T Consensus 424 RLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~- 502 (683)
T KOG0696|consen 424 RLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF- 502 (683)
T ss_pred heeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccccc-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999983111
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003232 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNA 822 (837)
Q Consensus 743 stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~ 822 (837)
....+.+.+|||.|+|||++...+|+..+|+||+||+|||||.|.+||.+
T Consensus 503 ------------------------------~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG 552 (683)
T KOG0696|consen 503 ------------------------------DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG 552 (683)
T ss_pred ------------------------------CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC
Confidence 11234678999999999999999999999999999999999999999999
Q ss_pred CCcCH
Q 003232 823 EHPQV 827 (837)
Q Consensus 823 ~dpdv 827 (837)
++.+.
T Consensus 553 eDE~e 557 (683)
T KOG0696|consen 553 EDEDE 557 (683)
T ss_pred CCHHH
Confidence 87553
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=268.30 Aligned_cols=202 Identities=27% Similarity=0.443 Sum_probs=168.5
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLV 667 (837)
.++|++.++||.|+||.||+|.+..+ ..||+|++..... ....+.+|+.+++.++||||+++++.+. ....|+|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv 78 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIV 78 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEE
Confidence 35699999999999999999998654 4699999975332 2246788999999999999999998774 4568999
Q ss_pred EEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCC
Q 003232 668 MEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745 (837)
Q Consensus 668 mEy~~GGSL~dlLk~~--g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~std 745 (837)
|||+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+.......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~-- 156 (262)
T cd05071 79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-- 156 (262)
T ss_pred EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc--
Confidence 9999999999999753 347889999999999999999999999999999999999999999999999886311000
Q ss_pred CCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 003232 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEH 824 (837)
Q Consensus 746 dl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~~~d 824 (837)
........++..|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus 157 ----------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~ 208 (262)
T cd05071 157 ----------------------------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 208 (262)
T ss_pred ----------------------------cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 000112346778999999998889999999999999999999 889997654
Q ss_pred c
Q 003232 825 P 825 (837)
Q Consensus 825 p 825 (837)
+
T Consensus 209 ~ 209 (262)
T cd05071 209 N 209 (262)
T ss_pred h
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=256.87 Aligned_cols=200 Identities=38% Similarity=0.656 Sum_probs=177.1
Q ss_pred CeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEE
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmE 669 (837)
+|++.+.||.|++|.||++.+..+++.+++|++..... .....+.+|+.+++.++||||+++++.+......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 48899999999999999999988999999999976532 355688999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCC
Q 003232 670 YLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (837)
Q Consensus 670 y~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~ 748 (837)
|+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~----- 152 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK----- 152 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccc-----
Confidence 99999999999775 579999999999999999999999999999999999999999999999999876310000
Q ss_pred CCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 749 ~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+
T Consensus 153 ---------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 201 (253)
T cd05122 153 ---------------------------ARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELP 201 (253)
T ss_pred ---------------------------cccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCc
Confidence 0123467889999999998888999999999999999999999998763
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=276.31 Aligned_cols=208 Identities=26% Similarity=0.424 Sum_probs=171.3
Q ss_pred cccCCeEEEEEecccCceEEEEEEECC-------CCcEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEeE
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRT-------TGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYS 657 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~-------tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~gs 657 (837)
...++|.+.+.||.|+||.||+|++.. ....+|+|.+.... .......+.+|+.+++.+ +||||++++++
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGV 86 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEE
Confidence 344679999999999999999998642 34579999987532 234456788999999999 69999999999
Q ss_pred eecCCeEEEEEEecCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEE
Q 003232 658 FTCRENLYLVMEYLNGGDLYSLLRNL----------------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLL 721 (837)
Q Consensus 658 f~d~~~lyLVmEy~~GGSL~dlLk~~----------------g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNIL 721 (837)
+.....+|+||||+++++|.+++... ..++...+..++.||+.||.|||++|++|+||||+|||
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil 166 (314)
T cd05099 87 CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVL 166 (314)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEE
Confidence 99989999999999999999999653 24788889999999999999999999999999999999
Q ss_pred EccCCcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchH
Q 003232 722 IAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA 801 (837)
Q Consensus 722 Ld~dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kS 801 (837)
++.++.++|+|||+++....... ........++..|+|||++.+..++.++
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 217 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDY-----------------------------YKKTSNGRLPVKWMAPEALFDRVYTHQS 217 (314)
T ss_pred EcCCCcEEEcccccccccccccc-----------------------------ccccccCCCCccccCHHHHccCCcCccc
Confidence 99999999999999863110000 0001112345679999999998999999
Q ss_pred HHHHHHHHHHHHHc-CCCCCCCCC
Q 003232 802 DWWSVGIILFELIV-GIPPFNAEH 824 (837)
Q Consensus 802 DIWSLGVILyELLT-Gr~PF~~~d 824 (837)
||||||+++|+|++ |..||.+..
T Consensus 218 DiwslG~~l~el~~~g~~p~~~~~ 241 (314)
T cd05099 218 DVWSFGILMWEIFTLGGSPYPGIP 241 (314)
T ss_pred hhhHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999998 899997654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-31 Score=270.35 Aligned_cols=212 Identities=28% Similarity=0.458 Sum_probs=171.9
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC--
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE-- 662 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~-- 662 (837)
....++|++.+.||.|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++++....
T Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (310)
T cd07865 8 CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATP 86 (310)
T ss_pred cchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCCCCCccceEEEEeccccc
Confidence 4556789999999999999999999999999999999865331 1222345668999999999999999999876543
Q ss_pred ------eEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCC
Q 003232 663 ------NLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGL 735 (837)
Q Consensus 663 ------~lyLVmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGL 735 (837)
..|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 87 YNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCC
Confidence 4699999995 5888877654 3689999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCC-CCCchHHHHHHHHHHHHHH
Q 003232 736 SKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELI 814 (837)
Q Consensus 736 Arvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~-~~s~kSDIWSLGVILyELL 814 (837)
+.......... ........++..|+|||++.+. .++.++||||||+++|+|+
T Consensus 166 ~~~~~~~~~~~---------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~ 218 (310)
T cd07865 166 ARAFSLSKNSK---------------------------PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMW 218 (310)
T ss_pred cccccCCcccC---------------------------CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHH
Confidence 86321110000 0011234578899999998764 4688999999999999999
Q ss_pred cCCCCCCCCCc
Q 003232 815 VGIPPFNAEHP 825 (837)
Q Consensus 815 TGr~PF~~~dp 825 (837)
+|..||.+.++
T Consensus 219 t~~~~~~~~~~ 229 (310)
T cd07865 219 TRSPIMQGNTE 229 (310)
T ss_pred hCCCCCCCCCH
Confidence 99999987654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=269.52 Aligned_cols=202 Identities=30% Similarity=0.557 Sum_probs=170.3
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEeEeec------
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTC------ 660 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~gsf~d------ 660 (837)
.+.|++.+.||.|+||.||+|.+..+++.+|+|++.... .....+..|+.+++++ +||||+++++.+..
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 357999999999999999999999999999999986532 2335678899999888 79999999999853
Q ss_pred CCeEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccc
Q 003232 661 RENLYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (837)
Q Consensus 661 ~~~lyLVmEy~~GGSL~dlLk~~--g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArv 738 (837)
...+|++|||+.+++|.+++... ..+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++..
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~ 170 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 170 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence 45789999999999999998653 4588888999999999999999999999999999999999999999999998763
Q ss_pred cccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhc-----CCCCCchHHHHHHHHHHHHH
Q 003232 739 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-----GTGHGTTADWWSVGIILFEL 813 (837)
Q Consensus 739 g~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLl-----g~~~s~kSDIWSLGVILyEL 813 (837)
.... ........|++.|+|||++. +..++.++|||||||++|+|
T Consensus 171 ~~~~-------------------------------~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el 219 (282)
T cd06636 171 LDRT-------------------------------VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEM 219 (282)
T ss_pred hhcc-------------------------------ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHH
Confidence 1000 00112356889999999986 35678899999999999999
Q ss_pred HcCCCCCCCCC
Q 003232 814 IVGIPPFNAEH 824 (837)
Q Consensus 814 LTGr~PF~~~d 824 (837)
++|..||....
T Consensus 220 ~~g~~p~~~~~ 230 (282)
T cd06636 220 AEGAPPLCDMH 230 (282)
T ss_pred HhCCCCccccC
Confidence 99999997644
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-31 Score=274.91 Aligned_cols=211 Identities=26% Similarity=0.381 Sum_probs=175.7
Q ss_pred CCcccCCeEEEEEecccCceEEEEEEEC-----CCCcEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEeE
Q 003232 584 DRTSIDDFEIIKPISRGAFGRVFLAKKR-----TTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYS 657 (837)
Q Consensus 584 ~g~~lddYeIlkkLGsG~FGtVYkArdk-----~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~gs 657 (837)
+....++|.+.+.||.|+||.||++.+. .++..+|+|.++... .....+.+.+|+.+++++ +||||+++++.
T Consensus 30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 107 (302)
T cd05055 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGA 107 (302)
T ss_pred ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence 3445567999999999999999999852 345689999987542 233456789999999999 79999999999
Q ss_pred eecCCeEEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCC
Q 003232 658 FTCRENLYLVMEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGL 735 (837)
Q Consensus 658 f~d~~~lyLVmEy~~GGSL~dlLk~~g--~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGL 735 (837)
+......|+||||+.+++|.+++.... .+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||+
T Consensus 108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcc
Confidence 999999999999999999999997543 389999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc
Q 003232 736 SKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV 815 (837)
Q Consensus 736 Arvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT 815 (837)
++....... ........++..|+|||++.+..++.++|||||||++|+|++
T Consensus 188 ~~~~~~~~~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t 238 (302)
T cd05055 188 ARDIMNDSN-----------------------------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238 (302)
T ss_pred cccccCCCc-----------------------------eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHh
Confidence 863111000 000112346778999999999999999999999999999998
Q ss_pred -CCCCCCCCCc
Q 003232 816 -GIPPFNAEHP 825 (837)
Q Consensus 816 -Gr~PF~~~dp 825 (837)
|..||.....
T Consensus 239 ~g~~p~~~~~~ 249 (302)
T cd05055 239 LGSNPYPGMPV 249 (302)
T ss_pred CCCCCcCCCCc
Confidence 9999976553
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-31 Score=315.16 Aligned_cols=207 Identities=33% Similarity=0.638 Sum_probs=173.4
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeec--CC
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC--RE 662 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d--~~ 662 (837)
...+++|++++.||.|+||+||+|++..++..||+|++..... .......+..|+.+++.++||||++++++|.. ..
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 3455789999999999999999999999999999999876442 33445678999999999999999999998865 45
Q ss_pred eEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-------CcccccCCCCcEEEcc-------
Q 003232 663 NLYLVMEYLNGGDLYSLLRN----LGCLDEDVARVYIAEVVLALEYLHSL-------RVVHRDLKPDNLLIAH------- 724 (837)
Q Consensus 663 ~lyLVmEy~~GGSL~dlLk~----~g~Lsee~irkIl~QIa~ALsYLHSk-------GIIHRDIKPeNILLd~------- 724 (837)
.+||||||+++++|.+++.. .+.+++..++.|+.||+.||.|||+. +||||||||+|||++.
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 79999999999999999864 25699999999999999999999984 4999999999999964
Q ss_pred ----------CCcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC
Q 003232 725 ----------DGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG 794 (837)
Q Consensus 725 ----------dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg 794 (837)
.+.++|+|||++...... .......||+.|+|||++.+
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~--------------------------------s~~~s~vGTp~YmAPEvL~g 215 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIE--------------------------------SMAHSCVGTPYYWSPELLLH 215 (1021)
T ss_pred ccccccccCCCCceEEccCCcccccccc--------------------------------ccccccCCCccccCHHHHhc
Confidence 235899999998631000 00123479999999999965
Q ss_pred --CCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 795 --TGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 795 --~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
..++.++|||||||+||+|++|..||....
T Consensus 216 e~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 216 ETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred cCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 457899999999999999999999997543
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=265.61 Aligned_cols=199 Identities=27% Similarity=0.397 Sum_probs=168.0
Q ss_pred EEecccCceEEEEEEECC-CCc--EEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEEec
Q 003232 595 KPISRGAFGRVFLAKKRT-TGD--LFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYL 671 (837)
Q Consensus 595 kkLGsG~FGtVYkArdk~-tG~--~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmEy~ 671 (837)
+.||.|++|.||+|.+.. .++ .||+|.+...... ...+.+.+|+.++++++||||+++++.+.. ..+++||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 368999999999999865 333 6999999875432 566789999999999999999999999988 8899999999
Q ss_pred CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCC
Q 003232 672 NGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 749 (837)
Q Consensus 672 ~GGSL~dlLk~~g--~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~ 749 (837)
++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||+++........
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~---- 153 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH---- 153 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccc----
Confidence 9999999997654 6899999999999999999999999999999999999999999999999998742110000
Q ss_pred CCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 003232 750 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEH 824 (837)
Q Consensus 750 p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~~~d 824 (837)
........++..|+|||++.+..++.++|||||||++|+|++ |..||...+
T Consensus 154 ------------------------~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 205 (257)
T cd05040 154 ------------------------YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS 205 (257)
T ss_pred ------------------------eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCC
Confidence 000113457788999999999899999999999999999998 999996543
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=268.19 Aligned_cols=198 Identities=24% Similarity=0.343 Sum_probs=159.5
Q ss_pred EecccCceEEEEEEECC--CCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEEecCC
Q 003232 596 PISRGAFGRVFLAKKRT--TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 673 (837)
Q Consensus 596 kLGsG~FGtVYkArdk~--tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmEy~~G 673 (837)
.||.|+||.||+|.... ....+++|.+.... .......+.+|+.+++.++||||+++++.+.....+|+||||+++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 58999999999997533 34578888776432 234456788999999999999999999999999999999999999
Q ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCC
Q 003232 674 GDLYSLLRNLG-----CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (837)
Q Consensus 674 GSL~dlLk~~g-----~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~ 748 (837)
++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~---- 155 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY---- 155 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchh----
Confidence 99999997642 246778889999999999999999999999999999999999999999998762100000
Q ss_pred CCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-------CCCCchHHHHHHHHHHHHHHc-CCCCC
Q 003232 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-------TGHGTTADWWSVGIILFELIV-GIPPF 820 (837)
Q Consensus 749 ~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-------~~~s~kSDIWSLGVILyELLT-Gr~PF 820 (837)
........+++.|+|||++.. ..++.++|||||||++|+|++ |..||
T Consensus 156 -------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~ 210 (269)
T cd05042 156 -------------------------YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPY 210 (269)
T ss_pred -------------------------eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCC
Confidence 000123346778999999743 456789999999999999998 88898
Q ss_pred CCCC
Q 003232 821 NAEH 824 (837)
Q Consensus 821 ~~~d 824 (837)
....
T Consensus 211 ~~~~ 214 (269)
T cd05042 211 PDLS 214 (269)
T ss_pred CcCC
Confidence 7654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=259.59 Aligned_cols=203 Identities=35% Similarity=0.664 Sum_probs=179.3
Q ss_pred CeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEE
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmE 669 (837)
+|++.+.||.|++|.||++.+..+++.|++|.+..... .......+.+|+++++.++|||++++++.+.....++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI-KEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc-CHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 48899999999999999999998999999999987542 23456789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCC
Q 003232 670 YLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 749 (837)
Q Consensus 670 y~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~ 749 (837)
|+++++|.+++...+.+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~----- 154 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK----- 154 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc-----
Confidence 999999999998888899999999999999999999999999999999999999999999999999873110000
Q ss_pred CCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 750 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 750 p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
......|+..|+|||.+.+..++.++||||||+++|+|++|..||...+
T Consensus 155 --------------------------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~ 203 (254)
T cd06627 155 --------------------------DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN 203 (254)
T ss_pred --------------------------cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc
Confidence 0123457889999999988888999999999999999999999997654
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=268.50 Aligned_cols=204 Identities=29% Similarity=0.452 Sum_probs=173.0
Q ss_pred CCeEEEEEecccCceEEEEEEECC-----CCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCe
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRT-----TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCREN 663 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~-----tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ 663 (837)
++|++++.||.|+||.||+|+.+. +.+.+++|.+.... .......+.+|++++++++||||+++++.+.....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 569999999999999999999754 34679999886532 23355678999999999999999999999999899
Q ss_pred EEEEEEecCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecC
Q 003232 664 LYLVMEYLNGGDLYSLLRNLG---------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFG 734 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk~~g---------~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFG 734 (837)
.|+||||+++++|.+++.... .+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~ 162 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLS 162 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccc
Confidence 999999999999999997655 68999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHH
Q 003232 735 LSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI 814 (837)
Q Consensus 735 LArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELL 814 (837)
++....... ........++..|+|||.+.+..++.++||||||+++|+|+
T Consensus 163 ~~~~~~~~~------------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~ 212 (275)
T cd05046 163 LSKDVYNSE------------------------------YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVF 212 (275)
T ss_pred cccccCccc------------------------------ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHH
Confidence 876210000 00112335677899999998888899999999999999999
Q ss_pred c-CCCCCCCCC
Q 003232 815 V-GIPPFNAEH 824 (837)
Q Consensus 815 T-Gr~PF~~~d 824 (837)
+ |..||....
T Consensus 213 ~~~~~p~~~~~ 223 (275)
T cd05046 213 TQGELPFYGLS 223 (275)
T ss_pred hCCCCCccccc
Confidence 8 889996543
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=273.43 Aligned_cols=204 Identities=31% Similarity=0.512 Sum_probs=172.4
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecC--CeEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR--ENLY 665 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~--~~ly 665 (837)
.++|++.+.||.|+||.||+|.+..+++.+++|.++..... ......+.+|+.+++.++||||+++++++... ..+|
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 46799999999999999999999989999999999754322 23334677899999999999999999998877 8899
Q ss_pred EEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCC
Q 003232 666 LVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (837)
Q Consensus 666 LVmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~st 744 (837)
+||||+. ++|.+++... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 83 lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~- 160 (293)
T cd07843 83 MVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL- 160 (293)
T ss_pred EEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc-
Confidence 9999996 5999988764 458999999999999999999999999999999999999999999999999886311000
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003232 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAE 823 (837)
Q Consensus 745 ddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~-~~s~kSDIWSLGVILyELLTGr~PF~~~ 823 (837)
.......+++.|+|||.+.+. .++.++||||||+++|+|++|.+||...
T Consensus 161 ------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~ 210 (293)
T cd07843 161 ------------------------------KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGK 210 (293)
T ss_pred ------------------------------cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 001223568889999998764 4688999999999999999999999865
Q ss_pred C
Q 003232 824 H 824 (837)
Q Consensus 824 d 824 (837)
+
T Consensus 211 ~ 211 (293)
T cd07843 211 S 211 (293)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=267.62 Aligned_cols=202 Identities=30% Similarity=0.474 Sum_probs=167.1
Q ss_pred CCeEEEEEecccCceEEEEEEE----CCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeec--CC
Q 003232 589 DDFEIIKPISRGAFGRVFLAKK----RTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC--RE 662 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArd----k~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d--~~ 662 (837)
.+|++++.||.|+||+||++.. ..++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 4699999999999999999974 4578899999987542 3445678899999999999999999987643 35
Q ss_pred eEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCcccccc
Q 003232 663 NLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 741 (837)
Q Consensus 663 ~lyLVmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~ 741 (837)
.+|+||||+++++|.+++... ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 689999999999999999754 4689999999999999999999999999999999999999999999999999873211
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCC
Q 003232 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFN 821 (837)
Q Consensus 742 ~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~ 821 (837)
.... ........++..|+|||++.+..++.++||||||+++|+|++|..|+.
T Consensus 161 ~~~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~ 212 (284)
T cd05081 161 DKEY----------------------------YKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSC 212 (284)
T ss_pred CCcc----------------------------eeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCC
Confidence 0000 000011224456999999999899999999999999999999877754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=274.19 Aligned_cols=201 Identities=34% Similarity=0.630 Sum_probs=174.3
Q ss_pred CeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEE
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmE 669 (837)
.|++++.||.|+||.||+|.+..++..||+|.+.... .......+.+|+.+++.++||||+++++.+.....+|+|||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc--chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 4777788999999999999998899999999987543 23345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCC
Q 003232 670 YLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 749 (837)
Q Consensus 670 y~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~ 749 (837)
|+++++|.+++.. +.+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~------- 154 (277)
T cd06642 83 YLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT------- 154 (277)
T ss_pred ccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCc-------
Confidence 9999999998865 56899999999999999999999999999999999999999999999999987631000
Q ss_pred CCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 750 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 750 p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
........|+..|+|||++.+..++.++|+||||+++|+|++|..||....
T Consensus 155 ------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 205 (277)
T cd06642 155 ------------------------QIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLH 205 (277)
T ss_pred ------------------------chhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccc
Confidence 001123457889999999999889999999999999999999999997543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=269.93 Aligned_cols=202 Identities=33% Similarity=0.571 Sum_probs=171.1
Q ss_pred CeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEE
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmE 669 (837)
+|++++.||.|++|.||+|++..+++.||+|.+..... .......+.+|+.++++++||||+++++++......++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 48999999999999999999999999999999875431 22233568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCC
Q 003232 670 YLNGGDLYSLLRN--LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (837)
Q Consensus 670 y~~GGSL~dlLk~--~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl 747 (837)
|+. ++|..++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~---- 154 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---- 154 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc----
Confidence 995 689888865 3568999999999999999999999999999999999999999999999999876311000
Q ss_pred CCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCC-CCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 748 ~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~-~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
.......+++.|+|||++.+.. ++.++||||||+++|+|+||+.||...+
T Consensus 155 ---------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 205 (284)
T cd07860 155 ---------------------------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 205 (284)
T ss_pred ---------------------------cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 0012235688899999887644 5889999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=308.12 Aligned_cols=210 Identities=28% Similarity=0.492 Sum_probs=173.6
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcC-CCceEEEEeEeec-------
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTC------- 660 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~Lr-HPNIVkL~gsf~d------- 660 (837)
.+++|.+.|.+|||+.||+|++...|..||+|.+-.. ++...+.+.+|+.+|+.|+ |+|||.|++....
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 3589999999999999999999888899999998764 5778889999999999997 9999999994322
Q ss_pred CCeEEEEEEecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCCCCcEEEccCCcEEEEecCCc
Q 003232 661 RENLYLVMEYLNGGDLYSLLRN--LGCLDEDVARVYIAEVVLALEYLHSLR--VVHRDLKPDNLLIAHDGHIKLTDFGLS 736 (837)
Q Consensus 661 ~~~lyLVmEy~~GGSL~dlLk~--~g~Lsee~irkIl~QIa~ALsYLHSkG--IIHRDIKPeNILLd~dG~IKLiDFGLA 736 (837)
...++|.||||.||+|-+++.. ...|++.++++|+.|+++|+.+||.+. |||||||-+||||..+|+.||||||.+
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 1347899999999999999974 345999999999999999999999987 999999999999999999999999998
Q ss_pred cccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhh---cCCCCCchHHHHHHHHHHHHH
Q 003232 737 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEIL---LGTGHGTTADWWSVGIILFEL 813 (837)
Q Consensus 737 rvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVL---lg~~~s~kSDIWSLGVILyEL 813 (837)
... +..+. ....+.. ........-|+.|+|||++ .+.+.+.|+|||+|||+||.|
T Consensus 194 tt~-------~~~~~---------~~~e~~~------ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkL 251 (738)
T KOG1989|consen 194 TTK-------ILSPT---------SAQEVNY------VEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKL 251 (738)
T ss_pred ccc-------cCCCc---------cHHHHHH------HHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHH
Confidence 631 11110 0111111 1112233468999999997 578899999999999999999
Q ss_pred HcCCCCCCCC
Q 003232 814 IVGIPPFNAE 823 (837)
Q Consensus 814 LTGr~PF~~~ 823 (837)
++...||...
T Consensus 252 Cy~t~PFe~s 261 (738)
T KOG1989|consen 252 CYFTTPFEES 261 (738)
T ss_pred HHhCCCcCcC
Confidence 9999999865
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=268.03 Aligned_cols=200 Identities=32% Similarity=0.554 Sum_probs=172.8
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecC--CeEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR--ENLYL 666 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~--~~lyL 666 (837)
++|+..+.||.|++|.||++.+..+++.+|+|.+.... .......+.+|+++++.++||||+++++.+... ..+|+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC--chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 46999999999999999999999999999999987543 224456789999999999999999999988653 47899
Q ss_pred EEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccC
Q 003232 667 VMEYLNGGDLYSLLRN----LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~----~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~ 742 (837)
||||++|++|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999999988643 345889999999999999999999999999999999999999999999999987521000
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003232 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNA 822 (837)
Q Consensus 743 stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~ 822 (837)
......++..|+|||.+.+..++.++||||||+++|+|++|..||..
T Consensus 159 ---------------------------------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 205 (287)
T cd06621 159 ---------------------------------LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPP 205 (287)
T ss_pred ---------------------------------ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCc
Confidence 01123567889999999999999999999999999999999999987
Q ss_pred C
Q 003232 823 E 823 (837)
Q Consensus 823 ~ 823 (837)
.
T Consensus 206 ~ 206 (287)
T cd06621 206 E 206 (287)
T ss_pred c
Confidence 6
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=269.07 Aligned_cols=203 Identities=32% Similarity=0.517 Sum_probs=168.1
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcC-CCceEEEEeEeecCCe----
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCREN---- 663 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~Lr-HPNIVkL~gsf~d~~~---- 663 (837)
++|++.+.||.|+||.||+|.+..+++.||+|.+.... ........+.+|+.+++.+. ||||+++++.+.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEM-DEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhc-cccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 46999999999999999999999999999999986543 22223356788999999995 6999999998887665
Q ss_pred -EEEEEEecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEcc-CCcEEEEecCCc
Q 003232 664 -LYLVMEYLNGGDLYSLLRNL-----GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH-DGHIKLTDFGLS 736 (837)
Q Consensus 664 -lyLVmEy~~GGSL~dlLk~~-----g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~-dG~IKLiDFGLA 736 (837)
.|+||||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||+|+||+++. ++.++|+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999975 898887542 35799999999999999999999999999999999999998 889999999988
Q ss_pred cccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHc
Q 003232 737 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIV 815 (837)
Q Consensus 737 rvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLT 815 (837)
....... .......+++.|+|||++.+ ..++.++||||||+++|+|++
T Consensus 159 ~~~~~~~-------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~ 207 (295)
T cd07837 159 RAFSIPV-------------------------------KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSR 207 (295)
T ss_pred eecCCCc-------------------------------cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHc
Confidence 6311000 00112356788999999865 457899999999999999999
Q ss_pred CCCCCCCCC
Q 003232 816 GIPPFNAEH 824 (837)
Q Consensus 816 Gr~PF~~~d 824 (837)
|..||.+.+
T Consensus 208 g~~~~~~~~ 216 (295)
T cd07837 208 KQPLFPGDS 216 (295)
T ss_pred CCCCCCCCC
Confidence 999997654
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=274.60 Aligned_cols=205 Identities=26% Similarity=0.428 Sum_probs=170.1
Q ss_pred CCeEEEEEecccCceEEEEEEECCCC--------------cEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTG--------------DLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRF 654 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG--------------~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL 654 (837)
++|++.+.||+|+||.||++++..++ ..||+|.++... .......+.+|+++++.++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 57999999999999999999875432 358999987542 23445678999999999999999999
Q ss_pred EeEeecCCeEEEEEEecCCCCHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEE
Q 003232 655 FYSFTCRENLYLVMEYLNGGDLYSLLRNLG------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI 722 (837)
Q Consensus 655 ~gsf~d~~~lyLVmEy~~GGSL~dlLk~~g------------~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILL 722 (837)
++++......|+||||+.+++|.+++.... .++...+..++.|++.||.|||+.|++|+||||+||++
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill 162 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV 162 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEE
Confidence 999999999999999999999999986432 36788889999999999999999999999999999999
Q ss_pred ccCCcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHH
Q 003232 723 AHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTAD 802 (837)
Q Consensus 723 d~dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSD 802 (837)
+.++.++|+|||++........ ........++..|+|||++.+..++.++|
T Consensus 163 ~~~~~~kl~dfg~~~~~~~~~~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 213 (295)
T cd05097 163 GNHYTIKIADFGMSRNLYSGDY-----------------------------YRIQGRAVLPIRWMAWESILLGKFTTASD 213 (295)
T ss_pred cCCCcEEecccccccccccCcc-----------------------------eeccCcCcCceeecChhhhccCCcCchhh
Confidence 9999999999999863110000 00112234577899999999888999999
Q ss_pred HHHHHHHHHHHHc--CCCCCCCCC
Q 003232 803 WWSVGIILFELIV--GIPPFNAEH 824 (837)
Q Consensus 803 IWSLGVILyELLT--Gr~PF~~~d 824 (837)
||||||++|+|++ |..||...+
T Consensus 214 vwSlG~~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 214 VWAFGVTLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred HHHHHHHHHHHHHcCCCCCCcccC
Confidence 9999999999988 678887644
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-31 Score=273.87 Aligned_cols=200 Identities=30% Similarity=0.479 Sum_probs=172.8
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVm 668 (837)
..|++.+.||.|+||+||+|.+..+++.||+|.+.............+.+|+.+++.++||||+++++.+......|+||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 55999999999999999999999899999999987554344455567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCC
Q 003232 669 EYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (837)
Q Consensus 669 Ey~~GGSL~dlLk~-~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl 747 (837)
||+. ++|.+++.. .+.+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~------- 166 (307)
T cd06607 95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVS------- 166 (307)
T ss_pred HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecC-------
Confidence 9996 577777653 4568999999999999999999999999999999999999999999999999876310
Q ss_pred CCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhc---CCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL---GTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 748 ~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLl---g~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
......|++.|+|||++. ...++.++||||||+++|+|++|..||...+
T Consensus 167 ----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~ 218 (307)
T cd06607 167 ----------------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218 (307)
T ss_pred ----------------------------CCCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc
Confidence 011235788899999884 3567889999999999999999999997644
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=273.28 Aligned_cols=205 Identities=26% Similarity=0.445 Sum_probs=169.8
Q ss_pred CCeEEEEEecccCceEEEEEEECC----------------CCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRT----------------TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVV 652 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~----------------tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIV 652 (837)
++|++.+.||.|+||.||++++.. ++..+|+|++.... .......+.+|+.+++.++||||+
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcc
Confidence 569999999999999999986532 34579999987542 234456788999999999999999
Q ss_pred EEEeEeecCCeEEEEEEecCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEE
Q 003232 653 RFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG-----------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLL 721 (837)
Q Consensus 653 kL~gsf~d~~~lyLVmEy~~GGSL~dlLk~~g-----------~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNIL 721 (837)
++++++......|+||||+.+++|.+++.... .++...+..++.||+.||.|||++|++|+||||+|||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil 162 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL 162 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence 99999999999999999999999999987532 3667789999999999999999999999999999999
Q ss_pred EccCCcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchH
Q 003232 722 IAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA 801 (837)
Q Consensus 722 Ld~dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kS 801 (837)
++.++.++|+|||+++....... ........+++.|+|||+..+..++.++
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~ 213 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDY-----------------------------YRIQGRAVLPIRWMSWESILLGKFTTAS 213 (296)
T ss_pred EcCCCCEEeccCcccccccCCcc-----------------------------eeccCcCcCccccCCHHHHhcCCccchh
Confidence 99999999999999863100000 0011123456789999999888899999
Q ss_pred HHHHHHHHHHHHHc--CCCCCCCCC
Q 003232 802 DWWSVGIILFELIV--GIPPFNAEH 824 (837)
Q Consensus 802 DIWSLGVILyELLT--Gr~PF~~~d 824 (837)
|||||||++|||++ |..||...+
T Consensus 214 DiwSlG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05095 214 DVWAFGVTLWEILTLCKEQPYSQLS 238 (296)
T ss_pred hhhHHHHHHHHHHHhCCCCCccccC
Confidence 99999999999998 788997644
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=294.87 Aligned_cols=195 Identities=25% Similarity=0.330 Sum_probs=167.9
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLV 667 (837)
..+|.+.+.||.|+||.||++.+..+++.||||.... ..+.+|+.++++++||||+++++++......|+|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 3469999999999999999999999999999996432 2356899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCC
Q 003232 668 MEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (837)
Q Consensus 668 mEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stdd 746 (837)
||++. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++........
T Consensus 239 ~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~- 316 (461)
T PHA03211 239 LPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST- 316 (461)
T ss_pred EEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc-
Confidence 99994 6888887653 56999999999999999999999999999999999999999999999999998742110000
Q ss_pred CCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCC
Q 003232 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFN 821 (837)
Q Consensus 747 l~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~ 821 (837)
.......||+.|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus 317 ----------------------------~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 317 ----------------------------PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred ----------------------------ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 00123579999999999999999999999999999999999886643
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-31 Score=267.95 Aligned_cols=195 Identities=29% Similarity=0.450 Sum_probs=163.5
Q ss_pred EecccCceEEEEEEECCCCc--EEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEeEeecCCeEEEEEEecC
Q 003232 596 PISRGAFGRVFLAKKRTTGD--LFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLVMEYLN 672 (837)
Q Consensus 596 kLGsG~FGtVYkArdk~tG~--~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~gsf~d~~~lyLVmEy~~ 672 (837)
.||.|+||.||+|.+..++. .+++|.++.. ........+.+|+.+++++ +||||+++++.+.....+|+||||++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 58999999999999987776 4688887642 2234456788999999999 89999999999999999999999999
Q ss_pred CCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCc
Q 003232 673 GGDLYSLLRNLG----------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS 736 (837)
Q Consensus 673 GGSL~dlLk~~g----------------~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLA 736 (837)
+++|.+++.... .++...+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~ 159 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 159 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCc
Confidence 999999987532 3788999999999999999999999999999999999999999999999987
Q ss_pred cccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-
Q 003232 737 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV- 815 (837)
Q Consensus 737 rvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT- 815 (837)
..... .........+..|+|||++.+..++.++||||||+++|+|++
T Consensus 160 ~~~~~--------------------------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~ 207 (270)
T cd05047 160 RGQEV--------------------------------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL 207 (270)
T ss_pred cccch--------------------------------hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcC
Confidence 51000 000111233567999999998899999999999999999996
Q ss_pred CCCCCCCCC
Q 003232 816 GIPPFNAEH 824 (837)
Q Consensus 816 Gr~PF~~~d 824 (837)
|..||...+
T Consensus 208 g~~pf~~~~ 216 (270)
T cd05047 208 GGTPYCGMT 216 (270)
T ss_pred CCCCccccC
Confidence 999996544
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=261.32 Aligned_cols=202 Identities=31% Similarity=0.558 Sum_probs=176.9
Q ss_pred CeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEE
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmE 669 (837)
+|++.+.||.|+||.||++.+..+++.+++|.+...... ......+.+|+.+++.++||||+++++.+......|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 589999999999999999999999999999999765432 3345677889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCC
Q 003232 670 YLNGGDLYSLLRN----LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745 (837)
Q Consensus 670 y~~GGSL~dlLk~----~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~std 745 (837)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|.||+++.++.++|+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--- 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--- 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence 9999999999865 356899999999999999999999999999999999999999999999999998631100
Q ss_pred CCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 746 dl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
......|++.|++||.+.+..++.++|+||||+++|+|++|+.||...+.
T Consensus 157 ------------------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~ 206 (256)
T cd08530 157 ------------------------------MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM 206 (256)
T ss_pred ------------------------------CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 01123578899999999999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=267.59 Aligned_cols=200 Identities=35% Similarity=0.644 Sum_probs=174.2
Q ss_pred eEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEEe
Q 003232 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEY 670 (837)
Q Consensus 591 YeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmEy 670 (837)
|++++.||.|+||.||+|.+..++..||+|++.... .......+.+|+.+++.++||||+++++.+......|+||||
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 888899999999999999998899999999986543 223446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCC
Q 003232 671 LNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 750 (837)
Q Consensus 671 ~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p 750 (837)
+++++|.+++.. ..++...+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 84 ~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~-------- 154 (277)
T cd06641 84 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT-------- 154 (277)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccc--------
Confidence 999999999865 56899999999999999999999999999999999999999999999999987631000
Q ss_pred CccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 751 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 751 ~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
........|+..|+|||.+.+..++.++|+|||||++|+|++|..||....
T Consensus 155 -----------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 205 (277)
T cd06641 155 -----------------------QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH 205 (277)
T ss_pred -----------------------hhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc
Confidence 001123467889999999988888999999999999999999999997544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-31 Score=273.19 Aligned_cols=206 Identities=35% Similarity=0.625 Sum_probs=177.3
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeE
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~l 664 (837)
+...++|++.+.||.|+||.||++.+..++..||+|.+.... ....+.+.+|+.+++.++||||+++++.+...+..
T Consensus 15 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~ 91 (293)
T cd06647 15 GDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDEL 91 (293)
T ss_pred cCchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcE
Confidence 333478999999999999999999998899999999986432 23346788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCC
Q 003232 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~st 744 (837)
|+|+||+++++|.+++.+ ..++...+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 92 ~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~-- 168 (293)
T cd06647 92 WVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-- 168 (293)
T ss_pred EEEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccc--
Confidence 999999999999999876 45789999999999999999999999999999999999999999999999987521000
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 745 ddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
........|++.|+|||.+.+..++.++|+||||+++|++++|+.||...+
T Consensus 169 -----------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~ 219 (293)
T cd06647 169 -----------------------------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (293)
T ss_pred -----------------------------ccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 001123468889999999988889999999999999999999999997654
Q ss_pred c
Q 003232 825 P 825 (837)
Q Consensus 825 p 825 (837)
+
T Consensus 220 ~ 220 (293)
T cd06647 220 P 220 (293)
T ss_pred h
Confidence 3
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=278.09 Aligned_cols=204 Identities=33% Similarity=0.582 Sum_probs=175.6
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEE
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyL 666 (837)
..+.|.....||.|+||.||++.+..++..||||.+.... ....+.+.+|+.+++.++||||+++++.+...+..|+
T Consensus 20 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~l 96 (292)
T cd06658 20 PREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWV 96 (292)
T ss_pred hHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEE
Confidence 3345676788999999999999999999999999986532 3345678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCC
Q 003232 667 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stdd 746 (837)
||||+++++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 97 v~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--- 172 (292)
T cd06658 97 VMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--- 172 (292)
T ss_pred EEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc---
Confidence 9999999999998855 568999999999999999999999999999999999999999999999999876210000
Q ss_pred CCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 747 l~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
.......|+..|+|||++.+..++.++|+||||+++|+|++|+.||...++
T Consensus 173 ----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~ 223 (292)
T cd06658 173 ----------------------------PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP 223 (292)
T ss_pred ----------------------------ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 011234688999999999988899999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=263.68 Aligned_cols=204 Identities=24% Similarity=0.413 Sum_probs=170.7
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEE
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 665 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ly 665 (837)
...++|++.+.||.|+||.||++.+. .+..+|+|.+.... .....+.+|+.+++.++|+||+++++.+.. ...+
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence 34567999999999999999999864 56679999887532 234578899999999999999999999887 7889
Q ss_pred EEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCC
Q 003232 666 LVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 666 LVmEy~~GGSL~dlLk~~--g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~s 743 (837)
++|||+++++|.+++... ..++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 999999999999999753 347888899999999999999999999999999999999999999999999886311000
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNA 822 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~~ 822 (837)
. .......++..|+|||++.+..++.++|+|||||++|++++ |..||..
T Consensus 157 ~------------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~ 206 (260)
T cd05073 157 Y------------------------------TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG 206 (260)
T ss_pred c------------------------------ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCC
Confidence 0 00112245677999999998889999999999999999998 9999986
Q ss_pred CCc
Q 003232 823 EHP 825 (837)
Q Consensus 823 ~dp 825 (837)
.+.
T Consensus 207 ~~~ 209 (260)
T cd05073 207 MSN 209 (260)
T ss_pred CCH
Confidence 543
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=266.26 Aligned_cols=198 Identities=28% Similarity=0.435 Sum_probs=163.3
Q ss_pred EecccCceEEEEEEEC--CCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEEecCC
Q 003232 596 PISRGAFGRVFLAKKR--TTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 673 (837)
Q Consensus 596 kLGsG~FGtVYkArdk--~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmEy~~G 673 (837)
.||.|+||.||+|.+. ..+..||+|++.... .....+.+.+|+.+++.++||||+++++.+. ....++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence 3899999999999775 345679999987542 2344567899999999999999999999875 4578999999999
Q ss_pred CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCCCc
Q 003232 674 GDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 752 (837)
Q Consensus 674 GSL~dlLk~-~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~ 752 (837)
++|.+++.. ...+++..+..++.||+.||.|||++|++|+||||+|||++.++.++|+|||++.........
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~------- 151 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY------- 151 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccc-------
Confidence 999999875 456899999999999999999999999999999999999999999999999988631110000
Q ss_pred cCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 003232 753 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEH 824 (837)
Q Consensus 753 SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~~~d 824 (837)
........+++.|+|||++.+..++.++|||||||++|++++ |..||....
T Consensus 152 ---------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 203 (257)
T cd05115 152 ---------------------YKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK 203 (257)
T ss_pred ---------------------eeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCC
Confidence 000112234678999999998889999999999999999996 999997644
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=262.00 Aligned_cols=201 Identities=24% Similarity=0.466 Sum_probs=171.0
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVm 668 (837)
.+|++.+.||.|+||.||++.+. .+..+|+|++...... ...+.+|+.+++.++||||+++++.+......|+||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF 78 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence 57999999999999999999885 4778999998754321 245788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCC
Q 003232 669 EYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (837)
Q Consensus 669 Ey~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl 747 (837)
||+.+++|.+++... +.+++..+..++.|++.+|.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~---- 154 (256)
T cd05112 79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ---- 154 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCc----
Confidence 999999999998764 568999999999999999999999999999999999999999999999999876310000
Q ss_pred CCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 003232 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEH 824 (837)
Q Consensus 748 ~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~~~d 824 (837)
........++..|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus 155 --------------------------~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 206 (256)
T cd05112 155 --------------------------YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS 206 (256)
T ss_pred --------------------------ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 000112335678999999998889999999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=277.34 Aligned_cols=209 Identities=25% Similarity=0.423 Sum_probs=171.6
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCC-------CcEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEe
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTT-------GDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFY 656 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~t-------G~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~g 656 (837)
.....+|++.+.||.|+||.||+|++... +..||+|++... ........+.+|+.+++++ +||||+++++
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD--ATDKDLSDLVSEMEMMKMIGKHKNIINLLG 85 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc--cCHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence 33445699999999999999999987432 236899988753 2334456889999999999 8999999999
Q ss_pred EeecCCeEEEEEEecCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcE
Q 003232 657 SFTCRENLYLVMEYLNGGDLYSLLRNLG----------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNL 720 (837)
Q Consensus 657 sf~d~~~lyLVmEy~~GGSL~dlLk~~g----------------~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNI 720 (837)
.+.....+|++|||+++++|.+++.... .++...+..++.||+.||.|||++|++||||||+||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 165 (334)
T cd05100 86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNV 165 (334)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceE
Confidence 9999999999999999999999986532 367788889999999999999999999999999999
Q ss_pred EEccCCcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCch
Q 003232 721 LIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT 800 (837)
Q Consensus 721 LLd~dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~k 800 (837)
|++.++.++|+|||+++....... ........++..|+|||++.+..++.+
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~ 216 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDY-----------------------------YKKTTNGRLPVKWMAPEALFDRVYTHQ 216 (334)
T ss_pred EEcCCCcEEECCcccceecccccc-----------------------------cccccCCCcCceEcCHHHhccCCcCch
Confidence 999999999999999863110000 000112234567999999999999999
Q ss_pred HHHHHHHHHHHHHHc-CCCCCCCCC
Q 003232 801 ADWWSVGIILFELIV-GIPPFNAEH 824 (837)
Q Consensus 801 SDIWSLGVILyELLT-Gr~PF~~~d 824 (837)
+||||||+++|+|++ |..||...+
T Consensus 217 ~Di~slG~il~el~~~g~~p~~~~~ 241 (334)
T cd05100 217 SDVWSFGVLLWEIFTLGGSPYPGIP 241 (334)
T ss_pred hhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 999999999999998 899997654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=268.48 Aligned_cols=204 Identities=40% Similarity=0.815 Sum_probs=172.7
Q ss_pred CeEEEEEecccCceEEEEEEEC---CCCcEEEEEEecccccc-cHHHHHHHHHHHHHHHhc-CCCceEEEEeEeecCCeE
Q 003232 590 DFEIIKPISRGAFGRVFLAKKR---TTGDLFAIKVLKKADMI-RKNAVESILAERDILISV-RNPFVVRFFYSFTCRENL 664 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk---~tG~~VAVKIikk~~~~-~~e~ie~~~rEieILk~L-rHPNIVkL~gsf~d~~~l 664 (837)
+|++.+.||.|+||.||+|++. .+|..||+|++...... .....+.+.+|+.+++.+ +|+||+.+++.+.....+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4899999999999999999985 47899999999764322 223346778899999999 589999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCC
Q 003232 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~st 744 (837)
|+||||+++++|.+++.....+++..+..++.|++.||.|||+.|++||||+|+|||++.++.++|+|||++........
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV 160 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence 99999999999999998878899999999999999999999999999999999999999999999999998863110000
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC--CCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003232 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG--TGHGTTADWWSVGIILFELIVGIPPFNA 822 (837)
Q Consensus 745 ddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg--~~~s~kSDIWSLGVILyELLTGr~PF~~ 822 (837)
.......|+..|+|||.+.+ ..++.++||||||+++|+|++|..||..
T Consensus 161 ------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 210 (290)
T cd05613 161 ------------------------------ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV 210 (290)
T ss_pred ------------------------------cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence 01123468889999999875 3467889999999999999999999974
Q ss_pred C
Q 003232 823 E 823 (837)
Q Consensus 823 ~ 823 (837)
.
T Consensus 211 ~ 211 (290)
T cd05613 211 D 211 (290)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=258.44 Aligned_cols=203 Identities=35% Similarity=0.686 Sum_probs=178.2
Q ss_pred CeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEE
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmE 669 (837)
+|++.+.||.|+||.||++.+..++..|++|++..... .......+.+|+++++.++|||++++++.+......++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 58999999999999999999998999999999976542 33455678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCC
Q 003232 670 YLNGGDLYSLLRNL----GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745 (837)
Q Consensus 670 y~~GGSL~dlLk~~----g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~std 745 (837)
|+++++|.+++... ..+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 157 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-- 157 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--
Confidence 99999999999763 679999999999999999999999999999999999999999999999999886311000
Q ss_pred CCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 746 dl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
.......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+
T Consensus 158 -----------------------------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 207 (258)
T cd08215 158 -----------------------------DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN 207 (258)
T ss_pred -----------------------------ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc
Confidence 01123468889999999999889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=263.69 Aligned_cols=202 Identities=27% Similarity=0.435 Sum_probs=168.0
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLV 667 (837)
.++|++...||.|+||.||+|.+..+ ..+|+|.+..... ..+.+.+|+.+++.++|||++++++.+. ....|+|
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIV 78 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEE
Confidence 35699999999999999999998544 4699998865432 2356788999999999999999998875 4568999
Q ss_pred EEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCC
Q 003232 668 MEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745 (837)
Q Consensus 668 mEy~~GGSL~dlLk~~--g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~std 745 (837)
|||+.+++|.+++... ..++...+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~- 157 (260)
T cd05069 79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY- 157 (260)
T ss_pred EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc-
Confidence 9999999999999753 3478899999999999999999999999999999999999999999999999863110000
Q ss_pred CCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 003232 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEH 824 (837)
Q Consensus 746 dl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~~~d 824 (837)
.......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+..
T Consensus 158 -----------------------------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 208 (260)
T cd05069 158 -----------------------------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV 208 (260)
T ss_pred -----------------------------cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 00112345678999999998889999999999999999999 999997754
Q ss_pred c
Q 003232 825 P 825 (837)
Q Consensus 825 p 825 (837)
+
T Consensus 209 ~ 209 (260)
T cd05069 209 N 209 (260)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=267.68 Aligned_cols=195 Identities=33% Similarity=0.602 Sum_probs=165.2
Q ss_pred CCeEEEEEe--cccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHh-cCCCceEEEEeEeecCCeEE
Q 003232 589 DDFEIIKPI--SRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILIS-VRNPFVVRFFYSFTCRENLY 665 (837)
Q Consensus 589 ddYeIlkkL--GsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~-LrHPNIVkL~gsf~d~~~ly 665 (837)
++|++.+.+ |.|+||.||++.++.++..+|+|++....... .|..+... .+||||+++++.|...+.+|
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 456666666 99999999999999999999999987543111 12222222 27999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCC-cEEEEecCCccccccCCC
Q 003232 666 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG-HIKLTDFGLSKVGLINST 744 (837)
Q Consensus 666 LVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG-~IKLiDFGLArvg~~~st 744 (837)
+||||+++++|.+++.....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++ .++|+|||++....
T Consensus 86 iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~---- 161 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG---- 161 (267)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecC----
Confidence 9999999999999998877899999999999999999999999999999999999999988 99999999876310
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 745 ddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
......|+..|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 162 -------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 210 (267)
T PHA03390 162 -------------------------------TPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE 210 (267)
T ss_pred -------------------------------CCccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 0012357889999999999999999999999999999999999998654
Q ss_pred cC
Q 003232 825 PQ 826 (837)
Q Consensus 825 pd 826 (837)
.+
T Consensus 211 ~~ 212 (267)
T PHA03390 211 DE 212 (267)
T ss_pred cc
Confidence 43
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-31 Score=280.03 Aligned_cols=208 Identities=28% Similarity=0.457 Sum_probs=169.6
Q ss_pred cccCCeEEEEEecccCceEEEEEEEC-----CCCcEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEeEee
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKR-----TTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFT 659 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk-----~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~gsf~ 659 (837)
...++|++.+.||.|+||.||+|.+. .+++.||||+++... .......+.+|+.++..+ +||||+++++++.
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT 81 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence 34567999999999999999999853 467899999997542 233456788999999999 6899999998876
Q ss_pred c-CCeEEEEEEecCCCCHHHHHHhc-------------------------------------------------------
Q 003232 660 C-RENLYLVMEYLNGGDLYSLLRNL------------------------------------------------------- 683 (837)
Q Consensus 660 d-~~~lyLVmEy~~GGSL~dlLk~~------------------------------------------------------- 683 (837)
. ...+++||||+++|+|.+++...
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 5 45689999999999999998642
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCCC
Q 003232 684 ------------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 751 (837)
Q Consensus 684 ------------g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~ 751 (837)
..++...+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~------- 234 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD------- 234 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcc-------
Confidence 1357778888999999999999999999999999999999999999999999863110000
Q ss_pred ccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 003232 752 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEH 824 (837)
Q Consensus 752 ~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~~~d 824 (837)
........+++.|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus 235 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 286 (343)
T cd05103 235 ----------------------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 286 (343)
T ss_pred ----------------------hhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcc
Confidence 001112345678999999999999999999999999999996 999997654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=260.50 Aligned_cols=196 Identities=28% Similarity=0.423 Sum_probs=165.5
Q ss_pred EecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEEecCCCC
Q 003232 596 PISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 675 (837)
Q Consensus 596 kLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmEy~~GGS 675 (837)
+||+|+||.||+|.. .++..+|+|++.... .......+.+|+.+++.++||||+++++.+......++||||+++++
T Consensus 2 ~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (250)
T cd05085 2 LLGKGNFGEVFKGTL-KDKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD 78 (250)
T ss_pred ccCCCCCceEEEEEe-cCCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence 689999999999986 468899999987543 23334568899999999999999999999999999999999999999
Q ss_pred HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCCCccC
Q 003232 676 LYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 754 (837)
Q Consensus 676 L~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~Sg 754 (837)
|.+++... ..+++..+..++.|++.+|.|+|++|++|+||+|+||+++.++.++|+|||++........
T Consensus 79 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~---------- 148 (250)
T cd05085 79 FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY---------- 148 (250)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccc----------
Confidence 99998653 4588999999999999999999999999999999999999999999999998863100000
Q ss_pred cccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 003232 755 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEH 824 (837)
Q Consensus 755 ttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~~~d 824 (837)
.......++..|+|||++.+..++.++||||||+++|++++ |..||....
T Consensus 149 --------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~ 199 (250)
T cd05085 149 --------------------SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMT 199 (250)
T ss_pred --------------------ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCC
Confidence 00112234567999999998889999999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=270.45 Aligned_cols=202 Identities=34% Similarity=0.546 Sum_probs=167.7
Q ss_pred EEEEEecccCceEEEEEEEC----CCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEE
Q 003232 592 EIIKPISRGAFGRVFLAKKR----TTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 592 eIlkkLGsG~FGtVYkArdk----~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLV 667 (837)
.+.+.||.|.||.||+|.+. ..+..|+||+++.. ......+.+.+|++.+++++||||+++++++......++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccc
Confidence 56789999999999999997 35678999999653 2344577899999999999999999999999988889999
Q ss_pred EEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCC
Q 003232 668 MEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745 (837)
Q Consensus 668 mEy~~GGSL~dlLk~~--g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~std 745 (837)
|||+++|+|.+++... ..++......++.||+.||.|||+++++|++|+++||+++.++.+||+|||++........
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~- 158 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK- 158 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS-
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-
Confidence 9999999999999876 6799999999999999999999999999999999999999999999999999874200000
Q ss_pred CCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 003232 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEH 824 (837)
Q Consensus 746 dl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~~~d 824 (837)
........+...|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 159 ----------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~ 210 (259)
T PF07714_consen 159 ----------------------------YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD 210 (259)
T ss_dssp ----------------------------EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC
T ss_pred ----------------------------cccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 011122345678999999988889999999999999999999 789997653
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=276.85 Aligned_cols=201 Identities=33% Similarity=0.583 Sum_probs=172.9
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVm 668 (837)
..|.....||.|+||.||++.+..+++.||+|.+.... ....+.+.+|+.+++.++||||+++++.+......|+||
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~ 97 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLM 97 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc---cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEE
Confidence 33555668999999999999999899999999986532 223456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCC
Q 003232 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (837)
Q Consensus 669 Ey~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~ 748 (837)
||+++++|..++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 98 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~------ 170 (297)
T cd06659 98 EFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD------ 170 (297)
T ss_pred ecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccc------
Confidence 99999999998765 56899999999999999999999999999999999999999999999999987521000
Q ss_pred CCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 749 ~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
........|+..|+|||++.+..++.++|||||||++|+|++|+.||...+
T Consensus 171 -------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 221 (297)
T cd06659 171 -------------------------VPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS 221 (297)
T ss_pred -------------------------cccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 001123468899999999999889999999999999999999999997554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-30 Score=261.67 Aligned_cols=202 Identities=31% Similarity=0.489 Sum_probs=169.2
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVm 668 (837)
+.+.....||+|+||.||+|.+..++..|++|.+.... ....+.+.+|+.+++.++|+||+++++++.....+++||
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 33444568999999999999999999999999987543 334567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEcc-CCcEEEEecCCccccccCCC
Q 003232 669 EYLNGGDLYSLLRNL-GCL--DEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH-DGHIKLTDFGLSKVGLINST 744 (837)
Q Consensus 669 Ey~~GGSL~dlLk~~-g~L--see~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~-dG~IKLiDFGLArvg~~~st 744 (837)
||+++++|.+++... ..+ ++..+..++.||+.||.|||++||+|+||||+||+++. ++.++|+|||++.......
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~- 163 (268)
T cd06624 85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN- 163 (268)
T ss_pred ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC-
Confidence 999999999998754 445 78888999999999999999999999999999999976 6799999999876311000
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCC--CCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003232 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT--GHGTTADWWSVGIILFELIVGIPPFNA 822 (837)
Q Consensus 745 ddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~--~~s~kSDIWSLGVILyELLTGr~PF~~ 822 (837)
.......|++.|+|||++.+. .++.++|+||||+++|+|++|+.||..
T Consensus 164 ------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~ 213 (268)
T cd06624 164 ------------------------------PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIE 213 (268)
T ss_pred ------------------------------CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcc
Confidence 001123578899999998664 378899999999999999999999975
Q ss_pred CC
Q 003232 823 EH 824 (837)
Q Consensus 823 ~d 824 (837)
..
T Consensus 214 ~~ 215 (268)
T cd06624 214 LG 215 (268)
T ss_pred cc
Confidence 43
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=272.13 Aligned_cols=206 Identities=34% Similarity=0.560 Sum_probs=170.9
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecC--CeE
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR--ENL 664 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~--~~l 664 (837)
..++|++.+.||.|+||.||+|.+..+|+.||+|+++.... .......+.+|+.+++.++|+||+++++++... ..+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNE-RDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccC-CCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 45789999999999999999999999999999999875432 122223456799999999999999999998765 568
Q ss_pred EEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCC
Q 003232 665 YLVMEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~-~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~s 743 (837)
|+||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 84 FLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 99999996 588888765 3668999999999999999999999999999999999999999999999999986311000
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNA 822 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLTGr~PF~~ 822 (837)
.......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||.+
T Consensus 163 -------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~ 211 (309)
T cd07845 163 -------------------------------KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPG 211 (309)
T ss_pred -------------------------------CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 00112345778999999876 5578999999999999999999999986
Q ss_pred CCc
Q 003232 823 EHP 825 (837)
Q Consensus 823 ~dp 825 (837)
.++
T Consensus 212 ~~~ 214 (309)
T cd07845 212 KSE 214 (309)
T ss_pred CCH
Confidence 553
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=269.45 Aligned_cols=206 Identities=25% Similarity=0.446 Sum_probs=171.3
Q ss_pred cCCeEEEEEecccCceEEEEEEECC-----CCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRT-----TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE 662 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~-----tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~ 662 (837)
.++|++.+.||.|+||.||+|.+.. ++..||+|++.... .......+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 3679999999999999999999753 67899999987543 2334467889999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcE
Q 003232 663 NLYLVMEYLNGGDLYSLLRNLG----------------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNL 720 (837)
Q Consensus 663 ~lyLVmEy~~GGSL~dlLk~~g----------------------~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNI 720 (837)
..|+||||+++++|.+++.... .+++..+..++.||+.||.|||+.|++||||||+||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni 161 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC 161 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence 9999999999999999996432 367788899999999999999999999999999999
Q ss_pred EEccCCcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCch
Q 003232 721 LIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT 800 (837)
Q Consensus 721 LLd~dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~k 800 (837)
+++.++.++|+|||++........ ........++..|+|||++.+..++.+
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~ 212 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADY-----------------------------YKASENDAIPIRWMPPESIFYNRYTTE 212 (288)
T ss_pred EecCCCceEECccccceecccCcc-----------------------------ccccCCCccChhhcCHHHHhcCCCCch
Confidence 999999999999998763110000 000112234567999999999999999
Q ss_pred HHHHHHHHHHHHHHc-CCCCCCCCC
Q 003232 801 ADWWSVGIILFELIV-GIPPFNAEH 824 (837)
Q Consensus 801 SDIWSLGVILyELLT-Gr~PF~~~d 824 (837)
+|||||||++|+|++ |..||.+..
T Consensus 213 ~Dv~slG~il~el~~~~~~p~~~~~ 237 (288)
T cd05050 213 SDVWAYGVVLWEIFSYGMQPYYGMA 237 (288)
T ss_pred hHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999997 888986543
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-33 Score=292.62 Aligned_cols=200 Identities=33% Similarity=0.635 Sum_probs=181.0
Q ss_pred CeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEE
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmE 669 (837)
-|.++.+||+|+||.||++.++.+|..+|||.+... ..++.+..|+.++++++.|++|++|++|.....+|||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 388999999999999999999999999999998764 345789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCC
Q 003232 670 YLNGGDLYSLLR-NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (837)
Q Consensus 670 y~~GGSL~dlLk-~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~ 748 (837)
||..|++.++++ ++++|+++++..+++..+.||+|||...-||||||..|||++.+|.+||+|||.+...
T Consensus 109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQL--------- 179 (502)
T KOG0574|consen 109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQL--------- 179 (502)
T ss_pred hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchh---------
Confidence 999999999986 5678999999999999999999999999999999999999999999999999998521
Q ss_pred CCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 749 ~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
...-.+.++..|||.|||||++..-+|+..+||||||++..||..|++||....|
T Consensus 180 ----------------------TDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHP 234 (502)
T KOG0574|consen 180 ----------------------TDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHP 234 (502)
T ss_pred ----------------------hhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccc
Confidence 0112345678999999999999999999999999999999999999999986543
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=259.80 Aligned_cols=202 Identities=30% Similarity=0.480 Sum_probs=172.0
Q ss_pred eEEEEEecccCceEEEEEEECCCC----cEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEE
Q 003232 591 FEIIKPISRGAFGRVFLAKKRTTG----DLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (837)
Q Consensus 591 YeIlkkLGsG~FGtVYkArdk~tG----~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyL 666 (837)
+++.+.||.|+||.||++.+...+ ..||+|++..... ......+..|+.+++.++|+||+++++.+...+..|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 356789999999999999998766 8999999976532 2255688999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCC
Q 003232 667 VMEYLNGGDLYSLLRNLGC--LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~~g~--Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~st 744 (837)
+|||+++++|.+++..... +++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 9999999999999976544 89999999999999999999999999999999999999999999999999863111100
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 003232 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAE 823 (837)
Q Consensus 745 ddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~~~ 823 (837)
.......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...
T Consensus 159 ------------------------------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~ 208 (258)
T smart00219 159 ------------------------------YKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM 208 (258)
T ss_pred ------------------------------cccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 00001226788999999988889999999999999999998 88999764
Q ss_pred C
Q 003232 824 H 824 (837)
Q Consensus 824 d 824 (837)
+
T Consensus 209 ~ 209 (258)
T smart00219 209 S 209 (258)
T ss_pred C
Confidence 3
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=267.07 Aligned_cols=198 Identities=25% Similarity=0.354 Sum_probs=160.7
Q ss_pred EecccCceEEEEEEECC--CCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEEecCC
Q 003232 596 PISRGAFGRVFLAKKRT--TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 673 (837)
Q Consensus 596 kLGsG~FGtVYkArdk~--tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmEy~~G 673 (837)
.||+|+||.||+|.+.. ++..+|+|.+..... ......+.+|+.+++.++||||+++++.+......++||||+++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 58999999999998643 456799998875432 23345788899999999999999999999998999999999999
Q ss_pred CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCC
Q 003232 674 GDLYSLLRNL-----GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (837)
Q Consensus 674 GSL~dlLk~~-----g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~ 748 (837)
++|.+++... ..++...+..++.|++.||.|||+.|++|+||||+||+++.+++++|+|||++.... ... .
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~--~~~-~- 155 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKY--KED-Y- 155 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCcccccccc--Ccc-e-
Confidence 9999998643 235667788899999999999999999999999999999999999999999886310 000 0
Q ss_pred CCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCC-------CCCchHHHHHHHHHHHHHHc-CCCCC
Q 003232 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-------GHGTTADWWSVGIILFELIV-GIPPF 820 (837)
Q Consensus 749 ~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~-------~~s~kSDIWSLGVILyELLT-Gr~PF 820 (837)
........|+..|+|||++.+. .++.++||||||+++|+|++ |+.||
T Consensus 156 -------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~ 210 (269)
T cd05087 156 -------------------------YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPY 210 (269)
T ss_pred -------------------------eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCC
Confidence 0011234577889999998642 35789999999999999996 99999
Q ss_pred CCCC
Q 003232 821 NAEH 824 (837)
Q Consensus 821 ~~~d 824 (837)
....
T Consensus 211 ~~~~ 214 (269)
T cd05087 211 RHLS 214 (269)
T ss_pred CCCC
Confidence 7644
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=262.85 Aligned_cols=190 Identities=22% Similarity=0.343 Sum_probs=161.7
Q ss_pred EEecccCceEEEEEEECCCC----------cEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeE
Q 003232 595 KPISRGAFGRVFLAKKRTTG----------DLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (837)
Q Consensus 595 kkLGsG~FGtVYkArdk~tG----------~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~l 664 (837)
+.||.|+||.||+|.+..++ ..+++|++.... .....+.+|+.+++.++||||+++++.+.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH----RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch----hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 36899999999999998766 357888776532 115678899999999999999999999887 778
Q ss_pred EEEEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCC-------cEEEEecCCc
Q 003232 665 YLVMEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG-------HIKLTDFGLS 736 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~g-~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG-------~IKLiDFGLA 736 (837)
++||||+.+++|.+++...+ .++...+..++.||+.||.|||++||+|+||||+|||++.++ .++|+|||++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999999998755 689999999999999999999999999999999999999887 7999999988
Q ss_pred cccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCC--CCCchHHHHHHHHHHHHHH
Q 003232 737 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT--GHGTTADWWSVGIILFELI 814 (837)
Q Consensus 737 rvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~--~~s~kSDIWSLGVILyELL 814 (837)
..... .....++..|+|||++.+. .++.++||||||+++|+|+
T Consensus 156 ~~~~~-----------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~ 200 (259)
T cd05037 156 ITVLS-----------------------------------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEIC 200 (259)
T ss_pred ccccc-----------------------------------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHH
Confidence 63100 1123466779999999876 7899999999999999999
Q ss_pred c-CCCCCCCCC
Q 003232 815 V-GIPPFNAEH 824 (837)
Q Consensus 815 T-Gr~PF~~~d 824 (837)
+ |..||...+
T Consensus 201 ~~~~~p~~~~~ 211 (259)
T cd05037 201 SNGEEPLSTLS 211 (259)
T ss_pred hCCCCCcccCC
Confidence 9 688887664
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-33 Score=306.74 Aligned_cols=209 Identities=40% Similarity=0.779 Sum_probs=193.6
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEE
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 665 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ly 665 (837)
..+.+++++..||-|+||.|=++........+|+|++++..+....+.+.+..|.++|..++.|+||++|-.|.+..++|
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY 496 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY 496 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence 34567889999999999999999987666679999999888888888899999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCC
Q 003232 666 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745 (837)
Q Consensus 666 LVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~std 745 (837)
+.||-|-||.|+.+++..+.+.+..++.|+.-+++|++|||++|||.|||||+|.|++.+|.+||.|||+|+..
T Consensus 497 mLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki------ 570 (732)
T KOG0614|consen 497 MLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKI------ 570 (732)
T ss_pred hhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHh------
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999841
Q ss_pred CCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 746 dl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
..++++.++||||.|.|||++++.+++..+|.||||+++||||+|.+||.+.+|
T Consensus 571 --------------------------~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp 624 (732)
T KOG0614|consen 571 --------------------------GSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP 624 (732)
T ss_pred --------------------------ccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch
Confidence 223456789999999999999999999999999999999999999999998776
Q ss_pred C
Q 003232 826 Q 826 (837)
Q Consensus 826 d 826 (837)
=
T Consensus 625 m 625 (732)
T KOG0614|consen 625 M 625 (732)
T ss_pred H
Confidence 3
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=267.24 Aligned_cols=202 Identities=33% Similarity=0.578 Sum_probs=171.5
Q ss_pred eEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEEe
Q 003232 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEY 670 (837)
Q Consensus 591 YeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmEy 670 (837)
|++.+.||.|++|.||+|.+..+|..||+|++.... ........+.+|+.+++.++||||+++++++......|++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLET-EDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccc-ccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 678899999999999999999999999999987543 2223335678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCC
Q 003232 671 LNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (837)
Q Consensus 671 ~~GGSL~dlLk~~g--~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~ 748 (837)
++ ++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~----- 153 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV----- 153 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc-----
Confidence 94 68999987655 68999999999999999999999999999999999999999999999999986210000
Q ss_pred CCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 749 ~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~-~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
.......+++.|+|||++.+. .++.++||||||+++|+|++|.+||...++
T Consensus 154 --------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 205 (283)
T cd07835 154 --------------------------RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE 205 (283)
T ss_pred --------------------------cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 001223467889999988764 568899999999999999999999976553
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-31 Score=269.77 Aligned_cols=202 Identities=27% Similarity=0.402 Sum_probs=168.8
Q ss_pred CeEEEEEecccCceEEEEEEE----CCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecC--Ce
Q 003232 590 DFEIIKPISRGAFGRVFLAKK----RTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR--EN 663 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArd----k~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~--~~ 663 (837)
-|++++.||+|+||.||+++. ..++..||+|.++... .......+.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 388999999999999999984 4578899999987542 234456789999999999999999999988775 57
Q ss_pred EEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccC
Q 003232 664 LYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~ 742 (837)
.++||||++|++|.+++... ..++...+..++.||+.||.|||++|++||||||+||+++.++.++|+|||+++.....
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 162 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence 89999999999999998654 45899999999999999999999999999999999999999999999999998631100
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCC
Q 003232 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFN 821 (837)
Q Consensus 743 stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~ 821 (837)
... ........|+..|+|||++.+..++.++||||||+++|+|+++..|+.
T Consensus 163 ~~~----------------------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~ 213 (284)
T cd05079 163 KEY----------------------------YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSES 213 (284)
T ss_pred ccc----------------------------eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCc
Confidence 000 000123456778999999998889999999999999999999877653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=268.70 Aligned_cols=212 Identities=16% Similarity=0.271 Sum_probs=161.8
Q ss_pred CCeEEEEEecccCceEEEEEEECCC---CcEEEEEEeccccccc--HH------HHHHHHHHHHHHHhcCCCceEEEEeE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTT---GDLFAIKVLKKADMIR--KN------AVESILAERDILISVRNPFVVRFFYS 657 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~t---G~~VAVKIikk~~~~~--~e------~ie~~~rEieILk~LrHPNIVkL~gs 657 (837)
++|++.+.||+|+||+||+|.+..+ +..+|+|+........ .. .......+...+..+.|+||+++++.
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 5699999999999999999999877 6678888754322110 00 01122334445567789999999987
Q ss_pred eecCC----eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEec
Q 003232 658 FTCRE----NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDF 733 (837)
Q Consensus 658 f~d~~----~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDF 733 (837)
+.... ..+++++++ ..++.+.+......++..+..++.|++.||.|||++||+||||||+|||++.++.++|+||
T Consensus 92 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DF 170 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDY 170 (294)
T ss_pred eeEecCCceEEEEEEehh-ccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEc
Confidence 65433 457888887 4577777776566788899999999999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHH
Q 003232 734 GLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 813 (837)
Q Consensus 734 GLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyEL 813 (837)
|+++....+... .. ..........||+.|+|||++.+..++.++|||||||++|+|
T Consensus 171 Gla~~~~~~~~~-~~-----------------------~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el 226 (294)
T PHA02882 171 GIASHFIIHGKH-IE-----------------------YSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKW 226 (294)
T ss_pred CCceeeccCCcc-cc-----------------------cccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHH
Confidence 998742211110 00 000112234699999999999999999999999999999999
Q ss_pred HcCCCCCCCCCc
Q 003232 814 IVGIPPFNAEHP 825 (837)
Q Consensus 814 LTGr~PF~~~dp 825 (837)
++|..||.....
T Consensus 227 ~~g~~P~~~~~~ 238 (294)
T PHA02882 227 AGIKLPWKGFGH 238 (294)
T ss_pred HhCCCCCCcccc
Confidence 999999987643
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=263.84 Aligned_cols=203 Identities=35% Similarity=0.597 Sum_probs=172.5
Q ss_pred eEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecC--CeEEEEE
Q 003232 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR--ENLYLVM 668 (837)
Q Consensus 591 YeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~--~~lyLVm 668 (837)
|++.+.||.|+||.||+|.+..+++.+|+|.+.... ........+.+|+.+++.++|||++++++.+... ...++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 788999999999999999999999999999998653 2334446788999999999999999999999888 8999999
Q ss_pred EecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCC
Q 003232 669 EYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (837)
Q Consensus 669 Ey~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl 747 (837)
||++ ++|.+++... ..+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 80 e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~--- 155 (287)
T cd07840 80 EYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS--- 155 (287)
T ss_pred cccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc---
Confidence 9996 4899888765 5799999999999999999999999999999999999999999999999998863111100
Q ss_pred CCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 748 ~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
.......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.
T Consensus 156 ---------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~ 207 (287)
T cd07840 156 ---------------------------ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE 207 (287)
T ss_pred ---------------------------ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 00122356788999998775 4578999999999999999999999986553
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=277.34 Aligned_cols=204 Identities=30% Similarity=0.502 Sum_probs=169.5
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecC-----C
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR-----E 662 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~-----~ 662 (837)
.++|++.+.||.|+||.||+|.+..+|+.||+|.+.... .......+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 367999999999999999999999999999999986432 233456678899999999999999999876543 3
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccC
Q 003232 663 NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (837)
Q Consensus 663 ~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~ 742 (837)
+.|+||||+. ++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++......
T Consensus 82 ~~~lv~e~~~-~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 82 DVYIVQELME-TDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred eEEEEehhcc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 5899999995 588887754 56999999999999999999999999999999999999999999999999988631100
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCC
Q 003232 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFN 821 (837)
Q Consensus 743 stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLTGr~PF~ 821 (837)
.. .........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.
T Consensus 160 ~~----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~ 211 (336)
T cd07849 160 HD----------------------------HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFP 211 (336)
T ss_pred cc----------------------------ccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 00 0001123568999999998765 568899999999999999999999997
Q ss_pred CC
Q 003232 822 AE 823 (837)
Q Consensus 822 ~~ 823 (837)
+.
T Consensus 212 ~~ 213 (336)
T cd07849 212 GK 213 (336)
T ss_pred CC
Confidence 54
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=268.56 Aligned_cols=200 Identities=32% Similarity=0.585 Sum_probs=173.6
Q ss_pred CeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEE
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmE 669 (837)
.|...+.||.|++|.||++.+..+++.+++|.+.... ....+.+.+|+.+++.++||||+++++.+...++.|+|+|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 3666689999999999999998899999999886432 2334568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCC
Q 003232 670 YLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 749 (837)
Q Consensus 670 y~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~ 749 (837)
|+.|++|.+++.. +.++...+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++......
T Consensus 97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~------- 168 (285)
T cd06648 97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE------- 168 (285)
T ss_pred ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccC-------
Confidence 9999999999887 67899999999999999999999999999999999999999999999999987521000
Q ss_pred CCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 750 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 750 p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
........|++.|+|||++.+..++.++||||||+++|+|++|..||...+
T Consensus 169 ------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~ 219 (285)
T cd06648 169 ------------------------VPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP 219 (285)
T ss_pred ------------------------CcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC
Confidence 001123468899999999998889999999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=267.30 Aligned_cols=204 Identities=35% Similarity=0.623 Sum_probs=178.6
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEE
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyL 666 (837)
..+.|++...||.|++|.||++.+..++..|++|++..... ....+.+|+.+++.++|+||+++++.+......|+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 34569999999999999999999988999999999976432 45678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCC
Q 003232 667 VMEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~~g-~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~std 745 (837)
|+||++|++|.+++.... .++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~--- 169 (286)
T cd06614 93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE--- 169 (286)
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccc---
Confidence 999999999999998866 7999999999999999999999999999999999999999999999999987521000
Q ss_pred CCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 746 dl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
........+++.|++||++.+..++.++|+||||+++|+|++|..||....+
T Consensus 170 ----------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~ 221 (286)
T cd06614 170 ----------------------------KSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP 221 (286)
T ss_pred ----------------------------hhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH
Confidence 0011234578899999999988899999999999999999999999986544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=265.75 Aligned_cols=206 Identities=21% Similarity=0.347 Sum_probs=172.3
Q ss_pred cCCeEEEEEecccCceEEEEEEECC----CCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeec-CC
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRT----TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC-RE 662 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~----tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d-~~ 662 (837)
.++|++.+.||.|+||.||+|.+.. ++..|++|++... ........+.+|+.+++.++||||+++++++.. ..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 4679999999999999999999875 3578999988643 234556778999999999999999999998665 56
Q ss_pred eEEEEEEecCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecC
Q 003232 663 NLYLVMEYLNGGDLYSLLRNL--------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFG 734 (837)
Q Consensus 663 ~lyLVmEy~~GGSL~dlLk~~--------g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFG 734 (837)
..+++++|+.+++|.+++... ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g 162 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNA 162 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCC
Confidence 789999999999999998653 348899999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHH
Q 003232 735 LSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI 814 (837)
Q Consensus 735 LArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELL 814 (837)
+++........ .......++..|+|||++.+..++.++||||||+++|+++
T Consensus 163 ~~~~~~~~~~~-----------------------------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~ 213 (280)
T cd05043 163 LSRDLFPMDYH-----------------------------CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELM 213 (280)
T ss_pred CcccccCCceE-----------------------------EeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHh
Confidence 98731111000 0001223567799999999999999999999999999999
Q ss_pred c-CCCCCCCCC
Q 003232 815 V-GIPPFNAEH 824 (837)
Q Consensus 815 T-Gr~PF~~~d 824 (837)
+ |++||...+
T Consensus 214 ~~g~~p~~~~~ 224 (280)
T cd05043 214 TLGQTPYVEID 224 (280)
T ss_pred cCCCCCcCcCC
Confidence 8 999997654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=263.04 Aligned_cols=205 Identities=28% Similarity=0.407 Sum_probs=170.0
Q ss_pred cCCeEEEEEecccCceEEEEEEECCC---CcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTT---GDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~t---G~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~l 664 (837)
.++|.+.+.||.|+||.||+|.+... ...|++|.+.... .....+.+.+|+.+++.++||||+++++++.. ...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~ 81 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV 81 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence 35699999999999999999987543 3468999886542 23445688999999999999999999998765 567
Q ss_pred EEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCC
Q 003232 665 YLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~s 743 (837)
|+||||+++++|.+++... ..++...+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||+++......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 82 WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 8999999999999999764 358999999999999999999999999999999999999999999999999886311110
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNA 822 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~~ 822 (837)
. .......++..|+|||.+.+..++.++||||||+++|++++ |..||..
T Consensus 162 ~------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~ 211 (270)
T cd05056 162 Y------------------------------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQG 211 (270)
T ss_pred c------------------------------eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCC
Confidence 0 00112234567999999988889999999999999999986 9999976
Q ss_pred CCc
Q 003232 823 EHP 825 (837)
Q Consensus 823 ~dp 825 (837)
.+.
T Consensus 212 ~~~ 214 (270)
T cd05056 212 VKN 214 (270)
T ss_pred CCH
Confidence 543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=260.24 Aligned_cols=203 Identities=33% Similarity=0.602 Sum_probs=174.0
Q ss_pred CeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEE
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmE 669 (837)
+|++.+.||.|+||.||++.++.+|..+|+|.+..... .....+.+.+|+.+++.++|+||+++++.+.....+|+|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc-cchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 48999999999999999999999999999999876432 22334577899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCc-EEEEecCCccccccCCCCC
Q 003232 670 YLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGH-IKLTDFGLSKVGLINSTDD 746 (837)
Q Consensus 670 y~~GGSL~dlLk~~g--~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~-IKLiDFGLArvg~~~stdd 746 (837)
|+.+++|.+++.... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||.+.... ...
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~-~~~-- 156 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN-DSM-- 156 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhcc-CCc--
Confidence 999999999987543 4789999999999999999999999999999999999988764 6999999876311 000
Q ss_pred CCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 747 l~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
.......|++.|+|||++.+..++.++|+||||+++|+|++|..||...+
T Consensus 157 ----------------------------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 206 (257)
T cd08225 157 ----------------------------ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN 206 (257)
T ss_pred ----------------------------ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 00112358889999999998889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=260.10 Aligned_cols=199 Identities=26% Similarity=0.389 Sum_probs=167.9
Q ss_pred EEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEEecCCC
Q 003232 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGG 674 (837)
Q Consensus 595 kkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmEy~~GG 674 (837)
++||.|+||.||++.+.. ++.|++|.+...... .....+.+|+.+++.++||||+++++.+......++||||+.++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 368999999999999977 999999998765422 34567899999999999999999999999999999999999999
Q ss_pred CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCCCcc
Q 003232 675 DLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753 (837)
Q Consensus 675 SL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~S 753 (837)
+|.+++... ..++...+..++.+++.+|.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~--------- 148 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY--------- 148 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcc---------
Confidence 999998653 5688999999999999999999999999999999999999999999999998863110000
Q ss_pred CcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCc
Q 003232 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHP 825 (837)
Q Consensus 754 gttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~~~dp 825 (837)
........++..|+|||.+.+..++.++||||||+++|+|++ |..||....+
T Consensus 149 --------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~ 201 (251)
T cd05041 149 --------------------TVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN 201 (251)
T ss_pred --------------------eeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH
Confidence 000011234567999999998889999999999999999998 8999976553
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=267.29 Aligned_cols=201 Identities=28% Similarity=0.536 Sum_probs=167.9
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcC-CCceEEEEeEeecCCeEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~Lr-HPNIVkL~gsf~d~~~lyLV 667 (837)
++|+..+.||.|+||.||++.+..+++.+|+|.+..... ......+.+|+.++.++. ||||+++++.+......+++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD--EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC--hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 457778899999999999999999999999999876432 244567889999999986 99999999999988999999
Q ss_pred EEecCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCcEEEccCCcEEEEecCCcccccc
Q 003232 668 MEYLNGGDLYSLLR-----NLGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 741 (837)
Q Consensus 668 mEy~~GGSL~dlLk-----~~g~Lsee~irkIl~QIa~ALsYLHS-kGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~ 741 (837)
|||+. ++|.++.. ....+++..+..++.|++.||+|||+ .|++||||||+||+++.++.++|+|||++.....
T Consensus 82 ~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 82 MELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred Eeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 99985 46555432 23569999999999999999999997 5999999999999999999999999999862100
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCC---CCCchHHHHHHHHHHHHHHcCCC
Q 003232 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT---GHGTTADWWSVGIILFELIVGIP 818 (837)
Q Consensus 742 ~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~---~~s~kSDIWSLGVILyELLTGr~ 818 (837)
. .......|++.|+|||++.+. .++.++|||||||++|+|++|+.
T Consensus 161 ~--------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~ 208 (288)
T cd06616 161 S--------------------------------IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKF 208 (288)
T ss_pred C--------------------------------CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCC
Confidence 0 011233578899999999776 68899999999999999999999
Q ss_pred CCCCCC
Q 003232 819 PFNAEH 824 (837)
Q Consensus 819 PF~~~d 824 (837)
||....
T Consensus 209 p~~~~~ 214 (288)
T cd06616 209 PYPKWN 214 (288)
T ss_pred Cchhcc
Confidence 997654
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=306.41 Aligned_cols=203 Identities=34% Similarity=0.474 Sum_probs=172.4
Q ss_pred CeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC------e
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE------N 663 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~------~ 663 (837)
.|..-+.||+|+||.||+++++.+|+.||||.++... .....+...+|+++|++++|||||+++++=.... .
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence 3677789999999999999999999999999998754 3344568899999999999999999987755433 5
Q ss_pred EEEEEEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEcc--CC--cEEEEecCCc
Q 003232 664 LYLVMEYLNGGDLYSLLRNL---GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH--DG--HIKLTDFGLS 736 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk~~---g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~--dG--~IKLiDFGLA 736 (837)
..+|||||.||||+..+... ..|++.+++.++.++..||.|||++||+||||||.||++.. +| ..||+|||.|
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 78999999999999999643 45999999999999999999999999999999999999843 34 3699999999
Q ss_pred cccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhc-CCCCCchHHHHHHHHHHHHHHc
Q 003232 737 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-GTGHGTTADWWSVGIILFELIV 815 (837)
Q Consensus 737 rvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLl-g~~~s~kSDIWSLGVILyELLT 815 (837)
+-...+ ..-.+..||+.|++||++. ...|+..+|.|||||++|++.|
T Consensus 172 rel~d~--------------------------------s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caT 219 (732)
T KOG4250|consen 172 RELDDN--------------------------------SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECAT 219 (732)
T ss_pred ccCCCC--------------------------------CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhc
Confidence 831111 1234678999999999998 4889999999999999999999
Q ss_pred CCCCCCCCCcC
Q 003232 816 GIPPFNAEHPQ 826 (837)
Q Consensus 816 Gr~PF~~~dpd 826 (837)
|..||-..-..
T Consensus 220 G~lPF~p~~~p 230 (732)
T KOG4250|consen 220 GELPFIPFGGP 230 (732)
T ss_pred cCCCCCcCCCc
Confidence 99999764433
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-30 Score=300.44 Aligned_cols=151 Identities=59% Similarity=1.008 Sum_probs=141.4
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLV 667 (837)
+++|+++++||+|+||+||+|++..+++.||||+++............+..|+.+++.++||||+++++.+....++|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 57899999999999999999999999999999999876555566667899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccc
Q 003232 668 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (837)
Q Consensus 668 mEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArv 738 (837)
|||+.|++|.+++...+.+++..++.++.||+.||.|||++|||||||||+|||++.++.++|+|||+++.
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~ 153 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCcc
Confidence 99999999999998888899999999999999999999999999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=271.03 Aligned_cols=205 Identities=24% Similarity=0.401 Sum_probs=169.8
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCc----EEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCe
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGD----LFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCREN 663 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~----~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ 663 (837)
.++|++.+.||.|+||.||+|.+..++. .+|+|.+.... .......+.+|+.+++.++||||+++++.+.. ..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-~~ 82 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLS-PT 82 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC-CC
Confidence 3569999999999999999999977776 46888886543 23334468899999999999999999998865 45
Q ss_pred EEEEEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccC
Q 003232 664 LYLVMEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk~~g-~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~ 742 (837)
.++++||+++|+|.+++.... .+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||+++.....
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCc
Confidence 679999999999999987643 5899999999999999999999999999999999999999999999999998731100
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCC
Q 003232 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFN 821 (837)
Q Consensus 743 stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~ 821 (837)
.. ........++..|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus 163 ~~-----------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~ 213 (303)
T cd05110 163 EK-----------------------------EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213 (303)
T ss_pred cc-----------------------------ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 00 001112345678999999999999999999999999999997 999997
Q ss_pred CCC
Q 003232 822 AEH 824 (837)
Q Consensus 822 ~~d 824 (837)
+..
T Consensus 214 ~~~ 216 (303)
T cd05110 214 GIP 216 (303)
T ss_pred CCC
Confidence 653
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=281.35 Aligned_cols=203 Identities=30% Similarity=0.542 Sum_probs=179.3
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEeccccc-----ccHHHHHHHHHHHHHHHhc-CCCceEEEEeEeecC
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADM-----IRKNAVESILAERDILISV-RNPFVVRFFYSFTCR 661 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~-----~~~e~ie~~~rEieILk~L-rHPNIVkL~gsf~d~ 661 (837)
.+.|...+.||.|..++|.++.++.+|..+|+|++..... ...+..+....|+.||+++ .||||+++.++|...
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 3568888999999999999999999999999999854221 1344456788899999887 699999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCcccccc
Q 003232 662 ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 741 (837)
Q Consensus 662 ~~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~ 741 (837)
..+++|+|.++.|.|++++...-.+++...+.+++|+..|++|||.++||||||||+|||++++.+++|+|||++...
T Consensus 96 sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l-- 173 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQL-- 173 (411)
T ss_pred chhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeecc--
Confidence 999999999999999999999888999999999999999999999999999999999999999999999999998620
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhc------CCCCCchHHHHHHHHHHHHHHc
Q 003232 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL------GTGHGTTADWWSVGIILFELIV 815 (837)
Q Consensus 742 ~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLl------g~~~s~kSDIWSLGVILyELLT 815 (837)
..+.+.+..||||+|+|||.+. ..+|+..+|+|++|||||-||.
T Consensus 174 ------------------------------~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLa 223 (411)
T KOG0599|consen 174 ------------------------------EPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLA 223 (411)
T ss_pred ------------------------------CCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHc
Confidence 1234456789999999999985 3578899999999999999999
Q ss_pred CCCCCCC
Q 003232 816 GIPPFNA 822 (837)
Q Consensus 816 Gr~PF~~ 822 (837)
|.+||+-
T Consensus 224 GcpPFwH 230 (411)
T KOG0599|consen 224 GCPPFWH 230 (411)
T ss_pred CCCchhH
Confidence 9999964
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=264.78 Aligned_cols=206 Identities=27% Similarity=0.416 Sum_probs=172.2
Q ss_pred CCeEEEEEecccCceEEEEEEECC----CCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeec--CC
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRT----TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC--RE 662 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~----tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d--~~ 662 (837)
..|++.+.||.|+||.||++.+.. ++..+|+|++...... .....+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 458889999999999999998643 4789999999865422 356789999999999999999999998877 56
Q ss_pred eEEEEEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCcccccc
Q 003232 663 NLYLVMEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 741 (837)
Q Consensus 663 ~lyLVmEy~~GGSL~dlLk~~g-~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~ 741 (837)
..++||||+++++|.+++.... .++...+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 8999999999999999997654 589999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCC
Q 003232 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFN 821 (837)
Q Consensus 742 ~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~ 821 (837)
.... ........++..|+|||.+.+..++.++||||||+++|+|++|..||.
T Consensus 162 ~~~~----------------------------~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~ 213 (284)
T cd05038 162 DKDY----------------------------YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQ 213 (284)
T ss_pred CCcc----------------------------eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcc
Confidence 0000 000112245567999999998899999999999999999999999987
Q ss_pred CCC
Q 003232 822 AEH 824 (837)
Q Consensus 822 ~~d 824 (837)
...
T Consensus 214 ~~~ 216 (284)
T cd05038 214 SPP 216 (284)
T ss_pred ccc
Confidence 643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=261.41 Aligned_cols=197 Identities=29% Similarity=0.509 Sum_probs=167.2
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEE
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyL 666 (837)
.+++|++.+.||.|+||.||++. .+++.||+|.++... ....+.+|+.+++.++||||+++++.+... ..|+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~ 75 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI 75 (254)
T ss_pred cHHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence 34679999999999999999987 468899999987532 235688999999999999999999988654 5799
Q ss_pred EEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCC
Q 003232 667 VMEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~~g--~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~st 744 (837)
||||+.+++|.+++.... .++...+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-- 153 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-- 153 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence 999999999999997643 4789999999999999999999999999999999999999999999999988631000
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 003232 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAE 823 (837)
Q Consensus 745 ddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~~~ 823 (837)
......+..|+|||.+.+..++.++|+||||+++|+|++ |++||...
T Consensus 154 --------------------------------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 201 (254)
T cd05083 154 --------------------------------VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM 201 (254)
T ss_pred --------------------------------CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccC
Confidence 001223467999999998889999999999999999997 99999766
Q ss_pred Cc
Q 003232 824 HP 825 (837)
Q Consensus 824 dp 825 (837)
+.
T Consensus 202 ~~ 203 (254)
T cd05083 202 SL 203 (254)
T ss_pred CH
Confidence 54
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=283.71 Aligned_cols=208 Identities=27% Similarity=0.528 Sum_probs=177.4
Q ss_pred eEEE-EEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcC-CCceEEEEeEeecCCeEEEEE
Q 003232 591 FEII-KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 591 YeIl-kkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~Lr-HPNIVkL~gsf~d~~~lyLVm 668 (837)
|++. +.||+|+|+.|--+....+|..||||++.+. ......++.+|++++..++ |+||++++++|.++..+||||
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVf 155 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVF 155 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEE
Confidence 5553 6899999999999999999999999999875 3455678999999999985 999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCC---cEEEEecCCccccccCCCC
Q 003232 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG---HIKLTDFGLSKVGLINSTD 745 (837)
Q Consensus 669 Ey~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG---~IKLiDFGLArvg~~~std 745 (837)
|-+.||+|..++.+...+++.++..++.+|+.||.|||.+||.|||+||+|||..... -+|||||.+..- ...++
T Consensus 156 EKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg--~k~~~ 233 (463)
T KOG0607|consen 156 EKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSG--IKLNN 233 (463)
T ss_pred ecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccc--cccCC
Confidence 9999999999999999999999999999999999999999999999999999996544 489999998763 22233
Q ss_pred CCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhc-----CCCCCchHHHHHHHHHHHHHHcCCCCC
Q 003232 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-----GTGHGTTADWWSVGIILFELIVGIPPF 820 (837)
Q Consensus 746 dl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLl-----g~~~s~kSDIWSLGVILyELLTGr~PF 820 (837)
+++ +..+ ....+.+|+..|||||+.. ..-|+.++|.|||||++|-||.|.+||
T Consensus 234 ~~s-past---------------------P~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPF 291 (463)
T KOG0607|consen 234 DCS-PAST---------------------PELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPF 291 (463)
T ss_pred CCC-CCCC---------------------ccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCc
Confidence 332 1111 1134678999999999863 345899999999999999999999999
Q ss_pred CCCCc
Q 003232 821 NAEHP 825 (837)
Q Consensus 821 ~~~dp 825 (837)
.+.-.
T Consensus 292 vG~Cg 296 (463)
T KOG0607|consen 292 VGHCG 296 (463)
T ss_pred cCccC
Confidence 87543
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=262.69 Aligned_cols=199 Identities=31% Similarity=0.489 Sum_probs=165.1
Q ss_pred eEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcC-CCceEEEEeEeecC--CeEEEE
Q 003232 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCR--ENLYLV 667 (837)
Q Consensus 591 YeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~Lr-HPNIVkL~gsf~d~--~~lyLV 667 (837)
|++++.||.|+||.||+|.+..+++.||+|.++.... ... .....+|+.++.++. ||||+++++++.+. +.+++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-SLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-Cch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 7889999999999999999999999999999876431 111 223457888888885 99999999999987 889999
Q ss_pred EEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCC
Q 003232 668 MEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (837)
Q Consensus 668 mEy~~GGSL~dlLk~-~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stdd 746 (837)
|||+. ++|.+.+.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++. +.++|+|||++......
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~---- 152 (282)
T cd07831 79 FELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK---- 152 (282)
T ss_pred EecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccC----
Confidence 99996 588887765 356899999999999999999999999999999999999999 99999999998631000
Q ss_pred CCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 747 l~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
.......++..|+|||++.+ ..++.++|||||||++|+|++|..||.+.++
T Consensus 153 ----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~ 204 (282)
T cd07831 153 ----------------------------PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE 204 (282)
T ss_pred ----------------------------CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH
Confidence 00112357889999998754 5568899999999999999999999977543
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-30 Score=269.96 Aligned_cols=199 Identities=30% Similarity=0.498 Sum_probs=172.1
Q ss_pred CeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEE
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmE 669 (837)
.|+..+.||+|+||.||++.+..++..+|+|.+.............+.+|+.+++.++|||++++++++......|+|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 38889999999999999999999999999999876544445556788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCC
Q 003232 670 YLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (837)
Q Consensus 670 y~~GGSL~dlLk~-~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~ 748 (837)
|+.| +|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 106 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~-------- 176 (317)
T cd06635 106 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS-------- 176 (317)
T ss_pred CCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccC--------
Confidence 9964 77777754 4568999999999999999999999999999999999999999999999999875210
Q ss_pred CCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhc---CCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL---GTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 749 ~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLl---g~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
......|++.|+|||++. +..++.++|||||||++|+|++|..||...+
T Consensus 177 ---------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 228 (317)
T cd06635 177 ---------------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 228 (317)
T ss_pred ---------------------------CcccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc
Confidence 011235788999999984 4567889999999999999999999997654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=284.82 Aligned_cols=211 Identities=27% Similarity=0.400 Sum_probs=174.5
Q ss_pred CCCcccCCeEEEEEecccCceEEEEEEEC-----CCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcC-CCceEEEEe
Q 003232 583 KDRTSIDDFEIIKPISRGAFGRVFLAKKR-----TTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFY 656 (837)
Q Consensus 583 k~g~~lddYeIlkkLGsG~FGtVYkArdk-----~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~Lr-HPNIVkL~g 656 (837)
.+....++|.+.+.||.|+||.||+|++. .+++.||+|+++... .......+.+|+.++..+. ||||+++++
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~ 108 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLG 108 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEE
Confidence 45666778999999999999999999964 345689999997643 2233457889999999997 999999999
Q ss_pred EeecCCeEEEEEEecCCCCHHHHHHhcC----------------------------------------------------
Q 003232 657 SFTCRENLYLVMEYLNGGDLYSLLRNLG---------------------------------------------------- 684 (837)
Q Consensus 657 sf~d~~~lyLVmEy~~GGSL~dlLk~~g---------------------------------------------------- 684 (837)
++......|+||||+.+|+|.+++...+
T Consensus 109 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (401)
T cd05107 109 ACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD 188 (401)
T ss_pred EEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence 9999999999999999999999986431
Q ss_pred ----------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCC
Q 003232 685 ----------------------------------------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPD 718 (837)
Q Consensus 685 ----------------------------------------------~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPe 718 (837)
.++...+..++.||+.||.|||+.|++||||||+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~ 268 (401)
T cd05107 189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAAR 268 (401)
T ss_pred ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcc
Confidence 2566678889999999999999999999999999
Q ss_pred cEEEccCCcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCC
Q 003232 719 NLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHG 798 (837)
Q Consensus 719 NILLd~dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s 798 (837)
|||++.++.++|+|||+++....... ........|++.|+|||++.+..++
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~ 319 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSN-----------------------------YISKGSTFLPLKWMAPESIFNNLYT 319 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccc-----------------------------cccCCCcCCCCceeChHHhcCCCCC
Confidence 99999999999999999863111000 0011233577889999999998899
Q ss_pred chHHHHHHHHHHHHHHc-CCCCCCCCC
Q 003232 799 TTADWWSVGIILFELIV-GIPPFNAEH 824 (837)
Q Consensus 799 ~kSDIWSLGVILyELLT-Gr~PF~~~d 824 (837)
.++||||||+++|||++ |..||....
T Consensus 320 ~~~DvwslGvil~e~l~~g~~P~~~~~ 346 (401)
T cd05107 320 TLSDVWSFGILLWEIFTLGGTPYPELP 346 (401)
T ss_pred cHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999998 899997543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=267.43 Aligned_cols=216 Identities=30% Similarity=0.493 Sum_probs=170.5
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecC------
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR------ 661 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~------ 661 (837)
.++|++.+.||.|+||.||+|.++.+++.+|+|.+..... .......+.+|+++++.++||||+++++.+...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE-KDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccC-CCCcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 5789999999999999999999999999999999865432 111223567899999999999999999877543
Q ss_pred --CeEEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccc
Q 003232 662 --ENLYLVMEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (837)
Q Consensus 662 --~~lyLVmEy~~GGSL~dlLk~-~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArv 738 (837)
..+|+||||+. ++|...+.. ...+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++..
T Consensus 86 ~~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 164 (311)
T cd07866 86 KRGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP 164 (311)
T ss_pred cCceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence 35799999995 467777654 35699999999999999999999999999999999999999999999999999874
Q ss_pred cccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHcCC
Q 003232 739 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGI 817 (837)
Q Consensus 739 g~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLTGr 817 (837)
........... ............|++.|+|||++.+ ..++.++||||||+++|+|++|+
T Consensus 165 ~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~ 224 (311)
T cd07866 165 YDGPPPNPKGG--------------------GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224 (311)
T ss_pred ccCCCcccccC--------------------CcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCC
Confidence 21111100000 0000112234567899999999865 45789999999999999999999
Q ss_pred CCCCCCCc
Q 003232 818 PPFNAEHP 825 (837)
Q Consensus 818 ~PF~~~dp 825 (837)
+||.+.++
T Consensus 225 ~~~~~~~~ 232 (311)
T cd07866 225 PILQGKSD 232 (311)
T ss_pred CCCCCCCH
Confidence 99976543
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-31 Score=266.53 Aligned_cols=192 Identities=24% Similarity=0.417 Sum_probs=159.6
Q ss_pred EecccCceEEEEEEECCCCcE-------EEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEE
Q 003232 596 PISRGAFGRVFLAKKRTTGDL-------FAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 596 kLGsG~FGtVYkArdk~tG~~-------VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVm 668 (837)
.||.|+||+||+|.+...+.. +++|.+... .....+.+.+|..+++.++||||+++++.+......++||
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcch---hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 589999999999998665443 888887543 2344567888999999999999999999999989999999
Q ss_pred EecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCc--------EEEEecCCcccc
Q 003232 669 EYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGH--------IKLTDFGLSKVG 739 (837)
Q Consensus 669 Ey~~GGSL~dlLk~~g-~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~--------IKLiDFGLArvg 739 (837)
||+++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+||+++.++. ++++|||++...
T Consensus 79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~ 158 (258)
T cd05078 79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV 158 (258)
T ss_pred ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence 9999999999997644 5899999999999999999999999999999999999987765 688999876520
Q ss_pred ccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHcC-C
Q 003232 740 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVG-I 817 (837)
Q Consensus 740 ~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLTG-r 817 (837)
. ......+++.|+|||++.+ ..++.++||||||+++|+|++| .
T Consensus 159 ~-----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~ 203 (258)
T cd05078 159 L-----------------------------------PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGD 203 (258)
T ss_pred C-----------------------------------CchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCC
Confidence 0 0112357788999999986 4578999999999999999998 5
Q ss_pred CCCCCCCc
Q 003232 818 PPFNAEHP 825 (837)
Q Consensus 818 ~PF~~~dp 825 (837)
+||...++
T Consensus 204 ~~~~~~~~ 211 (258)
T cd05078 204 KPLSALDS 211 (258)
T ss_pred CChhhccH
Confidence 67665443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-30 Score=256.31 Aligned_cols=197 Identities=52% Similarity=0.981 Sum_probs=174.9
Q ss_pred ecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEEecCCCCH
Q 003232 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 676 (837)
Q Consensus 597 LGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmEy~~GGSL 676 (837)
||.|+||.||++.+..+++.+++|++.............+.+|+.+++.++||||+++++.+......|+||||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 68999999999999888999999999876544455677899999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCCCccCcc
Q 003232 677 YSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 756 (837)
Q Consensus 677 ~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~Sgtt 756 (837)
.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~------------- 147 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG------------- 147 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-------------
Confidence 9999887789999999999999999999999999999999999999999999999999876311000
Q ss_pred cCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 757 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 757 Ll~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
.......|+..|++||.+.+..++.++|+||||+++|++++|..||...+
T Consensus 148 ------------------~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~ 197 (250)
T cd05123 148 ------------------SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED 197 (250)
T ss_pred ------------------CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 01224467889999999998888999999999999999999999997665
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=263.00 Aligned_cols=198 Identities=28% Similarity=0.473 Sum_probs=164.2
Q ss_pred EecccCceEEEEEEECCCC------cEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEE
Q 003232 596 PISRGAFGRVFLAKKRTTG------DLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (837)
Q Consensus 596 kLGsG~FGtVYkArdk~tG------~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmE 669 (837)
.||.|+||.||+|++.... +.+|+|.+.... .......+.+|+.+++.++||||+++++++......++|||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 5899999999999986543 689999886532 22345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCC-----cEEEEecCCcc
Q 003232 670 YLNGGDLYSLLRNL-------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG-----HIKLTDFGLSK 737 (837)
Q Consensus 670 y~~GGSL~dlLk~~-------g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG-----~IKLiDFGLAr 737 (837)
|+++++|.+++... ..+++..+..++.||+.||.|||+.+++|+||+|+||+++.++ .++|+|||++.
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~ 159 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence 99999999998642 2378889999999999999999999999999999999999877 89999999986
Q ss_pred ccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-C
Q 003232 738 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-G 816 (837)
Q Consensus 738 vg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-G 816 (837)
....... ........++..|+|||++.+..++.++|||||||++|+|++ |
T Consensus 160 ~~~~~~~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g 210 (269)
T cd05044 160 DIYKSDY-----------------------------YRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLG 210 (269)
T ss_pred ccccccc-----------------------------cccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcC
Confidence 3110000 001112345778999999999899999999999999999998 9
Q ss_pred CCCCCCCC
Q 003232 817 IPPFNAEH 824 (837)
Q Consensus 817 r~PF~~~d 824 (837)
..||...+
T Consensus 211 ~~p~~~~~ 218 (269)
T cd05044 211 QQPYPALN 218 (269)
T ss_pred CCCCcccC
Confidence 99997543
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=275.22 Aligned_cols=207 Identities=29% Similarity=0.438 Sum_probs=173.1
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeec----CCeE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC----RENL 664 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d----~~~l 664 (837)
++|++.+.||.|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++.. ...+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAF-DVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccc-ccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 57999999999999999999999999999999987543 222345677889999999999999999887753 3578
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCC
Q 003232 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~st 744 (837)
|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++........
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 99999995 68999998777899999999999999999999999999999999999999999999999999863111000
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003232 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAE 823 (837)
Q Consensus 745 ddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLTGr~PF~~~ 823 (837)
. .........|+..|+|||++.+ ..++.++|||||||++|+|++|+.||...
T Consensus 163 ~---------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 215 (334)
T cd07855 163 E---------------------------HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGK 215 (334)
T ss_pred C---------------------------CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCC
Confidence 0 0001123468899999999866 45789999999999999999999999765
Q ss_pred C
Q 003232 824 H 824 (837)
Q Consensus 824 d 824 (837)
+
T Consensus 216 ~ 216 (334)
T cd07855 216 N 216 (334)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-30 Score=273.45 Aligned_cols=201 Identities=32% Similarity=0.509 Sum_probs=171.5
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC----
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE---- 662 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~---- 662 (837)
..++|++++.||.|+||.||++.+..++..||+|++.... ........+.+|+.+++.++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 4567999999999999999999999999999999986532 22334456889999999999999999999887643
Q ss_pred --eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccc
Q 003232 663 --NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740 (837)
Q Consensus 663 --~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~ 740 (837)
.+|+||||+ |++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++....
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 169 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD 169 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence 469999998 7899988865 578999999999999999999999999999999999999999999999999876210
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCC
Q 003232 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPP 819 (837)
Q Consensus 741 ~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLTGr~P 819 (837)
.......+++.|+|||++.+ ..++.++|+||||+++|+|++|..|
T Consensus 170 ----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p 215 (343)
T cd07880 170 ----------------------------------SEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPL 215 (343)
T ss_pred ----------------------------------cCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 00112357888999999876 4578999999999999999999999
Q ss_pred CCCCC
Q 003232 820 FNAEH 824 (837)
Q Consensus 820 F~~~d 824 (837)
|...+
T Consensus 216 f~~~~ 220 (343)
T cd07880 216 FKGHD 220 (343)
T ss_pred CCCCC
Confidence 98654
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-30 Score=262.45 Aligned_cols=191 Identities=21% Similarity=0.330 Sum_probs=159.5
Q ss_pred EecccCceEEEEEEECCC------------CcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCe
Q 003232 596 PISRGAFGRVFLAKKRTT------------GDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCREN 663 (837)
Q Consensus 596 kLGsG~FGtVYkArdk~t------------G~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ 663 (837)
.||.|+||.||+|..... ...+++|++.... ......+.+|+.+++.++||||+++++++.....
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 589999999999986422 2358889876532 3344578889999999999999999999999889
Q ss_pred EEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCc-------EEEEecCC
Q 003232 664 LYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGH-------IKLTDFGL 735 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~-------IKLiDFGL 735 (837)
.++||||+++++|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++. ++++|||+
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~ 158 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158 (262)
T ss_pred CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence 99999999999999988753 56899999999999999999999999999999999999987664 89999998
Q ss_pred ccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhc-CCCCCchHHHHHHHHHHHHHH
Q 003232 736 SKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-GTGHGTTADWWSVGIILFELI 814 (837)
Q Consensus 736 Arvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLl-g~~~s~kSDIWSLGVILyELL 814 (837)
+.... ......|+..|+|||++. +..++.++|||||||++|+|+
T Consensus 159 ~~~~~-----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~ 203 (262)
T cd05077 159 PITVL-----------------------------------SRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEIC 203 (262)
T ss_pred Ccccc-----------------------------------CcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHH
Confidence 75210 011235778899999987 567899999999999999998
Q ss_pred -cCCCCCCCCC
Q 003232 815 -VGIPPFNAEH 824 (837)
Q Consensus 815 -TGr~PF~~~d 824 (837)
+|..||....
T Consensus 204 ~~~~~p~~~~~ 214 (262)
T cd05077 204 YNGEIPLKDKT 214 (262)
T ss_pred hCCCCCCCCcc
Confidence 6899987644
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-30 Score=265.49 Aligned_cols=207 Identities=33% Similarity=0.548 Sum_probs=170.3
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC---
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE--- 662 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~--- 662 (837)
...++|++.+.||.|+||.||+|.++.+++.||+|+++.... .......+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 345779999999999999999999999999999999975431 2223346778999999999999999999887654
Q ss_pred -------eEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecC
Q 003232 663 -------NLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFG 734 (837)
Q Consensus 663 -------~lyLVmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFG 734 (837)
.+|+||||+++ +|...+... ..+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccc
Confidence 79999999976 777777653 468999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHH
Q 003232 735 LSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFEL 813 (837)
Q Consensus 735 LArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyEL 813 (837)
++........ .......++..|+|||++.+ ..++.++|||||||++|+|
T Consensus 162 ~~~~~~~~~~------------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el 211 (302)
T cd07864 162 LARLYNSEES------------------------------RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 211 (302)
T ss_pred ccccccCCcc------------------------------cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHH
Confidence 8863111100 00112345778999998865 3568899999999999999
Q ss_pred HcCCCCCCCCC
Q 003232 814 IVGIPPFNAEH 824 (837)
Q Consensus 814 LTGr~PF~~~d 824 (837)
++|++||....
T Consensus 212 ~~g~~~~~~~~ 222 (302)
T cd07864 212 FTKKPIFQANQ 222 (302)
T ss_pred HhCCCCCCCCC
Confidence 99999997643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-30 Score=260.55 Aligned_cols=200 Identities=33% Similarity=0.522 Sum_probs=167.8
Q ss_pred eEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhc---CCCceEEEEeEeecCCe----
Q 003232 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV---RNPFVVRFFYSFTCREN---- 663 (837)
Q Consensus 591 YeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L---rHPNIVkL~gsf~d~~~---- 663 (837)
|++.+.||.|+||.||+|+++.+++.||+|++..... .......+.+|+.+++.+ +||||+++++.+.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 7889999999999999999988899999999975432 222234566777777665 69999999999988766
Q ss_pred -EEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccc
Q 003232 664 -LYLVMEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740 (837)
Q Consensus 664 -lyLVmEy~~GGSL~dlLk~~g--~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~ 740 (837)
++++|||+. ++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 80 ~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 999999996 48998887643 48999999999999999999999999999999999999999999999999886311
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCC
Q 003232 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820 (837)
Q Consensus 741 ~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF 820 (837)
.. .......++..|+|||++.+..++.++|+|||||++|+|++|.+||
T Consensus 159 ~~--------------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~ 206 (287)
T cd07838 159 FE--------------------------------MALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLF 206 (287)
T ss_pred CC--------------------------------cccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcc
Confidence 00 0011234788899999999999999999999999999999999999
Q ss_pred CCCC
Q 003232 821 NAEH 824 (837)
Q Consensus 821 ~~~d 824 (837)
....
T Consensus 207 ~~~~ 210 (287)
T cd07838 207 RGTS 210 (287)
T ss_pred cCCC
Confidence 8655
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=293.62 Aligned_cols=204 Identities=25% Similarity=0.365 Sum_probs=159.5
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCC-cEEEEEE--------------ecccccccHHHHHHHHHHHHHHHhcCCCc
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTG-DLFAIKV--------------LKKADMIRKNAVESILAERDILISVRNPF 650 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG-~~VAVKI--------------ikk~~~~~~e~ie~~~rEieILk~LrHPN 650 (837)
...++|++++.||+|+||+||+|..+... ...+.|. +.+...........+.+|+.+++.++|||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 34567999999999999999998765332 2222221 11111112234456889999999999999
Q ss_pred eEEEEeEeecCCeEEEEEEecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccC
Q 003232 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-----GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD 725 (837)
Q Consensus 651 IVkL~gsf~d~~~lyLVmEy~~GGSL~dlLk~~-----g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~d 725 (837)
|+++++++......|+|++++ +++|.+++... .......++.++.||+.||.|||++|||||||||+|||++.+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~ 303 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD 303 (501)
T ss_pred cCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence 999999999999999999998 46777776432 223466788899999999999999999999999999999999
Q ss_pred CcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHH
Q 003232 726 GHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWS 805 (837)
Q Consensus 726 G~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWS 805 (837)
+.+||+|||+++...... ........||+.|+|||++.+..++.++||||
T Consensus 304 ~~vkL~DFGla~~~~~~~------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 353 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKER------------------------------EAFDYGWVGTVATNSPEILAGDGYCEITDIWS 353 (501)
T ss_pred CCEEEEeCCCceecCccc------------------------------ccccccccCCcCCCCchhhcCCCCCcHHHHHH
Confidence 999999999986311000 00112357999999999999999999999999
Q ss_pred HHHHHHHHHcCCCCC
Q 003232 806 VGIILFELIVGIPPF 820 (837)
Q Consensus 806 LGVILyELLTGr~PF 820 (837)
|||++|||++|..++
T Consensus 354 lGvil~ell~~~~~p 368 (501)
T PHA03210 354 CGLILLDMLSHDFCP 368 (501)
T ss_pred HHHHHHHHHHCCCCC
Confidence 999999999987543
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=274.27 Aligned_cols=204 Identities=32% Similarity=0.476 Sum_probs=172.3
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecC-----C
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR-----E 662 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~-----~ 662 (837)
.++|++.+.||.|+||+||++++..+++.||+|.+.... ........+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAF-DNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccc-cccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 357999999999999999999999999999999987543 2233345677899999999999999999877643 3
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccC
Q 003232 663 NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (837)
Q Consensus 663 ~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~ 742 (837)
..|+||||+. ++|.+++...+.+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~- 160 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE- 160 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC-
Confidence 5899999995 78999998878899999999999999999999999999999999999999999999999999863100
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCC
Q 003232 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFN 821 (837)
Q Consensus 743 stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLTGr~PF~ 821 (837)
.. .......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.
T Consensus 161 -~~-----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 210 (337)
T cd07858 161 -KG-----------------------------DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFP 210 (337)
T ss_pred -Cc-----------------------------ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCC
Confidence 00 00123457889999999875 468899999999999999999999997
Q ss_pred CCC
Q 003232 822 AEH 824 (837)
Q Consensus 822 ~~d 824 (837)
+.+
T Consensus 211 ~~~ 213 (337)
T cd07858 211 GKD 213 (337)
T ss_pred CCC
Confidence 653
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=265.17 Aligned_cols=193 Identities=24% Similarity=0.355 Sum_probs=159.2
Q ss_pred EecccCceEEEEEEECCC------------------------CcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCce
Q 003232 596 PISRGAFGRVFLAKKRTT------------------------GDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFV 651 (837)
Q Consensus 596 kLGsG~FGtVYkArdk~t------------------------G~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNI 651 (837)
.||+|+||.||+|....+ ...|++|++.... ......+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 589999999999975321 2358889886532 2334578889999999999999
Q ss_pred EEEEeEeecCCeEEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCC----
Q 003232 652 VRFFYSFTCRENLYLVMEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG---- 726 (837)
Q Consensus 652 VkL~gsf~d~~~lyLVmEy~~GGSL~dlLk~-~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG---- 726 (837)
+++++++......|+||||+++++|..++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999999865 46689999999999999999999999999999999999997643
Q ss_pred ---cEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHH
Q 003232 727 ---HIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTAD 802 (837)
Q Consensus 727 ---~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSD 802 (837)
.++++|||++.... ......++..|+|||.+.+ ..++.++|
T Consensus 159 ~~~~~kl~d~g~~~~~~-----------------------------------~~~~~~~~~~~~aPe~~~~~~~~~~~~D 203 (274)
T cd05076 159 TSPFIKLSDPGVSFTAL-----------------------------------SREERVERIPWIAPECVPGGNSLSTAAD 203 (274)
T ss_pred ccceeeecCCccccccc-----------------------------------cccccccCCcccCchhhcCCCCCCcHHH
Confidence 37999999875200 0012346778999998875 56899999
Q ss_pred HHHHHHHHHHHH-cCCCCCCCCCcC
Q 003232 803 WWSVGIILFELI-VGIPPFNAEHPQ 826 (837)
Q Consensus 803 IWSLGVILyELL-TGr~PF~~~dpd 826 (837)
|||||+++|+|+ +|..||....+.
T Consensus 204 v~slG~~l~el~~~g~~p~~~~~~~ 228 (274)
T cd05076 204 KWSFGTTLLEICFDGEVPLKERTPS 228 (274)
T ss_pred HHHHHHHHHHHHhCCCCCccccChH
Confidence 999999999985 799999876543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-30 Score=272.71 Aligned_cols=201 Identities=31% Similarity=0.493 Sum_probs=170.0
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecC-----
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR----- 661 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~----- 661 (837)
..++|++.+.||+|+||.||++.+..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 93 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence 3477999999999999999999999999999999987643 2233346788899999999999999999887643
Q ss_pred -CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccc
Q 003232 662 -ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740 (837)
Q Consensus 662 -~~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~ 740 (837)
...|++++++ |++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++....
T Consensus 94 ~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~ 171 (345)
T cd07877 94 FNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 171 (345)
T ss_pred cccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccc
Confidence 3478888887 7899888765 468999999999999999999999999999999999999999999999999876210
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCC
Q 003232 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPP 819 (837)
Q Consensus 741 ~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLTGr~P 819 (837)
.......|+..|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus 172 ----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~p 217 (345)
T cd07877 172 ----------------------------------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 217 (345)
T ss_pred ----------------------------------ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCC
Confidence 00123467889999999876 5678899999999999999999999
Q ss_pred CCCCC
Q 003232 820 FNAEH 824 (837)
Q Consensus 820 F~~~d 824 (837)
|...+
T Consensus 218 f~~~~ 222 (345)
T cd07877 218 FPGTD 222 (345)
T ss_pred CCCCC
Confidence 97644
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-30 Score=257.72 Aligned_cols=198 Identities=26% Similarity=0.365 Sum_probs=159.0
Q ss_pred EecccCceEEEEEEECC---CCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEee-cCCeEEEEEEec
Q 003232 596 PISRGAFGRVFLAKKRT---TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFT-CRENLYLVMEYL 671 (837)
Q Consensus 596 kLGsG~FGtVYkArdk~---tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~-d~~~lyLVmEy~ 671 (837)
.||.|+||.||+|.+.. .+..+|+|.+... ........+.+|+.+++.++||||+++++.+. .....++||||+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 58999999999998753 3457999987542 22344567889999999999999999999765 455689999999
Q ss_pred CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCC
Q 003232 672 NGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 750 (837)
Q Consensus 672 ~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p 750 (837)
.+++|.+++... ..++...+..++.||+.||.|||+.|++||||||+|||++.++.++|+|||+++....... .
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~---~-- 154 (262)
T cd05058 80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY---Y-- 154 (262)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcc---e--
Confidence 999999999764 3467788888999999999999999999999999999999999999999999863110000 0
Q ss_pred CccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcC-CCCCCC
Q 003232 751 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVG-IPPFNA 822 (837)
Q Consensus 751 ~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTG-r~PF~~ 822 (837)
.........++..|+|||.+.+..++.++||||||+++|+|++| .+||..
T Consensus 155 ----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~ 205 (262)
T cd05058 155 ----------------------SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 205 (262)
T ss_pred ----------------------eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC
Confidence 00001123456789999999988999999999999999999995 666654
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-30 Score=262.71 Aligned_cols=204 Identities=43% Similarity=0.829 Sum_probs=172.7
Q ss_pred CeEEEEEecccCceEEEEEEEC---CCCcEEEEEEecccccc-cHHHHHHHHHHHHHHHhc-CCCceEEEEeEeecCCeE
Q 003232 590 DFEIIKPISRGAFGRVFLAKKR---TTGDLFAIKVLKKADMI-RKNAVESILAERDILISV-RNPFVVRFFYSFTCRENL 664 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk---~tG~~VAVKIikk~~~~-~~e~ie~~~rEieILk~L-rHPNIVkL~gsf~d~~~l 664 (837)
+|++.+.||.|+||.||++++. .+++.||+|+++..... .......+.+|+.++.++ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4889999999999999999864 46788999998754322 233456788999999999 599999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCC
Q 003232 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~st 744 (837)
|+||||+.+++|.+++.....+++..++.++.|++.+|.|||+.|++|+||+|.||+++.++.++|+|||+++......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 159 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE- 159 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccc-
Confidence 9999999999999999877789999999999999999999999999999999999999999999999999876311000
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCC--CCchHHHHHHHHHHHHHHcCCCCCCC
Q 003232 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG--HGTTADWWSVGIILFELIVGIPPFNA 822 (837)
Q Consensus 745 ddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~--~s~kSDIWSLGVILyELLTGr~PF~~ 822 (837)
........|+..|+|||.+.+.. .+.++|+||||+++|+|++|..||..
T Consensus 160 -----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 210 (288)
T cd05583 160 -----------------------------EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV 210 (288)
T ss_pred -----------------------------ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCccc
Confidence 00112346888999999987654 68899999999999999999999964
Q ss_pred C
Q 003232 823 E 823 (837)
Q Consensus 823 ~ 823 (837)
.
T Consensus 211 ~ 211 (288)
T cd05583 211 D 211 (288)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=267.36 Aligned_cols=198 Identities=30% Similarity=0.491 Sum_probs=171.2
Q ss_pred eEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEEe
Q 003232 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEY 670 (837)
Q Consensus 591 YeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmEy 670 (837)
|...+.||.|+||+||+|.+..++..|++|++.............+.+|+.+++.++|||++++++++......|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 77788899999999999999999999999999765444445556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCC
Q 003232 671 LNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 749 (837)
Q Consensus 671 ~~GGSL~dlLk~-~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~ 749 (837)
+. ++|.+++.. ...+++..+..++.||+.+|.|||++|++|+||+|+||+++.++.++|+|||++...
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~---------- 171 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKS---------- 171 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCccc----------
Confidence 95 577777754 456899999999999999999999999999999999999999999999999987520
Q ss_pred CCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhc---CCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 750 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL---GTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 750 p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLl---g~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
.......|+..|+|||++. +..++.++||||||+++|+|++|..||...+
T Consensus 172 -------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~ 224 (313)
T cd06633 172 -------------------------SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 224 (313)
T ss_pred -------------------------CCCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 0012346788999999984 4567889999999999999999999997654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=269.02 Aligned_cols=206 Identities=32% Similarity=0.456 Sum_probs=169.7
Q ss_pred CeEEEEEecccCceEEEEEEECCC--CcEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEeEeec----CC
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTT--GDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTC----RE 662 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~t--G~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~gsf~d----~~ 662 (837)
+|++.+.||.|+||.||++++..+ +..||+|.+.... ......+.+.+|+.+++.+ +||||+++++.+.. ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 489999999999999999999888 8999999986432 2233345778899999998 59999999986532 24
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccC
Q 003232 663 NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (837)
Q Consensus 663 ~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~ 742 (837)
.+|++++|+. ++|.+++.....+++..++.++.||+.||.|||+.|++||||||+|||++.++.++|+|||+++.....
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 5789999885 699999987788999999999999999999999999999999999999999999999999998732111
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCC
Q 003232 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFN 821 (837)
Q Consensus 743 stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLTGr~PF~ 821 (837)
... .........||+.|+|||++.+ ..++.++||||||+++|+|++|.+||.
T Consensus 159 ~~~---------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~ 211 (332)
T cd07857 159 PGE---------------------------NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFK 211 (332)
T ss_pred ccc---------------------------ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCC
Confidence 000 0001123578999999998866 568999999999999999999999998
Q ss_pred CCC
Q 003232 822 AEH 824 (837)
Q Consensus 822 ~~d 824 (837)
..+
T Consensus 212 ~~~ 214 (332)
T cd07857 212 GKD 214 (332)
T ss_pred CCC
Confidence 654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=258.70 Aligned_cols=203 Identities=33% Similarity=0.616 Sum_probs=171.5
Q ss_pred CeEEEEEecccCceEEEEEEECC-CCcEEEEEEeccccc-------ccHHHHHHHHHHHHHHHh-cCCCceEEEEeEeec
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRT-TGDLFAIKVLKKADM-------IRKNAVESILAERDILIS-VRNPFVVRFFYSFTC 660 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~-tG~~VAVKIikk~~~-------~~~e~ie~~~rEieILk~-LrHPNIVkL~gsf~d 660 (837)
+|++.+.||.|+||.||+|.+.. .++.+|+|.+..... ........+..|+.++.. ++||||+++++.+..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999999987 678999998864221 223445667888888864 799999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCcEEEccCCcEEEEecCC
Q 003232 661 RENLYLVMEYLNGGDLYSLLRN----LGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGL 735 (837)
Q Consensus 661 ~~~lyLVmEy~~GGSL~dlLk~----~g~Lsee~irkIl~QIa~ALsYLHS-kGIIHRDIKPeNILLd~dG~IKLiDFGL 735 (837)
..+.|+||||++|++|.+++.. ...+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999988743 3468999999999999999999996 7899999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc
Q 003232 736 SKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV 815 (837)
Q Consensus 736 Arvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT 815 (837)
+....... ......|+..|+|||++.+..++.++|+||||+++|+|++
T Consensus 161 ~~~~~~~~--------------------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~ 208 (269)
T cd08528 161 AKQKQPES--------------------------------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT 208 (269)
T ss_pred eeeccccc--------------------------------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHh
Confidence 86311000 1123468889999999998889999999999999999999
Q ss_pred CCCCCCCCC
Q 003232 816 GIPPFNAEH 824 (837)
Q Consensus 816 Gr~PF~~~d 824 (837)
|+.||....
T Consensus 209 g~~p~~~~~ 217 (269)
T cd08528 209 LQPPFYSTN 217 (269)
T ss_pred CCCcccccC
Confidence 999997643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=292.86 Aligned_cols=206 Identities=34% Similarity=0.616 Sum_probs=177.8
Q ss_pred eEEE--EEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEE
Q 003232 591 FEII--KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 591 YeIl--kkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVm 668 (837)
|+|. +.||+|.||+||-|.++++|+.||||++.+.... .....++.+|+.||++++||.||.+.-.|...+.+++||
T Consensus 564 YQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp-~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVM 642 (888)
T KOG4236|consen 564 YQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFP-TKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVM 642 (888)
T ss_pred HHhhhHhhccCCcceeeecceecccCceeeeeeeecccCC-CchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEe
Confidence 6654 7999999999999999999999999999876643 333478999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEcc---CCcEEEEecCCccccccCC
Q 003232 669 EYLNGGDLYSLLR--NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 669 Ey~~GGSL~dlLk--~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~---dG~IKLiDFGLArvg~~~s 743 (837)
|-+. |++.+++- ..+.+++...+.++.||+.||.|||-+||+|+||||+|||+.. .-.+||||||+|++...
T Consensus 643 EKl~-GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE-- 719 (888)
T KOG4236|consen 643 EKLH-GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE-- 719 (888)
T ss_pred hhhc-chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecch--
Confidence 9995 56666653 4578999999999999999999999999999999999999965 45799999999985211
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~ 823 (837)
..-.++.+|||.|+|||++.+++|+..-|+||+|||+|--|.|..||+.+
T Consensus 720 ------------------------------ksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd 769 (888)
T KOG4236|consen 720 ------------------------------KSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED 769 (888)
T ss_pred ------------------------------hhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc
Confidence 11234679999999999999999999999999999999999999999876
Q ss_pred CcCHHHH
Q 003232 824 HPQVSTL 830 (837)
Q Consensus 824 dpdv~~l 830 (837)
.+--+|+
T Consensus 770 EdIndQI 776 (888)
T KOG4236|consen 770 EDINDQI 776 (888)
T ss_pred cchhHHh
Confidence 6544444
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=271.08 Aligned_cols=206 Identities=31% Similarity=0.483 Sum_probs=176.0
Q ss_pred CeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC-----eE
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE-----NL 664 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~-----~l 664 (837)
+|++.+.||.|+||.||+|++..++..||+|.+.... ......+.+.+|+.+++.++||||+++++++.... .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 5899999999999999999998889999999987643 22344567899999999999999999999988765 78
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCC
Q 003232 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~st 744 (837)
|+||||+. ++|.+++.....+++..+..++.||+.||.|||+.||+|+||||.|||++.++.++|+|||++........
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 80 YIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred EEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 99999996 58999998877899999999999999999999999999999999999999999999999999874211100
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003232 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAE 823 (837)
Q Consensus 745 ddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~-~~s~kSDIWSLGVILyELLTGr~PF~~~ 823 (837)
. ........+++.|+|||++.+. .++.++|+||||+++|+|++|.+||.+.
T Consensus 159 ~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~ 210 (330)
T cd07834 159 E----------------------------KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGR 210 (330)
T ss_pred c----------------------------cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCC
Confidence 0 0012234678899999999887 7899999999999999999999999776
Q ss_pred Cc
Q 003232 824 HP 825 (837)
Q Consensus 824 dp 825 (837)
+.
T Consensus 211 ~~ 212 (330)
T cd07834 211 DY 212 (330)
T ss_pred CH
Confidence 53
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-30 Score=259.54 Aligned_cols=205 Identities=23% Similarity=0.361 Sum_probs=166.4
Q ss_pred eEEEEEecccCceEEEEEEECC---CCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC-----
Q 003232 591 FEIIKPISRGAFGRVFLAKKRT---TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE----- 662 (837)
Q Consensus 591 YeIlkkLGsG~FGtVYkArdk~---tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~----- 662 (837)
|.+.+.||.|+||.||+|.+.. +++.||+|++.... ......+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI-FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc-CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 6678899999999999998653 57899999997543 33445677889999999999999999999876532
Q ss_pred -eEEEEEEecCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCC
Q 003232 663 -NLYLVMEYLNGGDLYSLLRNL------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGL 735 (837)
Q Consensus 663 -~lyLVmEy~~GGSL~dlLk~~------g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGL 735 (837)
..+++++|+.+++|.+++... ..++...+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 357899999999999887432 2478899999999999999999999999999999999999999999999998
Q ss_pred ccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc
Q 003232 736 SKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV 815 (837)
Q Consensus 736 Arvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT 815 (837)
++....... ........+++.|++||.+.+..++.++|||||||++|+|++
T Consensus 160 ~~~~~~~~~-----------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~ 210 (273)
T cd05074 160 SKKIYSGDY-----------------------------YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210 (273)
T ss_pred cccccCCcc-----------------------------eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhh
Confidence 863110000 000112235567999999999999999999999999999999
Q ss_pred -CCCCCCCCCc
Q 003232 816 -GIPPFNAEHP 825 (837)
Q Consensus 816 -Gr~PF~~~dp 825 (837)
|.+||...+.
T Consensus 211 ~g~~p~~~~~~ 221 (273)
T cd05074 211 RGQTPYAGVEN 221 (273)
T ss_pred CCCCCCCCCCH
Confidence 8999976543
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=280.17 Aligned_cols=209 Identities=37% Similarity=0.746 Sum_probs=187.8
Q ss_pred CCCCcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHh-cCCCceEEEEeEeec
Q 003232 582 SKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILIS-VRNPFVVRFFYSFTC 660 (837)
Q Consensus 582 ~k~g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~-LrHPNIVkL~gsf~d 660 (837)
..+...+++|.++++||.|+|+.|.+++++.+.+.||+|++++.-....+.+.-...|-.+... .+||++|-++..|..
T Consensus 243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt 322 (593)
T KOG0695|consen 243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT 322 (593)
T ss_pred cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence 4567778999999999999999999999999999999999998665555666666777777755 479999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccc
Q 003232 661 RENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740 (837)
Q Consensus 661 ~~~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~ 740 (837)
+..+++|.||++||+|.-.+.+...++++.++.|..+|+.||+|||++|||.||||.+|+|++..|++||.|+|+++-+.
T Consensus 323 esrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 323 ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred cceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCC
Confidence 99999999999999999999888899999999999999999999999999999999999999999999999999998421
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCC
Q 003232 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820 (837)
Q Consensus 741 ~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF 820 (837)
.+ +..+.+.+|||.|+|||++.|..|+..+|+|+|||+||||+.|+-||
T Consensus 403 ~~-------------------------------gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspf 451 (593)
T KOG0695|consen 403 GP-------------------------------GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPF 451 (593)
T ss_pred CC-------------------------------CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCc
Confidence 11 11245789999999999999999999999999999999999999999
Q ss_pred C
Q 003232 821 N 821 (837)
Q Consensus 821 ~ 821 (837)
.
T Consensus 452 d 452 (593)
T KOG0695|consen 452 D 452 (593)
T ss_pred c
Confidence 6
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=268.09 Aligned_cols=219 Identities=27% Similarity=0.395 Sum_probs=173.7
Q ss_pred CCeEE-EEEecccCceEEEEEEECCCCcEEEEEEecccccccHH-----------HHHHHHHHHHHHHhcCCCceEEEEe
Q 003232 589 DDFEI-IKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKN-----------AVESILAERDILISVRNPFVVRFFY 656 (837)
Q Consensus 589 ddYeI-lkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e-----------~ie~~~rEieILk~LrHPNIVkL~g 656 (837)
++|.. .+.||.|+||+||+|.+..+++.||+|++......... ....+.+|+.+++.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45654 47799999999999999999999999998754322100 1124778999999999999999999
Q ss_pred EeecCCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCc
Q 003232 657 SFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS 736 (837)
Q Consensus 657 sf~d~~~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLA 736 (837)
++......|+||||+. ++|.+++.....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~ 166 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLA 166 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccce
Confidence 9999999999999996 699999988778999999999999999999999999999999999999999999999999998
Q ss_pred cccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCC-CCCchHHHHHHHHHHHHHHc
Q 003232 737 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIV 815 (837)
Q Consensus 737 rvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~-~~s~kSDIWSLGVILyELLT 815 (837)
................ . ...........+++.|+|||++.+. .++.++|||||||++|+|++
T Consensus 167 ~~~~~~~~~~~~~~~~---------~--------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~t 229 (335)
T PTZ00024 167 RRYGYPPYSDTLSKDE---------T--------MQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT 229 (335)
T ss_pred eecccccccccccccc---------c--------ccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHh
Confidence 6421111100000000 0 0000112234578899999998764 46899999999999999999
Q ss_pred CCCCCCCCCc
Q 003232 816 GIPPFNAEHP 825 (837)
Q Consensus 816 Gr~PF~~~dp 825 (837)
|..||...++
T Consensus 230 g~~p~~~~~~ 239 (335)
T PTZ00024 230 GKPLFPGENE 239 (335)
T ss_pred CCCCCCCCCH
Confidence 9999986653
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=298.57 Aligned_cols=196 Identities=31% Similarity=0.503 Sum_probs=174.7
Q ss_pred eEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEEe
Q 003232 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEY 670 (837)
Q Consensus 591 YeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmEy 670 (837)
|.-++.||.|+||.||.|++..+...||||.+.-......+.-..++.|+..|++++|||++.+-++|..+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 66678899999999999999999999999999766555556667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCC
Q 003232 671 LNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 749 (837)
Q Consensus 671 ~~GGSL~dlLk~-~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~ 749 (837)
| -||-.|++.- .+++.+-.+..|..+.+.||.|||+.+.||||||..|||++..|.+||+|||.+.+ .
T Consensus 108 C-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi---------~- 176 (948)
T KOG0577|consen 108 C-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASI---------M- 176 (948)
T ss_pred H-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhh---------c-
Confidence 9 5688888754 36799999999999999999999999999999999999999999999999999863 1
Q ss_pred CCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC---CCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003232 750 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG---TGHGTTADWWSVGIILFELIVGIPPFNA 822 (837)
Q Consensus 750 p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg---~~~s~kSDIWSLGVILyELLTGr~PF~~ 822 (837)
.+.++++|||.|||||+++. +.|+-++||||||++..||..+++|+..
T Consensus 177 -------------------------~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFn 227 (948)
T KOG0577|consen 177 -------------------------APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 227 (948)
T ss_pred -------------------------CchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccC
Confidence 12457899999999999964 5689999999999999999999999643
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=296.19 Aligned_cols=198 Identities=25% Similarity=0.501 Sum_probs=172.9
Q ss_pred eEEEEEecccCceEEEEEEECCCCcEEEEEEeccccc-ccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCe--EEEE
Q 003232 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADM-IRKNAVESILAERDILISVRNPFVVRFFYSFTCREN--LYLV 667 (837)
Q Consensus 591 YeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~-~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~--lyLV 667 (837)
.+...+||.|+|-+||+|.+..+|..||.-.++.... ......+++..|+.+|+.|+||||+++|.+|.+... +.+|
T Consensus 42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence 3445789999999999999999999998665544332 345567899999999999999999999999988654 8899
Q ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--CcccccCCCCcEEEc-cCCcEEEEecCCccccccCCC
Q 003232 668 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL--RVVHRDLKPDNLLIA-HDGHIKLTDFGLSKVGLINST 744 (837)
Q Consensus 668 mEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSk--GIIHRDIKPeNILLd-~dG~IKLiDFGLArvg~~~st 744 (837)
+|.+..|+|..|+++.+.++...++.|++||+.||.|||++ -|||||||.+||||+ ..|.+||+|+|+|++.
T Consensus 122 TEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~----- 196 (632)
T KOG0584|consen 122 TELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL----- 196 (632)
T ss_pred eecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHh-----
Confidence 99999999999999999999999999999999999999987 599999999999996 4689999999999741
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003232 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNA 822 (837)
Q Consensus 745 ddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~ 822 (837)
........+|||.|||||++. ..|+..+||||||++|+||+|+..||.-
T Consensus 197 ----------------------------r~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsE 245 (632)
T KOG0584|consen 197 ----------------------------RKSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSE 245 (632)
T ss_pred ----------------------------hccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhh
Confidence 111233568999999999998 7799999999999999999999999964
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=259.96 Aligned_cols=198 Identities=22% Similarity=0.329 Sum_probs=157.7
Q ss_pred EecccCceEEEEEEECCCC--cEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEEecCC
Q 003232 596 PISRGAFGRVFLAKKRTTG--DLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 673 (837)
Q Consensus 596 kLGsG~FGtVYkArdk~tG--~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmEy~~G 673 (837)
.||+|+||.||++.....+ ..+++|.+.... .....+.+.+|+.+++.++||||+++++.+......|+||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 5899999999999764332 346677665432 233456899999999999999999999999999999999999999
Q ss_pred CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCC
Q 003232 674 GDLYSLLRNL----GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 749 (837)
Q Consensus 674 GSL~dlLk~~----g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~ 749 (837)
++|.+++... ..++...++.++.||+.||.|||+.+++|+||||+|||++.++.++|+|||++...... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~---~--- 153 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE---D--- 153 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcc---h---
Confidence 9999998753 23566778899999999999999999999999999999999999999999987521000 0
Q ss_pred CCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-------CCCCchHHHHHHHHHHHHHHc-CCCCCC
Q 003232 750 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-------TGHGTTADWWSVGIILFELIV-GIPPFN 821 (837)
Q Consensus 750 p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-------~~~s~kSDIWSLGVILyELLT-Gr~PF~ 821 (837)
.........|+..|+|||++.+ ..++.++||||||+++|+|++ |..||.
T Consensus 154 -----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~ 210 (268)
T cd05086 154 -----------------------YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYS 210 (268)
T ss_pred -----------------------hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Confidence 0001123567889999999753 345788999999999999996 577886
Q ss_pred CCC
Q 003232 822 AEH 824 (837)
Q Consensus 822 ~~d 824 (837)
...
T Consensus 211 ~~~ 213 (268)
T cd05086 211 HLS 213 (268)
T ss_pred CCC
Confidence 544
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=299.61 Aligned_cols=202 Identities=35% Similarity=0.631 Sum_probs=179.4
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVm 668 (837)
+-|.|+..||.|+||.||+|.++.++-..|.|++.. ...+.++.++-|++||..+.||+|+++++.|...+.+||+.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet---kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET---KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc---cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence 348899999999999999999999988889998865 34677889999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCC
Q 003232 669 EYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (837)
Q Consensus 669 Ey~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl 747 (837)
|||.||-+..++-.. ..|++.++..+++|++.||+|||+++|||||||..|||++.+|.++|+|||.+..
T Consensus 109 EFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAK--------- 179 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAK--------- 179 (1187)
T ss_pred eecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeeccccccc---------
Confidence 999999999887654 5699999999999999999999999999999999999999999999999998642
Q ss_pred CCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhc-----CCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003232 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-----GTGHGTTADWWSVGIILFELIVGIPPFNA 822 (837)
Q Consensus 748 ~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLl-----g~~~s~kSDIWSLGVILyELLTGr~PF~~ 822 (837)
......+..+++|||+|||||+.. ..+|++++||||||++|.||..+.+|-..
T Consensus 180 ----------------------n~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe 237 (1187)
T KOG0579|consen 180 ----------------------NKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE 237 (1187)
T ss_pred ----------------------chhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc
Confidence 011234456889999999999974 57899999999999999999999999765
Q ss_pred CC
Q 003232 823 EH 824 (837)
Q Consensus 823 ~d 824 (837)
.+
T Consensus 238 ln 239 (1187)
T KOG0579|consen 238 LN 239 (1187)
T ss_pred cc
Confidence 43
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-29 Score=267.94 Aligned_cols=202 Identities=32% Similarity=0.517 Sum_probs=171.3
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeec-CCeEE
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC-RENLY 665 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d-~~~ly 665 (837)
..++|++.+.||.|+||.||++.+..+++.||+|.+.... ......+.+.+|+.+++.++||||++++++|.. ....|
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPF-STPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccc-cccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 3567999999999999999999999999999999886532 222344667899999999999999999999865 56789
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCC
Q 003232 666 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745 (837)
Q Consensus 666 LVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~std 745 (837)
+||||+ +++|..++.. ..+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++....
T Consensus 87 lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~----- 159 (328)
T cd07856 87 FVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQD----- 159 (328)
T ss_pred EEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccC-----
Confidence 999998 6789888765 468888999999999999999999999999999999999999999999999876210
Q ss_pred CCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 746 dl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
.......++..|+|||++.+ ..++.++||||||+++|+|++|+.||...+
T Consensus 160 -----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~ 210 (328)
T cd07856 160 -----------------------------PQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD 210 (328)
T ss_pred -----------------------------CCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 00112356788999999866 568999999999999999999999997655
Q ss_pred c
Q 003232 825 P 825 (837)
Q Consensus 825 p 825 (837)
+
T Consensus 211 ~ 211 (328)
T cd07856 211 H 211 (328)
T ss_pred H
Confidence 3
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=268.96 Aligned_cols=206 Identities=23% Similarity=0.382 Sum_probs=166.3
Q ss_pred EEeccc--CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEEecC
Q 003232 595 KPISRG--AFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLN 672 (837)
Q Consensus 595 kkLGsG--~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmEy~~ 672 (837)
..||.| +||+||++++..+|+.||+|++..... .....+.+.+|+.+++.++||||++++++|......|+||||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC-TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 346666 999999999999999999999876432 23445788999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCC
Q 003232 673 GGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 750 (837)
Q Consensus 673 GGSL~dlLk~~--g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p 750 (837)
+++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++++||+.+.........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~----- 157 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK----- 157 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc-----
Confidence 99999998764 34899999999999999999999999999999999999999999999999865311000000
Q ss_pred CccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCC--CCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 751 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT--GHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 751 ~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~--~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
..... .......++..|+|||++.+. .++.++|||||||++|+|++|..||.....
T Consensus 158 ---~~~~~----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~ 215 (328)
T cd08226 158 ---AKVVY----------------DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLR 215 (328)
T ss_pred ---ccccc----------------cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcCh
Confidence 00000 000112356679999999763 478999999999999999999999976543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-30 Score=270.78 Aligned_cols=209 Identities=33% Similarity=0.538 Sum_probs=171.3
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEeEeecC--Ce
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCR--EN 663 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~gsf~d~--~~ 663 (837)
..++|++.+.||.|+||.||+|.+..+++.+|+|.+.... ........+.+|+.+++.+ +||||+++++++... ..
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF-RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc-CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 4567999999999999999999998899999999886432 1223345677899999999 999999999988653 46
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCC
Q 003232 664 LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~s 743 (837)
+|+||||+. ++|.+++... .+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~ 161 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161 (337)
T ss_pred EEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence 899999996 5999988765 78889999999999999999999999999999999999999999999999987321111
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNA 822 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLTGr~PF~~ 822 (837)
... .........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+
T Consensus 162 ~~~--------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~ 215 (337)
T cd07852 162 ENP--------------------------ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPG 215 (337)
T ss_pred ccc--------------------------cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCC
Confidence 000 0011223468999999998865 4578899999999999999999999976
Q ss_pred CC
Q 003232 823 EH 824 (837)
Q Consensus 823 ~d 824 (837)
.+
T Consensus 216 ~~ 217 (337)
T cd07852 216 TS 217 (337)
T ss_pred CC
Confidence 44
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-30 Score=259.18 Aligned_cols=201 Identities=35% Similarity=0.602 Sum_probs=172.8
Q ss_pred eEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEEe
Q 003232 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEY 670 (837)
Q Consensus 591 YeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmEy 670 (837)
|++.+.||.|++|.||+|.+..+++.||+|++.... ........+..|+.+++.++|+||+++++++......++||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 677889999999999999999999999999998653 2233446778899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCC
Q 003232 671 LNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 749 (837)
Q Consensus 671 ~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~ 749 (837)
++ ++|.+++... ..+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~------ 152 (282)
T cd07829 80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL------ 152 (282)
T ss_pred cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCc------
Confidence 97 5999999875 579999999999999999999999999999999999999999999999999886311000
Q ss_pred CCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 750 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 750 p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~-~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+
T Consensus 153 -------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 203 (282)
T cd07829 153 -------------------------RTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS 203 (282)
T ss_pred -------------------------cccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc
Confidence 011123456789999999776 78899999999999999999999997754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-29 Score=260.58 Aligned_cols=206 Identities=30% Similarity=0.560 Sum_probs=169.3
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcC-CCceEEEEeEeecCCe
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCREN 663 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~Lr-HPNIVkL~gsf~d~~~ 663 (837)
....++|++.+.||.|+||.||+|.+..+++.||+|.++.... ......+..|+.++.... ||||+++++++.....
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 88 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD 88 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence 3455789999999999999999999988899999999976432 223445667777776664 9999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCcEEEccCCcEEEEecCCcccccc
Q 003232 664 LYLVMEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 741 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk~-~g~Lsee~irkIl~QIa~ALsYLHS-kGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~ 741 (837)
.|+||||+. ++|.+++.. ...+++..+..++.||+.||.|||+ .||+|+||+|+||+++.++.++|+|||++....
T Consensus 89 ~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~- 166 (296)
T cd06618 89 VFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV- 166 (296)
T ss_pred EEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhcc-
Confidence 999999984 577777755 4578999999999999999999997 699999999999999999999999999875210
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCC----CCchHHHHHHHHHHHHHHcCC
Q 003232 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG----HGTTADWWSVGIILFELIVGI 817 (837)
Q Consensus 742 ~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~----~s~kSDIWSLGVILyELLTGr 817 (837)
.. .......|+..|+|||++.+.. ++.++||||||+++|+|++|+
T Consensus 167 -~~------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~ 215 (296)
T cd06618 167 -DS------------------------------KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215 (296)
T ss_pred -CC------------------------------CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCC
Confidence 00 0011234778899999987654 788999999999999999999
Q ss_pred CCCCCCCc
Q 003232 818 PPFNAEHP 825 (837)
Q Consensus 818 ~PF~~~dp 825 (837)
.||.....
T Consensus 216 ~p~~~~~~ 223 (296)
T cd06618 216 FPYKNCKT 223 (296)
T ss_pred CCCCcchh
Confidence 99976433
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=257.27 Aligned_cols=201 Identities=35% Similarity=0.604 Sum_probs=172.2
Q ss_pred eEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEEe
Q 003232 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEY 670 (837)
Q Consensus 591 YeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmEy 670 (837)
|++.+.||.|++|.||++.+..+++.+++|.+..... .......+.+|+.+++.++||||+++++.+.....+++||||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 6778999999999999999998999999999876542 223456788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCC
Q 003232 671 LNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 749 (837)
Q Consensus 671 ~~GGSL~dlLk~-~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~ 749 (837)
+.+ +|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~------ 152 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV------ 152 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc------
Confidence 965 88888765 3578999999999999999999999999999999999999999999999999876311100
Q ss_pred CCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 750 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 750 p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~-~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+
T Consensus 153 -------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~ 203 (283)
T cd05118 153 -------------------------RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKS 203 (283)
T ss_pred -------------------------ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 001123577889999999876 78999999999999999999999997655
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=264.38 Aligned_cols=199 Identities=32% Similarity=0.582 Sum_probs=171.1
Q ss_pred eEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEEe
Q 003232 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEY 670 (837)
Q Consensus 591 YeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmEy 670 (837)
|+...+||.|+||.||++.+..+++.||+|.+.... ......+.+|+.+++.++||||+++++.+...++.|+||||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 98 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence 444467999999999999999999999999875432 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCC
Q 003232 671 LNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 750 (837)
Q Consensus 671 ~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p 750 (837)
+++++|.+++.. ..+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 99 ~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~------- 170 (292)
T cd06657 99 LEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV------- 170 (292)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc-------
Confidence 999999998754 568999999999999999999999999999999999999999999999999875211000
Q ss_pred CccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 751 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 751 ~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
.......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+
T Consensus 171 ------------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~ 220 (292)
T cd06657 171 ------------------------PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 220 (292)
T ss_pred ------------------------ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 01123458899999999988888999999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=259.31 Aligned_cols=199 Identities=35% Similarity=0.544 Sum_probs=168.7
Q ss_pred eEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcC-CCceEEEEeEeecCCeEEEEEE
Q 003232 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCRENLYLVME 669 (837)
Q Consensus 591 YeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~Lr-HPNIVkL~gsf~d~~~lyLVmE 669 (837)
|++.+.||.|++|+||+|....+++.|++|.+...... .......+|+..++.++ ||||+++++.+......|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 67889999999999999999889999999998754321 12234557889999999 9999999999999999999999
Q ss_pred ecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCC
Q 003232 670 YLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (837)
Q Consensus 670 y~~GGSL~dlLk~~g--~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl 747 (837)
|+ +++|.+++.... .+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++..... .
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~--~--- 152 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRS--R--- 152 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccC--C---
Confidence 99 889999887654 689999999999999999999999999999999999999999999999998863100 0
Q ss_pred CCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 748 ~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
.......|+..|+|||++.+ ..++.++|+||||+++|+|++|++||....
T Consensus 153 ---------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~ 203 (283)
T cd07830 153 ---------------------------PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSS 203 (283)
T ss_pred ---------------------------CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCC
Confidence 00112457889999998854 557899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=268.62 Aligned_cols=199 Identities=31% Similarity=0.513 Sum_probs=167.4
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecC------
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR------ 661 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~------ 661 (837)
.++|.+.+.||.|+||.||+|.+..+|+.||+|.+.... ........+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPF-QSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcc-ccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 467999999999999999999999999999999987543 1223345678999999999999999999988654
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCcccccc
Q 003232 662 ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 741 (837)
Q Consensus 662 ~~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~ 741 (837)
..+|+||||+. .+|..+.. ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||+++....
T Consensus 93 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 93 QDFYLVMPYMQ-TDLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA 169 (342)
T ss_pred ceEEEEecccc-cCHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence 34699999995 47776642 4689999999999999999999999999999999999999999999999998762100
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCC
Q 003232 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPF 820 (837)
Q Consensus 742 ~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLTGr~PF 820 (837)
......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||
T Consensus 170 ----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf 215 (342)
T cd07879 170 ----------------------------------EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLF 215 (342)
T ss_pred ----------------------------------CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCC
Confidence 0113457888999999876 46889999999999999999999999
Q ss_pred CCCC
Q 003232 821 NAEH 824 (837)
Q Consensus 821 ~~~d 824 (837)
.+.+
T Consensus 216 ~~~~ 219 (342)
T cd07879 216 KGKD 219 (342)
T ss_pred CCCC
Confidence 8754
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=264.67 Aligned_cols=200 Identities=30% Similarity=0.480 Sum_probs=170.9
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVm 668 (837)
+.|++.+.||.|+||.||+|+++.++..+|+|.+.............+.+|+.+++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34888899999999999999999999999999987543334445567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCC
Q 003232 669 EYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (837)
Q Consensus 669 Ey~~GGSL~dlLk~-~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl 747 (837)
||+. ++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~------- 166 (308)
T cd06634 95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------- 166 (308)
T ss_pred EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeec-------
Confidence 9996 588777653 4568999999999999999999999999999999999999999999999999876310
Q ss_pred CCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhc---CCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL---GTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 748 ~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLl---g~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
......|++.|+|||++. ...++.++|||||||++|+|++|..||...+
T Consensus 167 ----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 218 (308)
T cd06634 167 ----------------------------PANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218 (308)
T ss_pred ----------------------------CcccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcccc
Confidence 011235788999999985 3457889999999999999999999987644
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=268.72 Aligned_cols=203 Identities=29% Similarity=0.508 Sum_probs=166.7
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecC-------
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR------- 661 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~------- 661 (837)
.+|++.+.||.|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.+++.++||||+++++.+...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 579999999999999999999999999999999865432 3446788999999999999999998766543
Q ss_pred -------CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEcc-CCcEEEEec
Q 003232 662 -------ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH-DGHIKLTDF 733 (837)
Q Consensus 662 -------~~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~-dG~IKLiDF 733 (837)
...|+||||+. ++|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+||+++. ++.++|+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~df 159 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDF 159 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCc
Confidence 35899999996 589888764 56899999999999999999999999999999999999974 567899999
Q ss_pred CCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHH
Q 003232 734 GLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFE 812 (837)
Q Consensus 734 GLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyE 812 (837)
|++......... ........|+..|+|||++.+ ..++.++|||||||++|+
T Consensus 160 g~~~~~~~~~~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~e 211 (342)
T cd07854 160 GLARIVDPHYSH----------------------------KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAE 211 (342)
T ss_pred ccceecCCcccc----------------------------ccccccccccccccCHHHHhCccccCchhhHHHHHHHHHH
Confidence 988631100000 000112357889999998754 567889999999999999
Q ss_pred HHcCCCCCCCCC
Q 003232 813 LIVGIPPFNAEH 824 (837)
Q Consensus 813 LLTGr~PF~~~d 824 (837)
|++|+.||.+.+
T Consensus 212 l~~g~~pf~~~~ 223 (342)
T cd07854 212 MLTGKPLFAGAH 223 (342)
T ss_pred HHhCCCCCCCCC
Confidence 999999997654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=254.62 Aligned_cols=182 Identities=30% Similarity=0.469 Sum_probs=156.8
Q ss_pred cCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEEecCCCCHHHH
Q 003232 600 GAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 679 (837)
Q Consensus 600 G~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmEy~~GGSL~dl 679 (837)
|.+|.||+++++.+++.||+|.+.... ....|...+....||||+++++.+......|+||||++|++|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 899999999999999999999997643 123445555566799999999999999999999999999999999
Q ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCCCccCcccCC
Q 003232 680 LRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLG 759 (837)
Q Consensus 680 Lk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl~ 759 (837)
+.....+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+.....
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~------------------ 137 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED------------------ 137 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccc------------------
Confidence 98877899999999999999999999999999999999999999999999999997652100
Q ss_pred CCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003232 760 DEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823 (837)
Q Consensus 760 ~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~ 823 (837)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...
T Consensus 138 ----------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~ 185 (237)
T cd05576 138 ----------------SCDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECH 185 (237)
T ss_pred ----------------ccccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcC
Confidence 011224566799999998888999999999999999999999887643
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=268.90 Aligned_cols=202 Identities=31% Similarity=0.486 Sum_probs=171.9
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCe---
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCREN--- 663 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~--- 663 (837)
..++|++.+.||.|++|.||+|++..+++.||+|++.... ........+.+|+.+++.++||||+++++.+.....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc-chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 4567999999999999999999999999999999987543 223344667889999999999999999887765544
Q ss_pred ---EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccc
Q 003232 664 ---LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740 (837)
Q Consensus 664 ---lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~ 740 (837)
.|+|+||+ +++|.+++.. ..+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++....
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence 89999998 6799999876 569999999999999999999999999999999999999999999999999986310
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCC
Q 003232 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPP 819 (837)
Q Consensus 741 ~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLTGr~P 819 (837)
. ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.|
T Consensus 170 ~----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~p 215 (343)
T cd07851 170 D----------------------------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTL 215 (343)
T ss_pred c----------------------------------cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCC
Confidence 0 0123457888999999865 4678999999999999999999999
Q ss_pred CCCCCc
Q 003232 820 FNAEHP 825 (837)
Q Consensus 820 F~~~dp 825 (837)
|.....
T Consensus 216 f~~~~~ 221 (343)
T cd07851 216 FPGSDH 221 (343)
T ss_pred CCCCCh
Confidence 976543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.5e-29 Score=258.06 Aligned_cols=201 Identities=26% Similarity=0.374 Sum_probs=164.4
Q ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEEecCCCCHHHHH
Q 003232 601 AFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 680 (837)
Q Consensus 601 ~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmEy~~GGSL~dlL 680 (837)
+++.||+++...+++.||+|++.... ........+.+|+.+++.++||||+++++++......|++|||+++++|.+++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l 90 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL 90 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccc-cchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence 55667777777899999999997653 23445678999999999999999999999999999999999999999999999
Q ss_pred Hhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCCCccCcccC
Q 003232 681 RNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 758 (837)
Q Consensus 681 k~~--g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl 758 (837)
... ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||.+......... . .
T Consensus 91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~--~-~-------- 159 (314)
T cd08216 91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKR--Q-R-------- 159 (314)
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccc--c-c--------
Confidence 753 45899999999999999999999999999999999999999999999999987632111000 0 0
Q ss_pred CCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC--CCCCchHHHHHHHHHHHHHHcCCCCCCCCCcC
Q 003232 759 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG--TGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826 (837)
Q Consensus 759 ~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg--~~~s~kSDIWSLGVILyELLTGr~PF~~~dpd 826 (837)
..........++..|+|||++.+ ..++.++|+|||||++|+|++|..||....+.
T Consensus 160 -------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~ 216 (314)
T cd08216 160 -------------VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT 216 (314)
T ss_pred -------------ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 00001123457788999999976 45788999999999999999999999875543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-30 Score=264.35 Aligned_cols=210 Identities=27% Similarity=0.398 Sum_probs=175.7
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC-----
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE----- 662 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~----- 662 (837)
-++|++.+.||.|||+.||++++..++..||+|.+.... .+..+...+|++..++++|||+++++++...+.
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 356999999999999999999999999999999998754 456678999999999999999999987665433
Q ss_pred eEEEEEEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCCCCcEEEccCCcEEEEecCCc
Q 003232 663 NLYLVMEYLNGGDLYSLLRNL----GCLDEDVARVYIAEVVLALEYLHSLR--VVHRDLKPDNLLIAHDGHIKLTDFGLS 736 (837)
Q Consensus 663 ~lyLVmEy~~GGSL~dlLk~~----g~Lsee~irkIl~QIa~ALsYLHSkG--IIHRDIKPeNILLd~dG~IKLiDFGLA 736 (837)
..||+++|+..|+|.+.++.. ..+++.++..|+.+|++||.+||+.. +.||||||.|||+...+.++|.|||++
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCc
Confidence 499999999999999998642 35999999999999999999999998 999999999999999999999999998
Q ss_pred cccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhc---CCCCCchHHHHHHHHHHHHH
Q 003232 737 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL---GTGHGTTADWWSVGIILFEL 813 (837)
Q Consensus 737 rvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLl---g~~~s~kSDIWSLGVILyEL 813 (837)
......- .........+.+.....|..|+|||.+. +...+.++|||||||++|.|
T Consensus 177 ~~a~i~i----------------------~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~ 234 (302)
T KOG2345|consen 177 TQAPIQI----------------------EGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAM 234 (302)
T ss_pred cccceEe----------------------echHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHH
Confidence 7311110 0111222233344556788999999985 45568999999999999999
Q ss_pred HcCCCCCCC
Q 003232 814 IVGIPPFNA 822 (837)
Q Consensus 814 LTGr~PF~~ 822 (837)
+.|.-||..
T Consensus 235 mf~~sPfe~ 243 (302)
T KOG2345|consen 235 MFGESPFER 243 (302)
T ss_pred HHcCCcchH
Confidence 999999964
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-30 Score=293.42 Aligned_cols=194 Identities=34% Similarity=0.575 Sum_probs=169.5
Q ss_pred EEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEEecCCC
Q 003232 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGG 674 (837)
Q Consensus 595 kkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmEy~~GG 674 (837)
-+||+|.||+||.|++..+....|||.+.... ....+.+..|+.+.+.++|.|||+++|++...+++-|.||-++||
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG 657 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence 47999999999999999999999999987533 344567889999999999999999999999999999999999999
Q ss_pred CHHHHHHh-cCCC--CHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEc-cCCcEEEEecCCccccccCCCCCCCCC
Q 003232 675 DLYSLLRN-LGCL--DEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA-HDGHIKLTDFGLSKVGLINSTDDLSGP 750 (837)
Q Consensus 675 SL~dlLk~-~g~L--see~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd-~dG~IKLiDFGLArvg~~~stddl~~p 750 (837)
||.++++. .+++ ++..+-.|.+||++||.|||+..|||||||-+|||++ ..|.+||+|||-++-. .+-
T Consensus 658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRL--------Agi 729 (1226)
T KOG4279|consen 658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRL--------AGI 729 (1226)
T ss_pred cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhh--------ccC
Confidence 99999975 5887 8888999999999999999999999999999999995 5899999999987621 110
Q ss_pred CccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC--CCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003232 751 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG--TGHGTTADWWSVGIILFELIVGIPPFNA 822 (837)
Q Consensus 751 ~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg--~~~s~kSDIWSLGVILyELLTGr~PF~~ 822 (837)
. .-+.++.||..|||||++.. .+|+.++|||||||++.||.||++||..
T Consensus 730 n-----------------------P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~E 780 (1226)
T KOG4279|consen 730 N-----------------------PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVE 780 (1226)
T ss_pred C-----------------------ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeee
Confidence 0 11235679999999999975 5688999999999999999999999953
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=295.07 Aligned_cols=221 Identities=30% Similarity=0.487 Sum_probs=183.6
Q ss_pred cccCCeEEEEEecccCceEEEEEEECC-----CCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeec
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRT-----TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC 660 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~-----tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d 660 (837)
....+.+..+.||+|.||.||+|+-.. ....||||.++... ......+|.+|++++..++|||||+++|++..
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGVCRE 560 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence 334568888999999999999998743 34579999998754 34456789999999999999999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCC
Q 003232 661 RENLYLVMEYLNGGDLYSLLRNL--------------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG 726 (837)
Q Consensus 661 ~~~lyLVmEy~~GGSL~dlLk~~--------------g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG 726 (837)
++.+|+|+||+..|+|.+++... ++|+..+...|+.||+.|+.||-++.+|||||-.+|+|+.++-
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENL 640 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccce
Confidence 99999999999999999999532 1278889999999999999999999999999999999999999
Q ss_pred cEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHH
Q 003232 727 HIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSV 806 (837)
Q Consensus 727 ~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSL 806 (837)
.+||+|||+++ ..++++-+ +......-.++||+||.+....++.++||||+
T Consensus 641 ~VKIsDfGLsR--diYssDYY---------------------------k~~~~t~lPIRWMppEsIly~kFTteSDVWs~ 691 (774)
T KOG1026|consen 641 VVKISDFGLSR--DIYSSDYY---------------------------KVRGNTLLPIRWMPPESILYGKFTTESDVWSF 691 (774)
T ss_pred EEEecccccch--hhhhhhhh---------------------------cccCCceeeeecCCHHHhhcCcccchhhhhhh
Confidence 99999999998 22222211 11113345679999999999999999999999
Q ss_pred HHHHHHHHc-CCCCCCCCC-cCHHHHHHhcccC
Q 003232 807 GIILFELIV-GIPPFNAEH-PQVSTLLRKCQLL 837 (837)
Q Consensus 807 GVILyELLT-Gr~PF~~~d-pdv~~lle~~hL~ 837 (837)
||+|||+++ |+.||.+-+ .++.++.+..++|
T Consensus 692 GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~lL 724 (774)
T KOG1026|consen 692 GVVLWEIFSYGKQPYYGLSNQEVIECIRAGQLL 724 (774)
T ss_pred hhhhhhhhccccCcccccchHHHHHHHHcCCcc
Confidence 999999996 999987654 5555566555543
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-29 Score=250.99 Aligned_cols=202 Identities=29% Similarity=0.537 Sum_probs=168.8
Q ss_pred CeEEEEEecccCceEEEEEEECCCCcEEEEEEeccccc--ccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEE
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADM--IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~--~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLV 667 (837)
+|.+.+.||.|+||.||++.+...+..+++|+++.... ........+..|+.+++.++||||+++++.+......++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 48899999999999999999988877788887764322 1222334577889999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCC
Q 003232 668 MEYLNGGDLYSLLRN----LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 668 mEy~~GGSL~dlLk~----~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~s 743 (837)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++. +.++|+|||++.......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 999999999988853 356899999999999999999999999999999999999964 679999999876311000
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~ 823 (837)
.......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...
T Consensus 160 -------------------------------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~ 208 (260)
T cd08222 160 -------------------------------DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ 208 (260)
T ss_pred -------------------------------ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 0012345788999999998888899999999999999999999999653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=280.97 Aligned_cols=201 Identities=28% Similarity=0.496 Sum_probs=165.8
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcC-CCceEEEEeEeecCCeEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~Lr-HPNIVkL~gsf~d~~~lyLV 667 (837)
..|+++++||.||.+.||++..- +.+.||+|.+.-.. .+...+..+.+|+..|.+|+ |.+|++++++-..+..+|+|
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 35999999999999999999974 44556666554322 35667789999999999995 88999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCC
Q 003232 668 MEYLNGGDLYSLLRNLGC-LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (837)
Q Consensus 668 mEy~~GGSL~dlLk~~g~-Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stdd 746 (837)
|||= ..+|..+++.... ++...++.|..||+.++.++|.+||||.||||.|+|+ -.|.+||+|||+|.....+.+.
T Consensus 439 mE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DTTs- 515 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDTTS- 515 (677)
T ss_pred eecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCccccc-
Confidence 9964 6799999987544 4446899999999999999999999999999999999 6789999999999753322221
Q ss_pred CCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCC-----------CCchHHHHHHHHHHHHHHc
Q 003232 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-----------HGTTADWWSVGIILFELIV 815 (837)
Q Consensus 747 l~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~-----------~s~kSDIWSLGVILyELLT 815 (837)
-.....+||+.||+||.+.... .++++||||||||||+|+.
T Consensus 516 ----------------------------I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvY 567 (677)
T KOG0596|consen 516 ----------------------------IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVY 567 (677)
T ss_pred ----------------------------eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHh
Confidence 1134568999999999996433 3578999999999999999
Q ss_pred CCCCCCC
Q 003232 816 GIPPFNA 822 (837)
Q Consensus 816 Gr~PF~~ 822 (837)
|+.||..
T Consensus 568 gktPf~~ 574 (677)
T KOG0596|consen 568 GKTPFGQ 574 (677)
T ss_pred cCCchHH
Confidence 9999965
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-31 Score=314.34 Aligned_cols=208 Identities=37% Similarity=0.613 Sum_probs=180.2
Q ss_pred CeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEE
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmE 669 (837)
+|+-..+||.|.||.||-|.+..+|...|+|-++..... ......+.+|..++..++|||+|++|++-.+.+.++|.||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 466667899999999999999999999999998765533 5566788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCC
Q 003232 670 YLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 749 (837)
Q Consensus 670 y~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~ 749 (837)
||+||+|.+.+...+..++...+.|..|++.||.|||+.|||||||||.||+++.+|.+|++|||.|.....+ ..+.
T Consensus 1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~-~~~~-- 1391 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN-AQTM-- 1391 (1509)
T ss_pred HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCc-hhcC--
Confidence 9999999999988777888889999999999999999999999999999999999999999999998742111 1110
Q ss_pred CCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC---CCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 750 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG---TGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 750 p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg---~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
...-...+||+.|||||++.+ .+..-++|||||||++.||.||+.||..-+.
T Consensus 1392 ------------------------~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn 1446 (1509)
T KOG4645|consen 1392 ------------------------PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN 1446 (1509)
T ss_pred ------------------------CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc
Confidence 122347799999999999975 4567889999999999999999999975443
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-30 Score=271.67 Aligned_cols=199 Identities=33% Similarity=0.583 Sum_probs=168.5
Q ss_pred ccCCeEEE-EEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHH-hcCCCceEEEEeEeec----
Q 003232 587 SIDDFEII-KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILI-SVRNPFVVRFFYSFTC---- 660 (837)
Q Consensus 587 ~lddYeIl-kkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk-~LrHPNIVkL~gsf~d---- 660 (837)
+.++|.+- ++||.|-.|.|-.+.++.+++.+|+|++.... ...+|+++.- .-.|||||.++++|..
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~--------KARrEVeLHw~~s~h~~iV~IidVyeNs~~~ 130 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP--------KARREVELHWMASGHPHIVSIIDVYENSYQG 130 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH--------HHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence 34566664 68999999999999999999999999986432 3557777754 4479999999988764
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEcc---CCcEEEEecCC
Q 003232 661 RENLYLVMEYLNGGDLYSLLRNLGC--LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKLTDFGL 735 (837)
Q Consensus 661 ~~~lyLVmEy~~GGSL~dlLk~~g~--Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~---dG~IKLiDFGL 735 (837)
..++.+|||.++||.|+..+...+. +++.++..|++||+.|+.|||+.+|.||||||+|+|+.. +..+||+|||+
T Consensus 131 rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 131 RKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred ceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccc
Confidence 4578999999999999999987655 999999999999999999999999999999999999964 55799999999
Q ss_pred ccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc
Q 003232 736 SKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV 815 (837)
Q Consensus 736 Arvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT 815 (837)
|+.... .....+.+-||.|.|||++....|+..+|+||+||+||-||+
T Consensus 211 AK~t~~--------------------------------~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLC 258 (400)
T KOG0604|consen 211 AKETQE--------------------------------PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC 258 (400)
T ss_pred ccccCC--------------------------------CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhc
Confidence 983100 011235688999999999999999999999999999999999
Q ss_pred CCCCCCCCCc
Q 003232 816 GIPPFNAEHP 825 (837)
Q Consensus 816 Gr~PF~~~dp 825 (837)
|.+||.....
T Consensus 259 GyPPFYS~hg 268 (400)
T KOG0604|consen 259 GYPPFYSNHG 268 (400)
T ss_pred CCCcccccCC
Confidence 9999987543
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-29 Score=296.85 Aligned_cols=207 Identities=27% Similarity=0.465 Sum_probs=176.0
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCc-----EEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCe
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGD-----LFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCREN 663 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~-----~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ 663 (837)
...++...||+|+||.||.|....... .||+|.+++. .+......|.+|..+|+.++||||++++|++.+...
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~ 769 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP 769 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence 457888999999999999998865433 3888888764 346667899999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCc
Q 003232 664 LYLVMEYLNGGDLYSLLRNL-------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS 736 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk~~-------g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLA 736 (837)
.+|++|||.||+|..++++. ..++..++..++.||++|++||+++++|||||..+|+|++....+||+|||+|
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchh
Confidence 99999999999999999865 34899999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-
Q 003232 737 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV- 815 (837)
Q Consensus 737 rvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT- 815 (837)
+- .+..+- .+......-...|||||.+....++.++|||||||++||+++
T Consensus 850 rD--iy~~~y---------------------------yr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifsl 900 (1025)
T KOG1095|consen 850 RD--IYDKDY---------------------------YRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSL 900 (1025)
T ss_pred Hh--hhhchh---------------------------eeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhC
Confidence 81 111110 000111234568999999999999999999999999999997
Q ss_pred CCCCCCCCCcC
Q 003232 816 GIPPFNAEHPQ 826 (837)
Q Consensus 816 Gr~PF~~~dpd 826 (837)
|..||...+..
T Consensus 901 G~~PY~~~~n~ 911 (1025)
T KOG1095|consen 901 GATPYPSRSNF 911 (1025)
T ss_pred CCCCCCCcchH
Confidence 99999876543
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-30 Score=304.24 Aligned_cols=214 Identities=29% Similarity=0.475 Sum_probs=168.5
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeec------
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC------ 660 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d------ 660 (837)
-+.+|+.++.||+||||.||+|+++-+|+.||||.+.... .......+.+|+.+|.+|+|||||++|.+|.+
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 4567999999999999999999999999999999998654 45566789999999999999999999832200
Q ss_pred --------------------------------------------------------------------------------
Q 003232 661 -------------------------------------------------------------------------------- 660 (837)
Q Consensus 661 -------------------------------------------------------------------------------- 660 (837)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred -------------------------C--------CeEEEEEEecCCCCHHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHH
Q 003232 661 -------------------------R--------ENLYLVMEYLNGGDLYSLLRNLGCL-DEDVARVYIAEVVLALEYLH 706 (837)
Q Consensus 661 -------------------------~--------~~lyLVmEy~~GGSL~dlLk~~g~L-see~irkIl~QIa~ALsYLH 706 (837)
+ ..+||-||||+...|.+++..+... ....++.++++|++||.|+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence 0 1258999999988888888776544 47789999999999999999
Q ss_pred hCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCc
Q 003232 707 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDY 786 (837)
Q Consensus 707 SkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~Y 786 (837)
++|||||||||.||+++.++.+||+|||+|.....+...-...+.+ +...........+..+||..|
T Consensus 715 ~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~-------------~~~~~g~~~~~~Ts~VGTalY 781 (1351)
T KOG1035|consen 715 DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSF-------------STNRAGSNDGDLTSQVGTALY 781 (1351)
T ss_pred hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCc-------------cccccCCCCcccccccceeee
Confidence 9999999999999999999999999999997421111100000000 000011111234578999999
Q ss_pred cChhhhcCCC---CCchHHHHHHHHHHHHHHc
Q 003232 787 LAPEILLGTG---HGTTADWWSVGIILFELIV 815 (837)
Q Consensus 787 mAPEVLlg~~---~s~kSDIWSLGVILyELLT 815 (837)
+|||++.+.. |+.++|+||||++||||+.
T Consensus 782 vAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 782 VAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY 813 (1351)
T ss_pred ecHHHhcccccccccchhhhHHHHHHHHHHhc
Confidence 9999997755 9999999999999999985
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-28 Score=268.28 Aligned_cols=153 Identities=28% Similarity=0.486 Sum_probs=134.8
Q ss_pred CchhhhccccCCCCCCCCCCcccC--CeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHH
Q 003232 566 LEDDVVRSLRTSPIHPSKDRTSID--DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDIL 643 (837)
Q Consensus 566 lEeE~i~sl~ss~~~P~k~g~~ld--dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieIL 643 (837)
.++|....|..++|+|+.++..++ +|.+.++||+|.|+|||+|++....++||+|+.+... ...+..+.|+++|
T Consensus 53 ~eqE~~~dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL 128 (590)
T KOG1290|consen 53 EEQEDPEDYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLL 128 (590)
T ss_pred ccccChhhhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHH
Confidence 356667889999999999999887 5999999999999999999999999999999998753 4556678899999
Q ss_pred HhcC-----CC---ceEEEEeEeec----CCeEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh-C
Q 003232 644 ISVR-----NP---FVVRFFYSFTC----RENLYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHS-L 708 (837)
Q Consensus 644 k~Lr-----HP---NIVkL~gsf~d----~~~lyLVmEy~~GGSL~dlLk~~--g~Lsee~irkIl~QIa~ALsYLHS-k 708 (837)
++++ |+ .||++++.|.. ..|+|+|+|++ |.+|..+|... ..++...++.|++||+.||.|||. +
T Consensus 129 ~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec 207 (590)
T KOG1290|consen 129 QQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC 207 (590)
T ss_pred HHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc
Confidence 9884 33 69999999976 45899999999 88999998754 559999999999999999999996 7
Q ss_pred CcccccCCCCcEEEc
Q 003232 709 RVVHRDLKPDNLLIA 723 (837)
Q Consensus 709 GIIHRDIKPeNILLd 723 (837)
||||.||||+|||+.
T Consensus 208 gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 208 GIIHTDLKPENVLLC 222 (590)
T ss_pred CccccCCCcceeeee
Confidence 999999999999984
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-27 Score=232.19 Aligned_cols=200 Identities=47% Similarity=0.813 Sum_probs=173.8
Q ss_pred eEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEEe
Q 003232 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEY 670 (837)
Q Consensus 591 YeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmEy 670 (837)
|.+.+.||.|++|+||++.+..+++.+++|.+...... ...+.+.+|+..++.++|+|++++++.+......++++||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 56789999999999999999888999999999865422 2456888999999999999999999999988999999999
Q ss_pred cCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCC
Q 003232 671 LNGGDLYSLLRNLGC-LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 749 (837)
Q Consensus 671 ~~GGSL~dlLk~~g~-Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~ 749 (837)
+.+++|.+++..... +++..+..++.+++.+|.+||++|++|+||+|.||+++.++.++|+|||++.......
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~------ 152 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL------ 152 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc------
Confidence 999999999987666 8999999999999999999999999999999999999999999999999886311110
Q ss_pred CCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhh-cCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003232 750 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEIL-LGTGHGTTADWWSVGIILFELIVGIPPFNA 822 (837)
Q Consensus 750 p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVL-lg~~~s~kSDIWSLGVILyELLTGr~PF~~ 822 (837)
........++..|++||.+ ....++.++|+|+||+++|+|++|+.||..
T Consensus 153 ------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 153 ------------------------AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ------------------------cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 0011234577889999998 667788899999999999999999999976
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=262.14 Aligned_cols=212 Identities=30% Similarity=0.541 Sum_probs=179.6
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcC-CCceEEEEeEeecCCeEE
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCRENLY 665 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~Lr-HPNIVkL~gsf~d~~~ly 665 (837)
..++.+.+..||+|+.|.||+++.+.+|...|||.+.... +.+..++++..++++...+ +|+||+.+++|..+..++
T Consensus 90 dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~ 167 (391)
T KOG0983|consen 90 DINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVF 167 (391)
T ss_pred ChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHH
Confidence 4567888899999999999999999999999999998763 5667788999999987765 899999999999999999
Q ss_pred EEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCcEEEccCCcEEEEecCCccccccCC
Q 003232 666 LVMEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 666 LVmEy~~GGSL~dlLk~-~g~Lsee~irkIl~QIa~ALsYLHS-kGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~s 743 (837)
|.||.+ +..+..++++ .+++++..+-++...++.||.||.+ +||||||+||+|||+|..|++||||||++-.. .+
T Consensus 168 IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrl-vd- 244 (391)
T KOG0983|consen 168 ICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRL-VD- 244 (391)
T ss_pred HHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeeccccccee-ec-
Confidence 999988 4455555543 4679999999999999999999997 68999999999999999999999999987521 01
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC---CCCCchHHHHHHHHHHHHHHcCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG---TGHGTTADWWSVGIILFELIVGIPPF 820 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg---~~~s~kSDIWSLGVILyELLTGr~PF 820 (837)
.......+|.+.|||||.+.. ..|+-++||||||++++||.||..||
T Consensus 245 ------------------------------SkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy 294 (391)
T KOG0983|consen 245 ------------------------------SKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPY 294 (391)
T ss_pred ------------------------------ccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCC
Confidence 112234579999999999953 46889999999999999999999999
Q ss_pred CCCCcCHHHHHHh
Q 003232 821 NAEHPQVSTLLRK 833 (837)
Q Consensus 821 ~~~dpdv~~lle~ 833 (837)
.+.+.+...+...
T Consensus 295 ~~c~tdFe~ltkv 307 (391)
T KOG0983|consen 295 KGCKTDFEVLTKV 307 (391)
T ss_pred CCCCccHHHHHHH
Confidence 9988887765543
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=267.83 Aligned_cols=221 Identities=29% Similarity=0.471 Sum_probs=177.5
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCC----cEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeec-C
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTG----DLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC-R 661 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG----~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d-~ 661 (837)
.+..|+++..||.|.||.||+|..+.++ +.+|||.++... ..........+|+.+++.++||||+.+..+|.. +
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~k-d~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEK-DGTGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccC-CCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 4567999999999999999999655443 378999987643 122334567899999999999999999998887 7
Q ss_pred CeEEEEEEecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccC----CcEEEEe
Q 003232 662 ENLYLVMEYLNGGDLYSLLRNL-----GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD----GHIKLTD 732 (837)
Q Consensus 662 ~~lyLVmEy~~GGSL~dlLk~~-----g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~d----G~IKLiD 732 (837)
..+++++||.+ -+|.++++-+ ..++...++.+++||+.|+.|||++.|+||||||.|||+..+ |.+||+|
T Consensus 101 ~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 101 KKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred ceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeec
Confidence 89999999995 5899988532 569999999999999999999999999999999999999876 8999999
Q ss_pred cCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHH
Q 003232 733 FGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILF 811 (837)
Q Consensus 733 FGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILy 811 (837)
||+++..... +.+ .......+-|+.|+|||.++| ..|+.+.|+|++|||+.
T Consensus 180 lGlaR~~~~p----lkp------------------------l~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfa 231 (438)
T KOG0666|consen 180 LGLARLFNNP----LKP------------------------LASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFA 231 (438)
T ss_pred ccHHHHhhcc----ccc------------------------cccCCceEEEEEecChHHhcccccccchhhhHHHHHHHH
Confidence 9999852111 100 011223467899999999998 56899999999999999
Q ss_pred HHHcCCCCCCCCCc--------CHHHHHHhcccC
Q 003232 812 ELIVGIPPFNAEHP--------QVSTLLRKCQLL 837 (837)
Q Consensus 812 ELLTGr~PF~~~dp--------dv~~lle~~hL~ 837 (837)
||||-.+.|.+... +..|+.+++++|
T Consensus 232 ElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vL 265 (438)
T KOG0666|consen 232 ELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVL 265 (438)
T ss_pred HHHccCccccchhhhcccCCCchHHHHHHHHHHc
Confidence 99999999987543 345566666554
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.8e-29 Score=277.85 Aligned_cols=202 Identities=28% Similarity=0.519 Sum_probs=178.1
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHH-----HHHHHHHHHHHHhcC---CCceEEEEeEee
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNA-----VESILAERDILISVR---NPFVVRFFYSFT 659 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~-----ie~~~rEieILk~Lr---HPNIVkL~gsf~ 659 (837)
+.+|..++.+|.|+||.|++|.++.+...|+||.+.+........ +--+-.|+.||..++ |+||++++++|.
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 456999999999999999999999999999999998765432222 234567999999998 999999999999
Q ss_pred cCCeEEEEEEecC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccc
Q 003232 660 CRENLYLVMEYLN-GGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (837)
Q Consensus 660 d~~~lyLVmEy~~-GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArv 738 (837)
+++++||+||.-. |.+|++++...+.+++.+++.|+.|++.|+++||+.||||||||-+|+.++.+|-+||+|||.+..
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~ 719 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAY 719 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhh
Confidence 9999999999763 569999999999999999999999999999999999999999999999999999999999998763
Q ss_pred cccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCC-CchHHHHHHHHHHHHHHcCC
Q 003232 739 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVGI 817 (837)
Q Consensus 739 g~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~-s~kSDIWSLGVILyELLTGr 817 (837)
. ...+-...+||..|.|||++.|.+| +..-|||+||++||-++...
T Consensus 720 ~---------------------------------ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivyke 766 (772)
T KOG1152|consen 720 T---------------------------------KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKE 766 (772)
T ss_pred h---------------------------------cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEecc
Confidence 0 1122346789999999999999887 67889999999999999999
Q ss_pred CCCCC
Q 003232 818 PPFNA 822 (837)
Q Consensus 818 ~PF~~ 822 (837)
.||..
T Consensus 767 npyyn 771 (772)
T KOG1152|consen 767 NPYYN 771 (772)
T ss_pred CCCcC
Confidence 99974
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-29 Score=272.66 Aligned_cols=214 Identities=30% Similarity=0.498 Sum_probs=177.8
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccc----cHHHHHHHHHHHHHHHhcCCCceEEEEeEeecC-C
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMI----RKNAVESILAERDILISVRNPFVVRFFYSFTCR-E 662 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~----~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~-~ 662 (837)
.++|-++.+||.|||+.||+|.+....++||+|+-.....+ .....+...+|.+|.+.|.||.||++|++|..+ .
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 35699999999999999999999999999999996543322 234456788999999999999999999999765 5
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--CcccccCCCCcEEEcc---CCcEEEEecCCcc
Q 003232 663 NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL--RVVHRDLKPDNLLIAH---DGHIKLTDFGLSK 737 (837)
Q Consensus 663 ~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSk--GIIHRDIKPeNILLd~---dG~IKLiDFGLAr 737 (837)
.+|-|+|||+|.+|.-+++.++.+++.+++.|+.||+.||.||.+. .|||-||||.|||+-. -|.+||.|||+++
T Consensus 542 sFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK 621 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK 621 (775)
T ss_pred cceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence 6999999999999999999999999999999999999999999975 6999999999999954 4789999999998
Q ss_pred ccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC----CCCCchHHHHHHHHHHHHH
Q 003232 738 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG----TGHGTTADWWSVGIILFEL 813 (837)
Q Consensus 738 vg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg----~~~s~kSDIWSLGVILyEL 813 (837)
+-..++.+.. .+ ...+....||.+|++||.+.- ...+.++||||+|||+|..
T Consensus 622 IMdddSy~~v----------dG--------------meLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQC 677 (775)
T KOG1151|consen 622 IMDDDSYNSV----------DG--------------MELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQC 677 (775)
T ss_pred hccCCccCcc----------cc--------------eeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhh
Confidence 6332222110 00 112335679999999999853 2458899999999999999
Q ss_pred HcCCCCCCCCCc
Q 003232 814 IVGIPPFNAEHP 825 (837)
Q Consensus 814 LTGr~PF~~~dp 825 (837)
+.|+.||..+..
T Consensus 678 lYGrKPFGhnqs 689 (775)
T KOG1151|consen 678 LYGRKPFGHNQS 689 (775)
T ss_pred hccCCCCCCchh
Confidence 999999986543
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=245.35 Aligned_cols=215 Identities=33% Similarity=0.523 Sum_probs=179.6
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVm 668 (837)
.+|.-+++||+|.||+||+++++.+++.||+|.++-+. .++.......+|+-+++.++|.|||++++....++.+-+|+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrldd-ddegvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccC-CCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 35777899999999999999999999999999997654 33444567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCC
Q 003232 669 EYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (837)
Q Consensus 669 Ey~~GGSL~dlLk~-~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl 747 (837)
||| ...|..+... ++.++.+.++.++.|+++||.++|++++.|||+||.|.||+.+|.+||+|||+++..... .
T Consensus 81 e~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgip-v--- 155 (292)
T KOG0662|consen 81 EFC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP-V--- 155 (292)
T ss_pred HHh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCc-e---
Confidence 999 4578777754 577999999999999999999999999999999999999999999999999999831110 0
Q ss_pred CCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCC-CCCchHHHHHHHHHHHHHHc-CCCCCCCCCc
Q 003232 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIV-GIPPFNAEHP 825 (837)
Q Consensus 748 ~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~-~~s~kSDIWSLGVILyELLT-Gr~PF~~~dp 825 (837)
+-....+-|..|++|.++.|. -|+...|+||.||++.|+.. |++.|.+.+
T Consensus 156 ---------------------------rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~d- 207 (292)
T KOG0662|consen 156 ---------------------------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND- 207 (292)
T ss_pred ---------------------------EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCc-
Confidence 001234568899999999885 47888999999999999995 777776654
Q ss_pred CHHHHHHhcccC
Q 003232 826 QVSTLLRKCQLL 837 (837)
Q Consensus 826 dv~~lle~~hL~ 837 (837)
-..|+.+++++|
T Consensus 208 vddqlkrif~~l 219 (292)
T KOG0662|consen 208 VDDQLKRIFRLL 219 (292)
T ss_pred HHHHHHHHHHHh
Confidence 345677776653
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=288.43 Aligned_cols=189 Identities=26% Similarity=0.401 Sum_probs=161.1
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVm 668 (837)
..|.....||+|+||.||+|++..++..||+|.+...... ...|+.++++++||||+++++++......|+||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 4567778999999999999999999999999998653311 124578899999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCC
Q 003232 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLH---SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745 (837)
Q Consensus 669 Ey~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLH---SkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~std 745 (837)
||+++|+|.++++. +++.....++.||+.||.||| +.+|+||||||+||+++.++..++. ||.....
T Consensus 763 Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~------ 832 (968)
T PLN00113 763 EYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL------ 832 (968)
T ss_pred eCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccc------
Confidence 99999999999964 788999999999999999999 6799999999999999988887775 5544310
Q ss_pred CCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003232 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823 (837)
Q Consensus 746 dl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~ 823 (837)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 833 -----------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~ 881 (968)
T PLN00113 833 -----------------------------CTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAE 881 (968)
T ss_pred -----------------------------ccCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcc
Confidence 0011236789999999999999999999999999999999999999643
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=267.46 Aligned_cols=198 Identities=31% Similarity=0.529 Sum_probs=171.0
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcC--CC----ceEEEEeEeecC
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR--NP----FVVRFFYSFTCR 661 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~Lr--HP----NIVkL~gsf~d~ 661 (837)
.++|.++..+|+|.||.|-.+.+..++..||||+++... ...+...-|+++|+++. .| -++++.++|...
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~----kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD----KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH----HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 567999999999999999999999999999999998643 33456678999999984 23 377788889999
Q ss_pred CeEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEcc---------------
Q 003232 662 ENLYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH--------------- 724 (837)
Q Consensus 662 ~~lyLVmEy~~GGSL~dlLk~~--g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~--------------- 724 (837)
++.|||+|.+ |.|+++++..+ .+++...++.+.+|++.++.|||+.+++|.||||+|||+.+
T Consensus 164 ghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred CceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccce
Confidence 9999999988 77999999875 45889999999999999999999999999999999999842
Q ss_pred -----CCcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCc
Q 003232 725 -----DGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT 799 (837)
Q Consensus 725 -----dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~ 799 (837)
+..++|+|||.|++...+ ....+-|..|+|||++++.+|++
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~e~----------------------------------hs~iVsTRHYRAPEViLgLGwS~ 288 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDHEH----------------------------------HSTIVSTRHYRAPEVILGLGWSQ 288 (415)
T ss_pred eccCCCcceEEEecCCcceeccC----------------------------------cceeeeccccCCchheeccCcCC
Confidence 235899999999852211 13456788999999999999999
Q ss_pred hHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 800 TADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 800 kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
+|||||+||||+|+++|...|...+
T Consensus 289 pCDvWSiGCIL~ElytG~~LFqtHe 313 (415)
T KOG0671|consen 289 PCDVWSIGCILVELYTGETLFQTHE 313 (415)
T ss_pred ccCceeeeeEEEEeeccceecccCC
Confidence 9999999999999999999998766
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.9e-28 Score=270.86 Aligned_cols=205 Identities=28% Similarity=0.422 Sum_probs=174.3
Q ss_pred CeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEE
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmE 669 (837)
...+.++||+|.||.|.+|.- ..+..||+|+++... ..+....|..|+++|.+|+||||+.++++|..++.+|+|||
T Consensus 539 ~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDA--TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred heehhhhhcCcccceeEEEEe-cCceEEEEeecCccc--chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 477889999999999999996 457999999999864 34556789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCC
Q 003232 670 YLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (837)
Q Consensus 670 y~~GGSL~dlLk~~--g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl 747 (837)
|++.|+|.+++..+ ..+.......++.||+.|++||.+.++|||||.+.|+|++.++++||+|||+++-. +
T Consensus 616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~l-------y 688 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNL-------Y 688 (807)
T ss_pred HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCccccccc-------c
Confidence 99999999999876 23344556679999999999999999999999999999999999999999999821 1
Q ss_pred CCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHH--cCCCCCCCCCc
Q 003232 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI--VGIPPFNAEHP 825 (837)
Q Consensus 748 ~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELL--TGr~PF~~~dp 825 (837)
++++ .+.....+-..+|||||.+....++.++|+|+||+++||++ +...||...++
T Consensus 689 sg~y----------------------y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~ 746 (807)
T KOG1094|consen 689 SGDY----------------------YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD 746 (807)
T ss_pred cCCc----------------------eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH
Confidence 1110 11123345678999999999999999999999999999987 58899987554
Q ss_pred C
Q 003232 826 Q 826 (837)
Q Consensus 826 d 826 (837)
+
T Consensus 747 e 747 (807)
T KOG1094|consen 747 E 747 (807)
T ss_pred H
Confidence 3
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.1e-27 Score=228.13 Aligned_cols=188 Identities=50% Similarity=0.900 Sum_probs=165.5
Q ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEEecCCCCHHHHH
Q 003232 601 AFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 680 (837)
Q Consensus 601 ~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmEy~~GGSL~dlL 680 (837)
+||.||+|.+..+++.+++|++........ .+.+.+|+..++.++|+||+++++.+......+++|||+.+++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 589999999988899999999976543221 578899999999999999999999999989999999999999999999
Q ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCCCccCcccCCC
Q 003232 681 RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGD 760 (837)
Q Consensus 681 k~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~ 760 (837)
.....++...+..++.+++.+|.|||+.|++|+||+|.||+++.++.++|+|||.+.......
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----------------- 141 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG----------------- 141 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-----------------
Confidence 876668999999999999999999999999999999999999999999999999986311000
Q ss_pred CCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003232 761 EEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNA 822 (837)
Q Consensus 761 ~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~ 822 (837)
......|+..|++||.+.+..++.++||||||+++|+|++|..||..
T Consensus 142 ---------------~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 142 ---------------LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred ---------------ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 12234678889999999988899999999999999999999999976
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=272.08 Aligned_cols=198 Identities=32% Similarity=0.524 Sum_probs=170.3
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHh-cCCCceEEEEeEeecCCeEE
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILIS-VRNPFVVRFFYSFTCRENLY 665 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~-LrHPNIVkL~gsf~d~~~ly 665 (837)
..+.|.+...+|.|+|+.|-.+.+..+++..++|++.+.. ....+|+.++.. -+||||+++.+.+.+..+.|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCceee
Confidence 3467999999999999999999999999999999998652 123456655544 47999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEE-ccCCcEEEEecCCccccccCCC
Q 003232 666 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI-AHDGHIKLTDFGLSKVGLINST 744 (837)
Q Consensus 666 LVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILL-d~dG~IKLiDFGLArvg~~~st 744 (837)
+|||++.|+-|.+.+...+.+. ..+..|+++|+.|+.|||++|+|||||||+|||+ +..|+++|+|||.++...
T Consensus 393 ~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~---- 467 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE---- 467 (612)
T ss_pred eeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCc----
Confidence 9999999998888887755554 7778899999999999999999999999999999 689999999999987310
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 745 ddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
....+.+-|..|.|||++...+|+..|||||||++||+||+|+.||....
T Consensus 468 ------------------------------~~~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P 517 (612)
T KOG0603|consen 468 ------------------------------RSCDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHP 517 (612)
T ss_pred ------------------------------hhhcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCC
Confidence 00123466788999999999999999999999999999999999999877
Q ss_pred cC
Q 003232 825 PQ 826 (837)
Q Consensus 825 pd 826 (837)
.+
T Consensus 518 ~~ 519 (612)
T KOG0603|consen 518 AG 519 (612)
T ss_pred ch
Confidence 76
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.1e-29 Score=258.85 Aligned_cols=208 Identities=28% Similarity=0.518 Sum_probs=173.7
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHh-cCCCceEEEEeEeecCCeEEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILIS-VRNPFVVRFFYSFTCRENLYL 666 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~-LrHPNIVkL~gsf~d~~~lyL 666 (837)
.++.+-+..||.|+||+|++-.++.+|+..|||.++.... ....+++..|.+...+ -++||||++|++...++..||
T Consensus 63 ~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWi 140 (361)
T KOG1006|consen 63 SDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWI 140 (361)
T ss_pred cchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceee
Confidence 3557778899999999999999999999999999987653 4455778888887654 579999999999999999999
Q ss_pred EEEecCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCcEEEccCCcEEEEecCCccccc
Q 003232 667 VMEYLNGGDLYSLLR-----NLGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740 (837)
Q Consensus 667 VmEy~~GGSL~dlLk-----~~g~Lsee~irkIl~QIa~ALsYLHS-kGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~ 740 (837)
.||++ ..||..+.+ ....+++..+-.+..-.+.||+||-+ ..||||||||+|||++..|.+||||||++-.
T Consensus 141 CMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGq-- 217 (361)
T KOG1006|consen 141 CMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQ-- 217 (361)
T ss_pred eHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHh--
Confidence 99999 567766653 23568999998998899999999996 6999999999999999999999999999752
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC--CCCCchHHHHHHHHHHHHHHcCCC
Q 003232 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG--TGHGTTADWWSVGIILFELIVGIP 818 (837)
Q Consensus 741 ~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg--~~~s~kSDIWSLGVILyELLTGr~ 818 (837)
...+..++..+|...|||||.+.. .+|+-++|+||||++|||+.||..
T Consensus 218 ------------------------------Lv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~f 267 (361)
T KOG1006|consen 218 ------------------------------LVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNF 267 (361)
T ss_pred ------------------------------HHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCC
Confidence 112233455689999999999953 568999999999999999999999
Q ss_pred CCCCCCcCHHHH
Q 003232 819 PFNAEHPQVSTL 830 (837)
Q Consensus 819 PF~~~dpdv~~l 830 (837)
||..=+...+|+
T Consensus 268 Pyr~w~svfeql 279 (361)
T KOG1006|consen 268 PYRKWDSVFEQL 279 (361)
T ss_pred CcchHHHHHHHH
Confidence 997765544444
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-27 Score=241.39 Aligned_cols=209 Identities=31% Similarity=0.540 Sum_probs=174.2
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEeEeecCCeEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~gsf~d~~~lyLV 667 (837)
++...+..||.|+||.|-+.++..+|...|+|.+...- +....++..+|+.+..+. .+|++|.||+.+.....++|.
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIc 123 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWIC 123 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEe
Confidence 44566788999999999999999999999999997642 345567888999987654 799999999999999999999
Q ss_pred EEecCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCcEEEccCCcEEEEecCCccccccC
Q 003232 668 MEYLNGGDLYSLL----RNLGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (837)
Q Consensus 668 mEy~~GGSL~dlL----k~~g~Lsee~irkIl~QIa~ALsYLHS-kGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~ 742 (837)
||.+ ..||..+. ...+.+++..+-+++..++.||.|||+ ..+||||+||+||||+.+|++|+||||.+-.. .+
T Consensus 124 ME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L-~d 201 (282)
T KOG0984|consen 124 MELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYL-VD 201 (282)
T ss_pred HHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceee-hh
Confidence 9998 56887665 345679999999999999999999998 58999999999999999999999999987521 11
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC----CCCCchHHHHHHHHHHHHHHcCCC
Q 003232 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG----TGHGTTADWWSVGIILFELIVGIP 818 (837)
Q Consensus 743 stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg----~~~s~kSDIWSLGVILyELLTGr~ 818 (837)
+-..+...|.-.|||||.+.. ..|+-++||||||++++||.+++.
T Consensus 202 -------------------------------SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~ 250 (282)
T KOG0984|consen 202 -------------------------------SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRF 250 (282)
T ss_pred -------------------------------hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccc
Confidence 111223468888999999853 478999999999999999999999
Q ss_pred CCCCCCcCHHHHHH
Q 003232 819 PFNAEHPQVSTLLR 832 (837)
Q Consensus 819 PF~~~dpdv~~lle 832 (837)
||..-.....++..
T Consensus 251 PY~~w~tpF~qLkq 264 (282)
T KOG0984|consen 251 PYESWGTPFQQLKQ 264 (282)
T ss_pred cccccCCHHHHHHH
Confidence 99877666665543
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-28 Score=272.24 Aligned_cols=213 Identities=30% Similarity=0.453 Sum_probs=182.1
Q ss_pred CCCCCCCCCCcccCC-eEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCC------
Q 003232 576 TSPIHPSKDRTSIDD-FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN------ 648 (837)
Q Consensus 576 ss~~~P~k~g~~ldd-YeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrH------ 648 (837)
..+||...++..++. |.|....|+|-||+|.+|.+..-|..||||++.... ...+.=+.|+++|+.|+.
T Consensus 418 aEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE----~M~KtGl~EleiLkKL~~AD~Edk 493 (752)
T KOG0670|consen 418 AEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE----VMHKTGLKELEILKKLNDADPEDK 493 (752)
T ss_pred ccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch----HHhhhhhHHHHHHHHhhccCchhh
Confidence 457788888888875 999999999999999999999999999999998653 334456789999999974
Q ss_pred CceEEEEeEeecCCeEEEEEEecCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccC
Q 003232 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC---LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD 725 (837)
Q Consensus 649 PNIVkL~gsf~d~~~lyLVmEy~~GGSL~dlLk~~g~---Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~d 725 (837)
-|+++++-.|...+|+|||+|.+ ..+|.++++..+. |....++.|+.|+..||..|-.+||+|.||||+|||++..
T Consensus 494 ~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~ 572 (752)
T KOG0670|consen 494 FHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNES 572 (752)
T ss_pred hHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccC
Confidence 37899999999999999999998 6799999987654 8888999999999999999999999999999999999875
Q ss_pred C-cEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHH
Q 003232 726 G-HIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWW 804 (837)
Q Consensus 726 G-~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIW 804 (837)
. .+||||||.|.....+.. +.+.-+..|.|||+++|.+|++..|+|
T Consensus 573 k~iLKLCDfGSA~~~~enei---------------------------------tPYLVSRFYRaPEIiLG~~yd~~iD~W 619 (752)
T KOG0670|consen 573 KNILKLCDFGSASFASENEI---------------------------------TPYLVSRFYRAPEIILGLPYDYPIDTW 619 (752)
T ss_pred cceeeeccCccccccccccc---------------------------------cHHHHHHhccCcceeecCcccCCccce
Confidence 4 579999999874111110 112234569999999999999999999
Q ss_pred HHHHHHHHHHcCCCCCCCCCcC
Q 003232 805 SVGIILFELIVGIPPFNAEHPQ 826 (837)
Q Consensus 805 SLGVILyELLTGr~PF~~~dpd 826 (837)
|+||+||||+||+..|.+.+.+
T Consensus 620 SvgctLYElYtGkIlFpG~TNN 641 (752)
T KOG0670|consen 620 SVGCTLYELYTGKILFPGRTNN 641 (752)
T ss_pred eeceeeEEeeccceecCCCCcH
Confidence 9999999999999999998776
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.1e-28 Score=248.16 Aligned_cols=210 Identities=30% Similarity=0.513 Sum_probs=181.2
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcC-CCceEEEEeEeecC--Ce
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCR--EN 663 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~Lr-HPNIVkL~gsf~d~--~~ 663 (837)
..++|++++++|.|.|+.||.|.+..+++.++||++++. ..+.+.+|+.+|..|. ||||++++++..+. ..
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH------HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 457899999999999999999999999999999999874 3467899999999997 99999999998774 46
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEcc-CCcEEEEecCCccccccC
Q 003232 664 LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH-DGHIKLTDFGLSKVGLIN 742 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~-dG~IKLiDFGLArvg~~~ 742 (837)
+.||+||+++.+...+. +.++...++.++.+++.||.|+|++||+|||+||.|++|+. ...++|+|+|+|-+..
T Consensus 110 paLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH-- 184 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-- 184 (338)
T ss_pred chhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcC--
Confidence 88999999887777665 44888899999999999999999999999999999999986 4579999999987411
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCC
Q 003232 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFN 821 (837)
Q Consensus 743 stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLTGr~PF~ 821 (837)
. +..-+..+.+..|-.||.+.. ..|++.-|+|||||++..|+..+-||-
T Consensus 185 -p-----------------------------~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFF 234 (338)
T KOG0668|consen 185 -P-----------------------------GKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 234 (338)
T ss_pred -C-----------------------------CceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCccc
Confidence 0 111234456677889999976 568999999999999999999999999
Q ss_pred CCCcCHHHHHHhcccC
Q 003232 822 AEHPQVSTLLRKCQLL 837 (837)
Q Consensus 822 ~~dpdv~~lle~~hL~ 837 (837)
-..++.+|+.+++++|
T Consensus 235 hG~dN~DQLVkIakVL 250 (338)
T KOG0668|consen 235 HGHDNYDQLVKIAKVL 250 (338)
T ss_pred CCCCCHHHHHHHHHHh
Confidence 9999999999999875
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-27 Score=265.29 Aligned_cols=216 Identities=25% Similarity=0.417 Sum_probs=182.4
Q ss_pred CCCcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC
Q 003232 583 KDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE 662 (837)
Q Consensus 583 k~g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~ 662 (837)
+|.....+....++||-|.||.||.|.|++-...||||.++.+. ..++.|+.|..+|+.++|||+|+++++|..+.
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt----MeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep 336 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP 336 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc----hhHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence 45555566888899999999999999999999999999998754 45678999999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccc
Q 003232 663 NLYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740 (837)
Q Consensus 663 ~lyLVmEy~~GGSL~dlLk~~--g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~ 740 (837)
.+|||+|||..|+|.+|+++- ..++.-.+..++-||..|++||..+++|||||...|.|+.++..+|++|||++++-.
T Consensus 337 PFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 337 PFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred CeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence 999999999999999999753 336767778888899999999999999999999999999999999999999998522
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCC
Q 003232 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPP 819 (837)
Q Consensus 741 ~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~P 819 (837)
.+.... .....-.+.|.|||.+.-+.++.++|||+|||+|||+.| |..|
T Consensus 417 gDTYTA------------------------------HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsP 466 (1157)
T KOG4278|consen 417 GDTYTA------------------------------HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSP 466 (1157)
T ss_pred CCceec------------------------------ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCC
Confidence 111110 112223567999999999999999999999999999996 9999
Q ss_pred CCCCC-cCHHHHHH
Q 003232 820 FNAEH-PQVSTLLR 832 (837)
Q Consensus 820 F~~~d-pdv~~lle 832 (837)
|.+.+ .++..++|
T Consensus 467 YPGidlSqVY~LLE 480 (1157)
T KOG4278|consen 467 YPGIDLSQVYGLLE 480 (1157)
T ss_pred CCCccHHHHHHHHh
Confidence 98754 44444554
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=254.40 Aligned_cols=215 Identities=27% Similarity=0.430 Sum_probs=170.3
Q ss_pred CCcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHh--cCCCceEEEEeEeecC
Q 003232 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILIS--VRNPFVVRFFYSFTCR 661 (837)
Q Consensus 584 ~g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~--LrHPNIVkL~gsf~d~ 661 (837)
.+.+..+..+.+.||+|.||.||+|+|+ |+.||||++.... .....+|.+|++. |+|+||+.|+.+-..+
T Consensus 206 QRTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~ 277 (513)
T KOG2052|consen 206 QRTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHENILGFIAADNKD 277 (513)
T ss_pred HHhhhheeEEEEEecCccccceeecccc--CCceEEEEecccc------hhhhhhHHHHHHHHHhccchhhhhhhccccC
Confidence 3455567999999999999999999997 8899999997532 2467888888875 6999999998765543
Q ss_pred C----eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------CCcccccCCCCcEEEccCCcEE
Q 003232 662 E----NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS--------LRVVHRDLKPDNLLIAHDGHIK 729 (837)
Q Consensus 662 ~----~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHS--------kGIIHRDIKPeNILLd~dG~IK 729 (837)
+ .+|||++|-+.|||+|++.+ ..++.....+++..++.||.|||. -.|.|||||..|||+..+|..-
T Consensus 278 ~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~ 356 (513)
T KOG2052|consen 278 NGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 356 (513)
T ss_pred CCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE
Confidence 3 58999999999999999988 679999999999999999999993 2499999999999999999999
Q ss_pred EEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCC-----C-chHHH
Q 003232 730 LTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-----G-TTADW 803 (837)
Q Consensus 730 LiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~-----s-~kSDI 803 (837)
|+|+|+|.....+ ++.+. ...+..+||-+|||||++...-. + ..+||
T Consensus 357 IADLGLAv~h~~~-t~~id--------------------------i~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADI 409 (513)
T KOG2052|consen 357 IADLGLAVRHDSD-TDTID--------------------------IPPNPRVGTKRYMAPEVLDETINMKHFESYKRADI 409 (513)
T ss_pred EeeceeeEEeccc-CCccc--------------------------CCCCCccceeeccChHHhhhhcChhhhhhhhHHHH
Confidence 9999999642211 12111 12356799999999999964321 1 35799
Q ss_pred HHHHHHHHHHHcC----------CCCCCCCCcCHHHHHHhc
Q 003232 804 WSVGIILFELIVG----------IPPFNAEHPQVSTLLRKC 834 (837)
Q Consensus 804 WSLGVILyELLTG----------r~PF~~~dpdv~~lle~~ 834 (837)
||||+++||+..+ .+||..--|....+.+..
T Consensus 410 YafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMr 450 (513)
T KOG2052|consen 410 YAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMR 450 (513)
T ss_pred HHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHh
Confidence 9999999999852 468876544444444433
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-27 Score=272.05 Aligned_cols=207 Identities=27% Similarity=0.397 Sum_probs=178.2
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCc---EEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGD---LFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 665 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~---~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ly 665 (837)
....|.++||.|.||.|++|+.+..|+ .||||.++... .+.+...|+.|..||-+++||||+++.++......++
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvM 706 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVM 706 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeE
Confidence 457889999999999999999987664 79999998763 4555678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCC
Q 003232 666 LVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (837)
Q Consensus 666 LVmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~st 744 (837)
||+|||++|+|+.+++.+ +.++..++..+++.|+.|+.||-+.|+|||||..+|||++.+-..|++|||++++...+.
T Consensus 707 IiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~- 785 (996)
T KOG0196|consen 707 IITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP- 785 (996)
T ss_pred EEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCC-
Confidence 999999999999999764 779999999999999999999999999999999999999999999999999998632221
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHH-cCCCCCCCC
Q 003232 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI-VGIPPFNAE 823 (837)
Q Consensus 745 ddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELL-TGr~PF~~~ 823 (837)
+. .++ .....-..+|.|||.+....++..+||||+|++|||.+ .|+.||+.-
T Consensus 786 ~~-----------------~yt----------t~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdm 838 (996)
T KOG0196|consen 786 EA-----------------AYT----------TLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 838 (996)
T ss_pred Cc-----------------ccc----------ccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccccc
Confidence 10 000 11112357899999999999999999999999999988 599999865
Q ss_pred Cc
Q 003232 824 HP 825 (837)
Q Consensus 824 dp 825 (837)
+.
T Consensus 839 SN 840 (996)
T KOG0196|consen 839 SN 840 (996)
T ss_pred ch
Confidence 53
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=269.15 Aligned_cols=202 Identities=34% Similarity=0.619 Sum_probs=174.8
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEeEeec-----CC
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTC-----RE 662 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~gsf~d-----~~ 662 (837)
+-|++.+.||.|.+|.||+++++++++..|+|+..... +..+.+..|.++++.. .|||++.+|++|.. .+
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D 94 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD 94 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc----cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence 45999999999999999999999999999999998653 2334677889999876 69999999999975 35
Q ss_pred eEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccc
Q 003232 663 NLYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740 (837)
Q Consensus 663 ~lyLVmEy~~GGSL~dlLk~~--g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~ 740 (837)
.+|||||||.|||.-|++++. ..+.+..+..|++.++.||.+||...+||||||-.|||++.++.+||+|||++...
T Consensus 95 qLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQl- 173 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL- 173 (953)
T ss_pred eEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeee-
Confidence 799999999999999999764 45889999999999999999999999999999999999999999999999987631
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-----CCCCchHHHHHHHHHHHHHHc
Q 003232 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-----TGHGTTADWWSVGIILFELIV 815 (837)
Q Consensus 741 ~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-----~~~s~kSDIWSLGVILyELLT 815 (837)
.....+.++.+|||.|||||++.. ..|+..+|+||||++..||-.
T Consensus 174 ------------------------------dsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIElad 223 (953)
T KOG0587|consen 174 ------------------------------DSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAE 223 (953)
T ss_pred ------------------------------ecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcC
Confidence 011245678899999999999964 457888999999999999999
Q ss_pred CCCCCCCCCc
Q 003232 816 GIPPFNAEHP 825 (837)
Q Consensus 816 Gr~PF~~~dp 825 (837)
|.+|+..-.|
T Consensus 224 G~PPl~DmHP 233 (953)
T KOG0587|consen 224 GAPPLCDMHP 233 (953)
T ss_pred CCCCccCcch
Confidence 9999976443
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.6e-27 Score=257.61 Aligned_cols=195 Identities=25% Similarity=0.407 Sum_probs=159.9
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHh--cCCCceEEEEeEeecCC---
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILIS--VRNPFVVRFFYSFTCRE--- 662 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~--LrHPNIVkL~gsf~d~~--- 662 (837)
+...+++++||+|.||.||+|.. +++.||||++.. .....+.+|.+|++. ++|+||++|++.-....
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~ 280 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPE------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR 280 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc--cCceeEEEecCH------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence 55678889999999999999986 469999999875 334678888888875 58999999997765444
Q ss_pred -eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---------CCcccccCCCCcEEEccCCcEEEEe
Q 003232 663 -NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS---------LRVVHRDLKPDNLLIAHDGHIKLTD 732 (837)
Q Consensus 663 -~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHS---------kGIIHRDIKPeNILLd~dG~IKLiD 732 (837)
.++||++|.+.|||.++++. ..+++....+++..|++||+|||+ ..|+|||||..|||+..+++..|+|
T Consensus 281 ~eywLVt~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 281 MEYWLVTEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred cceeEEeeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 79999999999999999987 468999999999999999999995 2599999999999999999999999
Q ss_pred cCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCC------CchHHHHHH
Q 003232 733 FGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH------GTTADWWSV 806 (837)
Q Consensus 733 FGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~------s~kSDIWSL 806 (837)
||+|....... ........+||.+|||||++.|.-. -.+.||||+
T Consensus 360 FGLAl~~~p~~-----------------------------~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYam 410 (534)
T KOG3653|consen 360 FGLALRLEPGK-----------------------------PQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAM 410 (534)
T ss_pred cceeEEecCCC-----------------------------CCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHH
Confidence 99997422000 0111234689999999999976422 135799999
Q ss_pred HHHHHHHHcCCCCC
Q 003232 807 GIILFELIVGIPPF 820 (837)
Q Consensus 807 GVILyELLTGr~PF 820 (837)
|.+||||+++..-+
T Consensus 411 gLVLWEi~SRC~~~ 424 (534)
T KOG3653|consen 411 GLVLWEIASRCTDA 424 (534)
T ss_pred HHHHHHHHhhcccc
Confidence 99999999865443
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-27 Score=268.62 Aligned_cols=206 Identities=24% Similarity=0.368 Sum_probs=173.6
Q ss_pred CCeEEEEEecccCceEEEEEEECCCC---cEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTG---DLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 665 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG---~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ly 665 (837)
++..+.++||+|.||.|++|.|...+ ..||||.++...... ....|++|+.+|.+|+|||++++|++..+ ..+.
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~m 186 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAM 186 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chhh
Confidence 44677789999999999999997532 368999998765332 67899999999999999999999999887 7889
Q ss_pred EEEEecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCC
Q 003232 666 LVMEYLNGGDLYSLLRN--LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 666 LVmEy~~GGSL~dlLk~--~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~s 743 (837)
+|||+++.|||.+.++. ...|....+..|+.||+.|+.||.++++|||||...|+|+.....+||+|||+.+....+.
T Consensus 187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 99999999999999986 3458889999999999999999999999999999999999999999999999988422221
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNA 822 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~~ 822 (837)
. .+ . -.....-...|+|||.+....++.++|+|++||++|||++ |+.||-+
T Consensus 267 d--~Y-----------------v---------m~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G 318 (1039)
T KOG0199|consen 267 D--MY-----------------V---------MAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVG 318 (1039)
T ss_pred c--ce-----------------E---------ecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCC
Confidence 1 10 0 0112234567999999999999999999999999999996 8999988
Q ss_pred CCc
Q 003232 823 EHP 825 (837)
Q Consensus 823 ~dp 825 (837)
..+
T Consensus 319 ~~g 321 (1039)
T KOG0199|consen 319 CRG 321 (1039)
T ss_pred CCH
Confidence 654
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.1e-26 Score=262.95 Aligned_cols=200 Identities=23% Similarity=0.356 Sum_probs=142.8
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCC----CcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeE---
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTT----GDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYS--- 657 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~t----G~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gs--- 657 (837)
....++|++.+.||+|+||.||+|++..+ +..||+|.+..... .+...++ .++...+.++..+...
T Consensus 128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-----~e~~~~e--~l~~~~~~~~~~~~~~~~~ 200 (566)
T PLN03225 128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-----VEIWMNE--RVRRACPNSCADFVYGFLE 200 (566)
T ss_pred CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-----hHHHHHH--HHHhhchhhHHHHHHhhhc
Confidence 44567899999999999999999999888 89999998764321 1111111 1112222222222111
Q ss_pred ---eecCCeEEEEEEecCCCCHHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCccccc
Q 003232 658 ---FTCRENLYLVMEYLNGGDLYSLLRNLGC--------------------LDEDVARVYIAEVVLALEYLHSLRVVHRD 714 (837)
Q Consensus 658 ---f~d~~~lyLVmEy~~GGSL~dlLk~~g~--------------------Lsee~irkIl~QIa~ALsYLHSkGIIHRD 714 (837)
......+++||||+.+++|.+++..... .....+..++.||+.||.|||++||+|||
T Consensus 201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRD 280 (566)
T PLN03225 201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRD 280 (566)
T ss_pred ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCc
Confidence 2345679999999999999999865321 12334667999999999999999999999
Q ss_pred CCCCcEEEcc-CCcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhc
Q 003232 715 LKPDNLLIAH-DGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL 793 (837)
Q Consensus 715 IKPeNILLd~-dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLl 793 (837)
|||+|||++. ++.+||+|||+++...... ........||+.|+|||.+.
T Consensus 281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~------------------------------~~~~~~~~~t~~Y~APE~~~ 330 (566)
T PLN03225 281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGI------------------------------NYIPKEFLLDPRYAAPEQYI 330 (566)
T ss_pred CCHHHEEEeCCCCcEEEEeCCCcccccccc------------------------------ccCCcccccCCCccChHHhh
Confidence 9999999985 6899999999986310000 00112457899999999764
Q ss_pred CCC----------------------CCchHHHHHHHHHHHHHHcCCCCCC
Q 003232 794 GTG----------------------HGTTADWWSVGIILFELIVGIPPFN 821 (837)
Q Consensus 794 g~~----------------------~s~kSDIWSLGVILyELLTGr~PF~ 821 (837)
... ++.++|||||||++|||+++..|+.
T Consensus 331 ~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 331 MSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred ccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCc
Confidence 322 3445699999999999999877754
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=259.07 Aligned_cols=202 Identities=26% Similarity=0.418 Sum_probs=168.5
Q ss_pred CCeEEEEEecccCceEEEEEEECC--C--CcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRT--T--GDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~--t--G~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~l 664 (837)
+...+.++||.|.||.||.|.... . .--||||..+.+. ..+..+.|..|..+|++++||||++++|++.+ ...
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~ 465 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPM 465 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cce
Confidence 335566899999999999998743 2 2368999988754 23346789999999999999999999999874 678
Q ss_pred EEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCC
Q 003232 665 YLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~s 743 (837)
|||||.++-|.|..+++.+ ..++......|+.||+.||.|||+..+|||||..+|||+.....+||+|||+++....
T Consensus 466 WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed-- 543 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLED-- 543 (974)
T ss_pred eEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccc--
Confidence 9999999999999999765 4589999999999999999999999999999999999999999999999999984110
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNA 822 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~~ 822 (837)
+. ..+.....-.+.|||||.+.-..++.++|||.|||+|||+|. |..||.+
T Consensus 544 -~~---------------------------yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqg 595 (974)
T KOG4257|consen 544 -DA---------------------------YYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQG 595 (974)
T ss_pred -cc---------------------------hhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccc
Confidence 00 011122234667999999999999999999999999999985 9999976
Q ss_pred C
Q 003232 823 E 823 (837)
Q Consensus 823 ~ 823 (837)
-
T Consensus 596 v 596 (974)
T KOG4257|consen 596 V 596 (974)
T ss_pred c
Confidence 3
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-28 Score=255.40 Aligned_cols=201 Identities=30% Similarity=0.487 Sum_probs=168.9
Q ss_pred EEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC-----eEEEE
Q 003232 593 IIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE-----NLYLV 667 (837)
Q Consensus 593 IlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~-----~lyLV 667 (837)
.-+.||.|+||.||.+.+..+|+.||+|.+.... .+-...+++.+|+.+|..++|.|+...+++..... .+|++
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf-q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF-QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhcchHH-HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 3467999999999999999999999999886432 33445578999999999999999998887765432 36888
Q ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCC
Q 003232 668 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (837)
Q Consensus 668 mEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl 747 (837)
+|.+ ..+|..++-....++...++-+++||++||.|||+.||.||||||.|+|++.+..+||||||++++...
T Consensus 136 TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~------ 208 (449)
T KOG0664|consen 136 TELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ------ 208 (449)
T ss_pred HHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccch------
Confidence 8988 468888887778899999999999999999999999999999999999999999999999999985211
Q ss_pred CCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 748 ~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
......+..+-|-.|+|||++.| ..|+...||||+|||+.|||.++..|....|
T Consensus 209 ------------------------d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P 263 (449)
T KOG0664|consen 209 ------------------------RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP 263 (449)
T ss_pred ------------------------hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh
Confidence 11222334456778999999988 5689999999999999999999999987655
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-26 Score=254.49 Aligned_cols=242 Identities=24% Similarity=0.397 Sum_probs=190.0
Q ss_pred cCCeEEEEEecccCceEEEEEEECC---CCcEEEEEEecccccccHHHHHHHHHHHHHHHhcC-CCceEEEEeEeecCCe
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRT---TGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCREN 663 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~---tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~Lr-HPNIVkL~gsf~d~~~ 663 (837)
.+.|.++++||.|+|++||++.+.. .+++||+|.+.... ...++.+|+++|..+. +.||+++.+.+...+.
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 3569999999999999999999988 78899999987643 3356899999999885 7899999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEcc-CCcEEEEecCCccccccC
Q 003232 664 LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH-DGHIKLTDFGLSKVGLIN 742 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~-dG~IKLiDFGLArvg~~~ 742 (837)
.++||||++.....++... ++...++.|++.++.||.++|..|||||||||+|+|++. .+.-.|+|||+|.....+
T Consensus 110 v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~ 186 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGY 186 (418)
T ss_pred eEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhh
Confidence 9999999999998888865 678999999999999999999999999999999999975 577899999999731111
Q ss_pred C-C---CCC--------CCCCccCcccCCCC-CccchhhhhHHhhhhccCCCCCCCccChhhhcCCC-CCchHHHHHHHH
Q 003232 743 S-T---DDL--------SGPAVSGTTLLGDE-EPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTADWWSVGI 808 (837)
Q Consensus 743 s-t---ddl--------~~p~~SgttLl~~~-~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~-~s~kSDIWSLGV 808 (837)
. + ... .+.........+.. ...+................||++|+|||++...+ .++++||||.|+
T Consensus 187 ~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GV 266 (418)
T KOG1167|consen 187 QQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGV 266 (418)
T ss_pred hhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccc
Confidence 1 0 010 01111111111100 11111101122234455778999999999998755 578899999999
Q ss_pred HHHHHHcCCCCCCCCCcCHHHHHHhcccC
Q 003232 809 ILFELIVGIPPFNAEHPQVSTLLRKCQLL 837 (837)
Q Consensus 809 ILyELLTGr~PF~~~dpdv~~lle~~hL~ 837 (837)
|+.-++++..||....++...+++++.||
T Consensus 267 I~Lslls~~~PFf~a~dd~~al~ei~tif 295 (418)
T KOG1167|consen 267 ILLSLLSRRYPFFKAKDDADALAEIATIF 295 (418)
T ss_pred eeehhhccccccccCccccchHHHHHHHh
Confidence 99999999999999999999999999887
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-24 Score=203.63 Aligned_cols=184 Identities=43% Similarity=0.770 Sum_probs=159.1
Q ss_pred ecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEEecCCCCH
Q 003232 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 676 (837)
Q Consensus 597 LGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmEy~~GGSL 676 (837)
||.|++|.||++....+++.+++|++....... ....+.+|+..++.++|++|+++++.+......+++|||+.|++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999998654221 346789999999999999999999999998999999999999999
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEcc-CCcEEEEecCCccccccCCCCCCCCCCccC
Q 003232 677 YSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH-DGHIKLTDFGLSKVGLINSTDDLSGPAVSG 754 (837)
Q Consensus 677 ~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~-dG~IKLiDFGLArvg~~~stddl~~p~~Sg 754 (837)
.+++... ..++...+..++.+++.+|.+||+.|++|+||+|.||+++. ++.++|+|||.+........
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---------- 148 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---------- 148 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc----------
Confidence 9999875 46899999999999999999999999999999999999999 89999999998863111000
Q ss_pred cccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCC-CCCchHHHHHHHHHHHHH
Q 003232 755 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFEL 813 (837)
Q Consensus 755 ttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~-~~s~kSDIWSLGVILyEL 813 (837)
......+...|++||.+... .++.+.|+|+||+++|+|
T Consensus 149 ---------------------~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 149 ---------------------LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred ---------------------hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 11234577889999999877 788999999999999998
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-27 Score=247.09 Aligned_cols=208 Identities=29% Similarity=0.457 Sum_probs=170.6
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeec--------
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC-------- 660 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d-------- 660 (837)
..|+-+.+||+|.||.||+|+.+.+|+.||+|++--.+ ..........+|+.+|..++|+|++.+++.+..
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen-eKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc-cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 45888899999999999999999999999998764322 223333457899999999999999998877654
Q ss_pred CCeEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCcccc
Q 003232 661 RENLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 739 (837)
Q Consensus 661 ~~~lyLVmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg 739 (837)
...+|+||.+|+ -+|.-++.+. -.++...+++++.+++.||.|+|...|+|||+|+.|+||+.+|.++|+|||+++..
T Consensus 96 r~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~f 174 (376)
T KOG0669|consen 96 RATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAF 174 (376)
T ss_pred cceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccce
Confidence 235899999995 4888888654 56999999999999999999999999999999999999999999999999999742
Q ss_pred ccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCC
Q 003232 740 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIP 818 (837)
Q Consensus 740 ~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLTGr~ 818 (837)
....+. ...+.+..+-|..|++||.++| ..|+++.|||+.||++.+|++|.+
T Consensus 175 s~~~n~---------------------------~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrsp 227 (376)
T KOG0669|consen 175 STSKNV---------------------------VKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSP 227 (376)
T ss_pred eccccc---------------------------CCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCc
Confidence 211110 0111335567999999999987 568999999999999999999999
Q ss_pred CCCCCCc
Q 003232 819 PFNAEHP 825 (837)
Q Consensus 819 PF~~~dp 825 (837)
.|.+++.
T Consensus 228 imqgnte 234 (376)
T KOG0669|consen 228 IMQGNTE 234 (376)
T ss_pred cccCChH
Confidence 9987654
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=248.43 Aligned_cols=207 Identities=23% Similarity=0.334 Sum_probs=150.5
Q ss_pred cccCCeEEEEEecccCceEEEEEEEC----------------CCCcEEEEEEecccccccH-----------HHHHHHHH
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKR----------------TTGDLFAIKVLKKADMIRK-----------NAVESILA 638 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk----------------~tG~~VAVKIikk~~~~~~-----------e~ie~~~r 638 (837)
...++|++.++||+|+||+||+|.+. ..++.||||.+........ ...+....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 45678999999999999999999752 3456899999865321100 01123344
Q ss_pred HHHHHHhcCCCce-----EEEEeEeec--------CCeEEEEEEecCCCCHHHHHHhcC---------------------
Q 003232 639 ERDILISVRNPFV-----VRFFYSFTC--------RENLYLVMEYLNGGDLYSLLRNLG--------------------- 684 (837)
Q Consensus 639 EieILk~LrHPNI-----VkL~gsf~d--------~~~lyLVmEy~~GGSL~dlLk~~g--------------------- 684 (837)
|+.++.+++|.++ ++++++|.. +...|+||||+.+++|.+++....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6677777776654 556665542 356899999999999999886421
Q ss_pred ---CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCCCccCcccCCCC
Q 003232 685 ---CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDE 761 (837)
Q Consensus 685 ---~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~ 761 (837)
.++...++.++.|++.+|.|||+.+|+||||||+|||++.++.++|+|||++..... ..
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~--~~---------------- 363 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCT--GI---------------- 363 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCcccccc--CC----------------
Confidence 134567888999999999999999999999999999999999999999999862100 00
Q ss_pred CccchhhhhHHhhhhccCCCCCCCccChhhhcCCC--------------------C--CchHHHHHHHHHHHHHHcCCC-
Q 003232 762 EPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG--------------------H--GTTADWWSVGIILFELIVGIP- 818 (837)
Q Consensus 762 ~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~--------------------~--s~kSDIWSLGVILyELLTGr~- 818 (837)
........+|+.|+|||++.... + ....||||+||++|+|++|..
T Consensus 364 ------------~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~ 431 (507)
T PLN03224 364 ------------NFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELR 431 (507)
T ss_pred ------------ccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCC
Confidence 00011234578999999986432 1 124699999999999999986
Q ss_pred CCCC
Q 003232 819 PFNA 822 (837)
Q Consensus 819 PF~~ 822 (837)
||..
T Consensus 432 p~~~ 435 (507)
T PLN03224 432 PVAN 435 (507)
T ss_pred Cccc
Confidence 7753
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-25 Score=259.18 Aligned_cols=210 Identities=26% Similarity=0.391 Sum_probs=174.5
Q ss_pred eEEEEEecccCceEEEEEEECCCCc----EEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEE
Q 003232 591 FEIIKPISRGAFGRVFLAKKRTTGD----LFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (837)
Q Consensus 591 YeIlkkLGsG~FGtVYkArdk~tG~----~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyL 666 (837)
.+..++||+|+||+||+|.|...|+ +||+|++.... .......+..|+-+|..+.|||++++++++.... +.|
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t--~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT--SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC--CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence 5556899999999999999987665 68888886543 2344568999999999999999999999988655 889
Q ss_pred EEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCC
Q 003232 667 VMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~std 745 (837)
|++|+++|+|.++++.+ +.+-.+....|..||++|+.|||.++++||||-.+|||+..-.++|+.|||+++....+..+
T Consensus 775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 99999999999999764 56889999999999999999999999999999999999999999999999999853222211
Q ss_pred CCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 003232 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEH 824 (837)
Q Consensus 746 dl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~~~d 824 (837)
.......-.+.|||-|.+....|+.++|||||||++||++| |..||.+..
T Consensus 855 -----------------------------y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~ 905 (1177)
T KOG1025|consen 855 -----------------------------YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP 905 (1177)
T ss_pred -----------------------------ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC
Confidence 01112233567999999999999999999999999999997 999988765
Q ss_pred -cCHHHHHH
Q 003232 825 -PQVSTLLR 832 (837)
Q Consensus 825 -pdv~~lle 832 (837)
.++..++|
T Consensus 906 ~~eI~dlle 914 (1177)
T KOG1025|consen 906 AEEIPDLLE 914 (1177)
T ss_pred HHHhhHHHh
Confidence 34444544
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=253.01 Aligned_cols=208 Identities=29% Similarity=0.475 Sum_probs=173.2
Q ss_pred CCCcccCCeEEEEEecccCceEEEEEEECC-------CCcEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEE
Q 003232 583 KDRTSIDDFEIIKPISRGAFGRVFLAKKRT-------TGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRF 654 (837)
Q Consensus 583 k~g~~lddYeIlkkLGsG~FGtVYkArdk~-------tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL 654 (837)
.+....++..+.+.||.|.||.||+|.... ....||||..+.... ....+.+..|+.+|+.+ +||||+.+
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~--~~~~~~~~~El~~m~~~g~H~niv~l 367 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS--SSEKKDLMSELNVLKELGKHPNIVNL 367 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccC--cHHHHHHHHHHHHHHHhcCCcchhhh
Confidence 455555667777899999999999997542 145799999986542 35667899999999987 69999999
Q ss_pred EeEeecCCeEEEEEEecCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCC
Q 003232 655 FYSFTCRENLYLVMEYLNGGDLYSLLRNLG----------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPD 718 (837)
Q Consensus 655 ~gsf~d~~~lyLVmEy~~GGSL~dlLk~~g----------------~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPe 718 (837)
++.+.....+++|+||+..|+|..+++..+ .++..++..++.||+.|++||++.++|||||-.+
T Consensus 368 lG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaR 447 (609)
T KOG0200|consen 368 LGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAAR 447 (609)
T ss_pred eeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhh
Confidence 999999999999999999999999997655 3888999999999999999999999999999999
Q ss_pred cEEEccCCcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCC--CCCCccChhhhcCCC
Q 003232 719 NLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAV--GTPDYLAPEILLGTG 796 (837)
Q Consensus 719 NILLd~dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~v--GTp~YmAPEVLlg~~ 796 (837)
|||+..+..+||+|||+++-. ...+. ....... -...|||||.+....
T Consensus 448 NVLi~~~~~~kIaDFGlar~~--~~~~~----------------------------y~~~~~~~~LP~kWmApEsl~~~~ 497 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDH--YNKDY----------------------------YRTKSSAGTLPVKWMAPESLFDRV 497 (609)
T ss_pred hEEecCCCEEEEccccceecc--CCCCc----------------------------eEecCCCCccceeecCHHHhccCc
Confidence 999999999999999999821 00000 0000111 244699999999999
Q ss_pred CCchHHHHHHHHHHHHHHc-CCCCCCC
Q 003232 797 HGTTADWWSVGIILFELIV-GIPPFNA 822 (837)
Q Consensus 797 ~s~kSDIWSLGVILyELLT-Gr~PF~~ 822 (837)
++.++||||||++|||+++ |..||.+
T Consensus 498 ft~kSDVWSfGI~L~EifsLG~~PYp~ 524 (609)
T KOG0200|consen 498 FTSKSDVWSFGILLWEIFTLGGTPYPG 524 (609)
T ss_pred ccccchhhHHHHHHHHHhhCCCCCCCC
Confidence 9999999999999999997 8999987
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-25 Score=238.12 Aligned_cols=209 Identities=29% Similarity=0.455 Sum_probs=177.5
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC---
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE--- 662 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~--- 662 (837)
....+|.-+..+|.|.- .|..+.+.-.++.||+|....+. ......++..+|..++..++|+||++++.+|....
T Consensus 14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf-~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~ 91 (369)
T KOG0665|consen 14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPF-QNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLE 91 (369)
T ss_pred eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCcc-ccCccchhhhhhhhhhhhhcccceeeeeeccCccccHH
Confidence 34567999999999999 88889998999999999987653 34555578899999999999999999999997654
Q ss_pred ---eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCcccc
Q 003232 663 ---NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 739 (837)
Q Consensus 663 ---~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg 739 (837)
.+|+|||++ ..+|.+.+.. .++...+..++.|++.|+.|||+.||+||||||+||++..+..+||.|||+++..
T Consensus 92 ~~~e~y~v~e~m-~~nl~~vi~~--elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 92 EFQEVYLVMELM-DANLCQVILM--ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred HHHhHHHHHHhh-hhHHHHHHHH--hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhccc
Confidence 479999999 5689888873 4788899999999999999999999999999999999999999999999999731
Q ss_pred ccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCC
Q 003232 740 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPP 819 (837)
Q Consensus 740 ~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~P 819 (837)
..+ -..+.++.|..|.|||++.+.++...+||||+||++.||++|+..
T Consensus 169 ~~~--------------------------------~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vl 216 (369)
T KOG0665|consen 169 DTD--------------------------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVL 216 (369)
T ss_pred Ccc--------------------------------cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEE
Confidence 000 123456788999999999999999999999999999999999999
Q ss_pred CCCCCcCHHHHHH
Q 003232 820 FNAEHPQVSTLLR 832 (837)
Q Consensus 820 F~~~dpdv~~lle 832 (837)
|.+. +.++++.+
T Consensus 217 f~g~-d~idQ~~k 228 (369)
T KOG0665|consen 217 FPGK-DHIDQWNK 228 (369)
T ss_pred ecCc-hHHHHHHH
Confidence 9853 44555544
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-22 Score=198.10 Aligned_cols=207 Identities=43% Similarity=0.773 Sum_probs=174.4
Q ss_pred eEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCC-ceEEEEeEeecCCeEEEEEE
Q 003232 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP-FVVRFFYSFTCRENLYLVME 669 (837)
Q Consensus 591 YeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHP-NIVkL~gsf~d~~~lyLVmE 669 (837)
|.+...||.|+|+.||++.+. ..+++|.+.............+.+|..++..+.|+ +|+++++.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 788999999999999999986 78999999876544334567899999999999988 79999999987778899999
Q ss_pred ecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCC-cEEEEecCCccccccCCCC
Q 003232 670 YLNGGDLYSLLRNLG---CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG-HIKLTDFGLSKVGLINSTD 745 (837)
Q Consensus 670 y~~GGSL~dlLk~~g---~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG-~IKLiDFGLArvg~~~std 745 (837)
++.++++.+++.... .++......++.|++.++.|+|+.|++|||+||+||+++..+ .++++|||++.........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999999998877654 799999999999999999999999999999999999999988 7999999998621111000
Q ss_pred CCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC---CCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003232 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG---TGHGTTADWWSVGIILFELIVGIPPFNA 822 (837)
Q Consensus 746 dl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg---~~~s~kSDIWSLGVILyELLTGr~PF~~ 822 (837)
. .. ........||..|+|||.+.+ ..+....|+||+|++++++++|..||..
T Consensus 159 ~--------~~-----------------~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~ 213 (384)
T COG0515 159 S--------SI-----------------PALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEG 213 (384)
T ss_pred c--------cc-----------------cccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 0 00 012346689999999999988 5788999999999999999999999877
Q ss_pred CCc
Q 003232 823 EHP 825 (837)
Q Consensus 823 ~dp 825 (837)
...
T Consensus 214 ~~~ 216 (384)
T COG0515 214 EKN 216 (384)
T ss_pred CCc
Confidence 654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.1e-25 Score=250.86 Aligned_cols=201 Identities=34% Similarity=0.596 Sum_probs=176.1
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEE
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyL 666 (837)
..++|+++..+|+|.||.||+++++.+++..|+|+++-.. .....-+..|+-+++.++||||+-+++.+.....+++
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep---~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwi 89 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP---GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWI 89 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccC---CccccccccceeeeecCCCcChHHHHhhhhhhcCcEE
Confidence 3467999999999999999999999999999999997532 3344567789999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCC
Q 003232 667 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stdd 746 (837)
+||||.||+|.+...-.+++++-++....++.++||+|||+.|=+|||||-.|||++..|.+||+|||.+-..
T Consensus 90 cMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqi------- 162 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQI------- 162 (829)
T ss_pred EEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhh-------
Confidence 9999999999999988899999999999999999999999999999999999999999999999999986420
Q ss_pred CCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhh---cCCCCCchHHHHHHHHHHHHHHcCCCCCC
Q 003232 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEIL---LGTGHGTTADWWSVGIILFELIVGIPPFN 821 (837)
Q Consensus 747 l~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVL---lg~~~s~kSDIWSLGVILyELLTGr~PF~ 821 (837)
+ ..-.+..++.||+.|||||+. ....|+..||||++|++..|+-.-.+|..
T Consensus 163 -------------------t-----ati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplf 216 (829)
T KOG0576|consen 163 -------------------T-----ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLF 216 (829)
T ss_pred -------------------h-----hhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccc
Confidence 0 011234578999999999986 46789999999999999998877666643
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-24 Score=248.89 Aligned_cols=195 Identities=29% Similarity=0.424 Sum_probs=158.1
Q ss_pred EEEecccCceE-EEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEeEeecCCeEEEEEEec
Q 003232 594 IKPISRGAFGR-VFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLVMEYL 671 (837)
Q Consensus 594 lkkLGsG~FGt-VYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~gsf~d~~~lyLVmEy~ 671 (837)
-+.+|+|+.|+ ||+|.. .|+.||||.+-. +...-..+|+..|+.. .||||+++|+.-.+..+.||..|.|
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY--EGREVAVKRLLE------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred HHHcccCCCCcEEEEEee--CCceehHHHHhh------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 36789999875 588885 689999998764 3345677899999887 5999999999999999999999999
Q ss_pred CCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEcc---C--CcEEEEecCCccccccC
Q 003232 672 NGGDLYSLLRNLGC----LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---D--GHIKLTDFGLSKVGLIN 742 (837)
Q Consensus 672 ~GGSL~dlLk~~g~----Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~---d--G~IKLiDFGLArvg~~~ 742 (837)
..+|.+++..... ......+.++.|++.||++||+.+||||||||.||||+. + ..++|+|||+++.....
T Consensus 586 -~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~ 664 (903)
T KOG1027|consen 586 -ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG 664 (903)
T ss_pred -hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence 6799999987311 122445788999999999999999999999999999976 3 36899999999842222
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcC-CCCCC
Q 003232 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVG-IPPFN 821 (837)
Q Consensus 743 stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTG-r~PF~ 821 (837)
.+ .-.+.....||-+|+|||++.....+.++|||||||++|+.++| .+||.
T Consensus 665 ~s----------------------------S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFG 716 (903)
T KOG1027|consen 665 KS----------------------------SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFG 716 (903)
T ss_pred cc----------------------------hhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCC
Confidence 11 11224567899999999999998888899999999999999985 99997
Q ss_pred CCCc
Q 003232 822 AEHP 825 (837)
Q Consensus 822 ~~dp 825 (837)
....
T Consensus 717 d~~~ 720 (903)
T KOG1027|consen 717 DSLE 720 (903)
T ss_pred chHH
Confidence 6443
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.2e-22 Score=212.71 Aligned_cols=209 Identities=26% Similarity=0.378 Sum_probs=168.0
Q ss_pred CeEEEEEecccCceEEEEEEECCCC-cEEEEEEecccccccHHHHHHHHHHHHHHHhcCC----CceEEEEeEe-ecCCe
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTG-DLFAIKVLKKADMIRKNAVESILAERDILISVRN----PFVVRFFYSF-TCREN 663 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG-~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrH----PNIVkL~gsf-~d~~~ 663 (837)
+|.+.++||+|+||.||.|.+..++ ..+|+|+......... ..+..|..++..+.. +++..+++.+ ....+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 7999999999999999999997764 6899998765321111 156778888888763 6899999888 47778
Q ss_pred EEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccC-----CcEEEEecCCc
Q 003232 664 LYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD-----GHIKLTDFGLS 736 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk~~--g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~d-----G~IKLiDFGLA 736 (837)
.|+||+.+ |.+|.++.... +.++...+..++.|++.+|.+||+.|++||||||.|+++... ..++|.|||++
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999988 89999988654 569999999999999999999999999999999999999765 46999999999
Q ss_pred cc--cccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHH
Q 003232 737 KV--GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI 814 (837)
Q Consensus 737 rv--g~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELL 814 (837)
+. ...+...... ..........||..|.++.++.+...+.+.|+||++.++.+++
T Consensus 175 r~~~~~~~~~~~~~-----------------------~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~ 231 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLR-----------------------PPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELL 231 (322)
T ss_pred ccccccCCCCcccc-----------------------cCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHh
Confidence 72 1111110000 0011123566999999999999999999999999999999999
Q ss_pred cCCCCCCCCCc
Q 003232 815 VGIPPFNAEHP 825 (837)
Q Consensus 815 TGr~PF~~~dp 825 (837)
.|..||.....
T Consensus 232 ~g~LPW~~~~~ 242 (322)
T KOG1164|consen 232 KGSLPWEALEM 242 (322)
T ss_pred cCCCCCccccc
Confidence 99999976553
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.7e-22 Score=221.38 Aligned_cols=144 Identities=24% Similarity=0.204 Sum_probs=116.8
Q ss_pred CCcccCCeEEEEEecccCceEEEEEEECC-CCcEEEEEEeccccc--ccHHHHHHHHHHHHHHHhcCCCceEE-EEeEee
Q 003232 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRT-TGDLFAIKVLKKADM--IRKNAVESILAERDILISVRNPFVVR-FFYSFT 659 (837)
Q Consensus 584 ~g~~lddYeIlkkLGsG~FGtVYkArdk~-tG~~VAVKIikk~~~--~~~e~ie~~~rEieILk~LrHPNIVk-L~gsf~ 659 (837)
.....++|.+.+.||+|+||+||+|++.. +++.+|||++..... ........+.+|+++|+.++|+||+. ++..
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-- 90 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence 34456779999999999999999999876 678889998753211 12334567999999999999999885 4432
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccC-CCCcEEEccCCcEEEEecCCccc
Q 003232 660 CRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDL-KPDNLLIAHDGHIKLTDFGLSKV 738 (837)
Q Consensus 660 d~~~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDI-KPeNILLd~dG~IKLiDFGLArv 738 (837)
...|+||||++|++|... .. .. ...++.|++.+|.|||++||+|||| ||+|||++.++.++|+|||+++.
T Consensus 91 --~~~~LVmE~~~G~~L~~~-~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLHLA-RP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASV 161 (365)
T ss_pred --CCcEEEEEccCCCCHHHh-Cc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence 457999999999999732 11 11 1467889999999999999999999 99999999999999999999984
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.5e-23 Score=216.83 Aligned_cols=197 Identities=27% Similarity=0.468 Sum_probs=156.8
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEe-EeecCCeEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFY-SFTCRENLY 665 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~g-sf~d~~~ly 665 (837)
.+.|.|.+.||.|-||.+-+++++.++..+++|.+..+. ..+..|.+|..---.| .|.||+.-|+ .|...+.++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv 98 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV 98 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch----hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence 456999999999999999999999999999999998754 3455677777654334 5889987664 566677889
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEc--cCCcEEEEecCCccccccCC
Q 003232 666 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA--HDGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 666 LVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd--~dG~IKLiDFGLArvg~~~s 743 (837)
+++||++.|+|..-+.. ..+-+...+.++.|++.||.|+|++++||||||.+||||. +...+||||||..+.
T Consensus 99 F~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k----- 172 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRK----- 172 (378)
T ss_pred EeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccc-----
Confidence 99999999999987765 3478888999999999999999999999999999999994 345899999998762
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCC-----CCCchHHHHHHHHHHHHHHcCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-----GHGTTADWWSVGIILFELIVGIP 818 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~-----~~s~kSDIWSLGVILyELLTGr~ 818 (837)
.|++. . ..--+..|.+||+.... ..++.+|||.||+++|.+|||.+
T Consensus 173 ---------~g~tV--------------~------~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~ 223 (378)
T KOG1345|consen 173 ---------VGTTV--------------K------YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKF 223 (378)
T ss_pred ---------cCcee--------------h------hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCC
Confidence 01110 0 00123458999987532 23577899999999999999999
Q ss_pred CCCCC
Q 003232 819 PFNAE 823 (837)
Q Consensus 819 PF~~~ 823 (837)
||...
T Consensus 224 PWQka 228 (378)
T KOG1345|consen 224 PWQKA 228 (378)
T ss_pred cchhh
Confidence 99743
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.1e-22 Score=205.32 Aligned_cols=213 Identities=24% Similarity=0.348 Sum_probs=176.6
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCC-CceEEEEeEeecCCeE
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN-PFVVRFFYSFTCRENL 664 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrH-PNIVkL~gsf~d~~~l 664 (837)
.....|+++++||+|+||.+|.|....+|..||||+-+... ...++..|..+...|++ ..|..+..++.+..+-
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-----KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-----CCcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 34567999999999999999999999999999999976532 12356788889988875 5788888888888899
Q ss_pred EEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccC---CcEEEEecCCccccc
Q 003232 665 YLVMEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD---GHIKLTDFGLSKVGL 740 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~-~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~d---G~IKLiDFGLArvg~ 740 (837)
.+||+.+ |-||.++..- ...++...+.-++-|++.-|+|+|.+++|||||||+|+|+.-+ ..+.|+|||+++...
T Consensus 87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 9999998 8899988752 4568999999999999999999999999999999999999643 468999999998422
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCC
Q 003232 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820 (837)
Q Consensus 741 ~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF 820 (837)
...+ ..+...+......||.+|.+=..+.+...+...|+-|+|.++..+..|..||
T Consensus 166 d~~t------------------------~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPW 221 (341)
T KOG1163|consen 166 DIRT------------------------RQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPW 221 (341)
T ss_pred cccc------------------------cccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcc
Confidence 1111 2233345566788999999998888888899999999999999999999999
Q ss_pred CCCCcCHH
Q 003232 821 NAEHPQVS 828 (837)
Q Consensus 821 ~~~dpdv~ 828 (837)
.+..+...
T Consensus 222 Qglka~tk 229 (341)
T KOG1163|consen 222 QGLKAATK 229 (341)
T ss_pred cccchhhH
Confidence 98776544
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-21 Score=234.30 Aligned_cols=177 Identities=15% Similarity=0.167 Sum_probs=120.6
Q ss_pred cCC-CceEEEEeEe-------ecCCeEEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCC
Q 003232 646 VRN-PFVVRFFYSF-------TCRENLYLVMEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLK 716 (837)
Q Consensus 646 LrH-PNIVkL~gsf-------~d~~~lyLVmEy~~GGSL~dlLk~-~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIK 716 (837)
++| +||+.++++| .....++++|||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+|||||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 344 4666666666 2234678889987 6799999975 3459999999999999999999999999999999
Q ss_pred CCcEEEccCCcEEEEecCCccccccCCCCCCCCCCccCcccCCCCC-ccchhhhhH---HhhhhccCCCCCCCccChhhh
Q 003232 717 PDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEE-PQLTASEHQ---QERRKKRSAVGTPDYLAPEIL 792 (837)
Q Consensus 717 PeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~-~~~~~~~~~---~~~~k~~s~vGTp~YmAPEVL 792 (837)
|+|||++..|.++++|||++.....+.........+--........ ......... .........+||+.|||||++
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 187 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED 187 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence 9999998888888888888763211111111100000000000000 000000000 000112235789999999999
Q ss_pred cCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003232 793 LGTGHGTTADWWSVGIILFELIVGIPPFNAE 823 (837)
Q Consensus 793 lg~~~s~kSDIWSLGVILyELLTGr~PF~~~ 823 (837)
.+..++.++|||||||+||||++|.+||...
T Consensus 188 ~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~ 218 (793)
T PLN00181 188 NGSSSNCASDVYRLGVLLFELFCPVSSREEK 218 (793)
T ss_pred ccCCCCchhhhhhHHHHHHHHhhCCCchhhH
Confidence 9999999999999999999999999998643
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.4e-21 Score=203.68 Aligned_cols=208 Identities=23% Similarity=0.341 Sum_probs=175.0
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcC-CCceEEEEeEeecCCeEE
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCRENLY 665 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~Lr-HPNIVkL~gsf~d~~~ly 665 (837)
+--.|+|.++||.|+||.++.|.+..++++||||.-.... ..-++..|.+..+.|. .++|...|.+..+..+-.
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~Ni 100 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNI 100 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhh
Confidence 3346999999999999999999999999999999865422 2235677888888774 689999999999888999
Q ss_pred EEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccC-----CcEEEEecCCcccc
Q 003232 666 LVMEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD-----GHIKLTDFGLSKVG 739 (837)
Q Consensus 666 LVmEy~~GGSL~dlLk~-~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~d-----G~IKLiDFGLArvg 739 (837)
||||++ |-||.|+..- ...++...+..++.||+.-++|+|++.+|.|||||+|+||..- ..|.++|||+|+..
T Consensus 101 LVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 101 LVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred hhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 999998 8899988864 3569999999999999999999999999999999999999753 35899999999852
Q ss_pred ccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCC
Q 003232 740 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPP 819 (837)
Q Consensus 740 ~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~P 819 (837)
-...+ ..+...+...+..||.+||+=..++|...+.+.|+-|||-+++..|.|.+|
T Consensus 180 rDp~T------------------------kqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLP 235 (449)
T KOG1165|consen 180 RDPKT------------------------KQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 235 (449)
T ss_pred cCccc------------------------cccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCc
Confidence 22211 123334556678899999999999999999999999999999999999999
Q ss_pred CCCCC
Q 003232 820 FNAEH 824 (837)
Q Consensus 820 F~~~d 824 (837)
|.+.-
T Consensus 236 WQGLK 240 (449)
T KOG1165|consen 236 WQGLK 240 (449)
T ss_pred ccccc
Confidence 98744
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.1e-21 Score=190.71 Aligned_cols=140 Identities=25% Similarity=0.222 Sum_probs=110.0
Q ss_pred EEEecccCceEEEEEEECCCCcEEEEEEecccccccHH-----------------------HHHHHHHHHHHHHhcCCCc
Q 003232 594 IKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKN-----------------------AVESILAERDILISVRNPF 650 (837)
Q Consensus 594 lkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e-----------------------~ie~~~rEieILk~LrHPN 650 (837)
...||.|+||.||+|.+. +|+.||+|+++........ .......|+.++..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 367999999999999996 8999999999764311111 0123345999999998777
Q ss_pred eEEEEeEeecCCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCcccccCCCCcEEEccCCcEE
Q 003232 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYL-HSLRVVHRDLKPDNLLIAHDGHIK 729 (837)
Q Consensus 651 IVkL~gsf~d~~~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYL-HSkGIIHRDIKPeNILLd~dG~IK 729 (837)
+........ . ..+|||||++|+++.......+.++...+..++.|++.+|.|+ |+.||+||||||+|||++ ++.++
T Consensus 81 v~~p~~~~~-~-~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 81 IPCPEPILL-K-SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCCcEEEe-c-CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 644333222 2 2389999999887766544456789999999999999999999 799999999999999998 58899
Q ss_pred EEecCCcc
Q 003232 730 LTDFGLSK 737 (837)
Q Consensus 730 LiDFGLAr 737 (837)
|+|||++.
T Consensus 158 LiDFG~a~ 165 (190)
T cd05147 158 IIDVSQSV 165 (190)
T ss_pred EEEccccc
Confidence 99999986
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.7e-20 Score=182.94 Aligned_cols=141 Identities=23% Similarity=0.148 Sum_probs=111.9
Q ss_pred EEEecccCceEEEEEEECCCCcEEEEEEeccccccc-----------------------HHHHHHHHHHHHHHHhcCCCc
Q 003232 594 IKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIR-----------------------KNAVESILAERDILISVRNPF 650 (837)
Q Consensus 594 lkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~-----------------------~e~ie~~~rEieILk~LrHPN 650 (837)
...||+|+||.||+|.+. +|+.||||+++...... ......+..|...+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 468999999999999986 89999999998642110 011223467899999999998
Q ss_pred eEEEEeEeecCCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCcEEEccCCcEE
Q 003232 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIK 729 (837)
Q Consensus 651 IVkL~gsf~d~~~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHS-kGIIHRDIKPeNILLd~dG~IK 729 (837)
|......... ..|+||||++|+++.........++......++.|++.+|.++|+ .||+||||||+|||++ ++.++
T Consensus 81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~ 157 (190)
T cd05145 81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY 157 (190)
T ss_pred CCCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence 7554443332 248999999988654433234568888999999999999999999 9999999999999998 89999
Q ss_pred EEecCCccc
Q 003232 730 LTDFGLSKV 738 (837)
Q Consensus 730 LiDFGLArv 738 (837)
|+|||+++.
T Consensus 158 liDFG~a~~ 166 (190)
T cd05145 158 IIDVSQAVE 166 (190)
T ss_pred EEEccccee
Confidence 999999873
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.2e-20 Score=190.69 Aligned_cols=138 Identities=17% Similarity=0.201 Sum_probs=114.5
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHH------HHHHHHHHHhcCCCceEEEEeEeecC-
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVES------ILAERDILISVRNPFVVRFFYSFTCR- 661 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~------~~rEieILk~LrHPNIVkL~gsf~d~- 661 (837)
++|++++.||.|+||.||++.. ++..+|+|++.+.....+..... +.+|+..+.++.||+|..+...+...
T Consensus 31 ~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 31 YNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred CceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 5699999999999999999765 46789999998655444444344 57899999999999999998876543
Q ss_pred -------CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecC
Q 003232 662 -------ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFG 734 (837)
Q Consensus 662 -------~~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFG 734 (837)
...+|||||++|.+|.++.. +++ ..+.+++.+|..+|..|++|+|+||+||+++.+| ++|+|||
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg 179 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLS 179 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECC
Confidence 35799999999999988732 333 2456999999999999999999999999999988 9999999
Q ss_pred Ccc
Q 003232 735 LSK 737 (837)
Q Consensus 735 LAr 737 (837)
..+
T Consensus 180 ~~~ 182 (232)
T PRK10359 180 GKR 182 (232)
T ss_pred Ccc
Confidence 875
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.2e-19 Score=173.00 Aligned_cols=107 Identities=29% Similarity=0.385 Sum_probs=93.7
Q ss_pred CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCCCc
Q 003232 674 GDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 752 (837)
Q Consensus 674 GSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~ 752 (837)
|+|.+++... ..+++..++.++.||+.||.|||+.+ ||+|||++.++.+++ ||++.....
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~----------- 61 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTP----------- 61 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecc-----------
Confidence 6899999864 56999999999999999999999998 999999999999999 998863100
Q ss_pred cCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 753 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 753 SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
....||+.|||||++.+..++.++|||||||++|||++|+.||....
T Consensus 62 -------------------------~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~ 108 (176)
T smart00750 62 -------------------------EQSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEER 108 (176)
T ss_pred -------------------------ccCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccc
Confidence 01258899999999999999999999999999999999999997654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=7.3e-20 Score=199.72 Aligned_cols=209 Identities=22% Similarity=0.344 Sum_probs=166.4
Q ss_pred CCeEEEEEecccCceEEEEEEECCCC-----cEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeec-CC
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTG-----DLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC-RE 662 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG-----~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d-~~ 662 (837)
.+++....+-+|.||.||.|.|++.. +.|-+|.++.. ..+-+...+..|...+..+.|||+..+.++... ..
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~ 361 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYA 361 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccC
Confidence 35777888999999999999887543 34556665533 345566788999999999999999999888765 45
Q ss_pred eEEEEEEecCCCCHHHHHH-----h---cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecC
Q 003232 663 NLYLVMEYLNGGDLYSLLR-----N---LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFG 734 (837)
Q Consensus 663 ~lyLVmEy~~GGSL~dlLk-----~---~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFG 734 (837)
..++++.+..-|+|..++. . ...++..+...++.|++.|++|||+.|+||.||..+|.+|++.-.+||+|=.
T Consensus 362 ~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsa 441 (563)
T KOG1024|consen 362 TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSA 441 (563)
T ss_pred cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccch
Confidence 6889999998899999986 1 1347777888899999999999999999999999999999999999999998
Q ss_pred CccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHH
Q 003232 735 LSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI 814 (837)
Q Consensus 735 LArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELL 814 (837)
+++- -++.++. + ++ ...-....||+||.+.+..|+..+|+|||||+||||+
T Consensus 442 LSRD-------LFP~DYh--c--LG------------------DnEnRPvkWMslEal~n~~yssasDvWsfGVllWELm 492 (563)
T KOG1024|consen 442 LSRD-------LFPGDYH--C--LG------------------DNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELM 492 (563)
T ss_pred hccc-------cCccccc--c--cC------------------CCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHH
Confidence 8872 1111110 0 01 1122356799999999999999999999999999999
Q ss_pred c-CCCCCCCCCcCHH
Q 003232 815 V-GIPPFNAEHPQVS 828 (837)
Q Consensus 815 T-Gr~PF~~~dpdv~ 828 (837)
| |+.||...+|-..
T Consensus 493 tlg~~PyaeIDPfEm 507 (563)
T KOG1024|consen 493 TLGKLPYAEIDPFEM 507 (563)
T ss_pred hcCCCCccccCHHHH
Confidence 7 9999988877543
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.1e-18 Score=177.04 Aligned_cols=204 Identities=22% Similarity=0.241 Sum_probs=144.6
Q ss_pred eEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHHHhcC-CCceEEEEeEeecCCeEEEEE
Q 003232 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRK-NAVESILAERDILISVR-NPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 591 YeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~-e~ie~~~rEieILk~Lr-HPNIVkL~gsf~d~~~lyLVm 668 (837)
+.+...|+.|+||+||.+.. .+..++.+.+........ -....+.+|+++|++++ |++|++++++ ...|++|
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 34568899999999998775 677888777765432211 12235789999999995 4789988875 4569999
Q ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccC-CCCcEEEccCCcEEEEecCCccccccCCCCCC
Q 003232 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDL-KPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (837)
Q Consensus 669 Ey~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDI-KPeNILLd~dG~IKLiDFGLArvg~~~stddl 747 (837)
||+.|.+|.+.... . ...++.|++.+|.++|++||+|||| ||+|||++.+|.++|+|||++........
T Consensus 78 eyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~--- 147 (218)
T PRK12274 78 SYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR--- 147 (218)
T ss_pred eeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch---
Confidence 99999999765421 1 2357789999999999999999999 79999999999999999999873111000
Q ss_pred CCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCC-CCC-chHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHG-TTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 748 ~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~-~~s-~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
.. .+....... .-.+.....++.|+.|+...-. ..+ ...++++.|+.+|.++||..|+.++..
T Consensus 148 -------------~~-r~L~~rDl~-~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 148 -------------WM-RLLAREDLR-HLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred -------------HH-HHHHHHHHH-HHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 00 000000000 0011123478899999876432 223 567999999999999999999876543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.4e-20 Score=210.12 Aligned_cols=188 Identities=45% Similarity=0.805 Sum_probs=163.7
Q ss_pred ecccCceEEEEEEEC---CCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcC-CCceEEEEeEeecCCeEEEEEEecC
Q 003232 597 ISRGAFGRVFLAKKR---TTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCRENLYLVMEYLN 672 (837)
Q Consensus 597 LGsG~FGtVYkArdk---~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~Lr-HPNIVkL~gsf~d~~~lyLVmEy~~ 672 (837)
+|.|.||.|++++.. ..|..||+|+.++......... ....|..++..++ ||++++++..|..+...+++++|+.
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 789999999987642 4567899999887654433333 6677888888887 9999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCCCc
Q 003232 673 GGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 752 (837)
Q Consensus 673 GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~ 752 (837)
||.|...+.....+.+...+.+...++-+++++|+.||+|||+|++||+++.+|++++.|||+++..
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~------------- 147 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEA------------- 147 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHh-------------
Confidence 9999999988888999999999999999999999999999999999999999999999999998731
Q ss_pred cCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003232 753 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNA 822 (837)
Q Consensus 753 SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~ 822 (837)
.. ....|||..|||||++. ++...+|+||||+++|+|++|..||..
T Consensus 148 -------------------v~---~~~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 148 -------------------VK---EKIACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred -------------------Hh---hhhcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 00 11128999999999998 667889999999999999999999988
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.7e-18 Score=206.55 Aligned_cols=194 Identities=25% Similarity=0.393 Sum_probs=155.5
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcC---CCceEEEEeEeecCCeEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR---NPFVVRFFYSFTCRENLY 665 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~Lr---HPNIVkL~gsf~d~~~ly 665 (837)
+.|.|-+.||.|+||+||+|.+.. |+.||||+-+++..+.-....+ ++.+|+ -+.|..+...+...+.-+
T Consensus 698 ~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q------~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 698 EKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQ------VMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred eeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHH------HHHhhchhhhcchHHHHHHHccCCcce
Confidence 459999999999999999999966 9999999998876543322222 333343 234455555555566778
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEcc-------CCcEEEEecCCccc
Q 003232 666 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH-------DGHIKLTDFGLSKV 738 (837)
Q Consensus 666 LVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~-------dG~IKLiDFGLArv 738 (837)
||+||.+-|+|.+++...+.+++..+..+..||+..+++||.+||||+||||+|+||.. ...++|+|||-+.
T Consensus 771 lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si- 849 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI- 849 (974)
T ss_pred eeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccce-
Confidence 99999999999999998888999999999999999999999999999999999999953 3468999999875
Q ss_pred cccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCC
Q 003232 739 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIP 818 (837)
Q Consensus 739 g~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~ 818 (837)
|+ +|+.+ ..+-...++|-.+-.+|+..|++|++.+|.|.|+.+++-||+|+.
T Consensus 850 -------Dm--------~lfp~-------------~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 850 -------DM--------KLFPD-------------GTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred -------ee--------eEcCC-------------CcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 11 11111 112345678889999999999999999999999999999999974
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.2e-19 Score=206.31 Aligned_cols=207 Identities=29% Similarity=0.434 Sum_probs=165.1
Q ss_pred EEEEEecccCceEEEEEEECCCCcEEEEEEecc---cccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEE
Q 003232 592 EIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKK---ADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 592 eIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk---~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVm 668 (837)
.....+|.|++|.|+.+......+.++.|.+.. ...........+..|+-+-..+.|||++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 345789999999888888877777677776542 11122333334777888888899999988776666655555559
Q ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCC
Q 003232 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (837)
Q Consensus 669 Ey~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~ 748 (837)
|||++ +|+.++...+.+....+.-++.|++.||.|+|+.||.|||+||+|+++..+|.+||+|||.+.++......
T Consensus 401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~--- 476 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK--- 476 (601)
T ss_pred hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcch---
Confidence 99999 99999998778999999999999999999999999999999999999999999999999998753221111
Q ss_pred CCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCch-HHHHHHHHHHHHHHcCCCCCCCCCcC
Q 003232 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT-ADWWSVGIILFELIVGIPPFNAEHPQ 826 (837)
Q Consensus 749 ~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~k-SDIWSLGVILyELLTGr~PF~~~dpd 826 (837)
........+|+..|+|||++.+..|++. .||||.|+++..|.+|+.||......
T Consensus 477 ------------------------~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~ 531 (601)
T KOG0590|consen 477 ------------------------NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKS 531 (601)
T ss_pred ------------------------hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccc
Confidence 0123456789999999999999999765 69999999999999999999765443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.7e-17 Score=162.85 Aligned_cols=137 Identities=29% Similarity=0.348 Sum_probs=114.8
Q ss_pred EEecccCceEEEEEEECCCCcEEEEEEecccccc-----cHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEE
Q 003232 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMI-----RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (837)
Q Consensus 595 kkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~-----~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmE 669 (837)
+.||+|++|.||+|++ .|..+++|+....... .......+.+|+.++..+.|++|..+..++......++|||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5789999999999987 6778999987643221 11223468889999999999998877777767778899999
Q ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccc
Q 003232 670 YLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (837)
Q Consensus 670 y~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArv 738 (837)
|++|++|.+++..... ....++.+++.+|.++|+.|++|+|++|.|||++ ++.++|+|||.+..
T Consensus 80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999999865332 7788999999999999999999999999999998 88999999999874
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.5e-17 Score=166.89 Aligned_cols=134 Identities=16% Similarity=0.185 Sum_probs=106.6
Q ss_pred EEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhc-----CCCceEEEEeEeecCC---e-E
Q 003232 594 IKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-----RNPFVVRFFYSFTCRE---N-L 664 (837)
Q Consensus 594 lkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-----rHPNIVkL~gsf~d~~---~-l 664 (837)
.+.||+|+||.||. +..++.. +||++..... ...+.+.+|+.+++.+ .||||+++++++..+. . +
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 46899999999995 7666665 6998865421 2345789999999999 5799999999998863 4 3
Q ss_pred EEEEEe--cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHhCCcccccCCCCcEEEccC----CcEEEEecCCc
Q 003232 665 YLVMEY--LNGGDLYSLLRNLGCLDEDVARVYIAEVVLAL-EYLHSLRVVHRDLKPDNLLIAHD----GHIKLTDFGLS 736 (837)
Q Consensus 665 yLVmEy--~~GGSL~dlLk~~g~Lsee~irkIl~QIa~AL-sYLHSkGIIHRDIKPeNILLd~d----G~IKLiDFGLA 736 (837)
.+|||| +.+++|.+++.+ +.+++. ..++.|++.++ .|||+++|+||||||+|||++.. +.++|+||+-+
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 478999 557999999976 346655 35678888888 99999999999999999999743 37999994433
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.7e-17 Score=172.90 Aligned_cols=142 Identities=22% Similarity=0.150 Sum_probs=113.7
Q ss_pred eEEEEEecccCceEEEEEE-ECCCCcEEEEEEeccccccc---------------------HHHHHHHHHHHHHHHhcCC
Q 003232 591 FEIIKPISRGAFGRVFLAK-KRTTGDLFAIKVLKKADMIR---------------------KNAVESILAERDILISVRN 648 (837)
Q Consensus 591 YeIlkkLGsG~FGtVYkAr-dk~tG~~VAVKIikk~~~~~---------------------~e~ie~~~rEieILk~LrH 648 (837)
|.+.+.||.|+||.||+|. +..+|+.||+|+++...... ......+.+|+.+++++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 8888999999999999999 66789999999997542110 0112346789999999975
Q ss_pred C--ceEEEEeEeecCCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-cccccCCCCcEEEccC
Q 003232 649 P--FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLR-VVHRDLKPDNLLIAHD 725 (837)
Q Consensus 649 P--NIVkL~gsf~d~~~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkG-IIHRDIKPeNILLd~d 725 (837)
. .+.+++.. ...++||||+.|.+|.........+....+..++.||+.+|.+||+.| |+|+||||+||+++ +
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~ 184 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-D 184 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-C
Confidence 3 34444442 235899999999888776544455677778899999999999999999 99999999999998 8
Q ss_pred CcEEEEecCCcc
Q 003232 726 GHIKLTDFGLSK 737 (837)
Q Consensus 726 G~IKLiDFGLAr 737 (837)
+.++|+|||.+.
T Consensus 185 ~~i~LiDFg~a~ 196 (237)
T smart00090 185 GKVVIIDVSQSV 196 (237)
T ss_pred CCEEEEEChhhh
Confidence 899999999886
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.1e-17 Score=175.30 Aligned_cols=202 Identities=26% Similarity=0.364 Sum_probs=132.3
Q ss_pred CeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCC---C-------ceEEEEeEee
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN---P-------FVVRFFYSFT 659 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrH---P-------NIVkL~gsf~ 659 (837)
.+.....||.|+++.||.+++..+|+.+|+|++...........+.+.+|.-....+.+ | .++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 36777999999999999999999999999999866554445556777777655544332 1 2222222221
Q ss_pred c------------CC-----eEEEEEEecCCCCHHHHHH---hcCCC----CHHHHHHHHHHHHHHHHHHHhCCcccccC
Q 003232 660 C------------RE-----NLYLVMEYLNGGDLYSLLR---NLGCL----DEDVARVYIAEVVLALEYLHSLRVVHRDL 715 (837)
Q Consensus 660 d------------~~-----~lyLVmEy~~GGSL~dlLk---~~g~L----see~irkIl~QIa~ALsYLHSkGIIHRDI 715 (837)
. .. +.+++|+-+ .++|.+++. ..... .......+..|+++.+++||+.|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 1 11 246778877 568887763 22222 12222344579999999999999999999
Q ss_pred CCCcEEEccCCcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-
Q 003232 716 KPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG- 794 (837)
Q Consensus 716 KPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg- 794 (837)
+|+|++++.+|.++|+||+..... ++ .......+..|.+||....
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~--------------g~--------------------~~~~~~~~~~~~PPe~~~~~ 217 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRA--------------GT--------------------RYRCSEFPVAFTPPELESCA 217 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEET--------------TE--------------------EEEGGGS-TTTS-HHHHHHH
T ss_pred ceeeEEEcCCCCEEEcChHHHeec--------------Cc--------------------eeeccCCCcccCChhhhhhh
Confidence 999999999999999999876420 00 0011234467999998743
Q ss_pred -------CCCCchHHHHHHHHHHHHHHcCCCCCCCCCcC
Q 003232 795 -------TGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826 (837)
Q Consensus 795 -------~~~s~kSDIWSLGVILyELLTGr~PF~~~dpd 826 (837)
..++.+.|.|+||+++|.|+||+.||....+.
T Consensus 218 ~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~ 256 (288)
T PF14531_consen 218 GQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPE 256 (288)
T ss_dssp TSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGG
T ss_pred cccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCcc
Confidence 24688999999999999999999999865543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1e-17 Score=199.28 Aligned_cols=184 Identities=50% Similarity=0.883 Sum_probs=137.3
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEE
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyL 666 (837)
.-.+|..++.|..|+||-||+++|+.+.+.+|+|+=+. +.. .+ .++.....|++|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq-~li--------lR--nilt~a~npfvv-------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ-NLI--------LR--NILTFAGNPFVV-------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhccccc-chh--------hh--ccccccCCccee--------------
Confidence 34679999999999999999999999999999954332 211 11 033333445544
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCC
Q 003232 667 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stdd 746 (837)
|+-...+++-+.++... +.+++|+|+-||+|||+||+|.+|+.-|++|+.|||+++.+.......
T Consensus 136 -------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 -------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred -------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 34444555556665443 779999999999999999999999999999999999998765433321
Q ss_pred CCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCcC
Q 003232 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826 (837)
Q Consensus 747 l~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dpd 826 (837)
++ ..+.....+ .......+|||.|+|||++..++|+..+|+|++|+|+|+.+-|..||.+++|+
T Consensus 201 l~--------------eg~I~k~t~--Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe 264 (1205)
T KOG0606|consen 201 LK--------------EGHIEKDTH--EFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE 264 (1205)
T ss_pred hh--------------hcchHHHHH--HhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH
Confidence 11 111111111 12233568999999999999999999999999999999999999999998765
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.4e-16 Score=157.73 Aligned_cols=133 Identities=26% Similarity=0.287 Sum_probs=107.9
Q ss_pred EecccCceEEEEEEECCCCcEEEEEEecccccc-----cHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEEe
Q 003232 596 PISRGAFGRVFLAKKRTTGDLFAIKVLKKADMI-----RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEY 670 (837)
Q Consensus 596 kLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~-----~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmEy 670 (837)
.||+|+||.||++.+ ++..+++|........ ......++.+|+.++..++|+++..+...+......++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 379999999999985 5788999986543211 122346788999999999988765555555566677999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccc
Q 003232 671 LNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (837)
Q Consensus 671 ~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArv 738 (837)
++|++|.+++..... .++.+++.+|.+||+.|++|+|++|.||+++ ++.++++|||++..
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999998755321 7889999999999999999999999999998 89999999999873
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.6e-16 Score=156.25 Aligned_cols=136 Identities=20% Similarity=0.193 Sum_probs=107.4
Q ss_pred eEEEEEecccCceEEEEEEECCCCcEEEEEEeccccccc-------------------HHHHHHHHHHHHHHHhcCCCc-
Q 003232 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIR-------------------KNAVESILAERDILISVRNPF- 650 (837)
Q Consensus 591 YeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~-------------------~e~ie~~~rEieILk~LrHPN- 650 (837)
|.+.+.||.|+||.||++.+. +|+.||||++....... .........|..++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 777889999999999999874 79999999976532100 011123677888898888774
Q ss_pred -eEEEEeEeecCCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEE
Q 003232 651 -VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIK 729 (837)
Q Consensus 651 -IVkL~gsf~d~~~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IK 729 (837)
++..+. ....++||||++|++|..+... .....++.+++.++.++|+.|++|+||+|+||+++.++.++
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~ 165 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY 165 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence 444443 2445899999999998765431 34567889999999999999999999999999999999999
Q ss_pred EEecCCcc
Q 003232 730 LTDFGLSK 737 (837)
Q Consensus 730 LiDFGLAr 737 (837)
|+|||++.
T Consensus 166 liDfg~~~ 173 (198)
T cd05144 166 IIDWPQMV 173 (198)
T ss_pred EEECCccc
Confidence 99999986
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.1e-17 Score=195.46 Aligned_cols=202 Identities=26% Similarity=0.363 Sum_probs=153.2
Q ss_pred CeEEEEEecccCceEEEEEEECCCCcEEEEEEecccc-cccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEE
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKAD-MIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~-~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVm 668 (837)
+|...+.||.+.|=.|.+|++. .|. |++|++.+.. ...-....+.+.|++ ...+++||.+.+.-........|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 6888899999999999999984 444 9999986543 333333444555555 66779999998877666667788888
Q ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccc--cccCCCCC
Q 003232 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV--GLINSTDD 746 (837)
Q Consensus 669 Ey~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArv--g~~~stdd 746 (837)
+|+. -+|+|++...+-+..-+.+.|+-||+.||.-+|..||+|||||.+||||+.=+.+.|+||..-+- .+.++..+
T Consensus 101 qyvk-hnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad 179 (1431)
T KOG1240|consen 101 QYVK-HNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD 179 (1431)
T ss_pred HHHh-hhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence 9884 59999998877788889999999999999999999999999999999999999999999987542 11111111
Q ss_pred CCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCC----------C-CCchHHHHHHHHHHHHHHc
Q 003232 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT----------G-HGTTADWWSVGIILFELIV 815 (837)
Q Consensus 747 l~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~----------~-~s~kSDIWSLGVILyELLT 815 (837)
+ +.+ .. +...-.+|+|||.+... + .+++.||||+||+++||++
T Consensus 180 f--------~fF------FD------------TSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~ 233 (1431)
T KOG1240|consen 180 F--------TFF------FD------------TSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFL 233 (1431)
T ss_pred c--------eEE------Ee------------cCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHh
Confidence 1 000 00 00111369999998542 2 5678899999999999996
Q ss_pred -CCCCCC
Q 003232 816 -GIPPFN 821 (837)
Q Consensus 816 -Gr~PF~ 821 (837)
|++||.
T Consensus 234 Eg~PlF~ 240 (1431)
T KOG1240|consen 234 EGRPLFT 240 (1431)
T ss_pred cCCCccc
Confidence 899995
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.65 E-value=9.1e-16 Score=176.37 Aligned_cols=137 Identities=26% Similarity=0.235 Sum_probs=111.3
Q ss_pred eEEEEEecccCceEEEEEEECCCCcEEEEEEecccc-----cccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEE
Q 003232 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKAD-----MIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 665 (837)
Q Consensus 591 YeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~-----~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ly 665 (837)
|...+.||+|+||+||++.+.. ..+++|+..... .......+++.+|+++++.++|++++.+..++......+
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 412 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT 412 (535)
T ss_pred cCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence 4567899999999999998753 344555432211 111223467889999999999999988877777777789
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccc
Q 003232 666 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (837)
Q Consensus 666 LVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArv 738 (837)
+||||++|++|.+++. ....++.+++.+|.|||+.|++||||||+|||+ .++.++|+|||+++.
T Consensus 413 lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 9999999999999875 346788999999999999999999999999999 688999999999974
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.2e-15 Score=149.27 Aligned_cols=136 Identities=22% Similarity=0.266 Sum_probs=97.8
Q ss_pred EEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHH---------------------HHHHHHHHHHhcCCCc--
Q 003232 594 IKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVE---------------------SILAERDILISVRNPF-- 650 (837)
Q Consensus 594 lkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie---------------------~~~rEieILk~LrHPN-- 650 (837)
.+.||+|+||+||+|.+. +++.||||++............ ....|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999986 8999999998764321111111 1135666666664432
Q ss_pred eEEEEeEeecCCeEEEEEEecCCCCHHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCcEEEccCCcE
Q 003232 651 VVRFFYSFTCRENLYLVMEYLNGGDLYS-LLRNLGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHI 728 (837)
Q Consensus 651 IVkL~gsf~d~~~lyLVmEy~~GGSL~d-lLk~~g~Lsee~irkIl~QIa~ALsYLHS-kGIIHRDIKPeNILLd~dG~I 728 (837)
+.+++.. ...++||||++|+.+.. .+.... . ...+..++.+++.++.++|. .||+|+||||+||+++ ++.+
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~ 153 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV 153 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence 4444443 24589999999844321 111111 1 15678899999999999999 9999999999999999 9999
Q ss_pred EEEecCCcc
Q 003232 729 KLTDFGLSK 737 (837)
Q Consensus 729 KLiDFGLAr 737 (837)
+|+|||.+.
T Consensus 154 ~liDfg~a~ 162 (187)
T cd05119 154 YIIDVPQAV 162 (187)
T ss_pred EEEECcccc
Confidence 999999986
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.5e-14 Score=132.07 Aligned_cols=132 Identities=23% Similarity=0.305 Sum_probs=111.4
Q ss_pred EEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCC--CceEEEEeEeecCCeEEEEEEe
Q 003232 593 IIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN--PFVVRFFYSFTCRENLYLVMEY 670 (837)
Q Consensus 593 IlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrH--PNIVkL~gsf~d~~~lyLVmEy 670 (837)
+++.||.|.++.||++... +..+++|....... ...+.+|..+++.+++ +++++++..+...+..+++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 4578999999999999974 37899999876432 3467889999999976 5889998888877889999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCCCCcEEEccCCcEEEEecCCccc
Q 003232 671 LNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL---RVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (837)
Q Consensus 671 ~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSk---GIIHRDIKPeNILLd~dG~IKLiDFGLArv 738 (837)
++|+.+..+ +......++.+++.+|.++|.. +++|+|++|.||+++..+.++++|||.+..
T Consensus 75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 998777654 4456677889999999999984 799999999999999989999999999873
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.57 E-value=3e-14 Score=148.61 Aligned_cols=137 Identities=20% Similarity=0.320 Sum_probs=106.3
Q ss_pred EEec-ccCceEEEEEEECCCCcEEEEEEeccccc----------ccHHHHHHHHHHHHHHHhcCCCce--EEEEeEeecC
Q 003232 595 KPIS-RGAFGRVFLAKKRTTGDLFAIKVLKKADM----------IRKNAVESILAERDILISVRNPFV--VRFFYSFTCR 661 (837)
Q Consensus 595 kkLG-sG~FGtVYkArdk~tG~~VAVKIikk~~~----------~~~e~ie~~~rEieILk~LrHPNI--VkL~gsf~d~ 661 (837)
..|| .|+.|+||++... +..++||.+..... ........+.+|+.++..++|++| +.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4577 8999999999863 78899999864321 111233568889999999998775 6666554332
Q ss_pred C----eEEEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCc
Q 003232 662 E----NLYLVMEYLNG-GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS 736 (837)
Q Consensus 662 ~----~lyLVmEy~~G-GSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLA 736 (837)
. ..++|||+++| .+|.+++.. ..+++.. +.+|+.+|.+||++||+|+||||.|||++.++.++|+|||.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 2 23699999997 699988865 3455543 568999999999999999999999999999999999999998
Q ss_pred cc
Q 003232 737 KV 738 (837)
Q Consensus 737 rv 738 (837)
..
T Consensus 190 ~~ 191 (239)
T PRK01723 190 EL 191 (239)
T ss_pred cc
Confidence 74
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.57 E-value=6.3e-15 Score=161.93 Aligned_cols=211 Identities=28% Similarity=0.400 Sum_probs=147.1
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCCCc-----------------------------------EEEEEEecccc--c
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGD-----------------------------------LFAIKVLKKAD--M 627 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~tG~-----------------------------------~VAVKIikk~~--~ 627 (837)
+..+++|++...||+|....||.++...+|. +.|||.+..-. .
T Consensus 153 kFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s 232 (598)
T KOG4158|consen 153 KFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDS 232 (598)
T ss_pred ccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCC
Confidence 4567889999999999999999987654322 13455442111 1
Q ss_pred ccHHHHHHHHHHHHH--------------HHh--------cCCCceEEEEeEeecC------------------------
Q 003232 628 IRKNAVESILAERDI--------------LIS--------VRNPFVVRFFYSFTCR------------------------ 661 (837)
Q Consensus 628 ~~~e~ie~~~rEieI--------------Lk~--------LrHPNIVkL~gsf~d~------------------------ 661 (837)
......+.+.+|.-- .+. -+|||||+++..|.+.
T Consensus 233 ~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~ 312 (598)
T KOG4158|consen 233 GDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGA 312 (598)
T ss_pred chHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceeccccc
Confidence 112222333333211 111 2599999998877542
Q ss_pred ---CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEc--cCC--cEEEEecC
Q 003232 662 ---ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA--HDG--HIKLTDFG 734 (837)
Q Consensus 662 ---~~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd--~dG--~IKLiDFG 734 (837)
..+|+||..+ ..+|.+++-.+ ..+.....-++.|+++|+.|||.+|+.|||+|.+|||+. +++ .++|+|||
T Consensus 313 g~~~tlylvMkrY-~~tLr~yl~~~-~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFG 390 (598)
T KOG4158|consen 313 GEPKTLYLVMKRY-RQTLREYLWTR-HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFG 390 (598)
T ss_pred CCCceEEEehhcc-hhhHHHHHhcC-CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccc
Confidence 2479999988 56999998663 456777788999999999999999999999999999994 333 57899999
Q ss_pred CccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCC------CchHHHHHHHH
Q 003232 735 LSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH------GTTADWWSVGI 808 (837)
Q Consensus 735 LArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~------s~kSDIWSLGV 808 (837)
-|- .+.++-+..|+.+.. -..-|....||||+....+- -.++|.|+.|.
T Consensus 391 CcL---Ad~~hGlqlpy~S~~----------------------Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~Ga 445 (598)
T KOG4158|consen 391 CCL---ADDNHGLQLPYESDE----------------------VDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGA 445 (598)
T ss_pred eee---ecccccccccccccc----------------------ccCCCcceecchhhhhcCCCCceeeccchhhhhhhhh
Confidence 775 233332333332111 13346778999999865432 24789999999
Q ss_pred HHHHHHcCCCCCCC
Q 003232 809 ILFELIVGIPPFNA 822 (837)
Q Consensus 809 ILyELLTGr~PF~~ 822 (837)
+.||+++...||..
T Consensus 446 laYEIfg~~NPFY~ 459 (598)
T KOG4158|consen 446 LAYEIFGRSNPFYK 459 (598)
T ss_pred hHHHHhccCCcccc
Confidence 99999999999987
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.5e-15 Score=160.56 Aligned_cols=201 Identities=20% Similarity=0.370 Sum_probs=159.9
Q ss_pred CCcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCe
Q 003232 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCREN 663 (837)
Q Consensus 584 ~g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ 663 (837)
.+..+.+..++.+|.....|..|+|+|. |..+++|++.... ......+.|..|...|+-+.||||..+++.+....+
T Consensus 185 ~gid~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~-~t~risrdfneefp~lrifshpnilpvlgacnsppn 261 (448)
T KOG0195|consen 185 TGIDVSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVRE-VTARISRDFNEEFPALRIFSHPNILPVLGACNSPPN 261 (448)
T ss_pred cCcchhhhhhhhhhccCCCccccccccc--Ccchhhhhhhhhh-cchhhcchhhhhCcceeeecCCchhhhhhhccCCCC
Confidence 3556667888899999999999999996 5568888887543 223344678899999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCC--cccccCCCCcEEEccCCcEEEE--ecCCcc
Q 003232 664 LYLVMEYLNGGDLYSLLRNLGC--LDEDVARVYIAEVVLALEYLHSLR--VVHRDLKPDNLLIAHDGHIKLT--DFGLSK 737 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk~~g~--Lsee~irkIl~QIa~ALsYLHSkG--IIHRDIKPeNILLd~dG~IKLi--DFGLAr 737 (837)
+.++..|++.|||+..++.... .+..++.+++.+|++|+.|||+.. |----|....++|+++-+.+|. |--++.
T Consensus 262 lv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf 341 (448)
T KOG0195|consen 262 LVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF 341 (448)
T ss_pred ceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee
Confidence 9999999999999999987543 677788999999999999999864 3334578889999988776653 322221
Q ss_pred ccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCC---chHHHHHHHHHHHHHH
Q 003232 738 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHG---TTADWWSVGIILFELI 814 (837)
Q Consensus 738 vg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s---~kSDIWSLGVILyELL 814 (837)
. .....-.|.||+||.+...+-+ ..+|+|||++++|||.
T Consensus 342 q--------------------------------------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~ 383 (448)
T KOG0195|consen 342 Q--------------------------------------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELN 383 (448)
T ss_pred e--------------------------------------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhh
Confidence 0 1123456789999999876543 5689999999999999
Q ss_pred cCCCCCCCCCc
Q 003232 815 VGIPPFNAEHP 825 (837)
Q Consensus 815 TGr~PF~~~dp 825 (837)
|+..||..-+|
T Consensus 384 trevpfadlsp 394 (448)
T KOG0195|consen 384 TREVPFADLSP 394 (448)
T ss_pred ccccccccCCc
Confidence 99999986554
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.45 E-value=3.4e-14 Score=160.66 Aligned_cols=142 Identities=31% Similarity=0.480 Sum_probs=113.7
Q ss_pred CeEEEEEEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccc
Q 003232 662 ENLYLVMEYLNGGDLYSLLRNLG---CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (837)
Q Consensus 662 ~~lyLVmEy~~GGSL~dlLk~~g---~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArv 738 (837)
.++||.|++|.-.+|.+++.... ..+......++.|++.|+.| +|.+|+|+||.||++..+..++|.|||+..-
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 46899999999999999997543 35667788999999999999 9999999999999999999999999999762
Q ss_pred cccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc---
Q 003232 739 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV--- 815 (837)
Q Consensus 739 g~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT--- 815 (837)
.....+. ...........||..||+||.+.+..|+.++||||||++++|++.
T Consensus 406 ~~~~~~~-------------------------~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~ 460 (516)
T KOG1033|consen 406 QDKDETV-------------------------APAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFS 460 (516)
T ss_pred cccCCcc-------------------------cchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhc
Confidence 1111100 001123445689999999999999999999999999999999998
Q ss_pred --------------CCCC--CCCCCcCHHHHH
Q 003232 816 --------------GIPP--FNAEHPQVSTLL 831 (837)
Q Consensus 816 --------------Gr~P--F~~~dpdv~~ll 831 (837)
|..| |..+.|.-..++
T Consensus 461 T~~er~~t~~d~r~g~ip~~~~~d~p~e~~ll 492 (516)
T KOG1033|consen 461 TQFERIATLTDIRDGIIPPEFLQDYPEEYTLL 492 (516)
T ss_pred cHHHHHHhhhhhhcCCCChHHhhcCcHHHHHH
Confidence 5666 666666665544
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.39 E-value=2.3e-14 Score=167.64 Aligned_cols=208 Identities=27% Similarity=0.460 Sum_probs=168.2
Q ss_pred cCCeEEEEEecccCceEEEEEEECC-CCcEEEEEEecccccccHHHHHHHHHHHHHHHhcC-CCceEEEEeEeecCCeEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRT-TGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCRENLY 665 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~-tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~Lr-HPNIVkL~gsf~d~~~ly 665 (837)
...|.+.+.||+|+|+.|-...... ....+|.|.+.... ........+..|..+-+.+. |+|++.+++........+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 4558889999999999999887743 34466777766543 33445566677887777777 999999999999999999
Q ss_pred EEEEecCCCCHHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-hCCcccccCCCCcEEEccCC-cEEEEecCCcccccc
Q 003232 666 LVMEYLNGGDLYSLL-RNLG-CLDEDVARVYIAEVVLALEYLH-SLRVVHRDLKPDNLLIAHDG-HIKLTDFGLSKVGLI 741 (837)
Q Consensus 666 LVmEy~~GGSL~dlL-k~~g-~Lsee~irkIl~QIa~ALsYLH-SkGIIHRDIKPeNILLd~dG-~IKLiDFGLArvg~~ 741 (837)
++++|..|+++.+.+ .... ..+...+..++.|+..++.|+| ..++.|+||||+|.+++..+ .++++|||+|.....
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999999988 5544 5778888999999999999999 99999999999999999999 999999999974221
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCC-CCCccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCC
Q 003232 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVG-TPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPP 819 (837)
Q Consensus 742 ~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vG-Tp~YmAPEVLlg~-~~s~kSDIWSLGVILyELLTGr~P 819 (837)
.. .........+| ++.|+|||...+. -.....|+||.|+++.-+++|..|
T Consensus 178 ~~----------------------------g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p 229 (601)
T KOG0590|consen 178 KN----------------------------GAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELP 229 (601)
T ss_pred cC----------------------------CcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCC
Confidence 00 01122345577 9999999999885 446778999999999999999999
Q ss_pred CCCCC
Q 003232 820 FNAEH 824 (837)
Q Consensus 820 F~~~d 824 (837)
|....
T Consensus 230 ~~~~~ 234 (601)
T KOG0590|consen 230 WDFPS 234 (601)
T ss_pred ccccc
Confidence 87544
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.32 E-value=8.2e-12 Score=141.34 Aligned_cols=145 Identities=23% Similarity=0.271 Sum_probs=99.6
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccH-------------------------------HH-----
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRK-------------------------------NA----- 632 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~-------------------------------e~----- 632 (837)
..|. .+.||+|++|.||+|+. .+|+.||||+.++.....- +.
T Consensus 118 ~~fd-~~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~ 195 (437)
T TIGR01982 118 AEFE-EKPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLR 195 (437)
T ss_pred hhCC-CcceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHH
Confidence 3344 26799999999999997 5799999999875321000 00
Q ss_pred -HHHHHHHHHHHHhcC-----CCceEEEEeEeecCCeEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHH-HHHH
Q 003232 633 -VESILAERDILISVR-----NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVL-ALEY 704 (837)
Q Consensus 633 -ie~~~rEieILk~Lr-----HPNIVkL~gsf~d~~~lyLVmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~-ALsY 704 (837)
.-.+.+|...+.++. +++|.-...++......+|||||++|++|.++.... .... ...++.+++. .+..
T Consensus 196 ~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~q 272 (437)
T TIGR01982 196 RELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQ 272 (437)
T ss_pred HHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHH
Confidence 012445555555552 344332222222334579999999999998876432 1222 2345555555 4788
Q ss_pred HHhCCcccccCCCCcEEEccCCcEEEEecCCccc
Q 003232 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (837)
Q Consensus 705 LHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArv 738 (837)
+|..|++|+|++|.||+++.+|.++|+|||++..
T Consensus 273 l~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~ 306 (437)
T TIGR01982 273 VLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGR 306 (437)
T ss_pred HHhCCceeCCCCcccEEECCCCcEEEEeCCCeeE
Confidence 9999999999999999999999999999999863
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.4e-11 Score=118.22 Aligned_cols=128 Identities=19% Similarity=0.316 Sum_probs=95.9
Q ss_pred EEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCce-EEEEeEeecCCeEEEEEEecC
Q 003232 594 IKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFV-VRFFYSFTCRENLYLVMEYLN 672 (837)
Q Consensus 594 lkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNI-VkL~gsf~d~~~lyLVmEy~~ 672 (837)
++.|+.|.++.||+++.. +..|++|+...... ....+.+|..+++.+.+.++ .+++.... ...++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 467899999999999864 78899999865421 11245678888888765443 44554432 34579999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc-----ccccCCCCcEEEccCCcEEEEecCCccc
Q 003232 673 GGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRV-----VHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (837)
Q Consensus 673 GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGI-----IHRDIKPeNILLd~dG~IKLiDFGLArv 738 (837)
|.++... . .....++.+++.+|..||..++ +|+|++|.||+++ ++.++++||+.+..
T Consensus 75 G~~l~~~----~----~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 75 GSELLTE----D----FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred CCccccc----c----ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 9887643 0 1123456799999999999885 9999999999998 67899999998874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.28 E-value=2.2e-12 Score=149.40 Aligned_cols=146 Identities=22% Similarity=0.361 Sum_probs=98.1
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccc--------------------------c-H----HHH
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMI--------------------------R-K----NAV 633 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~--------------------------~-~----e~i 633 (837)
...+..|+. +.||+|++|.||+|+.+.+|+.||||+.++.-.. + . +..
T Consensus 116 ~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~ 194 (537)
T PRK04750 116 EEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFE 194 (537)
T ss_pred HHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHH
Confidence 344567887 8999999999999999877999999999754200 0 0 111
Q ss_pred HH------HHHHHHHHHhcC----CCceEEEEeEee-cCCeEEEEEEecCCCCHHHHH--HhcC----CCCHHHHHHHHH
Q 003232 634 ES------ILAERDILISVR----NPFVVRFFYSFT-CRENLYLVMEYLNGGDLYSLL--RNLG----CLDEDVARVYIA 696 (837)
Q Consensus 634 e~------~~rEieILk~Lr----HPNIVkL~gsf~-d~~~lyLVmEy~~GGSL~dlL--k~~g----~Lsee~irkIl~ 696 (837)
+. +.+|...+.++. +.+.+.+-.++. .....+|||||+.|+.+.++. ...+ .+.+..+..++.
T Consensus 195 ~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~ 274 (537)
T PRK04750 195 KTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFT 274 (537)
T ss_pred HHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHH
Confidence 22 334444444442 333233222222 245678999999999998753 3322 233444444555
Q ss_pred HHHHHHHHHHhCCcccccCCCCcEEEccCC----cEEEEecCCccc
Q 003232 697 EVVLALEYLHSLRVVHRDLKPDNLLIAHDG----HIKLTDFGLSKV 738 (837)
Q Consensus 697 QIa~ALsYLHSkGIIHRDIKPeNILLd~dG----~IKLiDFGLArv 738 (837)
|++ ..|++|+|+||.||+++.+| .++++|||++..
T Consensus 275 Qif-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~ 313 (537)
T PRK04750 275 QVF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGS 313 (537)
T ss_pred HHH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEE
Confidence 554 59999999999999999888 999999999763
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=6.3e-12 Score=143.49 Aligned_cols=154 Identities=27% Similarity=0.371 Sum_probs=123.5
Q ss_pred HHhcCCCceEEEEeEeecCCeEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCc-ccccCCCCcE
Q 003232 643 LISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRV-VHRDLKPDNL 720 (837)
Q Consensus 643 Lk~LrHPNIVkL~gsf~d~~~lyLVmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGI-IHRDIKPeNI 720 (837)
|+.+.|.|+.++++.+.+...+++|.+||..|+|.+.+... -.++......++++|+.||.|+|+-.| .|+.+++.|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 35688999999999999999999999999999999999873 457888888899999999999998654 9999999999
Q ss_pred EEccCCcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCC----
Q 003232 721 LIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG---- 796 (837)
Q Consensus 721 LLd~dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~---- 796 (837)
+++....+||.|||+...... +.... .. ....-...|.|||.+.+..
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~--~~~~~---------------------~~------~~~~~~~lw~aPellr~~~~~~~ 131 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEE--TAEPE---------------------AH------HPIRKALLWTAPELLRGALSQSL 131 (484)
T ss_pred eeeeeEEEEechhhhcccccc--ccccc---------------------cc------chhHHHHhccCHHHhcccccccc
Confidence 999999999999999764211 00000 00 0000123589999997631
Q ss_pred ---CCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 797 ---HGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 797 ---~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
.+.+.||||||++++|+++...||.....
T Consensus 132 ~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~ 163 (484)
T KOG1023|consen 132 ESALTQKGDIYSFGIIMYEILFRSGPFDLRNL 163 (484)
T ss_pred cccccccCCeehHHHHHHHHHhccCccccccc
Confidence 36678999999999999999999987443
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.25 E-value=5.7e-11 Score=121.90 Aligned_cols=137 Identities=23% Similarity=0.215 Sum_probs=100.3
Q ss_pred EEecccCceEEEEEEECC------CCcEEEEEEecccccc----------c---------HHHHHHHH----HHHHHHHh
Q 003232 595 KPISRGAFGRVFLAKKRT------TGDLFAIKVLKKADMI----------R---------KNAVESIL----AERDILIS 645 (837)
Q Consensus 595 kkLGsG~FGtVYkArdk~------tG~~VAVKIikk~~~~----------~---------~e~ie~~~----rEieILk~ 645 (837)
..||.|..+.||.|.... .+..+|||+++..... . ......+. +|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998643 3579999998642110 0 11122333 79999988
Q ss_pred cCC--CceEEEEeEeecCCeEEEEEEecCCCCHHH-HHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCcccccCCCCcEE
Q 003232 646 VRN--PFVVRFFYSFTCRENLYLVMEYLNGGDLYS-LLRNLGCLDEDVARVYIAEVVLALEYL-HSLRVVHRDLKPDNLL 721 (837)
Q Consensus 646 LrH--PNIVkL~gsf~d~~~lyLVmEy~~GGSL~d-lLk~~g~Lsee~irkIl~QIa~ALsYL-HSkGIIHRDIKPeNIL 721 (837)
+.. -++++++.. ..-+|||||+.+..+.. .++. ..++......++.+++.+|..+ |..||||+||++.|||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 854 456666654 45689999997654422 2222 3456667778889999999998 8999999999999999
Q ss_pred EccCCcEEEEecCCcc
Q 003232 722 IAHDGHIKLTDFGLSK 737 (837)
Q Consensus 722 Ld~dG~IKLiDFGLAr 737 (837)
+. ++.++|+|||.+.
T Consensus 158 ~~-~~~v~iIDF~qav 172 (197)
T cd05146 158 WH-DGKVWFIDVSQSV 172 (197)
T ss_pred EE-CCcEEEEECCCce
Confidence 96 5789999999886
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.16 E-value=2e-10 Score=117.20 Aligned_cols=134 Identities=26% Similarity=0.284 Sum_probs=104.1
Q ss_pred EEecccCceEEEEEEECCCCcEEEEEEe-----cccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEE
Q 003232 595 KPISRGAFGRVFLAKKRTTGDLFAIKVL-----KKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (837)
Q Consensus 595 kkLGsG~FGtVYkArdk~tG~~VAVKIi-----kk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmE 669 (837)
..+++|+-+.+|.+.+. |..+++|.= ..+.....-...+..+|.+++..++--.|..++-++.+.....|+||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 35789999999999763 555777753 33334444555788999999999876666666666667778889999
Q ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccc
Q 003232 670 YLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (837)
Q Consensus 670 y~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArv 738 (837)
|++|..|.+.+... . ..++..+-.-+.-||..||+|+||.++||++..++ +.++|||++.+
T Consensus 80 ~I~G~~lkd~l~~~---~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA---R----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc---c----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999998764 1 34566677777789999999999999999996554 99999999874
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.14 E-value=2.7e-10 Score=132.58 Aligned_cols=184 Identities=18% Similarity=0.301 Sum_probs=135.0
Q ss_pred eEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEEe
Q 003232 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEY 670 (837)
Q Consensus 591 YeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmEy 670 (837)
|.+ ...+.++.+..-.|..+.++.+|.+..++...- .......+-+..|+.++||||++++..+....++|||+|.
T Consensus 15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTEr 90 (690)
T KOG1243|consen 15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTER 90 (690)
T ss_pred ccc-ccccCCCcccccccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeec
Confidence 444 333444444222456667889999999876542 4455677888899999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCC
Q 003232 671 LNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLH-SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 749 (837)
Q Consensus 671 ~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLH-SkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~ 749 (837)
+. -|..++++. ....+...+.||+.||.||| .++++|++|.-..|+++..|..||++|.++.-.. ..+ .
T Consensus 91 V~--Pl~~~lk~l---~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~--~~~---~ 160 (690)
T KOG1243|consen 91 VR--PLETVLKEL---GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKAS--GFN---A 160 (690)
T ss_pred cc--cHHHHHHHh---HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccc--cCC---c
Confidence 84 566677663 36777888999999999998 5899999999999999999999999998764200 000 0
Q ss_pred CCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcC
Q 003232 750 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVG 816 (837)
Q Consensus 750 p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTG 816 (837)
......--..|..|+.+.... ...|.|.|||++|+++.|
T Consensus 161 --------------------------~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 161 --------------------------PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred --------------------------ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 000011112366676554332 457999999999999999
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.07 E-value=6.8e-10 Score=110.14 Aligned_cols=140 Identities=19% Similarity=0.240 Sum_probs=104.5
Q ss_pred EEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCC--CceEEEEeEeecC---CeEEEEEE
Q 003232 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN--PFVVRFFYSFTCR---ENLYLVME 669 (837)
Q Consensus 595 kkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrH--PNIVkL~gsf~d~---~~lyLVmE 669 (837)
+.|+.|.++.||++... +|+.+++|+....... .....+..|..+++.+.+ .++.+++...... +..++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 67899999999999874 3688999998654321 123467889999998875 3456666665543 26789999
Q ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 003232 670 YLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS------------------------------------------ 707 (837)
Q Consensus 670 y~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHS------------------------------------------ 707 (837)
|++|.++.+.+.. ..++......++.+++.+|.+||+
T Consensus 81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9999888765432 346666677777777777777773
Q ss_pred --------------CCcccccCCCCcEEEcc--CCcEEEEecCCccc
Q 003232 708 --------------LRVVHRDLKPDNLLIAH--DGHIKLTDFGLSKV 738 (837)
Q Consensus 708 --------------kGIIHRDIKPeNILLd~--dG~IKLiDFGLArv 738 (837)
..++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23699999999999988 56789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.06 E-value=8.2e-11 Score=135.04 Aligned_cols=204 Identities=26% Similarity=0.260 Sum_probs=156.5
Q ss_pred CeEEEEEecc--cCceEEEEEEE--CCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEeEeecCCeE
Q 003232 590 DFEIIKPISR--GAFGRVFLAKK--RTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENL 664 (837)
Q Consensus 590 dYeIlkkLGs--G~FGtVYkArd--k~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~gsf~d~~~l 664 (837)
.+.+.+.+|. |.+|.||.++. ..++..+|+|.-+..... .....+-.+|+.-.+.+ .|+|.++.+..+......
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~-p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSP-PLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCC-ccccccccchhhcccccCccccccccCcccccCCcc
Confidence 3777788999 99999999998 889999999985443211 11122334555555555 489999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHHhCCcccccCCCCcEEEccC-CcEEEEecCCccc
Q 003232 665 YLVMEYLNGGDLYSLLRNLGC-LDEDVARVYIAEVVL----ALEYLHSLRVVHRDLKPDNLLIAHD-GHIKLTDFGLSKV 738 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~g~-Lsee~irkIl~QIa~----ALsYLHSkGIIHRDIKPeNILLd~d-G~IKLiDFGLArv 738 (837)
++-+|++ +.+|..+...... ++...++.++.+... ||.++|+.+++|.|+||.||++..+ ...+++|||+...
T Consensus 194 fiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~ 272 (524)
T KOG0601|consen 194 FIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSK 272 (524)
T ss_pred eeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEE
Confidence 9999999 5788888876554 888899999999999 9999999999999999999999998 8899999998762
Q ss_pred cccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCC
Q 003232 739 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIP 818 (837)
Q Consensus 739 g~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~ 818 (837)
..... ++. .........|...|++||+..+. ++...|||+||.++.+..+|..
T Consensus 273 i~~~~--------~~~------------------~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~ 325 (524)
T KOG0601|consen 273 ISDGN--------FSS------------------VFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSH 325 (524)
T ss_pred ccCCc--------ccc------------------ceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcc
Confidence 11000 000 00111223577789999988754 6889999999999999988776
Q ss_pred CCCC
Q 003232 819 PFNA 822 (837)
Q Consensus 819 PF~~ 822 (837)
++..
T Consensus 326 ~~~~ 329 (524)
T KOG0601|consen 326 LPSV 329 (524)
T ss_pred cccC
Confidence 6543
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.4e-09 Score=109.50 Aligned_cols=144 Identities=22% Similarity=0.264 Sum_probs=112.6
Q ss_pred EEEEecccCceEEEEEEECCCCcEEEEEE-----ecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEE
Q 003232 593 IIKPISRGAFGRVFLAKKRTTGDLFAIKV-----LKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 593 IlkkLGsG~FGtVYkArdk~tG~~VAVKI-----ikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLV 667 (837)
.+..|-+|+.+.|+++.+ .|+..+||. ++++.....-...+..+|.+.|.++.--.|.-..-+|.+...-+|+
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 567899999999999986 477777764 4555555556667899999999988766666555567777788899
Q ss_pred EEecCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCC---cEEEEecCCccc
Q 003232 668 MEYLNG-GDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG---HIKLTDFGLSKV 738 (837)
Q Consensus 668 mEy~~G-GSL~dlLk~~--g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG---~IKLiDFGLArv 738 (837)
|||++| .++.+++... .....+....++.+|-..|.-||..+|||+||..+||++..++ .+.|+|||++.+
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 999987 4788887543 2233334467888999999999999999999999999997665 358999999864
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.94 E-value=4.2e-10 Score=129.26 Aligned_cols=198 Identities=28% Similarity=0.293 Sum_probs=151.3
Q ss_pred ccCCeEEEEEecccCceEEEEEEEC-CCCcEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEeEeecCCeE
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKR-TTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENL 664 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk-~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~gsf~d~~~l 664 (837)
...+|..+..||.|.|+.|+.+..+ .++..|++|............+ .-..|+.+...+ .|.+++.++..|....+.
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di-~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDI-FSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhh-cchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 3467999999999999999988765 6788999998876543333322 223444444444 588999999999988889
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccC-CcEEEEecCCccccccCC
Q 003232 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD-GHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~d-G~IKLiDFGLArvg~~~s 743 (837)
|+-.|||.++++.....-...+.+...+.+..|++.++.++|++.++|+|++|+||++..+ +..++.|||..+-....
T Consensus 342 ~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~- 420 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS- 420 (524)
T ss_pred cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee-
Confidence 9999999999988777655678888999999999999999999999999999999999876 77788999876410000
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCcc--ChhhhcCCCCCchHHHHHHHHHHHHHHcCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYL--APEILLGTGHGTTADWWSVGIILFELIVGIPP 819 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~Ym--APEVLlg~~~s~kSDIWSLGVILyELLTGr~P 819 (837)
.....+.-++. +|+......+..+.|++|||..+.+..+|.+.
T Consensus 421 ---------------------------------~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l 465 (524)
T KOG0601|consen 421 ---------------------------------SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL 465 (524)
T ss_pred ---------------------------------cccccccccccccchhhccccccccccccccccccccccccCccc
Confidence 00111222333 55555667888999999999999999988753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.82 E-value=1.5e-08 Score=103.45 Aligned_cols=126 Identities=24% Similarity=0.280 Sum_probs=83.5
Q ss_pred EEEEEEECCCCcEEEEEEeccccc-----------------------ccHHHHHHHHHHHHHHHhcCCC--ceEEEEeEe
Q 003232 604 RVFLAKKRTTGDLFAIKVLKKADM-----------------------IRKNAVESILAERDILISVRNP--FVVRFFYSF 658 (837)
Q Consensus 604 tVYkArdk~tG~~VAVKIikk~~~-----------------------~~~e~ie~~~rEieILk~LrHP--NIVkL~gsf 658 (837)
.||.|.. .+|..+|||+++.... ..........+|.+.|..+..- ++++++...
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3888887 5788999999864210 1112235678899999999765 567776542
Q ss_pred ecCCeEEEEEEecC--CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHhCCcccccCCCCcEEEccCCcEEEEecCC
Q 003232 659 TCRENLYLVMEYLN--GGDLYSLLRNLGCLDEDVARVYIAEVVLALEY-LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGL 735 (837)
Q Consensus 659 ~d~~~lyLVmEy~~--GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsY-LHSkGIIHRDIKPeNILLd~dG~IKLiDFGL 735 (837)
.-+|||||++ |..+..+.... ++......++.+++..+.. +|..||+|+|+++.|||++.+ .+.++|||.
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred ----CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence 3479999998 65555443321 2234566777888885555 579999999999999999776 999999998
Q ss_pred cc
Q 003232 736 SK 737 (837)
Q Consensus 736 Ar 737 (837)
+.
T Consensus 153 av 154 (188)
T PF01163_consen 153 AV 154 (188)
T ss_dssp EE
T ss_pred ce
Confidence 86
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.77 E-value=1.4e-07 Score=101.01 Aligned_cols=131 Identities=15% Similarity=0.107 Sum_probs=92.6
Q ss_pred EEEEEECCCCcEEEEEEeccccccc--H------HHHHHHHHHHHHHHhcCCCce--EEEEeEeec-----CCeEEEEEE
Q 003232 605 VFLAKKRTTGDLFAIKVLKKADMIR--K------NAVESILAERDILISVRNPFV--VRFFYSFTC-----RENLYLVME 669 (837)
Q Consensus 605 VYkArdk~tG~~VAVKIikk~~~~~--~------e~ie~~~rEieILk~LrHPNI--VkL~gsf~d-----~~~lyLVmE 669 (837)
|+++.. .|+.|.||.+....... . .-...+.+|...+..|..-+| +.+..++.. ....+||||
T Consensus 38 vvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 38 TLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred EEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 555543 46788899774432110 0 001136788888887743332 233333322 235789999
Q ss_pred ecCCC-CHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEcc-------CCcEEEEecCCcc
Q 003232 670 YLNGG-DLYSLLRN--LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH-------DGHIKLTDFGLSK 737 (837)
Q Consensus 670 y~~GG-SL~dlLk~--~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~-------dG~IKLiDFGLAr 737 (837)
++++. +|.+++.. ....+......++.+++..+.-||..||+|+|+++.|||++. ++.+.|+||+.+.
T Consensus 116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 99886 89999864 244566778899999999999999999999999999999975 4679999999875
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.61 E-value=3.8e-07 Score=93.25 Aligned_cols=105 Identities=26% Similarity=0.296 Sum_probs=83.4
Q ss_pred HHHHHHHHHHHhcCCCc--eEEEEeEeecC----CeEEEEEEecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 003232 634 ESILAERDILISVRNPF--VVRFFYSFTCR----ENLYLVMEYLNGG-DLYSLLRNLGCLDEDVARVYIAEVVLALEYLH 706 (837)
Q Consensus 634 e~~~rEieILk~LrHPN--IVkL~gsf~d~----~~lyLVmEy~~GG-SL~dlLk~~g~Lsee~irkIl~QIa~ALsYLH 706 (837)
....+|...+..+..-. +++++.+.... ...++|||+++|. +|.+++.....++......++.+++..+.-||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 46778888877775332 33444443332 2468999999884 89999987555777888899999999999999
Q ss_pred hCCcccccCCCCcEEEccCC---cEEEEecCCccc
Q 003232 707 SLRVVHRDLKPDNLLIAHDG---HIKLTDFGLSKV 738 (837)
Q Consensus 707 SkGIIHRDIKPeNILLd~dG---~IKLiDFGLArv 738 (837)
..||+|+|+++.|||++.++ .+.|+||+-++.
T Consensus 136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999999999999998887 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.56 E-value=3e-07 Score=98.97 Aligned_cols=137 Identities=23% Similarity=0.235 Sum_probs=104.5
Q ss_pred eEEEEEecccCceEEEEEEECCCCcEEEEEEecccc-------------------cccHHHHHHHHHHHHHHHhcCCC--
Q 003232 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKAD-------------------MIRKNAVESILAERDILISVRNP-- 649 (837)
Q Consensus 591 YeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~-------------------~~~~e~ie~~~rEieILk~LrHP-- 649 (837)
+.+...||-|.-|.||.|.+. .|.++|||.=+... ...........+|.++|+.|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 445678999999999999984 78999999743211 00112234567899999998755
Q ss_pred ceEEEEeEeecCCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEE
Q 003232 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIK 729 (837)
Q Consensus 650 NIVkL~gsf~d~~~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IK 729 (837)
.+++.++. +.-++||||++|.-|...- ++......++..|+.-+..+-..||||+|+++-||+++.+|.++
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~ 242 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV 242 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence 67777654 5678999999986665432 23555666777788877777799999999999999999999999
Q ss_pred EEecCCcc
Q 003232 730 LTDFGLSK 737 (837)
Q Consensus 730 LiDFGLAr 737 (837)
++||-.+.
T Consensus 243 vIDwPQ~v 250 (304)
T COG0478 243 VIDWPQAV 250 (304)
T ss_pred EEeCcccc
Confidence 99998764
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.55 E-value=1e-07 Score=104.22 Aligned_cols=152 Identities=24% Similarity=0.423 Sum_probs=113.1
Q ss_pred HHHHhcCCCceEEEEeEeecCC-----eEEEEEEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC--C
Q 003232 641 DILISVRNPFVVRFFYSFTCRE-----NLYLVMEYLNGGDLYSLLRNL----GCLDEDVARVYIAEVVLALEYLHSL--R 709 (837)
Q Consensus 641 eILk~LrHPNIVkL~gsf~d~~-----~lyLVmEy~~GGSL~dlLk~~----g~Lsee~irkIl~QIa~ALsYLHSk--G 709 (837)
..|-++-|-||++++.+|.+.+ ...+++||+.-|+|.+++++. ..+.....++|+-||+.||.|||+. -
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 3445567999999999887754 378899999999999999643 4578888899999999999999986 5
Q ss_pred cccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccCh
Q 003232 710 VVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAP 789 (837)
Q Consensus 710 IIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAP 789 (837)
|+|+++..+.|++..+|-+|+.--.... ++ +.... .....+....|-++|.||
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s------~h-----------------~s~~~----~~~~Ek~~~~~~~g~~a~ 251 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDS------TH-----------------PSVNS----TREAEKSVNTSLPGFSAP 251 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccc------cc-----------------hhhhh----hhHhhhhccccCCccccC
Confidence 9999999999999988888864211110 00 00000 011122234567889999
Q ss_pred hhhcCCCCCchHHHHHHHHHHHHHHcCCCC
Q 003232 790 EILLGTGHGTTADWWSVGIILFELIVGIPP 819 (837)
Q Consensus 790 EVLlg~~~s~kSDIWSLGVILyELLTGr~P 819 (837)
|.=.....+-.+|||+||.+..+|-.+..-
T Consensus 252 ~sg~~tn~~~a~dIy~fgmcAlemailEiq 281 (458)
T KOG1266|consen 252 ESGTTTNTTGASDIYKFGMCALEMAILEIQ 281 (458)
T ss_pred CcCcccccccchhhhhhhHHHHHHHHheec
Confidence 976556667789999999999999887654
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.55 E-value=6.9e-07 Score=102.43 Aligned_cols=134 Identities=20% Similarity=0.229 Sum_probs=106.7
Q ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeec----CCeEEEEEEecCC-CC
Q 003232 601 AFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC----RENLYLVMEYLNG-GD 675 (837)
Q Consensus 601 ~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d----~~~lyLVmEy~~G-GS 675 (837)
--.+.|++....+|..|++|.+........ .....-++.++++.|+|||++.++|.. +..+++|++|+++ ++
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence 346789999999999999999944322111 123345778999999999999998874 3468999999986 58
Q ss_pred HHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCcc
Q 003232 676 LYSLLRN---------------LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 737 (837)
Q Consensus 676 L~dlLk~---------------~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLAr 737 (837)
|.++.-. ....++..++.|+.|+..||.++|+.|+..+-|.|.+||++.+..++|...|..-
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~D 441 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMD 441 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEeccccee
Confidence 8887521 1236789999999999999999999999999999999999888888887766543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.43 E-value=7.6e-07 Score=103.40 Aligned_cols=146 Identities=23% Similarity=0.283 Sum_probs=95.3
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEeccccccc---------------------------H----HHH--
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIR---------------------------K----NAV-- 633 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~---------------------------~----e~i-- 633 (837)
.+..|.. +.|+.++-|.||+|+. .+|+.||||+.++.-... . +..
T Consensus 124 ~F~eF~~-~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~ 201 (517)
T COG0661 124 LFSEFEP-EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKR 201 (517)
T ss_pred HHHHcCC-CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHH
Confidence 3334443 7899999999999998 459999999987531100 0 001
Q ss_pred ----HHHHHHHHHHHhc-----CCCceEEEEeEeecCCeEEEEEEecCCCCHHHHH--HhcCCCCHHHHHHHHHHHHHHH
Q 003232 634 ----ESILAERDILISV-----RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL--RNLGCLDEDVARVYIAEVVLAL 702 (837)
Q Consensus 634 ----e~~~rEieILk~L-----rHPNIVkL~gsf~d~~~lyLVmEy~~GGSL~dlL--k~~g~Lsee~irkIl~QIa~AL 702 (837)
-.+.+|...+.++ +.|++.-..-++.....-.|+|||++|..+.+.. +. ...+...+...+.++ -+
T Consensus 202 l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~--f~ 278 (517)
T COG0661 202 LREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRA--FL 278 (517)
T ss_pred HHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHH--HH
Confidence 1233444444444 2466555555555566778999999999888874 33 334433222221111 12
Q ss_pred HHHHhCCcccccCCCCcEEEccCCcEEEEecCCcc
Q 003232 703 EYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 737 (837)
Q Consensus 703 sYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLAr 737 (837)
..+-..|++|.|.+|.||+++.+|.+.+.|||+..
T Consensus 279 ~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g 313 (517)
T COG0661 279 RQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVG 313 (517)
T ss_pred HHHHhcCccccCCCccceEEecCCcEEEEcCccee
Confidence 22234899999999999999999999999999865
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.37 E-value=2.1e-06 Score=96.79 Aligned_cols=189 Identities=15% Similarity=0.266 Sum_probs=127.0
Q ss_pred EEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEE--------EEeEeecCCeEEE
Q 003232 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVR--------FFYSFTCRENLYL 666 (837)
Q Consensus 595 kkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVk--------L~gsf~d~~~lyL 666 (837)
..||+|+.+.+|-.-.. ...+.|+|......-.. +... ++...-.||-+-. +++. .....+.+
T Consensus 17 r~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~~a---qk~a--~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~iGf 87 (637)
T COG4248 17 RPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAAQA---QKVA--ELAATPDAPLLNYRVAWPQATLHGG-RRGKVIGF 87 (637)
T ss_pred ccccCCccceeeecchh---hchhheeecCCCchHHH---HHHH--HhccCCCCcchhhhhcccHHHhhCC-CccceeEE
Confidence 56999999999965432 33577998765321111 1111 1122234553222 1111 11223678
Q ss_pred EEEecCCCC-HHHHH------HhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCcccc
Q 003232 667 VMEYLNGGD-LYSLL------RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 739 (837)
Q Consensus 667 VmEy~~GGS-L~dlL------k~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg 739 (837)
.|..+.|.. +..++ +......+..+....+.|+.+...||+.|.+-+|+.++|+|+.+++.++|.|-..-.+
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi- 166 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI- 166 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceee-
Confidence 888887652 22222 1123477888999999999999999999999999999999999999999998654321
Q ss_pred ccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhc-----CCCCCchHHHHHHHHHHHHHH
Q 003232 740 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-----GTGHGTTADWWSVGIILFELI 814 (837)
Q Consensus 740 ~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLl-----g~~~s~kSDIWSLGVILyELL 814 (837)
+. ........+|.+.|++||... +...+...|-|.||+++|++|
T Consensus 167 --~~-----------------------------ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL 215 (637)
T COG4248 167 --NA-----------------------------NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLL 215 (637)
T ss_pred --cc-----------------------------CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHH
Confidence 00 011234568999999999864 455677889999999999999
Q ss_pred cC-CCCCCCCC
Q 003232 815 VG-IPPFNAEH 824 (837)
Q Consensus 815 TG-r~PF~~~d 824 (837)
.| ++||.+..
T Consensus 216 ~ggrHPysGI~ 226 (637)
T COG4248 216 FGGRHPYSGIP 226 (637)
T ss_pred hcCCCCCCccc
Confidence 76 99998743
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.29 E-value=1.1e-05 Score=85.12 Aligned_cols=138 Identities=21% Similarity=0.304 Sum_probs=90.7
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHH------HHHHHHHHHhcCC---CceEEEEeEe-
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVES------ILAERDILISVRN---PFVVRFFYSF- 658 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~------~~rEieILk~LrH---PNIVkL~gsf- 658 (837)
.+|.+.+.+.......|.+.. .+|+.+++|..+......+..... ..+.+..+..++. -.+..++-+.
T Consensus 31 ~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 31 NNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred CCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 569999999999988888877 467899999987543222222211 1223333333322 2222222211
Q ss_pred ----ecCCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecC
Q 003232 659 ----TCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFG 734 (837)
Q Consensus 659 ----~d~~~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFG 734 (837)
.-....+++|||++|..|.++.. +++ .+...+..++.-||..|+.|+|.+|.|++++.+ .++++||+
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~~ 179 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDTQ 179 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEECc
Confidence 11234678999999988876532 222 234567788999999999999999999999754 59999998
Q ss_pred Ccc
Q 003232 735 LSK 737 (837)
Q Consensus 735 LAr 737 (837)
-.+
T Consensus 180 ~k~ 182 (229)
T PF06176_consen 180 GKR 182 (229)
T ss_pred ccc
Confidence 654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.28 E-value=6.1e-06 Score=88.14 Aligned_cols=136 Identities=24% Similarity=0.204 Sum_probs=94.7
Q ss_pred EEecccCceEEEEEEECCCCcEEEEEEecccccccHH-------------------HH--HHHHHHHHHHHhcC--CCce
Q 003232 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKN-------------------AV--ESILAERDILISVR--NPFV 651 (837)
Q Consensus 595 kkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e-------------------~i--e~~~rEieILk~Lr--HPNI 651 (837)
..|..|..+.||+|.. .++..+|+|+++........ .+ .=..+|+..|+++. +-.+
T Consensus 54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 4888999999999986 67899999999753321111 11 11234666666663 3445
Q ss_pred EEEEeEeecCCeEEEEEEecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCcEEEccCCcEE
Q 003232 652 VRFFYSFTCRENLYLVMEYLNGG-DLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIK 729 (837)
Q Consensus 652 VkL~gsf~d~~~lyLVmEy~~GG-SL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHS-kGIIHRDIKPeNILLd~dG~IK 729 (837)
++.+.+. .-.|||||+... .-.-.++. -++....+..+..++++.+.-|-. .|+||+||+.-|||+. ++.++
T Consensus 133 P~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~ 206 (268)
T COG1718 133 PEPIAFR----NNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPY 206 (268)
T ss_pred CCceeec----CCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEE
Confidence 5555543 347999999543 11111111 123333678888899999999887 9999999999999998 89999
Q ss_pred EEecCCcc
Q 003232 730 LTDFGLSK 737 (837)
Q Consensus 730 LiDFGLAr 737 (837)
++|||.+.
T Consensus 207 iID~~QaV 214 (268)
T COG1718 207 IIDVSQAV 214 (268)
T ss_pred EEECcccc
Confidence 99999886
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.1e-05 Score=84.47 Aligned_cols=138 Identities=16% Similarity=0.223 Sum_probs=99.5
Q ss_pred cccCceEEEEEEECCCCcEEEEEEec-ccc-ccc-HHHHHHHHHHHHHHHhcCCCc--eEEEEeEeec----CCeEEEEE
Q 003232 598 SRGAFGRVFLAKKRTTGDLFAIKVLK-KAD-MIR-KNAVESILAERDILISVRNPF--VVRFFYSFTC----RENLYLVM 668 (837)
Q Consensus 598 GsG~FGtVYkArdk~tG~~VAVKIik-k~~-~~~-~e~ie~~~rEieILk~LrHPN--IVkL~gsf~d----~~~lyLVm 668 (837)
|.||-|.|++.... |..+-+|.-. ... ... +.....+.+|+..++.+..-+ ++++...-.. ....+||+
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 56888899987753 4467777653 100 000 223456889999998886433 4444311111 23478999
Q ss_pred EecCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCc--EEEEecCCcc
Q 003232 669 EYLNG-GDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGH--IKLTDFGLSK 737 (837)
Q Consensus 669 Ey~~G-GSL~dlLk~~--g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~--IKLiDFGLAr 737 (837)
|-+.| .+|.+++... .+.+......++.+++..|.-||..|+.|+|+.+.|||++.+|. +.++||.-++
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 98865 5899888663 34677788899999999999999999999999999999987777 9999998765
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.18 E-value=2.6e-05 Score=77.40 Aligned_cols=138 Identities=26% Similarity=0.375 Sum_probs=82.5
Q ss_pred EEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCC--ceEEEEeEe---ecCCeEEEEE
Q 003232 594 IKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP--FVVRFFYSF---TCRENLYLVM 668 (837)
Q Consensus 594 lkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHP--NIVkL~gsf---~d~~~lyLVm 668 (837)
++.|+.|..+.||++.... ..+++|+.... .....+.+|..+++.+... .+.+++... ......+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 5789999999999999743 58999997653 3345677888888777432 345555533 2234579999
Q ss_pred EecCCCCHHH----------------HHH---hc----CCCCHHH------HHHH---------------HHHHHH-HHH
Q 003232 669 EYLNGGDLYS----------------LLR---NL----GCLDEDV------ARVY---------------IAEVVL-ALE 703 (837)
Q Consensus 669 Ey~~GGSL~d----------------lLk---~~----g~Lsee~------irkI---------------l~QIa~-ALs 703 (837)
++++|..+.. .+. .. ..+.... .... ...+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999988777 111 11 0001000 0000 111222 333
Q ss_pred HHHh-------CCcccccCCCCcEEEc-cCCcEEEEecCCccc
Q 003232 704 YLHS-------LRVVHRDLKPDNLLIA-HDGHIKLTDFGLSKV 738 (837)
Q Consensus 704 YLHS-------kGIIHRDIKPeNILLd-~dG~IKLiDFGLArv 738 (837)
.++. ..++|+|+.|.|||++ .++.+.|+||+.+..
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 3332 4599999999999999 566678999998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.14 E-value=2.6e-05 Score=81.43 Aligned_cols=134 Identities=16% Similarity=0.110 Sum_probs=83.7
Q ss_pred EEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCc--eEEEEeEeecCCeEEEEEEecC
Q 003232 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF--VVRFFYSFTCRENLYLVMEYLN 672 (837)
Q Consensus 595 kkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPN--IVkL~gsf~d~~~lyLVmEy~~ 672 (837)
..||.|..+.||+. .+..+++|+..... ....+.+|.++++.+..-. +.+++.+....+..++|||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 67899999999973 24568899987532 1234678999998886433 4667777777777889999999
Q ss_pred CCC-HH--------------HHH-------Hhc--CCCCHHHH-HHHHHH----------HHH-HHHHHH----hCCccc
Q 003232 673 GGD-LY--------------SLL-------RNL--GCLDEDVA-RVYIAE----------VVL-ALEYLH----SLRVVH 712 (837)
Q Consensus 673 GGS-L~--------------dlL-------k~~--g~Lsee~i-rkIl~Q----------Ia~-ALsYLH----SkGIIH 712 (837)
|.. +. ..+ +.. ........ ..+..+ +.. ...+|. ...++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 863 21 111 110 00111110 011000 111 122222 124789
Q ss_pred ccCCCCcEEEccCCcEEEEecCCccc
Q 003232 713 RDLKPDNLLIAHDGHIKLTDFGLSKV 738 (837)
Q Consensus 713 RDIKPeNILLd~dG~IKLiDFGLArv 738 (837)
+|+.|.||+++.++ +.++||+.+..
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcCc
Confidence 99999999999888 99999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.03 E-value=5.9e-05 Score=77.90 Aligned_cols=135 Identities=18% Similarity=0.133 Sum_probs=83.1
Q ss_pred EecccCc-eEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcC-CCceEEEEeEeecCCeEEEEEEecCC
Q 003232 596 PISRGAF-GRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCRENLYLVMEYLNG 673 (837)
Q Consensus 596 kLGsG~F-GtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~Lr-HPNIVkL~gsf~d~~~lyLVmEy~~G 673 (837)
.|..|.+ +.||++... +..+++|+..... ...+.+|+.+++.+. +--+.+++.........++|||+++|
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 76 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG 76 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence 4555666 789998753 4678899876532 224567888887773 34466777776666678999999999
Q ss_pred CCHHHHH----------------HhcCCCCH-----H-HHHHHHHH-----------------------HHHHHHHHH--
Q 003232 674 GDLYSLL----------------RNLGCLDE-----D-VARVYIAE-----------------------VVLALEYLH-- 706 (837)
Q Consensus 674 GSL~dlL----------------k~~g~Lse-----e-~irkIl~Q-----------------------Ia~ALsYLH-- 706 (837)
.+|.... ..-..++. . .....+.+ +...+..|-
T Consensus 77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 156 (244)
T cd05150 77 VPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEAT 156 (244)
T ss_pred ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhh
Confidence 8776431 10000100 0 00000000 111122221
Q ss_pred -----hCCcccccCCCCcEEEccCCcEEEEecCCccc
Q 003232 707 -----SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (837)
Q Consensus 707 -----SkGIIHRDIKPeNILLd~dG~IKLiDFGLArv 738 (837)
...++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 157 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 157 RPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 23489999999999999877788999998864
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00013 Score=85.37 Aligned_cols=137 Identities=23% Similarity=0.319 Sum_probs=85.8
Q ss_pred EEecccCceEEEEEEECCCCcEEEEEEeccccccc----------------------------HHHHH------HHHHHH
Q 003232 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIR----------------------------KNAVE------SILAER 640 (837)
Q Consensus 595 kkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~----------------------------~e~ie------~~~rEi 640 (837)
+.||..+.|.||+|+.+. |+.||||+-++.-... .+..+ .|.+|.
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 679999999999999965 9999999976521000 00111 223333
Q ss_pred HHHHh----cCCCc------eEEEEeEeecCCeEEEEEEecCCCCHHHH--HHhcCCCCHHHHHHHHHHHHHHHHH-HHh
Q 003232 641 DILIS----VRNPF------VVRFFYSFTCRENLYLVMEYLNGGDLYSL--LRNLGCLDEDVARVYIAEVVLALEY-LHS 707 (837)
Q Consensus 641 eILk~----LrHPN------IVkL~gsf~d~~~lyLVmEy~~GGSL~dl--Lk~~g~Lsee~irkIl~QIa~ALsY-LHS 707 (837)
+...+ +.|-+ |+++|.. ....-.|+|||++|..+.+. +.+.+ ++...+. ..+.++... |=.
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~~g-i~~~~i~---~~l~~~~~~qIf~ 319 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDKRG-ISPHDIL---NKLVEAYLEQIFK 319 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHHcC-CCHHHHH---HHHHHHHHHHHHh
Confidence 33322 23433 4444433 33467899999999877655 34433 4444332 222222111 224
Q ss_pred CCcccccCCCCcEEEcc----CCcEEEEecCCccc
Q 003232 708 LRVVHRDLKPDNLLIAH----DGHIKLTDFGLSKV 738 (837)
Q Consensus 708 kGIIHRDIKPeNILLd~----dG~IKLiDFGLArv 738 (837)
.|++|+|-+|.||+++. ++.+.+.|||+...
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~ 354 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAV 354 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEccccccc
Confidence 78999999999999984 66899999999763
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00028 Score=86.38 Aligned_cols=144 Identities=18% Similarity=0.349 Sum_probs=90.2
Q ss_pred EEEecccCceEEEEEEECCCC--cEEEEEEecccccccHHHHHHHHHHHHHHHhcC-CCce--EEEEeEeecC---CeEE
Q 003232 594 IKPISRGAFGRVFLAKKRTTG--DLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFV--VRFFYSFTCR---ENLY 665 (837)
Q Consensus 594 lkkLGsG~FGtVYkArdk~tG--~~VAVKIikk~~~~~~e~ie~~~rEieILk~Lr-HPNI--VkL~gsf~d~---~~ly 665 (837)
++.|+.|.+..+|+......+ ..+++|+........ ....+.+|.++++.+. |+++ ++++..+.+. +..|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~--~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ--SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc--cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 577899999999998875432 467888765432111 1236779999999885 6654 6777766553 4678
Q ss_pred EEEEecCCCCHHH--------------------HHH---hcC----------C---CCHHHHHHHHH-------------
Q 003232 666 LVMEYLNGGDLYS--------------------LLR---NLG----------C---LDEDVARVYIA------------- 696 (837)
Q Consensus 666 LVmEy~~GGSL~d--------------------lLk---~~g----------~---Lsee~irkIl~------------- 696 (837)
+||||++|..+.+ .+. ... . ....++..+..
T Consensus 121 lVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~ 200 (822)
T PLN02876 121 YIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPR 200 (822)
T ss_pred EEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCC
Confidence 9999998864311 111 100 0 00112222211
Q ss_pred --HHHHHHHHHHh-----------CCcccccCCCCcEEEccC-Cc-EEEEecCCcccc
Q 003232 697 --EVVLALEYLHS-----------LRVVHRDLKPDNLLIAHD-GH-IKLTDFGLSKVG 739 (837)
Q Consensus 697 --QIa~ALsYLHS-----------kGIIHRDIKPeNILLd~d-G~-IKLiDFGLArvg 739 (837)
.+...+.+|.. ..+||+|+++.|||++.+ +. +-|.||.++.++
T Consensus 201 ~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 201 NPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred ChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 12334566642 249999999999999753 33 579999998764
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00033 Score=73.14 Aligned_cols=128 Identities=23% Similarity=0.347 Sum_probs=92.4
Q ss_pred CCeEEEEEecccCc-eEEEEEEECCCCcEEEEEEecc---cc-------ccc--------HHHHHHHHHHHHHHHhcC--
Q 003232 589 DDFEIIKPISRGAF-GRVFLAKKRTTGDLFAIKVLKK---AD-------MIR--------KNAVESILAERDILISVR-- 647 (837)
Q Consensus 589 ddYeIlkkLGsG~F-GtVYkArdk~tG~~VAVKIikk---~~-------~~~--------~e~ie~~~rEieILk~Lr-- 647 (837)
.+++.++.||.|.- |.||+++. .|+.||||++.. .. ... ......|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 67999999999999 99999996 588999999321 10 000 133457888999887775
Q ss_pred -CCce--EEEEeEeecC------------------CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 003232 648 -NPFV--VRFFYSFTCR------------------ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLH 706 (837)
Q Consensus 648 -HPNI--VkL~gsf~d~------------------~~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLH 706 (837)
+.++ ++++++..-. ....||.||+.... .++.. -+.+|++-|..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~----~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIR----DIPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchh----HHHHHHHHHHHHH
Confidence 4455 8888877432 12468888876533 22322 3457777888899
Q ss_pred hCCcccccCCCCcEEEccCCcEEEEecCCc
Q 003232 707 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLS 736 (837)
Q Consensus 707 SkGIIHRDIKPeNILLd~dG~IKLiDFGLA 736 (837)
..||+-+|+++.|.. .-+|+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc-----CCEEEecccC
Confidence 999999999999986 3478999864
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.66 E-value=1.1e-05 Score=95.27 Aligned_cols=107 Identities=25% Similarity=0.441 Sum_probs=77.4
Q ss_pred HHHHHHHHHHHh-CCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhh
Q 003232 696 AEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQER 774 (837)
Q Consensus 696 ~QIa~ALsYLHS-kGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~ 774 (837)
.+++.||.|+|. .++||++|.|++|.++.+|..||+.|+++...... ++ +. ...+. +.
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~-~~-~p------~~~yd---~~---------- 164 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGP-TE-YP------FSEYD---PP---------- 164 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCC-Cc-cc------cccCC---CC----------
Confidence 355599999996 79999999999999999999999999987631111 10 10 00000 00
Q ss_pred hhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHH-cCCCCCCCCC
Q 003232 775 RKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI-VGIPPFNAEH 824 (837)
Q Consensus 775 ~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELL-TGr~PF~~~d 824 (837)
......-...|.|||++.+...+.++|+|||||++|.+. .|+..|.+..
T Consensus 165 -lp~~~~~~~~f~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~ 214 (700)
T KOG2137|consen 165 -LPLLLQPHLNFLAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANG 214 (700)
T ss_pred -CChhhccCcccccchhhccccccccccceeeeeEEEEEecCCcchhhccC
Confidence 001122345799999999988899999999999999999 6776666553
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.65 E-value=4.3e-06 Score=97.92 Aligned_cols=200 Identities=24% Similarity=0.284 Sum_probs=138.3
Q ss_pred CCCCCCCCCCcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCc-eEEE
Q 003232 576 TSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF-VVRF 654 (837)
Q Consensus 576 ss~~~P~k~g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPN-IVkL 654 (837)
.+.|.|........-|...+.+++|+++.+++.+...+...+ .+.+... ....-++++|.+++||| .+..
T Consensus 229 kS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~ 299 (829)
T KOG0576|consen 229 KSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRY 299 (829)
T ss_pred ccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccc
Confidence 445555555555555777778899999999998865443333 4444332 34556788999999999 7777
Q ss_pred EeEeecCCeEEEEEEecCCC-CHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEe
Q 003232 655 FYSFTCRENLYLVMEYLNGG-DLYSLL-RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTD 732 (837)
Q Consensus 655 ~gsf~d~~~lyLVmEy~~GG-SL~dlL-k~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiD 732 (837)
++.+..+.+.+++|+++.++ +..... ...-.+...+...+.+.-+++|+++|+.-=+|+| ||+..+ +..++.|
T Consensus 300 ~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~ 374 (829)
T KOG0576|consen 300 LEDYDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLD 374 (829)
T ss_pred cccCCcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-ccccccc
Confidence 78888888999999999876 222111 1111123334445566677899999988778888 777644 7788889
Q ss_pred cCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHH
Q 003232 733 FGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFE 812 (837)
Q Consensus 733 FGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyE 812 (837)
|+..... . . ....+...+|+.++|||+.....+....|.|++|+--.+
T Consensus 375 ~~v~~~L--------~--~----------------------~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~ 422 (829)
T KOG0576|consen 375 FAVPPQL--------T--R----------------------TMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQ 422 (829)
T ss_pred ccCCccc--------C--c----------------------ccccccCCCCCCCCCchhhcccccccCCCccCCCcchhh
Confidence 9875410 0 0 002356789999999999999999999999999986666
Q ss_pred HHcCCCCCC
Q 003232 813 LIVGIPPFN 821 (837)
Q Consensus 813 LLTGr~PF~ 821 (837)
+--|-+|-.
T Consensus 423 ~ap~~pPr~ 431 (829)
T KOG0576|consen 423 MAPGLPPRS 431 (829)
T ss_pred cCCCCCCCC
Confidence 666666643
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00025 Score=73.33 Aligned_cols=72 Identities=17% Similarity=0.163 Sum_probs=45.1
Q ss_pred EEecccCce-EEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCC---ceEEEEeEeecC---CeEEEE
Q 003232 595 KPISRGAFG-RVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP---FVVRFFYSFTCR---ENLYLV 667 (837)
Q Consensus 595 kkLGsG~FG-tVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHP---NIVkL~gsf~d~---~~lyLV 667 (837)
+.|+.|+.. .||+. +..+++|+.+... ....+.+|..++..+... -+.+++...... ...|++
T Consensus 3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~~-----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l 72 (235)
T cd05155 3 EPVDSGGTDNATFRL-----GDDMSVRLPSAAG-----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV 72 (235)
T ss_pred eeccCCCcccceEEc-----CCceEEEcCCccc-----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence 567777776 58875 2357888765421 234678899998877531 344444433322 245889
Q ss_pred EEecCCCCH
Q 003232 668 MEYLNGGDL 676 (837)
Q Consensus 668 mEy~~GGSL 676 (837)
|++++|.++
T Consensus 73 ~~~i~G~~l 81 (235)
T cd05155 73 YRWLEGETA 81 (235)
T ss_pred EEeecCCCC
Confidence 999998665
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00043 Score=71.25 Aligned_cols=130 Identities=22% Similarity=0.331 Sum_probs=92.0
Q ss_pred eEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceE-EEEeEeecCCeEEEEEE
Q 003232 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVV-RFFYSFTCRENLYLVME 669 (837)
Q Consensus 591 YeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIV-kL~gsf~d~~~lyLVmE 669 (837)
.++.+.|++|.+|.||++.+. |..+|+|+-+.+. ....+..|.++|..++..++. ++|.+. ..++.||
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me 92 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRME 92 (201)
T ss_pred hhhhhhhhcccccEEEEeecc--CceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhh
Confidence 456688999999999999985 6699999987653 234678899999998876654 333332 2345599
Q ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCC-CCcEEEccCCcEEEEecCCccc
Q 003232 670 YLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLK-PDNLLIAHDGHIKLTDFGLSKV 738 (837)
Q Consensus 670 y~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIK-PeNILLd~dG~IKLiDFGLArv 738 (837)
|+.|-.|...-... +.. -+..++..---|-..||-|+.|+ |..+++..++.+.|+||..|++
T Consensus 93 ~i~G~~L~~~~~~~---~rk----~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 93 YIDGRPLGKLEIGG---DRK----HLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhcCcchhhhhhcc---cHH----HHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 99998887765431 222 23345555444667899999986 4445555666999999999874
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.0017 Score=66.59 Aligned_cols=75 Identities=15% Similarity=0.239 Sum_probs=47.9
Q ss_pred EEEecccCceEEEEEEECC-CCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCC-CceEEEEeEeecCCeEEEEEEec
Q 003232 594 IKPISRGAFGRVFLAKKRT-TGDLFAIKVLKKADMIRKNAVESILAERDILISVRN-PFVVRFFYSFTCRENLYLVMEYL 671 (837)
Q Consensus 594 lkkLGsG~FGtVYkArdk~-tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrH-PNIVkL~gsf~d~~~lyLVmEy~ 671 (837)
++.|..|-...+|++.... .+..|++|++..... ..-...+|..+++.+.. ...++++..+. -.++|||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~----~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE----LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc----ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEee
Confidence 4677888888999997533 357899998764321 11123468888877743 23445544332 14799999
Q ss_pred CCCCH
Q 003232 672 NGGDL 676 (837)
Q Consensus 672 ~GGSL 676 (837)
+|.++
T Consensus 75 ~G~~l 79 (235)
T cd05157 75 PGRTL 79 (235)
T ss_pred CCCcC
Confidence 98665
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0027 Score=65.88 Aligned_cols=133 Identities=23% Similarity=0.276 Sum_probs=94.8
Q ss_pred EEecccCceEEEEEEECCCCcEEEEEEeccccc-------------ccHHHHHHHHHHHHHHHhcC------CCceEEEE
Q 003232 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADM-------------IRKNAVESILAERDILISVR------NPFVVRFF 655 (837)
Q Consensus 595 kkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~-------------~~~e~ie~~~rEieILk~Lr------HPNIVkL~ 655 (837)
..||.|+.=.||.-- .+....||+..+... .......+..+|+.....+. +.+|.+++
T Consensus 7 ~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 568999999999543 345678999876540 01123456667777766665 67899999
Q ss_pred eEeecCCeEEEEEEecCC------CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCC---
Q 003232 656 YSFTCRENLYLVMEYLNG------GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG--- 726 (837)
Q Consensus 656 gsf~d~~~lyLVmEy~~G------GSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG--- 726 (837)
|....+..+.+|+|.+.+ .+|.+++.. +.++. .... .+-.-..||-..+|+.+|++|.||++...+
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~~~---~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~ 158 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-ELRQ---ALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE 158 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HHHH---HHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence 999999899999998743 468888855 44555 3333 334455678899999999999999996432
Q ss_pred -cEEEEe-cCC
Q 003232 727 -HIKLTD-FGL 735 (837)
Q Consensus 727 -~IKLiD-FGL 735 (837)
.++|+| ||.
T Consensus 159 ~~lvlIDG~G~ 169 (199)
T PF10707_consen 159 FRLVLIDGLGE 169 (199)
T ss_pred eEEEEEeCCCC
Confidence 577887 443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0062 Score=69.44 Aligned_cols=80 Identities=18% Similarity=0.119 Sum_probs=54.6
Q ss_pred EEEecccCceEEEEEEECCCCcEEEEEEeccccc---cc-HHHHHHHHHHHHHHHhcC---CCceEEEEeEeecCCeEEE
Q 003232 594 IKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADM---IR-KNAVESILAERDILISVR---NPFVVRFFYSFTCRENLYL 666 (837)
Q Consensus 594 lkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~---~~-~e~ie~~~rEieILk~Lr---HPNIVkL~gsf~d~~~lyL 666 (837)
.+.||.|.+..||++.....++.++||.-.+-.. .. ....++...|.+.|+.+. ..++++++.+ +....++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 3679999999999999854335899998542110 00 123457778888887763 2467777765 4466789
Q ss_pred EEEecCCCC
Q 003232 667 VMEYLNGGD 675 (837)
Q Consensus 667 VmEy~~GGS 675 (837)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999997643
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0017 Score=73.35 Aligned_cols=140 Identities=29% Similarity=0.291 Sum_probs=94.7
Q ss_pred EEEEecccCceEEEEEEECCCCcEEEEEEecccccc---------------------cHHHHHH--HHHHHHHHHhcCCC
Q 003232 593 IIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMI---------------------RKNAVES--ILAERDILISVRNP 649 (837)
Q Consensus 593 IlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~---------------------~~e~ie~--~~rEieILk~LrHP 649 (837)
+-..|..|.-+-||.|.. .+|..+|||+|+..-+. ++..+-. ...|++.|++++..
T Consensus 148 inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 446789999999999986 68889999998742211 1111112 23467777888765
Q ss_pred ceEEEEeEeecCCeEEEEEEecCCCC-HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCcccccCCCCcEEEccCCc
Q 003232 650 FVVRFFYSFTCRENLYLVMEYLNGGD-LYSLLRNLGCLDEDVARVYIAEVVLALEYLH-SLRVVHRDLKPDNLLIAHDGH 727 (837)
Q Consensus 650 NIVkL~gsf~d~~~lyLVmEy~~GGS-L~dlLk~~g~Lsee~irkIl~QIa~ALsYLH-SkGIIHRDIKPeNILLd~dG~ 727 (837)
.|...--+.. ..-.|||+|+.... ..-.++ .-.++...+..+-.|++.-+.-|. .+++||.||+--|+|+ .+|.
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPkLK-d~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~ 302 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPKLK-DASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGK 302 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCCCcCcccc-cccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCE
Confidence 5443222211 23479999995321 111222 234666777888788888777776 5899999999999999 6789
Q ss_pred EEEEecCCcc
Q 003232 728 IKLTDFGLSK 737 (837)
Q Consensus 728 IKLiDFGLAr 737 (837)
++++|-+.+.
T Consensus 303 lyiIDVSQSV 312 (520)
T KOG2270|consen 303 LYIIDVSQSV 312 (520)
T ss_pred EEEEEccccc
Confidence 9999998765
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.0023 Score=66.99 Aligned_cols=132 Identities=20% Similarity=0.213 Sum_probs=75.3
Q ss_pred ecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCce-EEEEeEeecCCeEEEEEEecCCCC
Q 003232 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFV-VRFFYSFTCRENLYLVMEYLNGGD 675 (837)
Q Consensus 597 LGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNI-VkL~gsf~d~~~lyLVmEy~~GGS 675 (837)
+..|-...+|+.. .+++.+++|+....... ..-...+|..+++.+....+ .+++.... -++||||++|..
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~---~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~ 74 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKA---LGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEV 74 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCccccc---ccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcc
Confidence 4567778899887 45678889986543211 00124568888887754322 33443322 368999999865
Q ss_pred HHH--------------HHHh---cC----CCCH-HHHHHHHHHH---------HHHHHHHHh--------CCcccccCC
Q 003232 676 LYS--------------LLRN---LG----CLDE-DVARVYIAEV---------VLALEYLHS--------LRVVHRDLK 716 (837)
Q Consensus 676 L~d--------------lLk~---~g----~Lse-e~irkIl~QI---------a~ALsYLHS--------kGIIHRDIK 716 (837)
+.. .+.+ .. +++. ..+..+..++ ...+..+-. ..++|+|+.
T Consensus 75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~ 154 (256)
T TIGR02721 75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH 154 (256)
T ss_pred cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence 431 1111 11 1111 1122222111 111222221 258999999
Q ss_pred CCcEEEccCCcEEEEecCCccc
Q 003232 717 PDNLLIAHDGHIKLTDFGLSKV 738 (837)
Q Consensus 717 PeNILLd~dG~IKLiDFGLArv 738 (837)
|.||+++.++ +.|+||..+..
T Consensus 155 ~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 155 AYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred cCcEEEeCCC-CEEEeccccCc
Confidence 9999998877 78999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.0005 Score=76.37 Aligned_cols=136 Identities=15% Similarity=0.157 Sum_probs=95.3
Q ss_pred eEEEEEecccCceEEEEEEECCCCcEEEEEEecccc-----------------cccHH--HHHHHHHHHHHHHhcCCC--
Q 003232 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKAD-----------------MIRKN--AVESILAERDILISVRNP-- 649 (837)
Q Consensus 591 YeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~-----------------~~~~e--~ie~~~rEieILk~LrHP-- 649 (837)
+.+...||-|.-+.||.+-+ ..|.+.++|+-+-.. ...+. ..-...+|+..|+.|...
T Consensus 94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 66778899999999999988 678899999732111 00111 123456678888777532
Q ss_pred ceEEEEeEeecCCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEE
Q 003232 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIK 729 (837)
Q Consensus 650 NIVkL~gsf~d~~~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IK 729 (837)
-+++.++. +..|+|||++.|..|.+.-+- .+ +..+...++.-+.-|...|+||+|..--||+++.++.++
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v---~d---~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~ 242 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHV---ED---PPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV 242 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeeec---CC---hHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence 24444433 557899999998877765321 11 223444555666678889999999999999999999999
Q ss_pred EEecCCcc
Q 003232 730 LTDFGLSK 737 (837)
Q Consensus 730 LiDFGLAr 737 (837)
++||-.+.
T Consensus 243 vIDFPQmv 250 (465)
T KOG2268|consen 243 VIDFPQMV 250 (465)
T ss_pred EeechHhh
Confidence 99998654
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.0085 Score=63.64 Aligned_cols=137 Identities=19% Similarity=0.173 Sum_probs=81.4
Q ss_pred EEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCC--ceEEEEeE------eecCCeEE
Q 003232 594 IKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP--FVVRFFYS------FTCRENLY 665 (837)
Q Consensus 594 lkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHP--NIVkL~gs------f~d~~~ly 665 (837)
++.|..|....+|++.. .+..+++|++... . ...+..|+.++..+.+- .+++++.. ....+..+
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~---~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKV---S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCCC---C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 46677788789999874 3457899988641 1 13455677777666432 24444331 12245678
Q ss_pred EEEEecCCCCHHH--------H---H---Hhc-CCCCH--------HHHH------------HHHHHHHHHHHHHHh---
Q 003232 666 LVMEYLNGGDLYS--------L---L---RNL-GCLDE--------DVAR------------VYIAEVVLALEYLHS--- 707 (837)
Q Consensus 666 LVmEy~~GGSL~d--------l---L---k~~-g~Lse--------e~ir------------kIl~QIa~ALsYLHS--- 707 (837)
+|++|++|..+.. + + +.. ..+.. .... .....+..++.++..
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999999866421 1 1 100 00000 0000 011112334444443
Q ss_pred ----CCcccccCCCCcEEEccCCcEEEEecCCccc
Q 003232 708 ----LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (837)
Q Consensus 708 ----kGIIHRDIKPeNILLd~dG~IKLiDFGLArv 738 (837)
.+++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4799999999999999877778999998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.0026 Score=65.06 Aligned_cols=98 Identities=23% Similarity=0.259 Sum_probs=78.2
Q ss_pred HHHHHHHHhcCC-CceEEEEeEeecCCeEEEEEEecCCCCHHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHh---CC
Q 003232 637 LAERDILISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSL---LRNLGCLDEDVARVYIAEVVLALEYLHS---LR 709 (837)
Q Consensus 637 ~rEieILk~LrH-PNIVkL~gsf~d~~~lyLVmEy~~GGSL~dl---Lk~~g~Lsee~irkIl~QIa~ALsYLHS---kG 709 (837)
.+|.-+++.+++ +++++++|++- -++|+||+..+++... +...-..++.....++.++++.+.+|+. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 457888888876 69999999974 3679999987766421 1111235788899999999999999997 34
Q ss_pred cccccCCCCcEEEccCCcEEEEecCCccc
Q 003232 710 VVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (837)
Q Consensus 710 IIHRDIKPeNILLd~dG~IKLiDFGLArv 738 (837)
+.-.|++|+|+-++.+|.+|++|......
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 77799999999999999999999997653
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.011 Score=64.14 Aligned_cols=77 Identities=13% Similarity=0.050 Sum_probs=54.6
Q ss_pred EEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCC---CceEEEEeEeec---CCeEEE
Q 003232 593 IIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN---PFVVRFFYSFTC---RENLYL 666 (837)
Q Consensus 593 IlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrH---PNIVkL~gsf~d---~~~lyL 666 (837)
-.+.||.|..+.||+... .++ .+.+|..+... ....+.+|...|+.+.. ..++++++.+.. .+..+|
T Consensus 18 ~~~~i~~G~~~~vy~~~~-~~~-~~~~k~~~~~~-----~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L 90 (297)
T PRK10593 18 RVECISEQPYAALWALYD-SQG-NPMPLMARSFS-----TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL 90 (297)
T ss_pred eeeecCCccceeEEEEEc-CCC-CEEEEEecccc-----cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence 357799999999999875 233 47778754310 12367889999888753 357778876654 356899
Q ss_pred EEEecCCCCH
Q 003232 667 VMEYLNGGDL 676 (837)
Q Consensus 667 VmEy~~GGSL 676 (837)
|||+++|.++
T Consensus 91 VmE~i~G~~~ 100 (297)
T PRK10593 91 LLERLRGVSV 100 (297)
T ss_pred EEeccCCEec
Confidence 9999998754
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.028 Score=60.58 Aligned_cols=31 Identities=32% Similarity=0.358 Sum_probs=26.4
Q ss_pred CCcccccCCCCcEEEccCCcEEEEecCCccc
Q 003232 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (837)
Q Consensus 708 kGIIHRDIKPeNILLd~dG~IKLiDFGLArv 738 (837)
.|+||+|+.|.||+++.+...-|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 4899999999999998665568999998763
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.028 Score=60.62 Aligned_cols=141 Identities=21% Similarity=0.216 Sum_probs=81.0
Q ss_pred eEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCC--ceEEEEeEe------ecCC
Q 003232 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP--FVVRFFYSF------TCRE 662 (837)
Q Consensus 591 YeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHP--NIVkL~gsf------~d~~ 662 (837)
...++.++.|....+|++.. . +..+++|++.... .. ..+..|..++..|... .+++++... ...+
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t-~-~~~~vLK~~~~~~--~~---~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g 96 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTT-D-VGRYILTLYEKRV--KA---EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAG 96 (307)
T ss_pred ceeccccCCccccceEEEEe-C-CCcEEEEEecCCC--CH---HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCC
Confidence 33456677887789998874 3 3468899876521 11 2344556666665321 234443311 1245
Q ss_pred eEEEEEEecCCCCHH-----------HHH---Hhc-CCC--------CHHH----HH-----------HHHHHHHHHHHH
Q 003232 663 NLYLVMEYLNGGDLY-----------SLL---RNL-GCL--------DEDV----AR-----------VYIAEVVLALEY 704 (837)
Q Consensus 663 ~lyLVmEy~~GGSL~-----------dlL---k~~-g~L--------see~----ir-----------kIl~QIa~ALsY 704 (837)
..+++|+|++|..+. ..+ +.. ..+ .... .. .....+...+++
T Consensus 97 ~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~ 176 (307)
T TIGR00938 97 KPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDY 176 (307)
T ss_pred eEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHH
Confidence 678999999885421 111 110 001 0000 00 001123345555
Q ss_pred HH-------hCCcccccCCCCcEEEccCCcEEEEecCCccc
Q 003232 705 LH-------SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (837)
Q Consensus 705 LH-------SkGIIHRDIKPeNILLd~dG~IKLiDFGLArv 738 (837)
+. ..+++|+|+++.||+++.++...|+||+.+..
T Consensus 177 l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 177 LDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred HHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 54 26899999999999999888778999998763
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.009 Score=63.86 Aligned_cols=75 Identities=12% Similarity=0.111 Sum_probs=47.0
Q ss_pred EEEecccCceEEEEEEECC------CCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCc-eEEEEeEeecCCeEEE
Q 003232 594 IKPISRGAFGRVFLAKKRT------TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF-VVRFFYSFTCRENLYL 666 (837)
Q Consensus 594 lkkLGsG~FGtVYkArdk~------tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPN-IVkL~gsf~d~~~lyL 666 (837)
++.|..|-...+|++.... .++.+++|++.... .......+|..++..+.... ..+++..+.. .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFPN----GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence 3556667777899887533 25789999976532 11234567777777774322 3345554432 35
Q ss_pred EEEecCCCCH
Q 003232 667 VMEYLNGGDL 676 (837)
Q Consensus 667 VmEy~~GGSL 676 (837)
|+||++|..+
T Consensus 75 v~e~i~G~~l 84 (302)
T cd05156 75 IEEFIPSRTL 84 (302)
T ss_pred hhheeCCCcC
Confidence 8999988665
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.04 Score=69.43 Aligned_cols=191 Identities=21% Similarity=0.223 Sum_probs=121.9
Q ss_pred ecccCceEEEEEEECCCCc----EEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeE----EEEE
Q 003232 597 ISRGAFGRVFLAKKRTTGD----LFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL----YLVM 668 (837)
Q Consensus 597 LGsG~FGtVYkArdk~tG~----~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~l----yLVm 668 (837)
|..-.+|++++..+...-+ ++-++.-.......+..+.....|...+....|+|++.++.+....... .+..
T Consensus 186 ls~~~~~~l~l~k~~~~~qs~~~~~~~s~~~~~~~~~k~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~ 265 (1351)
T KOG1035|consen 186 LSHLTQGTLLLVKWVEQAQSLSEPIEISHDYESTPCGKKEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQ 265 (1351)
T ss_pred eccccCceEEEEehhhhHHhhcCcccccCcccCccchHHHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHH
Confidence 6677788888877632111 1111100000001123334455677778889999999998877655433 3456
Q ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCC---cEEEccCCcEEEE--ecCCccccccCC
Q 003232 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPD---NLLIAHDGHIKLT--DFGLSKVGLINS 743 (837)
Q Consensus 669 Ey~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPe---NILLd~dG~IKLi--DFGLArvg~~~s 743 (837)
+++..-++...+...+..+...++.+..++..||.|+|+....|.-+..+ +...+..+..... ||+..+......
T Consensus 266 ~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~ 345 (1351)
T KOG1035|consen 266 EICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNE 345 (1351)
T ss_pred hhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccceeEEecccccccccCccceeecchhhhcccccCCCcc
Confidence 78888899999888888999999999999999999999986555544444 3333444555555 777654211111
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCch--HHHHHHHHHHHHHHcCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT--ADWWSVGIILFELIVGIPP 819 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~k--SDIWSLGVILyELLTGr~P 819 (837)
. .....-+..|.+||.........+ .|+|.+|..+..+..|..+
T Consensus 346 ~--------------------------------~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i 391 (1351)
T KOG1035|consen 346 K--------------------------------SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDI 391 (1351)
T ss_pred c--------------------------------chhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcc
Confidence 1 111223445778888776666544 6999999999999887654
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.32 E-value=0.022 Score=61.50 Aligned_cols=30 Identities=40% Similarity=0.633 Sum_probs=25.6
Q ss_pred CcccccCCCCcEEEccCCc-EEEEecCCccc
Q 003232 709 RVVHRDLKPDNLLIAHDGH-IKLTDFGLSKV 738 (837)
Q Consensus 709 GIIHRDIKPeNILLd~dG~-IKLiDFGLArv 738 (837)
.++|+|++|.|||++.++. .-|+||+.+.+
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999987565 46999998875
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.32 E-value=0.00078 Score=85.46 Aligned_cols=198 Identities=21% Similarity=0.168 Sum_probs=132.0
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCc-EEEEEEecccccc--cHHHHHHHHHHHHHHHhcCCCceEEEEeEeecC--Ce
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGD-LFAIKVLKKADMI--RKNAVESILAERDILISVRNPFVVRFFYSFTCR--EN 663 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~-~VAVKIikk~~~~--~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~--~~ 663 (837)
..|++.--++.|.+ +++.+..... -+-+|+++.-... .+-..+....|+..++...|+++...+.-.... ..
T Consensus 1229 e~~EV~l~i~~~~~---~R~k~Lr~kid~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~e 1305 (2724)
T KOG1826|consen 1229 EHSEVNLGISNHFH---FRNKWLRSKIDWFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTE 1305 (2724)
T ss_pred hhhheeeeccccee---eccchHhhhhceeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChH
Confidence 34555444444443 3444432221 2355665543221 122234556666667778999988776554433 34
Q ss_pred EEEEEEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-C----cccccCCCCcEEEccCCcEEEEecC
Q 003232 664 LYLVMEYLNGGDLYSLLRNL----GCLDEDVARVYIAEVVLALEYLHSL-R----VVHRDLKPDNLLIAHDGHIKLTDFG 734 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk~~----g~Lsee~irkIl~QIa~ALsYLHSk-G----IIHRDIKPeNILLd~dG~IKLiDFG 734 (837)
.|.+++|+.+|.+++.+.+. .++....+.....+...+..-+|+. + -+|+++|+-|.+|..+-.++++++|
T Consensus 1306 e~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~g 1385 (2724)
T KOG1826|consen 1306 EYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGG 1385 (2724)
T ss_pred HHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccc
Confidence 68899999999999998542 3344444443334446777777753 2 6899999999999999999999999
Q ss_pred CccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHH
Q 003232 735 LSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI 814 (837)
Q Consensus 735 LArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELL 814 (837)
+.++.. +. ........+++.|+.|++...-.++.++|+|..|+-+|...
T Consensus 1386 LdKIkn---------p~----------------------~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1386 LDKIKN---------PV----------------------LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred cccccC---------ch----------------------HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 987310 00 01123456788999999998888888899999999999998
Q ss_pred cCCCCC
Q 003232 815 VGIPPF 820 (837)
Q Consensus 815 TGr~PF 820 (837)
.|..+|
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 888887
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.22 E-value=0.031 Score=63.23 Aligned_cols=76 Identities=21% Similarity=0.142 Sum_probs=48.7
Q ss_pred EecccCceEEEEEEECCCCcEEEEEEecccc----cccHHHHHHHHHHHHHHHhcC--CC-ceEEEEeEeecCCeEEEEE
Q 003232 596 PISRGAFGRVFLAKKRTTGDLFAIKVLKKAD----MIRKNAVESILAERDILISVR--NP-FVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 596 kLGsG~FGtVYkArdk~tG~~VAVKIikk~~----~~~~e~ie~~~rEieILk~Lr--HP-NIVkL~gsf~d~~~lyLVm 668 (837)
.||.|....||++.+...++.++||--.+-- ..-+-...+...|...|+... .| .++++|. .+.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 4799999999999985444689999743210 011233456667788886653 34 4555543 3455667999
Q ss_pred EecCC
Q 003232 669 EYLNG 673 (837)
Q Consensus 669 Ey~~G 673 (837)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.84 E-value=0.081 Score=60.84 Aligned_cols=77 Identities=19% Similarity=0.134 Sum_probs=51.4
Q ss_pred EEEEecccCceEEEEEEECCCCcEEEEEEeccccc-cc---HHHHHHHHHHHHHHHhcC---CCceEEEEeEeecCCeEE
Q 003232 593 IIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADM-IR---KNAVESILAERDILISVR---NPFVVRFFYSFTCRENLY 665 (837)
Q Consensus 593 IlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~-~~---~e~ie~~~rEieILk~Lr---HPNIVkL~gsf~d~~~ly 665 (837)
..+.||-|....||++.+. +..++||.-..-.. .. .....+...|...|+.+. ..++++++.+.. ...+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 3578899999999999873 45689998652111 00 123445566677776653 247777777655 4567
Q ss_pred EEEEecCC
Q 003232 666 LVMEYLNG 673 (837)
Q Consensus 666 LVmEy~~G 673 (837)
++|||+++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 88999976
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.69 E-value=0.083 Score=58.75 Aligned_cols=138 Identities=20% Similarity=0.235 Sum_probs=79.3
Q ss_pred EEEEecccCceEEEEEEECC----CCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCce-EEEEeEeecCCeEEEE
Q 003232 593 IIKPISRGAFGRVFLAKKRT----TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFV-VRFFYSFTCRENLYLV 667 (837)
Q Consensus 593 IlkkLGsG~FGtVYkArdk~----tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNI-VkL~gsf~d~~~lyLV 667 (837)
-+..|..|-.-.+|++.... .++.|++|++.... ...+ ...+|..+++.+..-++ .++++.+... .|
T Consensus 40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v 111 (344)
T PLN02236 40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RV 111 (344)
T ss_pred EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceee-chHHHHHHHHHHHHcCCCCceEEEECCc----eE
Confidence 34556558888999987532 24689999986542 1111 23568888877754333 3445555322 58
Q ss_pred EEecCCCCHHHH--------------HH---hcC------CCCHHHHHHHHHHH-----------------HHHHHHH--
Q 003232 668 MEYLNGGDLYSL--------------LR---NLG------CLDEDVARVYIAEV-----------------VLALEYL-- 705 (837)
Q Consensus 668 mEy~~GGSL~dl--------------Lk---~~g------~Lsee~irkIl~QI-----------------a~ALsYL-- 705 (837)
++|++|.+|... ++ ... ......+..++.++ ...+..|
T Consensus 112 ~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~ 191 (344)
T PLN02236 112 EEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEK 191 (344)
T ss_pred EEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHH
Confidence 999987665311 11 101 01112222332111 1112222
Q ss_pred --H----hCCcccccCCCCcEEEcc-CCcEEEEecCCccc
Q 003232 706 --H----SLRVVHRDLKPDNLLIAH-DGHIKLTDFGLSKV 738 (837)
Q Consensus 706 --H----SkGIIHRDIKPeNILLd~-dG~IKLiDFGLArv 738 (837)
. ...++|+|+++.|||++. ++.+.|+||..+..
T Consensus 192 ~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 192 ELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1 235899999999999976 47899999998874
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.67 E-value=0.21 Score=53.35 Aligned_cols=29 Identities=21% Similarity=0.397 Sum_probs=25.8
Q ss_pred CCcccccCCCCcEEEccCCcEEEEecCCcc
Q 003232 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 737 (837)
Q Consensus 708 kGIIHRDIKPeNILLd~dG~IKLiDFGLAr 737 (837)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 57999999999999987 678999999765
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.43 E-value=0.13 Score=57.33 Aligned_cols=145 Identities=21% Similarity=0.273 Sum_probs=80.8
Q ss_pred eEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCC--ceEEEEeEeecCC--eEEE
Q 003232 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP--FVVRFFYSFTCRE--NLYL 666 (837)
Q Consensus 591 YeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHP--NIVkL~gsf~d~~--~lyL 666 (837)
..++..+..|..-.+|..... ++.+++. ... ............+|+.+++.+.-- -+...++.+..+. ..|.
T Consensus 27 ~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~ 102 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFY 102 (321)
T ss_pred CceeeeccCCcccceEEEecC--CceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceE
Confidence 344455544444445555542 7788888 321 222334445677888888877542 2334445554444 6799
Q ss_pred EEEecCCCCHHHH------------------HHhc-----------C---CCCHHHHHHHHHH--------------HHH
Q 003232 667 VMEYLNGGDLYSL------------------LRNL-----------G---CLDEDVARVYIAE--------------VVL 700 (837)
Q Consensus 667 VmEy~~GGSL~dl------------------Lk~~-----------g---~Lsee~irkIl~Q--------------Ia~ 700 (837)
||+|++|..+.+. +..- + .....++..+..+ ...
T Consensus 103 v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~ 182 (321)
T COG3173 103 VMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADR 182 (321)
T ss_pred EEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHH
Confidence 9999988432211 1100 0 0001111111111 112
Q ss_pred HHHHHHhC--------CcccccCCCCcEEEccCCcEEEEecCCcccc
Q 003232 701 ALEYLHSL--------RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 739 (837)
Q Consensus 701 ALsYLHSk--------GIIHRDIKPeNILLd~dG~IKLiDFGLArvg 739 (837)
-..+++.+ .++|+|+.+.||+++.++-+=+.||+++.++
T Consensus 183 ~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 183 LIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 23333321 3799999999999999888999999998763
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.32 E-value=0.13 Score=56.75 Aligned_cols=140 Identities=16% Similarity=0.202 Sum_probs=77.7
Q ss_pred CeEEEEEecccCceEEEEEEECCC---CcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCce-EEEEeEeecCCeEE
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTT---GDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFV-VRFFYSFTCRENLY 665 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~t---G~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNI-VkL~gsf~d~~~ly 665 (837)
..++ +.|..|=...+|++..... +..|++|++..... ..-.-.+|..+++.+..-++ +++++.+. ..
T Consensus 16 ~i~i-~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~----~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G--- 86 (330)
T PLN02421 16 DFSV-ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD----YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG--- 86 (330)
T ss_pred ceEE-EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC----eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---
Confidence 3444 4454477778998875432 34799998865321 11223567788877754433 34555442 22
Q ss_pred EEEEecCCCCHHH--------------HHH---hcC-C----C-CHHHHHHHHHHH----------------------HH
Q 003232 666 LVMEYLNGGDLYS--------------LLR---NLG-C----L-DEDVARVYIAEV----------------------VL 700 (837)
Q Consensus 666 LVmEy~~GGSL~d--------------lLk---~~g-~----L-see~irkIl~QI----------------------a~ 700 (837)
+|.+|++|..|.. .++ ... + . ....+..++.++ ..
T Consensus 87 ~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 166 (330)
T PLN02421 87 MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRD 166 (330)
T ss_pred EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHH
Confidence 5889987765421 111 111 0 1 112222222221 11
Q ss_pred HHHHHH----hC----CcccccCCCCcEEEcc-CCcEEEEecCCccc
Q 003232 701 ALEYLH----SL----RVVHRDLKPDNLLIAH-DGHIKLTDFGLSKV 738 (837)
Q Consensus 701 ALsYLH----Sk----GIIHRDIKPeNILLd~-dG~IKLiDFGLArv 738 (837)
-+..+. .. -++|+|+.+.|||++. ++.++++||..|..
T Consensus 167 ~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 167 EIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 122211 11 2799999999999975 57899999998763
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.11 E-value=0.12 Score=59.25 Aligned_cols=78 Identities=22% Similarity=0.157 Sum_probs=52.0
Q ss_pred EEEecccCceEEEEEEECCCCcEEEEEEecc---cccccHHHHHHHHHHHHHHHhcC--CC-ceEEEEeEeecCCeEEEE
Q 003232 594 IKPISRGAFGRVFLAKKRTTGDLFAIKVLKK---ADMIRKNAVESILAERDILISVR--NP-FVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 594 lkkLGsG~FGtVYkArdk~tG~~VAVKIikk---~~~~~~e~ie~~~rEieILk~Lr--HP-NIVkL~gsf~d~~~lyLV 667 (837)
.+.||.|.-..||++.+...++.++||--.+ ....-.-..++...|.+.|+... .| +++++|. .+.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHH
Confidence 5788999999999999844456799986421 11011233467777888887663 34 5666654 345667789
Q ss_pred EEecCC
Q 003232 668 MEYLNG 673 (837)
Q Consensus 668 mEy~~G 673 (837)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999854
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=94.70 E-value=0.42 Score=51.85 Aligned_cols=30 Identities=17% Similarity=0.197 Sum_probs=27.9
Q ss_pred CcccccCCCCcEEEccCCcEEEEecCCccc
Q 003232 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (837)
Q Consensus 709 GIIHRDIKPeNILLd~dG~IKLiDFGLArv 738 (837)
+++|+|+.+.|||++.++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999999999999998874
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=93.95 E-value=0.18 Score=57.55 Aligned_cols=84 Identities=24% Similarity=0.349 Sum_probs=58.4
Q ss_pred CceEEEEeEe-ecCCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCcEEEccCC
Q 003232 649 PFVVRFFYSF-TCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDG 726 (837)
Q Consensus 649 PNIVkL~gsf-~d~~~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHS-kGIIHRDIKPeNILLd~dG 726 (837)
++..+.+.+- ....+.|++|++- |++|.-+ ..-..+++..++++-+..+.-+-. -.+-|||+.-.||||+ +|
T Consensus 285 ~~~e~~~vv~~de~~y~yl~~kdh-gt~is~i----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~G 358 (488)
T COG5072 285 VFLETLKVVSLDETLYLYLHFKDH-GTPISII----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EG 358 (488)
T ss_pred hhhhcceEEecCCceEEEEEEecC-Cceeeee----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cC
Confidence 4433333333 3445778888875 5555432 123456677777777766666654 3689999999999998 99
Q ss_pred cEEEEecCCccc
Q 003232 727 HIKLTDFGLSKV 738 (837)
Q Consensus 727 ~IKLiDFGLArv 738 (837)
++.|+||-+++.
T Consensus 359 nvtLIDfklsRl 370 (488)
T COG5072 359 NVTLIDFKLSRL 370 (488)
T ss_pred ceEEEEeeeeec
Confidence 999999999984
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=93.89 E-value=0.44 Score=52.24 Aligned_cols=75 Identities=20% Similarity=0.309 Sum_probs=47.3
Q ss_pred EEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcC---CCceEEEEeEeecCCeEEEEE
Q 003232 592 EIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR---NPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 592 eIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~Lr---HPNIVkL~gsf~d~~~lyLVm 668 (837)
+-.+.++-|....+|+.. .+++.+.||+-.... ...+..|..-|+.|. .-.+++++.........+|||
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLll 91 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESG------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLL 91 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGG------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEE
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecChhh------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEE
Confidence 345778889999999988 678889999876321 235667777777773 446788888887777779999
Q ss_pred EecCCC
Q 003232 669 EYLNGG 674 (837)
Q Consensus 669 Ey~~GG 674 (837)
||++.+
T Consensus 92 e~l~~~ 97 (288)
T PF03881_consen 92 EFLEMG 97 (288)
T ss_dssp E-----
T ss_pred EeecCC
Confidence 999765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.18 E-value=0.65 Score=52.88 Aligned_cols=75 Identities=19% Similarity=0.240 Sum_probs=44.0
Q ss_pred EEEecccCceEEEEEEECCCC-cE-----EEEEEecccccccHHHHHHHHHHHHHHHhcCCC-ceEEEEeEeecCCeEEE
Q 003232 594 IKPISRGAFGRVFLAKKRTTG-DL-----FAIKVLKKADMIRKNAVESILAERDILISVRNP-FVVRFFYSFTCRENLYL 666 (837)
Q Consensus 594 lkkLGsG~FGtVYkArdk~tG-~~-----VAVKIikk~~~~~~e~ie~~~rEieILk~LrHP-NIVkL~gsf~d~~~lyL 666 (837)
++.|..|-...+|++...... .. |.++++.... ...-.-.+|..+++.+..- .-.++++.+.. ++
T Consensus 55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~----~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~ 126 (383)
T PTZ00384 55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYN----SLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FT 126 (383)
T ss_pred EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCC----ceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EE
Confidence 345655888899998754321 22 4444432211 1111235678888888644 34456666542 68
Q ss_pred EEEecCCCCH
Q 003232 667 VMEYLNGGDL 676 (837)
Q Consensus 667 VmEy~~GGSL 676 (837)
|.||++|..|
T Consensus 127 l~efIeGr~l 136 (383)
T PTZ00384 127 IQEWVEGNTM 136 (383)
T ss_pred EEEEeccccC
Confidence 9999998665
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.05 E-value=2.9 Score=46.09 Aligned_cols=29 Identities=28% Similarity=0.436 Sum_probs=24.7
Q ss_pred CCcccccCCCCcEEEccCCcEEEEecCCccc
Q 003232 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (837)
Q Consensus 708 kGIIHRDIKPeNILLd~dG~IKLiDFGLArv 738 (837)
.++||+|+.+.|||++ + .+.|+||+-+..
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~ 224 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDARM 224 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence 4789999999999995 4 578999998764
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=92.59 E-value=2.4 Score=54.08 Aligned_cols=30 Identities=37% Similarity=0.591 Sum_probs=25.8
Q ss_pred CCcccccCCCCcEEEccCC--cEE-EEecCCcc
Q 003232 708 LRVVHRDLKPDNLLIAHDG--HIK-LTDFGLSK 737 (837)
Q Consensus 708 kGIIHRDIKPeNILLd~dG--~IK-LiDFGLAr 737 (837)
.++||+|+.+.|||++.++ .+. |+|||-+.
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 5799999999999998775 555 99999875
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=91.87 E-value=0.54 Score=50.83 Aligned_cols=115 Identities=15% Similarity=0.162 Sum_probs=70.9
Q ss_pred cCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEEecCCCCHHHH
Q 003232 600 GAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 679 (837)
Q Consensus 600 G~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmEy~~GGSL~dl 679 (837)
|+.++.-.+.-.. -+..+|.+...... -...-+.++.+++.+++ .|+++..- ....+.++.|+|.....
T Consensus 73 ~gNsTl~~~kt~i--G~L~lKKi~slp~~--~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i--- 141 (308)
T PF07387_consen 73 NGNSTLLIGKTKI--GPLFLKKIRSLPCC--INDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI--- 141 (308)
T ss_pred CCceEEEEecccc--chhhhhhccCCCcc--cchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc---
Confidence 5555555554432 34556666543211 01234577888888765 46666532 33357799999843211
Q ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHh--CCcccccCCCCcEEEccCCcEEEEecCC
Q 003232 680 LRNLGCLDEDVARVYIAEVVLALEYLHS--LRVVHRDLKPDNLLIAHDGHIKLTDFGL 735 (837)
Q Consensus 680 Lk~~g~Lsee~irkIl~QIa~ALsYLHS--kGIIHRDIKPeNILLd~dG~IKLiDFGL 735 (837)
.+. -++.-=+.+|.-+|+ .+.+|+|-.|+||+.+..|.+||.|=+.
T Consensus 142 ------~~~----N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 142 ------NFS----NFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred ------chh----HHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence 111 111112467788894 5799999999999999999999999764
|
The function of this family is unknown. |
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=91.09 E-value=1 Score=48.05 Aligned_cols=75 Identities=15% Similarity=0.100 Sum_probs=44.5
Q ss_pred cccCceEEEEEEECC----CC----cEEEEEEeccccccc--HHHHHHHHHHHHHHHhcC-------------CCceEEE
Q 003232 598 SRGAFGRVFLAKKRT----TG----DLFAIKVLKKADMIR--KNAVESILAERDILISVR-------------NPFVVRF 654 (837)
Q Consensus 598 GsG~FGtVYkArdk~----tG----~~VAVKIikk~~~~~--~e~ie~~~rEieILk~Lr-------------HPNIVkL 654 (837)
|.|-.|.+|++.-.. ++ ..++||......... ......+.+|+.+.+.+- ...+.++
T Consensus 2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~~ 81 (294)
T PF02958_consen 2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPKC 81 (294)
T ss_pred CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeeceE
Confidence 567778888876633 22 368888876222111 122356777777765441 1245666
Q ss_pred EeEeecCCeEEEEEEecC
Q 003232 655 FYSFTCRENLYLVMEYLN 672 (837)
Q Consensus 655 ~gsf~d~~~lyLVmEy~~ 672 (837)
+.........+||||-+.
T Consensus 82 ~~~~~~~~~~~lvlEDL~ 99 (294)
T PF02958_consen 82 YYADEDPGDEVLVLEDLS 99 (294)
T ss_pred EEeccCCCceeeehhhhh
Confidence 666655556889998763
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=90.37 E-value=2.4 Score=49.32 Aligned_cols=76 Identities=13% Similarity=0.214 Sum_probs=44.8
Q ss_pred EEEEecccCceEEEEEEECC--------CCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceE-EEEeEeecCCe
Q 003232 593 IIKPISRGAFGRVFLAKKRT--------TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVV-RFFYSFTCREN 663 (837)
Q Consensus 593 IlkkLGsG~FGtVYkArdk~--------tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIV-kL~gsf~d~~~ 663 (837)
-++.|..|-.-.+|++.... .++.|.++++.... +..-....|..+++.+..-+|. ++++.+.
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t----e~lIdR~~E~~v~~~ls~~gi~P~l~~~f~---- 180 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV----DELYNPISEFEVYKTMSKYRIAPQLLNTFS---- 180 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc----cceeCHHHHHHHHHHHHHCCCCCceEEEeC----
Confidence 45666667777788887542 25689999986532 1111334577777766543332 4445443
Q ss_pred EEEEEEecCCCCH
Q 003232 664 LYLVMEYLNGGDL 676 (837)
Q Consensus 664 lyLVmEy~~GGSL 676 (837)
-+.|.+|++|..|
T Consensus 181 gg~I~efi~g~~l 193 (442)
T PTZ00296 181 GGRIEEWLYGDPL 193 (442)
T ss_pred CCEEEEeeCCccC
Confidence 2457899987633
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=87.48 E-value=1.3 Score=51.39 Aligned_cols=61 Identities=28% Similarity=0.288 Sum_probs=45.2
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCcEEEccC
Q 003232 664 LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHD 725 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHS-kGIIHRDIKPeNILLd~d 725 (837)
..++=+|..|.++..+++.. ..++...+.++.-..+||--+-- .+++|.|++|.||++..+
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~-~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWK-SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred ceeeeeccccccHHhhhhcc-cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence 46677788898998888763 34556666776666666665553 689999999999999543
|
|
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=85.61 E-value=2.1 Score=46.25 Aligned_cols=74 Identities=23% Similarity=0.177 Sum_probs=52.5
Q ss_pred EEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHH---HHHHhcCCCceEEEEeEeecCCeEEEEEEec
Q 003232 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAER---DILISVRNPFVVRFFYSFTCRENLYLVMEYL 671 (837)
Q Consensus 595 kkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEi---eILk~LrHPNIVkL~gsf~d~~~lyLVmEy~ 671 (837)
..+..|..+.|+.++. .+|...++|+..+... ...|. ..|+..+....++++..- ...-.|++|.+
T Consensus 8 ~~~~~g~~s~V~pv~~-~dG~~avLKl~~p~~~--------~~~E~~g~~~L~~w~G~GaVrll~~d--~~~~AlLLErl 76 (253)
T PF04655_consen 8 GPPAHGSSSLVVPVRR-ADGTPAVLKLAPPHAE--------AEHEARGEAALRWWNGRGAVRLLAAD--PERGALLLERL 76 (253)
T ss_pred CCCCCCcceEEEEEEc-CCCCeEEEEecCCccc--------chhhhhHHhHhheeCCCCceeeeccc--cccchhhhhhc
Confidence 3456799999999985 6799999999886431 12232 557777888889998764 23556888988
Q ss_pred -CCCCHHHH
Q 003232 672 -NGGDLYSL 679 (837)
Q Consensus 672 -~GGSL~dl 679 (837)
+|.+|.++
T Consensus 77 ~~g~~L~~~ 85 (253)
T PF04655_consen 77 DPGRSLASL 85 (253)
T ss_pred cCCCchhhc
Confidence 44566544
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=81.51 E-value=15 Score=40.38 Aligned_cols=73 Identities=26% Similarity=0.342 Sum_probs=47.4
Q ss_pred ecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhc---CCCceEEEEeEeecCCeEEEEEEecCC
Q 003232 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV---RNPFVVRFFYSFTCRENLYLVMEYLNG 673 (837)
Q Consensus 597 LGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L---rHPNIVkL~gsf~d~~~lyLVmEy~~G 673 (837)
+.-|.--..|.+.+ ....+-+|+-. ......+..|+.-|..+ +.-.+.+++.+.....+.|+||||++-
T Consensus 24 v~gG~inea~~v~d--g~~~~FvK~n~------~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~ 95 (286)
T COG3001 24 VSGGDINEAWRLRD--GTDPFFVKCNQ------REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPT 95 (286)
T ss_pred cCCccccceeEeec--CCcceEEEecc------hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccC
Confidence 33344444455543 33467777633 33345666777666555 446678888888889999999999987
Q ss_pred CCHH
Q 003232 674 GDLY 677 (837)
Q Consensus 674 GSL~ 677 (837)
+.+.
T Consensus 96 ~~~d 99 (286)
T COG3001 96 GPLD 99 (286)
T ss_pred CCCC
Confidence 5543
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 837 | ||||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 8e-52 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 9e-52 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 9e-52 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-51 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-51 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-51 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-51 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-51 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-51 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-51 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-51 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-51 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 7e-51 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-51 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-51 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 8e-51 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 8e-51 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 8e-51 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-51 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 9e-51 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 9e-51 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-50 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-50 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-50 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-50 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-50 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-50 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-50 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-50 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-50 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-50 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-50 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-50 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-50 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-50 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-50 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-50 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-50 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-50 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-50 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-50 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-50 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-50 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-50 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-50 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-50 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-50 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-50 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-50 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 7e-50 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 9e-50 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-49 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-47 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 9e-47 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-46 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-46 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-46 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-46 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-46 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-46 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 8e-46 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 9e-46 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-45 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-45 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-45 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-45 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-45 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-45 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-45 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-45 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-44 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-44 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 8e-44 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 8e-44 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 9e-44 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 9e-44 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-43 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-43 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-43 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 8e-43 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-42 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-42 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-42 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-42 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-40 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-40 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-40 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-40 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-40 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-40 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-40 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-40 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-40 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 9e-40 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-40 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 9e-40 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-39 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-39 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-39 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-39 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-39 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-39 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-39 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-39 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-39 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-39 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-39 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-38 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-37 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-37 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-37 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-37 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-37 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-37 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-37 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 7e-37 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-37 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-36 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-36 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-36 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-36 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-36 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-36 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-36 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-36 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-36 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-36 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-36 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-36 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-36 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 7e-36 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 9e-36 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-35 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-35 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-35 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-35 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-35 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-35 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-35 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-35 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-35 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-35 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-35 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-35 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 6e-35 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-35 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-34 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-34 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-33 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-33 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-33 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-33 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-30 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-30 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-29 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-29 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-29 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-29 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-29 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-29 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-29 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-29 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 7e-29 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 7e-29 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-29 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-29 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-29 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-28 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-28 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-28 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-28 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-28 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-28 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-28 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-28 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-28 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-28 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-28 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-28 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-28 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-27 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-27 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-27 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-27 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-27 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-27 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-27 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-27 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-27 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-27 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-27 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-27 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-27 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-27 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 7e-27 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-27 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 8e-27 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 8e-27 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-27 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 9e-27 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-26 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-26 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-26 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-26 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-26 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-26 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-26 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-26 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-26 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-26 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 8e-26 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 9e-26 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-25 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-25 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-25 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-25 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-25 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-25 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-25 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-25 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-25 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-25 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-25 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-25 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-25 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-25 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-25 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-25 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-25 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-25 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 8e-25 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 8e-25 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-24 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-24 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-24 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-24 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-24 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-24 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-24 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-24 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-24 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-24 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-24 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-24 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-24 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-24 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-23 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-23 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-23 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 7e-23 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-23 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-23 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 9e-23 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-22 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-22 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-22 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-22 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-22 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-22 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-22 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-22 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-22 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 8e-22 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-21 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-21 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-21 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-21 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-21 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-21 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-21 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-21 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-21 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 7e-21 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 7e-21 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 8e-21 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 9e-21 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-20 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-20 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-20 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-20 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-20 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-20 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-20 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-20 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-20 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-20 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-20 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-20 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-20 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-20 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-20 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-20 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-20 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-20 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-20 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 8e-20 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 8e-20 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 9e-20 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-19 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-19 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-19 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-19 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-19 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-19 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-19 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-19 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-19 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-19 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-19 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-19 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-19 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-19 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-19 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-19 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-19 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-19 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-19 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-19 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 6e-19 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-19 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-19 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-19 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-19 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-19 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 7e-19 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-19 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-19 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 7e-19 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-19 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-19 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-19 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-19 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 8e-19 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 8e-19 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 8e-19 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-19 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 8e-19 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 8e-19 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 8e-19 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 8e-19 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 8e-19 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 8e-19 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 8e-19 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 8e-19 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 9e-19 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 9e-19 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 9e-19 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-18 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-18 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-18 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-18 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-18 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-18 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-18 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-18 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-18 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-18 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-18 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-18 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-18 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-18 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-18 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-18 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-18 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-18 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-18 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-18 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-18 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-18 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-18 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-18 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-18 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-18 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-18 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-18 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-18 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-18 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-18 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-18 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-18 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-18 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-18 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-18 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-18 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-18 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-18 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-18 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-18 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-18 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-18 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-18 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-18 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-18 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-18 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-18 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-18 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 9e-18 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 9e-18 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-17 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-17 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-17 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-17 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-17 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-17 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 8e-17 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 8e-17 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-16 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-16 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-16 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-16 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-16 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-16 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-16 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-16 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 8e-16 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 8e-16 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 8e-16 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-15 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-15 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-15 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-15 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-15 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-15 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-15 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-15 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-15 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-15 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-15 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-15 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-15 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-15 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-15 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-15 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-15 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-15 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-15 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-15 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-15 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-15 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-15 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-15 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-15 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-15 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-15 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-15 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-15 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-15 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-15 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-15 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-15 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-15 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-15 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-15 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-15 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-15 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-15 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-15 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-15 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-15 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-15 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-15 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-15 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-15 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-15 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-15 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-15 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-15 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-15 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-15 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-15 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-15 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-15 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-15 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-15 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-15 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-15 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 7e-15 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-15 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 7e-15 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 8e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 8e-15 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 8e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 8e-15 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-15 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 8e-15 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 8e-15 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-15 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 9e-15 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 9e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 9e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 9e-15 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-14 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-14 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-14 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-14 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-14 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-14 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-14 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-14 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-14 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-14 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-14 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-14 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-14 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-14 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-14 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-14 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-14 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-14 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-14 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-14 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-14 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-14 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-14 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-14 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-14 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-14 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-14 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-14 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-14 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-14 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-14 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-14 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 7e-14 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 7e-14 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 7e-14 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 7e-14 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-14 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 8e-14 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 8e-14 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 8e-14 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 8e-14 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 9e-14 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 9e-14 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 9e-14 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 9e-14 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-14 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-13 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-13 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-13 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-13 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-13 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-13 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-13 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-13 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-13 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-13 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-13 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-13 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-13 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-13 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-13 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-13 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-13 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-13 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-13 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-13 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-13 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-13 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-13 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-13 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-13 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-13 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-13 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-13 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-13 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-13 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-13 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-13 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-13 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-13 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-13 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-13 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-13 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-13 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-13 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-13 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-13 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-13 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-13 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-13 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-13 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-13 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-13 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-13 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-13 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-13 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-13 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-13 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-13 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-13 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-13 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-13 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-13 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-13 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-13 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-13 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-13 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-13 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-13 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-13 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-13 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-13 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-13 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-13 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-13 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-13 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-13 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-13 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-13 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 7e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-13 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 7e-13 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 8e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 8e-13 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-12 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-12 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-12 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-12 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-12 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-12 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-12 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-12 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-12 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-12 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-12 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 3e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-12 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-12 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-12 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 4e-12 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-12 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 7e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 7e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 8e-12 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 8e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 8e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 8e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 8e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 8e-12 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 9e-12 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 9e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 9e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 9e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 9e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-11 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-11 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-11 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-11 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-11 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-11 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-11 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-11 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 4e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-11 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-11 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 5e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-11 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 7e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-11 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-11 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 9e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-10 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-10 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-10 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 1e-10 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-10 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-10 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-10 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-10 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-10 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-10 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 1e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-10 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 1e-10 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 1e-10 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-10 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-10 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-10 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-10 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-10 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-10 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-10 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-10 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-10 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-10 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-10 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-10 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-10 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-10 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-10 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-10 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-10 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-10 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-10 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-10 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-10 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-10 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-10 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-10 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-10 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-10 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-10 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-10 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-10 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-10 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-10 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-10 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-10 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-10 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-10 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-10 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-10 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-10 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 7e-10 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-10 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-10 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 7e-10 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-10 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 8e-10 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 9e-10 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 9e-10 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 9e-10 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-09 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-09 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-09 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-09 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-09 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-09 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-09 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-09 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-09 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-09 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-09 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-09 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-09 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-09 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-09 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-09 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-09 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-09 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-09 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-09 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 3e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-09 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 3e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-09 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-09 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-09 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 5e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-09 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 6e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 7e-09 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 7e-09 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-09 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 8e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 8e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 9e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 9e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 9e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 9e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 9e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-08 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-08 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-08 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-08 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-08 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-08 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 1e-08 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-08 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-08 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-08 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-08 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-08 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-08 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 3e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-08 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 4e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 7e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 7e-08 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 1e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-07 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-07 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 1e-07 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 1e-07 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-07 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-07 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-07 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-07 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-07 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-07 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-07 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-07 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-07 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-07 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-07 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-07 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-07 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-07 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-07 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-07 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-07 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-07 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-07 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-07 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-07 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 3e-07 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-07 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-07 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-07 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-07 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-07 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-07 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-07 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 4e-07 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-07 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-07 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-07 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-07 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-07 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-07 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-07 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-07 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 6e-07 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 6e-07 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 7e-07 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-07 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 8e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 9e-07 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 9e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 9e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 9e-07 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-06 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-06 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-06 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-06 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-06 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-06 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-06 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-06 |
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 318 bits (818), Expect = e-102
Identities = 85/267 (31%), Positives = 138/267 (51%), Gaps = 29/267 (10%)
Query: 560 IEEDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAI 619
++ A SL+ + P + +DF+ K + G+F V LA++ T +AI
Sbjct: 1 MDGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAI 60
Query: 620 KVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 679
K+L+K +I++N V + ERD++ + +PF V+ +++F E LY + Y G+L
Sbjct: 61 KILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKY 120
Query: 680 LRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 739
+R +G DE R Y AE+V ALEYLH ++HRDLKP+N+L+ D HI++TDFG +KV
Sbjct: 121 IRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVL 180
Query: 740 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT 799
S + S VGT Y++PE+L
Sbjct: 181 SPESKQA-----------------------------RANSFVGTAQYVSPELLTEKSACK 211
Query: 800 TADWWSVGIILFELIVGIPPFNAEHPQ 826
++D W++G I+++L+ G+PPF A +
Sbjct: 212 SSDLWALGCIIYQLVAGLPPFRAGNEY 238
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 319 bits (820), Expect = e-101
Identities = 92/281 (32%), Positives = 146/281 (51%), Gaps = 39/281 (13%)
Query: 554 DITSTVIEEDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTT 613
++ ++ + +D + D + + + + R DDFEI+K I RGAF V + K + T
Sbjct: 27 ELGASELAQDKYVADFLQWA-EPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQT 85
Query: 614 GDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 673
G ++A+K++ K DM+++ V ERD+L++ ++ + ++F LYLVMEY G
Sbjct: 86 GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVG 145
Query: 674 GDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTD 732
GDL +LL G + ++AR Y+AE+V+A++ +H L VHRD+KPDN+L+ GHI+L D
Sbjct: 146 GDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLAD 205
Query: 733 FGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEIL 792
FG + T + AVGTPDYL+PEIL
Sbjct: 206 FGSCLKLRADGTV------------------------------RSLVAVGTPDYLSPEIL 235
Query: 793 LGTG-------HGTTADWWSVGIILFELIVGIPPFNAEHPQ 826
G +G DWW++G+ +E+ G PF A+
Sbjct: 236 QAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA 276
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 311 bits (799), Expect = 1e-99
Identities = 88/242 (36%), Positives = 138/242 (57%), Gaps = 34/242 (14%)
Query: 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILI 644
+ S+ DF+I++ + G+FGRV L + R G +A+KVLKK ++R VE ER +L
Sbjct: 2 KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 61
Query: 645 SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEY 704
V +PF++R + +F + ++++M+Y+ GG+L+SLLR VA+ Y AEV LALEY
Sbjct: 62 IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEY 121
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
LHS +++RDLKP+N+L+ +GHIK+TDFG +K P
Sbjct: 122 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAK-----------------------YVPD 158
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824
+T + GTPDY+APE++ + + DWWS GI+++E++ G PF +
Sbjct: 159 VT-----------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN 207
Query: 825 PQ 826
Sbjct: 208 TM 209
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 310 bits (796), Expect = 1e-97
Identities = 90/265 (33%), Positives = 139/265 (52%), Gaps = 36/265 (13%)
Query: 568 DDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADM 627
+ + + + R +DFEI+K I RGAFG V + K + +FA+K+L K +M
Sbjct: 53 LEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM 112
Query: 628 IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCL 686
+++ ERD+L++ + ++ Y+F NLYLVM+Y GGDL +LL L
Sbjct: 113 LKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRL 172
Query: 687 DEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746
E++AR Y+AE+V+A++ +H L VHRD+KPDN+L+ +GHI+L DFG + + T
Sbjct: 173 PEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV- 231
Query: 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-----TGHGTTA 801
+ AVGTPDY++PEIL +G
Sbjct: 232 -----------------------------QSSVAVGTPDYISPEILQAMEGGKGRYGPEC 262
Query: 802 DWWSVGIILFELIVGIPPFNAEHPQ 826
DWWS+G+ ++E++ G PF AE
Sbjct: 263 DWWSLGVCMYEMLYGETPFYAESLV 287
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 306 bits (787), Expect = 2e-97
Identities = 101/278 (36%), Positives = 155/278 (55%), Gaps = 38/278 (13%)
Query: 549 TDDKVDITSTVIEEDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLA 608
K +V E A ++D ++ T PS++ +D F+ IK + G+FGRV L
Sbjct: 5 AAKKGSEQESVKEFLAKAKEDFLKKWET----PSQNTAQLDQFDRIKTLGTGSFGRVMLV 60
Query: 609 KKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668
K + +G+ +A+K+L K +++ +E L E+ IL +V PF+V+ +SF NLY+VM
Sbjct: 61 KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHI 728
EY+ GG+++S LR +G E AR Y A++VL EYLHSL +++RDLKP+NLLI G+I
Sbjct: 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYI 180
Query: 729 KLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLA 788
++TDFG +K V G T + GTP+ LA
Sbjct: 181 QVTDFGFAKR-------------VKGRT---------------------WTLCGTPEALA 206
Query: 789 PEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826
PEI+L G+ DWW++G++++E+ G PPF A+ P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 307 bits (789), Expect = 5e-97
Identities = 103/310 (33%), Positives = 159/310 (51%), Gaps = 42/310 (13%)
Query: 528 TFGARIEKLIREKYLQLCELVTDDKVDITSTVIEE--DAPLE-----DDVVRSLRTSPIH 580
+F R EK+ E+ +D +D ++ + L D+ + + +
Sbjct: 1 SFETRFEKMDNLLRDPKSEVNSDCLLDGLDALVYDLDFPALRKNKNIDNFLSRYKDTINK 60
Query: 581 PSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAER 640
R +D+E++K I RGAFG V L + ++T ++A+K+L K +MI+++ ER
Sbjct: 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 120
Query: 641 DILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVL 700
DI+ +P+VV+ FY+F LY+VMEY+ GGDL +L+ N + E AR Y AEVVL
Sbjct: 121 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVL 179
Query: 701 ALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGD 760
AL+ +HS+ +HRD+KPDN+L+ GH+KL DFG
Sbjct: 180 ALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV--------------- 224
Query: 761 EEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG----HGTTADWWSVGIILFELIVG 816
+ +AVGTPDY++PE+L G +G DWWSVG+ L+E++VG
Sbjct: 225 ---------------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269
Query: 817 IPPFNAEHPQ 826
PF A+
Sbjct: 270 DTPFYADSLV 279
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 297 bits (762), Expect = 5e-94
Identities = 90/252 (35%), Positives = 144/252 (57%), Gaps = 35/252 (13%)
Query: 576 TSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRT---TGDLFAIKVLKKADMIRK-N 631
+ ++ ++ + FE+++ + +G +G+VF +K T TG +FA+KVLKKA ++R
Sbjct: 4 ETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAK 63
Query: 632 AVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVA 691
AER+IL V++PF+V Y+F LYL++EYL+GG+L+ L G ED A
Sbjct: 64 DTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTA 123
Query: 692 RVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 751
Y+AE+ +AL +LH +++RDLKP+N+++ H GH+KLTDFGL K + + T
Sbjct: 124 CFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT------- 176
Query: 752 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILF 811
T + GT +Y+APEIL+ +GH DWWS+G +++
Sbjct: 177 ---VT---------------------HTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMY 212
Query: 812 ELIVGIPPFNAE 823
+++ G PPF E
Sbjct: 213 DMLTGAPPFTGE 224
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 296 bits (761), Expect = 7e-94
Identities = 92/261 (35%), Positives = 146/261 (55%), Gaps = 35/261 (13%)
Query: 566 LEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRT---TGDLFAIKVL 622
+E + T + ++ FE++K + +G+FG+VFL KK + L+A+KVL
Sbjct: 1 MEGSIKEIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL 60
Query: 623 KKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN 682
KKA + ++ V ERDIL+ V +PF+V+ Y+F LYL++++L GGDL++ L
Sbjct: 61 KKATLKVRDRVR-TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK 119
Query: 683 LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742
E+ + Y+AE+ LAL++LHSL +++RDLKP+N+L+ +GHIKLTDFGLSK + +
Sbjct: 120 EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179
Query: 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTAD 802
S GT +Y+APE++ GH +AD
Sbjct: 180 ----------EKKA---------------------YSFCGTVEYMAPEVVNRRGHTQSAD 208
Query: 803 WWSVGIILFELIVGIPPFNAE 823
WWS G+++FE++ G PF +
Sbjct: 209 WWSFGVLMFEMLTGTLPFQGK 229
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 298 bits (764), Expect = 1e-93
Identities = 72/247 (29%), Positives = 129/247 (52%), Gaps = 35/247 (14%)
Query: 577 SPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESI 636
P+ + + D FEI++ I +G+FG+V + +K T ++A+K + K + +N V ++
Sbjct: 3 PPVFDENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNV 62
Query: 637 LAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIA 696
E I+ + +PF+V +YSF E++++V++ L GGDL L+ E+ +++I
Sbjct: 63 FKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC 122
Query: 697 EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 756
E+V+AL+YL + R++HRD+KPDN+L+ GH+ +TDF ++
Sbjct: 123 ELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAA------------------- 163
Query: 757 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL---GTGHGTTADWWSVGIILFEL 813
+ + GT Y+APE+ G G+ DWWS+G+ +EL
Sbjct: 164 -------------MLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYEL 210
Query: 814 IVGIPPF 820
+ G P+
Sbjct: 211 LRGRRPY 217
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 296 bits (760), Expect = 3e-93
Identities = 94/269 (34%), Positives = 148/269 (55%), Gaps = 41/269 (15%)
Query: 565 PLEDDVVRSLRTSPIHPS---------KDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGD 615
P E +++ + P PS DF +K I +G+FG+V LA+ +
Sbjct: 5 PQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEV 64
Query: 616 LFAIKVLKKADMIRKNAVESILAERDILI-SVRNPFVVRFFYSFTCRENLYLVMEYLNGG 674
+A+KVL+K +++K + I++ER++L+ +V++PF+V +SF + LY V++Y+NGG
Sbjct: 65 FYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG 124
Query: 675 DLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFG 734
+L+ L+ C E AR Y AE+ AL YLHSL +V+RDLKP+N+L+ GHI LTDFG
Sbjct: 125 ELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFG 184
Query: 735 LSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG 794
L K + + + TT + GTP+YLAPE+L
Sbjct: 185 LCKENIEH----------NSTT---------------------STFCGTPEYLAPEVLHK 213
Query: 795 TGHGTTADWWSVGIILFELIVGIPPFNAE 823
+ T DWW +G +L+E++ G+PPF +
Sbjct: 214 QPYDRTVDWWCLGAVLYEMLYGLPPFYSR 242
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 293 bits (753), Expect = 1e-92
Identities = 86/239 (35%), Positives = 136/239 (56%), Gaps = 31/239 (12%)
Query: 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILI 644
+ +++DF+ +K + +G FG+V L +++ TG +A+K+L+K +I K+ V + E +L
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 645 SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEY 704
+ R+PF+ Y+F + L VMEY NGG+L+ L E+ AR Y AE+V ALEY
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
LHS VV+RD+K +NL++ DGHIK+TDFGL K G+ + T
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD----------GATM-------- 162
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823
++ GTP+YLAPE+L +G DWW +G++++E++ G PF +
Sbjct: 163 -------------KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 208
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 291 bits (746), Expect = 3e-91
Identities = 90/267 (33%), Positives = 150/267 (56%), Gaps = 37/267 (13%)
Query: 567 EDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRT---TGDLFAIKVLK 623
V LRT+ + ++ I++FE++K + GA+G+VFL +K + TG L+A+KVLK
Sbjct: 32 LLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLK 91
Query: 624 KADMIRK-NAVESILAERDILISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR 681
KA +++K E ER +L +R PF+V Y+F L+L+++Y+NGG+L++ L
Sbjct: 92 KATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS 151
Query: 682 NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 741
E ++Y+ E+VLALE+LH L +++RD+K +N+L+ +GH+ LTDFGLSK +
Sbjct: 152 QRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 211
Query: 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG--TGHGT 799
+ T+ GT +Y+AP+I+ G +GH
Sbjct: 212 DETE---------RA---------------------YDFCGTIEYMAPDIVRGGDSGHDK 241
Query: 800 TADWWSVGIILFELIVGIPPFNAEHPQ 826
DWWS+G++++EL+ G PF + +
Sbjct: 242 AVDWWSLGVLMYELLTGASPFTVDGEK 268
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 290 bits (744), Expect = 4e-91
Identities = 90/244 (36%), Positives = 140/244 (57%), Gaps = 32/244 (13%)
Query: 581 PSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAER 640
+ + I+DF + K + +G+FG+VFLA+ + T FAIK LKK ++ + VE + E+
Sbjct: 9 SLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEK 68
Query: 641 DIL-ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVV 699
+L ++ +PF+ F +F +ENL+ VMEYLNGGDL +++ D A Y AE++
Sbjct: 69 RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEII 128
Query: 700 LALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLG 759
L L++LHS +V+RDLK DN+L+ DGHIK+ DFG+ K ++ T
Sbjct: 129 LGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG----------DAKT--- 175
Query: 760 DEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPP 819
+ GTPDY+APEILLG + + DWWS G++L+E+++G P
Sbjct: 176 ------------------NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
Query: 820 FNAE 823
F+ +
Sbjct: 218 FHGQ 221
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 289 bits (743), Expect = 5e-91
Identities = 96/244 (39%), Positives = 142/244 (58%), Gaps = 32/244 (13%)
Query: 581 PSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAER 640
S +R ID+FE I+ + +G+FG+V LA+ + TGDL+A+KVLKK +++ + VE + E+
Sbjct: 15 NSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEK 74
Query: 641 DILISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVV 699
IL RN PF+ + F F + L+ VME++NGGDL ++ DE AR Y AE++
Sbjct: 75 RILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEII 134
Query: 700 LALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLG 759
AL +LH +++RDLK DN+L+ H+GH KL DFG+ K G+ N TT
Sbjct: 135 SALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV----------TT--- 181
Query: 760 DEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPP 819
+ GTPDY+APEIL +G DWW++G++L+E++ G P
Sbjct: 182 ------------------ATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
Query: 820 FNAE 823
F AE
Sbjct: 224 FEAE 227
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 289 bits (742), Expect = 9e-91
Identities = 80/252 (31%), Positives = 138/252 (54%), Gaps = 32/252 (12%)
Query: 573 SLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNA 632
++ + ++DR + DF + + +G+FG+V L++++ T +L+A+K+LKK +I+ +
Sbjct: 4 TVSKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDD 63
Query: 633 VESILAERDILISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVA 691
VE + E+ +L PF+ + F + LY VMEY+NGGDL ++ +G E A
Sbjct: 64 VECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA 123
Query: 692 RVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 751
Y AE+ + L +L S +++RDLK DN+++ +GHIK+ DFG+ K + +
Sbjct: 124 VFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV------- 176
Query: 752 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILF 811
TT ++ GTPDY+APEI+ +G + DWW+ G++L+
Sbjct: 177 ---TT---------------------KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLY 212
Query: 812 ELIVGIPPFNAE 823
E++ G PF E
Sbjct: 213 EMLAGQAPFEGE 224
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 287 bits (738), Expect = 3e-90
Identities = 80/246 (32%), Positives = 131/246 (53%), Gaps = 32/246 (13%)
Query: 582 SKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERD 641
+ D + DF++++ I RG++ +V L + + T ++A+KV+KK + ++ + E+
Sbjct: 2 AMDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKH 61
Query: 642 ILISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVL 700
+ N PF+V F L+ V+EY+NGGDL ++ L E+ AR Y AE+ L
Sbjct: 62 VFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL 121
Query: 701 ALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGD 760
AL YLH +++RDLK DN+L+ +GHIKLTD+G+ K GL
Sbjct: 122 ALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL-------------------- 161
Query: 761 EEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820
+ + GTP+Y+APEIL G +G + DWW++G+++FE++ G PF
Sbjct: 162 -----------RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 210
Query: 821 NAEHPQ 826
+
Sbjct: 211 DIVGSS 216
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 285 bits (731), Expect = 1e-88
Identities = 79/260 (30%), Positives = 135/260 (51%), Gaps = 32/260 (12%)
Query: 568 DDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADM 627
++ ++ T + + DF++++ I RG++ +V L + + T ++A++V+KK +
Sbjct: 31 EEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELV 90
Query: 628 IRKNAVESILAERDILISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCL 686
++ + E+ + N PF+V F L+ V+EY+NGGDL ++ L
Sbjct: 91 NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKL 150
Query: 687 DEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746
E+ AR Y AE+ LAL YLH +++RDLK DN+L+ +GHIKLTD+G+ K GL
Sbjct: 151 PEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL------ 204
Query: 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSV 806
+ + GTP+Y+APEIL G +G + DWW++
Sbjct: 205 -------------------------RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWAL 239
Query: 807 GIILFELIVGIPPFNAEHPQ 826
G+++FE++ G PF+
Sbjct: 240 GVLMFEMMAGRSPFDIVGSS 259
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 286 bits (734), Expect = 2e-88
Identities = 97/288 (33%), Positives = 150/288 (52%), Gaps = 33/288 (11%)
Query: 538 REKYLQLCELVTDD-KVDITSTVIEEDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKP 596
RE++ + V D K + + D+ + K R ++++FE +K
Sbjct: 96 REEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKL 155
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFY 656
+ +G FG+V L K++ TG +A+K+LKK ++ K+ V L E +L + R+PF+ Y
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 215
Query: 657 SFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLR-VVHRDL 715
SF + L VMEY NGG+L+ L ED AR Y AE+V AL+YLHS + VV+RDL
Sbjct: 216 SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDL 275
Query: 716 KPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERR 775
K +NL++ DGHIK+TDFGL K E ++
Sbjct: 276 KLENLMLDKDGHIKITDFGLCK-------------------------------EGIKDGA 304
Query: 776 KKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823
++ GTP+YLAPE+L +G DWW +G++++E++ G PF +
Sbjct: 305 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 352
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 276 bits (707), Expect = 1e-86
Identities = 76/251 (30%), Positives = 130/251 (51%), Gaps = 33/251 (13%)
Query: 576 TSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVES 635
T+ K + +IDDF+I +P+ +G FG V+LA+++ + A+KVL K+ + ++
Sbjct: 1 TALAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ 60
Query: 636 ILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYI 695
+ E +I +R+P ++R + F R+ +YL++E+ G+LY L+ G DE + ++
Sbjct: 61 LRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFM 120
Query: 696 AEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGT 755
E+ AL Y H +V+HRD+KP+NLL+ + G +K+ DFG S
Sbjct: 121 EELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSV------------------ 162
Query: 756 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV 815
RR+ + GT DYL PE++ G H D W G++ +E +V
Sbjct: 163 -------------HAPSLRRR--TMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLV 207
Query: 816 GIPPFNAEHPQ 826
G+PPF++
Sbjct: 208 GMPPFDSPSHT 218
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 274 bits (702), Expect = 4e-86
Identities = 79/251 (31%), Positives = 125/251 (49%), Gaps = 35/251 (13%)
Query: 583 KDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDI 642
K + +++DFEI +P+ +G FG V+LA+++ + + A+KVL KA + + + E +I
Sbjct: 3 KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 62
Query: 643 LISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLAL 702
+R+P ++R + F +YL++EY G +Y L+ L DE YI E+ AL
Sbjct: 63 QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 122
Query: 703 EYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEE 762
Y HS RV+HRD+KP+NLL+ G +K+ DFG S
Sbjct: 123 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV------------------------- 157
Query: 763 PQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNA 822
++ GT DYL PE++ G H D WS+G++ +E +VG PPF A
Sbjct: 158 --------HAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 209
Query: 823 EHPQVSTLLRK 833
Q ++
Sbjct: 210 NTYQ--ETYKR 218
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 281 bits (721), Expect = 2e-85
Identities = 81/332 (24%), Positives = 138/332 (41%), Gaps = 45/332 (13%)
Query: 510 EDLRVVIDRRKFDALTVETFGARIEKLIREKYLQLCELVTDDKVDITSTVIEEDAPLEDD 569
+ LR + A L E + D + L
Sbjct: 100 DALRPQKAQALRAAYLEPQAQLFCSFLDAETVARARAGAGDGLFQPLLRAVLAH--LGQA 157
Query: 570 VVRSLRTSPI--------HPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKV 621
+ S D F + + RG FG VF + + TG L+A K
Sbjct: 158 PFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKK 217
Query: 622 LKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL----Y 677
L K + ++ + + E+ IL V + F+V Y+F + +L LVM +NGGD+ Y
Sbjct: 218 LNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIY 277
Query: 678 SLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 737
++ + E A Y A++V LE+LH +++RDLKP+N+L+ DG+++++D GL+
Sbjct: 278 NVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV 337
Query: 738 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH 797
E + + K + GTP ++APE+LLG +
Sbjct: 338 -------------------------------ELKAGQTKTKGYAGTPGFMAPELLLGEEY 366
Query: 798 GTTADWWSVGIILFELIVGIPPFNAEHPQVST 829
+ D++++G+ L+E+I PF A +V
Sbjct: 367 DFSVDYFALGVTLYEMIAARGPFRARGEKVEN 398
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 283 bits (726), Expect = 8e-85
Identities = 81/264 (30%), Positives = 141/264 (53%), Gaps = 32/264 (12%)
Query: 561 EEDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIK 620
+ E+ ++ + ++DR + DF + + +G+FG+V L++++ T +L+A+K
Sbjct: 313 QGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVK 372
Query: 621 VLKKADMIRKNAVESILAERDILISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 679
+LKK +I+ + VE + E+ +L PF+ + F + LY VMEY+NGGDL
Sbjct: 373 ILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYH 432
Query: 680 LRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 739
++ +G E A Y AE+ + L +L S +++RDLK DN+++ +GHIK+ DFG+ K
Sbjct: 433 IQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492
Query: 740 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT 799
+ + TT ++ GTPDY+APEI+ +G
Sbjct: 493 IWD----------GVTT---------------------KTFCGTPDYIAPEIIAYQPYGK 521
Query: 800 TADWWSVGIILFELIVGIPPFNAE 823
+ DWW+ G++L+E++ G PF E
Sbjct: 522 SVDWWAFGVLLYEMLAGQAPFEGE 545
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 273 bits (700), Expect = 4e-82
Identities = 73/243 (30%), Positives = 119/243 (48%), Gaps = 34/243 (13%)
Query: 583 KDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDI 642
+ + + F + + +G FG V + R TG ++A K L+K + ++ L E+ I
Sbjct: 178 RQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQI 237
Query: 643 LISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVL 700
L V + FVV Y++ ++ L LV+ +NGGDL + ++G E A Y AE+
Sbjct: 238 LEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICC 297
Query: 701 ALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGD 760
LE LH R+V+RDLKP+N+L+ GHI+++D GL+
Sbjct: 298 GLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAV----------------------- 334
Query: 761 EEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820
H E + + VGT Y+APE++ + + DWW++G +L+E+I G PF
Sbjct: 335 ---------HVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 385
Query: 821 NAE 823
Sbjct: 386 QQR 388
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 276 bits (707), Expect = 6e-82
Identities = 77/249 (30%), Positives = 123/249 (49%), Gaps = 37/249 (14%)
Query: 582 SKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERD 641
+++DF + + I RG FG V+ +K TG ++A+K L K + K L ER
Sbjct: 182 LNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERI 241
Query: 642 ILISVRN---PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEV 698
+L V PF+V Y+F + L +++ +NGGDL+ L G E R Y AE+
Sbjct: 242 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEI 301
Query: 699 VLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 758
+L LE++H+ VV+RDLKP N+L+ GH++++D GL+
Sbjct: 302 ILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-------------- 347
Query: 759 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-GTGHGTTADWWSVGIILFELIVGI 817
++VGT Y+APE+L G + ++ADW+S+G +LF+L+ G
Sbjct: 348 -------------------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
Query: 818 PPFNAEHPQ 826
PF +
Sbjct: 389 SPFRQHKTK 397
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 237 bits (606), Expect = 4e-72
Identities = 69/254 (27%), Positives = 125/254 (49%), Gaps = 34/254 (13%)
Query: 581 PSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAER 640
+ I+DF++ + +G+F V+ A+ TG AIK++ K M + V+ + E
Sbjct: 3 ATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEV 62
Query: 641 DILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVV 699
I +++P ++ + F +YLV+E + G++ L+N + E+ AR ++ +++
Sbjct: 63 KIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQII 122
Query: 700 LALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLG 759
+ YLHS ++HRDL NLL+ + +IK+ DFGL+
Sbjct: 123 TGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLA----------------------- 159
Query: 760 DEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPP 819
T + E+ + GTP+Y++PEI + HG +D WS+G + + L++G PP
Sbjct: 160 ------TQLKMPHEKHY--TLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP 211
Query: 820 FNAEHPQVSTLLRK 833
F+ + V L K
Sbjct: 212 FDTDT--VKNTLNK 223
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 238 bits (608), Expect = 1e-71
Identities = 55/279 (19%), Positives = 113/279 (40%), Gaps = 61/279 (21%)
Query: 580 HPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRK--------- 630
+ + I+D+ II+ +++G F ++ L +K +A+K +K+ + +K
Sbjct: 22 YVKEKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNND 79
Query: 631 -----NAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC 685
+ + E I+ ++N + + T + +Y++ EY+ +
Sbjct: 80 KISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFV 139
Query: 686 LD--------EDVARVYIAEVVLALEYLHSLR-VVHRDLKPDNLLIAHDGHIKLTDFGLS 736
LD V + I V+ + Y+H+ + + HRD+KP N+L+ +G +KL+DFG S
Sbjct: 140 LDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGES 199
Query: 737 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG 796
+ ++ K + GT +++ PE
Sbjct: 200 E-------------------------------YMVDKKIK--GSRGTYEFMPPEFFSNES 226
Query: 797 --HGTTADWWSVGIILFELIVGIPPFNAEHPQVSTLLRK 833
+G D WS+GI L+ + + PF+ + + L
Sbjct: 227 SYNGAKVDIWSLGICLYVMFYNVVPFSLKI-SLVELFNN 264
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 2e-70
Identities = 68/283 (24%), Positives = 108/283 (38%), Gaps = 40/283 (14%)
Query: 546 ELVTDDKVDITSTVIEEDAPLEDDVVRSLRTSPIHPSKDRTS--IDDFEIIKPISRGAFG 603
+L T++ + ++ SP + S F+ + + G++G
Sbjct: 12 DLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYG 71
Query: 604 RVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRE 662
VF + + G L+A+K K+ LAE V ++P VR ++
Sbjct: 72 EVFKVRSKEDGRLYAVKRSMSPFRGPKD-RARKLAEVGSHEKVGQHPCCVRLEQAWEEGG 130
Query: 663 NLYLVMEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLL 721
LYL E G L G L E Y+ + +LAL +LHS +VH D+KP N+
Sbjct: 131 ILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIF 189
Query: 722 IAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAV 781
+ G KL DFGL + +
Sbjct: 190 LGPRGRCKLGDFGLLVE--LGTAG------------------------------AGEVQE 217
Query: 782 GTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIP-PFNAE 823
G P Y+APE+L G +GT AD +S+G+ + E+ + P E
Sbjct: 218 GDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE 259
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 2e-70
Identities = 77/262 (29%), Positives = 121/262 (46%), Gaps = 40/262 (15%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
DFE I + +GAFG+V A+ +AIK ++ + + +IL+E +L S+ +
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLLASLNH 61
Query: 649 PFVVRFFYSFTCREN-------------LYLVMEYLNGGDLYSLLRNLGC-LDEDVARVY 694
+VVR++ ++ R N L++ MEY G LY L+ + D
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 695 IAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 754
+++ AL Y+HS ++HRDLKP N+ I ++K+ DFGL+K
Sbjct: 122 FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNV-----HRSLDILKLD 176
Query: 755 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFEL 813
+ L LT SA+GT Y+A E+L GTGH D +S+GII FE+
Sbjct: 177 SQNLPGSSDNLT------------SAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM 224
Query: 814 IVGIPPFNAEHPQVSTLLRKCQ 835
I P +L+K +
Sbjct: 225 I--YPFSTGMERV--NILKKLR 242
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 4e-70
Identities = 73/251 (29%), Positives = 116/251 (46%), Gaps = 33/251 (13%)
Query: 583 KDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDI 642
D S + + + +G F + F T ++FA K++ K+ +++ + E + E I
Sbjct: 9 VDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISI 68
Query: 643 LISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLAL 702
S+ + VV F F + +++V+E L L + L E AR Y+ ++VL
Sbjct: 69 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC 128
Query: 703 EYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEE 762
+YLH RV+HRDLK NL + D +K+ DFGL+
Sbjct: 129 QYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA-------------------------- 162
Query: 763 PQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNA 822
T E+ ER+K GTP+Y+APE+L GH D WS+G I++ L+VG PPF
Sbjct: 163 ---TKVEYDGERKK--VLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 217
Query: 823 EHPQVSTLLRK 833
+ +
Sbjct: 218 SC--LKETYLR 226
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 2e-69
Identities = 73/254 (28%), Positives = 116/254 (45%), Gaps = 33/254 (12%)
Query: 580 HPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAE 639
D S + + + +G F + F T ++FA K++ K+ +++ + E + E
Sbjct: 32 EVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSME 91
Query: 640 RDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVV 699
I S+ + VV F F + +++V+E L L + L E AR Y+ ++V
Sbjct: 92 ISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIV 151
Query: 700 LALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLG 759
L +YLH RV+HRDLK NL + D +K+ DFGL+
Sbjct: 152 LGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA----------------------- 188
Query: 760 DEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPP 819
T E+ ER+K GTP+Y+APE+L GH D WS+G I++ L+VG PP
Sbjct: 189 ------TKVEYDGERKK--VLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240
Query: 820 FNAEHPQVSTLLRK 833
F + +
Sbjct: 241 FETSC--LKETYLR 252
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 6e-68
Identities = 69/254 (27%), Positives = 124/254 (48%), Gaps = 36/254 (14%)
Query: 582 SKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERD 641
+ S++ + ++ I G+FG+ L K G + IK + + M K E E
Sbjct: 17 NLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK-EREESRREVA 75
Query: 642 ILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL--RNLGCLDEDVARVYIAEVV 699
+L ++++P +V++ SF +LY+VM+Y GGDL+ + + ED + ++
Sbjct: 76 VLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQIC 135
Query: 700 LALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLG 759
LAL+++H +++HRD+K N+ + DG ++L DFG+++V +NST +L
Sbjct: 136 LALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARV--LNSTVEL------------ 181
Query: 760 DEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPP 819
R+ +GTP YL+PEI + +D W++G +L+EL
Sbjct: 182 -----------------ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA 224
Query: 820 FNAEHPQVSTLLRK 833
F A + L+ K
Sbjct: 225 FEAGSMK--NLVLK 236
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 9e-68
Identities = 70/266 (26%), Positives = 120/266 (45%), Gaps = 35/266 (13%)
Query: 572 RSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKN 631
+ + P ++ +F I K I RG F V+ A G A+K ++ D++
Sbjct: 15 QFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAK 74
Query: 632 AVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG----CLD 687
A + E D+L + +P V++++ SF L +V+E + GDL ++++ +
Sbjct: 75 ARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIP 134
Query: 688 EDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747
E Y ++ ALE++HS RV+HRD+KP N+ I G +KL D GL + +S
Sbjct: 135 ERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTA 192
Query: 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVG 807
S VGTP Y++PE + G+ +D WS+G
Sbjct: 193 -----------------------------AHSLVGTPYYMSPERIHENGYNFKSDIWSLG 223
Query: 808 IILFELIVGIPPFNAEHPQVSTLLRK 833
+L+E+ PF + + +L +K
Sbjct: 224 CLLYEMAALQSPFYGDKMNLYSLCKK 249
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 1e-62
Identities = 68/249 (27%), Positives = 121/249 (48%), Gaps = 43/249 (17%)
Query: 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILIS 645
+ +D+E++ I G++GR ++++ G + K L M + +++E ++L
Sbjct: 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA-EKQMLVSEVNLLRE 61
Query: 646 VRNPFVVRFFYSFTCREN--LYLVMEYLNGGDLYSLLRNLG----CLDEDVARVYIAEVV 699
+++P +VR++ R N LY+VMEY GGDL S++ LDE+ + ++
Sbjct: 62 LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121
Query: 700 LALEYLHSLR-----VVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 754
LAL+ H V+HRDLKP N+ + ++KL DFGL+++ +N +
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFA------ 173
Query: 755 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI 814
++ VGTP Y++PE + + +D WS+G +L+EL
Sbjct: 174 -----------------------KTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELC 210
Query: 815 VGIPPFNAE 823
+PPF A
Sbjct: 211 ALMPPFTAF 219
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 3e-62
Identities = 64/276 (23%), Positives = 106/276 (38%), Gaps = 46/276 (16%)
Query: 573 SLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNA 632
L T ++ + I+K I G +VF ++AIK + +
Sbjct: 12 DLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNL-EEADNQT 69
Query: 633 VESILAERDILISVR--NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDV 690
++S E L ++ + ++R + + +Y+VME DL S L+ +D
Sbjct: 70 LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWE 128
Query: 691 ARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 750
+ Y ++ A+ +H +VH DLKP N LI DG +KL DFG++ ++T +
Sbjct: 129 RKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVV--- 184
Query: 751 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-----------HGT 799
K S VGT +Y+ PE +
Sbjct: 185 --------------------------KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISP 218
Query: 800 TADWWSVGIILFELIVGIPPFNAEHPQVSTLLRKCQ 835
+D WS+G IL+ + G PF Q+S L
Sbjct: 219 KSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 254
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 5e-62
Identities = 69/266 (25%), Positives = 119/266 (44%), Gaps = 41/266 (15%)
Query: 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR 647
+ DFE I+ + RG FG VF AK + +AIK ++ + + A E ++ E L +
Sbjct: 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR--ELAREKVMREVKALAKLE 61
Query: 648 NPFVVRFFYSFTCREN------------LYLVMEYLNGGDLYSLL---RNLGCLDEDVAR 692
+P +VR+F ++ + LY+ M+ +L + + + V
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 693 VYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 752
++ A+E+LHS ++HRDLKP N+ D +K+ DFGL
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTA-------------- 167
Query: 753 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFE 812
+ +E + T + VGT Y++PE + G + D +S+G+ILFE
Sbjct: 168 -----MDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222
Query: 813 LIVGIPPFNAEHPQVSTL--LRKCQL 836
L+ PF+ + +V TL +R +
Sbjct: 223 LLY---PFSTQMERVRTLTDVRNLKF 245
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 6e-61
Identities = 58/259 (22%), Positives = 105/259 (40%), Gaps = 58/259 (22%)
Query: 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDIL 643
D+ DF+ I+ I G FG+VF AK R G + IK +K + E E L
Sbjct: 6 DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKAL 58
Query: 644 ISVRNPFVVRFFYSF----------------TCRENLYLVMEYLNGGDLYSLL--RNLGC 685
+ + +V + + + + L++ ME+ + G L + R
Sbjct: 59 AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118
Query: 686 LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745
LD+ +A ++ ++Y+HS ++++RDLKP N+ + +K+ DFGL + +
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS--LKNDG 176
Query: 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWS 805
+ + GT Y++PE + +G D ++
Sbjct: 177 KRT------------------------------RSKGTLRYMSPEQISSQDYGKEVDLYA 206
Query: 806 VGIILFELI-VGIPPFNAE 823
+G+IL EL+ V F
Sbjct: 207 LGLILAELLHVCDTAFETS 225
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 7e-61
Identities = 62/259 (23%), Positives = 102/259 (39%), Gaps = 46/259 (17%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-- 647
+ I+K I G +VF ++AIK + + ++S E L ++
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNL-EEADNQTLDSYRNEIAYLNKLQQH 67
Query: 648 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS 707
+ ++R + + +Y+VME DL S L+ +D + Y ++ A+ +H
Sbjct: 68 SDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTA 767
+VH DLKP N LI DG +KL DFG++ ++T +
Sbjct: 127 HGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVV-------------------- 165
Query: 768 SEHQQERRKKRSAVGTPDYLAPEILLGTG-----------HGTTADWWSVGIILFELIVG 816
K S VGT +Y+ PE + +D WS+G IL+ + G
Sbjct: 166 ---------KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 216
Query: 817 IPPFNAEHPQVSTLLRKCQ 835
PF Q+S L
Sbjct: 217 KTPFQQIINQISKLHAIID 235
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 208 bits (530), Expect = 8e-61
Identities = 62/256 (24%), Positives = 104/256 (40%), Gaps = 51/256 (19%)
Query: 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILIS 645
TS + + + +GA VF + + TGDLFAIKV +R V+ + E ++L
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKK 63
Query: 646 VRNPFVVRFF--YSFTCRENLYLVMEYLNGGDLYSLLR---NLGCLDEDVARVYIAEVVL 700
+ + +V+ F T + L+ME+ G LY++L N L E + + +VV
Sbjct: 64 LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123
Query: 701 ALEYLHSLRVVHRDLKPDNLLIA----HDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 756
+ +L +VHR++KP N++ KLTDFG ++
Sbjct: 124 GMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR------------------- 164
Query: 757 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEIL--------LGTGHGTTADWWSVGI 808
++ + S GT +YL P++ +G T D WS+G+
Sbjct: 165 -------------ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGV 211
Query: 809 ILFELIVGIPPFNAEH 824
+ G PF
Sbjct: 212 TFYHAATGSLPFRPFE 227
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 208 bits (530), Expect = 5e-60
Identities = 62/257 (24%), Positives = 104/257 (40%), Gaps = 51/257 (19%)
Query: 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILIS 645
TS + + + +GA VF + + TGDLFAIKV +R V+ + E ++L
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKK 63
Query: 646 VRNPFVVRFF--YSFTCRENLYLVMEYLNGGDLYSLL---RNLGCLDEDVARVYIAEVVL 700
+ + +V+ F T + L+ME+ G LY++L N L E + + +VV
Sbjct: 64 LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123
Query: 701 ALEYLHSLRVVHRDLKPDNLLIA----HDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 756
+ +L +VHR++KP N++ KLTDFG ++
Sbjct: 124 GMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR------------------- 164
Query: 757 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEIL--------LGTGHGTTADWWSVGI 808
++ + S GT +YL P++ +G T D WS+G+
Sbjct: 165 -------------ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGV 211
Query: 809 ILFELIVGIPPFNAEHP 825
+ G PF
Sbjct: 212 TFYHAATGSLPFRPFEG 228
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 205 bits (522), Expect = 6e-59
Identities = 62/274 (22%), Positives = 103/274 (37%), Gaps = 46/274 (16%)
Query: 575 RTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVE 634
+ S + I+K I G +VF ++AIK + + ++
Sbjct: 42 KASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLD 99
Query: 635 SILAERDILISVR--NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVAR 692
S E L ++ + ++R + + +Y+VME DL S L+ +D +
Sbjct: 100 SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERK 158
Query: 693 VYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 752
Y ++ A+ +H +VH DLKP N LI DG +KL DFG++ ++T +
Sbjct: 159 SYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVV----- 212
Query: 753 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-----------HGTTA 801
K S VG +Y+ PE + +
Sbjct: 213 ------------------------KDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKS 248
Query: 802 DWWSVGIILFELIVGIPPFNAEHPQVSTLLRKCQ 835
D WS+G IL+ + G PF Q+S L
Sbjct: 249 DVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 282
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 2e-57
Identities = 76/241 (31%), Positives = 122/241 (50%), Gaps = 39/241 (16%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
F ++ + GAF VFL K+R TG LFA+K +KK+ R +++E+ E +L +++
Sbjct: 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLEN---EIAVLKKIKH 65
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
+V + + YLVM+ ++GG+L+ + G E A + I +V+ A++YLH
Sbjct: 66 ENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN 125
Query: 709 RVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQL 765
+VHRDLKP+NLL + I +TDFGLSK+ ++ +
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM---------------------EQNGIM 164
Query: 766 TASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825
+ +A GTP Y+APE+L + D WS+G+I + L+ G PPF E
Sbjct: 165 S------------TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE 212
Query: 826 Q 826
Sbjct: 213 S 213
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 198 bits (504), Expect = 5e-57
Identities = 59/262 (22%), Positives = 103/262 (39%), Gaps = 35/262 (13%)
Query: 565 PLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKK 624
+++ V + R + + RG+FG V K + TG A+K ++
Sbjct: 34 TEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRL 93
Query: 625 ADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG 684
+ E + +P +V + + + + ME L GG L L++ +G
Sbjct: 94 EVFRVE--------ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG 145
Query: 685 CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG-HIKLTDFGLSKVGLINS 743
CL ED A Y+ + + LEYLH+ R++H D+K DN+L++ DG L DFG +
Sbjct: 146 CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHAL------ 199
Query: 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADW 803
L + GT ++APE+++G D
Sbjct: 200 --------------------CLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDI 239
Query: 804 WSVGIILFELIVGIPPFNAEHP 825
WS ++ ++ G P+
Sbjct: 240 WSSCCMMLHMLNGCHPWTQYFR 261
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 8e-56
Identities = 72/241 (29%), Positives = 118/241 (48%), Gaps = 36/241 (14%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
D ++ + + +G+FG V L K + TG A+KV+ K + +K ES+L E +L + +
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
P +++ + F + YLV E GG+L+ + + E A I +V+ + Y+H
Sbjct: 86 PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 145
Query: 709 RVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQL 765
++VHRDLKP+NLL+ D +I++ DFGLS ++ +
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTH--FEASKKMKD---------------- 187
Query: 766 TASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825
+GT Y+APE+L GT + D WS G+IL+ L+ G PPFN +
Sbjct: 188 --------------KIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGANE 232
Query: 826 Q 826
Sbjct: 233 Y 233
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 1e-55
Identities = 73/259 (28%), Positives = 104/259 (40%), Gaps = 46/259 (17%)
Query: 581 PSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAER 640
PS + +E+ + + G FG V + TG+ AIK ++ ++ KN E E
Sbjct: 6 PSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQ-ELSPKN-RERWCLEI 63
Query: 641 DILISVRNPFVVRFF------YSFTCRENLYLVMEYLNGGDLYSLLR---NLGCLDEDVA 691
I+ + +P VV + L MEY GGDL L N L E
Sbjct: 64 QIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPI 123
Query: 692 RVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGH---IKLTDFGLSKVGLINSTDDLS 748
R ++++ AL YLH R++HRDLKP+N+++ K+ D G +K
Sbjct: 124 RTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE---------- 173
Query: 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGI 808
L E VGT YLAPE+L + T D+WS G
Sbjct: 174 ---------LDQGE-------------LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGT 211
Query: 809 ILFELIVGIPPFNAEHPQV 827
+ FE I G PF V
Sbjct: 212 LAFECITGFRPFLPNWQPV 230
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 1e-55
Identities = 51/257 (19%), Positives = 92/257 (35%), Gaps = 36/257 (14%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
+ I+ + G F V L + G +A+K + + E E D+ +P
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ---QDREEAQREADMHRLFNHP 86
Query: 650 FVVRFFYSFTCREN----LYLVMEYLNGGDLYSLLRNL----GCLDEDVARVYIAEVVLA 701
++R +L++ + G L++ + L L ED + +
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 702 LEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDE 761
LE +H+ HRDLKP N+L+ +G L D G L +
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ--------ACIHVEGSRQALTLQ 198
Query: 762 EPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH---GTTADWWSVGIILFELIVGIP 818
+ A++ T Y APE+ H D WS+G +L+ ++ G
Sbjct: 199 D---WAAQR-----------CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEG 244
Query: 819 PFNAEHPQVSTLLRKCQ 835
P++ + ++ Q
Sbjct: 245 PYDMVFQKGDSVALAVQ 261
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 1e-55
Identities = 61/249 (24%), Positives = 112/249 (44%), Gaps = 32/249 (12%)
Query: 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR 647
++D+++++ + GA+G V LA R T + A+K++ + + E+I E I +
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 648 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS 707
+ VV+F+ YL +EY +GG+L+ + + E A+ + +++ + YLH
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTA 767
+ + HRD+KP+NLL+ ++K++DFGL+ V
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATV----------------------------- 154
Query: 768 SEHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTADWWSVGIILFELIVGIPPFNAEHPQ 826
+ R GT Y+APE+L H D WS GI+L ++ G P++
Sbjct: 155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 214
Query: 827 VSTLLRKCQ 835
+
Sbjct: 215 CQEYSDWKE 223
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 2e-55
Identities = 67/241 (27%), Positives = 110/241 (45%), Gaps = 36/241 (14%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
D++++ + + +GAF V +TTG FA K++ + ++ + + E I +++
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD-FQKLEREARICRKLQH 64
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
P +VR S YLV + + GG+L+ + E A I +++ ++ Y HS
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124
Query: 709 RVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQL 765
+VHR+LKP+NLL+A +KL DFGL+ + D E
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE-------------------VNDSEAWH 165
Query: 766 TASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825
GTP YL+PE+L + D W+ G+IL+ L+VG PPF E
Sbjct: 166 G-------------FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ 212
Query: 826 Q 826
Sbjct: 213 H 213
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 6e-55
Identities = 69/238 (28%), Positives = 109/238 (45%), Gaps = 37/238 (15%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ + I+ + +G+FG V K R T +A+KV+ KA K+ +IL E ++L + +
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD-TSTILREVELLKKLDH 80
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
P +++ F + Y+V E GG+L+ + E A I +V + Y+H
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 709 RVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQL 765
+VHRDLKP+N+L+ D IK+ DFGLS +
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKMK----------------- 181
Query: 766 TASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823
+GT Y+APE+L GT + D WS G+IL+ L+ G PPF +
Sbjct: 182 -------------DRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGK 225
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 1e-54
Identities = 53/243 (21%), Positives = 94/243 (38%), Gaps = 23/243 (9%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-R 647
+F ++ I G FG VF KR G ++AIK KK + ++ L E + +
Sbjct: 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD-EQNALREVYAHAVLGQ 69
Query: 648 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL----RNLGCLDEDVARVYIAEVVLALE 703
+ VVR+F ++ +++ + EY NGG L + R + E + + +V L
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 704 YLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEP 763
Y+HS+ +VH D+KP N+ I+ + ++ +GD
Sbjct: 130 YIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK---------IGD--- 177
Query: 764 QLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNA 822
H + G +LA E+L H AD +++ + + P
Sbjct: 178 ----LGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN 233
Query: 823 EHP 825
Sbjct: 234 GDQ 236
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 2e-54
Identities = 61/249 (24%), Positives = 112/249 (44%), Gaps = 32/249 (12%)
Query: 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR 647
++D+++++ + GA+G V LA R T + A+K++ + + E+I E I +
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 648 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS 707
+ VV+F+ YL +EY +GG+L+ + + E A+ + +++ + YLH
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTA 767
+ + HRD+KP+NLL+ ++K++DFGL+ V
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATV----------------------------- 154
Query: 768 SEHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTADWWSVGIILFELIVGIPPFNAEHPQ 826
+ R GT Y+APE+L H D WS GI+L ++ G P++
Sbjct: 155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 214
Query: 827 VSTLLRKCQ 835
+
Sbjct: 215 CQEYSDWKE 223
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 2e-54
Identities = 76/258 (29%), Positives = 125/258 (48%), Gaps = 36/258 (13%)
Query: 577 SPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESI 636
S + ++ I ++ ++K I +G F +V LA+ TG AIK++ K + +++ +
Sbjct: 3 SIASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDK-TQLNPTSLQKL 61
Query: 637 LAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIA 696
E I+ + +P +V+ F + LYL+MEY +GG+++ L G + E AR
Sbjct: 62 FREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR 121
Query: 697 EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 756
++V A++Y H R+VHRDLK +NLL+ D +IK+ DFG S N G
Sbjct: 122 QIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFS-----NEFTV-------GGK 169
Query: 757 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTADWWSVGIILFELIV 815
L + G P Y APE+ G G D WS+G+IL+ L+
Sbjct: 170 L--------------------DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 209
Query: 816 GIPPFNAEHPQVSTLLRK 833
G PF+ ++ + L +
Sbjct: 210 GSLPFDGQN--LKELRER 225
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 2e-54
Identities = 82/307 (26%), Positives = 141/307 (45%), Gaps = 56/307 (18%)
Query: 534 EKLIREKYLQLCELVTDDKVDITSTVIEEDAPLEDDVVRSLRTSPIHPSKDRTSI-DDFE 592
E + + K L + ++ ++ + + V + S ++ D++
Sbjct: 90 ELVGKGKR---RPLNNNSEIALSLS--------RNKVFVFFDLTVDDQSVYPKALRDEYI 138
Query: 593 IIKPISRGAFGRVFLAKKRTTGDLFAIKVLKK-----ADMIRKNAVESILAERDILISVR 647
+ K + GA G V LA +R T AI+++ K + ++ E +IL +
Sbjct: 139 MSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN 198
Query: 648 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS 707
+P +++ F E+ Y+V+E + GG+L+ + L E ++Y +++LA++YLH
Sbjct: 199 HPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE 257
Query: 708 LRVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
++HRDLKP+N+L++ D IK+TDFG SK+ LG+
Sbjct: 258 NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-------------------LGETSLM 298
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLGT---GHGTTADWWSVGIILFELIVGIPPFN 821
T GTP YLAPE+L+ G+ D WS+G+ILF + G PPF+
Sbjct: 299 RT-------------LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 345
Query: 822 AEHPQVS 828
QVS
Sbjct: 346 EHRTQVS 352
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 2e-54
Identities = 74/257 (28%), Positives = 118/257 (45%), Gaps = 44/257 (17%)
Query: 580 HPSKDRTSI-------DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNA 632
H S R ++ + + I+ + +G+FG V K R T +A+KV+ KA K+
Sbjct: 6 HHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD- 64
Query: 633 VESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVAR 692
+IL E ++L + +P +++ F + Y+V E GG+L+ + E A
Sbjct: 65 TSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA 124
Query: 693 VYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGLINSTDDLSG 749
I +V + Y+H +VHRDLKP+N+L+ D IK+ DFGLS
Sbjct: 125 RIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLST------------ 172
Query: 750 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGII 809
Q+ K + +GT Y+APE+L GT + D WS G+I
Sbjct: 173 --------------------CFQQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVI 211
Query: 810 LFELIVGIPPFNAEHPQ 826
L+ L+ G PPF ++
Sbjct: 212 LYILLSGTPPFYGKNEY 228
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 3e-54
Identities = 72/253 (28%), Positives = 123/253 (48%), Gaps = 35/253 (13%)
Query: 582 SKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERD 641
R I + + + G FG+V + + + TG A+K+L + + + V I E
Sbjct: 4 HDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQ 63
Query: 642 ILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLA 701
L R+P +++ + + + ++VMEY++GG+L+ + G ++E AR +++ A
Sbjct: 64 NLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSA 123
Query: 702 LEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDE 761
++Y H VVHRDLKP+N+L+ + K+ DFGLS +
Sbjct: 124 VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM----------------------- 160
Query: 762 EPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTADWWSVGIILFELIVGIPPF 820
+ R++ G+P+Y APE++ G G D WS G+IL+ L+ G PF
Sbjct: 161 ---------MSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPF 211
Query: 821 NAEHPQVSTLLRK 833
+ EH V TL +K
Sbjct: 212 DDEH--VPTLFKK 222
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 4e-54
Identities = 66/246 (26%), Positives = 119/246 (48%), Gaps = 40/246 (16%)
Query: 586 TSIDDF-EIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNA---VESILAERD 641
+ ++D E+ + + G F V +++ TG +A K +KK + E I E +
Sbjct: 1 SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 642 ILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLA 701
IL +R+P ++ F + ++ L++E ++GG+L+ L L ED A ++ +++
Sbjct: 61 ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDG 120
Query: 702 LEYLHSLRVVHRDLKPDNLLIAH----DGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 757
+ YLHS R+ H DLKP+N+++ + IKL DFG++ I + ++
Sbjct: 121 VHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK--IEAGNEF---------- 168
Query: 758 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGI 817
++ GTP+++APEI+ G AD WS+G+I + L+ G
Sbjct: 169 --------------------KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 208
Query: 818 PPFNAE 823
PF E
Sbjct: 209 SPFLGE 214
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 4e-54
Identities = 36/259 (13%), Positives = 78/259 (30%), Gaps = 53/259 (20%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRT-----TGDLFAIKVLKKADMIRKNAVESILAERDIL 643
+ + GAF +V+ A + F +KV K A+ + L
Sbjct: 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERL 121
Query: 644 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-----NLGCLDEDVARVYIAEV 698
++F+ + + LV E + G L + + + + + + +
Sbjct: 122 KPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRM 181
Query: 699 VLALEYLHSLRVVHRDLKPDNLLIAH-----------DGHIKLTDFGLSKVGLINSTDDL 747
+ +E +H ++H D+KPDN ++ + + L D G S D+
Sbjct: 182 LYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI--------DM 233
Query: 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVG 807
+ + T + E+L D++ V
Sbjct: 234 K---------------------LFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVA 272
Query: 808 IILFELIVGIPPFNAEHPQ 826
++ ++ G
Sbjct: 273 ATVYCMLFGTYMKVKNEGG 291
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 4e-54
Identities = 78/251 (31%), Positives = 124/251 (49%), Gaps = 44/251 (17%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMI-----RKNAVESILAERDIL 643
D++ + K + GA G V LA +R T AIK++ K + ++ E +IL
Sbjct: 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 644 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALE 703
+ +P +++ F E+ Y+V+E + GG+L+ + L E ++Y +++LA++
Sbjct: 70 KKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 704 YLHSLRVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGD 760
YLH ++HRDLKP+N+L++ D IK+TDFG SK+ LG+
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-------------------LGE 169
Query: 761 EEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT---GHGTTADWWSVGIILFELIVGI 817
T GTP YLAPE+L+ G+ D WS+G+ILF + G
Sbjct: 170 TSLMRT-------------LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY 216
Query: 818 PPFNAEHPQVS 828
PPF+ QVS
Sbjct: 217 PPFSEHRTQVS 227
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 6e-54
Identities = 67/238 (28%), Positives = 110/238 (46%), Gaps = 36/238 (15%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
D++++ + + +GAF V +TTG FA K++ + + + E I +++
Sbjct: 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQH 87
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
P +VR S YLV + + GG+L+ + E A I +++ ++ Y HS
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 147
Query: 709 RVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQL 765
+VHR+LKP+NLL+A +KL DFGL+ +N ++ G
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE--VNDSEAWHG---------------- 189
Query: 766 TASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823
GTP YL+PE+L + D W+ G+IL+ L+VG PPF E
Sbjct: 190 --------------FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 233
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 8e-54
Identities = 65/256 (25%), Positives = 106/256 (41%), Gaps = 40/256 (15%)
Query: 581 PSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNA--VESILA 638
D D +E+ + I +G F V R TG FA+K++ A E +
Sbjct: 16 ADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKR 75
Query: 639 ERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY----SLLRNLGCLDEDVARVY 694
E I +++P +V +++ LY+V E+++G DL E VA Y
Sbjct: 76 EASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY 135
Query: 695 IAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGLINSTDDLSGPA 751
+ +++ AL Y H ++HRD+KP +L+A +KL FG++
Sbjct: 136 MRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ------------- 182
Query: 752 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILF 811
LG+ VGTP ++APE++ +G D W G+ILF
Sbjct: 183 ------LGESGLVAG------------GRVGTPHFMAPEVVKREPYGKPVDVWGCGVILF 224
Query: 812 ELIVGIPPFNAEHPQV 827
L+ G PF ++
Sbjct: 225 ILLSGCLPFYGTKERL 240
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 1e-53
Identities = 76/258 (29%), Positives = 115/258 (44%), Gaps = 40/258 (15%)
Query: 572 RSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKN 631
+ I S D FE+ + RGA V+ K++ T +A+KVLKK
Sbjct: 36 SLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKK-----TV 90
Query: 632 AVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVA 691
+ + E +L+ + +P +++ F + LV+E + GG+L+ + G E A
Sbjct: 91 DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDA 150
Query: 692 RVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGLINSTDDLS 748
+ +++ A+ YLH +VHRDLKP+NLL A D +K+ DFGLSK
Sbjct: 151 ADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSK----------- 199
Query: 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGI 808
+ + ++ GTP Y APEIL G +G D WSVGI
Sbjct: 200 ---------------------IVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGI 238
Query: 809 ILFELIVGIPPFNAEHPQ 826
I + L+ G PF E
Sbjct: 239 ITYILLCGFEPFYDERGD 256
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 1e-53
Identities = 72/258 (27%), Positives = 114/258 (44%), Gaps = 49/258 (18%)
Query: 580 HPSKDRTSI-------DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNA 632
H S R ++ D F + + GAFG V L ++R++G IK + K +
Sbjct: 6 HHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVP 63
Query: 633 VESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY----SLLRNLGCLDE 688
+E I AE ++L S+ +P +++ F F N+Y+VME GG+L S L E
Sbjct: 64 MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSE 123
Query: 689 DVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA---HDGHIKLTDFGLSKVGLINSTD 745
+ +++ AL Y HS VVH+DLKP+N+L IK+ DFGL+++ S +
Sbjct: 124 GYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL--FKSDE 181
Query: 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWS 805
+ +A GT Y+APE+ D WS
Sbjct: 182 HST------------------------------NAAGTALYMAPEVFKR-DVTFKCDIWS 210
Query: 806 VGIILFELIVGIPPFNAE 823
G++++ L+ G PF
Sbjct: 211 AGVVMYFLLTGCLPFTGT 228
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 2e-53
Identities = 66/284 (23%), Positives = 108/284 (38%), Gaps = 73/284 (25%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNA--VESILAERDILISV 646
+ + I +G++G V +A + T + AIK++ K + + N VE I E ++ +
Sbjct: 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 647 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG---------------------- 684
+P + R + + + + LVME +GG L L
Sbjct: 86 HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPEC 145
Query: 685 ------------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG 726
E + + ++ AL YLH+ + HRD+KP+N L + +
Sbjct: 146 NEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK 205
Query: 727 --HIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTP 784
IKL DFGLSK + E + GTP
Sbjct: 206 SFEIKLVDFGLSKE---------------------------FYKLNNGEYYGMTTKAGTP 238
Query: 785 DYLAPEILLGTGH--GTTADWWSVGIILFELIVGIPPFNAEHPQ 826
++APE+L T G D WS G++L L++G PF +
Sbjct: 239 YFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDA 282
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 2e-53
Identities = 66/252 (26%), Positives = 117/252 (46%), Gaps = 39/252 (15%)
Query: 579 IHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNA---VES 635
+ P K + D ++I + + G F V ++++TG +A K +KK E
Sbjct: 2 MEPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE 61
Query: 636 ILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYI 695
I E IL V + V+ + R ++ L++E ++GG+L+ L L E+ A +I
Sbjct: 62 IEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFI 121
Query: 696 AEVVLALEYLHSLRVVHRDLKPDNLLIA----HDGHIKLTDFGLSKVGLINSTDDLSGPA 751
+++ + YLH+ ++ H DLKP+N+++ HIKL DFGL+
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-------------- 167
Query: 752 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILF 811
++ + ++ GTP+++APEI+ G AD WS+G+I +
Sbjct: 168 ------------------EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 209
Query: 812 ELIVGIPPFNAE 823
L+ G PF +
Sbjct: 210 ILLSGASPFLGD 221
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 3e-53
Identities = 76/283 (26%), Positives = 119/283 (42%), Gaps = 62/283 (21%)
Query: 579 IHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRK-------- 630
S D ++ + + I +G++G V LA +A+KVL K +IR+
Sbjct: 3 SGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPP 62
Query: 631 ---------------NAVESILAERDILISVRNPFVVRFF--YSFTCRENLYLVMEYLNG 673
+E + E IL + +P VV+ ++LY+V E +N
Sbjct: 63 PRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQ 122
Query: 674 GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDF 733
G + + L ED AR Y +++ +EYLH +++HRD+KP NLL+ DGHIK+ DF
Sbjct: 123 GPVMEVPTL-KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADF 181
Query: 734 GLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL 793
G+S + L + VGTP ++APE L
Sbjct: 182 GVS-------------------NEFKGSDALL------------SNTVGTPAFMAPESLS 210
Query: 794 GTG---HGTTADWWSVGIILFELIVGIPPFNAEHPQVSTLLRK 833
T G D W++G+ L+ + G PF E + L K
Sbjct: 211 ETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER--IMCLHSK 251
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 5e-53
Identities = 68/241 (28%), Positives = 112/241 (46%), Gaps = 39/241 (16%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ + I RG++G V +A ++ T A K + K + V+ E +I+ S+ +
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDH 65
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
P ++R + +F ++YLVME GG+L+ + + E A + +V+ A+ Y H L
Sbjct: 66 PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL 125
Query: 709 RVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQL 765
V HRDLKP+N L D +KL DFGL+ +
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR--FKPGKMM------------------ 165
Query: 766 TASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825
R+ VGTP Y++P++L G +G D WS G++++ L+ G PPF+A
Sbjct: 166 ------------RTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTD 212
Query: 826 Q 826
Sbjct: 213 S 213
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 6e-53
Identities = 70/256 (27%), Positives = 115/256 (44%), Gaps = 41/256 (16%)
Query: 581 PSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKV--LKKADMIRKNAVESILA 638
+ DD+E+ + I GA V A + AIK L+K +++ +L
Sbjct: 7 ALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ----TSMDELLK 62
Query: 639 ERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL--------GCLDEDV 690
E + +P +V ++ SF ++ L+LVM+ L+GG + +++++ G LDE
Sbjct: 63 EIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST 122
Query: 691 ARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 750
+ EV+ LEYLH +HRD+K N+L+ DG +++ DFG
Sbjct: 123 IATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFG---------------- 166
Query: 751 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPE-ILLGTGHGTTADWWSVGII 809
VS L + +++ VGTP ++APE + G+ AD WS GI
Sbjct: 167 -VSA---------FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGIT 216
Query: 810 LFELIVGIPPFNAEHP 825
EL G P++ P
Sbjct: 217 AIELATGAAPYHKYPP 232
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 8e-53
Identities = 80/267 (29%), Positives = 129/267 (48%), Gaps = 45/267 (16%)
Query: 572 RSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKN 631
R+ T+ D ++ +K I G FG L + + T +L A+K +++ I +N
Sbjct: 3 RAPVTTGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN 62
Query: 632 AVESILAERDILI--SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDED 689
+R+I+ S+R+P +VRF +L ++MEY +GG+LY + N G ED
Sbjct: 63 V------QREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSED 116
Query: 690 VARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI--AHDGHIKLTDFGLSKVGLINSTDDL 747
AR + +++ + Y HS+++ HRDLK +N L+ + +K+ DFG SK +++S
Sbjct: 117 EARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---- 172
Query: 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTADWWSV 806
+S VGTP Y+APE+LL G AD WS
Sbjct: 173 ---------QP-------------------KSTVGTPAYIAPEVLLRQEYDGKIADVWSC 204
Query: 807 GIILFELIVGIPPFNAEHPQVSTLLRK 833
G+ L+ ++VG PF E P+ RK
Sbjct: 205 GVTLYVMLVGAYPF--EDPEEPRDYRK 229
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 8e-53
Identities = 72/241 (29%), Positives = 118/241 (48%), Gaps = 37/241 (15%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ ++ +K + GA+G V L + + T AIK+++K + + +L E +L + +
Sbjct: 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS-NSKLLEEVAVLKLLDH 95
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
P +++ + F + N YLVME GG+L+ + + +E A V I +V+ + YLH
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH 155
Query: 709 RVVHRDLKPDNLLIA---HDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQL 765
+VHRDLKP+NLL+ D IK+ DFGLS
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSA---------------------------- 187
Query: 766 TASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825
+ ++K + +GT Y+APE+L + D WS+G+ILF L+ G PPF +
Sbjct: 188 ----VFENQKKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTD 242
Query: 826 Q 826
Q
Sbjct: 243 Q 243
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 8e-53
Identities = 68/251 (27%), Positives = 116/251 (46%), Gaps = 46/251 (18%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIR----------KNAVESILA 638
+ + ++ + GA+G V L K++ AIKV+KK+ + + E I
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 639 ERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEV 698
E +L S+ +P +++ F F ++ YLV E+ GG+L+ + N DE A + ++
Sbjct: 96 EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQI 155
Query: 699 VLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGLINSTDDLSGPAVSGT 755
+ + YLH +VHRD+KP+N+L+ + +IK+ DFGLS + L
Sbjct: 156 LSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF--FSKDYKLRD------ 207
Query: 756 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV 815
+GT Y+APE+L + D WS G+I++ L+
Sbjct: 208 ------------------------RLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLC 242
Query: 816 GIPPFNAEHPQ 826
G PPF ++ Q
Sbjct: 243 GYPPFGGQNDQ 253
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 9e-53
Identities = 61/242 (25%), Positives = 111/242 (45%), Gaps = 39/242 (16%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNA---VESILAERDILIS 645
D ++ + + G F V ++++TG +A K +KK E I E IL
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 646 VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYL 705
+++P V+ + + ++ L++E + GG+L+ L L E+ A ++ +++ + YL
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 706 HSLRVVHRDLKPDNLLIAH----DGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDE 761
HSL++ H DLKP+N+++ IK+ DFGL+
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH------------------------ 166
Query: 762 EPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFN 821
+ ++ GTP+++APEI+ G AD WS+G+I + L+ G PF
Sbjct: 167 --------KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218
Query: 822 AE 823
+
Sbjct: 219 GD 220
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 1e-52
Identities = 64/260 (24%), Positives = 118/260 (45%), Gaps = 47/260 (18%)
Query: 571 VRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRK 630
+ + + + D ++I + + G F V ++++TG +A K +KK
Sbjct: 2 METFKQQKVE--------DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRAS 53
Query: 631 NA---VESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLD 687
E I E IL V +P ++ + R ++ L++E ++GG+L+ L L
Sbjct: 54 RRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLS 113
Query: 688 EDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH----DGHIKLTDFGLSKVGLINS 743
E+ A +I +++ + YLH+ ++ H DLKP+N+++ HIKL DFGL+
Sbjct: 114 EEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH------ 167
Query: 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADW 803
++ + ++ GTP+++APEI+ G AD
Sbjct: 168 --------------------------EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADM 201
Query: 804 WSVGIILFELIVGIPPFNAE 823
WS+G+I + L+ G PF +
Sbjct: 202 WSIGVITYILLSGASPFLGD 221
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 2e-52
Identities = 63/238 (26%), Positives = 110/238 (46%), Gaps = 35/238 (14%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+++++ + + +GAF V K G +A ++ + + + E I +++
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLKH 69
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
P +VR S + + YL+ + + GG+L+ + E A I +++ A+ + H +
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129
Query: 709 RVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQL 765
VVHR+LKP+NLL+A +KL DFGL+
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAI---------------------------- 161
Query: 766 TASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823
E + E++ GTP YL+PE+L +G D W+ G+IL+ L+VG PPF E
Sbjct: 162 ---EVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDE 216
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 2e-52
Identities = 54/267 (20%), Positives = 112/267 (41%), Gaps = 39/267 (14%)
Query: 560 IEEDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAI 619
I + +D+ + P+ + D ++I++ + GAFG V ++ TG +F
Sbjct: 23 INDYDKFYEDIWKKYVPQPVEVKQGSVY-DYYDILEELGSGAFGVVHRCVEKATGRVFVA 81
Query: 620 KVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY-S 678
K + + K ++ E I+ + +P ++ +F + + L++E+L+GG+L+
Sbjct: 82 KFINTPYPLDK---YTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDR 138
Query: 679 LLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH--DGHIKLTDFGLS 736
+ + E Y+ + L+++H +VH D+KP+N++ +K+ DFGL+
Sbjct: 139 IAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLA 198
Query: 737 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG 796
+ T ++ APEI+
Sbjct: 199 T--------------------------------KLNPDEIVKVTTATAEFAAPEIVDREP 226
Query: 797 HGTTADWWSVGIILFELIVGIPPFNAE 823
G D W++G++ + L+ G+ PF E
Sbjct: 227 VGFYTDMWAIGVLGYVLLSGLSPFAGE 253
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 3e-52
Identities = 68/258 (26%), Positives = 108/258 (41%), Gaps = 40/258 (15%)
Query: 573 SLRTSPIHPSKDRTSIDDFEII-KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKN 631
L T ++ + + + K + RG F V ++TG +A K LKK +
Sbjct: 12 DLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDC 71
Query: 632 AVESILAERDILISVR-NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL--RNLGCLDE 688
IL E +L + P V+ + + L++EY GG+++SL + E
Sbjct: 72 -RAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSE 130
Query: 689 DVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGLINSTD 745
+ I +++ + YLH +VH DLKP N+L++ G IK+ DFG+S+
Sbjct: 131 NDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR-------- 182
Query: 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWS 805
+ R +GTP+YLAPEIL T D W+
Sbjct: 183 ------------------------KIGHACELREIMGTPEYLAPEILNYDPITTATDMWN 218
Query: 806 VGIILFELIVGIPPFNAE 823
+GII + L+ PF E
Sbjct: 219 IGIIAYMLLTHTSPFVGE 236
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 4e-52
Identities = 60/247 (24%), Positives = 105/247 (42%), Gaps = 39/247 (15%)
Query: 581 PSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAER 640
+ + + + P+ GAFG V+ A + +K +KK ++ +E +
Sbjct: 16 AACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGK 75
Query: 641 -----DILISVRNPFVVRFFYSFTCRENLYLVME-YLNGGDLYSLLRNLGCLDEDVARVY 694
IL V + +++ F + LVME + +G DL++ + LDE +A
Sbjct: 76 VTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYI 135
Query: 695 IAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 754
++V A+ YL ++HRD+K +N++IA D IKL DFG +
Sbjct: 136 FRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY---------------- 179
Query: 755 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTADWWSVGIILFEL 813
+ + + GT +Y APE+L+G G + WS+G+ L+ L
Sbjct: 180 ----------------LERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTL 223
Query: 814 IVGIPPF 820
+ PF
Sbjct: 224 VFEENPF 230
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 5e-52
Identities = 70/261 (26%), Positives = 107/261 (40%), Gaps = 47/261 (18%)
Query: 581 PSKDRTS--IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAV----- 633
P T +++E + + RG V + T +A+K++ +A
Sbjct: 7 PGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQEL 66
Query: 634 -ESILAERDILISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVA 691
E+ L E DIL V P +++ ++ +LV + + G+L+ L L E
Sbjct: 67 REATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKET 126
Query: 692 RVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 751
R + ++ + LH L +VHRDLKP+N+L+ D +IKLTDFG S
Sbjct: 127 RKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ------------- 173
Query: 752 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG------TGHGTTADWWS 805
L E GTP YLAPEI+ G+G D WS
Sbjct: 174 ------LDPGEKLRE-------------VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWS 214
Query: 806 VGIILFELIVGIPPFNAEHPQ 826
G+I++ L+ G PPF
Sbjct: 215 TGVIMYTLLAGSPPFWHRKQM 235
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 6e-52
Identities = 65/257 (25%), Positives = 109/257 (42%), Gaps = 46/257 (17%)
Query: 574 LRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAV 633
++ SP + +D + KP+ G+F + + FA+K+ I K
Sbjct: 1 MKDSPFY---QHYDLDLKD--KPLGEGSFSICRKCVHKKSNQAFAVKI------ISKRME 49
Query: 634 ESILAERDILISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVAR 692
+ E L P +V+ F + + +LVME LNGG+L+ ++ E A
Sbjct: 50 ANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEAS 109
Query: 693 VYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGLINSTDDLSG 749
+ ++V A+ ++H + VVHRDLKP+NLL + IK+ DFG ++
Sbjct: 110 YIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR------------ 157
Query: 750 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGII 809
L + L + T Y APE+L G+ + D WS+G+I
Sbjct: 158 -------LKPPDNQPLK------------TPCFTLHYAAPELLNQNGYDESCDLWSLGVI 198
Query: 810 LFELIVGIPPFNAEHPQ 826
L+ ++ G PF +
Sbjct: 199 LYTMLSGQVPFQSHDRS 215
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 7e-52
Identities = 54/238 (22%), Positives = 99/238 (41%), Gaps = 39/238 (16%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ + I + + RG FG V + ++ + K +K + + E IL R+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV----KGTDQVLVKKEISILNIARH 60
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC-LDEDVARVYIAEVVLALEYLHS 707
++ SF E L ++ E+++G D++ + L+E Y+ +V AL++LHS
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 708 LRVVHRDLKPDNLLIAH--DGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQL 765
+ H D++P+N++ IK+ +FG ++
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR---------------------------- 152
Query: 766 TASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823
+ R P+Y APE+ T D WS+G +++ L+ GI PF AE
Sbjct: 153 ----QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE 206
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 7e-52
Identities = 77/239 (32%), Positives = 124/239 (51%), Gaps = 38/239 (15%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKV--LKKADMIRKNAVESILAERDILISV 646
+ F ++ I +G+FG VF T + AIK+ L++A+ + +E I E +L
Sbjct: 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE----DEIEDIQQEITVLSQC 77
Query: 647 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLH 706
+P+V +++ S+ L+++MEYL GG LL G LDE + E++ L+YLH
Sbjct: 78 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLH 136
Query: 707 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLT 766
S + +HRD+K N+L++ G +KL DFG V+G QLT
Sbjct: 137 SEKKIHRDIKAANVLLSEHGEVKLADFG-----------------VAG---------QLT 170
Query: 767 ASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825
+ + K+ + VGTP ++APE++ + + + AD WS+GI EL G PP + HP
Sbjct: 171 DT-----QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP 224
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 8e-52
Identities = 82/265 (30%), Positives = 133/265 (50%), Gaps = 51/265 (19%)
Query: 567 EDDVVRSLRT--SPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKK 624
+++++ LR+ S P + + I +GA G V+ A TG AI+ +
Sbjct: 2 DEEILEKLRSIVSVGDPK------KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM-- 53
Query: 625 ADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG 684
++ ++ E I+ E ++ +NP +V + S+ + L++VMEYL GG L ++
Sbjct: 54 -NLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-T 111
Query: 685 CLDEDVARVYIA----EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740
C+DE IA E + ALE+LHS +V+HRD+K DN+L+ DG +KLTDFG
Sbjct: 112 CMDEG----QIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA--- 164
Query: 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT 800
Q+T E+ K+ + VGTP ++APE++ +G
Sbjct: 165 -----------------------QIT-----PEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196
Query: 801 ADWWSVGIILFELIVGIPPFNAEHP 825
D WS+GI+ E+I G PP+ E+P
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENP 221
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 1e-51
Identities = 67/237 (28%), Positives = 122/237 (51%), Gaps = 35/237 (14%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ I G+ G V LA+++ +G A+K++ D+ ++ E + E I+ ++
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDYQH 101
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
VV + S+ E L+++ME+L GG L ++ L+E+ V+ AL YLH+
Sbjct: 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQ 160
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTAS 768
V+HRD+K D++L+ DG +KL+DFG Q++
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCA--------------------------QIS-- 192
Query: 769 EHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825
++ K++S VGTP ++APE++ + + T D WS+GI++ E++ G PP+ ++ P
Sbjct: 193 ---KDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP 246
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 1e-51
Identities = 74/295 (25%), Positives = 115/295 (38%), Gaps = 58/295 (19%)
Query: 565 PLEDDVVRSLRTSPIHPSKDRTS-IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLK 623
PL+ +P KDR + ++ + + +G FG VF + T AIKV+
Sbjct: 6 PLQGPPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIP 65
Query: 624 KADMIRKNAVES---ILAERDILISVRN----PFVVRFFYSFTCRENLYLVMEY-LNGGD 675
+ ++ + + E +L V P V+R F +E LV+E L D
Sbjct: 66 RNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQD 125
Query: 676 LYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI-AHDGHIKLTDFG 734
L+ + G L E +R + +VV A+++ HS VVHRD+K +N+LI G KL DFG
Sbjct: 126 LFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG 185
Query: 735 LSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG 794
A+ GT Y PE +
Sbjct: 186 SG--------------ALLHDEPY-------------------TDFDGTRVYSPPEWISR 212
Query: 795 TG-HGTTADWWSVGIILFELIVGIPPFNAEH--------------PQVSTLLRKC 834
H A WS+GI+L++++ G PF + P L+R+C
Sbjct: 213 HQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHVSPDCCALIRRC 267
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 2e-51
Identities = 66/253 (26%), Positives = 123/253 (48%), Gaps = 36/253 (14%)
Query: 582 SKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERD 641
+ + I + I + + G+FG+V LA T A+K + + + + + + E
Sbjct: 2 AISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREIS 61
Query: 642 ILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLA 701
L +R+P +++ + T ++ +V+EY GG+L+ + + ED R + +++ A
Sbjct: 62 YLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICA 120
Query: 702 LEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDE 761
+EY H ++VHRDLKP+NLL+ + ++K+ DFGLS +
Sbjct: 121 IEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNI----------------------- 157
Query: 762 EPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTADWWSVGIILFELIVGIPPF 820
+ +++ G+P+Y APE++ G G D WS GI+L+ ++VG PF
Sbjct: 158 ---------MTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPF 208
Query: 821 NAEHPQVSTLLRK 833
+ E + L +K
Sbjct: 209 DDEF--IPNLFKK 219
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 4e-51
Identities = 76/258 (29%), Positives = 125/258 (48%), Gaps = 35/258 (13%)
Query: 577 SPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESI 636
+ R I + + + G FG+V + K TG A+K+L + + + V I
Sbjct: 4 AEKQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKI 63
Query: 637 LAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIA 696
E L R+P +++ + + ++++VMEY++GG+L+ + G LDE +R
Sbjct: 64 RREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQ 123
Query: 697 EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 756
+++ ++Y H VVHRDLKP+N+L+ + K+ DFGLS N D G
Sbjct: 124 QILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS-----NMMSD-------GEF 171
Query: 757 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTADWWSVGIILFELIV 815
L R++ G+P+Y APE++ G G D WS G+IL+ L+
Sbjct: 172 L--------------------RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLC 211
Query: 816 GIPPFNAEHPQVSTLLRK 833
G PF+ +H V TL +K
Sbjct: 212 GTLPFDDDH--VPTLFKK 227
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 1e-50
Identities = 72/290 (24%), Positives = 112/290 (38%), Gaps = 52/290 (17%)
Query: 549 TDDKVDITSTVIEEDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLA 608
D + T + + ED++ + ++ I RG V
Sbjct: 62 NDAQPKGTENLYFQSMGPEDELPDWAAAKEFY--------QKYDPKDVIGRGVSSVVRRC 113
Query: 609 KKRTTGDLFAIKVLKKADMIRK-----NAVESILAERDILISVRN-PFVVRFFYSFTCRE 662
R TG FA+K+++ E+ E IL V P ++ S+
Sbjct: 114 VHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173
Query: 663 NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI 722
++LV + + G+L+ L L E R + ++ A+ +LH+ +VHRDLKP+N+L+
Sbjct: 174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL 233
Query: 723 AHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVG 782
+ I+L+DFG S L E G
Sbjct: 234 DDNMQIRLSDFGFSCH-------------------LEPGEKLRE-------------LCG 261
Query: 783 TPDYLAPEILLGT------GHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826
TP YLAPEIL + G+G D W+ G+ILF L+ G PPF
Sbjct: 262 TPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI 311
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 1e-50
Identities = 65/286 (22%), Positives = 115/286 (40%), Gaps = 56/286 (19%)
Query: 572 RSLRTSPIHPSKDRTS-IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKA---DM 627
L + + P K++ +++ + G FG V+ + + AIK ++K D
Sbjct: 25 NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDW 84
Query: 628 IRKNAVESILAERDILISVRN--PFVVRFFYSFTCRENLYLVMEYLNG-GDLYSLLRNLG 684
+ E +L V + V+R F ++ L++E DL+ + G
Sbjct: 85 GELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG 144
Query: 685 CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI-AHDGHIKLTDFGLSKVGLINS 743
L E++AR + +V+ A+ + H+ V+HRD+K +N+LI + G +KL DFG
Sbjct: 145 ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG------- 197
Query: 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTAD 802
A+ T+ GT Y PE + HG +A
Sbjct: 198 -------ALLKDTVY-------------------TDFDGTRVYSPPEWIRYHRYHGRSAA 231
Query: 803 WWSVGIILFELIVGIPPFNAEH--------------PQVSTLLRKC 834
WS+GI+L++++ G PF + + L+R C
Sbjct: 232 VWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWC 277
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 2e-50
Identities = 80/279 (28%), Positives = 123/279 (44%), Gaps = 41/279 (14%)
Query: 562 EDAPLEDDVVRSLRTSPIHPSKD-RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIK 620
E+ L++ + L K DDFE I + G G VF + +G + A K
Sbjct: 5 EELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARK 64
Query: 621 V--LKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYS 678
+ L+ IR I+ E +L +P++V F+ +F + + ME+++GG L
Sbjct: 65 LIHLEIKPAIRNQ----IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 120
Query: 679 LLRNLGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 737
+L+ G + E + V+ L YL +++HRD+KP N+L+ G IKL DFG
Sbjct: 121 VLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFG--- 177
Query: 738 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH 797
VSG QL S S VGT Y++PE L GT +
Sbjct: 178 --------------VSG---------QLIDS-------MANSFVGTRSYMSPERLQGTHY 207
Query: 798 GTTADWWSVGIILFELIVGIPPFNAEHPQVSTLLRKCQL 836
+D WS+G+ L E+ VG P + L+ CQ+
Sbjct: 208 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQV 246
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 2e-50
Identities = 70/243 (28%), Positives = 125/243 (51%), Gaps = 40/243 (16%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ +EI+ + GAFG+V+ AK + TG L A KV+ + + +E + E +IL + +
Sbjct: 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI---ETKSEEELEDYIVEIEILATCDH 75
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHS 707
P++V+ ++ L++++E+ GG + +++ L L E +V +++ AL +LHS
Sbjct: 76 PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 135
Query: 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTA 767
R++HRDLK N+L+ +G I+L DFG VS +
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADFG-----------------VSA---------KNLK 169
Query: 768 SEHQQERRKKRSAVGTPDYLAPEILL-----GTGHGTTADWWSVGIILFELIVGIPPFNA 822
+ +K+ S +GTP ++APE+++ T + AD WS+GI L E+ PP +
Sbjct: 170 T-----LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE 224
Query: 823 EHP 825
+P
Sbjct: 225 LNP 227
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 185 bits (470), Expect = 4e-50
Identities = 67/275 (24%), Positives = 116/275 (42%), Gaps = 39/275 (14%)
Query: 552 KVDITSTVIEEDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKR 611
V TV D+ + P+ D D ++I + + GAFG V +R
Sbjct: 121 IVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVL-DHYDIHEELGTGAFGVVHRVTER 179
Query: 612 TTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYL 671
TG+ FA K + ++ E++ E + +R+P +V +F + ++ E++
Sbjct: 180 ATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236
Query: 672 NGGDLYS-LLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH--DGHI 728
+GG+L+ + + ED A Y+ +V L ++H VH DLKP+N++ +
Sbjct: 237 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNEL 296
Query: 729 KLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLA 788
KL DFGL+ H ++ + GT ++ A
Sbjct: 297 KLIDFGLTA--------------------------------HLDPKQSVKVTTGTAEFAA 324
Query: 789 PEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823
PE+ G G D WSVG++ + L+ G+ PF E
Sbjct: 325 PEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE 359
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 5e-50
Identities = 57/237 (24%), Positives = 111/237 (46%), Gaps = 38/237 (16%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
+ + G FG+V ++ TG A K++K M K E + E ++ + +
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK---EEVKNEISVMNQLDHA 146
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC-LDEDVARVYIAEVVLALEYLHSL 708
+++ + +F + ++ LVMEY++GG+L+ + + L E +++ ++ + ++H +
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM 206
Query: 709 RVVHRDLKPDNLLIAH--DGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLT 766
++H DLKP+N+L + IK+ DFGL++
Sbjct: 207 YILHLDLKPENILCVNRDAKQIKIIDFGLAR----------------------------- 237
Query: 767 ASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823
+ R K + GTP++LAPE++ D WSVG+I + L+ G+ PF +
Sbjct: 238 ---RYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGD 291
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 1e-49
Identities = 71/238 (29%), Positives = 118/238 (49%), Gaps = 37/238 (15%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ F++++ + G++G V+ A + TG + AIK + ++ I+ E I+ +
Sbjct: 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDS 83
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHS 707
P VV+++ S+ +L++VMEY G + ++R L ED + + LEYLH
Sbjct: 84 PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF 143
Query: 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTA 767
+R +HRD+K N+L+ +GH KL DFG V+G QLT
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLADFG-----------------VAG---------QLT- 176
Query: 768 SEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825
K+ + +GTP ++APE++ G+ AD WS+GI E+ G PP+ HP
Sbjct: 177 ----DTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP 230
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 2e-49
Identities = 67/266 (25%), Positives = 116/266 (43%), Gaps = 46/266 (17%)
Query: 573 SLRTSPIHPSKDRTSIDDFEII-----KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADM 627
S+R++ + D+E + +G +G V+ + + AIK + + D
Sbjct: 1 SMRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD- 59
Query: 628 IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG--- 684
+ + E + +++ +V++ SF+ + + ME + GG L +LLR+
Sbjct: 60 --SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPL 117
Query: 685 CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI-AHDGHIKLTDFGLSKVGLINS 743
+E Y +++ L+YLH ++VHRD+K DN+LI + G +K++DFG SK
Sbjct: 118 KDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSK------ 171
Query: 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG--TGHGTTA 801
+L + GT Y+APEI+ G+G A
Sbjct: 172 --------------------RLAGI-----NPCTETFTGTLQYMAPEIIDKGPRGYGKAA 206
Query: 802 DWWSVGIILFELIVGIPPF-NAEHPQ 826
D WS+G + E+ G PPF PQ
Sbjct: 207 DIWSLGCTIIEMATGKPPFYELGEPQ 232
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 1e-48
Identities = 57/240 (23%), Positives = 101/240 (42%), Gaps = 43/240 (17%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILI-SVR 647
D +E+ + I G++ + T FA+K++ K K E +IL+ +
Sbjct: 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK----SK---RDPTEEIEILLRYGQ 74
Query: 648 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS 707
+P ++ + + +Y+V E + GG+L + E A + + +EYLH+
Sbjct: 75 HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA 134
Query: 708 LRVVHRDLKPDNLLIAHDGH----IKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEP 763
VVHRDLKP N+L + I++ DFG +K L +
Sbjct: 135 QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ------------------LRAENGL 176
Query: 764 QLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823
+T T +++APE+L G+ D WS+G++L+ ++ G PF
Sbjct: 177 LMT-------------PCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANG 223
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 2e-48
Identities = 67/258 (25%), Positives = 110/258 (42%), Gaps = 53/258 (20%)
Query: 581 PSKDRTSI-DDFEIIK-PISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILA 638
P + ++ DD+++ K + G G+V R TG A+K+L + R+
Sbjct: 19 PEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ-------- 70
Query: 639 ERDILISVRN-PFVVRFFYSF----TCRENLYLVMEYLNGGDLYS--LLRNLGCLDEDVA 691
E D P +V + + L ++ME + GG+L+S R E A
Sbjct: 71 EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREA 130
Query: 692 RVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGLINSTDDLS 748
+ ++ A+++LHS + HRD+KP+NLL D +KLTDFG +K
Sbjct: 131 AEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE---------- 180
Query: 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGI 808
+ L + TP Y+APE+L + + D WS+G+
Sbjct: 181 -----------TTQNALQ------------TPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 217
Query: 809 ILFELIVGIPPFNAEHPQ 826
I++ L+ G PPF + Q
Sbjct: 218 IMYILLCGFPPFYSNTGQ 235
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 5e-48
Identities = 59/240 (24%), Positives = 95/240 (39%), Gaps = 38/240 (15%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
F ++ I G+FG V+ A+ ++ AIK + + + I+ E L +R+
Sbjct: 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
P +++ + +LVMEY G L + L E + L YLHS
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 173
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTAS 768
++HRD+K N+L++ G +KL DFG + +
Sbjct: 174 NMIHRDVKAGNILLSEPGLVKLGDFG-----------------SAS---------IMA-- 205
Query: 769 EHQQERRKKRSAVGTPDYLAPEILLG---TGHGTTADWWSVGIILFELIVGIPPFNAEHP 825
S VGTP ++APE++L + D WS+GI EL PP +
Sbjct: 206 -------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 258
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 6e-48
Identities = 60/246 (24%), Positives = 103/246 (41%), Gaps = 37/246 (15%)
Query: 589 DDFEIIK-PISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR 647
D +++ + + GA RV T +A+K+++K ++ V E ++L +
Sbjct: 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFR---EVEMLYQCQ 68
Query: 648 N-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLH 706
V+ F + YLV E + GG + S + +E A V + +V AL++LH
Sbjct: 69 GHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLH 128
Query: 707 SLRVVHRDLKPDNLLIAHDGH---IKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEP 763
+ + HRDLKP+N+L H +K+ DF L +N T
Sbjct: 129 NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLT-------- 180
Query: 764 QLTASEHQQERRKKRSAVGTPDYLAPEILLG-----TGHGTTADWWSVGIILFELIVGIP 818
G+ +Y+APE++ + + D WS+G+IL+ L+ G P
Sbjct: 181 ----------------PCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYP 224
Query: 819 PFNAEH 824
PF
Sbjct: 225 PFVGRC 230
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 7e-48
Identities = 73/276 (26%), Positives = 118/276 (42%), Gaps = 51/276 (18%)
Query: 562 EDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEII-KPISRGAFGRVFLAKKRTTGDLFAIK 620
+ P K IDD+++ + + G G+V + T + FA+K
Sbjct: 34 QPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK 93
Query: 621 VLKKADMIRKNAVESILAERDILISVRN-PFVVRF--FY--SFTCRENLYLVMEYLNGGD 675
+L+ R+ E ++ P +VR Y + R+ L +VME L+GG+
Sbjct: 94 MLQDCPKARR--------EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGE 145
Query: 676 LYS--LLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKL 730
L+S R E A + + A++YLHS+ + HRD+KP+NLL + +KL
Sbjct: 146 LFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKL 205
Query: 731 TDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPE 790
TDFG +K S + L+ P TP Y+APE
Sbjct: 206 TDFGFAK--ETTSHNSLTTP------------------------------CYTPYYVAPE 233
Query: 791 ILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826
+L + + D WS+G+I++ L+ G PPF + H
Sbjct: 234 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 269
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 9e-48
Identities = 60/253 (23%), Positives = 108/253 (42%), Gaps = 39/253 (15%)
Query: 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVES-ILAERDILISV 646
I + + + G++G+V T A+K+LKK + R E+ + E +L +
Sbjct: 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL 63
Query: 647 RNPFVVRFF--YSFTCRENLYLVMEYLNGG--DLYSLLRNLGCLDEDVARVYIAEVVLAL 702
R+ V++ ++ +Y+VMEY G ++ + A Y +++ L
Sbjct: 64 RHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE-KRFPVCQAHGYFCQLIDGL 122
Query: 703 EYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEE 762
EYLHS +VH+D+KP NLL+ G +K++ G++ + P + T
Sbjct: 123 EYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVA---------EALHPFAADDTC----- 168
Query: 763 PQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG--HGTTADWWSVGIILFELIVGIPPF 820
R++ G+P + PEI G G D WS G+ L+ + G+ PF
Sbjct: 169 ---------------RTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF 213
Query: 821 NAEHPQVSTLLRK 833
++ + L
Sbjct: 214 EGDN--IYKLFEN 224
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 2e-47
Identities = 67/270 (24%), Positives = 111/270 (41%), Gaps = 49/270 (18%)
Query: 572 RSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKN 631
+ I + + I+D E + + G G+V+ + R TG + A+K +R++
Sbjct: 8 KQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQ------MRRS 61
Query: 632 AVES----ILAERDILI-SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCL 686
+ IL + D+++ S P++V+ F +F ++++ ME + R G +
Sbjct: 62 GNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPI 121
Query: 687 DEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745
E + +V AL YL V+HRD+KP N+L+ G IKL DFG
Sbjct: 122 PERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFG----------- 170
Query: 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEIL-----LGTGHGTT 800
+SG +L + K + G Y+APE + +
Sbjct: 171 ------ISG---------RLVDD------KAKDRSAGCAAYMAPERIDPPDPTKPDYDIR 209
Query: 801 ADWWSVGIILFELIVGIPPFNAEHPQVSTL 830
AD WS+GI L EL G P+ L
Sbjct: 210 ADVWSLGISLVELATGQFPYKNCKTDFEVL 239
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 4e-47
Identities = 61/259 (23%), Positives = 111/259 (42%), Gaps = 46/259 (17%)
Query: 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAV-ESILAERDIL 643
+ +D + + I RGA+G V + +G + A+K + + +L + D++
Sbjct: 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI---RSTVDEKEQKQLLMDLDVV 74
Query: 644 I-SVRNPFVVRFFYSFTCRENLYLVMEYLNGG--DLYSLLRNL--GCLDEDVARVYIAEV 698
+ S P++V+F+ + + ++ ME ++ Y + ++ + E++
Sbjct: 75 MRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLAT 134
Query: 699 VLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 757
V AL +L L+++HRD+KP N+L+ G+IKL DFG +SG
Sbjct: 135 VKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFG-----------------ISG--- 174
Query: 758 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT----ADWWSVGIILFEL 813
QL S K G Y+APE + + +D WS+GI L+EL
Sbjct: 175 ------QLVDS------IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYEL 222
Query: 814 IVGIPPFNAEHPQVSTLLR 832
G P+ + L +
Sbjct: 223 ATGRFPYPKWNSVFDQLTQ 241
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 7e-47
Identities = 49/245 (20%), Positives = 96/245 (39%), Gaps = 35/245 (14%)
Query: 589 DDFEIIKPISRGA--FGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV 646
+E++ I +G V LA+ + TG+ ++ + + V + E +
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRIN-LEACSNEMVTFLQGELHVSKLF 83
Query: 647 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEY 704
+P +V + +F L++V ++ G L+ ++E + V+ AL+Y
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
+H + VHR +K ++LI+ DG + L+ +
Sbjct: 144 IHHMGYVHRSVKASHILISVDGKVYLSGLR-----------------SNL---------S 177
Query: 765 LTASEHQQERRK--KRSAVGTPDYLAPEIL--LGTGHGTTADWWSVGIILFELIVGIPPF 820
+ + +Q + +V +L+PE+L G+ +D +SVGI EL G PF
Sbjct: 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 237
Query: 821 NAEHP 825
Sbjct: 238 KDMPA 242
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 8e-47
Identities = 35/324 (10%), Positives = 84/324 (25%), Gaps = 87/324 (26%)
Query: 555 ITSTVIEEDAPLEDDVVRSLRTSPIHPSKDRTSID--------DFEIIKPISRGAFGRVF 606
I + + SL ++ + + ++ + +
Sbjct: 31 IPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYL 90
Query: 607 LAKKRTTGDLFAIKVLKKADMIRKNAVE-------------------------SILAERD 641
A + TG+ F + V + NA++ + D
Sbjct: 91 EATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150
Query: 642 ILISVRNPFVVRFFYSFTCRE--NLYLVMEYLN------GGDLYSLLRNLGCLDEDVARV 693
++ + ++R + + + + G L S L
Sbjct: 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQ 210
Query: 694 YIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753
+V+ L LH +VH L+P ++++ G + LT F
Sbjct: 211 LTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV---------------- 254
Query: 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-----------GTGHGTTAD 802
+ + + + PE+ T + D
Sbjct: 255 -------------------RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFD 295
Query: 803 WWSVGIILFELIVGIPPFNAEHPQ 826
W++G++++ + P +
Sbjct: 296 AWALGLVIYWIWCADLPITKDAAL 319
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 2e-46
Identities = 56/272 (20%), Positives = 113/272 (41%), Gaps = 45/272 (16%)
Query: 561 EEDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIK 620
+E+ + D + L T + S D + I RG+F V+ T A
Sbjct: 1 QEERNQQQDDIEELETKAVGMSNDGRFLKFDIEI---GRGSFKTVYKGLDTETTVEVAWC 57
Query: 621 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC----RENLYLVMEYLNGGDL 676
L+ + K+ + E ++L +++P +VRF+ S+ ++ + LV E + G L
Sbjct: 58 ELQDRK-LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTL 116
Query: 677 YSLLRNLGCLDEDVARVYIAEVVLALEYLHS--LRVVHRDLKPDNLLI-AHDGHIKLTDF 733
+ L+ + V R + +++ L++LH+ ++HRDLK DN+ I G +K+ D
Sbjct: 117 KTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDL 176
Query: 734 GLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL 793
GL+ + ++ +GTP+++APE +
Sbjct: 177 GLAT---------------------------------LKRASFAKAVIGTPEFMAPE-MY 202
Query: 794 GTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825
+ + D ++ G+ + E+ P++
Sbjct: 203 EEKYDESVDVYAFGMCMLEMATSEYPYSECQN 234
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 1e-45
Identities = 67/253 (26%), Positives = 107/253 (42%), Gaps = 52/253 (20%)
Query: 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVES----ILAERDI 642
DD E I + RGA+G V + +G + A+K IR +L + DI
Sbjct: 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKR------IRATVNSQEQKRLLMDLDI 58
Query: 643 LI-SVRNPFVVRFFYSFTCRENLYLVMEYLNGG--DLY-SLLRNLGCLDEDVARVYIAEV 698
+ +V PF V F+ + ++++ ME ++ Y ++ + ED+ +
Sbjct: 59 SMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSI 118
Query: 699 VLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 757
V ALE+LHS L V+HRD+KP N+LI G +K+ DFG +SG
Sbjct: 119 VKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFG-----------------ISG--- 158
Query: 758 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT----ADWWSVGIILFEL 813
L K G Y+APE + + +D WS+GI + EL
Sbjct: 159 ------YLVDD------VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 206
Query: 814 IVGIPPFNA-EHP 825
+ P+++ P
Sbjct: 207 AILRFPYDSWGTP 219
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 1e-45
Identities = 63/251 (25%), Positives = 112/251 (44%), Gaps = 49/251 (19%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-R 647
FE+++ + G +G+V+ + TG L AIKV+ + + E I E ++L
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSH 79
Query: 648 NPFVVRFFYSF------TCRENLYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVV 699
+ + ++ +F + L+LVME+ G + L++N L E+ E++
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139
Query: 700 LALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLG 759
L +LH +V+HRD+K N+L+ + +KL DFG+S
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA---------------------- 177
Query: 760 DEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-----GTGHGTTADWWSVGIILFELI 814
QL + ++ + +GTP ++APE++ + +D WS+GI E+
Sbjct: 178 ----QLDRT-----VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMA 228
Query: 815 VGIPPFNAEHP 825
G PP HP
Sbjct: 229 EGAPPLCDMHP 239
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 2e-44
Identities = 45/319 (14%), Positives = 84/319 (26%), Gaps = 73/319 (22%)
Query: 556 TSTVIEEDAPLEDDVVRSL---RTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRT 612
++E A + + V ++ S ++++P+ G VFL +
Sbjct: 26 REEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVE 85
Query: 613 TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFF----------------- 655
+ FA+KV ++ +E + +
Sbjct: 86 RLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQ 145
Query: 656 ---------YSFTCRENLYLVMEYLNGGDLYSLLRNL-------GCLDEDVARVYIAEVV 699
N L+M DL L L G + A+++
Sbjct: 146 PPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLFSTLDFVYVFRGDEGILALHILTAQLI 204
Query: 700 LALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLG 759
L S +VH PDNL I DG + L D
Sbjct: 205 RLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW---------------------- 242
Query: 760 DEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG--TGHGTTADWWSVGIILFELIVGI 817
+ + ++ Y E L + W +G+ ++ +
Sbjct: 243 ------------KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
Query: 818 PPFNAEHPQVSTLLRKCQL 836
PF P + ++ L
Sbjct: 291 LPFGLVTPGIKGSWKRPSL 309
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 164 bits (415), Expect = 4e-44
Identities = 34/273 (12%), Positives = 72/273 (26%), Gaps = 68/273 (24%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVE---------------- 634
+ + A + TG+ F + V + NA++
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 635 ---------SILAERDILISVRNPFVVRFFYSFTCR--ENLYLVMEYLNG------GDLY 677
+ D++ + ++R + + + + L
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 678 SLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 737
S L +V+ L LH +VH L+P ++++ G + LT F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 259
Query: 738 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH 797
D ++ P+ A +L H
Sbjct: 260 R---------------------DGASAVSPI---------GRGFAPPETTAERMLPFGQH 289
Query: 798 GTT-----ADWWSVGIILFELIVGIPPFNAEHP 825
T D W++G+ ++ + P +
Sbjct: 290 HPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAA 322
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-43
Identities = 54/251 (21%), Positives = 102/251 (40%), Gaps = 38/251 (15%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN-P 649
+ + ++ G F V+ A+ +G +A+K L + + +I+ E + + P
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHP 86
Query: 650 FVVRFFYSF--------TCRENLYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVV 699
+V+F + T + L+ E G + L + G L D +
Sbjct: 87 NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146
Query: 700 LALEYLHSLR--VVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 757
A++++H + ++HRDLK +NLL+++ G IKL DFG + T
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSA-------------------TT 187
Query: 758 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH---GTTADWWSVGIILFELI 814
+ +++ + ++ + TP Y PEI+ + G D W++G IL+ L
Sbjct: 188 ISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLC 247
Query: 815 VGIPPFNAEHP 825
PF
Sbjct: 248 FRQHPFEDGAK 258
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 8e-43
Identities = 46/253 (18%), Positives = 87/253 (34%), Gaps = 24/253 (9%)
Query: 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV 646
++ I++ + ++ + + +
Sbjct: 60 KLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPS-VKIRRMDPF 118
Query: 647 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN---LGCLDEDVARVYIAEVVLALE 703
V + + LY+ M+ +L + L + V ++ A+E
Sbjct: 119 STKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVE 178
Query: 704 YLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEP 763
+LHS ++HRDLKP N+ D +K+ DFGL + +E
Sbjct: 179 FLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTA-------------------MDQDEE 219
Query: 764 QLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823
+ T VGT Y++PE + G + D +S+G+ILFEL+ E
Sbjct: 220 EQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM-E 278
Query: 824 HPQVSTLLRKCQL 836
++ T +R +
Sbjct: 279 RVRIITDVRNLKF 291
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 4e-10
Identities = 22/70 (31%), Positives = 37/70 (52%), Gaps = 2/70 (2%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
DFE I+ + RG FG VF AK + +AIK ++ + E ++ E L + +
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR--EKVMREVKALAKLEH 63
Query: 649 PFVVRFFYSF 658
P +VR+F ++
Sbjct: 64 PGIVRYFNAW 73
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 4e-42
Identities = 64/281 (22%), Positives = 117/281 (41%), Gaps = 50/281 (17%)
Query: 564 APLEDDVVRSLRTSPIHPSKDRTSIDDFEI-------IKPISRGAFGRVFLAKKRTTGDL 616
P + + S R+ P S+ + +++I + I +G FG+V+ + G++
Sbjct: 1 GPEMNLSLLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWH--GEV 58
Query: 617 FAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 676
AI+++ ++ +++ E R+ VV F + +L ++ G L
Sbjct: 59 -AIRLIDIERDN-EDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTL 116
Query: 677 YSLLRNLGC-LDEDVARVYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFG 734
YS++R+ LD + IA E+V + YLH+ ++H+DLK N+ +G + +TDFG
Sbjct: 117 YSVVRDAKIVLDVNK-TRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY-DNGKVVITDFG 174
Query: 735 LSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG 794
L +SG G E +L G +LAPEI+
Sbjct: 175 LFS--------------ISGVLQAGRREDKLRI------------QNGWLCHLAPEIIRQ 208
Query: 795 TGHGTT---------ADWWSVGIILFELIVGIPPFNAEHPQ 826
T +D +++G I +EL PF + +
Sbjct: 209 LSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE 249
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 4e-42
Identities = 57/234 (24%), Positives = 111/234 (47%), Gaps = 23/234 (9%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
D + + +G FG+ R TG++ +K L + D + + L E ++ + +
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD---EETQRTFLKEVKVMRCLEH 66
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC-LDEDVARVYIAE-VVLALEYLH 706
P V++F + L + EY+ GG L +++++ RV A+ + + YLH
Sbjct: 67 PNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQ-RVSFAKDIASGMAYLH 125
Query: 707 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLT 766
S+ ++HRDL N L+ + ++ + DFGL+++ + T P+
Sbjct: 126 SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ-----------------PEGL 168
Query: 767 ASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820
S + +R+K+ + VG P ++APE++ G + D +S GI+L E+I +
Sbjct: 169 RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNAD 222
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 1e-41
Identities = 65/241 (26%), Positives = 106/241 (43%), Gaps = 52/241 (21%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ E+ + + RGAFG V AK R AIK ++ ++ + E L V +
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESESER-----KAFIVELRQLSRVNH 60
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL---RNLGCLDEDVARVYIA-EVVLALEY 704
P +V+ + + C + LVMEY GG LY++L L + + + Y
Sbjct: 61 PNIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAH-AMSWCLQCSQGVAY 117
Query: 705 LHSLR---VVHRDLKPDNLLIAHDG-HIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGD 760
LHS++ ++HRDLKP NLL+ G +K+ DFG + D
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----------------------D 155
Query: 761 EEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820
+ +T + G+ ++APE+ G+ + D +S GIIL+E+I PF
Sbjct: 156 IQTHMT------------NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPF 203
Query: 821 N 821
+
Sbjct: 204 D 204
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-41
Identities = 78/270 (28%), Positives = 117/270 (43%), Gaps = 45/270 (16%)
Query: 561 EEDAPLEDDVVRSLRTSPIHPSKDRT--SID--DFEIIKPISRGAFGRVFLAKKRTTGDL 616
P+ D + + + D I D I + I G+FG V A+ G
Sbjct: 5 HHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH--GSD 62
Query: 617 FAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 676
A+K+L + D V L E I+ +R+P +V F + T NL +V EYL+ G L
Sbjct: 63 VAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSL 121
Query: 677 YSLLRNLGC---LDEDVARVYIA-EVVLALEYLHSLR--VVHRDLKPDNLLIAHDGHIKL 730
Y LL G LDE R+ +A +V + YLH+ +VHR+LK NLL+ +K+
Sbjct: 122 YRLLHKSGAREQLDERR-RLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKV 180
Query: 731 TDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPE 790
DFGLS++ +SA GTP+++APE
Sbjct: 181 CDFGLSRL-------------------------------KASTFLSSKSAAGTPEWMAPE 209
Query: 791 ILLGTGHGTTADWWSVGIILFELIVGIPPF 820
+L +D +S G+IL+EL P+
Sbjct: 210 VLRDEPSNEKSDVYSFGVILWELATLQQPW 239
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 3e-41
Identities = 54/258 (20%), Positives = 98/258 (37%), Gaps = 54/258 (20%)
Query: 581 PSKDRTSID--DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILA 638
P ++ + E K I +G FG V + + AIK L D + +
Sbjct: 9 PKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQ 68
Query: 639 ----ERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC-LDEDVARV 693
E I+ ++ +P +V+ + +VME++ GDLY L + + V ++
Sbjct: 69 EFQREVFIMSNLNHPNIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSV-KL 125
Query: 694 YIA-EVVLALEYLHSLR--VVHRDLKPDNLLIAHDG-----HIKLTDFGLSKVGLINSTD 745
+ ++ L +EY+ + +VHRDL+ N+ + K+ DFGLS+
Sbjct: 126 RLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ------- 178
Query: 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT--ADW 803
+G ++APE + T AD
Sbjct: 179 ---------------------------SVHSVSGLLGNFQWMAPETIGAEEESYTEKADT 211
Query: 804 WSVGIILFELIVGIPPFN 821
+S +IL+ ++ G PF+
Sbjct: 212 YSFAMILYTILTGEGPFD 229
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 8e-41
Identities = 52/255 (20%), Positives = 88/255 (34%), Gaps = 47/255 (18%)
Query: 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILI-SVRN 648
F + GA G + A+K + E +L S +
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFD-NRDVAVKRILPECF------SFADREVQLLRESDEH 77
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL-RNLGCLDEDVARVYIAEVVLALEYLHS 707
P V+R+F + R+ Y+ +E L + + + + L +LHS
Sbjct: 78 PNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS 136
Query: 708 LRVVHRDLKPDNLLIAHDGH-----IKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEE 762
L +VHRDLKP N+LI+ ++DFGL K
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK------------------------ 172
Query: 763 PQLTASEHQQERRKKRSAVGTPDYLAPEILLGT---GHGTTADWWSVGIILFELIV-GIP 818
+ + ++ GT ++APE+L T D +S G + + +I G
Sbjct: 173 ----LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
Query: 819 PFNAEHPQVSTLLRK 833
PF + + +L
Sbjct: 229 PFGKSLQRQANILLG 243
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-40
Identities = 57/282 (20%), Positives = 113/282 (40%), Gaps = 64/282 (22%)
Query: 581 PSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAER 640
P+ +++ + K + G+ G V G A+K + + L E
Sbjct: 7 PNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFC------DIALMEI 59
Query: 641 DILI-SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDV-------AR 692
+L S +P V+R++ S T LY+ +E +L L+ + DE++
Sbjct: 60 KLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPI 118
Query: 693 VYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH-------------DGHIKLTDFGLSKVG 739
+ ++ + +LHSL+++HRDLKP N+L++ + I ++DFGL K
Sbjct: 119 SLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK- 177
Query: 740 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-- 797
L + + + + GT + APE+L + +
Sbjct: 178 ------------------LDSGQSSFRTNLN--------NPSGTSGWRAPELLEESNNLQ 211
Query: 798 -----GTTADWWSVGIILFELIV-GIPPFNAEHPQVSTLLRK 833
+ D +S+G + + ++ G PF ++ + S ++R
Sbjct: 212 TKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRG 253
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 5e-40
Identities = 63/264 (23%), Positives = 102/264 (38%), Gaps = 72/264 (27%)
Query: 574 LRTSPIHPSKDRTSIDDFEII-KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNA 632
K IDD+++ + + G G+V + T + FA+K+L+ R+
Sbjct: 2 PHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-- 59
Query: 633 VESILAERDILISVRN-PFVVRFFYSF----TCRENLYLVMEYLNGGDLYS--LLRNLGC 685
E ++ P +VR + R+ L +VME L+GG+L+S R
Sbjct: 60 ------EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA 113
Query: 686 LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGLIN 742
E A + + A++YLHS+ + HRD+KP+NLL + +KLTDFG
Sbjct: 114 FTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG-------- 165
Query: 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTAD 802
A E G + + D
Sbjct: 166 --------------------------------------------FAKET-TGEKYDKSCD 180
Query: 803 WWSVGIILFELIVGIPPFNAEHPQ 826
WS+G+I++ L+ G PPF + H
Sbjct: 181 MWSLGVIMYILLCGYPPFYSNHGL 204
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-38
Identities = 57/252 (22%), Positives = 103/252 (40%), Gaps = 45/252 (17%)
Query: 580 HPSKDRTSIDDFEI-------IKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNA 632
H R + DD+EI + I G+FG V+ K GD+ A+K+L
Sbjct: 8 HHHGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWH--GDV-AVKMLNVTAP-TPQQ 63
Query: 633 VESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVAR 692
+++ E +L R+ ++ F ++ L +V ++ G LY L E
Sbjct: 64 LQAFKNEVGVLRKTRHVNILLF-MGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKL 122
Query: 693 VYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 751
+ IA + ++YLH+ ++HRDLK +N+ + D +K+ DFGL+
Sbjct: 123 IDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATE------------- 169
Query: 752 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHG---TTADWWSVGI 808
+ G+ ++APE++ +D ++ GI
Sbjct: 170 ----------------KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGI 213
Query: 809 ILFELIVGIPPF 820
+L+EL+ G P+
Sbjct: 214 VLYELMTGQLPY 225
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-37
Identities = 62/245 (25%), Positives = 103/245 (42%), Gaps = 50/245 (20%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKK-ADMIRKNAVESILAERDILISVR 647
+ + + I G FG+V+ A GD A+K + D +E++ E + ++
Sbjct: 7 AELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK 64
Query: 648 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIA-EVVLALEYLH 706
+P ++ NL LVME+ GG L +L + D+ V A ++ + YLH
Sbjct: 65 HPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR-IPPDI-LVNWAVQIARGMNYLH 122
Query: 707 S---LRVVHRDLKPDNLLIAHDGH--------IKLTDFGLSKVGLINSTDDLSGPAVSGT 755
+ ++HRDLK N+LI +K+TDFGL++
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE----------------- 165
Query: 756 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV 815
R K SA G ++APE++ + +D WS G++L+EL+
Sbjct: 166 ----------------WHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLT 209
Query: 816 GIPPF 820
G PF
Sbjct: 210 GEVPF 214
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-37
Identities = 60/242 (24%), Positives = 95/242 (39%), Gaps = 47/242 (19%)
Query: 591 FEIIKPISRGAFGRVFLAK-KRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP 649
+E+ I+ G G ++LA + G +K L + A +AER L V +P
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHP 139
Query: 650 FVVRFF-----YSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEY 704
+V+ F Y+VMEY+ G L L A Y+ E++ AL Y
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLLEILPALSY 197
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
LHS+ +V+ DLKP+N+++ + +KL D G ++
Sbjct: 198 LHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVS-------------RINSFG-------- 235
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824
GTP + APEI+ G D ++VG L L + +P N +
Sbjct: 236 --------------YLYGTPGFQAPEIVRT-GPTVATDIYTVGRTLAALTLDLPTRNGRY 280
Query: 825 PQ 826
Sbjct: 281 VD 282
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-37
Identities = 68/242 (28%), Positives = 109/242 (45%), Gaps = 40/242 (16%)
Query: 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESI----LAER 640
++ +E + + G F V+ A+ + T + AIK +K R A + I L E
Sbjct: 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGH--RSEAKDGINRTALREI 63
Query: 641 DILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC-LDEDVARVYIAEVV 699
+L + +P ++ +F + N+ LV +++ DL ++++ L + Y+ +
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTL 122
Query: 700 LALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLG 759
LEYLH ++HRDLKP+NLL+ +G +KL DFGL+K G
Sbjct: 123 QGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKS-------------------FG 163
Query: 760 DEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIVGIP 818
T HQ V T Y APE+L G D W+VG IL EL++ +P
Sbjct: 164 SPNRAYT---HQ---------VVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVP 211
Query: 819 PF 820
Sbjct: 212 FL 213
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-37
Identities = 61/237 (25%), Positives = 104/237 (43%), Gaps = 41/237 (17%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKA---DMIRKNAVESILAERDILIS 645
+ +E I I G++G VF + R TG + AIK ++ +I+K A L E +L
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIA----LREIRMLKQ 58
Query: 646 VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC-LDEDVARVYIAEVVLALEY 704
+++P +V F + L+LV EY + + L + E + + + + A+ +
Sbjct: 59 LKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNF 117
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
H +HRD+KP+N+LI IKL DFG +++ L
Sbjct: 118 CHKHNCIHRDVKPENILITKHSVIKLCDFGFARL-------------------LTGPSDY 158
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVGIPPF 820
+ V T Y +PE+L+G G D W++G + EL+ G+P +
Sbjct: 159 YD---DE---------VATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLW 203
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 4e-37
Identities = 57/243 (23%), Positives = 99/243 (40%), Gaps = 32/243 (13%)
Query: 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIR-KNAVESILAERDILI 644
T + + + + RG G V+ A+ + A+K++ + + E
Sbjct: 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMS-ETLSSDPVFRTRMQREARTAG 89
Query: 645 SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEY 704
++ P VV LY+ M +NG DL ++LR G L A + ++ AL+
Sbjct: 90 RLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDA 149
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
H+ HRD+KP+N+L++ D L DFG++ A +
Sbjct: 150 AHAAGATHRDVKPENILVSADDFAYLVDFGIAS-------------ATTDEK-------- 188
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824
LT + VGT Y+APE + AD +++ +L+E + G PP+ +
Sbjct: 189 LTQL---------GNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ 239
Query: 825 PQV 827
V
Sbjct: 240 LSV 242
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 8e-37
Identities = 63/239 (26%), Positives = 104/239 (43%), Gaps = 44/239 (18%)
Query: 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESI----LAERDIL 643
++ + + + G + V+ K + T +L A LK+ IR E + E +L
Sbjct: 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVA---LKE---IRLEHEEGAPCTAIREVSLL 54
Query: 644 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC-LDEDVARVYIAEVVLAL 702
+++ +V ++L LV EYL+ DL L + G ++ ++++ +++ L
Sbjct: 55 KDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGL 113
Query: 703 EYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEE 762
Y H +V+HRDLKP NLLI G +KL DFGL++
Sbjct: 114 AYCHRQKVLHRDLKPQNLLINERGELKLADFGLARA-------------------KSIPT 154
Query: 763 PQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIVGIPPF 820
++ V T Y P+ILLG+ +T D W VG I +E+ G P F
Sbjct: 155 KTYD---NE---------VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLF 201
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 60/246 (24%), Positives = 110/246 (44%), Gaps = 49/246 (19%)
Query: 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESI----LAERD 641
+S F+ ++ + G + V+ +TTG A LK+ ++ ++ E + E
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVA---LKE---VKLDSEEGTPSTAIREIS 55
Query: 642 ILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC------LDEDVARVYI 695
++ +++ +VR + L LV E+++ DL + + L+ ++ + +
Sbjct: 56 LMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQ 114
Query: 696 AEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGT 755
+++ L + H +++HRDLKP NLLI G +KL DFGL++
Sbjct: 115 WQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARA----------------- 157
Query: 756 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELI 814
G + + V T Y AP++L+G+ +T+ D WS G IL E+I
Sbjct: 158 --FGIPVNTFS---SE---------VVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMI 203
Query: 815 VGIPPF 820
G P F
Sbjct: 204 TGKPLF 209
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 62/235 (26%), Positives = 107/235 (45%), Gaps = 30/235 (12%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
++I+ + G V+LA+ AIK + ++ ++ E + +
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRV 710
+V + YLVMEY+ G L + + G L D A + +++ +++ H +R+
Sbjct: 73 IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRI 132
Query: 711 VHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEH 770
VHRD+KP N+LI + +K+ DFG++K A+S T+ LT +
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAK-------------ALSETS--------LTQTN- 170
Query: 771 QQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825
+GT Y +PE G D +S+GI+L+E++VG PPFN E
Sbjct: 171 --------HVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA 217
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-36
Identities = 58/239 (24%), Positives = 109/239 (45%), Gaps = 41/239 (17%)
Query: 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKA---DMIRKNAVESILAERDIL 643
S++ +E + + G++G V + + TG + AIK ++ M++K A + E +L
Sbjct: 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIA----MREIKLL 78
Query: 644 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC-LDEDVARVYIAEVVLAL 702
+R+ +V ++ YLV E+++ + L LD V + Y+ +++ +
Sbjct: 79 KQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGI 137
Query: 703 EYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEE 762
+ HS ++HRD+KP+N+L++ G +KL DFG ++ L
Sbjct: 138 GFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFART-------------------LAAPG 178
Query: 763 PQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVGIPPF 820
+ V T Y APE+L+G G D W++G ++ E+ +G P F
Sbjct: 179 EVYD---DE---------VATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLF 225
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 3e-36
Identities = 62/278 (22%), Positives = 110/278 (39%), Gaps = 55/278 (19%)
Query: 557 STVIEEDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDL 616
+ + + + + + TSID + I + G +G V+ A T +
Sbjct: 2 AHHHHHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNET 61
Query: 617 FAIKVLK--KAD------MIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668
AIK ++ + IR E +L +++ ++ L+L+
Sbjct: 62 VAIKRIRLEHEEEGVPGTAIR---------EVSLLKELQHRNIIELKSVIHHNHRLHLIF 112
Query: 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI-----A 723
EY DL + + V + ++ +++ + + HS R +HRDLKP NLL+ +
Sbjct: 113 EYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDAS 171
Query: 724 HDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGT 783
+K+ DFGL++ G Q T H+ + T
Sbjct: 172 ETPVLKIGDFGLARA-------------------FGIPIRQFT---HE---------IIT 200
Query: 784 PDYLAPEILLGTGHGTTA-DWWSVGIILFELIVGIPPF 820
Y PEILLG+ H +T+ D WS+ I E+++ P F
Sbjct: 201 LWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLF 238
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 7e-36
Identities = 64/248 (25%), Positives = 112/248 (45%), Gaps = 36/248 (14%)
Query: 575 RTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVE 634
+S + ++ ++ ++ + G +G V+ AK G + A+K ++ D +
Sbjct: 7 HSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIR-LDAEDEGIPS 64
Query: 635 SILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC-LDEDVARV 693
+ + E +L + +P +V L LV E++ DL +L L + ++
Sbjct: 65 TAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKI 123
Query: 694 YIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753
Y+ +++ + + H R++HRDLKP NLLI DG +KL DFGL++
Sbjct: 124 YLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARA--------------- 168
Query: 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFE 812
G T H+ V T Y AP++L+G+ +T+ D WS+G I E
Sbjct: 169 ----FGIPVRSYT---HE---------VVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAE 212
Query: 813 LIVGIPPF 820
+I G P F
Sbjct: 213 MITGKPLF 220
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 9e-36
Identities = 64/235 (27%), Positives = 114/235 (48%), Gaps = 36/235 (15%)
Query: 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR 647
++ + ++ I G +G V+ A+ G+ FA+K ++ + + + + E IL ++
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNNY-GETFALKKIR-LEKEDEGIPSTTIREISILKELK 58
Query: 648 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC-LDEDVARVYIAEVVLALEYLH 706
+ +V+ + ++ L LV E+L+ DL LL L+ A+ ++ +++ + Y H
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 707 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLT 766
RV+HRDLKP NLLI +G +K+ DFGL++ G + T
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARA-------------------FGIPVRKYT 158
Query: 767 ASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIVGIPPF 820
H+ + T Y AP++L+G+ +T D WSVG I E++ G P F
Sbjct: 159 ---HE---------IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF 201
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 9e-36
Identities = 62/239 (25%), Positives = 104/239 (43%), Gaps = 43/239 (17%)
Query: 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESI----LAERDIL 643
+ +E ++ I G +G VF AK R T ++ A+K ++ + E + L E +L
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR-----LDDDDEGVPSSALREICLL 55
Query: 644 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC-LDEDVARVYIAEVVLAL 702
+++ +VR + L LV E+ + DL + LD ++ + ++ +++ L
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGL 114
Query: 703 EYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEE 762
+ HS V+HRDLKP NLLI +G +KL +FGL++ G
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARA-------------------FGIPV 155
Query: 763 PQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIVGIPPF 820
+ + V T Y P++L G +T+ D WS G I EL P
Sbjct: 156 RCYS---AE---------VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 40/242 (16%), Positives = 80/242 (33%), Gaps = 48/242 (19%)
Query: 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR 647
+ ++ G ++ + + G+ +KVLK D E L
Sbjct: 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRD-WSTRKSRDFNEECPRLRIFS 65
Query: 648 NPFVVRFFYSFTC--RENLYLVMEYLNGGDLYSLLRNLGCLDEDVA-RVYIA-EVVLALE 703
+P V+ + + L+ ++ G LY++L D + V A ++ +
Sbjct: 66 HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMA 125
Query: 704 YLHSLR--VVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDE 761
+LH+L + L +++I D +++ +
Sbjct: 126 FLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFS----------------------- 162
Query: 762 EPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT---ADWWSVGIILFELIVGIP 818
+ + P ++APE L T AD WS ++L+EL+
Sbjct: 163 -------------FQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREV 209
Query: 819 PF 820
PF
Sbjct: 210 PF 211
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 7e-35
Identities = 63/246 (25%), Positives = 104/246 (42%), Gaps = 45/246 (18%)
Query: 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDI---- 642
+ +E + I GA+G V+ A+ +G A+K ++ + I R++
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 643 -LISVRNPFVVRFF-----YSFTCRENLYLVMEYLNGGDLYSLLRNLGC--LDEDVARVY 694
L + +P VVR + LV E+++ DL + L L + +
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDL 125
Query: 695 IAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 754
+ + + L++LH+ +VHRDLKP+N+L+ G +KL DFGL+++
Sbjct: 126 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARI---------------- 169
Query: 755 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI 814
+ LT V T Y APE+LL + + T D WSVG I E+
Sbjct: 170 ---YSYQMA-LT---PV---------VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 213
Query: 815 VGIPPF 820
P F
Sbjct: 214 RRKPLF 219
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 59/240 (24%), Positives = 108/240 (45%), Gaps = 34/240 (14%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIR-KNAVESILAERDILISVRNP 649
+E+ + + G V LA+ A+KVL+ AD+ R + E ++ +P
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLR-ADLARDPSFYLRFRREAQNAAALNHP 72
Query: 650 FVVRFF----YSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYL 705
+V + Y+VMEY++G L ++ G + A IA+ AL +
Sbjct: 73 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132
Query: 706 HSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQL 765
H ++HRD+KP N++I+ +K+ DFG+++ A++ + +
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIAR-------------AIADSG------NSV 173
Query: 766 TASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825
T + + +GT YL+PE G +D +S+G +L+E++ G PPF + P
Sbjct: 174 TQTA---------AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 5e-34
Identities = 59/237 (24%), Positives = 103/237 (43%), Gaps = 46/237 (19%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
DD+++++ + RG + VF A T + +K+LK + I E IL ++R
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK------IKREIKILENLRG 89
Query: 649 -PFVVRFFYSFT--CRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYL 705
P ++ LV E++N D L + L D D+ R Y+ E++ AL+Y
Sbjct: 90 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLT--DYDI-RFYMYEILKALDYC 146
Query: 706 HSLRVVHRDLKPDNLLIAHD-GHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
HS+ ++HRD+KP N++I H+ ++L D+GL++ +
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF--------------------YHPGQE 186
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIVGIPPF 820
R V + + PE+L+ + D WS+G +L +I PF
Sbjct: 187 YN------VR------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 54/259 (20%), Positives = 95/259 (36%), Gaps = 56/259 (21%)
Query: 582 SKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERD 641
S RT D +++ + +G +G V+ + G+ A+K+ D +S E +
Sbjct: 1 SMQRTVARDITLLECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDE------KSWFRETE 52
Query: 642 I--LISVRNPFVVRFF----YSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYI 695
+ + +R+ ++ F S L+L+ Y G LY L+ LD +
Sbjct: 53 LYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIV 111
Query: 696 AEVVLALEYLHSLR--------VVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747
+ L +LH + HRDLK N+L+ +G + D GL+ +
Sbjct: 112 LSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM--------- 162
Query: 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT------A 801
+ Q VGT Y+APE+L T
Sbjct: 163 ------------------HSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRV 204
Query: 802 DWWSVGIILFELIVGIPPF 820
D W+ G++L+E+ +
Sbjct: 205 DIWAFGLVLWEVARRMVSN 223
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-33
Identities = 72/254 (28%), Positives = 109/254 (42%), Gaps = 63/254 (24%)
Query: 587 SIDDFEIIKPISRGAFGRVFLAK-KRTTGDLFAIKVLKKADM-----------IRKNAVE 634
+ +E + I GA+G+VF A+ + G A LK+ + IR E
Sbjct: 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVA---LKRVRVQTGEEGMPLSTIR----E 61
Query: 635 -SILAERDILISVRNPFVVRFF-----YSFTCRENLYLVMEYLNGGDLYSLLRNLGC--L 686
++L L + +P VVR F L LV E+++ DL + L + +
Sbjct: 62 VAVLRH---LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGV 117
Query: 687 DEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746
+ + + +++ L++LHS RVVHRDLKP N+L+ G IKL DFGL+++
Sbjct: 118 PTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI-------- 169
Query: 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSV 806
+ LT V T Y APE+LL + + T D WSV
Sbjct: 170 ------------YSFQMALT---SV---------VVTLWYRAPEVLLQSSYATPVDLWSV 205
Query: 807 GIILFELIVGIPPF 820
G I E+ P F
Sbjct: 206 GCIFAEMFRRKPLF 219
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-33
Identities = 74/250 (29%), Positives = 114/250 (45%), Gaps = 54/250 (21%)
Query: 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIK-VLKKADMIRKNAVESILAERDI 642
DR + K I G+FG V+ AK +G+L AIK VL+ D KN E I
Sbjct: 49 DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ--DKRFKNR------ELQI 100
Query: 643 LISVRNPFVVR---FFYSFTCREN---LYLVMEYLNGGDLYSLLRNLGC----LDEDVAR 692
+ + + +VR FFYS +++ L LV++Y+ +Y + R+ L +
Sbjct: 101 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVK 159
Query: 693 VYIAEVVLALEYLHSLRVVHRDLKPDNLLI-AHDGHIKLTDFGLSKVGLINSTDDLSGPA 751
+Y+ ++ +L Y+HS + HRD+KP NLL+ +KL DFG +K
Sbjct: 160 LYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ------------- 206
Query: 752 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIIL 810
L EP S + + Y APE++ G T++ D WS G +L
Sbjct: 207 ------LVRGEP-------------NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 247
Query: 811 FELIVGIPPF 820
EL++G P F
Sbjct: 248 AELLLGQPIF 257
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-32
Identities = 67/249 (26%), Positives = 103/249 (41%), Gaps = 49/249 (19%)
Query: 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIR-KNAVES--ILAERDIL 643
+ +E + I +G FG VF A+ R TG A LKK + +N E I A R+I
Sbjct: 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVA---LKK---VLMENEKEGFPITALREIK 68
Query: 644 I--SVRNPFVVR--------FFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC-LDEDVAR 692
I +++ VV C+ ++YLV ++ DL LL N+ +
Sbjct: 69 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIK 127
Query: 693 VYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 752
+ ++ L Y+H +++HRD+K N+LI DG +KL DFGL A
Sbjct: 128 RVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL---------------AR 172
Query: 753 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILF 811
+ + + + T + V T Y PE+LLG D W G I+
Sbjct: 173 AFSLAKNSQPNRYT------------NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMA 220
Query: 812 ELIVGIPPF 820
E+ P
Sbjct: 221 EMWTRSPIM 229
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 58/256 (22%), Positives = 99/256 (38%), Gaps = 56/256 (21%)
Query: 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDI-- 642
RT +++K I +G +G V++ K R G+ A+KV + S E +I
Sbjct: 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE------ASWFRETEIYQ 84
Query: 643 LISVRNPFVVRFF----YSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEV 698
+ +R+ ++ F LYL+ +Y G LY L++ LD
Sbjct: 85 TVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSS 143
Query: 699 VLALEYLHSLR--------VVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 750
V L +LH+ + HRDLK N+L+ +G + D GL+ + ++ + P
Sbjct: 144 VSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPP 203
Query: 751 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT------ADWW 804
+ VGT Y+ PE+L + + AD +
Sbjct: 204 ---------------------------NTRVGTKRYMPPEVLDESLNRNHFQSYIMADMY 236
Query: 805 SVGIILFELIVGIPPF 820
S G+IL+E+
Sbjct: 237 SFGLILWEVARRCVSG 252
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-32
Identities = 71/243 (29%), Positives = 111/243 (45%), Gaps = 55/243 (22%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIK-VLKKADMIRKNAVESILAERDILISVRNP 649
+ K I G+FG VF AK + + AIK VL+ D KN E I+ V++P
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQ--DKRFKNR------ELQIMRIVKHP 92
Query: 650 FVVR---FFYSFTCREN---LYLVMEYLNGGDLYSLLRNLG----CLDEDVARVYIAEVV 699
VV FFYS +++ L LV+EY+ +Y R+ + + ++Y+ +++
Sbjct: 93 NVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLL 151
Query: 700 LALEYLHSLRVVHRDLKPDNLLI-AHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 758
+L Y+HS+ + HRD+KP NLL+ G +KL DFG +K+
Sbjct: 152 RSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI-------------------- 191
Query: 759 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIVGI 817
S + + Y APE++ G + TT D WS G ++ EL+ G
Sbjct: 192 ------------LIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
Query: 818 PPF 820
P F
Sbjct: 240 PLF 242
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 8e-32
Identities = 72/257 (28%), Positives = 116/257 (45%), Gaps = 56/257 (21%)
Query: 581 PSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIK--VLKKADMIRKNAVESILA 638
+ R +D F++ + +G FG V L K+++TG AIK + R L
Sbjct: 15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNR------ELQ 68
Query: 639 ERDILISVRNPFVVR---FFYSFTCREN----LYLVMEYLNGGDLYSLLRNLGC----LD 687
L + +P +V+ +FY+ R+ L +VMEY+ L+ RN
Sbjct: 69 IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPP 127
Query: 688 EDVARVYIAEVVLALEYLH--SLRVVHRDLKPDNLLI-AHDGHIKLTDFGLSKVGLINST 744
+ +V++ +++ ++ LH S+ V HRD+KP N+L+ DG +KL DFG +K
Sbjct: 128 PILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKK------ 181
Query: 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DW 803
L EP + + + + Y APE++ G H TTA D
Sbjct: 182 -------------LSPSEPNV-------------AYICSRYYRAPELIFGNQHYTTAVDI 215
Query: 804 WSVGIILFELIVGIPPF 820
WSVG I E+++G P F
Sbjct: 216 WSVGCIFAEMMLGEPIF 232
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-31
Identities = 60/240 (25%), Positives = 98/240 (40%), Gaps = 49/240 (20%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDIL--ISVRN 648
+E++K I +G+FG+V A A+K+++ + A E IL + ++
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA----AEEIRILEHLRKQD 154
Query: 649 P----FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC--LDEDVARVYIAEVVLAL 702
V+ +FT R ++ + E L +LY L++ + R + ++ L
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCL 213
Query: 703 EYLHSLRVVHRDLKPDNLLIAHDGH--IKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGD 760
+ LH R++H DLKP+N+L+ G IK+ DFG S
Sbjct: 214 DALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS-------------------CYEHQ 254
Query: 761 EEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820
S Y APE++LG +G D WS+G IL EL+ G P
Sbjct: 255 RVYTYIQSRF---------------YRAPEVILGARYGMPIDMWSLGCILAELLTGYPLL 299
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 59/295 (20%), Positives = 104/295 (35%), Gaps = 58/295 (19%)
Query: 551 DKVDITSTVIEEDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKK 610
D+ I+ +D L D+ S S + RT + + I +G FG V+ K
Sbjct: 6 DRPFISEGTTLKD--LIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW 63
Query: 611 RTTGDLFAIKVLKKADMIRKNAVESILAERDI--LISVRNPFVVRFFYSFTCREN----L 664
R G+ A+K+ + S E +I + +R+ ++ F + L
Sbjct: 64 R--GEEVAVKIFSSREE------RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 115
Query: 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS--------LRVVHRDLK 716
+LV +Y G L+ L + + L +LH + HRDLK
Sbjct: 116 WLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLK 174
Query: 717 PDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRK 776
N+L+ +G + D GL+ + A H+
Sbjct: 175 SKNILVKKNGTCCIADLGLAVR------------------HDSATDTIDIAPNHR----- 211
Query: 777 KRSAVGTPDYLAPEILLGTGHGTT------ADWWSVGIILFELIVGIPPFNAEHP 825
VGT Y+APE+L + + AD +++G++ +E+
Sbjct: 212 ----VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-31
Identities = 56/250 (22%), Positives = 94/250 (37%), Gaps = 55/250 (22%)
Query: 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDI--LIS 645
+D+ ++++ I RG +G V+ A+KV A+ ++ + E++I +
Sbjct: 12 LDNLKLLELIGRGRYGAVYKGSLD--ERPVAVKVFSFANR------QNFINEKNIYRVPL 63
Query: 646 VRNPFVVRFF-----YSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVL 700
+ + + RF + R LVMEY G L L D + V
Sbjct: 64 MEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-HTSDWVSSCRLAHSVTR 122
Query: 701 ALEYLHS---------LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 751
L YLH+ + HRDL N+L+ +DG ++DFGLS N
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEED 182
Query: 752 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-------GHGTTADWW 804
+ + VGT Y+APE+L G D +
Sbjct: 183 NAAISE-----------------------VGTIRYMAPEVLEGAVNLRDXESALKQVDMY 219
Query: 805 SVGIILFELI 814
++G+I +E+
Sbjct: 220 ALGLIYWEIF 229
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-30
Identities = 62/245 (25%), Positives = 105/245 (42%), Gaps = 38/245 (15%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDI------ 642
D +EI I G++G V A + + AIK K + ++ ++ R+I
Sbjct: 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIK---KILRVFEDLIDCKRILREIAILNRL 109
Query: 643 ----LISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEV 698
++ V + + + F + LY+V+E D L R L E + + +
Sbjct: 110 NHDHVVKVLDIVIPKDVEKF---DELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNL 165
Query: 699 VLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS--------KVGLINSTDDLSGP 750
++ ++Y+HS ++HRDLKP N L+ D +K+ DFGL+ + +
Sbjct: 166 LVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225
Query: 751 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGII 809
+ + + QLT H V T Y APE++L + T A D WS+G I
Sbjct: 226 NLVTFPHTKNLKRQLT--GH----------VVTRWYRAPELILLQENYTEAIDVWSIGCI 273
Query: 810 LFELI 814
EL+
Sbjct: 274 FAELL 278
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-30
Identities = 63/256 (24%), Positives = 109/256 (42%), Gaps = 33/256 (12%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDI------ 642
D++ I I RG++G V+LA + T AIK K + + ++ ++ R+I
Sbjct: 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIK---KVNRMFEDLIDCKRILREITILNRL 82
Query: 643 ----LISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEV 698
+I + + + F + LY+V+E DL L + L E+ + + +
Sbjct: 83 KSDYIIRLYDLIIPDDLLKF---DELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNL 138
Query: 699 VLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV---GLINSTDDLSGPAVSGT 755
+L ++H ++HRDLKP N L+ D +K+ DFGL++ + +
Sbjct: 139 LLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPG 198
Query: 756 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELI 814
+ + QLT H V T Y APE++L + T + D WS G I EL+
Sbjct: 199 PHNKNLKKQLT--SH----------VVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246
Query: 815 VGIPPFNAEHPQVSTL 830
+ + L
Sbjct: 247 NMLQSHINDPTNRFPL 262
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 6e-30
Identities = 64/271 (23%), Positives = 108/271 (39%), Gaps = 55/271 (20%)
Query: 587 SIDDFEIIKP-ISRGAFGRVFLAKKR--TTGDLFAIKVLKKADMIRKNAVESILAERDIL 643
D FE + RG +G V+ AK++ +A+K ++ + S E +L
Sbjct: 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALL 72
Query: 644 ISVRNPFVVRFFYSFTCREN--LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVL- 700
+++P V+ F + ++L+ +Y DL+ +++ + V + ++
Sbjct: 73 RELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVK 131
Query: 701 --------ALEYLHSLRVVHRDLKPDNLLIAHD----GHIKLTDFGLSKVGLINSTDDLS 748
+ YLH+ V+HRDLKP N+L+ + G +K+ D G ++
Sbjct: 132 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR----------- 180
Query: 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVG 807
L L + V T Y APE+LLG H T A D W++G
Sbjct: 181 --------LFNSPLKPLADLDPV---------VVTFWYRAPELLLGARHYTKAIDIWAIG 223
Query: 808 IILFELIVGIPPF--NAEHPQVSTLLRKCQL 836
I EL+ P F E + S QL
Sbjct: 224 CIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 254
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-29
Identities = 68/250 (27%), Positives = 104/250 (41%), Gaps = 55/250 (22%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDIL--ISVRN 648
+EI I +G+FG+V A R + AIK++K A E +L ++ +
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA----QIEVRLLELMNKHD 111
Query: 649 P----FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC--LDEDVARVYIAEVVLAL 702
++V F R +L LV E L +LY LLRN + ++ R + ++ AL
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTAL 170
Query: 703 EYLHS--LRVVHRDLKPDNLLIAHDGH--IKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 758
+L + L ++H DLKP+N+L+ + IK+ DFG S L
Sbjct: 171 LFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-------------------CQL 211
Query: 759 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIP 818
G Q S Y +PE+LLG + D WS+G IL E+ G P
Sbjct: 212 GQRIYQYIQSRF---------------YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEP 256
Query: 819 PF----NAEH 824
F +
Sbjct: 257 LFSGANEVDQ 266
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 47/273 (17%), Positives = 98/273 (35%), Gaps = 61/273 (22%)
Query: 576 TSPIHPSKDRTSID--DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAV 633
+S + + ++++ +RG FG V+ A+ + A+K+ D
Sbjct: 9 SSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDK------ 60
Query: 634 ESILAERDI--LISVRNPFVVRFFYSFTCREN----LYLVMEYLNGGDLYSLLRNLGCLD 687
+S E ++ L +++ +++F + + L+L+ + G L L+ +
Sbjct: 61 QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-NVVS 119
Query: 688 EDVARVYIAEVVLALEYLHS----------LRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 737
+ + L YLH + HRD+K N+L+ ++ + DFGL+
Sbjct: 120 WNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL 179
Query: 738 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH 797
+ + VGT Y+APE+L G +
Sbjct: 180 KFEAGKSAGDT-----------------------------HGQVGTRRYMAPEVLEGAIN 210
Query: 798 GTT-----ADWWSVGIILFELIVGIPPFNAEHP 825
D +++G++L+EL +
Sbjct: 211 FQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-29
Identities = 73/243 (30%), Positives = 124/243 (51%), Gaps = 31/243 (12%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAER-----DIL 643
+E++K + +GA+G V+ + R TG++ A+K K D + S A+R IL
Sbjct: 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVK--KIFDAFQN----STDAQRTFREIMIL 62
Query: 644 ISVRN-PFVVRFFYSFTCREN--LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVL 700
+ +V + +YLV +Y+ DL++++R L+ + + +++
Sbjct: 63 TELSGHENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVIRA-NILEPVHKQYVVYQLIK 120
Query: 701 ALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGL--SKVGLINSTDDLSGPAVSGTTLL 758
++YLHS ++HRD+KP N+L+ + H+K+ DFGL S V + T+++ T
Sbjct: 121 VIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENF 180
Query: 759 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIVGI 817
D++P LT ++ V T Y APEILLG+ T D WS+G IL E++ G
Sbjct: 181 DDDQPILT--DY----------VATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
Query: 818 PPF 820
P F
Sbjct: 229 PIF 231
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 3e-29
Identities = 64/243 (26%), Positives = 112/243 (46%), Gaps = 41/243 (16%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDI------ 642
DF++ + GA+G V A + TG++ AIK K + + ++ R+I
Sbjct: 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK---KIEPFD-KPLFALRTLREIKILKHF 66
Query: 643 ----LISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEV 698
+I++ N F +F +Y++ E + DL+ ++ L +D + +I +
Sbjct: 67 KHENIITIFNIQRPDSFENF---NEVYIIQELM-QTDLHRVIST-QMLSDDHIQYFIYQT 121
Query: 699 VLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 758
+ A++ LH V+HRDLKP NLLI + +K+ DFGL+++ + + +
Sbjct: 122 LRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARI---------IDESAADNSEP 172
Query: 759 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIVGI 817
++ + E V T Y APE++L + + A D WS G IL EL +
Sbjct: 173 TGQQSGMV--EF----------VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
Query: 818 PPF 820
P F
Sbjct: 221 PIF 223
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 4e-29
Identities = 53/250 (21%), Positives = 92/250 (36%), Gaps = 55/250 (22%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAV---ESILAERDI--- 642
+ + + IS G++G V + G AIK + + +S L +R +
Sbjct: 22 SPYTVQRFISSGSYGAVCAGV-DSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 643 ----------LISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVA 691
++ +R+ FV + LYLV E + DL ++ +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAM---HKLYLVTELM-RTDLAQVIHDQRIVISPQHI 136
Query: 692 RVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 751
+ ++ ++L L LH VVHRDL P N+L+A + I + DF L++
Sbjct: 137 QYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLARE------------- 183
Query: 752 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIIL 810
+ T + V Y APE+++ T D WS G ++
Sbjct: 184 -------DTADANKT--HY----------VTHRWYRAPELVMQFKGFTKLVDMWSAGCVM 224
Query: 811 FELIVGIPPF 820
E+ F
Sbjct: 225 AEMFNRKALF 234
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-28
Identities = 61/244 (25%), Positives = 100/244 (40%), Gaps = 55/244 (22%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKA-----DMIRKNAVESILAERDIL 643
+ + GA+G V A + +G+ AIK L + R E +L
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKR------AYRELLLL 77
Query: 644 ISVRNPFVVR---FFYSFTCREN---LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAE 697
+++ V+ F + N YLVM ++ DL ++ E+ + + +
Sbjct: 78 KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLK--FSEEKIQYLVYQ 134
Query: 698 VVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 757
++ L+Y+HS VVHRDLKP NL + D +K+ DFGL++
Sbjct: 135 MLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARH------------------- 175
Query: 758 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIVG 816
+ ++T + V T Y APE++L H D WSVG I+ E++ G
Sbjct: 176 ---ADAEMT--GY----------VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 220
Query: 817 IPPF 820
F
Sbjct: 221 KTLF 224
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 66/244 (27%), Positives = 107/244 (43%), Gaps = 45/244 (18%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIK------------VLKKADMIRKNAVESILA 638
+ +KP+ G G VF A AIK L++ +IR+ ++I+
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 639 ERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEV 698
+IL + S T ++Y+V EY+ DL ++L G L E+ AR+++ ++
Sbjct: 73 VFEILGP-SGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQ-GPLLEEHARLFMYQL 129
Query: 699 VLALEYLHSLRVVHRDLKPDNLLI-AHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 757
+ L+Y+HS V+HRDLKP NL I D +K+ DFGL++
Sbjct: 130 LRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLAR----------------IMDP 173
Query: 758 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIVG 816
+ L+ E + T Y +P +LL + T A D W+ G I E++ G
Sbjct: 174 HYSHKGHLS--EG----------LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 221
Query: 817 IPPF 820
F
Sbjct: 222 KTLF 225
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-28
Identities = 59/252 (23%), Positives = 99/252 (39%), Gaps = 39/252 (15%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR--- 647
F +I+ + G FGRV L + +A+KV++ ++A E DIL ++
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQNDD 92
Query: 648 --NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC--LDEDVARVYIAEVVLALE 703
N +V++ F +++ L+ E L G LY ++ + ++Y E++ AL
Sbjct: 93 INNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALN 151
Query: 704 YLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV-------SGTT 756
YL + + H DLKP+N+L+ K + T
Sbjct: 152 YLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCAT- 210
Query: 757 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVG 816
+ S + T Y APE++L G ++D WS G +L EL G
Sbjct: 211 ---------------FKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255
Query: 817 IPPF----NAEH 824
F + EH
Sbjct: 256 SLLFRTHEHMEH 267
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-28
Identities = 60/267 (22%), Positives = 101/267 (37%), Gaps = 70/267 (26%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIK-VLKKA----------------------DM 627
+ + K + G+FG V +G FA+K VL+ D
Sbjct: 9 YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDY 68
Query: 628 IRKNAVESILAERDILISVRNPFVVRFFYSFTCREN--------LYLVMEYLNGGDLYSL 679
E + + + L ++MEY+ L+ +
Sbjct: 69 FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV-PDTLHKV 127
Query: 680 LRNLGC----LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI-AHDGHIKLTDFG 734
L++ + ++ +YI ++ A+ ++HSL + HRD+KP NLL+ + D +KL DFG
Sbjct: 128 LKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFG 187
Query: 735 LSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG 794
+K L EP + + + Y APE++LG
Sbjct: 188 SAKK-------------------LIPSEP-SV------------AYICSRFYRAPELMLG 215
Query: 795 TGHGTTA-DWWSVGIILFELIVGIPPF 820
T + D WS+G + ELI+G P F
Sbjct: 216 ATEYTPSIDLWSIGCVFGELILGKPLF 242
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-28
Identities = 67/242 (27%), Positives = 100/242 (41%), Gaps = 46/242 (19%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVL----KKADMIRKNAVESILAERDILI 644
+ + I GA+G V A AIK + + R L E IL+
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQR------TLREIKILL 80
Query: 645 SVRNPFVVRFFYSFT--CREN---LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVV 699
R+ ++ E +Y+V + + DLY LL+ L D ++ +++
Sbjct: 81 RFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKT-QHLSNDHICYFLYQIL 138
Query: 700 LALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLG 759
L+Y+HS V+HRDLKP NLL+ +K+ DFGL++
Sbjct: 139 RGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR----------------VADPDH 182
Query: 760 DEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIVGIP 818
D LT E+ V T Y APEI+L + T + D WSVG IL E++ P
Sbjct: 183 DHTGFLT--EY----------VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230
Query: 819 PF 820
F
Sbjct: 231 IF 232
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-28
Identities = 62/242 (25%), Positives = 103/242 (42%), Gaps = 50/242 (20%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDI------ 642
++ +KPI GA G V A AIK K +N + A R++
Sbjct: 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIK---KLSRPFQNQTHAKRAYRELVLMKCV 81
Query: 643 ----LISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEV 698
+I + N V S +++Y+VME + +L +++ LD + + ++
Sbjct: 82 NHKNIIGLLN--VFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMSYLLYQM 136
Query: 699 VLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 758
+ +++LHS ++HRDLKP N+++ D +K+ DFGL++
Sbjct: 137 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-------------------- 176
Query: 759 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIP 818
+T V T Y APE++LG G+ D WSVG I+ E+I G
Sbjct: 177 AGTSFMMTPY------------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 224
Query: 819 PF 820
F
Sbjct: 225 LF 226
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-28
Identities = 63/243 (25%), Positives = 105/243 (43%), Gaps = 52/243 (21%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDI------ 642
+ ++P+ GA+G V A TG AIK K ++ + + A R++
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK---KLYRPFQSELFAKRAYRELRLLKHM 81
Query: 643 ----LISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEV 698
+I + + V + + YLVM ++ G DL L+++ L ED + + ++
Sbjct: 82 RHENVIGLLD--VFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQM 137
Query: 699 VLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 758
+ L Y+H+ ++HRDLKP NL + D +K+ DFGL++
Sbjct: 138 LKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ-------------------- 177
Query: 759 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIVGI 817
+ ++T V T Y APE++L T D WSVG I+ E+I G
Sbjct: 178 --ADSEMT------------GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
Query: 818 PPF 820
F
Sbjct: 224 TLF 226
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-28
Identities = 62/243 (25%), Positives = 104/243 (42%), Gaps = 52/243 (21%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDI------ 642
+ ++ + P+ GA+G V A TG A+K K ++ + + R++
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK---KLSRPFQSIIHAKRTYRELRLLKHM 85
Query: 643 ----LISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEV 698
+I + + V S ++YLV + G DL ++++ L +D + I ++
Sbjct: 86 KHENVIGLLD--VFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQI 141
Query: 699 VLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 758
+ L+Y+HS ++HRDLKP NL + D +K+ DFGL++
Sbjct: 142 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH-------------------- 181
Query: 759 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIVGI 817
++T V T Y APEI+L H D WSVG I+ EL+ G
Sbjct: 182 --TADEMT------------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
Query: 818 PPF 820
F
Sbjct: 228 TLF 230
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 6e-28
Identities = 59/243 (24%), Positives = 100/243 (41%), Gaps = 52/243 (21%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAER-----DIL 643
++ +KPI GA G V A AIK K + + A+R ++
Sbjct: 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQN----QTHAKRAYRELVLM 115
Query: 644 ISVRNPFVVR---FFYSFTCREN---LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAE 697
V + ++ F E +YLVME + +L +++ LD + + +
Sbjct: 116 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMSYLLYQ 172
Query: 698 VVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 757
++ +++LHS ++HRDLKP N+++ D +K+ DFGL++
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART------------------- 213
Query: 758 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGI 817
+T V T Y APE++LG G+ D WSVG I+ E++
Sbjct: 214 -AGTSFMMTPY------------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
Query: 818 PPF 820
F
Sbjct: 261 ILF 263
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 53/263 (20%), Positives = 101/263 (38%), Gaps = 63/263 (23%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP- 649
+ +++ + G F V+LAK A+K+++ + + A E +L V +
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAA----EDEIKLLQRVNDAD 76
Query: 650 ----------FVVRFFYSFTCREN----LYLVMEYLNGGDLYSLLRNLGC--LDEDVARV 693
+++ F + + +V E L G +L +L++ + +
Sbjct: 77 NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQ 135
Query: 694 YIAEVVLALEYLHS-LRVVHRDLKPDNLLIAH------DGHIKLTDFGLSKVGLINSTDD 746
+++L L+Y+H ++H D+KP+N+L+ IK+ D G + + T+
Sbjct: 136 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS 195
Query: 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSV 806
+ T +Y +PE+LLG G AD WS
Sbjct: 196 IQ----------------------------------TREYRSPEVLLGAPWGCGADIWST 221
Query: 807 GIILFELIVGIPPFNAEHPQVST 829
++FELI G F + T
Sbjct: 222 ACLIFELITGDFLFEPDEGHSYT 244
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 5e-27
Identities = 62/266 (23%), Positives = 103/266 (38%), Gaps = 71/266 (26%)
Query: 591 FEIIKPISRGAFGRVFLAK-KRTTGDLFAIKVLKKADMIRKNAVESILAERDIL--ISVR 647
+EI+ + GAFG+V + G A+K++K D + A +E +L ++
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA----RSEIQVLEHLNTT 71
Query: 648 NPF----VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC--LDEDVARVYIAEVVLA 701
+P V+ F ++ +V E L G Y ++ G D R ++ +
Sbjct: 72 DPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKS 130
Query: 702 LEYLHSLRVVHRDLKPDNLLIAHDGH-------------------IKLTDFGLSKVGLIN 742
+ +LHS ++ H DLKP+N+L + IK+ DFG +
Sbjct: 131 VNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG-------S 183
Query: 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTAD 802
+T D + L ++ H Y APE++L G D
Sbjct: 184 ATYD------------DEHHSTLVSTRH---------------YRAPEVILALGWSQPCD 216
Query: 803 WWSVGIILFELIVGIPPF----NAEH 824
WS+G IL E +G F + EH
Sbjct: 217 VWSIGCILIEYYLGFTVFPTHDSKEH 242
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 48/185 (25%), Positives = 91/185 (49%), Gaps = 12/185 (6%)
Query: 563 DAPLEDDVVRSLRTSPIHPSKDRTSID--DFEIIKPISRGAFGRVFLAK----KRTTGDL 616
D P +++ +D T + + ++ + +G FG V + + + TG++
Sbjct: 13 DIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEV 72
Query: 617 FAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFF--YSFTCRENLYLVMEYLNGG 674
A+K L+ + + E +IL S+++ +V++ R NL L+MEYL G
Sbjct: 73 VAVKKLQHSTE---EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 129
Query: 675 DLYSLLR-NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDF 733
L L+ + +D Y +++ +EYL + R +HRDL N+L+ ++ +K+ DF
Sbjct: 130 SLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDF 189
Query: 734 GLSKV 738
GL+KV
Sbjct: 190 GLTKV 194
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-26
Identities = 56/266 (21%), Positives = 91/266 (34%), Gaps = 71/266 (26%)
Query: 591 FEIIKPISRGAFGRVFLAK-KRTTGDLFAIKVLKKADMIRKNAVESILAERDIL--ISVR 647
+EI+ + G FG+V A+K+++ R+ A E ++L I +
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA----RLEINVLKKIKEK 76
Query: 648 NPF----VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC--LDEDVARVYIAEVVLA 701
+ V F ++ + E L G + + L+ R ++ A
Sbjct: 77 DKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHA 135
Query: 702 LEYLHSLRVVHRDLKPDNLLIAHDGH-------------------IKLTDFGLSKVGLIN 742
L +LH ++ H DLKP+N+L + I++ DFG
Sbjct: 136 LRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG-------- 187
Query: 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTAD 802
T + + A+ H Y PE++L G D
Sbjct: 188 -----------SATFDHEHHTTIVATRH---------------YRPPEVILELGWAQPCD 221
Query: 803 WWSVGIILFELIVGIPPF----NAEH 824
WS+G ILFE G F N EH
Sbjct: 222 VWSIGCILFEYYRGFTLFQTHENREH 247
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 1e-24
Identities = 59/267 (22%), Positives = 103/267 (38%), Gaps = 45/267 (16%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDIL--ISVRN 648
+ +I+ + G F V+L+ A+KV+K A+ + A++ E +L + +
Sbjct: 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD----EIRLLKSVRNSD 94
Query: 649 P------FVVRFFYSFT---------CRENLYLVMEYLNGGDLYSLLR--NLGCLDEDVA 691
P VV+ F C +V E L G L + N L
Sbjct: 95 PNDPNREMVVQLLDDFKISGVNGTHIC-----MVFEVL-GHHLLKWIIKSNYQGLPLPCV 148
Query: 692 RVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 750
+ I +V+ L+YLH+ R++H D+KP+N+L++ + + + SG
Sbjct: 149 KKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 208
Query: 751 AVSGTTL--------------LGDEEPQLTASEHQQERRKKRSAVGTPD-YLAPEILLGT 795
AVS + ++ + K + Y + E+L+G+
Sbjct: 209 AVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGS 268
Query: 796 GHGTTADWWSVGIILFELIVGIPPFNA 822
G+ T AD WS + FEL G F
Sbjct: 269 GYNTPADIWSTACMAFELATGDYLFEP 295
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-24
Identities = 45/151 (29%), Positives = 72/151 (47%), Gaps = 3/151 (1%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+D + + I RG FG VF + R L A+K ++ + L E IL +
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP--PDLKAKFLQEARILKQYSH 171
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIA-EVVLALEYLHS 707
P +VR T ++ +Y+VME + GGD + LR G + + + +EYL S
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738
+HRDL N L+ +K++DFG+S+
Sbjct: 232 KCCIHRDLAARNCLVTEKNVLKISDFGMSRE 262
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 46/165 (27%), Positives = 85/165 (51%), Gaps = 12/165 (7%)
Query: 583 KDRTSID--DFEIIKPISRGAFGRVFLAK----KRTTGDLFAIKVLKKADMIRKNAVESI 636
D T + + ++ + +G FG V + + + TG++ A+K L+ + +
Sbjct: 2 SDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE---EHLRDF 58
Query: 637 LAERDILISVRNPFVVRFF--YSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARV 693
E +IL S+++ +V++ R NL L+MEYL G L L+ + +D
Sbjct: 59 EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ 118
Query: 694 YIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738
Y +++ +EYL + R +HRDL N+L+ ++ +K+ DFGL+KV
Sbjct: 119 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV 163
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 54/179 (30%), Positives = 89/179 (49%), Gaps = 14/179 (7%)
Query: 577 SPIHPSKDRTSID--DFEIIKPISRGAFGRVFLAKKRTTGD----LFAIKVLKKADMIRK 630
+ ++ +D T + + I + +G FG V L + GD L A+K L+ +
Sbjct: 9 AQLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP--- 65
Query: 631 NAVESILAERDILISVRNPFVVRFF--YSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLD 687
+ E IL ++ + F+V++ R++L LVMEYL G L L+ + LD
Sbjct: 66 DQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLD 125
Query: 688 EDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746
+Y +++ +EYL S R VHRDL N+L+ + H+K+ DFGL+K L+ D
Sbjct: 126 ASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAK--LLPLDKD 182
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 27/235 (11%), Positives = 56/235 (23%), Gaps = 60/235 (25%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF 650
+ ++ + + A A+ + ++ + ++ L+ L + P
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRV 710
V R R +V E++ GG L + R + + A + H V
Sbjct: 93 VARVLDVVHTRAGGLVVAEWIRGGSLQEVADT-SPSPVGAIRA-MQSLAAAADAAHRAGV 150
Query: 711 VHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEH 770
P + ++ DG + L
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAYPA------------------------------------ 174
Query: 771 QQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825
+ D +G L+ L+V P
Sbjct: 175 ---------------TMPDA-------NPQDDIRGIGASLYALLVNRWPLPEAGV 207
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 44/168 (26%), Positives = 77/168 (45%), Gaps = 11/168 (6%)
Query: 580 HPSKDRTSID--DFEIIKPISRGAFGRVFLAKKRTTGD----LFAIKVLKKADMIRKNAV 633
D T + + I+ + G FG+V L + GD A+K LK N +
Sbjct: 10 ATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHI 67
Query: 634 ESILAERDILISVRNPFVVRFF--YSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDV 690
+ E +IL ++ + +V++ + + L+ME+L G L L N ++
Sbjct: 68 ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQ 127
Query: 691 ARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738
Y ++ ++YL S + VHRDL N+L+ + +K+ DFGL+K
Sbjct: 128 QLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA 175
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 7e-23
Identities = 45/179 (25%), Positives = 75/179 (41%), Gaps = 15/179 (8%)
Query: 568 DDVVRSLRTSPIHPSKDRTSI--DDFEIIKPISRGAFGRVFLAKKRTTGD----LFAIKV 621
+ L P D T + I+ + G FG+V L T D + A+K
Sbjct: 12 HGALEVLFQGP----GDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKA 67
Query: 622 LKKADMIRKNAVESILAERDILISVRNPFVVRFF--YSFTCRENLYLVMEYLNGGDLYSL 679
LK E DIL ++ + ++++ +L LVMEY+ G L
Sbjct: 68 LKADAG--PQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDY 125
Query: 680 LRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738
L + ++ ++ + YLH+ +HRDL N+L+ +D +K+ DFGL+K
Sbjct: 126 LPR-HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 5e-22
Identities = 58/239 (24%), Positives = 96/239 (40%), Gaps = 38/239 (15%)
Query: 589 DDFEIIKPISRGAFGRVFLAK-KRTTGDLF--AIKVLKKADMIRKNAVESILAERDILIS 645
D +++ + G+FG V + +G A+K LK + + A++ + E + + S
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 646 VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARVYIAEVVLALEY 704
+ + ++R Y + +V E G L LR + G Y +V + Y
Sbjct: 78 LDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 136
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
L S R +HRDL NLL+A +K+ DFGL + L +
Sbjct: 137 LESKRFIHRDLAARNLLLATRDLVKIGDFGLMR-------------------ALPQNDDH 177
Query: 765 LTASEHQQERRKKRSAVGTP-DYLAPEILLGTGHGTTA-DWWSVGIILFELI-VGIPPF 820
EH++ P + APE L T + A D W G+ L+E+ G P+
Sbjct: 178 YVMQEHRK----------VPFAWCAPESLK-TRTFSHASDTWMFGVTLWEMFTYGQEPW 225
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 6e-22
Identities = 60/252 (23%), Positives = 102/252 (40%), Gaps = 44/252 (17%)
Query: 578 PIHPSK---DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF--AIKVLKKADMIRKNA 632
I P + DR + + K + G FG V + + A+K+LK
Sbjct: 5 EIRPKEVYLDRKLLTLED--KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPAL 61
Query: 633 VESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVAR 692
+ +LAE +++ + NP++VR E+ LVME G L L+ + +
Sbjct: 62 KDELLAEANVMQQLDNPYIVRM-IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNII 120
Query: 693 VYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 752
+ +V + ++YL VHRDL N+L+ + K++DFGLSK
Sbjct: 121 ELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA-------------- 166
Query: 753 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHG--TTA-DWWSVGII 809
L +E A H + K + APE + + ++ D WS G++
Sbjct: 167 -----LRADENYYKAQTHGKWPVK---------WYAPECIN---YYKFSSKSDVWSFGVL 209
Query: 810 LFELI-VGIPPF 820
++E G P+
Sbjct: 210 MWEAFSYGQKPY 221
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 8e-22
Identities = 67/240 (27%), Positives = 103/240 (42%), Gaps = 42/240 (17%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLF----AIKVLKKADMIRKNAVESILAERDILI 644
+F+ IK + GAFG V+ G+ AIK L++A A + IL E ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMA 72
Query: 645 SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARVYIAEVVLALE 703
SV NP V R + L+ + + G L +R + + + ++ +
Sbjct: 73 SVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 704 YLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEP 763
YL R+VHRDL N+L+ H+K+TDFGL+K LLG EE
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK-------------------LLGAEE- 171
Query: 764 QLTASEHQQERRKKRSAVGTP-DYLAPEILLGTGHGTTA-DWWSVGIILFELI-VGIPPF 820
E+ E K P ++A E +L T D WS G+ ++EL+ G P+
Sbjct: 172 ----KEYHAEGGK------VPIKWMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKPY 220
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 2e-21
Identities = 55/228 (24%), Positives = 100/228 (43%), Gaps = 38/228 (16%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ + + +G FG V++ T + AIK LK M + E+ L E ++ +R+
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRH 238
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVAR-VYIA-EVVLALEYLH 706
+V+ + + E +Y+V EY++ G L L+ + + V +A ++ + Y+
Sbjct: 239 EKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 297
Query: 707 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLT 766
+ VHRDL+ N+L+ + K+ DFGL+++ E+ + T
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLI---------------------EDNEYT 336
Query: 767 ASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI 814
A + + K + APE L +D WS GI+L EL
Sbjct: 337 ARQGAKFPIK---------WTAPEAALYGRFTIKSDVWSFGILLTELT 375
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 2e-21
Identities = 55/235 (23%), Positives = 98/235 (41%), Gaps = 37/235 (15%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
D + + G +G V+ + A+K LK+ M VE L E ++ +++
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKH 275
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVAR-VYIA-EVVLALEYLH 706
P +V+ T Y++ E++ G+L LR + +Y+A ++ A+EYL
Sbjct: 276 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 335
Query: 707 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLT 766
+HR+L N L+ + +K+ DFGLS++ + GD T
Sbjct: 336 KKNFIHRNLAARNCLVGENHLVKVADFGLSRL------------------MTGDT---YT 374
Query: 767 ASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI-VGIPPF 820
A + K APE L +D W+ G++L+E+ G+ P+
Sbjct: 375 AHAGAKFPIKW---------TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 420
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 2e-21
Identities = 58/241 (24%), Positives = 103/241 (42%), Gaps = 40/241 (16%)
Query: 578 PIHPSKDRTSID--DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVES 635
+KD I + + +G FG V++ T + AIK LK M + E+
Sbjct: 254 TQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEA 308
Query: 636 ILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVAR-VY 694
L E ++ +R+ +V+ + + E +Y+V EY++ G L L+ + + V
Sbjct: 309 FLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD 367
Query: 695 IA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753
+A ++ + Y+ + VHRDL+ N+L+ + K+ DFGL+++
Sbjct: 368 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI-------------- 413
Query: 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 813
E+ + TA + + K + APE L +D WS GI+L EL
Sbjct: 414 -------EDNEYTARQGAKFPIK---------WTAPEAALYGRFTIKSDVWSFGILLTEL 457
Query: 814 I 814
Sbjct: 458 T 458
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 2e-21
Identities = 37/151 (24%), Positives = 70/151 (46%), Gaps = 6/151 (3%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ ++ I G FG V L + AIK +++ M + E + E ++++ + +
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTIREGAM----SEEDFIEEAEVMMKLSH 62
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARVYIAEVVLALEYLHS 707
P +V+ + + + LV E++ G L LR G + +V + YL
Sbjct: 63 PKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 122
Query: 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738
V+HRDL N L+ + IK++DFG+++
Sbjct: 123 ACVIHRDLAARNCLVGENQVIKVSDFGMTRF 153
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 4e-21
Identities = 42/162 (25%), Positives = 78/162 (48%), Gaps = 8/162 (4%)
Query: 581 PSKDRTSID--DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILA 638
P+ D+ ++ D + + G +G V+ + A+K LK+ M VE L
Sbjct: 3 PNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLK 58
Query: 639 ERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVAR-VYIA- 696
E ++ +++P +V+ T Y++ E++ G+L LR + +Y+A
Sbjct: 59 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118
Query: 697 EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738
++ A+EYL +HRDL N L+ + +K+ DFGLS++
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 160
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 40/151 (26%), Positives = 81/151 (53%), Gaps = 6/151 (3%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
++ ++K + G FG V L K + D+ A+K++K+ M + + E ++ + +
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDV-AVKMIKEGSM----SEDEFFQEAQTMMKLSH 62
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIA-EVVLALEYLHS 707
P +V+F+ + +Y+V EY++ G L + LR+ G E + + +V + +L S
Sbjct: 63 PKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES 122
Query: 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738
+ +HRDL N L+ D +K++DFG+++
Sbjct: 123 HQFIHRDLAARNCLVDRDLCVKVSDFGMTRY 153
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 96.2 bits (239), Expect = 1e-20
Identities = 80/368 (21%), Positives = 133/368 (36%), Gaps = 47/368 (12%)
Query: 461 QIDLLLAGKGALSEHDDFPQMNELADIARCVATTPLDDDSSIPYLLSFLEDLRVVIDRRK 520
I AGK + E F + +L + + + Y L +
Sbjct: 212 LISQDKAGKYCIPEGTKFDTLWQLVEYLKL-------KADGLIYCLKEACPNSSASNASG 264
Query: 521 FDALTVETFGARIEKLIREKYLQLCELVTDDKVDITSTVIEEDAPLEDDVVRSLRTSPIH 580
A T+ + + R + T + ITS P++ V S + P
Sbjct: 265 AAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEE 324
Query: 581 PSKDRTSIDDFEII---KPISRGAFGRVFLAKKRTTGDLF--AIKVLKKADMIRKNAVES 635
+ + ++ + G FG V R AIKVLK+ K E
Sbjct: 325 LKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--KADTEE 382
Query: 636 ILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARVY 694
++ E I+ + NP++VR E L LVME GG L+ L +
Sbjct: 383 MMREAQIMHQLDNPYIVRL-IGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAEL 441
Query: 695 IAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 754
+ +V + ++YL VHR+L N+L+ + + K++DFGLSK
Sbjct: 442 LHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKA---------------- 485
Query: 755 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFEL 813
LG ++ TA + K + APE + ++ D WS G+ ++E
Sbjct: 486 ---LGADDSYYTARSAGKWPLK---------WYAPECIN-FRKFSSRSDVWSYGVTMWEA 532
Query: 814 I-VGIPPF 820
+ G P+
Sbjct: 533 LSYGQKPY 540
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 36/166 (21%), Positives = 70/166 (42%), Gaps = 19/166 (11%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLF-------AIKVLKKADMIRKNAVESILAERD 641
+D + + +G F ++F +R GD +KVL KA N ES
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR---NYSESFFEAAS 64
Query: 642 ILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARVYIAEVVL 700
++ + + +V + C + LV E++ G L + L+ N C++ ++
Sbjct: 65 MMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAA 124
Query: 701 ALEYLHSLRVVHRDLKPDNLLIAHDGH--------IKLTDFGLSKV 738
A+ +L ++H ++ N+L+ + IKL+D G+S
Sbjct: 125 AMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT 170
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 44/160 (27%), Positives = 82/160 (51%), Gaps = 8/160 (5%)
Query: 582 SKDRTSID--DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAE 639
ID D +K + G FG V K R D+ AIK++K+ M + + + E
Sbjct: 15 GYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSM----SEDEFIEE 69
Query: 640 RDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIA-EV 698
+++++ + +V+ + T + ++++ EY+ G L + LR + + + + +V
Sbjct: 70 AKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDV 129
Query: 699 VLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738
A+EYL S + +HRDL N L+ G +K++DFGLS+
Sbjct: 130 CEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY 169
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 2e-20
Identities = 34/152 (22%), Positives = 81/152 (53%), Gaps = 8/152 (5%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ ++++ + G FG V++ + A+K LK+ M + ++ LAE +++ +++
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQLQH 67
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVAR-VYIA-EVVLALEYLH 706
+VR + T +E +Y++ EY+ G L L+ + + + + +A ++ + ++
Sbjct: 68 QRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 707 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738
+HRDL+ N+L++ K+ DFGL+++
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARL 158
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 3e-20
Identities = 41/159 (25%), Positives = 70/159 (44%), Gaps = 10/159 (6%)
Query: 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF---AIKVLKKADMIRKNAVESILAER 640
R + + + + G FG V+ A+K KK + E ++E
Sbjct: 10 AREDV---VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLD--NKEKFMSEA 64
Query: 641 DILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARVYIAEVV 699
I+ ++ +P +V+ E +++ME G+L L N L +Y ++
Sbjct: 65 VIMKNLDHPHIVKL-IGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQIC 123
Query: 700 LALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738
A+ YL S+ VHRD+ N+L+A +KL DFGLS+
Sbjct: 124 KAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY 162
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 46/159 (28%), Positives = 67/159 (42%), Gaps = 9/159 (5%)
Query: 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF---AIKVLKKADMIRKNAVESILAER 640
+ + I I K I G G V + R G AIK LK + L+E
Sbjct: 47 EASRI---HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT--ERQRRDFLSEA 101
Query: 641 DILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARVYIAEVV 699
I+ +P ++R T +V EY+ G L + LR + G + V
Sbjct: 102 SIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVG 161
Query: 700 LALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738
+ YL L VHRDL N+L+ + K++DFGLS+V
Sbjct: 162 AGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 4e-20
Identities = 46/155 (29%), Positives = 74/155 (47%), Gaps = 8/155 (5%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLF----AIKVLKKADMIRKNAVESILAERDILI 644
+F+ IK + GAFG V+ G+ AIK L++A A + IL E ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMA 72
Query: 645 SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARVYIAEVVLALE 703
SV NP V R + L+ + + G L +R + + + ++ +
Sbjct: 73 SVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 704 YLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738
YL R+VHRDL N+L+ H+K+TDFGL+K+
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 4e-20
Identities = 38/165 (23%), Positives = 83/165 (50%), Gaps = 10/165 (6%)
Query: 578 PIHPSKDRTSID--DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVES 635
KD I ++ K + G FG V++A + A+K +K M +VE+
Sbjct: 175 QKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSM----SVEA 229
Query: 636 ILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVAR-VY 694
LAE +++ ++++ +V+ T +E +Y++ E++ G L L++ + + + +
Sbjct: 230 FLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLID 288
Query: 695 IA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738
+ ++ + ++ +HRDL+ N+L++ K+ DFGL++V
Sbjct: 289 FSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV 333
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 7e-20
Identities = 63/238 (26%), Positives = 97/238 (40%), Gaps = 38/238 (15%)
Query: 589 DDFEIIK-PISRGAFGRVFLAKKRTTGDLF--AIKVLKKADMIRKNAVESILAERDILIS 645
D+ I + G FG V R AIKVLK+ K E ++ E I+
Sbjct: 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--KADTEEMMREAQIMHQ 66
Query: 646 VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARVYIAEVVLALEY 704
+ NP++VR E L LVME GG L+ L + + +V + ++Y
Sbjct: 67 LDNPYIVRL-IGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKY 125
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
L VHRDL N+L+ + + K++DFGLSK LG ++
Sbjct: 126 LEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA-------------------LGADDSY 166
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELI-VGIPPF 820
TA + K + APE + ++ D WS G+ ++E + G P+
Sbjct: 167 YTARSAGKWPLK---------WYAPECIN-FRKFSSRSDVWSYGVTMWEALSYGQKPY 214
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 7e-20
Identities = 43/186 (23%), Positives = 78/186 (41%), Gaps = 25/186 (13%)
Query: 582 SKDRTSIDDFEI-------IKPISRGAFGRVFLAKKRTTGDLF---AIKVLKKADMIRKN 631
+ + ++D I + + +G FG V A+ + F A+K+LK D+I +
Sbjct: 9 DELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKA-DIIASS 67
Query: 632 AVESILAERDILISVRNPFVVRFF------YSFTCRENLYLVMEYLNGGDLYSLLRNLGC 685
+E L E + +P V + + +++ ++ GDL++ L
Sbjct: 68 DIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRI 127
Query: 686 LDEDVA-----RVYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 739
+ V ++ +EYL S +HRDL N ++A D + + DFGLS+
Sbjct: 128 GENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRK- 186
Query: 740 LINSTD 745
I S D
Sbjct: 187 -IYSGD 191
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 39/160 (24%), Positives = 67/160 (41%), Gaps = 10/160 (6%)
Query: 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF----AIKVLKKADMIRKNAVESILAE 639
+ + K I G FG V+ +T+ AIK LK + L E
Sbjct: 42 HPSCV---TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--EKQRVDFLGE 96
Query: 640 RDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARVYIAEV 698
I+ + ++R + + + ++ EY+ G L LR G + +
Sbjct: 97 AGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGI 156
Query: 699 VLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738
++YL ++ VHRDL N+L+ + K++DFGLS+V
Sbjct: 157 AAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 2e-19
Identities = 45/159 (28%), Positives = 69/159 (43%), Gaps = 10/159 (6%)
Query: 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF---AIKVLKKADMIRKNAVESILAER 640
R I E+ + I G FG V + + AIK K E L E
Sbjct: 13 QRERI---ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS--VREKFLQEA 67
Query: 641 DILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARVYIAEVV 699
+ +P +V+ ++++ME G+L S L+ LD +Y ++
Sbjct: 68 LTMRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 126
Query: 700 LALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738
AL YL S R VHRD+ N+L++ + +KL DFGLS+
Sbjct: 127 TALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 3e-19
Identities = 54/240 (22%), Positives = 90/240 (37%), Gaps = 51/240 (21%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN-P 649
F + K I G FG + L K T + AIK+ K+ + E + +
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEP-----MKSRAPQLHLEYRFYKQLGSGD 65
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVL--------A 701
+ + +Y C + +V+E L G L L R + + VL
Sbjct: 66 GIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCD-------RTFSLKTVLMIAIQLISR 117
Query: 702 LEYLHSLRVVHRDLKPDNLLIAHDGH-----IKLTDFGLSKVGLINSTDDLSGPAVSGTT 756
+EY+HS +++RD+KP+N LI G+ I + DF L+K + T
Sbjct: 118 MEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK----------- 166
Query: 757 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVG 816
+H R+ +S GT Y++ LG D ++G + + G
Sbjct: 167 ------------KH-IPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRG 213
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 4e-19
Identities = 49/240 (20%), Positives = 83/240 (34%), Gaps = 51/240 (21%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN-P 649
+++ + I G+FG +F AIK R++ + E +
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP-----RRSDAPQLRDEYRTYKLLAGCT 66
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVL--------A 701
+ +Y + LV++ L G L LL G R + + V
Sbjct: 67 GIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCG-------RKFSVKTVAMAAKQMLAR 118
Query: 702 LEYLHSLRVVHRDLKPDNLLI-----AHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 756
++ +H +V+RD+KPDN LI + I + DFG+ K T
Sbjct: 119 VQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK----------- 167
Query: 757 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVG 816
+H R KK + GT Y++ LG D ++G + + G
Sbjct: 168 ------------QHIPYREKK-NLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRG 214
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 91.5 bits (227), Expect = 4e-19
Identities = 43/154 (27%), Positives = 68/154 (44%), Gaps = 7/154 (4%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLF---AIKVLKKADMIRKNAVESILAERDILIS 645
+ E+ + I G FG V + + AIK K E L E +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR--EKFLQEALTMRQ 447
Query: 646 VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARVYIAEVVLALEY 704
+P +V+ ++++ME G+L S L+ LD +Y ++ AL Y
Sbjct: 448 FDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAY 506
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738
L S R VHRD+ N+L++ + +KL DFGLS+
Sbjct: 507 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 5e-19
Identities = 44/159 (27%), Positives = 68/159 (42%), Gaps = 9/159 (5%)
Query: 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF---AIKVLKKADMIRKNAVESILAER 640
D T+I I K + G FG V + + AIK LK + L E
Sbjct: 43 DATNI---SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEA 97
Query: 641 DILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARVYIAEVV 699
I+ +P ++R T + + +V EY+ G L S LR + + +
Sbjct: 98 SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIA 157
Query: 700 LALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738
++YL + VHRDL N+LI + K++DFGL +V
Sbjct: 158 SGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRV 196
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 6e-19
Identities = 44/172 (25%), Positives = 77/172 (44%), Gaps = 19/172 (11%)
Query: 589 DDFEIIKPISRGAFGRVFLAK-KRTTGD----LFAIKVLKKADMIRKNAVESILAERDIL 643
+ + + + +G+FG V+ K D AIK + +A +R L E ++
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVM 82
Query: 644 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVAR---------VY 694
VVR + + ++ME + GDL S LR+L + +
Sbjct: 83 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142
Query: 695 IA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745
+A E+ + YL++ + VHRDL N ++A D +K+ DFG+++ I TD
Sbjct: 143 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD--IYETD 192
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 6e-19
Identities = 51/189 (26%), Positives = 85/189 (44%), Gaps = 28/189 (14%)
Query: 580 HPSKDRTSI--DDFEIIKPISRGAFGRVFLAK-KRTTGD----LFAIKVLKKADMIRKNA 632
H I D + + + GAFG+VFLA+ + L A+K LK + A
Sbjct: 4 HSGIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL---AA 60
Query: 633 VESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVAR 692
+ E ++L ++++ +V+F+ + L +V EY+ GDL LR G +
Sbjct: 61 RKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVD 120
Query: 693 ---------------VYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS 736
++IA ++ + YL S VHRDL N L+ + +K+ DFG+S
Sbjct: 121 GQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180
Query: 737 KVGLINSTD 745
+ + STD
Sbjct: 181 RD--VYSTD 187
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 34/160 (21%), Positives = 68/160 (42%), Gaps = 11/160 (6%)
Query: 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF----AIKVLKKADMIRKNAVESILAE 639
T + +K + G FG V G+ IKV++ + + +++
Sbjct: 11 KETEL---RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG--RQSFQAVTDH 65
Query: 640 RDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARVYIAEV 698
+ S+ + +VR +L LV +YL G L +R + G L + + ++
Sbjct: 66 MLAIGSLDHAHIVRL-LGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI 124
Query: 699 VLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738
+ YL +VHR+L N+L+ +++ DFG++ +
Sbjct: 125 AKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADL 164
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 44/152 (28%), Positives = 74/152 (48%), Gaps = 10/152 (6%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ ++++ I +G FG V L R A+K +K ++ LAE ++ +R+
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDAT-----AQAFLAEASVMTQLRH 73
Query: 649 PFVVRFFYSFTCRE-NLYLVMEYLNGGDLYSLLRNLGCLDEDVAR-VYIA-EVVLALEYL 705
+V+ + LY+V EY+ G L LR+ G + + +V A+EYL
Sbjct: 74 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 133
Query: 706 HSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 737
VHRDL N+L++ D K++DFGL+K
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 165
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 52/241 (21%), Positives = 87/241 (36%), Gaps = 49/241 (20%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN-P 649
+ + + I G+FG ++L G+ AIK+ K + E I ++
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLEC-----VKTKHPQLHIESKIYKMMQGGV 65
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVL--------A 701
+ + + +VME L G L L R + + VL
Sbjct: 66 GIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCS-------RKFSLKTVLLLADQMISR 117
Query: 702 LEYLHSLRVVHRDLKPDNLLIAHDGH---IKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 758
+EY+HS +HRD+KPDN L+ + + DFGL+K ++
Sbjct: 118 IEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK-KYRDARTH------------ 164
Query: 759 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIP 818
+H R+ ++ GT Y + LG D S+G +L +G
Sbjct: 165 ----------QH-IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSL 213
Query: 819 P 819
P
Sbjct: 214 P 214
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 41/189 (21%), Positives = 74/189 (39%), Gaps = 24/189 (12%)
Query: 578 PIHPSKDRTSIDDFEI-------IKPISRGAFGRVFLAKKRTTGDLF---AIKVLKKADM 627
P + + ++D I K + G FG V + A+K +K +
Sbjct: 16 PRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS 75
Query: 628 IRKNAVESILAERDILISVRNPFVVRFF-----YSFTCRENLYLVMEYLNGGDLYSLLRN 682
++ +E L+E + +P V+R S +++ ++ GDL++ L
Sbjct: 76 SQR-EIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLY 134
Query: 683 LGCLDEDVA-----RVYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS 736
+ ++ L +EYL + +HRDL N ++ D + + DFGLS
Sbjct: 135 SRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLS 194
Query: 737 KVGLINSTD 745
K I S D
Sbjct: 195 KK--IYSGD 201
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 52/173 (30%), Positives = 80/173 (46%), Gaps = 26/173 (15%)
Query: 584 DRTSIDDFEIIKPISRGAFGRVFLAK-KRTTGD----LFAIKVLKKADMIRKNAVESILA 638
R I + + GAFG+VFLA+ + L A+K LK+A +A +
Sbjct: 39 KRRDI---VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE---SARQDFQR 92
Query: 639 ERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVAR------ 692
E ++L +++ +VRFF T L +V EY+ GDL LR+ G + +A
Sbjct: 93 EAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAP 152
Query: 693 --------VYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS 736
+ +A +V + YL L VHRDL N L+ +K+ DFG+S
Sbjct: 153 GPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 3e-18
Identities = 42/180 (23%), Positives = 70/180 (38%), Gaps = 25/180 (13%)
Query: 581 PSKDRTSIDD-----FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLK-----KADMIRK 630
P + +DD + + K I G FG ++LA + A V+K + +
Sbjct: 24 PFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSE 83
Query: 631 NAVESILAERDILISVRNPFV--------VRFFYSFTCRENLY--LVMEYLNGGDLYSLL 680
+A++D + + Y +VME L G DL +
Sbjct: 84 LKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKIS 142
Query: 681 RNLGCLDED-VARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI--AHDGHIKLTDFGLSK 737
G + V ++ I ++ LEY+H VH D+K NLL+ + + L D+GLS
Sbjct: 143 GQNGTFKKSTVLQLGI-RMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 5e-18
Identities = 42/189 (22%), Positives = 77/189 (40%), Gaps = 14/189 (7%)
Query: 562 EDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF---A 618
+ + L ++V++++ I P + + I RG FG V+ A
Sbjct: 3 DLSALNPELVQAVQHVVIGP--SSLIV---HFNEVIGRGHFGCVYHGTLLDNDGKKIHCA 57
Query: 619 IKVLKKADMIRKNAVESILAERDILISVRNPFVVRFF-YSFTCRENLYLVMEYLNGGDLY 677
+K L + I V L E I+ +P V+ + +V+ Y+ GDL
Sbjct: 58 VKSLNRITDIG--EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 115
Query: 678 SLLRNLGCLDEDVARVYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS 736
+ +RN + +V ++YL S + VHRDL N ++ +K+ DFGL+
Sbjct: 116 NFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 175
Query: 737 KVGLINSTD 745
+ + +
Sbjct: 176 RD--MYDKE 182
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 1e-17
Identities = 45/152 (29%), Positives = 76/152 (50%), Gaps = 10/152 (6%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ ++++ I +G FG V L R G+ A+K +K ++ LAE ++ +R+
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDAT-----AQAFLAEASVMTQLRH 245
Query: 649 PFVVRFF-YSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVAR-VYIA-EVVLALEYL 705
+V+ + LY+V EY+ G L LR+ G + + +V A+EYL
Sbjct: 246 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 305
Query: 706 HSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 737
VHRDL N+L++ D K++DFGL+K
Sbjct: 306 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 337
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 42/181 (23%), Positives = 83/181 (45%), Gaps = 28/181 (15%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLF-------AIKVLKKADMIRKNAVESILAERD 641
D + KP+ GAFG+V +A+ A+K+LK + + +++E +
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEME 92
Query: 642 ILISV-RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVAR-------- 692
++ + ++ ++ + T LY+++EY + G+L LR + +
Sbjct: 93 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 693 -------VYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744
V ++ +EYL S + +HRDL N+L+ + +K+ DFGL++ IN+
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNI 210
Query: 745 D 745
D
Sbjct: 211 D 211
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 39/183 (21%), Positives = 68/183 (37%), Gaps = 28/183 (15%)
Query: 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGD-----LFAIKVLKKADMIRKNAVESILA 638
+++ ++ + FG+V+ AIK LK E
Sbjct: 7 SLSAV---RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE--GPLREEFRH 61
Query: 639 ERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEV 698
E + +++P VV T + L ++ Y + GDL+ L + + V
Sbjct: 62 EAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV 121
Query: 699 VLAL----------------EYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742
AL EYL S VVH+DL N+L+ ++K++D GL + +
Sbjct: 122 KSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFRE--VY 179
Query: 743 STD 745
+ D
Sbjct: 180 AAD 182
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 35/192 (18%), Positives = 68/192 (35%), Gaps = 28/192 (14%)
Query: 572 RSLRTSPIHPSKDRTSIDD-----FEIIKPISRGAFGRVFLAKKRTTGDL--------FA 618
T+ + T + D +++ +R G ++ A +T F+
Sbjct: 20 FQSMTTSLEALPTGTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFS 79
Query: 619 IKVLKK-------ADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY--LVME 669
+K+ K + ++ A + + L S + F ++ Y LV+
Sbjct: 80 LKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMG-FGVHQDKYRFLVLP 138
Query: 670 YLNGGDLYSLLRNLGCLDEDVARVY-IAEVVL-ALEYLHSLRVVHRDLKPDNLLI--AHD 725
L G L S L V +A +L ALE+LH VH ++ +N+ +
Sbjct: 139 SL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQ 197
Query: 726 GHIKLTDFGLSK 737
+ L +G +
Sbjct: 198 SQVTLAGYGFAF 209
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 43/186 (23%), Positives = 79/186 (42%), Gaps = 33/186 (17%)
Query: 589 DDFEIIKPISRGAFGRVFLAK-----KRTTGDLFAIKVLKKADMIRKNAVESILAERDIL 643
+ + K + G FG+V A R A+K+LK+ + +L+E ++L
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPS--ELRDLLSEFNVL 80
Query: 644 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVAR----------- 692
V +P V++ + + + L L++EY G L LR +
Sbjct: 81 KQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 693 ------------VYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 739
+ A ++ ++YL +++VHRDL N+L+A +K++DFGLS+
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSR-- 198
Query: 740 LINSTD 745
+ D
Sbjct: 199 DVYEED 204
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 3e-17
Identities = 37/167 (22%), Positives = 65/167 (38%), Gaps = 12/167 (7%)
Query: 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF---AIKVLKKADMIRKNAVESILAER 640
+ + I RG FG V+ A+K L + I V L E
Sbjct: 87 SSLIV---HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEG 141
Query: 641 DILISVRNPFVVRFF-YSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIA-EV 698
I+ +P V+ + +V+ Y+ GDL + +RN + +V
Sbjct: 142 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 201
Query: 699 VLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745
+++L S + VHRDL N ++ +K+ DFGL++ + +
Sbjct: 202 AKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD--MYDKE 246
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 4e-17
Identities = 42/181 (23%), Positives = 83/181 (45%), Gaps = 28/181 (15%)
Query: 589 DDFEIIKPISRGAFGRVFLAK-------KRTTGDLFAIKVLKKADMIRKNAVESILAERD 641
D + KP+ G FG+V +A+ K A+K+LK + + +++E +
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEME 138
Query: 642 ILISV-RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVAR-------- 692
++ + ++ ++ + T LY+++EY + G+L LR + +
Sbjct: 139 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 198
Query: 693 -------VYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744
V ++ +EYL S + +HRDL N+L+ + +K+ DFGL++ IN+
Sbjct: 199 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNI 256
Query: 745 D 745
D
Sbjct: 257 D 257
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 5e-17
Identities = 45/181 (24%), Positives = 82/181 (45%), Gaps = 28/181 (15%)
Query: 589 DDFEIIKPISRGAFGRVFLAK-------KRTTGDLFAIKVLKKADMIRKNAVESILAERD 641
D + KP+ GAFG+V LA+ K A+K+LK + + +++E +
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEME 126
Query: 642 ILISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVAR-------- 692
++ + ++ + T LY+++EY + G+L L+ + +
Sbjct: 127 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186
Query: 693 -------VYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744
V A +V +EYL S + +HRDL N+L+ D +K+ DFGL++ I+
Sbjct: 187 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR--DIHHI 244
Query: 745 D 745
D
Sbjct: 245 D 245
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 6e-17
Identities = 38/169 (22%), Positives = 70/169 (41%), Gaps = 12/169 (7%)
Query: 582 SKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF---AIKVLKKADMIRKNAVESILA 638
+R + I +G FG V+ + AIK L + ++ VE+ L
Sbjct: 17 PHERVVT---HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQ--QVEAFLR 71
Query: 639 ERDILISVRNPFVVRFFYSFTCREN-LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIA- 696
E ++ + +P V+ E ++++ Y+ GDL +R+ +
Sbjct: 72 EGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGL 131
Query: 697 EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745
+V +EYL + VHRDL N ++ +K+ DFGL++ I +
Sbjct: 132 QVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARD--ILDRE 178
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 8e-17
Identities = 60/248 (24%), Positives = 98/248 (39%), Gaps = 49/248 (19%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
++F+ I G FG+V+ R G A+K +E E + L R+
Sbjct: 39 NNFDHKFLIGHGVFGKVYKGVLRD-GAKVALKRRTPES---SQGIEEFETEIETLSFCRH 94
Query: 649 PFVVRFF-YSFTCREN--LYLVMEYLNGGDLYSLL----RNLGCLDEDVARVYIA-EVVL 700
P +V + C E + L+ +Y+ G+L L + + R+ I
Sbjct: 95 PHLVSLIGF---CDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWE-QRLEICIGAAR 150
Query: 701 ALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGD 760
L YLH+ ++HRD+K N+L+ + K+TDFG+SK G LS
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS------------ 198
Query: 761 EEPQLTASEHQQERRKKRSAV-GTPDYLAPEILLGTGHGTT-ADWWSVGIILFELIVGIP 818
+ V GT Y+ PE + G T +D +S G++LFE++
Sbjct: 199 ------------------TVVKGTLGYIDPEYFI-KGRLTEKSDVYSFGVVLFEVLCARS 239
Query: 819 PFNAEHPQ 826
P+
Sbjct: 240 AIVQSLPR 247
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 48/186 (25%), Positives = 78/186 (41%), Gaps = 33/186 (17%)
Query: 589 DDFEIIKPISRGAFGRVFLAK-----KRTTGDLFAIKVLKKADMIRKNAVESILAERDIL 643
++ E ++ I GAFGRVF A+ + A+K+LK+ + E ++
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALM 104
Query: 644 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN------LGCLDEDVAR----- 692
NP +V+ + + L+ EY+ GDL LR+ D++
Sbjct: 105 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 164
Query: 693 ------------VYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 739
+ IA +V + YL + VHRDL N L+ + +K+ DFGLS+
Sbjct: 165 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN- 223
Query: 740 LINSTD 745
I S D
Sbjct: 224 -IYSAD 228
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 82.4 bits (203), Expect = 2e-16
Identities = 55/241 (22%), Positives = 87/241 (36%), Gaps = 49/241 (20%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN-P 649
F + + I G+FG ++L T + AIK+ K +L E I ++
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN-----VKTKHPQLLYESKIYRILQGGT 63
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVL--------A 701
+ + + LVM+ L G L L R + VL
Sbjct: 64 GIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS-------RKLSLKTVLMLADQMINR 115
Query: 702 LEYLHSLRVVHRDLKPDNLLIAHDGH---IKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 758
+E++HS +HRD+KPDN L+ + + DFGL+K ST
Sbjct: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH------------- 162
Query: 759 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIP 818
+H R+ ++ GT Y + LG D S+G +L + G
Sbjct: 163 ----------QH-IPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSL 211
Query: 819 P 819
P
Sbjct: 212 P 212
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 53/246 (21%), Positives = 87/246 (35%), Gaps = 56/246 (22%)
Query: 597 ISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIR-KNAVESILAERDILISVRNPFVVRFF 655
+ G FG V+ K A+K L I + + E ++ ++ +V
Sbjct: 39 MGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 96
Query: 656 -YSFTCRENLYLVMEYLNGGDLYSLL---RNLGCLD--------EDVARVYIAEVVLALE 703
+S + LV Y+ G L L L + A +
Sbjct: 97 GFSSDGDDLC-LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAAN--------GIN 147
Query: 704 YLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEP 763
+LH +HRD+K N+L+ K++DFGL++ ++
Sbjct: 148 FLHENHHIHRDIKSANILLDEAFTAKISDFGLAR--------------------ASEKF- 186
Query: 764 QLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT-ADWWSVGIILFELIVGIPPFNA 822
A R VGT Y+APE L G T +D +S G++L E+I G+P +
Sbjct: 187 ---AQTVMTSR-----IVGTTAYMAPEAL--RGEITPKSDIYSFGVVLLEIITGLPAVDE 236
Query: 823 EHPQVS 828
Sbjct: 237 HREPQL 242
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 41/181 (22%), Positives = 69/181 (38%), Gaps = 28/181 (15%)
Query: 589 DDFEIIKPISRGAFGRVFLAK-----KRTTGDLFAIKVLKKADMIRKNAVESILAERDIL 643
+ K + GAFG+V A K A+K+LK + + E++++E +L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT--EREALMSELKVL 80
Query: 644 ISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYI------- 695
+ N +V + T ++ EY GDL + LR
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 696 -----------AEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744
+V + +L S +HRDL N+L+ H K+ DFGL++ I +
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARD--IKND 198
Query: 745 D 745
Sbjct: 199 S 199
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 40/177 (22%), Positives = 71/177 (40%), Gaps = 24/177 (13%)
Query: 589 DDFEIIKPISRGAFGRVFLAK-----KRTTGDLFAIKVLKKADMIRKNAVESILAERDIL 643
++ + K + GAFG+V A K A+K+LK E++++E I+
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD--EKEALMSELKIM 103
Query: 644 ISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLAL 702
+ +V + T + ++ EY GDL + LR + E IA +
Sbjct: 104 SHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAST 163
Query: 703 --------------EYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745
+L S +HRD+ N+L+ + K+ DFGL++ I +
Sbjct: 164 RDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR--DIMNDS 218
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 44/168 (26%), Positives = 70/168 (41%), Gaps = 21/168 (12%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGD--LFAIKVLKKADMIRKNAVESILAERDILISV 646
+D + I G FG+V A+ + G AIK +K+ K+ E ++L +
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--KDDHRDFAGELEVLCKL 82
Query: 647 -RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLAL--- 702
+P ++ + R LYL +EY G+L LR L+ D A L
Sbjct: 83 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142
Query: 703 -------------EYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 737
+YL + +HRDL N+L+ + K+ DFGLS+
Sbjct: 143 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 190
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 6e-16
Identities = 45/180 (25%), Positives = 80/180 (44%), Gaps = 27/180 (15%)
Query: 589 DDFEIIKPISRGAFGRVFLAK-----KRTTGDLFAIKVLKKADMIRKNAVESILAERDIL 643
D ++ KP+ RGAFG+V A K T A+K+LK+ ++++E IL
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKIL 84
Query: 644 ISV-RNPFVVRFFYSFTCREN-LYLVMEYLNGGDLYSLLRNLGCLDEDVAR--------- 692
I + + VV + T L +++E+ G+L + LR+
Sbjct: 85 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144
Query: 693 ------VYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745
+ + +V +E+L S + +HRDL N+L++ +K+ DFGL++ I
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD--IYKDP 202
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 38/172 (22%), Positives = 68/172 (39%), Gaps = 19/172 (11%)
Query: 589 DDFEIIKPISRGAFGRVFLAK-KRTTGDLF----AIKVLKKADMIRKNAVESILAERDIL 643
+ +I+ + GAFG V+ + D A+K L + + L E I+
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ--DELDFLMEALII 87
Query: 644 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVAR------VYIA- 696
+ +VR +++ME + GGDL S LR + +++A
Sbjct: 88 SKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 147
Query: 697 EVVLALEYLHSLRVVHRDLKPDNLLIAHDGH---IKLTDFGLSKVGLINSTD 745
++ +YL +HRD+ N L+ G K+ DFG+++ I
Sbjct: 148 DIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--IYRAS 197
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 37/172 (21%), Positives = 68/172 (39%), Gaps = 19/172 (11%)
Query: 589 DDFEIIKPISRGAFGRVFLAK-KRTTGDLF----AIKVLKKADMIRKNAVESILAERDIL 643
+ +I+ + GAFG V+ + D A+K L + + L E I+
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ--DELDFLMEALII 128
Query: 644 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVAR------VYIA- 696
+ +VR ++++E + GGDL S LR + +++A
Sbjct: 129 SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 188
Query: 697 EVVLALEYLHSLRVVHRDLKPDNLLIAHDGH---IKLTDFGLSKVGLINSTD 745
++ +YL +HRD+ N L+ G K+ DFG+++ I
Sbjct: 189 DIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--IYRAG 238
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 45/186 (24%), Positives = 75/186 (40%), Gaps = 33/186 (17%)
Query: 589 DDFEIIKPISRGAFGRVFLAK-----KRTTGDLFAIKVLKKADMIRKNAVESILAERDIL 643
++ E K + GAFG+V A K A+K+LK+ E++++E ++
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS--EREALMSELKMM 102
Query: 644 ISV-RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLAL 702
+ + +V + T +YL+ EY GDL + LR+ + Y + L
Sbjct: 103 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 162
Query: 703 -----------------------EYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 739
E+L VHRDL N+L+ H +K+ DFGL++
Sbjct: 163 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLAR-- 220
Query: 740 LINSTD 745
I S
Sbjct: 221 DIMSDS 226
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 3e-15
Identities = 37/198 (18%), Positives = 71/198 (35%), Gaps = 40/198 (20%)
Query: 572 RSLRTSPIHPSKDRTSIDD-----FEIIKPISRGAFGRVFLAKKRTTGDL-----FAIKV 621
S + I D +++ PI +G FG ++LA ++ + +KV
Sbjct: 13 SSAKRHLAEQFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKV 72
Query: 622 LKK--------ADMIRKNAVESILAERDILISVRNPFVVRFFYS--FTCRENLY--LVME 669
++ A + + ++ V +++ S Y ++M+
Sbjct: 73 EPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMD 132
Query: 670 YLNGGDLYSLLRNLGCLDEDVARVYIAEVVL--------ALEYLHSLRVVHRDLKPDNLL 721
G DL + + + + VL LEY+H VH D+K NLL
Sbjct: 133 RF-GSDLQKIYEANA-------KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLL 184
Query: 722 I--AHDGHIKLTDFGLSK 737
+ + + L D+GL+
Sbjct: 185 LNYKNPDQVYLVDYGLAY 202
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 67/249 (26%), Positives = 103/249 (41%), Gaps = 50/249 (20%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVES-ILAERDILISVR 647
D+F + RG FG+V+ + G L A+K LK+ R E E +++
Sbjct: 30 DNFSNKNILGRGGFGKVYKGRLAD-GTLVAVKRLKEE---RTQGGELQFQTEVEMISMAV 85
Query: 648 NPFVVRFF-YSFTCRENLYLVMEYLNGGDLYSLLRNLG----CLDEDVARVYIAEVVLA- 701
+ ++R + T E L LV Y+ G + S LR LD R IA + A
Sbjct: 86 HRNLLRLRGFCMTPTERL-LVYPYMANGSVASCLRERPESQPPLDWP-KRQRIA-LGSAR 142
Query: 702 -LEYLH---SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 757
L YLH +++HRD+K N+L+ + + DFGL+K+ T V+ T +
Sbjct: 143 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH------VT-TAV 195
Query: 758 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT-ADWWSVGIILFELIVG 816
GT ++APE L TG + D + G++L ELI G
Sbjct: 196 -----------------------RGTIGHIAPEYLS-TGKSSEKTDVFGYGVMLLELITG 231
Query: 817 IPPFNAEHP 825
F+
Sbjct: 232 QRAFDLARL 240
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 72.2 bits (176), Expect = 1e-13
Identities = 40/197 (20%), Positives = 63/197 (31%), Gaps = 50/197 (25%)
Query: 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVL-----KKADMIRKNAVESILAERD 641
+ + + I G FG VF AIK++ + + E IL E
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75
Query: 642 IL-----------------ISVRNPFVVRFFY----------------------SFTCRE 662
I I + + V+ Y F +
Sbjct: 76 ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135
Query: 663 NLYLVMEYLNGG-DLYSLLRNLGCLDEDVARVYIAEVVLALEYLH-SLRVVHRDLKPDNL 720
L++V+E+ GG DL + L A+ + ++ +L SLR HRDL N+
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTKL--SSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNV 193
Query: 721 LIAHDGHIKLTDFGLSK 737
L+ KL K
Sbjct: 194 LLKKTSLKKLHYTLNGK 210
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 71.4 bits (174), Expect = 9e-13
Identities = 77/533 (14%), Positives = 152/533 (28%), Gaps = 127/533 (23%)
Query: 285 HQHKVSWGYWGDQQNISDDSSSIICRICEEEVPTSHVEDHSKICAIADRCDQ--KGLSVN 342
H H + + G+ Q D S+ + V+D K + D
Sbjct: 3 HHHHMDFET-GEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAV 61
Query: 343 ERLLRISETLEKMMESSVQKDIHNVVVGSPDVAKVSNSSVTEESDVLSPKFSDWSRRGSE 402
LR+ TL E VQK + V+ + L R+ S
Sbjct: 62 SGTLRLFWTLLSKQEEMVQKFVEEVL--RINY------------KFLMSPIKTEQRQPSM 107
Query: 403 DMLDYVPEA-----DNSVFMDD-------LKGLPSMACKTRFGPKSD---QGMT----TS 443
Y+ + DN VF L + R P + G+ T
Sbjct: 108 MTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELR--PAKNVLIDGVLGSGKTW 165
Query: 444 SAGSMTPRSPLLTPRTSQIDLLLAGKGALSEHDDFPQMNELADIARCVATTPLDDDSSIP 503
A + + +I L S + +L T+ D S+I
Sbjct: 166 VALDVCLSYKVQCKMDFKIFWLNLKN-CNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIK 224
Query: 504 YLLSFLEDLRVVIDRRKFDALTVETFGARIEKLIREKYLQLCELVTDDKVDITSTVIEED 563
+ ++ + +L++ K + C LV + + +
Sbjct: 225 LRIHSIQA--------------------ELRRLLKSKPYENCLLVLLNVQN--AKAWN-- 260
Query: 564 APLEDDV-VRSLRTSPIHPSKDRTSID--DFEIIKPISRGAFGRVFLAKKRTTGDLFAIK 620
++ + L T ++ + D IS L K
Sbjct: 261 -AF--NLSCKILLT-----TRFKQVTDFLSAATTTHISLDHHSMTLT--PDEVKSLLL-K 309
Query: 621 VLK-KADMIRKNAVE------SILAERDILISVRNPFVVRF-FYSFTCRENLYLVME--- 669
L + + + + SI+AE S+R+ + + + + L ++E
Sbjct: 310 YLDCRPQDLPREVLTTNPRRLSIIAE-----SIRD-GLATWDNWKHVNCDKLTTIIESSL 363
Query: 670 -YLNGGDLYSLLRNLGCLDEDVARVYIAEVVLA--------------LEYLHSLRVVHRD 714
L + + L +I ++L+ + LH +V +
Sbjct: 364 NVLEPAEYRKMFDRLSVFPPS---AHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQ 420
Query: 715 LKPDNLLIAHDGHIKLT-----DFGLSKVGLINS--------TDDLSGPAVSG 754
K + I +++L ++ L + +++ +DDL P +
Sbjct: 421 PKESTISI-PSIYLELKVKLENEYALHRS-IVDHYNIPKTFDSDDLIPPYLDQ 471
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 61.4 bits (148), Expect = 1e-09
Identities = 104/716 (14%), Positives = 202/716 (28%), Gaps = 208/716 (29%)
Query: 136 HMFQFRQSRVLHSADKRIP---QGTLRDGKGSTIAKASKAASSRKSYSQEQHGLDWKRDH 192
H F + + + + + K+ S++ DH
Sbjct: 5 HHMDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEI-----------DH 53
Query: 193 AVKQGN-----------ILSPPGDDNAKSLESSAARDR---MSSWK---KLPSPVGKIMK 235
+ + +LS + K +E + MS K + PS + + M
Sbjct: 54 IIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTR-MY 112
Query: 236 ESPTSKEQNDGKVEPLKSSNIRRGLSEIDLTAKPSEFPP-----------------AAET 278
+ ND + N+ R + L E P A +
Sbjct: 113 IEQRDRLYND--NQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDV 170
Query: 279 LEHSSKHQHKVSWG-YWGDQQNISDDSSSIICRICEEEVPTSHVEDHSKICAIADRCDQK 337
S K Q K+ + +W N+ + +S P + +E K+ + D
Sbjct: 171 CL-SYKVQCKMDFKIFW---LNLKNCNS-----------PETVLEMLQKLLY---QIDPN 212
Query: 338 GLSVNERLLRISETLEKMMESSVQKDIHNVVVGSPDVAKVSNSSVTEESDVLSPKFSDWS 397
S ++ I + L
Sbjct: 213 WTSRSDHSSNIKLRIH------------------------------SIQAELRRLLKSKP 242
Query: 398 RRGSEDMLDYVPEADNSV---FMDDLKGLPSMACKTRFGPKSDQGMTTSSAGSMTPRSPL 454
+L V + F +L CK +TT S
Sbjct: 243 YENCLLVLLNV--QNAKAWNAF--NLS------CKIL--------LTTRFKQVTDFLSAA 284
Query: 455 LTPRTSQIDLLLAGKGALSEHDDFPQMNELADIARCVATT----PLDDDSSIPYLLSFL- 509
T S L+ ++ L + + + P + ++ P LS +
Sbjct: 285 TTTHISLDHH----SMTLTP----DEVKSL--LLKYLDCRPQDLPREVLTTNPRRLSIIA 334
Query: 510 EDLRVVIDRRKF------DALTVETFGARIEKL----IREKYLQLCELVTDDKVDITSTV 559
E +R + D LT + + L R+ + +L V I + +
Sbjct: 335 ESIRDGLATWDNWKHVNCDKLT-TIIESSLNVLEPAEYRKMFDRLS--VFPPSAHIPTIL 391
Query: 560 IE---EDAPLED--DVVRSLRTSPI---HPSKDRTSIDDFEIIKPISRGAFGRVFLAKKR 611
+ D D VV L + P + SI ++L K
Sbjct: 392 LSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPS--------------IYLELKV 437
Query: 612 TTGDLFAI--KVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV-- 667
+ +A+ ++ ++ + + ++ P++ ++FYS ++
Sbjct: 438 KLENEYALHRSIVDHYNIPKTFDSDDLIP----------PYLDQYFYS-------HIGHH 480
Query: 668 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKP-DNLLIAHDG 726
++ + + +L R + LD I A S+ + LK + +D
Sbjct: 481 LKNIEHPERMTLFRMV-FLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDP 539
Query: 727 HIK-----LTDFGLSKVG--LINSTD-DLSGPAVSGTTLLGDEEPQLTASEHQQER 774
+ + DF L K+ LI S DL A L+ ++E + Q +R
Sbjct: 540 KYERLVNAILDF-LPKIEENLICSKYTDLLRIA-----LMAEDEAIFEEAHKQVQR 589
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 51.5 bits (123), Expect = 6e-07
Identities = 28/101 (27%), Positives = 49/101 (48%), Gaps = 9/101 (8%)
Query: 589 DDFEIIKPISRGAFGRVFLAK-----KRTTGDLFAIKVLKKADMIRKNAVESILAERDIL 643
D ++ KP+ RGAFG+V A K T A+K+LK + + ++++E IL
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK--EGATHSEHRALMSELKIL 79
Query: 644 ISVRN-PFVVRFF-YSFTCRENLYLVMEYLNGGDLYSLLRN 682
I + + VV L +++E+ G+L + LR+
Sbjct: 80 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 120
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 27/118 (22%), Positives = 50/118 (42%), Gaps = 29/118 (24%)
Query: 697 EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 756
+V +E+L S + +HRDL N+L++ +K+ DFGL++ I
Sbjct: 201 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR--DIYKDP----------- 247
Query: 757 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI 814
+ +K A ++APE + + +D WS G++L+E+
Sbjct: 248 ----------------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 289
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 5e-04
Identities = 18/78 (23%), Positives = 34/78 (43%), Gaps = 10/78 (12%)
Query: 661 RENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNL 720
+N ++M Y+NG ++ + + + + + LH V+H DL N
Sbjct: 411 LDNKRIMMSYINGKLAKDVIEDNLDIAYKIGE-IVGK-------LHKNDVIHNDLTTSNF 462
Query: 721 LIAHDGHIKLTDFGLSKV 738
+ D + + DFGL K+
Sbjct: 463 IF--DKDLYIIDFGLGKI 478
|
| >3k1f_M Transcription initiation factor IIB; RNA polymerase II, TFIIB, transcription factor, DNA-binding, DNA-directed RNA polymerase; 4.30A {Saccharomyces cerevisiae} Length = 197 | Back alignment and structure |
|---|
Score = 41.2 bits (96), Expect = 5e-04
Identities = 18/63 (28%), Positives = 27/63 (42%), Gaps = 16/63 (25%)
Query: 292 GYWGDQQNISDDSSSIICRICEEEVPTSHVEDHSK---ICAIADRCDQKGLSVNERLL-R 347
G G NI + C C+ P VE S+ +CA C GL ++++L+
Sbjct: 12 GRRGPNLNIV-----LTCPECKVY-PPKIVERFSEGDVVCA---LC---GLVLSDKLVDT 59
Query: 348 ISE 350
SE
Sbjct: 60 RSE 62
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 837 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.98 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.97 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.78 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.62 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.27 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.14 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.0 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.84 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.6 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.39 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.39 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.15 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.05 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.96 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.89 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.81 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.5 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.32 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.19 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.9 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.8 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.8 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.74 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.57 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.33 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.12 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.06 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.83 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.23 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.12 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 91.99 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 90.24 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-48 Score=415.01 Aligned_cols=211 Identities=38% Similarity=0.743 Sum_probs=189.9
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEE
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 665 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ly 665 (837)
...++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|+.++||||++++++|.+.+++|
T Consensus 29 ~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~y 108 (311)
T 4aw0_A 29 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY 108 (311)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 34578999999999999999999999999999999998765444555678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCC
Q 003232 666 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745 (837)
Q Consensus 666 LVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~std 745 (837)
||||||+||+|.+++.+.+.+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.......
T Consensus 109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~- 187 (311)
T 4aw0_A 109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK- 187 (311)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT-
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC-
Confidence 9999999999999999889999999999999999999999999999999999999999999999999999984211110
Q ss_pred CCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 746 dl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
.....+.+||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+.
T Consensus 188 ----------------------------~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~ 239 (311)
T 4aw0_A 188 ----------------------------QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 239 (311)
T ss_dssp ----------------------------CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ----------------------------cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 1123467899999999999999999999999999999999999999987553
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=410.14 Aligned_cols=207 Identities=30% Similarity=0.568 Sum_probs=178.7
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEE
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyL 666 (837)
.+++|++++.||+|+||+||+|+++.+|+.||||++..... .....+.+.+|+.+|+.++|||||+++++|.+.+.+||
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yi 100 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYI 100 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 35789999999999999999999999999999999987553 34456789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCC
Q 003232 667 VMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~~--g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~st 744 (837)
|||||+||+|.+++... ..+++..++.|+.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+...
T Consensus 101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~---- 176 (350)
T 4b9d_A 101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN---- 176 (350)
T ss_dssp EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCC----
T ss_pred EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeec----
Confidence 99999999999999754 357999999999999999999999999999999999999999999999999997310
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 745 ddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
.........+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+
T Consensus 177 ---------------------------~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~ 229 (350)
T 4b9d_A 177 ---------------------------STVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS 229 (350)
T ss_dssp ---------------------------HHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ---------------------------CCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 00111234679999999999999999999999999999999999999998765
Q ss_pred c
Q 003232 825 P 825 (837)
Q Consensus 825 p 825 (837)
.
T Consensus 230 ~ 230 (350)
T 4b9d_A 230 M 230 (350)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=394.58 Aligned_cols=207 Identities=31% Similarity=0.626 Sum_probs=170.4
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeE
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~l 664 (837)
+..+++|++++.||+|+||+||+|+++.+|+.||+|++.+...........+.+|+.+++.++||||++++++|.+.+.+
T Consensus 9 G~~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~ 88 (275)
T 3hyh_A 9 GAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEI 88 (275)
T ss_dssp -----CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCEeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 44568899999999999999999999999999999999876554555567899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCC
Q 003232 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~st 744 (837)
|+||||+ +|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+....
T Consensus 89 ~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~--- 164 (275)
T 3hyh_A 89 IMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD--- 164 (275)
T ss_dssp EEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred EEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCC---
Confidence 9999999 789999999889999999999999999999999999999999999999999999999999999973100
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCC-CchHHHHHHHHHHHHHHcCCCCCCCC
Q 003232 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVGIPPFNAE 823 (837)
Q Consensus 745 ddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~-s~kSDIWSLGVILyELLTGr~PF~~~ 823 (837)
.......+||+.|||||++.+..+ +.++|||||||++|+|++|+.||.+.
T Consensus 165 -----------------------------~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~ 215 (275)
T 3hyh_A 165 -----------------------------GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE 215 (275)
T ss_dssp ---------------------------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred -----------------------------CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC
Confidence 011234689999999999999886 58999999999999999999999875
Q ss_pred C
Q 003232 824 H 824 (837)
Q Consensus 824 d 824 (837)
+
T Consensus 216 ~ 216 (275)
T 3hyh_A 216 S 216 (275)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=403.70 Aligned_cols=202 Identities=32% Similarity=0.576 Sum_probs=181.1
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVm 668 (837)
..|+++++||+|+||+||+|+++.+|+.||||++...... ..+.+.+|+.+|+.++|||||+++++|.+.+++||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS---SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4699999999999999999999999999999999764322 2346789999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCC
Q 003232 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 748 (837)
Q Consensus 669 Ey~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~ 748 (837)
|||+||+|.+++.+ +.+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.....
T Consensus 151 Ey~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~------ 223 (346)
T 4fih_A 151 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE------ 223 (346)
T ss_dssp CCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS------
T ss_pred eCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCC------
Confidence 99999999999976 57999999999999999999999999999999999999999999999999999741110
Q ss_pred CCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 749 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 749 ~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
.......+||+.|||||++.+..|+.++|||||||++|||++|++||.+.++
T Consensus 224 -------------------------~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~ 275 (346)
T 4fih_A 224 -------------------------VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP 275 (346)
T ss_dssp -------------------------SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred -------------------------CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH
Confidence 0113457899999999999999999999999999999999999999987543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=398.79 Aligned_cols=205 Identities=27% Similarity=0.460 Sum_probs=179.2
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEE
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyL 666 (837)
..+.|++.++||+|+||+||+|+++.+|+.||||+++.... ..+|+.+++.++|||||+++++|.+.+.+||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~i 127 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVNI 127 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45679999999999999999999999999999999976432 2469999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCC-cEEEEecCCccccccCCCC
Q 003232 667 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG-HIKLTDFGLSKVGLINSTD 745 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG-~IKLiDFGLArvg~~~std 745 (837)
|||||+||+|.++++..+.+++..++.|+.||+.||.|||++|||||||||+|||++.+| .+||+|||+|+....+...
T Consensus 128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 999999999999999889999999999999999999999999999999999999999988 6999999999742111000
Q ss_pred CCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 746 dl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
.........+||+.|||||++.+.+|+.++|||||||++|||++|++||.+.+.
T Consensus 208 --------------------------~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~ 261 (336)
T 4g3f_A 208 --------------------------KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFR 261 (336)
T ss_dssp --------------------------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCC
T ss_pred --------------------------cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH
Confidence 001122356899999999999999999999999999999999999999987654
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=398.31 Aligned_cols=206 Identities=44% Similarity=0.829 Sum_probs=176.8
Q ss_pred cCCeEEEEEecccCceEEEEEEEC---CCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKR---TTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk---~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~l 664 (837)
.++|++++.||+|+||+||+|++. .+++.||+|++++...... ....+.+|+.+|+.++||||++++++|.+.+.+
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 101 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEVNHPFIVKLHYAFQTEGKL 101 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC------CCCCCCCCTTEECEEEEEEETTEE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 367999999999999999999984 4678999999976543222 123578899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCC
Q 003232 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~st 744 (837)
|||||||+||+|.+++.+.+.+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+....
T Consensus 102 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--- 178 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID--- 178 (304)
T ss_dssp EEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC------
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccC---
Confidence 99999999999999999989999999999999999999999999999999999999999999999999999973100
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 745 ddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
........+||+.|||||++.+..|+.++|||||||++|+|+||++||.+.+
T Consensus 179 ----------------------------~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~ 230 (304)
T 3ubd_A 179 ----------------------------HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD 230 (304)
T ss_dssp ------------------------------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ----------------------------CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC
Confidence 0112345789999999999999999999999999999999999999998765
Q ss_pred c
Q 003232 825 P 825 (837)
Q Consensus 825 p 825 (837)
.
T Consensus 231 ~ 231 (304)
T 3ubd_A 231 R 231 (304)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=385.14 Aligned_cols=199 Identities=25% Similarity=0.487 Sum_probs=176.1
Q ss_pred eEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeec----CCeEEE
Q 003232 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC----RENLYL 666 (837)
Q Consensus 591 YeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d----~~~lyL 666 (837)
|++.++||+|+||+||+|+++.++..||+|++..... .....+.+.+|+.+++.++|||||+++++|.. ...+||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~l 106 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEE
Confidence 4788899999999999999999999999999976543 34456789999999999999999999999865 356899
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCCCCcEEEcc-CCcEEEEecCCccccccCC
Q 003232 667 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLR--VVHRDLKPDNLLIAH-DGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkG--IIHRDIKPeNILLd~-dG~IKLiDFGLArvg~~~s 743 (837)
|||||+||+|.+++.+.+.+++..++.++.||+.||.|||++| ||||||||+|||++. +|.+||+|||+|+....
T Consensus 107 vmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~-- 184 (290)
T 3fpq_A 107 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-- 184 (290)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT--
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC--
Confidence 9999999999999998899999999999999999999999998 999999999999974 79999999999974100
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~ 823 (837)
......+||+.|||||++.+ .|+.++|||||||++|||+||++||...
T Consensus 185 -------------------------------~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~ 232 (290)
T 3fpq_A 185 -------------------------------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC 232 (290)
T ss_dssp -------------------------------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred -------------------------------CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 01235689999999999876 5999999999999999999999999764
Q ss_pred C
Q 003232 824 H 824 (837)
Q Consensus 824 d 824 (837)
.
T Consensus 233 ~ 233 (290)
T 3fpq_A 233 Q 233 (290)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=406.06 Aligned_cols=203 Identities=32% Similarity=0.569 Sum_probs=181.5
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLV 667 (837)
.+.|+++++||+|+||+||+|+++.+|+.||||++...... ..+.+.+|+.+|+.++|||||+++++|...+.+|||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV 226 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 226 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS---SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh---HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence 35699999999999999999999999999999999764322 234688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCC
Q 003232 668 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (837)
Q Consensus 668 mEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl 747 (837)
||||+||+|.+++.. +.+++..++.|+.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.....
T Consensus 227 mEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~----- 300 (423)
T 4fie_A 227 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE----- 300 (423)
T ss_dssp EECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS-----
T ss_pred EeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCC-----
Confidence 999999999999976 56999999999999999999999999999999999999999999999999999741100
Q ss_pred CCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 748 ~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
.......+||+.|||||++.+..|+.++|||||||++|||++|++||.+.++
T Consensus 301 --------------------------~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~ 352 (423)
T 4fie_A 301 --------------------------VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP 352 (423)
T ss_dssp --------------------------CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred --------------------------CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH
Confidence 0112456899999999999999999999999999999999999999987553
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=382.18 Aligned_cols=207 Identities=28% Similarity=0.452 Sum_probs=177.4
Q ss_pred ccCCeEEEEEecccCceEEEEEEEC-----CCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecC
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKR-----TTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR 661 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk-----~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~ 661 (837)
..++|.+.+.||+|+||+||+|++. .++..||||+++.. .....+.+.+|+.+|++++|||||++++++.+.
T Consensus 11 ~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~ 87 (299)
T 4asz_A 11 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 87 (299)
T ss_dssp CGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred CHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 3467999999999999999999975 35789999999764 344567899999999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcE
Q 003232 662 ENLYLVMEYLNGGDLYSLLRNL-------------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHI 728 (837)
Q Consensus 662 ~~lyLVmEy~~GGSL~dlLk~~-------------g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~I 728 (837)
+.+|||||||++|+|.+++... ..+++..+..++.||+.||.|||+++||||||||+|||++.++.+
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcE
Confidence 9999999999999999999754 359999999999999999999999999999999999999999999
Q ss_pred EEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHH
Q 003232 729 KLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGI 808 (837)
Q Consensus 729 KLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGV 808 (837)
||+|||+|+...... .........||+.|||||++.+..|+.++|||||||
T Consensus 168 Ki~DFGla~~~~~~~-----------------------------~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gv 218 (299)
T 4asz_A 168 KIGDFGMSRDVYSTD-----------------------------YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGV 218 (299)
T ss_dssp EECCCSCHHHHTGGG-----------------------------CEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred EECCcccceecCCCC-----------------------------ceeecCceecChhhcCHHHHcCCCCCchhhHHHHHH
Confidence 999999997311000 001122346899999999999999999999999999
Q ss_pred HHHHHHc-CCCCCCCCCc
Q 003232 809 ILFELIV-GIPPFNAEHP 825 (837)
Q Consensus 809 ILyELLT-Gr~PF~~~dp 825 (837)
++|||+| |+.||.+.++
T Consensus 219 vl~Ellt~G~~Pf~~~~~ 236 (299)
T 4asz_A 219 VLWEIFTYGKQPWYQLSN 236 (299)
T ss_dssp HHHHHHTTTCCTTTTSCH
T ss_pred HHHHHHcCCCCCCCCCCH
Confidence 9999998 9999987653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=379.28 Aligned_cols=213 Identities=30% Similarity=0.511 Sum_probs=167.3
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC-----
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE----- 662 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~----- 662 (837)
+++|++++.||+|+||+||+|+++.+|+.||||+++... .....+.+.+|+.+|+.++|||||+++++|...+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 81 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL 81 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence 457999999999999999999999999999999997543 3445568999999999999999999999987543
Q ss_pred -------eEEEEEEecCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEe
Q 003232 663 -------NLYLVMEYLNGGDLYSLLRNLGC---LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTD 732 (837)
Q Consensus 663 -------~lyLVmEy~~GGSL~dlLk~~g~---Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiD 732 (837)
++|+|||||+||+|.+++...+. .....++.++.||+.||+|||++|||||||||+|||++.+|.+||+|
T Consensus 82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEcc
Confidence 47999999999999999987654 44566889999999999999999999999999999999999999999
Q ss_pred cCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHH
Q 003232 733 FGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFE 812 (837)
Q Consensus 733 FGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyE 812 (837)
||+|+.......... . .............+||+.|||||++.+..|+.++|||||||++||
T Consensus 162 FGla~~~~~~~~~~~--------~-----------~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilye 222 (299)
T 4g31_A 162 FGLVTAMDQDEEEQT--------V-----------LTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222 (299)
T ss_dssp CCCC---------------------------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHH
T ss_pred CccceecCCCccccc--------c-----------ccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHH
Confidence 999985322111100 0 000011122346789999999999999999999999999999999
Q ss_pred HHcCCCCCCCCC
Q 003232 813 LIVGIPPFNAEH 824 (837)
Q Consensus 813 LLTGr~PF~~~d 824 (837)
|++ ||....
T Consensus 223 ll~---Pf~~~~ 231 (299)
T 4g31_A 223 LLY---PFSTQM 231 (299)
T ss_dssp HHS---CCSSHH
T ss_pred Hcc---CCCCcc
Confidence 996 886543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=380.02 Aligned_cols=209 Identities=24% Similarity=0.391 Sum_probs=176.1
Q ss_pred CCCcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC
Q 003232 583 KDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE 662 (837)
Q Consensus 583 k~g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~ 662 (837)
.|....++|++.++||+|+||+||+|++. ..||||+++... ......+.|.+|+.++++++|||||++++++. .+
T Consensus 30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~ 104 (307)
T 3omv_A 30 YWEIEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVD-PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KD 104 (307)
T ss_dssp CCBCCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred CcEEcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CC
Confidence 35666788999999999999999999864 369999997644 34456678999999999999999999999875 45
Q ss_pred eEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCcccccc
Q 003232 663 NLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 741 (837)
Q Consensus 663 ~lyLVmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~ 741 (837)
.+|||||||+||+|.+++... +.+++..+..++.||+.||.|||++|||||||||+|||++.++++||+|||+|+....
T Consensus 105 ~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 105 NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp SCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred eEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 689999999999999999764 5799999999999999999999999999999999999999999999999999974111
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC---CCCCchHHHHHHHHHHHHHHcCCC
Q 003232 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG---TGHGTTADWWSVGIILFELIVGIP 818 (837)
Q Consensus 742 ~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg---~~~s~kSDIWSLGVILyELLTGr~ 818 (837)
.. ........+||+.|||||++.+ .+|+.++|||||||++|||+||+.
T Consensus 185 ~~-----------------------------~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~ 235 (307)
T 3omv_A 185 WS-----------------------------GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGEL 235 (307)
T ss_dssp --------------------------------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred CC-----------------------------cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCC
Confidence 00 0112335689999999999964 458999999999999999999999
Q ss_pred CCCCCCc
Q 003232 819 PFNAEHP 825 (837)
Q Consensus 819 PF~~~dp 825 (837)
||.+.++
T Consensus 236 Pf~~~~~ 242 (307)
T 3omv_A 236 PYSHINN 242 (307)
T ss_dssp TTTTCCC
T ss_pred CCCCCCh
Confidence 9987554
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=379.36 Aligned_cols=207 Identities=30% Similarity=0.464 Sum_probs=174.4
Q ss_pred ccCCeEEEEEecccCceEEEEEEEC-----CCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecC
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKR-----TTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR 661 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk-----~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~ 661 (837)
..++|.+.++||+|+||+||+|+++ .+++.||||+++.. .....+.|.+|+.+|++++|||||++++++.+.
T Consensus 39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~ 115 (329)
T 4aoj_A 39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCTEG 115 (329)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 3467999999999999999999975 36789999999764 344567899999999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCC
Q 003232 662 ENLYLVMEYLNGGDLYSLLRNL---------------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG 726 (837)
Q Consensus 662 ~~lyLVmEy~~GGSL~dlLk~~---------------g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG 726 (837)
..+|||||||++|+|.++++.. +++++..+..++.||+.||.|||+++||||||||+|||++.++
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL 195 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCC
Confidence 9999999999999999999753 3589999999999999999999999999999999999999999
Q ss_pred cEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHH
Q 003232 727 HIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSV 806 (837)
Q Consensus 727 ~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSL 806 (837)
.+||+|||+++...... ........+||+.|||||++.+..++.++|||||
T Consensus 196 ~~Ki~DFGla~~~~~~~-----------------------------~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~ 246 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTD-----------------------------YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSF 246 (329)
T ss_dssp EEEECCCC---------------------------------------------CCCCGGGCCHHHHTTCCCCHHHHHHHH
T ss_pred cEEEcccccceeccCCC-----------------------------cceecCcccccccccChhhhcCCCCCccccccch
Confidence 99999999997311000 0011234579999999999999999999999999
Q ss_pred HHHHHHHHc-CCCCCCCCCc
Q 003232 807 GIILFELIV-GIPPFNAEHP 825 (837)
Q Consensus 807 GVILyELLT-Gr~PF~~~dp 825 (837)
||++|||+| |+.||.+.++
T Consensus 247 Gvvl~Ellt~G~~Pf~~~~~ 266 (329)
T 4aoj_A 247 GVVLWEIFTYGKQPWYQLSN 266 (329)
T ss_dssp HHHHHHHHTTSCCTTCSSCH
T ss_pred HHHHHHHHcCCCCCCCCCCH
Confidence 999999998 9999987553
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=376.03 Aligned_cols=209 Identities=23% Similarity=0.376 Sum_probs=178.2
Q ss_pred cccCCeEEEEEecccCceEEEEEEEC-----CCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeec
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKR-----TTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC 660 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk-----~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d 660 (837)
....+++++++||+|+||+||+|++. .+++.||||+++... .....+.|.+|+.++++++|||||++++++..
T Consensus 23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 100 (308)
T 4gt4_A 23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVTK 100 (308)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence 34567999999999999999999874 367899999997543 22334679999999999999999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEcc
Q 003232 661 RENLYLVMEYLNGGDLYSLLRNL----------------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH 724 (837)
Q Consensus 661 ~~~lyLVmEy~~GGSL~dlLk~~----------------g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~ 724 (837)
...+|||||||++|+|.+++... ..+++..+..++.||+.||.|||+++||||||||+|||++.
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYD 180 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECC
Confidence 99999999999999999999642 35899999999999999999999999999999999999999
Q ss_pred CCcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHH
Q 003232 725 DGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWW 804 (837)
Q Consensus 725 dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIW 804 (837)
++++||+|||+++....... .......+||+.|||||++.+..++.++|||
T Consensus 181 ~~~~Ki~DFGlar~~~~~~~-----------------------------~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVw 231 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAADY-----------------------------YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIW 231 (308)
T ss_dssp GGCEEECCSCCBCGGGGGGC-----------------------------BCSSSSSCBCGGGCCHHHHHHCCCCHHHHHH
T ss_pred CCCEEECCcccceeccCCCc-----------------------------eeEecccccCCcccCHHHHhCCCCCccchhh
Confidence 99999999999974211100 0112346799999999999999999999999
Q ss_pred HHHHHHHHHHc-CCCCCCCCCc
Q 003232 805 SVGIILFELIV-GIPPFNAEHP 825 (837)
Q Consensus 805 SLGVILyELLT-Gr~PF~~~dp 825 (837)
||||++|||+| |..||.+.++
T Consensus 232 SfGvvl~El~t~g~~Pf~~~~~ 253 (308)
T 4gt4_A 232 SYGVVLWEVFSYGLQPYCGYSN 253 (308)
T ss_dssp HHHHHHHHHHTTTCCTTTTCCH
T ss_pred hHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999998 8999987653
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=384.24 Aligned_cols=208 Identities=29% Similarity=0.453 Sum_probs=179.5
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeec------C
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC------R 661 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d------~ 661 (837)
.++|++++.||+|+||+||+|+++.+|+.||||+++... ......+.+.+|+.+|+.++||||+++++++.. .
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 131 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF-DVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF 131 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccc-cchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence 357999999999999999999999999999999997654 234455788999999999999999999998764 3
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCcccccc
Q 003232 662 ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 741 (837)
Q Consensus 662 ~~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~ 741 (837)
+++|||||||+ |+|.+++...+.+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+++....
T Consensus 132 ~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~ 210 (398)
T 4b99_A 132 KSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCT 210 (398)
T ss_dssp CCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred CEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence 67999999995 68999998888999999999999999999999999999999999999999999999999999973211
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCC
Q 003232 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPF 820 (837)
Q Consensus 742 ~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~-~~s~kSDIWSLGVILyELLTGr~PF 820 (837)
... .........+||+.|||||++.+. .++.++|||||||++|||++|++||
T Consensus 211 ~~~---------------------------~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF 263 (398)
T 4b99_A 211 SPA---------------------------EHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLF 263 (398)
T ss_dssp --------------------------------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSS
T ss_pred Ccc---------------------------ccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCC
Confidence 000 011123467899999999999885 4699999999999999999999999
Q ss_pred CCCC
Q 003232 821 NAEH 824 (837)
Q Consensus 821 ~~~d 824 (837)
.+.+
T Consensus 264 ~g~~ 267 (398)
T 4b99_A 264 PGKN 267 (398)
T ss_dssp CCSS
T ss_pred CCCC
Confidence 8765
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=376.11 Aligned_cols=237 Identities=27% Similarity=0.408 Sum_probs=179.9
Q ss_pred cCCeEEEEEecccCceEEEEEEEC---CCCcEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEeEeecCCe
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKR---TTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCREN 663 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk---~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~gsf~d~~~ 663 (837)
.+.|++.++||+|+||+||+|+++ .+++.||+|.+.... ...++.+|+.+|+.+ +||||++++++|...++
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 356999999999999999999875 467899999986543 224678899999988 69999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccC-CcEEEEecCCccccccC
Q 003232 664 LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD-GHIKLTDFGLSKVGLIN 742 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~d-G~IKLiDFGLArvg~~~ 742 (837)
+|+||||++||+|.+++. .+++..++.++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+.....
T Consensus 95 ~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~ 171 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT 171 (361)
T ss_dssp EEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTC
T ss_pred EEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc
Confidence 999999999999999983 58999999999999999999999999999999999999876 89999999999742211
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCCC
Q 003232 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFN 821 (837)
Q Consensus 743 stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~-~~s~kSDIWSLGVILyELLTGr~PF~ 821 (837)
...... +............................+||+.|||||++.+. .|+.++||||+||++|+|++|+.||.
T Consensus 172 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 172 KIELLK---FVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248 (361)
T ss_dssp SCGGGG---GC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred cccccc---cccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence 110000 00000000000000000001112234567899999999999876 48999999999999999999999999
Q ss_pred CCCcCHHHHHHhcc
Q 003232 822 AEHPQVSTLLRKCQ 835 (837)
Q Consensus 822 ~~dpdv~~lle~~h 835 (837)
..+++..++..+.+
T Consensus 249 ~~~~~~~~l~~I~~ 262 (361)
T 4f9c_A 249 KASDDLTALAQIMT 262 (361)
T ss_dssp CCSSHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHH
Confidence 88887777665543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=405.01 Aligned_cols=208 Identities=36% Similarity=0.655 Sum_probs=181.0
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHH---HHHHHHhcCCCceEEEEeEeecC
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILA---ERDILISVRNPFVVRFFYSFTCR 661 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~r---EieILk~LrHPNIVkL~gsf~d~ 661 (837)
...+++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+ ++.+++.++|||||+++++|.+.
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~ 264 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 264 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence 345788999999999999999999999999999999997654332222233344 45566677999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCcccccc
Q 003232 662 ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 741 (837)
Q Consensus 662 ~~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~ 741 (837)
.++|||||||+||+|.+++.+.+.+++..++.|+.||+.||.|||++|||||||||+|||++.+|++||+|||+|+....
T Consensus 265 ~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 99999999999999999999989999999999999999999999999999999999999999999999999999973110
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhc-CCCCCchHHHHHHHHHHHHHHcCCCCC
Q 003232 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-GTGHGTTADWWSVGIILFELIVGIPPF 820 (837)
Q Consensus 742 ~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLl-g~~~s~kSDIWSLGVILyELLTGr~PF 820 (837)
....+.+||+.|||||++. +..|+.++|||||||++|||++|.+||
T Consensus 345 ---------------------------------~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF 391 (689)
T 3v5w_A 345 ---------------------------------KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391 (689)
T ss_dssp ---------------------------------CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred ---------------------------------CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 1123568999999999996 568999999999999999999999999
Q ss_pred CCCCc
Q 003232 821 NAEHP 825 (837)
Q Consensus 821 ~~~dp 825 (837)
.+.+.
T Consensus 392 ~~~~~ 396 (689)
T 3v5w_A 392 RQHKT 396 (689)
T ss_dssp CGGGC
T ss_pred CCCCh
Confidence 86543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=373.11 Aligned_cols=215 Identities=27% Similarity=0.435 Sum_probs=181.7
Q ss_pred CCCCCcccCCeEEEEEecccCceEEEEEEECCCC-----cEEEEEEecccccccHHHHHHHHHHHHHHHhcCC-CceEEE
Q 003232 581 PSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTG-----DLFAIKVLKKADMIRKNAVESILAERDILISVRN-PFVVRF 654 (837)
Q Consensus 581 P~k~g~~lddYeIlkkLGsG~FGtVYkArdk~tG-----~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrH-PNIVkL 654 (837)
+.+|....++|++.+.||+|+||+||+|++...+ +.||||.++... .....+.+.+|+.+|+.++| ||||++
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 3456667789999999999999999999986543 589999997643 23445789999999999965 899999
Q ss_pred EeEeec-CCeEEEEEEecCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCC
Q 003232 655 FYSFTC-RENLYLVMEYLNGGDLYSLLRNL----------------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKP 717 (837)
Q Consensus 655 ~gsf~d-~~~lyLVmEy~~GGSL~dlLk~~----------------g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKP 717 (837)
+++|.. ...+|||||||++|+|.++++.. ..+++..+..++.||+.||.|||+++||||||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~ 213 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA 213 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCc
Confidence 999876 45789999999999999999753 3488999999999999999999999999999999
Q ss_pred CcEEEccCCcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCC
Q 003232 718 DNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH 797 (837)
Q Consensus 718 eNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~ 797 (837)
+|||++.++.+||+|||+|+....+.. .......+||+.|||||++.+..|
T Consensus 214 ~NILl~~~~~vKi~DFGlar~~~~~~~-----------------------------~~~~~~~~gt~~ymAPE~l~~~~y 264 (353)
T 4ase_A 214 RNILLSEKNVVKICDFGLARDIYKDPD-----------------------------YVRKGDARLPLKWMAPETIFDRVY 264 (353)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTT-----------------------------SEEETTEEECGGGCCHHHHHHCCC
T ss_pred cceeeCCCCCEEECcchhhhhcccCCC-----------------------------ceeeccccccccccCHHHHhcCCC
Confidence 999999999999999999973111100 012234578999999999999999
Q ss_pred CchHHHHHHHHHHHHHHc-CCCCCCCCCcC
Q 003232 798 GTTADWWSVGIILFELIV-GIPPFNAEHPQ 826 (837)
Q Consensus 798 s~kSDIWSLGVILyELLT-Gr~PF~~~dpd 826 (837)
+.++|||||||++|||+| |+.||.+....
T Consensus 265 ~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~ 294 (353)
T 4ase_A 265 TIQSDVWSFGVLLWEIFSLGASPYPGVKID 294 (353)
T ss_dssp CHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred CCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999998 99999876543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=384.52 Aligned_cols=206 Identities=29% Similarity=0.552 Sum_probs=183.1
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeE
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~l 664 (837)
...+++|++++.||+|+||+||+|+++.+|+.||+|++.... ....+.+.+|+.+|+.++||||++++++|.+..++
T Consensus 153 ~~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 229 (573)
T 3uto_A 153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM 229 (573)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEE
T ss_pred CcCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 345688999999999999999999999999999999997643 33346788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccC--CcEEEEecCCcccccc
Q 003232 665 YLVMEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD--GHIKLTDFGLSKVGLI 741 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~-~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~d--G~IKLiDFGLArvg~~ 741 (837)
|||||||+||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus 230 ~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 230 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp EEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred EEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 999999999999999864 4679999999999999999999999999999999999999854 8999999999974110
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCC
Q 003232 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFN 821 (837)
Q Consensus 742 ~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~ 821 (837)
.......+||+.|||||++.+.+|+.++|||||||++|+|++|.+||.
T Consensus 310 --------------------------------~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~ 357 (573)
T 3uto_A 310 --------------------------------KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG 357 (573)
T ss_dssp --------------------------------TSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSC
T ss_pred --------------------------------CCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 011234689999999999999999999999999999999999999998
Q ss_pred CCCc
Q 003232 822 AEHP 825 (837)
Q Consensus 822 ~~dp 825 (837)
+.+.
T Consensus 358 ~~~~ 361 (573)
T 3uto_A 358 GEND 361 (573)
T ss_dssp CSSH
T ss_pred CcCH
Confidence 7654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=356.38 Aligned_cols=199 Identities=23% Similarity=0.333 Sum_probs=160.5
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC----eE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE----NL 664 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~----~l 664 (837)
.+|.+.++||+|+||+||+|++ +|+.||||+++... ........|+..+..++||||+++++++...+ .+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 4589999999999999999997 58999999997532 11122334566667889999999999998653 68
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CcccccCCCCcEEEccCCcEEEEecCCc
Q 003232 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL--------RVVHRDLKPDNLLIAHDGHIKLTDFGLS 736 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSk--------GIIHRDIKPeNILLd~dG~IKLiDFGLA 736 (837)
||||||++||+|.++++. ..+++..+..++.|++.||.|||++ +||||||||+|||++.++++||+|||++
T Consensus 77 ~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 999999999999999976 4689999999999999999999987 9999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCC------CCCchHHHHHHHHHH
Q 003232 737 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT------GHGTTADWWSVGIIL 810 (837)
Q Consensus 737 rvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~------~~s~kSDIWSLGVIL 810 (837)
+........ ........+||+.|||||++.+. .++.++|||||||++
T Consensus 156 ~~~~~~~~~---------------------------~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl 208 (303)
T 3hmm_A 156 VRHDSATDT---------------------------IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVF 208 (303)
T ss_dssp EEEETTTTE---------------------------ESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHH
T ss_pred ccccCCCCc---------------------------eeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHH
Confidence 742111100 00012245799999999999765 357799999999999
Q ss_pred HHHHcCCCCCC
Q 003232 811 FELIVGIPPFN 821 (837)
Q Consensus 811 yELLTGr~PF~ 821 (837)
|||+||.+||.
T Consensus 209 ~El~tg~~~~~ 219 (303)
T 3hmm_A 209 WEIARRCSIGG 219 (303)
T ss_dssp HHHHHTBCBTT
T ss_pred HHHHHCCCCCC
Confidence 99999987664
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=346.18 Aligned_cols=208 Identities=41% Similarity=0.801 Sum_probs=186.0
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEE
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyL 666 (837)
.+++|++++.||+|+||+||+|+++.+|+.||+|++++...........+.+|+.+++.++||||+++++++....++|+
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence 45789999999999999999999999999999999986543344455678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCC
Q 003232 667 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stdd 746 (837)
||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 83 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~---- 158 (337)
T 1o6l_A 83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD---- 158 (337)
T ss_dssp EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT----
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC----
Confidence 9999999999999988888999999999999999999999999999999999999999999999999998731100
Q ss_pred CCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 747 l~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 159 ---------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 210 (337)
T 1o6l_A 159 ---------------------------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 210 (337)
T ss_dssp ---------------------------TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ---------------------------CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH
Confidence 0112356799999999999999999999999999999999999999987543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=349.89 Aligned_cols=210 Identities=43% Similarity=0.828 Sum_probs=182.5
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEeEeecCCe
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCREN 663 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~gsf~d~~~ 663 (837)
...+++|++++.||+|+||+||+|+++.+++.||+|++++...........+.+|..+++.+ +||||+++++++.....
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 45568899999999999999999999999999999999876544455567788999999988 79999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCC
Q 003232 664 LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~s 743 (837)
+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.....
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~- 177 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN- 177 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccC-
Confidence 9999999999999999998889999999999999999999999999999999999999999999999999998731100
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~ 823 (837)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 178 ------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~ 227 (353)
T 3txo_A 178 ------------------------------GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE 227 (353)
T ss_dssp --------------------------------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ------------------------------CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC
Confidence 01123568999999999999999999999999999999999999999876
Q ss_pred Cc
Q 003232 824 HP 825 (837)
Q Consensus 824 dp 825 (837)
+.
T Consensus 228 ~~ 229 (353)
T 3txo_A 228 NE 229 (353)
T ss_dssp SH
T ss_pred CH
Confidence 54
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=331.55 Aligned_cols=209 Identities=27% Similarity=0.474 Sum_probs=183.6
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEE
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyL 666 (837)
..++|++++.||+|+||+||+|++..+++.||+|++...........+.+.+|+.+++.++||||+++++++.....+|+
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 34679999999999999999999999999999999976655566677889999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCC
Q 003232 667 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stdd 746 (837)
||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.....
T Consensus 89 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---- 164 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET---- 164 (294)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc----
Confidence 9999999999999998889999999999999999999999999999999999999999999999999998731100
Q ss_pred CCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 747 l~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
.........||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+.
T Consensus 165 --------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~ 217 (294)
T 4eqm_A 165 --------------------------SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA 217 (294)
T ss_dssp ------------------------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH
T ss_pred --------------------------cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 00112345799999999999999999999999999999999999999987654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=342.95 Aligned_cols=206 Identities=42% Similarity=0.808 Sum_probs=185.5
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEE
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 665 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ly 665 (837)
..+++|++++.||.|+||+||+|+++.+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.....+|
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 34678999999999999999999999999999999998654333344567889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCC
Q 003232 666 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745 (837)
Q Consensus 666 LVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~std 745 (837)
+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~----- 157 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP----- 157 (318)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECS-----
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecC-----
Confidence 999999999999999988889999999999999999999999999999999999999999999999999987310
Q ss_pred CCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 746 dl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 158 -----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 208 (318)
T 1fot_A 158 -----------------------------DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT 208 (318)
T ss_dssp -----------------------------SCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred -----------------------------CccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH
Confidence 012245799999999999999999999999999999999999999987543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=339.31 Aligned_cols=206 Identities=34% Similarity=0.654 Sum_probs=184.6
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEE
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 665 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ly 665 (837)
...++|++++.||+|+||.||+|++..+|+.||+|++.... ......+.+.+|+.+++.++||||+++++++.....+|
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 90 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQ-LNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLY 90 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence 45678999999999999999999999999999999997654 23455678899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCC
Q 003232 666 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745 (837)
Q Consensus 666 LVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~std 745 (837)
+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~---- 166 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV---- 166 (328)
T ss_dssp EEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS----
T ss_pred EEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCC----
Confidence 9999999999999998888999999999999999999999999999999999999999999999999999863100
Q ss_pred CCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCC-chHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHG-TTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 746 dl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s-~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
.......+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+
T Consensus 167 ----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 218 (328)
T 3fe3_A 167 ----------------------------GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218 (328)
T ss_dssp ----------------------------SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ----------------------------CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC
Confidence 0112346799999999999988875 89999999999999999999998754
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=343.73 Aligned_cols=210 Identities=43% Similarity=0.823 Sum_probs=184.7
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEeEeecCCe
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCREN 663 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~gsf~d~~~ 663 (837)
....++|++.+.||+|+||.||+|+++.+|+.||+|++++...........+..|..++..+ +||||+++++++.....
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 45668899999999999999999999999999999999875433334456788899999876 99999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCC
Q 003232 664 LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~s 743 (837)
+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~- 171 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG- 171 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC-
Confidence 9999999999999999998888999999999999999999999999999999999999999999999999998731100
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~ 823 (837)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 172 ------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 221 (345)
T 1xjd_A 172 ------------------------------DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ 221 (345)
T ss_dssp ------------------------------TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ------------------------------CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCC
Confidence 01124568999999999999999999999999999999999999999875
Q ss_pred Cc
Q 003232 824 HP 825 (837)
Q Consensus 824 dp 825 (837)
+.
T Consensus 222 ~~ 223 (345)
T 1xjd_A 222 DE 223 (345)
T ss_dssp SH
T ss_pred CH
Confidence 53
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=345.29 Aligned_cols=206 Identities=44% Similarity=0.867 Sum_probs=186.0
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEE
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 665 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ly 665 (837)
..+++|++++.||.|+||.||+|+++.+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.....+|
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 117 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 44678999999999999999999999999999999997654434445578899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCC
Q 003232 666 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745 (837)
Q Consensus 666 LVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~std 745 (837)
+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.++|+|||+++...
T Consensus 118 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~----- 192 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----- 192 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECS-----
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceecc-----
Confidence 999999999999999988889999999999999999999999999999999999999999999999999987310
Q ss_pred CCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 746 dl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||...++
T Consensus 193 -----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 243 (350)
T 1rdq_E 193 -----------------------------GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243 (350)
T ss_dssp -----------------------------SCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred -----------------------------CCcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH
Confidence 011245799999999999999999999999999999999999999987543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=339.79 Aligned_cols=206 Identities=38% Similarity=0.762 Sum_probs=186.1
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEeEeecCCeE
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENL 664 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~gsf~d~~~l 664 (837)
..+++|++++.||+|+||.||+|+++.+++.||+|++.+...........+.+|..+++.+ +||||+++++++.....+
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 85 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 85 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence 3457899999999999999999999999999999999876655666677899999999987 899999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCC
Q 003232 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~st 744 (837)
|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.....
T Consensus 86 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~-- 163 (345)
T 3a8x_A 86 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-- 163 (345)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT--
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCC--
Confidence 999999999999999988888999999999999999999999999999999999999999999999999998731100
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003232 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNA 822 (837)
Q Consensus 745 ddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~ 822 (837)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 164 -----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 164 -----------------------------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp -----------------------------TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred -----------------------------CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 0112356899999999999999999999999999999999999999975
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=350.55 Aligned_cols=207 Identities=37% Similarity=0.757 Sum_probs=183.5
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEeEeecCCe
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCREN 663 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~gsf~d~~~ 663 (837)
...+++|++++.||+|+||+||+|+++.+++.||+|++++...........+.+|..++..+ +||||++++++|.....
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 127 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 127 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence 45568899999999999999999999999999999999876555555556788999999876 89999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCC
Q 003232 664 LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~s 743 (837)
+|+||||++||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.....
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~- 206 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP- 206 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-
T ss_pred EEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccC-
Confidence 9999999999999999998889999999999999999999999999999999999999999999999999998731100
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNA 822 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~ 822 (837)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 207 ------------------------------~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~ 255 (396)
T 4dc2_A 207 ------------------------------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 255 (396)
T ss_dssp ------------------------------TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred ------------------------------CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 0123456899999999999999999999999999999999999999964
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=343.59 Aligned_cols=210 Identities=37% Similarity=0.763 Sum_probs=185.3
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEeEeecCCe
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCREN 663 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~gsf~d~~~ 663 (837)
...+++|++++.||+|+||+||+|+++.+++.||+|++++.........+.+..|..++..+ +||||+++++++.....
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 34568899999999999999999999999999999999875443444556788999999887 89999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCC
Q 003232 664 LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~s 743 (837)
+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~- 174 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD- 174 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC-
Confidence 9999999999999999998888999999999999999999999999999999999999999999999999998731100
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~ 823 (837)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.
T Consensus 175 ------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~ 224 (353)
T 2i0e_A 175 ------------------------------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 224 (353)
T ss_dssp ------------------------------TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ------------------------------CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC
Confidence 01123568999999999999999999999999999999999999999876
Q ss_pred Cc
Q 003232 824 HP 825 (837)
Q Consensus 824 dp 825 (837)
+.
T Consensus 225 ~~ 226 (353)
T 2i0e_A 225 DE 226 (353)
T ss_dssp SH
T ss_pred CH
Confidence 53
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=343.58 Aligned_cols=211 Identities=41% Similarity=0.828 Sum_probs=177.9
Q ss_pred CCcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHH-HHhcCCCceEEEEeEeecCC
Q 003232 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDI-LISVRNPFVVRFFYSFTCRE 662 (837)
Q Consensus 584 ~g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieI-Lk~LrHPNIVkL~gsf~d~~ 662 (837)
.....++|++++.||+|+||.||+|+++.+++.||+|++.+...........+.+|..+ ++.++||||++++++|....
T Consensus 33 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~ 112 (373)
T 2r5t_A 33 PHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD 112 (373)
T ss_dssp TTCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSS
T ss_pred CCCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC
Confidence 34566889999999999999999999999999999999987665555556677788877 46789999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccC
Q 003232 663 NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (837)
Q Consensus 663 ~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~ 742 (837)
.+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.....
T Consensus 113 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 113 KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 99999999999999999998888999999999999999999999999999999999999999999999999998731110
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003232 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNA 822 (837)
Q Consensus 743 stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~ 822 (837)
. ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+
T Consensus 193 ~-------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~ 241 (373)
T 2r5t_A 193 N-------------------------------STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 241 (373)
T ss_dssp C-------------------------------CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred C-------------------------------CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence 0 112356899999999999999999999999999999999999999987
Q ss_pred CCc
Q 003232 823 EHP 825 (837)
Q Consensus 823 ~dp 825 (837)
.+.
T Consensus 242 ~~~ 244 (373)
T 2r5t_A 242 RNT 244 (373)
T ss_dssp SBH
T ss_pred CCH
Confidence 543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=331.30 Aligned_cols=214 Identities=26% Similarity=0.435 Sum_probs=181.1
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC--
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE-- 662 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~-- 662 (837)
....++|++.+.||.|+||+||+|++..+++.||+|++.............+.+|+.+++.++||||+++++++....
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 87 (311)
T 3ork_A 8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 87 (311)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETT
T ss_pred ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCC
Confidence 445678999999999999999999999999999999998765555666778999999999999999999999987654
Q ss_pred --eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccc
Q 003232 663 --NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740 (837)
Q Consensus 663 --~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~ 740 (837)
..|+||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 88 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 88 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred CcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 359999999999999999888889999999999999999999999999999999999999999999999999986311
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCC
Q 003232 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820 (837)
Q Consensus 741 ~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF 820 (837)
.... .........||+.|+|||++.+..++.++||||||+++|+|++|+.||
T Consensus 168 ~~~~----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf 219 (311)
T 3ork_A 168 DSGN----------------------------SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF 219 (311)
T ss_dssp ------------------------------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSC
T ss_pred cccc----------------------------ccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCC
Confidence 1000 001123457999999999999999999999999999999999999999
Q ss_pred CCCCcC
Q 003232 821 NAEHPQ 826 (837)
Q Consensus 821 ~~~dpd 826 (837)
.+.++.
T Consensus 220 ~~~~~~ 225 (311)
T 3ork_A 220 TGDSPV 225 (311)
T ss_dssp CCSSHH
T ss_pred CCCChH
Confidence 876543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=346.18 Aligned_cols=210 Identities=33% Similarity=0.736 Sum_probs=186.5
Q ss_pred CCcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCe
Q 003232 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCREN 663 (837)
Q Consensus 584 ~g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ 663 (837)
....+++|++++.||.|+||.||+|++..+++.||+|++.............+.+|+.+++.++||||++++++|.....
T Consensus 10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 89 (384)
T 4fr4_A 10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED 89 (384)
T ss_dssp CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 34556889999999999999999999999999999999976554444556788999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCC
Q 003232 664 LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~s 743 (837)
+|+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.++|+|||+++....
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~-- 167 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR-- 167 (384)
T ss_dssp EEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT--
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccC--
Confidence 999999999999999999888899999999999999999999999999999999999999999999999999873110
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC---CCCCchHHHHHHHHHHHHHHcCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG---TGHGTTADWWSVGIILFELIVGIPPF 820 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg---~~~s~kSDIWSLGVILyELLTGr~PF 820 (837)
.......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||
T Consensus 168 ------------------------------~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf 217 (384)
T 4fr4_A 168 ------------------------------ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPY 217 (384)
T ss_dssp ------------------------------TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred ------------------------------CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCC
Confidence 011235689999999999974 46899999999999999999999999
Q ss_pred CCCCc
Q 003232 821 NAEHP 825 (837)
Q Consensus 821 ~~~dp 825 (837)
.....
T Consensus 218 ~~~~~ 222 (384)
T 4fr4_A 218 HIRSS 222 (384)
T ss_dssp CCCTT
T ss_pred CCCCC
Confidence 86543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=327.68 Aligned_cols=206 Identities=35% Similarity=0.630 Sum_probs=181.8
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeE
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~l 664 (837)
+...++|++.+.||+|+||+||+|++..+++.||+|++....... .+.+.+|+.+++.++||||+++++++.....+
T Consensus 16 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 92 (297)
T 3fxz_A 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDEL 92 (297)
T ss_dssp SCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEE
Confidence 344578999999999999999999999999999999997644222 35688999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCC
Q 003232 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~st 744 (837)
|+||||++|++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 93 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 169 (297)
T 3fxz_A 93 WVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-- 169 (297)
T ss_dssp EEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST--
T ss_pred EEEEECCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc--
Confidence 999999999999999977 46999999999999999999999999999999999999999999999999998631100
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 745 ddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
........||+.|+|||++.+..++.++|||||||++|+|++|..||...+
T Consensus 170 -----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 220 (297)
T 3fxz_A 170 -----------------------------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (297)
T ss_dssp -----------------------------TCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred -----------------------------ccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 011234579999999999999999999999999999999999999998765
Q ss_pred c
Q 003232 825 P 825 (837)
Q Consensus 825 p 825 (837)
+
T Consensus 221 ~ 221 (297)
T 3fxz_A 221 P 221 (297)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=380.69 Aligned_cols=208 Identities=34% Similarity=0.639 Sum_probs=184.2
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEE
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 665 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ly 665 (837)
...++|++++.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+++.++||||+++++++.....+|
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 34577999999999999999999999999999999997654433444567889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCC
Q 003232 666 LVMEYLNGGDLYSLLRNLGC--LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 666 LVmEy~~GGSL~dlLk~~g~--Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~s 743 (837)
+||||++||+|.+++...+. +++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~- 339 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG- 339 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccC-
Confidence 99999999999999976543 999999999999999999999999999999999999999999999999998731100
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~ 823 (837)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 340 -------------------------------~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~ 388 (576)
T 2acx_A 340 -------------------------------QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 388 (576)
T ss_dssp -------------------------------CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCS
T ss_pred -------------------------------ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccc
Confidence 0123458999999999999999999999999999999999999999876
Q ss_pred Cc
Q 003232 824 HP 825 (837)
Q Consensus 824 dp 825 (837)
..
T Consensus 389 ~~ 390 (576)
T 2acx_A 389 KK 390 (576)
T ss_dssp SS
T ss_pred cc
Confidence 53
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=352.63 Aligned_cols=209 Identities=42% Similarity=0.785 Sum_probs=182.1
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEE
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyL 666 (837)
..++|+++++||+|+||+||+|+++.+++.||+|++.+...........+.+|+.++..++||||++++++|.+...+|+
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l 151 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYL 151 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEE
Confidence 34679999999999999999999999999999999976443333333458899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCC
Q 003232 667 VMEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~-~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~std 745 (837)
||||++||+|.+++.. .+.+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+++......
T Consensus 152 V~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~-- 229 (437)
T 4aw2_A 152 VMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-- 229 (437)
T ss_dssp EECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS--
T ss_pred EEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC--
Confidence 9999999999999987 4679999999999999999999999999999999999999999999999999986311100
Q ss_pred CCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhc-----CCCCCchHHHHHHHHHHHHHHcCCCCC
Q 003232 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-----GTGHGTTADWWSVGIILFELIVGIPPF 820 (837)
Q Consensus 746 dl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLl-----g~~~s~kSDIWSLGVILyELLTGr~PF 820 (837)
.......+||+.|+|||++. +..++.++|||||||++|||++|+.||
T Consensus 230 ----------------------------~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf 281 (437)
T 4aw2_A 230 ----------------------------TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF 281 (437)
T ss_dssp ----------------------------CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTT
T ss_pred ----------------------------CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCC
Confidence 01123468999999999997 567899999999999999999999999
Q ss_pred CCCCc
Q 003232 821 NAEHP 825 (837)
Q Consensus 821 ~~~dp 825 (837)
.+.+.
T Consensus 282 ~~~~~ 286 (437)
T 4aw2_A 282 YAESL 286 (437)
T ss_dssp CCSSH
T ss_pred CCCCh
Confidence 87653
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=350.72 Aligned_cols=208 Identities=45% Similarity=0.817 Sum_probs=181.4
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEE
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyL 666 (837)
..++|++++.||+|+||+||+|+++.+++.||+|++.+...........+.+|+.+++.++||||++++++|.+..++|+
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 146 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 146 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 45779999999999999999999999999999999976433223333457899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCC
Q 003232 667 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stdd 746 (837)
||||++||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++......
T Consensus 147 V~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~--- 222 (410)
T 3v8s_A 147 VMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG--- 222 (410)
T ss_dssp EECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS---
T ss_pred EEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCC---
Confidence 9999999999999976 569999999999999999999999999999999999999999999999999987311000
Q ss_pred CCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCC----CCchHHHHHHHHHHHHHHcCCCCCCC
Q 003232 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG----HGTTADWWSVGIILFELIVGIPPFNA 822 (837)
Q Consensus 747 l~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~----~s~kSDIWSLGVILyELLTGr~PF~~ 822 (837)
.......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+
T Consensus 223 ---------------------------~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 275 (410)
T 3v8s_A 223 ---------------------------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 275 (410)
T ss_dssp ---------------------------EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ---------------------------cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCC
Confidence 01123568999999999998766 78999999999999999999999987
Q ss_pred CCc
Q 003232 823 EHP 825 (837)
Q Consensus 823 ~dp 825 (837)
.+.
T Consensus 276 ~~~ 278 (410)
T 3v8s_A 276 DSL 278 (410)
T ss_dssp SSH
T ss_pred CCh
Confidence 654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=321.28 Aligned_cols=208 Identities=31% Similarity=0.495 Sum_probs=177.1
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLV 667 (837)
+++|++++.||+|+||+||+|+++.+++.||+|++.... ........+.+|+.+++.++||||+++++++.....+|+|
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccC-CcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence 367999999999999999999999999999999997654 2344456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCC
Q 003232 668 MEYLNGGDLYSLL-RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (837)
Q Consensus 668 mEy~~GGSL~dlL-k~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stdd 746 (837)
|||+.+ +|.+.+ ...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++......
T Consensus 80 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 155 (292)
T 3o0g_A 80 FEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--- 155 (292)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC---
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc---
Confidence 999976 555554 446789999999999999999999999999999999999999999999999999987311000
Q ss_pred CCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCC-CCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 747 l~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~-~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.....
T Consensus 156 ----------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~ 207 (292)
T 3o0g_A 156 ----------------------------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207 (292)
T ss_dssp ----------------------------SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS
T ss_pred ----------------------------ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC
Confidence 1123457899999999998766 79999999999999999998888655444
Q ss_pred CHH
Q 003232 826 QVS 828 (837)
Q Consensus 826 dv~ 828 (837)
...
T Consensus 208 ~~~ 210 (292)
T 3o0g_A 208 VDD 210 (292)
T ss_dssp HHH
T ss_pred HHH
Confidence 433
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=329.13 Aligned_cols=210 Identities=41% Similarity=0.830 Sum_probs=175.5
Q ss_pred CcccCCeEEEEEecccCceEEEEEEEC---CCCcEEEEEEecccccc-cHHHHHHHHHHHHHHHhcCCCceEEEEeEeec
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKR---TTGDLFAIKVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTC 660 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk---~tG~~VAVKIikk~~~~-~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d 660 (837)
....++|++.+.||+|+||.||+|++. .+++.||+|+++..... .......+.+|+.+++.++||||+++++++..
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 92 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT 92 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence 345578999999999999999999985 68999999999865422 22344567899999999999999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccc
Q 003232 661 RENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740 (837)
Q Consensus 661 ~~~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~ 740 (837)
...+|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 99999999999999999999888889999999999999999999999999999999999999999999999999986310
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCC
Q 003232 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820 (837)
Q Consensus 741 ~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF 820 (837)
.. .......+||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 173 ~~-------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf 221 (327)
T 3a62_A 173 HD-------------------------------GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF 221 (327)
T ss_dssp -------------------------------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred cC-------------------------------CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCC
Confidence 00 01123457999999999999999999999999999999999999999
Q ss_pred CCCCc
Q 003232 821 NAEHP 825 (837)
Q Consensus 821 ~~~dp 825 (837)
.+.+.
T Consensus 222 ~~~~~ 226 (327)
T 3a62_A 222 TGENR 226 (327)
T ss_dssp CCSSH
T ss_pred CCCCH
Confidence 87543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=348.66 Aligned_cols=209 Identities=42% Similarity=0.788 Sum_probs=182.7
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEE
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyL 666 (837)
..++|++++.||+|+||+||+|+++.+|+.||+|++.+...........+.+|+.++..++||||++++++|.+..++|+
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l 138 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYL 138 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 34789999999999999999999999999999999976543334444568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCC
Q 003232 667 VMEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~~g-~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~std 745 (837)
||||++||+|.+++.+.+ .+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++......
T Consensus 139 VmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~-- 216 (412)
T 2vd5_A 139 VMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG-- 216 (412)
T ss_dssp EECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS--
T ss_pred EEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCC--
Confidence 999999999999998754 79999999999999999999999999999999999999999999999999987311100
Q ss_pred CCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhc-------CCCCCchHHHHHHHHHHHHHHcCCC
Q 003232 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-------GTGHGTTADWWSVGIILFELIVGIP 818 (837)
Q Consensus 746 dl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLl-------g~~~s~kSDIWSLGVILyELLTGr~ 818 (837)
.......+||+.|+|||++. +..++.++|||||||++|||++|+.
T Consensus 217 ----------------------------~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~ 268 (412)
T 2vd5_A 217 ----------------------------TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQT 268 (412)
T ss_dssp ----------------------------CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSC
T ss_pred ----------------------------ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCC
Confidence 01123468999999999997 4568999999999999999999999
Q ss_pred CCCCCCc
Q 003232 819 PFNAEHP 825 (837)
Q Consensus 819 PF~~~dp 825 (837)
||.+.+.
T Consensus 269 Pf~~~~~ 275 (412)
T 2vd5_A 269 PFYADST 275 (412)
T ss_dssp TTCCSSH
T ss_pred CCCCCCH
Confidence 9987654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=319.64 Aligned_cols=218 Identities=24% Similarity=0.447 Sum_probs=182.1
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEE
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyL 666 (837)
..++|++.+.||+|+||+||+|.+..+++.||+|++... .....+.+.+|+.+++.++||||+++++++......|+
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNF 84 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEE
Confidence 356799999999999999999999999999999998653 34566789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCC
Q 003232 667 VMEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~-~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~std 745 (837)
||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++........
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 85 ITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp EEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred EEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 9999999999999987 467999999999999999999999999999999999999999999999999998742111110
Q ss_pred CCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 746 dl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
... ................||+.|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 165 ~~~-----------------~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~ 226 (310)
T 3s95_A 165 PEG-----------------LRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYL 226 (310)
T ss_dssp --------------------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTS
T ss_pred ccc-----------------cccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchh
Confidence 000 00000011122346789999999999999999999999999999999999999987543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=346.17 Aligned_cols=210 Identities=43% Similarity=0.809 Sum_probs=176.9
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeE
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~l 664 (837)
....++|++++.||+|+||.||+|++..+|+.||+|++.............+.+|+.+++.++||||+++++++...+.+
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 223 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL 223 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEE
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEE
Confidence 44567899999999999999999999999999999999865444455566788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCcEEEccCCcEEEEecCCccccccCC
Q 003232 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHS-kGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~s 743 (837)
|+||||++|++|.+++...+.+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++.....
T Consensus 224 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~- 302 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD- 302 (446)
T ss_dssp EEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred EEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC-
Confidence 9999999999999999888899999999999999999999998 99999999999999999999999999998731100
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~ 823 (837)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 303 ------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 352 (446)
T 4ejn_A 303 ------------------------------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 352 (446)
T ss_dssp ----------------------------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ------------------------------CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence 01123568999999999999999999999999999999999999999775
Q ss_pred Cc
Q 003232 824 HP 825 (837)
Q Consensus 824 dp 825 (837)
+.
T Consensus 353 ~~ 354 (446)
T 4ejn_A 353 DH 354 (446)
T ss_dssp SH
T ss_pred CH
Confidence 43
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=337.45 Aligned_cols=208 Identities=31% Similarity=0.541 Sum_probs=183.0
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccH---HHHHHHHHHHHHHHhcCCCceEEEEeEeecCC
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRK---NAVESILAERDILISVRNPFVVRFFYSFTCRE 662 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~---e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~ 662 (837)
...+.|++.+.||.|+||+||+|+++.+|+.||+|++........ ...+.+.+|+.+++.++||||++++++|....
T Consensus 9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 88 (361)
T 2yab_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT 88 (361)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC
Confidence 445679999999999999999999999999999999976542211 12457889999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCC----cEEEEecCCccc
Q 003232 663 NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG----HIKLTDFGLSKV 738 (837)
Q Consensus 663 ~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG----~IKLiDFGLArv 738 (837)
.+|+||||+.|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++ .++|+|||+++.
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 9999999999999999998888899999999999999999999999999999999999998776 799999999873
Q ss_pred cccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCC
Q 003232 739 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIP 818 (837)
Q Consensus 739 g~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~ 818 (837)
.... ......+||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 169 ~~~~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~ 216 (361)
T 2yab_A 169 IEDG--------------------------------VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 216 (361)
T ss_dssp CCTT--------------------------------CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCC
T ss_pred cCCC--------------------------------CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCC
Confidence 1100 01234579999999999999999999999999999999999999
Q ss_pred CCCCCCc
Q 003232 819 PFNAEHP 825 (837)
Q Consensus 819 PF~~~dp 825 (837)
||.+.+.
T Consensus 217 Pf~~~~~ 223 (361)
T 2yab_A 217 PFLGDTK 223 (361)
T ss_dssp SSCCSSH
T ss_pred CCCCCCH
Confidence 9987543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=334.19 Aligned_cols=205 Identities=32% Similarity=0.533 Sum_probs=181.8
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEE
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyL 666 (837)
..++|++.+.||.|+||.||+|.++.+++.||+|++..... .....+.+.+|+.+++.++||||+++++++......|+
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 34579999999999999999999999999999999976542 34455778999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccC---CcEEEEecCCccccccCC
Q 003232 667 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD---GHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~d---G~IKLiDFGLArvg~~~s 743 (837)
||||+.|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++.....
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~-- 183 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND-- 183 (362)
T ss_dssp EECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT--
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC--
Confidence 99999999999999888889999999999999999999999999999999999999765 4599999999863110
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~ 823 (837)
........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 184 ------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~ 233 (362)
T 2bdw_A 184 ------------------------------SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 233 (362)
T ss_dssp ------------------------------CCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ------------------------------CcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 00122457999999999999999999999999999999999999999875
Q ss_pred C
Q 003232 824 H 824 (837)
Q Consensus 824 d 824 (837)
+
T Consensus 234 ~ 234 (362)
T 2bdw_A 234 D 234 (362)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=316.59 Aligned_cols=208 Identities=37% Similarity=0.693 Sum_probs=183.4
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeE
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~l 664 (837)
...+++|++.+.||.|+||+||+|++..++..||+|++.............+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 84 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence 45678899999999999999999999999999999999765433334456788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCC
Q 003232 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~st 744 (837)
|+||||+++++|.+++.....+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.....
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~--- 161 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--- 161 (279)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc---
Confidence 99999999999999998888899999999999999999999999999999999999999999999999998752100
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 745 ddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
.......||+.|+|||++.+..++.++||||||+++|+|++|..||...+
T Consensus 162 ------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 211 (279)
T 3fdn_A 162 ------------------------------SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 211 (279)
T ss_dssp ------------------------------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ------------------------------ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc
Confidence 01124578999999999999999999999999999999999999998654
Q ss_pred c
Q 003232 825 P 825 (837)
Q Consensus 825 p 825 (837)
.
T Consensus 212 ~ 212 (279)
T 3fdn_A 212 Y 212 (279)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=333.70 Aligned_cols=205 Identities=31% Similarity=0.608 Sum_probs=180.9
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEE
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 665 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ly 665 (837)
...++|++.+.||+|+||+||+|++..+++.||+|++.............+.+|+.+++.++||||+++++++.....+|
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 85 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIV 85 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 34678999999999999999999999999999999997643333333457889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCC
Q 003232 666 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745 (837)
Q Consensus 666 LVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~std 745 (837)
+||||+ +|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 86 lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~---- 160 (336)
T 3h4j_B 86 MVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD---- 160 (336)
T ss_dssp EEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT----
T ss_pred EEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccC----
Confidence 999999 789999998888999999999999999999999999999999999999999999999999999863110
Q ss_pred CCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCC-CchHHHHHHHHHHHHHHcCCCCCCCC
Q 003232 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVGIPPFNAE 823 (837)
Q Consensus 746 dl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~-s~kSDIWSLGVILyELLTGr~PF~~~ 823 (837)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...
T Consensus 161 ----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~ 211 (336)
T 3h4j_B 161 ----------------------------GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE 211 (336)
T ss_dssp ----------------------------SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCS
T ss_pred ----------------------------CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCc
Confidence 011234579999999999998876 78999999999999999999999764
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=325.05 Aligned_cols=207 Identities=29% Similarity=0.540 Sum_probs=181.8
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEeccccccc---HHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCe
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIR---KNAVESILAERDILISVRNPFVVRFFYSFTCREN 663 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~---~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ 663 (837)
..+.|++.+.||.|+||.||+|+++.+++.||+|++....... ....+.+.+|+.+++.++||||+++++++.....
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 3456999999999999999999999999999999997643221 1124578899999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCC----cEEEEecCCcccc
Q 003232 664 LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG----HIKLTDFGLSKVG 739 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG----~IKLiDFGLArvg 739 (837)
+|+||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++ .++|+|||+++..
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 168 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence 999999999999999998888899999999999999999999999999999999999998877 8999999998731
Q ss_pred ccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCC
Q 003232 740 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPP 819 (837)
Q Consensus 740 ~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~P 819 (837)
... .......||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 169 ~~~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p 216 (326)
T 2y0a_A 169 DFG--------------------------------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216 (326)
T ss_dssp CTT--------------------------------SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCS
T ss_pred CCC--------------------------------CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCC
Confidence 100 011245799999999999999999999999999999999999999
Q ss_pred CCCCCc
Q 003232 820 FNAEHP 825 (837)
Q Consensus 820 F~~~dp 825 (837)
|.+.+.
T Consensus 217 f~~~~~ 222 (326)
T 2y0a_A 217 FLGDTK 222 (326)
T ss_dssp SCCSSH
T ss_pred CCCCCH
Confidence 976543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=328.72 Aligned_cols=216 Identities=22% Similarity=0.358 Sum_probs=184.3
Q ss_pred cccCCeEEEEEeccc--CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCe
Q 003232 586 TSIDDFEIIKPISRG--AFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCREN 663 (837)
Q Consensus 586 ~~lddYeIlkkLGsG--~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ 663 (837)
...++|++++.||+| +||+||+|+++.+++.||||++.... ........+.+|+.+++.++||||+++++++...+.
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 100 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEA-CSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE 100 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGG-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCE
Confidence 345679999999999 99999999999999999999997654 334566788999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCcccccc
Q 003232 664 LYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 741 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk~~--g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~ 741 (837)
+|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 99999999999999999875 6799999999999999999999999999999999999999999999999998763211
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC--CCCCchHHHHHHHHHHHHHHcCCCC
Q 003232 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG--TGHGTTADWWSVGIILFELIVGIPP 819 (837)
Q Consensus 742 ~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg--~~~s~kSDIWSLGVILyELLTGr~P 819 (837)
....... .........||+.|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus 181 ~~~~~~~------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~p 236 (389)
T 3gni_B 181 HGQRQRV------------------------VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236 (389)
T ss_dssp TTEECSC------------------------BCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred ccccccc------------------------cccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCC
Confidence 1000000 0001123478999999999988 6789999999999999999999999
Q ss_pred CCCCCcC
Q 003232 820 FNAEHPQ 826 (837)
Q Consensus 820 F~~~dpd 826 (837)
|.+.+..
T Consensus 237 f~~~~~~ 243 (389)
T 3gni_B 237 FKDMPAT 243 (389)
T ss_dssp TTTCCST
T ss_pred CCCCCHH
Confidence 9875543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=328.84 Aligned_cols=209 Identities=29% Similarity=0.517 Sum_probs=180.2
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEE
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyL 666 (837)
..++|++++.||+|+||+||+|++..+++.||+|++..... ....+.+.+|+.+++.++||||+++++++......|+
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 82 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 35789999999999999999999999999999999975432 2233568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCC
Q 003232 667 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stdd 746 (837)
||||++|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++........
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-- 160 (323)
T 3tki_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-- 160 (323)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE--
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCc--
Confidence 999999999999998777899999999999999999999999999999999999999999999999999874211110
Q ss_pred CCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCC-CchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 747 l~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~-s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.....
T Consensus 161 ---------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 213 (323)
T 3tki_A 161 ---------------------------ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (323)
T ss_dssp ---------------------------ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCT
T ss_pred ---------------------------ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCch
Confidence 011234679999999999988776 7789999999999999999999987665
Q ss_pred C
Q 003232 826 Q 826 (837)
Q Consensus 826 d 826 (837)
.
T Consensus 214 ~ 214 (323)
T 3tki_A 214 S 214 (323)
T ss_dssp T
T ss_pred H
Confidence 4
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=322.50 Aligned_cols=209 Identities=35% Similarity=0.545 Sum_probs=175.5
Q ss_pred CCCcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC
Q 003232 583 KDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE 662 (837)
Q Consensus 583 k~g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~ 662 (837)
......++|++.+.||+|+||+||+|++ +++.||+|++.... ......+.+.+|+.+++.++||||+++++++....
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQD-FHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP 107 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCC-CSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 3445567899999999999999999987 58899999997654 34455678999999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC--cccccCCCCcEEEccCCcEEEEecCCcc
Q 003232 663 NLYLVMEYLNGGDLYSLLRNLGC---LDEDVARVYIAEVVLALEYLHSLR--VVHRDLKPDNLLIAHDGHIKLTDFGLSK 737 (837)
Q Consensus 663 ~lyLVmEy~~GGSL~dlLk~~g~---Lsee~irkIl~QIa~ALsYLHSkG--IIHRDIKPeNILLd~dG~IKLiDFGLAr 737 (837)
.+|+||||+++++|.+++...+. +++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 187 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence 99999999999999999986543 999999999999999999999999 9999999999999999999999999986
Q ss_pred ccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCC
Q 003232 738 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGI 817 (837)
Q Consensus 738 vg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr 817 (837)
..... ........||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 188 ~~~~~-------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 236 (309)
T 3p86_A 188 LKAST-------------------------------FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQ 236 (309)
T ss_dssp ---------------------------------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCC
T ss_pred ccccc-------------------------------ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 31000 01123457999999999999999999999999999999999999
Q ss_pred CCCCCCCc
Q 003232 818 PPFNAEHP 825 (837)
Q Consensus 818 ~PF~~~dp 825 (837)
.||...++
T Consensus 237 ~Pf~~~~~ 244 (309)
T 3p86_A 237 QPWGNLNP 244 (309)
T ss_dssp CTTTTSCH
T ss_pred CCCCCCCH
Confidence 99987554
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=326.19 Aligned_cols=203 Identities=27% Similarity=0.453 Sum_probs=179.8
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEE
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyL 666 (837)
..++|++.+.||+|+||+||+|.+..+++.||+|++.... .....+.+|+.+++.++||||+++++++.....+|+
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 78 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEE
Confidence 4578999999999999999999999999999999987532 334568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEcc--CCcEEEEecCCccccccCC
Q 003232 667 VMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH--DGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~--dG~IKLiDFGLArvg~~~s 743 (837)
||||++|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++. ++.++|+|||++.....
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~-- 156 (321)
T 1tki_A 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-- 156 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT--
T ss_pred EEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC--
Confidence 99999999999999765 46999999999999999999999999999999999999987 78999999999873110
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~ 823 (837)
........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 157 ------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 206 (321)
T 1tki_A 157 ------------------------------GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE 206 (321)
T ss_dssp ------------------------------TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred ------------------------------CCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCC
Confidence 00122356899999999999988999999999999999999999999875
Q ss_pred Cc
Q 003232 824 HP 825 (837)
Q Consensus 824 dp 825 (837)
+.
T Consensus 207 ~~ 208 (321)
T 1tki_A 207 TN 208 (321)
T ss_dssp SH
T ss_pred CH
Confidence 53
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=311.03 Aligned_cols=204 Identities=32% Similarity=0.544 Sum_probs=181.3
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLV 667 (837)
.++|++.+.||+|+||+||+|.+..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++......|+|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 4679999999999999999999999999999999976542 344557789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCc---EEEEecCCccccccCCC
Q 003232 668 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGH---IKLTDFGLSKVGLINST 744 (837)
Q Consensus 668 mEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~---IKLiDFGLArvg~~~st 744 (837)
|||+.+++|.+.+...+.+++..+..++.||+.||.|||++||+||||||+||+++.++. ++|+|||++......
T Consensus 84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~-- 161 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-- 161 (284)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS--
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC--
Confidence 999999999999988888999999999999999999999999999999999999986655 999999998631100
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 745 ddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
.......||+.|+|||++.+..++.++||||||+++|+|++|..||...+
T Consensus 162 ------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 211 (284)
T 3kk8_A 162 ------------------------------EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 211 (284)
T ss_dssp ------------------------------CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ------------------------------ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc
Confidence 01124578999999999999999999999999999999999999997654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=329.33 Aligned_cols=205 Identities=30% Similarity=0.535 Sum_probs=176.4
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEeccccccc--HHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIR--KNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~--~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyL 666 (837)
+.|++.+.||+|+||+||+|+++.+++.||+|++....... ....+.+.+|+.+++.++||||+++++++.....+|+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 56999999999999999999999999999999996533211 1124678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCc---EEEEecCCcccc
Q 003232 667 VMEYLNGGDLYSLLRNL----GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGH---IKLTDFGLSKVG 739 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~~----g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~---IKLiDFGLArvg 739 (837)
||||++|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++...
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 183 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence 99999999998887542 35899999999999999999999999999999999999987654 999999998731
Q ss_pred ccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCC
Q 003232 740 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPP 819 (837)
Q Consensus 740 ~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~P 819 (837)
.... ......+||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 184 ~~~~-------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p 232 (351)
T 3c0i_A 184 GESG-------------------------------LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232 (351)
T ss_dssp CTTS-------------------------------CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cCCC-------------------------------eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCC
Confidence 1000 012345799999999999999999999999999999999999999
Q ss_pred CCCCC
Q 003232 820 FNAEH 824 (837)
Q Consensus 820 F~~~d 824 (837)
|.+..
T Consensus 233 f~~~~ 237 (351)
T 3c0i_A 233 FYGTK 237 (351)
T ss_dssp SCSSH
T ss_pred CCCcH
Confidence 98754
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=316.78 Aligned_cols=207 Identities=29% Similarity=0.489 Sum_probs=177.6
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLV 667 (837)
+++|++++.||+|+||+||+|++..+|+.||+|++.... ......+.+.+|+.+++.++||||+++++++......++|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 468999999999999999999999999999999987653 3344557788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCC
Q 003232 668 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (837)
Q Consensus 668 mEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl 747 (837)
|||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----- 155 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP----- 155 (311)
T ss_dssp EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc-----
Confidence 999999999999988888999999999999999999999999999999999999999999999999998731100
Q ss_pred CCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCcC
Q 003232 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826 (837)
Q Consensus 748 ~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLTGr~PF~~~dpd 826 (837)
........||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+..
T Consensus 156 --------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 209 (311)
T 4agu_A 156 --------------------------SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDV 209 (311)
T ss_dssp ------------------------------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred --------------------------ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 001123468999999999986 66799999999999999999999999876543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=317.53 Aligned_cols=213 Identities=29% Similarity=0.469 Sum_probs=172.5
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC-----
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE----- 662 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~----- 662 (837)
.++|++++.||+|+||.||+|+++.+|+.||||++.... .....+.+.+|+.+++.++||||++++++|....
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 467999999999999999999999999999999997543 2334567899999999999999999999885533
Q ss_pred ----------------------------------------------------eEEEEEEecCCCCHHHHHHhcCC---CC
Q 003232 663 ----------------------------------------------------NLYLVMEYLNGGDLYSLLRNLGC---LD 687 (837)
Q Consensus 663 ----------------------------------------------------~lyLVmEy~~GGSL~dlLk~~g~---Ls 687 (837)
++|+||||++|++|.+++..... .+
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 162 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE 162 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence 38999999999999999987543 56
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchh
Q 003232 688 EDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTA 767 (837)
Q Consensus 688 ee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~ 767 (837)
...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...........
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~------------------- 223 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV------------------- 223 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC-------------------------
T ss_pred hHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccc-------------------
Confidence 6678999999999999999999999999999999999999999999998742211110000
Q ss_pred hhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCC
Q 003232 768 SEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFN 821 (837)
Q Consensus 768 ~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~ 821 (837)
..............||+.|+|||++.+..++.++|||||||++|+|++|..|+.
T Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~ 277 (332)
T 3qd2_B 224 LTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM 277 (332)
T ss_dssp --------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred cccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh
Confidence 000001122345679999999999999999999999999999999999988763
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=328.27 Aligned_cols=201 Identities=17% Similarity=0.283 Sum_probs=171.5
Q ss_pred cCCeEEEEEecccCceEEEEE-----EECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcC---CCceEEEEeEee
Q 003232 588 IDDFEIIKPISRGAFGRVFLA-----KKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR---NPFVVRFFYSFT 659 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkA-----rdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~Lr---HPNIVkL~gsf~ 659 (837)
.++|.+.+.||+|+||+||+| .+..+++.||+|++.... ...+..|..+++.++ |+||+++++.+.
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 456999999999999999999 467789999999997643 235677788887776 899999999999
Q ss_pred cCCeEEEEEEecCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEcc----------
Q 003232 660 CRENLYLVMEYLNGGDLYSLLRN-----LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---------- 724 (837)
Q Consensus 660 d~~~lyLVmEy~~GGSL~dlLk~-----~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~---------- 724 (837)
..+..|+||||++||+|.+++.. ...+++..++.++.||+.||.|||++|||||||||+|||++.
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-----
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccccc
Confidence 99999999999999999999973 456999999999999999999999999999999999999988
Q ss_pred -CCcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHH
Q 003232 725 -DGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADW 803 (837)
Q Consensus 725 -dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDI 803 (837)
++.+||+|||+++...... ........+||+.|+|||++.+..++.++||
T Consensus 218 ~~~~~kl~DFG~a~~~~~~~-----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 268 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDMKLFP-----------------------------KGTIFTAKCETSGFQCVEMLSNKPWNYQIDY 268 (365)
T ss_dssp -CTTEEECCCTTCEEGGGSC-----------------------------TTEEECCSSCTTSCCCHHHHTTCCBSTHHHH
T ss_pred ccCCEEEeeCchhhhhhccC-----------------------------CCceeeeecCCCCCCChHHhcCCCCCccccH
Confidence 8999999999996311000 0112345679999999999999999999999
Q ss_pred HHHHHHHHHHHcCCCCCCCC
Q 003232 804 WSVGIILFELIVGIPPFNAE 823 (837)
Q Consensus 804 WSLGVILyELLTGr~PF~~~ 823 (837)
|||||++|+|++|+.||...
T Consensus 269 wslG~il~elltg~~pf~~~ 288 (365)
T 3e7e_A 269 FGVAATVYCMLFGTYMKVKN 288 (365)
T ss_dssp HHHHHHHHHHHHSSCCCEEE
T ss_pred HHHHHHHHHHHhCCCccccC
Confidence 99999999999999998643
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=328.03 Aligned_cols=203 Identities=35% Similarity=0.628 Sum_probs=171.3
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEE
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 665 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ly 665 (837)
...++|++++.||+|+||+||+++++.+++.||+|++....... +.+.+|+.+++.++||||+++++++.....+|
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 92 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLA 92 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC----HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc----HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence 44578999999999999999999999999999999997643222 45779999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCc--EEEEecCCccccccCC
Q 003232 666 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGH--IKLTDFGLSKVGLINS 743 (837)
Q Consensus 666 LVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~--IKLiDFGLArvg~~~s 743 (837)
+||||+.|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++....
T Consensus 93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~-- 170 (361)
T 3uc3_A 93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-- 170 (361)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc--
Confidence 99999999999999988888999999999999999999999999999999999999987665 99999999862100
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCch-HHHHHHHHHHHHHHcCCCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT-ADWWSVGIILFELIVGIPPFNA 822 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~k-SDIWSLGVILyELLTGr~PF~~ 822 (837)
........||+.|+|||++.+..++.+ +|||||||++|+|++|+.||..
T Consensus 171 ------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 220 (361)
T 3uc3_A 171 ------------------------------HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFED 220 (361)
T ss_dssp ----------------------------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC-
T ss_pred ------------------------------cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCC
Confidence 011234579999999999998888766 8999999999999999999986
Q ss_pred CC
Q 003232 823 EH 824 (837)
Q Consensus 823 ~d 824 (837)
..
T Consensus 221 ~~ 222 (361)
T 3uc3_A 221 PE 222 (361)
T ss_dssp --
T ss_pred Cc
Confidence 44
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=340.11 Aligned_cols=206 Identities=30% Similarity=0.518 Sum_probs=181.0
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEE
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyL 666 (837)
..++|++.+.||+|+||+||+|.++.+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++......|+
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 34679999999999999999999999999999999976542 33445678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEc---cCCcEEEEecCCccccccCC
Q 003232 667 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA---HDGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd---~dG~IKLiDFGLArvg~~~s 743 (837)
||||+.||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.....
T Consensus 88 v~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~- 166 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE- 166 (444)
T ss_dssp EECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT-
T ss_pred EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC-
Confidence 999999999999999888999999999999999999999999999999999999998 4678999999998631100
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~ 823 (837)
........||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.
T Consensus 167 ------------------------------~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~ 216 (444)
T 3soa_A 167 ------------------------------QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDE 216 (444)
T ss_dssp ------------------------------CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ------------------------------CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCc
Confidence 01123457999999999999999999999999999999999999999765
Q ss_pred C
Q 003232 824 H 824 (837)
Q Consensus 824 d 824 (837)
+
T Consensus 217 ~ 217 (444)
T 3soa_A 217 D 217 (444)
T ss_dssp S
T ss_pred c
Confidence 4
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=318.58 Aligned_cols=219 Identities=28% Similarity=0.416 Sum_probs=179.7
Q ss_pred hhhccccCCCCCCCCCCccc-CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHh-c
Q 003232 569 DVVRSLRTSPIHPSKDRTSI-DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILIS-V 646 (837)
Q Consensus 569 E~i~sl~ss~~~P~k~g~~l-ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~-L 646 (837)
+....+....+.|...+..+ ++|+++++||+|+||+||+|++..+++.||||++........ .......|+..+.. .
T Consensus 36 ~~~~~~~~~~~~p~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~~~~~~ 114 (311)
T 3p1a_A 36 EASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPK-DRARKLAEVGSHEKVG 114 (311)
T ss_dssp CSCSSCCCTTCCTTSSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHH-HHHHHHHHHHHHHHHC
T ss_pred CCCcccCCCCCCCCCccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChH-HHHHHHHHHHHHHHhc
Confidence 33445666777888766655 459999999999999999999999999999999876443333 33445555555554 4
Q ss_pred CCCceEEEEeEeecCCeEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccC
Q 003232 647 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD 725 (837)
Q Consensus 647 rHPNIVkL~gsf~d~~~lyLVmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~d 725 (837)
+||||+++++++.....+|+||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 115 ~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~ 193 (311)
T 3p1a_A 115 QHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPR 193 (311)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGG
T ss_pred CCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCC
Confidence 9999999999999999999999999 77999888654 459999999999999999999999999999999999999999
Q ss_pred CcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHH
Q 003232 726 GHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWS 805 (837)
Q Consensus 726 G~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWS 805 (837)
+.+||+|||++..... ........||+.|+|||++.+ .++.++||||
T Consensus 194 ~~~kl~DFG~a~~~~~--------------------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~Diws 240 (311)
T 3p1a_A 194 GRCKLGDFGLLVELGT--------------------------------AGAGEVQEGDPRYMAPELLQG-SYGTAADVFS 240 (311)
T ss_dssp GCEEECCCTTCEECC--------------------------------------CCCCCGGGCCGGGGGT-CCSTHHHHHH
T ss_pred CCEEEccceeeeeccc--------------------------------CCCCcccCCCccccCHhHhcC-CCCchhhHHH
Confidence 9999999999863100 011224569999999999987 6899999999
Q ss_pred HHHHHHHHHcCCCCCCC
Q 003232 806 VGIILFELIVGIPPFNA 822 (837)
Q Consensus 806 LGVILyELLTGr~PF~~ 822 (837)
|||++|+|++|..||..
T Consensus 241 lG~il~el~~g~~~~~~ 257 (311)
T 3p1a_A 241 LGLTILEVACNMELPHG 257 (311)
T ss_dssp HHHHHHHHHHTCCCCSS
T ss_pred HHHHHHHHHhCCCCCCC
Confidence 99999999999766643
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=310.16 Aligned_cols=207 Identities=33% Similarity=0.560 Sum_probs=185.5
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEE
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyL 666 (837)
..++|++.+.||+|+||+||+|++..+++.||+|++...........+.+.+|+.+++.++||||+++++++...+..|+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 34679999999999999999999999999999999987655556667789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCC
Q 003232 667 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stdd 746 (837)
||||+++++|.+++...+.+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.......
T Consensus 93 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~--- 169 (294)
T 2rku_A 93 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--- 169 (294)
T ss_dssp EEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT---
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCc---
Confidence 99999999999999888889999999999999999999999999999999999999999999999999986311000
Q ss_pred CCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 747 l~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
.......||+.|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 170 ----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 219 (294)
T 2rku_A 170 ----------------------------ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 219 (294)
T ss_dssp ----------------------------CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ----------------------------cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 01234578999999999999999999999999999999999999997654
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=313.69 Aligned_cols=207 Identities=35% Similarity=0.725 Sum_probs=183.8
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeE
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~l 664 (837)
....++|++.+.||.|+||.||+|++..+++.||+|++.............+.+|+.+++.++||||+++++++......
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 89 (284)
T 2vgo_A 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI 89 (284)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEE
Confidence 44567899999999999999999999999999999999764433333346788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCC
Q 003232 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~st 744 (837)
|+||||+++++|.+++...+.+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.....
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~--- 166 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS--- 166 (284)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS---
T ss_pred EEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcc---
Confidence 99999999999999998888899999999999999999999999999999999999999999999999998863100
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 745 ddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
.......||+.|+|||++.+..++.++||||||+++|+|++|..||...+
T Consensus 167 ------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 216 (284)
T 2vgo_A 167 ------------------------------LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS 216 (284)
T ss_dssp ------------------------------SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ------------------------------cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC
Confidence 01124568999999999999999999999999999999999999997654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=321.33 Aligned_cols=201 Identities=31% Similarity=0.548 Sum_probs=177.5
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcC-----CCceEEEEeEee
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-----NPFVVRFFYSFT 659 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~Lr-----HPNIVkL~gsf~ 659 (837)
....++|+++++||+|+||+||+|++..+++.||||++... ......+..|+.+++.++ ||||+++++++.
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~ 106 (360)
T 3llt_A 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM 106 (360)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE
T ss_pred eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeecccceee
Confidence 34456799999999999999999999999999999999753 234456778999999986 999999999999
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEcc-------------
Q 003232 660 CRENLYLVMEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH------------- 724 (837)
Q Consensus 660 d~~~lyLVmEy~~GGSL~dlLk~~g--~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~------------- 724 (837)
...++|+||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 107 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~ 185 (360)
T 3llt_A 107 YYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRV 185 (360)
T ss_dssp ETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred ECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcc
Confidence 999999999999 999999998654 4999999999999999999999999999999999999975
Q ss_pred ------------CCcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhh
Q 003232 725 ------------DGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEIL 792 (837)
Q Consensus 725 ------------dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVL 792 (837)
++.+||+|||+++... .......||+.|+|||++
T Consensus 186 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~----------------------------------~~~~~~~gt~~y~aPE~~ 231 (360)
T 3llt_A 186 TDGKKIQIYRTKSTGIKLIDFGCATFKS----------------------------------DYHGSIINTRQYRAPEVI 231 (360)
T ss_dssp TTCCEEEEEEESCCCEEECCCTTCEETT----------------------------------SCCCSCCSCGGGCCHHHH
T ss_pred cccccccccccCCCCEEEEeccCceecC----------------------------------CCCcCccCcccccCcHHH
Confidence 7899999999987310 011245789999999999
Q ss_pred cCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 793 LGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 793 lg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
.+..++.++|||||||++|+|++|+.||...+
T Consensus 232 ~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 263 (360)
T 3llt_A 232 LNLGWDVSSDMWSFGCVLAELYTGSLLFRTHE 263 (360)
T ss_dssp TTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cCCCCCCccchHHHHHHHHHHHHCCCCCCCCc
Confidence 99999999999999999999999999998755
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=313.02 Aligned_cols=209 Identities=31% Similarity=0.612 Sum_probs=163.8
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeE
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~l 664 (837)
+..+++|++.+.||+|+||.||+|++..+++.||+|++...........+.+.+|+.+++.++||||+++++++......
T Consensus 7 g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (278)
T 3cok_A 7 GEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYV 86 (278)
T ss_dssp CSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEE
T ss_pred ccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeE
Confidence 44567899999999999999999999999999999999764433333456789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCC
Q 003232 665 YLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~s 743 (837)
|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~- 165 (278)
T 3cok_A 87 YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP- 165 (278)
T ss_dssp EEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC-
Confidence 9999999999999999865 66999999999999999999999999999999999999999999999999998631100
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~ 823 (837)
........||+.|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus 166 ------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 215 (278)
T 3cok_A 166 ------------------------------HEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTD 215 (278)
T ss_dssp --------------------------------------------------------CTHHHHHHHHHHHHHHSSCSSCCC
T ss_pred ------------------------------CCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCh
Confidence 00112346899999999999999999999999999999999999999765
Q ss_pred C
Q 003232 824 H 824 (837)
Q Consensus 824 d 824 (837)
.
T Consensus 216 ~ 216 (278)
T 3cok_A 216 T 216 (278)
T ss_dssp S
T ss_pred h
Confidence 4
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=319.67 Aligned_cols=209 Identities=29% Similarity=0.510 Sum_probs=175.4
Q ss_pred CCcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCe
Q 003232 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCREN 663 (837)
Q Consensus 584 ~g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ 663 (837)
.....++|++++.||+|+||+||+|++. +++.||+|++.... ........+.+|+.+++.++||||+++++++....+
T Consensus 16 ~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 93 (311)
T 3niz_A 16 FQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDA-EDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERC 93 (311)
T ss_dssp EECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSC
T ss_pred ecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEeccc-ccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCE
Confidence 3455678999999999999999999994 59999999997543 233345678899999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccC
Q 003232 664 LYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~ 742 (837)
+|+||||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 94 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 94 LTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp EEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred EEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 9999999975 888887654 45999999999999999999999999999999999999999999999999998731100
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCC
Q 003232 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFN 821 (837)
Q Consensus 743 stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLTGr~PF~ 821 (837)
. .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.
T Consensus 173 ~-------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 221 (311)
T 3niz_A 173 V-------------------------------RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFP 221 (311)
T ss_dssp C-------------------------------C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred c-------------------------------ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCC
Confidence 0 01224578999999999987 568999999999999999999999998
Q ss_pred CCCcC
Q 003232 822 AEHPQ 826 (837)
Q Consensus 822 ~~dpd 826 (837)
+.+..
T Consensus 222 ~~~~~ 226 (311)
T 3niz_A 222 GVTDD 226 (311)
T ss_dssp CSSTT
T ss_pred CCChH
Confidence 75543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=325.11 Aligned_cols=220 Identities=28% Similarity=0.443 Sum_probs=180.7
Q ss_pred chhhhccccCCCCCCCCCCccc-CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHh
Q 003232 567 EDDVVRSLRTSPIHPSKDRTSI-DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILIS 645 (837)
Q Consensus 567 EeE~i~sl~ss~~~P~k~g~~l-ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~ 645 (837)
+++....+....+++...+..+ ++|++.+.||+|+||+||+|++..+++.||||++... ....+.+.+|+.+++.
T Consensus 14 ~~e~~~~~~~~~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~ 89 (397)
T 1wak_A 14 EQEDPNDYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKS 89 (397)
T ss_dssp --------CC--CCSSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHH
T ss_pred cccccccCCCCCceEEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHH
Confidence 4555677777888888877665 5699999999999999999999999999999999753 3345678899999998
Q ss_pred cC--------CCceEEEEeEee----cCCeEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-Cc
Q 003232 646 VR--------NPFVVRFFYSFT----CRENLYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSL-RV 710 (837)
Q Consensus 646 Lr--------HPNIVkL~gsf~----d~~~lyLVmEy~~GGSL~dlLk~~--g~Lsee~irkIl~QIa~ALsYLHSk-GI 710 (837)
++ ||||+++++.+. ...++|+||||+ +++|.+.+... ..+++..++.++.||+.||.|||++ ||
T Consensus 90 l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~gi 168 (397)
T 1wak_A 90 VRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRI 168 (397)
T ss_dssp HHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCE
T ss_pred HhhcCCCCCCcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCE
Confidence 85 788999999987 566899999999 66777666543 5699999999999999999999998 99
Q ss_pred ccccCCCCcEEEccCC-------------------------------------------------cEEEEecCCcccccc
Q 003232 711 VHRDLKPDNLLIAHDG-------------------------------------------------HIKLTDFGLSKVGLI 741 (837)
Q Consensus 711 IHRDIKPeNILLd~dG-------------------------------------------------~IKLiDFGLArvg~~ 741 (837)
+||||||+|||++.++ .++|+|||++....
T Consensus 169 vHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~- 247 (397)
T 1wak_A 169 IHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH- 247 (397)
T ss_dssp ECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETT-
T ss_pred ecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccc-
Confidence 9999999999998775 79999999987310
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCC
Q 003232 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFN 821 (837)
Q Consensus 742 ~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~ 821 (837)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 248 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 294 (397)
T 1wak_A 248 ---------------------------------KHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFE 294 (397)
T ss_dssp ---------------------------------BCSCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ---------------------------------ccCccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCC
Confidence 01123478999999999999999999999999999999999999998
Q ss_pred CCCc
Q 003232 822 AEHP 825 (837)
Q Consensus 822 ~~dp 825 (837)
..+.
T Consensus 295 ~~~~ 298 (397)
T 1wak_A 295 PHSG 298 (397)
T ss_dssp CCCC
T ss_pred CCcc
Confidence 7553
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=320.02 Aligned_cols=211 Identities=31% Similarity=0.526 Sum_probs=183.8
Q ss_pred CCCCcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccH---HHHHHHHHHHHHHHhcCCCceEEEEeEe
Q 003232 582 SKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRK---NAVESILAERDILISVRNPFVVRFFYSF 658 (837)
Q Consensus 582 ~k~g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~---e~ie~~~rEieILk~LrHPNIVkL~gsf 658 (837)
.......++|++.+.||.|+||.||+|++..+|+.||+|++........ ...+.+.+|+.+++.++||||+++++++
T Consensus 5 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 84 (321)
T 2a2a_A 5 FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVY 84 (321)
T ss_dssp CBCSCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 3344455679999999999999999999999999999999976432211 1246788999999999999999999999
Q ss_pred ecCCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCC----cEEEEecC
Q 003232 659 TCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG----HIKLTDFG 734 (837)
Q Consensus 659 ~d~~~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG----~IKLiDFG 734 (837)
.....+|+||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++ .++|+|||
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 85 ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred ecCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 99999999999999999999999888899999999999999999999999999999999999999887 79999999
Q ss_pred CccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHH
Q 003232 735 LSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI 814 (837)
Q Consensus 735 LArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELL 814 (837)
++...... .......||+.|+|||++.+..++.++||||||+++|+|+
T Consensus 165 ~~~~~~~~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 212 (321)
T 2a2a_A 165 LAHEIEDG--------------------------------VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 212 (321)
T ss_dssp TCEECCTT--------------------------------CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred cceecCcc--------------------------------ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHH
Confidence 98631100 0112346899999999999999999999999999999999
Q ss_pred cCCCCCCCCC
Q 003232 815 VGIPPFNAEH 824 (837)
Q Consensus 815 TGr~PF~~~d 824 (837)
+|..||.+.+
T Consensus 213 ~g~~pf~~~~ 222 (321)
T 2a2a_A 213 SGASPFLGDT 222 (321)
T ss_dssp HSCCSSCCSS
T ss_pred HCCCCCCCCC
Confidence 9999997654
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=322.17 Aligned_cols=206 Identities=32% Similarity=0.532 Sum_probs=183.0
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEE
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyL 666 (837)
..++|++++.||.|+||+||+|++..+++.||+|++.... .....+.+.+|+.+++.++||||+++++++.....+|+
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 108 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 108 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEE
Confidence 3467999999999999999999999999999999997642 34556789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCcEEEccCCcEEEEecCCccccccCCCC
Q 003232 667 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL-RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSk-GIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~std 745 (837)
||||++|++|.+++...+.+++..+..++.||+.||.|||+. ||+||||||+|||++.++.++|+|||++...
T Consensus 109 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~------ 182 (360)
T 3eqc_A 109 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL------ 182 (360)
T ss_dssp EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHH------
T ss_pred EEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccc------
Confidence 999999999999999888899999999999999999999996 9999999999999999999999999988621
Q ss_pred CCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 746 dl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
.........||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 183 ---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 235 (360)
T 3eqc_A 183 ---------------------------IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 235 (360)
T ss_dssp ---------------------------HHHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCH
T ss_pred ---------------------------ccccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 01122345799999999999999999999999999999999999999987654
Q ss_pred CH
Q 003232 826 QV 827 (837)
Q Consensus 826 dv 827 (837)
..
T Consensus 236 ~~ 237 (360)
T 3eqc_A 236 KE 237 (360)
T ss_dssp HH
T ss_pred HH
Confidence 43
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-37 Score=317.20 Aligned_cols=213 Identities=25% Similarity=0.400 Sum_probs=176.9
Q ss_pred CCCcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC
Q 003232 583 KDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE 662 (837)
Q Consensus 583 k~g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~ 662 (837)
..+..+++|++.+.||+|+||.||+|++..+++.||+|++...........+.+.+|+.+++.++||||+++++++....
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 2h34_A 28 REGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG 107 (309)
T ss_dssp ------CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred CCCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC
Confidence 45666789999999999999999999999999999999998765455566678999999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccC
Q 003232 663 NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (837)
Q Consensus 663 ~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~ 742 (837)
.+|+||||++|++|.+++...+.+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++......
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 108 QLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 99999999999999999998888999999999999999999999999999999999999999999999999998631100
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003232 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNA 822 (837)
Q Consensus 743 stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~ 822 (837)
. ........||+.|+|||++.+..++.++||||||+++|+|++|+.||..
T Consensus 188 ~------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 237 (309)
T 2h34_A 188 K------------------------------LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQG 237 (309)
T ss_dssp ---------------------------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCS
T ss_pred c------------------------------cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCC
Confidence 0 0112245689999999999999999999999999999999999999986
Q ss_pred CCc
Q 003232 823 EHP 825 (837)
Q Consensus 823 ~dp 825 (837)
.+.
T Consensus 238 ~~~ 240 (309)
T 2h34_A 238 DQL 240 (309)
T ss_dssp CHH
T ss_pred chH
Confidence 543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=314.68 Aligned_cols=203 Identities=33% Similarity=0.569 Sum_probs=172.4
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLV 667 (837)
+++|++++.||+|+||+||+|++ .+++.||+|++..... .......+.+|+.+++.++||||+++++++.....+|+|
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence 36799999999999999999999 6799999999975432 222235678999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCC
Q 003232 668 MEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (837)
Q Consensus 668 mEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stdd 746 (837)
|||+.+ +|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---- 153 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP---- 153 (288)
T ss_dssp EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc----
Confidence 999975 999998764 67999999999999999999999999999999999999999999999999998631100
Q ss_pred CCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 747 l~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~-~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+
T Consensus 154 ---------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 205 (288)
T 1ob3_A 154 ---------------------------VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS 205 (288)
T ss_dssp -----------------------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ---------------------------ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 0112234689999999999764 58999999999999999999999998754
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=318.55 Aligned_cols=203 Identities=28% Similarity=0.462 Sum_probs=175.1
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC--eEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE--NLY 665 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~--~ly 665 (837)
.++|++.+.||+|+||+||+|++..+++.||||++...... ...+.+.+|+.+++.++||||+++++++.... ++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence 35699999999999999999999999999999999764322 22456789999999999999999999988755 789
Q ss_pred EEEEecCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEE----ccCCcEEEEecCCccc
Q 003232 666 LVMEYLNGGDLYSLLRNLGC---LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI----AHDGHIKLTDFGLSKV 738 (837)
Q Consensus 666 LVmEy~~GGSL~dlLk~~g~---Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILL----d~dG~IKLiDFGLArv 738 (837)
+||||+++++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 99999999999999976433 9999999999999999999999999999999999999 7778899999999873
Q ss_pred cccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhc--------CCCCCchHHHHHHHHHH
Q 003232 739 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL--------GTGHGTTADWWSVGIIL 810 (837)
Q Consensus 739 g~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLl--------g~~~s~kSDIWSLGVIL 810 (837)
.... .......||+.|+|||++. +..++.++|||||||++
T Consensus 166 ~~~~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il 213 (319)
T 4euu_A 166 LEDD--------------------------------EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213 (319)
T ss_dssp CCTT--------------------------------CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHH
T ss_pred cCCC--------------------------------CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHH
Confidence 1100 0122456999999999986 57789999999999999
Q ss_pred HHHHcCCCCCCCCC
Q 003232 811 FELIVGIPPFNAEH 824 (837)
Q Consensus 811 yELLTGr~PF~~~d 824 (837)
|+|++|..||....
T Consensus 214 ~el~~g~~pf~~~~ 227 (319)
T 4euu_A 214 YHAATGSLPFRPFE 227 (319)
T ss_dssp HHHHHSSCSEECTT
T ss_pred HHHHhCCCCCCCCC
Confidence 99999999997544
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=319.05 Aligned_cols=208 Identities=24% Similarity=0.364 Sum_probs=178.4
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEeEeecCCeEEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYL 666 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~gsf~d~~~lyL 666 (837)
.++|++.+.||.|+||+||+|++..+++.||||++..... ...+.+|+.+++.+ +||||+++++++......|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 82 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM 82 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence 4679999999999999999999999999999999875432 13577899999999 99999999999999999999
Q ss_pred EEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCc-----EEEEecCCccccc
Q 003232 667 VMEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGH-----IKLTDFGLSKVGL 740 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~-~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~-----IKLiDFGLArvg~ 740 (837)
||||+ +++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++. ++|+|||+++...
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 83 VLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred EEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 99999 9999999986 367999999999999999999999999999999999999998887 9999999997421
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCC
Q 003232 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820 (837)
Q Consensus 741 ~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF 820 (837)
....... ..........||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 162 ~~~~~~~------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf 217 (330)
T 2izr_A 162 DPETKKH------------------------IPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPW 217 (330)
T ss_dssp CTTTCCB------------------------CCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred cCCCCcc------------------------ccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCc
Confidence 1111000 0001224568999999999999999999999999999999999999999
Q ss_pred CCCCc
Q 003232 821 NAEHP 825 (837)
Q Consensus 821 ~~~dp 825 (837)
.+.+.
T Consensus 218 ~~~~~ 222 (330)
T 2izr_A 218 QGLKA 222 (330)
T ss_dssp TTCCC
T ss_pred ccccc
Confidence 87553
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=356.90 Aligned_cols=210 Identities=37% Similarity=0.763 Sum_probs=185.8
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEeEeecCCe
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCREN 663 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~gsf~d~~~ 663 (837)
...+++|++++.||+|+||.||+|+++.+++.||||++++.........+.+..|..++..+ +||||++++++|.....
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 44568899999999999999999999999999999999875444444556788999999887 79999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCC
Q 003232 664 LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~s 743 (837)
+||||||++||+|.+++...+.+++..++.|+.||+.||.|||++|||||||||+|||++.+|++||+|||+++.....
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~- 495 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD- 495 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCT-
T ss_pred EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccC-
Confidence 9999999999999999998889999999999999999999999999999999999999999999999999998731110
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~ 823 (837)
.......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus 496 ------------------------------~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~ 545 (674)
T 3pfq_A 496 ------------------------------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 545 (674)
T ss_dssp ------------------------------TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ------------------------------CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC
Confidence 01123568999999999999999999999999999999999999999876
Q ss_pred Cc
Q 003232 824 HP 825 (837)
Q Consensus 824 dp 825 (837)
+.
T Consensus 546 ~~ 547 (674)
T 3pfq_A 546 DE 547 (674)
T ss_dssp SH
T ss_pred CH
Confidence 54
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=327.49 Aligned_cols=211 Identities=23% Similarity=0.409 Sum_probs=180.2
Q ss_pred CCcccCCeEEEEEecccCceEEEEEEEC-------CCCcEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEE
Q 003232 584 DRTSIDDFEIIKPISRGAFGRVFLAKKR-------TTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFF 655 (837)
Q Consensus 584 ~g~~lddYeIlkkLGsG~FGtVYkArdk-------~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~ 655 (837)
+....++|++.+.||+|+||+||+|++. .++..||+|+++... .......+.+|+.+++.+ +||||++++
T Consensus 76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 153 (370)
T 2psq_A 76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL 153 (370)
T ss_dssp TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEE
T ss_pred ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 3445678999999999999999999975 345679999997652 345567899999999999 899999999
Q ss_pred eEeecCCeEEEEEEecCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCc
Q 003232 656 YSFTCRENLYLVMEYLNGGDLYSLLRNLG----------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDN 719 (837)
Q Consensus 656 gsf~d~~~lyLVmEy~~GGSL~dlLk~~g----------------~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeN 719 (837)
+++.....+|+||||+++|+|.+++.... .++...+..++.||+.||.|||++||+||||||+|
T Consensus 154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 233 (370)
T 2psq_A 154 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 233 (370)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred EEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhh
Confidence 99999999999999999999999997643 47899999999999999999999999999999999
Q ss_pred EEEccCCcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCc
Q 003232 720 LLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT 799 (837)
Q Consensus 720 ILLd~dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~ 799 (837)
||++.++.+||+|||+++....... ........||+.|+|||++.+..++.
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~~~-----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~ 284 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNIDY-----------------------------YKKTTNGRLPVKWMAPEALFDRVYTH 284 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCCCT-----------------------------TCTTTTTTSCGGGCCHHHHHTCCCCH
T ss_pred EEECCCCCEEEccccCCcccCcccc-----------------------------eecccCCCcccceECHhHhcCCCCCc
Confidence 9999999999999999873111000 00122345788999999999999999
Q ss_pred hHHHHHHHHHHHHHHc-CCCCCCCCCc
Q 003232 800 TADWWSVGIILFELIV-GIPPFNAEHP 825 (837)
Q Consensus 800 kSDIWSLGVILyELLT-Gr~PF~~~dp 825 (837)
++|||||||++|+|++ |..||.+...
T Consensus 285 ~~DvwslG~il~ellt~g~~p~~~~~~ 311 (370)
T 2psq_A 285 QSDVWSFGVLMWEIFTLGGSPYPGIPV 311 (370)
T ss_dssp HHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred HHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 9999999999999999 9999987553
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=310.11 Aligned_cols=215 Identities=31% Similarity=0.536 Sum_probs=176.2
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeE
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~l 664 (837)
...+++|++.+.||.|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++...+..
T Consensus 28 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 107 (310)
T 2wqm_A 28 YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL 107 (310)
T ss_dssp TSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred cccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcE
Confidence 34567899999999999999999999999999999999865545566677899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccc
Q 003232 665 YLVMEYLNGGDLYSLLRN----LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~----~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~ 740 (837)
++||||+++++|.+++.. ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999999864 4568999999999999999999999999999999999999999999999999986311
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCC
Q 003232 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820 (837)
Q Consensus 741 ~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF 820 (837)
.. ........||+.|+|||++.+..++.++||||||+++|+|++|..||
T Consensus 188 ~~-------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~ 236 (310)
T 2wqm_A 188 SK-------------------------------TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 236 (310)
T ss_dssp ------------------------------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred CC-------------------------------CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 00 00112346899999999999999999999999999999999999999
Q ss_pred CCCCcCHHHH
Q 003232 821 NAEHPQVSTL 830 (837)
Q Consensus 821 ~~~dpdv~~l 830 (837)
.+.......+
T Consensus 237 ~~~~~~~~~~ 246 (310)
T 2wqm_A 237 YGDKMNLYSL 246 (310)
T ss_dssp C---CCHHHH
T ss_pred cccchhHHHH
Confidence 8765554433
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=347.66 Aligned_cols=209 Identities=34% Similarity=0.623 Sum_probs=184.8
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeE
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~l 664 (837)
....++|++++.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+++.++||||++++++|.....+
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 260 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL 260 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence 34567899999999999999999999999999999999765443344456789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccc
Q 003232 665 YLVMEYLNGGDLYSLLRNL----GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~----g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~ 740 (837)
|+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++...
T Consensus 261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 9999999999999999763 369999999999999999999999999999999999999999999999999987311
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCC
Q 003232 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820 (837)
Q Consensus 741 ~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF 820 (837)
... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 341 ~~~-------------------------------~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF 389 (543)
T 3c4z_A 341 AGQ-------------------------------TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389 (543)
T ss_dssp TTC-------------------------------CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCC-------------------------------cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCC
Confidence 000 0123458999999999999999999999999999999999999999
Q ss_pred CCCC
Q 003232 821 NAEH 824 (837)
Q Consensus 821 ~~~d 824 (837)
.+..
T Consensus 390 ~~~~ 393 (543)
T 3c4z_A 390 RARG 393 (543)
T ss_dssp CCTT
T ss_pred CCCc
Confidence 8764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=315.74 Aligned_cols=207 Identities=35% Similarity=0.644 Sum_probs=172.1
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEeccccccc-----------------------HHHHHHHHHHHHH
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIR-----------------------KNAVESILAERDI 642 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~-----------------------~e~ie~~~rEieI 642 (837)
...++|++.+.||+|+||.||+|++..+++.||+|++....... ....+.+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 34678999999999999999999999999999999997643211 1224578899999
Q ss_pred HHhcCCCceEEEEeEeec--CCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcE
Q 003232 643 LISVRNPFVVRFFYSFTC--RENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNL 720 (837)
Q Consensus 643 Lk~LrHPNIVkL~gsf~d--~~~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNI 720 (837)
++.++||||+++++++.. ...+|+||||+++++|.+++. .+.+++..++.++.||+.||.|||++||+||||||+||
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL 168 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence 999999999999999986 568999999999999988653 35799999999999999999999999999999999999
Q ss_pred EEccCCcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCC---C
Q 003232 721 LIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG---H 797 (837)
Q Consensus 721 LLd~dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~---~ 797 (837)
|++.++.+||+|||++....... .......||+.|+|||++.+.. +
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~~~-------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~ 217 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKGSD-------------------------------ALLSNTVGTPAFMAPESLSETRKIFS 217 (298)
T ss_dssp EECTTSCEEECCCTTCEECSSSS-------------------------------CEECCCCSCGGGCCGGGCCTTCCCEE
T ss_pred EECCCCCEEEecCCCcccccccc-------------------------------ccccCCcCCccccChhhhccCCCCCC
Confidence 99999999999999987311000 0122457999999999998765 3
Q ss_pred CchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 798 GTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 798 s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
+.++|||||||++|+|++|..||....
T Consensus 218 ~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 218 GKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp SHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 788999999999999999999997643
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=326.17 Aligned_cols=226 Identities=29% Similarity=0.490 Sum_probs=170.1
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcC-CCceEEEEeEeecCC--
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCRE-- 662 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~Lr-HPNIVkL~gsf~d~~-- 662 (837)
...++|++++.||+|+||+||+|.++.+|+.||+|++.... ........+.+|+.+++.+. ||||+++++++...+
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 34578999999999999999999999999999999986543 33455677889999999997 999999999997544
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccC
Q 003232 663 NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (837)
Q Consensus 663 ~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~ 742 (837)
.+|+||||+. ++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred EEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 7999999996 589999876 57999999999999999999999999999999999999999999999999999742111
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCC
Q 003232 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFN 821 (837)
Q Consensus 743 stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLTGr~PF~ 821 (837)
... ... ..+.... ...............+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.
T Consensus 163 ~~~--~~~----~~~~~~~----~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 232 (388)
T 3oz6_A 163 RRV--TNN----IPLSINE----NTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFP 232 (388)
T ss_dssp CCC--CCC----GGGCCC-------------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccc--ccc----ccccccc----cccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCC
Confidence 100 000 0000000 00000111223446789999999999987 678999999999999999999999998
Q ss_pred CCC
Q 003232 822 AEH 824 (837)
Q Consensus 822 ~~d 824 (837)
+.+
T Consensus 233 ~~~ 235 (388)
T 3oz6_A 233 GSS 235 (388)
T ss_dssp CSS
T ss_pred CCC
Confidence 765
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=317.27 Aligned_cols=206 Identities=33% Similarity=0.559 Sum_probs=185.4
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLV 667 (837)
.++|.+.+.||+|+||.||++++..+++.||+|++...........+.+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 45799999999999999999999999999999999876555566677899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCC
Q 003232 668 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (837)
Q Consensus 668 mEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl 747 (837)
|||+.+++|.+++...+.+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.......
T Consensus 120 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~---- 195 (335)
T 2owb_A 120 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG---- 195 (335)
T ss_dssp ECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT----
T ss_pred EecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc----
Confidence 9999999999999888889999999999999999999999999999999999999999999999999987311000
Q ss_pred CCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 748 ~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
.......||+.|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 196 ---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 245 (335)
T 2owb_A 196 ---------------------------ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 245 (335)
T ss_dssp ---------------------------CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ---------------------------ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC
Confidence 11234579999999999999999999999999999999999999998654
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=321.55 Aligned_cols=210 Identities=27% Similarity=0.446 Sum_probs=171.6
Q ss_pred CCCcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC
Q 003232 583 KDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE 662 (837)
Q Consensus 583 k~g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~ 662 (837)
.....+++|++++.||+|+||+||+|++..+++.||+|++.... ........+.+|+.+++.++||||+++++++....
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (329)
T 3gbz_A 28 PSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH-EEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNH 106 (329)
T ss_dssp ----CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETT
T ss_pred CcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccc-cccccchhHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence 34566788999999999999999999999999999999997653 23334567789999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEc-----cCCcEEEEecCCcc
Q 003232 663 NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA-----HDGHIKLTDFGLSK 737 (837)
Q Consensus 663 ~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd-----~dG~IKLiDFGLAr 737 (837)
.+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.++|+|||+++
T Consensus 107 ~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 107 RLHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp EEEEEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred EEEEEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 9999999997 59999999888899999999999999999999999999999999999994 45569999999986
Q ss_pred ccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCC-CCCchHHHHHHHHHHHHHHcC
Q 003232 738 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVG 816 (837)
Q Consensus 738 vg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~-~~s~kSDIWSLGVILyELLTG 816 (837)
..... ........||+.|+|||++.+. .++.++|||||||++|+|++|
T Consensus 186 ~~~~~-------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g 234 (329)
T 3gbz_A 186 AFGIP-------------------------------IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMK 234 (329)
T ss_dssp HHC------------------------------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHS
T ss_pred ccCCc-------------------------------ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHC
Confidence 31100 0112345689999999999874 489999999999999999999
Q ss_pred CCCCCCCCc
Q 003232 817 IPPFNAEHP 825 (837)
Q Consensus 817 r~PF~~~dp 825 (837)
..||.+.+.
T Consensus 235 ~~pf~~~~~ 243 (329)
T 3gbz_A 235 TPLFPGDSE 243 (329)
T ss_dssp SCSSCCSSH
T ss_pred CCCcCCCCH
Confidence 999987654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=322.91 Aligned_cols=204 Identities=36% Similarity=0.597 Sum_probs=168.6
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEE
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 665 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ly 665 (837)
...++|++.+.||+|+||+||+|++..+++.||+|++.... ..+.+.+|+.+++.++||||+++++++.....+|
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 124 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence 34467999999999999999999999999999999997642 2356788999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEcc---CCcEEEEecCCccccccC
Q 003232 666 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGLIN 742 (837)
Q Consensus 666 LVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~---dG~IKLiDFGLArvg~~~ 742 (837)
+||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++. ++.++|+|||+++....
T Consensus 125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~- 203 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH- 203 (349)
T ss_dssp EEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc-
Confidence 99999999999999988888999999999999999999999999999999999999975 88999999999873100
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003232 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNA 822 (837)
Q Consensus 743 stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~ 822 (837)
........||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 204 -------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 252 (349)
T 2w4o_A 204 -------------------------------QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYD 252 (349)
T ss_dssp ----------------------------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred -------------------------------ccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence 0011245789999999999999999999999999999999999999977
Q ss_pred CCcC
Q 003232 823 EHPQ 826 (837)
Q Consensus 823 ~dpd 826 (837)
....
T Consensus 253 ~~~~ 256 (349)
T 2w4o_A 253 ERGD 256 (349)
T ss_dssp TTCH
T ss_pred Cccc
Confidence 6544
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=308.41 Aligned_cols=204 Identities=33% Similarity=0.572 Sum_probs=179.9
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEE
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 665 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ly 665 (837)
...++|++.+.||+|+||+||+|.+..++..||+|++...... ..+.+.+|+.+++.++||||+++++++......|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE---DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIY 82 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEE
Confidence 3456799999999999999999999999999999999764322 2457889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEE---ccCCcEEEEecCCccccccC
Q 003232 666 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI---AHDGHIKLTDFGLSKVGLIN 742 (837)
Q Consensus 666 LVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILL---d~dG~IKLiDFGLArvg~~~ 742 (837)
+||||+++++|.+++...+.+++..+..++.||+.||.|||++||+|+||||+|||+ +.++.++|+|||++......
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 83 LVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred EEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 999999999999999888889999999999999999999999999999999999999 78899999999998631100
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003232 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNA 822 (837)
Q Consensus 743 stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~ 822 (837)
.......||+.|+|||++.+. ++.++||||||+++|+|++|..||..
T Consensus 163 --------------------------------~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (277)
T 3f3z_A 163 --------------------------------KMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSA 209 (277)
T ss_dssp --------------------------------SCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred --------------------------------cchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCC
Confidence 112345799999999998765 89999999999999999999999987
Q ss_pred CCc
Q 003232 823 EHP 825 (837)
Q Consensus 823 ~dp 825 (837)
.+.
T Consensus 210 ~~~ 212 (277)
T 3f3z_A 210 PTD 212 (277)
T ss_dssp SSH
T ss_pred CCH
Confidence 543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=332.67 Aligned_cols=233 Identities=27% Similarity=0.384 Sum_probs=166.1
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeec-----
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC----- 660 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d----- 660 (837)
...++|++++.||.|+||+||+|+++.+++.||||++.... ......+.+.+|+.+|+.++||||+++++++..
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 128 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEK 128 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCccc
Confidence 44578999999999999999999999999999999997543 344556789999999999999999999999844
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccc
Q 003232 661 RENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740 (837)
Q Consensus 661 ~~~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~ 740 (837)
...+|+||||+ +++|.+++.....+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+++...
T Consensus 129 ~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 129 FDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp CCCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred CceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 35799999998 67999999988889999999999999999999999999999999999999999999999999998532
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhh-cCCCCCchHHHHHHHHHHHHHHc----
Q 003232 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEIL-LGTGHGTTADWWSVGIILFELIV---- 815 (837)
Q Consensus 741 ~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVL-lg~~~s~kSDIWSLGVILyELLT---- 815 (837)
.........+..... .....................+||+.|+|||++ .+..++.++|||||||++|||++
T Consensus 208 ~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~ 283 (458)
T 3rp9_A 208 YPENGNSQLPISPRE----DDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283 (458)
T ss_dssp SCTTCCCCCC-------------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred CccccccccccCccc----cccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccc
Confidence 211110000000000 000000000001112234567899999999987 45679999999999999999999
Q ss_pred -------CCCCCCCCC
Q 003232 816 -------GIPPFNAEH 824 (837)
Q Consensus 816 -------Gr~PF~~~d 824 (837)
|+++|.+.+
T Consensus 284 ~~~~~~~~~p~f~g~~ 299 (458)
T 3rp9_A 284 NVAYHADRGPLFPGSS 299 (458)
T ss_dssp TCSSGGGCCCSCC---
T ss_pred cccccccccccCCCCc
Confidence 777776654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=317.17 Aligned_cols=210 Identities=25% Similarity=0.441 Sum_probs=179.6
Q ss_pred CcccCCeEEEEEecccCceEEEEEEEC-----CCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEee
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKR-----TTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFT 659 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk-----~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~ 659 (837)
....++|++.+.||+|+||.||+|++. .+++.||+|+++... .......+.+|+.+++.++||||+++++++.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 344578999999999999999999997 345899999997643 3445678999999999999999999999999
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccC
Q 003232 660 CRENLYLVMEYLNGGDLYSLLRNL------------------------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDL 715 (837)
Q Consensus 660 d~~~lyLVmEy~~GGSL~dlLk~~------------------------g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDI 715 (837)
....+|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl 200 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 200 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 999999999999999999999763 56899999999999999999999999999999
Q ss_pred CCCcEEEccCCcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCC
Q 003232 716 KPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT 795 (837)
Q Consensus 716 KPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~ 795 (837)
||+|||++.++.++|+|||+++....... ........||+.|+|||++.+.
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-----------------------------~~~~~~~~~t~~y~aPE~~~~~ 251 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADY-----------------------------YKADGNDAIPIRWMPPESIFYN 251 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGC-----------------------------BC----CCBCGGGCCHHHHHHC
T ss_pred CcceEEECCCCeEEEeecCCCcccccCcc-----------------------------ccccCCCcccceecChhhhccC
Confidence 99999999999999999999863110000 0112234678899999999999
Q ss_pred CCCchHHHHHHHHHHHHHHc-CCCCCCCCCc
Q 003232 796 GHGTTADWWSVGIILFELIV-GIPPFNAEHP 825 (837)
Q Consensus 796 ~~s~kSDIWSLGVILyELLT-Gr~PF~~~dp 825 (837)
.++.++||||||+++|+|++ |..||...+.
T Consensus 252 ~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 282 (343)
T 1luf_A 252 RYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 282 (343)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred CcCcccccHHHHHHHHHHHhcCCCcCCCCCh
Confidence 99999999999999999999 9999976543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=318.23 Aligned_cols=204 Identities=29% Similarity=0.506 Sum_probs=162.5
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLV 667 (837)
.++|++++.||+|+||+||+|+++.+|+.||+|+++.... ......+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE--EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCST--TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc--cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence 3579999999999999999999999999999999975431 22235678999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCcccccc
Q 003232 668 MEYLNGGDLYSLLRNL------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 741 (837)
Q Consensus 668 mEy~~GGSL~dlLk~~------g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~ 741 (837)
|||++ ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 99997 5999998653 3589999999999999999999999999999999999999999999999999873110
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCC
Q 003232 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPF 820 (837)
Q Consensus 742 ~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLTGr~PF 820 (837)
.. .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||
T Consensus 161 ~~-------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf 209 (317)
T 2pmi_A 161 PV-------------------------------NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLF 209 (317)
T ss_dssp CC-------------------------------CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred Cc-------------------------------ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 00 01124578999999999987 46899999999999999999999999
Q ss_pred CCCCc
Q 003232 821 NAEHP 825 (837)
Q Consensus 821 ~~~dp 825 (837)
.+.+.
T Consensus 210 ~~~~~ 214 (317)
T 2pmi_A 210 PGTND 214 (317)
T ss_dssp CCSSH
T ss_pred CCCCh
Confidence 87654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=321.80 Aligned_cols=213 Identities=28% Similarity=0.449 Sum_probs=179.3
Q ss_pred CCCcccCCeEEEEEecccCceEEEEEE-----ECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEe
Q 003232 583 KDRTSIDDFEIIKPISRGAFGRVFLAK-----KRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFY 656 (837)
Q Consensus 583 k~g~~lddYeIlkkLGsG~FGtVYkAr-----dk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~g 656 (837)
.+....++|++.+.||.|+||.||+|+ +..+++.||||+++... .....+.+.+|+.+++.+ +||||+++++
T Consensus 16 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~ 93 (359)
T 3vhe_A 16 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLG 93 (359)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence 345556789999999999999999999 45567899999997643 344456899999999999 7899999999
Q ss_pred EeecCC-eEEEEEEecCCCCHHHHHHhcCC--------------------------------------------------
Q 003232 657 SFTCRE-NLYLVMEYLNGGDLYSLLRNLGC-------------------------------------------------- 685 (837)
Q Consensus 657 sf~d~~-~lyLVmEy~~GGSL~dlLk~~g~-------------------------------------------------- 685 (837)
++.... .+++||||+.+|+|.+++.....
T Consensus 94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (359)
T 3vhe_A 94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173 (359)
T ss_dssp EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence 988754 48999999999999999976432
Q ss_pred ----------------CCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCC
Q 003232 686 ----------------LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 749 (837)
Q Consensus 686 ----------------Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~ 749 (837)
+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.......
T Consensus 174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~----- 248 (359)
T 3vhe_A 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD----- 248 (359)
T ss_dssp ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT-----
T ss_pred chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc-----
Confidence 89999999999999999999999999999999999999999999999999873111000
Q ss_pred CCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCcC
Q 003232 750 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQ 826 (837)
Q Consensus 750 p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~~~dpd 826 (837)
........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+....
T Consensus 249 ------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 302 (359)
T 3vhe_A 249 ------------------------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 302 (359)
T ss_dssp ------------------------CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ------------------------chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh
Confidence 011224567899999999999999999999999999999998 99999876543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=307.24 Aligned_cols=208 Identities=33% Similarity=0.632 Sum_probs=175.9
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeE
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~l 664 (837)
....++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++......
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF 86 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence 34567899999999999999999999999999999999765433334456789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCC
Q 003232 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~st 744 (837)
|+||||+++++|.+++...+.+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~-- 164 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-- 164 (276)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred EEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC--
Confidence 999999999999999988888999999999999999999999999999999999999999999999999998631000
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCC-CchHHHHHHHHHHHHHHcCCCCCCCC
Q 003232 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVGIPPFNAE 823 (837)
Q Consensus 745 ddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~-s~kSDIWSLGVILyELLTGr~PF~~~ 823 (837)
.......||+.|+|||++.+..+ +.++||||||+++|+|++|..||...
T Consensus 165 ------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 214 (276)
T 2h6d_A 165 ------------------------------EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214 (276)
T ss_dssp ------------------------------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ------------------------------cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 01123468999999999988776 68999999999999999999999765
Q ss_pred C
Q 003232 824 H 824 (837)
Q Consensus 824 d 824 (837)
.
T Consensus 215 ~ 215 (276)
T 2h6d_A 215 H 215 (276)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=316.26 Aligned_cols=209 Identities=27% Similarity=0.493 Sum_probs=181.1
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeE
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~l 664 (837)
...+++|++++.||.|+||+||+|++..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++.....+
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 99 (331)
T 4aaa_A 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRW 99 (331)
T ss_dssp CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEE
Confidence 345678999999999999999999999999999999987643 3344556788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCC
Q 003232 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~st 744 (837)
|+||||+.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 100 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 177 (331)
T 4aaa_A 100 YLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP-- 177 (331)
T ss_dssp EEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC--
Confidence 999999999999998887788999999999999999999999999999999999999999999999999998631000
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003232 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAE 823 (837)
Q Consensus 745 ddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~-~~s~kSDIWSLGVILyELLTGr~PF~~~ 823 (837)
........||+.|+|||++.+. .++.++|||||||++|+|++|+.||...
T Consensus 178 -----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 228 (331)
T 4aaa_A 178 -----------------------------GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGD 228 (331)
T ss_dssp -----------------------------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred -----------------------------ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 0112345789999999999875 7899999999999999999999999876
Q ss_pred Cc
Q 003232 824 HP 825 (837)
Q Consensus 824 dp 825 (837)
+.
T Consensus 229 ~~ 230 (331)
T 4aaa_A 229 SD 230 (331)
T ss_dssp SH
T ss_pred Cc
Confidence 54
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-37 Score=313.34 Aligned_cols=212 Identities=26% Similarity=0.431 Sum_probs=181.3
Q ss_pred CCcccCCeEEEEEecccCceEEEEEEEC-----CCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEe
Q 003232 584 DRTSIDDFEIIKPISRGAFGRVFLAKKR-----TTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSF 658 (837)
Q Consensus 584 ~g~~lddYeIlkkLGsG~FGtVYkArdk-----~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf 658 (837)
+....++|++.+.||.|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++.++||||+++++++
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 95 (314)
T 2ivs_A 18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGAC 95 (314)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence 3445678999999999999999999983 455899999997543 345567899999999999999999999999
Q ss_pred ecCCeEEEEEEecCCCCHHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCccccc
Q 003232 659 TCRENLYLVMEYLNGGDLYSLLRNLGC------------------------LDEDVARVYIAEVVLALEYLHSLRVVHRD 714 (837)
Q Consensus 659 ~d~~~lyLVmEy~~GGSL~dlLk~~g~------------------------Lsee~irkIl~QIa~ALsYLHSkGIIHRD 714 (837)
......|+||||+++++|.+++..... +++..+..++.||+.||.|||++||+|||
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~d 175 (314)
T 2ivs_A 96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRD 175 (314)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccc
Confidence 999999999999999999999976543 88999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC
Q 003232 715 LKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG 794 (837)
Q Consensus 715 IKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg 794 (837)
|||+|||++.++.++|+|||++........ ........||+.|+|||++.+
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~-----------------------------~~~~~~~~~~~~y~aPE~~~~ 226 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDS-----------------------------YVKRSQGRIPVKWMAIESLFD 226 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSC-----------------------------EECSSCCCSCGGGCCHHHHHH
T ss_pred cchheEEEcCCCCEEEcccccccccccccc-----------------------------ceeccCCCCcccccChhhhcC
Confidence 999999999999999999999873111000 001223457889999999999
Q ss_pred CCCCchHHHHHHHHHHHHHHc-CCCCCCCCCcC
Q 003232 795 TGHGTTADWWSVGIILFELIV-GIPPFNAEHPQ 826 (837)
Q Consensus 795 ~~~s~kSDIWSLGVILyELLT-Gr~PF~~~dpd 826 (837)
..++.++||||||+++|+|++ |..||.+....
T Consensus 227 ~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 259 (314)
T 2ivs_A 227 HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE 259 (314)
T ss_dssp CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred CCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999999999 99999876543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=319.78 Aligned_cols=211 Identities=26% Similarity=0.363 Sum_probs=178.7
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCCCc---EEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecC
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGD---LFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR 661 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~tG~---~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~ 661 (837)
....++|++.+.||+|+||+||+|++..++. .||||+++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 122 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG 122 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 3445679999999999999999999986555 59999997642 344557899999999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccc
Q 003232 662 ENLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740 (837)
Q Consensus 662 ~~lyLVmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~ 740 (837)
...|+||||++|++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++...
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 9999999999999999999754 579999999999999999999999999999999999999999999999999987421
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCC
Q 003232 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPP 819 (837)
Q Consensus 741 ~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~P 819 (837)
..... ........||+.|+|||++.+..++.++||||||+++|+|++ |..|
T Consensus 203 ~~~~~----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p 254 (325)
T 3kul_A 203 DDPDA----------------------------AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254 (325)
T ss_dssp ----C----------------------------CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCT
T ss_pred cCccc----------------------------eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCC
Confidence 11000 001123356888999999999999999999999999999999 9999
Q ss_pred CCCCCc
Q 003232 820 FNAEHP 825 (837)
Q Consensus 820 F~~~dp 825 (837)
|.....
T Consensus 255 ~~~~~~ 260 (325)
T 3kul_A 255 YWNMTN 260 (325)
T ss_dssp TTTSCH
T ss_pred cccCCH
Confidence 976543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=336.19 Aligned_cols=212 Identities=33% Similarity=0.586 Sum_probs=180.6
Q ss_pred CCCCCcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccH----------HHHHHHHHHHHHHHhcCCCc
Q 003232 581 PSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRK----------NAVESILAERDILISVRNPF 650 (837)
Q Consensus 581 P~k~g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~----------e~ie~~~rEieILk~LrHPN 650 (837)
....+...++|+++++||+|+||+||+|+++.+++.||+|++........ ...+.+.+|+.+++.++|||
T Consensus 28 ~~~~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn 107 (504)
T 3q5i_A 28 RKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPN 107 (504)
T ss_dssp CEECSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTT
T ss_pred eccCCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCC
Confidence 33455667889999999999999999999999999999999976442211 23467899999999999999
Q ss_pred eEEEEeEeecCCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCC---c
Q 003232 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG---H 727 (837)
Q Consensus 651 IVkL~gsf~d~~~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG---~ 727 (837)
|+++++++.....+|+||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++ .
T Consensus 108 iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 108 IIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp BCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSS
T ss_pred CCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCcc
Confidence 9999999999999999999999999999998888899999999999999999999999999999999999998776 6
Q ss_pred EEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHH
Q 003232 728 IKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVG 807 (837)
Q Consensus 728 IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLG 807 (837)
++|+|||++...... ......+||+.|+|||++.+ .++.++||||||
T Consensus 188 ~kl~Dfg~a~~~~~~--------------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG 234 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKD--------------------------------YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCG 234 (504)
T ss_dssp EEECCCTTCEECCTT--------------------------------SCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHH
T ss_pred EEEEECCCCEEcCCC--------------------------------CccccccCCcCCCCHHHhcc-CCCchHHHHHHH
Confidence 999999998731100 11234579999999999874 589999999999
Q ss_pred HHHHHHHcCCCCCCCCCc
Q 003232 808 IILFELIVGIPPFNAEHP 825 (837)
Q Consensus 808 VILyELLTGr~PF~~~dp 825 (837)
|++|+|++|.+||.+.+.
T Consensus 235 ~il~~ll~g~~pf~~~~~ 252 (504)
T 3q5i_A 235 VIMYILLCGYPPFGGQND 252 (504)
T ss_dssp HHHHHHHHSSCSSCCSSH
T ss_pred HHHHHHHhCCCCCCCCCH
Confidence 999999999999987654
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=338.72 Aligned_cols=208 Identities=35% Similarity=0.617 Sum_probs=182.6
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeE
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~l 664 (837)
....++|++.+.||+|+||+||+|+++.+++.||||++.............+.+|+.+++.++||||+++++++.....+
T Consensus 22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 101 (484)
T 3nyv_A 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYF 101 (484)
T ss_dssp CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 34456799999999999999999999999999999999765443344557889999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEE---ccCCcEEEEecCCcccccc
Q 003232 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI---AHDGHIKLTDFGLSKVGLI 741 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILL---d~dG~IKLiDFGLArvg~~ 741 (837)
|+||||+.|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 102 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 102 YLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp EEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 9999999999999999988889999999999999999999999999999999999999 5678999999999863100
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCC
Q 003232 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFN 821 (837)
Q Consensus 742 ~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~ 821 (837)
. ......+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.
T Consensus 182 ~--------------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~ 228 (484)
T 3nyv_A 182 S--------------------------------KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFN 228 (484)
T ss_dssp C--------------------------------CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred c--------------------------------cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCC
Confidence 0 00123469999999999987 68999999999999999999999998
Q ss_pred CCCc
Q 003232 822 AEHP 825 (837)
Q Consensus 822 ~~dp 825 (837)
+.++
T Consensus 229 ~~~~ 232 (484)
T 3nyv_A 229 GANE 232 (484)
T ss_dssp CSSH
T ss_pred CCCH
Confidence 7543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=310.26 Aligned_cols=209 Identities=33% Similarity=0.528 Sum_probs=178.1
Q ss_pred CCCCCcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeec
Q 003232 581 PSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC 660 (837)
Q Consensus 581 P~k~g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d 660 (837)
+...+...++|++.+.||+|+||+||+|++..++..+|+|++..... ....+.+.+|+.+++.++||||+++++++..
T Consensus 14 ~~~~g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 91 (285)
T 3is5_A 14 LYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLDHPNIIKIFEVFED 91 (285)
T ss_dssp CEESSCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--CSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred CCCCCChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc--chhHHHHHHHHHHHHhCCCchHHhHHHheec
Confidence 33456677889999999999999999999999999999999976532 2234678899999999999999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEE---ccCCcEEEEec
Q 003232 661 RENLYLVMEYLNGGDLYSLLRN----LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI---AHDGHIKLTDF 733 (837)
Q Consensus 661 ~~~lyLVmEy~~GGSL~dlLk~----~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILL---d~dG~IKLiDF 733 (837)
....|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.++|+||
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Df 171 (285)
T 3is5_A 92 YHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDF 171 (285)
T ss_dssp SSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCC
T ss_pred CCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEee
Confidence 9999999999999999998853 3679999999999999999999999999999999999999 45688999999
Q ss_pred CCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHH
Q 003232 734 GLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 813 (837)
Q Consensus 734 GLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyEL 813 (837)
|++..... ........||+.|+|||++. ..++.++||||||+++|+|
T Consensus 172 g~a~~~~~--------------------------------~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~l 218 (285)
T 3is5_A 172 GLAELFKS--------------------------------DEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFL 218 (285)
T ss_dssp CCCCC------------------------------------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHH
T ss_pred ecceecCC--------------------------------cccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHH
Confidence 99863110 01122456899999999986 5689999999999999999
Q ss_pred HcCCCCCCCCC
Q 003232 814 IVGIPPFNAEH 824 (837)
Q Consensus 814 LTGr~PF~~~d 824 (837)
++|+.||.+.+
T Consensus 219 l~g~~pf~~~~ 229 (285)
T 3is5_A 219 LTGCLPFTGTS 229 (285)
T ss_dssp HHSSCSSCCSS
T ss_pred HhCCCCCCCCC
Confidence 99999998654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=304.66 Aligned_cols=207 Identities=23% Similarity=0.420 Sum_probs=178.9
Q ss_pred CCcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCe
Q 003232 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCREN 663 (837)
Q Consensus 584 ~g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ 663 (837)
+....++|++.+.||+|+||+||+|++. +++.||+|++...... .+.+.+|+.+++.++||||+++++++.....
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 79 (269)
T 4hcu_A 5 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 79 (269)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred EEeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCc
Confidence 3445578999999999999999999986 5778999999865422 2468899999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccC
Q 003232 664 LYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~ 742 (837)
.|+||||+++++|.+++... +.+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~- 158 (269)
T 4hcu_A 80 ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD- 158 (269)
T ss_dssp EEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC-
T ss_pred eEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccc-
Confidence 99999999999999999754 5589999999999999999999999999999999999999999999999999863100
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCC
Q 003232 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFN 821 (837)
Q Consensus 743 stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~ 821 (837)
..........||+.|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus 159 -----------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~ 209 (269)
T 4hcu_A 159 -----------------------------DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE 209 (269)
T ss_dssp -----------------------------HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred -----------------------------cccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCC
Confidence 01112234567888999999999999999999999999999999 999998
Q ss_pred CCCc
Q 003232 822 AEHP 825 (837)
Q Consensus 822 ~~dp 825 (837)
..+.
T Consensus 210 ~~~~ 213 (269)
T 4hcu_A 210 NRSN 213 (269)
T ss_dssp TCCH
T ss_pred CCCH
Confidence 7543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=306.01 Aligned_cols=205 Identities=32% Similarity=0.586 Sum_probs=178.6
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEeccccccc---HHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIR---KNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 665 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~---~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ly 665 (837)
++|++.+.||.|+||+||+|++..+++.||+|++....... ....+.+.+|+.+++.++||||+++++++......|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 56999999999999999999999999999999997643221 112467889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCC----cEEEEecCCcccccc
Q 003232 666 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG----HIKLTDFGLSKVGLI 741 (837)
Q Consensus 666 LVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG----~IKLiDFGLArvg~~ 741 (837)
+||||+++++|.+++.....+++..+..++.||+.||.|||++||+|+||||+||+++.++ .++|+|||++.....
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~ 164 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 164 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence 9999999999999998888899999999999999999999999999999999999998877 899999999863100
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCC
Q 003232 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFN 821 (837)
Q Consensus 742 ~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~ 821 (837)
. .......||+.|+|||++.+..++.++||||||+++|+|++|..||.
T Consensus 165 ~--------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 212 (283)
T 3bhy_A 165 G--------------------------------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 212 (283)
T ss_dssp ---------------------------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred C--------------------------------CcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCC
Confidence 0 01123468999999999999999999999999999999999999998
Q ss_pred CCCc
Q 003232 822 AEHP 825 (837)
Q Consensus 822 ~~dp 825 (837)
..+.
T Consensus 213 ~~~~ 216 (283)
T 3bhy_A 213 GETK 216 (283)
T ss_dssp CSSH
T ss_pred Ccch
Confidence 7543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=328.17 Aligned_cols=207 Identities=25% Similarity=0.483 Sum_probs=181.5
Q ss_pred CCCcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC
Q 003232 583 KDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE 662 (837)
Q Consensus 583 k~g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~ 662 (837)
+.+...++|++++.||.|+||+||+|.++.+++.||+|++.... ......+.+|+.+++.++||||+++++++....
T Consensus 45 ~~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 121 (387)
T 1kob_A 45 KQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY 121 (387)
T ss_dssp BCSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS
T ss_pred cCCccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCC
Confidence 44566788999999999999999999999999999999997643 223457889999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEcc--CCcEEEEecCCcccc
Q 003232 663 NLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH--DGHIKLTDFGLSKVG 739 (837)
Q Consensus 663 ~lyLVmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~--dG~IKLiDFGLArvg 739 (837)
.+|+||||+.|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++..
T Consensus 122 ~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~ 201 (387)
T 1kob_A 122 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 201 (387)
T ss_dssp EEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceec
Confidence 999999999999999998754 36999999999999999999999999999999999999974 578999999998731
Q ss_pred ccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCC
Q 003232 740 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPP 819 (837)
Q Consensus 740 ~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~P 819 (837)
... .......||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 202 ~~~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P 249 (387)
T 1kob_A 202 NPD--------------------------------EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249 (387)
T ss_dssp CTT--------------------------------SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCS
T ss_pred CCC--------------------------------cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCC
Confidence 100 011234689999999999999999999999999999999999999
Q ss_pred CCCCC
Q 003232 820 FNAEH 824 (837)
Q Consensus 820 F~~~d 824 (837)
|.+.+
T Consensus 250 f~~~~ 254 (387)
T 1kob_A 250 FAGED 254 (387)
T ss_dssp SCCSS
T ss_pred CCCCC
Confidence 98754
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=336.27 Aligned_cols=209 Identities=33% Similarity=0.600 Sum_probs=181.1
Q ss_pred CCCcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC
Q 003232 583 KDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE 662 (837)
Q Consensus 583 k~g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~ 662 (837)
..+...++|++++.||+|+||+||+|+++.+++.||+|++...... ......+.+|+.+++.++||||+++++++....
T Consensus 16 ~~g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 94 (486)
T 3mwu_A 16 FQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSS 94 (486)
T ss_dssp TCCHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHB-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred ccCChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccccc-chHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCC
Confidence 4556677899999999999999999999999999999999754321 223467889999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEc---cCCcEEEEecCCcccc
Q 003232 663 NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA---HDGHIKLTDFGLSKVG 739 (837)
Q Consensus 663 ~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd---~dG~IKLiDFGLArvg 739 (837)
.+|+||||+.|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++..
T Consensus 95 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 95 SFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 9999999999999999998888899999999999999999999999999999999999995 4567999999998631
Q ss_pred ccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCC
Q 003232 740 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPP 819 (837)
Q Consensus 740 ~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~P 819 (837)
... ......+||+.|+|||++.+ .++.++|||||||++|+|++|.+|
T Consensus 175 ~~~--------------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~p 221 (486)
T 3mwu_A 175 QQN--------------------------------TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPP 221 (486)
T ss_dssp CCC------------------------------------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred CCC--------------------------------CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCC
Confidence 100 01224579999999999986 489999999999999999999999
Q ss_pred CCCCCc
Q 003232 820 FNAEHP 825 (837)
Q Consensus 820 F~~~dp 825 (837)
|.+.+.
T Consensus 222 f~~~~~ 227 (486)
T 3mwu_A 222 FYGKNE 227 (486)
T ss_dssp SCCSSH
T ss_pred CCCCCH
Confidence 987543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=313.07 Aligned_cols=206 Identities=30% Similarity=0.466 Sum_probs=170.3
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccc--cHHHHHHHHHHHHHHHhc---CCCceEEEEeEeecC
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMI--RKNAVESILAERDILISV---RNPFVVRFFYSFTCR 661 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~--~~e~ie~~~rEieILk~L---rHPNIVkL~gsf~d~ 661 (837)
..++|++++.||+|+||+||+|++..+++.||+|++...... .......+.+|+.+++.+ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 346799999999999999999999999999999998753311 111112455666666555 599999999999775
Q ss_pred C-----eEEEEEEecCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecC
Q 003232 662 E-----NLYLVMEYLNGGDLYSLLRNLGC--LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFG 734 (837)
Q Consensus 662 ~-----~lyLVmEy~~GGSL~dlLk~~g~--Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFG 734 (837)
. .+++||||+. ++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 165 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFG 165 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCS
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCc
Confidence 4 5899999996 599999987644 9999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHH
Q 003232 735 LSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI 814 (837)
Q Consensus 735 LArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELL 814 (837)
+++..... .......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 166 ~a~~~~~~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~ 213 (308)
T 3g33_A 166 LARIYSYQ--------------------------------MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 213 (308)
T ss_dssp CTTTSTTC--------------------------------CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTT
T ss_pred cccccCCC--------------------------------cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHH
Confidence 98631100 0112357899999999999999999999999999999999
Q ss_pred cCCCCCCCCCc
Q 003232 815 VGIPPFNAEHP 825 (837)
Q Consensus 815 TGr~PF~~~dp 825 (837)
+|++||.+.+.
T Consensus 214 ~g~~pf~~~~~ 224 (308)
T 3g33_A 214 RRKPLFCGNSE 224 (308)
T ss_dssp TSSCSCCCSSH
T ss_pred hCCCCCCCCCH
Confidence 99999987654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=329.56 Aligned_cols=204 Identities=33% Similarity=0.598 Sum_probs=170.5
Q ss_pred CCCCCcccCCeEEE-EEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHH-HhcCCCceEEEEeEe
Q 003232 581 PSKDRTSIDDFEII-KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDIL-ISVRNPFVVRFFYSF 658 (837)
Q Consensus 581 P~k~g~~lddYeIl-kkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieIL-k~LrHPNIVkL~gsf 658 (837)
....+..+++|.+. +.||.|+||+||+|+++.+++.||||++... ..+.+|+.++ +..+||||++++++|
T Consensus 53 ~~~~~~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~ 124 (400)
T 1nxk_A 53 QIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVY 124 (400)
T ss_dssp CCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred ccCCCcccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEE
Confidence 34456677889988 7899999999999999999999999999643 2456788877 456899999999988
Q ss_pred ec----CCeEEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEcc---CCcEE
Q 003232 659 TC----RENLYLVMEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIK 729 (837)
Q Consensus 659 ~d----~~~lyLVmEy~~GGSL~dlLk~~g--~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~---dG~IK 729 (837)
.. ..++|+||||++||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+|
T Consensus 125 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~k 204 (400)
T 1nxk_A 125 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILK 204 (400)
T ss_dssp EEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEE
T ss_pred eecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEE
Confidence 75 567999999999999999998643 5999999999999999999999999999999999999987 78999
Q ss_pred EEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHH
Q 003232 730 LTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGII 809 (837)
Q Consensus 730 LiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVI 809 (837)
|+|||+++..... ......+||+.|+|||++.+..++.++|||||||+
T Consensus 205 l~DFG~a~~~~~~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 252 (400)
T 1nxk_A 205 LTDFGFAKETTSH--------------------------------NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 252 (400)
T ss_dssp ECCCTTCEECC-------------------------------------------CTTCCGGGSCCCCSSSHHHHHHHHHH
T ss_pred EEecccccccCCC--------------------------------CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHH
Confidence 9999998731100 01234578999999999999999999999999999
Q ss_pred HHHHHcCCCCCCCCC
Q 003232 810 LFELIVGIPPFNAEH 824 (837)
Q Consensus 810 LyELLTGr~PF~~~d 824 (837)
+|+|++|..||....
T Consensus 253 l~ell~g~~pf~~~~ 267 (400)
T 1nxk_A 253 MYILLCGYPPFYSNH 267 (400)
T ss_dssp HHHHHHSSCSCCCCT
T ss_pred HHHHHhCCCCCCCCc
Confidence 999999999997654
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=310.49 Aligned_cols=207 Identities=28% Similarity=0.457 Sum_probs=174.4
Q ss_pred cccCCeEEEEEecccCceEEEEEE----ECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeec-
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAK----KRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC- 660 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkAr----dk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d- 660 (837)
...++|++++.||+|+||+||+|+ +..+++.||+|++... .....+.+.+|+.+++.++||||+++++++..
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 83 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 345679999999999999999999 5668999999999764 34556788999999999999999999999865
Q ss_pred -CCeEEEEEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccc
Q 003232 661 -RENLYLVMEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (837)
Q Consensus 661 -~~~lyLVmEy~~GGSL~dlLk~~g-~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArv 738 (837)
..++|+||||+++++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 356899999999999999997654 499999999999999999999999999999999999999999999999999874
Q ss_pred cccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCC
Q 003232 739 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIP 818 (837)
Q Consensus 739 g~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~ 818 (837)
...... .........||+.|+|||++.+..++.++||||||+++|+|++|..
T Consensus 164 ~~~~~~----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~ 215 (295)
T 3ugc_A 164 LPQDKE----------------------------FFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE 215 (295)
T ss_dssp ----------------------------------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTC
T ss_pred ccCCcc----------------------------eeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhccc
Confidence 211100 0011223457788999999999999999999999999999999999
Q ss_pred CCCCC
Q 003232 819 PFNAE 823 (837)
Q Consensus 819 PF~~~ 823 (837)
||...
T Consensus 216 ~~~~~ 220 (295)
T 3ugc_A 216 KSKSP 220 (295)
T ss_dssp TTCSH
T ss_pred ccCCC
Confidence 98653
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=305.28 Aligned_cols=208 Identities=25% Similarity=0.430 Sum_probs=177.4
Q ss_pred CCCcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC
Q 003232 583 KDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE 662 (837)
Q Consensus 583 k~g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~ 662 (837)
.+....++|++++.||+|+||+||++.+. ++..||+|++...... .+.+.+|+.+++.++||||+++++++....
T Consensus 18 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 92 (283)
T 3gen_A 18 SWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQR 92 (283)
T ss_dssp TTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEecCC
Confidence 45566678999999999999999999985 6778999999865422 246889999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCcccccc
Q 003232 663 NLYLVMEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 741 (837)
Q Consensus 663 ~lyLVmEy~~GGSL~dlLk~-~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~ 741 (837)
.+|+||||+.+++|.+++.. ...+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.....
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 93 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp SEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred CeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 99999999999999999976 46799999999999999999999999999999999999999999999999999863100
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCC
Q 003232 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPF 820 (837)
Q Consensus 742 ~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF 820 (837)
..........||+.|+|||++.+..++.++||||||+++|+|++ |+.||
T Consensus 173 ------------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~ 222 (283)
T 3gen_A 173 ------------------------------DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY 222 (283)
T ss_dssp ------------------------------HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred ------------------------------cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 01112234457888999999998899999999999999999998 99999
Q ss_pred CCCCc
Q 003232 821 NAEHP 825 (837)
Q Consensus 821 ~~~dp 825 (837)
...+.
T Consensus 223 ~~~~~ 227 (283)
T 3gen_A 223 ERFTN 227 (283)
T ss_dssp TTSCH
T ss_pred cccCh
Confidence 86543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=315.47 Aligned_cols=200 Identities=32% Similarity=0.562 Sum_probs=176.9
Q ss_pred CeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEE
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmE 669 (837)
.|+..+.||+|+||.||+|++..+|+.||||++..... ...+.+.+|+.+++.++||||+++++++......|+|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch---hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 38888999999999999999998999999999975432 234568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCC
Q 003232 670 YLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 749 (837)
Q Consensus 670 y~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~ 749 (837)
|++|++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 123 ~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~------ 195 (321)
T 2c30_A 123 FLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV------ 195 (321)
T ss_dssp CCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS------
T ss_pred cCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc------
Confidence 9999999999865 569999999999999999999999999999999999999999999999999986311100
Q ss_pred CCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 750 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 750 p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
.......||+.|+|||++.+..++.++||||||+++|+|++|+.||...+
T Consensus 196 -------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~ 245 (321)
T 2c30_A 196 -------------------------PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS 245 (321)
T ss_dssp -------------------------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred -------------------------cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 01234579999999999999999999999999999999999999997654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=339.47 Aligned_cols=208 Identities=33% Similarity=0.632 Sum_probs=184.6
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeE
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~l 664 (837)
....++|.+.+.||.|+||.||+|++..+|+.||||++.............+.+|+.+++.++||||+++++++.....+
T Consensus 12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 91 (476)
T 2y94_A 12 RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDI 91 (476)
T ss_dssp CCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 34567899999999999999999999999999999999765433334456789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCC
Q 003232 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~st 744 (837)
|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 92 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~--- 168 (476)
T 2y94_A 92 FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD--- 168 (476)
T ss_dssp EEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCT---
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccc---
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999873110
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCC-CchHHHHHHHHHHHHHHcCCCCCCCC
Q 003232 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVGIPPFNAE 823 (837)
Q Consensus 745 ddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~-s~kSDIWSLGVILyELLTGr~PF~~~ 823 (837)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...
T Consensus 169 -----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~ 219 (476)
T 2y94_A 169 -----------------------------GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDD 219 (476)
T ss_dssp -----------------------------TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred -----------------------------cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCC
Confidence 001234579999999999998776 68999999999999999999999865
Q ss_pred C
Q 003232 824 H 824 (837)
Q Consensus 824 d 824 (837)
+
T Consensus 220 ~ 220 (476)
T 2y94_A 220 H 220 (476)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=301.59 Aligned_cols=199 Identities=26% Similarity=0.390 Sum_probs=172.1
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEeEeecCCeEEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYL 666 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~gsf~d~~~lyL 666 (837)
.++|++.+.||+|+||+||+|++..+++.||+|++..... .......+.+|+..+..+ +||||+++++++......|+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA-GSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCT-TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccc-ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 4579999999999999999999999999999999986532 233456788999999998 99999999999999999999
Q ss_pred EEEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccC-----------------
Q 003232 667 VMEYLNGGDLYSLLRNL----GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD----------------- 725 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~~----g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~d----------------- 725 (837)
||||++|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~ 168 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS 168 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence 99999999999999764 679999999999999999999999999999999999999844
Q ss_pred --CcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCC-CCCchHH
Q 003232 726 --GHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTAD 802 (837)
Q Consensus 726 --G~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~-~~s~kSD 802 (837)
..++|+|||++.... ......||+.|+|||++.+. .++.++|
T Consensus 169 ~~~~~kl~Dfg~~~~~~-----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~D 213 (289)
T 1x8b_A 169 NKVMFKIGDLGHVTRIS-----------------------------------SPQVEEGDSRFLANEVLQENYTHLPKAD 213 (289)
T ss_dssp -CCCEEECCCTTCEETT-----------------------------------CSCCCCCCGGGCCHHHHTTCCTTHHHHH
T ss_pred CceEEEEcccccccccC-----------------------------------CccccCCCccccChhHhcCCCCCCchhh
Confidence 479999999886310 01123589999999999876 5668999
Q ss_pred HHHHHHHHHHHHcCCCCCCC
Q 003232 803 WWSVGIILFELIVGIPPFNA 822 (837)
Q Consensus 803 IWSLGVILyELLTGr~PF~~ 822 (837)
||||||++|+|++|.+||..
T Consensus 214 i~slG~il~~l~~~~~~~~~ 233 (289)
T 1x8b_A 214 IFALALTVVCAAGAEPLPRN 233 (289)
T ss_dssp HHHHHHHHHHHTTCCCCCSS
T ss_pred HHHHHHHHHHHhcCCCCCcc
Confidence 99999999999999987643
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=303.54 Aligned_cols=202 Identities=25% Similarity=0.471 Sum_probs=176.9
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeec----CCeE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC----RENL 664 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d----~~~l 664 (837)
..|++.+.||+|+||+||+|.+..++..||+|++.... ......+.+.+|+.+++.++||||+++++++.. ...+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK-LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG-SCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchh-hCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 34999999999999999999999999999999997654 234556789999999999999999999998865 4579
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCCCCcEEEc-cCCcEEEEecCCcccccc
Q 003232 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLR--VVHRDLKPDNLLIA-HDGHIKLTDFGLSKVGLI 741 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkG--IIHRDIKPeNILLd-~dG~IKLiDFGLArvg~~ 741 (837)
|+||||+++++|.+++...+.+++..++.++.||+.||.|||+.| |+|+||||+|||++ .++.++|+|||++.....
T Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~ 184 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence 999999999999999998888999999999999999999999999 99999999999997 789999999999863100
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCC
Q 003232 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFN 821 (837)
Q Consensus 742 ~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~ 821 (837)
.......||+.|+|||++.+ .++.++||||||+++|+|++|+.||.
T Consensus 185 ---------------------------------~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~ 230 (290)
T 1t4h_A 185 ---------------------------------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYS 230 (290)
T ss_dssp ---------------------------------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred ---------------------------------cccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCC
Confidence 01123568999999998875 48999999999999999999999997
Q ss_pred CCCc
Q 003232 822 AEHP 825 (837)
Q Consensus 822 ~~dp 825 (837)
....
T Consensus 231 ~~~~ 234 (290)
T 1t4h_A 231 ECQN 234 (290)
T ss_dssp TCSS
T ss_pred CcCc
Confidence 6443
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=306.61 Aligned_cols=208 Identities=29% Similarity=0.523 Sum_probs=181.4
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLV 667 (837)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... ....+.+.+|+.+++.++||||+++++++......|+|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence 4679999999999999999999999999999999975432 23456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCC
Q 003232 668 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (837)
Q Consensus 668 mEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl 747 (837)
|||+++++|.+++.....+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++........
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--- 160 (276)
T 2yex_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR--- 160 (276)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE---
T ss_pred EEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc---
Confidence 99999999999998777899999999999999999999999999999999999999999999999999863111100
Q ss_pred CCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCC-CchHHHHHHHHHHHHHHcCCCCCCCCCcC
Q 003232 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVGIPPFNAEHPQ 826 (837)
Q Consensus 748 ~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~-s~kSDIWSLGVILyELLTGr~PF~~~dpd 826 (837)
........||+.|+|||++.+..+ +.++||||||+++|+|++|..||......
T Consensus 161 --------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 214 (276)
T 2yex_A 161 --------------------------ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 214 (276)
T ss_dssp --------------------------ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT
T ss_pred --------------------------hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH
Confidence 011234578999999999988775 77899999999999999999999876654
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=319.18 Aligned_cols=200 Identities=30% Similarity=0.553 Sum_probs=157.5
Q ss_pred CCeEEE---EEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcC-CCceEEEEeEeecCCeE
Q 003232 589 DDFEII---KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCRENL 664 (837)
Q Consensus 589 ddYeIl---kkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~Lr-HPNIVkL~gsf~d~~~l 664 (837)
++|++. +.||+|+||+||+|.++.+++.||+|++... ....+.+|+.+++.+. ||||+++++++......
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~ 81 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHT 81 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEE
Confidence 457765 7899999999999999999999999999753 2346778999999997 99999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCC---cEEEEecCCcccccc
Q 003232 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG---HIKLTDFGLSKVGLI 741 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG---~IKLiDFGLArvg~~ 741 (837)
|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .++|+|||+++....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 161 (325)
T 3kn6_A 82 FLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP 161 (325)
T ss_dssp EEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC
T ss_pred EEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCC
Confidence 99999999999999999888899999999999999999999999999999999999997765 899999999873110
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCC
Q 003232 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFN 821 (837)
Q Consensus 742 ~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~ 821 (837)
. .......+||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 162 ~-------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 210 (325)
T 3kn6_A 162 D-------------------------------NQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQ 210 (325)
T ss_dssp -----------------------------------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred C-------------------------------CCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 0 011234568999999999999999999999999999999999999998
Q ss_pred CCCc
Q 003232 822 AEHP 825 (837)
Q Consensus 822 ~~dp 825 (837)
..+.
T Consensus 211 ~~~~ 214 (325)
T 3kn6_A 211 SHDR 214 (325)
T ss_dssp ----
T ss_pred CCcc
Confidence 6543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=302.07 Aligned_cols=210 Identities=21% Similarity=0.284 Sum_probs=178.2
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEeEeecCCeE
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENL 664 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~gsf~d~~~l 664 (837)
...++|++.+.||+|+||+||+|++..+++.||+|++..... ...+.+|+.+++.+ +|+||+++++++......
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 81 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 81 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCcee
Confidence 344679999999999999999999999999999999865431 23477899999999 799999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCc-----EEEEecCCccc
Q 003232 665 YLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGH-----IKLTDFGLSKV 738 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~-----IKLiDFGLArv 738 (837)
|+||||+ +++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++. ++|+|||+++.
T Consensus 82 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 9999999 99999999865 45999999999999999999999999999999999999987776 99999999874
Q ss_pred cccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCC
Q 003232 739 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIP 818 (837)
Q Consensus 739 g~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~ 818 (837)
......... ..........||+.|+|||++.+..++.++||||||+++|+|++|+.
T Consensus 161 ~~~~~~~~~------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 216 (298)
T 1csn_A 161 YRDPVTKQH------------------------IPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSL 216 (298)
T ss_dssp SBCTTTCCB------------------------CCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred ccccccccc------------------------ccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCC
Confidence 221111000 00012345679999999999999999999999999999999999999
Q ss_pred CCCCCCc
Q 003232 819 PFNAEHP 825 (837)
Q Consensus 819 PF~~~dp 825 (837)
||...+.
T Consensus 217 pf~~~~~ 223 (298)
T 1csn_A 217 PWQGLKA 223 (298)
T ss_dssp TTSSCCS
T ss_pred Ccchhhc
Confidence 9987543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=336.55 Aligned_cols=212 Identities=35% Similarity=0.599 Sum_probs=178.0
Q ss_pred CCCCCCcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEee
Q 003232 580 HPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFT 659 (837)
Q Consensus 580 ~P~k~g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~ 659 (837)
.+...+...+.|++++.||+|+||+||+|+++.++..||+|++...... ......+.+|+.+++.++||||+++++++.
T Consensus 28 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 106 (494)
T 3lij_A 28 ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS-TSSNSKLLEEVAVLKLLDHPNIMKLYDFFE 106 (494)
T ss_dssp CCCCBCCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred eecCCCchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccC-chHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 3344455566799999999999999999999999999999999765421 222457889999999999999999999999
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEcc---CCcEEEEecCCc
Q 003232 660 CRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKLTDFGLS 736 (837)
Q Consensus 660 d~~~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~---dG~IKLiDFGLA 736 (837)
....+|+||||+.||+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 107 ~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a 186 (494)
T 3lij_A 107 DKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLS 186 (494)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence 99999999999999999999988888999999999999999999999999999999999999976 455999999998
Q ss_pred cccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcC
Q 003232 737 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVG 816 (837)
Q Consensus 737 rvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTG 816 (837)
..... .......+||+.|+|||++. ..++.++|||||||++|+|++|
T Consensus 187 ~~~~~--------------------------------~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g 233 (494)
T 3lij_A 187 AVFEN--------------------------------QKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAG 233 (494)
T ss_dssp EECBT--------------------------------TBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHS
T ss_pred eECCC--------------------------------CccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhC
Confidence 74110 01123457999999999986 4689999999999999999999
Q ss_pred CCCCCCCCc
Q 003232 817 IPPFNAEHP 825 (837)
Q Consensus 817 r~PF~~~dp 825 (837)
.+||.+.++
T Consensus 234 ~~pf~~~~~ 242 (494)
T 3lij_A 234 YPPFGGQTD 242 (494)
T ss_dssp SCSSCCSSH
T ss_pred CCCCCCCCH
Confidence 999987654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-36 Score=316.37 Aligned_cols=208 Identities=29% Similarity=0.460 Sum_probs=174.0
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCC--CceEEEEeEeecCCeEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN--PFVVRFFYSFTCRENLY 665 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrH--PNIVkL~gsf~d~~~ly 665 (837)
.++|++++.||+|+||+||++.+ .+++.||+|++.... ......+.+.+|+.+++.++| |||+++++++.....+|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 85 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 85 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccc-cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence 35699999999999999999998 568999999997654 344556789999999999987 99999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCC
Q 003232 666 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745 (837)
Q Consensus 666 LVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~std 745 (837)
+||| +.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++......
T Consensus 86 lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~-- 161 (343)
T 3dbq_A 86 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT-- 161 (343)
T ss_dssp EEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------
T ss_pred EEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccc--
Confidence 9999 55889999999988999999999999999999999999999999999999996 6889999999987311000
Q ss_pred CCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-----------CCCCchHHHHHHHHHHHHHH
Q 003232 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-----------TGHGTTADWWSVGIILFELI 814 (837)
Q Consensus 746 dl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-----------~~~s~kSDIWSLGVILyELL 814 (837)
........+||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 162 ---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell 214 (343)
T 3dbq_A 162 ---------------------------TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 214 (343)
T ss_dssp -----------------------------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHH
T ss_pred ---------------------------ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHH
Confidence 0011234579999999999965 67899999999999999999
Q ss_pred cCCCCCCCCCcCHH
Q 003232 815 VGIPPFNAEHPQVS 828 (837)
Q Consensus 815 TGr~PF~~~dpdv~ 828 (837)
+|+.||........
T Consensus 215 ~g~~pf~~~~~~~~ 228 (343)
T 3dbq_A 215 YGKTPFQQIINQIS 228 (343)
T ss_dssp HSSCTTTTCCSHHH
T ss_pred hCCCcchhhhhHHH
Confidence 99999987554433
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=312.94 Aligned_cols=212 Identities=27% Similarity=0.484 Sum_probs=174.3
Q ss_pred ccCCeEEE-EEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEeEeecCCeE
Q 003232 587 SIDDFEII-KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENL 664 (837)
Q Consensus 587 ~lddYeIl-kkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~gsf~d~~~l 664 (837)
..+.|++. +.||+|+||+||+|++..+++.||||++.... ......+.+|+.++.++ +||||+++++++...+.+
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~ 86 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRF 86 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence 34569996 78999999999999999999999999997643 22345788999999884 799999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCc---EEEEecCCcccccc
Q 003232 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGH---IKLTDFGLSKVGLI 741 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~---IKLiDFGLArvg~~ 741 (837)
|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. ++|+|||++.....
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 87 YLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred EEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 999999999999999988888999999999999999999999999999999999999988776 99999999863211
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-----CCCCchHHHHHHHHHHHHHHcC
Q 003232 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-----TGHGTTADWWSVGIILFELIVG 816 (837)
Q Consensus 742 ~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-----~~~s~kSDIWSLGVILyELLTG 816 (837)
..... ..........+||+.|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 167 ~~~~~------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g 222 (316)
T 2ac3_A 167 NGDCS------------------------PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222 (316)
T ss_dssp ---------------------------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHS
T ss_pred CCccc------------------------cccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHC
Confidence 10000 000111234579999999999975 4578899999999999999999
Q ss_pred CCCCCCCCc
Q 003232 817 IPPFNAEHP 825 (837)
Q Consensus 817 r~PF~~~dp 825 (837)
+.||.....
T Consensus 223 ~~pf~~~~~ 231 (316)
T 2ac3_A 223 YPPFVGRCG 231 (316)
T ss_dssp SCSCCCCCC
T ss_pred CCCCccccc
Confidence 999987643
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=334.73 Aligned_cols=202 Identities=28% Similarity=0.448 Sum_probs=172.5
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecC-----
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR----- 661 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~----- 661 (837)
..++|++++.||+|+||+||+|++..+++.||||++.... ......+.+.+|+.+++.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence 4578999999999999999999999999999999997653 3445567889999999999999999999999654
Q ss_pred -CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccc
Q 003232 662 -ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740 (837)
Q Consensus 662 -~~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~ 740 (837)
.++|+||||+++ +|.+.+.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 139 ~~~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 139 FQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215 (464)
T ss_dssp CCEEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred CCeEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence 468999999965 56666643 48999999999999999999999999999999999999999999999999987310
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCC
Q 003232 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820 (837)
Q Consensus 741 ~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF 820 (837)
. .......+||+.|+|||++.+..++.++|||||||++|+|++|++||
T Consensus 216 ~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF 263 (464)
T 3ttj_A 216 T--------------------------------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 263 (464)
T ss_dssp ---------------------------------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred C--------------------------------CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCC
Confidence 0 01123467999999999999999999999999999999999999999
Q ss_pred CCCC
Q 003232 821 NAEH 824 (837)
Q Consensus 821 ~~~d 824 (837)
.+.+
T Consensus 264 ~g~~ 267 (464)
T 3ttj_A 264 PGRD 267 (464)
T ss_dssp CCSS
T ss_pred CCCC
Confidence 8755
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=310.31 Aligned_cols=202 Identities=37% Similarity=0.631 Sum_probs=177.0
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEE
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyL 666 (837)
..++|++.+.||+|+||+||+|++..+|+.||+|++..... .....+.+|+.+++.++||||+++++++.....+|+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYL 83 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEE
Confidence 34579999999999999999999999999999999986432 223568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEE---ccCCcEEEEecCCccccccCC
Q 003232 667 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI---AHDGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILL---d~dG~IKLiDFGLArvg~~~s 743 (837)
||||+++++|.+++...+.+++..+..++.||+.||.|||++||+|+||||+||++ +.++.++|+|||++.....
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~-- 161 (304)
T 2jam_A 84 VMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN-- 161 (304)
T ss_dssp EECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC--
T ss_pred EEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC--
Confidence 99999999999999888889999999999999999999999999999999999999 7789999999999863100
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~ 823 (837)
.......||+.|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 162 -------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 210 (304)
T 2jam_A 162 -------------------------------GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEE 210 (304)
T ss_dssp -------------------------------BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred -------------------------------CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 0011235899999999999999999999999999999999999999765
Q ss_pred C
Q 003232 824 H 824 (837)
Q Consensus 824 d 824 (837)
+
T Consensus 211 ~ 211 (304)
T 2jam_A 211 T 211 (304)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=317.02 Aligned_cols=211 Identities=31% Similarity=0.520 Sum_probs=173.9
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEeccccc--ccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADM--IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 665 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~--~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ly 665 (837)
.++|++.+.||+|+||+||+|++..+++.||+|++..... ......+.+.+|+.+++.++||||+++++++......|
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 4569999999999999999999999999999999976432 12345578999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhc----------------------------------------CCCCHHHHHHHHHHHHHHHHHH
Q 003232 666 LVMEYLNGGDLYSLLRNL----------------------------------------GCLDEDVARVYIAEVVLALEYL 705 (837)
Q Consensus 666 LVmEy~~GGSL~dlLk~~----------------------------------------g~Lsee~irkIl~QIa~ALsYL 705 (837)
+||||++|++|.+++... ..+++..++.++.||+.||.||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 999999999999988421 1135778889999999999999
Q ss_pred HhCCcccccCCCCcEEEccCC--cEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCC
Q 003232 706 HSLRVVHRDLKPDNLLIAHDG--HIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGT 783 (837)
Q Consensus 706 HSkGIIHRDIKPeNILLd~dG--~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGT 783 (837)
|++||+||||||+|||++.++ .++|+|||+++........ .........||
T Consensus 185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~---------------------------~~~~~~~~~gt 237 (345)
T 3hko_A 185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNG---------------------------EYYGMTTKAGT 237 (345)
T ss_dssp HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC-----------------------------------CCC
T ss_pred HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCcc---------------------------ccccccccCCC
Confidence 999999999999999998776 8999999998742111110 00112345799
Q ss_pred CCccChhhhcC--CCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 784 PDYLAPEILLG--TGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 784 p~YmAPEVLlg--~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.
T Consensus 238 ~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 281 (345)
T 3hko_A 238 PYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVND 281 (345)
T ss_dssp GGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCh
Confidence 99999999975 6789999999999999999999999976543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=322.11 Aligned_cols=211 Identities=40% Similarity=0.829 Sum_probs=178.0
Q ss_pred CCcccCCeEEEEEecccCceEEEEEEEC---CCCcEEEEEEecccccc-cHHHHHHHHHHHHHHHhc-CCCceEEEEeEe
Q 003232 584 DRTSIDDFEIIKPISRGAFGRVFLAKKR---TTGDLFAIKVLKKADMI-RKNAVESILAERDILISV-RNPFVVRFFYSF 658 (837)
Q Consensus 584 ~g~~lddYeIlkkLGsG~FGtVYkArdk---~tG~~VAVKIikk~~~~-~~e~ie~~~rEieILk~L-rHPNIVkL~gsf 658 (837)
.....++|++.+.||+|+||+||+|++. .+++.||||+++..... .....+.+.+|+.+++.+ +||||+++++++
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 128 (355)
T 1vzo_A 49 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 128 (355)
T ss_dssp CCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred ccccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE
Confidence 3445678999999999999999999984 58999999999764321 122234567899999999 699999999999
Q ss_pred ecCCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccc
Q 003232 659 TCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (837)
Q Consensus 659 ~d~~~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArv 738 (837)
.....+|+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 129 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 129 QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 99999999999999999999998888899999999999999999999999999999999999999999999999999873
Q ss_pred cccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC--CCCCchHHHHHHHHHHHHHHcC
Q 003232 739 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG--TGHGTTADWWSVGIILFELIVG 816 (837)
Q Consensus 739 g~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg--~~~s~kSDIWSLGVILyELLTG 816 (837)
.... ........+||+.|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 209 ~~~~------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g 258 (355)
T 1vzo_A 209 FVAD------------------------------ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258 (355)
T ss_dssp CCGG------------------------------GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHS
T ss_pred cccC------------------------------CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHC
Confidence 1100 0111234579999999999986 4478999999999999999999
Q ss_pred CCCCCCCC
Q 003232 817 IPPFNAEH 824 (837)
Q Consensus 817 r~PF~~~d 824 (837)
+.||....
T Consensus 259 ~~pf~~~~ 266 (355)
T 1vzo_A 259 ASPFTVDG 266 (355)
T ss_dssp SCTTSCTT
T ss_pred CCCCccCC
Confidence 99997543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=312.61 Aligned_cols=210 Identities=22% Similarity=0.366 Sum_probs=163.1
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCCc---EEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGD---LFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE 662 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG~---~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~ 662 (837)
...++|++.+.||+|+||+||+|++..++. .||+|++..... .....+.+.+|+.+++.++||||+++++++....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-ASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc-CHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 334679999999999999999999877665 899999976432 3344678999999999999999999999998766
Q ss_pred eE------EEEEEecCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEE
Q 003232 663 NL------YLVMEYLNGGDLYSLLRNLG------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKL 730 (837)
Q Consensus 663 ~l------yLVmEy~~GGSL~dlLk~~g------~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKL 730 (837)
.. ++||||+.+++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEE
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEE
Confidence 54 99999999999999986432 5899999999999999999999999999999999999999999999
Q ss_pred EecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHH
Q 003232 731 TDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIIL 810 (837)
Q Consensus 731 iDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVIL 810 (837)
+|||+++...... .........||+.|+|||++.+..++.++|||||||++
T Consensus 179 ~Dfg~a~~~~~~~-----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 229 (323)
T 3qup_A 179 ADFGLSRKIYSGD-----------------------------YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTM 229 (323)
T ss_dssp CCCCC----------------------------------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred eeccccccccccc-----------------------------cccccccccCcccccCchhhcCCCCCCccchhhHHHHH
Confidence 9999986311000 00112234568889999999999999999999999999
Q ss_pred HHHHc-CCCCCCCCCc
Q 003232 811 FELIV-GIPPFNAEHP 825 (837)
Q Consensus 811 yELLT-Gr~PF~~~dp 825 (837)
|+|++ |..||.+.+.
T Consensus 230 ~ell~~g~~p~~~~~~ 245 (323)
T 3qup_A 230 WEIMTRGQTPYAGIEN 245 (323)
T ss_dssp HHHHTTSCCTTTTCCG
T ss_pred HHHHhCCCCCccccCh
Confidence 99999 9999987543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=302.66 Aligned_cols=206 Identities=24% Similarity=0.431 Sum_probs=177.2
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeE
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~l 664 (837)
....++|++.+.||+|+||+||+|.+. ++..||+|++...... .+.+.+|+.+++.++||||+++++++......
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI 78 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence 344577999999999999999999885 6778999999765422 24688999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCC
Q 003232 665 YLVMEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~g-~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~s 743 (837)
|+||||+++++|.+++...+ .+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 99999999999999997654 59999999999999999999999999999999999999999999999999987311000
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNA 822 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~~ 822 (837)
........||+.|+|||++.+..++.++||||||+++|+|++ |..||..
T Consensus 159 ------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 208 (268)
T 3sxs_A 159 ------------------------------YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDL 208 (268)
T ss_dssp ------------------------------EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred ------------------------------hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccc
Confidence 011123456788999999999889999999999999999999 9999976
Q ss_pred CCc
Q 003232 823 EHP 825 (837)
Q Consensus 823 ~dp 825 (837)
.+.
T Consensus 209 ~~~ 211 (268)
T 3sxs_A 209 YTN 211 (268)
T ss_dssp SCH
T ss_pred cCh
Confidence 543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-36 Score=317.34 Aligned_cols=212 Identities=19% Similarity=0.268 Sum_probs=171.3
Q ss_pred CCeEEEEEecccCceEEEEEEECCC-----CcEEEEEEecccccccHH--------HHHHHHHHHHHHHhcCCCceEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTT-----GDLFAIKVLKKADMIRKN--------AVESILAERDILISVRNPFVVRFF 655 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~t-----G~~VAVKIikk~~~~~~e--------~ie~~~rEieILk~LrHPNIVkL~ 655 (837)
++|++.+.||+|+||+||+|.+..+ ++.||+|++......... ....+..|+..+..++||||++++
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~ 114 (364)
T 3op5_A 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW 114 (364)
T ss_dssp CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence 4799999999999999999999764 588999998764311110 112344566677788999999999
Q ss_pred eEeecC----CeEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEc--cCCcE
Q 003232 656 YSFTCR----ENLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA--HDGHI 728 (837)
Q Consensus 656 gsf~d~----~~lyLVmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd--~dG~I 728 (837)
+++... .+.|+||||+ |++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~ 193 (364)
T 3op5_A 115 GSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQV 193 (364)
T ss_dssp EEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCE
T ss_pred eeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeE
Confidence 998764 5689999999 99999999775 6799999999999999999999999999999999999998 88999
Q ss_pred EEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHH
Q 003232 729 KLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGI 808 (837)
Q Consensus 729 KLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGV 808 (837)
||+|||+++........... .........||+.|+|||++.+..++.++|||||||
T Consensus 194 kl~DFG~a~~~~~~~~~~~~------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 249 (364)
T 3op5_A 194 YLVDYGLAYRYCPEGVHKAY------------------------AADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGY 249 (364)
T ss_dssp EECCCTTCEESSGGGCCCCS------------------------SCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHH
T ss_pred EEEECCcceecccCCccccc------------------------ccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHH
Confidence 99999999742211111000 001123456999999999999999999999999999
Q ss_pred HHHHHHcCCCCCCCCCc
Q 003232 809 ILFELIVGIPPFNAEHP 825 (837)
Q Consensus 809 ILyELLTGr~PF~~~dp 825 (837)
++|+|++|+.||.+...
T Consensus 250 ~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 250 CMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp HHHHHHHSCCTTGGGTT
T ss_pred HHHHHHhCCCCcccccc
Confidence 99999999999986443
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=302.92 Aligned_cols=207 Identities=25% Similarity=0.405 Sum_probs=175.7
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHH----HHHHHHHHHHHHhcCCCceEEEEeEeecC
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNA----VESILAERDILISVRNPFVVRFFYSFTCR 661 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~----ie~~~rEieILk~LrHPNIVkL~gsf~d~ 661 (837)
...++|++.+.||.|+||+||+|++..+++.||+|++.......... .+.+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 34567999999999999999999999999999999997544322222 16789999999999999999999998765
Q ss_pred CeEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCCCCcEEEccCCc-----EEEEec
Q 003232 662 ENLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLR--VVHRDLKPDNLLIAHDGH-----IKLTDF 733 (837)
Q Consensus 662 ~~lyLVmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkG--IIHRDIKPeNILLd~dG~-----IKLiDF 733 (837)
. ++||||+++++|.+++... ..+++..+..++.||+.||.|||++| |+||||||+|||++.++. ++|+||
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 5 6999999999999888654 46999999999999999999999999 999999999999988776 999999
Q ss_pred CCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhc--CCCCCchHHHHHHHHHHH
Q 003232 734 GLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL--GTGHGTTADWWSVGIILF 811 (837)
Q Consensus 734 GLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLl--g~~~s~kSDIWSLGVILy 811 (837)
|+++... .......||+.|+|||++. +..++.++|||||||++|
T Consensus 174 g~~~~~~----------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~ 219 (287)
T 4f0f_A 174 GLSQQSV----------------------------------HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILY 219 (287)
T ss_dssp TTCBCCS----------------------------------SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHH
T ss_pred Ccccccc----------------------------------ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHH
Confidence 9986210 0122457999999999984 456789999999999999
Q ss_pred HHHcCCCCCCCCCcCHH
Q 003232 812 ELIVGIPPFNAEHPQVS 828 (837)
Q Consensus 812 ELLTGr~PF~~~dpdv~ 828 (837)
+|++|+.||........
T Consensus 220 ~l~~g~~pf~~~~~~~~ 236 (287)
T 4f0f_A 220 TILTGEGPFDEYSYGKI 236 (287)
T ss_dssp HHHHSSCTTTTCCCCHH
T ss_pred HHHcCCCCCccccccHH
Confidence 99999999987665543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=323.40 Aligned_cols=199 Identities=27% Similarity=0.501 Sum_probs=173.7
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEeEeecCCeEE
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLY 665 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~gsf~d~~~ly 665 (837)
..++|++.+.||.|+||.||+|+++.+++.||+|++..... ...+|+.++.++ +||||+++++++.+...+|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~ 92 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVY 92 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEE
Confidence 34679999999999999999999999999999999976532 234677888777 7999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccC----CcEEEEecCCcccccc
Q 003232 666 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD----GHIKLTDFGLSKVGLI 741 (837)
Q Consensus 666 LVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~d----G~IKLiDFGLArvg~~ 741 (837)
+||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+... +.+||+|||+++....
T Consensus 93 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 93 VVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp EEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 999999999999999988889999999999999999999999999999999999998543 3599999999873110
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCC
Q 003232 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFN 821 (837)
Q Consensus 742 ~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~ 821 (837)
.. ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 173 ~~-------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~ 221 (342)
T 2qr7_A 173 EN-------------------------------GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFA 221 (342)
T ss_dssp TT-------------------------------CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CC-------------------------------CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCC
Confidence 00 11234578999999999998889999999999999999999999998
Q ss_pred CC
Q 003232 822 AE 823 (837)
Q Consensus 822 ~~ 823 (837)
..
T Consensus 222 ~~ 223 (342)
T 2qr7_A 222 NG 223 (342)
T ss_dssp SS
T ss_pred CC
Confidence 64
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=300.73 Aligned_cols=203 Identities=19% Similarity=0.336 Sum_probs=176.3
Q ss_pred CCcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecC--
Q 003232 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR-- 661 (837)
Q Consensus 584 ~g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~-- 661 (837)
.+...++|++.+.||.|+||+||+|++. ++.||+|++.... ......+.+.+|+.+++.++||||+++++++...
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 81 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRD-WSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA 81 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTT-CCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTS
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCC
Confidence 3456678999999999999999999984 8899999998654 2344557799999999999999999999999887
Q ss_pred CeEEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--cccccCCCCcEEEccCCcEEEEecCCcc
Q 003232 662 ENLYLVMEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLR--VVHRDLKPDNLLIAHDGHIKLTDFGLSK 737 (837)
Q Consensus 662 ~~lyLVmEy~~GGSL~dlLk~~g--~Lsee~irkIl~QIa~ALsYLHSkG--IIHRDIKPeNILLd~dG~IKLiDFGLAr 737 (837)
...++||||+++++|.+++.... .+++..+..++.||+.||.|||++| ++||||||+|||++.++.++|+|||++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~ 161 (271)
T 3kmu_A 82 PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF 161 (271)
T ss_dssp SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEecccee
Confidence 78999999999999999998765 4899999999999999999999999 9999999999999999999999998764
Q ss_pred ccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCc---hHHHHHHHHHHHHHH
Q 003232 738 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT---TADWWSVGIILFELI 814 (837)
Q Consensus 738 vg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~---kSDIWSLGVILyELL 814 (837)
. .......||+.|+|||++.+..++. ++||||||+++|+|+
T Consensus 162 ~------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~ 205 (271)
T 3kmu_A 162 S------------------------------------FQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELV 205 (271)
T ss_dssp T------------------------------------TSCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHH
T ss_pred e------------------------------------ecccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHH
Confidence 1 0012346889999999998765544 799999999999999
Q ss_pred cCCCCCCCCCc
Q 003232 815 VGIPPFNAEHP 825 (837)
Q Consensus 815 TGr~PF~~~dp 825 (837)
+|..||...+.
T Consensus 206 ~g~~p~~~~~~ 216 (271)
T 3kmu_A 206 TREVPFADLSN 216 (271)
T ss_dssp HCSCTTTTSCH
T ss_pred hCCCCccccCh
Confidence 99999976543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=323.64 Aligned_cols=209 Identities=23% Similarity=0.363 Sum_probs=176.3
Q ss_pred cccCCeEEEEEecccCceEEEEEEE-----CCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeec
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKK-----RTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC 660 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArd-----k~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d 660 (837)
...++|++.+.||+|+||+||+|++ ..+++.||||+++... .......+.+|+.+++.++||||+++++++..
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 145 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 145 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 3456799999999999999999994 4567899999997532 34445678899999999999999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCC---cEEE
Q 003232 661 RENLYLVMEYLNGGDLYSLLRNLG-------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG---HIKL 730 (837)
Q Consensus 661 ~~~lyLVmEy~~GGSL~dlLk~~g-------~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG---~IKL 730 (837)
....|+||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+| .+||
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEE
Confidence 999999999999999999997643 489999999999999999999999999999999999998555 5999
Q ss_pred EecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHH
Q 003232 731 TDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIIL 810 (837)
Q Consensus 731 iDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVIL 810 (837)
+|||+++...... .........||+.|+|||++.+..++.++|||||||++
T Consensus 226 ~DFG~a~~~~~~~-----------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il 276 (367)
T 3l9p_A 226 GDFGMARDIYRAG-----------------------------YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLL 276 (367)
T ss_dssp CCCHHHHHHHHHS-----------------------------SCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred CCCcccccccccc-----------------------------ccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHH
Confidence 9999986311000 00112345688999999999999999999999999999
Q ss_pred HHHHc-CCCCCCCCCc
Q 003232 811 FELIV-GIPPFNAEHP 825 (837)
Q Consensus 811 yELLT-Gr~PF~~~dp 825 (837)
|+|++ |..||...+.
T Consensus 277 ~ellt~g~~pf~~~~~ 292 (367)
T 3l9p_A 277 WEIFSLGYMPYPSKSN 292 (367)
T ss_dssp HHHHTTSCCSSTTCCH
T ss_pred HHHHhCCCCCCCCCCH
Confidence 99998 9999987553
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-36 Score=326.35 Aligned_cols=223 Identities=27% Similarity=0.443 Sum_probs=173.2
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecC----
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR---- 661 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~---- 661 (837)
...++|++.+.||+|+||+||+|+++.+++.||||++.... ......+.+.+|+.+++.++||||+++++++...
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 101 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLK 101 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCc
Confidence 34578999999999999999999999999999999997643 3445567899999999999999999999999776
Q ss_pred -CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccc
Q 003232 662 -ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740 (837)
Q Consensus 662 -~~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~ 740 (837)
..+|+||||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 102 ~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 102 FDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp CCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred CCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 57999999985 6999999988889999999999999999999999999999999999999999999999999998522
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhh-cCCCCCchHHHHHHHHHHHHHHcCCCC
Q 003232 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEIL-LGTGHGTTADWWSVGIILFELIVGIPP 819 (837)
Q Consensus 741 ~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVL-lg~~~s~kSDIWSLGVILyELLTGr~P 819 (837)
........... ....................+||+.|+|||++ .+..++.++|||||||++|||++|..|
T Consensus 181 ~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p 251 (432)
T 3n9x_A 181 SEKDTNIVNDL---------EENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251 (432)
T ss_dssp ---------------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTT
T ss_pred ccccccccccc---------cccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccc
Confidence 11110000000 00000000000111234577899999999996 456799999999999999999984333
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=308.31 Aligned_cols=212 Identities=26% Similarity=0.370 Sum_probs=180.9
Q ss_pred CCcccCCeEEEEEecccCceEEEEEEE-----CCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEeE
Q 003232 584 DRTSIDDFEIIKPISRGAFGRVFLAKK-----RTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYS 657 (837)
Q Consensus 584 ~g~~lddYeIlkkLGsG~FGtVYkArd-----k~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~gs 657 (837)
+....++|++.+.||.|+||+||+|++ ..+++.||+|++.... .....+.+.+|+.+++.+ +||||++++++
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 95 (313)
T 1t46_A 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (313)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence 344557899999999999999999985 4567899999997653 234457899999999999 99999999999
Q ss_pred eecCCeEEEEEEecCCCCHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCc
Q 003232 658 FTCRENLYLVMEYLNGGDLYSLLRNLG------------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDN 719 (837)
Q Consensus 658 f~d~~~lyLVmEy~~GGSL~dlLk~~g------------------~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeN 719 (837)
+......++||||+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N 175 (313)
T 1t46_A 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (313)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccce
Confidence 999999999999999999999997653 48999999999999999999999999999999999
Q ss_pred EEEccCCcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCc
Q 003232 720 LLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT 799 (837)
Q Consensus 720 ILLd~dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~ 799 (837)
||++.++.++|+|||++........ ........||+.|+|||++.+..++.
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~ 226 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSN-----------------------------YVVKGNARLPVKWMAPESIFNCVYTF 226 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTT-----------------------------SEECSSSEECGGGCCHHHHHHCCCCH
T ss_pred EEEcCCCCEEEcccccccccccccc-----------------------------ceeccCCCCcceeeChHHhcCCCCCh
Confidence 9999999999999999863111000 00122345788899999999999999
Q ss_pred hHHHHHHHHHHHHHHc-CCCCCCCCCcC
Q 003232 800 TADWWSVGIILFELIV-GIPPFNAEHPQ 826 (837)
Q Consensus 800 kSDIWSLGVILyELLT-Gr~PF~~~dpd 826 (837)
++||||||+++|+|++ |..||......
T Consensus 227 ~~Di~slG~il~ellt~g~~p~~~~~~~ 254 (313)
T 1t46_A 227 ESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (313)
T ss_dssp HHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence 9999999999999998 99999876544
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=305.19 Aligned_cols=209 Identities=24% Similarity=0.410 Sum_probs=181.9
Q ss_pred CCCcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC
Q 003232 583 KDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE 662 (837)
Q Consensus 583 k~g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~ 662 (837)
.+....++|++.+.||+|+||+||+|.+..++..||+|++.... ...+.+.+|+.+++.++||||+++++++....
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 82 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 82 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS----THHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 34556678999999999999999999999999999999997643 34567889999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccc
Q 003232 663 NLYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740 (837)
Q Consensus 663 ~lyLVmEy~~GGSL~dlLk~~--g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~ 740 (837)
.+|+||||+.|++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++....
T Consensus 83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 999999999999999999864 449999999999999999999999999999999999999999999999999987411
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCC
Q 003232 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPP 819 (837)
Q Consensus 741 ~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~P 819 (837)
.... .......||+.|+|||++.+..++.++||||||+++|+|++ |..|
T Consensus 163 ~~~~------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p 212 (288)
T 3kfa_A 163 GDTY------------------------------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212 (288)
T ss_dssp SSSS------------------------------EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred CCcc------------------------------ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 1000 01123456788999999999999999999999999999999 9999
Q ss_pred CCCCCc
Q 003232 820 FNAEHP 825 (837)
Q Consensus 820 F~~~dp 825 (837)
|...+.
T Consensus 213 ~~~~~~ 218 (288)
T 3kfa_A 213 YPGIDL 218 (288)
T ss_dssp STTCCG
T ss_pred CCCCCH
Confidence 987553
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=301.94 Aligned_cols=207 Identities=29% Similarity=0.459 Sum_probs=164.9
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEE
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 665 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ly 665 (837)
...++|++.+.||+|+||+||+|++..+++.||+|++.... ........+..+...++.++||||+++++++......|
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~ 82 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV-NSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW 82 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC----CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeeccc-CcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence 45578999999999999999999999999999999997643 22333344555555678899999999999999999999
Q ss_pred EEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCcEEEccCCcEEEEecCCccccc
Q 003232 666 LVMEYLNGGDLYSLLRN----LGCLDEDVARVYIAEVVLALEYLHSL-RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740 (837)
Q Consensus 666 LVmEy~~GGSL~dlLk~----~g~Lsee~irkIl~QIa~ALsYLHSk-GIIHRDIKPeNILLd~dG~IKLiDFGLArvg~ 740 (837)
+||||++ ++|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.++|+|||++....
T Consensus 83 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 83 ICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred EEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9999997 588777643 46799999999999999999999997 99999999999999999999999999986310
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhh----cCCCCCchHHHHHHHHHHHHHHcC
Q 003232 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEIL----LGTGHGTTADWWSVGIILFELIVG 816 (837)
Q Consensus 741 ~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVL----lg~~~s~kSDIWSLGVILyELLTG 816 (837)
. ........||+.|+|||++ .+..++.++||||||+++|+|++|
T Consensus 162 ~--------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g 209 (290)
T 3fme_A 162 D--------------------------------DVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAIL 209 (290)
T ss_dssp ----------------------------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHT
T ss_pred c--------------------------------cccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHC
Confidence 0 0111234699999999996 566789999999999999999999
Q ss_pred CCCCCCCCcC
Q 003232 817 IPPFNAEHPQ 826 (837)
Q Consensus 817 r~PF~~~dpd 826 (837)
..||......
T Consensus 210 ~~p~~~~~~~ 219 (290)
T 3fme_A 210 RFPYDSWGTP 219 (290)
T ss_dssp SCSSCCCSCH
T ss_pred CCCccccCch
Confidence 9999764433
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=317.72 Aligned_cols=204 Identities=30% Similarity=0.539 Sum_probs=169.7
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLV 667 (837)
+++|++++.||+|+||+||+|++..+++.||+|++..... ......+.+|+.+++.++||||+++++++.....+|+|
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 78 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence 3679999999999999999999999999999999975431 11122455799999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCC
Q 003232 668 MEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (837)
Q Consensus 668 mEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stdd 746 (837)
|||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.....
T Consensus 79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~---- 153 (324)
T 3mtl_A 79 FEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP---- 153 (324)
T ss_dssp EECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred ecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCC----
Confidence 99996 5899888764 45999999999999999999999999999999999999999999999999998631100
Q ss_pred CCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 747 l~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.
T Consensus 154 ---------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 206 (324)
T 3mtl_A 154 ---------------------------TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV 206 (324)
T ss_dssp ------------------------------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ---------------------------ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 011223468999999999987 5689999999999999999999999987653
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=321.98 Aligned_cols=205 Identities=29% Similarity=0.494 Sum_probs=179.0
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEeccccccc-----HHHHHHHHHHHHHHHhcCCCceEEEEeEeec
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIR-----KNAVESILAERDILISVRNPFVVRFFYSFTC 660 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~-----~e~ie~~~rEieILk~LrHPNIVkL~gsf~d 660 (837)
...++|++++.||.|+||+||+|+++.+++.||+|++....... ......+.+|+.+++.++||||+++++++..
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 34567999999999999999999999999999999997653211 1133456789999999999999999999999
Q ss_pred CCeEEEEEEecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCcccc
Q 003232 661 RENLYLVMEYLNGG-DLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 739 (837)
Q Consensus 661 ~~~lyLVmEy~~GG-SL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg 739 (837)
...+++||||+.+| +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence 99999999999766 99999998888999999999999999999999999999999999999999999999999998731
Q ss_pred ccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCC-CchHHHHHHHHHHHHHHcCCC
Q 003232 740 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVGIP 818 (837)
Q Consensus 740 ~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~-s~kSDIWSLGVILyELLTGr~ 818 (837)
... .......||+.|+|||++.+..+ +.++|||||||++|+|++|..
T Consensus 181 ~~~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~ 228 (335)
T 3dls_A 181 ERG--------------------------------KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEEN 228 (335)
T ss_dssp CTT--------------------------------CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSC
T ss_pred CCC--------------------------------CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCC
Confidence 100 01123569999999999998887 889999999999999999999
Q ss_pred CCCC
Q 003232 819 PFNA 822 (837)
Q Consensus 819 PF~~ 822 (837)
||..
T Consensus 229 pf~~ 232 (335)
T 3dls_A 229 PFCE 232 (335)
T ss_dssp SCSS
T ss_pred chhh
Confidence 9965
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=322.45 Aligned_cols=202 Identities=32% Similarity=0.496 Sum_probs=172.0
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC---
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE--- 662 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~--- 662 (837)
...++|++++.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+++.++||||+++++++....
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 100 (367)
T 1cm8_A 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD 100 (367)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccc
Confidence 34567999999999999999999999999999999996543 33455678999999999999999999999997653
Q ss_pred ---eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCcccc
Q 003232 663 ---NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 739 (837)
Q Consensus 663 ---~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg 739 (837)
.+|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 101 ~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 101 DFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp TCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred cCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 469999999 8899999877 67999999999999999999999999999999999999999999999999998731
Q ss_pred ccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCC
Q 003232 740 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIP 818 (837)
Q Consensus 740 ~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLTGr~ 818 (837)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.
T Consensus 179 ~~----------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 224 (367)
T 1cm8_A 179 DS----------------------------------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 224 (367)
T ss_dssp CS----------------------------------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred cc----------------------------------ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCC
Confidence 00 1124578999999999987 778999999999999999999999
Q ss_pred CCCCCC
Q 003232 819 PFNAEH 824 (837)
Q Consensus 819 PF~~~d 824 (837)
||.+.+
T Consensus 225 pf~~~~ 230 (367)
T 1cm8_A 225 LFKGSD 230 (367)
T ss_dssp SSCCSS
T ss_pred CCCCCC
Confidence 998755
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=317.29 Aligned_cols=200 Identities=30% Similarity=0.488 Sum_probs=177.3
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVm 668 (837)
+.|++++.||+|+||+||+|++..+++.||||++...........+.+.+|+.+++.++||||+++++++......|+||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 45999999999999999999999999999999997654445556678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCC
Q 003232 669 EYLNGGDLYSLLR-NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (837)
Q Consensus 669 Ey~~GGSL~dlLk-~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl 747 (837)
||+. |+|.+++. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~------- 205 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------- 205 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS-------
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecC-------
Confidence 9997 68888775 45679999999999999999999999999999999999999999999999999986310
Q ss_pred CCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhc---CCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL---GTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 748 ~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLl---g~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
......||+.|+|||++. +..++.++|||||||++|+|++|+.||...+
T Consensus 206 ----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 257 (348)
T 1u5q_A 206 ----------------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 257 (348)
T ss_dssp ----------------------------SBCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ----------------------------CCCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 012357899999999985 5678999999999999999999999997654
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=302.74 Aligned_cols=207 Identities=32% Similarity=0.535 Sum_probs=180.1
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEeccccc------ccHHHHHHHHHHHHHHHhcC-CCceEEEEeEe
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADM------IRKNAVESILAERDILISVR-NPFVVRFFYSF 658 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~------~~~e~ie~~~rEieILk~Lr-HPNIVkL~gsf 658 (837)
...++|++.+.||.|+||.||+|+++.+++.||+|++..... ......+.+.+|+.+++.+. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 345789999999999999999999999999999999975431 11234567889999999995 99999999999
Q ss_pred ecCCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccc
Q 003232 659 TCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (837)
Q Consensus 659 ~d~~~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArv 738 (837)
......|+||||+++++|.+++.....+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred ccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence 99999999999999999999998888899999999999999999999999999999999999999999999999999863
Q ss_pred cccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhc------CCCCCchHHHHHHHHHHHH
Q 003232 739 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL------GTGHGTTADWWSVGIILFE 812 (837)
Q Consensus 739 g~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLl------g~~~s~kSDIWSLGVILyE 812 (837)
.... .......||+.|+|||++. ...++.++||||||+++|+
T Consensus 174 ~~~~--------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~ 221 (298)
T 1phk_A 174 LDPG--------------------------------EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYT 221 (298)
T ss_dssp CCTT--------------------------------CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHH
T ss_pred cCCC--------------------------------cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHH
Confidence 1100 0122456899999999985 4567899999999999999
Q ss_pred HHcCCCCCCCCC
Q 003232 813 LIVGIPPFNAEH 824 (837)
Q Consensus 813 LLTGr~PF~~~d 824 (837)
|++|..||...+
T Consensus 222 l~~g~~p~~~~~ 233 (298)
T 1phk_A 222 LLAGSPPFWHRK 233 (298)
T ss_dssp HHHSSCSSCCSS
T ss_pred HHHCCCCCcCcc
Confidence 999999997654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=315.20 Aligned_cols=212 Identities=27% Similarity=0.416 Sum_probs=177.8
Q ss_pred CCcccCCeEEEEEecccCceEEEEEEEC-----CCCcEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEeE
Q 003232 584 DRTSIDDFEIIKPISRGAFGRVFLAKKR-----TTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYS 657 (837)
Q Consensus 584 ~g~~lddYeIlkkLGsG~FGtVYkArdk-----~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~gs 657 (837)
+....++|++.+.||.|+||+||+|++. .++..||+|++.... .....+.+.+|+.+++.+ +||||++++++
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 117 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGA 117 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 4455678999999999999999999973 356789999997542 233446789999999999 89999999999
Q ss_pred eecCCeEEEEEEecCCCCHHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCccccc
Q 003232 658 FTCRENLYLVMEYLNGGDLYSLLRNLG-----------------------CLDEDVARVYIAEVVLALEYLHSLRVVHRD 714 (837)
Q Consensus 658 f~d~~~lyLVmEy~~GGSL~dlLk~~g-----------------------~Lsee~irkIl~QIa~ALsYLHSkGIIHRD 714 (837)
+......|+||||+++++|.+++.... .+++..+..++.||+.||.|||++||+|||
T Consensus 118 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D 197 (344)
T 1rjb_A 118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 197 (344)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred EeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 999999999999999999999997643 278999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC
Q 003232 715 LKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG 794 (837)
Q Consensus 715 IKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg 794 (837)
|||+|||++.++.++|+|||++........ ........||+.|+|||++.+
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-----------------------------~~~~~~~~~t~~y~aPE~~~~ 248 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSN-----------------------------YVVRGNARLPVKWMAPESLFE 248 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTT-----------------------------SEEETTEEECGGGCCHHHHHH
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCcc-----------------------------ceeccCccCccCccCHHHhcc
Confidence 999999999999999999999873211100 011223457889999999999
Q ss_pred CCCCchHHHHHHHHHHHHHHc-CCCCCCCCCcC
Q 003232 795 TGHGTTADWWSVGIILFELIV-GIPPFNAEHPQ 826 (837)
Q Consensus 795 ~~~s~kSDIWSLGVILyELLT-Gr~PF~~~dpd 826 (837)
..++.++||||||+++|+|++ |..||......
T Consensus 249 ~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 281 (344)
T 1rjb_A 249 GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 281 (344)
T ss_dssp CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred CCCChhHhHHHHHHHHHHHHcCCCCCcccCCcH
Confidence 999999999999999999998 99999876644
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-36 Score=309.41 Aligned_cols=215 Identities=24% Similarity=0.368 Sum_probs=182.3
Q ss_pred CCCCCCCcccCCeEEEEEecccCceEEEEEEEC-----CCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEE
Q 003232 579 IHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKR-----TTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVR 653 (837)
Q Consensus 579 ~~P~k~g~~lddYeIlkkLGsG~FGtVYkArdk-----~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVk 653 (837)
+.+..+....++|++.+.||.|+||.||+|.+. .+++.||+|++.... .......+.+|+.+++.++||||++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~ 92 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVR 92 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCC
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEee
Confidence 344556666788999999999999999999886 357889999997543 2344567899999999999999999
Q ss_pred EEeEeecCCeEEEEEEecCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEc
Q 003232 654 FFYSFTCRENLYLVMEYLNGGDLYSLLRNL----------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA 723 (837)
Q Consensus 654 L~gsf~d~~~lyLVmEy~~GGSL~dlLk~~----------g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd 723 (837)
+++++......|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 93 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~ 172 (322)
T 1p4o_A 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA 172 (322)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEEC
T ss_pred eEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEc
Confidence 999999999999999999999999998653 3578999999999999999999999999999999999999
Q ss_pred cCCcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHH
Q 003232 724 HDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADW 803 (837)
Q Consensus 724 ~dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDI 803 (837)
.++.++|+|||+++...... .........||+.|+|||++.+..++.++||
T Consensus 173 ~~~~~kl~Dfg~~~~~~~~~-----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 223 (322)
T 1p4o_A 173 EDFTVKIGDFGMTRDIYETD-----------------------------YYRKGGKGLLPVRWMSPESLKDGVFTTYSDV 223 (322)
T ss_dssp TTCCEEECCTTCCCGGGGGG-----------------------------CEEGGGSSEECGGGCCHHHHHHCCCCHHHHH
T ss_pred CCCeEEECcCcccccccccc-----------------------------ccccccCCCCCCCccChhhhccCCCCchhhH
Confidence 99999999999986311000 0011234467889999999999999999999
Q ss_pred HHHHHHHHHHHc-CCCCCCCCC
Q 003232 804 WSVGIILFELIV-GIPPFNAEH 824 (837)
Q Consensus 804 WSLGVILyELLT-Gr~PF~~~d 824 (837)
||||+++|+|++ |..||...+
T Consensus 224 ~slG~il~el~~~g~~p~~~~~ 245 (322)
T 1p4o_A 224 WSFGVVLWEIATLAEQPYQGLS 245 (322)
T ss_dssp HHHHHHHHHHHHTSCCTTTTSC
T ss_pred HHHHHHHHHHHhcCCCccccCC
Confidence 999999999999 899997654
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=305.62 Aligned_cols=198 Identities=23% Similarity=0.380 Sum_probs=171.0
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCC-------cEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEee
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTG-------DLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFT 659 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG-------~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~ 659 (837)
..++|++.+.||+|+||+||+|++..++ ..||+|++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 82 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGVCV 82 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEEEC
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence 4467999999999999999999998777 479999997543 334467899999999999999999999999
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCc--------EEE
Q 003232 660 CRENLYLVMEYLNGGDLYSLLRNLGC-LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGH--------IKL 730 (837)
Q Consensus 660 d~~~lyLVmEy~~GGSL~dlLk~~g~-Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~--------IKL 730 (837)
.....|+||||+.|++|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++.++. ++|
T Consensus 83 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 83 CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp CTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred eCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeee
Confidence 99999999999999999999987554 999999999999999999999999999999999999998887 999
Q ss_pred EecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHH
Q 003232 731 TDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGII 809 (837)
Q Consensus 731 iDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVI 809 (837)
+|||++.... ......||+.|+|||++.+ ..++.++||||||++
T Consensus 163 ~Dfg~~~~~~-----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i 207 (289)
T 4fvq_A 163 SDPGISITVL-----------------------------------PKDILQERIPWVPPECIENPKNLNLATDKWSFGTT 207 (289)
T ss_dssp CCCCSCTTTS-----------------------------------CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHH
T ss_pred ccCccccccc-----------------------------------CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHH
Confidence 9999886200 0011236788999999988 778999999999999
Q ss_pred HHHHHcCC-CCCCC
Q 003232 810 LFELIVGI-PPFNA 822 (837)
Q Consensus 810 LyELLTGr-~PF~~ 822 (837)
+|+|++|. +||..
T Consensus 208 l~el~~g~~~~~~~ 221 (289)
T 4fvq_A 208 LWEICSGGDKPLSA 221 (289)
T ss_dssp HHHHHTTTCCTTTT
T ss_pred HHHHHcCCCCCccc
Confidence 99999954 55544
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=329.80 Aligned_cols=202 Identities=16% Similarity=0.196 Sum_probs=166.5
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHH---HHHhcCCCceEEEE-------e
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERD---ILISVRNPFVVRFF-------Y 656 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEie---ILk~LrHPNIVkL~-------g 656 (837)
..++|++.+.||+|+||+||+|++..+|+.||||++...........+.+.+|+. +++.++||||++++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 3467999999999999999999999999999999998654444556678899994 55556899999988 5
Q ss_pred EeecCC-----------------eEEEEEEecCCCCHHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHhCCccc
Q 003232 657 SFTCRE-----------------NLYLVMEYLNGGDLYSLLRNLGCLDE-------DVARVYIAEVVLALEYLHSLRVVH 712 (837)
Q Consensus 657 sf~d~~-----------------~lyLVmEy~~GGSL~dlLk~~g~Lse-------e~irkIl~QIa~ALsYLHSkGIIH 712 (837)
++...+ ..|+||||+ +|+|.+++...+.+++ ..+..++.||+.||.|||++||+|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH 229 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 229 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 554442 389999999 6899999986555555 778889999999999999999999
Q ss_pred ccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhh
Q 003232 713 RDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEIL 792 (837)
Q Consensus 713 RDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVL 792 (837)
|||||+|||++.++.+||+|||+++.. .......+| +.|+|||++
T Consensus 230 rDikp~NIll~~~~~~kL~DFG~a~~~----------------------------------~~~~~~~~g-~~y~aPE~~ 274 (377)
T 3byv_A 230 TYLRPVDIVLDQRGGVFLTGFEHLVRD----------------------------------GARVVSSVS-RGFEPPELE 274 (377)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEET----------------------------------TCEEECCCC-TTCCCHHHH
T ss_pred CCCCHHHEEEcCCCCEEEEechhheec----------------------------------CCcccCCCC-cCccChhhh
Confidence 999999999999999999999998720 001234567 999999999
Q ss_pred cCC-----------CCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 793 LGT-----------GHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 793 lg~-----------~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
.+. .++.++|||||||++|+|++|+.||...+
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~ 317 (377)
T 3byv_A 275 ARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDA 317 (377)
T ss_dssp HHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred cccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccc
Confidence 887 89999999999999999999999997643
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=317.16 Aligned_cols=203 Identities=29% Similarity=0.447 Sum_probs=170.7
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC----
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE---- 662 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~---- 662 (837)
..++|++++.||+|+||+||+|++..+++.||||++.... ........+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence 4578999999999999999999999999999999997643 33455677899999999999999999999997654
Q ss_pred --eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccc
Q 003232 663 --NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740 (837)
Q Consensus 663 --~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~ 740 (837)
.+|+||||+. ++|.+++. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 102 ~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 102 FQDVYIVMELMD-ANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp CCEEEEEEECCS-EEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred ccceEEEEEcCC-CCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 7899999996 57888875 458999999999999999999999999999999999999999999999999986310
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCC
Q 003232 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820 (837)
Q Consensus 741 ~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF 820 (837)
. ........||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 179 ~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf 226 (371)
T 2xrw_A 179 T--------------------------------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 226 (371)
T ss_dssp -------------------------------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred c--------------------------------ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCC
Confidence 0 00122457899999999999999999999999999999999999999
Q ss_pred CCCCc
Q 003232 821 NAEHP 825 (837)
Q Consensus 821 ~~~dp 825 (837)
.+.+.
T Consensus 227 ~~~~~ 231 (371)
T 2xrw_A 227 PGTDH 231 (371)
T ss_dssp CCSSH
T ss_pred CCCCH
Confidence 87653
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=307.66 Aligned_cols=204 Identities=29% Similarity=0.504 Sum_probs=176.8
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcC-CCceEEEEeEeec--CCeE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTC--RENL 664 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~Lr-HPNIVkL~gsf~d--~~~l 664 (837)
.++|++.+.||+|+||+||+|++..+++.||+|++.... .+.+.+|+.+++.++ ||||+++++++.. ....
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence 467999999999999999999999999999999997532 246889999999997 9999999999987 6789
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCC-cEEEEecCCccccccCC
Q 003232 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG-HIKLTDFGLSKVGLINS 743 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG-~IKLiDFGLArvg~~~s 743 (837)
++||||+.+++|.+++.. +++..++.++.||+.||.|||++||+||||||+|||++.++ .++|+|||+++.....
T Consensus 109 ~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~- 184 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG- 184 (330)
T ss_dssp EEEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT-
T ss_pred EEEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC-
Confidence 999999999999998753 89999999999999999999999999999999999999776 8999999998731100
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNA 822 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLTGr~PF~~ 822 (837)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|..||..
T Consensus 185 -------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~ 233 (330)
T 3nsz_A 185 -------------------------------QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 233 (330)
T ss_dssp -------------------------------CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred -------------------------------CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 01224578999999999987 6789999999999999999999999977
Q ss_pred CCcCHHHHHH
Q 003232 823 EHPQVSTLLR 832 (837)
Q Consensus 823 ~dpdv~~lle 832 (837)
.......+..
T Consensus 234 ~~~~~~~l~~ 243 (330)
T 3nsz_A 234 GHDNYDQLVR 243 (330)
T ss_dssp CSSHHHHHHH
T ss_pred CCchHHHHHH
Confidence 6665554443
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-36 Score=304.34 Aligned_cols=208 Identities=26% Similarity=0.408 Sum_probs=168.6
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCC---CcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecC
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTT---GDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR 661 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~t---G~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~ 661 (837)
....++|++.+.||+|+||+||+|++..+ +..||+|++.... .....+.+.+|+.+++.++||||+++++++. .
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 87 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 87 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-c
Confidence 34457799999999999999999998654 4579999987542 3445678999999999999999999999874 5
Q ss_pred CeEEEEEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccc
Q 003232 662 ENLYLVMEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740 (837)
Q Consensus 662 ~~lyLVmEy~~GGSL~dlLk~~g-~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~ 740 (837)
+..|+||||+.+++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++...
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 88 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccC
Confidence 67899999999999999997654 69999999999999999999999999999999999999999999999999987311
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCC
Q 003232 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPP 819 (837)
Q Consensus 741 ~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~P 819 (837)
... ........+|+.|+|||++.+..++.++||||||+++|+|++ |..|
T Consensus 168 ~~~------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p 217 (281)
T 1mp8_A 168 DST------------------------------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 217 (281)
T ss_dssp -----------------------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCT
T ss_pred ccc------------------------------ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCC
Confidence 000 001123457789999999999999999999999999999996 9999
Q ss_pred CCCCCc
Q 003232 820 FNAEHP 825 (837)
Q Consensus 820 F~~~dp 825 (837)
|.....
T Consensus 218 f~~~~~ 223 (281)
T 1mp8_A 218 FQGVKN 223 (281)
T ss_dssp TTTCCG
T ss_pred CCcCCH
Confidence 987554
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-36 Score=301.34 Aligned_cols=204 Identities=28% Similarity=0.491 Sum_probs=167.0
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEeccccccc-HHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeE
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIR-KNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~-~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~l 664 (837)
...++|++.+.||+|+||+||+|.+. +..||+|++....... ....+.+.+|+.+++.++||||+++++++......
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL 81 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred cchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 34578999999999999999999974 8899999987643222 23346788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCCCCcEEEcc--------CCcEEEEec
Q 003232 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLR---VVHRDLKPDNLLIAH--------DGHIKLTDF 733 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkG---IIHRDIKPeNILLd~--------dG~IKLiDF 733 (837)
|+||||+++++|.+++.. +.+++..+..++.||+.||.|||++| |+||||||+|||++. ++.++|+||
T Consensus 82 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EEEEECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 999999999999999854 57999999999999999999999999 899999999999986 778999999
Q ss_pred CCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHH
Q 003232 734 GLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 813 (837)
Q Consensus 734 GLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyEL 813 (837)
|++..... .......||+.|+|||++.+..++.++||||||+++|+|
T Consensus 161 g~~~~~~~---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l 207 (271)
T 3dtc_A 161 GLAREWHR---------------------------------TTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWEL 207 (271)
T ss_dssp CC----------------------------------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHH
T ss_pred Cccccccc---------------------------------ccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHH
Confidence 99863100 011234689999999999999999999999999999999
Q ss_pred HcCCCCCCCCCc
Q 003232 814 IVGIPPFNAEHP 825 (837)
Q Consensus 814 LTGr~PF~~~dp 825 (837)
++|+.||...+.
T Consensus 208 ~~g~~p~~~~~~ 219 (271)
T 3dtc_A 208 LTGEVPFRGIDG 219 (271)
T ss_dssp HHCCCTTTTSCH
T ss_pred HhCCCCCCCCCH
Confidence 999999987553
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-36 Score=314.61 Aligned_cols=210 Identities=29% Similarity=0.477 Sum_probs=175.4
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeec------
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC------ 660 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d------ 660 (837)
..++|++++.||+|+||+||+|+++.+|+.||+|++..... .......+.+|+.+++.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 93 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSC-SSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccc-cccchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence 45789999999999999999999999999999999865432 22223467799999999999999999999877
Q ss_pred --CCeEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCcc
Q 003232 661 --RENLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 737 (837)
Q Consensus 661 --~~~lyLVmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLAr 737 (837)
.+.+|+||||+.+ +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++
T Consensus 94 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp ---CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred cCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 4468999999975 777777543 569999999999999999999999999999999999999999999999999987
Q ss_pred ccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHcC
Q 003232 738 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVG 816 (837)
Q Consensus 738 vg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLTG 816 (837)
........ .........||+.|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 173 ~~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g 225 (351)
T 3mi9_A 173 AFSLAKNS---------------------------QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 225 (351)
T ss_dssp ECCCCSSS---------------------------SCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHS
T ss_pred cccccccc---------------------------cccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhC
Confidence 42111110 0011234578999999999986 4579999999999999999999
Q ss_pred CCCCCCCCc
Q 003232 817 IPPFNAEHP 825 (837)
Q Consensus 817 r~PF~~~dp 825 (837)
.+||.+.+.
T Consensus 226 ~~pf~~~~~ 234 (351)
T 3mi9_A 226 SPIMQGNTE 234 (351)
T ss_dssp SCSCCCSSH
T ss_pred CCCCCCCCh
Confidence 999987654
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=315.69 Aligned_cols=210 Identities=24% Similarity=0.383 Sum_probs=180.4
Q ss_pred CCCcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC
Q 003232 583 KDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE 662 (837)
Q Consensus 583 k~g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~ 662 (837)
......++|++.+.||+|+||+||+|++ .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++....
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 4455668899999999999999999997 478999999987643 234567899999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccc
Q 003232 663 NLYLVMEYLNGGDLYSLLRNLG----CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (837)
Q Consensus 663 ~lyLVmEy~~GGSL~dlLk~~g----~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArv 738 (837)
..|+||||+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 188 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKK 188 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccc
Confidence 9999999999999999986542 489999999999999999999999999999999999999999999999999874
Q ss_pred cccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCC
Q 003232 739 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIP 818 (837)
Q Consensus 739 g~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~ 818 (837)
....... .......||+.|+|||++.+..++.++||||||+++|+|++|+.
T Consensus 189 ~~~~~~~-----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~ 239 (321)
T 2qkw_B 189 GTELDQT-----------------------------HLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARS 239 (321)
T ss_dssp CSSSSCC-----------------------------CCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCT
T ss_pred ccccccc-----------------------------ccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCC
Confidence 2111000 01123458999999999998899999999999999999999999
Q ss_pred CCCCCCc
Q 003232 819 PFNAEHP 825 (837)
Q Consensus 819 PF~~~dp 825 (837)
||....+
T Consensus 240 p~~~~~~ 246 (321)
T 2qkw_B 240 AIVQSLP 246 (321)
T ss_dssp TCSCSSS
T ss_pred cccccCc
Confidence 9976544
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=303.57 Aligned_cols=206 Identities=32% Similarity=0.592 Sum_probs=176.5
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeec--CCeEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC--RENLY 665 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d--~~~ly 665 (837)
.++|++.+.||+|+||+||+|++..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.. ...+|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 4679999999999999999999999999999999976542 34456789999999999999999999998753 57899
Q ss_pred EEEEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC-----cccccCCCCcEEEccCCcEEEEecCCc
Q 003232 666 LVMEYLNGGDLYSLLRNL----GCLDEDVARVYIAEVVLALEYLHSLR-----VVHRDLKPDNLLIAHDGHIKLTDFGLS 736 (837)
Q Consensus 666 LVmEy~~GGSL~dlLk~~----g~Lsee~irkIl~QIa~ALsYLHSkG-----IIHRDIKPeNILLd~dG~IKLiDFGLA 736 (837)
+||||+++++|.+++... ..+++..+..++.||+.||.|||+.| |+|+||||+|||++.++.++|+|||++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 999999999999998653 34999999999999999999999999 999999999999999999999999998
Q ss_pred cccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcC
Q 003232 737 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVG 816 (837)
Q Consensus 737 rvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTG 816 (837)
...... ........||+.|+|||++.+..++.++||||||+++|+|++|
T Consensus 164 ~~~~~~-------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 212 (279)
T 2w5a_A 164 RILNHD-------------------------------TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCAL 212 (279)
T ss_dssp HHC----------------------------------CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHS
T ss_pred eeeccc-------------------------------cccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHC
Confidence 631000 0001124589999999999999999999999999999999999
Q ss_pred CCCCCCCCc
Q 003232 817 IPPFNAEHP 825 (837)
Q Consensus 817 r~PF~~~dp 825 (837)
..||...+.
T Consensus 213 ~~p~~~~~~ 221 (279)
T 2w5a_A 213 MPPFTAFSQ 221 (279)
T ss_dssp SCSSCCSSH
T ss_pred CCCCcccCH
Confidence 999987643
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=297.65 Aligned_cols=205 Identities=23% Similarity=0.430 Sum_probs=178.1
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeE
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~l 664 (837)
....++|++.+.||+|+||.||+|.+. +++.||+|++...... .+.+.+|+.+++.++||||+++++++......
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (267)
T 3t9t_A 4 VIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 78 (267)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred EEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCe
Confidence 344578999999999999999999995 6788999999865422 24688999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCC
Q 003232 665 YLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~s 743 (837)
|+||||+++++|.+++... +.+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~-- 156 (267)
T 3t9t_A 79 CLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-- 156 (267)
T ss_dssp EEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC--
T ss_pred EEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccc--
Confidence 9999999999999999765 5689999999999999999999999999999999999999999999999999863100
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNA 822 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~~ 822 (837)
..........||+.|+|||++.+..++.++||||||+++|+|++ |..||..
T Consensus 157 ----------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 208 (267)
T 3t9t_A 157 ----------------------------DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 208 (267)
T ss_dssp ----------------------------HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ----------------------------ccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCC
Confidence 00112234567889999999998899999999999999999999 8999986
Q ss_pred CC
Q 003232 823 EH 824 (837)
Q Consensus 823 ~d 824 (837)
.+
T Consensus 209 ~~ 210 (267)
T 3t9t_A 209 RS 210 (267)
T ss_dssp CC
T ss_pred CC
Confidence 54
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=314.50 Aligned_cols=203 Identities=22% Similarity=0.337 Sum_probs=170.7
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC---
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE--- 662 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~--- 662 (837)
...++|++.+.||+|+||+||+|++. ++.||||++.... ........|+.+++.++||||+++++++....
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVD 94 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred cchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCC
Confidence 34467999999999999999999975 7899999997542 23345566888999999999999999998743
Q ss_pred -eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC----------CcccccCCCCcEEEccCCcEEEE
Q 003232 663 -NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL----------RVVHRDLKPDNLLIAHDGHIKLT 731 (837)
Q Consensus 663 -~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSk----------GIIHRDIKPeNILLd~dG~IKLi 731 (837)
.+|+||||+++|+|.+++.. ..+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+
T Consensus 95 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 95 VDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred ceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence 47999999999999999977 4599999999999999999999999 99999999999999999999999
Q ss_pred ecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCC-----CCCchHHHHHH
Q 003232 732 DFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-----GHGTTADWWSV 806 (837)
Q Consensus 732 DFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~-----~~s~kSDIWSL 806 (837)
|||+++....... ........||+.|+|||++.+. .++.++|||||
T Consensus 174 DFg~a~~~~~~~~-----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diwsl 224 (322)
T 3soc_A 174 DFGLALKFEAGKS-----------------------------AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAM 224 (322)
T ss_dssp CCTTCEEECTTSC-----------------------------CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHH
T ss_pred cCCcccccccccC-----------------------------ccccccCccCccccCHhhcccccccCcCCCccchhHHH
Confidence 9999864211110 0012235799999999999873 45678899999
Q ss_pred HHHHHHHHcCCCCCCCCC
Q 003232 807 GIILFELIVGIPPFNAEH 824 (837)
Q Consensus 807 GVILyELLTGr~PF~~~d 824 (837)
||++|+|++|+.||.+..
T Consensus 225 G~il~el~tg~~pf~~~~ 242 (322)
T 3soc_A 225 GLVLWELASRCTAADGPV 242 (322)
T ss_dssp HHHHHHHHTTBTTSSSCC
T ss_pred HHHHHHHHhCCCCCCCCc
Confidence 999999999999998654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=325.76 Aligned_cols=212 Identities=28% Similarity=0.427 Sum_probs=181.0
Q ss_pred CCCcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC
Q 003232 583 KDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE 662 (837)
Q Consensus 583 k~g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~ 662 (837)
.+....++|++.+.||+|+||.||+|++..+++.||+|+++... .......+.+|+.+++.++||||+++++++....
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 185 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ 185 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC
Confidence 34555678999999999999999999999899999999987542 3444567889999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCcccccc
Q 003232 663 NLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 741 (837)
Q Consensus 663 ~lyLVmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~ 741 (837)
.+|+||||+++++|.+++... ..++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 186 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 186 PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 999999999999999999765 3599999999999999999999999999999999999999999999999999873100
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCC
Q 003232 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPF 820 (837)
Q Consensus 742 ~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF 820 (837)
... ........+++.|+|||++.+..++.++|||||||++|||++ |..||
T Consensus 266 ~~~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~ 316 (377)
T 3cbl_A 266 GVY-----------------------------AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPY 316 (377)
T ss_dssp SEE-----------------------------ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred Cce-----------------------------eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 000 000112235678999999998889999999999999999998 99999
Q ss_pred CCCCc
Q 003232 821 NAEHP 825 (837)
Q Consensus 821 ~~~dp 825 (837)
...+.
T Consensus 317 ~~~~~ 321 (377)
T 3cbl_A 317 PNLSN 321 (377)
T ss_dssp TTSCH
T ss_pred CCCCH
Confidence 76543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=313.74 Aligned_cols=206 Identities=28% Similarity=0.430 Sum_probs=167.6
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEE----EEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCe
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLF----AIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCREN 663 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~V----AVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ 663 (837)
.++|++++.||+|+||+||+|++..+++.+ |+|.+.... .....+.+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 90 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-
Confidence 467999999999999999999998887755 777765432 2334467899999999999999999999998754
Q ss_pred EEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccC
Q 003232 664 LYLVMEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk~-~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~ 742 (837)
.++|+||+.+|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 170 (327)
T 3poz_A 91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence 7899999999999999976 456999999999999999999999999999999999999999999999999998742111
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCC
Q 003232 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFN 821 (837)
Q Consensus 743 stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~ 821 (837)
.. ........||+.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 171 ~~-----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 221 (327)
T 3poz_A 171 EK-----------------------------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221 (327)
T ss_dssp CC------------------------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cc-----------------------------cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCcc
Confidence 10 011123457889999999999999999999999999999999 999998
Q ss_pred CCCc
Q 003232 822 AEHP 825 (837)
Q Consensus 822 ~~dp 825 (837)
+...
T Consensus 222 ~~~~ 225 (327)
T 3poz_A 222 GIPA 225 (327)
T ss_dssp TCCG
T ss_pred CCCH
Confidence 7654
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=304.01 Aligned_cols=206 Identities=33% Similarity=0.606 Sum_probs=174.3
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEE
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 665 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ly 665 (837)
...++|++++.||.|+||.||+|++..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.....+|
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 92 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLW 92 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEE
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEE
Confidence 34467999999999999999999999999999999987543 233467889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCC
Q 003232 666 LVMEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (837)
Q Consensus 666 LVmEy~~GGSL~dlLk~-~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~st 744 (837)
+||||+++++|.+++.. ...+++..+..++.||+.||.|||++|++|+||||+|||++.++.++|+|||++...
T Consensus 93 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~----- 167 (302)
T 2j7t_A 93 IMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKN----- 167 (302)
T ss_dssp EEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHH-----
T ss_pred EEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccc-----
Confidence 99999999999999865 466999999999999999999999999999999999999999999999999986520
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhh-----cCCCCCchHHHHHHHHHHHHHHcCCCC
Q 003232 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEIL-----LGTGHGTTADWWSVGIILFELIVGIPP 819 (837)
Q Consensus 745 ddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVL-----lg~~~s~kSDIWSLGVILyELLTGr~P 819 (837)
...........||+.|+|||++ .+..++.++||||||+++|+|++|..|
T Consensus 168 --------------------------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 221 (302)
T 2j7t_A 168 --------------------------LKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221 (302)
T ss_dssp --------------------------HHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCT
T ss_pred --------------------------cccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCC
Confidence 0111122345799999999998 467789999999999999999999999
Q ss_pred CCCCCc
Q 003232 820 FNAEHP 825 (837)
Q Consensus 820 F~~~dp 825 (837)
|...++
T Consensus 222 ~~~~~~ 227 (302)
T 2j7t_A 222 HHELNP 227 (302)
T ss_dssp TTTSCH
T ss_pred CccCCH
Confidence 987543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=304.91 Aligned_cols=200 Identities=28% Similarity=0.507 Sum_probs=174.5
Q ss_pred ccCCeEEEEEecccCceEEEEEEE-CCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCC------ceEEEEeEee
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKK-RTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP------FVVRFFYSFT 659 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArd-k~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHP------NIVkL~gsf~ 659 (837)
..++|++.+.||+|+||+||+|.+ ..+++.||+|+++.. ....+.+.+|+.+++.++|+ +|+++++++.
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~ 87 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE 87 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence 346799999999999999999998 568899999999753 23456788899999888765 4999999999
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEcc-------------
Q 003232 660 CRENLYLVMEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH------------- 724 (837)
Q Consensus 660 d~~~lyLVmEy~~GGSL~dlLk~~g--~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~------------- 724 (837)
...++|+||||+ +++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 88 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 88 HHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred cCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccc
Confidence 999999999999 899999998765 6899999999999999999999999999999999999987
Q ss_pred ------CCcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCC
Q 003232 725 ------DGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHG 798 (837)
Q Consensus 725 ------dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s 798 (837)
++.++|+|||+++... .......||+.|+|||++.+..++
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~ 212 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDD----------------------------------EHHSTLVSTRHYRAPEVILALGWS 212 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETT----------------------------------SCCCSSCSCGGGCCHHHHTTSCCC
T ss_pred ccccccCCCceEeeCcccccCc----------------------------------cccccccCCccccChHHhhCCCCC
Confidence 6689999999987310 011245789999999999999999
Q ss_pred chHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 799 TTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 799 ~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
.++|||||||++|+|++|..||...+.
T Consensus 213 ~~~Di~slG~il~el~~g~~pf~~~~~ 239 (339)
T 1z57_A 213 QPCDVWSIGCILIEYYLGFTVFPTHDS 239 (339)
T ss_dssp THHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred cchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 999999999999999999999987654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=309.67 Aligned_cols=213 Identities=28% Similarity=0.443 Sum_probs=179.4
Q ss_pred CCCcccCCeEEEEEecccCceEEEEEEE-----CCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEe
Q 003232 583 KDRTSIDDFEIIKPISRGAFGRVFLAKK-----RTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFY 656 (837)
Q Consensus 583 k~g~~lddYeIlkkLGsG~FGtVYkArd-----k~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~g 656 (837)
.+....++|++.+.||.|+||+||+|++ ..+++.||+|++.... .......+.+|+.+++.+ +||||+++++
T Consensus 21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 3445567899999999999999999985 3567899999997653 334456789999999999 7999999999
Q ss_pred EeecCC-eEEEEEEecCCCCHHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCc
Q 003232 657 SFTCRE-NLYLVMEYLNGGDLYSLLRNLGC----------------LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDN 719 (837)
Q Consensus 657 sf~d~~-~lyLVmEy~~GGSL~dlLk~~g~----------------Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeN 719 (837)
++...+ .+|+||||+++++|.+++..... +++..+..++.||+.||.|||++||+||||||+|
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~N 178 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 178 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccce
Confidence 987654 59999999999999999987543 8899999999999999999999999999999999
Q ss_pred EEEccCCcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCc
Q 003232 720 LLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT 799 (837)
Q Consensus 720 ILLd~dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~ 799 (837)
||++.++.++|+|||+++....... ........||+.|+|||++.+..++.
T Consensus 179 il~~~~~~~kl~Dfg~~~~~~~~~~-----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~ 229 (316)
T 2xir_A 179 ILLSEKNVVKICDFGLARDIYKDPD-----------------------------YVRKGDARLPLKWMAPETIFDRVYTI 229 (316)
T ss_dssp EEECGGGCEEECCCGGGSCTTTCTT-----------------------------SEEETTEEECGGGCCHHHHHHCCCCH
T ss_pred EEECCCCCEEECCCccccccccCcc-----------------------------ceeccCCCcceeecCchhhccccccc
Confidence 9999999999999999863110000 01122345788999999999999999
Q ss_pred hHHHHHHHHHHHHHHc-CCCCCCCCCcC
Q 003232 800 TADWWSVGIILFELIV-GIPPFNAEHPQ 826 (837)
Q Consensus 800 kSDIWSLGVILyELLT-Gr~PF~~~dpd 826 (837)
++||||||+++|+|++ |..||......
T Consensus 230 ~~Di~slG~il~~l~t~g~~p~~~~~~~ 257 (316)
T 2xir_A 230 QSDVWSFGVLLWEIFSLGASPYPGVKID 257 (316)
T ss_dssp HHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred hhHHHHHHHHHHHHHhCCCCCCcccchh
Confidence 9999999999999998 99999876544
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=319.60 Aligned_cols=207 Identities=29% Similarity=0.467 Sum_probs=174.7
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcC--CCceEEEEeEeecCCeEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR--NPFVVRFFYSFTCRENLYL 666 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~Lr--HPNIVkL~gsf~d~~~lyL 666 (837)
..|++++.||+|+||+||+|.+.. ++.||||++.... ........+.+|+.+++.++ ||||+++++++.....+|+
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEeccc-ccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 459999999999999999999864 8999999997654 24455678999999999996 5999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCC
Q 003232 667 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stdd 746 (837)
||| +.+++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++......
T Consensus 134 v~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~--- 208 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT--- 208 (390)
T ss_dssp EEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-------
T ss_pred EEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC---
Confidence 999 56889999999888899999999999999999999999999999999999995 6899999999987311000
Q ss_pred CCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-----------CCCCchHHHHHHHHHHHHHHc
Q 003232 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-----------TGHGTTADWWSVGIILFELIV 815 (837)
Q Consensus 747 l~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-----------~~~s~kSDIWSLGVILyELLT 815 (837)
........+||+.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 209 --------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~ 262 (390)
T 2zmd_A 209 --------------------------TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 262 (390)
T ss_dssp -------------------------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHH
T ss_pred --------------------------ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHH
Confidence 0011235679999999999975 368999999999999999999
Q ss_pred CCCCCCCCCcCHH
Q 003232 816 GIPPFNAEHPQVS 828 (837)
Q Consensus 816 Gr~PF~~~dpdv~ 828 (837)
|+.||........
T Consensus 263 G~~Pf~~~~~~~~ 275 (390)
T 2zmd_A 263 GKTPFQQIINQIS 275 (390)
T ss_dssp SSCTTTTCCCHHH
T ss_pred CCCcchhhhHHHH
Confidence 9999987654433
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=316.88 Aligned_cols=210 Identities=26% Similarity=0.424 Sum_probs=180.1
Q ss_pred CCcccCCeEEEEEecccCceEEEEEEECCC-------CcEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEE
Q 003232 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTT-------GDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFF 655 (837)
Q Consensus 584 ~g~~lddYeIlkkLGsG~FGtVYkArdk~t-------G~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~ 655 (837)
+....++|++.+.||+|+||+||+|++..+ +..||+|++.... .......+.+|+.+++.+ +||||++++
T Consensus 64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 141 (382)
T 3tt0_A 64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLL 141 (382)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhhe
Confidence 455567899999999999999999997543 3579999997653 345567899999999999 999999999
Q ss_pred eEeecCCeEEEEEEecCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCc
Q 003232 656 YSFTCRENLYLVMEYLNGGDLYSLLRNLG----------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDN 719 (837)
Q Consensus 656 gsf~d~~~lyLVmEy~~GGSL~dlLk~~g----------------~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeN 719 (837)
+++......|+||||+.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|
T Consensus 142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 221 (382)
T 3tt0_A 142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 221 (382)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcce
Confidence 99999999999999999999999998653 48999999999999999999999999999999999
Q ss_pred EEEccCCcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCc
Q 003232 720 LLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT 799 (837)
Q Consensus 720 ILLd~dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~ 799 (837)
||++.++.+||+|||+++....... ........||+.|+|||++.+..++.
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~-----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~ 272 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDY-----------------------------YKKTTNGRLPVKWMAPEALFDRIYTH 272 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCT-----------------------------TCCCTTCCCGGGGSCHHHHHSCCCCH
T ss_pred EEEcCCCcEEEcccCcccccccccc-----------------------------cccccCCCCCcceeCHHHhcCCCCCc
Confidence 9999999999999999873111000 01122345788999999999999999
Q ss_pred hHHHHHHHHHHHHHHc-CCCCCCCCC
Q 003232 800 TADWWSVGIILFELIV-GIPPFNAEH 824 (837)
Q Consensus 800 kSDIWSLGVILyELLT-Gr~PF~~~d 824 (837)
++|||||||++|+|++ |..||...+
T Consensus 273 ~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 273 QSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp HHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999 999998654
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=302.83 Aligned_cols=204 Identities=34% Similarity=0.635 Sum_probs=179.9
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLV 667 (837)
.+.|++++.||.|+||+||+|++..+++.||+|++..... ....+.+.+|+.+++.++||||+++++++.....+|+|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 98 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 98 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 3569999999999999999999999999999999976432 23356789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCC
Q 003232 668 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (837)
Q Consensus 668 mEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl 747 (837)
|||+++++|.+++.. +.+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 99 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~---- 173 (303)
T 3a7i_A 99 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ---- 173 (303)
T ss_dssp EECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB----
T ss_pred EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc----
Confidence 999999999999865 679999999999999999999999999999999999999999999999999986311000
Q ss_pred CCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 748 ~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
.......||+.|+|||++.+..++.++||||||+++|+|++|..||....+
T Consensus 174 ---------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 224 (303)
T 3a7i_A 174 ---------------------------IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP 224 (303)
T ss_dssp ---------------------------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred ---------------------------cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH
Confidence 012345789999999999999999999999999999999999999976543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=316.03 Aligned_cols=204 Identities=33% Similarity=0.578 Sum_probs=178.5
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEeccccc-----ccHHHHHHHHHHHHHHHhc-CCCceEEEEeEeecCC
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADM-----IRKNAVESILAERDILISV-RNPFVVRFFYSFTCRE 662 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~-----~~~e~ie~~~rEieILk~L-rHPNIVkL~gsf~d~~ 662 (837)
++|++.+.||.|+||.||+|++..+|+.||||++..... ......+.+.+|+.+++.+ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 569999999999999999999998999999999875431 1123356788999999999 7999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccC
Q 003232 663 NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (837)
Q Consensus 663 ~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~ 742 (837)
..|+||||++|++|.+++.....+++..+..++.||+.||.|||+.||+|+||||+|||++.+|.++|+|||++......
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~ 253 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG 253 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCCC
Confidence 99999999999999999988888999999999999999999999999999999999999999999999999988631100
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC------CCCCchHHHHHHHHHHHHHHcC
Q 003232 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG------TGHGTTADWWSVGIILFELIVG 816 (837)
Q Consensus 743 stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg------~~~s~kSDIWSLGVILyELLTG 816 (837)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 254 --------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g 301 (365)
T 2y7j_A 254 --------------------------------EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301 (365)
T ss_dssp --------------------------------CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHS
T ss_pred --------------------------------cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHC
Confidence 01234579999999999863 3578999999999999999999
Q ss_pred CCCCCCCC
Q 003232 817 IPPFNAEH 824 (837)
Q Consensus 817 r~PF~~~d 824 (837)
..||....
T Consensus 302 ~~pf~~~~ 309 (365)
T 2y7j_A 302 SPPFWHRR 309 (365)
T ss_dssp SCSSCCSS
T ss_pred CCCCCCCC
Confidence 99997654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=318.70 Aligned_cols=202 Identities=27% Similarity=0.524 Sum_probs=171.1
Q ss_pred CCeEE--EEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEE
Q 003232 589 DDFEI--IKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (837)
Q Consensus 589 ddYeI--lkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyL 666 (837)
..|.+ .+.||.|+||.||+|++..+|+.||+|+++... ....+.+.+|+.+++.++||||+++++++.....+|+
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 163 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVL 163 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 34555 678999999999999999999999999998643 2345678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEE--ccCCcEEEEecCCccccccCC
Q 003232 667 VMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI--AHDGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILL--d~dG~IKLiDFGLArvg~~~s 743 (837)
||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 164 v~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~- 242 (373)
T 2x4f_A 164 VMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR- 242 (373)
T ss_dssp EEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT-
T ss_pred EEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc-
Confidence 99999999999988654 469999999999999999999999999999999999999 56789999999998731100
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~ 823 (837)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 243 -------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 291 (373)
T 2x4f_A 243 -------------------------------EKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGD 291 (373)
T ss_dssp -------------------------------CBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred -------------------------------cccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 0122346999999999999999999999999999999999999999876
Q ss_pred Cc
Q 003232 824 HP 825 (837)
Q Consensus 824 dp 825 (837)
++
T Consensus 292 ~~ 293 (373)
T 2x4f_A 292 ND 293 (373)
T ss_dssp SH
T ss_pred CH
Confidence 53
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=307.43 Aligned_cols=214 Identities=31% Similarity=0.554 Sum_probs=159.9
Q ss_pred CCcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCe
Q 003232 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCREN 663 (837)
Q Consensus 584 ~g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ 663 (837)
+....++|++.+.||.|+||+||+|++..+++.||+|++..... ......+.+|+.+++.++||||+++++++.....
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 87 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE 87 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence 34456789999999999999999999988999999999875431 2345678899999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCC
Q 003232 664 LYLVMEYLNGGDLYSLLRN--------LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGL 735 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk~--------~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGL 735 (837)
.|+||||++|++|.+++.. .+.+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||+
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 9999999999999999864 35699999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHH
Q 003232 736 SKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELI 814 (837)
Q Consensus 736 Arvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELL 814 (837)
+........ ...........||+.|+|||++.+ ..++.++||||||+++|+|+
T Consensus 168 ~~~~~~~~~--------------------------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~ 221 (303)
T 2vwi_A 168 SAFLATGGD--------------------------ITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELA 221 (303)
T ss_dssp HHHCC-----------------------------------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHH
T ss_pred hheeccCCC--------------------------ccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHH
Confidence 863111000 000111234579999999999976 56899999999999999999
Q ss_pred cCCCCCCCCCc
Q 003232 815 VGIPPFNAEHP 825 (837)
Q Consensus 815 TGr~PF~~~dp 825 (837)
+|..||....+
T Consensus 222 ~g~~pf~~~~~ 232 (303)
T 2vwi_A 222 TGAAPYHKYPP 232 (303)
T ss_dssp HSSCTTTTSCG
T ss_pred hCCCCCccCch
Confidence 99999987543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=310.09 Aligned_cols=209 Identities=24% Similarity=0.427 Sum_probs=177.8
Q ss_pred CcccCCeEEEEEecccCceEEEEEEEC-------CCCcEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEe
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKR-------TTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFY 656 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk-------~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~g 656 (837)
....++|++.+.||+|+||+||+|++. .++..||+|++.... .......+.+|+.+++.+ +||||+++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 108 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 108 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEE
Confidence 445578999999999999999999986 356789999997643 344567899999999999 8999999999
Q ss_pred EeecCCeEEEEEEecCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcE
Q 003232 657 SFTCRENLYLVMEYLNGGDLYSLLRNLG----------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNL 720 (837)
Q Consensus 657 sf~d~~~lyLVmEy~~GGSL~dlLk~~g----------------~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNI 720 (837)
++.....+|+||||+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||
T Consensus 109 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 188 (334)
T 2pvf_A 109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 188 (334)
T ss_dssp EECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred EEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceE
Confidence 9999999999999999999999997643 389999999999999999999999999999999999
Q ss_pred EEccCCcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCch
Q 003232 721 LIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT 800 (837)
Q Consensus 721 LLd~dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~k 800 (837)
|++.++.+||+|||+++....... ........||+.|+|||++.+..++.+
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~ 239 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDY-----------------------------YKKTTNGRLPVKWMAPEALFDRVYTHQ 239 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSS-----------------------------EECCSCCCCCGGGCCHHHHHHCEECHH
T ss_pred EEcCCCCEEEcccccccccccccc-----------------------------ccccCCCCcccceeChHHhcCCCcChH
Confidence 999999999999999873110000 011223457889999999998889999
Q ss_pred HHHHHHHHHHHHHHc-CCCCCCCCC
Q 003232 801 ADWWSVGIILFELIV-GIPPFNAEH 824 (837)
Q Consensus 801 SDIWSLGVILyELLT-Gr~PF~~~d 824 (837)
+||||||+++|+|++ |..||.+.+
T Consensus 240 ~Di~slG~il~ellt~g~~p~~~~~ 264 (334)
T 2pvf_A 240 SDVWSFGVLMWEIFTLGGSPYPGIP 264 (334)
T ss_dssp HHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred HHHHHHHHHHHHHHhCCCCCcCcCC
Confidence 999999999999999 999997654
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=303.36 Aligned_cols=205 Identities=26% Similarity=0.389 Sum_probs=172.5
Q ss_pred ccCCeEEEEEecccCceEEEEEE----ECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecC-
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAK----KRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR- 661 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkAr----dk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~- 661 (837)
....|++++.||+|+||.||+|+ +..+++.||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus 19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (302)
T 4e5w_A 19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDG 96 (302)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--
T ss_pred hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence 34569999999999999999999 56789999999997643 223346788999999999999999999999876
Q ss_pred -CeEEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCcccc
Q 003232 662 -ENLYLVMEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 739 (837)
Q Consensus 662 -~~lyLVmEy~~GGSL~dlLk~-~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg 739 (837)
..+|+||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++...
T Consensus 97 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 97 GNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp -CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccc
Confidence 679999999999999999954 456999999999999999999999999999999999999999999999999998742
Q ss_pred ccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCC
Q 003232 740 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPP 819 (837)
Q Consensus 740 ~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~P 819 (837)
..... .........||..|+|||++.+..++.++||||||+++|+|++|..|
T Consensus 177 ~~~~~----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 228 (302)
T 4e5w_A 177 ETDKE----------------------------YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDS 228 (302)
T ss_dssp CTTCC----------------------------EEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCG
T ss_pred cCCCc----------------------------ceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCC
Confidence 11100 00112345688899999999999999999999999999999999998
Q ss_pred CC
Q 003232 820 FN 821 (837)
Q Consensus 820 F~ 821 (837)
|.
T Consensus 229 ~~ 230 (302)
T 4e5w_A 229 DS 230 (302)
T ss_dssp GG
T ss_pred Cc
Confidence 64
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-36 Score=312.83 Aligned_cols=208 Identities=21% Similarity=0.349 Sum_probs=172.1
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcE----EEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDL----FAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE 662 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~----VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~ 662 (837)
..++|++++.||+|+||+||+|++..+++. ||+|++.... .......+.+|+.+++.++||||+++++++. ..
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~ 87 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GS 87 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BS
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CC
Confidence 346799999999999999999999888876 6777664332 1122245678999999999999999999886 56
Q ss_pred eEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCcccccc
Q 003232 663 NLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 741 (837)
Q Consensus 663 ~lyLVmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~ 741 (837)
..++||||+.+++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++....
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 789999999999999999764 5799999999999999999999999999999999999999999999999999974211
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCC
Q 003232 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPF 820 (837)
Q Consensus 742 ~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF 820 (837)
.... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 168 ~~~~-----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~ 218 (325)
T 3kex_A 168 DDKQ-----------------------------LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPY 218 (325)
T ss_dssp CTTC-----------------------------CC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred cccc-----------------------------ccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCc
Confidence 1100 01123467889999999999999999999999999999999 99999
Q ss_pred CCCCcC
Q 003232 821 NAEHPQ 826 (837)
Q Consensus 821 ~~~dpd 826 (837)
.+....
T Consensus 219 ~~~~~~ 224 (325)
T 3kex_A 219 AGLRLA 224 (325)
T ss_dssp TTSCTT
T ss_pred cccCHH
Confidence 876543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=309.41 Aligned_cols=212 Identities=25% Similarity=0.388 Sum_probs=180.7
Q ss_pred CCcccCCeEEEEEecccCceEEEEEEECCCCc-----EEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEeE
Q 003232 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGD-----LFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYS 657 (837)
Q Consensus 584 ~g~~lddYeIlkkLGsG~FGtVYkArdk~tG~-----~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~gs 657 (837)
+....++|++.+.||.|+||+||+|.+..+++ .||+|++.... .....+.+.+|+.+++.+ +||||++++++
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 44556789999999999999999999977664 79999997643 334557899999999999 89999999999
Q ss_pred eecCCeEEEEEEecCCCCHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEc
Q 003232 658 FTCRENLYLVMEYLNGGDLYSLLRNL--------------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA 723 (837)
Q Consensus 658 f~d~~~lyLVmEy~~GGSL~dlLk~~--------------g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd 723 (837)
+.....+|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT 198 (333)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE
T ss_pred EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC
Confidence 99999999999999999999998642 3579999999999999999999999999999999999999
Q ss_pred cCCcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHH
Q 003232 724 HDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADW 803 (837)
Q Consensus 724 ~dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDI 803 (837)
.++.++|+|||++........ ........||+.|+|||++.+..++.++||
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 249 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSN-----------------------------YIVKGNARLPVKWMAPESIFDCVYTVQSDV 249 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTT-----------------------------SEECSSCEECGGGSCHHHHHHCCCCHHHHH
T ss_pred CCCeEEECccccccccccccc-----------------------------eeecCCCCCCccccCHHHhccCCCChHHHH
Confidence 999999999999873111100 001223457888999999999999999999
Q ss_pred HHHHHHHHHHHc-CCCCCCCCCcC
Q 003232 804 WSVGIILFELIV-GIPPFNAEHPQ 826 (837)
Q Consensus 804 WSLGVILyELLT-Gr~PF~~~dpd 826 (837)
||||+++|+|++ |..||.+....
T Consensus 250 ~slG~il~el~t~g~~p~~~~~~~ 273 (333)
T 2i1m_A 250 WSYGILLWEIFSLGLNPYPGILVN 273 (333)
T ss_dssp HHHHHHHHHHTTTSCCSSTTCCSS
T ss_pred HHHHHHHHHHHcCCCCCCcccchh
Confidence 999999999998 99999876544
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-36 Score=319.48 Aligned_cols=203 Identities=20% Similarity=0.256 Sum_probs=157.8
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhc--CCCceEEEEeE-------e
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV--RNPFVVRFFYS-------F 658 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L--rHPNIVkL~gs-------f 658 (837)
..+|++.+.||.|+||+||+|++..+++.||+|++...........+.+.+|+.+++.+ +||||++++.. +
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 34599999999999999999999999999999999886654556667788886655555 69998886633 3
Q ss_pred ecC-----------------CeEEEEEEecCCCCHHHHHHhc-CCCCHHHH------HHHHHHHHHHHHHHHhCCccccc
Q 003232 659 TCR-----------------ENLYLVMEYLNGGDLYSLLRNL-GCLDEDVA------RVYIAEVVLALEYLHSLRVVHRD 714 (837)
Q Consensus 659 ~d~-----------------~~lyLVmEy~~GGSL~dlLk~~-g~Lsee~i------rkIl~QIa~ALsYLHSkGIIHRD 714 (837)
... .++|+||||++ ++|.+++... ..+..... ..++.||+.||.|||++||+|||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 222 34899999998 8999999763 33444444 56679999999999999999999
Q ss_pred CCCCcEEEccCCcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC
Q 003232 715 LKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG 794 (837)
Q Consensus 715 IKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg 794 (837)
|||+|||++.++.+||+|||+++... .......||+.|+|||++.+
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~----------------------------------~~~~~~~~t~~y~aPE~~~~ 265 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVG----------------------------------TRGPASSVPVTYAPREFLNA 265 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETT----------------------------------CEEEGGGSCGGGCCHHHHTC
T ss_pred CCHHHEEECCCCCEEEEecceeeecC----------------------------------CCccCccCCcCCcChhhccC
Confidence 99999999999999999999987310 00113356799999999987
Q ss_pred --CCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 795 --TGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 795 --~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
..++.++|||||||++|+|++|+.||....+
T Consensus 266 ~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~ 298 (371)
T 3q60_A 266 STATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298 (371)
T ss_dssp SEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCT
T ss_pred CCCCcCccccHHHHHHHHHHHHhCCCCCCCcCc
Confidence 7899999999999999999999999987743
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=303.51 Aligned_cols=201 Identities=32% Similarity=0.627 Sum_probs=173.3
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLV 667 (837)
.++|++++.||.|+||.||+|.+..+|+.||+|++.... ....+.+|+.+++.++||||+++++++.....+|+|
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV 102 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 467999999999999999999999999999999997643 234688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCC
Q 003232 668 MEYLNGGDLYSLLR-NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (837)
Q Consensus 668 mEy~~GGSL~dlLk-~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stdd 746 (837)
|||+.+++|.+++. ....+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 103 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~--- 179 (314)
T 3com_A 103 MEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM--- 179 (314)
T ss_dssp EECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB---
T ss_pred eecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc---
Confidence 99999999999997 45679999999999999999999999999999999999999999999999999986311000
Q ss_pred CCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 747 l~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
.......||+.|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 180 ----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 229 (314)
T 3com_A 180 ----------------------------AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH 229 (314)
T ss_dssp ----------------------------SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ----------------------------cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 01234578999999999999999999999999999999999999998654
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=304.25 Aligned_cols=207 Identities=30% Similarity=0.543 Sum_probs=172.4
Q ss_pred CCcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEeEeec--
Q 003232 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTC-- 660 (837)
Q Consensus 584 ~g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~gsf~d-- 660 (837)
.....++|++.+.||.|+||.||+|++..+++.||+|++..... ....+.+|+.+++.+ +||||+++++++..
T Consensus 19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 94 (326)
T 2x7f_A 19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKN 94 (326)
T ss_dssp CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc----cHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence 34456789999999999999999999999999999999975432 234678999999998 89999999999977
Q ss_pred ----CCeEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecC
Q 003232 661 ----RENLYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFG 734 (837)
Q Consensus 661 ----~~~lyLVmEy~~GGSL~dlLk~~--g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFG 734 (837)
...+|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg 174 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFG 174 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCT
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCc
Confidence 46899999999999999999764 569999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhc-----CCCCCchHHHHHHHHH
Q 003232 735 LSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-----GTGHGTTADWWSVGII 809 (837)
Q Consensus 735 LArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLl-----g~~~s~kSDIWSLGVI 809 (837)
++...... ........||+.|+|||++. +..++.++|||||||+
T Consensus 175 ~~~~~~~~-------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~i 223 (326)
T 2x7f_A 175 VSAQLDRT-------------------------------VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGIT 223 (326)
T ss_dssp TTC--------------------------------------------CCGGGCCHHHHC--------CCTTHHHHHHHHH
T ss_pred CceecCcC-------------------------------ccccccccCCccccChhhhccccccCcCCCccchHHHHHHH
Confidence 98631000 01122457899999999997 5678899999999999
Q ss_pred HHHHHcCCCCCCCCCc
Q 003232 810 LFELIVGIPPFNAEHP 825 (837)
Q Consensus 810 LyELLTGr~PF~~~dp 825 (837)
+|+|++|..||....+
T Consensus 224 l~~l~~g~~p~~~~~~ 239 (326)
T 2x7f_A 224 AIEMAEGAPPLCDMHP 239 (326)
T ss_dssp HHHHHHSSCTTTTSCH
T ss_pred HHHHHhCCCCCCCCcH
Confidence 9999999999976543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=303.20 Aligned_cols=203 Identities=27% Similarity=0.467 Sum_probs=167.3
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHh--cCCCceEEEEeEeec---
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILIS--VRNPFVVRFFYSFTC--- 660 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~--LrHPNIVkL~gsf~d--- 660 (837)
...++|++.+.||+|+||+||+|++ +++.||||++.... ...+..|.+++.. ++||||+++++.+..
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~ 76 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSRH 76 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEET
T ss_pred cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeeccccC
Confidence 3456799999999999999999997 58999999987532 2345667777766 799999999988654
Q ss_pred -CCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCcccccCCCCcEEEccCCcEEEE
Q 003232 661 -RENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLH--------SLRVVHRDLKPDNLLIAHDGHIKLT 731 (837)
Q Consensus 661 -~~~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLH--------SkGIIHRDIKPeNILLd~dG~IKLi 731 (837)
...+|+||||+++++|.++++. ..+++..+..++.||+.||.||| ++||+||||||+|||++.++.+||+
T Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 77 SSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp TEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred CCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEe
Confidence 3568999999999999999955 57999999999999999999999 9999999999999999999999999
Q ss_pred ecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCC------CCCchHHHHH
Q 003232 732 DFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT------GHGTTADWWS 805 (837)
Q Consensus 732 DFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~------~~s~kSDIWS 805 (837)
|||+++........ .........||+.|+|||++.+. .++.++||||
T Consensus 156 Dfg~a~~~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Dvws 208 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQ---------------------------LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWA 208 (301)
T ss_dssp CCTTCEEEETTTTE---------------------------EECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHH
T ss_pred eCCCeeeccccccc---------------------------ccccccccccccceeChhhhcCcCCCCcccCCchhhHHH
Confidence 99998642111100 00112345799999999999876 4557899999
Q ss_pred HHHHHHHHHcC----------CCCCCCCC
Q 003232 806 VGIILFELIVG----------IPPFNAEH 824 (837)
Q Consensus 806 LGVILyELLTG----------r~PF~~~d 824 (837)
|||++|+|++| ..||....
T Consensus 209 lG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 209 FGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp HHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred HHHHHHHHHhhhcCccccccccccccccC
Confidence 99999999999 88986543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-36 Score=305.29 Aligned_cols=212 Identities=24% Similarity=0.362 Sum_probs=176.1
Q ss_pred CCcccCCeEEEE-EecccCceEEEEEEE--CCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeec
Q 003232 584 DRTSIDDFEIIK-PISRGAFGRVFLAKK--RTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC 660 (837)
Q Consensus 584 ~g~~lddYeIlk-kLGsG~FGtVYkArd--k~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d 660 (837)
.....++|++.+ .||.|+||+||+|.+ ..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++ .
T Consensus 11 ~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~ 88 (291)
T 1xbb_A 11 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGIC-E 88 (291)
T ss_dssp CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E
T ss_pred eeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C
Confidence 344456799998 999999999999954 5667899999997653 2334467899999999999999999999998 5
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccc
Q 003232 661 RENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740 (837)
Q Consensus 661 ~~~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~ 740 (837)
....|+||||+++++|.+++...+.+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++....
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 89 AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 67789999999999999999988889999999999999999999999999999999999999999999999999987311
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCC
Q 003232 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPP 819 (837)
Q Consensus 741 ~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~P 819 (837)
..... ........||+.|+|||++.+..++.++||||||+++|+|++ |..|
T Consensus 169 ~~~~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p 220 (291)
T 1xbb_A 169 ADENY----------------------------YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220 (291)
T ss_dssp TTCSE----------------------------EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCS
T ss_pred cCCCc----------------------------ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCC
Confidence 11000 001123356788999999998889999999999999999999 9999
Q ss_pred CCCCCc
Q 003232 820 FNAEHP 825 (837)
Q Consensus 820 F~~~dp 825 (837)
|...+.
T Consensus 221 ~~~~~~ 226 (291)
T 1xbb_A 221 YRGMKG 226 (291)
T ss_dssp STTCCH
T ss_pred CCCCCH
Confidence 987543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=304.55 Aligned_cols=210 Identities=23% Similarity=0.396 Sum_probs=173.0
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEee----cCCe
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFT----CREN 663 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~----d~~~ 663 (837)
.++|++.+.||+|+||.||++++..+++.||+|++... .....+.+.+|+.+++.++||||+++++++. ....
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 35699999999999999999999999999999998653 2445567899999999999999999999886 3457
Q ss_pred EEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCcccc
Q 003232 664 LYLVMEYLNGGDLYSLLRN----LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 739 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk~----~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg 739 (837)
.|+||||+.+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++...
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 8999999999999999875 466999999999999999999999999999999999999999999999999988631
Q ss_pred ccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCC---CCchHHHHHHHHHHHHHHcC
Q 003232 740 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG---HGTTADWWSVGIILFELIVG 816 (837)
Q Consensus 740 ~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~---~s~kSDIWSLGVILyELLTG 816 (837)
..... ...............||+.|+|||++.+.. ++.++||||||+++|+|++|
T Consensus 185 ~~~~~----------------------~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g 242 (317)
T 2buj_A 185 CIHVE----------------------GSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFG 242 (317)
T ss_dssp CEEEE----------------------SHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHS
T ss_pred ccccc----------------------cccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhC
Confidence 10000 000001111123346899999999997654 68899999999999999999
Q ss_pred CCCCCC
Q 003232 817 IPPFNA 822 (837)
Q Consensus 817 r~PF~~ 822 (837)
+.||..
T Consensus 243 ~~p~~~ 248 (317)
T 2buj_A 243 EGPYDM 248 (317)
T ss_dssp SCTTHH
T ss_pred CCChhh
Confidence 999953
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=309.73 Aligned_cols=206 Identities=34% Similarity=0.634 Sum_probs=171.9
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccc-----cHHHHHHHHHHHHHHHhcCCCceEEEEeEeecC
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMI-----RKNAVESILAERDILISVRNPFVVRFFYSFTCR 661 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~-----~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~ 661 (837)
..++|++.+.||.|+||.||+|++..+++.||||++...... .......+.+|+.+++.++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 346799999999999999999999999999999999754321 122334688999999999999999999998765
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCc---EEEEecCCccc
Q 003232 662 ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGH---IKLTDFGLSKV 738 (837)
Q Consensus 662 ~~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~---IKLiDFGLArv 738 (837)
. .|+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. ++|+|||+++.
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 166 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred c-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence 4 8999999999999999988888999999999999999999999999999999999999987664 99999999873
Q ss_pred cccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhc---CCCCCchHHHHHHHHHHHHHHc
Q 003232 739 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL---GTGHGTTADWWSVGIILFELIV 815 (837)
Q Consensus 739 g~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLl---g~~~s~kSDIWSLGVILyELLT 815 (837)
... . .......||+.|+|||++. +..++.++|||||||++|+|++
T Consensus 167 ~~~--------------------------~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~ 214 (322)
T 2ycf_A 167 LGE--------------------------T------SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS 214 (322)
T ss_dssp CCC--------------------------C------HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHH
T ss_pred ccc--------------------------c------cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHh
Confidence 100 0 0011245899999999974 5678899999999999999999
Q ss_pred CCCCCCCCCc
Q 003232 816 GIPPFNAEHP 825 (837)
Q Consensus 816 Gr~PF~~~dp 825 (837)
|..||.....
T Consensus 215 g~~pf~~~~~ 224 (322)
T 2ycf_A 215 GYPPFSEHRT 224 (322)
T ss_dssp SSCSSCSTTC
T ss_pred CCCCCcccch
Confidence 9999986544
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-35 Score=304.89 Aligned_cols=213 Identities=30% Similarity=0.470 Sum_probs=175.8
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecC-----
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR----- 661 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~----- 661 (837)
..++|++.+.||.|+||+||+|++..+|+.||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 86 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF 86 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence 4467999999999999999999999999999999996532 344556788999999999999999999987654
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCcccccc
Q 003232 662 ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 741 (837)
Q Consensus 662 ~~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~ 741 (837)
...|+||||+. ++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++....
T Consensus 87 ~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (353)
T 2b9h_A 87 NEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164 (353)
T ss_dssp CCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence 67999999996 699999876 5799999999999999999999999999999999999999999999999999874211
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCC
Q 003232 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPF 820 (837)
Q Consensus 742 ~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLTGr~PF 820 (837)
..... ..............||+.|+|||++.+ ..++.++|||||||++|+|++|..||
T Consensus 165 ~~~~~---------------------~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf 223 (353)
T 2b9h_A 165 SAADN---------------------SEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIF 223 (353)
T ss_dssp ------------------------------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSC
T ss_pred ccccc---------------------cCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCC
Confidence 11000 000001112335679999999998865 77899999999999999999999999
Q ss_pred CCCC
Q 003232 821 NAEH 824 (837)
Q Consensus 821 ~~~d 824 (837)
.+.+
T Consensus 224 ~~~~ 227 (353)
T 2b9h_A 224 PGRD 227 (353)
T ss_dssp CCSS
T ss_pred CCCC
Confidence 8765
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=297.66 Aligned_cols=195 Identities=28% Similarity=0.460 Sum_probs=171.4
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeec-------
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC------- 660 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d------- 660 (837)
..+|++.+.||+|+||.||+|++..+++.||+|++.... ..+.+|+.+++.++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence 356999999999999999999999999999999997643 246689999999999999999998854
Q ss_pred ---------CCeEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEE
Q 003232 661 ---------RENLYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIK 729 (837)
Q Consensus 661 ---------~~~lyLVmEy~~GGSL~dlLk~~--g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IK 729 (837)
...+|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEE
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEE
Confidence 45689999999999999999754 5799999999999999999999999999999999999999999999
Q ss_pred EEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHH
Q 003232 730 LTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGII 809 (837)
Q Consensus 730 LiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVI 809 (837)
|+|||++...... .......||+.|+|||++.+..++.++||||||++
T Consensus 163 l~Dfg~~~~~~~~--------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 210 (284)
T 2a19_B 163 IGDFGLVTSLKND--------------------------------GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLI 210 (284)
T ss_dssp ECCCTTCEESSCC--------------------------------SCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHH
T ss_pred ECcchhheecccc--------------------------------ccccccCCcccccChhhhccCCCcchhhhHHHHHH
Confidence 9999998631100 01123468999999999999999999999999999
Q ss_pred HHHHHcCCCCCC
Q 003232 810 LFELIVGIPPFN 821 (837)
Q Consensus 810 LyELLTGr~PF~ 821 (837)
+|+|++|..||.
T Consensus 211 l~~l~~~~~~~~ 222 (284)
T 2a19_B 211 LAELLHVCDTAF 222 (284)
T ss_dssp HHHHHSCCSSHH
T ss_pred HHHHHhcCCcch
Confidence 999999999874
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=303.66 Aligned_cols=211 Identities=22% Similarity=0.362 Sum_probs=169.4
Q ss_pred cccCCeEEEEEecccCceEEEEEEECC---CCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRT---TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE 662 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~---tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~ 662 (837)
...++|++.+.||.|+||+||+|++.. ++..||+|++.... ......+.+.+|+.+++.++||||+++++++....
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDN-SSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---C-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccc-cchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence 345679999999999999999998865 45589999997653 23445678999999999999999999999987754
Q ss_pred -----eEEEEEEecCCCCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEE
Q 003232 663 -----NLYLVMEYLNGGDLYSLLRN------LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLT 731 (837)
Q Consensus 663 -----~lyLVmEy~~GGSL~dlLk~------~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLi 731 (837)
..|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~ 189 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVA 189 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEEC
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEe
Confidence 45999999999999999843 3569999999999999999999999999999999999999999999999
Q ss_pred ecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHH
Q 003232 732 DFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILF 811 (837)
Q Consensus 732 DFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILy 811 (837)
|||++....... .........|++.|+|||++.+..++.++||||||+++|
T Consensus 190 Dfg~~~~~~~~~-----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 240 (313)
T 3brb_A 190 DFGLSKKIYSGD-----------------------------YYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMW 240 (313)
T ss_dssp SCSCC---------------------------------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHH
T ss_pred ecCcceeccccc-----------------------------ccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHH
Confidence 999986311000 001122345788999999999999999999999999999
Q ss_pred HHHc-CCCCCCCCCcC
Q 003232 812 ELIV-GIPPFNAEHPQ 826 (837)
Q Consensus 812 ELLT-Gr~PF~~~dpd 826 (837)
+|++ |..||......
T Consensus 241 el~~~g~~p~~~~~~~ 256 (313)
T 3brb_A 241 EIATRGMTPYPGVQNH 256 (313)
T ss_dssp HHHTTSCCSSTTCCGG
T ss_pred HHHhcCCCCCccCCHH
Confidence 9999 99999875543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-36 Score=325.44 Aligned_cols=206 Identities=34% Similarity=0.631 Sum_probs=168.8
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccc-----cHHHHHHHHHHHHHHHhcCCCceEEEEeEeecC
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMI-----RKNAVESILAERDILISVRNPFVVRFFYSFTCR 661 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~-----~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~ 661 (837)
..++|.+.+.||+|+||+||+|.+..+++.||+|++...... .......+.+|+.+++.++||||+++++++. .
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~ 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 346799999999999999999999999999999999764321 1222335789999999999999999999875 4
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCC---cEEEEecCCccc
Q 003232 662 ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG---HIKLTDFGLSKV 738 (837)
Q Consensus 662 ~~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG---~IKLiDFGLArv 738 (837)
...|+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~ 291 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 291 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccccee
Confidence 56899999999999999998888899999999999999999999999999999999999997544 599999999873
Q ss_pred cccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC---CCCCchHHHHHHHHHHHHHHc
Q 003232 739 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG---TGHGTTADWWSVGIILFELIV 815 (837)
Q Consensus 739 g~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg---~~~s~kSDIWSLGVILyELLT 815 (837)
... .......+||+.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 292 ~~~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~llt 339 (419)
T 3i6u_A 292 LGE--------------------------------TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS 339 (419)
T ss_dssp CC-------------------------------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHH
T ss_pred cCC--------------------------------CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHH
Confidence 100 011224579999999999864 667889999999999999999
Q ss_pred CCCCCCCCCc
Q 003232 816 GIPPFNAEHP 825 (837)
Q Consensus 816 Gr~PF~~~dp 825 (837)
|..||.....
T Consensus 340 g~~pf~~~~~ 349 (419)
T 3i6u_A 340 GYPPFSEHRT 349 (419)
T ss_dssp SSCSSCCCSS
T ss_pred CCCCCCCCcc
Confidence 9999986543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=319.36 Aligned_cols=209 Identities=25% Similarity=0.364 Sum_probs=169.3
Q ss_pred cccCCeEEEEEecccCceEEEEEEEC---CCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKR---TTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE 662 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk---~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~ 662 (837)
...++|++.+.||+|+||.||+|+++ .++..||||+++... .....+.+.+|+.+++.++||||+++++++....
T Consensus 42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 119 (373)
T 2qol_A 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK 119 (373)
T ss_dssp CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 34567999999999999999999986 467789999997642 3445578999999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCcccccc
Q 003232 663 NLYLVMEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 741 (837)
Q Consensus 663 ~lyLVmEy~~GGSL~dlLk~~g-~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~ 741 (837)
.+|+||||+++++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 9999999999999999998654 699999999999999999999999999999999999999999999999999874211
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCC
Q 003232 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPF 820 (837)
Q Consensus 742 ~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF 820 (837)
.... ........+|+.|+|||++.+..++.++||||||+++|+|++ |+.||
T Consensus 200 ~~~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~ 251 (373)
T 2qol_A 200 DPEA----------------------------AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251 (373)
T ss_dssp ------------------------------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTT
T ss_pred CCcc----------------------------ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCC
Confidence 1000 001112346788999999999999999999999999999997 99999
Q ss_pred CCCC
Q 003232 821 NAEH 824 (837)
Q Consensus 821 ~~~d 824 (837)
...+
T Consensus 252 ~~~~ 255 (373)
T 2qol_A 252 WEMS 255 (373)
T ss_dssp TTCC
T ss_pred CCCC
Confidence 7654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-35 Score=311.15 Aligned_cols=205 Identities=31% Similarity=0.488 Sum_probs=175.4
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecC-----Ce
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR-----EN 663 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~-----~~ 663 (837)
++|++++.||+|+||.||+|++..+++.||+|++.... .......+.+|+.+++.++||||+++++++... ..
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 57999999999999999999999999999999997532 344557889999999999999999999998654 46
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCC
Q 003232 664 LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~s 743 (837)
.|+||||+. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 105 ~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 182 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182 (364)
T ss_dssp EEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence 899999996 599999876 569999999999999999999999999999999999999999999999999987421111
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNA 822 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLTGr~PF~~ 822 (837)
.. ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+
T Consensus 183 ~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 234 (364)
T 3qyz_A 183 DH----------------------------TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 234 (364)
T ss_dssp CB----------------------------CCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred Cc----------------------------cccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCC
Confidence 00 001234579999999998765 5589999999999999999999999987
Q ss_pred CCc
Q 003232 823 EHP 825 (837)
Q Consensus 823 ~dp 825 (837)
.+.
T Consensus 235 ~~~ 237 (364)
T 3qyz_A 235 KHY 237 (364)
T ss_dssp SSG
T ss_pred CCh
Confidence 653
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=312.62 Aligned_cols=213 Identities=21% Similarity=0.263 Sum_probs=171.0
Q ss_pred CCeEEEEEecccCceEEEEEEECC---CCcEEEEEEecccccccH--------HHHHHHHHHHHHHHhcCCCceEEEEeE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRT---TGDLFAIKVLKKADMIRK--------NAVESILAERDILISVRNPFVVRFFYS 657 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~---tG~~VAVKIikk~~~~~~--------e~ie~~~rEieILk~LrHPNIVkL~gs 657 (837)
++|++.+.||+|+||+||+|++.. ++..+|+|++........ .....+.+|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 569999999999999999999987 788999999876432111 111346788889999999999999999
Q ss_pred eec----CCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCC--cEEEE
Q 003232 658 FTC----RENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG--HIKLT 731 (837)
Q Consensus 658 f~d----~~~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG--~IKLi 731 (837)
+.. ....|+||||+ |++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .++|+
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~ 195 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLA 195 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEEC
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEE
Confidence 987 77899999999 999999998777899999999999999999999999999999999999998877 99999
Q ss_pred ecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHH
Q 003232 732 DFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILF 811 (837)
Q Consensus 732 DFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILy 811 (837)
|||+++.......... ..........||+.|+|||++.+..++.++|||||||++|
T Consensus 196 Dfg~a~~~~~~~~~~~------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ 251 (345)
T 2v62_A 196 DYGLSYRYCPNGNHKQ------------------------YQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCML 251 (345)
T ss_dssp CCTTCEESSGGGCCCC------------------------CCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHH
T ss_pred eCCCceeccccccccc------------------------chhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHH
Confidence 9999974221111000 0001123567999999999999999999999999999999
Q ss_pred HHHcCCCCCCCCCcC
Q 003232 812 ELIVGIPPFNAEHPQ 826 (837)
Q Consensus 812 ELLTGr~PF~~~dpd 826 (837)
+|++|+.||.....+
T Consensus 252 ell~g~~pf~~~~~~ 266 (345)
T 2v62_A 252 RWLCGKLPWEQNLKD 266 (345)
T ss_dssp HHHHSSCTTGGGTTC
T ss_pred HHHhCCCCccccccc
Confidence 999999999764433
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-35 Score=299.96 Aligned_cols=206 Identities=30% Similarity=0.474 Sum_probs=168.7
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEee-------
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFT------- 659 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~------- 659 (837)
..++|++++.||.|+||+||+|.+..+++.||+|++... .....+.+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 85 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT 85 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCC
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccc
Confidence 346799999999999999999999999999999998754 3455678899999999999999999998873
Q ss_pred -------cCCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEc-cCCcEEEE
Q 003232 660 -------CRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA-HDGHIKLT 731 (837)
Q Consensus 660 -------d~~~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd-~dG~IKLi 731 (837)
.....|+||||+. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.++|+
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 86 DDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp C----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred cccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEc
Confidence 3468999999997 699999865 6799999999999999999999999999999999999997 56799999
Q ss_pred ecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHH
Q 003232 732 DFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIIL 810 (837)
Q Consensus 732 DFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVIL 810 (837)
|||+++....... .........||+.|+|||++.+ ..++.++||||||+++
T Consensus 164 Dfg~~~~~~~~~~----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il 215 (320)
T 2i6l_A 164 DFGLARIMDPHYS----------------------------HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIF 215 (320)
T ss_dssp CCTTCBCC------------------------------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHH
T ss_pred cCccccccCCCcc----------------------------cccccccccccccccCcHHhcCcccCCchhhhHhHHHHH
Confidence 9999874110000 0011223467999999999876 6789999999999999
Q ss_pred HHHHcCCCCCCCCCc
Q 003232 811 FELIVGIPPFNAEHP 825 (837)
Q Consensus 811 yELLTGr~PF~~~dp 825 (837)
|+|++|+.||.+.+.
T Consensus 216 ~el~~g~~pf~~~~~ 230 (320)
T 2i6l_A 216 AEMLTGKTLFAGAHE 230 (320)
T ss_dssp HHHHHSSCSSCCSSH
T ss_pred HHHHhCCCCCCCCCH
Confidence 999999999987653
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=319.15 Aligned_cols=203 Identities=31% Similarity=0.491 Sum_probs=162.3
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecC----
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR---- 661 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~---- 661 (837)
...++|++++.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+++.++||||+++++++...
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 104 (367)
T 2fst_X 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 104 (367)
T ss_dssp EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccc
Confidence 34478999999999999999999999999999999997643 3344567889999999999999999999998654
Q ss_pred --CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCcccc
Q 003232 662 --ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 739 (837)
Q Consensus 662 --~~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg 739 (837)
..+|+||||+ +++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 105 ~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 105 EFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp GCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred cCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 5689999999 7899998876 67999999999999999999999999999999999999999999999999998631
Q ss_pred ccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCC
Q 003232 740 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIP 818 (837)
Q Consensus 740 ~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLTGr~ 818 (837)
. .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.
T Consensus 183 ~----------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 228 (367)
T 2fst_X 183 A----------------------------------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228 (367)
T ss_dssp ------------------------------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSC
T ss_pred c----------------------------------ccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCC
Confidence 0 01124579999999999987 678999999999999999999999
Q ss_pred CCCCCCc
Q 003232 819 PFNAEHP 825 (837)
Q Consensus 819 PF~~~dp 825 (837)
||.+.+.
T Consensus 229 pf~~~~~ 235 (367)
T 2fst_X 229 LFPGTDH 235 (367)
T ss_dssp SCCCSSH
T ss_pred CCCCCCH
Confidence 9987653
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=312.45 Aligned_cols=208 Identities=30% Similarity=0.522 Sum_probs=169.8
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEeccccccc--HHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCe
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIR--KNAVESILAERDILISVRNPFVVRFFYSFTCREN 663 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~--~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ 663 (837)
...++|++.+.||.|+||+||+|++..+|+.||+|++....... ......+.+|+.+++.++||||+++++++.....
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34577999999999999999999999999999999997543211 1223467899999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccC
Q 003232 664 LYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~ 742 (837)
.|+||||+++ +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence 9999999975 898888654 45899999999999999999999999999999999999999999999999998731100
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCCC
Q 003232 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFN 821 (837)
Q Consensus 743 stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~-~~s~kSDIWSLGVILyELLTGr~PF~ 821 (837)
. .......||+.|+|||++.+. .++.++|||||||++|+|++|.+||.
T Consensus 166 ~-------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~ 214 (346)
T 1ua2_A 166 N-------------------------------RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLP 214 (346)
T ss_dssp C-------------------------------CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred c-------------------------------ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 0 012345789999999999764 58999999999999999999999998
Q ss_pred CCCc
Q 003232 822 AEHP 825 (837)
Q Consensus 822 ~~dp 825 (837)
+.++
T Consensus 215 ~~~~ 218 (346)
T 1ua2_A 215 GDSD 218 (346)
T ss_dssp CSSH
T ss_pred CCCH
Confidence 7653
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=301.57 Aligned_cols=206 Identities=23% Similarity=0.381 Sum_probs=165.3
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeE
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~l 664 (837)
....++|++.+.||+|+||+||+|++. ..||+|+++... ......+.+.+|+.+++.++||||++++++. .....
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~ 94 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQL 94 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSC
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccC-CCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCcc
Confidence 444567999999999999999999864 359999997654 3455567899999999999999999999854 56678
Q ss_pred EEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCC
Q 003232 665 YLVMEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~-~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~s 743 (837)
++||||+.+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 95 AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174 (289)
T ss_dssp EEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred EEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccccc
Confidence 999999999999999954 3569999999999999999999999999999999999999999999999999986311000
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhc---CCCCCchHHHHHHHHHHHHHHcCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL---GTGHGTTADWWSVGIILFELIVGIPPF 820 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLl---g~~~s~kSDIWSLGVILyELLTGr~PF 820 (837)
.........||+.|+|||++. +..++.++||||||+++|+|++|+.||
T Consensus 175 -----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~ 225 (289)
T 3og7_A 175 -----------------------------GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY 225 (289)
T ss_dssp --------------------------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred -----------------------------ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCc
Confidence 001122456999999999997 677889999999999999999999999
Q ss_pred CCCC
Q 003232 821 NAEH 824 (837)
Q Consensus 821 ~~~d 824 (837)
....
T Consensus 226 ~~~~ 229 (289)
T 3og7_A 226 SNIN 229 (289)
T ss_dssp SSCC
T ss_pred cccc
Confidence 7644
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=302.34 Aligned_cols=213 Identities=25% Similarity=0.408 Sum_probs=158.0
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcC-CCceEEEEeEee-------
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFT------- 659 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~Lr-HPNIVkL~gsf~------- 659 (837)
..+|++.+.||+|+||.||+|++..+++.||+|++... .......+.+|+.+++.+. ||||+++++++.
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 103 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD 103 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence 34799999999999999999999999999999998654 2445567899999999996 999999999983
Q ss_pred -cCCeEEEEEEecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCCCCcEEEccCCcEEEEec
Q 003232 660 -CRENLYLVMEYLNGGDLYSLLRN---LGCLDEDVARVYIAEVVLALEYLHSLR--VVHRDLKPDNLLIAHDGHIKLTDF 733 (837)
Q Consensus 660 -d~~~lyLVmEy~~GGSL~dlLk~---~g~Lsee~irkIl~QIa~ALsYLHSkG--IIHRDIKPeNILLd~dG~IKLiDF 733 (837)
....+++||||+. |+|.+++.. .+.+++..++.++.||+.||.|||++| |+||||||+|||++.++.++|+||
T Consensus 104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 104 TGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp TSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred cCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecC
Confidence 3456899999995 799988864 466999999999999999999999999 999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhh---cCCCCCchHHHHHHHHHH
Q 003232 734 GLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEIL---LGTGHGTTADWWSVGIIL 810 (837)
Q Consensus 734 GLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVL---lg~~~s~kSDIWSLGVIL 810 (837)
|+++........... ..............||+.|+|||++ .+..++.++|||||||++
T Consensus 183 g~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il 243 (337)
T 3ll6_A 183 GSATTISHYPDYSWS-------------------AQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCIL 243 (337)
T ss_dssp TTCBCCSSCC--------------------------------------------------CCTTSCSSHHHHHHHHHHHH
T ss_pred ccceeccccCccccc-------------------ccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHH
Confidence 998742111110000 0000001122355799999999998 567789999999999999
Q ss_pred HHHHcCCCCCCCC
Q 003232 811 FELIVGIPPFNAE 823 (837)
Q Consensus 811 yELLTGr~PF~~~ 823 (837)
|+|++|..||...
T Consensus 244 ~el~~g~~p~~~~ 256 (337)
T 3ll6_A 244 YLLCFRQHPFEDG 256 (337)
T ss_dssp HHHHHSSCCC---
T ss_pred HHHHhCCCCCcch
Confidence 9999999999753
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-35 Score=320.15 Aligned_cols=203 Identities=30% Similarity=0.511 Sum_probs=176.8
Q ss_pred CCcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhc------CCCceEEEEeE
Q 003232 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV------RNPFVVRFFYS 657 (837)
Q Consensus 584 ~g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L------rHPNIVkL~gs 657 (837)
......+|++++.||+|+||+||+|++..+++.||||++... ......+.+|+.+++.+ +|+||+++++.
T Consensus 92 ~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~ 167 (429)
T 3kvw_A 92 HDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLEN 167 (429)
T ss_dssp TCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEE
T ss_pred CCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEee
Confidence 344567799999999999999999999999999999999753 23345677888888777 57799999999
Q ss_pred eecCCeEEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCc--EEEEec
Q 003232 658 FTCRENLYLVMEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGH--IKLTDF 733 (837)
Q Consensus 658 f~d~~~lyLVmEy~~GGSL~dlLk~~g--~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~--IKLiDF 733 (837)
+....++|+||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+||
T Consensus 168 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DF 246 (429)
T 3kvw_A 168 FTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDF 246 (429)
T ss_dssp EEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred cccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeec
Confidence 999999999999995 69999987653 4999999999999999999999999999999999999999887 999999
Q ss_pred CCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHH
Q 003232 734 GLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 813 (837)
Q Consensus 734 GLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyEL 813 (837)
|++.... ......+||+.|+|||++.+..++.++|||||||++|+|
T Consensus 247 G~a~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 292 (429)
T 3kvw_A 247 GSSCYEH----------------------------------QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAEL 292 (429)
T ss_dssp TTCEETT----------------------------------CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHH
T ss_pred ccceecC----------------------------------CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHH
Confidence 9986310 012245789999999999999999999999999999999
Q ss_pred HcCCCCCCCCCc
Q 003232 814 IVGIPPFNAEHP 825 (837)
Q Consensus 814 LTGr~PF~~~dp 825 (837)
++|.+||.+.+.
T Consensus 293 ltG~~pf~~~~~ 304 (429)
T 3kvw_A 293 LTGYPLLPGEDE 304 (429)
T ss_dssp HHSSCSSCCSSH
T ss_pred HhCCCCCCCCCH
Confidence 999999987654
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-35 Score=302.75 Aligned_cols=207 Identities=25% Similarity=0.442 Sum_probs=175.2
Q ss_pred CCCCCCc-ccCCeEEEEEecccCceEEEEEEECCCC-cEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCc------e
Q 003232 580 HPSKDRT-SIDDFEIIKPISRGAFGRVFLAKKRTTG-DLFAIKVLKKADMIRKNAVESILAERDILISVRNPF------V 651 (837)
Q Consensus 580 ~P~k~g~-~lddYeIlkkLGsG~FGtVYkArdk~tG-~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPN------I 651 (837)
++...+. ..++|++.+.||+|+||+||+|.+..++ +.||+|+++.. ....+.+.+|+.+++.++|++ +
T Consensus 9 ~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~ 84 (355)
T 2eu9_A 9 LVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLC 84 (355)
T ss_dssp BCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCB
T ss_pred cccccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeE
Confidence 3344443 3467999999999999999999998777 69999999753 234467788999999887665 8
Q ss_pred EEEEeEeecCCeEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEE-------
Q 003232 652 VRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI------- 722 (837)
Q Consensus 652 VkL~gsf~d~~~lyLVmEy~~GGSL~dlLk~~--g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILL------- 722 (837)
+.+++++....++|+||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 85 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~ 163 (355)
T 2eu9_A 85 VLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFET 163 (355)
T ss_dssp CCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEE
T ss_pred EEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccc
Confidence 99999999999999999999 67777777654 369999999999999999999999999999999999999
Q ss_pred ------------ccCCcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChh
Q 003232 723 ------------AHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPE 790 (837)
Q Consensus 723 ------------d~dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPE 790 (837)
+.++.++|+|||+++... .......||+.|+|||
T Consensus 164 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~----------------------------------~~~~~~~gt~~y~aPE 209 (355)
T 2eu9_A 164 LYNEHKSCEEKSVKNTSIRVADFGSATFDH----------------------------------EHHTTIVATRHYRPPE 209 (355)
T ss_dssp EECCC-CCCEEEESCCCEEECCCTTCEETT----------------------------------SCCCSSCSCGGGCCHH
T ss_pred cccccccccccccCCCcEEEeecCcccccc----------------------------------ccccCCcCCCcccCCe
Confidence 567899999999987310 0112457899999999
Q ss_pred hhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 791 ILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 791 VLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
++.+..++.++|||||||++|+|++|..||...+.
T Consensus 210 ~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (355)
T 2eu9_A 210 VILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN 244 (355)
T ss_dssp HHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred eeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999999999999999999999999999987553
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-36 Score=322.75 Aligned_cols=203 Identities=28% Similarity=0.458 Sum_probs=173.8
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC--eEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE--NLY 665 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~--~ly 665 (837)
.++|++.+.||+|+||+||+|++..+++.||||++...... ...+.+.+|+.+++.++||||+++++++.... +.|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 85 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence 35699999999999999999999999999999999764322 22456789999999999999999999988755 789
Q ss_pred EEEEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEE----ccCCcEEEEecCCccc
Q 003232 666 LVMEYLNGGDLYSLLRNLG---CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI----AHDGHIKLTDFGLSKV 738 (837)
Q Consensus 666 LVmEy~~GGSL~dlLk~~g---~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILL----d~dG~IKLiDFGLArv 738 (837)
+||||++|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 9999999999999997543 39999999999999999999999999999999999999 7778899999999873
Q ss_pred cccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC--------CCCCchHHHHHHHHHH
Q 003232 739 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG--------TGHGTTADWWSVGIIL 810 (837)
Q Consensus 739 g~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg--------~~~s~kSDIWSLGVIL 810 (837)
... ........||+.|+|||++.+ ..++.++|||||||++
T Consensus 166 ~~~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il 213 (396)
T 4eut_A 166 LED--------------------------------DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213 (396)
T ss_dssp CCC--------------------------------GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHH
T ss_pred ccC--------------------------------CCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHH
Confidence 100 011234579999999999865 4577899999999999
Q ss_pred HHHHcCCCCCCCCC
Q 003232 811 FELIVGIPPFNAEH 824 (837)
Q Consensus 811 yELLTGr~PF~~~d 824 (837)
|+|++|+.||....
T Consensus 214 ~el~tg~~Pf~~~~ 227 (396)
T 4eut_A 214 YHAATGSLPFRPFE 227 (396)
T ss_dssp HHHHHSSCSEECTT
T ss_pred HHHHHCCCCCCCCC
Confidence 99999999997533
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=309.17 Aligned_cols=206 Identities=28% Similarity=0.442 Sum_probs=174.8
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCCcEE--EEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEeEeecCC
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF--AIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRE 662 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG~~V--AVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~gsf~d~~ 662 (837)
...++|++.+.||.|+||.||+|++..++..+ |+|.+.... .....+.+.+|+.+++.+ +||||+++++++....
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 99 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence 45578999999999999999999998888865 999887532 234456788999999999 8999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCC
Q 003232 663 NLYLVMEYLNGGDLYSLLRNLG----------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG 726 (837)
Q Consensus 663 ~lyLVmEy~~GGSL~dlLk~~g----------------~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG 726 (837)
.+|+||||+++++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence 9999999999999999997654 699999999999999999999999999999999999999999
Q ss_pred cEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHH
Q 003232 727 HIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSV 806 (837)
Q Consensus 727 ~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSL 806 (837)
.++|+|||+++..... .......+++.|+|||++.+..++.++|||||
T Consensus 180 ~~kL~Dfg~~~~~~~~--------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 227 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVY--------------------------------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSY 227 (327)
T ss_dssp CEEECCTTCEESSCEE--------------------------------CCC----CCTTTCCHHHHHHCEECHHHHHHHH
T ss_pred eEEEcccCcCcccccc--------------------------------ccccCCCCCccccChhhhccccCCchhcchHH
Confidence 9999999998621000 01123357889999999998889999999999
Q ss_pred HHHHHHHHc-CCCCCCCCCc
Q 003232 807 GIILFELIV-GIPPFNAEHP 825 (837)
Q Consensus 807 GVILyELLT-Gr~PF~~~dp 825 (837)
|+++|+|++ |..||.+.+.
T Consensus 228 G~il~ellt~g~~pf~~~~~ 247 (327)
T 1fvr_A 228 GVLLWEIVSLGGTPYCGMTC 247 (327)
T ss_dssp HHHHHHHHTTSCCTTTTCCH
T ss_pred HHHHHHHHcCCCCCCCCCcH
Confidence 999999998 9999977543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-35 Score=313.82 Aligned_cols=199 Identities=29% Similarity=0.491 Sum_probs=167.3
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeec------
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC------ 660 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d------ 660 (837)
..++|++.+.||+|+||+||+|++..+|+.||+|++..... ...+|+.+++.++||||++++++|..
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 34679999999999999999999999999999999875431 12369999999999999999999843
Q ss_pred --------------------------------CCeEEEEEEecCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHH
Q 003232 661 --------------------------------RENLYLVMEYLNGGDLYSLLR----NLGCLDEDVARVYIAEVVLALEY 704 (837)
Q Consensus 661 --------------------------------~~~lyLVmEy~~GGSL~dlLk----~~g~Lsee~irkIl~QIa~ALsY 704 (837)
..++++||||++ ++|.+.+. ....+++..++.++.||+.||.|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 345899999997 57776664 35679999999999999999999
Q ss_pred HHhCCcccccCCCCcEEEc-cCCcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCC
Q 003232 705 LHSLRVVHRDLKPDNLLIA-HDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGT 783 (837)
Q Consensus 705 LHSkGIIHRDIKPeNILLd-~dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGT 783 (837)
||++||+||||||+|||++ .++.+||+|||+++..... .......||
T Consensus 157 LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~--------------------------------~~~~~~~~t 204 (383)
T 3eb0_A 157 IHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS--------------------------------EPSVAYICS 204 (383)
T ss_dssp HHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT--------------------------------SCCCCCCCC
T ss_pred HHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC--------------------------------CCCcCcccC
Confidence 9999999999999999997 6899999999998731100 112345789
Q ss_pred CCccChhhhcCCC-CCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 784 PDYLAPEILLGTG-HGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 784 p~YmAPEVLlg~~-~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.
T Consensus 205 ~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 247 (383)
T 3eb0_A 205 RFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETS 247 (383)
T ss_dssp SSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCh
Confidence 9999999998754 89999999999999999999999987653
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-35 Score=322.11 Aligned_cols=200 Identities=31% Similarity=0.531 Sum_probs=174.0
Q ss_pred CCcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC-
Q 003232 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE- 662 (837)
Q Consensus 584 ~g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~- 662 (837)
+....++|++.+.||+|+||.||+|.+. ++.||||+++... ..+.+.+|+.+++.++||||+++++++....
T Consensus 188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 260 (450)
T 1k9a_A 188 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 260 (450)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTS
T ss_pred cccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCC
Confidence 4456678999999999999999999985 7899999997643 2357889999999999999999999987655
Q ss_pred eEEEEEEecCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccc
Q 003232 663 NLYLVMEYLNGGDLYSLLRNLGC--LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740 (837)
Q Consensus 663 ~lyLVmEy~~GGSL~dlLk~~g~--Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~ 740 (837)
.+|+||||+++|+|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 261 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 261 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp CEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred ceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 79999999999999999986543 7999999999999999999999999999999999999999999999999987310
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCC
Q 003232 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPP 819 (837)
Q Consensus 741 ~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~P 819 (837)
. ......+++.|+|||++.+..++.++||||||+++|||++ |..|
T Consensus 341 ~----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P 386 (450)
T 1k9a_A 341 S----------------------------------TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 386 (450)
T ss_dssp ----------------------------------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred c----------------------------------cccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 0 0112257889999999999999999999999999999998 9999
Q ss_pred CCCCC
Q 003232 820 FNAEH 824 (837)
Q Consensus 820 F~~~d 824 (837)
|...+
T Consensus 387 ~~~~~ 391 (450)
T 1k9a_A 387 YPRIP 391 (450)
T ss_dssp STTSC
T ss_pred CCCCC
Confidence 98654
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=294.45 Aligned_cols=207 Identities=23% Similarity=0.340 Sum_probs=169.6
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEe-EeecCCeEEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFY-SFTCRENLYL 666 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~g-sf~d~~~lyL 666 (837)
.++|++.+.||+|+||+||+|++..+++.||+|++..... ...+.+|+.+++.++|++++..+. ++......++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence 3679999999999999999999999999999998765331 235778999999999877655544 4466788999
Q ss_pred EEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEE---ccCCcEEEEecCCccccccC
Q 003232 667 VMEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI---AHDGHIKLTDFGLSKVGLIN 742 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~-~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILL---d~dG~IKLiDFGLArvg~~~ 742 (837)
||||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.++|+|||+++.....
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp EEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 99999 9999999974 4679999999999999999999999999999999999999 78999999999998742211
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003232 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNA 822 (837)
Q Consensus 743 stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~ 822 (837)
...... .........||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 162 ~~~~~~------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 217 (296)
T 4hgt_A 162 RTHQHI------------------------PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQG 217 (296)
T ss_dssp TTCCBC------------------------CCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred ccCccC------------------------CCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcc
Confidence 110000 00122356799999999999999999999999999999999999999986
Q ss_pred CC
Q 003232 823 EH 824 (837)
Q Consensus 823 ~d 824 (837)
..
T Consensus 218 ~~ 219 (296)
T 4hgt_A 218 LK 219 (296)
T ss_dssp CC
T ss_pred cc
Confidence 44
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=310.32 Aligned_cols=209 Identities=18% Similarity=0.295 Sum_probs=173.6
Q ss_pred CCeEEEEEecccCceEEEEEEECC--------CCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEE-------
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRT--------TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVR------- 653 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~--------tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVk------- 653 (837)
++|++.+.||.|+||+||+|++.. .++.||+|++... ..+.+|+.+++.++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 679999999999999999999987 4889999998754 25788999999999999887
Q ss_pred --------EEeEeec-CCeEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEE
Q 003232 654 --------FFYSFTC-RENLYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI 722 (837)
Q Consensus 654 --------L~gsf~d-~~~lyLVmEy~~GGSL~dlLk~~--g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILL 722 (837)
+++++.. ....|+||||+ +++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV 192 (352)
T ss_dssp CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEE
T ss_pred CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE
Confidence 5566655 67899999999 99999999875 779999999999999999999999999999999999999
Q ss_pred ccCC--cEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCch
Q 003232 723 AHDG--HIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT 800 (837)
Q Consensus 723 d~dG--~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~k 800 (837)
+.++ .++|+|||+++.......... ..........||+.|+|||++.+..++.+
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 248 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVA------------------------YVEGSRSPHEGDLEFISMDLHKGCGPSRR 248 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCC------------------------CCTTSSCTTCSCTTTCCHHHHTTCCCCHH
T ss_pred cCCCCceEEEecCcceeeccCCCcccc------------------------ccccccccccCCccccCHHHHccCCCCch
Confidence 9988 899999999974211110000 00011234579999999999999999999
Q ss_pred HHHHHHHHHHHHHHcCCCCCCCCCcCHHHH
Q 003232 801 ADWWSVGIILFELIVGIPPFNAEHPQVSTL 830 (837)
Q Consensus 801 SDIWSLGVILyELLTGr~PF~~~dpdv~~l 830 (837)
+|||||||++|+|++|+.||....+....+
T Consensus 249 ~Di~slG~il~el~~g~~pf~~~~~~~~~~ 278 (352)
T 2jii_A 249 SDLQSLGYCMLKWLYGFLPWTNCLPNTEDI 278 (352)
T ss_dssp HHHHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred hhHHHHHHHHHHHHhCCCCcccCCcCHHHH
Confidence 999999999999999999998876554443
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-35 Score=296.25 Aligned_cols=208 Identities=24% Similarity=0.338 Sum_probs=174.6
Q ss_pred CCcccCCeEEEEEecccCceEEEEEEECCC---CcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeec
Q 003232 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTT---GDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC 660 (837)
Q Consensus 584 ~g~~lddYeIlkkLGsG~FGtVYkArdk~t---G~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d 660 (837)
.+...++|++.+.||+|+||+||+|++... +..||+|++.... .....+.+.+|+.+++.++||||+++++++..
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 84 (281)
T 3cc6_A 7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE 84 (281)
T ss_dssp CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS
T ss_pred ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC
Confidence 345567899999999999999999997543 3469999997653 33455789999999999999999999998765
Q ss_pred CCeEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCcccc
Q 003232 661 RENLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 739 (837)
Q Consensus 661 ~~~lyLVmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg 739 (837)
...|+||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++...
T Consensus 85 -~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 85 -EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred -CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 4568999999999999999765 45999999999999999999999999999999999999999999999999998731
Q ss_pred ccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCC
Q 003232 740 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIP 818 (837)
Q Consensus 740 ~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~ 818 (837)
.... ........||+.|+|||++.+..++.++||||||+++|+|++ |+.
T Consensus 164 ~~~~------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~ 213 (281)
T 3cc6_A 164 EDED------------------------------YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQ 213 (281)
T ss_dssp ---------------------------------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred cccc------------------------------ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCC
Confidence 1000 011223457889999999998999999999999999999998 999
Q ss_pred CCCCCC
Q 003232 819 PFNAEH 824 (837)
Q Consensus 819 PF~~~d 824 (837)
||....
T Consensus 214 p~~~~~ 219 (281)
T 3cc6_A 214 PFFWLE 219 (281)
T ss_dssp TTTTSC
T ss_pred CcccCC
Confidence 997544
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-35 Score=296.27 Aligned_cols=208 Identities=24% Similarity=0.423 Sum_probs=175.9
Q ss_pred CCCCcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecC
Q 003232 582 SKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR 661 (837)
Q Consensus 582 ~k~g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~ 661 (837)
..+....++|++.+.||+|+||+||+|.+. ++..||+|++..... ..+.+.+|+.+++.++||||+++++++. .
T Consensus 6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~ 79 (279)
T 1qpc_A 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVT-Q 79 (279)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred hhcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc----cHHHHHHHHHHHHhCCCcCcceEEEEEc-C
Confidence 345556678999999999999999999984 677899999976432 2356889999999999999999999876 4
Q ss_pred CeEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCcccc
Q 003232 662 ENLYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 739 (837)
Q Consensus 662 ~~lyLVmEy~~GGSL~dlLk~~--g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg 739 (837)
+..++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++...
T Consensus 80 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 159 (279)
T 1qpc_A 80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (279)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence 5689999999999999998653 26999999999999999999999999999999999999999999999999998742
Q ss_pred ccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCC
Q 003232 740 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIP 818 (837)
Q Consensus 740 ~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~ 818 (837)
..... .......|++.|+|||++.+..++.++||||||+++|+|++ |..
T Consensus 160 ~~~~~------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~ 209 (279)
T 1qpc_A 160 EDNEY------------------------------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI 209 (279)
T ss_dssp SSSCE------------------------------ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCC
T ss_pred cCccc------------------------------ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCC
Confidence 11000 01123457889999999998889999999999999999999 999
Q ss_pred CCCCCCc
Q 003232 819 PFNAEHP 825 (837)
Q Consensus 819 PF~~~dp 825 (837)
||...+.
T Consensus 210 p~~~~~~ 216 (279)
T 1qpc_A 210 PYPGMTN 216 (279)
T ss_dssp SSTTCCH
T ss_pred CCcccCH
Confidence 9976543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=298.44 Aligned_cols=201 Identities=30% Similarity=0.526 Sum_probs=169.4
Q ss_pred CCCcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecC-
Q 003232 583 KDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR- 661 (837)
Q Consensus 583 k~g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~- 661 (837)
.+....++|++.+.||+|+||+||++++. |+.||+|++.... ..+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (278)
T 1byg_A 15 GWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 87 (278)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred cccCChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 44556788999999999999999999974 8899999997542 345788999999999999999999987554
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCcccc
Q 003232 662 ENLYLVMEYLNGGDLYSLLRNLGC--LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 739 (837)
Q Consensus 662 ~~lyLVmEy~~GGSL~dlLk~~g~--Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg 739 (837)
..+|+||||+++++|.+++...+. +++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++...
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 167 (278)
T 1byg_A 88 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 167 (278)
T ss_dssp -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred CceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccc
Confidence 478999999999999999976543 899999999999999999999999999999999999999999999999987621
Q ss_pred ccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCC
Q 003232 740 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIP 818 (837)
Q Consensus 740 ~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~ 818 (837)
. .......+++.|+|||++.+..++.++||||||+++|+|++ |..
T Consensus 168 ~----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~ 213 (278)
T 1byg_A 168 S----------------------------------STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 213 (278)
T ss_dssp ------------------------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred c----------------------------------ccccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCC
Confidence 0 00112357889999999999999999999999999999998 999
Q ss_pred CCCCCC
Q 003232 819 PFNAEH 824 (837)
Q Consensus 819 PF~~~d 824 (837)
||...+
T Consensus 214 p~~~~~ 219 (278)
T 1byg_A 214 PYPRIP 219 (278)
T ss_dssp SCTTSC
T ss_pred CCCCCC
Confidence 997654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=295.36 Aligned_cols=206 Identities=25% Similarity=0.347 Sum_probs=171.8
Q ss_pred CeEEEEEecccCceEEEEEEECCCCc---EEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeE-E
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTGD---LFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL-Y 665 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG~---~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~l-y 665 (837)
.|++.++||+|+||+||+|++..++. .||+|++... ......+.+.+|+.+++.++||||+++++++...+.. +
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 47888999999999999999866555 7999998753 2345567899999999999999999999999876654 9
Q ss_pred EEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCC
Q 003232 666 LVMEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744 (837)
Q Consensus 666 LVmEy~~GGSL~dlLk~-~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~st 744 (837)
+||||+.+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.......
T Consensus 100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 99999999999999976 45689999999999999999999999999999999999999999999999999863110000
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCC-CCCC
Q 003232 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPP-FNAE 823 (837)
Q Consensus 745 ddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~P-F~~~ 823 (837)
..........||+.|+|||++.+..++.++||||||+++|+|++|..| |...
T Consensus 180 ---------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~ 232 (298)
T 3pls_A 180 ---------------------------YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI 232 (298)
T ss_dssp ---------------------------GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred ---------------------------cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccC
Confidence 001122345688899999999999999999999999999999995554 5443
Q ss_pred C
Q 003232 824 H 824 (837)
Q Consensus 824 d 824 (837)
+
T Consensus 233 ~ 233 (298)
T 3pls_A 233 D 233 (298)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=291.90 Aligned_cols=208 Identities=23% Similarity=0.346 Sum_probs=172.4
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEE-eEeecCCeEE
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFF-YSFTCRENLY 665 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~-gsf~d~~~ly 665 (837)
..++|++.+.||.|+||+||+|++..+++.||+|++...... ..+.+|+.+++.++|++++..+ .++......|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCceE
Confidence 346799999999999999999999999999999998754321 3578899999999988755444 4446677899
Q ss_pred EEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEE---ccCCcEEEEecCCcccccc
Q 003232 666 LVMEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI---AHDGHIKLTDFGLSKVGLI 741 (837)
Q Consensus 666 LVmEy~~GGSL~dlLk~-~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILL---d~dG~IKLiDFGLArvg~~ 741 (837)
+||||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++.....
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 82 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 999999 9999999974 4579999999999999999999999999999999999999 4889999999999874221
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCC
Q 003232 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFN 821 (837)
Q Consensus 742 ~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~ 821 (837)
...... ..........||+.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 161 ~~~~~~------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 216 (296)
T 3uzp_A 161 ARTHQH------------------------IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQ 216 (296)
T ss_dssp TTTCCB------------------------CCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred cccccc------------------------cccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 111000 00011235679999999999999999999999999999999999999998
Q ss_pred CCC
Q 003232 822 AEH 824 (837)
Q Consensus 822 ~~d 824 (837)
...
T Consensus 217 ~~~ 219 (296)
T 3uzp_A 217 GLK 219 (296)
T ss_dssp SCC
T ss_pred CcC
Confidence 643
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=305.41 Aligned_cols=209 Identities=24% Similarity=0.344 Sum_probs=173.0
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCC----cEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecC
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTG----DLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR 661 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG----~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~ 661 (837)
....+|++.+.||+|+||+||+|.+..++ ..||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus 41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 118 (333)
T 1mqb_A 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 118 (333)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence 34567999999999999999999986553 359999997643 334456789999999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccc
Q 003232 662 ENLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740 (837)
Q Consensus 662 ~~lyLVmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~ 740 (837)
...|+||||+++++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++...
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 9999999999999999999764 569999999999999999999999999999999999999999999999999987311
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCC
Q 003232 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPP 819 (837)
Q Consensus 741 ~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~P 819 (837)
.... .........||+.|+|||++.+..++.++||||||+++|+|++ |..|
T Consensus 199 ~~~~----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p 250 (333)
T 1mqb_A 199 DDPE----------------------------ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250 (333)
T ss_dssp ----------------------------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred cccc----------------------------cccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCC
Confidence 1100 0001123356889999999999999999999999999999998 9999
Q ss_pred CCCCC
Q 003232 820 FNAEH 824 (837)
Q Consensus 820 F~~~d 824 (837)
|...+
T Consensus 251 f~~~~ 255 (333)
T 1mqb_A 251 YWELS 255 (333)
T ss_dssp TTTCC
T ss_pred cccCC
Confidence 97654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=308.49 Aligned_cols=207 Identities=28% Similarity=0.430 Sum_probs=169.9
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEE----EEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCe
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLF----AIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCREN 663 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~V----AVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ 663 (837)
.++|++++.||+|+||+||+|++..+++.+ |+|.+.... .......+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 90 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-
Confidence 467999999999999999999998888766 555554322 2234467889999999999999999999988654
Q ss_pred EEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccC
Q 003232 664 LYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~ 742 (837)
.++||+|+.+++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.....
T Consensus 91 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~ 170 (327)
T 3lzb_A 91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence 78999999999999999764 56999999999999999999999999999999999999999999999999998731100
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCC
Q 003232 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFN 821 (837)
Q Consensus 743 stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~ 821 (837)
. .........||+.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 171 ~-----------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~ 221 (327)
T 3lzb_A 171 E-----------------------------KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221 (327)
T ss_dssp --------------------------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred c-----------------------------ccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCC
Confidence 0 0011223457889999999999999999999999999999999 999998
Q ss_pred CCCcC
Q 003232 822 AEHPQ 826 (837)
Q Consensus 822 ~~dpd 826 (837)
+....
T Consensus 222 ~~~~~ 226 (327)
T 3lzb_A 222 GIPAS 226 (327)
T ss_dssp TCCGG
T ss_pred CCCHH
Confidence 75543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-35 Score=301.48 Aligned_cols=204 Identities=34% Similarity=0.523 Sum_probs=171.1
Q ss_pred cCCeEEEEEecccCceEEEEEEEC-CCCcEEEEEEecccccccHHHHHHHHHHHHHHHhc---CCCceEEEEeEee----
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKR-TTGDLFAIKVLKKADMIRKNAVESILAERDILISV---RNPFVVRFFYSFT---- 659 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk-~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L---rHPNIVkL~gsf~---- 659 (837)
.++|++.+.||+|+||+||+|++. .+++.||+|++...... ......+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccc-ccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 467999999999999999999995 67899999999754321 11112455677666655 8999999999987
Q ss_pred -cCCeEEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCc
Q 003232 660 -CRENLYLVMEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS 736 (837)
Q Consensus 660 -d~~~lyLVmEy~~GGSL~dlLk~~g--~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLA 736 (837)
....+++||||+. ++|.+++.... .+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~ 167 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 167 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccc
Confidence 5568999999997 69999997643 4999999999999999999999999999999999999999999999999998
Q ss_pred cccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcC
Q 003232 737 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVG 816 (837)
Q Consensus 737 rvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTG 816 (837)
..... ........||+.|+|||++.+..++.++||||||+++|+|++|
T Consensus 168 ~~~~~--------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 215 (326)
T 1blx_A 168 RIYSF--------------------------------QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR 215 (326)
T ss_dssp CCCCG--------------------------------GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred ccccC--------------------------------CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcC
Confidence 63100 0112346789999999999999999999999999999999999
Q ss_pred CCCCCCCCc
Q 003232 817 IPPFNAEHP 825 (837)
Q Consensus 817 r~PF~~~dp 825 (837)
..||.+.+.
T Consensus 216 ~~pf~~~~~ 224 (326)
T 1blx_A 216 KPLFRGSSD 224 (326)
T ss_dssp SCSCCCSSH
T ss_pred CCCCCCCCH
Confidence 999987653
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-35 Score=320.93 Aligned_cols=207 Identities=24% Similarity=0.421 Sum_probs=177.4
Q ss_pred CCCCcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecC
Q 003232 582 SKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR 661 (837)
Q Consensus 582 ~k~g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~ 661 (837)
..+....++|++.+.||+|+||+||+|.+. ++..||||+++.... ..+.+.+|+.+++.++||||+++++++. .
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~ 254 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVT-K 254 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-S
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-C
Confidence 345566778999999999999999999985 577899999986432 2467899999999999999999999886 6
Q ss_pred CeEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCcccc
Q 003232 662 ENLYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 739 (837)
Q Consensus 662 ~~lyLVmEy~~GGSL~dlLk~~--g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg 739 (837)
..+|+||||+.+|+|.+++... ..++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 255 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 255 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 6789999999999999999753 36899999999999999999999999999999999999999999999999998731
Q ss_pred ccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCC
Q 003232 740 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIP 818 (837)
Q Consensus 740 ~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~ 818 (837)
.. ..........+|+.|+|||++.+..++.++|||||||++|||++ |+.
T Consensus 335 ~~------------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~ 384 (454)
T 1qcf_A 335 ED------------------------------NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRI 384 (454)
T ss_dssp CC------------------------------HHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred CC------------------------------CceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCC
Confidence 00 00111233457889999999998899999999999999999999 999
Q ss_pred CCCCCC
Q 003232 819 PFNAEH 824 (837)
Q Consensus 819 PF~~~d 824 (837)
||.+.+
T Consensus 385 P~~~~~ 390 (454)
T 1qcf_A 385 PYPGMS 390 (454)
T ss_dssp SSTTCC
T ss_pred CCCCCC
Confidence 997654
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=305.51 Aligned_cols=209 Identities=23% Similarity=0.361 Sum_probs=172.0
Q ss_pred cccCCeEEEEEecccCceEEEEEE-----ECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeec
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAK-----KRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC 660 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkAr-----dk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d 660 (837)
...++|++.+.||.|+||+||+|+ +..++..||+|++.... .......+.+|+.+++.++||||+++++++..
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 104 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence 344679999999999999999999 55678899999997532 34455678999999999999999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEcc---CCcEEE
Q 003232 661 RENLYLVMEYLNGGDLYSLLRNLG-------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKL 730 (837)
Q Consensus 661 ~~~lyLVmEy~~GGSL~dlLk~~g-------~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~---dG~IKL 730 (837)
....|+||||+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++. +..++|
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEE
Confidence 999999999999999999998653 4899999999999999999999999999999999999984 446999
Q ss_pred EecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHH
Q 003232 731 TDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIIL 810 (837)
Q Consensus 731 iDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVIL 810 (837)
+|||++....... .........||+.|+|||++.+..++.++||||||+++
T Consensus 185 ~Dfg~~~~~~~~~-----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 235 (327)
T 2yfx_A 185 GDFGMARDIYRAS-----------------------------YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLL 235 (327)
T ss_dssp CCCHHHHHHHC-----------------------------------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred Ccccccccccccc-----------------------------ccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHH
Confidence 9999986311000 00112344678999999999999999999999999999
Q ss_pred HHHHc-CCCCCCCCCc
Q 003232 811 FELIV-GIPPFNAEHP 825 (837)
Q Consensus 811 yELLT-Gr~PF~~~dp 825 (837)
|+|++ |..||.....
T Consensus 236 ~ellt~g~~p~~~~~~ 251 (327)
T 2yfx_A 236 WEIFSLGYMPYPSKSN 251 (327)
T ss_dssp HHHHTTSCCSSTTCCH
T ss_pred HHHHcCCCCCCCCcCH
Confidence 99998 9999986543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-35 Score=308.67 Aligned_cols=212 Identities=25% Similarity=0.454 Sum_probs=173.9
Q ss_pred ccCCCCCCCCCCcc--cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcC----
Q 003232 574 LRTSPIHPSKDRTS--IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR---- 647 (837)
Q Consensus 574 l~ss~~~P~k~g~~--lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~Lr---- 647 (837)
|..+.++|...+.. .++|++.+.||.|+||+||+|++..+++.||+|++.... .....+.+|+.+++.++
T Consensus 2 y~~~~~~p~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~ 77 (373)
T 1q8y_A 2 YRPGGYHPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADN 77 (373)
T ss_dssp -----CCCCCTTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCC
T ss_pred CCCCCceeeecCCcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc----cchhhhhHHHHHHHHhhcccc
Confidence 34456666654444 357999999999999999999999999999999997532 33456788999988876
Q ss_pred -------CCceEEEEeEeecCC----eEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-Ccccc
Q 003232 648 -------NPFVVRFFYSFTCRE----NLYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSL-RVVHR 713 (837)
Q Consensus 648 -------HPNIVkL~gsf~d~~----~lyLVmEy~~GGSL~dlLk~~--g~Lsee~irkIl~QIa~ALsYLHSk-GIIHR 713 (837)
||||+++++++.... ++++||||+ +++|.+++... ..+++..+..++.||+.||.|||++ ||+||
T Consensus 78 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~ 156 (373)
T 1q8y_A 78 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHT 156 (373)
T ss_dssp SHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECS
T ss_pred cchhccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEec
Confidence 899999999988654 799999999 89999999763 4599999999999999999999998 99999
Q ss_pred cCCCCcEEEcc------CCcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCcc
Q 003232 714 DLKPDNLLIAH------DGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYL 787 (837)
Q Consensus 714 DIKPeNILLd~------dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~Ym 787 (837)
||||+|||++. .+.++|+|||++.... .......||+.|+
T Consensus 157 Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~----------------------------------~~~~~~~~t~~y~ 202 (373)
T 1q8y_A 157 DIKPENVLMEIVDSPENLIQIKIADLGNACWYD----------------------------------EHYTNSIQTREYR 202 (373)
T ss_dssp CCSGGGEEEEEEETTTTEEEEEECCCTTCEETT----------------------------------BCCCSCCSCGGGC
T ss_pred CCChHHeEEeccCCCcCcceEEEcccccccccC----------------------------------CCCCCCCCCcccc
Confidence 99999999953 3479999999986310 0112346899999
Q ss_pred ChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 788 APEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 788 APEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
|||++.+..++.++|||||||++|+|++|..||...+
T Consensus 203 aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 203 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp CHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred CcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 9999999999999999999999999999999998655
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=305.60 Aligned_cols=205 Identities=30% Similarity=0.467 Sum_probs=176.1
Q ss_pred cCCeEEEEEecccCceEEEEEE----ECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEee--cC
Q 003232 588 IDDFEIIKPISRGAFGRVFLAK----KRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFT--CR 661 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkAr----dk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~--d~ 661 (837)
.++|++++.||+|+||.||+|+ +..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++. ..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 98 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR 98 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence 3579999999999999999999 46788999999997643 445567899999999999999999999886 45
Q ss_pred CeEEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccc
Q 003232 662 ENLYLVMEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740 (837)
Q Consensus 662 ~~lyLVmEy~~GGSL~dlLk~-~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~ 740 (837)
..+|+||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++....
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 679999999999999999976 3569999999999999999999999999999999999999999999999999987421
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCC
Q 003232 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820 (837)
Q Consensus 741 ~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF 820 (837)
.... .........||+.|+|||++.+..++.++||||||+++|+|++|..||
T Consensus 179 ~~~~----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~ 230 (327)
T 3lxl_A 179 LDKD----------------------------YYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS 230 (327)
T ss_dssp TTCS----------------------------EEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGG
T ss_pred cCCc----------------------------cceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCC
Confidence 1100 001122446888999999999999999999999999999999999998
Q ss_pred CCC
Q 003232 821 NAE 823 (837)
Q Consensus 821 ~~~ 823 (837)
...
T Consensus 231 ~~~ 233 (327)
T 3lxl_A 231 CSP 233 (327)
T ss_dssp GSH
T ss_pred ccc
Confidence 653
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=307.79 Aligned_cols=204 Identities=32% Similarity=0.519 Sum_probs=175.2
Q ss_pred CCeEEE-EEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcC-CCceEEEEeEeecCCeEEE
Q 003232 589 DDFEII-KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCRENLYL 666 (837)
Q Consensus 589 ddYeIl-kkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~Lr-HPNIVkL~gsf~d~~~lyL 666 (837)
+.|.+. +.||+|+||+||+|++..+++.||+|++...... ......+.+|+.+++.+. ||||+++++++.....+|+
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l 106 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRG-QDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL 106 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETT-EECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence 458887 8999999999999999999999999999765422 223457889999999985 6999999999999999999
Q ss_pred EEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEcc---CCcEEEEecCCcccccc
Q 003232 667 VMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGLI 741 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~~--g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~---dG~IKLiDFGLArvg~~ 741 (837)
||||+.+++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++. ++.++|+|||+++....
T Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 186 (327)
T 3lm5_A 107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186 (327)
T ss_dssp EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence 99999999999998543 66999999999999999999999999999999999999987 78999999999873100
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCC
Q 003232 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFN 821 (837)
Q Consensus 742 ~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~ 821 (837)
........||+.|+|||++.+..++.++||||||+++|+|++|+.||.
T Consensus 187 --------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 234 (327)
T 3lm5_A 187 --------------------------------ACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFV 234 (327)
T ss_dssp ---------------------------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred --------------------------------ccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 001123579999999999999999999999999999999999999997
Q ss_pred CCCc
Q 003232 822 AEHP 825 (837)
Q Consensus 822 ~~dp 825 (837)
..+.
T Consensus 235 ~~~~ 238 (327)
T 3lm5_A 235 GEDN 238 (327)
T ss_dssp CSSH
T ss_pred CCCc
Confidence 7554
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-36 Score=310.76 Aligned_cols=204 Identities=26% Similarity=0.387 Sum_probs=174.2
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeE
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~l 664 (837)
....++|++.+.||+|+||+||+|++ .+++.||+|++...... .....+.+|+.+++.++||||+++++++......
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (326)
T 3uim_A 26 QVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 102 (326)
T ss_dssp HTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCC
T ss_pred HHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCc--hHHHHHHHHHHHHHhccCCCccceEEEEecCCce
Confidence 34456799999999999999999986 46899999999764321 1123588999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccccCCCCcEEEccCCcEEEEecCCcc
Q 003232 665 YLVMEYLNGGDLYSLLRNLG----CLDEDVARVYIAEVVLALEYLHSL---RVVHRDLKPDNLLIAHDGHIKLTDFGLSK 737 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~g----~Lsee~irkIl~QIa~ALsYLHSk---GIIHRDIKPeNILLd~dG~IKLiDFGLAr 737 (837)
++||||+.+++|.+++.... .+++..+..++.||+.||.|||++ ||+||||||+|||++.++.++|+|||+++
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~ 182 (326)
T 3uim_A 103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182 (326)
T ss_dssp EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccc
Confidence 99999999999999997643 489999999999999999999999 99999999999999999999999999987
Q ss_pred ccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCC
Q 003232 738 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGI 817 (837)
Q Consensus 738 vg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr 817 (837)
....... .......||+.|+|||++.+..++.++||||||+++|+|++|.
T Consensus 183 ~~~~~~~------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 232 (326)
T 3uim_A 183 LMDYKDT------------------------------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 232 (326)
T ss_dssp ECCSSSS------------------------------CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCC
T ss_pred ccCcccc------------------------------cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCC
Confidence 4211100 1123456999999999999888999999999999999999999
Q ss_pred CCCC
Q 003232 818 PPFN 821 (837)
Q Consensus 818 ~PF~ 821 (837)
.||.
T Consensus 233 ~pf~ 236 (326)
T 3uim_A 233 RAFD 236 (326)
T ss_dssp CSBC
T ss_pred Cccc
Confidence 9995
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=310.50 Aligned_cols=200 Identities=30% Similarity=0.455 Sum_probs=173.4
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeE--
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL-- 664 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~l-- 664 (837)
..++|.+.+.||+|+||+||+|.+..+|+.||+|++.... ........+.+|+.+++.++||||+++++++......
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 118 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 118 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTT
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccc
Confidence 3467999999999999999999999999999999997643 3345567889999999999999999999999876654
Q ss_pred ----EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccc
Q 003232 665 ----YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740 (837)
Q Consensus 665 ----yLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~ 740 (837)
|+||||+. ++|.+++. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++...
T Consensus 119 ~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 119 FYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp CCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred ceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 99999996 68888764 349999999999999999999999999999999999999999999999999986310
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCC
Q 003232 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPP 819 (837)
Q Consensus 741 ~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLTGr~P 819 (837)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus 196 ----------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~p 241 (371)
T 4exu_A 196 ----------------------------------AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTL 241 (371)
T ss_dssp --------------------------------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred ----------------------------------cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCC
Confidence 01224578999999999987 7889999999999999999999999
Q ss_pred CCCCC
Q 003232 820 FNAEH 824 (837)
Q Consensus 820 F~~~d 824 (837)
|.+.+
T Consensus 242 f~~~~ 246 (371)
T 4exu_A 242 FKGKD 246 (371)
T ss_dssp CCCSS
T ss_pred CCCCC
Confidence 98755
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-35 Score=298.74 Aligned_cols=207 Identities=28% Similarity=0.497 Sum_probs=171.9
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEeccccccc-HHHHHHHHHHHHHHHhcCCCceEEEEeEee--cCCeE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIR-KNAVESILAERDILISVRNPFVVRFFYSFT--CRENL 664 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~-~e~ie~~~rEieILk~LrHPNIVkL~gsf~--d~~~l 664 (837)
.++|++.+.||+|+||.||+|.+..+++.||+|++....... ......+.+|+.+++.++||||+++++++. .....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 467999999999999999999999999999999997643211 234567899999999999999999999984 45689
Q ss_pred EEEEEecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccC
Q 003232 665 YLVMEYLNGGDLYSLLRN--LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~--~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~ 742 (837)
|+||||+.++ |.+++.. ...+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++......
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 9999999876 7777765 356999999999999999999999999999999999999999999999999998731100
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCC--CchHHHHHHHHHHHHHHcCCCCC
Q 003232 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH--GTTADWWSVGIILFELIVGIPPF 820 (837)
Q Consensus 743 stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~--s~kSDIWSLGVILyELLTGr~PF 820 (837)
.. ........||+.|+|||++.+... +.++||||||+++|+|++|..||
T Consensus 163 ~~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 213 (305)
T 2wtk_C 163 AA-----------------------------DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF 213 (305)
T ss_dssp CS-----------------------------SCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSC
T ss_pred cc-----------------------------ccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCC
Confidence 00 011234568999999999987544 78999999999999999999999
Q ss_pred CCCC
Q 003232 821 NAEH 824 (837)
Q Consensus 821 ~~~d 824 (837)
...+
T Consensus 214 ~~~~ 217 (305)
T 2wtk_C 214 EGDN 217 (305)
T ss_dssp CCSS
T ss_pred CCch
Confidence 8654
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=300.90 Aligned_cols=198 Identities=31% Similarity=0.504 Sum_probs=167.4
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEE
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyL 666 (837)
..++|++.+.||+|+||+||++++. ++.||+|++... ...+.+.+|+.+++.++||||+++++++.. ..|+
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~l 76 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCL 76 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEE
T ss_pred CHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEE
Confidence 3567999999999999999999974 788999998643 234678999999999999999999998773 4789
Q ss_pred EEEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCcccccCCCCcEEEccCCc-EEEEecCCcccc
Q 003232 667 VMEYLNGGDLYSLLRNLG---CLDEDVARVYIAEVVLALEYLHS---LRVVHRDLKPDNLLIAHDGH-IKLTDFGLSKVG 739 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~~g---~Lsee~irkIl~QIa~ALsYLHS---kGIIHRDIKPeNILLd~dG~-IKLiDFGLArvg 739 (837)
||||++|++|.+++.... .++...+..++.||+.||.|||+ +||+||||||+|||++.++. +||+|||++...
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 77 VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156 (307)
T ss_dssp EEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred EEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence 999999999999998654 37889999999999999999999 89999999999999998886 799999998621
Q ss_pred ccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCC
Q 003232 740 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPP 819 (837)
Q Consensus 740 ~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~P 819 (837)
. .......||+.|+|||++.+..++.++||||||+++|+|++|+.|
T Consensus 157 ~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 202 (307)
T 2eva_A 157 Q----------------------------------THMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP 202 (307)
T ss_dssp ------------------------------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCT
T ss_pred c----------------------------------cccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 0 001223589999999999999999999999999999999999999
Q ss_pred CCCCCcCH
Q 003232 820 FNAEHPQV 827 (837)
Q Consensus 820 F~~~dpdv 827 (837)
|.......
T Consensus 203 ~~~~~~~~ 210 (307)
T 2eva_A 203 FDEIGGPA 210 (307)
T ss_dssp TTTTCSSH
T ss_pred chhhCccH
Confidence 98655443
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-35 Score=298.28 Aligned_cols=206 Identities=34% Similarity=0.614 Sum_probs=177.3
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeE
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~l 664 (837)
+...++|++.+.||.|+||+||+|++..+++.||+|++...... ......+.+|+.+++.++||||+++++++.....+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence 34456799999999999999999999999999999999764422 23346788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccC---CcEEEEecCCcccccc
Q 003232 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD---GHIKLTDFGLSKVGLI 741 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~d---G~IKLiDFGLArvg~~ 741 (837)
|+||||+.+++|.+++...+.+++..+..++.||+.||.|||++||+|+||||+||+++.+ +.++|+|||++.....
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~ 176 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (287)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence 9999999999999999887889999999999999999999999999999999999999754 4799999999863110
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCC
Q 003232 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFN 821 (837)
Q Consensus 742 ~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~ 821 (837)
.. ......||+.|+|||++.+. ++.++||||||+++|+|++|..||.
T Consensus 177 ~~--------------------------------~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~ 223 (287)
T 2wei_A 177 NT--------------------------------KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFY 223 (287)
T ss_dssp CS--------------------------------SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CC--------------------------------ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCC
Confidence 00 01122467889999998765 8999999999999999999999997
Q ss_pred CCC
Q 003232 822 AEH 824 (837)
Q Consensus 822 ~~d 824 (837)
..+
T Consensus 224 ~~~ 226 (287)
T 2wei_A 224 GKN 226 (287)
T ss_dssp CSS
T ss_pred CCC
Confidence 654
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=296.01 Aligned_cols=209 Identities=28% Similarity=0.408 Sum_probs=175.9
Q ss_pred cccCCeEEEE-EecccCceEEEEEEEC--CCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC
Q 003232 586 TSIDDFEIIK-PISRGAFGRVFLAKKR--TTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE 662 (837)
Q Consensus 586 ~~lddYeIlk-kLGsG~FGtVYkArdk--~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~ 662 (837)
...++|.+.+ .||+|+||+||+|.+. .++..||+|++.... .....+.+.+|+.+++.++||||+++++++ ..+
T Consensus 6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~ 82 (287)
T 1u59_A 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE 82 (287)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS
T ss_pred ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC
Confidence 3446788887 9999999999999864 467889999998642 345567899999999999999999999998 456
Q ss_pred eEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCcccccc
Q 003232 663 NLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 741 (837)
Q Consensus 663 ~lyLVmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~ 741 (837)
..++||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.....
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 799999999999999999653 5699999999999999999999999999999999999999999999999999874211
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCC
Q 003232 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPF 820 (837)
Q Consensus 742 ~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF 820 (837)
.... ........||+.|+|||++.+..++.++||||||+++|+|++ |+.||
T Consensus 163 ~~~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~ 214 (287)
T 1u59_A 163 DDSY----------------------------YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 214 (287)
T ss_dssp CSCE----------------------------ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred Ccce----------------------------eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCc
Confidence 1000 001123457889999999998889999999999999999998 99999
Q ss_pred CCCCc
Q 003232 821 NAEHP 825 (837)
Q Consensus 821 ~~~dp 825 (837)
.....
T Consensus 215 ~~~~~ 219 (287)
T 1u59_A 215 KKMKG 219 (287)
T ss_dssp TTCCT
T ss_pred ccCCH
Confidence 76543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=297.03 Aligned_cols=207 Identities=26% Similarity=0.358 Sum_probs=169.8
Q ss_pred CCeEEEEEecccCceEEEEEEECCCC---cEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEe-ecCCeE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTG---DLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSF-TCRENL 664 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG---~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf-~d~~~l 664 (837)
.+|++.+.||+|+||+||+|++..++ ..+|+|.+... ......+.+.+|+.+++.++||||+++++++ ......
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 46999999999999999999975433 36899998763 2345567899999999999999999999985 456688
Q ss_pred EEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCC
Q 003232 665 YLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~s 743 (837)
|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++......
T Consensus 103 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 182 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 182 (298)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGG
T ss_pred EEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccc
Confidence 9999999999999999763 558999999999999999999999999999999999999999999999999987311000
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNA 822 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~~ 822 (837)
. ..........||+.|+|||++.+..++.++||||||+++|+|++ |.+||..
T Consensus 183 ~---------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~ 235 (298)
T 3f66_A 183 Y---------------------------YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 235 (298)
T ss_dssp G---------------------------CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred h---------------------------hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 0 00011234567889999999999999999999999999999999 6667765
Q ss_pred CC
Q 003232 823 EH 824 (837)
Q Consensus 823 ~d 824 (837)
..
T Consensus 236 ~~ 237 (298)
T 3f66_A 236 VN 237 (298)
T ss_dssp SC
T ss_pred CC
Confidence 44
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-35 Score=326.18 Aligned_cols=208 Identities=24% Similarity=0.414 Sum_probs=180.7
Q ss_pred CCcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCe
Q 003232 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCREN 663 (837)
Q Consensus 584 ~g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ 663 (837)
+....++|++.+.||+|+||.||+|.++.++..||||+++.... ..+.+.+|+.+++.++||||+++++++.....
T Consensus 215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 290 (495)
T 1opk_A 215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 290 (495)
T ss_dssp CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 44556789999999999999999999998899999999976432 24578999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCcccccc
Q 003232 664 LYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 741 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk~~--g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~ 741 (837)
+|+||||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 291 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 291 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 99999999999999999764 4589999999999999999999999999999999999999999999999999874110
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCC
Q 003232 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPF 820 (837)
Q Consensus 742 ~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF 820 (837)
.. ........+++.|+|||++.+..++.++|||||||++|||++ |..||
T Consensus 371 ~~------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~ 420 (495)
T 1opk_A 371 DT------------------------------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 420 (495)
T ss_dssp CC------------------------------EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred Cc------------------------------eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCC
Confidence 00 001123456788999999998899999999999999999999 99999
Q ss_pred CCCCc
Q 003232 821 NAEHP 825 (837)
Q Consensus 821 ~~~dp 825 (837)
.+.+.
T Consensus 421 ~~~~~ 425 (495)
T 1opk_A 421 PGIDL 425 (495)
T ss_dssp TTCCG
T ss_pred CCCCH
Confidence 87553
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=298.03 Aligned_cols=210 Identities=25% Similarity=0.377 Sum_probs=166.2
Q ss_pred ccCCeEEEEEecccCceEEEEEEECC-CCc--EEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCe
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRT-TGD--LFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCREN 663 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~-tG~--~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ 663 (837)
..++|++.+.||.|+||+||+|++.. ++. .||+|+++..........+.+.+|+.+++.++||||+++++++....
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP- 94 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence 34679999999999999999998743 333 68999998655444566778999999999999999999999988755
Q ss_pred EEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccC
Q 003232 664 LYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~ 742 (837)
.++||||+.+++|.+++... +.+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++......
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 174 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccccc
Confidence 88999999999999999764 56999999999999999999999999999999999999999999999999998742111
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCC
Q 003232 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFN 821 (837)
Q Consensus 743 stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~ 821 (837)
... ........||+.|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus 175 ~~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~ 226 (291)
T 1u46_A 175 DDH----------------------------YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI 226 (291)
T ss_dssp CCE----------------------------EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ccc----------------------------hhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 000 001123457888999999998889999999999999999999 999997
Q ss_pred CCCc
Q 003232 822 AEHP 825 (837)
Q Consensus 822 ~~dp 825 (837)
..+.
T Consensus 227 ~~~~ 230 (291)
T 1u46_A 227 GLNG 230 (291)
T ss_dssp TCCH
T ss_pred cCCH
Confidence 6543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=297.58 Aligned_cols=211 Identities=29% Similarity=0.458 Sum_probs=174.4
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcC--CCceEEEEeEeecCC
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR--NPFVVRFFYSFTCRE 662 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~Lr--HPNIVkL~gsf~d~~ 662 (837)
....++|++++.||.|+||.||++.+. +++.||+|++.... ........+.+|+.+++.++ ||||+++++++....
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 101 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 101 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEecccc-ccccchHHHHHHHHHHHhccccCCceEEEEEEeecCC
Confidence 344466999999999999999999985 58999999997643 23455678999999999997 599999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccC
Q 003232 663 NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (837)
Q Consensus 663 ~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~ 742 (837)
.+|+||| +.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++ ++.++|+|||++......
T Consensus 102 ~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~ 179 (313)
T 3cek_A 102 YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 179 (313)
T ss_dssp EEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC----
T ss_pred EEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCc
Confidence 9999999 55889999999888899999999999999999999999999999999999995 589999999998631100
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-----------CCCCchHHHHHHHHHHH
Q 003232 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-----------TGHGTTADWWSVGIILF 811 (837)
Q Consensus 743 stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-----------~~~s~kSDIWSLGVILy 811 (837)
.. ........||+.|+|||++.+ ..++.++||||||+++|
T Consensus 180 ~~-----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~ 230 (313)
T 3cek_A 180 TT-----------------------------SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY 230 (313)
T ss_dssp ---------------------------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHH
T ss_pred cc-----------------------------cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHH
Confidence 00 011224569999999999976 46889999999999999
Q ss_pred HHHcCCCCCCCCCcCHH
Q 003232 812 ELIVGIPPFNAEHPQVS 828 (837)
Q Consensus 812 ELLTGr~PF~~~dpdv~ 828 (837)
+|++|..||........
T Consensus 231 el~~g~~pf~~~~~~~~ 247 (313)
T 3cek_A 231 YMTYGKTPFQQIINQIS 247 (313)
T ss_dssp HHHHSSCTTTTCCSHHH
T ss_pred HHHhCCCchhhHHHHHH
Confidence 99999999987654433
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=305.13 Aligned_cols=203 Identities=26% Similarity=0.407 Sum_probs=167.1
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEeccccc--------ccHHHHHHHHHHHHHHHhcCCCceEEEEeEee
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADM--------IRKNAVESILAERDILISVRNPFVVRFFYSFT 659 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~--------~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~ 659 (837)
.++|++.+.||+|+||.||+|.+. +|+.||||++..... ......+.+.+|+.+++.++||||+++++++.
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred ccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 467999999999999999999985 499999999865321 22344578999999999999999999999984
Q ss_pred c-----CCeEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEec
Q 003232 660 C-----RENLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDF 733 (837)
Q Consensus 660 d-----~~~lyLVmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDF 733 (837)
. ...+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+||
T Consensus 100 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Df 178 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDF 178 (362)
T ss_dssp ECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCT
T ss_pred eccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEec
Confidence 3 347899999997 6888887654 46999999999999999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHH
Q 003232 734 GLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFE 812 (837)
Q Consensus 734 GLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyE 812 (837)
|++..... ........||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 179 g~~~~~~~--------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ 226 (362)
T 3pg1_A 179 NLAREDTA--------------------------------DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAE 226 (362)
T ss_dssp TC-----------------------------------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHH
T ss_pred Cccccccc--------------------------------ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHH
Confidence 99862100 011234578999999999987 678999999999999999
Q ss_pred HHcCCCCCCCCC
Q 003232 813 LIVGIPPFNAEH 824 (837)
Q Consensus 813 LLTGr~PF~~~d 824 (837)
|++|+.||.+.+
T Consensus 227 l~~g~~pf~~~~ 238 (362)
T 3pg1_A 227 MFNRKALFRGST 238 (362)
T ss_dssp HHHSSCSCCCSS
T ss_pred HHhCCCCCCCCC
Confidence 999999998755
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=307.67 Aligned_cols=207 Identities=25% Similarity=0.537 Sum_probs=178.6
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccH--------------HHHHHHHHHHHHHHhcCCCc
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRK--------------NAVESILAERDILISVRNPF 650 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~--------------e~ie~~~rEieILk~LrHPN 650 (837)
....++|++.+.||.|+||.||+|++ +++.||+|++........ .....+.+|+.+++.++|||
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 104 (348)
T 2pml_X 27 DKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEY 104 (348)
T ss_dssp CEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTT
T ss_pred ccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCC
Confidence 34567899999999999999999998 899999999975432211 11267899999999999999
Q ss_pred eEEEEeEeecCCeEEEEEEecCCCCHHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCcEE
Q 003232 651 VVRFFYSFTCRENLYLVMEYLNGGDLYSL------LRN--LGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLL 721 (837)
Q Consensus 651 IVkL~gsf~d~~~lyLVmEy~~GGSL~dl------Lk~--~g~Lsee~irkIl~QIa~ALsYLHS-kGIIHRDIKPeNIL 721 (837)
|+++++++.....+|+||||+++++|.++ +.. ...+++..++.++.||+.||.|||+ +||+|+||||+|||
T Consensus 105 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil 184 (348)
T 2pml_X 105 CLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL 184 (348)
T ss_dssp BCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEE
T ss_pred cceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEE
Confidence 99999999999999999999999999998 655 5679999999999999999999999 99999999999999
Q ss_pred EccCCcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCC-CCCc-
Q 003232 722 IAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGT- 799 (837)
Q Consensus 722 Ld~dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~-~~s~- 799 (837)
++.++.++|+|||++..... .......||+.|+|||++.+. .++.
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~ 231 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVD---------------------------------KKIKGSRGTYEFMPPEFFSNESSYNGA 231 (348)
T ss_dssp ECTTSCEEECCCTTCEECBT---------------------------------TEECSSCSCGGGCCGGGGSSCCCEEHH
T ss_pred EcCCCcEEEecccccccccc---------------------------------ccccCCCCCcCccCchhhcCCCCCCcc
Confidence 99999999999999863100 012345789999999999887 6666
Q ss_pred hHHHHHHHHHHHHHHcCCCCCCCCCcC
Q 003232 800 TADWWSVGIILFELIVGIPPFNAEHPQ 826 (837)
Q Consensus 800 kSDIWSLGVILyELLTGr~PF~~~dpd 826 (837)
++||||||+++|+|++|..||...+..
T Consensus 232 ~~Di~slG~il~~l~~g~~pf~~~~~~ 258 (348)
T 2pml_X 232 KVDIWSLGICLYVMFYNVVPFSLKISL 258 (348)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSCS
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 999999999999999999999876653
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-35 Score=303.11 Aligned_cols=208 Identities=28% Similarity=0.422 Sum_probs=162.0
Q ss_pred CCCcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHH--HHhcCCCceEEEEeEeec
Q 003232 583 KDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDI--LISVRNPFVVRFFYSFTC 660 (837)
Q Consensus 583 k~g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieI--Lk~LrHPNIVkL~gsf~d 660 (837)
.+...+++|++.+.||+|+||+||+|++ +++.||||++.... ...+..|.++ +..++||||+++++.+..
T Consensus 7 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~ 78 (336)
T 3g2f_A 7 EPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDER 78 (336)
T ss_dssp --CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred CCCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheecccc
Confidence 3456678999999999999999999986 68999999997542 1233344444 445899999999875432
Q ss_pred -----CCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CcccccCCCCcEEEccCC
Q 003232 661 -----RENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL---------RVVHRDLKPDNLLIAHDG 726 (837)
Q Consensus 661 -----~~~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSk---------GIIHRDIKPeNILLd~dG 726 (837)
...+|+||||+++|+|.+++... ..++..+..++.||+.||.|||+. ||+||||||+|||++.++
T Consensus 79 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~ 157 (336)
T 3g2f_A 79 VTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG 157 (336)
T ss_dssp ECTTSCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS
T ss_pred cccCCCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC
Confidence 34689999999999999999764 458899999999999999999999 999999999999999999
Q ss_pred cEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-------CCCCc
Q 003232 727 HIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-------TGHGT 799 (837)
Q Consensus 727 ~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-------~~~s~ 799 (837)
.+||+|||+++......... ............||+.|+|||++.+ ..++.
T Consensus 158 ~~kL~DFG~a~~~~~~~~~~-----------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~ 214 (336)
T 3g2f_A 158 TCVISDFGLSMRLTGNRLVR-----------------------PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALK 214 (336)
T ss_dssp CEEECCCTTCEECSSSSCC--------------------------------CCTTSCGGGCCHHHHTTCCCGGGHHHHHH
T ss_pred cEEEeeccceeecccccccC-----------------------ccccccccccCCCccceeCchhhcCCccccccccccc
Confidence 99999999997421111000 0001112335679999999999987 45567
Q ss_pred hHHHHHHHHHHHHHHcCCCCCCC
Q 003232 800 TADWWSVGIILFELIVGIPPFNA 822 (837)
Q Consensus 800 kSDIWSLGVILyELLTGr~PF~~ 822 (837)
++|||||||++|+|++|..||..
T Consensus 215 ~~DiwslG~il~ell~g~~p~~~ 237 (336)
T 3g2f_A 215 QVDMYALGLIYWEIFMRCTDLFP 237 (336)
T ss_dssp HHHHHHHHHHHHHHHTTBGGGST
T ss_pred ccchHHHHHHHHHHHhcCCcCCC
Confidence 89999999999999999777643
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=290.68 Aligned_cols=207 Identities=33% Similarity=0.548 Sum_probs=163.4
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeec-------
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC------- 660 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d------- 660 (837)
.++|++.+.||.|+||+||+|++..+++.||+|++... ......+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP 80 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence 35699999999999999999999999999999999653 3455788999999999999999999998765
Q ss_pred ------CCeEEEEEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEec
Q 003232 661 ------RENLYLVMEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDF 733 (837)
Q Consensus 661 ------~~~lyLVmEy~~GGSL~dlLk~~g-~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDF 733 (837)
...+|+||||+++++|.+++...+ .+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+||
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 81 MTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp -----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred hcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeC
Confidence 457899999999999999998643 5788999999999999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCC-CCCchHHHHHHHHHHHH
Q 003232 734 GLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFE 812 (837)
Q Consensus 734 GLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~-~~s~kSDIWSLGVILyE 812 (837)
|++........ .... ................||+.|+|||++.+. .++.++|||||||++|+
T Consensus 161 g~~~~~~~~~~-~~~~----------------~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~ 223 (303)
T 1zy4_A 161 GLAKNVHRSLD-ILKL----------------DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223 (303)
T ss_dssp CCCSCTTC------------------------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHH
T ss_pred cchhhcccccc-hhcc----------------ccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHH
Confidence 99873211000 0000 000000011223456799999999999865 68999999999999999
Q ss_pred HHc
Q 003232 813 LIV 815 (837)
Q Consensus 813 LLT 815 (837)
|++
T Consensus 224 l~~ 226 (303)
T 1zy4_A 224 MIY 226 (303)
T ss_dssp HHS
T ss_pred HHh
Confidence 998
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=294.83 Aligned_cols=202 Identities=30% Similarity=0.460 Sum_probs=170.9
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVm 668 (837)
++|.....||.|+||+||+|++..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++......++||
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 98 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFM 98 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEE
Confidence 34555568999999999999999999999999997643 234467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEcc-CCcEEEEecCCccccccCCC
Q 003232 669 EYLNGGDLYSLLRNL---GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH-DGHIKLTDFGLSKVGLINST 744 (837)
Q Consensus 669 Ey~~GGSL~dlLk~~---g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~-dG~IKLiDFGLArvg~~~st 744 (837)
||+++++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+||+++. ++.++|+|||++......
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~-- 176 (295)
T 2clq_A 99 EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI-- 176 (295)
T ss_dssp ECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred EeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCC--
Confidence 999999999999764 24678899999999999999999999999999999999987 899999999998631100
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCC--CCchHHHHHHHHHHHHHHcCCCCCCC
Q 003232 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG--HGTTADWWSVGIILFELIVGIPPFNA 822 (837)
Q Consensus 745 ddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~--~s~kSDIWSLGVILyELLTGr~PF~~ 822 (837)
........||+.|+|||++.+.. ++.++||||||+++|+|++|+.||..
T Consensus 177 -----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 227 (295)
T 2clq_A 177 -----------------------------NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYE 227 (295)
T ss_dssp ---------------------------------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGG
T ss_pred -----------------------------CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccC
Confidence 00122456899999999997643 78999999999999999999999975
Q ss_pred CC
Q 003232 823 EH 824 (837)
Q Consensus 823 ~d 824 (837)
..
T Consensus 228 ~~ 229 (295)
T 2clq_A 228 LG 229 (295)
T ss_dssp GS
T ss_pred CC
Confidence 43
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=303.59 Aligned_cols=204 Identities=30% Similarity=0.483 Sum_probs=159.0
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC--
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE-- 662 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~-- 662 (837)
...+++|++.+.||+|+||+||+|+++.+++.||||++...... .....+++..+..++||||+++++++....
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF----RNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC----CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc----cHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 34567899999999999999999999999999999998654322 234567788888999999999999986533
Q ss_pred -----eEEEEEEecCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH--hCCcccccCCCCcEEEcc-CCcEEE
Q 003232 663 -----NLYLVMEYLNGGDLYSLLR----NLGCLDEDVARVYIAEVVLALEYLH--SLRVVHRDLKPDNLLIAH-DGHIKL 730 (837)
Q Consensus 663 -----~lyLVmEy~~GGSL~dlLk----~~g~Lsee~irkIl~QIa~ALsYLH--SkGIIHRDIKPeNILLd~-dG~IKL 730 (837)
.+|+||||+.+ +|...+. ....+++..++.++.||+.||.||| ++||+||||||+|||++. ++.+||
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl 173 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKL 173 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEE
Confidence 38999999976 5544433 4567899999999999999999999 999999999999999996 899999
Q ss_pred EecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCC-CCchHHHHHHHHH
Q 003232 731 TDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTADWWSVGII 809 (837)
Q Consensus 731 iDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~-~s~kSDIWSLGVI 809 (837)
+|||+++..... .......||+.|+|||++.+.. ++.++|||||||+
T Consensus 174 ~Dfg~a~~~~~~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~i 221 (360)
T 3e3p_A 174 CDFGSAKKLSPS--------------------------------EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCI 221 (360)
T ss_dssp CCCTTCBCCCTT--------------------------------SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred eeCCCceecCCC--------------------------------CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHH
Confidence 999998731100 0112456899999999997654 8999999999999
Q ss_pred HHHHHcCCCCCCCCCc
Q 003232 810 LFELIVGIPPFNAEHP 825 (837)
Q Consensus 810 LyELLTGr~PF~~~dp 825 (837)
+|+|++|+.||.+.+.
T Consensus 222 l~ell~g~~pf~~~~~ 237 (360)
T 3e3p_A 222 FAEMMLGEPIFRGDNS 237 (360)
T ss_dssp HHHHHHSSCSSCCSSH
T ss_pred HHHHHhCCCCcCCCCh
Confidence 9999999999987654
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=297.19 Aligned_cols=203 Identities=29% Similarity=0.482 Sum_probs=165.9
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHh--cCCCceEEEEeEeecC-
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILIS--VRNPFVVRFFYSFTCR- 661 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~--LrHPNIVkL~gsf~d~- 661 (837)
....++|++.+.||.|+||.||+|++. ++.||||++.... ......|.+++.. ++||||+++++++...
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 344567999999999999999999985 8999999986532 1234455666554 4999999999999877
Q ss_pred ---CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CcccccCCCCcEEEccCCcEEE
Q 003232 662 ---ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL--------RVVHRDLKPDNLLIAHDGHIKL 730 (837)
Q Consensus 662 ---~~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSk--------GIIHRDIKPeNILLd~dG~IKL 730 (837)
..+|+||||+++++|.+++.. ..+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred CCCCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 789999999999999999976 4699999999999999999999998 9999999999999999999999
Q ss_pred EecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCch------HHHH
Q 003232 731 TDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT------ADWW 804 (837)
Q Consensus 731 iDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~k------SDIW 804 (837)
+|||+++....... ..........||+.|+|||++.+..++.. +|||
T Consensus 184 ~Dfg~a~~~~~~~~---------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Diw 236 (337)
T 3mdy_A 184 ADLGLAVKFISDTN---------------------------EVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMY 236 (337)
T ss_dssp CCCTTCEECC------------------------------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHH
T ss_pred EeCCCceeeccccc---------------------------cccCCCCCCccCcceeChhhcccccCCccccCccccchH
Confidence 99999863111100 00111235579999999999988766554 9999
Q ss_pred HHHHHHHHHHcC----------CCCCCCC
Q 003232 805 SVGIILFELIVG----------IPPFNAE 823 (837)
Q Consensus 805 SLGVILyELLTG----------r~PF~~~ 823 (837)
||||++|+|++| ..||...
T Consensus 237 slG~il~el~tg~~~~~~~~~~~~p~~~~ 265 (337)
T 3mdy_A 237 SFGLILWEVARRCVSGGIVEEYQLPYHDL 265 (337)
T ss_dssp HHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred HHHHHHHHHHhccCcccccccccccHhhh
Confidence 999999999999 7777653
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=317.00 Aligned_cols=197 Identities=31% Similarity=0.504 Sum_probs=165.2
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeec------C
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC------R 661 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d------~ 661 (837)
..+|++.+.||+|+||+||+|++..+|+.||||++..... ...+|+.+++.++||||++++++|.. .
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~ 125 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 125 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence 3469999999999999999999999999999999865421 23469999999999999999988853 2
Q ss_pred CeEEEEEEecCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccC-CcEEEEecCCc
Q 003232 662 ENLYLVMEYLNGGDLYSLLR----NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD-GHIKLTDFGLS 736 (837)
Q Consensus 662 ~~lyLVmEy~~GGSL~dlLk----~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~d-G~IKLiDFGLA 736 (837)
.++++||||+++ +|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++
T Consensus 126 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 126 VYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred eeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhh
Confidence 347899999975 6666553 34679999999999999999999999999999999999999865 57899999999
Q ss_pred cccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCC-CCCchHHHHHHHHHHHHHHc
Q 003232 737 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIV 815 (837)
Q Consensus 737 rvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~-~~s~kSDIWSLGVILyELLT 815 (837)
+..... .......||+.|+|||++.+. .++.++|||||||++|||++
T Consensus 205 ~~~~~~--------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~ 252 (420)
T 1j1b_A 205 KQLVRG--------------------------------EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLL 252 (420)
T ss_dssp EECCTT--------------------------------CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred hhcccC--------------------------------CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHh
Confidence 731100 012245789999999999775 78999999999999999999
Q ss_pred CCCCCCCCC
Q 003232 816 GIPPFNAEH 824 (837)
Q Consensus 816 Gr~PF~~~d 824 (837)
|+.||.+.+
T Consensus 253 G~~pf~~~~ 261 (420)
T 1j1b_A 253 GQPIFPGDS 261 (420)
T ss_dssp SSCSSCCSS
T ss_pred CCCCCCCCC
Confidence 999998765
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-34 Score=293.62 Aligned_cols=207 Identities=29% Similarity=0.510 Sum_probs=159.9
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEE
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 665 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ly 665 (837)
..+++|++++.||.|+||.||+|+++.+|+.||+|++..... .....+.+..+..+++.++||||+++++++.....+|
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 100 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVF 100 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Confidence 346789999999999999999999999999999999976532 2233344555556788889999999999999999999
Q ss_pred EEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCcEEEccCCcEEEEecCCccccccCC
Q 003232 666 LVMEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSL-RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 666 LVmEy~~GGSL~dlLk~-~g~Lsee~irkIl~QIa~ALsYLHSk-GIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~s 743 (837)
+||||+ ++.+..+... .+.+++..+..++.||+.||.|||++ ||+|+||||+|||++.++.++|+|||++.....
T Consensus 101 lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~-- 177 (318)
T 2dyl_A 101 IAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD-- 177 (318)
T ss_dssp EEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred EEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC--
Confidence 999999 5666666543 46799999999999999999999995 999999999999999999999999999863100
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhc-----CCCCCchHHHHHHHHHHHHHHcCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-----GTGHGTTADWWSVGIILFELIVGIP 818 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLl-----g~~~s~kSDIWSLGVILyELLTGr~ 818 (837)
........||+.|+|||++. +..++.++||||||+++|+|++|+.
T Consensus 178 ------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 227 (318)
T 2dyl_A 178 ------------------------------DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQF 227 (318)
T ss_dssp ---------------------------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSC
T ss_pred ------------------------------CccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCC
Confidence 00112346899999999994 5668899999999999999999999
Q ss_pred CCCCCCcC
Q 003232 819 PFNAEHPQ 826 (837)
Q Consensus 819 PF~~~dpd 826 (837)
||.....+
T Consensus 228 pf~~~~~~ 235 (318)
T 2dyl_A 228 PYKNCKTD 235 (318)
T ss_dssp TTTTCCSH
T ss_pred CCCCCCcc
Confidence 99875443
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=302.98 Aligned_cols=212 Identities=25% Similarity=0.380 Sum_probs=174.7
Q ss_pred CCCCCcccCCe-EEEEEecccCceEEEEEEE----CCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEE
Q 003232 581 PSKDRTSIDDF-EIIKPISRGAFGRVFLAKK----RTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFF 655 (837)
Q Consensus 581 P~k~g~~lddY-eIlkkLGsG~FGtVYkArd----k~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~ 655 (837)
|..+....++| ++++.||+|+||+||++.+ ..+++.||+|++.... .......+.+|+.+++.++||||++++
T Consensus 22 pg~~~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~ 99 (318)
T 3lxp_A 22 PGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYK 99 (318)
T ss_dssp --CCCBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCCCceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEE
Confidence 33344444455 9999999999999988764 3478899999998652 344567899999999999999999999
Q ss_pred eEeec--CCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEec
Q 003232 656 YSFTC--RENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDF 733 (837)
Q Consensus 656 gsf~d--~~~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDF 733 (837)
+++.. ...+|+||||+++++|.+++... .+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+||
T Consensus 100 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Df 178 (318)
T 3lxp_A 100 GCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDF 178 (318)
T ss_dssp EEEEETTTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCG
T ss_pred EEEecCCCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCc
Confidence 99987 46899999999999999999764 5999999999999999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHH
Q 003232 734 GLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 813 (837)
Q Consensus 734 GLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyEL 813 (837)
|++........ .........||+.|+|||++.+..++.++||||||+++|+|
T Consensus 179 g~a~~~~~~~~----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 230 (318)
T 3lxp_A 179 GLAKAVPEGHE----------------------------YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYEL 230 (318)
T ss_dssp GGCEECCTTCS----------------------------EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHH
T ss_pred ccccccccccc----------------------------ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHH
Confidence 99874211000 00112234688899999999999999999999999999999
Q ss_pred HcCCCCCCCC
Q 003232 814 IVGIPPFNAE 823 (837)
Q Consensus 814 LTGr~PF~~~ 823 (837)
++|..||...
T Consensus 231 l~g~~p~~~~ 240 (318)
T 3lxp_A 231 LTHCDSSQSP 240 (318)
T ss_dssp HTTTCGGGSH
T ss_pred HhCCCccccc
Confidence 9999999753
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=305.68 Aligned_cols=199 Identities=30% Similarity=0.456 Sum_probs=172.0
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCe----
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCREN---- 663 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~---- 663 (837)
.++|.+.+.||.|+||+||+|++..+|+.||||++.... ........+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 467999999999999999999999999999999997643 334556788999999999999999999999987653
Q ss_pred --EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCcccccc
Q 003232 664 --LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 741 (837)
Q Consensus 664 --lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~ 741 (837)
+|+||||+. ++|.+++. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++...
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~- 177 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD- 177 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred eeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCC-
Confidence 599999996 58887764 358999999999999999999999999999999999999999999999999986310
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCC
Q 003232 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPF 820 (837)
Q Consensus 742 ~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLTGr~PF 820 (837)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|..||
T Consensus 178 ---------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf 224 (353)
T 3coi_A 178 ---------------------------------AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF 224 (353)
T ss_dssp ---------------------------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred ---------------------------------CCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 00123478999999999987 67899999999999999999999999
Q ss_pred CCCC
Q 003232 821 NAEH 824 (837)
Q Consensus 821 ~~~d 824 (837)
.+.+
T Consensus 225 ~~~~ 228 (353)
T 3coi_A 225 KGKD 228 (353)
T ss_dssp BSSC
T ss_pred CCCC
Confidence 8765
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-35 Score=305.96 Aligned_cols=213 Identities=27% Similarity=0.428 Sum_probs=175.2
Q ss_pred CCCCCCCCC-cccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccH---HHHHHHHHHHHHHHhcC--CCc
Q 003232 577 SPIHPSKDR-TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRK---NAVESILAERDILISVR--NPF 650 (837)
Q Consensus 577 s~~~P~k~g-~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~---e~ie~~~rEieILk~Lr--HPN 650 (837)
..+.|...+ ...++|++.+.||+|+||+||+|++..+++.||||++........ .....+.+|+.+++.++ |||
T Consensus 30 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~ 109 (320)
T 3a99_A 30 TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109 (320)
T ss_dssp ----------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCS
T ss_pred hccCcccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCC
Confidence 334444333 344569999999999999999999999999999999976432211 12235677999999996 599
Q ss_pred eEEEEeEeecCCeEEEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEc-cCCcE
Q 003232 651 VVRFFYSFTCRENLYLVMEYLNG-GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA-HDGHI 728 (837)
Q Consensus 651 IVkL~gsf~d~~~lyLVmEy~~G-GSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd-~dG~I 728 (837)
|+++++++......++|||++.+ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+
T Consensus 110 i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~ 189 (320)
T 3a99_A 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGEL 189 (320)
T ss_dssp BCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEE
T ss_pred ceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCE
Confidence 99999999999999999999976 89999998888899999999999999999999999999999999999998 78999
Q ss_pred EEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCC-CchHHHHHHH
Q 003232 729 KLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVG 807 (837)
Q Consensus 729 KLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~-s~kSDIWSLG 807 (837)
||+|||+++.... .......||+.|+|||++.+..+ +.++||||||
T Consensus 190 kL~Dfg~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG 236 (320)
T 3a99_A 190 KLIDFGSGALLKD---------------------------------TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLG 236 (320)
T ss_dssp EECCCTTCEECCS---------------------------------SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHH
T ss_pred EEeeCcccccccc---------------------------------ccccCCCCCccCCChHHhccCCCCCccchHHhHH
Confidence 9999999873110 01123468999999999987666 6889999999
Q ss_pred HHHHHHHcCCCCCCC
Q 003232 808 IILFELIVGIPPFNA 822 (837)
Q Consensus 808 VILyELLTGr~PF~~ 822 (837)
+++|+|++|+.||..
T Consensus 237 ~il~el~~g~~pf~~ 251 (320)
T 3a99_A 237 ILLYDMVCGDIPFEH 251 (320)
T ss_dssp HHHHHHHHSSCSCCS
T ss_pred HHHHHHHHCCCCCCC
Confidence 999999999999964
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-34 Score=305.73 Aligned_cols=202 Identities=32% Similarity=0.518 Sum_probs=174.1
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcC-CC-----ceEEEEeEe
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NP-----FVVRFFYSF 658 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~Lr-HP-----NIVkL~gsf 658 (837)
....++|++.+.||+|+||+||+|++..+++.||||+++.. ......+..|+.+++.++ |+ +|+++++.+
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~ 125 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF 125 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence 34567899999999999999999999999999999999753 234556778888888875 44 499999999
Q ss_pred ecCCeEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCcccccCCCCcEEEc--cCCcEEEEe
Q 003232 659 TCRENLYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLH--SLRVVHRDLKPDNLLIA--HDGHIKLTD 732 (837)
Q Consensus 659 ~d~~~lyLVmEy~~GGSL~dlLk~~--g~Lsee~irkIl~QIa~ALsYLH--SkGIIHRDIKPeNILLd--~dG~IKLiD 732 (837)
....++|+||||+. ++|.+++... +.+++..++.++.||+.||.||| +.||+||||||+|||++ .++.+||+|
T Consensus 126 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 126 MFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp EETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred ccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 99999999999995 5999999765 45999999999999999999999 57999999999999995 478899999
Q ss_pred cCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHH
Q 003232 733 FGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFE 812 (837)
Q Consensus 733 FGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyE 812 (837)
||+++... .......||+.|+|||++.+..++.++|||||||++|+
T Consensus 205 FG~a~~~~----------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~e 250 (382)
T 2vx3_A 205 FGSSCQLG----------------------------------QRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVE 250 (382)
T ss_dssp CTTCEETT----------------------------------CCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHH
T ss_pred ccCceecc----------------------------------cccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHH
Confidence 99987310 01124578999999999999999999999999999999
Q ss_pred HHcCCCCCCCCCc
Q 003232 813 LIVGIPPFNAEHP 825 (837)
Q Consensus 813 LLTGr~PF~~~dp 825 (837)
|++|+.||.+.+.
T Consensus 251 lltg~~pf~~~~~ 263 (382)
T 2vx3_A 251 MHTGEPLFSGANE 263 (382)
T ss_dssp HHHSSCSSCCSSH
T ss_pred HHhCCCCCCCCCH
Confidence 9999999987653
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=295.09 Aligned_cols=202 Identities=23% Similarity=0.342 Sum_probs=171.0
Q ss_pred eEEEEEecccCceEEEEEEECCCCcEEEEEEeccccc-ccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEE
Q 003232 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADM-IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (837)
Q Consensus 591 YeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~-~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmE 669 (837)
|...+.||+|+||+||+|.+ +++.||+|++..... ......+.+.+|+.+++.++||||+++++++......|+|||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 33447899999999999986 688999999875432 234456789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCC
Q 003232 670 YLNGGDLYSLLRN---LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (837)
Q Consensus 670 y~~GGSL~dlLk~---~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stdd 746 (837)
|+++++|.+++.. ...+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++........
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-- 188 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ-- 188 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSS--
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccc--
Confidence 9999999999874 34699999999999999999999999999999999999999999999999999873111000
Q ss_pred CCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 747 l~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
........||+.|+|||++.+ .++.++||||||+++|+|++|..||....
T Consensus 189 ---------------------------~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 238 (307)
T 2nru_A 189 ---------------------------TVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHR 238 (307)
T ss_dssp ---------------------------CEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTB
T ss_pred ---------------------------cccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCc
Confidence 001224578999999999876 47899999999999999999999998654
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=315.67 Aligned_cols=207 Identities=26% Similarity=0.412 Sum_probs=173.4
Q ss_pred CCCCcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecC
Q 003232 582 SKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR 661 (837)
Q Consensus 582 ~k~g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~ 661 (837)
..+....++|++.+.||+|+||.||+|.+.. +..||||+++.... ..+.+.+|+.+++.++||||+++++++..
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 250 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 250 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-
Confidence 3455666789999999999999999999964 56799999986542 13568899999999999999999998876
Q ss_pred CeEEEEEEecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCcccc
Q 003232 662 ENLYLVMEYLNGGDLYSLLRN--LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 739 (837)
Q Consensus 662 ~~lyLVmEy~~GGSL~dlLk~--~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg 739 (837)
...|+||||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 251 ~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 330 (452)
T 1fmk_A 251 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 330 (452)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceec
Confidence 678999999999999999964 356999999999999999999999999999999999999999999999999998731
Q ss_pred ccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCC
Q 003232 740 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIP 818 (837)
Q Consensus 740 ~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~ 818 (837)
.... ........+|+.|+|||++.+..++.++||||||+++|+|++ |+.
T Consensus 331 ~~~~------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~ 380 (452)
T 1fmk_A 331 EDNE------------------------------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 380 (452)
T ss_dssp ------------------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred CCCc------------------------------eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCC
Confidence 1000 001123457888999999998999999999999999999999 999
Q ss_pred CCCCCC
Q 003232 819 PFNAEH 824 (837)
Q Consensus 819 PF~~~d 824 (837)
||.+..
T Consensus 381 P~~~~~ 386 (452)
T 1fmk_A 381 PYPGMV 386 (452)
T ss_dssp SSTTCC
T ss_pred CCCCCC
Confidence 997654
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=298.14 Aligned_cols=206 Identities=27% Similarity=0.484 Sum_probs=156.9
Q ss_pred CCcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHH-HHHhcCCCceEEEEeEeecCC
Q 003232 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERD-ILISVRNPFVVRFFYSFTCRE 662 (837)
Q Consensus 584 ~g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEie-ILk~LrHPNIVkL~gsf~d~~ 662 (837)
+....++|++.+.||.|+||.||+|.++.+|+.||||++.... .......+..|.. +++.++||||+++++++...+
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~ 94 (327)
T 3aln_A 17 WDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREG 94 (327)
T ss_dssp ECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSS
T ss_pred cccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCC
Confidence 3455678999999999999999999999999999999997643 2233345556665 677789999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCcEEEccCCcEEEEecCCc
Q 003232 663 NLYLVMEYLNGGDLYSLLRN-----LGCLDEDVARVYIAEVVLALEYLHSL-RVVHRDLKPDNLLIAHDGHIKLTDFGLS 736 (837)
Q Consensus 663 ~lyLVmEy~~GGSL~dlLk~-----~g~Lsee~irkIl~QIa~ALsYLHSk-GIIHRDIKPeNILLd~dG~IKLiDFGLA 736 (837)
..|+||||+.+ +|.+++.. ...+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++
T Consensus 95 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~ 173 (327)
T 3aln_A 95 DCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGIS 173 (327)
T ss_dssp EEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSS
T ss_pred ceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCc
Confidence 99999999975 88888763 46799999999999999999999998 9999999999999999999999999998
Q ss_pred cccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhh----cCCCCCchHHHHHHHHHHHH
Q 003232 737 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEIL----LGTGHGTTADWWSVGIILFE 812 (837)
Q Consensus 737 rvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVL----lg~~~s~kSDIWSLGVILyE 812 (837)
+..... .......||+.|+|||++ .+..++.++||||||+++|+
T Consensus 174 ~~~~~~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~ 221 (327)
T 3aln_A 174 GQLVDS--------------------------------IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYE 221 (327)
T ss_dssp CC--------------------------------------------------------------CCSHHHHHHHHHHHHH
T ss_pred eecccc--------------------------------cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHH
Confidence 631000 011233689999999998 46678999999999999999
Q ss_pred HHcCCCCCCCCC
Q 003232 813 LIVGIPPFNAEH 824 (837)
Q Consensus 813 LLTGr~PF~~~d 824 (837)
|++|..||....
T Consensus 222 l~~g~~pf~~~~ 233 (327)
T 3aln_A 222 LATGRFPYPKWN 233 (327)
T ss_dssp HHHSCCCSSCC-
T ss_pred HHHCCCCCCCcc
Confidence 999999997643
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=311.52 Aligned_cols=203 Identities=27% Similarity=0.482 Sum_probs=156.9
Q ss_pred CeEEE-EEecccCceEEEEEEEC--CCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEee--cCCeE
Q 003232 590 DFEII-KPISRGAFGRVFLAKKR--TTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFT--CRENL 664 (837)
Q Consensus 590 dYeIl-kkLGsG~FGtVYkArdk--~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~--d~~~l 664 (837)
.|++. ++||+|+||+||+|+++ .+++.||+|++..... ...+.+|+.+++.++||||+++++++. ....+
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence 46663 57999999999999976 4688999999976432 135778999999999999999999995 46789
Q ss_pred EEEEEecCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEE----ccCCcEEEE
Q 003232 665 YLVMEYLNGGDLYSLLRNL---------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI----AHDGHIKLT 731 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~---------g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILL----d~dG~IKLi 731 (837)
|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 96 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 96 WLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 99999996 5888887532 249999999999999999999999999999999999999 677899999
Q ss_pred ecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCC-CCCchHHHHHHHHHH
Q 003232 732 DFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIIL 810 (837)
Q Consensus 732 DFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~-~~s~kSDIWSLGVIL 810 (837)
|||+++...... .........+||+.|+|||++.+. .++.++|||||||++
T Consensus 175 Dfg~a~~~~~~~----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il 226 (405)
T 3rgf_A 175 DMGFARLFNSPL----------------------------KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIF 226 (405)
T ss_dssp CTTCCC--------------------------------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHH
T ss_pred ECCCceecCCCC----------------------------cccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHH
Confidence 999987411000 001122346799999999999874 589999999999999
Q ss_pred HHHHcCCCCCCCCCcC
Q 003232 811 FELIVGIPPFNAEHPQ 826 (837)
Q Consensus 811 yELLTGr~PF~~~dpd 826 (837)
|+|++|++||.+...+
T Consensus 227 ~ell~g~~pf~~~~~~ 242 (405)
T 3rgf_A 227 AELLTSEPIFHCRQED 242 (405)
T ss_dssp HHHHHSSCTTCCCC--
T ss_pred HHHHhCCCCCCCcccc
Confidence 9999999999876553
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=303.11 Aligned_cols=202 Identities=31% Similarity=0.546 Sum_probs=150.6
Q ss_pred CCcccCCeEEEE-EecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeec--
Q 003232 584 DRTSIDDFEIIK-PISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC-- 660 (837)
Q Consensus 584 ~g~~lddYeIlk-kLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d-- 660 (837)
.....++|++++ .||.|+||+||+|+++.+++.||+|++.... .. .......++.++||||+++++++..
T Consensus 23 ~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~---~~e~~~~~~~~~h~~i~~~~~~~~~~~ 95 (336)
T 3fhr_A 23 KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KA---RQEVDHHWQASGGPHIVCILDVYENMH 95 (336)
T ss_dssp CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HH---HHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred CccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HH---HHHHHHHHHhcCCCChHHHHHHHhhcc
Confidence 345667899965 6999999999999999999999999987532 11 1222334567899999999999876
Q ss_pred --CCeEEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEcc---CCcEEEEec
Q 003232 661 --RENLYLVMEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKLTDF 733 (837)
Q Consensus 661 --~~~lyLVmEy~~GGSL~dlLk~~g--~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~---dG~IKLiDF 733 (837)
...+|+||||++|++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++. ++.++|+||
T Consensus 96 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Df 175 (336)
T 3fhr_A 96 HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDF 175 (336)
T ss_dssp TTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred CCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecc
Confidence 456899999999999999998653 6999999999999999999999999999999999999976 455999999
Q ss_pred CCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHH
Q 003232 734 GLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 813 (837)
Q Consensus 734 GLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyEL 813 (837)
|++..... .......||+.|+|||++.+..++.++||||||+++|+|
T Consensus 176 g~~~~~~~---------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l 222 (336)
T 3fhr_A 176 GFAKETTQ---------------------------------NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL 222 (336)
T ss_dssp TTCEEC-------------------------------------------------------CHHHHHHHHHHHHHHHHHH
T ss_pred ccceeccc---------------------------------cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHH
Confidence 99863100 011234689999999999988899999999999999999
Q ss_pred HcCCCCCCCCCc
Q 003232 814 IVGIPPFNAEHP 825 (837)
Q Consensus 814 LTGr~PF~~~dp 825 (837)
++|..||.....
T Consensus 223 ~~g~~pf~~~~~ 234 (336)
T 3fhr_A 223 LCGFPPFYSNTG 234 (336)
T ss_dssp HHSSCCC-----
T ss_pred HHCCCCCCCccc
Confidence 999999976543
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=299.20 Aligned_cols=204 Identities=30% Similarity=0.461 Sum_probs=167.2
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccH---HHHHHHHHHHHHHHhc----CCCceEEEEeEe
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRK---NAVESILAERDILISV----RNPFVVRFFYSF 658 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~---e~ie~~~rEieILk~L----rHPNIVkL~gsf 658 (837)
...++|++.+.||+|+||.||+|++..+++.||+|++........ .....+.+|+.++..+ +||||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 344679999999999999999999999999999999976542221 2233466789999888 899999999999
Q ss_pred ecCCeEEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEc-cCCcEEEEecCCc
Q 003232 659 TCRENLYLVMEY-LNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA-HDGHIKLTDFGLS 736 (837)
Q Consensus 659 ~d~~~lyLVmEy-~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd-~dG~IKLiDFGLA 736 (837)
...+..++|||| +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++ .++.++|+|||++
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~ 187 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG 187 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchh
Confidence 999999999999 78999999999888899999999999999999999999999999999999998 7899999999998
Q ss_pred cccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCC-chHHHHHHHHHHHHHHc
Q 003232 737 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHG-TTADWWSVGIILFELIV 815 (837)
Q Consensus 737 rvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s-~kSDIWSLGVILyELLT 815 (837)
..... .......||+.|+|||++.+..+. .++||||||+++|+|++
T Consensus 188 ~~~~~---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 234 (312)
T 2iwi_A 188 ALLHD---------------------------------EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVC 234 (312)
T ss_dssp EECCS---------------------------------SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHH
T ss_pred hhccc---------------------------------CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHH
Confidence 73110 011245689999999999876664 58999999999999999
Q ss_pred CCCCCCC
Q 003232 816 GIPPFNA 822 (837)
Q Consensus 816 Gr~PF~~ 822 (837)
|+.||..
T Consensus 235 g~~pf~~ 241 (312)
T 2iwi_A 235 GDIPFER 241 (312)
T ss_dssp SSCSCCS
T ss_pred CCCCCCC
Confidence 9999964
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-34 Score=308.27 Aligned_cols=198 Identities=31% Similarity=0.456 Sum_probs=162.6
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC-----
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE----- 662 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~----- 662 (837)
..+|++.+.||+|+||+||+|++..++. +|+|.+..... ...+|+.+++.++||||++++++|....
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~-------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 110 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR-------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDE 110 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSC
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc-------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCc
Confidence 4569999999999999999999977665 78887754321 1236999999999999999999985433
Q ss_pred -eEEEEEEecCCCCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEc-cCCcEEEEecCCcc
Q 003232 663 -NLYLVMEYLNGGDLYSLL---RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA-HDGHIKLTDFGLSK 737 (837)
Q Consensus 663 -~lyLVmEy~~GGSL~dlL---k~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd-~dG~IKLiDFGLAr 737 (837)
.+|+||||++++.+.... .....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++
T Consensus 111 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 111 VFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 489999999765433332 2346799999999999999999999999999999999999998 79999999999987
Q ss_pred ccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCC-CCCchHHHHHHHHHHHHHHcC
Q 003232 738 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVG 816 (837)
Q Consensus 738 vg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~-~~s~kSDIWSLGVILyELLTG 816 (837)
..... .......||+.|+|||++.+. .++.++|||||||++|+|++|
T Consensus 191 ~~~~~--------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g 238 (394)
T 4e7w_A 191 ILIAG--------------------------------EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQG 238 (394)
T ss_dssp ECCTT--------------------------------CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS
T ss_pred cccCC--------------------------------CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 41100 112245789999999999775 589999999999999999999
Q ss_pred CCCCCCCCc
Q 003232 817 IPPFNAEHP 825 (837)
Q Consensus 817 r~PF~~~dp 825 (837)
+.||.+.+.
T Consensus 239 ~~pf~~~~~ 247 (394)
T 4e7w_A 239 QPLFPGESG 247 (394)
T ss_dssp SCSSCCSSH
T ss_pred CCCCCCCCH
Confidence 999987653
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-34 Score=297.64 Aligned_cols=205 Identities=27% Similarity=0.455 Sum_probs=174.0
Q ss_pred ccCCeEEEEEecccCceEEEEEEE----CCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKK----RTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE 662 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArd----k~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~ 662 (837)
..++|++++.||+|+||.||+|++ ..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++....
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 115 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 115 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC---SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC
Confidence 345699999999999999999994 5689999999997642 345568899999999999999999999887644
Q ss_pred --eEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCcccc
Q 003232 663 --NLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 739 (837)
Q Consensus 663 --~lyLVmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg 739 (837)
.+++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++...
T Consensus 116 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 116 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp --CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 789999999999999999875 45999999999999999999999999999999999999999999999999998742
Q ss_pred ccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCC
Q 003232 740 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPP 819 (837)
Q Consensus 740 ~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~P 819 (837)
...... ........++..|+|||++.+..++.++||||||+++|+|++|..|
T Consensus 196 ~~~~~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~ 247 (326)
T 2w1i_A 196 PQDKEY----------------------------YKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK 247 (326)
T ss_dssp CSSCSE----------------------------EECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCG
T ss_pred cccccc----------------------------cccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCC
Confidence 111000 0011234577889999999988899999999999999999999999
Q ss_pred CCC
Q 003232 820 FNA 822 (837)
Q Consensus 820 F~~ 822 (837)
|..
T Consensus 248 ~~~ 250 (326)
T 2w1i_A 248 SKS 250 (326)
T ss_dssp GGS
T ss_pred CCC
Confidence 864
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-34 Score=307.97 Aligned_cols=207 Identities=25% Similarity=0.356 Sum_probs=165.2
Q ss_pred CCeEEEEEecccCceEEEEEEECCCC---cEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEee-cCCeE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTG---DLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFT-CRENL 664 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG---~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~-d~~~l 664 (837)
..|++.+.||+|+||+||+|++..++ ..||+|.+... ......+.+.+|+.+++.++||||+++++++. .....
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence 34899999999999999999985433 46899998753 23455678999999999999999999999865 45688
Q ss_pred EEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCC
Q 003232 665 YLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~s 743 (837)
|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 9999999999999999764 458899999999999999999999999999999999999999999999999987311000
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNA 822 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~~ 822 (837)
. ..........||+.|+|||++.+..++.++|||||||++|+|++ |.+||..
T Consensus 247 ~---------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~ 299 (373)
T 3c1x_A 247 F---------------------------DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 299 (373)
T ss_dssp --------------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT
T ss_pred c---------------------------ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCC
Confidence 0 00011233467889999999999999999999999999999999 7888876
Q ss_pred CC
Q 003232 823 EH 824 (837)
Q Consensus 823 ~d 824 (837)
.+
T Consensus 300 ~~ 301 (373)
T 3c1x_A 300 VN 301 (373)
T ss_dssp SC
T ss_pred CC
Confidence 54
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=327.33 Aligned_cols=207 Identities=25% Similarity=0.394 Sum_probs=171.1
Q ss_pred CCeEEE-EEecccCceEEEEEEE--CCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEE
Q 003232 589 DDFEII-KPISRGAFGRVFLAKK--RTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 665 (837)
Q Consensus 589 ddYeIl-kkLGsG~FGtVYkArd--k~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ly 665 (837)
..+.+. +.||.|+||+||+|.+ ..+++.||||+++... ......+.+.+|+.+++.++||||+++++++.. ...+
T Consensus 368 ~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~ 445 (635)
T 4fl3_A 368 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWM 445 (635)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred hhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEE
Confidence 345554 4899999999999955 4567899999997653 233445789999999999999999999998864 5689
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCC
Q 003232 666 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745 (837)
Q Consensus 666 LVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~std 745 (837)
+||||+.+|+|.+++...+.+++..+..++.||+.||.|||++|||||||||+|||++.++.+||+|||+++.......
T Consensus 446 lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~- 524 (635)
T 4fl3_A 446 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN- 524 (635)
T ss_dssp EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred EEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc-
Confidence 9999999999999999888899999999999999999999999999999999999999999999999999874211100
Q ss_pred CCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCC
Q 003232 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEH 824 (837)
Q Consensus 746 dl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~~~d 824 (837)
.........||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+
T Consensus 525 ---------------------------~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~ 577 (635)
T 4fl3_A 525 ---------------------------YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 577 (635)
T ss_dssp -------------------------------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ---------------------------ccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 0011123457889999999999999999999999999999998 999998765
Q ss_pred c
Q 003232 825 P 825 (837)
Q Consensus 825 p 825 (837)
.
T Consensus 578 ~ 578 (635)
T 4fl3_A 578 G 578 (635)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=318.40 Aligned_cols=206 Identities=26% Similarity=0.414 Sum_probs=176.2
Q ss_pred CCCcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC
Q 003232 583 KDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE 662 (837)
Q Consensus 583 k~g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~ 662 (837)
.+....++|++.+.||+|+||.||+|.+.. +..||||+++.... ..+.+.+|+.+|+.++||||+++++++.. .
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~ 334 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 334 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEee-c
Confidence 455666789999999999999999999964 56799999986542 13568999999999999999999998876 6
Q ss_pred eEEEEEEecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccc
Q 003232 663 NLYLVMEYLNGGDLYSLLRN--LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740 (837)
Q Consensus 663 ~lyLVmEy~~GGSL~dlLk~--~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~ 740 (837)
.+||||||+.+|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 335 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 335 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 78999999999999999964 3569999999999999999999999999999999999999999999999999987310
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCC
Q 003232 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPP 819 (837)
Q Consensus 741 ~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~P 819 (837)
. ..........++..|+|||++.+..++.++|||||||++|||++ |+.|
T Consensus 415 ~------------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P 464 (535)
T 2h8h_A 415 D------------------------------NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 464 (535)
T ss_dssp C------------------------------HHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCS
T ss_pred C------------------------------CceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 0 00111223457889999999998899999999999999999999 9999
Q ss_pred CCCCC
Q 003232 820 FNAEH 824 (837)
Q Consensus 820 F~~~d 824 (837)
|.+..
T Consensus 465 ~~~~~ 469 (535)
T 2h8h_A 465 YPGMV 469 (535)
T ss_dssp STTCC
T ss_pred CCCCC
Confidence 97654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=293.60 Aligned_cols=201 Identities=24% Similarity=0.381 Sum_probs=169.1
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHh--cCCCceEEEEeEeecCC---
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILIS--VRNPFVVRFFYSFTCRE--- 662 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~--LrHPNIVkL~gsf~d~~--- 662 (837)
.++|++.+.||+|+||+||+|.+ +++.||+|++.... ...+.+|.+++.. ++||||+++++++....
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 45799999999999999999998 48999999987532 2457788888887 79999999999998875
Q ss_pred -eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCcccccCCCCcEEEccCCcEEEEec
Q 003232 663 -NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLH--------SLRVVHRDLKPDNLLIAHDGHIKLTDF 733 (837)
Q Consensus 663 -~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLH--------SkGIIHRDIKPeNILLd~dG~IKLiDF 733 (837)
.+|+||||+++++|.+++.. ..+++..+..++.||+.||.||| +.||+||||||+|||++.++.++|+||
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 191 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 191 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred ceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence 89999999999999999976 46899999999999999999999 899999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCC------CCchHHHHHHH
Q 003232 734 GLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG------HGTTADWWSVG 807 (837)
Q Consensus 734 GLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~------~s~kSDIWSLG 807 (837)
|++......... .........||+.|+|||++.+.. ++.++||||||
T Consensus 192 g~~~~~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG 244 (342)
T 1b6c_B 192 GLAVRHDSATDT---------------------------IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMG 244 (342)
T ss_dssp TTCEEEETTTTE---------------------------EEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHH
T ss_pred CCceeccccccc---------------------------cccccccCCcCcccCCHhhhcccccccccccCCcccHHHHH
Confidence 998642111000 000123457999999999998753 33689999999
Q ss_pred HHHHHHHcC----------CCCCCCCC
Q 003232 808 IILFELIVG----------IPPFNAEH 824 (837)
Q Consensus 808 VILyELLTG----------r~PF~~~d 824 (837)
+++|+|++| ..||....
T Consensus 245 ~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 245 LVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp HHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred HHHHHHHhccCcCCcccccccCccccC
Confidence 999999999 88997653
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=322.19 Aligned_cols=209 Identities=27% Similarity=0.408 Sum_probs=171.3
Q ss_pred cccCCeEEEE-EecccCceEEEEEEECC--CCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC
Q 003232 586 TSIDDFEIIK-PISRGAFGRVFLAKKRT--TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE 662 (837)
Q Consensus 586 ~~lddYeIlk-kLGsG~FGtVYkArdk~--tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~ 662 (837)
...++|.+.+ .||.|+||.||+|.++. ++..||||+++... .....+.+.+|+.+|+.++||||+++++++.. +
T Consensus 332 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~ 408 (613)
T 2ozo_A 332 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E 408 (613)
T ss_dssp CCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-S
T ss_pred ccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-C
Confidence 3345677776 89999999999998753 56679999997643 23345679999999999999999999999876 5
Q ss_pred eEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCcccccc
Q 003232 663 NLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 741 (837)
Q Consensus 663 ~lyLVmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~ 741 (837)
.+|+||||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 409 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 409 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp SEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred CeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 699999999999999999654 4599999999999999999999999999999999999999999999999999874211
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCC
Q 003232 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPF 820 (837)
Q Consensus 742 ~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF 820 (837)
... .........+|+.|+|||++.+..++.++|||||||++|||++ |+.||
T Consensus 489 ~~~----------------------------~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf 540 (613)
T 2ozo_A 489 DDS----------------------------YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 540 (613)
T ss_dssp -----------------------------------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CCc----------------------------eeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 000 0001122346789999999999999999999999999999998 99999
Q ss_pred CCCCc
Q 003232 821 NAEHP 825 (837)
Q Consensus 821 ~~~dp 825 (837)
...+.
T Consensus 541 ~~~~~ 545 (613)
T 2ozo_A 541 KKMKG 545 (613)
T ss_dssp TTCCS
T ss_pred CCCCH
Confidence 87553
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=299.21 Aligned_cols=212 Identities=25% Similarity=0.396 Sum_probs=171.9
Q ss_pred CCCcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC
Q 003232 583 KDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE 662 (837)
Q Consensus 583 k~g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~ 662 (837)
.+....++|++.+.||.|+||+||+|++.. .+|+|++..... .....+.+.+|+.+++.++||||+++++++....
T Consensus 27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD-NEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC-CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred cccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC-CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 345567889999999999999999999853 499999875431 2222345778999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCcccccc
Q 003232 663 NLYLVMEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 741 (837)
Q Consensus 663 ~lyLVmEy~~GGSL~dlLk~~g-~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~ 741 (837)
.+++||||++|++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++ ++.++|+|||++.....
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 9999999999999999997654 699999999999999999999999999999999999997 78999999999863111
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC---------CCCCchHHHHHHHHHHHH
Q 003232 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG---------TGHGTTADWWSVGIILFE 812 (837)
Q Consensus 742 ~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg---------~~~s~kSDIWSLGVILyE 812 (837)
.... ..........||+.|+|||++.+ ..++.++||||||+++|+
T Consensus 182 ~~~~--------------------------~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~e 235 (319)
T 2y4i_B 182 LQAG--------------------------RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYE 235 (319)
T ss_dssp --------------------------------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHH
T ss_pred cccc--------------------------ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHH
Confidence 0000 00112234568999999999975 457899999999999999
Q ss_pred HHcCCCCCCCCCc
Q 003232 813 LIVGIPPFNAEHP 825 (837)
Q Consensus 813 LLTGr~PF~~~dp 825 (837)
|++|..||.....
T Consensus 236 l~~g~~p~~~~~~ 248 (319)
T 2y4i_B 236 LHAREWPFKTQPA 248 (319)
T ss_dssp HHHSSCSSSSCCH
T ss_pred HHhCCCCCCCCCH
Confidence 9999999986543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-32 Score=286.68 Aligned_cols=179 Identities=15% Similarity=0.171 Sum_probs=159.7
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEE
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyL 666 (837)
..++|++.+.||+|+||.||+|++..+++.||||++...........+.+.+|+.+++.++||||+++++++...+..|+
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 33679999999999999999999999999999999987655556667889999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCC
Q 003232 667 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stdd 746 (837)
||||++|++|.+++.. + .....+..++.||+.||.|||++||+||||||+|||++.+|.++|++++
T Consensus 109 v~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~------------ 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------------ 174 (286)
T ss_dssp EEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC------------
T ss_pred EEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc------------
Confidence 9999999999999954 3 4666788899999999999999999999999999999999999987443
Q ss_pred CCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 747 l~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
|++| ++.++|||||||++|+|++|+.||.+.+.
T Consensus 175 ---------------------------------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~ 207 (286)
T 3uqc_A 175 ---------------------------------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGV 207 (286)
T ss_dssp ---------------------------------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSB
T ss_pred ---------------------------------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 3332 68899999999999999999999987654
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-33 Score=310.23 Aligned_cols=209 Identities=24% Similarity=0.351 Sum_probs=175.2
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCC-CceEEEEeEeecCCeEE
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN-PFVVRFFYSFTCRENLY 665 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrH-PNIVkL~gsf~d~~~ly 665 (837)
..++|++.++||.|+||.||+|++..+++.||||++...... ..+.+|+.+++.++| ++|..+..++......|
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~ 79 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV 79 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence 346799999999999999999999999999999998654321 247789999999987 56666667777788999
Q ss_pred EEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEE---ccCCcEEEEecCCcccccc
Q 003232 666 LVMEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI---AHDGHIKLTDFGLSKVGLI 741 (837)
Q Consensus 666 LVmEy~~GGSL~dlLk~-~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILL---d~dG~IKLiDFGLArvg~~ 741 (837)
|||||+ +++|.+++.. ...+++..++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||+++....
T Consensus 80 lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 999999 9999999975 4679999999999999999999999999999999999999 6889999999999974221
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCC
Q 003232 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFN 821 (837)
Q Consensus 742 ~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~ 821 (837)
...... ..........||+.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 159 ~~~~~~------------------------~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~ 214 (483)
T 3sv0_A 159 TSTHQH------------------------IPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQ 214 (483)
T ss_dssp TTTCCB------------------------CCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred Cccccc------------------------cccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCc
Confidence 111100 00112235679999999999999999999999999999999999999998
Q ss_pred CCCc
Q 003232 822 AEHP 825 (837)
Q Consensus 822 ~~dp 825 (837)
....
T Consensus 215 ~~~~ 218 (483)
T 3sv0_A 215 GLKA 218 (483)
T ss_dssp SCCC
T ss_pred cccc
Confidence 7554
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-35 Score=306.77 Aligned_cols=195 Identities=20% Similarity=0.262 Sum_probs=162.0
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccc-----cHHHHHHHHHHHHHHHhcC---------CCceEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMI-----RKNAVESILAERDILISVR---------NPFVVR 653 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~-----~~e~ie~~~rEieILk~Lr---------HPNIVk 653 (837)
.++|++.+.||+|+||+||+|++ +|+.||||++...... .....+.+.+|+.+++.++ ||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 46799999999999999999998 6899999999765321 2233467888999988885 777777
Q ss_pred EEeEee-----------------c-------------CCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 003232 654 FFYSFT-----------------C-------------RENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALE 703 (837)
Q Consensus 654 L~gsf~-----------------d-------------~~~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALs 703 (837)
+.+.+. . ...+|+||||+++|++.+.+.+ +.+++..++.++.||+.||.
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHH
Confidence 766542 2 6789999999999976666644 56899999999999999999
Q ss_pred HHH-hCCcccccCCCCcEEEccCC--------------------cEEEEecCCccccccCCCCCCCCCCccCcccCCCCC
Q 003232 704 YLH-SLRVVHRDLKPDNLLIAHDG--------------------HIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEE 762 (837)
Q Consensus 704 YLH-SkGIIHRDIKPeNILLd~dG--------------------~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~ 762 (837)
||| ++||+||||||+|||++.++ .+||+|||+++...
T Consensus 176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~---------------------- 233 (336)
T 2vuw_A 176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLER---------------------- 233 (336)
T ss_dssp HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEE----------------------
T ss_pred HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecC----------------------
Confidence 999 99999999999999999887 89999999997310
Q ss_pred ccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHH-HHHHHcCCCCCCC
Q 003232 763 PQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGII-LFELIVGIPPFNA 822 (837)
Q Consensus 763 ~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVI-LyELLTGr~PF~~ 822 (837)
....+||+.|+|||++.+.. +.++||||||++ .++++.|..||..
T Consensus 234 --------------~~~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 234 --------------DGIVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp --------------TTEEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred --------------CCcEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc
Confidence 01247999999999999877 899999998777 7888899999853
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-33 Score=321.76 Aligned_cols=195 Identities=31% Similarity=0.475 Sum_probs=167.4
Q ss_pred ccCCeEEEEEecccCceEEEEEEECC-CCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCe--
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRT-TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCREN-- 663 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~-tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~-- 663 (837)
..++|++.+.||+|+||+||+|.+.. +++.||||++.... .......+.+|+.+++.++||||+++++++.....
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 155 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG 155 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence 34779999999999999999999976 78999999987542 34555678999999999999999999999987654
Q ss_pred ---EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccc
Q 003232 664 ---LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740 (837)
Q Consensus 664 ---lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~ 740 (837)
.||||||++|++|.+++.. .+++..++.++.||+.||.|||++|||||||||+|||++.+ .+||+|||+++...
T Consensus 156 ~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~ 232 (681)
T 2pzi_A 156 DPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN 232 (681)
T ss_dssp CEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred CceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence 7999999999999988765 69999999999999999999999999999999999999875 99999999987310
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCC
Q 003232 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820 (837)
Q Consensus 741 ~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF 820 (837)
......||+.|+|||++.+.. +.++|||||||++|+|++|..||
T Consensus 233 -----------------------------------~~~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~ 276 (681)
T 2pzi_A 233 -----------------------------------SFGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTR 276 (681)
T ss_dssp -----------------------------------CCSCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEE
T ss_pred -----------------------------------cCCccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCC
Confidence 012357999999999997654 89999999999999999999998
Q ss_pred CC
Q 003232 821 NA 822 (837)
Q Consensus 821 ~~ 822 (837)
.+
T Consensus 277 ~~ 278 (681)
T 2pzi_A 277 NG 278 (681)
T ss_dssp TT
T ss_pred cc
Confidence 75
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-32 Score=301.02 Aligned_cols=203 Identities=27% Similarity=0.394 Sum_probs=157.5
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEeEeecCCeEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~gsf~d~~~lyLV 667 (837)
+.|.+.+.||+|+||+||.+. ..+|+.||||++.... .+.+.+|+.+++.+ +||||+++++++.....+|+|
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv 87 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA 87 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred heeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence 346777999999999998764 4679999999986532 24567899999876 899999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCC-------HHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccC-------------Cc
Q 003232 668 MEYLNGGDLYSLLRNLGCLD-------EDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD-------------GH 727 (837)
Q Consensus 668 mEy~~GGSL~dlLk~~g~Ls-------ee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~d-------------G~ 727 (837)
|||+. |+|.+++....... +..+..++.||+.||.|||++||+||||||+|||++.+ +.
T Consensus 88 ~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 88 LELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp ECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred EecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceE
Confidence 99995 69999997654322 23456799999999999999999999999999999754 48
Q ss_pred EEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-------CCCCch
Q 003232 728 IKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-------TGHGTT 800 (837)
Q Consensus 728 IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-------~~~s~k 800 (837)
++|+|||+++....... ..........||+.|+|||++.+ ..++.+
T Consensus 167 ~kL~DFG~a~~~~~~~~---------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~ 219 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQS---------------------------SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRS 219 (434)
T ss_dssp EEECCCTTCEECCC-----------------------------------------CCTTSCHHHHSCCCTTSCCCCCCTH
T ss_pred EEEcccccceecCCCCc---------------------------cceeeecCCCCCCCccCHHHhccccccccccCcchh
Confidence 99999999874211000 00011234579999999999976 668999
Q ss_pred HHHHHHHHHHHHHHc-CCCCCCCCCcC
Q 003232 801 ADWWSVGIILFELIV-GIPPFNAEHPQ 826 (837)
Q Consensus 801 SDIWSLGVILyELLT-Gr~PF~~~dpd 826 (837)
+|||||||++|+|++ |..||......
T Consensus 220 ~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 220 IDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp HHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred hhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 999999999999998 99999765443
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-32 Score=279.26 Aligned_cols=183 Identities=33% Similarity=0.629 Sum_probs=158.6
Q ss_pred CCCCCcccCCeEEE-EEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHH-HhcCCCceEEEEeEe
Q 003232 581 PSKDRTSIDDFEII-KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDIL-ISVRNPFVVRFFYSF 658 (837)
Q Consensus 581 P~k~g~~lddYeIl-kkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieIL-k~LrHPNIVkL~gsf 658 (837)
+...+...++|.++ +.||.|+||.||+|.+..+++.||+|++... ..+.+|+.++ +.++||||+++++++
T Consensus 9 ~~~~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~ 80 (299)
T 3m2w_A 9 QIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVY 80 (299)
T ss_dssp CCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred cCcccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhh
Confidence 34556778899998 7899999999999999999999999999753 2456788887 667999999999998
Q ss_pred ec----CCeEEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEcc---CCcEE
Q 003232 659 TC----RENLYLVMEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIK 729 (837)
Q Consensus 659 ~d----~~~lyLVmEy~~GGSL~dlLk~~g--~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~---dG~IK 729 (837)
.. ...+|+||||++|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.++
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~k 160 (299)
T 3m2w_A 81 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILK 160 (299)
T ss_dssp EEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEE
T ss_pred hhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEE
Confidence 76 678999999999999999998754 6999999999999999999999999999999999999988 78999
Q ss_pred EEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHH
Q 003232 730 LTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGII 809 (837)
Q Consensus 730 LiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVI 809 (837)
|+|||++... .+..++.++|||||||+
T Consensus 161 l~Dfg~a~~~-----------------------------------------------------~~~~~~~~~DiwslG~i 187 (299)
T 3m2w_A 161 LTDFGFAKET-----------------------------------------------------TGEKYDKSCDMWSLGVI 187 (299)
T ss_dssp ECCCTTCEEC-----------------------------------------------------TTCGGGGHHHHHHHHHH
T ss_pred Eecccccccc-----------------------------------------------------ccccCCchhhHHHHHHH
Confidence 9999988620 01335778999999999
Q ss_pred HHHHHcCCCCCCCCC
Q 003232 810 LFELIVGIPPFNAEH 824 (837)
Q Consensus 810 LyELLTGr~PF~~~d 824 (837)
+|+|++|..||....
T Consensus 188 l~el~tg~~pf~~~~ 202 (299)
T 3m2w_A 188 MYILLCGYPPFYSNH 202 (299)
T ss_dssp HHHHHHSSCSCCC--
T ss_pred HHHHHHCCCCCCCCc
Confidence 999999999996543
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-32 Score=316.20 Aligned_cols=207 Identities=27% Similarity=0.411 Sum_probs=173.0
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCC---CcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTT---GDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE 662 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~t---G~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~ 662 (837)
...++|++.+.||+|+||+||+|.+..+ +..||+|++.... .....+.+.+|+.+++.++||||+++++++. .+
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 463 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 463 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence 3446799999999999999999998654 4579999987542 3445578999999999999999999999885 46
Q ss_pred eEEEEEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCcccccc
Q 003232 663 NLYLVMEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 741 (837)
Q Consensus 663 ~lyLVmEy~~GGSL~dlLk~~g-~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~ 741 (837)
..|+||||+++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 543 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence 7899999999999999997654 689999999999999999999999999999999999999999999999999873110
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCC
Q 003232 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPF 820 (837)
Q Consensus 742 ~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF 820 (837)
.. ........||+.|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 544 ~~------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf 593 (656)
T 2j0j_A 544 ST------------------------------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 593 (656)
T ss_dssp ----------------------------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred Cc------------------------------ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCC
Confidence 00 001123457789999999999999999999999999999997 99999
Q ss_pred CCCCc
Q 003232 821 NAEHP 825 (837)
Q Consensus 821 ~~~dp 825 (837)
.+...
T Consensus 594 ~~~~~ 598 (656)
T 2j0j_A 594 QGVKN 598 (656)
T ss_dssp TTCCH
T ss_pred CCCCH
Confidence 86543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=6.3e-33 Score=324.20 Aligned_cols=212 Identities=32% Similarity=0.458 Sum_probs=173.9
Q ss_pred CCCCCCCCcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeE
Q 003232 578 PIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYS 657 (837)
Q Consensus 578 ~~~P~k~g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gs 657 (837)
+++|..++...++|++.+.||.|+||+||+|.+..+|+.||||++.... .....+.+.+|+.+++.++||||++++++
T Consensus 3 G~~p~~pg~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v 80 (676)
T 3qa8_A 3 GRSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREV 80 (676)
T ss_dssp --------------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEEC
T ss_pred CCCCCCCCCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeee
Confidence 4566667777889999999999999999999999999999999987642 34556789999999999999999999998
Q ss_pred eec------CCeEEEEEEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCc-
Q 003232 658 FTC------RENLYLVMEYLNGGDLYSLLRNLG---CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGH- 727 (837)
Q Consensus 658 f~d------~~~lyLVmEy~~GGSL~dlLk~~g---~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~- 727 (837)
+.. ....|+||||++|++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.
T Consensus 81 ~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~ 160 (676)
T 3qa8_A 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQR 160 (676)
T ss_dssp CTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSS
T ss_pred ecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCc
Confidence 765 667899999999999999998644 5899999999999999999999999999999999999987765
Q ss_pred --EEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHH
Q 003232 728 --IKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWS 805 (837)
Q Consensus 728 --IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWS 805 (837)
++|+|||++...... .......||+.|+|||++.+..++.++||||
T Consensus 161 ~~vKL~DFG~a~~~~~~--------------------------------~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwS 208 (676)
T 3qa8_A 161 LIHKIIDLGYAKELDQG--------------------------------ELCTEFVGTLQYLAPELLEQKKYTVTVDYWS 208 (676)
T ss_dssp CEEEECSCCCCCBTTSC--------------------------------CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHH
T ss_pred eeEEEcccccccccccc--------------------------------cccccccCCcccCChHHhccCCCCchhHHHH
Confidence 999999998731100 0112457899999999999999999999999
Q ss_pred HHHHHHHHHcCCCCCCCC
Q 003232 806 VGIILFELIVGIPPFNAE 823 (837)
Q Consensus 806 LGVILyELLTGr~PF~~~ 823 (837)
||+++|+|++|..||...
T Consensus 209 LGviLyeLltG~~Pf~~~ 226 (676)
T 3qa8_A 209 FGTLAFECITGFRPFLPN 226 (676)
T ss_dssp HHHHHHHHHSSCSSCCSS
T ss_pred HHHHHHHHHHCCCCCCcc
Confidence 999999999999999754
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.4e-32 Score=297.39 Aligned_cols=201 Identities=25% Similarity=0.337 Sum_probs=159.2
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEeEeecCCeEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~gsf~d~~~lyLV 667 (837)
.+|.+.+.||+|+||+||.. ...+++.||||++...... .+.+|+.+++.+ +||||+++++++......|+|
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv 96 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA 96 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred EEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence 35999999999999997643 3468999999999764321 245799999998 799999999999999999999
Q ss_pred EEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEcc---C--CcEEEEecCCcccccc
Q 003232 668 MEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---D--GHIKLTDFGLSKVGLI 741 (837)
Q Consensus 668 mEy~~GGSL~dlLk~~g-~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~---d--G~IKLiDFGLArvg~~ 741 (837)
|||+. ++|.+++.... .+.+..+..++.||+.||.|||++||+||||||+|||++. + ..++|+|||+++....
T Consensus 97 ~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 97 IELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp EECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred EECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 99995 69999997653 3555667889999999999999999999999999999953 2 3588999999874211
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhc---CCCCCchHHHHHHHHHHHHHHc-CC
Q 003232 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL---GTGHGTTADWWSVGIILFELIV-GI 817 (837)
Q Consensus 742 ~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLl---g~~~s~kSDIWSLGVILyELLT-Gr 817 (837)
... .........||+.|+|||++. +..++.++|||||||++|+|++ |.
T Consensus 176 ~~~----------------------------~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~ 227 (432)
T 3p23_A 176 GRH----------------------------SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGS 227 (432)
T ss_dssp --------------------------------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSC
T ss_pred CCc----------------------------ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCC
Confidence 000 001123467999999999997 4567889999999999999999 99
Q ss_pred CCCCCCCc
Q 003232 818 PPFNAEHP 825 (837)
Q Consensus 818 ~PF~~~dp 825 (837)
.||.....
T Consensus 228 ~pf~~~~~ 235 (432)
T 3p23_A 228 HPFGKSLQ 235 (432)
T ss_dssp BTTBSTTT
T ss_pred CCcchhhH
Confidence 99965443
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-32 Score=295.01 Aligned_cols=202 Identities=16% Similarity=0.155 Sum_probs=156.4
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCC-Cc---------------
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN-PF--------------- 650 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrH-PN--------------- 650 (837)
....|.+.+.||+|+||+||+|++..+|+.||||++...........+.+.+|+.+++.++| .|
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 34568999999999999999999999999999999985443333445678899999999977 21
Q ss_pred ------eEEEEeEeec-----CCeEEEEEEecCCCCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 003232 651 ------VVRFFYSFTC-----RENLYLVMEYLNGGDLYSLLRN-------LGCLDEDVARVYIAEVVLALEYLHSLRVVH 712 (837)
Q Consensus 651 ------IVkL~gsf~d-----~~~lyLVmEy~~GGSL~dlLk~-------~g~Lsee~irkIl~QIa~ALsYLHSkGIIH 712 (837)
...+...+.. ...++++|+++ +++|.+++.. ...+++..+..++.||+.||.|||++||+|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH 234 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 234 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 1111111111 22467788866 6899998841 233677788899999999999999999999
Q ss_pred ccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhh
Q 003232 713 RDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEIL 792 (837)
Q Consensus 713 RDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVL 792 (837)
|||||+|||++.++.+||+|||+++... ......+| +.|+|||++
T Consensus 235 rDiKp~NILl~~~~~~kL~DFG~a~~~~----------------------------------~~~~~~~g-~~y~aPE~~ 279 (413)
T 3dzo_A 235 TYLRPVDIVLDQRGGVFLTGFEHLVRDG----------------------------------ASAVSPIG-RGFAPPETT 279 (413)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETT----------------------------------EEECCCCC-TTTCCHHHH
T ss_pred CCcccceEEEecCCeEEEEeccceeecC----------------------------------CccccCCC-CceeCchhh
Confidence 9999999999999999999999987310 01234577 999999999
Q ss_pred ----------cCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 793 ----------LGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 793 ----------lg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
.+..++.++|||||||++|+|++|+.||...+
T Consensus 280 ~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~ 321 (413)
T 3dzo_A 280 AERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDA 321 (413)
T ss_dssp HHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTG
T ss_pred hccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 55668899999999999999999999998654
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-30 Score=295.80 Aligned_cols=190 Identities=17% Similarity=0.114 Sum_probs=136.0
Q ss_pred EEecccCceEEEEEEECCCCcEEEEEEeccccc-------ccHHHHHHHHHHHHHHHhc-CCCceEEEEeEeecCCeEEE
Q 003232 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADM-------IRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYL 666 (837)
Q Consensus 595 kkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~-------~~~e~ie~~~rEieILk~L-rHPNIVkL~gsf~d~~~lyL 666 (837)
..++.|++|.+..++....|+.|++|++.+... ......+.+.+|+++|+++ .|+||+++++++.++..+||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 456778888888888888999999999975421 1234456799999999999 79999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCC
Q 003232 667 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stdd 746 (837)
||||++|++|.+++...+++++. .|+.||+.||.|+|++|||||||||+|||++.+|.+||+|||+++......
T Consensus 320 VMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~--- 393 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC--- 393 (569)
T ss_dssp EEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC------
T ss_pred EEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC---
Confidence 99999999999999998888865 478999999999999999999999999999999999999999997411100
Q ss_pred CCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCC
Q 003232 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPP 819 (837)
Q Consensus 747 l~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~P 819 (837)
....+.+||+.|||||++.+. +...+|+||+|+++|+++++..+
T Consensus 394 ----------------------------~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 394 ----------------------------SWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ----------------------------CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred ----------------------------ccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 011235799999999999865 56789999999998876655433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-25 Score=255.75 Aligned_cols=193 Identities=18% Similarity=0.150 Sum_probs=145.5
Q ss_pred EEEEecccCceEEEEEEECCCCcEEEEEEeccccc-----ccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEE
Q 003232 593 IIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADM-----IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 593 IlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~-----~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLV 667 (837)
..+.||+|+||+||++. ..++.+++|....... ......+++.+|+.++++++||||+++..++......|+|
T Consensus 340 ~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp --------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 35689999999999995 5688999998754322 1222346689999999999999999555455566777999
Q ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCC
Q 003232 668 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (837)
Q Consensus 668 mEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl 747 (837)
|||++|++|.+++.. +..++.||+.||.|||++||+||||||+|||++. .+||+|||+++.....
T Consensus 418 mE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~----- 482 (540)
T 3en9_A 418 MSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD----- 482 (540)
T ss_dssp EECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCH-----
T ss_pred EECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCc-----
Confidence 999999999999865 5689999999999999999999999999999988 9999999999841000
Q ss_pred CCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC--CCCCchHHHHHHHHHHHHHHcCCCCCC
Q 003232 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG--TGHGTTADWWSVGIILFELIVGIPPFN 821 (837)
Q Consensus 748 ~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg--~~~s~kSDIWSLGVILyELLTGr~PF~ 821 (837)
..............+||+.|||||++.+ ..|+..+|+|+..+-..+.+.++.+|.
T Consensus 483 -------------------~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 483 -------------------EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp -------------------HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred -------------------cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 0000000112235679999999999987 667788899999999999888888774
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=4.3e-23 Score=215.83 Aligned_cols=134 Identities=22% Similarity=0.217 Sum_probs=108.5
Q ss_pred eEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccH---------------HHHHHHHHHHHHHHhcCCCceEEEE
Q 003232 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRK---------------NAVESILAERDILISVRNPFVVRFF 655 (837)
Q Consensus 591 YeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~---------------e~ie~~~rEieILk~LrHPNIVkL~ 655 (837)
|.+.+.||.|+||.||+|++ .+|+.||+|+++....... .....+.+|+.+++.++|+++..
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~~~v~~-- 168 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPK-- 168 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCC--
T ss_pred EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccCCCcCe--
Confidence 55669999999999999999 8899999999965321110 24567899999999998544444
Q ss_pred eEeecCCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCC
Q 003232 656 YSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGL 735 (837)
Q Consensus 656 gsf~d~~~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGL 735 (837)
.+.. +..|+||||++|++|.+ +. ......++.||+.||.|||++||+||||||+|||++ ++.++|+|||+
T Consensus 169 -~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~ 238 (282)
T 1zar_A 169 -VYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQ 238 (282)
T ss_dssp -EEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTT
T ss_pred -EEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCC
Confidence 3332 55699999999999988 31 123557999999999999999999999999999999 99999999999
Q ss_pred cc
Q 003232 736 SK 737 (837)
Q Consensus 736 Ar 737 (837)
++
T Consensus 239 a~ 240 (282)
T 1zar_A 239 SV 240 (282)
T ss_dssp CE
T ss_pred Ce
Confidence 86
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=1.9e-19 Score=184.97 Aligned_cols=139 Identities=22% Similarity=0.209 Sum_probs=108.8
Q ss_pred eEEEEEecccCceEEEEEEECCCCcE--EEEEEecccccc---------------------cHHHHHHHHHHHHHHHhcC
Q 003232 591 FEIIKPISRGAFGRVFLAKKRTTGDL--FAIKVLKKADMI---------------------RKNAVESILAERDILISVR 647 (837)
Q Consensus 591 YeIlkkLGsG~FGtVYkArdk~tG~~--VAVKIikk~~~~---------------------~~e~ie~~~rEieILk~Lr 647 (837)
|++.+.||.|+||.||+|.+..+|+. ||||+++..... .......+.+|+.+++.++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 78999999999999999998778989 999998653211 0112246789999999998
Q ss_pred CCce--EEEEeEeecCCeEEEEEEecCC-C----CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCcccccCCCCc
Q 003232 648 NPFV--VRFFYSFTCRENLYLVMEYLNG-G----DLYSLLRNLGCLDEDVARVYIAEVVLALEYLH-SLRVVHRDLKPDN 719 (837)
Q Consensus 648 HPNI--VkL~gsf~d~~~lyLVmEy~~G-G----SL~dlLk~~g~Lsee~irkIl~QIa~ALsYLH-SkGIIHRDIKPeN 719 (837)
|+++ +.++.. ...+|||||+.+ | +|.++... .++..+..++.||+.+|.||| ++||+||||||+|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N 201 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN 201 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence 7754 333332 356899999942 3 77776432 234567889999999999999 9999999999999
Q ss_pred EEEccCCcEEEEecCCccc
Q 003232 720 LLIAHDGHIKLTDFGLSKV 738 (837)
Q Consensus 720 ILLd~dG~IKLiDFGLArv 738 (837)
||++. .++|+|||++..
T Consensus 202 ILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 202 IMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp EEESS--SEEECCCTTCEE
T ss_pred EEEcC--cEEEEECccccc
Confidence 99988 999999999873
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.62 E-value=4.7e-16 Score=172.23 Aligned_cols=136 Identities=11% Similarity=0.115 Sum_probs=101.2
Q ss_pred eEEEEEecccCceEEEEEEECCCCcEEEEEEecccccc--------------c---HHHH--HHHHHHHHHHHhcCCCce
Q 003232 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMI--------------R---KNAV--ESILAERDILISVRNPFV 651 (837)
Q Consensus 591 YeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~--------------~---~e~i--e~~~rEieILk~LrHPNI 651 (837)
|.+...||.|+||.||+|.+ .+|+.||||+++..... . .... ....+|...|.++.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 99999999999999999998 57999999998643210 0 0001 112457777877765544
Q ss_pred E--EEEeEeecCCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCC---
Q 003232 652 V--RFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG--- 726 (837)
Q Consensus 652 V--kL~gsf~d~~~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG--- 726 (837)
. .++.. ...+|||||++|+.|.++. .......++.||+.+|.|||++|||||||||.|||++.+|
T Consensus 176 ~vp~p~~~----~~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 176 PVPEPIAQ----SRHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp SCCCEEEE----ETTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred CCCeeeec----cCceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence 3 23322 1237999999998886542 2234567889999999999999999999999999998776
Q ss_pred -------cEEEEecCCcc
Q 003232 727 -------HIKLTDFGLSK 737 (837)
Q Consensus 727 -------~IKLiDFGLAr 737 (837)
.++|+||+.+.
T Consensus 246 d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp CTTSEEEEEEECCCTTCE
T ss_pred cccccccceEEEEeCCcc
Confidence 38999999875
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.27 E-value=1.4e-11 Score=124.64 Aligned_cols=143 Identities=16% Similarity=0.141 Sum_probs=113.1
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcC-CCceEEEEeEeecCCeE
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCRENL 664 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~Lr-HPNIVkL~gsf~d~~~l 664 (837)
..+..|++...++.|+++.||++.. .+..+++|+........ ...+.+|+.+++.+. +..++++++.+...+..
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~ 85 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHhccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCce
Confidence 3456799999999999999999984 36899999987532111 125788999998884 66788888888888899
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 003232 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS------------------------------------- 707 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHS------------------------------------- 707 (837)
|+||||++|.+|.+... +......++.+++.+|..||+
T Consensus 86 ~lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 86 NLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 99999999999987521 122344678899999999998
Q ss_pred ----------------------CCcccccCCCCcEEEccCCcEEEEecCCccc
Q 003232 708 ----------------------LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (837)
Q Consensus 708 ----------------------kGIIHRDIKPeNILLd~dG~IKLiDFGLArv 738 (837)
..++|+|++|.|||++.++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 4589999999999997655567999998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.14 E-value=9.2e-11 Score=116.48 Aligned_cols=138 Identities=16% Similarity=0.143 Sum_probs=101.0
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCc--eEEEEeEeecCCe
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF--VVRFFYSFTCREN 663 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPN--IVkL~gsf~d~~~ 663 (837)
....+|.+....+.|..+.||++.. .+|..+++|+..... ...+.+|..+++.+.+.+ +.+++......+.
T Consensus 17 ~~~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~ 89 (264)
T 1nd4_A 17 ERLFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGR 89 (264)
T ss_dssp TTTTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSC
T ss_pred HhcCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCC
Confidence 3445677655444666799999965 567789999976531 134678888888885443 5668888877778
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------
Q 003232 664 LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLR---------------------------------- 709 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkG---------------------------------- 709 (837)
.++||||++|.+|. . .... ...++.+++..|..||+..
T Consensus 90 ~~~v~e~i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (264)
T 1nd4_A 90 DWLLLGEVPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEE 161 (264)
T ss_dssp EEEEEECCSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGG
T ss_pred CEEEEEecCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhh
Confidence 99999999998874 1 1122 2256677777788888643
Q ss_pred ------------------------cccccCCCCcEEEccCCcEEEEecCCccc
Q 003232 710 ------------------------VVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (837)
Q Consensus 710 ------------------------IIHRDIKPeNILLd~dG~IKLiDFGLArv 738 (837)
++|+|++|.|||++.++.+.|+||+.+..
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 162 HQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp GTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999997766667999999864
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.00 E-value=8.6e-10 Score=117.23 Aligned_cols=140 Identities=16% Similarity=0.311 Sum_probs=105.2
Q ss_pred EEEEecccCceEEEEEEECCCCcEEEEEEec--ccccccHHHHHHHHHHHHHHHhcC--CCceEEEEeEeecC---CeEE
Q 003232 593 IIKPISRGAFGRVFLAKKRTTGDLFAIKVLK--KADMIRKNAVESILAERDILISVR--NPFVVRFFYSFTCR---ENLY 665 (837)
Q Consensus 593 IlkkLGsG~FGtVYkArdk~tG~~VAVKIik--k~~~~~~e~ie~~~rEieILk~Lr--HPNIVkL~gsf~d~---~~ly 665 (837)
.++.|+.|.++.||++... +..+++|+.. ..... .....+.+|..+++.+. +..+++++..+.+. +..|
T Consensus 42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp EEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 4678899999999999853 5688999876 33211 12346788999999887 44577888877665 4589
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 003232 666 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS-------------------------------------- 707 (837)
Q Consensus 666 LVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHS-------------------------------------- 707 (837)
+||||++|..+.+. ....++......++.+++..|..||+
T Consensus 118 ~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 99999999877431 12346788888899999999999997
Q ss_pred --------------------CCcccccCCCCcEEEccCCc--EEEEecCCccc
Q 003232 708 --------------------LRVVHRDLKPDNLLIAHDGH--IKLTDFGLSKV 738 (837)
Q Consensus 708 --------------------kGIIHRDIKPeNILLd~dG~--IKLiDFGLArv 738 (837)
.+++|+|++|.|||++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 36899999999999987753 68999999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.84 E-value=1.1e-09 Score=114.14 Aligned_cols=132 Identities=18% Similarity=0.225 Sum_probs=97.6
Q ss_pred EEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcC-CCc--eEEEEeEeecCC---eEEEEE
Q 003232 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPF--VVRFFYSFTCRE---NLYLVM 668 (837)
Q Consensus 595 kkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~Lr-HPN--IVkL~gsf~d~~---~lyLVm 668 (837)
+.++.|....||++. ..+++|+.... .....+.+|..+++.+. +.. +.+++....... ..|+||
T Consensus 26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm 95 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF 95 (304)
T ss_dssp CEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred EecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence 348999999999864 46899986542 33467889999998873 332 344444433332 358899
Q ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 003232 669 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS----------------------------------------- 707 (837)
Q Consensus 669 Ey~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHS----------------------------------------- 707 (837)
++++|.+|.+... ..++..+...++.+++..|..||+
T Consensus 96 ~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 96 TKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp ECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred cccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9999988865432 346777788888888888888885
Q ss_pred -----------------CCcccccCCCCcEEEcc--CCcEEEEecCCccc
Q 003232 708 -----------------LRVVHRDLKPDNLLIAH--DGHIKLTDFGLSKV 738 (837)
Q Consensus 708 -----------------kGIIHRDIKPeNILLd~--dG~IKLiDFGLArv 738 (837)
..++|+|++|.||+++. .+.+.|+||+.+..
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~ 223 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAI 223 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEE
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCcc
Confidence 13699999999999988 45678999999875
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.39 E-value=3.4e-06 Score=88.69 Aligned_cols=133 Identities=17% Similarity=0.254 Sum_probs=93.6
Q ss_pred EEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCC---ceEEEEeEee-cCCeEEEEEE
Q 003232 594 IKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP---FVVRFFYSFT-CRENLYLVME 669 (837)
Q Consensus 594 lkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHP---NIVkL~gsf~-d~~~lyLVmE 669 (837)
++.++.|....||+. +..+++|+... ......+.+|..+|+.+.+. .+.+++.... ..+..|+|||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 355788998999988 56789998542 23446788999999998752 3555555553 4556789999
Q ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 003232 670 YLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL----------------------------------------- 708 (837)
Q Consensus 670 y~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSk----------------------------------------- 708 (837)
|++|..|....- ..++......++.++...|..||+.
T Consensus 94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 999988876321 2244555555555555555555532
Q ss_pred -------------------CcccccCCCCcEEEcc---CCcE-EEEecCCccc
Q 003232 709 -------------------RVVHRDLKPDNLLIAH---DGHI-KLTDFGLSKV 738 (837)
Q Consensus 709 -------------------GIIHRDIKPeNILLd~---dG~I-KLiDFGLArv 738 (837)
.++|+|++|.|||++. ++.+ .|+||+.+..
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3599999999999987 4554 7999998875
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.39 E-value=4.5e-06 Score=84.42 Aligned_cols=139 Identities=17% Similarity=0.191 Sum_probs=99.8
Q ss_pred CCeEEEEEecccCce-EEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcC-CCceEEEEeEeecCCeEEE
Q 003232 589 DDFEIIKPISRGAFG-RVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCRENLYL 666 (837)
Q Consensus 589 ddYeIlkkLGsG~FG-tVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~Lr-HPNIVkL~gsf~d~~~lyL 666 (837)
..|+. +.+..|..+ .||+......+..+++|+.... ....+.+|..+|+.+. +--+.+++.++.+.+..|+
T Consensus 25 ~g~~~-~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~l 97 (272)
T 4gkh_A 25 YGYRW-ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWL 97 (272)
T ss_dssp TTCEE-EEEECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred cCCeE-EEccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEE
Confidence 34544 334445544 7999888777888999987643 2346778999888774 2236677788888889999
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------
Q 003232 667 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL-------------------------------------- 708 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSk-------------------------------------- 708 (837)
|||+++|.++.+..... ......+..++...|..||..
T Consensus 98 vme~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (272)
T 4gkh_A 98 LTTAIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNG 173 (272)
T ss_dssp EEECCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTT
T ss_pred EEEeeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccc
Confidence 99999998887765431 122334556666666667631
Q ss_pred --------------------CcccccCCCCcEEEccCCcEEEEecCCccc
Q 003232 709 --------------------RVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (837)
Q Consensus 709 --------------------GIIHRDIKPeNILLd~dG~IKLiDFGLArv 738 (837)
.++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 174 ~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 174 WPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp CCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 158999999999998877777999998875
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.05 E-value=6.4e-06 Score=88.78 Aligned_cols=79 Identities=25% Similarity=0.268 Sum_probs=49.6
Q ss_pred EEEecccCceEEEEEEECCCCcEEEEEEeccccc-ccH---HHHHHHHHHHHHHHhcCC--C-ceEEEEeEeecCCeEEE
Q 003232 594 IKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADM-IRK---NAVESILAERDILISVRN--P-FVVRFFYSFTCRENLYL 666 (837)
Q Consensus 594 lkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~-~~~---e~ie~~~rEieILk~LrH--P-NIVkL~gsf~d~~~lyL 666 (837)
++.||.|.++.||++....+++.+++|...+... ... ....++..|.++++.+.. | .+++++.+ +....++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 5789999999999997655678999998654211 000 112356778888887642 3 34455543 3345689
Q ss_pred EEEecCCC
Q 003232 667 VMEYLNGG 674 (837)
Q Consensus 667 VmEy~~GG 674 (837)
||||+.|.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.89 E-value=9.8e-05 Score=76.36 Aligned_cols=31 Identities=19% Similarity=0.327 Sum_probs=28.2
Q ss_pred CCcccccCCCCcEEEccCCcEEEEecCCccc
Q 003232 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (837)
Q Consensus 708 kGIIHRDIKPeNILLd~dG~IKLiDFGLArv 738 (837)
.+++|+|+++.|||++.++.+.|+||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 6799999999999998888999999998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.81 E-value=3.1e-05 Score=81.85 Aligned_cols=85 Identities=14% Similarity=0.147 Sum_probs=53.9
Q ss_pred EEEEEe-cccCceEEEEEEEC--C----CCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCC---CceEEEEeEeecC
Q 003232 592 EIIKPI-SRGAFGRVFLAKKR--T----TGDLFAIKVLKKADMIRKNAVESILAERDILISVRN---PFVVRFFYSFTCR 661 (837)
Q Consensus 592 eIlkkL-GsG~FGtVYkArdk--~----tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrH---PNIVkL~gsf~d~ 661 (837)
..++.| +.|....+|++... . ++..+++|+..............+.+|..+++.+.. ..+.+++......
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 445778 88989999998753 0 256899998765320000001245677777777642 3466677665544
Q ss_pred ---CeEEEEEEecCCCCH
Q 003232 662 ---ENLYLVMEYLNGGDL 676 (837)
Q Consensus 662 ---~~lyLVmEy~~GGSL 676 (837)
...|+||||++|..+
T Consensus 103 ~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp TTTSSCEEEEECCCCBCC
T ss_pred CccCCceEEEEecCCCCh
Confidence 356899999988654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.50 E-value=0.0003 Score=76.79 Aligned_cols=31 Identities=19% Similarity=0.386 Sum_probs=27.8
Q ss_pred hCCcccccCCCCcEEEccCCcEEEEecCCccc
Q 003232 707 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (837)
Q Consensus 707 SkGIIHRDIKPeNILLd~dG~IKLiDFGLArv 738 (837)
...++|+|++|.|||++.++ +.|+||+.+..
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 56799999999999998776 99999998875
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.32 E-value=0.00028 Score=73.27 Aligned_cols=132 Identities=15% Similarity=0.105 Sum_probs=72.8
Q ss_pred EEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCce-EEEEeEeecCCeEEEEEEec-
Q 003232 594 IKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFV-VRFFYSFTCRENLYLVMEYL- 671 (837)
Q Consensus 594 lkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNI-VkL~gsf~d~~~lyLVmEy~- 671 (837)
++.|+.|....+|++ ..+++|+...... ......+|..+++.+...++ .+++... ...-++++||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~----~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTE----EYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCcc----ceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecC
Confidence 577889999999998 4589999875321 01122457777666532222 3444433 33457899999
Q ss_pred CCCCHHHH---------------H---HhcCC-C----C-HHHHHHHHHH--------------HHHHHHHHH-------
Q 003232 672 NGGDLYSL---------------L---RNLGC-L----D-EDVARVYIAE--------------VVLALEYLH------- 706 (837)
Q Consensus 672 ~GGSL~dl---------------L---k~~g~-L----s-ee~irkIl~Q--------------Ia~ALsYLH------- 706 (837)
+|.+|... + +..+. + . ...+..+... +...+..+.
T Consensus 91 ~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~ 170 (301)
T 3dxq_A 91 GAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHP 170 (301)
T ss_dssp TCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSC
T ss_pred CCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcC
Confidence 66444210 1 11110 1 0 1111111111 111111111
Q ss_pred -hCCcccccCCCCcEEEccCCcEEEEecCCccc
Q 003232 707 -SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (837)
Q Consensus 707 -SkGIIHRDIKPeNILLd~dG~IKLiDFGLArv 738 (837)
...++|+|+.|.||+ ..++.+.|+||..+..
T Consensus 171 ~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 171 LPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 124899999999999 5677889999998764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.19 E-value=0.0021 Score=68.74 Aligned_cols=75 Identities=16% Similarity=0.169 Sum_probs=58.5
Q ss_pred EEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcC---CCceEEEEeEeecCCeEEEEEEe
Q 003232 594 IKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR---NPFVVRFFYSFTCRENLYLVMEY 670 (837)
Q Consensus 594 lkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~Lr---HPNIVkL~gsf~d~~~lyLVmEy 670 (837)
++.|+.|....+|++.. ++..+++|+.... ....+..|...|+.+. ...+++++.........++||||
T Consensus 41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~ 112 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEA 112 (312)
T ss_dssp EEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEEC
T ss_pred eEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEe
Confidence 47789999999999984 5678999987643 1346778888888773 35677888777777889999999
Q ss_pred cCCCCH
Q 003232 671 LNGGDL 676 (837)
Q Consensus 671 ~~GGSL 676 (837)
++|..+
T Consensus 113 l~G~~~ 118 (312)
T 3jr1_A 113 LNKSKN 118 (312)
T ss_dssp CCCCCC
T ss_pred ccCCCC
Confidence 998754
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.90 E-value=0.0081 Score=61.84 Aligned_cols=78 Identities=13% Similarity=-0.007 Sum_probs=54.2
Q ss_pred CeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCC---CceEEEEeEeecCCeEEE
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN---PFVVRFFYSFTCRENLYL 666 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrH---PNIVkL~gsf~d~~~lyL 666 (837)
...-++.+|.|..+.||+++. .+|+.|++|+........ ...+..|...|+.+.. --+++++... .-++
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~l 87 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTL 87 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEE
T ss_pred CeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEecc----CceE
Confidence 356678899999999999987 678999999876432111 1246788888887742 1344444432 2378
Q ss_pred EEEecCCCC
Q 003232 667 VMEYLNGGD 675 (837)
Q Consensus 667 VmEy~~GGS 675 (837)
||||+.++.
T Consensus 88 v~e~l~~~~ 96 (288)
T 3f7w_A 88 AMEWVDERP 96 (288)
T ss_dssp EEECCCCCC
T ss_pred EEEeecccC
Confidence 999998764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.80 E-value=0.0015 Score=67.76 Aligned_cols=141 Identities=18% Similarity=0.140 Sum_probs=78.3
Q ss_pred eEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCc--eEEEEeE------eecCC
Q 003232 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF--VVRFFYS------FTCRE 662 (837)
Q Consensus 591 YeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPN--IVkL~gs------f~d~~ 662 (837)
..-++.|+.|....+|++... +| .+++|++.... ....+..|..+++.+...+ +.+++.. ....+
T Consensus 24 ~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~-----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g 96 (322)
T 2ppq_A 24 LTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSG 96 (322)
T ss_dssp EEEEEEECC---EEEEEEEES-SC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETT
T ss_pred ceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC-----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECC
Confidence 344677888988999999863 33 68899987521 1123445666666553211 2333311 11235
Q ss_pred eEEEEEEecCCCCHH-----------HH---HHhc-CC--------CCHHHHHH---------------HHHHHHHHHHH
Q 003232 663 NLYLVMEYLNGGDLY-----------SL---LRNL-GC--------LDEDVARV---------------YIAEVVLALEY 704 (837)
Q Consensus 663 ~lyLVmEy~~GGSL~-----------dl---Lk~~-g~--------Lsee~irk---------------Il~QIa~ALsY 704 (837)
..+++|+|++|..+. .. ++.. .. .....-.. +-..+...+.+
T Consensus 97 ~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~ 176 (322)
T 2ppq_A 97 RPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDY 176 (322)
T ss_dssp EEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHH
T ss_pred EEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHH
Confidence 678999999885431 11 1110 00 01100000 00113445555
Q ss_pred HHh-------CCcccccCCCCcEEEccCCcEEEEecCCccc
Q 003232 705 LHS-------LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (837)
Q Consensus 705 LHS-------kGIIHRDIKPeNILLd~dG~IKLiDFGLArv 738 (837)
+.. .+++|+|+++.|||++.++.+.|+||+.+..
T Consensus 177 l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 177 LAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 552 3699999999999998766668999998764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.80 E-value=0.0034 Score=65.27 Aligned_cols=136 Identities=15% Similarity=0.186 Sum_probs=76.5
Q ss_pred EEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCC--ceEEEEeE-----eecCCeEEEE
Q 003232 595 KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNP--FVVRFFYS-----FTCRENLYLV 667 (837)
Q Consensus 595 kkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHP--NIVkL~gs-----f~d~~~lyLV 667 (837)
..|+ |....||++.. .+|+.+++|++..... . ...+..|..+++.+... .+++++.. ....+..+++
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~-~---~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW-T---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS-C---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCC-C---HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 3456 78889998865 3566799999874321 1 13455677777666321 23344332 1124567899
Q ss_pred EEecCCCCH-----HHH------H---Hh----cC-----CCCHHHH----HHHH--------------H-HHHHHHHHH
Q 003232 668 MEYLNGGDL-----YSL------L---RN----LG-----CLDEDVA----RVYI--------------A-EVVLALEYL 705 (837)
Q Consensus 668 mEy~~GGSL-----~dl------L---k~----~g-----~Lsee~i----rkIl--------------~-QIa~ALsYL 705 (837)
|+|++|..+ ..+ + +. .. .++.... ..++ . .+-..+..+
T Consensus 106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l 185 (328)
T 1zyl_A 106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV 185 (328)
T ss_dssp EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence 999987432 111 1 11 00 1111110 1111 0 111122233
Q ss_pred H-------hCCcccccCCCCcEEEccCCcEEEEecCCccc
Q 003232 706 H-------SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (837)
Q Consensus 706 H-------SkGIIHRDIKPeNILLd~dG~IKLiDFGLArv 738 (837)
. ...++|+|+++.|||++ + .+.|+||+.+..
T Consensus 186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 2 34689999999999998 4 899999998765
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.74 E-value=0.0038 Score=65.44 Aligned_cols=32 Identities=34% Similarity=0.601 Sum_probs=27.7
Q ss_pred CCcccccCCCCcEEEccC----CcEEEEecCCcccc
Q 003232 708 LRVVHRDLKPDNLLIAHD----GHIKLTDFGLSKVG 739 (837)
Q Consensus 708 kGIIHRDIKPeNILLd~d----G~IKLiDFGLArvg 739 (837)
..++|+|+.+.|||++.+ +.+.|+||+.+..+
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 479999999999999874 68999999998753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.57 E-value=0.0046 Score=68.51 Aligned_cols=72 Identities=17% Similarity=0.235 Sum_probs=48.1
Q ss_pred EEEecccCceEEEEEEECC-------CCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCc-eEEEEeEeecCCeEE
Q 003232 594 IKPISRGAFGRVFLAKKRT-------TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF-VVRFFYSFTCRENLY 665 (837)
Q Consensus 594 lkkLGsG~FGtVYkArdk~-------tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPN-IVkL~gsf~d~~~ly 665 (837)
++.|+.|....||++.... .+..+++|++.... . ...+..|..+++.+...+ .+++++.+.. .
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g 148 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----G 148 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----C
Confidence 4678888889999998743 25789999985421 1 123457888888774333 3556665542 3
Q ss_pred EEEEecCCC
Q 003232 666 LVMEYLNGG 674 (837)
Q Consensus 666 LVmEy~~GG 674 (837)
+|+||++|.
T Consensus 149 ~v~e~l~G~ 157 (429)
T 1nw1_A 149 RLEEYIPSR 157 (429)
T ss_dssp EEECCCCEE
T ss_pred EEEEEeCCc
Confidence 899999863
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.33 E-value=0.0039 Score=66.48 Aligned_cols=74 Identities=14% Similarity=0.164 Sum_probs=42.9
Q ss_pred EEEecccCceEEEEEEECC--------CCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCc-eEEEEeEeecCCeE
Q 003232 594 IKPISRGAFGRVFLAKKRT--------TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF-VVRFFYSFTCRENL 664 (837)
Q Consensus 594 lkkLGsG~FGtVYkArdk~--------tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPN-IVkL~gsf~d~~~l 664 (837)
++.|+.|....+|++.... .+..+++|+....... ......|..+++.+...+ +.+++..+. -
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~----~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~ 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE----LYNTISEFEVYKTMSKYKIAPQLLNTFN----G 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG----TSCHHHHHHHHHHHHHTTSSCCEEEEET----T
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc----eecHHHHHHHHHHHHhcCCCCceEEecC----C
Confidence 4667888888999998643 1368999998653211 112356777777664222 345554432 2
Q ss_pred EEEEEecCCCC
Q 003232 665 YLVMEYLNGGD 675 (837)
Q Consensus 665 yLVmEy~~GGS 675 (837)
++||||++|..
T Consensus 110 ~~v~e~i~G~~ 120 (369)
T 3c5i_A 110 GRIEEWLYGDP 120 (369)
T ss_dssp EEEEECCCSEE
T ss_pred cEEEEEecCCc
Confidence 68999998753
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.12 E-value=0.0052 Score=67.48 Aligned_cols=136 Identities=15% Similarity=0.232 Sum_probs=79.3
Q ss_pred EEecccCceEEEEEEECC-------CCcEEEEEEecccccccHHHHHHHHHHHHHHHhcC-CCceEEEEeEeecCCeEEE
Q 003232 595 KPISRGAFGRVFLAKKRT-------TGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCRENLYL 666 (837)
Q Consensus 595 kkLGsG~FGtVYkArdk~-------tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~Lr-HPNIVkL~gsf~d~~~lyL 666 (837)
+.|..|-...+|++.... +++.+++|++.... .....+.+|..+++.+. +.-..++++.+.. .+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~----~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~ 127 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL----QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GR 127 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc----chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence 456667777888887632 35789999974321 11234568888887774 2223555655543 28
Q ss_pred EEEecCCCCHH--------------HHHH---hcC-----CCC--HHHHHHHHHHHHH-------------------HHH
Q 003232 667 VMEYLNGGDLY--------------SLLR---NLG-----CLD--EDVARVYIAEVVL-------------------ALE 703 (837)
Q Consensus 667 VmEy~~GGSL~--------------dlLk---~~g-----~Ls--ee~irkIl~QIa~-------------------ALs 703 (837)
||||++|..|. +.+. ... ... ..++..++.++.. .+.
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 99999875432 1111 111 111 3445555544422 233
Q ss_pred HHH----h----CCcccccCCCCcEEEccC----CcEEEEecCCccc
Q 003232 704 YLH----S----LRVVHRDLKPDNLLIAHD----GHIKLTDFGLSKV 738 (837)
Q Consensus 704 YLH----S----kGIIHRDIKPeNILLd~d----G~IKLiDFGLArv 738 (837)
.|. . ..++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 333 2 259999999999999876 7899999998874
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.06 E-value=0.036 Score=59.05 Aligned_cols=31 Identities=19% Similarity=0.439 Sum_probs=27.8
Q ss_pred CCcccccCCCCcEEEccCCcEEEEecCCccc
Q 003232 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (837)
Q Consensus 708 kGIIHRDIKPeNILLd~dG~IKLiDFGLArv 738 (837)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4699999999999998888899999998764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.83 E-value=0.035 Score=62.36 Aligned_cols=74 Identities=15% Similarity=0.165 Sum_probs=47.3
Q ss_pred EEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCce-EEEEeEeecCCeEEEEEEecC
Q 003232 594 IKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFV-VRFFYSFTCRENLYLVMEYLN 672 (837)
Q Consensus 594 lkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNI-VkL~gsf~d~~~lyLVmEy~~ 672 (837)
++.|+.|-...+|++.....+..+++|++...... . -...+|..+++.+...++ +++++.+. + .+||||++
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~---~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~ 184 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE---I-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMD 184 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS---C-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh---h-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeC
Confidence 46788888999999987544578999998542110 0 012478888888864443 46666653 2 25999998
Q ss_pred CCC
Q 003232 673 GGD 675 (837)
Q Consensus 673 GGS 675 (837)
|.+
T Consensus 185 G~~ 187 (458)
T 2qg7_A 185 GYA 187 (458)
T ss_dssp SEE
T ss_pred Ccc
Confidence 743
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.12 E-value=0.12 Score=57.66 Aligned_cols=75 Identities=13% Similarity=0.154 Sum_probs=46.5
Q ss_pred EEEEecccCceEEEEEEECCC-------CcEEEEEEecccccccHHHHHHHHHHHHHHHhcC-CCceEEEEeEeecCCeE
Q 003232 593 IIKPISRGAFGRVFLAKKRTT-------GDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCRENL 664 (837)
Q Consensus 593 IlkkLGsG~FGtVYkArdk~t-------G~~VAVKIikk~~~~~~e~ie~~~rEieILk~Lr-HPNIVkL~gsf~d~~~l 664 (837)
-++.|..|-...+|++..... +..+++++..... ...-...+|..+++.+. +.-..++++.+. -
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t----~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~ 145 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV----GKFYDSKVELDVFRYLSNINIAPNIIADFP----E 145 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-----CCCCHHHHHHHHHHHHHTTSSCCEEEEET----T
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc----chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----C
Confidence 346677788889999987421 5789999975432 11112346777777664 222344554332 2
Q ss_pred EEEEEecCCCC
Q 003232 665 YLVMEYLNGGD 675 (837)
Q Consensus 665 yLVmEy~~GGS 675 (837)
++||||++|..
T Consensus 146 ~~I~efI~G~~ 156 (424)
T 3mes_A 146 GRIEEFIDGEP 156 (424)
T ss_dssp EEEEECCCSEE
T ss_pred CEEEEEeCCcc
Confidence 68999999855
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=91.99 E-value=0.68 Score=48.08 Aligned_cols=101 Identities=19% Similarity=0.137 Sum_probs=65.8
Q ss_pred CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCCC
Q 003232 674 GDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 751 (837)
Q Consensus 674 GSL~dlLk~-~g~Lsee~irkIl~QIa~ALsYLHS-kGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~ 751 (837)
-||.+++.. ..++++++++.++.|.+.+|.-+-. +.-..+=+.|..|++..+|++-+.+ +.+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------- 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc--------------
Confidence 379999975 4679999999999999999877622 2212333457889999999887543 1110
Q ss_pred ccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCC
Q 003232 752 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPP 819 (837)
Q Consensus 752 ~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~P 819 (837)
.....+.|||... ...+.+.=|||||+++|..+--..|
T Consensus 98 -----------------------------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -----------------------------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp --------------------------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -----------------------------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0112356787653 3456889999999999998854443
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=90.24 E-value=0.67 Score=50.43 Aligned_cols=29 Identities=28% Similarity=0.490 Sum_probs=25.3
Q ss_pred cccccCCCCcEEE------ccCCcEEEEecCCccc
Q 003232 710 VVHRDLKPDNLLI------AHDGHIKLTDFGLSKV 738 (837)
Q Consensus 710 IIHRDIKPeNILL------d~dG~IKLiDFGLArv 738 (837)
++|+|+.+.|||+ +.++.+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 3467899999999875
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 837 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-68 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-65 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-64 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-63 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-60 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-60 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-60 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-59 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-58 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-58 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-58 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-57 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-56 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-56 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-55 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-54 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-54 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-53 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-53 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-53 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-51 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-50 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-50 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-50 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 9e-50 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-49 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 7e-49 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-48 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-48 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-48 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-48 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-47 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-47 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-46 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-46 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-46 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-46 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 9e-46 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-45 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-45 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-45 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 9e-45 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-44 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-44 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-44 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-44 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-44 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-44 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-44 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-43 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-42 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-42 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-42 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-41 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-40 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-40 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-39 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-38 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-38 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-38 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-37 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-29 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-19 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (571), Expect = 7e-68
Identities = 78/240 (32%), Positives = 122/240 (50%), Gaps = 33/240 (13%)
Query: 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV 646
+++DFEI +P+ +G FG V+LA+++ + + A+KVL KA + + + E +I +
Sbjct: 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 63
Query: 647 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLH 706
R+P ++R + F +YL++EY G +Y L+ L DE YI E+ AL Y H
Sbjct: 64 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 123
Query: 707 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLT 766
S RV+HRD+KP+NLL+ G +K+ DFG S
Sbjct: 124 SKRVIHRDIKPENLLLGSAGELKIADFGWSV----------------------------- 154
Query: 767 ASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826
++ + GT DYL PE++ G H D WS+G++ +E +VG PPF A Q
Sbjct: 155 ----HAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 210
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (557), Expect = 1e-65
Identities = 83/248 (33%), Positives = 135/248 (54%), Gaps = 31/248 (12%)
Query: 580 HPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAE 639
P K R +DF+ K + G+F V LA++ T +AIK+L+K +I++N V + E
Sbjct: 1 QPRKKRP--EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRE 58
Query: 640 RDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVV 699
RD++ + +PF V+ +++F E LY + Y G+L +R +G DE R Y AE+V
Sbjct: 59 RDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 118
Query: 700 LALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLG 759
ALEYLH ++HRDLKP+N+L+ D HI++TDFG +KV
Sbjct: 119 SALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKV--------------------- 157
Query: 760 DEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPP 819
+ ++ + S VGT Y++PE+L ++D W++G I+++L+ G+PP
Sbjct: 158 --------LSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 209
Query: 820 FNAEHPQV 827
F A + +
Sbjct: 210 FRAGNEYL 217
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 3e-64
Identities = 70/250 (28%), Positives = 111/250 (44%), Gaps = 36/250 (14%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
DDFE I + G G VF + +G + A K++ I+ I+ E +L +
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNS 63
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS- 707
P++V F+ +F + + ME+++GG L +L+ G + E + V+ L YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTA 767
+++HRD+KP N+L+ G IKL DFG+S
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSG------------------------------ 153
Query: 768 SEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQV 827
Q S VGT Y++PE L GT + +D WS+G+ L E+ VG P +
Sbjct: 154 ---QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 210
Query: 828 STLLRKCQLL 837
L+ CQ+
Sbjct: 211 LELMFGCQVE 220
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 2e-63
Identities = 62/246 (25%), Positives = 113/246 (45%), Gaps = 32/246 (13%)
Query: 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR 647
++D+++++ + GA+G V LA R T + A+K++ + + E+I E I +
Sbjct: 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 61
Query: 648 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS 707
+ VV+F+ YL +EY +GG+L+ + + E A+ + +++ + YLH
Sbjct: 62 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTA 767
+ + HRD+KP+NLL+ ++K++DFGL+ V N+ + L
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN------------------ 163
Query: 768 SEHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTADWWSVGIILFELIVGIPPFNAEHPQ 826
GT Y+APE+L H D WS GI+L ++ G P++
Sbjct: 164 -----------KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 212
Query: 827 VSTLLR 832
Sbjct: 213 CQEYSD 218
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 1e-60
Identities = 74/253 (29%), Positives = 122/253 (48%), Gaps = 40/253 (15%)
Query: 580 HPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAE 639
H ++D D +EII + GAFG+V+ A+ + T L A KV+ + +E + E
Sbjct: 3 HVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVE 59
Query: 640 RDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEV 698
DIL S +P +V+ +F NL++++E+ GG + +++ L L E +V +
Sbjct: 60 IDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQT 119
Query: 699 VLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 758
+ AL YLH +++HRDLK N+L DG IKL DFG+S
Sbjct: 120 LDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKN------------------- 160
Query: 759 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-----GHGTTADWWSVGIILFEL 813
+ +++ S +GTP ++APE+++ + AD WS+GI L E+
Sbjct: 161 ------------TRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 208
Query: 814 IVGIPPFNAEHPQ 826
PP + +P
Sbjct: 209 AEIEPPHHELNPM 221
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (516), Expect = 4e-60
Identities = 67/249 (26%), Positives = 117/249 (46%), Gaps = 43/249 (17%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+D+E++ I G++GR ++++ G + K L M + +++E ++L +++
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE-KQMLVSEVNLLRELKH 62
Query: 649 PFVVRFFYSFTCREN--LYLVMEYLNGGDLYSLLRNL----GCLDEDVARVYIAEVVLAL 702
P +VR++ R N LY+VMEY GGDL S++ LDE+ + ++ LAL
Sbjct: 63 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 703 EYLHSL-----RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 757
+ H V+HRDLKP N+ + ++KL DFGL++ +
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR-------------------I 163
Query: 758 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGI 817
L + A TP Y++PE + + +D WS+G +L+EL +
Sbjct: 164 LNHDTSFAKAFVG------------TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM 211
Query: 818 PPFNAEHPQ 826
PPF A +
Sbjct: 212 PPFTAFSQK 220
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 6e-60
Identities = 91/240 (37%), Positives = 139/240 (57%), Gaps = 32/240 (13%)
Query: 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDIL-ISV 646
I+DF + K + +G+FG+VFLA+ + T FAIK LKK ++ + VE + E+ +L ++
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60
Query: 647 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLH 706
+PF+ F +F +ENL+ VMEYLNGGDL +++ D A Y AE++L L++LH
Sbjct: 61 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 120
Query: 707 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLT 766
S +V+RDLK DN+L+ DGHIK+ DFG+ K
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCK----------------------------- 151
Query: 767 ASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826
E+ K + GTPDY+APEILLG + + DWWS G++L+E+++G PF+ + +
Sbjct: 152 --ENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE 209
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 202 bits (515), Expect = 6e-59
Identities = 55/270 (20%), Positives = 113/270 (41%), Gaps = 39/270 (14%)
Query: 560 IEEDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAI 619
I + +D+ + P+ K + D ++I++ + GAFG V ++ TG +F
Sbjct: 1 INDYDKFYEDIWKKYVPQPVEV-KQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVA 59
Query: 620 KVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 679
K + + K ++ E I+ + +P ++ +F + + L++E+L+GG+L+
Sbjct: 60 KFINTPYPLDK---YTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDR 116
Query: 680 LRNLGC-LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA--HDGHIKLTDFGLS 736
+ + E Y+ + L+++H +VH D+KP+N++ +K+ DFGL+
Sbjct: 117 IAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLA 176
Query: 737 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG 796
+ T ++ APEI+
Sbjct: 177 T--------------------------------KLNPDEIVKVTTATAEFAAPEIVDREP 204
Query: 797 HGTTADWWSVGIILFELIVGIPPFNAEHPQ 826
G D W++G++ + L+ G+ PF E
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGLSPFAGEDDL 234
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 201 bits (513), Expect = 1e-58
Identities = 65/261 (24%), Positives = 114/261 (43%), Gaps = 39/261 (14%)
Query: 569 DVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMI 628
D+ + P+ D +D ++I + + GAFG V +R TG+ FA K +
Sbjct: 7 DIWKQYYPQPVEIKHDHV-LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES 65
Query: 629 RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL-RNLGCLD 687
K E++ E + +R+P +V +F + ++ E+++GG+L+ + +
Sbjct: 66 DK---ETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMS 122
Query: 688 EDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD--GHIKLTDFGLSKVGLINSTD 745
ED A Y+ +V L ++H VH DLKP+N++ +KL DFGL+
Sbjct: 123 EDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA-------- 174
Query: 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWS 805
H ++ + GT ++ APE+ G G D WS
Sbjct: 175 ------------------------HLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWS 210
Query: 806 VGIILFELIVGIPPFNAEHPQ 826
VG++ + L+ G+ PF E+
Sbjct: 211 VGVLSYILLSGLSPFGGENDD 231
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 198 bits (505), Expect = 2e-58
Identities = 67/251 (26%), Positives = 104/251 (41%), Gaps = 45/251 (17%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIR------KNAVESILAERDI 642
+++E + + RG V + T +A+K++ + E+ L E DI
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 643 LISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLA 701
L V P +++ ++ +LV + + G+L+ L L E R + ++
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122
Query: 702 LEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDE 761
+ LH L +VHRDLKP+N+L+ D +IKLTDFG S
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC------------------------ 158
Query: 762 EPQLTASEHQQERRKKRSAVGTPDYLAPEILLG------TGHGTTADWWSVGIILFELIV 815
K R GTP YLAPEI+ G+G D WS G+I++ L+
Sbjct: 159 --------QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 210
Query: 816 GIPPFNAEHPQ 826
G PPF
Sbjct: 211 GSPPFWHRKQM 221
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 2e-58
Identities = 75/238 (31%), Positives = 117/238 (49%), Gaps = 35/238 (14%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ + I +GA G V+ A TG AI+ + +K E I+ E ++ +N
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKN 76
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
P +V + S+ + L++VMEYL GG L ++ C+DE E + ALE+LHS
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSN 135
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTAS 768
+V+HRD+K DN+L+ DG +KLTDFG
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCA------------------------------- 164
Query: 769 EHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826
+ E+ K+ + VGTP ++APE++ +G D WS+GI+ E+I G PP+ E+P
Sbjct: 165 QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL 222
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 197 bits (503), Expect = 1e-57
Identities = 60/241 (24%), Positives = 95/241 (39%), Gaps = 38/241 (15%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
F ++ I G+FG V+ A+ ++ AIK + + + I+ E L +R+
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
P +++ + +LVMEY G L + L E + L YLHS
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTAS 768
++HRD+K N+L++ G +KL DFG + +
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASI------------------------------ 164
Query: 769 EHQQERRKKRSAVGTPDYLAPEILLGTGHG---TTADWWSVGIILFELIVGIPPFNAEHP 825
S VGTP ++APE++L G D WS+GI EL PP +
Sbjct: 165 -----MAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219
Query: 826 Q 826
Sbjct: 220 M 220
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 194 bits (494), Expect = 2e-56
Identities = 73/241 (30%), Positives = 115/241 (47%), Gaps = 37/241 (15%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
D ++ + GAF V LA+ + T L AIK + K + + S+ E +L +++
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIAVLHKIKH 66
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
P +V + +LYL+M+ ++GG+L+ + G E A I +V+ A++YLH L
Sbjct: 67 PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL 126
Query: 709 RVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQL 765
+VHRDLKP+NLL D I ++DFGLSK+
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--------------------------- 159
Query: 766 TASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825
+ +A GTP Y+APE+L + D WS+G+I + L+ G PPF E+
Sbjct: 160 -----EDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND 214
Query: 826 Q 826
Sbjct: 215 A 215
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 193 bits (490), Expect = 6e-56
Identities = 86/240 (35%), Positives = 134/240 (55%), Gaps = 34/240 (14%)
Query: 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV 646
S+ DF+I++ + G+FGRV L + R G +A+KVLKK ++R VE ER +L V
Sbjct: 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 61
Query: 647 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLH 706
+PF++R + +F + ++++M+Y+ GG+L+SLLR VA+ Y AEV LALEYLH
Sbjct: 62 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH 121
Query: 707 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLT 766
S +++RDLKP+N+L+ +GHIK+TDFG +K
Sbjct: 122 SKDIIYRDLKPENILLDKNGHIKITDFGFAK----------------------------- 152
Query: 767 ASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826
+ GTPDY+APE++ + + DWWS GI+++E++ G PF +
Sbjct: 153 -----YVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM 207
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 4e-55
Identities = 85/242 (35%), Positives = 135/242 (55%), Gaps = 31/242 (12%)
Query: 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILI 644
+ +++DF+ +K + +G FG+V L +++ TG +A+K+L+K +I K+ V + E +L
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 645 SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEY 704
+ R+PF+ Y+F + L VMEY NGG+L+ L E+ AR Y AE+V ALEY
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
LHS VV+RD+K +NL++ DGHIK+TDFGL K G
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG------------------------- 155
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824
+ ++ GTP+YLAPE+L +G DWW +G++++E++ G PF +
Sbjct: 156 ------ISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209
Query: 825 PQ 826
+
Sbjct: 210 HE 211
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 190 bits (484), Expect = 2e-54
Identities = 77/254 (30%), Positives = 129/254 (50%), Gaps = 37/254 (14%)
Query: 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAER---DIL 643
+++DF + + I RG FG V+ +K TG ++A+K L K + K L ER ++
Sbjct: 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 61
Query: 644 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALE 703
+ PF+V Y+F + L +++ +NGGDL+ L G E R Y AE++L LE
Sbjct: 62 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 121
Query: 704 YLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEP 763
++H+ VV+RDLKP N+L+ GH++++D GL+
Sbjct: 122 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC-------------------------- 155
Query: 764 QLTASEHQQERRKKRSAVGTPDYLAPEILL-GTGHGTTADWWSVGIILFELIVGIPPFNA 822
++K ++VGT Y+APE+L G + ++ADW+S+G +LF+L+ G PF
Sbjct: 156 -------DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 208
Query: 823 EHPQVSTLLRKCQL 836
+ + + L
Sbjct: 209 HKTKDKHEIDRMTL 222
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 186 bits (473), Expect = 5e-54
Identities = 55/242 (22%), Positives = 102/242 (42%), Gaps = 32/242 (13%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
D +E+ + + G V LA+ A+KVL+ + E ++ +
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66
Query: 649 PFVVRFFYSFTCREN----LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEY 704
P +V + + Y+VMEY++G L ++ G + A IA+ AL +
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
H ++HRD+KP N++I+ +K+ DFG+++
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIAR--------------------------- 159
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824
++ + + +GT YL+PE G +D +S+G +L+E++ G PPF +
Sbjct: 160 -AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 218
Query: 825 PQ 826
P
Sbjct: 219 PV 220
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 186 bits (473), Expect = 4e-53
Identities = 97/270 (35%), Positives = 154/270 (57%), Gaps = 38/270 (14%)
Query: 557 STVIEEDAPLEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDL 616
+V E A ++D ++ T PS++ +D F+ IK + G+FGRV L K + +G+
Sbjct: 13 ESVKEFLAKAKEDFLKKWET----PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNH 68
Query: 617 FAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 676
+A+K+L K +++ +E L E+ IL +V PF+V+ +SF NLY+VMEY+ GG++
Sbjct: 69 YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 677 YSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS 736
+S LR +G E AR Y A++VL EYLHSL +++RDLKP+NLLI G+I++TDFG +
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 737 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG 796
K + + + + GTP+ LAPEI+L G
Sbjct: 189 K----------------------------------RVKGRTWTLCGTPEALAPEIILSKG 214
Query: 797 HGTTADWWSVGIILFELIVGIPPFNAEHPQ 826
+ DWW++G++++E+ G PPF A+ P
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPI 244
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 5e-53
Identities = 47/242 (19%), Positives = 95/242 (39%), Gaps = 38/242 (15%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ + I G+FG V+ K A+K+L +++ E +L R+
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNV-TAPTPQQLQAFKNEVGVLRKTRH 63
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHS 707
++ F ++ L +V ++ G LY L + + + ++YLH+
Sbjct: 64 VNILLF-MGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTA 767
++HRDLK +N+ + D +K+ DFGL+ V
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATV----------------------------- 153
Query: 768 SEHQQERRKKRSAVGTPDYLAPEILLGTGHG---TTADWWSVGIILFELIVGIPPFNAEH 824
+ G+ ++APE++ +D ++ GI+L+EL+ G P++ +
Sbjct: 154 KSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213
Query: 825 PQ 826
+
Sbjct: 214 NR 215
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 8e-53
Identities = 53/256 (20%), Positives = 106/256 (41%), Gaps = 44/256 (17%)
Query: 586 TSIDD--FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDIL 643
S D + I RG+F V+ T A L+ + K+ + E ++L
Sbjct: 4 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEML 62
Query: 644 ISVRNPFVVRFFYSFTC----RENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVV 699
+++P +VRF+ S+ ++ + LV E + G L + L+ + V R + +++
Sbjct: 63 KGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQIL 122
Query: 700 LALEYLHSL--RVVHRDLKPDNLLI-AHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 756
L++LH+ ++HRDLK DN+ I G +K+ D GL+ +
Sbjct: 123 KGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL------------------ 164
Query: 757 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVG 816
+ ++ +GTP+++APE+ + + D ++ G+ + E+
Sbjct: 165 ---------------KRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATS 208
Query: 817 IPPFNAEHPQVSTLLR 832
P++ R
Sbjct: 209 EYPYSECQNAAQIYRR 224
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 2e-51
Identities = 55/241 (22%), Positives = 100/241 (41%), Gaps = 39/241 (16%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ + I + + RG FG V + ++ + K +K + + E IL R+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV----KGTDQVLVKKEISILNIARH 60
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC-LDEDVARVYIAEVVLALEYLHS 707
++ SF E L ++ E+++G D++ + L+E Y+ +V AL++LHS
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 708 LRVVHRDLKPDNLLIAHD--GHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQL 765
+ H D++P+N++ IK+ +FG ++
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR---------------------------- 152
Query: 766 TASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825
+ R P+Y APE+ T D WS+G +++ L+ GI PF AE
Sbjct: 153 ----QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN 208
Query: 826 Q 826
Q
Sbjct: 209 Q 209
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 2e-50
Identities = 68/255 (26%), Positives = 115/255 (45%), Gaps = 51/255 (20%)
Query: 583 KDRTSIDDFEII-KPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERD 641
K IDD+++ + + G G+V + T + FA+K+L+ R+ E +
Sbjct: 5 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVE 56
Query: 642 ILISV-RNPFVVRFFYSF----TCRENLYLVMEYLNGGDLYSLLRNLG--CLDEDVARVY 694
+ + P +VR + R+ L +VME L+GG+L+S +++ G E A
Sbjct: 57 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 116
Query: 695 IAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGLINSTDDLSGPA 751
+ + A++YLHS+ + HRD+KP+NLL + +KLTDFG +K
Sbjct: 117 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-------------- 162
Query: 752 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILF 811
+ TP Y+APE+L + + D WS+G+I++
Sbjct: 163 ------------------ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMY 204
Query: 812 ELIVGIPPFNAEHPQ 826
L+ G PPF + H
Sbjct: 205 ILLCGYPPFYSNHGL 219
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 4e-50
Identities = 62/245 (25%), Positives = 113/245 (46%), Gaps = 39/245 (15%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKN---AVESILAERDILIS 645
D ++ + + G F V ++++TG +A K +KK + E I E IL
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 646 VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYL 705
+++P V+ + + ++ L++E + GG+L+ L L E+ A ++ +++ + YL
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 129
Query: 706 HSLRVVHRDLKPDNLLIAHDG----HIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDE 761
HSL++ H DLKP+N+++ IK+ DFGL+
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH------------------------ 165
Query: 762 EPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFN 821
+ ++ GTP+++APEI+ G AD WS+G+I + L+ G PF
Sbjct: 166 --------KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 217
Query: 822 AEHPQ 826
+ Q
Sbjct: 218 GDTKQ 222
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 5e-50
Identities = 90/264 (34%), Positives = 149/264 (56%), Gaps = 37/264 (14%)
Query: 570 VVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKK---RTTGDLFAIKVLKKAD 626
V LRT+ + ++ I++FE++K + GA+G+VFL +K TG L+A+KVLKKA
Sbjct: 5 VKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKAT 64
Query: 627 MIRK-NAVESILAERDILISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG 684
+++K E ER +L +R PF+V Y+F L+L+++Y+NGG+L++ L
Sbjct: 65 IVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE 124
Query: 685 CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744
E ++Y+ E+VLALE+LH L +++RD+K +N+L+ +GH+ LTDFGLSK + + T
Sbjct: 125 RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET 184
Query: 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG--TGHGTTAD 802
+ GT +Y+AP+I+ G +GH D
Sbjct: 185 ERAYDF------------------------------CGTIEYMAPDIVRGGDSGHDKAVD 214
Query: 803 WWSVGIILFELIVGIPPFNAEHPQ 826
WWS+G++++EL+ G PF + +
Sbjct: 215 WWSLGVLMYELLTGASPFTVDGEK 238
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 9e-50
Identities = 62/238 (26%), Positives = 100/238 (42%), Gaps = 34/238 (14%)
Query: 592 EIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMI--RKNAVESILAERDILISVRNP 649
E + + G F V+ A+ + T + AIK +K + + L E +L + +P
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLR 709
++ +F + N+ LV +++ + N L + Y+ + LEYLH
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 710 VVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASE 769
++HRDLKP+NLL+ +G +KL DFGL+K
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAK-------------------------------S 149
Query: 770 HQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 826
R V T Y APE+L G +G D W+VG IL EL++ +P +
Sbjct: 150 FGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL 207
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (438), Expect = 2e-49
Identities = 64/244 (26%), Positives = 105/244 (43%), Gaps = 45/244 (18%)
Query: 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV 646
++ + ++++ I +G FG V L R G+ A+K +K ++ LAE ++ +
Sbjct: 5 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKN-----DATAQAFLAEASVMTQL 57
Query: 647 RNPFVVRFF-YSFTCRENLYLVMEYLNGGDLYSLLRNLGC--LDEDVARVYIAEVVLALE 703
R+ +V+ + LY+V EY+ G L LR+ G L D + +V A+E
Sbjct: 58 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 117
Query: 704 YLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEP 763
YL VHRDL N+L++ D K++DFGL+K +ST D
Sbjct: 118 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQD----------------- 158
Query: 764 QLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI-VGIPPFNA 822
+ + APE L T +D WS GI+L+E+ G P+
Sbjct: 159 ---------------TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 203
Query: 823 EHPQ 826
+
Sbjct: 204 IPLK 207
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 7e-49
Identities = 59/248 (23%), Positives = 92/248 (37%), Gaps = 39/248 (15%)
Query: 583 KDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGD--LFAIKVLKKADMIRKNAVESILAER 640
+D I D E+ G FG V R AIKVLK+ K E ++ E
Sbjct: 7 RDNLLIADIEL----GCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREA 60
Query: 641 DILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVV 699
I+ + NP++VR L LVME GG L+ L + + +V
Sbjct: 61 QIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 119
Query: 700 LALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLG 759
+ ++YL VHRDL N+L+ + + K++DFGLSK
Sbjct: 120 MGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA--------------------- 158
Query: 760 DEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI-VGIP 818
+ + + APE + + +D WS G+ ++E + G
Sbjct: 159 -------LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 211
Query: 819 PFNAEHPQ 826
P+
Sbjct: 212 PYKKMKGP 219
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 3e-48
Identities = 56/245 (22%), Positives = 103/245 (42%), Gaps = 41/245 (16%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVES---ILAERDIL-- 643
+++ + G FG V+ + + AIK ++K + + + + E +L
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 644 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGG-DLYSLLRNLGCLDEDVARVYIAEVVLAL 702
+S V+R F ++ L++E DL+ + G L E++AR + +V+ A+
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 703 EYLHSLRVVHRDLKPDNLLI-AHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDE 761
+ H+ V+HRD+K +N+LI + G +KL DFG +
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----------------------- 160
Query: 762 EPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPF 820
+ GT Y PE + HG +A WS+GI+L++++ G PF
Sbjct: 161 ----------LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 210
Query: 821 NAEHP 825
+
Sbjct: 211 EHDEE 215
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 4e-48
Identities = 59/249 (23%), Positives = 98/249 (39%), Gaps = 37/249 (14%)
Query: 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV 646
+ +E + I +G FG VF A+ R TG A+K + + ++ + L E IL +
Sbjct: 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLL 66
Query: 647 RNPFVVRFFYSFT--------CRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEV 698
++ VV C+ ++YLV ++ L L + + +
Sbjct: 67 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML 126
Query: 699 VLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 758
+ L Y+H +++HRD+K N+LI DG +KL DFGL++ +
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ------------ 174
Query: 759 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGI 817
+ + V T Y PE+LLG +G D W G I+ E+
Sbjct: 175 ---------------PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 219
Query: 818 PPFNAEHPQ 826
P Q
Sbjct: 220 PIMQGNTEQ 228
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 170 bits (431), Expect = 4e-48
Identities = 62/239 (25%), Positives = 109/239 (45%), Gaps = 34/239 (14%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ + ++ I G +G V+ A+ G+ FA+K ++ + + + + E IL +++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNY-GETFALKKIRL-EKEDEGIPSTTIREISILKELKH 59
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
+V+ + ++ L LV E+L+ L G L+ A+ ++ +++ + Y H
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTAS 768
RV+HRDLKP NLLI +G +K+ DFGL++
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARA------------------------------ 149
Query: 769 EHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTADWWSVGIILFELIVGIPPFNAEHPQ 826
RK + T Y AP++L+G+ + TT D WSVG I E++ G P F
Sbjct: 150 -FGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA 207
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 4e-48
Identities = 52/251 (20%), Positives = 98/251 (39%), Gaps = 37/251 (14%)
Query: 579 IHPSKDRTSIDDFEIIKPISRGAFGRVFLA--KKRTTGDLFAIKVLKKADMIRKNAVESI 636
++ + +++D K + G FG V + + A+K+LK + + +
Sbjct: 1 VYLDRKLLTLED----KELGSGNFGTVKKGYYQMKKVVKTVAVKILKN-EANDPALKDEL 55
Query: 637 LAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIA 696
LAE +++ + NP++VR E+ LVME G L L+ + + +
Sbjct: 56 LAEANVMQQLDNPYIVRM-IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVH 114
Query: 697 EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 756
+V + ++YL VHRDL N+L+ + K++DFGLSK
Sbjct: 115 QVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA------------------ 156
Query: 757 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI-V 815
+ + + + APE + + +D WS G++++E
Sbjct: 157 ----------LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSY 206
Query: 816 GIPPFNAEHPQ 826
G P+
Sbjct: 207 GQKPYRGMKGS 217
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 1e-47
Identities = 49/245 (20%), Positives = 89/245 (36%), Gaps = 34/245 (13%)
Query: 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGD---LFAIKVLKKADMIRKNAVESILAERDIL 643
D +++ + G+FG V + A+K LK + + A++ + E + +
Sbjct: 6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 65
Query: 644 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL-RNLGCLDEDVARVYIAEVVLAL 702
S+ + ++R + + +V E G L L ++ G Y +V +
Sbjct: 66 HSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 124
Query: 703 EYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEE 762
YL S R +HRDL NLL+A +K+ DFGL +
Sbjct: 125 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA------------------------ 160
Query: 763 PQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFN 821
++ + + APE L +D W G+ L+E+ G P+
Sbjct: 161 ----LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI 216
Query: 822 AEHPQ 826
+
Sbjct: 217 GLNGS 221
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 1e-47
Identities = 66/241 (27%), Positives = 110/241 (45%), Gaps = 34/241 (14%)
Query: 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR 647
+++F+ ++ I G +G V+ A+ + TG++ A+K ++ D + + + E +L +
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELN 59
Query: 648 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL-LRNLGCLDEDVARVYIAEVVLALEYLH 706
+P +V+ LYLV E+L+ + L + + + Y+ +++ L + H
Sbjct: 60 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 707 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLT 766
S RV+HRDLKP NLLI +G IKL DFGL++
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARA---------------------------- 151
Query: 767 ASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIVGIPPFNAEHP 825
R V T Y APEILLG + +TA D WS+G I E++ F +
Sbjct: 152 ---FGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE 208
Query: 826 Q 826
Sbjct: 209 I 209
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 165 bits (419), Expect = 2e-46
Identities = 55/245 (22%), Positives = 89/245 (36%), Gaps = 33/245 (13%)
Query: 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGD---LFAIKVLKKADMIRKNAVESILAERDIL 643
I +I + I G FG V + G AIK LK + L+E I+
Sbjct: 24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT--EKQRRDFLSEASIM 81
Query: 644 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARVYIAEVVLAL 702
+P V+ T + ++ E++ G L S LR N G + + +
Sbjct: 82 GQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGM 141
Query: 703 EYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEE 762
+YL + VHRDL N+L+ + K++DFGLS+
Sbjct: 142 KYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSR------------------------- 176
Query: 763 PQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI-VGIPPFN 821
L + APE + + +D WS GI+++E++ G P+
Sbjct: 177 -FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW 235
Query: 822 AEHPQ 826
Q
Sbjct: 236 DMTNQ 240
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 3e-46
Identities = 51/240 (21%), Positives = 98/240 (40%), Gaps = 37/240 (15%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
D +K + G FG V K R AIK++K+ M + E +++++ +
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDE----FIEEAKVMMNLSH 58
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHS 707
+V+ + T + ++++ EY+ G L + LR + +V A+EYL S
Sbjct: 59 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTA 767
+ +HRDL N L+ G +K++DFGLS+
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSR------------------------------ 148
Query: 768 SEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI-VGIPPFNAEHPQ 826
E + + PE+L+ + + +D W+ G++++E+ +G P+
Sbjct: 149 YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS 208
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 164 bits (416), Expect = 5e-46
Identities = 41/242 (16%), Positives = 81/242 (33%), Gaps = 35/242 (14%)
Query: 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN-P 649
+++ + I G+FG +F AIK + ++ + E +
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-----RSDAPQLRDEYRTYKLLAGCT 61
Query: 650 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLR 709
+ +Y + LV++ L L + +++ ++ +H
Sbjct: 62 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121
Query: 710 VVHRDLKPDNLLIA-----HDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
+V+RD+KPDN LI + I + DFG+ K T
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT-------------------- 161
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824
+ R+K++ GT Y++ LG D ++G + + G P+
Sbjct: 162 ----KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 217
Query: 825 PQ 826
Sbjct: 218 AA 219
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 7e-46
Identities = 66/244 (27%), Positives = 102/244 (41%), Gaps = 38/244 (15%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ + I GA+G V A AIK + + + + L E IL+ R+
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH--QTYCQRTLREIKILLRFRH 65
Query: 649 PFVVRFF-----YSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALE 703
++ + +++YLV + G DLY LL+ L D ++ +++ L+
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLM-GADLYKLLKT-QHLSNDHICYFLYQILRGLK 123
Query: 704 YLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEP 763
Y+HS V+HRDLKP NLL+ +K+ DFGL++V
Sbjct: 124 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV------------------------- 158
Query: 764 QLTASEHQQERRKKRSAVGTPDYLAPEILL-GTGHGTTADWWSVGIILFELIVGIPPFNA 822
A V T Y APEI+L G+ + D WSVG IL E++ P F
Sbjct: 159 ---ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 215
Query: 823 EHPQ 826
+H
Sbjct: 216 KHYL 219
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 9e-46
Identities = 49/241 (20%), Positives = 98/241 (40%), Gaps = 39/241 (16%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ ++++ + G FG V++ A+K LK+ M ++ LAE +++ +++
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGSMSP----DAFLAEANLMKQLQH 67
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLH 706
+VR Y+ +E +Y++ EY+ G L L+ L + A++ + ++
Sbjct: 68 QRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 707 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLT 766
+HRDL+ N+L++ K+ DFGL+++
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLI--------------------------- 159
Query: 767 ASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHP 825
E + A + APE + +D WS GI+L E++ G P+
Sbjct: 160 ---EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 216
Query: 826 Q 826
Sbjct: 217 P 217
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 1e-45
Identities = 44/243 (18%), Positives = 91/243 (37%), Gaps = 36/243 (14%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ ++ I G FG V L D AIK +++ M ++ + E ++++ + +
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEED----FIEEAEVMMKLSH 59
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCL-DEDVARVYIAEVVLALEYLHS 707
P +V+ + + + LV E++ G L LR L + +V + YL
Sbjct: 60 PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 119
Query: 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTA 767
V+HRDL N L+ + IK++DFG+++
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFV---------------------------- 151
Query: 768 SEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQV 827
+ + +PE+ + + + +D WS G++++E+
Sbjct: 152 --LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS 209
Query: 828 STL 830
+
Sbjct: 210 EVV 212
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 1e-45
Identities = 54/258 (20%), Positives = 95/258 (36%), Gaps = 50/258 (19%)
Query: 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV 646
+D + I G FG+V A+ + G + + + K+ E ++L +
Sbjct: 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 67
Query: 647 RN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN----------------LGCLDED 689
+ P ++ + R LYL +EY G+L LR L
Sbjct: 68 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127
Query: 690 VARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 749
+ A+V ++YL + +HRDL N+L+ + K+ DFGLS+
Sbjct: 128 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR------------ 175
Query: 750 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGII 809
Q+ KK ++A E L + + T +D WS G++
Sbjct: 176 --------------------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVL 215
Query: 810 LFELIV-GIPPFNAEHPQ 826
L+E++ G P+
Sbjct: 216 LWEIVSLGGTPYCGMTCA 233
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 161 bits (409), Expect = 5e-45
Identities = 54/268 (20%), Positives = 96/268 (35%), Gaps = 61/268 (22%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKR-----TTGDLFAIKVLKKADMIRKNAVESILAERDIL 643
++ E ++ I GAFGRVF A+ + A+K+LK+ + E ++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALM 70
Query: 644 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG------------------- 684
NP +V+ + + L+ EY+ GDL LR++
Sbjct: 71 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130
Query: 685 -----CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 739
L +V + YL + VHRDL N L+ + +K+ DFGLS+
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 190
Query: 740 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT 799
G + ++ PE + + T
Sbjct: 191 YSADYYKADG-----------------------------NDAIPIRWMPPESIFYNRYTT 221
Query: 800 TADWWSVGIILFELIV-GIPPFNAEHPQ 826
+D W+ G++L+E+ G+ P+ +
Sbjct: 222 ESDVWAYGVVLWEIFSYGLQPYYGMAHE 249
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 9e-45
Identities = 57/268 (21%), Positives = 102/268 (38%), Gaps = 61/268 (22%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDL-----FAIKVLKKADMIRKNAVESILAERDIL 643
++ E K + GAFG+V A A+K+LK+ + E++++E ++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMM 94
Query: 644 ISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN-------------------- 682
+ + +V + T +YL+ EY GDL + LR+
Sbjct: 95 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154
Query: 683 ---LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 739
L L + + +V +E+L VHRDL N+L+ H +K+ DFGL++
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARD- 213
Query: 740 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT 799
+ +A ++APE L +
Sbjct: 214 ----------------------------IMSDSNYVVRGNARLPVKWMAPESLFEGIYTI 245
Query: 800 TADWWSVGIILFELI-VGIPPFNAEHPQ 826
+D WS GI+L+E+ +G+ P+
Sbjct: 246 KSDVWSYGILLWEIFSLGVNPYPGIPVD 273
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 1e-44
Identities = 67/250 (26%), Positives = 104/250 (41%), Gaps = 43/250 (17%)
Query: 587 SIDDFEIIKPISRGAFGRVFLAK-KRTTGDLFAIKVLKKADMIRKNAVESILAERDI--- 642
+ +E + I GA+G+VF A+ + G A+K ++ + S + E +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRV-QTGEEGMPLSTIREVAVLRH 63
Query: 643 LISVRNPFVVRFFYSFTCREN-----LYLVMEYLNGGDL-YSLLRNLGCLDEDVARVYIA 696
L + +P VVR F T L LV E+++ Y + + + +
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 697 EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 756
+++ L++LHS RVVHRDLKP N+L+ G IKL DFGL+++
Sbjct: 124 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI------------------ 165
Query: 757 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVG 816
+ S V T Y APE+LL + + T D WSVG I E+
Sbjct: 166 --------------YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR 211
Query: 817 IPPFNAEHPQ 826
P F
Sbjct: 212 KPLFRGSSDV 221
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 1e-44
Identities = 64/267 (23%), Positives = 105/267 (39%), Gaps = 51/267 (19%)
Query: 571 VRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRK 630
V ++ +P DR + K I G+FG V+ AK +G+L AIK + + +
Sbjct: 3 VTTVVATPGQG-PDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN 61
Query: 631 NAVESILAERDILISVRNPFVVRFFYSFTC------RENLYLVMEYLNGGDLYSLLRNL- 683
E I+ + + +VR Y F L LV++Y+
Sbjct: 62 R-------ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 114
Query: 684 --GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG-HIKLTDFGLSKVGL 740
L ++Y+ ++ +L Y+HS + HRD+KP NLL+ D +KL DFG +K
Sbjct: 115 AKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--- 171
Query: 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGT 799
S + + Y APE++ G + +
Sbjct: 172 -----------------------------QLVRGEPNVSYICSRYYRAPELIFGATDYTS 202
Query: 800 TADWWSVGIILFELIVGIPPFNAEHPQ 826
+ D WS G +L EL++G P F +
Sbjct: 203 SIDVWSAGCVLAELLLGQPIFPGDSGV 229
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 161 bits (407), Expect = 2e-44
Identities = 60/256 (23%), Positives = 111/256 (43%), Gaps = 46/256 (17%)
Query: 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISV 646
+ DD+++++ + RG + VF A T + +K+LK + I E IL ++
Sbjct: 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK------KKIKREIKILENL 86
Query: 647 R-NPFVVRFFYSFTCREN--LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALE 703
R P ++ + LV E++N D L + L + R Y+ E++ AL+
Sbjct: 87 RGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALD 143
Query: 704 YLHSLRVVHRDLKPDNLLIAHDG-HIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEE 762
Y HS+ ++HRD+KP N++I H+ ++L D+GL++
Sbjct: 144 YCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY----------------------- 180
Query: 763 PQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFN 821
++ V + + PE+L+ + + D WS+G +L +I PF
Sbjct: 181 ---------HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 231
Query: 822 AEHPQVSTLLRKCQLL 837
H L+R ++L
Sbjct: 232 HGHDNYDQLVRIAKVL 247
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (404), Expect = 2e-44
Identities = 46/242 (19%), Positives = 82/242 (33%), Gaps = 33/242 (13%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ + + + I G+FG ++L G+ AIK+ K + E I ++
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV-----KTKHPQLHIESKIYKMMQG 61
Query: 649 P-FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS 707
+ + + +VME L + +++ +EY+HS
Sbjct: 62 GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 121
Query: 708 LRVVHRDLKPDNLLIA---HDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
+HRD+KPDN L+ + + DFGL+K T
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART-------------------- 161
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824
R+ ++ GT Y + LG D S+G +L +G P+
Sbjct: 162 ----HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 217
Query: 825 PQ 826
Sbjct: 218 AA 219
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 4e-44
Identities = 59/250 (23%), Positives = 99/250 (39%), Gaps = 41/250 (16%)
Query: 582 SKDRTSI--DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAE 639
+KD I + + + +G FG V++ T AIK LK M E+ L E
Sbjct: 8 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSP----EAFLQE 62
Query: 640 RDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC--LDEDVARVYIAE 697
++ +R+ +V+ Y+ E +Y+V EY++ G L L+ L A+
Sbjct: 63 AQVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 121
Query: 698 VVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 757
+ + Y+ + VHRDL+ N+L+ + K+ DFGL+++
Sbjct: 122 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI------------------ 163
Query: 758 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-G 816
E ++ A + APE L +D WS GI+L EL G
Sbjct: 164 ------------EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 211
Query: 817 IPPFNAEHPQ 826
P+ +
Sbjct: 212 RVPYPGMVNR 221
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 5e-44
Identities = 66/250 (26%), Positives = 106/250 (42%), Gaps = 33/250 (13%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+E ++ I G +G VF AK R T ++ A+K ++ D + S L E +L +++
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKH 60
Query: 649 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL 708
+VR + L LV E+ + G LD ++ + ++ +++ L + HS
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 709 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTAS 768
V+HRDLKP NLLI +G +KL +FGL++
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARA------------------------------ 150
Query: 769 EHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTADWWSVGIILFELIVGIPPFNAEHPQV 827
R + V T Y P++L G + T+ D WS G I EL P +
Sbjct: 151 -FGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD 209
Query: 828 STLLRKCQLL 837
L R +LL
Sbjct: 210 DQLKRIFRLL 219
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 158 bits (400), Expect = 7e-44
Identities = 54/255 (21%), Positives = 97/255 (38%), Gaps = 39/255 (15%)
Query: 577 SPIHPSKDRTSID--DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVE 634
P P+ D+ ++ D + + G +G V+ + A+K LK+ M VE
Sbjct: 3 DPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVE 58
Query: 635 SILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL--RNLGCLDEDVAR 692
L E ++ +++P +V+ T Y++ E++ G+L L N + V
Sbjct: 59 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL 118
Query: 693 VYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 752
++ A+EYL +HRDL N L+ + +K+ DFGLS++
Sbjct: 119 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL-------------- 164
Query: 753 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFE 812
A + APE L +D W+ G++L+E
Sbjct: 165 ----------------MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 208
Query: 813 LIV-GIPPFNAEHPQ 826
+ G+ P+
Sbjct: 209 IATYGMSPYPGIDLS 223
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 2e-43
Identities = 53/241 (21%), Positives = 88/241 (36%), Gaps = 32/241 (13%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKA--DMIRKNAVESILAERDILISV 646
+F+ IK + GAFG V+ G+ I V K + A + IL E ++ SV
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 647 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLH 706
NP V R + G L + + + + ++ + YL
Sbjct: 69 DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 707 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLT 766
R+VHRDL N+L+ H+K+TDFGL+K+
Sbjct: 129 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---------------------- 166
Query: 767 ASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI-VGIPPFNAEHP 825
++A E +L + +D WS G+ ++EL+ G P++
Sbjct: 167 -------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 219
Query: 826 Q 826
Sbjct: 220 S 220
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 1e-42
Identities = 57/271 (21%), Positives = 99/271 (36%), Gaps = 55/271 (20%)
Query: 589 DDFEIIKPISRGAFGRVFLAK-----KRTTGDLFAIKVLKKADMIRKNAVESILAERDIL 643
+ K + GAFG+V A K A+K+LK + + + E++++E +L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE--REALMSELKVL 80
Query: 644 ISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR------------------NLG 684
+ N +V + T ++ EY GDL + LR +
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 685 CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 744
LD + + +V + +L S +HRDL N+L+ H K+ DFGL++
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARD------ 194
Query: 745 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWW 804
++ K +A ++APE + + +D W
Sbjct: 195 -----------------------IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVW 231
Query: 805 SVGIILFELIVGIPPFNAEHPQVSTLLRKCQ 835
S GI L+EL P S + +
Sbjct: 232 SYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 262
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 3e-42
Identities = 66/245 (26%), Positives = 104/245 (42%), Gaps = 44/245 (17%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ ++P+ GA+G V A TG AIK L + + + E +L +R+
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMRH 76
Query: 649 PFVVRFFYSFTCRE------NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLAL 702
V+ FT E + YLVM ++ G DL L+++ L ED + + +++ L
Sbjct: 77 ENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGL 134
Query: 703 EYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEE 762
Y+H+ ++HRDLKP NL + D +K+ DFGL++
Sbjct: 135 RYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR------------------------- 169
Query: 763 PQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTADWWSVGIILFELIVGIPPFN 821
Q + V T Y APE++L + T D WSVG I+ E+I G F
Sbjct: 170 ---------QADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK 220
Query: 822 AEHPQ 826
Sbjct: 221 GSDHL 225
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 6e-42
Identities = 55/243 (22%), Positives = 92/243 (37%), Gaps = 38/243 (15%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGD---LFAIKVLKKADMIRKNAVESILAERDILIS 645
+ E+ + I G FG V + + AIK K + E L E +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQ 64
Query: 646 VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL-RNLGCLDEDVARVYIAEVVLALEY 704
+P +V+ T ++++ME G+L S L LD +Y ++ AL Y
Sbjct: 65 FDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 123
Query: 705 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 764
L S R VHRD+ N+L++ + +KL DFGLS+
Sbjct: 124 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR--------------------------- 156
Query: 765 LTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAE 823
K ++APE + + +D W G+ ++E+++ G+ PF
Sbjct: 157 ---YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 213
Query: 824 HPQ 826
Sbjct: 214 KNN 216
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 2e-41
Identities = 57/247 (23%), Positives = 99/247 (40%), Gaps = 42/247 (17%)
Query: 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILIS 645
T + ++ +KPI GA G V A AIK L + + + E ++
Sbjct: 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKC 72
Query: 646 VRNPFVVRFFYSFTCR------ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVV 699
V + ++ FT + +++YLVME ++ + LD + + +++
Sbjct: 73 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQML 129
Query: 700 LALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLG 759
+++LHS ++HRDLKP N+++ D +K+ DFGL++
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---------------------- 167
Query: 760 DEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPP 819
V T Y APE++LG G+ D WSVG I+ E++
Sbjct: 168 ----------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL 217
Query: 820 FNAEHPQ 826
F
Sbjct: 218 FPGRDYI 224
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 4e-40
Identities = 52/254 (20%), Positives = 94/254 (37%), Gaps = 47/254 (18%)
Query: 589 DDFEIIKPISRGAFGRVFLAK-----KRTTGDLFAIKVLKKADMIRKNAVESILAERDIL 643
+ + + + +G+FG V+ K AIK + +A +R+ L E ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE--RIEFLNEASVM 77
Query: 644 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN----------LGCLDEDVARV 693
VVR + + ++ME + GDL S LR+ L
Sbjct: 78 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137
Query: 694 YIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 753
E+ + YL++ + VHRDL N ++A D +K+ DFG+++
Sbjct: 138 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD--------------- 182
Query: 754 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 813
RK + +++PE L T +D WS G++L+E+
Sbjct: 183 --------------IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 228
Query: 814 IVGI-PPFNAEHPQ 826
P+ +
Sbjct: 229 ATLAEQPYQGLSNE 242
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 6e-40
Identities = 52/256 (20%), Positives = 90/256 (35%), Gaps = 42/256 (16%)
Query: 576 TSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGD----LFAIKVLKKADMIRKN 631
T+ IHPS K I G FG V+ +T+ AIK LK +
Sbjct: 1 TTEIHPS-------CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--EK 51
Query: 632 AVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL-LRNLGCLDEDV 690
L E I+ + ++R + + + ++ EY+ G L G
Sbjct: 52 QRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQ 111
Query: 691 ARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 750
+ + ++YL ++ VHRDL N+L+ + K++DFGLS+V
Sbjct: 112 LVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV------------ 159
Query: 751 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIIL 810
+ + + APE + + +D WS GI++
Sbjct: 160 ----------------LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVM 203
Query: 811 FELIVGIPPFNAEHPQ 826
+E++ E
Sbjct: 204 WEVMTYGERPYWELSN 219
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (365), Expect = 4e-39
Identities = 59/273 (21%), Positives = 109/273 (39%), Gaps = 58/273 (21%)
Query: 581 PSKDRTSI--DDFEIIKPISRGAFGRVFLAKKRTTGD-------LFAIKVLKKADMIRKN 631
P R + D + KP+ GAFG+V LA+ A+K+LK D K+
Sbjct: 3 PEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS-DATEKD 61
Query: 632 AVESILAERDILISV-RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC----- 685
+ +++E +++ + ++ ++ + T LY+++EY + G+L L+
Sbjct: 62 -LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEY 120
Query: 686 -----------LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFG 734
L +V +EYL S + +HRDL N+L+ D +K+ DFG
Sbjct: 121 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFG 180
Query: 735 LSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG 794
L++ H +K + ++APE L
Sbjct: 181 LARD-----------------------------IHHIDYYKKTTNGRLPVKWMAPEALFD 211
Query: 795 TGHGTTADWWSVGIILFELI-VGIPPFNAEHPQ 826
+ +D WS G++L+E+ +G P+ +
Sbjct: 212 RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 244
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (365), Expect = 1e-38
Identities = 63/244 (25%), Positives = 103/244 (42%), Gaps = 42/244 (17%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ ++ + P+ GA+G V A TG A+K L + +A + E +L +++
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTYRELRLLKHMKH 76
Query: 649 PFVVRFFYSFT-----CRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALE 703
V+ FT N ++ +L G DL ++++ L +D + I +++ L+
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLK 135
Query: 704 YLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEP 763
Y+HS ++HRDLKP NL + D +K+ DFGL+
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--------------------------- 168
Query: 764 QLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVGIPPFNA 822
+ + V T Y APEI+L H T D WSVG I+ EL+ G F
Sbjct: 169 -------RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221
Query: 823 EHPQ 826
Sbjct: 222 TDHI 225
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 2e-38
Identities = 49/256 (19%), Positives = 88/256 (34%), Gaps = 52/256 (20%)
Query: 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN 648
+ + I +G FG V+ K G+ A+K+ R+ AE + +R+
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSS----REERSWFREAEIYQTVMLRH 56
Query: 649 PFVVRFFYSFTCREN----LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEY 704
++ F + L+LV +Y G L+ L E + ++ + L +
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLAL-STASGLAH 115
Query: 705 LHS--------LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 756
LH + HRDLK N+L+ +G + D GL+
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV------------------- 156
Query: 757 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH------GTTADWWSVGIIL 810
S VGT Y+APE+L + + AD +++G++
Sbjct: 157 --------RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVF 208
Query: 811 FELIVGIPPFNAEHPQ 826
+E+
Sbjct: 209 WEIARRCSIGGIHEDY 224
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 4e-38
Identities = 59/281 (20%), Positives = 107/281 (38%), Gaps = 54/281 (19%)
Query: 578 PIHPSKDRTSIDDFEIIKPISRGAFGRVFLAK-----KRTTGDLFAIKVLKKADMIRKNA 632
P SK D ++ KP+ RGAFG+V A K T A+K+LK+ +
Sbjct: 2 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSE 59
Query: 633 VESILAERDILISVRNPFVVRFFYSFTCREN--LYLVMEYLNGGDLYSLLRN-------- 682
++++E ILI + + V + L +++E+ G+L + LR+
Sbjct: 60 HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 119
Query: 683 --------LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFG 734
L + Y +V +E+L S + +HRDL N+L++ +K+ DFG
Sbjct: 120 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFG 179
Query: 735 LSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG 794
L++ + +K A ++APE +
Sbjct: 180 LARD-----------------------------IYKDPDYVRKGDARLPLKWMAPETIFD 210
Query: 795 TGHGTTADWWSVGIILFELIVGIPPFNAEHPQVSTLLRKCQ 835
+ +D WS G++L+E+ R+ +
Sbjct: 211 RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 251
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 2e-37
Identities = 58/267 (21%), Positives = 101/267 (37%), Gaps = 40/267 (14%)
Query: 566 LEDDVVRSLRTSPIHPSKDRTSIDDFEIIKPISRGAFGRVFLAK---KRTTGDLFAIKVL 622
L ++V++++ I PS ++ I RG FG V+ A+K L
Sbjct: 9 LNPELVQAVQHVVIGPSSLIVHFNEV-----IGRGHFGCVYHGTLLDNDGKKIHCAVKSL 63
Query: 623 KKADMIRKNAVESILAERDILISVRNPFVVRFF-YSFTCRENLYLVMEYLNGGDLYSLLR 681
+ I + V L E I+ +P V+ + +V+ Y+ GDL + +R
Sbjct: 64 NRITDIGE--VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR 121
Query: 682 NLGCLDEDVARVYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740
N + +V +++L S + VHRDL N ++ +K+ DFGL++
Sbjct: 122 NETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--- 178
Query: 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT 800
+ K A ++A E L T
Sbjct: 179 ------------------------DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTK 214
Query: 801 ADWWSVGIILFELIV-GIPPFNAEHPQ 826
+D WS G++L+EL+ G PP+ +
Sbjct: 215 SDVWSFGVLLWELMTRGAPPYPDVNTF 241
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 119 bits (298), Expect = 1e-29
Identities = 48/266 (18%), Positives = 98/266 (36%), Gaps = 45/266 (16%)
Query: 580 HPSK--DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESIL 637
HP+ + + +++ + G F V+LAK A+K+++ + + A + I
Sbjct: 2 HPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIK 61
Query: 638 AERDI-------LISVRNPFVVRFFYSFT--CRENLYLVMEYLNGG---DLYSLLRNLGC 685
+ + S+ +++ F +++VM + G
Sbjct: 62 LLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRG 121
Query: 686 LDEDVARVYIAEVVLALEYLHSLR-VVHRDLKPDNLLIAHDGHI-KLTDFGLSKVGLINS 743
+ + +++L L+Y+H ++H D+KP+N+L+ L ++ +G
Sbjct: 122 IPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG---- 177
Query: 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADW 803
+++ T +Y +PE+LLG G AD
Sbjct: 178 -------------------------NACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADI 212
Query: 804 WSVGIILFELIVGIPPFNAEHPQVST 829
WS ++FELI G F + T
Sbjct: 213 WSTACLIFELITGDFLFEPDEGHSYT 238
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 84.1 bits (207), Expect = 3e-19
Identities = 26/161 (16%), Positives = 50/161 (31%), Gaps = 28/161 (17%)
Query: 592 EIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADM---------------IRKNAVESI 636
I K + G VF +K K A+ S
Sbjct: 3 AIGKLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSA 61
Query: 637 LAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIA 696
E L ++ V + + ++ME ++ +LY + + +
Sbjct: 62 RNEFRALQKLQGLAVPKVYAWE----GNAVLMELIDAKELY-------RVRVENPDEVLD 110
Query: 697 EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 737
++ + + +VH DL N+L+ + I + DF S
Sbjct: 111 MILEEVAKFYHRGIVHGDLSQYNVLV-SEEGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 837 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.22 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.88 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.76 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.77 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.64 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.63 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-46 Score=386.12 Aligned_cols=206 Identities=37% Similarity=0.705 Sum_probs=186.3
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEE
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyL 666 (837)
.+++|++.+.||+|+||+||+|+++.+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i 83 (263)
T d2j4za1 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 83 (263)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEE
Confidence 46789999999999999999999999999999999976554444456778999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCC
Q 003232 667 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stdd 746 (837)
||||++||+|.+++...+.+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+++....
T Consensus 84 vmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~----- 158 (263)
T d2j4za1 84 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS----- 158 (263)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC-----
T ss_pred EEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCC-----
Confidence 999999999999999888999999999999999999999999999999999999999999999999999873110
Q ss_pred CCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 747 l~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
.......||+.|||||++.+..++.++|||||||++|+|++|+.||.+.+.
T Consensus 159 ----------------------------~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~ 209 (263)
T d2j4za1 159 ----------------------------SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 209 (263)
T ss_dssp ----------------------------CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred ----------------------------CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH
Confidence 011235799999999999999999999999999999999999999987654
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-46 Score=390.99 Aligned_cols=210 Identities=31% Similarity=0.529 Sum_probs=186.3
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEE
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyL 666 (837)
..++|++++.||+|+||+||+|+++.+|+.||+|+++... .......+.+|+.+|+.++||||++++++|.+..++|+
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i 81 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 81 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 3467999999999999999999999999999999997643 23445678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCcEEEccCCcEEEEecCCccccccCCCC
Q 003232 667 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHS-kGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~std 745 (837)
||||++||+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+|+..
T Consensus 82 VmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~------ 155 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL------ 155 (322)
T ss_dssp EEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHH------
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCcccc------
Confidence 99999999999999988899999999999999999999997 59999999999999999999999999998731
Q ss_pred CCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 746 dl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
........+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+.
T Consensus 156 ---------------------------~~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~ 208 (322)
T d1s9ja_ 156 ---------------------------IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208 (322)
T ss_dssp ---------------------------HHHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred ---------------------------CCCccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 01123456899999999999999999999999999999999999999988776
Q ss_pred CHHHHH
Q 003232 826 QVSTLL 831 (837)
Q Consensus 826 dv~~ll 831 (837)
...++.
T Consensus 209 ~~~~~~ 214 (322)
T d1s9ja_ 209 KELELM 214 (322)
T ss_dssp THHHHH
T ss_pred HHHHHH
Confidence 554433
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-46 Score=387.29 Aligned_cols=209 Identities=39% Similarity=0.752 Sum_probs=185.3
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLV 667 (837)
.++|++.+.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.++++++||||++++++|.+.+.+|+|
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence 36799999999999999999999999999999999865544445567899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCC
Q 003232 668 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (837)
Q Consensus 668 mEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl 747 (837)
|||++||+|.+++...+.+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+......
T Consensus 87 mEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~---- 162 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES---- 162 (288)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred EEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCC----
Confidence 9999999999999988999999999999999999999999999999999999999999999999999997421110
Q ss_pred CCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 748 ~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.++
T Consensus 163 -------------------------~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~ 215 (288)
T d1uu3a_ 163 -------------------------KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 215 (288)
T ss_dssp --------------------------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred -------------------------cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH
Confidence 01123356899999999999999999999999999999999999999987653
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-46 Score=384.55 Aligned_cols=210 Identities=29% Similarity=0.519 Sum_probs=181.8
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLV 667 (837)
.++|++++.||+|+||+||+|+++.+|+.||||++..... ....+.+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv 81 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 81 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence 4679999999999999999999999999999999976432 23345789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCC
Q 003232 668 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (837)
Q Consensus 668 mEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl 747 (837)
|||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 82 mEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~--- 158 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR--- 158 (271)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE---
T ss_pred EeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCc---
Confidence 99999999999998878899999999999999999999999999999999999999999999999999974211111
Q ss_pred CCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCC-CchHHHHHHHHHHHHHHcCCCCCCCCCcC
Q 003232 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVGIPPFNAEHPQ 826 (837)
Q Consensus 748 ~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~-s~kSDIWSLGVILyELLTGr~PF~~~dpd 826 (837)
.......+||+.|||||++.+..+ +.++|||||||++|+|++|++||......
T Consensus 159 --------------------------~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~ 212 (271)
T d1nvra_ 159 --------------------------ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 212 (271)
T ss_dssp --------------------------ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTT
T ss_pred --------------------------cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChH
Confidence 011235689999999999998886 57899999999999999999999876554
Q ss_pred HH
Q 003232 827 VS 828 (837)
Q Consensus 827 v~ 828 (837)
..
T Consensus 213 ~~ 214 (271)
T d1nvra_ 213 CQ 214 (271)
T ss_dssp SH
T ss_pred HH
Confidence 43
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-45 Score=389.74 Aligned_cols=210 Identities=40% Similarity=0.798 Sum_probs=189.7
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEE
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 665 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ly 665 (837)
..+++|++++.||+|+||.||+|+++.+|+.||+|++++.........+.+.+|+.+|+.++||||++++++|.+.+++|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 35688999999999999999999999999999999998765444455678899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCC
Q 003232 666 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 745 (837)
Q Consensus 666 LVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~std 745 (837)
+||||++||+|.+++...+.+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+......
T Consensus 82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~-- 159 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-- 159 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT--
T ss_pred cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCC--
Confidence 999999999999999998999999999999999999999999999999999999999999999999999997321100
Q ss_pred CCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 746 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 746 dl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
......+||+.|+|||++.+.+|+.++|||||||++|+|++|++||.+.+.
T Consensus 160 -----------------------------~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~ 210 (337)
T d1o6la_ 160 -----------------------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 210 (337)
T ss_dssp -----------------------------CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred -----------------------------cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH
Confidence 112356899999999999999999999999999999999999999988664
Q ss_pred C
Q 003232 826 Q 826 (837)
Q Consensus 826 d 826 (837)
.
T Consensus 211 ~ 211 (337)
T d1o6la_ 211 E 211 (337)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.6e-45 Score=383.96 Aligned_cols=205 Identities=42% Similarity=0.815 Sum_probs=186.6
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEE
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyL 666 (837)
.+++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.+++.++||||+++++++.+...+|+
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence 35789999999999999999999999999999999986554444556789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCC
Q 003232 667 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stdd 746 (837)
||||+.||+|..++.....+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+++...
T Consensus 82 vmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~------ 155 (316)
T d1fota_ 82 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP------ 155 (316)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECS------
T ss_pred EeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEec------
Confidence 99999999999999998899999999999999999999999999999999999999999999999999997411
Q ss_pred CCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 747 l~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
......+||+.|||||++.+..++.++|||||||++|+|++|+.||.+.+.
T Consensus 156 ----------------------------~~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~ 206 (316)
T d1fota_ 156 ----------------------------DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT 206 (316)
T ss_dssp ----------------------------SCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred ----------------------------cccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH
Confidence 012346899999999999999999999999999999999999999987553
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-44 Score=378.73 Aligned_cols=203 Identities=36% Similarity=0.635 Sum_probs=180.8
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLV 667 (837)
.++|++++.||+|+||+||+|+++.+|+.||||++...... ..+.+.+|+.+++.++||||++++++|...+++|+|
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 95 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh---HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEE
Confidence 35699999999999999999999999999999999765422 235789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCC
Q 003232 668 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (837)
Q Consensus 668 mEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl 747 (837)
||||+||+|.+++.. +.+++..++.++.||+.||.|||++|||||||||+|||++.+|++||+|||+++.....
T Consensus 96 mEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~----- 169 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE----- 169 (293)
T ss_dssp EECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST-----
T ss_pred EEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccc-----
Confidence 999999999998866 57999999999999999999999999999999999999999999999999998731100
Q ss_pred CCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 748 ~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.++
T Consensus 170 --------------------------~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~ 221 (293)
T d1yhwa1 170 --------------------------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP 221 (293)
T ss_dssp --------------------------TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred --------------------------cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH
Confidence 0112356799999999999999999999999999999999999999987553
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.9e-44 Score=385.53 Aligned_cols=205 Identities=44% Similarity=0.870 Sum_probs=186.4
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEE
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyL 666 (837)
.+++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|+.++||||+++++++.....+|+
T Consensus 39 ~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 118 (350)
T d1rdqe_ 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccc
Confidence 35789999999999999999999999999999999976544444556788999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCC
Q 003232 667 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stdd 746 (837)
||||+.||+|.+++...+.+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+++...
T Consensus 119 v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~------ 192 (350)
T d1rdqe_ 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------ 192 (350)
T ss_dssp EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECS------
T ss_pred ccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecc------
Confidence 99999999999999988899999999999999999999999999999999999999999999999999997310
Q ss_pred CCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 747 l~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
.......||+.|||||++.+..++.++|||||||++|+|++|+.||.+.++
T Consensus 193 ----------------------------~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~ 243 (350)
T d1rdqe_ 193 ----------------------------GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243 (350)
T ss_dssp ----------------------------SCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ----------------------------cccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH
Confidence 011245799999999999999999999999999999999999999987653
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-44 Score=373.97 Aligned_cols=204 Identities=35% Similarity=0.603 Sum_probs=179.9
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 668 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVm 668 (837)
+.|++++.||+|+||+||+|+++.+++.||+|++.... ....+.+.+|+.+|+.++||||+++++++...+.+|+||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 46999999999999999999999999999999997643 233457889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCC
Q 003232 669 EYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (837)
Q Consensus 669 Ey~~GGSL~dlLk~-~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl 747 (837)
||++||+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~------- 161 (288)
T d2jfla1 89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNT------- 161 (288)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECH-------
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccC-------
Confidence 99999999999765 4679999999999999999999999999999999999999999999999999986310
Q ss_pred CCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhc-----CCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003232 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-----GTGHGTTADWWSVGIILFELIVGIPPFNA 822 (837)
Q Consensus 748 ~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLl-----g~~~s~kSDIWSLGVILyELLTGr~PF~~ 822 (837)
.........+||+.|+|||++. +..|+.++|||||||++|+|++|+.||.+
T Consensus 162 ------------------------~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~ 217 (288)
T d2jfla1 162 ------------------------RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHE 217 (288)
T ss_dssp ------------------------HHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ------------------------CCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCC
Confidence 0112234678999999999984 45688999999999999999999999987
Q ss_pred CCcC
Q 003232 823 EHPQ 826 (837)
Q Consensus 823 ~dpd 826 (837)
.++.
T Consensus 218 ~~~~ 221 (288)
T d2jfla1 218 LNPM 221 (288)
T ss_dssp SCGG
T ss_pred CCHH
Confidence 6543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.8e-44 Score=377.22 Aligned_cols=201 Identities=29% Similarity=0.465 Sum_probs=182.2
Q ss_pred CeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEE
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 669 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmE 669 (837)
.|++++.||+|+||+||+|+++.+|+.||||++...........+.+.+|+.+|+.++||||+++++++.+.+++|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 49999999999999999999999999999999987665556667889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCC
Q 003232 670 YLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 749 (837)
Q Consensus 670 y~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~ 749 (837)
||.+|+|..++...+.+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+++...
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~--------- 166 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA--------- 166 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS---------
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccC---------
Confidence 99999998888877889999999999999999999999999999999999999999999999999987310
Q ss_pred CCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC---CCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 750 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG---TGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 750 p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg---~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
.....+||+.|||||++.+ ..|+.++|||||||++|+|++|..||.+.++
T Consensus 167 --------------------------~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~ 219 (309)
T d1u5ra_ 167 --------------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219 (309)
T ss_dssp --------------------------SBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred --------------------------CCCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH
Confidence 1124579999999999965 4588999999999999999999999986543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-44 Score=371.09 Aligned_cols=206 Identities=32% Similarity=0.595 Sum_probs=171.6
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeec--CCeEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC--RENLY 665 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d--~~~ly 665 (837)
.++|++++.||+|+||+||+|+++.+|+.||+|++..... .....+.+.+|+.++++++||||+++++++.+ .+.+|
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 3679999999999999999999999999999999987653 34456789999999999999999999999865 45689
Q ss_pred EEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----cccccCCCCcEEEccCCcEEEEecCCc
Q 003232 666 LVMEYLNGGDLYSLLRN----LGCLDEDVARVYIAEVVLALEYLHSLR-----VVHRDLKPDNLLIAHDGHIKLTDFGLS 736 (837)
Q Consensus 666 LVmEy~~GGSL~dlLk~----~g~Lsee~irkIl~QIa~ALsYLHSkG-----IIHRDIKPeNILLd~dG~IKLiDFGLA 736 (837)
+|||||+||+|.+++.. .+.+++..++.++.||+.||.|||++| ||||||||+|||++.++.+||+|||++
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 99999999999999853 367999999999999999999999976 999999999999999999999999998
Q ss_pred cccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcC
Q 003232 737 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVG 816 (837)
Q Consensus 737 rvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTG 816 (837)
+..... .......+||+.|||||++.+..++.++|||||||++|+|++|
T Consensus 162 ~~~~~~-------------------------------~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg 210 (269)
T d2java1 162 RILNHD-------------------------------TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCAL 210 (269)
T ss_dssp HHC------------------------------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred eecccC-------------------------------CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhC
Confidence 741100 0112346799999999999999999999999999999999999
Q ss_pred CCCCCCCCc
Q 003232 817 IPPFNAEHP 825 (837)
Q Consensus 817 r~PF~~~dp 825 (837)
+.||.+.+.
T Consensus 211 ~~Pf~~~~~ 219 (269)
T d2java1 211 MPPFTAFSQ 219 (269)
T ss_dssp SCSCCCSSH
T ss_pred CCCCCCCCH
Confidence 999987554
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.7e-44 Score=377.27 Aligned_cols=204 Identities=36% Similarity=0.598 Sum_probs=168.4
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEE
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 666 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyL 666 (837)
..+.|++.+.||+|+||+||+|+++.+|+.||||++...... .....+.+|+.+|+.++||||+++++++.+.+.+||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 84 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYL 84 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 346699999999999999999999999999999999765432 223568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEc---cCCcEEEEecCCccccccCC
Q 003232 667 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA---HDGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd---~dG~IKLiDFGLArvg~~~s 743 (837)
|||||+||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+. .++.+||+|||+++....
T Consensus 85 vmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~-- 162 (307)
T d1a06a_ 85 IMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP-- 162 (307)
T ss_dssp EECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred EEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccC--
Confidence 999999999999999888999999999999999999999999999999999999995 478999999999873100
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~ 823 (837)
.......+||+.|||||++.+..++.++|||||||++|+|++|+.||.+.
T Consensus 163 ------------------------------~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 212 (307)
T d1a06a_ 163 ------------------------------GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE 212 (307)
T ss_dssp ----------------------------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ------------------------------CCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCC
Confidence 01123457999999999999999999999999999999999999999875
Q ss_pred C
Q 003232 824 H 824 (837)
Q Consensus 824 d 824 (837)
+
T Consensus 213 ~ 213 (307)
T d1a06a_ 213 N 213 (307)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.8e-43 Score=364.13 Aligned_cols=210 Identities=26% Similarity=0.447 Sum_probs=179.3
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC----e
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE----N 663 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~----~ 663 (837)
.++|++.+.||+|+||+||+|+++.+|+.||||+++............+.+|+.+++.++||||+++++++.... .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467999999999999999999999999999999998766556667788999999999999999999999987643 4
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCC
Q 003232 664 LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~s 743 (837)
+|+||||++|++|.+++...+.+++..++.++.||+.||.|||++|||||||||+|||++.++..+|+|||.+.......
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~ 165 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 165 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccc
Confidence 89999999999999999888899999999999999999999999999999999999999999999999999876311111
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~ 823 (837)
. ........+||+.|+|||++.+..++.++|||||||++|+|+||++||.+.
T Consensus 166 ~----------------------------~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 217 (277)
T d1o6ya_ 166 N----------------------------SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD 217 (277)
T ss_dssp -----------------------------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred c----------------------------cccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCc
Confidence 0 111234568999999999999999999999999999999999999999876
Q ss_pred Cc
Q 003232 824 HP 825 (837)
Q Consensus 824 dp 825 (837)
++
T Consensus 218 ~~ 219 (277)
T d1o6ya_ 218 SP 219 (277)
T ss_dssp SH
T ss_pred CH
Confidence 54
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-43 Score=363.78 Aligned_cols=200 Identities=25% Similarity=0.483 Sum_probs=175.6
Q ss_pred eEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeec----CCeEEE
Q 003232 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC----RENLYL 666 (837)
Q Consensus 591 YeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d----~~~lyL 666 (837)
|++.++||+|+||+||+|+++.+++.||+|++..... .....+.+.+|+++|++++||||++++++|.. ...+|+
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 5778899999999999999999999999999976543 34456789999999999999999999999865 456899
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCCCCcEEEc-cCCcEEEEecCCccccccCC
Q 003232 667 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLR--VVHRDLKPDNLLIA-HDGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkG--IIHRDIKPeNILLd-~dG~IKLiDFGLArvg~~~s 743 (837)
||||++||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||+++....
T Consensus 90 vmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~-- 167 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-- 167 (270)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT--
T ss_pred EEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC--
Confidence 9999999999999998889999999999999999999999998 99999999999996 578999999999873100
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~ 823 (837)
......+||+.|||||++.+ .++.++|||||||++|+|++|+.||...
T Consensus 168 -------------------------------~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~ 215 (270)
T d1t4ha_ 168 -------------------------------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC 215 (270)
T ss_dssp -------------------------------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred -------------------------------CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCc
Confidence 01234579999999999876 5999999999999999999999999765
Q ss_pred Cc
Q 003232 824 HP 825 (837)
Q Consensus 824 dp 825 (837)
.+
T Consensus 216 ~~ 217 (270)
T d1t4ha_ 216 QN 217 (270)
T ss_dssp SS
T ss_pred cc
Confidence 43
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-43 Score=365.66 Aligned_cols=207 Identities=29% Similarity=0.540 Sum_probs=182.9
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEeccccccc---HHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCe
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIR---KNAVESILAERDILISVRNPFVVRFFYSFTCREN 663 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~---~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ 663 (837)
..+.|++.+.||+|+||+||+|+++.+|+.||||++.+..... ....+.+.+|+.+|+.++||||++++++|.+..+
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 3466999999999999999999999999999999997643221 2235678999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCC----cEEEEecCCcccc
Q 003232 664 LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG----HIKLTDFGLSKVG 739 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG----~IKLiDFGLArvg 739 (837)
+|||||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 999999999999999998888999999999999999999999999999999999999998776 5999999998741
Q ss_pred ccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCC
Q 003232 740 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPP 819 (837)
Q Consensus 740 ~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~P 819 (837)
... .......||+.|+|||++.+..++.++|||||||++|+|++|+.|
T Consensus 168 ~~~--------------------------------~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~P 215 (293)
T d1jksa_ 168 DFG--------------------------------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215 (293)
T ss_dssp TTS--------------------------------CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred CCC--------------------------------ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCC
Confidence 100 112345789999999999999999999999999999999999999
Q ss_pred CCCCCc
Q 003232 820 FNAEHP 825 (837)
Q Consensus 820 F~~~dp 825 (837)
|.+.+.
T Consensus 216 f~~~~~ 221 (293)
T d1jksa_ 216 FLGDTK 221 (293)
T ss_dssp SCCSSH
T ss_pred CCCCCH
Confidence 987553
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-43 Score=371.47 Aligned_cols=207 Identities=43% Similarity=0.834 Sum_probs=183.4
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHH-hcCCCceEEEEeEeecCCeEEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILI-SVRNPFVVRFFYSFTCRENLYL 666 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk-~LrHPNIVkL~gsf~d~~~lyL 666 (837)
+++|++.+.||+|+||+||+|+++.+|+.||||++++.........+.+..|..++. .++||||+++++++.+.+++|+
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 368999999999999999999999999999999997654333444566777777765 6899999999999999999999
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCC
Q 003232 667 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stdd 746 (837)
||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~--- 157 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--- 157 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT---
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccc---
Confidence 99999999999999988899999999999999999999999999999999999999999999999999987311000
Q ss_pred CCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 747 l~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.++
T Consensus 158 ----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~ 208 (320)
T d1xjda_ 158 ----------------------------AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE 208 (320)
T ss_dssp ----------------------------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ----------------------------ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH
Confidence 112345799999999999999999999999999999999999999987654
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.3e-43 Score=376.07 Aligned_cols=206 Identities=29% Similarity=0.550 Sum_probs=182.7
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeE
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~l 664 (837)
+..+++|++++.||+|+||+||+|+++.+|+.||||++.... ....+.+.+|+.+|+.++||||++++++|.+.+++
T Consensus 22 ~~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 98 (350)
T d1koaa2 22 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM 98 (350)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEE
T ss_pred CCCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 456789999999999999999999999999999999997643 33456788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEcc--CCcEEEEecCCcccccc
Q 003232 665 YLVMEYLNGGDLYSLLR-NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH--DGHIKLTDFGLSKVGLI 741 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk-~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~--dG~IKLiDFGLArvg~~ 741 (837)
|+|||||+||+|.+++. ..+.+++..++.++.||+.||.|||++|||||||||+|||++. ++.+||+|||+++....
T Consensus 99 ~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 99 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp EEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred EEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 99999999999999985 4467999999999999999999999999999999999999964 67899999999873110
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCC
Q 003232 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFN 821 (837)
Q Consensus 742 ~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~ 821 (837)
........||+.|||||++.+..++.++|||||||++|+|++|+.||.
T Consensus 179 --------------------------------~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~ 226 (350)
T d1koaa2 179 --------------------------------KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG 226 (350)
T ss_dssp --------------------------------TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred --------------------------------ccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCC
Confidence 011234679999999999999999999999999999999999999998
Q ss_pred CCCc
Q 003232 822 AEHP 825 (837)
Q Consensus 822 ~~dp 825 (837)
+.+.
T Consensus 227 ~~~~ 230 (350)
T d1koaa2 227 GEND 230 (350)
T ss_dssp CSSH
T ss_pred CCCH
Confidence 7543
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5e-43 Score=377.77 Aligned_cols=207 Identities=35% Similarity=0.651 Sum_probs=179.1
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHH---HHHHHHHHhcCCCceEEEEeEeecCCe
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESI---LAERDILISVRNPFVVRFFYSFTCREN 663 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~---~rEieILk~LrHPNIVkL~gsf~d~~~ 663 (837)
.+++|++++.||+|+||+||+|+++.+|+.||||++.+...........+ .+++.+++.++||||++++++|...+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 46889999999999999999999999999999999976443222222233 344666777789999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCC
Q 003232 664 LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~s 743 (837)
+|+||||++||+|.+++.....+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+....
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~-- 159 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-- 159 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS--
T ss_pred EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCC--
Confidence 999999999999999999888999999999999999999999999999999999999999999999999999873110
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhc-CCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-GTGHGTTADWWSVGIILFELIVGIPPFNA 822 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLl-g~~~s~kSDIWSLGVILyELLTGr~PF~~ 822 (837)
......+||+.|+|||++. +..++.++|||||||++|+|++|+.||.+
T Consensus 160 -------------------------------~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~ 208 (364)
T d1omwa3 160 -------------------------------KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 208 (364)
T ss_dssp -------------------------------SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred -------------------------------CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCC
Confidence 0123457999999999996 46789999999999999999999999987
Q ss_pred CCcC
Q 003232 823 EHPQ 826 (837)
Q Consensus 823 ~dpd 826 (837)
....
T Consensus 209 ~~~~ 212 (364)
T d1omwa3 209 HKTK 212 (364)
T ss_dssp SCSS
T ss_pred CCHH
Confidence 6543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=6.4e-43 Score=375.67 Aligned_cols=208 Identities=25% Similarity=0.481 Sum_probs=183.4
Q ss_pred CCCcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC
Q 003232 583 KDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE 662 (837)
Q Consensus 583 k~g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~ 662 (837)
..+...++|++++.||+|+||+||+|+++.+|+.||||+++... ......+.+|+.+|++++||||++++++|.+..
T Consensus 23 ~~~~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 99 (352)
T d1koba_ 23 KQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY 99 (352)
T ss_dssp BCSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS
T ss_pred CCCCcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc---hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 34566788999999999999999999999999999999997653 223457889999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEc--cCCcEEEEecCCcccc
Q 003232 663 NLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA--HDGHIKLTDFGLSKVG 739 (837)
Q Consensus 663 ~lyLVmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd--~dG~IKLiDFGLArvg 739 (837)
++|||||||+||+|.+++... ..+++..++.++.||+.||.|||++|||||||||+|||++ .++.+||+|||+|+..
T Consensus 100 ~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 100 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 179 (352)
T ss_dssp EEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceec
Confidence 999999999999999987654 4699999999999999999999999999999999999997 5789999999999741
Q ss_pred ccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCC
Q 003232 740 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPP 819 (837)
Q Consensus 740 ~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~P 819 (837)
... .......||+.|+|||++.+..++.++|||||||++|+|++|+.|
T Consensus 180 ~~~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~P 227 (352)
T d1koba_ 180 NPD--------------------------------EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 227 (352)
T ss_dssp CTT--------------------------------SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCS
T ss_pred CCC--------------------------------CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCC
Confidence 100 112345789999999999999999999999999999999999999
Q ss_pred CCCCCc
Q 003232 820 FNAEHP 825 (837)
Q Consensus 820 F~~~dp 825 (837)
|.+.+.
T Consensus 228 f~~~~~ 233 (352)
T d1koba_ 228 FAGEDD 233 (352)
T ss_dssp SCCSSH
T ss_pred CCCCCH
Confidence 987543
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-42 Score=360.78 Aligned_cols=207 Identities=24% Similarity=0.371 Sum_probs=180.0
Q ss_pred CCCcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC
Q 003232 583 KDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE 662 (837)
Q Consensus 583 k~g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~ 662 (837)
+|....++|++.+.||+|+||+||+|+++.+++.||||+++.... ..+.+.+|+.+|+.++||||+++++++...+
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 86 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 86 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc----hHHHHHHHHHHHHhCCCCCEecCCccEeeCC
Confidence 456667889999999999999999999999999999999976432 2356899999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccc
Q 003232 663 NLYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740 (837)
Q Consensus 663 ~lyLVmEy~~GGSL~dlLk~~--g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~ 740 (837)
.+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 87 ~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 87 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 166 (287)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred eeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecC
Confidence 999999999999999999754 568999999999999999999999999999999999999999999999999997421
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCC
Q 003232 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820 (837)
Q Consensus 741 ~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF 820 (837)
.... .......||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus 167 ~~~~------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~ 216 (287)
T d1opja_ 167 GDTY------------------------------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 216 (287)
T ss_dssp SSSS------------------------------EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCS
T ss_pred CCCc------------------------------eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCC
Confidence 1100 0112345889999999999999999999999999999999977666
Q ss_pred CCC
Q 003232 821 NAE 823 (837)
Q Consensus 821 ~~~ 823 (837)
...
T Consensus 217 ~~~ 219 (287)
T d1opja_ 217 YPG 219 (287)
T ss_dssp STT
T ss_pred CCc
Confidence 543
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-42 Score=360.61 Aligned_cols=208 Identities=24% Similarity=0.376 Sum_probs=173.3
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeE
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~l 664 (837)
....++|++.+.||+|+||+||+|++. ..||||+++... ......+.+.+|+.++++++||||+++++++. ...+
T Consensus 4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~ 78 (276)
T d1uwha_ 4 EIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQL 78 (276)
T ss_dssp BCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSS-CCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred ccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEccc-CCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEE
Confidence 445578999999999999999999863 369999997654 23445678999999999999999999998765 4568
Q ss_pred EEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCC
Q 003232 665 YLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~s 743 (837)
|+||||++||+|.+++... ..+++..+..++.||+.||.|||++|||||||||+|||++.++.+||+|||+++......
T Consensus 79 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp EEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 9999999999999999754 569999999999999999999999999999999999999999999999999987411100
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC---CCCCchHHHHHHHHHHHHHHcCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG---TGHGTTADWWSVGIILFELIVGIPPF 820 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg---~~~s~kSDIWSLGVILyELLTGr~PF 820 (837)
.........||+.|||||++.+ ..++.++|||||||++|||+||+.||
T Consensus 159 -----------------------------~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf 209 (276)
T d1uwha_ 159 -----------------------------GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 209 (276)
T ss_dssp ------------------------------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred -----------------------------CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCC
Confidence 0111235679999999999965 35799999999999999999999999
Q ss_pred CCCCcC
Q 003232 821 NAEHPQ 826 (837)
Q Consensus 821 ~~~dpd 826 (837)
.+.++.
T Consensus 210 ~~~~~~ 215 (276)
T d1uwha_ 210 SNINNR 215 (276)
T ss_dssp TTCCCH
T ss_pred CCCChH
Confidence 876543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.7e-41 Score=352.88 Aligned_cols=207 Identities=32% Similarity=0.538 Sum_probs=182.2
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEeccccccc------HHHHHHHHHHHHHHHhcC-CCceEEEEeEeec
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIR------KNAVESILAERDILISVR-NPFVVRFFYSFTC 660 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~------~e~ie~~~rEieILk~Lr-HPNIVkL~gsf~d 660 (837)
.++|++.+.||+|+||+||+|+++.+|+.||||++....... ....+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 368999999999999999999999999999999997643221 233457889999999997 9999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccc
Q 003232 661 RENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740 (837)
Q Consensus 661 ~~~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~ 740 (837)
.+++||||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 99999999999999999999988999999999999999999999999999999999999999999999999999997411
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC------CCCCchHHHHHHHHHHHHHH
Q 003232 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG------TGHGTTADWWSVGIILFELI 814 (837)
Q Consensus 741 ~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg------~~~s~kSDIWSLGVILyELL 814 (837)
.. .......||+.|+|||++.+ ..++.++||||+||++|+|+
T Consensus 162 ~~--------------------------------~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml 209 (277)
T d1phka_ 162 PG--------------------------------EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLL 209 (277)
T ss_dssp TT--------------------------------CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHH
T ss_pred CC--------------------------------CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhc
Confidence 00 11234679999999999853 45688999999999999999
Q ss_pred cCCCCCCCCCcC
Q 003232 815 VGIPPFNAEHPQ 826 (837)
Q Consensus 815 TGr~PF~~~dpd 826 (837)
+|++||.+.++.
T Consensus 210 ~g~~Pf~~~~~~ 221 (277)
T d1phka_ 210 AGSPPFWHRKQM 221 (277)
T ss_dssp HSSCSSCCSSHH
T ss_pred cCCCCCCCCCHH
Confidence 999999877643
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.6e-42 Score=359.32 Aligned_cols=211 Identities=25% Similarity=0.379 Sum_probs=169.7
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCc---EEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCe
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGD---LFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCREN 663 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~---~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ 663 (837)
..++|++.+.||+|+||+||+|+++.+++ .||||.+.... .....+.+.+|+.+|++++||||+++++++...+.
T Consensus 24 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~ 101 (299)
T d1jpaa_ 24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP 101 (299)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred ChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 34679999999999999999999987665 58888876543 34455789999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccC
Q 003232 664 LYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~ 742 (837)
+|+||||+++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||+++.....
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCC
Confidence 99999999999999988764 56999999999999999999999999999999999999999999999999999742111
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCC
Q 003232 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFN 821 (837)
Q Consensus 743 stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~ 821 (837)
... ..........||+.|||||++.+..++.++|||||||++|||+| |+.||.
T Consensus 182 ~~~--------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~ 235 (299)
T d1jpaa_ 182 TSD--------------------------PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW 235 (299)
T ss_dssp ----------------------------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CCc--------------------------ceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCC
Confidence 100 00011223468999999999999999999999999999999998 899998
Q ss_pred CCCc
Q 003232 822 AEHP 825 (837)
Q Consensus 822 ~~dp 825 (837)
+.++
T Consensus 236 ~~~~ 239 (299)
T d1jpaa_ 236 DMTN 239 (299)
T ss_dssp TCCH
T ss_pred CCCH
Confidence 7654
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-42 Score=363.08 Aligned_cols=204 Identities=26% Similarity=0.459 Sum_probs=180.6
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEE
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 665 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ly 665 (837)
..+++|++++.||+|+||+||+|+++.+++.||+|+++... .....+.+|+.+|+.++||||++++++|.+.+++|
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 77 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELV 77 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 45688999999999999999999999999999999997643 22346789999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccC--CcEEEEecCCccccccC
Q 003232 666 LVMEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD--GHIKLTDFGLSKVGLIN 742 (837)
Q Consensus 666 LVmEy~~GGSL~dlLk~~g-~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~d--G~IKLiDFGLArvg~~~ 742 (837)
||||||+||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.+ +.++|+|||+++....
T Consensus 78 lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~- 156 (321)
T d1tkia_ 78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP- 156 (321)
T ss_dssp EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT-
T ss_pred EEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcccc-
Confidence 9999999999999997655 69999999999999999999999999999999999999854 4899999999873100
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003232 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNA 822 (837)
Q Consensus 743 stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~ 822 (837)
........||+.|+|||.+.+..++.++|||||||++|+|++|..||.+
T Consensus 157 -------------------------------~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~ 205 (321)
T d1tkia_ 157 -------------------------------GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA 205 (321)
T ss_dssp -------------------------------TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred -------------------------------CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCC
Confidence 0112345689999999999999999999999999999999999999987
Q ss_pred CCc
Q 003232 823 EHP 825 (837)
Q Consensus 823 ~dp 825 (837)
.+.
T Consensus 206 ~~~ 208 (321)
T d1tkia_ 206 ETN 208 (321)
T ss_dssp SSH
T ss_pred CCH
Confidence 654
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-42 Score=361.26 Aligned_cols=213 Identities=27% Similarity=0.427 Sum_probs=178.3
Q ss_pred CCCcccCCeEEEEEecccCceEEEEEEECCCCc-----EEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEe
Q 003232 583 KDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGD-----LFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFY 656 (837)
Q Consensus 583 k~g~~lddYeIlkkLGsG~FGtVYkArdk~tG~-----~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~g 656 (837)
+|....++|++.+.||+|+||+||+|++..+++ .||+|.+.... .......+.+|+.+++++ +||||+++++
T Consensus 31 kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~ 108 (325)
T d1rjba_ 31 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLG 108 (325)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEE
Confidence 445566789999999999999999999876554 69999986543 233446789999999988 8999999999
Q ss_pred EeecCCeEEEEEEecCCCCHHHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 003232 657 SFTCRENLYLVMEYLNGGDLYSLLRNL-----------------------GCLDEDVARVYIAEVVLALEYLHSLRVVHR 713 (837)
Q Consensus 657 sf~d~~~lyLVmEy~~GGSL~dlLk~~-----------------------g~Lsee~irkIl~QIa~ALsYLHSkGIIHR 713 (837)
++...+.+|+|||||+||+|.+++... ..+++..++.++.||+.||.|||++|||||
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHR 188 (325)
T d1rjba_ 109 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 188 (325)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 999999999999999999999999754 248899999999999999999999999999
Q ss_pred cCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhc
Q 003232 714 DLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL 793 (837)
Q Consensus 714 DIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLl 793 (837)
||||+|||++.++.+||+|||+|+....... ........||+.|||||++.
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-----------------------------~~~~~~~~gt~~y~aPE~l~ 239 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSN-----------------------------YVVRGNARLPVKWMAPESLF 239 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTT-----------------------------SEEETTEEECGGGCCHHHHH
T ss_pred cCchhccccccCCeEEEeeccccccccCCCc-----------------------------eeeeccccCCCccCChHHHc
Confidence 9999999999999999999999974211110 01122456899999999999
Q ss_pred CCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCcC
Q 003232 794 GTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQ 826 (837)
Q Consensus 794 g~~~s~kSDIWSLGVILyELLT-Gr~PF~~~dpd 826 (837)
+..++.++|||||||++|||+| |.+||.+.+.+
T Consensus 240 ~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 240 EGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred CCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999999997 89999876554
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-42 Score=355.44 Aligned_cols=202 Identities=30% Similarity=0.488 Sum_probs=170.8
Q ss_pred EEEEecccCceEEEEEEECCCCcEEEEEEeccccccc--HHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEEe
Q 003232 593 IIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIR--KNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEY 670 (837)
Q Consensus 593 IlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~--~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmEy 670 (837)
.+++||+|+||+||+|+++.+|+.||||+++...... ....+.+.+|+.+++.++||||+++++++...+++|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 5789999999999999999999999999997643221 22235788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCC
Q 003232 671 LNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 750 (837)
Q Consensus 671 ~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p 750 (837)
+.++++..+......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~------- 154 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN------- 154 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-------
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCc-------
Confidence 9988887777667789999999999999999999999999999999999999999999999999986311000
Q ss_pred CccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 751 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 751 ~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.++
T Consensus 155 ------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~ 206 (299)
T d1ua2a_ 155 ------------------------RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD 206 (299)
T ss_dssp ------------------------CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ------------------------ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH
Confidence 11234579999999999875 4679999999999999999999999987653
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-41 Score=345.64 Aligned_cols=202 Identities=23% Similarity=0.431 Sum_probs=167.3
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLV 667 (837)
.++|++++.||+|+||+||+|+++ +++.||||+++..... .+.+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv 78 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 78 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceEEE
Confidence 357999999999999999999985 5778999999764422 24689999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCC
Q 003232 668 MEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (837)
Q Consensus 668 mEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stdd 746 (837)
|||+++|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++......
T Consensus 79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~--- 155 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--- 155 (263)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCC---
Confidence 9999999999998754 568899999999999999999999999999999999999999999999999987311100
Q ss_pred CCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcC-CCCCCCCC
Q 003232 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVG-IPPFNAEH 824 (837)
Q Consensus 747 l~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTG-r~PF~~~d 824 (837)
........||+.|+|||++.+..++.++|||||||++|||+|+ .+||...+
T Consensus 156 ---------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~ 207 (263)
T d1sm2a_ 156 ---------------------------YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 207 (263)
T ss_dssp ------------------------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC
T ss_pred ---------------------------ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC
Confidence 0112235689999999999999999999999999999999995 66665433
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-41 Score=361.82 Aligned_cols=202 Identities=32% Similarity=0.583 Sum_probs=173.9
Q ss_pred CCcccCCeEEEE-EecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHh-cCCCceEEEEeEeec-
Q 003232 584 DRTSIDDFEIIK-PISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILIS-VRNPFVVRFFYSFTC- 660 (837)
Q Consensus 584 ~g~~lddYeIlk-kLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~-LrHPNIVkL~gsf~d- 660 (837)
....+++|+++. .||+|+||+||+|+++.+++.||||+++.. ..+.+|+.++.+ ++||||++++++|.+
T Consensus 6 ~~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~ 77 (335)
T d2ozaa1 6 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENL 77 (335)
T ss_dssp CSCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred CCCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeec
Confidence 345578899986 599999999999999999999999998753 246689988755 589999999999865
Q ss_pred ---CCeEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEcc---CCcEEEEe
Q 003232 661 ---RENLYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKLTD 732 (837)
Q Consensus 661 ---~~~lyLVmEy~~GGSL~dlLk~~--g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~---dG~IKLiD 732 (837)
..++|+|||||+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. .+.+||+|
T Consensus 78 ~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~D 157 (335)
T d2ozaa1 78 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 157 (335)
T ss_dssp ETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred ccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccc
Confidence 46799999999999999999864 46999999999999999999999999999999999999975 56799999
Q ss_pred cCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHH
Q 003232 733 FGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFE 812 (837)
Q Consensus 733 FGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyE 812 (837)
||+++..... ......+||+.|+|||++.+..|+.++|||||||++|+
T Consensus 158 FG~a~~~~~~--------------------------------~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~ 205 (335)
T d2ozaa1 158 FGFAKETTSH--------------------------------NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYI 205 (335)
T ss_dssp CTTCEECCCC--------------------------------CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHH
T ss_pred cceeeeccCC--------------------------------CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHH
Confidence 9999741111 01234579999999999999999999999999999999
Q ss_pred HHcCCCCCCCCCc
Q 003232 813 LIVGIPPFNAEHP 825 (837)
Q Consensus 813 LLTGr~PF~~~dp 825 (837)
|+||++||.+.+.
T Consensus 206 lltg~~Pf~~~~~ 218 (335)
T d2ozaa1 206 LLCGYPPFYSNHG 218 (335)
T ss_dssp HTTSSCSCEETTC
T ss_pred HhhCCCCCCCCCH
Confidence 9999999976543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-41 Score=347.72 Aligned_cols=204 Identities=23% Similarity=0.390 Sum_probs=172.2
Q ss_pred CCCcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC
Q 003232 583 KDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE 662 (837)
Q Consensus 583 k~g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~ 662 (837)
.+....++|++.+.||+|+||+||+|+++ +++.||||+++.... ..+.+.+|+.++++++||||+++++++. .+
T Consensus 7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~ 80 (272)
T d1qpca_ 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVT-QE 80 (272)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred CeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC----CHHHHHHHHHHHHhCCCCCEeEEEeeec-cC
Confidence 44555678999999999999999999985 678899999976432 2356899999999999999999999775 45
Q ss_pred eEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccc
Q 003232 663 NLYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740 (837)
Q Consensus 663 ~lyLVmEy~~GGSL~dlLk~~--g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~ 740 (837)
.+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 81 ~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEcc
Confidence 679999999999999977432 359999999999999999999999999999999999999999999999999997421
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCC
Q 003232 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820 (837)
Q Consensus 741 ~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF 820 (837)
... ........||+.|+|||++.+..++.++|||||||++|||+||..||
T Consensus 161 ~~~------------------------------~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~ 210 (272)
T d1qpca_ 161 DNE------------------------------YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210 (272)
T ss_dssp SSC------------------------------EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCS
T ss_pred CCc------------------------------cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCC
Confidence 100 01123457899999999999889999999999999999999965554
Q ss_pred CC
Q 003232 821 NA 822 (837)
Q Consensus 821 ~~ 822 (837)
..
T Consensus 211 ~~ 212 (272)
T d1qpca_ 211 YP 212 (272)
T ss_dssp ST
T ss_pred CC
Confidence 33
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-41 Score=351.44 Aligned_cols=206 Identities=31% Similarity=0.526 Sum_probs=172.9
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLV 667 (837)
+++|++++.||+|+||+||+|+++.+|+.||||+++... ........+.+|+.++++++||||++++++|.+..++|+|
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhh-cChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence 478999999999999999999999999999999997543 2233346789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCC
Q 003232 668 MEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (837)
Q Consensus 668 mEy~~GGSL~dlLk~-~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stdd 746 (837)
|||+.++.+...... .+.+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+++.....
T Consensus 80 ~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~---- 155 (298)
T d1gz8a_ 80 FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---- 155 (298)
T ss_dssp EECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC----
T ss_pred EeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCC----
Confidence 999965444433333 456999999999999999999999999999999999999999999999999998741110
Q ss_pred CCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCC-CCchHHHHHHHHHHHHHHcCCCCCCCCCc
Q 003232 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTADWWSVGIILFELIVGIPPFNAEHP 825 (837)
Q Consensus 747 l~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~-~s~kSDIWSLGVILyELLTGr~PF~~~dp 825 (837)
........||+.|+|||++.... ++.++|||||||++|+|++|+.||.+.++
T Consensus 156 ---------------------------~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~ 208 (298)
T d1gz8a_ 156 ---------------------------VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE 208 (298)
T ss_dssp ---------------------------SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ---------------------------cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH
Confidence 01123457999999999987766 47899999999999999999999987553
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-41 Score=350.02 Aligned_cols=201 Identities=25% Similarity=0.405 Sum_probs=168.7
Q ss_pred EEecccCceEEEEEEECC--CCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEEEEecC
Q 003232 595 KPISRGAFGRVFLAKKRT--TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLN 672 (837)
Q Consensus 595 kkLGsG~FGtVYkArdk~--tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLVmEy~~ 672 (837)
++||+|+||+||+|.++. +++.||||+++... ......+.+.+|+.+|++++||||+++++++.. +..||||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCC
Confidence 479999999999998653 45789999997543 334455789999999999999999999999864 56789999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCCCCCCc
Q 003232 673 GGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 752 (837)
Q Consensus 673 GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~ 752 (837)
+|+|.+++.....+++..+..++.||+.||.|||++|||||||||+|||++.++.+||+|||+++........
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~------- 163 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY------- 163 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE-------
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccc-------
Confidence 9999999998888999999999999999999999999999999999999999999999999999742111100
Q ss_pred cCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCc
Q 003232 753 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHP 825 (837)
Q Consensus 753 SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~~~dp 825 (837)
........||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+.
T Consensus 164 ---------------------~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~ 216 (277)
T d1xbba_ 164 ---------------------YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 216 (277)
T ss_dssp ---------------------EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred ---------------------cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH
Confidence 011224578999999999999999999999999999999997 8999987553
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-41 Score=349.04 Aligned_cols=207 Identities=28% Similarity=0.414 Sum_probs=174.9
Q ss_pred cCCeEEEEE-ecccCceEEEEEEECC--CCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeE
Q 003232 588 IDDFEIIKP-ISRGAFGRVFLAKKRT--TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (837)
Q Consensus 588 lddYeIlkk-LGsG~FGtVYkArdk~--tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~l 664 (837)
.++|.+.+. ||+|+||+||+|.++. ++..||||+++... .....+.+.+|+.+|++++||||+++++++.. +.+
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~ 83 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL 83 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeE
Confidence 356888884 9999999999998764 44579999997643 34556789999999999999999999998864 568
Q ss_pred EEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCC
Q 003232 665 YLVMEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~-~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~s 743 (837)
|+||||+++|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163 (285)
T ss_dssp EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence 999999999999999865 3579999999999999999999999999999999999999999999999999997421111
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNA 822 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~~ 822 (837)
.. ........||+.|+|||++.+..++.++|||||||++|||+| |+.||.+
T Consensus 164 ~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~ 215 (285)
T d1u59a_ 164 SY----------------------------YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK 215 (285)
T ss_dssp CE----------------------------ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cc----------------------------cccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCC
Confidence 00 011234568999999999999999999999999999999998 9999987
Q ss_pred CCc
Q 003232 823 EHP 825 (837)
Q Consensus 823 ~dp 825 (837)
.+.
T Consensus 216 ~~~ 218 (285)
T d1u59a_ 216 MKG 218 (285)
T ss_dssp CCT
T ss_pred CCH
Confidence 543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-40 Score=342.21 Aligned_cols=206 Identities=24% Similarity=0.312 Sum_probs=169.4
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCC----cEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCe
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTG----DLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCREN 663 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG----~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~ 663 (837)
.+.|++.++||+|+||+||+|.++.++ ..||||++.... .......+.+|+.+++.++||||+++++++.....
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~ 83 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 83 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCc
Confidence 356999999999999999999987654 479999987543 23445678999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccC
Q 003232 664 LYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~ 742 (837)
.++||||+.++++.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred eEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 99999999999999988654 67999999999999999999999999999999999999999999999999999742111
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003232 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNA 822 (837)
Q Consensus 743 stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~ 822 (837)
.. .........||+.|+|||++.+..++.++|||||||++|||++|..||..
T Consensus 164 ~~----------------------------~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~ 215 (283)
T d1mqba_ 164 PE----------------------------ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW 215 (283)
T ss_dssp --------------------------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred Cc----------------------------cceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccc
Confidence 00 00112234689999999999999999999999999999999997666544
Q ss_pred C
Q 003232 823 E 823 (837)
Q Consensus 823 ~ 823 (837)
.
T Consensus 216 ~ 216 (283)
T d1mqba_ 216 E 216 (283)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-41 Score=348.10 Aligned_cols=201 Identities=27% Similarity=0.426 Sum_probs=173.5
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEeccccccc---HHHHHHHHHHHHHHHhcC--CCceEEEEeEeecCCe
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIR---KNAVESILAERDILISVR--NPFVVRFFYSFTCREN 663 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~---~e~ie~~~rEieILk~Lr--HPNIVkL~gsf~d~~~ 663 (837)
++|++.+.||+|+||+||+|+++.+|+.||||++.+..... .....++.+|+.+++.++ ||||+++++++...+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 56999999999999999999999999999999997643221 111234678999999987 8999999999999999
Q ss_pred EEEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEcc-CCcEEEEecCCcccccc
Q 003232 664 LYLVMEYLNG-GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH-DGHIKLTDFGLSKVGLI 741 (837)
Q Consensus 664 lyLVmEy~~G-GSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~-dG~IKLiDFGLArvg~~ 741 (837)
+|+||||+.+ +++.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++....
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~ 163 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD 163 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCS
T ss_pred EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceeccc
Confidence 9999999976 688899988889999999999999999999999999999999999999985 47999999999874110
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCC-CchHHHHHHHHHHHHHHcCCCCC
Q 003232 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVGIPPF 820 (837)
Q Consensus 742 ~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~-s~kSDIWSLGVILyELLTGr~PF 820 (837)
.......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||
T Consensus 164 ---------------------------------~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf 210 (273)
T d1xwsa_ 164 ---------------------------------TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 210 (273)
T ss_dssp ---------------------------------SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSC
T ss_pred ---------------------------------ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCC
Confidence 01234579999999999987765 57789999999999999999999
Q ss_pred CC
Q 003232 821 NA 822 (837)
Q Consensus 821 ~~ 822 (837)
..
T Consensus 211 ~~ 212 (273)
T d1xwsa_ 211 EH 212 (273)
T ss_dssp CS
T ss_pred CC
Confidence 75
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-40 Score=344.73 Aligned_cols=204 Identities=33% Similarity=0.485 Sum_probs=168.8
Q ss_pred CCeEEEEEecccCceEEEEEEECCC-CcEEEEEEecccccccHHHHHHHHHHHHHHHhc---CCCceEEEEeEeec----
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTT-GDLFAIKVLKKADMIRKNAVESILAERDILISV---RNPFVVRFFYSFTC---- 660 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~t-G~~VAVKIikk~~~~~~e~ie~~~rEieILk~L---rHPNIVkL~gsf~d---- 660 (837)
++|++++.||+|+||+||+|++..+ ++.||||+++..... ......+.+|+.+++.+ +||||++++++|..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhcc-chHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 6799999999999999999999765 678999999754321 11122355667666655 89999999998853
Q ss_pred -CCeEEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccc
Q 003232 661 -RENLYLVMEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (837)
Q Consensus 661 -~~~lyLVmEy~~GGSL~dlLk~-~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArv 738 (837)
..++|++|||+.++.+...... ...+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+++.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 3578999999988777655443 35699999999999999999999999999999999999999999999999999863
Q ss_pred cccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCC
Q 003232 739 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIP 818 (837)
Q Consensus 739 g~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~ 818 (837)
.. .........||+.|+|||++.+.+|+.++|||||||++|||++|++
T Consensus 166 ~~--------------------------------~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~ 213 (305)
T d1blxa_ 166 YS--------------------------------FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 213 (305)
T ss_dssp CC--------------------------------GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred hc--------------------------------ccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCC
Confidence 10 0112345689999999999999999999999999999999999999
Q ss_pred CCCCCCc
Q 003232 819 PFNAEHP 825 (837)
Q Consensus 819 PF~~~dp 825 (837)
||.+.++
T Consensus 214 pf~~~~~ 220 (305)
T d1blxa_ 214 LFRGSSD 220 (305)
T ss_dssp SCCCSSH
T ss_pred CCCCCCH
Confidence 9987654
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.3e-40 Score=343.12 Aligned_cols=204 Identities=31% Similarity=0.521 Sum_probs=175.3
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLV 667 (837)
+++|+++++||+|+||+||+|+++ +|+.||||+++.... .....+.+.+|+.+|+.++||||+++++.|...+..|++
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence 478999999999999999999995 789999999976542 333456889999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCC
Q 003232 668 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (837)
Q Consensus 668 mEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl 747 (837)
|||+.++.+..+....+.+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||++......
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~----- 153 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP----- 153 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccC-----
Confidence 999988877777777788999999999999999999999999999999999999999999999999998631100
Q ss_pred CCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 748 ~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~-~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
........|++.|+|||.+.+. .++.++|||||||++|||++|++||.+.+
T Consensus 154 --------------------------~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~ 205 (286)
T d1ob3a_ 154 --------------------------VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS 205 (286)
T ss_dssp ----------------------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred --------------------------ccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCC
Confidence 0112344689999999999764 56899999999999999999999998654
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-40 Score=340.23 Aligned_cols=208 Identities=26% Similarity=0.400 Sum_probs=168.4
Q ss_pred cccCCeEEEEEecccCceEEEEEEECCCC---cEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC
Q 003232 586 TSIDDFEIIKPISRGAFGRVFLAKKRTTG---DLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE 662 (837)
Q Consensus 586 ~~lddYeIlkkLGsG~FGtVYkArdk~tG---~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~ 662 (837)
...++|++.+.||+|+||+||+|++..++ ..||||.++... .....+.+.+|+.++++++||||+++++++. .+
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 80 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 80 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence 44578999999999999999999987543 468888886532 3455678999999999999999999999986 56
Q ss_pred eEEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCcccccc
Q 003232 663 NLYLVMEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 741 (837)
Q Consensus 663 ~lyLVmEy~~GGSL~dlLk~-~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~ 741 (837)
.+|+||||+++|+|.+++.. ...+++..++.++.||+.||.|||++|||||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 81 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred eEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccC
Confidence 78999999999999998765 45699999999999999999999999999999999999999999999999999873110
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCC
Q 003232 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPF 820 (837)
Q Consensus 742 ~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF 820 (837)
. .........||+.|+|||++.+..++.++|||||||++|||++ |.+||
T Consensus 161 ~------------------------------~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~ 210 (273)
T d1mp8a_ 161 S------------------------------TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 210 (273)
T ss_dssp ----------------------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred C------------------------------cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCC
Confidence 0 0011234568999999999999999999999999999999998 89999
Q ss_pred CCCCcC
Q 003232 821 NAEHPQ 826 (837)
Q Consensus 821 ~~~dpd 826 (837)
...++.
T Consensus 211 ~~~~~~ 216 (273)
T d1mp8a_ 211 QGVKNN 216 (273)
T ss_dssp TTCCGG
T ss_pred CCCCHH
Confidence 876543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-40 Score=338.97 Aligned_cols=203 Identities=25% Similarity=0.437 Sum_probs=177.3
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLV 667 (837)
.++|++.++||+|+||+||+|++ .+++.||||+++..... .+.+.+|+.++++++||||+++++++...+.+++|
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv 77 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 77 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Confidence 36799999999999999999998 47889999999875432 24688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCC
Q 003232 668 MEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 746 (837)
Q Consensus 668 mEy~~GGSL~dlLk~-~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stdd 746 (837)
|||+.+|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-- 155 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-- 155 (258)
T ss_dssp EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC--
T ss_pred EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCc--
Confidence 999999999999764 46689999999999999999999999999999999999999999999999999873211100
Q ss_pred CCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCc
Q 003232 747 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHP 825 (837)
Q Consensus 747 l~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~~~dp 825 (837)
.......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+.
T Consensus 156 ----------------------------~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~ 207 (258)
T d1k2pa_ 156 ----------------------------TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN 207 (258)
T ss_dssp ----------------------------CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH
T ss_pred ----------------------------eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH
Confidence 01123568999999999999999999999999999999998 8999987653
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-40 Score=345.80 Aligned_cols=205 Identities=28% Similarity=0.438 Sum_probs=168.3
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCc----EEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGD----LFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~----~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~l 664 (837)
++|++++.||+|+||+||+|++..+|+ .||+|.++... .....+.+.+|+.++++++||||+++++++.. ...
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLT-STV 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCe
Confidence 569999999999999999999988876 57888776432 23345679999999999999999999999876 456
Q ss_pred EEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCC
Q 003232 665 YLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~s 743 (837)
+++|||+.+++|.+++... ..+++..+..++.||+.||.|||++|||||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 7889999999999887654 579999999999999999999999999999999999999999999999999997421111
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNA 822 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~~ 822 (837)
. ........||+.|+|||++.+..++.++|||||||++|||+| |.+||.+
T Consensus 166 ~-----------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~ 216 (317)
T d1xkka_ 166 K-----------------------------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 216 (317)
T ss_dssp C-------------------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred c-----------------------------cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCC
Confidence 0 011123468999999999999999999999999999999998 8999987
Q ss_pred CCc
Q 003232 823 EHP 825 (837)
Q Consensus 823 ~dp 825 (837)
.+.
T Consensus 217 ~~~ 219 (317)
T d1xkka_ 217 IPA 219 (317)
T ss_dssp SCG
T ss_pred CCH
Confidence 654
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-39 Score=332.68 Aligned_cols=211 Identities=30% Similarity=0.454 Sum_probs=183.6
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeEEEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 667 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~lyLV 667 (837)
+++|++++.||+|+||+||+|+++.+++.||||+++... .......++.+|+.+++.++||||+++++++....+.++|
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh-CChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence 468999999999999999999999999999999997654 3445667899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCC
Q 003232 668 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (837)
Q Consensus 668 mEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl 747 (837)
|+++.+++|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.++.......
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~--- 156 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--- 156 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS---
T ss_pred eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCc---
Confidence 99999999999998888999999999999999999999999999999999999999999999999999874211110
Q ss_pred CCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCC-CCchHHHHHHHHHHHHHHcCCCCCCCCCcC
Q 003232 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTADWWSVGIILFELIVGIPPFNAEHPQ 826 (837)
Q Consensus 748 ~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~-~s~kSDIWSLGVILyELLTGr~PF~~~dpd 826 (837)
......+++.|+|||++.+.. ++.++|||||||++|+|++|+.||......
T Consensus 157 ----------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~ 208 (292)
T d1unla_ 157 ----------------------------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV 208 (292)
T ss_dssp ----------------------------CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH
T ss_pred ----------------------------cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCH
Confidence 112345778899999998765 689999999999999999999997665544
Q ss_pred HHHH
Q 003232 827 VSTL 830 (837)
Q Consensus 827 v~~l 830 (837)
...+
T Consensus 209 ~~~~ 212 (292)
T d1unla_ 209 DDQL 212 (292)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 4433
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-40 Score=340.41 Aligned_cols=212 Identities=27% Similarity=0.419 Sum_probs=167.0
Q ss_pred CCcccCCeEEEEEecccCceEEEEEEECC-----CCcEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEeE
Q 003232 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRT-----TGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYS 657 (837)
Q Consensus 584 ~g~~lddYeIlkkLGsG~FGtVYkArdk~-----tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~gs 657 (837)
|....++|++.+.||+|+||.||+|++.. +++.||||+++... .....+.+.+|..++.++ +|+||+.++++
T Consensus 8 wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 8 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 44555789999999999999999999754 44689999987543 234456778888888776 68899999988
Q ss_pred eecC-CeEEEEEEecCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcE
Q 003232 658 FTCR-ENLYLVMEYLNGGDLYSLLRNL----------------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNL 720 (837)
Q Consensus 658 f~d~-~~lyLVmEy~~GGSL~dlLk~~----------------g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNI 720 (837)
+... ..+++|||||++|+|.+++... ..+++..+..++.||+.||.|||++|||||||||+||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NI 165 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 165 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccce
Confidence 7654 5689999999999999999643 2488999999999999999999999999999999999
Q ss_pred EEccCCcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCch
Q 003232 721 LIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT 800 (837)
Q Consensus 721 LLd~dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~k 800 (837)
|++.++.+||+|||+|+....... ........||+.|+|||++.+..++.+
T Consensus 166 Ll~~~~~~Kl~DFGla~~~~~~~~-----------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~ 216 (299)
T d1ywna1 166 LLSEKNVVKICDFGLARDIYKDPD-----------------------------YVRKGDARLPLKWMAPETIFDRVYTIQ 216 (299)
T ss_dssp EECGGGCEEECC------CCSCTT-----------------------------SCCTTSCCCGGGGCCHHHHHHCCCCHH
T ss_pred eECCCCcEEEccCcchhhcccccc-----------------------------ccccCceeeCccccchhHhhcCCCCcc
Confidence 999999999999999974211110 011234579999999999999999999
Q ss_pred HHHHHHHHHHHHHHcC-CCCCCCCCcC
Q 003232 801 ADWWSVGIILFELIVG-IPPFNAEHPQ 826 (837)
Q Consensus 801 SDIWSLGVILyELLTG-r~PF~~~dpd 826 (837)
+|||||||++|||++| .+||.+....
T Consensus 217 sDiwS~Gvil~ellt~~~~p~~~~~~~ 243 (299)
T d1ywna1 217 SDVWSFGVLLWEIFSLGASPYPGVKID 243 (299)
T ss_dssp HHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred cceeehHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999986 5678765543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-40 Score=346.12 Aligned_cols=201 Identities=32% Similarity=0.497 Sum_probs=170.5
Q ss_pred ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC----
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE---- 662 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~---- 662 (837)
..++|+++++||+|+||+||+|+++.+|+.||||+++... ......+.+.+|+.+|+.++||||++++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~ 94 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 94 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccc
Confidence 3567999999999999999999999999999999997643 34555678999999999999999999999997654
Q ss_pred --eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccc
Q 003232 663 --NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740 (837)
Q Consensus 663 --~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~ 740 (837)
++|+||||+ +.+|..+++. +.+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+++...
T Consensus 95 ~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~ 172 (346)
T d1cm8a_ 95 FTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 172 (346)
T ss_dssp CCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred cceEEEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccC
Confidence 579999999 6778877755 679999999999999999999999999999999999999999999999999987310
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCC
Q 003232 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPP 819 (837)
Q Consensus 741 ~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~-~~s~kSDIWSLGVILyELLTGr~P 819 (837)
.......||+.|+|||++.+. .++.++|||||||++|+|++|++|
T Consensus 173 ----------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~p 218 (346)
T d1cm8a_ 173 ----------------------------------SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 218 (346)
T ss_dssp ----------------------------------SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred ----------------------------------CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCC
Confidence 012345799999999999874 568999999999999999999999
Q ss_pred CCCCC
Q 003232 820 FNAEH 824 (837)
Q Consensus 820 F~~~d 824 (837)
|.+.+
T Consensus 219 f~~~~ 223 (346)
T d1cm8a_ 219 FKGSD 223 (346)
T ss_dssp SCCSS
T ss_pred CCCCC
Confidence 98764
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-40 Score=340.73 Aligned_cols=210 Identities=27% Similarity=0.434 Sum_probs=173.5
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeec-------
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC------- 660 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d------- 660 (837)
.++|+++++||+|+||+||+|+++.+|+.||||++..... .......+.+|+.+|+.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 5789999999999999999999999999999999866432 23344678899999999999999999998855
Q ss_pred -CCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCcccc
Q 003232 661 -RENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 739 (837)
Q Consensus 661 -~~~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg 739 (837)
..++|+||||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeec
Confidence 3468999999987776666556677999999999999999999999999999999999999999999999999998632
Q ss_pred ccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCC
Q 003232 740 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIP 818 (837)
Q Consensus 740 ~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~-~~s~kSDIWSLGVILyELLTGr~ 818 (837)
...... ........+||+.|+|||++.+. .+++++|||||||++|+|++|+.
T Consensus 168 ~~~~~~---------------------------~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~ 220 (318)
T d3blha1 168 SLAKNS---------------------------QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 220 (318)
T ss_dssp CC--------------------------------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cccccc---------------------------ccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCC
Confidence 111000 01122346799999999999865 68999999999999999999999
Q ss_pred CCCCCCc
Q 003232 819 PFNAEHP 825 (837)
Q Consensus 819 PF~~~dp 825 (837)
||.+.++
T Consensus 221 pf~~~~~ 227 (318)
T d3blha1 221 IMQGNTE 227 (318)
T ss_dssp SCCCSSH
T ss_pred CCCCCCH
Confidence 9987554
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-39 Score=339.75 Aligned_cols=207 Identities=25% Similarity=0.424 Sum_probs=176.1
Q ss_pred ccCCeEEEEEecccCceEEEEEEECC-----CCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecC
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKRT-----TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR 661 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk~-----tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~ 661 (837)
..++|++++.||+|+||+||+|+++. +++.||||+++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 88 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVG 88 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeeccC
Confidence 34679999999999999999999853 56789999987543 344567899999999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCC
Q 003232 662 ENLYLVMEYLNGGDLYSLLRNLG------------------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKP 717 (837)
Q Consensus 662 ~~lyLVmEy~~GGSL~dlLk~~g------------------------~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKP 717 (837)
...++||||+.+|+|.+++.... .++...+..++.||+.||.|||++|||||||||
T Consensus 89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp 168 (301)
T d1lufa_ 89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 168 (301)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcc
Confidence 99999999999999999986432 378889999999999999999999999999999
Q ss_pred CcEEEccCCcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCC
Q 003232 718 DNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH 797 (837)
Q Consensus 718 eNILLd~dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~ 797 (837)
+|||++.++.+||+|||+++....... ........||+.|+|||++.+..+
T Consensus 169 ~NILld~~~~~Kl~DFGls~~~~~~~~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~ 219 (301)
T d1lufa_ 169 RNCLVGENMVVKIADFGLSRNIYSADY-----------------------------YKADGNDAIPIRWMPPESIFYNRY 219 (301)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGC-----------------------------BC----CCBCGGGCCHHHHHHCCC
T ss_pred cceEECCCCcEEEccchhheeccCCcc-----------------------------ccccCCCCcCcCcCCHHHHccCCC
Confidence 999999999999999999873111100 111234578999999999999999
Q ss_pred CchHHHHHHHHHHHHHHcCC-CCCCCCC
Q 003232 798 GTTADWWSVGIILFELIVGI-PPFNAEH 824 (837)
Q Consensus 798 s~kSDIWSLGVILyELLTGr-~PF~~~d 824 (837)
+.++|||||||++|||++|. +||...+
T Consensus 220 t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 220 TTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp CHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 99999999999999999985 6776654
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-39 Score=337.81 Aligned_cols=207 Identities=26% Similarity=0.376 Sum_probs=171.0
Q ss_pred CCCCcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecC
Q 003232 582 SKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR 661 (837)
Q Consensus 582 ~k~g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~ 661 (837)
..|....++|++.+.||+|+||+||+|+++. ++.||||+++.... ..+.+.+|+.++++++||||+++++++.+
T Consensus 10 ~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~~~----~~~~~~~E~~~l~~l~h~nIv~~~g~~~~- 83 (285)
T d1fmka3 10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 83 (285)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred cceEcCHHHEEEeeEEeeCCCeEEEEEEECC-CCEEEEEEECcccC----CHHHHHHHHHHHHhcccCCEeEEEEEEec-
Confidence 3455667889999999999999999999964 46799999976432 12568999999999999999999999864
Q ss_pred CeEEEEEEecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCcccc
Q 003232 662 ENLYLVMEYLNGGDLYSLLRN--LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 739 (837)
Q Consensus 662 ~~lyLVmEy~~GGSL~dlLk~--~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg 739 (837)
+.+|+||||+++|+|..++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||+++..
T Consensus 84 ~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~ 163 (285)
T d1fmka3 84 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 163 (285)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhc
Confidence 567899999999999988843 457999999999999999999999999999999999999999999999999998731
Q ss_pred ccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCC
Q 003232 740 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPP 819 (837)
Q Consensus 740 ~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~P 819 (837)
... .........||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus 164 ~~~------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p 213 (285)
T d1fmka3 164 EDN------------------------------EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 213 (285)
T ss_dssp ------------------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred cCC------------------------------CceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCC
Confidence 000 00112345689999999999999999999999999999999997666
Q ss_pred CCCCC
Q 003232 820 FNAEH 824 (837)
Q Consensus 820 F~~~d 824 (837)
|....
T Consensus 214 ~~~~~ 218 (285)
T d1fmka3 214 PYPGM 218 (285)
T ss_dssp SSTTC
T ss_pred CCCCC
Confidence 54443
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-39 Score=337.40 Aligned_cols=210 Identities=25% Similarity=0.370 Sum_probs=166.1
Q ss_pred cCCeEEEEEecccCceEEEEEEECCC-C--cEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCCeE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTT-G--DLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 664 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~t-G--~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~~l 664 (837)
.++|++++.||+|+||+||+|++... + ..||||++++.........+.+.+|+.++++++||||+++++++.+ ..+
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 35699999999999999999987533 3 3689999987665556667889999999999999999999999965 567
Q ss_pred EEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCC
Q 003232 665 YLVMEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~-~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~s 743 (837)
++||||+++++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~ 165 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence 899999999999988754 4569999999999999999999999999999999999999999999999999998421111
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNA 822 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~PF~~ 822 (837)
.. ........||+.|+|||++.+..++.++||||||+++|||+| |++||.+
T Consensus 166 ~~----------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~ 217 (273)
T d1u46a_ 166 DH----------------------------YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG 217 (273)
T ss_dssp CE----------------------------EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred Cc----------------------------ceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCC
Confidence 10 011223467889999999999999999999999999999998 8999976
Q ss_pred CCcC
Q 003232 823 EHPQ 826 (837)
Q Consensus 823 ~dpd 826 (837)
.+..
T Consensus 218 ~~~~ 221 (273)
T d1u46a_ 218 LNGS 221 (273)
T ss_dssp CCHH
T ss_pred cCHH
Confidence 5443
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-39 Score=334.07 Aligned_cols=202 Identities=30% Similarity=0.521 Sum_probs=169.8
Q ss_pred CCcccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeec-CC
Q 003232 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC-RE 662 (837)
Q Consensus 584 ~g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d-~~ 662 (837)
|...+++|++++.||+|+||.||+|+++ |..||||+++... ..+.+.+|+.++++++||||+++++++.+ .+
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 74 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 74 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC
Confidence 4566788999999999999999999984 7899999997542 33578899999999999999999998865 45
Q ss_pred eEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccc
Q 003232 663 NLYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 740 (837)
Q Consensus 663 ~lyLVmEy~~GGSL~dlLk~~--g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~ 740 (837)
.+|+||||+++|+|.+++... ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.++|+|||+++...
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 154 (262)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecC
Confidence 689999999999999998654 348999999999999999999999999999999999999999999999999987310
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHc-CCCC
Q 003232 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPP 819 (837)
Q Consensus 741 ~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLT-Gr~P 819 (837)
.......+|+.|+|||++.+..++.++|||||||++|||+| |++|
T Consensus 155 ----------------------------------~~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p 200 (262)
T d1byga_ 155 ----------------------------------STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 200 (262)
T ss_dssp -----------------------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ----------------------------------CCCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCC
Confidence 01123457889999999999999999999999999999998 7888
Q ss_pred CCCCCcC
Q 003232 820 FNAEHPQ 826 (837)
Q Consensus 820 F~~~dpd 826 (837)
|...+..
T Consensus 201 ~~~~~~~ 207 (262)
T d1byga_ 201 YPRIPLK 207 (262)
T ss_dssp CTTSCGG
T ss_pred CCCCCHH
Confidence 8775543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5e-39 Score=337.23 Aligned_cols=205 Identities=29% Similarity=0.490 Sum_probs=175.7
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcC-CCceEEEEeEeec--CCeE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTC--RENL 664 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~Lr-HPNIVkL~gsf~d--~~~l 664 (837)
.++|+++++||+|+||+||+|+++.+|+.||||+++... .+++.+|+.+|+.++ ||||++++++|.. ..++
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 467999999999999999999999999999999997643 246789999999995 9999999999874 4579
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCC-cEEEEecCCccccccCC
Q 003232 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG-HIKLTDFGLSKVGLINS 743 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG-~IKLiDFGLArvg~~~s 743 (837)
|+||||+.+++|..+. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .++|+|||+|+.....
T Consensus 108 ~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~- 183 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG- 183 (328)
T ss_dssp EEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT-
T ss_pred eEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC-
Confidence 9999999999997763 5699999999999999999999999999999999999998655 6999999998741100
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCC-CCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNA 822 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~-~~s~kSDIWSLGVILyELLTGr~PF~~ 822 (837)
......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||..
T Consensus 184 -------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~ 232 (328)
T d3bqca1 184 -------------------------------QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 232 (328)
T ss_dssp -------------------------------CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred -------------------------------CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCC
Confidence 112345789999999998875 479999999999999999999999998
Q ss_pred CCcCHHHHHHh
Q 003232 823 EHPQVSTLLRK 833 (837)
Q Consensus 823 ~dpdv~~lle~ 833 (837)
..+...+....
T Consensus 233 ~~~~~~~~~~i 243 (328)
T d3bqca1 233 GHDNYDQLVRI 243 (328)
T ss_dssp CSSHHHHHHHH
T ss_pred CchhHHHHHHH
Confidence 87766554443
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-39 Score=339.41 Aligned_cols=207 Identities=30% Similarity=0.449 Sum_probs=171.3
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC----e
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE----N 663 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~----~ 663 (837)
.++|+++++||+|+||+||+|+++.+|+.||||++.+.. .....+.+.+|+.+|+.++||||+++++++.... .
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence 356999999999999999999999999999999997643 3455678899999999999999999999986543 2
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCC
Q 003232 664 LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~s 743 (837)
.+++++|+.|++|.+++.. ..+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~ 163 (345)
T d1pmea_ 85 DVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 163 (345)
T ss_dssp CEEEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred eEEEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence 3444556679999999976 579999999999999999999999999999999999999999999999999997422111
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhc-CCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-GTGHGTTADWWSVGIILFELIVGIPPFNA 822 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLl-g~~~s~kSDIWSLGVILyELLTGr~PF~~ 822 (837)
.. .......+||+.|+|||++. +..++.++||||+||++|+|++|+.||.+
T Consensus 164 ~~----------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~ 215 (345)
T d1pmea_ 164 DH----------------------------TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 215 (345)
T ss_dssp CB----------------------------CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cc----------------------------ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCC
Confidence 10 01123467999999999984 45678999999999999999999999987
Q ss_pred CCc
Q 003232 823 EHP 825 (837)
Q Consensus 823 ~dp 825 (837)
.+.
T Consensus 216 ~~~ 218 (345)
T d1pmea_ 216 KHY 218 (345)
T ss_dssp SSH
T ss_pred CCH
Confidence 654
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-39 Score=334.66 Aligned_cols=211 Identities=26% Similarity=0.424 Sum_probs=174.7
Q ss_pred CCcccCCeEEEEEecccCceEEEEEEECCCC-------cEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEE
Q 003232 584 DRTSIDDFEIIKPISRGAFGRVFLAKKRTTG-------DLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFF 655 (837)
Q Consensus 584 ~g~~lddYeIlkkLGsG~FGtVYkArdk~tG-------~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~ 655 (837)
+....++|++.+.||+|+||.||+|++..++ ..||||+++... .......+.+|...+.++ +||||++++
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~ 85 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLL 85 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEecc
Confidence 4456688999999999999999999986554 379999997653 334456788899999887 899999999
Q ss_pred eEeecCCeEEEEEEecCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCc
Q 003232 656 YSFTCRENLYLVMEYLNGGDLYSLLRNL----------------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDN 719 (837)
Q Consensus 656 gsf~d~~~lyLVmEy~~GGSL~dlLk~~----------------g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeN 719 (837)
+++.+...+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++|||||||||+|
T Consensus 86 ~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~N 165 (299)
T d1fgka_ 86 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 165 (299)
T ss_dssp EEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred cccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccc
Confidence 9999999999999999999999999644 348999999999999999999999999999999999
Q ss_pred EEEccCCcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCc
Q 003232 720 LLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT 799 (837)
Q Consensus 720 ILLd~dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~ 799 (837)
||++.++.+||+|||+++....... ........||+.|+|||++.+..++.
T Consensus 166 iLl~~~~~~kl~dfg~~~~~~~~~~-----------------------------~~~~~~~~~~~~y~aPE~l~~~~y~~ 216 (299)
T d1fgka_ 166 VLVTEDNVMKIADFGLARDIHHIDY-----------------------------YKKTTNGRLPVKWMAPEALFDRIYTH 216 (299)
T ss_dssp EEECTTCCEEECSTTCCCCGGGCCT-----------------------------TCCCTTSCCGGGGSCHHHHHHCCCCH
T ss_pred eeecCCCCeEeccchhhcccccccc-----------------------------ccccccCCCChhhhhhhHhcCCCCCc
Confidence 9999999999999999874211110 01123567899999999999999999
Q ss_pred hHHHHHHHHHHHHHHc-CCCCCCCCCc
Q 003232 800 TADWWSVGIILFELIV-GIPPFNAEHP 825 (837)
Q Consensus 800 kSDIWSLGVILyELLT-Gr~PF~~~dp 825 (837)
++|||||||++|||++ |.+||...+.
T Consensus 217 k~DiwS~Gvvl~ell~~g~~p~~~~~~ 243 (299)
T d1fgka_ 217 QSDVWSFGVLLWEIFTLGGSPYPGVPV 243 (299)
T ss_dssp HHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred hhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence 9999999999999998 7889976554
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-39 Score=342.81 Aligned_cols=211 Identities=27% Similarity=0.386 Sum_probs=171.9
Q ss_pred CCCCCCCc----ccCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEE
Q 003232 579 IHPSKDRT----SIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRF 654 (837)
Q Consensus 579 ~~P~k~g~----~lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL 654 (837)
|+|...+. .+++|+++++||+|+||+||+|+++.+|+.||||++.... .......++.+|+.+++.++||||+++
T Consensus 3 ~~~~~~~~~~f~i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~~ 81 (355)
T d2b1pa1 3 FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISL 81 (355)
T ss_dssp EEEEEETTEEEEEETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTT-SSHHHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred CEEEEeCCcceeecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhh-cCHHHHHHHHHHHHHHHhcCCCCeeEE
Confidence 34554444 3478999999999999999999999999999999997654 345556789999999999999999999
Q ss_pred EeEeec------CCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcE
Q 003232 655 FYSFTC------RENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHI 728 (837)
Q Consensus 655 ~gsf~d------~~~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~I 728 (837)
+++|.. ..++|+||||+.++.+ +.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 82 ~~~f~~~~~~~~~~~~~iv~Ey~~~~l~-~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~ 158 (355)
T d2b1pa1 82 LNVFTPQKTLEEFQDVYLVMELMDANLC-QVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 158 (355)
T ss_dssp SEEECSCCSTTTCCEEEEEEECCSEEHH-HHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCE
T ss_pred EEEEecccccccCceeEEEEeccchHHH-Hhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccce
Confidence 999964 4689999999976544 444 3568999999999999999999999999999999999999999999
Q ss_pred EEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHH
Q 003232 729 KLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGI 808 (837)
Q Consensus 729 KLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGV 808 (837)
+++|||+++... ........+||+.|+|||++.+..+++++||||+||
T Consensus 159 kl~df~~~~~~~--------------------------------~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~ 206 (355)
T d2b1pa1 159 KILDFGLARTAG--------------------------------TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 206 (355)
T ss_dssp EECCCCC-----------------------------------------------CCTTCCHHHHTTCCCCTTHHHHHHHH
T ss_pred eeechhhhhccc--------------------------------cccccccccccccccChhhhcCCCCCCCcccccccc
Confidence 999999876310 011223557899999999999999999999999999
Q ss_pred HHHHHHcCCCCCCCCCc
Q 003232 809 ILFELIVGIPPFNAEHP 825 (837)
Q Consensus 809 ILyELLTGr~PF~~~dp 825 (837)
++|+|++|++||.+.+.
T Consensus 207 ~l~ell~g~~pF~~~~~ 223 (355)
T d2b1pa1 207 IMGEMVRHKILFPGRDY 223 (355)
T ss_dssp HHHHHHHSSCSSCCSSH
T ss_pred hHHHHhhCCCCCCCCCH
Confidence 99999999999987653
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-39 Score=336.04 Aligned_cols=206 Identities=27% Similarity=0.421 Sum_probs=171.8
Q ss_pred CcccCCeEEEEEecccCceEEEEEEECCCCcE--EEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEeEeecC
Q 003232 585 RTSIDDFEIIKPISRGAFGRVFLAKKRTTGDL--FAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCR 661 (837)
Q Consensus 585 g~~lddYeIlkkLGsG~FGtVYkArdk~tG~~--VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~gsf~d~ 661 (837)
....++|++.++||+|+||+||+|+++.+|.. ||||.++.. ......+.+.+|+++|+++ +||||+++++++...
T Consensus 6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~ 83 (309)
T d1fvra_ 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 83 (309)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcc--cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC
Confidence 34568899999999999999999999888875 566666533 2334456799999999998 799999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccC
Q 003232 662 ENLYLVMEYLNGGDLYSLLRNL----------------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD 725 (837)
Q Consensus 662 ~~lyLVmEy~~GGSL~dlLk~~----------------g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~d 725 (837)
+.+|+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~ 163 (309)
T d1fvra_ 84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 163 (309)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCC
Confidence 9999999999999999999643 568999999999999999999999999999999999999999
Q ss_pred CcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHH
Q 003232 726 GHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWS 805 (837)
Q Consensus 726 G~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWS 805 (837)
+.+||+|||+++..... .......||+.|+|||.+.+..++.++||||
T Consensus 164 ~~~kl~DfG~a~~~~~~--------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwS 211 (309)
T d1fvra_ 164 YVAKIADFGLSRGQEVY--------------------------------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWS 211 (309)
T ss_dssp GCEEECCTTCEESSCEE--------------------------------CCC----CCTTTCCHHHHHHCEECHHHHHHH
T ss_pred CceEEcccccccccccc--------------------------------ccccceecCCcccchHHhccCCCCccceeeh
Confidence 99999999998731110 0112346899999999999999999999999
Q ss_pred HHHHHHHHHcCC-CCCCCCC
Q 003232 806 VGIILFELIVGI-PPFNAEH 824 (837)
Q Consensus 806 LGVILyELLTGr-~PF~~~d 824 (837)
|||++|||++|. +||.+.+
T Consensus 212 fGvil~ell~~~~~p~~~~~ 231 (309)
T d1fvra_ 212 YGVLLWEIVSLGGTPYCGMT 231 (309)
T ss_dssp HHHHHHHHHTTSCCTTTTCC
T ss_pred hHHHHHHHHhcCCCCCCCCC
Confidence 999999999975 5676543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.3e-38 Score=326.86 Aligned_cols=209 Identities=21% Similarity=0.290 Sum_probs=176.0
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCC-CceEEEEeEeecCCeEEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN-PFVVRFFYSFTCRENLYL 666 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrH-PNIVkL~gsf~d~~~lyL 666 (837)
-++|++.+.||+|+||+||+|++..+|+.||||++..... ...+.+|+++++.++| +|++.+++++....+.|+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~ 78 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence 3579999999999999999999999999999999865331 1246678899999876 899999999999999999
Q ss_pred EEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEcc-----CCcEEEEecCCccccc
Q 003232 667 VMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH-----DGHIKLTDFGLSKVGL 740 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~-----dG~IKLiDFGLArvg~ 740 (837)
||||+ +++|.+++... ..++...+..++.|++.||.|||++|||||||||+|||++. ++.++|+|||+++...
T Consensus 79 vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 99999 78999998765 46999999999999999999999999999999999999964 5789999999998522
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCC
Q 003232 741 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 820 (837)
Q Consensus 741 ~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF 820 (837)
........ ........+||+.|||||++.+..++.++|||||||++|+|++|..||
T Consensus 158 ~~~~~~~~------------------------~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf 213 (293)
T d1csna_ 158 DPVTKQHI------------------------PYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW 213 (293)
T ss_dssp CTTTCCBC------------------------CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred cCccccce------------------------eecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcC
Confidence 11111000 011234568999999999999999999999999999999999999999
Q ss_pred CCCCcC
Q 003232 821 NAEHPQ 826 (837)
Q Consensus 821 ~~~dpd 826 (837)
.+....
T Consensus 214 ~~~~~~ 219 (293)
T d1csna_ 214 QGLKAA 219 (293)
T ss_dssp SSCCSC
T ss_pred CCccch
Confidence 865543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-38 Score=338.57 Aligned_cols=196 Identities=32% Similarity=0.482 Sum_probs=165.4
Q ss_pred CeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeec------CCe
Q 003232 590 DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC------REN 663 (837)
Q Consensus 590 dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d------~~~ 663 (837)
+|+.+++||+|+||+||+|+++.+|+.||||++..... ...+|+.+|+.++||||++++++|.. ..+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence 69999999999999999999999999999999976432 23479999999999999999999854 346
Q ss_pred EEEEEEecCCCCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCC-cEEEEecCCcccc
Q 003232 664 LYLVMEYLNGGDLYSLL---RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG-HIKLTDFGLSKVG 739 (837)
Q Consensus 664 lyLVmEy~~GGSL~dlL---k~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG-~IKLiDFGLArvg 739 (837)
+|+||||++++.+..+. .....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 89999999766433332 3446799999999999999999999999999999999999999775 8999999998731
Q ss_pred ccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcC-CCCCchHHHHHHHHHHHHHHcCCC
Q 003232 740 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIP 818 (837)
Q Consensus 740 ~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg-~~~s~kSDIWSLGVILyELLTGr~ 818 (837)
... ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.
T Consensus 174 ~~~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~ 221 (350)
T d1q5ka_ 174 VRG--------------------------------EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 221 (350)
T ss_dssp CTT--------------------------------SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSC
T ss_pred cCC--------------------------------cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCC
Confidence 100 11234579999999999875 568999999999999999999999
Q ss_pred CCCCCC
Q 003232 819 PFNAEH 824 (837)
Q Consensus 819 PF~~~d 824 (837)
||...+
T Consensus 222 pf~~~~ 227 (350)
T d1q5ka_ 222 IFPGDS 227 (350)
T ss_dssp SSCCSS
T ss_pred CCCCCC
Confidence 998765
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-39 Score=339.26 Aligned_cols=208 Identities=41% Similarity=0.833 Sum_probs=178.5
Q ss_pred ccCCeEEEEEecccCceEEEEEEEC---CCCcEEEEEEecccccc-cHHHHHHHHHHHHHHHhcCC-CceEEEEeEeecC
Q 003232 587 SIDDFEIIKPISRGAFGRVFLAKKR---TTGDLFAIKVLKKADMI-RKNAVESILAERDILISVRN-PFVVRFFYSFTCR 661 (837)
Q Consensus 587 ~lddYeIlkkLGsG~FGtVYkArdk---~tG~~VAVKIikk~~~~-~~e~ie~~~rEieILk~LrH-PNIVkL~gsf~d~ 661 (837)
.+++|++++.||+|+||+||+|++. .+|+.||||+++..... .....+.+.+|+.++++++| |||+++++++.+.
T Consensus 22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~ 101 (322)
T d1vzoa_ 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 101 (322)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence 4588999999999999999999984 46899999999764422 22334568899999999976 8999999999999
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCcccccc
Q 003232 662 ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 741 (837)
Q Consensus 662 ~~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~ 741 (837)
..+|+||||+.+|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.++|+|||+++....
T Consensus 102 ~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~ 181 (322)
T d1vzoa_ 102 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 181 (322)
T ss_dssp TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence 99999999999999999999988999999999999999999999999999999999999999999999999999873110
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCC--CCCchHHHHHHHHHHHHHHcCCCC
Q 003232 742 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT--GHGTTADWWSVGIILFELIVGIPP 819 (837)
Q Consensus 742 ~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~--~~s~kSDIWSLGVILyELLTGr~P 819 (837)
. .........|++.|+|||.+.+. .++.++|||||||++|+|++|+.|
T Consensus 182 ~------------------------------~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~P 231 (322)
T d1vzoa_ 182 D------------------------------ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231 (322)
T ss_dssp G------------------------------GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCT
T ss_pred c------------------------------ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCC
Confidence 0 01123355799999999999764 467899999999999999999999
Q ss_pred CCCCC
Q 003232 820 FNAEH 824 (837)
Q Consensus 820 F~~~d 824 (837)
|.+..
T Consensus 232 F~~~~ 236 (322)
T d1vzoa_ 232 FTVDG 236 (322)
T ss_dssp TSCTT
T ss_pred CCCCC
Confidence 97754
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-38 Score=331.59 Aligned_cols=213 Identities=27% Similarity=0.371 Sum_probs=179.9
Q ss_pred CCCcccCCeEEEEEecccCceEEEEEEEC-----CCCcEEEEEEecccccccHHHHHHHHHHHHHHHhc-CCCceEEEEe
Q 003232 583 KDRTSIDDFEIIKPISRGAFGRVFLAKKR-----TTGDLFAIKVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFY 656 (837)
Q Consensus 583 k~g~~lddYeIlkkLGsG~FGtVYkArdk-----~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~L-rHPNIVkL~g 656 (837)
+|....++|++.+.||.|+||.||+|++. .+++.||||+++... .......+.+|+.+++.+ +||||+++++
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g 94 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLG 94 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 45556688999999999999999999873 466789999997653 234456799999999998 6999999999
Q ss_pred EeecCCeEEEEEEecCCCCHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCC
Q 003232 657 SFTCRENLYLVMEYLNGGDLYSLLRNLG------------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPD 718 (837)
Q Consensus 657 sf~d~~~lyLVmEy~~GGSL~dlLk~~g------------------~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPe 718 (837)
++.....+|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++|+|||||||+
T Consensus 95 ~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~ 174 (311)
T d1t46a_ 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174 (311)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccc
Confidence 9999999999999999999999987543 5889999999999999999999999999999999
Q ss_pred cEEEccCCcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCC
Q 003232 719 NLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHG 798 (837)
Q Consensus 719 NILLd~dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s 798 (837)
|||++.++.++|+|||+++....... ........||+.|+|||++.+..++
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~~-----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~ 225 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDSN-----------------------------YVVKGNARLPVKWMAPESIFNCVYT 225 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTT-----------------------------SEECSSSEECGGGCCHHHHHHCCCC
T ss_pred cccccccCcccccccchheeccCCCc-----------------------------ceEeeecccChHHcCHHHhcCCCCC
Confidence 99999999999999999874211000 0112345789999999999999999
Q ss_pred chHHHHHHHHHHHHHHc-CCCCCCCCCcC
Q 003232 799 TTADWWSVGIILFELIV-GIPPFNAEHPQ 826 (837)
Q Consensus 799 ~kSDIWSLGVILyELLT-Gr~PF~~~dpd 826 (837)
.++|||||||++|||+| |.+||...+..
T Consensus 226 ~~~DIwS~G~~l~ellt~g~p~~~~~~~~ 254 (311)
T d1t46a_ 226 FESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (311)
T ss_dssp HHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred CcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999998 56666555443
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-38 Score=331.61 Aligned_cols=215 Identities=24% Similarity=0.362 Sum_probs=181.5
Q ss_pred CCCCCCCcccCCeEEEEEecccCceEEEEEEECC-----CCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEE
Q 003232 579 IHPSKDRTSIDDFEIIKPISRGAFGRVFLAKKRT-----TGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVR 653 (837)
Q Consensus 579 ~~P~k~g~~lddYeIlkkLGsG~FGtVYkArdk~-----tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVk 653 (837)
+.|..|....++|++.+.||+|+||+||+|.++. ++..||||+++... .......+.+|+.++++++||||++
T Consensus 10 ~~~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~ 87 (308)
T d1p4oa_ 10 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVR 87 (308)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCC
T ss_pred cCccceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEee
Confidence 3455666777899999999999999999999853 35789999997643 3344567899999999999999999
Q ss_pred EEeEeecCCeEEEEEEecCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEc
Q 003232 654 FFYSFTCRENLYLVMEYLNGGDLYSLLRNL----------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA 723 (837)
Q Consensus 654 L~gsf~d~~~lyLVmEy~~GGSL~dlLk~~----------g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd 723 (837)
+++++......++||||+.+|+|.+++... ..++...+..++.|++.||.|||+++|+||||||+|||++
T Consensus 88 ~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld 167 (308)
T d1p4oa_ 88 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA 167 (308)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEEC
T ss_pred eeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeec
Confidence 999999999999999999999999998532 2468889999999999999999999999999999999999
Q ss_pred cCCcEEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHH
Q 003232 724 HDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADW 803 (837)
Q Consensus 724 ~dG~IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDI 803 (837)
.++++||+|||+++...... .........||+.|+|||.+.+..++.++||
T Consensus 168 ~~~~~Kl~DFGla~~~~~~~-----------------------------~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv 218 (308)
T d1p4oa_ 168 EDFTVKIGDFGMTRDIYETD-----------------------------YYRKGGKGLLPVRWMSPESLKDGVFTTYSDV 218 (308)
T ss_dssp TTCCEEECCTTCCCGGGGGG-----------------------------CEEGGGSSEECGGGCCHHHHHHCCCCHHHHH
T ss_pred CCceEEEeecccceeccCCc-----------------------------ceeeccceecccccCCHHHHccCCCCccccc
Confidence 99999999999987411110 0112234568999999999999999999999
Q ss_pred HHHHHHHHHHHcCC-CCCCCCC
Q 003232 804 WSVGIILFELIVGI-PPFNAEH 824 (837)
Q Consensus 804 WSLGVILyELLTGr-~PF~~~d 824 (837)
||||+++|||+||. +||.+.+
T Consensus 219 ~S~G~il~El~t~~~~p~~~~~ 240 (308)
T d1p4oa_ 219 WSFGVVLWEIATLAEQPYQGLS 240 (308)
T ss_dssp HHHHHHHHHHHHTSCCTTTTSC
T ss_pred ccHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999985 7776543
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-38 Score=336.18 Aligned_cols=202 Identities=30% Similarity=0.448 Sum_probs=171.2
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecC-----C
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR-----E 662 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~-----~ 662 (837)
.++|++++.||+|+||+||+|+++.+|+.||||+++... ......+.+.+|+.+|+.++||||+++++++... .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh-cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 467999999999999999999999999999999998654 3344556789999999999999999999998643 3
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccC
Q 003232 663 NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 742 (837)
Q Consensus 663 ~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~ 742 (837)
..+++|+|+.||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.++++|||++...
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~--- 171 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--- 171 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CC---
T ss_pred ceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhccc---
Confidence 34666778889999999865 57999999999999999999999999999999999999999999999999998631
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCC-CCchHHHHHHHHHHHHHHcCCCCCC
Q 003232 743 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTADWWSVGIILFELIVGIPPFN 821 (837)
Q Consensus 743 stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~-~s~kSDIWSLGVILyELLTGr~PF~ 821 (837)
........||+.|+|||++.+.. ++.++|||||||++|+|++|++||.
T Consensus 172 -------------------------------~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~ 220 (348)
T d2gfsa1 172 -------------------------------DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 220 (348)
T ss_dssp -------------------------------TGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred -------------------------------CcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCC
Confidence 01123457889999999987754 5899999999999999999999998
Q ss_pred CCCc
Q 003232 822 AEHP 825 (837)
Q Consensus 822 ~~dp 825 (837)
+.+.
T Consensus 221 ~~~~ 224 (348)
T d2gfsa1 221 GTDH 224 (348)
T ss_dssp CSSH
T ss_pred CCCH
Confidence 7653
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.9e-38 Score=323.70 Aligned_cols=207 Identities=23% Similarity=0.358 Sum_probs=169.4
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCc-eEEEEeEeecCCeEEEE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPF-VVRFFYSFTCRENLYLV 667 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPN-IVkL~gsf~d~~~lyLV 667 (837)
++|++.+.||+|+||+||+|++..+|+.||||++...... ..+..|+++++.++|+| |+.+..++......++|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 5699999999999999999999999999999998764321 24678999999998765 55666777788899999
Q ss_pred EEecCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEcc---CCcEEEEecCCccccccCC
Q 003232 668 MEYLNGGDLYSLLR-NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGLINS 743 (837)
Q Consensus 668 mEy~~GGSL~dlLk-~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~---dG~IKLiDFGLArvg~~~s 743 (837)
|||+ +++|.+.+. ..+.+++..+..++.|++.||.|||++|||||||||+|||++. +..++|+|||+++......
T Consensus 82 me~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 82 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred EEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 9999 566666654 4567999999999999999999999999999999999999864 5579999999998522111
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 003232 744 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 823 (837)
Q Consensus 744 tddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~ 823 (837)
..... .........||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 161 ~~~~~------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~ 216 (299)
T d1ckia_ 161 THQHI------------------------PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 216 (299)
T ss_dssp TCCBC------------------------CCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred cccce------------------------eccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCccccc
Confidence 11000 011234568999999999999999999999999999999999999999765
Q ss_pred Cc
Q 003232 824 HP 825 (837)
Q Consensus 824 dp 825 (837)
..
T Consensus 217 ~~ 218 (299)
T d1ckia_ 217 KA 218 (299)
T ss_dssp C-
T ss_pred ch
Confidence 43
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-37 Score=322.11 Aligned_cols=203 Identities=25% Similarity=0.335 Sum_probs=168.7
Q ss_pred EEEEecccCceEEEEEEECCCC---cEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeec-CCeEEEEE
Q 003232 593 IIKPISRGAFGRVFLAKKRTTG---DLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC-RENLYLVM 668 (837)
Q Consensus 593 IlkkLGsG~FGtVYkArdk~tG---~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d-~~~lyLVm 668 (837)
.-++||+|+||+||+|++..++ ..||||.++.. ......+.+.+|+++|++++||||+++++++.. +...++||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 3578999999999999986643 36899998753 345566889999999999999999999998765 56899999
Q ss_pred EecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCCccccccCCCCCC
Q 003232 669 EYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 747 (837)
Q Consensus 669 Ey~~GGSL~dlLk~~-g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGLArvg~~~stddl 747 (837)
||+++++|.+++... ..++...+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.........
T Consensus 109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~- 187 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS- 187 (311)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC-
T ss_pred EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc-
Confidence 999999999998754 457788899999999999999999999999999999999999999999999997421111100
Q ss_pred CCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 748 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 748 ~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
........||+.|+|||++.+..++.++||||||+++|||+||..||....
T Consensus 188 --------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~ 238 (311)
T d1r0pa_ 188 --------------------------VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 238 (311)
T ss_dssp --------------------------TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--
T ss_pred --------------------------ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCC
Confidence 011234578999999999999999999999999999999999888876543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-37 Score=324.23 Aligned_cols=200 Identities=23% Similarity=0.332 Sum_probs=161.0
Q ss_pred CCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCceEEEEeEeecCC----eE
Q 003232 589 DDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE----NL 664 (837)
Q Consensus 589 ddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNIVkL~gsf~d~~----~l 664 (837)
.+|.+.+.||+|+||+||+|++ +|+.||||+++... ........|+..+..++||||+++++++.... .+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~ 76 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence 4689999999999999999996 58899999986532 11112223444556789999999999997653 68
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------CCcccccCCCCcEEEccCCcEEEEecCCc
Q 003232 665 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS--------LRVVHRDLKPDNLLIAHDGHIKLTDFGLS 736 (837)
Q Consensus 665 yLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHS--------kGIIHRDIKPeNILLd~dG~IKLiDFGLA 736 (837)
|+||||+++|+|.+++++. .+++.....++.|++.||.|+|+ +|||||||||+|||++.++.+||+|||++
T Consensus 77 ~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 9999999999999999874 68999999999999999999996 59999999999999999999999999998
Q ss_pred cccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhcCCC------CCchHHHHHHHHHH
Q 003232 737 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG------HGTTADWWSVGIIL 810 (837)
Q Consensus 737 rvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLlg~~------~s~kSDIWSLGVIL 810 (837)
+........ .........||+.|+|||++.+.. ++.++|||||||++
T Consensus 156 ~~~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl 208 (303)
T d1vjya_ 156 VRHDSATDT---------------------------IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVF 208 (303)
T ss_dssp EEEETTTTE---------------------------ECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHH
T ss_pred ccccCCCcc---------------------------eeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHH
Confidence 742211110 001123467999999999987643 56789999999999
Q ss_pred HHHHcCCCCCCC
Q 003232 811 FELIVGIPPFNA 822 (837)
Q Consensus 811 yELLTGr~PF~~ 822 (837)
|||+||..||..
T Consensus 209 ~el~tg~~~~~~ 220 (303)
T d1vjya_ 209 WEIARRCSIGGI 220 (303)
T ss_dssp HHHHHTBCBTTB
T ss_pred HHHhhCCCCCCc
Confidence 999999988754
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.5e-34 Score=299.57 Aligned_cols=208 Identities=25% Similarity=0.429 Sum_probs=167.4
Q ss_pred CCCCCCCcccC--CeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcC---------
Q 003232 579 IHPSKDRTSID--DFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR--------- 647 (837)
Q Consensus 579 ~~P~k~g~~ld--dYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~Lr--------- 647 (837)
|+|...|..+. +|+++++||+|+||+||+|+++.+|+.||||+++... ...+.+.+|+.+++.++
T Consensus 1 ~~p~~~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~ 76 (362)
T d1q8ya_ 1 YHPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDS 76 (362)
T ss_dssp CCCCCTTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHH
T ss_pred CCCCCCCCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhh
Confidence 57787888765 4999999999999999999999999999999998643 23356778888888775
Q ss_pred --CCceEEEEeEeec--CCeEEEEEEecCCCCH-HHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCc
Q 003232 648 --NPFVVRFFYSFTC--RENLYLVMEYLNGGDL-YSLL--RNLGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDN 719 (837)
Q Consensus 648 --HPNIVkL~gsf~d--~~~lyLVmEy~~GGSL-~dlL--k~~g~Lsee~irkIl~QIa~ALsYLHS-kGIIHRDIKPeN 719 (837)
|+||+++++++.. ....+++|+++..+.. .... .....+++..++.++.||+.||.|||+ .||+||||||+|
T Consensus 77 ~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~N 156 (362)
T d1q8ya_ 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPEN 156 (362)
T ss_dssp HHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGG
T ss_pred cCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhH
Confidence 5789999888764 3566777777655433 2222 233568999999999999999999998 899999999999
Q ss_pred EEEccCCc------EEEEecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhHHhhhhccCCCCCCCccChhhhc
Q 003232 720 LLIAHDGH------IKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL 793 (837)
Q Consensus 720 ILLd~dG~------IKLiDFGLArvg~~~stddl~~p~~SgttLl~~~~~~~~~~~~~~~~~k~~s~vGTp~YmAPEVLl 793 (837)
||++.++. ++++|||.+.... ......+||+.|+|||++.
T Consensus 157 Ill~~~~~~~~~~~~kl~dfg~s~~~~----------------------------------~~~~~~~gt~~y~aPE~~~ 202 (362)
T d1q8ya_ 157 VLMEIVDSPENLIQIKIADLGNACWYD----------------------------------EHYTNSIQTREYRSPEVLL 202 (362)
T ss_dssp EEEEEEETTTTEEEEEECCCTTCEETT----------------------------------BCCCSCCSCGGGCCHHHHH
T ss_pred eeeeccCcccccceeeEeecccccccc----------------------------------cccccccccccccChhhcc
Confidence 99986653 8999999986311 1123457999999999999
Q ss_pred CCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 003232 794 GTGHGTTADWWSVGIILFELIVGIPPFNAEH 824 (837)
Q Consensus 794 g~~~s~kSDIWSLGVILyELLTGr~PF~~~d 824 (837)
+..++.++|||||||++++|++|+.||....
T Consensus 203 ~~~~~~~~DiwSlG~il~el~~g~~pF~~~~ 233 (362)
T d1q8ya_ 203 GAPWGCGADIWSTACLIFELITGDFLFEPDE 233 (362)
T ss_dssp TCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred ccCCCccccccchHHHHHHHHHCCCCCCCCc
Confidence 9999999999999999999999999998654
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=1.1e-22 Score=197.55 Aligned_cols=134 Identities=19% Similarity=0.178 Sum_probs=106.6
Q ss_pred eEEEEEecccCceEEEEEEECCCCcEEEEEEeccccc---------------ccHHHHHHHHHHHHHHHhcCCCceEEEE
Q 003232 591 FEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADM---------------IRKNAVESILAERDILISVRNPFVVRFF 655 (837)
Q Consensus 591 YeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~---------------~~~e~ie~~~rEieILk~LrHPNIVkL~ 655 (837)
+.+.++||+|+||+||+|++ .+|+.||||+++.... ...........|...+.++.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 45789999999999999998 4789999999764211 0112234556788999999999999887
Q ss_pred eEeecCCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEEccCCcEEEEecCC
Q 003232 656 YSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGL 735 (837)
Q Consensus 656 gsf~d~~~lyLVmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSkGIIHRDIKPeNILLd~dG~IKLiDFGL 735 (837)
+... .+++|||+++..+.+ ++...+..++.||+.+|.|||++||+||||||+|||++.+ .++|+|||+
T Consensus 81 ~~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~ 148 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ 148 (191)
T ss_dssp EEET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred EecC----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCC
Confidence 6532 379999998765432 4556677899999999999999999999999999999865 589999999
Q ss_pred cc
Q 003232 736 SK 737 (837)
Q Consensus 736 Ar 737 (837)
|+
T Consensus 149 a~ 150 (191)
T d1zara2 149 SV 150 (191)
T ss_dssp CE
T ss_pred cc
Confidence 86
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.22 E-value=2e-06 Score=84.22 Aligned_cols=141 Identities=14% Similarity=0.123 Sum_probs=93.1
Q ss_pred cCCeEEEEEecccCceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcC-CCceEEEEeEeecCCeEEE
Q 003232 588 IDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCRENLYL 666 (837)
Q Consensus 588 lddYeIlkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~Lr-HPNIVkL~gsf~d~~~lyL 666 (837)
+..|+..+..+-++.+.||++. .++..+++|+........ ...+.+|...+..+. +--+.+++......+..++
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l 87 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred hhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence 4567777765555567899886 456778899886543211 224567777777664 3335666777777888999
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------
Q 003232 667 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL-------------------------------------- 708 (837)
Q Consensus 667 VmEy~~GGSL~dlLk~~g~Lsee~irkIl~QIa~ALsYLHSk-------------------------------------- 708 (837)
||++++|.++.+..... .....++.+++..|..||+.
T Consensus 88 v~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T d1j7la_ 88 LMSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp EEECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTC
T ss_pred EEEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccc
Confidence 99999998876543211 11222334444444444421
Q ss_pred ---------------------CcccccCCCCcEEEccCCcEEEEecCCccc
Q 003232 709 ---------------------RVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (837)
Q Consensus 709 ---------------------GIIHRDIKPeNILLd~dG~IKLiDFGLArv 738 (837)
.++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 268999999999998766667999998874
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.88 E-value=1.9e-05 Score=76.65 Aligned_cols=147 Identities=15% Similarity=0.097 Sum_probs=86.9
Q ss_pred CCcccCCeEEEEEecccC-ceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCC--CceEEEEeEeec
Q 003232 584 DRTSIDDFEIIKPISRGA-FGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRN--PFVVRFFYSFTC 660 (837)
Q Consensus 584 ~g~~lddYeIlkkLGsG~-FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrH--PNIVkL~gsf~d 660 (837)
+...+..+++. .+..|. .+.||++.. ..+..+++|....... ..+..|...++.+.. -.+.+++....+
T Consensus 6 ~~~~l~g~~~~-~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~ 77 (255)
T d1nd4a_ 6 WVERLFGYDWA-QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTE 77 (255)
T ss_dssp GTTTTTTCEEE-ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEEC
T ss_pred HHHhccCCceE-EcCCcccCCeEEEEEe-CCCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeeccc
Confidence 34444455553 445555 468999886 4566789998765431 235667777766643 335667777777
Q ss_pred CCeEEEEEEecCCCCHHH--------------HHHhcCC-------C--CHHHHHH-----H---------------HHH
Q 003232 661 RENLYLVMEYLNGGDLYS--------------LLRNLGC-------L--DEDVARV-----Y---------------IAE 697 (837)
Q Consensus 661 ~~~lyLVmEy~~GGSL~d--------------lLk~~g~-------L--see~irk-----I---------------l~Q 697 (837)
.+..++||++++|.++.+ .+..-.. + ....... + ...
T Consensus 78 ~~~~~~v~~~i~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
T d1nd4a_ 78 AGRDWLLLGEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 157 (255)
T ss_dssp SSCEEEEEECCSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred ccceEEEEEeeeccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhH
Confidence 888999999998765421 1111000 0 0000000 0 000
Q ss_pred HHHHHHHHHhC-------CcccccCCCCcEEEccCCcEEEEecCCccc
Q 003232 698 VVLALEYLHSL-------RVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (837)
Q Consensus 698 Ia~ALsYLHSk-------GIIHRDIKPeNILLd~dG~IKLiDFGLArv 738 (837)
....+..+... .++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 158 ~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 158 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 11223333321 379999999999998776678999998764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.76 E-value=1.9e-05 Score=83.82 Aligned_cols=80 Identities=24% Similarity=0.222 Sum_probs=49.4
Q ss_pred EEEecccCceEEEEEEECCCCcEEEEEEecccccc----cHHHHHHHHHHHHHHHhcC-C--CceEEEEeEeecCCeEEE
Q 003232 594 IKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMI----RKNAVESILAERDILISVR-N--PFVVRFFYSFTCRENLYL 666 (837)
Q Consensus 594 lkkLGsG~FGtVYkArdk~tG~~VAVKIikk~~~~----~~e~ie~~~rEieILk~Lr-H--PNIVkL~gsf~d~~~lyL 666 (837)
.+.||.|....||++.+..+++.++||...+-... -.....+...|.+.|+.+. + ..+++++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 45789999999999998777889999975431100 0112234556787777653 2 345666543 3445678
Q ss_pred EEEecCCCC
Q 003232 667 VMEYLNGGD 675 (837)
Q Consensus 667 VmEy~~GGS 675 (837)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.77 E-value=0.0011 Score=67.74 Aligned_cols=130 Identities=14% Similarity=0.218 Sum_probs=73.4
Q ss_pred ceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHHHhcCCCce--EEEE-----eEeecCCeEEEEEEecCCC
Q 003232 602 FGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILISVRNPFV--VRFF-----YSFTCRENLYLVMEYLNGG 674 (837)
Q Consensus 602 FGtVYkArdk~tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~LrHPNI--VkL~-----gsf~d~~~lyLVmEy~~GG 674 (837)
.-.||+++. .+|..|++|++++... ...++..|...+..|....| +... ..+......+.+++++.|.
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~~----s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCCC----CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 368999986 6788999999986531 12346677777776642221 1111 1122355688999998763
Q ss_pred CH-----HHH------H---Hh----c-----CCCC-------------------HHHHHHHHHHHHHHHHHHH------
Q 003232 675 DL-----YSL------L---RN----L-----GCLD-------------------EDVARVYIAEVVLALEYLH------ 706 (837)
Q Consensus 675 SL-----~dl------L---k~----~-----g~Ls-------------------ee~irkIl~QIa~ALsYLH------ 706 (837)
.+ ..+ + +. . ..++ ......+...+...+..+.
T Consensus 110 ~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~ 189 (325)
T d1zyla1 110 QFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRED 189 (325)
T ss_dssp ECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSC
T ss_pred CCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhcccc
Confidence 21 111 1 10 0 0111 1111112222223333333
Q ss_pred -hCCcccccCCCCcEEEccCCcEEEEecCCccc
Q 003232 707 -SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (837)
Q Consensus 707 -SkGIIHRDIKPeNILLd~dG~IKLiDFGLArv 738 (837)
..++||+|+.|.|||++. + ..++||+-+..
T Consensus 190 ~p~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~ 220 (325)
T d1zyla1 190 FTVLRLHGDCHAGNILWRD-G-PMFVDLDDARN 220 (325)
T ss_dssp SCCEECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred CCceeecCCCCcccEEEeC-C-ceEEechhccc
Confidence 146899999999999964 3 45899998875
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.64 E-value=0.0082 Score=59.93 Aligned_cols=31 Identities=32% Similarity=0.366 Sum_probs=27.4
Q ss_pred CCcccccCCCCcEEEccCCcEEEEecCCccc
Q 003232 708 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 738 (837)
Q Consensus 708 kGIIHRDIKPeNILLd~dG~IKLiDFGLArv 738 (837)
.|+||+|+.++||+++.+...-|+||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 4799999999999999887778999998763
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.63 E-value=0.014 Score=60.84 Aligned_cols=75 Identities=16% Similarity=0.250 Sum_probs=49.6
Q ss_pred eEEEEEecccCceEEEEEEECC-------CCcEEEEEEecccccccHHHHHHHHHHHHHHHhcC-CCceEEEEeEeecCC
Q 003232 591 FEIIKPISRGAFGRVFLAKKRT-------TGDLFAIKVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCRE 662 (837)
Q Consensus 591 YeIlkkLGsG~FGtVYkArdk~-------tG~~VAVKIikk~~~~~~e~ie~~~rEieILk~Lr-HPNIVkL~gsf~d~~ 662 (837)
+++ +.|+-|-.-.+|++.... .++.|.++++.... .. ....+|..+++.+. +.-.+++++.+..
T Consensus 45 l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~----~~-idr~~E~~i~~~ls~~gl~Pkll~~~~~-- 116 (395)
T d1nw1a_ 45 LRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE----TE-SHLVAESVIFTLLSERHLGPKLYGIFSG-- 116 (395)
T ss_dssp EEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC----CH-HHHHHHHHHHHHHHHTTSSSCEEEEETT--
T ss_pred eEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc----hh-hHHHHHHHHHHHHHhCCCCCeEEEEcCC--
Confidence 444 678888889999998753 34678888876322 11 23457888888774 3334567776643
Q ss_pred eEEEEEEecCCCC
Q 003232 663 NLYLVMEYLNGGD 675 (837)
Q Consensus 663 ~lyLVmEy~~GGS 675 (837)
.+||||++|.+
T Consensus 117 --g~I~efi~g~~ 127 (395)
T d1nw1a_ 117 --GRLEEYIPSRP 127 (395)
T ss_dssp --EEEECCCCEEE
T ss_pred --ceEEEEecccc
Confidence 67899998744
|